PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Demeter, F; Shackelford, L; Westaway, K; Duringer, P; Bacon, AM; Ponche, JL; Wu, XJ; Sayavongkhamdy, T; Zhao, JX; Barnes, L; Boyon, M; Sichanthongtip, P; Senegas, F; Karpoff, AM; Patole-Edoumba, E; Coppens, Y; Braga, J				Demeter, Fabrice; Shackelford, Laura; Westaway, Kira; Duringer, Philippe; Bacon, Anne-Marie; Ponche, Jean-Luc; Wu, Xiujie; Sayavongkhamdy, Thongsa; Zhao, Jian-Xin; Barnes, Lani; Boyon, Marc; Sichanthongtip, Phonephanh; Senegas, Frank; Karpoff, Anne-Marie; Patole-Edoumba, Elise; Coppens, Yves; Braga, Jose			Early Modern Humans and Morphological Variation in Southeast Asia: Fossil Evidence from Tam Pa Ling, Laos	PLOS ONE			English	Article							HUMAN REMAINS; HOMINID SITE; HOMO; MIDDLE; MANDIBLES; GUANGXI; SUPPORT; CAVE	Little is known about the timing of modern human emergence and occupation in Eastern Eurasia. However a rapid migration out of Africa into Southeast Asia by at least 60 ka is supported by archaeological, paleogenetic and paleoanthropological data. Recent discoveries in Laos, a modern human cranium (TPL1) from Tam Pa Ling's cave, provided the first evidence for the presence of early modern humans in mainland Southeast Asia by 63-46 ka. In the current study, a complete human mandible representing a second individual, TPL 2, is described using discrete traits and geometric morphometrics with an emphasis on determining its population affinity. The TPL2 mandible has a chin and other discrete traits consistent with early modern humans, but it retains a robust lateral corpus and internal corporal morphology typical of archaic humans across the Old World. The mosaic morphology of TPL2 and the fully modern human morphology of TPL1 suggest that a large range of morphological variation was present in early modern human populations residing in the eastern Eurasia by MIS 3.	[Demeter, Fabrice] Musee Homme Paris, Dept Homme Nat Soc, Unite Mixte Rech 7206, Unite Sci Museum 104,Museum Natl Hist Nat, Paris, France; [Demeter, Fabrice] Univ Paris 06, Chaire Sorbonne Univ FaciLe, Inst Calcul & Simulat, Paris, France; [Shackelford, Laura] Univ Illinois, Dept Anthropol, Urbana, IL USA; [Westaway, Kira; Barnes, Lani] Macquarie Univ, Dept Geog & Environm, Sydney, NSW 2109, Australia; [Duringer, Philippe; Boyon, Marc; Karpoff, Anne-Marie] Univ Strasbourg, Ecole Observ Sci Terre, CNRS, Unite Mixte Rech 7516,Inst Phys Globe Strasbourg, Strasbourg, France; [Bacon, Anne-Marie; Senegas, Frank] CNRS, Unite Propre Rech 2147, Paris, France; [Wu, Xiujie] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Sayavongkhamdy, Thongsa; Sichanthongtip, Phonephanh] Minist Informat & Culture, Dept Natl Heritage, Viangchan, Laos; [Zhao, Jian-Xin] Univ Queensland, Sch Earth Sci, Brisbane, Qld, Australia; [Ponche, Jean-Luc] Univ Strasbourg, Inst Chim & Proc Energie Environm & Sante, CNRS, Unite Mixte Rech 7515, Strasbourg, France; [Ponche, Jean-Luc] Ecole & Observ Sci Terre, Unite Mixte Rech 7516 & 7362, Strasbourg, France; [Patole-Edoumba, Elise] Museum Hist Nat Rochelle, La Rochelle, France; [Coppens, Yves] Coll France, F-75231 Paris, France; [Braga, Jose] Univ Toulouse 3, Unite Mixte Rech Anthropobiol & Imagerie Anat 528, CNRS, F-31062 Toulouse, France; [Braga, Jose] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Braga, Jose] Univ Witwatersrand, Kromdraai Res Project, Johannesburg, South Africa	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Illinois System; University of Illinois Urbana-Champaign; Macquarie University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Queensland; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Witwatersrand; University of Witwatersrand	Demeter, F (corresponding author), Musee Homme Paris, Dept Homme Nat Soc, Unite Mixte Rech 7206, Unite Sci Museum 104,Museum Natl Hist Nat, Paris, France.	demeter@mnhn.fr; llshacke@illinois.edu	Zhao, Jian-xin/A-5938-2008	Zhao, Jian-xin/0000-0002-2413-6178; Westaway, Kira/0000-0001-5315-778X	Australian Research Council (ARC) Discovery Grant [DP1093049]; LIEF [LE100100094]; French Ministry of Foreign Affair; Ministry of Culture and Information of LAO PDR; University of Illinois at Urbana-Champaign, USA; CNRS [UPR2147]; MNHN, Paris [UMR7206]; CNRS/IPGS Strasbourg [UMR7516]	Australian Research Council (ARC) Discovery Grant(Australian Research Council); LIEF; French Ministry of Foreign Affair; Ministry of Culture and Information of LAO PDR; University of Illinois at Urbana-Champaign, USA; CNRS(Centre National de la Recherche Scientifique (CNRS)); MNHN, Paris; CNRS/IPGS Strasbourg	The chronological aspects of this research were funded by Australian Research Council (ARC) Discovery Grant DP1093049 and LIEF Grant LE100100094. This work is supported by the French Ministry of Foreign Affair, the Ministry of Culture and Information of LAO PDR and the University of Illinois at Urbana-Champaign, USA, the UPR2147 (CNRS), the UMR7206 (MNHN, Paris), the UMR7516 (CNRS/IPGS Strasbourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brauer G, 2008, EVOL ANTHROPOL, V17, P22, DOI 10.1002/evan.20157; Brauer G, 1988, ANTHROPOLOGIE, P160; Brown P, 2009, J HUM EVOL, V57, P571, DOI 10.1016/j.jhevol.2009.06.002; Chang CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7037; DAY MH, 1969, NATURE, V222, P1135, DOI 10.1038/2221135a0; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Dobson SD, 2002, J HUM EVOL, V43, P67, DOI 10.1006/jhev.2002.0563; Fromaget J., 1936, CR Acad Sci Paris, V203, P738; Fromaget J, 1940, RECENTES DECOUVERTES, P51; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; [高斌 GAO Bin], 2007, [暨南大学学报. 自然科学与医学版, Journal of Jinan University], V28, P308; Jia L, 1959, PALEOVERTEBRATA PALE, V1, P16; Jidoi K, 2000, ANTHROPOL SCI, V108, P345, DOI 10.1537/ase.108.345; Kennedy KAR, 1999, EVOL ANTHROPOL, V8, P165, DOI 10.1002/(SICI)1520-6505(1999)8:5<165::AID-EVAN5>3.0.CO;2-0; KENNEDY KAR, 1987, AM J PHYS ANTHROPOL, V72, P441, DOI 10.1002/ajpa.1330720405; Lague MR, 2008, J ANAT, V213, P670, DOI 10.1111/j.1469-7580.2008.00989.x; Lebel S, 2002, J HUM EVOL, V43, P659, DOI 10.1006/jhev.2002.0598; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Lumley M. A, 1982, HOMO ERECTUS PLACE H, P814; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Pierret A, 2012, P NATL ACAD SCI USA, V109, pE3523, DOI 10.1073/pnas.1216774109; Quam RM, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P405; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; Rightmire P, 1990, EVOLUTION HOMO ERECT; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; ROSAS A, 1995, J HUM EVOL, V28, P533, DOI 10.1006/jhev.1995.1041; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Shang H, 2010, EARLY MODERN HUMAN T; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Shen GJ, 2002, J HUM EVOL, V43, P817, DOI 10.1006/jhev.2002.0601; Shen GJ, 2007, J ARCHAEOL SCI, V34, P2109, DOI 10.1016/j.jas.2007.02.008; Stefan VH, 1998, J HUM EVOL, V34, P443, DOI 10.1006/jhev.1997.0210; Trinkaus E, 2014, LIFE DEATH PESTERA C; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Viterbo KMA, 2012, AM J PHYS ANTHROPOL, V147, P294; Walker MJ, 2010, AM J PHYS ANTHROPOL, V142, P261, DOI 10.1002/ajpa.21223; Weidenreich F., 1936, Palaeontologia Sinica, VD7, P1; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Woo J, 1959, SCI REC, V3, P165; WOO J. K., 1959, VERTEBR PALASIAT [CHINA], V3, P109; WOO JU-KANG, 1958, VERTEBR PALASIAT [CHINA], V2, P208; Woo RK, 1959, VERTEBRAT PALASIATIC, V3, P176; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2014, CR PALEVOL, V13, P333, DOI 10.1016/j.crpv.2013.10.002; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Yuan S.X., 1986, ACTA ANTHROPOL SIN, V5, P179	52	38	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121193	10.1371/journal.pone.0121193	http://dx.doi.org/10.1371/journal.pone.0121193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849125	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800048
J	Girihagama, L; Nof, D; Hancock, C				Girihagama, Lakshika; Nof, Doron; Hancock, Cathrine			Bubble-Induced Cave Collapse	PLOS ONE			English	Article							VELOCITY; LIMESTONE; STRENGTH	Conventional wisdom among cave divers is that submerged caves in aquifers, such as in Florida or the Yucatan, are unstable due to their ever-growing size from limestone dissolution in water. Cave divers occasionally noted partial cave collapses occurring while they were in the cave, attributing this to their unintentional (and frowned upon) physical contact with the cave walls or the aforementioned "natural" instability of the cave. Here, we suggest that these cave collapses do not necessarily result from cave instability or contacts with walls, but rather from divers bubbles rising to the ceiling and reducing the buoyancy acting on isolated ceiling rocks. Using familiar theories for the strength of flat and arched (un-cracked) beams, we first show that the flat ceiling of a submerged limestone cave can have a horizontal expanse of 63 meters. This is much broader than that of most submerged Florida caves (similar to 10 m). Similarly, we show that an arched cave roof can have a still larger expanse of 240 meters, again implying that Florida caves are structurally stable. Using familiar bubble dynamics, fluid dynamics of bubble-induced flows, and accustomed diving practices, we show that a group of 1-3 divers submerged below a loosely connected ceiling rock will quickly trigger it to fall causing a "collapse". We then present a set of qualitative laboratory experiments illustrating such a collapse in a circular laboratory cave (i.e., a cave with a circular cross section), with concave and convex ceilings. In these experiments, a metal ball represented the rock (attached to the cave ceiling with a magnet), and the bubbles were produced using a syringe located at the cave floor.	[Girihagama, Lakshika; Nof, Doron; Hancock, Cathrine] Florida State Univ, Inst Geophys Fluid Dynam, Tallahassee, FL 32306 USA; [Nof, Doron] Florida State Univ, Dept Earth Ocean & Atmospher Sci Dept, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Girihagama, L (corresponding author), Florida State Univ, Inst Geophys Fluid Dynam, Tallahassee, FL 32306 USA.	lng09@my.fsu.edu			AGS Grant [1032403]; LANL/IGPP Grant [1815]; NSF [OCE-0752225, OCE-9911342, OCE-0545204, OCE-0241036]; BSF [2006296]; NASA [NNX07AL97G]	AGS Grant; LANL/IGPP Grant; NSF(National Science Foundation (NSF)); BSF(US-Israel Binational Science Foundation); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by an AGS Grant (1032403), LANL/IGPP Grant (1815), NSF (OCE-0752225, OCE-9911342, OCE-0545204, and OCE-0241036), BSF (2006296), and NASA (NNX07AL97G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1953, EXPT INVESTIGATION D; Bagde MN, 2005, INT J ROCK MECH MIN, V42, P237, DOI 10.1016/j.ijrmms.2004.08.008; BATCHELOR GK, 1987, J FLUID MECH, V184, P399, DOI 10.1017/S0022112087002945; Batchelor GK, 1967, INTRO FLUID DYNAMICS, P475; Baykasoglu A, 2008, EXPERT SYST APPL, V35, P111, DOI 10.1016/j.eswa.2007.06.006; Bozzano G, 2001, COMPUT CHEM ENG, V25, P571, DOI 10.1016/S0098-1354(01)00636-6; Geschwindner LF, 1999, STRUCTURAL STEEL DES, P41; Hibbeler RC, 1997, STRUCTURAL ANAL; Iannacchione AT, 1998, 17TH INTERNATIONAL CONFERENCE ON GROUND CONTROL IN MINING, PROCEEDINGS, P102; Joseph DD, 2003, J FLUID MECH, V488, P213, DOI 10.1017/S0022112003004968; Kenyon KE, 2011, PHYS ESSAYS, V24; Nof D, 2012, J FORENSIC SCI, V57, P932, DOI 10.1111/j.1556-4029.2011.02038.x; Nof D, 2010, SAFETY SCI, V48, P607, DOI 10.1016/j.ssci.2010.01.010; Tahir M, 2011, J HIMAL EARTH SCI, V44, P45; Zheng L, 2000, J HYDRAUL ENG-ASCE, V126, P852, DOI 10.1061/(ASCE)0733-9429(2000)126:11(852)	15	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122349	10.1371/journal.pone.0122349	http://dx.doi.org/10.1371/journal.pone.0122349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849088	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800120
J	Kim, HJ; Kim, MK; Lee, MJ; Won, HJ; Choi, SS; Kim, ES				Kim, Hye-Jin; Kim, Min-Kyung; Lee, Mi-Jin; Won, Hyung-Jin; Choi, Si-Sun; Kim, Eung-Soo			Post-PKS Tailoring Steps of a Disaccharide-Containing Polyene NPP in Pseudonocardia autotrophica	PLOS ONE			English	Article							POLYKETIDE SYNTHASE; CONJUGAL TRANSFER; ESCHERICHIA-COLI; AMPHOTERICIN-B; BIOSYNTHESIS; DERIVATIVES; NYSTATIN; CLONING; GLYCOSYLTRANSFERASES; MACROLIDES	A novel polyene compound NPP identified in a rare actinomycetes, Pseudonocardia autotrophica KCTC9441, was shown to contain an aglycone identical to nystatin but to harbor a unique di-sugar moiety, mycosaminyl-(alpha 1-4)-N-acetyl-glucosamine, which led to higher solubility and reduced hemolytic activity. Although the nppDI was proved to be responsible for the transfer of first polyene sugar, mycosamine in NPP biosynthesis, the gene responsible for the second sugar extending glycosyltransferase (GT) as well as NPP post-PKS tailoring mechanism remained unknown. Here, we identified a NPP-specific second sugar extending GT gene named nppY, located at the edge of the NPP biosynthetic gene cluster. Targeted nppY gene deletion and its complementation proved that nppY is indeed responsible for the transfer of second sugar, N-acetyl-glucosamine in NPP biosynthesis. Site-directed mutagenesis on nppY also revealed several amino acid residues critical for NppY GT function. Moreover, a combination of deletions and complementations of two GT genes (nppDI and nppY) and one P450 hydroxylase gene (nppL) involved in the NPP post-PKS biosynthesis revealed that NPP aglycone is sequentially modified by the two different GTs encoded by nppDI and nppY, respectively, followed by the nppL-driven regio-specific hydroxylation at the NPP C10 position. These results set the stage for the biotechnological application of sugar diversification for the biosynthesis of novel polyene compounds in actinomycetes.	[Kim, Hye-Jin; Kim, Min-Kyung; Lee, Mi-Jin; Won, Hyung-Jin; Choi, Si-Sun; Kim, Eung-Soo] Inha Univ, Dept Biol Engn, Inchon, South Korea	Inha University	Kim, ES (corresponding author), Inha Univ, Dept Biol Engn, Inchon, South Korea.	eungsoo@inha.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011296]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ011296), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Baginski M, 2006, CHEM REC, V6, P320, DOI 10.1002/tcr.20096; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Brautaset T, 2011, APPL ENVIRON MICROB, V77, P6636, DOI 10.1128/AEM.05780-11; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Bruheim P, 2004, ANTIMICROB AGENTS CH, V48, P4120, DOI 10.1128/AAC.48.11.4120-4129.2004; Butts A, 2012, PLOS PATHOG, P8; Byrne B, 2003, CHEM BIOL, V10, P1215, DOI 10.1016/j.chembiol.2003.12.001; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; Carmody M, 2005, J BIOL CHEM, V280, P34420, DOI 10.1074/jbc.M506689200; Choi SU, 2004, ARCH MICROBIOL, V181, P294, DOI 10.1007/s00203-004-0654-8; De Poire E, 2013, APPL ENVIRON MICROB, V79, P6156, DOI 10.1128/AEM.02197-13; Ellepola ANB, 2000, CRIT REV ORAL BIOL M, V11, P172, DOI 10.1177/10454411000110020301; Hansen SF, 2010, MOL BIOSYST, V6, P1773, DOI 10.1039/c000238k; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Kim BG, 2009, J IND MICROBIOL BIOT, V36, P1425, DOI 10.1007/s10295-009-0629-5; Kim HJ, 2014, J MICROBIOL BIOTECHN, V25, P143; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee MJ, 2012, APPL MICROBIOL BIOT, V95, P157, DOI 10.1007/s00253-012-3955-x; Luzhetskyy A, 2008, CURR TOP MED CHEM, V8, P680, DOI 10.2174/156802608784221514; Luzhetskyy A, 2007, APPL MICROBIOL BIOT, V75, P1367, DOI 10.1007/s00253-007-0950-8; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Mulichak AM, 2014, BIOCHEMISTRY-US, V43, P5170; Murphy B, 2010, ORG BIOMOL CHEM, V8, P3758, DOI 10.1039/b922074g; Nosanchuk Joshua D, 2006, Recent Pat Antiinfect Drug Discov, V1, P75, DOI 10.2174/157489106775244109; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Power P, 2008, CHEM BIOL, V15, P78, DOI 10.1016/j.chembiol.2007.11.008; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Sekurova O, 1999, FEMS MICROBIOL LETT, V177, P297, DOI 10.1111/j.1574-6968.1999.tb13746.x; Stephens N, 2013, BIOSCI BIOTECH BIOCH, V77, P880, DOI 10.1271/bbb.120961; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Volokhan O, 2006, APPL ENVIRON MICROB, V72, P2514, DOI 10.1128/AEM.72.4.2514-2519.2006; Wakiec R, 2007, MYCOSES, V50, P109, DOI [10.1111/j.1439-0507.2006.01327.x, 10.1111/j.0933-7407.2006.01327.x]; WeymouthWilson AC, 1997, NAT PROD REP, V14, P99, DOI 10.1039/np9971400099; Williams David, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5771; Zotchev SB, 2003, CURR MED CHEM, V10, P211, DOI 10.2174/0929867033368448	38	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123270	10.1371/journal.pone.0123270	http://dx.doi.org/10.1371/journal.pone.0123270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849545	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800220
J	Knight, GM; Dodd, PJ; Grant, AD; Fielding, KL; Churchyard, GJ; White, RG				Knight, Gwenan M.; Dodd, Peter J.; Grant, Alison D.; Fielding, Katherine L.; Churchyard, Gavin J.; White, Richard G.			Tuberculosis Prevention in South Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RANDOMIZED TRIAL; TRANSMISSION; INFECTION; DIAGNOSIS; RISK	Background South Africa has one of the highest per capita rates of tuberculosis (TB) incidence in the world. In 2012, the South African government produced a National Strategic Plan (NSP) to control the spread of TB with the ambitious aim of zero new TB infections and deaths by 2032, and a halving of the 2012 rates by 2016. Methods We used a transmission model to investigate whether the NSP targets could be reached if immediate scale up of control methods had happened in 2014. We explored the potential impact of four intervention portfolios; 1) "NSP" represents the NSP strategy, 2) "WHO" investigates increasing antiretroviral therapy eligibility, 3) "Novel Strategies" considers new isoniazid preventive therapy strategies and HIV "Universal Test and Treat" and 4) "Optimised" contains the most effective interventions. Findings We find that even with this scale-up, the NSP targets are unlikely to be achieved. The portfolio that achieved the greatest impact was "Optimised", followed closely by "NSP". The "WHO" and "Novel Strategies" had little impact on TB incidence by 2050. Of the individual interventions explored, the most effective were active case finding and reductions in pretreatment loss to follow up which would have a large impact on TB burden. Conclusion Use of existing control strategies has the potential to have a large impact on TB disease burden in South Africa. However, our results suggest that the South African TB targets are unlikely to be reached without new technologies. Despite this, TB incidence could be dramatically reduced by finding and starting more TB cases on treatment.	[Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, TB Modelling Grp, London WC1, England; [Knight, Gwenan M.; Grant, Alison D.; Fielding, Katherine L.; Churchyard, Gavin J.; White, Richard G.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Dodd, Peter J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; University of Witwatersrand	Knight, GM (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, TB Modelling Grp, London WC1, England.	gwen.knight@lshtm.ac.uk	Knight, Gwen/AAF-1176-2020; Knight, Gwen/AGE-2703-2022; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Knight, Gwenan/0000-0002-7263-9896; Dodd, Pete/0000-0001-5825-9347; Churchyard, Gavin/0000-0002-4269-3699	CDC/PEPFAR via the Aurum Institute [U2GPS0008111]; Medical Research Council (UK) [MR/J005088/1]; Bill and Melinda Gates Foundation [21675 / OPP1084276, 19790.01]; MRC [MR/J005088/1] Funding Source: UKRI; Medical Research Council [MR/J005088/1, MR/K012126/1] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish	CDC/PEPFAR via the Aurum Institute; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by CDC/PEPFAR via the Aurum Institute (U2GPS0008111). RGW is also funded by the Medical Research Council (UK) (MR/J005088/1), the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium: Grants 21675 / OPP1084276 and Consortium to Respond Effectively to the AIDS/TB Epidemic: 19790.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], 2013, GLOB TUB CONTR; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Botha E, 2008, INT J TUBERC LUNG D, V12, P936; Churchyard G, 2014, EFFECT XPERT MTB RIF; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI [10.1056/NEJMoa1214289, 10.1056/NEJMc1402073]; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dodd PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075466; Dodd PJ, MYCOBACTERI IN PRESS; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fielding KL, 2014, XPERT 1 LINE TB TEST; Houben RMGJ, 2014, P NATL ACAD SCI US; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; SANAC, 2012, YEAR 1 KEY NSP THEM; South African National AIDS Commission (SANAC), 2012, GLOB AIDS RESP PROGR; South African National AIDS Council (SANAC), 2012, NAT STRAT PLAN HIV S; South African National AIDS Council (SANAC), 2010, NAT HIV COUNS TEST C; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; [UN DEPARTMENT OF ECONOMIC AND SOCIAL AFFAIRS P. D.], 2011, WORLD POP PROSP 2010; UNAIDS, 2021, AIDSINFO; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; WHO, 2013, TB DAT; WHO, 2012, GLOB TUB CONTR; World Health Organization, SYST SCREEN ACT TUB; Zelner JL, 2014, AM J RESP CRIT CARE	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122514	10.1371/journal.pone.0122514	http://dx.doi.org/10.1371/journal.pone.0122514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849558	gold, Green Published, Green Accepted			2022-12-27	WOS:000352477800137
J	Otten, C; De Benedetti, S; Gaballah, A; Buhl, H; Klockner, A; Brauner, J; Sahl, HG; Henrichfreise, B				Otten, Christian; De Benedetti, Stefania; Gaballah, Ahmed; Buehl, Henrike; Kloeckner, Anna; Brauner, Jarryd; Sahl, Hans-Georg; Henrichfreise, Beate			Co-Solvents as Stabilizing Agents during Heterologous Overexpression in Escherichia coli - Application to Chlamydial Penicillin-Binding Protein 6	PLOS ONE			English	Article							RECOMBINANT PROTEINS; PEPTIDOGLYCAN; PNEUMONIAE; AGGREGATION; EXPRESSION; WALL	Heterologous overexpression of foreign proteins in Escherichia coli often leads to insoluble aggregates of misfolded inactive proteins, so-called inclusion bodies. To solve this problem use of chaperones or in vitro refolding procedures are the means of choice. These methods are time consuming and cost intensive, due to additional purification steps to get rid of the chaperons or the process of refolding itself. We describe an easy to use lab-scale method to avoid formation of inclusion bodies. The method systematically combines use of co-solvents, usually applied for in vitro stabilization of biologicals in biopharmaceutical formulation, and periplasmic expression and can be completed in one week using standard equipment in any life science laboratory. Demonstrating the unique power of our method, we overproduced and purified for the first time an active chlamydial penicillin-binding protein, demonstrated its function as penicillin sensitive DD-carboxypeptidase and took a major leap towards understanding the "chlamydial anomaly."	[Otten, Christian; De Benedetti, Stefania; Gaballah, Ahmed; Buehl, Henrike; Kloeckner, Anna; Brauner, Jarryd; Sahl, Hans-Georg; Henrichfreise, Beate] Univ Bonn, Inst Pharmaceut Microbiol, Bonn, Germany	University of Bonn	Otten, C (corresponding author), Univ Bonn, Inst Pharmaceut Microbiol, Bonn, Germany.	cfotten@uni-bonn.de; bhenrich@uni-bonn.de	Gaballah, Ahmed/AFL-6554-2022	Gaballah, Ahmed/0000-0002-9038-6597; Klockner, Anna/0000-0001-9372-4144	Jurgen Manchot foundation; German Academic Exchange Service (DAAD); NRW International Graduate Research School Biotech-Pharma	Jurgen Manchot foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NRW International Graduate Research School Biotech-Pharma	CO and HB received a PhD fellowship from the Jurgen Manchot foundation. AG and SDB obtained a fellowship from the German Academic Exchange Service (DAAD) and from the NRW International Graduate Research School Biotech-Pharma, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; BOWDEN GA, 1990, J BIOL CHEM, V265, P16760; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; Ghuysen JM, 1999, ANTIMICROB AGENTS CH, V43, P2339, DOI 10.1128/AAC.43.10.2339; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Klockner A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5201; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumarasiri M, 2014, PROTEINS, V82, P1348, DOI 10.1002/prot.24501; Lee JC, 2000, CURR OPIN BIOTECH, V11, P81, DOI 10.1016/S0958-1669(99)00058-0; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Mac TT, 2008, J BIOL CHEM, V283, P824, DOI 10.1074/jbc.M707863200; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Margreiter Gerd, 2008, Biotechnology Journal, V3, P1245, DOI 10.1002/biot.200800072; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; Oliva M, 2003, PROTEINS, V53, P88, DOI 10.1002/prot.10450; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pilhofer M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3856; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Ramon A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00056; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Timasheff SN, 1998, ADV PROTEIN CHEM, V51, P355; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	31	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122110	10.1371/journal.pone.0122110	http://dx.doi.org/10.1371/journal.pone.0122110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849314	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800098
J	Terblanche, W; Wilson, T				Terblanche, Wilma; Wilson, Tom			An Evaluation of Nearly-Extinct Cohort Methods for Estimating the Very Elderly Populations of Australia and New Zealand	PLOS ONE			English	Article							MORTALITY; AGES	The rapid growth of very elderly populations requires accurate population estimates up to the highest ages. However, it is recognised that estimates derived from census counts are often unreliable. Methods that make use of death data have not previously been evaluated for Australia and New Zealand. The aim was to evaluate a number of nearly-extinct cohort methods for producing very elderly population estimates by age and sex for Australia and New Zealand. The accuracy of official estimates was also assessed. Variants of three nearly-extinct cohort methods, the Survivor Ratio method, the Das Gupta method and a new method explicitly allowing for falling mortality over time, were evaluated by retrospective application over the period 1976-1996. Estimates by sex and single years of age were compared against numbers derived from the extinct cohort method. Errors were measured by the Weighted Mean Absolute Percentage Error. It is confirmed that for Australian females the Survivor Ratio method constrained to official estimates for ages 90+ performed well. However, for Australian males and both sexes in New Zealand, more accurate estimates were obtained by constraining the Survivor Ratio method to official estimates for ages 85+. Official estimates in Australia proved reasonably accurate for ages 90+ but at 100+ they varied significantly in accuracy from year to year. Estimates produced by Statistics New Zealand in aggregate for ages 90+ proved very accurate. We recommend the use of the Survivor Ratio method constrained to official estimates for ages 85+ to create very elderly population estimates for Australia and New Zealand.	[Terblanche, Wilma] Univ Queensland, Sch Geog Planning & Environm Management, Queensland Ctr Populat Res, Brisbane, Qld, Australia; [Wilson, Tom] New Farm, Adv Demog Modelling, Brisbane, Qld, Australia	University of Queensland	Terblanche, W (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Queensland Ctr Populat Res, Brisbane, Qld, Australia.	w.terblanche@uq.edu.au		Wilson, Tom/0000-0001-8812-7556	University of Queensland	University of Queensland(University of Queensland)	The first author was in receipt of a scholarship from the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2014, EL DAT CUST DEATH DA; ABS (Australian Bureau of Statistics), 2013, AUSTR DEM STAT; Andreev KF, 2004, DEMOGR RES, V11, P235; Andreev KF, 1999, THESIS U SO DENMARK; Australian Institute of Health and Welfare (AIHW), 2007, OLD AUSTR GLANC; Bourbeau R, 2000, DEMOGR RES, V2, P1, DOI DOI 10.4054/DEMRES.2000.2.3; COALE A J, 1990, Genus, V46, P1; COALE AJ, 1986, POP STUD-J DEMOG, V40, P389, DOI 10.1080/0032472031000142316; Coale AJ, 1990, ASIAN PACIFIC POPULA, V4, P1; Das Gupta P., 1990, RECONSTRUCTION AGE D; DEPOID F, 1973, POPULATION, V28, P755, DOI 10.2307/1531256; Hill ME, 2000, DEMOGRAPHY, V37, P175, DOI 10.2307/2648119; Jdanov DA, 2005, WP2005010 MPIDR; Jdanov DA, 2008, WP200813 MPIDR; KANNISTO V, 1988, POP STUD-J DEMOG, V42, P389, DOI 10.1080/0032472031000143546; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Kannisto V, 1994, MONOGRAPHS POPULATIO, V1, DOI [10.1097/CCM.0b013e31825fec26, DOI 10.1097/CCM.0B013E31825FEC26]; Khawaja M., 2010, NZ POPULATION REV, V36, P117; Mesle F, 2002, POPULATION, V57, P603, DOI 10.2307/1534798; ONS, 2012, QUAL METH INF POP ES; Preston SH, 1999, POP STUD-J DEMOG, V53, P165, DOI 10.1080/00324720308075; Siegel J. S., 2002, APPL DEMOGRAPHY APPL; Statistics New Zealand, 2013, NAT POP EST 30 JUN 2; Statistics New Zealand, 2012, NAT POP PROJ 2011 BA; Terblanche W, 2014, J POPUL AGEING, V7, P301, DOI 10.1007/s12062-014-9107-6; THATCHER AR, 1992, POP STUD-J DEMOG, V46, P411, DOI 10.1080/0032472031000146426; Thatcher AR., 2002, DEMOGR RES, V6, P1, DOI [10.4054/DemRes.2002.6.1, DOI 10.4054/DEMRES.2002.6.1]; Thatcher R, 1999, Popul Trends, P5; Vincent P, 1951, POPULATION, V6, P181, DOI 10.2307/1524149; Wilmoth JR, 2007, METHODS PROTOCOL HUM; Wilson T, 2012, NZ POPULATION REV, V38, P95; Wilson T, 2004, DEMOGR RES, V11, P195	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123692	10.1371/journal.pone.0123692	http://dx.doi.org/10.1371/journal.pone.0123692			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849096	gold, Green Published			2022-12-27	WOS:000352477800252
J	Salinero-Fort, MA; Gomez-Campelo, P; Bragado-Alvarez, C; Abanades-Herranz, JC; Jimenez-Garcia, R; de Burgos-Lunar, C				Angel Salinero-Fort, Miguel; Gomez-Campelo, Paloma; Bragado-Alvarez, Carmen; Carlos Abanades-Herranz, Juan; Jimenez-Garcia, Rodrigo; de Burgos-Lunar, Carmen		Hlth Immigration Grp	Health-Related Quality of Life of Latin-American Immigrants and Spanish-Born Attended in Spanish Primary Health Care: Socio-Demographic and Psychosocial Factors	PLOS ONE			English	Article							HISPANIC PARADOX; MENTAL-HEALTH; MIGRATION	Background This study compares the health-related quality of life of Spanish-born and Latin American-born individuals settled in Spain. Socio-demographic and psychosocial factors associated with health-related quality of life are analyzed. Methods A cross-sectional Primary Health Care multi center-based study of Latin American-born (n = 691) and Spanish-born (n = 903) outpatients from 15 Primary Health Care Centers (Madrid, Spain). The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess health-related quality of life. Socio-demographic, psychosocial, and specific migration data were also collected. Results Compared to Spanish-born participants, Latin American-born participants reported higher health-related quality of life in the physical functioning and vitality dimensions. Across the entire sample, Latin American-born participants, younger participants, men and those with high social support reported significantly higher levels of physical health. Men with higher social support and a higher income reported significantly higher mental health. When stratified by gender, data show that for men physical health was only positively associated with younger age. For women, in addition to age, social support and marital status were significantly related. Both men and women with higher social support and income had significantly better mental health. Finally, for immigrants, the physical and mental health components of health-related quality of life were not found to be significantly associated with any of the pre-migration factors or conditions of migration. Only the variable "exposure to political violence" was significantly associated with the mental health component (p = 0.014). Conclusions The key factors to understanding HRQoL among Latin American-born immigrants settled in Spain are age, sex and social support. Therefore, strategies to maintain optimal health outcomes in these immigrant communities should include public policies on social inclusion in the host society and focus on improving social support networks in order to foster and maintain the health and HRQoL of this group.	[Angel Salinero-Fort, Miguel] Serv Madrileno Salud, Atenc Primaria, Gerencia Adjunta Planificac & Calidad, Madrid, Spain; [Angel Salinero-Fort, Miguel; Gomez-Campelo, Paloma; Carlos Abanades-Herranz, Juan; de Burgos-Lunar, Carmen] Hosp La Paz Inst Hlth Research IdiPAZ, Grp Aging & Fragil Elderly 27, Madrid, Spain; [Angel Salinero-Fort, Miguel; de Burgos-Lunar, Carmen] Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Gomez-Campelo, Paloma] Hosp La Paz Inst Hlth Res IdiPAZ, Plataforma Apoyo Investigador Novel PAIN Platform, Madrid, Spain; [Bragado-Alvarez, Carmen] Univ Complutense Madrid, Fac Psicol, Madrid, Spain; [Carlos Abanades-Herranz, Juan] Serv Madrileno Salud, Atenc Primaria, Gerencia Adjunta Planificac & Calidad, Direcc Tecn Docencia & Invest, Madrid, Spain; [Jimenez-Garcia, Rodrigo] Univ Rey Juan Carlos, Dept Prevent Med, Madrid, Spain; [de Burgos-Lunar, Carmen] Hosp Univ La Paz, Serv Med Prevent, Madrid, Spain	Complutense University of Madrid; Universidad Rey Juan Carlos; Hospital Universitario La Paz	Salinero-Fort, MA (corresponding author), Serv Madrileno Salud, Atenc Primaria, Gerencia Adjunta Planificac & Calidad, Madrid, Spain.	miguel.salinero@salud.madrid.org	Jimenez-Garcia, Rodrigo/D-4953-2019; Campos, Caroline/AAT-5847-2021; SALINERO-FORT, MIGUEL A./GOP-2536-2022	Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116	Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III [PI06/1407]	Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III	This work was supported by the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III under Grant "number PI06/1407".	Arango J., 2004, INFORM SITUACION DEM, P161; Blom S, 2008, INNVANDRERNES HELSE, V35; Borrell Carme, 2006, Gac Sanit, V20, P396, DOI 10.1157/13093210; Rodriguez YB, 2009, GAC SANIT, V23, P200, DOI 10.1016/j.gaceta.2009.07.005; Cavazos-Rehg PA, 2007, J NATL MED ASSOC, V99, P1126; Criado M, 2009, IMMIGRACION POBLACIO; Cunningham SA, 2008, HEALTH PLACE, V14, P623, DOI 10.1016/j.healthplace.2007.12.002; Daher AM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-407; De la Revilla L, 2005, MED FAM, V1, P10; Eisenman DP, 2003, JAMA-J AM MED ASSOC, V290, P627, DOI 10.1001/jama.290.5.627; Esteban y Pena M M, 2001, Aten Primaria, V27, P25; Esteban-Vasallo MD, 2009, FAM PRACT, V26, P445, DOI 10.1093/fampra/cmp062; Ferrer C, 2009, GAC SANIT, V23, P38, DOI [10.1016/j.gaceta.2009.09.008, 10.1016/j.gaceta.2008.05.004]; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Fuertes MC, 2010, AN SIST SANIT NAVAR, V33, P179, DOI 10.4321/s1137-66272010000300006; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Koochek A, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-60; Kumar B, 2008, OSLO IMMIGRANT PROFI, P7; Kurita GP, 2012, PAIN, V153, P2332, DOI 10.1016/j.pain.2012.07.023; Lahana E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/127389; Lindert J, 2008, EUR PSYCHIAT, V23, pS14, DOI 10.1016/S0924-9338(08)70057-9; Malmusi D, 2010, SOC SCI MED, V71, P1610, DOI 10.1016/j.socscimed.2010.07.043; Martlinez R, 2003, RECIENTE IMMIGRACION; Mier N, 2008, SOC SCI MED, V66, P1760, DOI 10.1016/j.socscimed.2007.12.017; Moreno A, 2013, BAROMETRO EC CIUDAD, V38, P87; Nesterko Y, 2013, QUAL LIFE RES, V22, P1005, DOI 10.1007/s11136-012-0239-y; NIE (Instituto Nacional de Estadistica), 2011, STAT MUN 2011; NIS (National Institute of Statistics), 2011, STAT MUN 2011; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Salinero-Fort MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038462; Sevillano V, 2014, ETHNIC HEALTH, V19, P178, DOI 10.1080/13557858.2013.797569; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Smith DP, 2006, AM J PUBLIC HEALTH, V96, P1686, DOI 10.2105/AJPH.2003.035378; Soler-Gonzalez J, 2008, ATEN PRIM, V40, P225, DOI 10.1157/13120019; SUNDQUIST J, 1995, SCAND J PRIM HEALTH, V13, P128, DOI 10.3109/02813439508996749; Thapa SB, 2007, NORD J PSYCHIAT, V61, P459, DOI 10.1080/08039480701773261; Thomson EF, 2013, INT J ENV RES PUB HE, V10, P1786, DOI 10.3390/ijerph10051786; Vazquez Maria Luisa, 2014, Gac Sanit, V28 Suppl 1, P142, DOI 10.1016/j.gaceta.2014.02.012; Ware J., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019	42	14	15	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122318	10.1371/journal.pone.0122318	http://dx.doi.org/10.1371/journal.pone.0122318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835714	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000094
J	Denardo, SJ; Gong, Y; Cooper-DeHoff, RM; Farsang, C; Keltai, M; Szirmai, L; Messerli, FH; Bavry, AA; Handberg, EM; Mancia, G; Pepine, CJ				Denardo, Scott J.; Gong, Yan; Cooper-DeHoff, Rhonda M.; Farsang, Csaba; Keltai, Matyas; Szirmai, Laszlo; Messerli, Franz H.; Bavry, Anthony A.; Handberg, Eileen M.; Mancia, Giuseppe; Pepine, Carl J.			Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy	PLOS ONE			English	Article							EARLY-MORNING SURGE; CARDIOVASCULAR RISK; PROGNOSTIC VALUE; CIRCADIAN VARIATION; VARIABILITY; MORTALITY; PREDICTOR; INHIBITOR; INVEST; DAMAGE	Elevated nighttime blood pressure (BP) and heart rate (HR), increased BP and HR variability, and altered diurnal variations of BP and HR (nighttime dipping and morning surge) in patients with systemic hypertension are each associated with increased adverse cardiovascular events. However, there are no reports on the effect of hypertension treatment on these important hemodynamic parameters in the growing population of hypertensive patients with atherosclerotic coronary artery disease (CAD). This was a pre-specified subgroup analysis of the INternational VErapamil SR-Trandolapril STudy (INVEST), which involved 22,576 clinically stable patients aged >= 50 years with hypertension and CAD randomized to either verapamil SR- or atenolol-based hypertension treatment strategies. The subgroup consisted of 117 patients undergoing 24-hour ambulatory monitoring at baseline and after 1 year of treatment. Hourly systolic and diastolic BP (SBP and DBP) decreased after 1 year for both verapamil SR- and atenolol-based treatment strategies compared with baseline (P<0.0001). Atenolol also decreased hourly HR (P<0.0001). Both treatment strategies decreased SBP variability (weighted standard deviation: P = 0.012 and 0.021, respectively). Compared with verapamil SR, atenolol also increased the prevalence of BP and HR nighttime dipping among prior non-dippers (BP: OR = 3.37; 95% CI: 1.26 - 8.97; P = 0.015; HR: OR = 4.06; 95% CI: 1.35-12.17; P = 0.012) and blunted HR morning surge (+2.8 vs. +4.5 beats/min/hr; P = 0.019). Both verapamil SR- and especially atenolol-based strategies resulted in favorable changes in ambulatory monitoring parameters that have been previously associated with increased adverse cardiovascular events.	[Denardo, Scott J.; Cooper-DeHoff, Rhonda M.; Bavry, Anthony A.; Handberg, Eileen M.; Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32611 USA; [Gong, Yan] Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL USA; [Cooper-DeHoff, Rhonda M.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Farsang, Csaba] St Imre Teaching Hosp, Cardiometab Ctr, Budapest, Hungary; [Keltai, Matyas] Semmelweis Univ, Hungarian Inst Cardiol, H-1085 Budapest, Hungary; [Szirmai, Laszlo] N&Sz StudyMaster Med Res Ctr Ltd, Szentendre, Hungary; [Messerli, Franz H.] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Cardiol, New York, NY USA; [Messerli, Franz H.] Columbia Univ, Coll Med & Phys, New York, NY USA; [Bavry, Anthony A.] North Florida South Georgia Vet Affairs Hlth Syst, Gainesville, FL USA; [Mancia, Giuseppe] Univ Milano Bicocca, Med Clin, Osped San Gerardo Tintori Monza, Milan, Italy	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Semmelweis University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Columbia University; University of Milano-Bicocca	Pepine, CJ (corresponding author), Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32611 USA.	Carl.Pepine@medicine.ufl.edu	Messerli, Franz/AAR-4783-2021	Handberg, Eileen/0000-0002-7805-9577; Pepine, Carl/0000-0002-6011-681X	BASF Pharma, Ludwigshafen, Germany; Abbott Laboratories, Abbott Park, IL, USA; University of Florida Research Foundation and Opportunity Fund; National Institutes of Health [HL086558]; NIH/NCRR Clinical and Translational Science Award [UL1 TR000064]; N&Sz StudyMaster Medical Research Center Ltd; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001427] Funding Source: NIH RePORTER	BASF Pharma, Ludwigshafen, Germany(BASF); Abbott Laboratories, Abbott Park, IL, USA(Abbott Laboratories); University of Florida Research Foundation and Opportunity Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR Clinical and Translational Science Award; N&Sz StudyMaster Medical Research Center Ltd; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Original INVEST funding: BASF Pharma, Ludwigshafen, Germany; Abbott Laboratories, Abbott Park, IL, USA; University of Florida Research Foundation and Opportunity Fund. Study also supported in part by National Institutes of Health, HL086558 (Dr. Cooper-Dehoff). Dr. Pepine receives support in part from the NIH/NCRR Clinical and Translational Science Award to the University of Florida UL1 TR000064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. N&Sz StudyMaster Medical Research Center Ltd provided support in the form of salaries for author LS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section	Ben-Dov IZ, 2007, ARCH INTERN MED, V167, P2116, DOI 10.1001/archinte.167.19.2116; Bilo G, 2007, J HYPERTENS, V25, P2058, DOI 10.1097/HJH.0b013e32829c6a60; Brotman DJ, 2008, AM J HYPERTENS, V21, P92, DOI 10.1038/ajh.2007.7; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; Fagard RH, 2008, BLOOD PRESS MONIT, V13, P325, DOI 10.1097/MBP.0b013e32831054f5; Hansen TW, 2008, HYPERTENSION, V52, P229, DOI 10.1161/HYPERTENSIONAHA.108.113191; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; Hermida RC, 2011, AM J HYPERTENS, V24, P383, DOI 10.1038/ajh.2010.217; Hermida RC, 2009, HYPERTENSION, V54, P40, DOI 10.1161/HYPERTENSIONAHA.109.130203; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; Kikuya M, 2005, HYPERTENSION, V45, P240, DOI 10.1161/01.HYP.0000152079.04553.2c; Leary AC, 2002, J HYPERTENS, V20, P865, DOI 10.1097/00004872-200205000-00020; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Mancia G, 2001, J HYPERTENS, V19, P1981, DOI 10.1097/00004872-200111000-00008; Mancia G, 2012, HYPERTENSION, V60, P512, DOI 10.1161/HYPERTENSIONAHA.112.194340; MARLER JR, 1989, STROKE, V20, P473, DOI 10.1161/01.STR.20.4.473; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Ohkubo T, 1997, AM J HYPERTENS, V10, P1201, DOI 10.1016/S0895-7061(97)00274-4; Omboni S, 1998, J HYPERTENS, V16, P733, DOI 10.1097/00004872-199816060-00003; Pepine CJ, 1998, J AM COLL CARDIOL, V32, P1228, DOI 10.1016/S0735-1097(98)00423-9; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Pierdomenico SD, 2006, AM J HYPERTENS, V19, P991, DOI 10.1016/j.amjhyper.2006.03.009; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Sega R, 2002, HYPERTENSION, V39, P710, DOI 10.1161/hy0202.104376; Shimada K, 2010, CLIN THER, V32, P861, DOI 10.1016/j.clinthera.2010.04.020; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Verdecchia, 1997, Blood Press Monit, V2, P347; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Vollmer WM, 2005, J HUM HYPERTENS, V19, P77, DOI 10.1038/sj.jhh.1001772; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; White WB, 2001, BLOOD PRESS MONIT, V6, P63, DOI 10.1097/00126097-200104000-00001; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Zhang Y, 2011, HYPERTENSION, V58, P155, DOI 10.1161/HYPERTENSIONAHA.111.174383	39	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122726	10.1371/journal.pone.0122726	http://dx.doi.org/10.1371/journal.pone.0122726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835002	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000109
J	Kayser, BD; Goran, MI; Bouret, SG				Kayser, Brandon D.; Goran, Michael I.; Bouret, Sebastien G.			Perinatal Overnutrition Exacerbates Adipose Tissue Inflammation Caused by High-Fat Feeding in C57BL/6J Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; VISCERAL FAT; OBESITY; MACROPHAGES; SENSITIVITY; METABOLISM; MECHANISMS; CHILDHOOD; SIZE; DIET	Obesity causes white adipose tissue (WAT) inflammation and insulin resistance in some, but not all individuals. Here, we used a mouse model of early postnatal overfeeding to determine the role of neonatal nutrition in lifelong WAT inflammation and metabolic dysfunction. C57BL/6J mice were reared in small litters of 3 (SL) or normal litters of 7 pups (NL) and fed either regular chow or a 60% high fat diet (HFD) from 5 to 17 weeks. At weaning, SL mice did not develop WAT inflammation despite increased fat mass, although there was an up-regulation of WAT Arg1 and Tlr4 expression. On HFD, adult SL mice had greater inguinal fat mass compared to NL mice, however both groups showed similar increases in visceral fat depots and adipocyte hypertrophy. Despite the similar levels of visceral adiposity, SL-HFD mice displayed greater impairments in glucose homeostasis and more pronounced hepatic steatosis compared to NL-HFD mice. In addition, WAT from SL mice fed a HFD displayed greater crown-like structure formation, increased M1 macrophages, and higher cytokine gene expression. Together, these data suggest that early postnatal overnutrition may be a critical determinant of fatty liver and insulin resistance in obese adults by programming the inflammatory capacity of adipose tissue.	[Kayser, Brandon D.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Human & Evolutionary Biol Program, Los Angeles, CA 90089 USA; [Kayser, Brandon D.; Goran, Michael I.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Childhood Obes Res Ctr, Los Angeles, CA 90033 USA; [Bouret, Sebastien G.] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dev Neurosci Program, Los Angeles, CA USA	University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Goran, MI (corresponding author), Univ So Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Human & Evolutionary Biol Program, Los Angeles, CA 90089 USA.	goran@usc.edu	Bouret, Sebastien/AAG-7120-2021	Bouret, Sebastien/0000-0002-4174-9769	Dr. Robert C. and Veronica Atkins endowed chair funds; National Institutes of Health [R01DK84142, P01ES022845]; United States Environment Protection Agency [RD83544101]; EU [266408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022845] Funding Source: NIH RePORTER	Dr. Robert C. and Veronica Atkins endowed chair funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Environment Protection Agency; EU(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Dr. Robert C. and Veronica Atkins endowed chair funds (to M.I.G.), the National Institutes of Health (Grants R01DK84142, P01ES022845 to S.G.B.), the United States Environment Protection Agency (Grant RD83544101 to SGB), and the EU FP7 integrated project (grant agreement no. 266408, "Full4Health", to SGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2013, FAST FACTS DAT STAT; [Anonymous], 2014, R LANG ENV STAT COMP; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; AUBERT R, 1980, J NUTR, V110, P649, DOI 10.1093/jn/110.4.649; BARKER DJP, 1986, LANCET, V1, P1077; Boullu-Ciocca S, 2008, DIABETES, V57, P669, DOI 10.2337/db07-1316; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Habbout A, 2013, J NUTR, V143, P553, DOI 10.3945/jn.112.172825; HIRSCH J, 1968, J LIPID RES, V9, P110; HOLM S, 1979, SCAND J STAT, V6, P65; Huang RC, 2011, DIABETES CARE, V34, P1019, DOI 10.2337/dc10-1809; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kenny SJ, 1995, DIABETES AM, P47; Kloting N, 2010, AM J PHYSL ENDOCRINO; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Liu ZG, 2013, J ENDOCRINOL, V219, P131, DOI 10.1530/JOE-13-0111; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; PAIK MC, 1988, COMMUN STAT SIMULAT, V17, P1155, DOI 10.1080/03610918808812718; Parkes AS, 1926, ANN APPL BIOL, V13, P374, DOI 10.1111/j.1744-7348.1926.tb04284.x; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Plagemann A, 2004, J PERINAT MED, V32, P297, DOI 10.1515/JPM.2004.055; Rodrigues AL, 2011, J NUTR BIOCHEM, V22, P109, DOI 10.1016/j.jnutbio.2009.11.013; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Vogt M, 2014, CELL; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	49	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121954	10.1371/journal.pone.0121954	http://dx.doi.org/10.1371/journal.pone.0121954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835281	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000070
J	Tietze, E; Dabrowski, PW; Prager, R; Radonic, A; Fruth, A; Aurass, P; Nitsche, A; Mielke, M; Flieger, A				Tietze, Erhard; Dabrowski, Piotr Wojciech; Prager, Rita; Radonic, Aleksandar; Fruth, Angelika; Aurass, Philipp; Nitsche, Andreas; Mielke, Martin; Flieger, Antje			Comparative Genomic Analysis of Two Novel Sporadic Shiga Toxin-Producing Escherichia coli O104:H4 Strains Isolated 2011 in Germany	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; O104/H4 OUTBREAK; FRANCE	A large outbreak of gastrointestinal disease occurred in 2011 in Germany which resulted in almost 4000 patients with acute gastroenteritis or hemorrhagic colitis, 855 cases of a hemolytic uremic syndrome and 53 deaths. The pathogen was an uncommon, multiresistant Escherichia coli strain of serotype O104:H4 which expressed a Shiga toxin characteristic of enterohemorrhagic E. coli and in addition virulence factors common to enteroaggregative E. coli. During post-epidemic surveillance of Shiga toxin-producing E. coli (STEC) all but two of O104:H4 isolates were indistinguishable from the epidemic strain. Here we describe two novel STEC O104:H4 strains isolated in close spatiotemporal proximity to the outbreak which show a virulence gene panel, a Shiga toxin-mediated cytotoxicity towards Vero cells and aggregative adherence to Hep-2 cells comparable to the outbreak strain. They differ however both from the epidemic strain and from each other, by their antibiotic resistance phenotypes and some other features as determined by routine epidemiological subtyping methods. Whole genome sequencing of these two strains, of ten outbreak strain isolates originating from different time points of the outbreak and of one historical sporadic EHEC O104:H4 isolate was performed. Sequence analysis revealed a clear phylogenetic distance between the two variant strains and the outbreak strain finally identifying them as epidemiologically unrelated isolates from sporadic cases. These findings add to the knowledge about this emerging pathogen, illustrating a certain diversity within the bacterial core genome as well as loss and gain of accessory elements. Our results do also support the view that distinct new variants of STEC O104:H4 repeatedly might originate from yet unknown reservoirs, rather than that there would be a continuous diversification of a single epidemic strain established and circulating in Germany after the large outbreak in 2011.	[Tietze, Erhard; Prager, Rita; Fruth, Angelika; Aurass, Philipp; Flieger, Antje] Robert Koch Inst, Natl Reference Ctr Salmonella & Other Bacterial E, Div Enteropathogen Bacteria & Legionella, Dept Infect Dis,Wernigerode Branch, Berlin, Germany; [Dabrowski, Piotr Wojciech; Radonic, Aleksandar; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany; [Mielke, Martin] Robert Koch Inst, Dept Infect Dis, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Tietze, E (corresponding author), Robert Koch Inst, Natl Reference Ctr Salmonella & Other Bacterial E, Div Enteropathogen Bacteria & Legionella, Dept Infect Dis,Wernigerode Branch, Berlin, Germany.	tietzee@rki.de	Radonić, Aleksandar/AAP-2612-2020; Dabrowski, Piotr Wojtek/L-1423-2015	Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Flieger, Antje/0000-0003-3819-2979; Nitsche, Andreas/0000-0001-8185-3176; Radonic, Aleksandar/0000-0001-6200-9607				Abu Sin M, 2013, J INFECT DIS, V207, P432, DOI 10.1093/infdis/jis702; Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; [Anonymous], 2011, REP FIN PRES EV EP F; [Anonymous], 2011, CHAR PATH INF ASS RK; Beutin L, 2012, J VIROL, V86, P10444, DOI 10.1128/JVI.00986-12; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Chevreux B, 2005, THESIS GERMAN CANC R; De Rauw K, 2014, New Microbes New Infect, V2, P138, DOI 10.1002/nmi2.58; Frank C., 2011, EURO SURVEILL, V19; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gault G, 2011, EUROSURVEILLANCE, V16, P5; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, pE3629, DOI 10.1073/pnas.1209419110; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Guy L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063027; Guy L, 2012, P NATL ACAD SCI USA, V109, pE3627, DOI 10.1073/pnas.1206246110; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jourdan-da Silva N, 2012, EUROSURVEILLANCE, V17, P10; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li D, 2011, GENOMIC DATA ESCHERI, DOI [10.5524/100001, DOI 10.5524/100001]; Mariani-Kurkdjian P, 2011, LANCET INFECT DIS, V11, P732, DOI 10.1016/S1473-3099(11)70266-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Monecke S, 2011, APPL ENVIRON MICROB, V77, P8784, DOI 10.1128/AEM.06524-11; Mossoro C, 2002, J CLIN MICROBIOL, V40, P3086, DOI 10.1128/JCM.40.8.3086-3088.2002; National Center for Biotechnology Information, BAS LOC AL SEARCH TO; Prager R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095379; Prager R, 2011, INT J MED MICROBIOL, V301, P181, DOI 10.1016/j.ijmm.2010.06.003; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Robert Koch-Institut, 2011, EPIDEMIOL B, V35, P325; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Scheutz F, 2011, EUROSURVEILLANCE, V16, P5; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	36	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122074	10.1371/journal.pone.0122074	http://dx.doi.org/10.1371/journal.pone.0122074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836671	Green Published, gold			2022-12-27	WOS:000352139000078
J	Watt, C; Abuya, T; Warren, CE; Obare, F; Kanya, L; Bellows, B				Watt, Claire; Abuya, Timothy; Warren, Charlotte E.; Obare, Francis; Kanya, Lucy; Bellows, Ben			Can Reproductive Health Voucher Programs Improve Quality of Postnatal Care? A Quasi-Experimental Evaluation of Kenya's Safe Motherhood Voucher Scheme	PLOS ONE			English	Article							OF-CARE; INTERVENTION; NEWBORN	This study tests the group-level causal relationship between the expansion of Kenya's Safe Motherhood voucher program and changes in quality of postnatal care (PNC) provided at voucher-contracted facilities. We compare facilities accredited since program inception in 2006 (phase I) and facilities accredited since 2010-2011 (phase II) relative to comparable non-voucher facilities. PNC quality is assessed using observed clinical content processes, as well as client-reported outcome measures. Two-tailed unpaired t-tests are used to identify differences in mean process quality scores and client-reported outcome measures, comparing changes between intervention and comparison groups at the 2010 and 2012 data collection periods. Difference-in-differences analysis is used to estimate the reproductive health (RH) voucher program's causal effect on quality of care by exploiting group-level differences between voucher-accredited and non-accredited facilities in 2010 and 2012. Participation in the voucher scheme since 2006 significantly improves overall quality of postnatal care by 39% (p=0.02), where quality is defined as the observable processes or components of service provision that occur during a PNC consultation. Program participation since phase I is estimated to improve the quality of observed maternal postnatal care by 86% (p=0.02), with the largest quality improvements in counseling on family planning methods (IRR 5.0; p=0.01) and return to fertility (IRR 2.6; p=0.01). Despite improvements in maternal aspects of PNC, we find a high proportion of mothers who seek PNC are not being checked by any provider after delivery. Additional strategies will be necessary to standardize provision of packaged postnatal interventions to both mother and newborn. This study addresses an important gap in the existing RH literature by using a strong evaluation design to assess RH voucher program effectiveness on quality improvement.	[Watt, Claire] Jacaranda Hlth, Nairobi, Kenya; [Abuya, Timothy; Obare, Francis; Kanya, Lucy; Bellows, Ben] Populat Council, Nairobi, Kenya; [Warren, Charlotte E.] Populat Council, Washington, DC USA	Population Council	Watt, C (corresponding author), Jacaranda Hlth, Nairobi, Kenya.	cew690@mail.harvard.edu	Abuya, Timothy/AAH-5479-2020	Rothschild, Claire/0000-0002-2419-9881; Bellows, Ben/0000-0001-9205-6623	Bill & Melinda Gates Foundation [51761]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for the Reproductive Health Voucher Program Evaluation was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/). Project Title: Evaluation of voucher and accreditation interventions for improving business models applied to reproductive health service delivery systems (Grant Number 51761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-540; Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Anderson ML, 2008, J AM STAT ASSOC, V103, P1481, DOI 10.1198/016214508000000841; Bellows B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-667; Bellows N., 2012, VOUCHERS REPROD HLTH; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bhatia M. R., 2007, Journal of International Development, V19, P975, DOI 10.1002/jid.1361; Bhutta ZA, 2011, SYSTEMATIC REV HUMAN; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Gabrysch S, 2012, TROP MED INT HEALTH, V17, P2, DOI 10.1111/j.1365-3156.2011.02851.x; Hatt L., 2010, EC EVALUATION DEMAND; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Kanya L, 2014, HEALTH POLICY PLANN, V29, pI4, DOI 10.1093/heapol/czt079; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lawn J, 2009, STATE WORLDS CHILDRE; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Meuwissen LE, 2006, INT J QUAL HEALTH C, V18, P35, DOI 10.1093/intqhc/mzi073; Meuwissen LE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-204; Meuwissen LE, 2006, TROP MED INT HEALTH, V11, P889, DOI 10.1111/j.1365-3156.2006.01632.x; Morgan L., 2011, MORE CHOICES WOMEN V; Obare F, 2013, LANCET, V2013, P381, DOI [10.1016/S0140-6736(13)61354-9, DOI 10.1016/S0140-6736(13)61354-9]; Obare F, 2013, HEALTH POLICY PLANN, V28, P165, DOI 10.1093/heapol/czs033; Rogo KO, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P223; Ross JA, 2001, INT FAM PLAN PERSPEC, V27, P20, DOI 10.2307/2673801; Sandiford P, 2005, GUIDE COMPETITIVE VO; Warren C, 2006, POSTNATAL CARE OPPOR, P79; Warren C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-177; World Health Organization, 2014, WHO REC POSTN CAR MO; Zwane AP, 2011, P NATL ACAD SCI USA, V108, P1821, DOI 10.1073/pnas.1000776108	35	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122828	10.1371/journal.pone.0122828	http://dx.doi.org/10.1371/journal.pone.0122828			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835713	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352139000114
J	Cozar, A; Sanz-Martin, M; Marti, E; Gonzalez-Gordillo, JI; Ubeda, B; Galvez, JA; Irigoien, X; Duarte, CM				Cozar, Andres; Sanz-Martin, Marina; Marti, Elisa; Gonzalez-Gordillo, J. Ignacio; Ubeda, Barbara; Galvez, Jose A.; Irigoien, Xabier; Duarte, Carlos M.			Plastic Accumulation in the Mediterranean Sea	PLOS ONE			English	Article							MARINE DEBRIS; FLOATING DEBRIS; SURFACE; MICROPLASTICS; ENVIRONMENT; ABUNDANCE; CHEMICALS; FISH	Concentrations of floating plastic were measured throughout the Mediterranean Sea to assess whether this basin can be regarded as a great accumulation region of plastic debris. We found that the average density of plastic (1 item per 4 m(2)), as well as its frequency of occurrence (100% of the sites sampled), are comparable to the accumulation zones described for the five subtropical ocean gyres. Plastic debris in the Mediterranean surface waters was dominated by millimeter-sized fragments, but showed a higher proportion of large plastic objects than that present in oceanic gyres, reflecting the closer connection with pollution sources. The accumulation of floating plastic in the Mediterranean Sea (between 1,000 and 3,000 tons) is likely related to the high human pressure together with the hydrodynamics of this semi-enclosed basin, with outflow mainly occurring through a deep water layer. Given the biological richness and concentration of economic activities in the Mediterranean Sea, the affects of plastic pollution on marine and human life are expected to be particularly frequent in this plastic accumulation region.	[Cozar, Andres; Marti, Elisa; Gonzalez-Gordillo, J. Ignacio; Ubeda, Barbara; Galvez, Jose A.] Univ Cadiz, Fac Ciencias Mar & Ambient, Dept Biol, E-11510 Puerto Real, Spain; [Sanz-Martin, Marina; Duarte, Carlos M.] CSIC UIB, IMEDEA, Inst Mediterraneo Estudios Avanzados, Dept Global Change Res, Esporles 07190, Spain; [Sanz-Martin, Marina] Univ Barcelona, Fac Geol, Dept Geol Dinam Geofis & Paleontol, E-08028 Barcelona, Spain; [Irigoien, Xabier; Duarte, Carlos M.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia	Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; University of Barcelona; King Abdullah University of Science & Technology	Cozar, A (corresponding author), Univ Cadiz, Fac Ciencias Mar & Ambient, Dept Biol, Campus Excelencia Int Mar, E-11510 Puerto Real, Spain.	andres.cozar@uca.es	Iturraspe, Juan Ignacio/AAT-9984-2020; Ubeda, Barbara/AAT-6839-2020; Marti, Elisa/AAA-1559-2020; Irigoien, Xabier/B-8171-2009; Duarte, Carlos M/A-7670-2013; Galvez, Jose Angel/AAN-4367-2020; Cozar, Andres/G-2141-2016; Duarte Quesada, Carlos Manuel/ABD-6208-2021	Iturraspe, Juan Ignacio/0000-0003-2859-3939; Irigoien, Xabier/0000-0002-5411-6741; Duarte, Carlos M/0000-0002-1213-1361; Galvez, Jose Angel/0000-0001-6203-5186; Cozar, Andres/0000-0003-1370-9935; Sanz-Martin, Marina/0000-0002-9777-5894; Ubeda Sanchez, Barbara/0000-0001-8165-2091	EU; Spanish Ministry of Economy and Competitiveness through project MedSeA (EU) [FP7-2010-265103]; Spanish Ministry of Education, Culture and Sport [PRX14/00743]; Spanish Ministry of Economy and Competitiveness through project ESTRESX [CTM2012-32603]; Spanish Ministry of Economy and Competitiveness through project MEGAN [CTM2013-49048-C2-1-R]	EU(European Commission); Spanish Ministry of Economy and Competitiveness through project MedSeA (EU); Spanish Ministry of Education, Culture and Sport(Spanish Government); Spanish Ministry of Economy and Competitiveness through project ESTRESX; Spanish Ministry of Economy and Competitiveness through project MEGAN	The present study was funded by the EU's Framework Programme 7 and the Spanish Ministry of Economy and Competitiveness through projects MedSeA (EU contract number FP7-2010-265103), ESTRESX (ref. CTM2012-32603) and MEGAN (ref. CTM2013-49048-C2-1-R). Andres Cozar is grateful for the funding of a "Salvador de Madariaga" stay to continue the study of the plastic pollution in the Mediterranean Sea (Spanish Ministry of Education, Culture and Sport, ref. PRX14/00743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliani S, 2003, MAR POLLUT BULL, V46, P1142, DOI 10.1016/S0025-326X(03)00192-9; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; [Anonymous], NAT AGGR GEOSP DAT P; Association of Plastic Manufacturers, 2011, PLAST FACTS 2011 ANA; Beranger K, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005648; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Campani T, 2013, MAR POLLUT BULL, V74, P225, DOI 10.1016/j.marpolbul.2013.06.053; Codina-Garcia M, 2013, MAR POLLUT BULL, V77, P220, DOI 10.1016/j.marpolbul.2013.10.002; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; de Lucia GA, 2014, MAR ENVIRON RES, V100, P10, DOI 10.1016/j.marenvres.2014.03.017; de Stephanis R, 2013, MAR POLLUT BULL, V69, P206, DOI 10.1016/j.marpolbul.2013.01.033; Doyle MJ, 2011, MAR ENVIRON RES, V71, P41, DOI 10.1016/j.marenvres.2010.10.001; Engler RE, 2012, ENVIRON SCI TECHNOL, V46, P12302, DOI 10.1021/es3027105; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Foekema EM, 2013, ENVIRON SCI TECHNOL, V47, P8818, DOI 10.1021/es400931b; Fossi MC, 2014, MAR ENVIRON RES, V100, P17, DOI 10.1016/j.marenvres.2014.02.002; GALGANI F, 1995, MAR POLLUT BULL, V30, P713, DOI 10.1016/0025-326X(95)00055-R; Gassel M, 2013, MAR POLLUT BULL, V73, P231, DOI 10.1016/j.marpolbul.2013.05.014; Goldstein MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080020; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; LACOMBE H, 1981, OCEANOL ACTA, V4, P247; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Lechner A, 2014, ENVIRON POLLUT, V188, P177, DOI 10.1016/j.envpol.2014.02.006; Leggett C., 2014, ASSESSING EC BENEFIT; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; MCCOY FW, 1988, MAR POLLUT BULL, V19, P25, DOI 10.1016/0025-326X(88)90749-7; MORRIS RJ, 1980, MAR POLLUT BULL, V11, P125, DOI 10.1016/0025-326X(80)90073-9; Obbard RW, 2014, EARTHS FUTURE, V2, P315, DOI 10.1002/2014EF000240; Pham CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095839; Poulain PM, 2013, OCEANOGRAPHY, V26, P38, DOI 10.5670/oceanog.2013.03; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Rochman C.M., 2014, SCI TOTAL ENV; Ryan PG, 2013, MAR POLLUT BULL, V69, P128, DOI 10.1016/j.marpolbul.2013.01.016; Soto-Navarro J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006302; SUARIA G, 2014, MAR POLLUT BULL, P8061; Suaria G, 2014, MAR POLLUT B; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Topcu E.N., 2010, RAPP COMM INT MER M, V39, P804; UNEP, 2009, MARINE LITTER A GLOB; UNEP/MAP-Plan Bleu, 2009, STAT ENV DEV MED; United Nations Environment Programme/Mediterranean Action Plan (UNEP/MAP), 2011, ASS STAT MAR LITT ME; Van Cauwenberghe L, 2014, ENVIRON POLLUT, V193, P65, DOI 10.1016/j.envpol.2014.06.010; van Sebille E, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044040; Zhou P, 2011, MAR POLLUT BULL, V62, P1998, DOI 10.1016/j.marpolbul.2011.06.018	50	413	423	8	237	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121762	10.1371/journal.pone.0121762	http://dx.doi.org/10.1371/journal.pone.0121762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831129	Green Published, gold			2022-12-27	WOS:000352135600083
J	Hendricks, JR				Hendricks, Jonathan R.			Glowing Seashells: Diversity of Fossilized Coloration Patterns on Coral Reef-Associated Cone Snail (Gastropoda: Conidae) Shells from the Neogene of the Dominican Republic	PLOS ONE			English	Article							EVOLUTION; MOLLUSCA; PALEOBIOGEOGRAPHY; BASIN; SEA	The biology of modern Conidae (cone snails)-which includes the hyperdiverse genus Conus-has been intensively studied, but the fossil record of the clade remains poorly understood, particularly within an evolutionary framework. Here, ultraviolet light is used to reveal and characterize the original shell coloration patterns of 28 species of cone snails from three Neogene coral reef-associated deposits from the Cibao Valley, northern Dominican Republic. These fossils come from the upper Miocene Cercado Fm. and lower Pliocene Gurabo Fm., and range in age from about 6.6-4.8 Ma. Comparison of the revealed coloration patterns with those of extant species allow the taxa to be assigned to three genera of cone snails (Profundiconus, Conasprella, and Conus) and at least nine subgenera. Thirteen members of these phylogenetically diverse reef faunas are described as new species. These include: Profundiconus? hennigi, Conasprella (Ximeniconus) ageri, Conus anningae, Conus lyelli, Conus (Atlanticonus?) franklinae, Conus (Stephanoconus) gouldi, Conus (Stephanoconus) bellacoensis, Conus (Ductoconus) cashi, Conus (Dauciconus) garrisoni, Conus (Dauciconus?) zambaensis, Conus (Spuriconus?) kaesleri, Conus (Spuriconus?) lombardii, and Conus (Lautoconus?) carlottae. Each of the three reef deposits contain a minimum of 14-16 cone snail species, levels of diversity that are similar to modern Indo-Pacific reef systems. Finally, most of the 28 species can be assigned to modern clades and thus have important implications for understanding the biogeographic and temporal histories of these clades in tropical America.	San Jose State Univ, US Amer & Paleontol Res Inst, Dept Geol, Ithaca, NY USA	California State University System; San Jose State University	Hendricks, JR (corresponding author), San Jose State Univ, US Amer & Paleontol Res Inst, Dept Geol, Ithaca, NY USA.	jonathan.hendricks@sjsu.edu			California State University Research Fund grant	California State University Research Fund grant	A California State University Research Fund grant (no grant number or website is available) supported travel to the Natural History Museum, London and and Naturhistorisches Museum Basel in 2009. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Otherwise, the author received no specific funding for this work.	Ager D, 1981, NATURE STRATIGRAPHIC; Allmon WD, SPECIES SPE IN PRESS; [Anonymous], 1995, MANUAL LIVING CONIDA; Arnold LB, 2010, EARTH SCI HIST, V29, P52, DOI 10.17704/eshi.29.1.j01207158q182348; Arnold LB, 2009, EARTH SCI HIST, V28, P219, DOI 10.17704/eshi.28.2.343vu112512w8170; BOSE E, 1906, B I GEOLOGICO MEXICO, V22, P1; Brown Amos, 1911, Proceedings of the Academy of Natural Sciences of Philadelphia, V63; Caze B, 2011, ACTA PALAEONTOL POL, V56, P329, DOI 10.4202/app.2009.0084; Caze B, 2011, CR PALEVOL, V10, P171, DOI 10.1016/j.crpv.2010.10.005; Caze B, 2010, GEODIVERSITAS, V32, P417, DOI 10.5252/g2010n3a4; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; Duda TF, 2005, MOL PHYLOGENET EVOL, V34, P257, DOI 10.1016/j.ympev.2004.09.012; Duda TF, 2009, BIOL BULL-US, V217, P292, DOI 10.1086/BBLv217n3p292; Duda TF, 2008, MOL PHYLOGENET EVOL, V49, P867, DOI 10.1016/j.ympev.2008.08.009; Finlay H. J., 1927, Transactions and Proceedings of the New Zealand Institute, V57, P488; Gabb WM, 1873, T AM PHILOS SOC, V15, P49, DOI DOI 10.2307/1005417; Garcia Emilio Fabian, 2006, Novapex, V7, P71; Gmelin JF, 1791, SYSTEMA NATURAE RE 6, V1; Gong ZQ, 2012, P NATL ACAD SCI USA, V109, pE234, DOI 10.1073/pnas.1119859109; GUPPY RJL, 1867, P SCI ASS TRINIDAD 3, P145; GUPPY RJL, 1866, Q J GEOL SOC LOND, V22, P281, DOI DOI 10.1144/GSL.JGS.1866.022.01-02.19; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; Hendricks J., 2009, BULL AM PALEONTOL, V375, P1; Hendricks JR, 2008, NAUTILUS, V122, P79; Hendricks JR, 2014, PALEOBIOLOGY, V40, P511, DOI 10.1666/13076; Hermsen EJ, 2008, ANN MO BOT GARD, V95, P72, DOI 10.3417/2006206; Hoerle S.E., 1976, Tulane Stud Geol Paleont, V12, P1; Holt BG, 2014, SYST BIOL, V63, P1010, DOI 10.1093/sysbio/syu061; Jackson JBC, 2013, B MAR SCI, V89, P779, DOI 10.5343/bms.2012.1096; Kamp Krueger K., 1974, Curator, V11, P36; Kase T, 2008, PALEONTOL RES, V12, P345, DOI 10.2517/prpsj.12.345; Klaus JS, 2003, PALAIOS, V18, P3, DOI 10.1669/0883-1351(2003)018<0003:COCCRC>2.0.CO;2; Kohn A.J., 2014, CONUS SE US CARIBBEA; KOHN AJ, 1975, MAR BIOL, V29, P211, DOI 10.1007/BF00391848; KOHN AJ, 1983, OECOLOGIA, V60, P293, DOI 10.1007/BF00376841; KOHN AJ, 1967, AM NAT, V101, P251, DOI 10.1086/282488; KOHN AJ, 1990, MALACOLOGIA, V32, P55; Kohn AJ, 2001, CORAL REEFS, V20, P25; Kominsky EV, 2007, RUSS J MAR BIOL+, V33, P238, DOI 10.1134/S1063074007040062; Landau B, 2008, PALAEOGEOGR PALAEOCL, V257, P445, DOI 10.1016/j.palaeo.2007.10.019; Landau Bernard M., 2013, Cainozoic Research, V11-1, P3; Marks J. G., 1951, Bulletins of American Paleontology, V33, P1; Maury C.J., 1917, BULL AM PALEONTOL, V5, P1; McNeill DF, 2012, GEOL SOC AM BULL, V124, P35, DOI 10.1130/B30391.1; MEINHARDT H, 2003, ALGORITHMIC BEAUTY S; Nehm Ross H., 2008, V30, P1; Olivera BM, 2014, ANNU REV ANIM BIOSCI, V2, P487, DOI 10.1146/annurev-animal-022513-114124; Olsson A.A, 1967, SOME TERTIARY MOLLUS; Petuch EJ, 2003, CENOZOIC SEAS THE VI; Petuch EJ, 1987, NEW CARIBBEAN MOLLUS; Pflug H. D., 1961, Acta Humboldtiana Geol Palaeont, V1, P1; Pilsbry H. A., 1922, Proceedings of the Academy of Natural Sciences of Philadelphia, V73, P305; Pitt William D., 1993, Tulane Studies in Geology and Paleontology, V26, P1; Puillandre N, 2015, J MOLLUS STUD, V81, P1, DOI 10.1093/mollus/eyu055; Puillandre N, 2014, MOL PHYLOGENET EVOL, V78, P290, DOI 10.1016/j.ympev.2014.05.023; Saunders J.B., 1986, Bulletins of American Paleontology, V89, P1; Smith UE, 2013, SYST BIOL, V62, P366, DOI 10.1093/sysbio/syt002; SOWERBY GBI, 1850, Q J GEOL SOC LOND, V6, P44; Tucker JK, 2013, CONE SHELLS FLORIDA; Tucker JK, 2009, SYSTEMATIC CLASSIFIC; Vokes E.H., 1989, Bulletins of American Paleontology, V97, P5; Vokes H. E., 1968, Tulane Studies in Geology, V6, P71; Waller Thomas R., 2011, Bulletins of American Paleontology, P1; Woodring W.P., 1928, MIOCENE MOLLUSKS B 2; WOODRING WP, 1966, P AM PHILOS SOC, V110, P425; WOODRING WP, 1970, US GEOLOGICAL SURV D, V306, P299, DOI DOI 10.3133/PP306D	66	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120924	10.1371/journal.pone.0120924	http://dx.doi.org/10.1371/journal.pone.0120924			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830769	Green Published, gold			2022-12-27	WOS:000352135600050
J	Kim, BS; Serebreni, L; Fallica, J; Hamdan, O; Wang, L; Johnston, L; Kolb, T; Damarla, M; Damico, R; Hassoun, PM				Kim, Bo S.; Serebreni, Leonid; Fallica, Jonathan; Hamdan, Omar; Wang, Lan; Johnston, Laura; Kolb, Todd; Damarla, Mahendra; Damico, Rachel; Hassoun, Paul M.			Cyclin-Dependent Kinase Five Mediates Activation of Lung Xanthine Oxidoreductase in Response to Hypoxia	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE FLUID; OXIDASE ACTIVITY; OXIDATIVE STRESS; CDK5; PHOSPHORYLATION; BRAIN; DEHYDROGENASE; INHIBITION; APOPTOSIS	Background Xanthine oxidoreductase (XOR) is involved in oxidative metabolism of purines and is a source of reactive oxygen species (ROS). As such, XOR has been implicated in oxidantmediated injury in multiple cardiopulmonary diseases. XOR enzyme activity is regulated, in part, via a phosphorylation-dependent, post-translational mechanism, although the kinase (s) responsible for such hyperactivation are unknown. Methods and Results Using an in silico approach, we identified a cyclin-dependent kinase 5 (CDK5) consensus motif adjacent to the XOR flavin adenine dinucleotide (FAD) binding domain. CDK5 is a proline- directed serine/threonine kinase historically linked to neural development and injury. We tested the hypothesis that CDK5 and its activators are mediators of hypoxia-induced hyperactivation of XOR in pulmonary microvascular endothelial cells (EC) and the intact murine lung. Using complementary molecular and pharmacologic approaches, we demonstrated that hypoxia significantly increased CDK5 activity in EC. This was coincident with increased expression of the CDK5 activators, cyclin-dependent kinase 5 activator 1 (CDK5r1 or p35/p25), and decreased expression of the CDK5 inhibitory peptide, p10. Expression of p35/p25 was necessary for XOR hyperactivation. Further, CDK5 physically associated with XOR and was necessary and sufficient for XOR phosphorylation and hyperactivation both in vitro and in vivo. XOR hyperactivation required the target threonine (T222) within the CDK5-consensus motif. Conclusions and Significance These results indicate that p35/CDK5-mediated phosphorylation of T222 is required for hypoxia-induced XOR hyperactivation in the lung. Recognizing the contribution of XOR to oxidative injury in cardiopulmonary disease, these observations identify p35/CDK5 as novel regulators of XOR and potential modifiers of ROS-mediated injury.	[Kim, Bo S.; Serebreni, Leonid; Hamdan, Omar; Wang, Lan; Johnston, Laura; Kolb, Todd; Damarla, Mahendra; Damico, Rachel; Hassoun, Paul M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21224 USA; [Fallica, Jonathan; Damico, Rachel] Johns Hopkins Univ, Sch Publ Hlth, Environm Hlth Sci, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University	Hassoun, PM (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21224 USA.	phassoun1@jhmi.edu	Kolb, Todd/ABD-8204-2020		National Institute of Health [NIH/NHLBI 5R01HL049441-17, K08HL088320, F32HL097588]; Flight attendants medical research institute [072129, 110627]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097588, K08HL088320, R01HL049441] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight attendants medical research institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institute of Health: NIH/NHLBI 5R01HL049441-17 (PMH). Role: study design, data analysis, preparation of manuscript. http://grants.nih.gov/grants/oer.htm. National Institute of Health: K08HL088320 (RD). Role: study design, data analysis, preparation of manuscript. National Institute of Health: F32HL097588 (BSK). Role: study design, data analysis, data collection, manuscript prep. Flight attendants medical research institute: 072129 (BSK) and 110627 (RD). Role: study design, data analysis, manuscript prep. http://www.famri.org/core/.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Cai XH, 1997, NEUROSCI RES, V28, P355, DOI 10.1016/S0168-0102(97)00063-1; Damico RL, 2008, AM J RESP CELL MOL, V39, P77, DOI 10.1165/rcmb.2007-0248OC; Girgis RE, 2003, AM J PHYSIOL-HEART C, V285, pH938, DOI 10.1152/ajpheart.01097.2002; Green SL, 1997, NEUROCHEM INT, V31, P617, DOI 10.1016/S0197-0186(97)00012-0; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Heunks LMA, 1999, AM J PHYSIOL-REG I, V277, pR1697, DOI 10.1152/ajpregu.1999.277.6.R1697; HOSHINO T, 1988, TRANSPLANTATION, V45, P284, DOI 10.1097/00007890-198802000-00006; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; Kim BS, 2013, FREE RADICAL BIO MED, V60, P336, DOI 10.1016/j.freeradbiomed.2013.01.023; LEW J, 1992, J BIOL CHEM, V267, P13383; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Minhas KM, 2006, CIRC RES, V98, P271, DOI 10.1161/01.RES.0000200181.59551.71; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Page S, 1998, BBA-GEN SUBJECTS, V1381, P191, DOI 10.1016/S0304-4165(98)00028-2; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pinamonti S, 1998, FREE RADICAL BIO MED, V25, P771, DOI 10.1016/S0891-5849(98)00128-2; Pinamonti S, 1996, FREE RADICAL BIO MED, V21, P147, DOI 10.1016/0891-5849(96)00030-5; Poss WB, 1996, AM J PHYSIOL-LUNG C, V270, pL941, DOI 10.1152/ajplung.1996.270.6.L941; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Sharma MR, 2004, J CELL BIOCHEM, V91, P398, DOI 10.1002/jcb.10762; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0124189	10.1371/journal.pone.0124189	http://dx.doi.org/10.1371/journal.pone.0124189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831123	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600153
J	Mannava, AG; Tolwinski, NS				Mannava, Anirudh G.; Tolwinski, Nicholas S.			Membrane Bound GSK-3 Activates Wnt Signaling through Disheveled and Arrow	PLOS ONE			English	Article							POLARITY GENE ARMADILLO; ADENOMATOUS POLYPOSIS-COLI; TUMOR-SUPPRESSOR PROTEIN; BETA-CATENIN; DROSOPHILA HOMOLOG; WINGLESS SIGNAL; AXIN; PHOSPHORYLATION; INHIBITION; EXPRESSION	Wnt ligands and their downstream pathway components coordinate many developmental and cellular processes. In adults, they regulate tissue homeostasis through regulation of stem cells. Mechanistically, signal transduction through this pathway is complicated by pathway components having both positive and negative roles in signal propagation. Here we examine the positive role of GSK-3/Zw3 in promoting signal transduction at the plasma membrane. We find that targeting GSK-3 to the plasma membrane activates signaling in Drosophila embryos. This activation requires the presence of the co-receptor Arrow-LRP5/6 and the pathway activating protein Disheveled. Our results provide genetic evidence for evolutionarily conserved, separable roles for GSK-3 at the membrane and in the cytosol, and are consistent with a model where the complex cycles from cytosol to membrane in order to promote signaling at the membrane and to prevent it in the cytosol.	[Tolwinski, Nicholas S.] Natl Univ Singapore, Yale NUS Coll, Singapore 117599, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Translat Med, Dept Biol Sci, Singapore 117599, Singapore	National University of Singapore; Yale NUS College; National University of Singapore	Tolwinski, NS (corresponding author), Natl Univ Singapore, Yale NUS Coll, 14 Med Dr,Level 10 South,10-02M, Singapore 117599, Singapore.	nicholas.tolwinski@yale-nus.edu.sg	Tolwinski, Nicholas/Q-5782-2019	Tolwinski, Nicholas/0000-0002-8507-2737; GAUTAM, ANIRUDH/0000-0002-1724-9625	Academic Research Fund (AcRF) of the Ministry of Education, Singapore [MOE2014-T2-2-039]	Academic Research Fund (AcRF) of the Ministry of Education, Singapore	This work was supported by an Academic Research Fund (AcRF) grant (MOE2014-T2-2-039) of the Ministry of Education, Singapore to N. Tolwinski. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHOU TB, 1992, GENETICS, V131, P643; Chou TB, 1996, GENETICS, V144, P1673; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Colosimo PF, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000009; Colosimo PF, 2010, DEV DYNAM, V239, P115, DOI 10.1002/dvdy.21963; Cruciat CM, 2014, CURR OPIN CELL BIOL, V31, P46, DOI 10.1016/j.ceb.2014.08.003; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOUGAN S, 1992, NATURE, V360, P347, DOI 10.1038/360347a0; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Kaplan NA, 2009, GENETICS, V183, P897, DOI 10.1534/genetics.109.108878; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Roberts DM, 2012, MOL BIOL CELL, V23, P2041, DOI 10.1091/mbc.E11-11-0965; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schwarz-Romond T, 2005, J CELL SCI; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tacchelly-Benites O, 2013, BIOESSAYS, V35, P1063, DOI 10.1002/bies.201300101; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2009, GENETICS, V181, P1169, DOI 10.1534/genetics.108.098236; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	57	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121879	10.1371/journal.pone.0121879	http://dx.doi.org/10.1371/journal.pone.0121879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848770	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800082
J	Mazzone, P; Scudiero, I; Ferravante, A; Paolucci, M; D'Andrea, LE; Varricchio, E; Telesio, G; De Maio, C; Pizzulo, M; Zotti, T; Reale, C; Vito, P; Stilo, R				Mazzone, Pellegrino; Scudiero, Ivan; Ferravante, Angela; Paolucci, Marina; D'Andrea, Luca E.; Varricchio, Ettore; Telesio, Gianluca; De Maio, Chiara; Pizzulo, Maddalena; Zotti, Tiziana; Reale, Carla; Vito, Pasquale; Stilo, Romania			Functional Characterization of Zebrafish (Danio rerio) Bcl10	PLOS ONE			English	Article							NF-KAPPA-B; CASPASE RECRUITMENT DOMAIN; CONTAINING PROTEIN; CARMA PROTEINS; MALT LYMPHOMA; FAMILY MEMBER; ACTIVATION; REGULATOR; PATHWAY; GENE	The complexes formed by BCL10, MALT1 and specific members of the family of CARMA proteins (CBM complex), have recently focused much attention because they represent a central hub regulating activation of the transcription factor NF-kappa B following various cellular stimulations. In this manuscript, we report the functional characterization of a Danio rerio 241 amino acids polypeptide ortholog of the Caspase recruiting domain (CARD)-containing protein BCL10. Biochemical studies show that zebrafish Bcl10 (zBcl10) dimerizes and binds to components of the CBM complex. Fluorescence microscopy observations demonstrate that zBcl10 forms cytoplasmic filaments similar to that formed by human BCL10 (hBCL10). Functionally, in human cells zBcl10 is more effective in activating NF-kappa B compared to hBCL10, possibly due to the lack of carboxy-terminal inhibitory serine residues present in the human protein. Also, depletion experiments carried out through expression of short hairpin RNAs targeting hBCL10 indicate that zBcl10 can functionally replace the human protein. Finally, we show that the zebrafish cell line PAC2 is suitable to carry out reporter assays for monitoring the activation state of NF-kappa B transcription factor. In conclusion, this work shows that zebrafish may excellently serve as a model organism to study complex and intricate signal transduction pathways, such as those that control NF-kappa B activation.	[Mazzone, Pellegrino; Scudiero, Ivan; Ferravante, Angela; D'Andrea, Luca E.; De Maio, Chiara; Pizzulo, Maddalena; Reale, Carla; Vito, Pasquale] Biogem, Ariano Irpino, AV, Italy; [Paolucci, Marina; Varricchio, Ettore; Zotti, Tiziana; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy; [Telesio, Gianluca] Univ Naples Federico II, Naples, Italy	University of Sannio; University of Naples Federico II	Vito, P (corresponding author), Biogem, Via Camporeale, Ariano Irpino, AV, Italy.	vito@unisannio.it	Varricchio, Ettore/GQZ-1929-2022; Mazzone, Pellegrino/AAC-6576-2020; Reale, Carla/AAB-7939-2020; vito, pasquale/ABF-5505-2020; Zotti, Tiziana/AAV-6768-2021	Varricchio, Ettore/0000-0001-6241-7096; Mazzone, Pellegrino/0000-0002-6217-1505; Reale, Carla/0000-0001-7682-4784; Zotti, Tiziana/0000-0003-4753-116X; Paolucci, Marina/0000-0002-1784-3843; ferravante, angela/0000-0002-4932-3877; vito, pasquale/0000-0002-5721-7716; scudiero, ivan/0000-0001-5559-5548	Qatar National Research Fund (a member of Qatar Foundation) [NPRP 7-466-3-119]	Qatar National Research Fund (a member of Qatar Foundation)	Part of this work was made possible by the NPRP grant NPRP 7-466-3-119 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; Chang MX, 2010, DEV COMP IMMUNOL, V34, P1, DOI 10.1016/j.dci.2009.08.002; Costanzo A, 1999, J BIOL CHEM, V274, P20127, DOI 10.1074/jbc.274.29.20127; D' Andrea EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116062; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042775; Marasco D, 2009, BIOCHEM J, V422, P553, DOI 10.1042/BJ20090055; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Park Y, 2013, P NATL ACAD SCI USA, V110, P9433, DOI 10.1073/pnas.1221925110; Paul S, 2014, SCI SIGNAL, V7, DOI [10.1126/scisignal.2005032, DOI 10.1126/SCISIGNAL.2005032]; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sakamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085762; Scudiero I, 2014, J CELL PHYSIOL, V229, P990, DOI 10.1002/jcp.24543; Scudiero I, 2012, J BIOL CHEM, V287, P6053, DOI 10.1074/jbc.M111.300137; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vessichelli M, 2012, J BIOL CHEM, V287, P13722, DOI 10.1074/jbc.M111.304436; Vito P, 2014, IMMUNOL LETT, V160, P102, DOI 10.1016/j.imlet.2014.02.002; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yoneda T, 2000, J BIOL CHEM, V275, P11114, DOI 10.1074/jbc.275.15.11114; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zotti T, 2014, MOL IMMUNOL, V58, P27, DOI 10.1016/j.molimm.2013.10.015; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	48	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122365	10.1371/journal.pone.0122365	http://dx.doi.org/10.1371/journal.pone.0122365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849213	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800121
J	Sidik, SM; Salsman, J; Dellaire, G; Rohde, JR				Sidik, Saima M.; Salsman, Jayme; Dellaire, Graham; Rohde, John R.			Shigella Infection Interferes with SUMOylation and Increases PML-NB Number	PLOS ONE			English	Article							NUCLEAR-BODIES; DNA-DAMAGE; EFFECTOR OSPG; PROTEIN; UBIQUITIN; SECRETION; BODY; SUMO; MECHANISMS; EXPRESSION	Shigellosis is a severe diarrheal disease that affects hundreds of thousands of individuals resulting in significant morbidity and mortality worldwide. Shigellosis is caused by Shigella spp., a gram-negative bacterium that uses a Type 3 Secretion System (T3SS) to deliver effector proteins into the cytosol of infected human cells. Shigella infection triggers multiple signaling programs that result in a robust host transcriptional response that includes the induction of multiple proinflammatory cytokines. PML nuclear bodies (PML-NBs) are dynamic subnuclear structures that coordinate immune signaling programs and have a demonstrated role in controlling viral infection. We show that PML-NB number increases upon Shigella infection. We examined the effects of Shigella infection on SUMOylation and found that upon Shigella infection the localization of SUMOylated proteins is altered and the level of SUMOylated proteins decreases. Although Shigella infection does not alter the abundance of SUMO activating enzymes SAE1 or SAE2, it dramatically decreases the level of the SUMO conjugating enzyme Ubc9. All Shigella-induced alterations to the SUMOylation system are dependent upon a T3SS. Thus, we demonstrate that Shigella uses one or more T3SS effectors to influence both PML-NB number and the SUMOylation machinery in human cells.	[Sidik, Saima M.; Rohde, John R.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Salsman, Jayme; Dellaire, Graham] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Dellaire, Graham] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Dellaire, Graham] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Rohde, JR (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	John.Rohde@Dal.Ca	Dellaire, Graham/L-9948-2014	Dellaire, Graham/0000-0002-3466-6316	Natural Sciences and Engineering Research Council [RGPIN 386297]; Canadian Institutes of Health Research [MOP-102594, MOP-84260]; Beatrice Hunter Cancer Research Institute; Terry Fox Foundation as part of a Strategic Health Research Training Program in Cancer Research at CIHR	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute; Terry Fox Foundation as part of a Strategic Health Research Training Program in Cancer Research at CIHR(Canadian Institutes of Health Research (CIHR))	Natural Sciences and Engineering Research Council: RGPIN 386297 Canadian Institutes of Health Research: MOP-102594 and MOP-84260 SS was an Alexander Graham Bell Canada Graduate Scholar, GD is a Senior Scientist of the Beatrice Hunter Cancer Research Institute (BHCRI), JS was supported by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided the Terry Fox Foundation as part of a Strategic Health Research Training Program in Cancer Research at CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; ALLAOUI A, 1993, MOL MICROBIOL, V7, P59, DOI 10.1111/j.1365-2958.1993.tb01097.x; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bergounioux J, 2012, CELL HOST MICROBE, V11, P240, DOI 10.1016/j.chom.2012.01.013; Beyer AR, 2015, CELL MICROBIOL, V17, P504, DOI 10.1111/cmi.12380; Bloch DB, 1999, MOL CELL BIOL, V19, P4423; Bourdeau V, 2009, FRONT BIOSCI-LANDMRK, V14, P475, DOI 10.2741/3256; Brouwer AK, 2009, MOL BIOL CELL, V20, P4804, DOI 10.1091/mbc.E09-04-0309; Dellaire G, 2006, J CELL SCI, V119, P1034, DOI 10.1242/jcs.02817; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; Dunphy PS, 2014, INFECT IMMUN, V82, P4154, DOI 10.1128/IAI.01984-14; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Eskiw CH, 2002, BIOCHEM CELL BIOL, V80, P301, DOI 10.1139/O02-079; Everett RD, 2005, J VIROL, V79, P5078, DOI 10.1128/JVI.79.8.5078-5089.2005; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Fritah S, 2014, EMBO REP, V15, P965, DOI 10.15252/embr.201338386; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gomes R, 2010, VIROLOGY, V396, P256, DOI 10.1016/j.virol.2009.10.005; Huibregtse J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004255; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jehl SP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002809; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; LABIGNEROUSSEL AF, 1984, INFECT IMMUN, V46, P251, DOI 10.1128/IAI.46.1.251-259.1984; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lunardi Andrea, 2011, Genes Cancer, V2, P10, DOI 10.1177/1947601911402682; Maarifi G, 2014, CYTOKINE GROWTH F R, V25, P551, DOI 10.1016/j.cytogfr.2014.04.008; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Onodera NT, 2012, J BACTERIOL, V194, P3022, DOI 10.1128/JB.00393-12; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Pruneda JN, 2014, EMBO J, V33, P437, DOI 10.1002/embj.201386386; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Sahin U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5187; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000100; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sidik S, 2014, G3-GENES GENOM GENET, V4, P2493, DOI 10.1534/g3.114.014381; Sivachandran N, 2012, J VIROL, V86, P6146, DOI 10.1128/JVI.00013-12; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Tavalai N, 2011, VIRUS RES, V157, P128, DOI 10.1016/j.virusres.2010.10.002; Ulrich HD, 2014, NAT STRUCT MOL BIOL, V21, P317, DOI 10.1038/nsmb.2805; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998	57	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122585	10.1371/journal.pone.0122585	http://dx.doi.org/10.1371/journal.pone.0122585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848798	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800142
J	Cesbron, Y; Shaheen, U; Free, P; Levy, R				Cesbron, Yann; Shaheen, Umbreen; Free, Paul; Levy, Raphael			TAT and HA2 Facilitate Cellular Uptake of Gold Nanoparticles but Do Not Lead to Cytosolic Localisation	PLOS ONE			English	Article							PEPTIDES; PROTEIN; DELIVERY; CELLS; SIZE; PENETRATION; TRAFFICKING; ABSORPTION; EFFICIENCY; MICROSCOPY	The methods currently available to deliver functional labels and drugs to the cell cytosol are inefficient and this constitutes a major obstacle to cell biology (delivery of sensors and imaging probes) and therapy (drug access to the cell internal machinery). As cell membranes are impermeable to most molecular cargos, viral peptides have been used to bolster their internalisation through endocytosis and help their release to the cytosol by bursting the endosomal vesicles. However, conflicting results have been reported on the extent of the cytosolic delivery achieved. To evaluate their potential, we used gold nanoparticles as model cargos and systematically assessed how the functionalisation of their surface by either or both of the viral peptides TAT and HA2 influenced their intracellular delivery. We evaluated the number of gold nanoparticles present in cells after internalisation using photothermal microscopy and their subcellular localisation by electron microscopy. While their uptake increased when the TAT and/or HA2 viral peptides were present on their surface, we did not observe a significant cytosolic delivery of the gold nanoparticles.	[Cesbron, Yann] Univ Liverpool, Dept Chem, Liverpool L69 3BX, Merseyside, England; [Cesbron, Yann; Shaheen, Umbreen; Free, Paul; Levy, Raphael] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Cesbron, Yann] CNRS, Inst Genet & Dev Rennes, UMR 6290, Rennes, France; [Cesbron, Yann] Univ Rennes 1, Univ Europeenne Bretagne Struct Fed Rech Biosit, Rennes, France; [Free, Paul] ASTAR, Inst Mat Res & Engn, Singapore, Singapore	University of Liverpool; University of Liverpool; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE)	Levy, R (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	rapha@liverpool.ac.uk	Free, Paul/AAW-7885-2021; Levy, Raphael/D-1474-2009; Cesbron, Yann/A-6485-2010	Free, Paul/0000-0002-6231-6989; Levy, Raphael/0000-0001-5728-0531; Cesbron, Yann/0000-0002-6953-1913	Engineering and Physical Sciences Research Council; Higher Education Commission of Pakistan; Biotechnology and Biological Sciences Research Council (David Phillips Fellowship) [BB/D020638/1]; Medical Research Council [MR/K015931/1]; BBSRC [BB/D020638/1] Funding Source: UKRI; MRC [MR/K015931/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D020638/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Biotechnology and Biological Sciences Research Council (David Phillips Fellowship)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	YC thanks the Engineering and Physical Sciences Research Council for the award of a Liverpool University Doctoral Training Grant studentship. US thanks the Higher Education Commission of Pakistan for a PhD scholarship. RL thanks the Biotechnology and Biological Sciences Research Council (David Phillips Fellowship BB/D020638/1) and the Medical Research Council (MR/K015931/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts Bruce, 2009, Science, V324, P463, DOI 10.1126/science.324_463a; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Berciaud S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045424; Berciaud S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.257402; Berciaud S, 2005, NANO LETT, V5, P515, DOI 10.1021/nl050062t; Berciaud S, 2007, NANO LETT, V7, P1203, DOI 10.1021/nl062933k; Berciaud S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077402; Berry CC, 2007, IEEE T NANOBIOSCI, V6, P262, DOI 10.1109/TNB.2007.908973; Bogart LK, 2014, ACS NANO, V8, P3107, DOI 10.1021/nn500962q; Bogart LK, 2012, ACS NANO, V6, P5961, DOI 10.1021/nn300868z; Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528; Cesbron Y, 2014, INTRACELLULAR DELIVE; Cesbron Y, 2014, CCALNN PEG MONOLAYER; Cesbron Y, 2012, SMALL, V8, P3714, DOI 10.1002/smll.201001465; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Conde J, 2012, ACS NANO, V6, P8316, DOI 10.1021/nn3030223; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; de la Fuente JM, 2005, BIOCONJUGATE CHEM, V16, P1176, DOI 10.1021/bc050033+; Dokka S, 2000, ADV DRUG DELIVER REV, V44, P35, DOI 10.1016/S0169-409X(00)00082-X; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HARFORD CG, 1957, J BIOPHYS BIOCHEM CY, V3, P749, DOI 10.1083/jcb.3.5.749; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; Kaplan IM, 2005, J CONTROL RELEASE, V107, P571, DOI 10.1016/j.jconrel.2004.10.018; Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w; Krpetic Z, 2011, ACS NANO, V5, P5195, DOI 10.1021/nn201369k; Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i; Lasne D, 2006, BIOPHYS J, V91, P4598, DOI 10.1529/biophysj.106.089771; Lee YJ, 2011, BBA-GEN SUBJECTS, V1810, P752, DOI 10.1016/j.bbagen.2011.05.013; Levy R, 2006, CHEMBIOCHEM, V7, P592, DOI 10.1002/cbic.200500457; Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269; Levy R, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.4889; Liou JS, 2012, PEPTIDES, V37, P273, DOI 10.1016/j.peptides.2012.07.019; Liu XL, 2013, INT J PHARMACEUT, V448, P159, DOI 10.1016/j.ijpharm.2013.03.033; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006; Pujals S, 2009, CHEMBIOCHEM, V10, P1025, DOI 10.1002/cbic.200800843; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Santra S, 2004, CHEM COMMUN, P2810, DOI 10.1039/b411916a; Santra S, 2005, CHEM COMMUN, P3144, DOI 10.1039/b503234b; See V, 2009, ACS NANO, V3, P2461, DOI 10.1021/nn9006994; Shaheen U, 2014, EFFECT PEG INTRACELL; Shaheen U, 2014, INFLUENCE PROPORTION; Shaheen U, 2014, ORIENTATION HA2 PEPT; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Stirling J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108482; Sugita T, 2007, BIOCHEM BIOPH RES CO, V363, P1027, DOI 10.1016/j.bbrc.2007.09.077; Todorova N, 2014, NANO LETT, V14, P5229, DOI 10.1021/nl5021848; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Xia HM, 2012, INT J PHARMACEUT, V436, P840, DOI 10.1016/j.ijpharm.2012.07.029; Yguerabide J, 1998, ANAL BIOCHEM, V262, P137, DOI 10.1006/abio.1998.2759; Yin P, 2010, MAT SCI ENG C-MATER, V30, P1260, DOI 10.1016/j.msec.2010.07.006; Yu M, 2012, SMALL, V8, P3720, DOI 10.1002/smll.201202322; Zhang Y, 2008, CURR OPIN BIOTECH, V19, P506, DOI 10.1016/j.copbio.2008.07.005	70	20	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121683	10.1371/journal.pone.0121683	http://dx.doi.org/10.1371/journal.pone.0121683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836335	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000056
J	Jacobsen, E; Dart, AJ; Mondori, T; Horadogoda, N; Jeffcott, LB; Little, CB; Smith, MM				Jacobsen, Else; Dart, Andrew J.; Mondori, Takamitsu; Horadogoda, Neil; Jeffcott, Leo B.; Little, Christopher B.; Smith, Margaret M.			Focal Experimental Injury Leads to Widespread Gene Expression and Histologic Changes in Equine Flexor Tendons	PLOS ONE			English	Article							HUMAN ACHILLES-TENDON; MESSENGER-RNA; ANIMAL-MODELS; EXTRACELLULAR-MATRIX; PATELLAR TENDON; ELITE FOOTBALL; TENDINITIS; METALLOPROTEINASES; TENDINOSIS; AGGRECAN	It is not known how extensively a localised flexor tendon injury affects the entire tendon. This study examined the extent of and relationship between histopathologic and gene expression changes in equine superficial digital flexor tendon after a surgical injury. One forelimb tendon was hemi-transected in six horses, and in three other horses, one tendon underwent a sham operation. After euthanasia at six weeks, transected and control (sham and non-operated contralateral) tendons were regionally sampled (medial and lateral halves each divided into six 3cm regions) for histologic (scoring and immunohistochemistry) and gene expression (real time PCR) analysis of extracellular matrix changes. The histopathology score was significantly higher in transected tendons compared to control tendons in all regions except for the most distal (P <= 0.03) with no differences between overstressed (medial) and stress-deprived (lateral) tendon halves. Proteoglycan scores were increased by transection in all but the most proximal region (P < 0.02), with increased immunostaining for aggrecan, biglycan and versican. After correcting for location within the tendon, gene expression for aggrecan, versican, biglycan, lumican, collagen types I, II and III, MMP14 and TIMP1 was increased in transected tendons compared with control tendons (P < 0.02) and decreased for ADAMTS4, MMP3 and TIMP3 (P < 0.001). Aggrecan, biglycan, fibromodulin, and collagen types I and III expression positively correlated with all histopathology scores (P < 0.001), whereas lumican, ADAMTS4 and MMP14 expression positively correlated only with collagen fiber malalignment (P < 0.001). In summary, histologic and associated gene expression changes were significant and widespread six weeks after injury to the equine SDFT, suggesting rapid and active development of tendinopathy throughout the entire length of the tendon. These extensive changes distant to the focal injury may contribute to poor functional outcomes and re-injury in clinical cases. Our data suggest that successful treatments of focal injuries will need to address pathology in the entire tendon, and that better methods to monitor the development and resolution of tendinopathy are required.	[Jacobsen, Else; Dart, Andrew J.; Horadogoda, Neil; Jeffcott, Leo B.] Univ Sydney, Univ Vet Teaching Hosp, Res & Clin Training Unit, Camden, NSW, Australia; [Mondori, Takamitsu; Little, Christopher B.; Smith, Margaret M.] Univ Sydney, Royal N Shore Hosp, Raymond Purves Bone & Joint Res Labs, Inst Bone & Joint Res,Kolling Inst Med Res, St Leonards, NSW 2065, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Smith, MM (corresponding author), Univ Sydney, Royal N Shore Hosp, Raymond Purves Bone & Joint Res Labs, Inst Bone & Joint Res,Kolling Inst Med Res, St Leonards, NSW 2065, Australia.	mobsmith@sydney.edu.au	Dart, A. J./K-7113-2017; Smith, Margaret/E-9633-2010; Jeffcott, Leo/S-8887-2017; little, christopher/A-9280-2015	Dart, A. J./0000-0002-9102-8003; Smith, Margaret/0000-0002-2020-0056; Jacobson, Else/0000-0001-7524-7655; Jeffcott, Leo/0000-0002-2855-6946; little, christopher/0000-0002-0353-7634	Australian Orthopaedic Association; Hillcrest Foundation; National Health and Medical Research Council of Australia [570922]	Australian Orthopaedic Association; Hillcrest Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was partially funded by grants from the Australian Orthopaedic Association (www.aoa.org.au) and the Hillcrest Foundation (https://www.bankofamerica.com/philanthropic/foundation.go?fnId=89). MMS was funded by the National Health and Medical Research Council of Australia (Project #570922; www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2723; Alfredson H, 2003, J ORTHOPAED RES, V21, P970, DOI 10.1016/S0736-0266(03)00107-4; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; Attia M, 2014, BRIT J SPORT MED, V48, P469, DOI 10.1136/bjsports-2013-092633; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Bey MJ, 2012, J SHOULDER ELB SURG, V21, P149, DOI 10.1016/j.jse.2011.10.023; Burssens A, 2013, KNEE SURG SPORT TR A, V21, P1459, DOI 10.1007/s00167-012-2203-3; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; Corps AN, 2004, RHEUMATOLOGY, V43, P969, DOI 10.1093/rheumatology/keh222; Corps AN, 2008, MATRIX BIOL, V27, P393, DOI 10.1016/j.matbio.2008.02.002; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; Crevier-Denoix N, 2005, J BIOMECH, V38, P2212, DOI 10.1016/j.jbiomech.2004.09.026; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dakin SG, 2014, VET IMMUNOL IMMUNOP, V158, P121, DOI 10.1016/j.vetimm.2014.01.007; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; Demehri S, 2014, J COMPUT ASSIST TOMO, V38, P299, DOI 10.1097/RCT.0b013e3182aa72bf; Docking SI, 2012, VET J, V194, P338, DOI 10.1016/j.tvjl.2012.04.024; Donaldson Peter R, 2012, Clin J Sport Med, V22, P169, DOI 10.1097/JSM.0b013e31824c2b2c; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dy CJ, 2012, J HAND SURG-AM, V37A, P919, DOI 10.1016/j.jhsa.2012.02.003; Dyment NA, 2012, J ORTHOP RES, V30, P28, DOI 10.1002/jor.21484; Dyson SJ, 2004, EQUINE VET J, V36, P415, DOI 10.2746/0425164044868422; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hosaka YZ, 2010, TISSUE CELL, V42, P9, DOI 10.1016/j.tice.2009.06.002; Ireland D, 2001, MATRIX BIOL, V20, P159, DOI 10.1016/S0945-053X(01)00128-7; Jelinsky SA, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-86; John T, 2010, J ORTHOP RES, V28, P1071, DOI 10.1002/jor.21079; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y; Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460; Leigh DR, 2008, J ORTHOP RES, V26, P1306, DOI 10.1002/jor.20650; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Longo UG, 2011, SPORTS MED ARTHROSC, V19, P184, DOI 10.1097/JSA.0b013e318205470e; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Lui PPY, 2012, J ORTHOP RES, V30, P37, DOI 10.1002/jor.21495; Lundin AC, 2014, SCAND J MED SCI SPOR, V24, P363, DOI 10.1111/j.1600-0838.2012.01514.x; Mazzocca AD, 2013, ARTHROSCOPY, V29, P972, DOI 10.1016/j.arthro.2013.02.002; Nilsson-Helander K, 2010, AM J SPORT MED, V38, P2186, DOI 10.1177/0363546510376052; O'Meara B, 2010, EQUINE VET J, V42, P322, DOI 10.1111/j.2042-3306.2009.00021.x; Oikawa Masa-aki, 2002, Journal of Equine Science, V13, P41, DOI 10.1294/jes.13.41; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Patterson-Kane JC, 2009, VET J, V181, P79, DOI 10.1016/j.tvjl.2008.02.009; Peffers MJ, 2014, J BIOL CHEM, V289, P25867, DOI 10.1074/jbc.M114.566554; Petersen J, 2010, SCAND J MED SCI SPOR, V20, P588, DOI 10.1111/j.1600-0838.2009.00995.x; Rand T, 1998, INVEST RADIOL, V33, P433, DOI 10.1097/00004424-199808000-00002; Reardon RJM, 2013, VET J, V195, P325, DOI 10.1016/j.tvjl.2012.06.033; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley GP, 2005, SCAND J MED SCI SPOR, V15, P241, DOI 10.1111/j.1600-0838.2005.00456.x; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Schramme M, 2010, VET COMP ORTHOPAED, V23, P231, DOI 10.3415/VCOT-09-10-0106; Scott A, 2008, SCAND J MED SCI SPOR, V18, P427, DOI 10.1111/j.1600-0838.2007.00735.x; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Sivaguru M, 2014, METHODS, V66, P256, DOI 10.1016/j.ymeth.2013.07.016; Slager R F, 1977, Am J Sports Med, V5, P37, DOI 10.1177/036354657700500201; Smith MM, 2008, ARTHRITIS RHEUM-US, V58, P1055, DOI 10.1002/art.23388; Sobhani S, 2013, SCAND J MED SCI SPOR, V23, P669, DOI 10.1111/j.1600-0838.2012.01509.x; Stanton H, 2011, BBA-MOL BASIS DIS, V1812, P1616, DOI 10.1016/j.bbadis.2011.08.009; Sztrolovics R, 2002, BIOCHEM J, V362, P465, DOI 10.1042/0264-6021:3620465; Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002; Thornton GM, 2011, J MUSCULOSKEL NEURON, V11, P94; van Hamel SE, 2014, EQUINE VET J, V46, P300, DOI 10.1111/evj.12129; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342; Watanabe T, 2012, J ANAT, V220, P156, DOI 10.1111/j.1469-7580.2011.01456.x; WATKINS JP, 1985, AM J VET RES, V46, P2091; Watts AE, 2012, EQUINE VET J, V44, P576, DOI 10.1111/j.2042-3306.2011.00471.x; Wilkins R, 2012, AM J SPORT MED, V40, P2154, DOI 10.1177/0363546512453293; Williams RB, 2001, EQUINE VET J, V33, P478, DOI 10.2746/042516401776254808; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	71	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122220	10.1371/journal.pone.0122220	http://dx.doi.org/10.1371/journal.pone.0122220			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837713	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000086
J	Nicholson, J; Azim, S; Rebecchi, MJ; Galbavy, W; Feng, T; Reinsel, R; Rizwan, S; Fowler, CJ; Benveniste, H; Kaczocha, M				Nicholson, James; Azim, Syed; Rebecchi, Mario J.; Galbavy, William; Feng, Tian; Reinsel, Ruth; Rizwan, Sabeen; Fowler, Christopher J.; Benveniste, Helene; Kaczocha, Martin			Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebrospinal Fluid of Patients with Osteoarthritis	PLOS ONE			English	Article							CIRCULATING ENDOCANNABINOID LEVELS; CARDIOMETABOLIC RISK-FACTORS; ANANDAMIDE LEVELS; CANNABINOID RECEPTOR; SERUM LEPTIN; SYSTEM; DIET; ACTIVATION; ADIPOSE; OBESITY	` Background There is compelling evidence in humans that peripheral endocannabinoid signaling is disrupted in obesity. However, little is known about the corresponding central signaling. Here, we have investigated the relationship between gender, leptin, body mass index (BMI) and levels of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in the serum and cerebrospinal fluid (CSF) of primarily overweight to obese patients with osteoarthritis. Methodology/Principal Findings Patients (20 females, 15 males, age range 44-78 years, BMI range 24-42) undergoing total knee arthroplasty for end-stage osteoarthritis were recruited for the study. Endocannabinoids were quantified by liquid chromatography - mass spectrometry. AEA and 2-AG levels in the serum and CSF did not correlate with either age or BMI. However, 2-AG levels in the CSF, but not serum, correlated negatively with CSF leptin levels (Spearman's. -0.48, P=0.0076, n=30). No such correlations were observed for AEA and leptin. Conclusions/Significance In the patient sample investigated, there is a negative association between 2-AG and leptin levels in the CSF. This is consistent with pre-clinical studies in animals, demonstrating that leptin controls the levels of hypothalamic endocannabinoids that regulate feeding behavior.	[Nicholson, James] SUNY Stony Brook, Dept Orthoped Surg, Stony Brook, NY 11794 USA; [Azim, Syed; Rebecchi, Mario J.; Galbavy, William; Reinsel, Ruth; Rizwan, Sabeen; Benveniste, Helene; Kaczocha, Martin] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Feng, Tian] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Kaczocha, Martin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Umea University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Benveniste, H (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.	Helene.Benveniste@Stonybrookmedicine.edu; Martin.Kaczocha@Stonybrook.edu	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Galbavy, William/0000-0003-0948-9538; Kaczocha, Martin/0000-0002-2527-1398	Department of Anesthesiology; National Institutes of Health [DA035923, DA035949]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035949, R01DA035923] Funding Source: NIH RePORTER	Department of Anesthesiology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Department of Anesthesiology and National Institutes of Health grants DA035923 and DA035949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour J, 2014, OBESITY, V22, P211, DOI 10.1002/oby.20498; Annuzzi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-43; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Azim S, 2015, PAIN, V156, P341, DOI 10.1097/01.j.pain.0000460315.80981.59; Banni S, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-7; Bennetzen MF, 2011, INT J OBESITY, V35, P1377, DOI 10.1038/ijo.2011.8; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; Borner C, 2008, NEUROIMMUNOMODULAT, V14, P281, DOI 10.1159/000117809; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Cable JC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-129; Cardinal P, 2014, MOL METAB, V3, P705, DOI 10.1016/j.molmet.2014.07.004; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Chiara V, 2013, NEUROSCIENCE, V250, P232, DOI 10.1016/j.neuroscience.2013.06.069; De Vry J, 2004, EUR J PHARMACOL, V483, P55, DOI 10.1016/j.ejphar.2003.10.012; Di Filippo M, 2008, J NEUROL NEUROSUR PS, V79, P1224, DOI 10.1136/jnnp.2007.139071; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; DiPatrizio NV, 2012, TRENDS NEUROSCI, V35, P403, DOI 10.1016/j.tins.2012.04.006; Dube JJ, 2007, AM J PHYSIOL-REG I, V293, pR642, DOI 10.1152/ajpregu.00133.2007; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Fernandez-Aranda F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104534; Fujioka K, 1999, JAMA-J AM MED ASSOC, V282, P1517, DOI 10.1001/jama.282.16.1517; Gatta-Cherifi B, 2012, INT J OBESITY, V36, P880, DOI 10.1038/ijo.2011.165; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; Hagan MM, 1999, J CLIN ENDOCR METAB, V84, P3579, DOI 10.1210/jc.84.10.3579; Hanlon EC, 2015, J CLIN ENDOCR METAB, V100, P220, DOI 10.1210/jc.2014-3455; Hauer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062741; Hickey MS, 1996, BIOCHEM MOL MED, V59, P1, DOI 10.1006/bmme.1996.0056; Hill MN, 2013, PSYCHONEUROENDOCRINO, V38, P2952, DOI 10.1016/j.psyneuen.2013.08.004; Ho WSV, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-32; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, P787, DOI 10.1210/jc.2010-2028; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; Koethe D, 2009, BRIT J PSYCHIAT, V194, P371, DOI 10.1192/bjp.bp.108.053843; Koethe D, 2009, J NEURAL TRANSM, V116, P301, DOI 10.1007/s00702-008-0169-6; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Lehmann R., 1977, BIOMETRICAL J, V19, P229; Leweke FM, 2007, SCHIZOPHR RES, V94, P29, DOI 10.1016/j.schres.2007.04.025; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Maccarrone M, 2001, J IMMUNOL, V166, P7183, DOI 10.4049/jimmunol.166.12.7183; Martins CJM, 2014, HORM METAB RES, V46, P529, DOI 10.1055/s-0034-1375653; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Monteleone P, 2005, NEUROPSYCHOPHARMACOL, V30, P1216, DOI 10.1038/sj.npp.1300695; Morgan CJA, 2013, BRIT J PSYCHIAT, V202, P381, DOI 10.1192/bjp.bp.112.121178; Nam SY, 2001, J CLIN ENDOCR METAB, V86, P4849, DOI 10.1210/jc.86.10.4849; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Pisani A, 2005, ANN NEUROL, V57, P777, DOI 10.1002/ana.20462; Pisani V, 2010, MOVEMENT DISORD, V25, P920, DOI 10.1002/mds.23014; Quarta C, 2011, TRENDS MOL MED, V17, P518, DOI 10.1016/j.molmed.2011.05.002; Quercioli A, 2013, EUR HEART J, V34, P2063, DOI 10.1093/eurheartj/eht085; Rojo ML, 2013, LIFE SCI, V92, P757, DOI 10.1016/j.lfs.2013.02.002; Romigi A, 2010, EPILEPSIA, V51, P768, DOI 10.1111/j.1528-1167.2009.02334.x; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Sarchielli P, 2007, NEUROPSYCHOPHARMACOL, V32, P1384, DOI 10.1038/sj.npp.1301246; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Team R.C, R LANG ENV STAT COMP; Van Gaal LF, 2008, EUR HEART J, V29, P1761, DOI 10.1093/eurheartj/ehn076; Watanabe T, 2009, J BIOL CHEM, V284, P1803, DOI 10.1074/jbc.M807120200; Wong A, 2014, J LIPID RES, V55, P1902, DOI 10.1194/jlr.M048694	69	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123132	10.1371/journal.pone.0123132	http://dx.doi.org/10.1371/journal.pone.0123132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835291	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000130
J	Plewnia, C; Schroeder, PA; Kunze, R; Faehling, F; Wolkenstein, L				Plewnia, Christian; Schroeder, Philipp A.; Kunze, Roland; Faehling, Florian; Wolkenstein, Larissa			Keep Calm and Carry On: Improved Frustration Tolerance and Processing Speed by Transcranial Direct Current Stimulation (tDCS)	PLOS ONE			English	Article							SERIAL ADDITION TEST; COGNITIVE CONTROL; PREFRONTAL CORTEX; WORKING-MEMORY; DEPRESSED-PATIENTS; NEGATIVE AFFECT; NEURAL MECHANISMS; PERFORMANCE; TASK; INTERFERENCE	Cognitive control (CC) of attention is a major prerequisite for effective information processing. Emotional distractors can bias and impair goal-directed deployment of attentional resources. Frustration-induced negative affect and cognition can act as internal distractors with negative impact on task performance. Consolidation of CC may thus support task-oriented behavior under challenging conditions. Recently, transcranial direct current stimulation (tDCS) has been put forward as an effective tool to modulate CC. Particularly, anodal, activity enhancing tDCS to the left dorsolateral prefrontal cortex (dlPFC) can increase insufficient CC in depression as indicated by a reduction of attentional biases induced by emotionally salient stimuli. With this study, we provide first evidence that, compared to sham stimulation, tDCS to the left dlPFC enhances processing speed measured by an adaptive version of the Paced Auditory Serial Addition Task (PASAT) that is typically thwarted by frustration. Notably, despite an even larger amount of error-related negative feedback, the task-induced upset was suppressed in the group receiving anodal tDCS. Moreover, inhibition of task-related negative affect was correlated with performance gains, suggesting a close link between enhanced processing speed and consolidation of CC by tDCS. Together, these data provide first evidence that activity enhancing anodal tDCS to the left dlPFC can support focused cognitive processing particularly when challenged by frustration-induced negative affect.	[Plewnia, Christian; Schroeder, Philipp A.; Kunze, Roland; Faehling, Florian] Univ Tubingen, Dept Psychiat & Psychotherapy Neurophysiol & Inte, D-72076 Tubingen, Germany; [Plewnia, Christian] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Wolkenstein, Larissa] Univ Tubingen, Dept Psychol Clin Psychol & Psychotherapy, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Plewnia, C (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy Neurophysiol & Inte, Calwerstr 14, D-72076 Tubingen, Germany.	christian.plewnia@uni-tuebingen.de	Schroeder, Philipp/E-5148-2018	Schroeder, Philipp/0000-0002-9941-6086; Plewnia, Christian/0000-0003-3852-9906	GCBS research consortium - German Federal Ministry of Education and Research [FKZ 01EE1403D]; University of Tubingen Faculty of Medicine (IZKF-Promotionskolleg ) [2013-217]	GCBS research consortium - German Federal Ministry of Education and Research; University of Tubingen Faculty of Medicine (IZKF-Promotionskolleg )	This work was supported by the GCBS research consortium (FKZ 01EE1403D) funded by the German Federal Ministry of Education and Research. Christian Plewnia and Florian Faehling received a grant from the University of Tubingen Faculty of Medicine (IZKF-Promotionskolleg 2013-217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Anticevic A, 2010, COGN AFFECT BEHAV NE, V10, P159, DOI 10.3758/CABN.10.2.159; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brunoni AR, 2014, J AFFECT DISORDERS, V162, P43, DOI 10.1016/j.jad.2014.03.026; Calkins Amanda W, 2015, Behav Cogn Psychother, V43, P578, DOI 10.1017/S1352465814000046; Carver C, 2014, INT HDB EMOTIONS ED; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003; Clemens B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095984; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Davidson RJ, 2003, AM J PSYCHIAT, V160, P64, DOI 10.1176/appi.ajp.160.1.64; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; DEARY IJ, 1991, PERS INDIV DIFFER, V12, P983, DOI 10.1016/0191-8869(91)90027-9; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Filmer HL, 2014, TRENDS NEUROSCI, V37, P742, DOI 10.1016/j.tins.2014.08.003; Foland-Ross LC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00489; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gemar M C, 1996, Depression, V4, P81, DOI 10.1002/(SICI)1522-7162(1996)4:2<81::AID-DEPR8>3.0.CO;2-I; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gronwall D.M.A., 1974, PSYCHOL EFFECTS CONC, V128, P501, DOI 10.1192/S000712500010443X; Herz DM, 2014, J NEUROSCI, V34, P3210, DOI 10.1523/JNEUROSCI.4081-13.2014; Hester R, 2005, MEM COGNITION, V33, P221, DOI 10.3758/BF03195311; Holdwick DJ, 1999, ARCH CLIN NEUROPSYCH, V14, P273, DOI 10.1016/S0887-6177(98)00021-3; INGRAM RE, 1987, J PERS SOC PSYCHOL, V53, P734, DOI 10.1037/0022-3514.53.4.734; Jones NP, 2010, COGN AFFECT BEHAV NE, V10, P129, DOI 10.3758/CABN.10.1.129; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Kuo MF, 2012, CLIN EEG NEUROSCI, V43, P192, DOI 10.1177/1550059412444975; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Lejuez C. W., 2003, BEHAV THERAPIST, DOI DOI 10.1002/DA.20091; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Moriya J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034244, 10.1371/journal.pone.0047221]; Nejad AB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00666; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Oatley K, 2014, TRENDS COGN SCI, V18, P134, DOI 10.1016/j.tics.2013.12.004; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Oei NYL, 2012, SOC COGN AFFECT NEUR, V7, P403, DOI 10.1093/scan/nsr024; Okada G, 2003, NEUROPSYCHOBIOLOGY, V47, P21, DOI 10.1159/000068871; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plewnia C, 2013, CORTEX, V49, P1801, DOI 10.1016/j.cortex.2012.11.002; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Segrave RA, 2014, BRAIN STIMUL, V7, P325, DOI 10.1016/j.brs.2013.12.008; Siegle GJ, 2007, COGNITIVE THER RES, V31, P235, DOI 10.1007/s10608-006-9118-6; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Staal M. A., 2004, 212824 NASA; Subramaniam K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00452; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Vanderhasselt MA, 2015, PROG NEURO-PSYCHOPH, V57, P93, DOI 10.1016/j.pnpbp.2014.09.015; Vanderhasselt MA, 2013, NEUROPSYCHOLOGIA, V51, P2581, DOI 10.1016/j.neuropsychologia.2013.08.011; Vanderhasselt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062219; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wells A., 1995, ATTENTION EMOTION CL; Wessa M, 2013, SOC COGN AFFECT NEUR, V8, P305, DOI 10.1093/scan/nsr098; Wolkenstein L, 2014, CORTEX, V59, P103, DOI 10.1016/j.cortex.2014.07.011; Wolkenstein L, 2013, BIOL PSYCHIAT, V73, P646, DOI 10.1016/j.biopsych.2012.10.010; Zwissler B, 2014, J NEUROSCI, V34, P4022, DOI 10.1523/JNEUROSCI.5407-13.2014	75	39	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122578	10.1371/journal.pone.0122578	http://dx.doi.org/10.1371/journal.pone.0122578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837520	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000102
J	Shin, E; Lee, H; Yoo, SA; Chong, SC				Shin, Eunsam; Lee, Hunjae; Yoo, Sang-Ah; Chong, Sang Chul			Training Improves the Capacity of Visual Working Memory When It Is Adaptive, Individualized, and Targeted	PLOS ONE			English	Article							SHORT-TERM-MEMORY; STORAGE CAPACITY; INFORMATION; MECHANISMS; EXPERTISE; OBJECTS; FILTER; ADULTS; TASK	The current study investigated whether training improves the capacity of visual working memory using individualized adaptive training methods. Two groups of participants were trained for two targeted processes, filtering and consolidation. Before and after the training, the participants, including those with no training, performed a lateralized change detection task in which one side of the visual display had to be selected and the other side ignored. Across ten-day training sessions, the participants performed two modified versions of the lateralized change detection task. The number of distractors and duration of the consolidation period were adjusted individually to increase the task difficulty of the filtering and consolidation training, respectively. Results showed that the degree of improvement shown during the training was positively correlated with the increase in memory capacity, and training-induced benefits were most evident for larger set sizes in the filtering training group. These results suggest that visual working memory training is effective, especially when it is adaptive, individualized, and targeted.	[Shin, Eunsam] Yonsei Univ, Ctr Cognit Sci, Seoul 120749, South Korea; [Lee, Hunjae; Yoo, Sang-Ah; Chong, Sang Chul] Yonsei Univ, Grad Program Cognit Sci, Seoul 120749, South Korea; [Chong, Sang Chul] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University	Chong, SC (corresponding author), Yonsei Univ, Grad Program Cognit Sci, Seoul 120749, South Korea.	scchong@yonsei.ac.kr		Chong, Sang Chul/0000-0002-1901-4715; Yoo, Sang-Ah/0000-0002-6797-2846	National Research Foundation of Korea - Korean Government (MEST) [20110025005]	National Research Foundation of Korea - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (MEST, No. 20110025005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Arend AM, 2012, NEUROPSYCHOLOGIA, V50, P2379, DOI 10.1016/j.neuropsychologia.2012.06.007; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Chen DY, 2006, VIS COGN, V14, P37, DOI 10.1080/13506280544000282; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curby KM, 2009, J EXP PSYCHOL HUMAN, V35, P94, DOI 10.1037/0096-1523.35.1.94; GEGENFURTNER KR, 1993, J EXP PSYCHOL HUMAN, V19, P845, DOI 10.1037/0096-1523.19.4.845; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Moore CD, 2006, J NEUROSCI, V26, P11187, DOI 10.1523/JNEUROSCI.1873-06.2006; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson IR, 2005, J EXP PSYCHOL HUMAN, V31, P889, DOI 10.1037/0096-1523.31.5.889; Olson IR, 2004, MEM COGNITION, V32, P1326, DOI 10.3758/BF03206323; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rouder JN, 2011, PSYCHON B REV, V18, P682, DOI 10.3758/s13423-011-0088-7; Sorensen TA, 2012, ACTA PSYCHOL, V140, P158, DOI 10.1016/j.actpsy.2012.04.004; Stout DM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00058; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zimmer HD, 2012, BRAIN RES, V1466, P44, DOI 10.1016/j.brainres.2012.05.019	29	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121702	10.1371/journal.pone.0121702	http://dx.doi.org/10.1371/journal.pone.0121702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25836651	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000057
J	Ullenhag, GJ; Rossmann, E; Liljefors, M				Ullenhag, Gustav J.; Rossmann, Eva; Liljefors, Maria			A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer	PLOS ONE			English	Article							THALIDOMIDE ANALOG; CLINICAL-TRIAL; III TRIAL; T-CELLS; CARCINOMA; SURVIVAL; CC-5013; THROMBOPROPHYLAXIS; ADENOCARCINOMA; THROMBOSIS	Purpose Lenalidomide have both immunomodulatory and anti-angiogenic properties which could confer anti-cancer effects. The aim of this study was to assess the feasibility of combining lenalidomide with the standard treatment gemcitabine in pancreatic cancer patients with advanced disease. Patients and Methods Eligible patients had locally advanced or metastatic adenocarcinoma of the pancreas. Patients received lenalidomide days 1-21 orally and gemcitabine 1000 mg/m(2) intravenously (days 1, 8 and 15), each 28 day cycle. Three cohorts of lenalidomide were examined (Cohort I = 15 mg, Cohort II = 20 mg and Cohort III = 25 mg daily). The maximum tolerated dose (MTD) of lenalidomide given in combination with gemcitabine was defined as the highest dose level at which no more than one out of four (25%) subjects experiences a dose-limiting toxicity (DLT). Patients should also be able to receive daily low molecular weight heparin (LMWH) (e.g. dalteparin 5000 IU s.c. daily) as a prophylactic anticoagulant for venous thromboembolic events (VTEs). Twelve patients (n = 4, n = 3 and n = 5 in cohort I, II and III, respectively) were enrolled in this study. Results Median duration of treatment was 11 weeks (range 1-66), and median number of treatment cycles were three (range 1-14). The only DLT was a cardiac failure grade 3 in cohort III. Frequent treatment-related adverse events (AEs) (all grades) included neutropenia, leucopenia and fatigue (83% each, but there was no febrile neutropenia); thrombocytopenia (75%); dermatological toxicity (75%); diarrhea and nausea (42% each); and neuropathy (42%). Discussion This phase I study demonstrates the feasibility of the combination of lenalidomide and gemcitabine as first-line treatment in patients with advanced pancreatic cancer. The tolerability profile demonstrated in the dose escalation schedule of lenalidomide suggests the dosing of lenalidomide to be 25 mg daily on days 1-21 with standard dosing of gemcitabine and merits further evaluation in a phase II trial.	[Ullenhag, Gustav J.] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Sect Oncol, Uppsala, Sweden; [Ullenhag, Gustav J.] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden; [Rossmann, Eva; Liljefors, Maria] Karolinska Univ Hosp Solna, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol & Pathol Radiumhemmet, Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital	Liljefors, M (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol & Pathol Radiumhemmet, Stockholm, Sweden.	maria.gustafsson-liljefors@karolinska.se		Gustafsson Liljefors, Maria/0000-0002-7914-2372	Swedish Cancer Society; Karolinska Institute Foundation; Stockholm County Council; Research Foundation Stiftelsen Onkologiska Klinikens i Uppsala Forskningsfond; Lion's Cancer Fund; Celgene Corporation, Summit, NJ	Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute Foundation(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Research Foundation Stiftelsen Onkologiska Klinikens i Uppsala Forskningsfond; Lion's Cancer Fund; Celgene Corporation, Summit, NJ(Bristol-Myers SquibbCelgene Corporation)	This study was supported by the Swedish Cancer Society, The Karolinska Institute Foundation and the Stockholm County Council, the Research Foundation Stiftelsen Onkologiska Klinikens i Uppsala Forskningsfond, Lion's Cancer Fund and in part by a grant from Celgene Corporation, Summit, NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hejleh T, 2012, CURR ONCOL REP, V14, P277, DOI 10.1007/s11912-012-0238-8; Alexakis N, 2004, BRIT J SURG, V91, P1410, DOI 10.1002/bjs.4794; Amato RJ, 2008, AM J CLIN ONCOL-CANC, V31, P244, DOI [10.1097/COC.0b013e31815e45H, 10.1097/COC.0b013e31815e451f]; Andhavarapu S, 2013, EXPERT REV HEMATOL, V6, P69, DOI [10.1586/EHM.12.62, 10.1586/ehm.12.62]; Arkenau H, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e14640; Bartlett JB, 2004, BRIT J CANCER, V90, P955, DOI 10.1038/sj.bjc.6601579; Bergmann-Leitner ES, 2001, CANCER IMMUNOL IMMUN, V50, P445, DOI 10.1007/s002620100229; Blom JW, 2006, EUR J CANCER, V42, P410, DOI 10.1016/j.ejca.2005.09.013; Bringhen S, 2012, EXPERT OPIN DRUG MET, V8, P1209, DOI 10.1517/17425255.2012.712685; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Corral LG, 1999, J IMMUNOL, V163, P380; Correale P, 2005, J CLIN ONCOL, V23, P8950, DOI 10.1200/JCO.2005.12.147; Crane E, 2005, CANCER INVEST, V23, P625, DOI 10.1080/07357900500283101; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Dimopoulos MA, 2012, BLOOD, V119, P2764, DOI 10.1182/blood-2011-08-373514; Dredge K, 2005, MICROVASC RES, V69, P56, DOI 10.1016/j.mvr.2005.01.002; Freelove R, 2006, AM FAM PHYSICIAN, V73, P485; Howe HL, 2006, CANCER-AM CANCER SOC, V107, P1711, DOI 10.1002/cncr.22193; Infante JR, 2013, CANCER BIOL THER, V14, P340, DOI 10.4161/cbt.23625; Infante JR, 2011, EUR J CANCER, V47, P199, DOI 10.1016/j.ejca.2010.09.002; Khorana AA, 2004, LANCET ONCOL, V5, P655, DOI 10.1016/S1470-2045(04)01606-7; Kindler HL, 2011, LANCET ONCOL, V12, P256, DOI 10.1016/S1470-2045(11)70004-3; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Le Tourneau C, 2009, J CLIN ONCOL, V27, P5965, DOI 10.1200/JCO.2009.22.3685; LeBlanc R, 2004, BLOOD, V103, P1787, DOI 10.1182/blood-2003-02-0361; Mandala M, 2011, EXPERT REV ANTICANC, V11, P579, DOI [10.1586/era.10.184, 10.1586/ERA.10.184]; Maples WJ, 2004, J CLIN ONCOL, V22, P4082; Maraveyas A, 2012, EUR J CANCER, V48, P1283, DOI 10.1016/j.ejca.2011.10.017; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Miller AA, 2007, J THORAC ONCOL, V2, P445, DOI 10.1097/01.JTO.0000268679.33238.67; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nowak AK, 2003, J IMMUNOL, V170, P4905, DOI 10.4049/jimmunol.170.10.4905; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Plate JMD, 2005, CANCER IMMUNOL IMMUN, V54, P915, DOI 10.1007/s00262-004-0638-1; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Sanborn SL, 2009, INVEST NEW DRUG, V27, P453, DOI 10.1007/s10637-008-9200-x; Sharma RA, 2006, EUR J CANCER, V42, P2318, DOI 10.1016/j.ejca.2006.05.018; Shevchenko I, 2013, INT J CANCER, V133, P98, DOI 10.1002/ijc.27990; Soeda A, 2009, JPN J CLIN ONCOL, V39, P797, DOI 10.1093/jjco/hyp112; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Storer BE, 2001, STAT MED, V20, P2399, DOI 10.1002/sim.903.abs; Tabernero J, 2009, J CLIN ONCOL, V27, P5487, DOI 10.1200/JCO.2009.23.3098; Teo SK, 2005, AAPS J, V7, pE14, DOI 10.1208/aapsj070103; Vizio B, 2012, EXP THER MED, V4, P70, DOI 10.3892/etm.2012.553; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wu L, 2011, CANCER IMMUNOL IMMUN, V60, P61, DOI 10.1007/s00262-010-0919-9	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121197	10.1371/journal.pone.0121197	http://dx.doi.org/10.1371/journal.pone.0121197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837499	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000041
J	Werncke, T; Ringe, KI; von Falck, C; Kruschewski, M; Wacker, F; Meyer, BC				Werncke, Thomas; Ringe, Kristina Imeen; von Falck, Christian; Kruschewski, Martin; Wacker, Frank; Meyer, Bernhard Christian			Diagnostic Confidence of Run-Off CT-Angiography as the Primary Diagnostic Imaging Modality in Patients Presenting with Acute or Chronic Peripheral Arterial Disease	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; CRITICAL LIMB ISCHEMIA; OCCLUSIVE DISEASE; MDCT ANGIOGRAPHY; PERFORMANCE; ACCURACY; TRIAL; AORTA	Objectives To investigate the reliability of CT-angiography of the lower extremities (run-off CTA) to derive a treatment decision in patients with acute and chronic peripheral artery disease (PAD). Materials and Methods 314 patients referred for run-off CTA were includ-ed in this retrospective study. First, diagnostic confidence of run-off CTA to derive a treat-ment decision was assessed in an interdisciplinary vascular conference using a 2 point scale (sufficient or not sufficient diagnostic confidence) and compared with the image quality eval-uated by two readers in consensus in four different levels (abdominopelvic, thigh, calf, foot arteries). Second, reliability of treatment decision was verified in all patients undergoing re-vascularization therapy. Results Diagnostic confidence of run-off CTA to derive a treatment deci-sion was sufficient in all patients with acute and in 97% of patients (215/221) with chronic PAD, whereas the rate of run-off CTA with non-diagnostic image quality was considerably higher in the calf and foot level (acute vs. chronic; calf: 28% vs. 17%; foot: 52% vs. 20%). Reliability of treatment decision was superior for patients with chronic (123/133 = 92%) than for patients with acute PAD (64/78 = 82%, P = 0.02). Conclusion Run-off CTA is a reliable imaging modality for primary diag-nostic work-up of patients with acute and chronic PAD.	[Werncke, Thomas; Kruschewski, Martin; Meyer, Bernhard Christian] Charite, Radiol Klin, D-13353 Berlin, Germany; [Ringe, Kristina Imeen; von Falck, Christian; Wacker, Frank] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School	Werncke, T (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.	Werncke.Thomas@mh-hannover.de	Meyer, Bernhard/AAH-3329-2019; Werncke, Thomas/AFV-2471-2022; von Falck, Christian/AAO-2108-2020	Meyer, Bernhard/0000-0001-6486-7955; 	German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) [02NUK008D]; German Research Foundation project "Open Access Publication"	German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Research Foundation project "Open Access Publication"	This study was in part supported by the German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) through the grant 02NUK008D (http://www.helmholtzmuenchen.de/iss/forschung/arbeitsgruppen/experimentelle-radiooekologie/projekte/kompetenzverbund-strahlenforschung-kvsf/index.html). The publication of this study is supported by the German Research Foundation project "Open Access Publication." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no further current funding sources for this study.	Adriaensen MEAPM, 2004, RADIOLOGY, V233, P385, DOI 10.1148/radiol.2331031595; Albrecht T, 2007, AM J ROENTGENOL, V189, P702, DOI 10.2214/AJR.07.2333; Biswas D, 2009, J BONE JOINT SURG AM, V91A, P1882, DOI 10.2106/JBJS.H.01199; Bradbury AW, 2010, J VASC SURG, V51, p18S, DOI 10.1016/j.jvs.2010.01.074; Callum K, 2000, BRIT MED J, V320, P764, DOI 10.1136/bmj.320.7237.764; Duan YH, 2013, AM J ROENTGENOL, V201, pW906, DOI 10.2214/AJR.12.10209; European Society of Urogenital Radiology, 2014, ESUR GUID CONTR MED; Fotiadis N, 2011, CLIN RADIOL, V66, P945, DOI 10.1016/j.crad.2011.04.015; Fujihara M, 2015, CATHETER CARDIO INTE, V85, P870, DOI 10.1002/ccd.25722; Iezzi R, 2012, RADIOLOGY, V263, P287, DOI 10.1148/radiol.11110700; Jens S, 2013, EUR RADIOL, V23, P3104, DOI 10.1007/s00330-013-2933-8; Laswed T, 2008, EUR RADIOL, V18, P263, DOI 10.1007/s00330-007-0749-0; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Met R, 2009, JAMA-J AM MED ASSOC, V301, P415, DOI 10.1001/jama.301.4.415; Meyer BC, 2008, EUR RADIOL, V18, P1546, DOI 10.1007/s00330-008-0914-0; Meyer BC, 2010, EUR RADIOL, V20, P497, DOI 10.1007/s00330-009-1555-7; Napoli A, 2011, RADIOLOGY, V261, P976, DOI 10.1148/radiol.11103564; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ouwendijk R, 2008, AM J ROENTGENOL, V190, P1349, DOI 10.2214/AJR.07.3359; Pollak AW, 2012, CIRC-CARDIOVASC IMAG, V5, P797, DOI 10.1161/CIRCIMAGING.111.970814; Qi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099112; Sandhu GS, 2012, AM J ROENTGENOL, V198, P686, DOI 10.2214/AJR.11.7065; Schernthaner R, 2008, EUR RADIOL, V18, P665, DOI 10.1007/s00330-007-0822-8; Schernthaner R, 2009, AM J ROENTGENOL, V192, P1416, DOI 10.2214/AJR.08.1078; Siriapisith T, 2010, J CARDIOVASC COMPUT, V4, P173, DOI 10.1016/j.jcct.2010.03.011; Sommer WH, 2010, EUR RADIOL, V20, P2876, DOI 10.1007/s00330-010-1861-0; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Werncke T, 2013, EUR RADIOL, V23, P2482, DOI 10.1007/s00330-013-2865-3; Werncke T, 2012, INVEST RADIOL, V47, P530, DOI 10.1097/RLI.0b013e31825cc629	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119900	10.1371/journal.pone.0119900	http://dx.doi.org/10.1371/journal.pone.0119900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835948	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000015
J	Stateva, SR; Salas, V; Benaim, G; Menendez, M; Solis, D; Villalobo, A				Stateva, Silviya R.; Salas, Valentina; Benaim, Gustavo; Menendez, Margarita; Solis, Dolores; Villalobo, Antonio			Characterization of Phospho-(Tyrosine)-Mimetic Calmodulin Mutants	PLOS ONE			English	Article							CALCIUM-BINDING; TYROSINE-PHOSPHORYLATION; TARGET RECOGNITION; CRYSTAL-STRUCTURES; DOMAINS; RECEPTOR; TESTIS	Calmodulin (CaM) phosphorylated at different serine/threonine and tyrosine residues is known to exert differential regulatory effects on a variety of CaM-binding enzymes as compared to non-phosphorylated CaM. In this report we describe the preparation and characterization of a series of phospho-(Y)-mimetic CaM mutants in which either one or the two tyrosine residues present in CaM (Y99 and Y138) were substituted to aspartic acid or glutamic acid. It was expected that the negative charge of the respective carboxyl group of these amino acids mimics the negative charge of phosphate and reproduce the effects that distinct phospho-(Y)-CaM species may have on target proteins. We describe some physicochemical properties of these CaM mutants as compared to wild type CaM, after their expression in Escherichia coli and purification to homogeneity, including: i) changes in their electrophoretic mobility in the absence and presence of Ca2+; ii) ultraviolet (UV) light absorption spectra, far-and near-UV circular dichroism data; iii) thermal stability in the absence and presence of Ca2+; and iv) Tb3+-emitted fluorescence upon tyrosine excitation. We also describe some biochemical properties of these CaM mutants, such as their differential phosphorylation by the tyrosine kinase c-Src, and their action as compared to wild type CaM, on the activity of two CaM-dependent enzymes: cyclic nucleotide phosphodiesterase 1 (PDE1) and endothelial nitric oxide synthase (eNOS) assayed in vitro.	[Stateva, Silviya R.; Salas, Valentina; Villalobo, Antonio] CSIC, Inst Invest Biomed, Madrid, Spain; [Stateva, Silviya R.; Salas, Valentina; Villalobo, Antonio] Univ Autonoma Madrid, Madrid, Spain; [Salas, Valentina; Benaim, Gustavo] Cent Univ Venezuela, Fac Ciencias, Inst Biol Expt, Caracas, Venezuela; [Benaim, Gustavo] Inst Estudios Avanzados IDEA, Caracas, Venezuela; [Menendez, Margarita; Solis, Dolores] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; University of Central Venezuela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Villalobo, A (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	antonio.villalobo@iib.uam.es	Solís, Dolores/E-5992-2015; Villalobo, Antonio/K-2902-2017; Menendez, Margarita/M-1795-2014; Villalobo, Antonio/O-9621-2019; Benaim, Gustavo/H-5552-2019	Solís, Dolores/0000-0002-8148-1875; Menendez, Margarita/0000-0002-3267-4443; Villalobo, Antonio/0000-0002-4200-374X; Benaim, Gustavo/0000-0002-9359-5546	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [SAF2011-23494]; Consejeria de Educacion de la Comunidad de Madrid [S2011/BMD-2349]; European Commission [PITN-GA-2011-289033 DYNANO]; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias; Marie Curie contract from the European Commission; Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela [03-00-6057-2005, PG-03-8728-2013]	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Consejeria de Educacion de la Comunidad de Madrid; European Commission(European CommissionEuropean Commission Joint Research Centre); Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias; Marie Curie contract from the European Commission; Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela	This work was funded by grants to AV from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (SAF2011-23494) and the Consejeria de Educacion de la Comunidad de Madrid (S2011/BMD-2349), and grant to AV and DS from the European Commission (contract PITN-GA-2011-289033 DYNANO). Additional funding to DS and MM was provided by the Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias. SRS was funded by a Marie Curie contract from the European Commission and VS and GB were supported by fellowship and grants (03-00-6057-2005 and PG-03-8728-2013) from the Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BENGURIA A, 1994, EUR J BIOCHEM, V224, P909, DOI 10.1111/j.1432-1033.1994.00909.x; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRZESKA H, 1983, FEBS LETT, V153, P169, DOI 10.1016/0014-5793(83)80141-0; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Corti C, 1999, EUR J BIOCHEM, V262, P790, DOI 10.1046/j.1432-1327.1999.00441.x; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Fasman GD, 1996, CIRCULAR DICHROISM C, P381; Fiske CH, 1925, J BIOL CHEM, V66, P375; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; FUKAMI Y, 1986, P NATL ACAD SCI USA, V83, P4190, DOI 10.1073/pnas.83.12.4190; GANGOLA P, 1983, BIOCHEM BIOPH RES CO, V111, P301, DOI 10.1016/S0006-291X(83)80151-X; GRAVES CB, 1986, J BIOL CHEM, V261, P429; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kelly SM, 2005, BIOCHIM BIOPHYS ACTA, V1751, P19; KILHOFFER MC, 1981, BIOCHEMISTRY-US, V20, P4407, DOI 10.1021/bi00518a027; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; Palomo-Jimenez PI, 1999, PROTEIN EXPRES PURIF, V16, P388, DOI 10.1006/prep.1999.1092; Panina S, 2012, J BIOL CHEM, V287, P18173, DOI 10.1074/jbc.M112.339382; Piazza M, 2012, BIOCHEMISTRY-US, V51, P3651, DOI 10.1021/bi300327z; Protasevich I, 1997, BIOCHEMISTRY-US, V36, P2017, DOI 10.1021/bi962538g; Salas V, 2005, PROTEIN EXPRES PURIF, V41, P384, DOI 10.1016/j.pep.2005.01.004; SAVILLE MK, 1994, BIOCHEM J, V299, P863, DOI 10.1042/bj2990863; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Sun H, 2001, BIOCHEMISTRY-US, V40, P9605, DOI 10.1021/bi0104266; Sun HY, 1999, BIOCHEMISTRY-US, V38, P12266, DOI 10.1021/bi9818671; Ten Broeke R, 2004, CLIN EXP ALLERGY, V34, P170; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; WALLACE RW, 1982, J BIOL CHEM, V257, P1845; Wang Q, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002114; WILLIAMS JP, 1994, ARCH BIOCHEM BIOPHYS, V315, P119, DOI 10.1006/abbi.1994.1479; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; Yin G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000996	43	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120798	10.1371/journal.pone.0120798	http://dx.doi.org/10.1371/journal.pone.0120798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830911	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600042
J	Chekmarev, SF				Chekmarev, Sergei F.			Protein Folding as a Complex Reaction: A Two-Component Potential for the Driving Force of Folding and Its Variation with Folding Scenario	PLOS ONE			English	Article							BETA-SHEET MINIPROTEIN; FREE-ENERGY SURFACES; SYMMETRICAL PROTEIN; B-DOMAIN; PATHWAYS; STATE; STABILIZATION; OPTIMIZATION; PERSPECTIVE; LANDSCAPE	The Helmholtz decomposition of the vector field of probability fluxes in a two-dimensional space of collective variables makes it possible to introduce a potential for the driving force of protein folding [Chekmarev, J. Chem. Phys. 139 (2013) 145103]. The potential has two components: one component (Phi) is responsible for the source and sink of the folding flow, which represent, respectively, the unfolded and native state of the protein, and the other (psi) accounts for the flow vorticity inherently generated at the periphery of the flow field and provides the canalization of the flow between the source and sink. Both components obey Poisson's equations with the corresponding source/sink terms. In the present paper, we consider how the shape of the potential changes depending on the scenario of protein folding. To mimic protein folding dynamics projected onto a two-dimensional space of collective variables, the two-dimensional Muller and Brown potential is employed. Three characteristic scenarios are considered: a single pathway from the unfolded to the native state without intermediates, two parallel pathways without intermediates, and a single pathway with an off-pathway intermediate. To determine the probability fluxes, the hydrodynamic description of the folding reaction is used, in which the first-passage folding is viewed as a steady flow of the representative points of the protein from the unfolded to the native state. We show that despite the possible complexity of the folding process, the Phi-component is simple and universal in shape. The psi-component is more complex and reveals characteristic features of the process of folding. The present approach is potentially applicable to other complex reactions, for which the transition from the reactant to the product can be described in a space of two (collective) variables.	[Chekmarev, Sergei F.] Russian Acad Sci, Inst Thermophys, Novosibirsk 630090, Russia; [Chekmarev, Sergei F.] Novosibirsk State Univ, Dept Phys, Novosibirsk 630090, Russia	Russian Academy of Sciences; S.S. Kutateladze Institute of Thermophysics, Siberian Division of the Russian Academy of Sciences; Novosibirsk State University	Chekmarev, SF (corresponding author), Russian Acad Sci, Inst Thermophys, Novosibirsk 630090, Russia.	chekmarev@itp.nsc.ru	Chekmarev, Sergei F/N-4255-2017	Chekmarev, Sergei F/0000-0002-5603-8193	Russian Science Foundation [14-14-00325]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation, grant No. 14-14-00325; http://www.rscf.ru/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NH, 2006, J AM CHEM SOC, V128, P6101, DOI 10.1021/ja054971w; BISWAS R, 1986, PHYS REV B, V34, P895, DOI 10.1103/PhysRevB.34.895; BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103; Caflisch A, 2006, CURR OPIN STRUC BIOL, V16, P71, DOI 10.1016/j.sbi.2006.01.002; Chekmarev SF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018107; Chekmarev SF, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4824133; Chekmarev SF, 2005, J PHYS CHEM B, V109, P5312, DOI 10.1021/jp047012h; Dagan S, 2013, P NATL ACAD SCI USA, V110, P10628, DOI 10.1073/pnas.1302284110; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; DORR FW, 1970, SIAM REV, V12, P248, DOI 10.1137/1012045; Eyink GL, 1996, J STAT PHYS, V83, P385, DOI 10.1007/BF02183738; Forst, 1973, THEORY UNIMOLECULAR; GRAHAM R, 1977, Z PHYS B CON MAT, V26, P397, DOI 10.1007/BF01570750; Itoh K, 2006, P NATL ACAD SCI USA, V103, P7298, DOI 10.1073/pnas.0510324103; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jas GS, 2012, J PHYS CHEM B, V116, P6598, DOI 10.1021/jp211645s; Kalgin IV, 2014, J PHYS CHEM B, V118, P4287, DOI 10.1021/jp412729r; Kalgin IV, 2013, J PHYS CHEM B, V117, P6092, DOI 10.1021/jp401742y; Kalgin IV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011920; Kalgin IV, 2009, J PHYS CHEM B, V113, P12759, DOI 10.1021/jp903325z; Krivov SV, 2004, P NATL ACAD SCI USA, V101, P14766, DOI 10.1073/pnas.0406234101; Landau L.D., 1987, PHYS TODAY; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Levy RM, 2013, PROTEIN SCI, V22, P1459, DOI 10.1002/pro.2335; McLeish TCB, 2005, BIOPHYS J, V88, P172, DOI 10.1529/biophysj.103.036616; MULLER K, 1979, THEOR CHIM ACTA, V53, P75, DOI 10.1007/BF00547608; MUNOZ V, 1994, BIOCHEMISTRY-US, V33, P5858, DOI 10.1021/bi00185a025; Olender R, 1996, J CHEM PHYS, V105, P9299, DOI 10.1063/1.472727; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Otzen DE, 1999, P NATL ACAD SCI USA, V96, P11746, DOI 10.1073/pnas.96.21.11746; Palyanov AY, 2007, J PHYS CHEM B, V111, P2675, DOI 10.1021/jp067027a; Rimratchada S, 2014, BIOPHYS J, V106, P1729, DOI 10.1016/j.bpj.2014.01.051; Sato S, 2007, J MOL BIOL, V372, P254, DOI 10.1016/j.jmb.2007.06.043; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Sobolev SL., 1989, PARTIAL DIFFERENTIAL; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; TOMITA K, 1974, PROG THEOR PHYS, V51, P1731, DOI 10.1143/PTP.51.1731; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Wales D., 2003, ENERGY LANDSCAPES AP; Wang J, 1996, PHYS REV LETT, V76, P4861, DOI 10.1103/PhysRevLett.76.4861; Weber H. J., 2004, ESSENTIAL MATH METHO; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Zheng WW, 2011, J PHYS CHEM B, V115, P13065, DOI 10.1021/jp2076935; 2010, ANNU REV PHYS CHEM, V61, P391, DOI DOI 10.1146/ANNUREV.PHYSCHEM.040808.090412	48	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121640	10.1371/journal.pone.0121640	http://dx.doi.org/10.1371/journal.pone.0121640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848943	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800071
J	Ghosh, S; Lasko, P				Ghosh, Sanjay; Lasko, Paul			Loss-of-Function Analysis Reveals Distinct Requirements of the Translation Initiation Factors eIF4E, eIF4E-3, eIF4G and eIF4G2 in Drosophila Spermatogenesis	PLOS ONE			English	Article							MEIOTIC CELL-CYCLE; SPERMATID DIFFERENTIATION; DON-JUAN; MELANOGASTER SPERMATOGENESIS; POSTMEIOTIC TRANSCRIPTION; GENE-EXPRESSION; CDC25 HOMOLOG; GERM-CELLS; MECHANISMS; PROTEINS	In eukaryotes, post-transcriptional regulation of gene expression has a key role in many cellular and developmental processes. Spermatogenesis involves a complex developmental program that includes changes in cell cycle dynamics and dramatic cellular remodeling. Translational control is critical for spermatogenesis in Drosophila as many mRNAs synthesized in the spermatocytes are translated only much later during spermatid differentiation. Testes-specific translation initiation factors eIF4E-3 and eIF4G2 are essential specifically for male fertility. However, details of their roles during different stages of spermatogenesis are unknown, and the role of canonical translation initiation factors in spermatogenesis remains unexplored. In this study, we addressed the functional role of eIF4E-1, eIF4E-3, eIF4G and eIF4G2 in testes development and formation of mature sperm. Using the UAS-Gal4 system and RNA interference, we systematically knocked down these four genes in different stages of germ cell development, and in the somatic cells. Our results show that eIF4E-1 function in early germ cells and the surrounding somatic cells is critical for spermatogenesis. Both eIF4E-1 and eIF4E-3 are required in spermatocytes for chromosome condensation and cytokinesis during the meiotic stages. Interestingly, we find that eIF4G knockdown did not affect male fertility while eIF4G2 has distinct functions during spermatogenesis; it is required in early germ cells for proper meiotic divisions and spermatid elongation while its abrogation in spermatocytes caused meiotic arrest. Double knockdown of eIF4G and eIF4G2 shows that these proteins act redundantly during the early stages of spermatogenesis. Taken together, our analysis reveals spatio-temporal roles of the canonical and testes-specific translation initiation factors in coordinating developmental programs during spermatogenesis.	[Ghosh, Sanjay; Lasko, Paul] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Ghosh, S (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford, England.	sanjay.ghosh@mcgill.ca; paul.lasko@mcgill.ca	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501; Ghosh, Sanjay/0000-0002-8833-9468	CIHR [IOP-107945]	CIHR(Canadian Institutes of Health Research (CIHR))	Funding was provided by CIHR grant IOP-107945 to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; Amiri A, 2001, DEVELOPMENT, V128, P3899; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Barreau C, 2008, DEVELOPMENT, V135, P1897, DOI 10.1242/dev.021949; BRAND AH, 1993, DEVELOPMENT, V118, P401; CENCI G, 1994, J CELL SCI, V107, P3521; Eun SH, 2014, SCIENCE, V343, P1513, DOI 10.1126/science.1246514; Franklin-Dumont TM, 2007, DEVELOPMENT, V134, P2851, DOI 10.1242/dev.003517; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; GONCZY P, 1994, CELL, V77, P1015, DOI 10.1016/0092-8674(94)90441-3; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hempel LU, 2006, DEV DYNAM, V235, P1053, DOI 10.1002/dvdy.20698; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Hernandez G, 2012, DEVELOPMENT, V139, P3211, DOI 10.1242/dev.073122; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kibanov MV, 2013, ANAL BIOCHEM, V436, P55, DOI 10.1016/j.ab.2013.01.009; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; LANTZ V, 1992, DEVELOPMENT, V115, P75; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Lin TY, 1996, DEVELOPMENT, V122, P1331; LINDSLEY DL, 1980, GENETICS BIOL DROSOP, P00225, DOI DOI 10.1111/J.1601-5223.1952.TB02915.X; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; OLIVIERI G, 1965, MUTAT RES, V2, P366, DOI 10.1016/0027-5107(65)90072-2; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Robalino J, 2004, J BIOL CHEM, V279, P10532, DOI 10.1074/jbc.M313688200; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Santel A, 1998, J CELL SCI, V111, P3299; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIGRIST S, 1995, MECH DEVELOP, V53, P247, DOI 10.1016/0925-4773(95)00441-3; Sitaram P, 2014, JOVE-J VIS EXP, DOI 10.3791/51058; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song AR, 2010, J CELL SCI, V123, P2228, DOI 10.1242/jcs.063107; STERN B, 1993, DEVELOPMENT, V117, P219; Tettweiler G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/960420; Toledano H, 2012, NAT PROTOC, V7, P1808, DOI 10.1038/nprot.2012.105; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; White-Cooper H, 1998, DEVELOPMENT, V125, P125; White-Cooper Helen, 2012, Spermatogenesis, V2, P11; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083; WHITECOOPER H, 1993, J CELL SCI, V106, P1035; Xu SW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003079	47	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122519	10.1371/journal.pone.0122519	http://dx.doi.org/10.1371/journal.pone.0122519			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849588	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800138
J	Hoffer, LJ; Robitaille, L; Zakarian, R; Melnychuk, D; Kavan, P; Agulnik, J; Cohen, V; Small, D; Miller, WH				Hoffer, L. John; Robitaille, Line; Zakarian, Robert; Melnychuk, David; Kavan, Petr; Agulnik, Jason; Cohen, Victor; Small, David; Miller, Wilson H., Jr.			High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial	PLOS ONE			English	Article							ASCORBATE-INDUCED CYTOTOXICITY; QUALITY-OF-LIFE; ANTIOXIDANT SUPPLEMENTATION; PHARMACOLOGICAL ASCORBATE; ACID; THERAPY; GEMCITABINE; PROOXIDANT; TOXICITY; BARRIERS	Background Biological and some clinical evidence suggest that high-dose intravenous vitamin C (IVC) could increase the effectiveness of cancer chemotherapy. IVC is widely used by integrative and complementary cancer therapists, but rigorous data are lacking as to its safety and which cancers and chemotherapy regimens would be the most promising to investigate in detail. Methods and Findings We carried out a phase I-II safety, tolerability, pharmacokinetic and efficacy trial of IVC combined with chemotherapy in patients whose treating oncologist judged that standard-of-care or off-label chemotherapy offered less than a 33% likelihood of a meaningful response. We documented adverse events and toxicity associated with IVC infusions, determined pre- and post-chemotherapy vitamin C and oxalic acid pharmacokinetic profiles, and monitored objective clinical responses, mood and quality of life. Fourteen patients were enrolled. IVC was safe and generally well tolerated, although some patients experienced transient adverse events during or after IVC infusions. The pre- and post-chemotherapy pharmacokinetic profiles suggested that tissue uptake of vitamin C increases after chemotherapy, with no increase in urinary oxalic acid excretion. Three patients with different types of cancer experienced unexpected transient stable disease, increased energy and functional improvement. Conclusions Despite IVC's biological and clinical plausibility, career cancer investigators currently ignore it while integrative cancer therapists use it widely but without reporting the kind of clinical data that is normally gathered in cancer drug development. The present study neither proves nor disproves IVC's value in cancer therapy, but it provides practical information, and indicates a feasible way to evaluate this plausible but unproven therapy in an academic environment that is currently uninterested in it. If carried out in sufficient numbers, simple studies like this one could identify specific clusters of cancer type, chemotherapy regimen and IVC in which exceptional responses occur frequently enough to justify appropriately focused clinical trials.	[Hoffer, L. John] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Robitaille, Line; Zakarian, Robert; Melnychuk, David; Kavan, Petr; Agulnik, Jason; Cohen, Victor; Small, David; Miller, Wilson H., Jr.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Zakarian, Robert; Miller, Wilson H., Jr.] McGill Univ, Jewish Gen Hosp, Clin Res Unit, Montreal, PQ H3T 1E2, Canada; [Melnychuk, David] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Kavan, Petr; Cohen, Victor; Miller, Wilson H., Jr.] Segal Canc Ctr, Dept Oncol, Montreal, PQ, Canada; [Kavan, Petr; Cohen, Victor; Miller, Wilson H., Jr.] Segal Canc Ctr, Dept Med, Montreal, PQ, Canada; [Agulnik, Jason; Cohen, Victor; Small, David] McGill Univ, Jewish Gen Hosp, Peter Brojde Lung Canc Ctr, Dept Med, Montreal, PQ H3T 1E2, Canada; [Agulnik, Jason; Cohen, Victor; Small, David] McGill Univ, Jewish Gen Hosp, Peter Brojde Lung Canc Ctr, Dept Oncol, Montreal, PQ H3T 1E2, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University	Hoffer, LJ (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada.	l.hoffer@mcgill.ca			Lotte & John Hecht Memorial Foundation, Vancouver, BC, Canada	Lotte & John Hecht Memorial Foundation, Vancouver, BC, Canada	This research was supported by the Lotte & John Hecht Memorial Foundation, Vancouver, BC, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block KI, 2008, INT J CANCER, V123, P1227, DOI 10.1002/ijc.23754; Block KI, 2007, CANCER TREAT REV, V33, P407, DOI 10.1016/j.ctrv.2007.01.005; Block Keith I, 2003, Integr Cancer Ther, V2, P147, DOI 10.1177/1534735403002002007; Brown SR, 2011, BRIT J CANCER, V105, P194, DOI 10.1038/bjc.2011.235; Cabanillas F, 2010, P R HEALTH SCI J, V29, P215; CHALLEM J, 2009, ALTERN COMPLEMENT TH, V15, P81, DOI DOI 10.1089/act.2009.15206; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Doroshow JH, 2006, JNCI-J NATL CANCER I, V98, P223, DOI 10.1093/jnci/djj065; Drazen JM, 2014, NEW ENGL J MED, V370, P2240, DOI 10.1056/NEJMe1405032; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Fritz H, 2014, INTEGR CANCER THER, V13, P280, DOI 10.1177/1534735414534463; Fromberg A, 2011, CANCER CHEMOTH PHARM, V67, P1157, DOI 10.1007/s00280-010-1418-6; Ho J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-263; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; Jonas CR, 2000, AM J CLIN NUTR, V72, P181; Kawada H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062717; Klingelhoeffer C, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-61; Levine M, 2009, FREE RADICAL BIO MED, V47, P27, DOI 10.1016/j.freeradbiomed.2009.04.001; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; Ma Y, 2013, J AM COLL NUTR, V32, P187, DOI 10.1080/07315724.2013.791167; Mailankody S, 2014, NEW ENGL J MED, V370, P1478, DOI 10.1056/NEJMp1400104; MARCUS SL, 1991, AM J CLIN NUTR, V54, pS1292, DOI 10.1093/ajcn/54.6.1292s; MEADOWS GG, 1991, AM J CLIN NUTR, V54, pS1284, DOI 10.1093/ajcn/54.6.1284s; Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Nakayama A, 2011, CANCER INVEST, V29, P655, DOI 10.3109/07357907.2011.626479; Ohno S, 2009, ANTICANCER RES, V29, P809; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Padayatty SJ, 2006, CAN MED ASSOC J, V174, P937, DOI 10.1503/cmaj.050346; Park JH, 2012, NUTR RES, V32, P873, DOI 10.1016/j.nutres.2012.09.011; Parrow NL, 2013, ANTIOXID REDOX SIGN, V19, P2141, DOI 10.1089/ars.2013.5372; Perrone F, 2003, LANCET ONCOL, V4, P305, DOI 10.1016/S1470-2045(03)01078-7; Pollard HB, 2010, IN VIVO, V24, P249; Putchala MC, 2013, ARCH ORAL BIOL, V58, P563, DOI 10.1016/j.archoralbio.2013.01.016; Rawal M, 2013, CANCER RES, V73, P5232, DOI 10.1158/0008-5472.CAN-13-0470; Riordan Hugh D, 2005, P R Health Sci J, V24, P269; Riordan Hugh D, 2003, P R Health Sci J, V22, P287; RIORDAN NH, 1995, MED HYPOTHESES, V44, P207, DOI 10.1016/0306-9877(95)90137-X; Robitaille L, 2009, METABOLISM, V58, P263, DOI 10.1016/j.metabol.2008.09.023; Sarna Suniti, 1993, Archivum Immunologiae et Therapiae Experimentalis, V41, P327; Schwartz L, 2014, ANTICANCER RES, V34, P973; Stephenson CM, 2013, CANCER CHEMOTH PHARM, V72, P139, DOI 10.1007/s00280-013-2179-9; STORER BE, 1989, BIOMETRICS, V45, P925, DOI 10.2307/2531693; Suh SY, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-7; Takahashi H., 2012, PERS MED UNIVERSE, V1, P49, DOI [10.1016/j.pmu.2012.05.008, DOI 10.1016/J.PMU.2012.05.008, DOI 10.1016/j.pmu.2012.05.008]; Takemura Y, 2010, BIOCHEM BIOPH RES CO, V394, P249, DOI 10.1016/j.bbrc.2010.02.012; Trotti A, 2007, J CLIN ONCOL, V25, P5121, DOI 10.1200/JCO.2007.12.4784; Vasudevan S, 2014, DIABETES CARE, V37, pE93, DOI 10.2337/dc13-2452; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Vollbracht C, 2011, IN VIVO, V25, P983; Wang YF, 2013, AM J CLIN NUTR, V98, P705, DOI 10.3945/ajcn.112.056366; Weeks L., 2014, OPEN MED PEER REV IN, V8, pE54; Weijl NI, 1998, ANN ONCOL, V9, P1331, DOI 10.1023/A:1008407014084; Welsh JL, 2013, CANCER CHEMOTH PHARM, V71, P765, DOI 10.1007/s00280-013-2070-8; Yeom CH, 2007, J KOREAN MED SCI, V22, P7, DOI 10.3346/jkms.2007.22.1.7; Yeom CH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-70	60	64	65	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120228	10.1371/journal.pone.0120228	http://dx.doi.org/10.1371/journal.pone.0120228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848948	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800023
J	Jiang, HY; Huang, TB; Xu, L; Yu, J; Wu, Y; Geng, J; Yao, XD				Jiang, Hai-yan; Huang, Tian-bao; Xu, Lei; Yu, Jing; Wu, Yan; Geng, Jiang; Yao, Xu-dong			Aspirin Use and Lung Cancer Risk: A Possible Relationship? Evidence from an Updated Meta-Analysis	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUG-USE; LOW-DOSE ASPIRIN; COHORT; ASSOCIATION	Background and Purpose Growing evidence has emerged and controversial results reported on possible relationship between aspirin use and lung cancer risk. We, therefore, conducted this updated and comprehensive meta-analysis to evaluate this issue, with focus on dose-risk and durationrisk relationships. Methods We searched electronic databases including PUBMED, EMBASE and Cochrane library to identify eligible studies. Relative risk (RR) and its 95% confidence interval (CI) were used for cohort studies, while odds ratio (OR) were employed for case-control studies. The random effects and fixed effects models were used for analyses. Results 18 studies were identified including 19835 lung cancer cases, which were eligible for inclusion in the present meta-analysis. Pooled data from case-control studies showed a significant inverse association between regular aspirin use and lung cancer risk. But for cohort studies, insignificant association was detected with little evidence of heterogeneity (RR: 1.05, 95% CI: 0.95 - 1.16; I-2: 10.3%, p value: 0.351). In case-control studies, standard aspirin use (>325mg) was related to lower lung cancer incidence, compared with low-dose aspirin use (75-100mg). A similar trend was observed in cohort studies. Besides, when analysis was restricted to long time regular aspirin use (>5years), insignificant results were reported in both cohort and case-control studies. Finally, regular aspirin use might result in higher reduction of non-small cell lung cancer incidence among men. Conclusions Our findings do not support the protective effect of regular aspirin use on lung cancer risk. Long time aspirin use, sex, dose and type of lung cancer might alter the effect of aspirin use on lung cancer risk. More well-designed studies are needed to further clarify these associations.	[Huang, Tian-bao; Geng, Jiang; Yao, Xu-dong] Tongji Univ, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China; [Jiang, Hai-yan] Tongji Univ, Shanghai Peoples Hosp 10, Electrocardiograph Room, Shanghai 200092, Peoples R China; [Huang, Tian-bao; Xu, Lei; Yao, Xu-dong] Nanjing Med Univ, Dept Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Xu, Lei] Tongji Univ, Shanghai Peoples Hosp 10, Dept Resp Med, Shanghai 200092, Peoples R China; [Yu, Jing; Wu, Yan] Tongji Univ, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Nanjing Medical University; Tongji University; Tongji University	Yao, XD (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China.	yaoxudong1215@163.com						Akhmedkhanov A, 2002, BRIT J CANCER, V87, P49, DOI 10.1038/sj.bjc.6600370; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Brasky TM, 2012, J THORAC ONCOL, V7, P1503, DOI 10.1097/JTO.0b013e3182641bdc; Chen Mingsheng, 2005, Zhongguo Fei Ai Za Zhi, V8, P300, DOI 10.3779/j.issn.1009-3419.2005.04.10; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Feskanich D, 2007, BRIT J CANCER, V97, P1295, DOI 10.1038/sj.bjc.6603996; Harris RE, 2007, INT J BIOL SCI, V3, P328; Hayes JH, 2006, CANCER EPIDEM BIOMAR, V15, P2226, DOI 10.1158/1055-9965.EPI-06-0172; Hernandez-Diaz S, 2007, INT J CANCER, V120, P1565, DOI 10.1002/ijc.22514; Holick CN, 2003, BRIT J CANCER, V89, P1705, DOI 10.1038/sj.bjc.6601343; Ishikawa H, 2013, CANCER MED-US, V2, P50, DOI 10.1002/cam4.46; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Kelly JP, 2008, PHARMACOEPIDEM DR S, V17, P322, DOI 10.1002/pds.1532; Lim WY, 2012, LUNG CANCER, V77, P246, DOI 10.1016/j.lungcan.2012.03.005; McCormack VA, 2011, CANCER CAUSE CONTROL, V22, P1709, DOI 10.1007/s10552-011-9847-z; Moysich KB, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-31; Muscat JE, 2003, CANCER, V97, P1732, DOI 10.1002/cncr.11242; Oh SW, 2011, ANN ONCOL, V22, P2456, DOI 10.1093/annonc/mdq779; Olsen JH, 2008, BRIT J CANCER, V98, P232, DOI 10.1038/sj.bjc.6604151; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; Pelucchi C, 2011, ANN ONCOL, V22, P1487, DOI 10.1093/annonc/mdq610; Rodriguez C, 2008, CANCER EPIDEM BIOMAR, V17, P655, DOI 10.1158/1055-9965.EPI-07-2683; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Sivarasan N, 2013, J DIGEST DIS, V14, P222, DOI 10.1111/1751-2980.12047; Slatore CG, 2009, CANCER EPIDEM BIOMAR, V18, P1203, DOI 10.1158/1055-9965.EPI-08-1110; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thorat MA, 2013, CURR ONCOL REP, V15, P533, DOI 10.1007/s11912-013-0351-3; Van Dyke AL, 2008, CANCER EPIDEM BIOMAR, V17, P148, DOI 10.1158/1055-9965.EPI-07-0517; Xu JL, 2012, CLIN LUNG CANCER, V13, P44, DOI 10.1016/j.cllc.2011.06.009; Ye XH, 2013, INT J ANTENN PROPAG, V2013, DOI 10.1155/2013/106516; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014	34	15	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122962	10.1371/journal.pone.0122962	http://dx.doi.org/10.1371/journal.pone.0122962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849465	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800184
J	Lin, CY; Huang, FP; Ling, YS; Liang, HJ; Lee, SH; Hu, MY; Tsao, PN				Lin, Ching-Yu; Huang, Feng-Peng; Ling, Yee Soon; Liang, Hao-Jan; Lee, Sheng-Han; Hu, Mei-Yun; Tsao, Po-Nien			Use of Nuclear Magnetic Resonance-Based Metabolomics to Characterize the Biochemical Effects of Naphthalene on Various Organs of Tolerant Mice	PLOS ONE			English	Article							CLARA CELL CYTOTOXICITY; CYTOCHROME-P-450 ACTIVITY; GLUTATHIONE DEPLETION; RESPIRATORY-TRACT; EARLY EVENTS; TOXICITY; METABOLISM; NMR; LACTATE; EXPOSURES	Naphthalene, the most common polycyclic aromatic hydrocarbon, causes airway epithelium injury in mice. Repeated exposure of mice to naphthalene induces airway epithelia that are resistant to further injury. Previous studies revealed that alterations in bioactivation enzymes and increased levels of gamma-glutamylcysteine synthase in the bronchioles protect tolerant mice from naphthalene and its reactive metabolites. In our current study, tolerance was induced in male ICR mice using a total of 7 daily intraperitoneal injections of naphthalene (200 mg/kg). Both naphthalene-tolerant and non-tolerantmice were challenged with a dose of 300 mg/kg naphthalene on day 8 to investigate metabolite differences. The lungs, liver, and kidneys were collected for histopathology 24 h after the challenge dose. Bronchial alveolar lavage fluid (BALF) and both hydrophilic and hydrophobic extracts from each organ were analyzed using nuclear magnetic resonance (NMR)-based metabolomics. The histological results showed no observable injuries to the airway epithelium of naphthalene-tolerant mice when compared with the control. In contrast, airway injuries were observed in mice given a single challenge dose (injury mice). The metabolomics analysis revealed that the energy metabolism in the lungs of tolerant and injury mice was significantly perturbed. However, antioxidant metabolites, such as glutathione and succinate, were significantly increased in the lungs of tolerant mice, suggesting a role for these compounds in the protection of organs from naphthalene-induced electrophilic metabolites and free radicals. Damage to the airway cellular membrane, as shown by histopathological results and increased acetone in the BALF and perturbation of hydrophobic lung extracts, including cholesterol, phosphorylcholine-containing lipids, and fatty acyl chains, were observed in injury mice. Consistent with our histopathological results, fewer metabolic effects were observed in the liver and kidney of mice after naphthalene treatments. In conclusion, NMR-based metabolomics reveals possible mechanisms of naphthalene tolerance and naphthalene-induced toxicity in the respiratory system of mice.	[Lin, Ching-Yu; Huang, Feng-Peng; Ling, Yee Soon; Liang, Hao-Jan; Lee, Sheng-Han] Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 100, Taiwan; [Hu, Mei-Yun; Tsao, Po-Nien] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, CY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 100, Taiwan.	chingyulin@ntu.edu.tw	Ling, Yee_Soon/H-6815-2016	Ling, Yee_Soon/0000-0002-1042-7820; LIN, CHING-YU/0000-0002-7144-0383; TSAO, PO-NIEN/0000-0002-6114-1769	Ministry of Science and Technology [MST 99-2314-B-002-127-MY3, MST 102-2628-B-002 -048 -MY3]; National Health Research Institutes [NHRI-EX100-9915EC, NHRI-EX101-9915EC]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan)	Funding was provided by the Ministry of Science and Technology (http://www.most.gov.tw/) (MST 99-2314-B-002-127-MY3 and MST 102-2628-B-002 -048 -MY3) and National Health Research Institutes (http://www.nhri.org.tw/) (NHRI-EX100-9915EC and NHRI-EX101-9915EC) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Bellomo R, 2002, CRIT CARE, V6, P322; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYD MR, 1981, TOXICOLOGY, V19, P85, DOI 10.1016/0300-483X(81)90091-3; Buckpitt A, 2002, DRUG METAB REV, V34, P791, DOI 10.1081/DMR-120015694; BUCKPITT A, 1995, MOL PHARMACOL, V47, P74; Chen WX, 2011, MAGN RESON MED, V66, P1531, DOI 10.1002/mrm.22957; CHO M, 1995, DRUG METAB REV, V27, P369, DOI 10.3109/03602539509029830; DEVEREUX TR, 1989, PHARMACOL THERAPEUT, V41, P243, DOI 10.1016/0163-7258(89)90109-5; Fonville JM, 2010, ANAL CHEM, V82, P1811, DOI 10.1021/ac902443k; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Gudkov SV, 2006, RADIAT RES, V165, P538, DOI 10.1667/RR3552.1; Hong JH, 2014, J APPL TOXICOL, V34, P1379, DOI 10.1002/jat.2970; Hu JZ, 2008, TOXICOL MECH METHOD, V18, P385, DOI 10.1080/15376510701611032; Jia CR, 2010, INT J ENV RES PUB HE, V7, P2903, DOI 10.3390/ijerph7072903; Jurkowitz MS, 1998, J NEUROCHEM, V71, P535; Lakritz J, 1996, J PHARMACOL EXP THER, V278, P1408; Lankadurai BP, 2013, ENVIRON REV, V21, P180, DOI 10.1139/er-2013-0011; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Lin CY, 2006, PROTEOMICS, V6, P972, DOI 10.1002/pmic.200500170; Lin CY, 2005, CHEM RES TOXICOL, V18, P802, DOI 10.1021/tx049746r; Ling YS, 2014, MOL BIOSYST, V10, P1918, DOI 10.1039/c4mb00090k; Ludwig C, 2010, PHYTOCHEM ANALYSIS, V21, P22, DOI 10.1002/pca.1186; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; Mitchell AE, 2000, ARCH TOXICOL, V74, P215, DOI 10.1007/s002040000120; NAKANISHI T, 1989, P NATL ACAD SCI USA, V86, P6002, DOI 10.1073/pnas.86.15.6002; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; OBRIEN KAF, 1989, TOXICOL APPL PHARM, V99, P487, DOI 10.1016/0041-008X(89)90156-7; Oostendorp M, 2006, CLIN CHEM, V52, P1395, DOI 10.1373/clinchem.2006.069112; Phimister AJ, 2004, TOXICOL SCI, V82, P268, DOI 10.1093/toxsci/kfh258; Phypers B, 2006, BJA EDUC, V6, P128, DOI 10.1093/bjaceaccp/mkl018; PLOPPER CG, 1987, EXP LUNG RES, V13, P59, DOI 10.3109/01902148709064309; PLOPPER CG, 1992, J PHARMACOL EXP THER, V261, P353; PLOPPER CG, 1992, LAB INVEST, V67, P553; Plopper CG, 2001, AM J RESP CELL MOL, V24, P272, DOI 10.1165/ajrcmb.24.3.4247; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; Robinson MS, 2008, ANN OCCUP HYG, V52, P497, DOI 10.1093/annhyg/men027; Sehirli O, 2008, ECOTOX ENVIRON SAFE, V71, P301, DOI 10.1016/j.ecoenv.2007.08.023; Stohs SJ, 2002, TOXICOLOGY, V180, P97, DOI 10.1016/S0300-483X(02)00384-0; Van Winkle LS, 1999, AM J RESP CELL MOL, V21, P44, DOI 10.1165/ajrcmb.21.1.3630; Viant Mark R., 2008, V410, P137; Viant MR, 2003, BIOCHEM BIOPH RES CO, V310, P943, DOI 10.1016/j.bbrc.2003.09.092; West JAA, 2000, J PHARMACOL EXP THER, V294, P516; West JAA, 2001, TOXICOL APPL PHARM, V173, P114, DOI 10.1006/taap.2001.9151; West JAA, 2003, TOXICOL SCI, V75, P161, DOI 10.1093/toxsci/kfg156; West JAA, 2002, AM J PATHOL, V160, P1115, DOI 10.1016/S0002-9440(10)64932-2; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zira A, 2013, TOXICOLOGY, V303, P115, DOI 10.1016/j.tox.2012.10.015	52	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120429	10.1371/journal.pone.0120429	http://dx.doi.org/10.1371/journal.pone.0120429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849086	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800024
J	Liu, SH; Hou, JY; Zhang, H; Wu, YS; Hu, MB; Zhang, LM; Xu, JF; Na, R; Jiang, HW; Ding, Q				Liu, Shenghua; Hou, Junyao; Zhang, Hu; Wu, Yishuo; Hu, Mengbo; Zhang, Limin; Xu, Jianfeng; Na, Rong; Jiang, Haowen; Ding, Qiang			The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population	PLOS ONE			English	Article							UROTHELIAL CARCINOMA; SCORING MODEL; T1; TA; INSTILLATION; PROGRESSION; TABLES	Objective The risk factors of bladder cancer recurrence after transurethral resection of bladder tumor (TURBt) were poorly understood, especially in Chinese population. This study evaluated the potential risk factors of recurrence based on a Chinese population. Materials and Methods A total of 698 patients that received TURBt procedure in our institute from 2000 to 2012 were recruited in this study. Clinical information was collected. The patients were followed up according to the schedule recommended by Chinese guideline. Results A total of 583 males (83.5%) and 115 females (16.5%) were enrolled in our study. The median follow-up duration was 51.5 months. Gender, chief complain, tumor size, number of lesions, histological grade and chemotherapeutic agents were found significantly associated with patients' short-term recurrence (less than 1 year) (All p<0.05). In the multivariate analysis, tumor size, number of lesions, histological grade and chemotherapeutic agents were significantly related to patients' short-term recurrence (less than 1 year) (All p<0.05). A multivariate model based on tumor size, number of lesions, histological grade and chemotherapeutic agents had an AUC of 0.697, which significantly improved the prediction utility for bladder cancer short-term recurrence (less than 1 year) than any single factor In the multivariate Cox regression, tumor size greater than 3 cm, multifocal lesions, worsen histological grade and non-urothelial carcinoma was related to time to recurrence (TR). Conclusion Patients with larger tumor size, multifocal number of lesions, higher tumor grade and who received chemotherapeutic agents other than Epirubicin and Pirarubicin might have higher risks of recurrence less than 1 year. Tumor size, number of lesions, pathology and histological grade might be associated with TR. As Bacille Calmette-Guerin (BCG) is currently not approved for bladder cancer in China, Epirubicin and Pirarubicin might be considered prior to other chemotherapy medications when providing post-operative instillation of chemotherapy.	[Liu, Shenghua; Hou, Junyao; Zhang, Hu; Wu, Yishuo; Hu, Mengbo; Zhang, Limin; Xu, Jianfeng; Na, Rong; Jiang, Haowen; Ding, Qiang] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Liu, Shenghua; Hou, Junyao; Zhang, Hu; Wu, Yishuo; Hu, Mengbo; Zhang, Limin; Xu, Jianfeng; Na, Rong; Jiang, Haowen; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Sch Med, Ctr Canc Genom, Winston Salem, NC USA	Fudan University; Fudan University; Fudan University; Wake Forest University	Na, R (corresponding author), Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China.	narong.hs@gmail.com; haowenjiang.urol@outlook.com	Na, Rong/AAN-8655-2021; Hu, Meng-Bo/HDL-7502-2022	Na, Rong/0000-0001-7470-5108; 	National Natural Science Foundation of China [81272853, 81402339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Natural Science Foundation of China (Grand No. 81272853, 81402339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1998, BRIT J UROL, V81, P692; [Anonymous], 1973, HISTOLOGICAL TYPING; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Berrum-Svennung I, 2008, J UROLOGY, V179, P101, DOI 10.1016/j.juro.2007.08.166; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chamie K, 2013, CANCER-AM CANCER SOC, V119, P3219, DOI 10.1002/cncr.28147; Chen WQ, 2012, CHINESE J CANCER RES, V24, P1, DOI 10.1007/s11670-012-0001-6; Ding WH, 2014, CANCER EPIDEMIOL, V38, P157, DOI 10.1016/j.canep.2014.02.001; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Gudjonsson S, 2009, EUR UROL, V55, P773, DOI 10.1016/j.eururo.2009.01.006; Kobayashi H, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-5; KURTH KH, 1995, EUR J CANCER, V31A, P1840, DOI 10.1016/0959-8049(95)00287-S; Pycha A, 1999, UROLOGY, V53, P92, DOI 10.1016/S0090-4295(98)00461-0; Rodriguez-Alonso A, 2002, CANCER, V94, P1677, DOI 10.1002/cncr.10376; Rosevear HM, 2011, J UROLOGY, V185, P67, DOI 10.1016/j.juro.2010.08.083; Shelley MD, 2010, CANCER TREAT REV, V36, P195, DOI 10.1016/j.ctrv.2009.12.005; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soukup V, 2014, UROL INT, V92, P150, DOI 10.1159/000355358; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Sylvester RJ, 2004, J UROLOGY, V171, P2186, DOI 10.1097/01.ju.0000125486.92260.b2; Wyszynski A, 2014, CANCER-AM CANCER SOC, V120, P408, DOI 10.1002/cncr.28394; Xylinas E, 2013, BRIT J CANCER, V109, P1460, DOI 10.1038/bjc.2013.372	22	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123617	10.1371/journal.pone.0123617	http://dx.doi.org/10.1371/journal.pone.0123617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849552	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800245
J	Lyons, R; Stiller, J; Powell, J; Rusu, A; Manners, JM; Kazan, K				Lyons, Rebecca; Stiller, Jiri; Powell, Jonathan; Rusu, Anca; Manners, John M.; Kazan, Kemal			Fusarium oxysporum Triggers Tissue-Specific Transcriptional Reprogramming in Arabidopsis thaliana	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; PLANT DEFENSE RESPONSES; MANNOSE-BINDING-LECTIN; DISEASE-RESISTANCE; SALICYLIC-ACID; ABSCISIC-ACID; GENE-EXPRESSION; FACTOR-2 ARF2; ROOT; AUXIN	Some of the most devastating agricultural diseases are caused by root-infecting pathogens, yet the majority of studies on these interactions to date have focused on the host responses of aerial tissues rather than those belowground. Fusarium oxysporum is a root-infecting pathogen that causes wilt disease on several plant species including Arabidopsis thaliana. To investigate and compare transcriptional changes triggered by F. oxysporum in different Arabidopsis tissues, we infected soil-grown plants with F. oxysporum and subjected root and leaf tissue harvested at early and late timepoints to RNA-seq analyses. At least half of the genes induced or repressed by F. oxysporum showed tissue-specific regulation. Regulators of auxin and ABA signalling, mannose binding lectins and peroxidases showed strong differential expression in root tissue. We demonstrate that ARF2 and PRX33, two genes regulated in the roots, promote susceptibility to F. oxysporum. In the leaves, defensins and genes associated with the response to auxin, cold and senescence were strongly regulated while jasmonate biosynthesis and signalling genes were induced throughout the plant.	[Lyons, Rebecca; Stiller, Jiri; Powell, Jonathan; Rusu, Anca; Kazan, Kemal] CSIRO Agr Flagship, Queensland Biosci Precinct, Brisbane, Qld, Australia; [Manners, John M.] CSIRO Agr Flagship, Black Mt Labs, Brisbane, Qld, Australia; [Kazan, Kemal] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4067, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Lyons, R (corresponding author), CSIRO Agr Flagship, Queensland Biosci Precinct, Brisbane, Qld, Australia.	rebeccalyons23@hotmail.com	Kazan, Kemal/B-8032-2008; Stiller, Jiri/E-1564-2012; Manners, John M/A-4922-2008	Kazan, Kemal/0000-0002-5169-8934; Powell, Jonathan/0000-0002-6222-8030	CSIRO OCE (Office of the Chief Executive)	CSIRO OCE (Office of the Chief Executive)	This work was partially funded by the CSIRO OCE (Office of the Chief Executive) postdoctoral fellowship to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio AM, 2011, PLANT CELL, V23, P3303, DOI 10.1105/tpc.111.088989; Ali MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-47; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Araujo JH, 2010, J AGR FOOD CHEM, V58, P4090, DOI 10.1021/jf903254b; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Balmer D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00256; Balmer D, 2013, PLANT J, V74, P213, DOI 10.1111/tpj.12114; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05584; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; Cole SJ, 2014, MOL PLANT PATHOL, V15, P589, DOI 10.1111/mpp.12117; Cox KD, 2006, PLANTA, V224, P1373, DOI 10.1007/s00425-006-0322-0; Czymmek KJ, 2007, FUNGAL GENET BIOL, V44, P1011, DOI 10.1016/j.fgb.2007.01.012; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Dong X, 2014, WORLD J MICROB BIOT, V30, P1399, DOI 10.1007/s11274-013-1564-1; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furutani M, 2011, DEVELOPMENT, V138, P2069, DOI 10.1242/dev.057745; Guidarelli M, 2014, MOL PLANT PATHOL, V15, P832, DOI 10.1111/mpp.12143; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Hwang IS, 2011, PLANT PHYSIOL, V155, P447, DOI 10.1104/pp.110.164848; Jin J, 2011, PLANT SIGNAL BEHAV, V6, P1778, DOI 10.4161/psb.6.11.17684; Jing HC, 2008, PLANT BIOLOGY, V10, P85, DOI 10.1111/j.1438-8677.2008.00087.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Kiirika LM, 2012, PLANT PHYSIOL, V159, P501, DOI 10.1104/pp.112.193706; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Korves TM, 2003, PLANT PHYSIOL, V133, P339, DOI 10.1104/pp.103.027094; Lee SH, 2015, J INTEGR PLANT BIOL, V57, P562, DOI 10.1111/jipb.12276; Lev-Yadun S, 2009, LIFES COLORFUL SOLUT, P22; Lim CW, 2014, PLANT CELL PHYSIOL, V55, P1691, DOI 10.1093/pcp/pcu100; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liu PP, 2010, MOL PLANT MICROBE IN, V23, P82, DOI 10.1094/MPMI-23-1-0082; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Lyons R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02866; Mammarella ND, 2015, PHYTOCHEMISTRY, V112, P110, DOI 10.1016/j.phytochem.2014.07.010; Manzano C, 2014, PLANT PHYSIOL, V165, P1105, DOI 10.1104/pp.114.238873; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Miyakawa T, 2014, PLANT PHYSIOL, V166, P766, DOI 10.1104/pp.114.242636; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Mueller-Roeber B, 2014, J PLANT GROWTH REGUL, V33, P21, DOI 10.1007/s00344-013-9398-5; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; O'Brien JA, 2012, PLANT PHYSIOL, V158, P2013, DOI 10.1104/pp.111.190140; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Pantelides IS, 2013, PLANT PATHOL, V62, P1302, DOI 10.1111/ppa.12042; Passardi F, 2006, PLANTA, V223, P965, DOI 10.1007/s00425-005-0153-4; Plancot B, 2013, PLANT PHYSIOL, V163, P1584, DOI 10.1104/pp.113.222356; Ranjan A, 2015, 3 BIOTECH, V5, P585, DOI 10.1007/s13205-014-0257-2; Reitz MU, 2012, PLANT PHYSIOL, V160, P349, DOI 10.1104/pp.112.201319; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Seo S, 2012, PLANT CELL PHYSIOL, V53, P1432, DOI 10.1093/pcp/pcs085; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Sun XW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1486; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Thatcher LF, 2012, PLANT PHYSIOL, V160, P407, DOI 10.1104/pp.112.199067; Thatcher LF, 2012, MOL PLANT MICROBE IN, V25, P180, DOI 10.1094/MPMI-08-11-0212; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Tytgat TO, 2013, MOL ECOL, V22, P6179, DOI [10.1111/mec.12555, DOI 10.1111/MEC.12555]; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078484; Wang XC, 2001, PLANT J, V25, P651, DOI 10.1046/j.1365-313x.2001.00999.x; Wang Z, 2009, MOL PLANT, V2, P323, DOI 10.1093/mp/ssn078; Zhang KW, 2013, P NATL ACAD SCI USA, V110, P14807, DOI 10.1073/pnas.1302702110; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhu AH, 2012, GENE, V10, P259	89	58	63	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121902	10.1371/journal.pone.0121902	http://dx.doi.org/10.1371/journal.pone.0121902			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849296	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800085
J	Tadeu, AMB; Lin, S; Hou, L; Chung, LS; Zhong, M; Zhao, HY; Horsley, V				Tadeu, Ana Mafalda Baptista; Lin, Samantha; Hou, Lin; Chung, Lisa; Zhong, Mei; Zhao, Hongyu; Horsley, Valerie			Transcriptional Profiling of Ectoderm Specification to Keratinocyte Fate in Human Embryonic Stem Cells	PLOS ONE			English	Article							LARGE GENE LISTS; EPIDERMAL DIFFERENTIATION; TERMINAL DIFFERENTIATION; SKIN DEVELOPMENT; HOMEOBOX GENE; EPITHELIAL DIFFERENTIATION; EPIDERMOLYSIS-BULLOSA; FOLLICLE DEVELOPMENT; SIGNALING PATHWAYS; AP-2 FACTORS	In recent years, several studies have shed light into the processes that regulate epidermal specification and homeostasis. We previously showed that a broad-spectrum gamma-secretase inhibitor DAPT promoted early keratinocyte specification in human embryonic stem cells triggered to undergo ectoderm specification. Here, we show that DAPT accelerates human embryonic stem cell differentiation and induces expression of the ectoderm protein AP2. Furthermore, we utilize RNA sequencing to identify several candidate regulators of ectoderm specification including those involved in epithelial and epidermal development in human embryonic stem cells. Genes associated with transcriptional regulation and growth factor activity are significantly enriched upon DAPT treatment during specification of human embryonic stem cells to the ectoderm lineage. The human ectoderm cell signature identified in this study contains several genes expressed in ectodermal and epithelial tissues. Importantly, these genes are also associated with skin disorders and ectodermal defects, providing a platform for understanding the biology of human epidermal keratinocyte development under diseased and homeostatic conditions.	[Tadeu, Ana Mafalda Baptista; Lin, Samantha; Horsley, Valerie] Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06511 USA; [Hou, Lin; Chung, Lisa; Zhao, Hongyu] Yale Univ, Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Zhong, Mei] Yale Univ, Yale Stem Cell Ctr, Genom Facil, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Horsley, V (corresponding author), Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06511 USA.	valerie.horsley@yale.edu			State of CT Stem Cell Fund [12-SCB-YALE-01]; NIH [AR060295]; Clinical and Translational Science Award from the National Center for Research Resources, National Institutes of Health [UL1 RR024139]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060295] Funding Source: NIH RePORTER	State of CT Stem Cell Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award from the National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the State of CT Stem Cell Fund (12-SCB-YALE-01) to V. H. A. T. was a Fundacao para a Ciencia e Tecnologia postdoctoral fellow. V. H. is a Pew Scholar in Biomedical Research and is funded by the NIH (AR060295). L.C. and L.H. were supported in part by the Clinical and Translational Science Award UL1 RR024139 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2007, CELL CYCLE, V6, P291, DOI 10.4161/cc.6.3.3800; Aberdam E, 2008, STEM CELLS, V26, P440, DOI 10.1634/stemcells.2007-0588; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bilousova Ganna, 2013, Methods Mol Biol, V961, P337, DOI 10.1007/978-1-62703-227-8_22; Bilousova G, 2011, J INVEST DERMATOL, V131, P857, DOI 10.1038/jid.2010.364; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; DELLAMBRA E, 1995, J CELL SCI, V108, P3569; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; El-Hashash AHK, 2011, DEV BIOL, V350, P112, DOI 10.1016/j.ydbio.2010.11.022; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Finch JL, 1999, INT J CANCER, V80, P533, DOI 10.1002/(SICI)1097-0215(19990209)80:4<533::AID-IJC9>3.0.CO;2-5; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gordon K, 2013, J INVEST DERMATOL, V133, P712, DOI 10.1038/jid.2012.391; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Guttormsen J, 2008, DEV BIOL, V317, P187, DOI 10.1016/j.ydbio.2008.02.017; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Ji L, 2006, TISSUE ENG, V12, P665, DOI 10.1089/ten.2006.12.665; Kaplan N, 2012, INVEST OPHTH VIS SCI, V53, P936, DOI 10.1167/iovs.11-8685; Koch PJ, 2004, J INVEST DERMATOL, V123, pX, DOI 10.1111/j.0022-202X.2004.23495.x; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2010, J INVEST DERMATOL, V130, P2352, DOI 10.1038/jid.2010.119; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Laugel-Haushalter Virginie, 2013, BMC Res Notes, V6, P113, DOI 10.1186/1756-0500-6-113; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; LEFFERS H, 1993, J MOL BIOL, V231, P982, DOI 10.1006/jmbi.1993.1346; Lin S, 2012, SEMIN CELL DEV BIOL, V23, P92, DOI 10.1016/j.semcdb.2011.10.017; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Luo T, 2002, DEV BIOL, V245, P136, DOI 10.1006/dbio.2002.0621; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nagarajan P, 2008, CRIT REV EUKAR GENE, V18, P57; Nakagawa N, 2012, J DERMATOL SCI, V65, P196, DOI 10.1016/j.jdermsci.2011.12.011; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Olson LE, 2005, P NATL ACAD SCI USA, V102, P3708, DOI 10.1073/pnas.0500519102; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Sander G, 2000, J INVEST DERMATOL, V115, P753, DOI 10.1046/j.1523-1747.2000.00122.x; Shalom-Feuerstein R, 2013, P NATL ACAD SCI USA, V110, P2152, DOI 10.1073/pnas.1201753109; Short K, 2007, IUBMB LIFE, V59, P427, DOI 10.1080/15216540701510581; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Tadeu AMB, 2013, DEVELOPMENT, V140, P3777, DOI 10.1242/dev.093948; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tolar J, 2013, J INVEST DERMATOL, V133, P562, DOI 10.1038/jid.2012.278; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TSENG H, 1992, P NATL ACAD SCI USA, V89, P10311, DOI 10.1073/pnas.89.21.10311; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; White BEP, 2014, CELL ADHES MIGR, V8, P327, DOI 10.4161/19336918.2014.970012; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	81	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122493	10.1371/journal.pone.0122493	http://dx.doi.org/10.1371/journal.pone.0122493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849374	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800135
J	Tisa, F; Davoody, M; Raman, AAA; Daud, WMAW				Tisa, Farhana; Davoody, Meysam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan			Degradation and Mineralization of Phenol Compounds with Goethite Catalyst and Mineralization Prediction Using Artificial Intelligence	PLOS ONE			English	Article							NEURAL-NETWORKS; HYDROGEN-PEROXIDE; FENTON; OXIDATION; DECOLORIZATION; KINETICS; DECOMPOSITION; SIMULATION; MODEL; H2O2	The efficiency of phenol degradation via Fenton reaction using mixture of heterogeneous goethite catalyst with homogeneous ferrous ion was analyzed as a function of three independent variables, initial concentration of phenol (60 to 100 mg /L), weight ratio of initial concentration of phenol to that of H2O2 (1: 6 to 1: 14) and, weight ratio of initial concentration of goethite catalyst to that of H2O2 (1:0.3 to 1:0.7). More than 90 % of phenol removal and more than 40% of TOC removal were achieved within 60 minutes of reaction. Two separate models were developed using artificial neural networks to predict degradation percentage by a combination of Fe3+ and Fe2+ catalyst. Five operational parameters were employed as inputs while phenol degradation and TOC removal were considered as outputs of the developed models. Satisfactory agreement was observed between testing data and the predicted values (R-Phenol(2) = 0.9214 and (RTOC)-T-2 = 0.9082).	[Tisa, Farhana; Davoody, Meysam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan] Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Raman, AAA (corresponding author), Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia.	azizraman@um.edu.my	ABDUL RAMAN, ABDUL AZIZ/B-8094-2010; DAUD, WAN MOHD ASHRI WAN/C-1022-2010; Davoody, Meysam/N-6409-2015	ABDUL RAMAN, ABDUL AZIZ/0000-0001-7586-1903; Davoody, Meysam/0000-0002-2089-3331	Ministry of Higher Education of Malaysia and University of Malaya [HIR-MOHE-D000038-16001]	Ministry of Higher Education of Malaysia and University of Malaya	The authors thank the University of Malaya High Impact Research Grant (HIR-MOHE-D000038-16001) from the Ministry of Higher Education of Malaysia and University of Malaya for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleboyeh A, 2008, DYES PIGMENTS, V77, P288, DOI 10.1016/j.dyepig.2007.05.014; Babuponnusami A, 2011, CLEAN-SOIL AIR WATER, V39, P142, DOI 10.1002/clen.201000072; Bach A, 2010, DESALINATION, V264, P188, DOI 10.1016/j.desal.2010.04.011; Bayat M, 2012, J IND ENG CHEM, V18, P957, DOI 10.1016/j.jiec.2011.09.004; Chamjangali MA, 2007, J MOL GRAPH MODEL, V26, P360, DOI 10.1016/j.jmgm.2007.01.005; Chiang WYK, 2006, DECIS SUPPORT SYST, V41, P514, DOI 10.1016/j.dss.2004.08.016; Choi JS, 2006, CATAL TODAY, V111, P280, DOI 10.1016/j.cattod.2005.10.037; Chou SS, 2001, ENVIRON SCI TECHNOL, V35, P1247, DOI 10.1021/es001129b; Cinar S, 2004, ADV ENVIRON RES, V8, P477, DOI 10.1016/S1093-0191(02)00146-6; Daneshvar N, 2006, J HAZARD MATER, V137, P1788, DOI 10.1016/j.jhazmat.2006.05.042; Duran A, 2006, APPL CATAL B-ENVIRON, V65, P127, DOI 10.1016/j.apcatb.2006.01.004; Dutta S, 2010, J PETROL SCI ENG, V72, P93, DOI 10.1016/j.petrol.2010.03.007; Dutta S, 2010, EXPERT SYST APPL, V37, P8634, DOI 10.1016/j.eswa.2010.06.090; Elmolla ES, 2010, J HAZARD MATER, V179, P127, DOI 10.1016/j.jhazmat.2010.02.068; Garson G.D., 1991, AI EXPERT, V6, P46; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Gob S, 1999, CHEM ENG PROCESS, V38, P373, DOI 10.1016/S0255-2701(99)00028-8; Graupe D., 2007, PRINCIPLES ARTIFICIA; Guimaraes IR, 2008, APPL CATAL A-GEN, V347, P89, DOI 10.1016/j.apcata.2008.06.001; Hamed MM, 2004, ENVIRON MODELL SOFTW, V19, P919, DOI 10.1016/j.envsoft.2003.10.005; Hanbay D, 2008, EXPERT SYST APPL, V34, P1038, DOI 10.1016/j.eswa.2006.10.030; Hassan H, 2011, CHEM ENG J, V171, P912, DOI 10.1016/j.cej.2011.04.040; Huang CP, 2008, APPL CATAL A-GEN, V346, P140, DOI 10.1016/j.apcata.2008.05.017; Huang CP, 2009, APPL CATAL A-GEN, V357, P135, DOI 10.1016/j.apcata.2008.12.043; Hush DR, 1993, IEEE SIGNAL PROC MAG, V10, P8, DOI 10.1109/79.180705; Hussain MA, 2002, J FOOD ENG, V51, P239, DOI 10.1016/S0260-8774(01)00063-2; Jorjani E, 2008, FUEL, V87, P2727, DOI 10.1016/j.fuel.2008.01.029; Kasiri MB, 2008, ENVIRON SCI TECHNOL, V42, P7970, DOI 10.1021/es801372q; Kavitha V, 2004, CHEMOSPHERE, V55, P1235, DOI 10.1016/j.chemosphere.2003.12.022; Lek S, 1999, ECOL MODEL, V120, P65, DOI 10.1016/S0304-3800(99)00092-7; Lu MC, 2000, CHEMOSPHERE, V40, P125, DOI 10.1016/S0045-6535(99)00213-1; Maren AJ, 1990, HDB NEURAL COMPUTING, DOI [10.1016/c2013-0-11292-5, DOI 10.1016/C2013-0-11292-5]; Martinez F, 2007, IND ENG CHEM RES, V46, P4396, DOI 10.1021/ie070165h; Meng YB, 2008, ECOTOX ENVIRON SAFE, V71, P172, DOI 10.1016/j.ecoenv.2007.06.011; Monteagudo JM, 2010, CHEM ENG J, V162, P702, DOI 10.1016/j.cej.2010.06.029; de la Plata GBO, 2012, J PHOTOCH PHOTOBIO A, V233, P53, DOI 10.1016/j.jphotochem.2012.02.023; Pareek VK, 2003, CHEM ENG SCI, V58, P859, DOI 10.1016/S0009-2509(02)00617-6; Pontes RFF, 2010, J HAZARD MATER, V176, P402, DOI 10.1016/j.jhazmat.2009.11.044; Saien J, 2012, DESALIN WATER TREAT, V40, P174, DOI 10.5004/dwt.2012.2847; Salari D, 2005, J HAZARD MATER, V125, P205, DOI 10.1016/j.jhazmat.2005.05.030; Shojaeefard MH, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/574914; Toma FL, 2004, J PHOTOCH PHOTOBIO A, V165, P91, DOI 10.1016/j.jphotochem.2004.03.004; Wen CH, 1998, ENG APPL ARTIF INTEL, V11, P685, DOI 10.1016/S0952-1976(98)00036-0; Wu JJ, 2006, CATAL COMMUN, V7, P901, DOI 10.1016/j.catcom.2006.03.015; Xu LJ, 2011, J HAZARD MATER, V186, P256, DOI 10.1016/j.jhazmat.2010.10.116; Zazo JA, 2005, ENVIRON SCI TECHNOL, V39, P9295, DOI 10.1021/es050452h; Zhang JB, 2008, CHEMOSPHERE, V73, P1524, DOI 10.1016/j.chemosphere.2008.05.050; ZINDER B, 1986, GEOCHIM COSMOCHIM AC, V50, P1861, DOI 10.1016/0016-7037(86)90244-9	48	1	1	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119933	10.1371/journal.pone.0119933	http://dx.doi.org/10.1371/journal.pone.0119933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849556	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800017
J	Xu, ZX; Wang, YY; Li, HZ				Xu, Zuxin; Wang, Yiyao; Li, Huaizheng			Stoichiometric Determination of Nitrate Fate in Agricultural Ecosystems during Rainfall Events	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; GROWTH EFFICIENCY; NITROGEN; STREAM; DENITRIFICATION; GROUNDWATER; TRANSFORMATION; REMOVAL	Ecologists have found a close relationship between the concentrations of nitrate (NO3-) and dissolved organic carbon (DOC) in ecosystems. However, it is difficult to determine the NO3- fate exactly because of the low coefficient in the constructed relationship. In the present paper, a negative power-function equation (r(2) = 0.87) was developed by using 411 NO3- data points and DOC: NO3- ratios from several agricultural ecosystems during different rainfall events. Our analysis of the stoichiometric method reveals several observations. First, the NO3- concentration demonstrated the largest changes when the DOC: NO3- ratio increased from 1 to 10. Second, the biodegradability of DOC was an important factor in controlling the NO3- concentration of agricultural ecosystems. Third, sediment was important not only as a denitrification site, but also as a major source of DOC for the overlying water. Fourth, a high DOC concentration was able to maintain a low NO3- concentration in the groundwater. In conclusion, this new stoichiometric method can be used for the accurate estimation and analysis of NO3- concentrations in ecosystems.	[Xu, Zuxin; Wang, Yiyao; Li, Huaizheng] Tongji Univ, Inst Water Environm Rehabil, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China	Tongji University	Wang, YY (corresponding author), Tongji Univ, Inst Water Environm Rehabil, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China.	wyy1042@aliyun.com			Ministry of Science and Technology of the RRC [2012BAJ21B06-04]	Ministry of Science and Technology of the RRC	This study is part of the Twelfth Five-year Country Program founded by the Ministry of Science and Technology of the RRC (2012BAJ21B06-04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkenhead JA, 2000, GLOBAL BIOGEOCHEM CY, V14, P127, DOI 10.1029/1999GB900083; Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Apple JK, 2007, ISME J, V1, P729, DOI 10.1038/ismej.2007.86; Arango CP, 2007, FRESHWATER BIOL, V52, P1210, DOI 10.1111/j.1365-2427.2007.01758.x; Battin TJ, 2000, LIMNOL OCEANOGR, V45, P1308, DOI 10.4319/lo.2000.45.6.1308; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Buss S.R., 2005, USING SCI CREATE BET; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fan AM, 1996, REGUL TOXICOL PHARM, V23, P35, DOI 10.1006/rtph.1996.0006; Findlay S, 1996, J N AM BENTHOL SOC, V15, P35, DOI 10.2307/1467431; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goodale CL, 2005, ECOSYSTEMS, V8, P334, DOI 10.1007/s10021-003-0162-8; Hill AR, 2000, BIOGEOCHEMISTRY, V51, P193, DOI 10.1023/A:1006476514038; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Inwood SE, 2005, J N AM BENTHOL SOC, V24, P227, DOI 10.1899/04-032.1; Johnson LT, 2012, ECOSYSTEMS, V15, P1027, DOI 10.1007/s10021-012-9563-x; Konohira E, 2005, ECOL RES, V20, P359, DOI 10.1007/s11284-005-0051-z; Lapworth DJ, 2008, SCI TOTAL ENVIRON, V390, P241, DOI 10.1016/j.scitotenv.2007.09.043; Mason C F., 2002, BIOL FRESHWATER POLL; Mehler WT, 2010, CHEMOSPHERE, V78, P814, DOI 10.1016/j.chemosphere.2009.11.052; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Pasten-Zapata E, 2014, SCI TOTAL ENVIRON, V470, P855, DOI 10.1016/j.scitotenv.2013.10.043; QUALLS RG, 1992, SOIL SCI SOC AM J, V56, P578, DOI 10.2136/sssaj1992.03615995005600020038x; Ram ASP, 2003, MICROBIAL ECOL, V45, P88, DOI 10.1007/s00248-002-3005-9; REDFIELD AC, 1958, AM SCI, V46, P205; SEPA, 2002, METH WAT AN; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Sobczak WV, 2002, ECOLOGY, V83, P3194, DOI 10.1890/0012-9658(2002)083[3194:VIBODO]2.0.CO;2; Sobczak WV, 2003, BIOGEOCHEMISTRY, V62, P309, DOI 10.1023/A:1021192631423; Stadler S, 2012, WATER SA, V38, P213, DOI 10.4314/wsa.v38i2.6; Stelzer RS, 2011, BIOGEOCHEMISTRY, V103, P91, DOI 10.1007/s10533-010-9449-y; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Ward BB, 2013, SCIENCE, V341, P352, DOI 10.1126/science.1240314; Zarnetske JP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001356	36	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122484	10.1371/journal.pone.0122484	http://dx.doi.org/10.1371/journal.pone.0122484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849210	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800133
J	Lombardot, B; Oh, CT; Kwak, J; Genovesio, A; Kang, M; Hansen, MAE; Han, SJ				Lombardot, Benoit; Oh, Chun-Taek; Kwak, Jihoon; Genovesio, Auguste; Kang, Myungjoo; Hansen, Michael Adsett Edberg; Han, Sung-Jun			High-Throughput In Vivo Genotoxicity Testing: An Automated Readout System for the Somatic Mutation and Recombination Test (SMART)	PLOS ONE			English	Article							PLANAR CELL POLARITY; DROSOPHILA-MELANOGASTER; 3D SEGMENTATION; NUCLEI; DESIGN; ASSAY; 2D	Genotoxicity testing is an important component of toxicity assessment. As illustrated by the European registration, evaluation, authorization, and restriction of chemicals (REACH) directive, it concerns all the chemicals used in industry. The commonly used in vivo mammalian tests appear to be ill adapted to tackle the large compound sets involved, due to throughput, cost, and ethical issues. The somatic mutation and recombination test (SMART) represents a more scalable alternative, since it uses Drosophila, which develops faster and requires less infrastructure. Despite these advantages, the manual scoring of the hairs on Drosophila wings required for the SMART limits its usage. To overcome this limitation, we have developed an automated SMART readout. It consists of automated imaging, followed by an image analysis pipeline that measures individual wing genotoxicity scores. Finally, we have developed a wing score-based dose-dependency approach that can provide genotoxicity profiles. We have validated our method using 6 compounds, obtaining profiles almost identical to those obtained from manual measures, even for low-genotoxicity compounds such as urethane. The automated SMART, with its faster and more reliable readout, fulfills the need for a high-throughput in vivo test. The flexible imaging strategy we describe and the analysis tools we provide should facilitate the optimization and dissemination of our methods.	[Lombardot, Benoit; Kwak, Jihoon; Genovesio, Auguste; Hansen, Michael Adsett Edberg] Inst Pasteur Korea, Image Min Grp, Songnam, Gyeonggi Do, South Korea; [Oh, Chun-Taek; Han, Sung-Jun] Inst Pasteur Korea, Drug Biol Grp, Songnam, Gyeonggi Do, South Korea; [Kang, Myungjoo] Seoul Natl Univ, Dept Math Sci, Seoul 151747, South Korea	Institut Pasteur Korea; Institut Pasteur Korea; Seoul National University (SNU)	Hansen, MAE (corresponding author), Inst Pasteur Korea, Image Min Grp, Sampyeong Dong 696, Songnam, Gyeonggi Do, South Korea.	michael.adsetts.edberg.hansen@gmail.com; sjhanfr@hotmail.com	GENOVESIO, Auguste/I-1656-2017; Hansen, Michael Adsetts Edberg/C-9028-2011	Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Genovesio, Auguste/0000-0003-1877-5595	National Research Foundation of Korea (NRF) grants - Korean government (MSIP) [2007-00559, 2009-0090095, 2014R1A2A1A10050531]; Gyeonggi-do; KISTI	National Research Foundation of Korea (NRF) grants - Korean government (MSIP); Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI))	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIP) (No. 2007-00559, 2009-0090095 and 2014R1A2A1A10050531), Gyeonggi-do, and KISTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SK, 1996, FOOD CHEM TOXICOL, V34, P1, DOI 10.1016/0278-6915(95)00087-9; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Bajpayee M, 2005, TOXICOL MECH METHOD, V15, P155, DOI 10.1080/15376520590945667; Bocker W, 1999, CYTOMETRY, V35, P134; de Bruijne M, 2003, LECT NOTES COMPUT SC, V2732, P136; Fragiorge EJ, 2008, FOOD CHEM TOXICOL, V46, P393, DOI 10.1016/j.fct.2007.08.022; FREI H, 1995, MUTAT RES-ENVIR MUTA, V334, P247, DOI 10.1016/0165-1161(95)90018-7; Rojo MG, 2006, INT J SURG PATHOL, V14, P285, DOI 10.1177/1066896906292274; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L; Hu T, 2004, MUTAT RES-FUND MOL M, V549, P5, DOI 10.1016/j.mrfmmm.2003.11.012; ICH (Internationl Conference of Harmonisation), 2012, GUID GEN TEST DAT IN; Jena G. B., 2002, Indian Journal of Pharmacology, V34, P86; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lotufo RA, 2002, SIBGRAPI 2002: XV BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P146, DOI 10.1109/SIBGRA.2002.1167137; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; May JE, 2009, BRIT J BIOMED SCI, V66, P160, DOI 10.1080/09674845.2009.11730265; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; PARVATHI D, 2011, DROS INF SERV, V94, P53; Salembier P, 1998, IEEE T IMAGE PROCESS, V7, P555, DOI 10.1109/83.663500; Vogel EW, 1998, IARC SCI PUBL, V146, P427; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wilkinson M.H.F., 2001, P 4 INT C MED IM COM, V2208, P770, DOI DOI 10.1007/3-540-45468-3_92; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Yun HS, 2000, J KOREAN ASS CANC PR, V5, P135, DOI DOI 10.1089/JMF.2017.0021; Zhang B, 2006, I S BIOMED IMAGING, P1296	28	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121287	10.1371/journal.pone.0121287	http://dx.doi.org/10.1371/journal.pone.0121287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830368	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600067
J	Ventham, NT; Gardner, RA; Kennedy, NA; Shubhakar, A; Kalla, R; Nimmo, ER; Fernandes, DL; Satsangi, J; Spencer, DIR				Ventham, Nicholas T.; Gardner, Richard A.; Kennedy, Nicholas A.; Shubhakar, Archana; Kalla, Rahul; Nimmo, Elaine R.; Fernandes, Daryl L.; Satsangi, Jack; Spencer, Daniel I. R.		IBD-BIOM Consortium	Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease	PLOS ONE			English	Article							BLOOD COLLECTION TUBES; THERAPEUTIC DRUGS; GLYCOSYLATION; COMMON; PERFORMANCE; ABSORPTION; STABILITY; ARTHRITIS; GEL	Introduction Serum N-glycans have been identified as putative biomarkers for numerous diseases. The impact of different serum sample tubes and processing methods on N-glycan analysis has received relatively little attention. This study aimed to determine the effect of different sample tubes and processing methods on the whole serum N-glycan profile in both health and disease. A secondary objective was to describe a robot automated N-glycan release, labeling and cleanup process for use in a biomarker discovery system. Methods 25 patients with active and quiescent inflammatory bowel disease and controls had three different serum sample tubes taken at the same draw. Two different processing methods were used for three types of tube ( with and without gel-separation medium). Samples were randomised and processed in a blinded fashion. Whole serum N-glycan release, 2-aminobenzamide labeling and cleanup was automated using a Hamilton Microlab STARlet Liquid Handling robot. Samples were analysed using a hydrophilic interaction liquid chromatography/ethylene bridged hybrid(BEH) column on an ultra-high performance liquid chromatography instrument. Data were analysed quantitatively by pairwise correlation and hierarchical clustering using the area under each chromatogram peak. Qualitatively, a blinded assessor attempted to match chromatograms to each individual. Results There was small intra-individual variation in serum N-glycan profiles from samples collected using different sample processing methods. Intra-individual correlation coefficients were between 0.99 and 1. Unsupervised hierarchical clustering and principal coordinate analyses accurately matched samples from the same individual. Qualitative analysis demonstrated good chromatogram overlay and a blinded assessor was able to accurately match individuals based on chromatogram profile, regardless of disease status. Conclusions The three different serum sample tubes processed using the described methods cause minimal inter-individual variation in serum whole N-glycan profile when processed using an automated workstream. This has important implications for N-glycan biomarker discovery studies using different serum processing standard operating procedures.	[Ventham, Nicholas T.; Kennedy, Nicholas A.; Kalla, Rahul; Nimmo, Elaine R.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Ctr Genet & Mol Med, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Gardner, Richard A.; Shubhakar, Archana; Fernandes, Daryl L.; Spencer, Daniel I. R.] Ludger Ltd, Culham Sci Ctr, Oxford OX14 3EB, Oxon, England	University of Edinburgh; Culham Science Centre; UK Atomic Energy Authority	Spencer, DIR (corresponding author), Ludger Ltd, Culham Sci Ctr, Oxford OX14 3EB, Oxon, England.	Daniel.Spencer@ludger.com	Kalla, Rahul/M-2694-2019; Kennedy, Nicholas Alexander/AET-5648-2022	Kalla, Rahul/0000-0002-3276-6751; Kennedy, Nicholas Alexander/0000-0003-4368-1961; Boyapati, Ray/0000-0001-9683-8411	Wellcome Trust [WT097943MA]; European Commission FP7 grant: European Commission IBD-BIOM [305479]; European Commission FP7 grant: European Commission HighGlycan [278535]; European Commission FP7 grant: European Commission IBD-CHARACTER [2858546]; Ludger Ltd.; MRC [G0800675, G0600329, G0800759] Funding Source: UKRI; Medical Research Council [G0800675, G0800759, G0600329, 1202121] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/137, ETM/75] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission FP7 grant: European Commission IBD-BIOM; European Commission FP7 grant: European Commission HighGlycan; European Commission FP7 grant: European Commission IBD-CHARACTER; Ludger Ltd.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The study has been funded by the following European Commission FP7 grants: European Commission IBD-BIOM (contract # 305479); HighGlycan (contract # 278535); IBD-CHARACTER (contract # 2858546). NAK is funded by the Wellcome Trust (grant number WT097943MA). Ludger Ltd. provided support in the form of salaries for authors AG, AS, DF and DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Bowen RAR, 2010, CLIN BIOCHEM, V43, P4, DOI 10.1016/j.clinbiochem.2009.10.001; Chen CY, 2009, J PROTEOME RES, V8, P463, DOI 10.1021/pr800656e; Collins ES, 2013, RHEUMATOLOGY, V52, P1572, DOI 10.1093/rheumatology/ket189; Cuhadar S, 2012, BIOCHEM MEDICA, V22, P202; Dasgupta A, 2000, THER DRUG MONIT, V22, P427, DOI 10.1097/00007691-200008000-00011; DASGUPTA A, 1994, AM J CLIN PATHOL, V101, P456; Drake SK, 2004, CLIN CHEM, V50, P2398, DOI 10.1373/clinchem.2004.040303; Ercan A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3756; Ercan A, 2010, ARTHRITIS RHEUM-US, V62, P2239, DOI 10.1002/art.27533; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Hanson B.A., 2014, CHEMOSPEC EXPLORATOR; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Herrmann E., 2013, LOKERN KERNEL REGRES; Hsieh SY, 2006, PROTEOMICS, V6, P3189, DOI 10.1002/pmic.200500535; Huffman JE, 2014, MOL CELL PROTEOMICS, V13, P1598, DOI 10.1074/mcp.M113.037465; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Miyahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074861; Novokmet M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04347; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Pucic M, 2010, GLYCOBIOLOGY, V20, P970, DOI 10.1093/glycob/cwq052; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Sharratt CL, 2009, INT J CLIN PRACT, V63, P1259, DOI 10.1111/j.1742-1241.2008.01981.x; Shi RZ, 2012, CLIN BIOCHEM, V45, P1706, DOI 10.1016/j.clinbiochem.2012.08.008; Shinzaki S, 2008, AM J GASTROENTEROL, V103, P1173, DOI 10.1111/j.1572-0241.2007.01699.x; Zolg JW, 2004, MOL CELL PROTEOMICS, V3, P345, DOI 10.1074/mcp.M400007-MCP200	29	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123028	10.1371/journal.pone.0123028	http://dx.doi.org/10.1371/journal.pone.0123028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831126	Green Published, gold			2022-12-27	WOS:000352135600133
J	Grubbs, KJ; Scott, JJ; Budsberg, KJ; Read, H; Balser, TC; Currie, CR				Grubbs, Kirk J.; Scott, Jarrod J.; Budsberg, Kevin J.; Read, Harry; Balser, Teri C.; Currie, Cameron R.			Unique Honey Bee (Apis mellifera) Hive Component-Based Communities as Detected by a Hybrid of Phospholipid Fatty-Acid and Fatty-Acid Methyl Ester Analyses	PLOS ONE			English	Article							MICROBIAL COMMUNITY; SOIL; DIVERSITY; BACTERIA; BIOMASS; POLLEN; LARVAE; GUT; LIPOPOLYSACCHARIDES; RECLASSIFICATION	Microbial communities (microbiomes) are associated with almost all metazoans, including the honey bee Apis mellifera. Honey bees are social insects, maintaining complex hive systems composed of a variety of integral components including bees, comb, propolis, honey, and stored pollen. Given that the different components within hives can be physically separated and are nutritionally variable, we hypothesize that unique microbial communities may occur within the different microenvironments of honey bee colonies. To explore this hypothesis and to provide further insights into the microbiome of honey bees, we use a hybrid of fatty acid methyl ester (FAME) and phospholipid-derived fatty acid (PLFA) analysis to produce broad, lipid-based microbial community profiles of stored pollen, adults, pupae, honey, empty comb, and propolis for 11 honey bee hives. Averaging component lipid profiles by hive, we show that, in decreasing order, lipid markers representing fungi, Gram-negative bacteria, and Gram-positive bacteria have the highest relative abundances within honey bee colonies. Our lipid profiles reveal the presence of viable microbial communities in each of the six hive components sampled, with overall microbial community richness varying from lowest to highest in honey, comb, pupae, pollen, adults and propolis, respectively. Finally, microbial community lipid profiles were more similar when compared by component than by hive, location, or sampling year. Specifically, we found that individual hive components typically exhibited several dominant lipids and that these dominant lipids differ between components. Principal component and two-way clustering analyses both support significant grouping of lipids by hive component. Our findings indicate that in addition to the microbial communities present in individual workers, honey bee hives have resident microbial communities associated with different colony components.	[Grubbs, Kirk J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Scott, Jarrod J.] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Budsberg, Kevin J.; Read, Harry; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Balser, Teri C.] Univ Florida, Dept Soil & Water Sci, Gainesville, FL USA	University of North Carolina; University of North Carolina Chapel Hill; Bigelow Laboratory for Ocean Sciences; University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida	Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	Currie@bact.wisc.edu		Scott, Jarrod/0000-0001-9863-1318	National Institute of Food and Agriculture, United States Department of Agriculture [WISO1321]; National Science Foundation [MCB-0702025]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Institute of Food and Agriculture, United States Department of Agriculture, under ID number WISO1321, and National Science Foundation grant MCB-0702025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Ashiralieva A, 2006, APIDOLOGIE, V37, P411, DOI 10.1051/apido:2006028; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; BAILEY L, 1983, J APPL BACTERIOL, V55, P65, DOI 10.1111/j.1365-2672.1983.tb02648.x; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bull ID, 2000, NATURE, V405, P175, DOI 10.1038/35012061; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Foote H., 1957, AM BEE J, V97, P476; Fritze H, 2000, EUR J SOIL SCI, V51, P565, DOI 10.1046/j.1365-2389.2000.00346.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1979, APIDOLOGIE, V10, P43, DOI 10.1051/apido:19790106; GILLIAM M, 1989, APIDOLOGIE, V20, P53, DOI 10.1051/apido:19890106; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gilliam M, 1979, MICROBIOLOGY POLLEN; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Heyndrickx M, 1996, INT J SYST BACTERIOL, V46, P270, DOI 10.1099/00207713-46-1-270; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Keith-Roach MJ, 2002, BIOGEOCHEMISTRY, V60, P77, DOI 10.1023/A:1016553225977; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Lee FJ, 2014, ENVIRON MICROBIOL, pn/a; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Mentzer JL, 2006, PLANT SOIL, V284, P85, DOI 10.1007/s11104-006-0032-1; Midi I, 2001, SHERLOCK MICROBIAL I; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Oravecz O, 2004, FOLIA MICROBIOL, V49, P83, DOI 10.1007/BF02931652; Petersen SO, 2002, SOIL SCI SOC AM J, V66, P826, DOI 10.2136/sssaj2002.0826; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Scott JJ, 2010, PLOS ONE, V5; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; STANDIFER LN, 1980, APIDOLOGIE, V11, P163, DOI 10.1051/apido:19800206; TOLLEFSON TS, 1983, SOIL BIOL BIOCHEM, V15, P145, DOI 10.1016/0038-0717(83)90095-0; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wahdan HAL, 1998, INFECTION, V26, P30; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; White D, 1983, ANAL MICROORGANISMS; Winston M. L. L., 1991, BIOL HONEY BEE; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; ZELLES L, 1992, SOIL BIOL BIOCHEM, V24, P317, DOI 10.1016/0038-0717(92)90191-Y; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	56	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121697	10.1371/journal.pone.0121697	http://dx.doi.org/10.1371/journal.pone.0121697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849080	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800072
J	He, FZ; Luo, JQ; Zhang, ZT; Luo, ZY; Fan, L; He, YJ; Wen, JG; Zhu, DIL; Gao, JP; Wang, Y; Qian, YS; Zhou, HH; Chen, XP; Zhang, W				He, Fazhong; Luo, Jianquan; Zhang, Zhitao; Luo, Zhiying; Fan, Lan; He, Yijing; Wen, Jiagen; Zhu, Dingilang; Gao, Jinping; Wang, Yan; Qian, Yuesheng; Zhou, Honghao; Chen, Xiaoping; Zhang, Wei			The RGS2 (-391, C > G) Genetic Variation Correlates to Antihypertensive Drug Responses in Chinese Patients with Essential Hypertension	PLOS ONE			English	Article							G-PROTEIN SIGNALING-2; ANGIOTENSIN-II; REGULATOR; EXPRESSION; IV; G-PROTEIN-SIGNALING-2; SUSCEPTIBILITY; ASSOCIATION; PROMOTER	Objective Regulators of G-protein signaling protein 2 (RGS2) play an irreplaceable role in the control of normal blood pressure (BP). One RGS2 (-391, C>G) genetic variation markedly changes its mRNA expression levels. This study explored the relationship between this genetic variation and the responses to antihypertensive drugs in Chinese patients with essential hypertension. Methods Genetic variations of RGS2 were successfully identified in 367 specimens using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assays. All patients were treated with conventional doses of antihypertensives after a 2-week run-in period and followed-up according to our protocol. A general linear model multivariate analysis of variance (ANOVA) was used for the data analysis. Results A significant difference in the mean systolic BP change was observed between RGS2 (-391, C>G) CC/CG (n = 82) and GG (n = 38) genotype carriers (-13.6 vs. -19.9 mmHg, P = 0.043) who were treated with candesartan, irbesartan or imidapril at the end of 6 weeks. In addition, the patients' BP responses to alpha, beta-adrenergic receptor blockers exhibited an age-specific association with the RGS2 (-391, C>G) genetic variation at the end of 4 weeks. Conclusion The RGS2 (-391, C>G) genetic polymorphism may serve as a biomarker to predict a patient's response to antihypertensive drug therapy, but future studies need to confirm this.	[He, Fazhong; Luo, Jianquan; Luo, Zhiying; Fan, Lan; He, Yijing; Wen, Jiagen; Zhou, Honghao; Chen, Xiaoping; Zhang, Wei] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Zhu, Dingilang; Gao, Jinping; Wang, Yan; Qian, Yuesheng] Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Zhitao] Han Dan Cent Hosp, Uropoiesis Surg Dept 2, Handan, Peoples R China; [He, Fazhong; Luo, Jianquan; Luo, Zhiying; Fan, Lan; He, Yijing; Wen, Jiagen; Zhou, Honghao; Chen, Xiaoping; Zhang, Wei] Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [He, Fazhong; Luo, Jianquan; Luo, Zhiying; Fan, Lan; He, Yijing; Wen, Jiagen; Zhou, Honghao; Chen, Xiaoping; Zhang, Wei] Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China	Central South University; Shanghai Jiao Tong University; Central South University	Chen, XP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China.	chenxp74@hotmail.com; yjsd2003@163.com			National Scientific Foundation of China [81273595, 30901834, 81001476]; Scientific Foundation of Hunan [11K073, 10JJ4020]; "863" Project [2012AA02A518, NCET-10-0843]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Hunan; "863" Project(National High Technology Research and Development Program of China)	This work was supported by the National Scientific Foundation of China (No. 81273595, 30901834, 81001476), the Scientific Foundation of Hunan (No. 11K073, 10JJ4020), the "863" Project (No. 2012AA02A518) and NCET-10-0843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakir K, 2011, J MOL CELL CARDIOL, V50, P1000, DOI 10.1016/j.yjmcc.2011.01.015; Cui H, 2008, NEUROPSYCHOPHARMACOL, V33, P1537, DOI 10.1038/sj.npp.1301557; Faure S, 2006, J PHYSIOL PHARMACOL, V57, P329; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; He FZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061317; Hercule HC, 2007, EXP PHYSIOL, V92, P1014, DOI 10.1113/expphysiol.2007.038240; Heximer SP, 2003, J CLIN INVEST, V111, P1259, DOI 10.1172/JCI200318099C; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Holden NS, 2011, P NATL ACAD SCI USA, V108, P19713, DOI 10.1073/pnas.1110226108; Ju-hong Zhang, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P200, DOI 10.3881/j.issn.1000-503X.2011.02.020; Mao YJ, 2014, J CARDIOVASC MED, V15, P572, DOI 10.2459/JCM.0b013e3283629c30; Matsumoto S, 2010, HYPERTENS RES, V33, P1244, DOI 10.1038/hr.2010.184; Romero DG, 2006, ENDOCRINOLOGY, V147, P3889, DOI 10.1210/en.2005-1532; Ruiz-Ortega M, 2007, TRENDS CARDIOVAS MED, V17, P19, DOI 10.1016/j.tcm.2006.10.003; Semplicini A, 2006, J HYPERTENS, V24, P1115, DOI 10.1097/01.hjh.0000226202.80689.8f; Semplicini A, 2010, J HYPERTENS, V28, P1104, DOI 10.1097/HJH.0b013e328339930f; SIDEROVSKI DP, 1994, DNA CELL BIOL, V13, P125, DOI 10.1089/dna.1994.13.125; Sugimoto K, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/196307; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Yang H, 2011, PEPTIDES, V32, P2108, DOI 10.1016/j.peptides.2011.09.015; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	28	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121483	10.1371/journal.pone.0121483	http://dx.doi.org/10.1371/journal.pone.0121483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849301	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800061
J	Kekkonen, M; Mutanen, M; Kaila, L; Nieminen, M; Hebert, PDN				Kekkonen, Mari; Mutanen, Marko; Kaila, Lauri; Nieminen, Marko; Hebert, Paul D. N.			Delineating Species with DNA Barcodes: A Case of Taxon Dependent Method Performance in Moths	PLOS ONE			English	Article							INTEGRATIVE APPROACH; MOLECULAR PHYLOGENY; DELIMITATION METHOD; DIVERSITY; LEPIDOPTERA; MODEL; COLEOPTERA; INSIGHTS; CLASSIFICATION; MYGALOMORPHAE	The accelerating loss of biodiversity has created a need for more effective ways to discover species. Novel algorithmic approaches for analyzing sequence data combined with rapidly expanding DNA barcode libraries provide a potential solution. While several analytical methods are available for the delineation of operational taxonomic units (OTUs), few studies have compared their performance. This study compares the performance of one morphology- based and four DNA-based (BIN, parsimony networks, ABGD, GMYC) methods on two groups of gelechioid moths. It examines 92 species of Finnish Gelechiinae and 103 species of Australian Elachistinae which were delineated by traditional taxonomy. The results reveal a striking difference in performance between the two taxa with all four DNA-based methods. OTU counts in the Elachistinae showed a wider range and a relatively low (ca. 65%) OTU match with reference species while OTU counts were more congruent and performance was higher (ca. 90%) in the Gelechiinae. Performance rose when only monophyletic species were compared, but the taxon-dependence remained. None of the DNA-based methods produced a correct match with non-monophyletic species, but singletons were handled well. A simulated test of morphospecies-grouping performed very poorly in revealing taxon diversity in these small, dull-colored moths. Despite the strong performance of analyses based on DNA barcodes, species delineated using single-locus mtDNA data are best viewed as OTUs that require validation by subsequent integrative taxonomic work.	[Kekkonen, Mari; Kaila, Lauri] Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland; [Kekkonen, Mari; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mutanen, Marko] Univ Oulu, Dept Genet & Physiol, Oulu, Finland; [Nieminen, Marko] Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, Helsinki, Finland	University of Helsinki; University of Guelph; University of Oulu; University of Helsinki	Kekkonen, M (corresponding author), Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland.	kekkonen@uoguelph.ca	Kekkonen, Mari/I-7352-2017; Hebert, Paul DN/C-4161-2013	Kekkonen, Mari/0000-0001-7906-1698; Hebert, Paul DN/0000-0002-3081-6700; Kaila, Lauri/0000-0003-0277-1872	Research Foundation of the University of Helsinki; Finnish Concordia Fund; Ella and Georg Ehrnrooth Foundation; Academy of Finland [1110906]; HOK-Elanto; government of Canada; Ontario Genomics Institute	Research Foundation of the University of Helsinki; Finnish Concordia Fund; Ella and Georg Ehrnrooth Foundation; Academy of Finland(Academy of Finland); HOK-Elanto; government of Canada(CGIAR); Ontario Genomics Institute	This work was supported by the Research Foundation of the University of Helsinki (MK) (http:// www.helsinki.fi/tiedesaatio/english/), Finnish Concordia Fund (MK) (https://www.konkordia-liitto.com/index. html), Ella and Georg Ehrnrooth Foundation (MK, MN) (http://www.ellageorg.fi/en/about), Academy of Finland LK (project 1110906) (http:// www.aka.fi/en-GB/A/), HOK-Elanto LK (http://www.hok-elanto.fi/in-brief/), and the government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life project PDNH (http://www.genomecanada.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; [Anonymous], 2010, MICROLEPIDOPT EUROPE, DOI [10.1163/9789004260986, DOI 10.1163/9789004260986]; Ardila NE, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-246; Astrin JJ, 2012, MOL PHYLOGENET EVOL, V63, P1, DOI 10.1016/j.ympev.2011.11.018; Barco A, 2013, ZOOL J LINN SOC-LOND, V169, P389, DOI 10.1111/zoj.12069; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Barrett CF, 2011, MOL ECOL, V20, P2771, DOI 10.1111/j.1365-294X.2011.05124.x; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Brewer MS, 2012, MOL PHYLOGENET EVOL, V64, P232, DOI 10.1016/j.ympev.2012.04.003; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Condamine FL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-82; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ezard T, 2009, PACKAGE SPLITS SPECI; Farris J.S., 1981, Advances in Cladistics, V1, P3; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heikkila Maria, 2014, Cladistics, V30, P563, DOI 10.1111/cla.12064; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hendrixson BE, 2013, MOL PHYLOGENET EVOL, V66, P327, DOI 10.1016/j.ympev.2012.10.004; Hodges R.W., 1998, LEPIDOPTERA MOTHS BU, VIV, P131, DOI DOI 10.1515/9783110804744.131; Huemer Peter, 1999, Microlepidoptera of Europe, V3, P1; Huemer P, 2012, ZOOTAXA, P1; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Huemer P, 2011, ZOOTAXA, P1; Huemer P, 2013, ZOOTAXA, V 3746, P69, DOI 10.11646/zootaxa.3746.1.3; Jorger KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-245; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kaila L, 2006, ZOOTAXA, P1; Kaila L, 2011, MONOGR AUST LEPIDOPT, V11, P1; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kullberg J., 2002, SAHLBERGIA, V6, P45; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Mutanen M, 2015, MOL ECOL RESOUR, V15, P967, DOI 10.1111/1755-0998.12361; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Pantaleoni RA, 2012, B INSECTOL, V65, P139; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2011, MOL PHYLOGENET EVOL, V59, P251, DOI 10.1016/j.ympev.2011.02.013; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prevot V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060736; Prockow M, 2013, ZOOL J LINN SOC-LOND, V169, P124, DOI 10.1111/zoj.12048; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ceccarelli FS, 2012, MOL PHYLOGENET EVOL, V62, P485, DOI 10.1016/j.ympev.2011.10.018; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Seehausen Ole, 2009, P155; Sipek P, 2011, SYST ENTOMOL, V36, P628, DOI 10.1111/j.1365-3113.2011.00582.x; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TEMPLETON AR, 1992, GENETICS, V132, P619; Vahtera V, 2006, CLADISTICS, V22, P222, DOI 10.1111/j.1096-0031.2006.00099.x; Weigand AM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-18; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	94	89	92	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122481	10.1371/journal.pone.0122481	http://dx.doi.org/10.1371/journal.pone.0122481			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849083	Green Published, gold			2022-12-27	WOS:000352477800132
J	Wang, HJ; Si, QJ; Shan, ZL; Guo, YT; Lin, K; Zhao, XN; Wang, YT				Wang, Hai-Jun; Si, Quan-Jin; Shan, Zhao-Liang; Guo, Yu-Tao; Lin, Kun; Zhao, Xiao-Ning; Wang, Yu-Tang			Effects of Body Mass Index on Risks for Ischemic Stroke, Thromboembolism, and Mortality in Chinese Atrial Fibrillation Patients: A Single-Center Experience	PLOS ONE			English	Article							GENDER-DIFFERENCES; PREDICTING STROKE; OBESITY; OUTCOMES	Background Obesity is considered to be related to recurrence of atrial fibrillation (AF), left atrial thrombus formation, and atrial remodeling. However, whether obesity is an independent risk factor for stroke and other thromboembolic events is still controversial. Objective This study aimed to investigate the effects of body mass index (BMI) on the risks of stroke, thromboembolism, and mortality in AF patients. Methods Patients who were diagnosed with nonvalvular AF were included in this observational, retrospective study. The study population was stratified by BMI at baseline. The Cox proportional hazard model was adopted to calculate adjusted hazard ratios of risk factors for adverse clinical events (stroke, thromboembolism, and mortality). Results A total of 1286 AF patients (males, 78.30%; mean age, 74.50 years; 94.48% paroxysmal AF) were followed up for a median of 2.1 years (IQR: 1.5-2.9 years). Overall, 159 patients died. A total of 84 strokes and 35 thromboembolic events occurred. Multivariate analysis showed that overweight (25.0 <= BMI<30.0 kg/m(2)) and age >= 75 years were independent risk factors for ischemic stroke (both P<0.01). Obesity (BMI >= 30.0 kg/m(2)), age >= 75 years, persistent/permanent AF, and prior thromboembolism were independent risk factors for thromboembolism (all P<0.05). Underweight (BMI <18.5 kg/m(2)), age >= 75 years, prior ischemic stroke/transient ischemic attack, renal dysfunction, and heart failure were independent risk factors for all-cause deaths (all P<0.05). Conclusions Overweight or obesity may be a risk factor of ischemic stroke and thromboembolism in AF patients. Excessive low weight is significantly associated with increased all-cause mortality.	[Wang, Hai-Jun; Guo, Yu-Tao; Zhao, Xiao-Ning; Wang, Yu-Tang] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China; [Si, Quan-Jin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Healthcare Dept 2, Sanya, Peoples R China; [Shan, Zhao-Liang; Lin, Kun] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Si, QJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Healthcare Dept 2, Sanya, Peoples R China.	quanjin2004@sohu.com; wangyutang2014@163.com			Science and Technology Innovation Fund of Chinese PLA General Hospital [14KMM14]	Science and Technology Innovation Fund of Chinese PLA General Hospital	This work was supported by the Science and Technology Innovation Fund of Chinese PLA General Hospital (14KMM14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Azarbal F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001127; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Banerjee A, 2013, INT J CARDIOL, V167, P2682, DOI 10.1016/j.ijcard.2012.06.118; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chilukuri K, 2010, J CARDIOVASC ELECTR, V21, P521, DOI 10.1111/j.1540-8167.2009.01653.x; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Disertori M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-28; Dublin S, 2006, ARCH INTERN MED, V166, P2322, DOI 10.1001/archinte.166.21.2322; Facila L, 2013, WORLD J CARDIOL, V5, P124, DOI 10.4330/wjc.v5.i5.124; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Guglin M, 2011, AM J CARDIOL, V107, P579, DOI 10.1016/j.amjcard.2010.10.018; Karasoy D, 2013, EUROPACE, V15, P781, DOI 10.1093/europace/eus422; Letsas KP, 2009, EUROPACE, V11, P158, DOI 10.1093/europace/eun309; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Naderi S, 2014, ETHNIC DIS, V24, P144; Nakagawa K, 2011, AM J CARDIOL, V107, P912, DOI 10.1016/j.amjcard.2010.10.074; Novo G, 2008, INT ANGIOL, V27, P433; Overvad TF, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.11.024; Poli D, 2013, THROMB RES, V131, P12, DOI 10.1016/j.thromres.2012.10.009; Reas DL, BMC PUBLIC HLTH, V30, P267; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Sasahara E, 2012, J CARDIOL, V60, P484, DOI 10.1016/j.jjcc.2012.09.001; Schnabel RB, 2009, AM J CARDIOL, V104, P92, DOI 10.1016/j.amjcard.2009.02.053; Shen AYJ, 2008, CNS DRUGS, V22, P815, DOI 10.2165/00023210-200822100-00003; Shen AYJ, 2010, J NATL MED ASSOC, V102, P906; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000250; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tang RB, 2009, AM J CARDIOL, V104, P1699, DOI 10.1016/j.amjcard.2009.07.054; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Tsang TSM, 2008, EUR HEART J, V29, P2227, DOI 10.1093/eurheartj/ehn324; Wang J, 2014, INT J CARDIOL, V176, P1356, DOI 10.1016/j.ijcard.2014.07.264; Yazdan-Ashoori P, 2011, INT J CARDIOL, V146, P131, DOI 10.1016/j.ijcard.2010.10.104	34	22	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123516	10.1371/journal.pone.0123516	http://dx.doi.org/10.1371/journal.pone.0123516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848965	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800239
J	Gowrishankar, K; Gunatilake, D; Gallagher, SJ; Tiffen, J; Rizos, H; Hersey, P				Gowrishankar, Kavitha; Gunatilake, Dilini; Gallagher, Stuart J.; Tiffen, Jessamy; Rizos, Helen; Hersey, Peter			Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-kappa B	PLOS ONE			English	Article							UP-REGULATION; TUMOR-SUPPRESSOR; B7-H1 EXPRESSION; BRAF INHIBITION; APOPTOSIS; INFLAMMATION; KINASE; SAFETY; GAMMA; TRANSCRIPTION	Monoclonal antibodies against immune checkpoint blockade have proven to be a major success in the treatment of melanoma. The programmed death receptor-1 ligand-1 (PD-L1) expression on melanoma cells is believed to have an inhibitory effect on T cell responses and to be an important escape mechanism from immune attack. Previous studies have shown that PD-L1 can be expressed constitutively or can be induced by IFN-gamma secreted by infiltrating lymphocytes. In the present study we have investigated the mechanism underlying these two modes of PD-L1 expression in melanoma cells including cells that had acquired resistance to the BRAF inhibitor vemurafenib. PD-L1 expression was examined by flow cytometry and immunoblotting. Specific inhibitors and siRNA knockdown approaches were used to examine the roles of the RAF/MEK, PI3K, NF-kappa B, STAT3 and AP1/c-Jun pathways. IFN-gamma inducible expression of PD-L1 was dependent on NF-kappa B as shown by inhibition with BMS-345541, an inhibitor of I kappa B and the BET protein inhibitor I-BET151, as well as by siRNA knockdown of NF-kappa B subunits. We were unable to implicate the BRAF/MEK pathway as major regulators in PD-L1 expression on vemurafenib resistant cells. Similarly the PI3K/AKT pathway and the transcription factors STAT3 and c-Jun had only minor roles in IFN-gamma induced expression of PD-L1. The mechanism underlying constitutive expression remains unresolved. We suggest these results have significance in selection of treatments that can be used in combination with monoclonal antibodies against PD1, to enhance their effectiveness and to reduce inhibitory effects melanoma cells have against cytotoxic T cell activity.	[Gowrishankar, Kavitha; Gunatilake, Dilini; Gallagher, Stuart J.; Tiffen, Jessamy; Hersey, Peter] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Melanoma Res, Sydney, NSW 2006, Australia; [Rizos, Helen] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Macquarie University	Hersey, P (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Melanoma Res, Sydney, NSW 2006, Australia.	peter.hersey@sydney.edu.au	Rizos, Helen/AAE-5010-2020; Gallagher, Stuart/S-6718-2019	Rizos, Helen/0000-0002-2094-9198; Gallagher, Stuart/0000-0003-2651-9671	Australian National Health and Medical Research Council (NHMRC) [633004]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the program grant 633004 from the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Azuma K, 2014, ANN ONCOLOGY OFFICIA; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chen J, 2012, CANCER IMMUNOL IMMUN, V61, P101, DOI 10.1007/s00262-011-1094-3; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Gallagher SJ, 2014, J INVEST DERMATOL; Gallagher SJ, 2014, PIGMENT CELL MELANOM; Gowrishankar K, 2012, J INVEST DERMATOL, V132, P1850, DOI 10.1038/jid.2012.63; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hamid O, 2013, EXPERT OPIN BIOL TH, V13, P847, DOI 10.1517/14712598.2013.770836; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; He XH, 2005, ACTA PHARMACOL SIN, V26, P462, DOI 10.1111/j.1745-7254.2005.00086.x; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Irvine M, 2010, CELL CYCLE, V9, P829, DOI 10.4161/cc.9.4.10785; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Kamphorst AO, 2013, CURR OPIN IMMUNOL, V25, P381, DOI 10.1016/j.coi.2013.03.003; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lai F, 2012, MELANOMA RES, V22, P244, DOI 10.1097/CMR.0b013e328353eff2; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lee SK, 2005, J DERMATOL SCI, V40, P95, DOI 10.1016/j.jdermsci.2005.06.008; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mijatov BSK, 2012, PIGM CELL MELANOMA R, V25, P875; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Taube JM, 2014, CLIN CANC RES; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2013, J CLIN ONCOL, V31; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220; Zhang XD, 1999, CANCER RES, V59, P2747	43	157	170	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123410	10.1371/journal.pone.0123410	http://dx.doi.org/10.1371/journal.pone.0123410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844720	Green Published, gold, Green Submitted			2022-12-27	WOS:000352475700021
J	Jian, WS; Wu, MS; Shi, HL; Wang, LT; Zhang, L; Luo, SQ				Jian, Wushuai; Wu, Mingshu; Shi, Hongli; Wang, Liting; Zhang, Lu; Luo, Shuqian			Signs Analysis and Clinical Assessment: Phase-Contrast Computed Tomography of Human Breast Tumours	PLOS ONE			English	Article							SYNCHROTRON-RADIATION; HIGH-RESOLUTION; MAMMOGRAPHY; CANCER; RADIOLOGY; CT; VISUALIZATION; CARCINOMA; SPECIMENS	Purpose To analyse the diagnostic signs present in slices of human breast tumour specimens using synchrotron radiation phase-contrast imaging computed tomography (PCI-CT) for the first time and assess the feasibility of this technique for clinical applications. Materials and Methods The ethics committee of our university and relevant clinical hospital approved this prospective study, and written informed consent was obtained from all patients. PCI-CT of human breast tumour specimens with synchrotron radiation was performed at the Shanghai Synchrotron Radiation Facility (SSRF). A total of 14 specimens of early-stage carcinomas and 8 specimens of adenomas were enrolled. Based on raw data reconstruction, the diagnostic signs present in the slices were analysed and correlated with histopathology. We proposed a criterion for clinical diagnosis according to the evaluated signs and the Breast Imaging Reporting and Data System (BI-RADS) for reference. The criterion was then assessed by clinicians in a double-blind method. Finally, descriptive statistics were evaluated, depending on the assessment results. Results The 14 carcinoma specimens and 8 adenoma specimens were diagnosed as malignant and benign tumours, respectively. The total coincidence rate was 100%. Conclusion Our study results demonstrate that the X-ray diagnostic signs observed in the specimen slices and the criterion used for clinical diagnosis were accurate and reliable. The criterion based on signs analysis can be used to differentiate early-stage benign or malignant tumours. As a promising imaging method, PCI-CT can serve as a possible and feasible supplement to BI-RADS in the future.	[Jian, Wushuai; Wu, Mingshu; Shi, Hongli; Wang, Liting; Zhang, Lu; Luo, Shuqian] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Capital Medical University	Luo, SQ (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	sqluo@ieee.org			National Natural Science Foundation of China [60532090, 61227802, 30770593]; 7th Framework Programme of the European Community [PIRSES-GA-2009-269124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 7th Framework Programme of the European Community	This work was supported by the National Natural Science Foundation of China (Grant Numbers 60532090, 61227802 and 30770593) and was partly supported by the 7th Framework Programme of the European Community (Grant Agreement Number: PIRSES-GA-2009-269124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACR, 2003, ACR BI RADS MRI BREA; Arfelli F, 1998, PHYS MED BIOL, V43, P2845, DOI 10.1088/0031-9155/43/10/013; Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; BURATTINI E, 1995, RADIOLOGY, V195, P239, DOI 10.1148/radiology.195.1.7892478; Burattini E, 1992, Radiol Med, V84, P181; Castelli E, 2011, RADIOLOGY, V259, P684, DOI 10.1148/radiol.11100745; Chen RC, 2012, J SYNCHROTRON RADIAT, V19, P836, DOI 10.1107/S0909049512029731; Curado MP, 2011, SALUD PUBLICA MEXICO, V53, P372; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Fernandez M, 2005, PHYS MED BIOL, V50, P2991, DOI 10.1088/0031-9155/50/13/002; Fiedler S, 2004, PHYS MED BIOL, V49, P175, DOI 10.1088/0031-9155/49/2/001; Fitzgerald R, 2000, PHYS TODAY, V53, P23, DOI 10.1063/1.1292471; Gao DC, 1998, RADIOGRAPHICS, V18, P1257, DOI 10.1148/radiographics.18.5.9747618; Karellas A, 2008, MED PHYS, V35, P4878, DOI 10.1118/1.2986144; Keyrilainen J, 2005, EUR J RADIOL, V53, P226, DOI 10.1016/j.ejrad.2004.03.015; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Kilburn-Toppin F, 2013, CLIN ONCOL-UK, V25, P93, DOI 10.1016/j.clon.2012.10.002; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liberman L, 2002, RADIOL CLIN N AM, V40, P409, DOI 10.1016/S0033-8389(01)00017-3; Margaritondo G, 2003, EUR RADIOL, V13, P2633, DOI 10.1007/s00330-003-2073-7; Morimoto T, 2009, BREAST CANCER-TOKYO, V16, P2, DOI 10.1007/s12282-008-0077-5; Olivo A, 2009, APPL RADIAT ISOTOPES, V67, P1033, DOI 10.1016/j.apradiso.2009.01.075; Pisano ED, 2000, RADIOLOGY, V214, P895, DOI 10.1148/radiology.214.3.r00mr26895; Quai E, 2013, RADIOL MED, V118, P89, DOI 10.1007/s11547-012-0847-1; Schmidt MM, 2011, CLIN OBSTET GYNECOL, V54, P103, DOI 10.1097/GRF.0b013e31820800c2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sledge George W Jr, 2004, Clin Breast Cancer, V5, P11; Smetherman DH, 2013, SURG CLIN N AM, V93, P309, DOI 10.1016/j.suc.2013.01.004; Smith JA, 2004, ANN ONCOL, V15, pI18, DOI 10.1093/annonc/mdh653; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Tao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039936; Vanel D, 2007, EUR J RADIOL, V61, P183, DOI 10.1016/j.ejrad.2006.08.030; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Williams IM, 2008, EUR J RADIOL, V68, pS73, DOI 10.1016/j.ejrad.2008.04.042; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3780; Xi Y, 2012, J SYNCHROTRON RADIAT, V19, P821, DOI 10.1107/S0909049512029354; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017400; Zhang L, 2011, EUR J RADIOL, V80, P158, DOI 10.1016/j.ejrad.2010.08.019; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0124143	10.1371/journal.pone.0124143	http://dx.doi.org/10.1371/journal.pone.0124143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844722	gold, Green Published, Green Submitted			2022-12-27	WOS:000352475700025
J	Bolsheva, NL; Zelenin, AV; Nosova, IV; Amosova, AV; Samatadze, TE; Yurkevich, OY; Melnikova, NV; Zelenina, DA; Volkov, AA; Muravenko, OV				Bolsheva, Nadezhda L.; Zelenin, Alexander V.; Nosova, Inna V.; Amosova, Alexandra V.; Samatadze, Tatiana E.; Yurkevich, Olga Yu.; Melnikova, Nataliya V.; Zelenina, Daria A.; Volkov, Alexander A.; Muravenko, Olga V.			The Diversity of Karyotypes and Genomes within Section Syllinum of the Genus Linum (Linaceae) Revealed by Molecular Cytogenetic Markers and RAPD Analysis	PLOS ONE			English	Article							B-CHROMOSOME; PATTERNS; ADENOLINUM; ORIGIN; GENES; PCR	The wide variation in chromosome number found in species of the genus Linum (2n = 16, 18, 20, 26, 28, 30, 32, 36, 42, 72, 84) indicates that chromosomal mutations have played an important role in the speciation of this taxon. To contribute to a better understanding of the genetic diversity and species relationships in this genus, comparative studies of karyotypes and genomes of species within section Syllinum Griseb. (2n = 26, 28) were carried out. Elongated with 9-aminoacridine chromosomes of 10 species of section Syllinum were investigated by C-and DAPI/.-banding, CMA and Ag-NOR-staining, FISH with probes of rDNA and of telomere repeats. RAPD analysis was also performed. All the chromosome pairs in karyotypes of the studied species were identified. Chromosome DAPI/C-banding patterns of 28-chromosomal species were highly similar. Two of the species differed from the others in chromosomal location of rDNA sites. B chromosomes were revealed in all the 28-chromosomal species. Chromosomes of Linum nodiflorum L. (2n = 26) and the 28-chromosomal species were similar in DAPI/C-banding pattern and localization of several rDNA sites, but they differed in chromosomal size and number. The karyotype of L. nodiflorum was characterized by an intercalary site of telomere repeat, one additional 26S rDNA site and also by the absence of B chromosomes. Structural similarities between different chromosome pairs in karyotypes of the studied species were found indicating their tetraploid origin. RAPD analysis did not distinguish the species except L. nodiflorum. The species of section Syllinum probably originated from a common tetraploid ancestor. The 28-chromosomal species were closely related, but L. nodiflorum diverged significantly from the rest of the species probably due to chromosomal rearrangements occurring during evolution.	[Bolsheva, Nadezhda L.; Zelenin, Alexander V.; Nosova, Inna V.; Amosova, Alexandra V.; Samatadze, Tatiana E.; Yurkevich, Olga Yu.; Melnikova, Nataliya V.; Muravenko, Olga V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Zelenina, Daria A.; Volkov, Alexander A.] Russian Fed Res Inst Fisheries & Oceanog, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Research lnstitute of Fisheries & Oceanography	Bolsheva, NL (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	nlbolsheva@mail.ru	Tatiana, Samatadze/AAD-4816-2019; Zelenina, Daria/AAK-2025-2021; Melnikova, Nataliya V./E-5894-2014; Yurkevich, Olga Yu./CAF-7659-2022; Volkov, Alexander A/C-8405-2014; Yurkevich, Olga Yu./CAI-2654-2022; Muravenko, Olga/A-3889-2017	Tatiana, Samatadze/0000-0002-1012-3560; Melnikova, Nataliya V./0000-0001-8083-3018; Yurkevich, Olga Yu./0000-0003-4124-2367; Volkov, Alexander A/0000-0002-4305-8726; Yurkevich, Olga Yu./0000-0003-4124-2367; Muravenko, Olga/0000-0003-3150-8598	Russian Foundation of Basic Research [13-04-01770, 14-08-01167, 15-04-08519]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	The Russian Foundation of Basic Research (https://kias.rfbr.ru/) grant N 13-04-01770 AZ; grant N 14-08-01167 OM; grant N 15-04-08519 NB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolkhovskikh Z., 1969, CHROMOSOME NUMBERS F; CHENNAVEERAIAH MS, 1983, CYTOLOGIA, V48, P833, DOI 10.1508/cytologia.48.833; COX AV, 1993, ANN BOT-LONDON, V72, P239, DOI 10.1006/anbo.1993.1104; Dhar MK, 2002, CHROMOSOMA, V111, P332, DOI 10.1007/s00412-002-0214-4; Fu YB, 2010, GENET RESOUR CROP EV, V57, P667, DOI 10.1007/s10722-009-9502-7; GILL KS, 1967, CROP SCI, V7, P623, DOI 10.2135/cropsci1967.0011183X000700060021x; Goldblatt P., 1979, INDEX PLANT CHROMOSO; Guerra M, 2000, GENET MOL BIOL, V23, P1029, DOI 10.1590/S1415-47572000000400049; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; JAMILENA M, 1994, J CELL SCI, V107, P703; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; JONES RN, 1975, INT REV CYTOL, V40, P1, DOI 10.1016/S0074-7696(08)60951-1; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Kutuzova SN, 1999, T BOT GENET SEL, V156, P29; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; McDill J, 2009, SYST BOT, V34, P386, DOI 10.1600/036364409788606244; McDill JR, 2011, BOT J LINN SOC, V165, P64, DOI 10.1111/j.1095-8339.2010.01096.x; Melnikova NV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231589; Muravenko O V, 2010, Genetika, V46, P1339; Muravenko OV, 2009, RUSS J GENET+, V45, P1338, DOI 10.1134/S1022795409110088; Muravenko OV, 2009, GENETICA, V135, P245, DOI 10.1007/s10709-008-9273-7; Muravenko OV, 2003, CYTOM PART A, V51A, P52, DOI 10.1002/cyto.a.10002; Nosova IV, 2005, BIOL MEMBRANY, V22, P244; Nosova IV, 2008, COT ZHURN RUSSIA, V91, P138; Optasyuk OM, 2010, UKR BOT ZH, V67, P405; Phitos D, 1988, BOT CHRON, V8, P45; Rachinskaia O A, 2011, Genetika, V47, P65; Ray C, 1944, AM J BOT, V31, P241, DOI 10.2307/2437613; Saleem M, 2005, NAT PROD REP, V22, P696, DOI 10.1039/b514045p; Schmidt TJ, 2010, PHYTOCHEMISTRY, V71, P1714, DOI 10.1016/j.phytochem.2010.06.015; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; [Светлова А.А. Svetlova A.], 2009, [Новости систематики высших растений, Novitates Systematicae Plantarum Vascularium, Novosti sistematiki vysshikh rastenii], P99; Velasco L, 2000, PLANT SYST EVOL, V221, P77, DOI 10.1007/BF01086382; Vromans J., 2006, THESIS WAGENINGEN U; Webb D.A., 1968, FLORA EUROPEA, V2, P206; Yurkevich OY, 2013, GENET RESOUR CROP EV, V60, P661, DOI 10.1007/s10722-012-9865-z; Zelenina DA, 2006, RUSS J GENET+, V42, P563, DOI 10.1134/S1022795406050140	37	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122015	10.1371/journal.pone.0122015	http://dx.doi.org/10.1371/journal.pone.0122015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835524	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000073
J	Dahlin, LB; Guner, N; Larsson, HE; Speidel, T				Dahlin, Lars B.; Guner, Nuray; Larsson, Helena Elding; Speidel, Toni			Vibrotactile Perception in Finger Pulps and in the Sole of the Foot in Healthy Subjects among Children or Adolescents	PLOS ONE			English	Article							VIBRATORY PERCEPTION; DETECTION THRESHOLDS; SENSE; NEUROPATHY; HAND; AGE; TEMPERATURE; SENSIBILITY; SENSITIVITY; STIMULI	Aims To evaluate vibrotactile perception at different frequencies in fingers and in foot in healthy girls and boys. Methods Vibration perception thresholds (VPTs) were measured in 283 healthy (8-20 years), consecutively included, girls (n= 146) and boys (n= 137); i.e., 269 children after excluding those with diseases or disorders possibly affecting the nervous system. Thresholds were measured in finger pulps of index and little fingers (seven frequencies; 8-500 Hz) and at first and fifth metatarsal head and at heel in the sole of the foot (six frequencies; 8-250 Hz;) using Multi Frequency Tactilometry. Results VPTs, divided in six groups by age and gender (i.e., 8-10 years, 11-15 years and 16-20 years), at all three sites in the sole increased with higher frequencies, but without gender differences. Thresholds at 64 and 125 Hz were generally higher at heel compared to metatarsal heads. VPTs in finger pulps of index and little fingers, with no finger differences, had a different pattern with increasing thresholds with frequency, but with lower thresholds at 64 and 125 Hz. Thresholds at lower frequencies were higher in finger pulps, while at higher frequencies VPTs were lower in finger pulps than in the sole of the foot; thus, vibration perception in the sole was better than perception in finger pulps at lower frequencies and opposite at higher frequencies. VPTs were higher among adolescents than in younger children in the foot, while thresholds were lower in the finger pulps among adolescents, particularly in index finger. Thresholds in finger pulps of index and little fingers, particularly at higher frequencies, correlated with each other, which the three sites in the sole also did. Conclusions VPTs in fingers and in feet are different as related to frequency in healthy girls and boys. Multi Frequency Tactilometry is a future valuable method to detect neuropathy in children and adolescents.	[Dahlin, Lars B.] Lund Univ, Skane Univ Hosp, Dept Translat Med Hand Surg, Malmo, Sweden; [Guner, Nuray] Skane Univ Hosp, Reg Skane Competence Ctr, Lund, Sweden; [Larsson, Helena Elding] Skane Univ Hosp, Dept Clin Sci Malmo Paediat Endocrinol, Malmo, Sweden; [Speidel, Toni] PID AB, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Dahlin, LB (corresponding author), Lund Univ, Skane Univ Hosp, Dept Translat Med Hand Surg, Malmo, Sweden.	Lars.Dahlin@med.lu.se		Elding Larsson, Helena/0000-0003-3306-1742	Swedish Research Council (Medicine), Diabetesforeningen Malmo med omnejd, Region Skane; University Hospital Malmo, Sweden	Swedish Research Council (Medicine), Diabetesforeningen Malmo med omnejd, Region Skane; University Hospital Malmo, Sweden	The project was supported by grants from the Swedish Research Council (Medicine), Diabetesforeningen Malmo med omnejd, Region Skane and Funds from the University Hospital Malmo, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg ML, 2008, J DIABETES COMPLICAT, V22, P83, DOI 10.1016/j.jdiacomp.2007.06.009; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Blankenburg M, 2012, DIABETIC MED, V29, P1425, DOI 10.1111/j.1464-5491.2012.03685.x; Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24; Cederlund RI, 2009, J DIABETES COMPLICAT, V23, P32, DOI 10.1016/j.jdiacomp.2007.09.002; Chemnitz A, 2013, J BONE JOINT SURG AM, V95A, P329, DOI 10.2106/JBJS.L.00074; Dahlin LB, 2008, DIABETIC MED, V25, P543, DOI 10.1111/j.1464-5491.2008.02433.x; Dahlin LB, 2011, DIABETIC MED, V28, P1045, DOI 10.1111/j.1464-5491.2011.03328.x; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P411; GESCHEIDER GA, 1994, SOMATOSENS MOT RES, V11, P345, DOI 10.3109/08990229409028878; Hilz MJ, 1998, J NEUROL SCI, V159, P219, DOI 10.1016/S0022-510X(98)00177-4; Inami K, 2005, J ORTHOP SCI, V10, P291, DOI 10.1007/s00776-005-0897-5; Karvestedt L, 2009, DIABETES CARE, V32, P317, DOI 10.2337/dc08-1250; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Louraki M, 2012, DIABETES METAB, V38, P281, DOI 10.1016/j.diabet.2012.02.006; Louraki M, 2013, PRIM CARE DIABETES; LUNDBORG G, 1992, SCAND J PLAST RECONS, V26, P275, DOI 10.3109/02844319209015271; Lundborg GN, 2010, DIABETIC MED, V27, P823, DOI 10.1111/j.1464-5491.2010.03014.x; LUNDSTROM R, 1992, INT ARCH OCC ENV HEA, V64, P201, DOI 10.1007/BF00380910; LUNDSTROM RJ, 1986, SCAND J WORK ENV HEA, V12, P413, DOI 10.5271/sjweh.2121; MEH D, 1995, J NEUROL SCI, V134, P136, DOI 10.1016/0022-510X(95)00230-9; Meier PM, 2001, MUSCLE NERVE, V24, P1339, DOI 10.1002/mus.1153; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; Nelander J, 2012, DIABETIC MED, V29, pe449, DOI 10.1111/dme.12024; O'Brien JC, 2008, J MOTOR BEHAV, V40, P43, DOI 10.3200/JMBR.40.1.43-61; OLSEN BS, 1994, DIABETIC MED, V11, P888, DOI 10.1111/j.1464-5491.1994.tb00374.x; Schlee G, 2012, RES DEV DISABIL, V33, P1957, DOI 10.1016/j.ridd.2012.05.020; Schlee G, 2009, CLIN NEUROPHYSIOL, V120, P1548, DOI 10.1016/j.clinph.2009.06.010; Stromberg T, 1998, SCAND J WORK ENV HEA, V24, P495, DOI 10.5271/sjweh.374; Thomsen NOB, 2011, DIABETIC MED, V28, P1401, DOI 10.1111/j.1464-5491.2011.03308.x; Thomsen NOB, 2009, DIABETIC MED, V26, P1120, DOI 10.1111/j.1464-5491.2009.02823.x; Thrainsdottir S, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2008.01118.x; VERRILLO RT, 1980, J GERONTOL, V35, P185, DOI 10.1093/geronj/35.2.185; Verrillo RT, 2003, SOMATOSENS MOT RES, V20, P133, DOI 10.1080/089902203100105163; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; Williams CM, 2012, J CHILD NEUROL, V27, P1017, DOI 10.1177/0883073811432748	36	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119753	10.1371/journal.pone.0119753	http://dx.doi.org/10.1371/journal.pone.0119753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835710	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000014
J	Huang, CC; Zeng, L				Huang, Chencheng; Zeng, Li			An Active Contour Model for the Segmentation of Images with Intensity Inhomogeneities and Bias Field Estimation	PLOS ONE			English	Article							LEVEL SET METHODS	Intensity inhomogeneity causes many difficulties in image segmentation and the understanding of magnetic resonance (MR) images. Bias correction is an important method for addressing the intensity inhomogeneity of MR images before quantitative analysis. In this paper, a modified model is developed for segmenting images with intensity inhomogeneity and estimating the bias field simultaneously. In the modified model, a clustering criterion energy function is defined by considering the difference between the measured image and estimated image in local region. By using this difference in local region, the modified method can obtain accurate segmentation results and an accurate estimation of the bias field. The energy function is incorporated into a level set formulation with a level set regularization term, and the energy minimization is conducted by a level set evolution process. The proposed model first appeared as a two-phase model and then extended to a multi-phase one. The experimental results demonstrate the advantages of our model in terms of accuracy and insensitivity to the location of the initial contours. In particular, our method has been applied to various synthetic and real images with desirable results.	[Huang, Chencheng; Zeng, Li] Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, Chongqing 400044, Peoples R China; [Zeng, Li] Chongqing Univ, Coll Math & Stat, Chongqing 401331, Peoples R China; [Huang, Chencheng] Chongqing Univ, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Educ Minist China, Chongqing 400044, Peoples R China	Chongqing University; Chongqing University; Chongqing University	Zeng, L (corresponding author), Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, Chongqing 400044, Peoples R China.	drlizeng@cqu.edu.cn			National Natural Science Foundation of China [61271313]; National Instrumentation Program of China [2013YQ030629]; Chongqing science and technology research plan project [cstc2012gg-yyjs70016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Instrumentation Program of China; Chongqing science and technology research plan project	This work is supported by the National Natural Science Foundation of China under grant (61271313) (http://www.nsfc.gov.cn), National Instrumentation Program of China (2013YQ030629) (http://www.most.gov.cn), and Chongqing science and technology research plan project (cstc2012gg-yyjs70016) (http://www.ctin.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 2002, STAT METHODS MED RES; CASELLES V, 1993, NUMER MATH, V66, P1, DOI 10.1007/BF01385685; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chen YJ, 2009, COMPUT MED IMAG GRAP, V33, P510, DOI 10.1016/j.compmedimag.2009.04.009; Cohen MS, 2000, HUM BRAIN MAPP, V10, P204, DOI 10.1002/1097-0193(200008)10:4<204::AID-HBM60>3.0.CO;2-2; Evans LC, 1996, PARTIAL DIFFERENTIAL; Ge Q, 2013, DIGIT SIGNAL PROCESS, V23, P1186, DOI 10.1016/j.dsp.2012.12.015; Han C, 2001, J MAGN RESON IMAGING, V13, P428, DOI 10.1002/jmri.1062; Jungke M, 1988, INFORM PROCESSING ME, V39, P471, DOI DOI 10.1007/978-1-4615-7263-3_31; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; KICHENASSAMY S, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P810, DOI 10.1109/ICCV.1995.466855; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; LI C, 2007, P IEEE C COMP VIS PA, V1, P1, DOI DOI 10.1109/CVPR.2007.383014; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Li CM, 2005, PROC CVPR IEEE, P430; Li WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081616; Liao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103334; Liu LH, 2013, OPT LASER ENG, V51, P1235, DOI 10.1016/j.optlaseng.2013.04.019; Liu LX, 2013, MAGN RESON IMAGING, V31, P567, DOI 10.1016/j.mri.2012.10.010; Liu SG, 2012, PATTERN RECOGN, V45, P2769, DOI 10.1016/j.patcog.2011.11.019; MALLADI R, 1995, IEEE T PATTERN ANAL, V17, P158, DOI 10.1109/34.368173; MARKOWSKI CA, 1990, AM STAT, V44, P322, DOI 10.2307/2684360; MCVEIGH ER, 1986, MED PHYS, V13, P806, DOI 10.1118/1.595967; Morse BS, 2001, COMPUTER VISION PATT, P1; Paragios N, 2002, INT J COMPUT VISION, V46, P223, DOI 10.1023/A:1014080923068; RONFARD R, 1994, INT J COMPUT VISION, V13, P229, DOI 10.1007/BF01427153; Roy K, 2011, OPT LASER ENG, V49, P578, DOI 10.1016/j.optlaseng.2010.09.011; Salvado O, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P1143; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Tsai YHR, 2005, ACT NUMERIC, V14, P509, DOI 10.1017/S0962492904000273; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268; Vasilevskiy A, 2002, IEEE T PATTERN ANAL, V24, P1565, DOI 10.1109/TPAMI.2002.1114849; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Wang L, 2009, COMPUT MED IMAG GRAP, V33, P520, DOI 10.1016/j.compmedimag.2009.04.010; Wang XF, 2010, PATTERN RECOGN, V43, P603, DOI 10.1016/j.patcog.2009.08.002; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zhan TM, 2013, MAGN RESON IMAGING, V31, P439, DOI 10.1016/j.mri.2012.08.002; Zhang K., 2013, ARXIV13057053; Zhang KH, 2010, IMAGE VISION COMPUT, V28, P668, DOI 10.1016/j.imavis.2009.10.009; Zheng Q, 2013, COMPUT BIOL MED, V43, P459, DOI 10.1016/j.compbiomed.2013.01.002	42	24	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120399	10.1371/journal.pone.0120399	http://dx.doi.org/10.1371/journal.pone.0120399			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837416	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000021
J	Musoke, D; Miiro, G; Karani, G; Morris, K; Kasasa, S; Ndejjo, R; Nakiyingi-Miiro, J; Guwatudde, D; Musoke, MB				Musoke, David; Miiro, George; Karani, George; Morris, Keith; Kasasa, Simon; Ndejjo, Rawlance; Nakiyingi-Miiro, Jessica; Guwatudde, David; Musoke, Miph Boses			Promising Perceptions, Divergent Practices and Barriers to Integrated Malaria Prevention in Wakiso District, Uganda: A Mixed Methods Study	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; PERSONAL-PROTECTION; VECTOR CONTROL; INTERVENTIONS; ACHIEVEMENTS; COMMUNITIES; CHALLENGES; AFRICA; KENYA	Background The World Health Organization recommends use of multiple approaches to control malaria. The integrated approach to malaria prevention advocates the use of several malaria prevention methods in a holistic manner. This study assessed perceptions and practices on integrated malaria prevention in Wakiso district, Uganda. Methods A clustered cross-sectional survey was conducted among 727 households from 29 villages using both quantitative and qualitative methods. Assessment was done on awareness of various malaria prevention methods, potential for use of the methods in a holistic manner, and reasons for dislike of certain methods. Households were classified as using integrated malaria prevention if they used at least two methods. Logistic regression was used to test for factors associated with the use of integrated malaria prevention while adjusting for clustering within villages. Results Participants knew of the various malaria prevention methods in the integrated approach including use of insecticide treated nets (97.5%), removing mosquito breeding sites (89.1%), clearing overgrown vegetation near houses (97.9%), and closing windows and doors early in the evenings (96.4%). If trained, most participants (68.6%) would use all the suggested malaria prevention methods of the integrated approach. Among those who would not use all methods, the main reasons given were there being too many (70.2%) and cost (32.0%). Only 33.0% households were using the integrated approach to prevent malaria. Use of integrated malaria prevention by households was associated with reading newspapers (AOR 0.34; 95% CI 0.22 -0.53) and ownership of a motorcycle/car (AOR 1.75; 95% CI 1.03 - 2.98). Conclusion Although knowledge of malaria prevention methods was high and perceptions on the integrated approach promising, practices on integrated malaria prevention was relatively low. The use of the integrated approach can be improved by promoting use of multiple malaria prevention methods through various communication channels such as mass media.	[Musoke, David; Ndejjo, Rawlance] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Miiro, George] Uganda Virus Res Inst, Entebbe, Uganda; [Karani, George; Morris, Keith] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Cardiff, S Glam, Wales; [Kasasa, Simon; Guwatudde, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Nakiyingi-Miiro, Jessica] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Musoke, Miph Boses] Nkumba Univ, Sch Sci, Entebbe, Uganda	Makerere University; Uganda Virus Research Institute; Cardiff Metropolitan University; Cardiff University; Makerere University; Uganda Virus Research Institute	Musoke, D (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	dmusoke@musph.ac.ug		Musoke, David/0000-0003-3262-3918; Ndejjo, Rawlance/0000-0001-9263-557X	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust [087540]; TDR; Special Programme for Research and Training in Tropical Diseases; UNICEF; UNDP; World Bank; WHO	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust; TDR; Special Programme for Research and Training in Tropical Diseases; UNICEF; UNDP; World Bank(The World Bank India); WHO(World Health Organization)	The work was supported by Training Health Researchers into Vocational Excellence (THRiVE) in East Africa, grant number 087540, funded by Wellcome Trust. This investigation also received financial support from TDR, the Special Programme for Research and Training in Tropical Diseases, co-sponsored by UNICEF, UNDP, the World Bank and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjah ESO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-123; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2013, J ENV HLTH RES; Babu BV, 2007, ANN TROP MED PARASIT, V101, P601, DOI 10.1179/136485907X193897; Berthelemy JC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-200; Centers for Disease Control and Prevention, 2008, AN MOS; De Allegri M, 2013, INT J HEALTH PLAN M, V28, P102, DOI 10.1002/hpm.2116; Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x; Fernando SD, 2008, T ROY SOC TROP MED H, V102, P1081, DOI 10.1016/j.trstmh.2008.06.007; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fullman N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-62; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hlongwana KW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-118; Hwang J, 2007, PLOS ONE, V5; Ingstad B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-15; Kish L, 1965, SURVEY SAMPLING; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Knox Stephanie A, 2004, BMC Med Res Methodol, V4, P30, DOI 10.1186/1471-2288-4-30; Musoke D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-327; Ng'ang'a PN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-146; Onwujekwe O, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-315; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ruberto I, 2014, J VECTOR DIS, V51, P119; Sharma S K, 2001, Indian J Public Health, V45, P93; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Soper FL, 1943, ANOPHELES GAMBIAE BR; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2004, WHOCDSCPEPVC200410; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122699	10.1371/journal.pone.0122699	http://dx.doi.org/10.1371/journal.pone.0122699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837978	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000107
J	Simpfendorfer, KR; Strugnell, RA; Brodnicki, TC; Wijburg, OLC				Simpfendorfer, Kim R.; Strugnell, Richard A.; Brodnicki, Thomas C.; Wijburg, Odilia L. C.			Increased Autoimmune Diabetes in pIgR-Deficient NOD Mice Is Due to a "Hitchhiking" Interval that Refines the Genetic Effect of Idd5.4	PLOS ONE			English	Article							INBRED MOUSE STRAINS; SECRETORY ANTIBODIES; CONGENIC MICE; INTESTINAL MICROBIOTA; MUCOSAL IMMUNITY; PD-1 PATHWAY; MODEL; LOCI; EXPRESSION; HOMEOSTASIS	Selective breeding to introduce a gene mutation from one mouse strain onto the genetic background of another strain invariably produces "hitchhiking"(i. e. flanking) genomic intervals, which may independently affect a disease trait of interest. To investigate a role for the polymeric Ig receptor in autoimmune diabetes, a congenic nonobese diabetic (NOD) mouse strain was generated that harbors a Pigr null allele derived from C57BL/6 (B6) mice. These pIgR-deficient NOD mice exhibited increased serum IgA along with an increased diabetes incidence. However, the Pigr null allele was encompassed by a relatively large "hitchhiking"genomic interval that was derived from B6 mice and overlaps Idd5.4, a susceptibility locus for autoimmune diabetes. Additional congenic NOD mouse strains, harboring smaller B6derived intervals, confirmed Idd5.4 independently of the other three known susceptibility loci on chromosome 1, and further localized Idd5.4 to an interval proximal to Pigr. Moreover, these congenic NOD mice showed that B6 mice harbor a more diabetogenic allele than NOD mice for this locus. The smallest B6-derived interval encompassing the Pigr null allele may, however, confer a small degree of protection against diabetes, but this protection appears to be dependent on the absence of the diabetogenic B6 allele for Idd5.4. This study provides another example of the potential hidden effects of "hitchhiking"genomic intervals and how such intervals can be used to localize disease susceptibility loci.	[Simpfendorfer, Kim R.; Strugnell, Richard A.; Wijburg, Odilia L. C.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Strugnell, Richard A.; Wijburg, Odilia L. C.] Univ Melbourne, Australian Bacterial Pathogenesis Program, Parkville, Vic 3052, Australia; [Brodnicki, Thomas C.] St Vincents Inst Med Res, Immunol & Diabet Unit, Fitzroy, Vic 3065, Australia	University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Wijburg, OLC (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	odilia@unimelb.edu.au	Simpfendorfer, Kim R/AAG-1940-2019	Simpfendorfer, Kim R/0000-0002-1906-2899; Strugnell, Richard/0000-0003-0614-5641	NHMRC [400011]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the NHMRC (grant ID 400011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Brodnicki TC, 2003, DIABETES, V52, P218, DOI 10.2337/diabetes.52.1.218; Chen YG, 2014, DIABETES, V63, P68, DOI 10.2337/db13-0192; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Gorrell RJ, 2013, INFECT IMMUN, V81, P3880, DOI 10.1128/IAI.01424-12; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hollis-Moffatt JE, 2005, DIABETES, V54, P2820, DOI 10.2337/diabetes.54.9.2820; Hunter K, 2007, J IMMUNOL, V179, P8341, DOI 10.4049/jimmunol.179.12.8341; Irie J, 2008, J IMMUNOL, V180, P1071, DOI 10.4049/jimmunol.180.2.1071; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kanagawa O, 2000, J IMMUNOL, V164, P3919, DOI 10.4049/jimmunol.164.7.3919; Lamhamedi-Cherradi SE, 2001, DIABETES, V50, P2874, DOI 10.2337/diabetes.50.12.2874; Leiter EH, 2002, DIABETOLOGIA, V45, P296, DOI 10.1007/s00125-001-0743-z; Lin XT, 2013, J IMMUNOL, V190, P3109, DOI 10.4049/jimmunol.1203422; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Morgan MAJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071974, 10.1371/journal.pone.0056738, 10.1371/journal.pone.0069936]; Morin J, 2006, MAMM GENOME, V17, P1105, DOI 10.1007/s00335-006-0076-9; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Ridgway WM, 2007, NAT IMMUNOL, V8, P669, DOI 10.1038/ni0707-669; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Rogner UC, 2003, NAT REV IMMUNOL, V3, P243, DOI 10.1038/nri1031; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang N, 2014, IMMUNOGENETICS, V66, P501, DOI 10.1007/s00251-014-0782-5; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121979	10.1371/journal.pone.0121979	http://dx.doi.org/10.1371/journal.pone.0121979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835383	Green Published, gold			2022-12-27	WOS:000352139000071
J	Choi, JY; Lyoo, CH; Kim, JS; Kim, KM; Kang, JH; Choi, SH; Kim, JJ; Ryu, YH				Choi, Jae Yong; Lyoo, Chul Hyoung; Kim, Jin Su; Kim, Kyeong Min; Kang, Jee Hae; Choi, Soo-Hee; Kim, Jae-Jin; Ryu, Young Hoon			F-18-Mefway PET Imaging of Serotonin 1A Receptors in Humans: A Comparison with F-18-FCWAY	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BRAIN 5-HT1A RECEPTORS; DRUG-METABOLISM; P-GLYCOPROTEIN; RADIOLIGAND; BINDING; RAT; REPRODUCIBILITY; DEFLUORINATION; INHIBITION	Introduction The purpose of this research is to evaluate the prospects for the use of 4-(trans-F-18-fluoranylmethyl)-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexane-1carboxamide (F-18-Mefway) in comparison to F-18-trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (F-18-FCWAY) for the quantification of 5-HT1A receptors in human subjects. Method Five healthy male controls were included for two positron emission tomography (PET) studies: F-18-FCWAY PET after the pretreatment with 500 mg of disulfiram and two months later, F-18-Mefway PET without disulfiram. Regional time-activity curves (TACs) were extracted from nine cortical and subcortical regions in dynamic PET images. Using cerebellar cortex without vermis as reference tissue, in vivo kinetics for both radioligands were compared based on the distribution volume ratio (DVR) calculated by non-invasive Logan graphical analysis and area under the curve ratio of the TACs (AUC ratio). Result Although the pattern of regional uptakes in the F-18-Mefway PET was similar to that of the F-18-FCWAY PET (highest in the hippocampus and lowest in the cerebellar cortex), the amount of regional uptake in F-18-Mefway PET was almost half of that in F-18-FCWAY PET. The skull uptake in F-18-Mefway PET was only 25% of that in F-18-FCWAY PET with disulfiram pretreatment. The regional DVR values and AUC ratio values for F-18-Mefway were 17-40% lower than those of F-18-FCWAY. In contrast to a small overestimation of DVR values by AUC ratio values (< 10%) in F-18-FCWAY PET, the overestimation bias of AUC ratio values was much higher (up to 21%) in F-18-Mefway PET. Conclusion As F-18-Mefway showed lower DVR values and greater overestimation bias of AUC ratio values, F-18-Mefway may appear less favorable than F-18-FCWAY. However, in contrast to F-18-FCWAY, the resistance to in vivo defluorination of F-18-Mefway obviates the need for the use of a defluorination inhibitor. Thus, F-18-Mefway may be a good candidate PET radioligand for 5-HT1A receptor imaging in human.	[Choi, Jae Yong; Ryu, Young Hoon] Yonsei Univ, Coll Med, Dept Nucl Med, Gangnam Severance Hosp, Seoul, South Korea; [Lyoo, Chul Hyoung] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea; [Kim, Jin Su; Kim, Kyeong Min] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Kang, Jee Hae] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA; [Choi, Soo-Hee] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Soo-Hee] Seoul Natl Univ, Coll Med, Inst Human Behav Sci, Seoul, South Korea; [Kim, Jae-Jin] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Jae-Jin] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Institute of Radiological & Medical Sciences; Swarthmore College; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ryu, YH (corresponding author), Yonsei Univ, Coll Med, Dept Nucl Med, Gangnam Severance Hosp, Seoul, South Korea.	ryuyh@yuhs.ac	KIM, JIN SU/U-2112-2019	KIM, JIN SU/0000-0001-8965-9538; Kim, Jae-Jin/0000-0002-1395-4562; RYU, YOUNG HOON/0000-0002-9000-5563; Lyoo, Chul Hyoung/0000-0003-2231-672X	Yonsei University College of Medicine [6-2008-2037]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine (6-2008-2037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; CARSON RE, 1993, J CEREBR BLOOD F MET, V13, P24, DOI 10.1038/jcbfm.1993.6; Carson RE, 2000, NUCL MED BIOL, V27, P493, DOI 10.1016/S0969-8051(00)00118-9; Cho YN, 2011, MOVEMENT DISORD, V26, P763, DOI 10.1002/mds.23496; Choi JY, 2013, J LABELLED COMPD RAD, V56, P589, DOI 10.1002/jlcr.3067; Choi JY, 2012, SYNAPSE, V66, P1015, DOI 10.1002/syn.21607; Choi J, 2014, PERS INDIV DIFFER, V68, P1, DOI 10.1016/j.paid.2014.03.040; Costes N, 2007, J NUCL MED, V48, P1279, DOI 10.2967/jnumed.107.041905; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Giovacchini G, 2009, J NUCL MED, V50, P1794, DOI 10.2967/jnumed.109.063743; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grasby PM, 1997, CURR OPIN PSYCHIATR, V10, P73, DOI 10.1097/00001504-199703000-00003; Hillmer AT, 2014, J NUCL MED, V55, P1973, DOI 10.2967/jnumed.114.145151; Hirvonen J, 2007, J CEREBR BLOOD F MET, V27, P185, DOI 10.1038/sj.jcbfm.9600326; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Kumar JS, 2007, DRUG DISCOV TODAY, P12; Lacan G, 2008, EUR J NUCL MED MOL I, V35, P2256, DOI 10.1007/s00259-008-0832-z; Lang LX, 1999, J MED CHEM, V42, P1576, DOI 10.1021/jm980456f; Lanzenberger RR, 2007, BIOL PSYCHIAT, V61, P1081, DOI 10.1016/j.biopsych.2006.05.022; LAPLANE D, 1992, J NEUROL NEUROSUR PS, V55, P925, DOI 10.1136/jnnp.55.10.925; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Moses-Kolko EL, 2008, FERTIL STERIL, V89, P685, DOI 10.1016/j.fertnstert.2007.03.059; Parsey RV, 2000, J CEREBR BLOOD F MET, V20, P1111, DOI 10.1097/00004647-200007000-00011; Parsey RV, 2005, J CEREBR BLOOD F MET, V25, P785, DOI 10.1038/sj.jcbfm.9600072; Passchier J, 2000, EUR J PHARMACOL, V407, P273, DOI 10.1016/S0014-2999(00)00752-4; Paterson LM, 2013, MED RES REV, V33, P54, DOI 10.1002/med.20245; Ryu YH, 2007, J NUCL MED, V48, P1154, DOI 10.2967/jnumed.107.039933; Saigal N, 2006, J NUCL MED, V47, P1697; Saigal N, 2013, SYNAPSE, V67, P596, DOI 10.1002/syn.21665; Tipre DN, 2006, J NUCL MED, V47, P345; Venkatakrishnan K, 2001, J CLIN PHARMACOL, V41, P1149, DOI 10.1177/00912700122012724; Wooten DW, 2011, SYNAPSE, V65, P592, DOI 10.1002/syn.20878; Yasuno F, 2004, BIOL PSYCHIAT, V55, P439, DOI 10.1016/j.biopsych.2003.11.016; Zhang XY, 2007, SYNAPSE, V61, P469, DOI 10.1002/syn.20392	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121342	10.1371/journal.pone.0121342	http://dx.doi.org/10.1371/journal.pone.0121342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830772	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600070
J	Mason-Jones, AJ; Cabieses, B				Mason-Jones, Amanda J.; Cabieses, Baltica			Alcohol, Binge Drinking and Associated Mental Health Problems in Young Urban Chileans	PLOS ONE			English	Article							SUBSTANCE USE; CARE PATIENTS; USE DISORDERS; CONSUMPTION; YOUTH; ADOLESCENTS; PREVENTION; DEPRESSION; BEHAVIOR; DISEASE	Objective To explore the link between alcohol use, binge drinking and mental health problems in a representative sample of adolescent and young adult Chileans. Methods Age and sex-adjusted Odds Ratios (OR) for four mental wellbeing measures were estimated with separate conditional logistic regression models for adolescents aged 15-20 years, and young adults aged 21-25 years, using population-based estimates of alcohol use prevalence rates from the Chilean National Health Survey 2010. Results Sixty five per cent of adolescents and 85% of young adults reported drinking alcohol in the last year and of those 83% per cent of adolescents and 86% of young adults reported binge drinking in the previous month. Adolescents who reported binging alcohol were also more likely, compared to young adults, to report being always or almost always depressed (OR 12.97 [95% CI, 1.86-19.54]) or to feel very anxious in the last month (OR 9.37 [1.77-19.54]). Adolescent females were more likely to report poor life satisfaction in the previous year than adolescent males (OR 8.50 [1.61-15.78]), feel always or almost always depressed (OR 3.41 [1.25-9.58]). Being female was also associated with a self-reported diagnosis of depression for both age groups (adolescents, OR 4.74 [1.49-15.08] and young adults, OR 4.08 [1.65-10.05]). Conclusion Young people in Chile self-report a high prevalence of alcohol use, binge drinking and associated mental health problems. The harms associated with alcohol consumption need to be highlighted through evidence-based prevention programs. Health and education systems need to be strengthened to screen and support young people. Focussing on policy initiatives to limit beverage companies targeting alcohol to young people will also be needed.	[Mason-Jones, Amanda J.; Cabieses, Baltica] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Mason-Jones, Amanda J.] Univ Cape Town, Adolescent Hlth Res Unit, ZA-7925 Cape Town, South Africa; [Cabieses, Baltica] Univ Desarrollo, Santiago, Chile	University of York - UK; University of Cape Town; Universidad del Desarrollo	Mason-Jones, AJ (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	amanda.mason-jones@york.ac.uk	Cabieses, Baltica/V-5024-2017; Mason-Jones, Amanda/ABF-1565-2020	Cabieses, Baltica/0000-0003-0756-1954; Mason-Jones, Amanda/0000-0002-4292-3183	University of York, BC by Universidad del Desarrollo	University of York, BC by Universidad del Desarrollo	AMJ was supported by the University of York, BC by Universidad del Desarrollo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; [Anonymous], 2007, ALCOHOL PUBLIC HLTH; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Bares CB, 2011, J SOC SOC WORK RES, V2, P6332; Benegal V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000170; Bennett LA, 1998, ALCOHOL HEALTH RES W, V22, P243; Bradizza CM, 2006, CLIN PSYCHOL REV, V26, P162, DOI 10.1016/j.cpr.2005.11.005; Burns Jonathan Kenneth, 2009, Health Hum Rights, V11, P19; Capezza NM, 2012, J ADDICT MED, V6, P297, DOI 10.1097/ADM.0b013e3182664d80; Carlini-Marlatt B, 2003, SUBST USE MISUSE, V38, P905, DOI 10.1081/JA-120017617; Carpenter C, 2005, J HEALTH ECON, V24, P613, DOI 10.1016/j.jhealeco.2004.09.014; Chávez Luz María Carvajal, 2005, Rev. Latino-Am. Enfermagem, V13, P784, DOI 10.1590/S0104-11692005000700004; Castillo-Carniglia A, 2013, ALCOHOL ALCOHOLISM, V48, P729, DOI 10.1093/alcalc/agt066; Chilean Ministry of Health, 2010, AT HLTH SURV 2009 20; Alvarado ME, 2009, REV MED CHILE, V137, P1463, DOI /S0034-98872009001100008; Fleming LC, 2009, J SCHOOL HEALTH, V79, P130, DOI 10.1111/j.1746-1561.2008.0397.x; Foxcroft DR, 2003, ADDICTION, V98, P397, DOI 10.1046/j.1360-0443.2003.00355.x; Foxcroft DR., 2012, EVIDENCE BASED CHILD, V7, P450, DOI [DOI 10.1002/EBCH.1829, 10.1002/ebch.1829]; Fuhr DC, 2011, ALCOHOL ALCOHOLISM, V46, P88, DOI 10.1093/alcalc/agq071; Garcia F, 2002, REV ELECT PENAL CRIM, V4, P1; Garcia-Huidobro D, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630098; Glaberson H, 2010, BEVERAGEDAILYCOM; Dantes H, 2011, SALUD PUBLICA MEXICO, V53, pS72; Gordon R, 2010, ALCOHOL ALCOHOLISM, V45, P470, DOI 10.1093/alcalc/agq047; Graziano F, 2012, J ADOLESCENCE, V35, P823, DOI 10.1016/j.adolescence.2011.11.010; Harmer A, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-15; Institute of National Statistics in Chile, 2012, POP SIZ PROJ INE; Jernigan DH, 2011, J PUBLIC HEALTH POL, V32, P165, DOI 10.1057/jphp.2011.5; Kessler DA, 2005, J PUBLIC HEALTH POL, V26, P292, DOI 10.1057/palgrave.jphp.3200041; Keyes KM, 2012, ALCOHOL RES-CURR REV, V34, P391; King M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022175; Latorres M, 2012, REV MED CHILE, V140, P1140, DOI 10.4067/S0034-98872012000900006; Licciardone JC, 2003, AM J DRUG ALCOHOL AB, V29, P803, DOI 10.1081/ADA-120026262; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Limaye RJ, 2012, DRUG ALCOHOL REV, V31, P357, DOI 10.1111/j.1465-3362.2011.00393.x; Mason-Jones AJ, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-49; Odejide OA, 2006, AFRICAN J DRUG ALCOH, V5, P1; OECD, 2014, COUNTRY STAT PROF CH; Page RM, 2011, YOUTH SOC, V43, P900, DOI 10.1177/0044118X10368932; Patel V, 2007, ANN EPIDEMIOL, V17, pS87, DOI 10.1016/j.annepidem.2007.01.019; Patel V, 2013, ARCH DIS CHILD, V98, P323, DOI 10.1136/archdischild-2012-302079; Planificacion Md, 2011, MIDEPLAN, P91; Rojas G, 2012, REV MED CHILE, V140, P184, DOI 10.4067/S0034-98872012000200006; Salvo L, 2013, REV MED CHILE, V141, P428, DOI 10.4067/S0034-98872013000400002; Sanhueza Guillermo E, 2013, INT J ALCOHOL DRUG R, V2, P89, DOI 10.7895/ijadr.v2i1.71; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; SCHUCKIT MA, 1994, ACTA PSYCHIAT SCAND, V89, P28, DOI 10.1111/j.1600-0447.1994.tb05798.x; Spears M, 2014, SOC PSYCH PSYCH EPID, V49, P629, DOI 10.1007/s00127-013-0767-y; Stapinski LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078323; StataCorp, 2009, STAT STAT SOFTW REL; De TCW, 2012, REV MED CHILE, V140, P1145, DOI 10.4067/S0034-98872012000900007; World Health Organisation, 2014, YOUNG PEOPL HLTH RIS; World Health Organization, 2010, GLOB STRAT RED HARMF; World Health Organization, 2004, NEUR PSYCH SUBST US; Yu HJ, 1996, AMERICAN STATISTICAL ASSOCIATION - 1996 PROCEEDINGS OF THE SECTION ON SURVEY RESEARCH METHODS, VOLS I AND II, P468	57	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121116	10.1371/journal.pone.0121116	http://dx.doi.org/10.1371/journal.pone.0121116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830508	gold, Green Published, Green Accepted			2022-12-27	WOS:000352135600058
J	Rousseau, A; Nasser, G; Chiquet, C; Barreau, E; Gendron, G; Kaswin, G; M'Garrech, M; Benoudiba, F; Ducreux, D; Labetoulle, M				Rousseau, Antoine; Nasser, Ghaidaa; Chiquet, Christophe; Barreau, Emmanuel; Gendron, Gael; Kaswin, Godefroy; M'Garrech, Mohamed; Benoudiba, Farida; Ducreux, Denis; Labetoulle, Marc			Diffusion Tensor Magnetic Resonance Imaging of Trigeminal Nerves in Relapsing Herpetic Keratouveitis	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; AXONAL INJURY; CORNEAL SENSATION; SIMPLEX KERATITIS; CRANIAL NERVES; DOUBLE-BLIND; OPHTHALMICUS; GANGLIA; DNA; BRAIN	Background Corneal hypoesthesia is the landmark of HSV and VZV keratitis and can lead to neurotrophic keratitis. Diffusion tensor imaging (DTI) is a new magnetic resonance imaging (MRI) derived technique, which offers possibilities to study axonal architecture. We aimed at assessing the potential impact of recurrent HSV or VZV-related keratitis on the axonal architecture of trigeminal nerves using DTI. Design Prospective non-interventional study. Participants Twelve patients and 24 controls. Methods DTI using MRI of the trigeminal fibers and corneal esthesiometry using the Cochet-Bonnet esthesiometer were acquired for patients affected by unilateral and recurrent HSV or VZVrelated keratitis (3 months after the last corneal inflammatory event), and control subjects with no history of ocular or neuronal disease affecting the trigeminal pathways. Main Outcome Measures Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were compared between the 2 eyes of both patients and controls, and correlated with corneal esthesiometry. Results FA was lower in the trigeminal fibers ipsilateral to the affected eye compared to the non-affected side (0.39 +/- 0.02 versus 0.46 +/- 0.04, P=0.03). This difference was more important than the intra-individual variability observed in controls. Concomitantly, the asymmetry in ADC results was significantly correlated with the loss of corneal sensitivity in the affected eye. Conclusions Corneal hypoesthesia related to HSV and VZV keratitis is associated with persistent modifications in the architecture and functionality of the trigeminal fibers. These results add further explanation to the pathogenesis of HSV and VZV-induced neurotrophic keratitis, which may occur despite an apparent quiescence of the disease.	[Rousseau, Antoine; Barreau, Emmanuel; Gendron, Gael; Kaswin, Godefroy; M'Garrech, Mohamed; Labetoulle, Marc] Univ Paris Sud, Bicetre Hosp, AP HP, Dept Ophthalmol, Le Kremlin Bicetre, France; [Nasser, Ghaidaa; Benoudiba, Farida; Ducreux, Denis] Univ Paris Sud, Bicetre Hosp, AP HP, Dept Neuroradiol, Le Kremlin Bicetre, France; [Chiquet, Christophe] Grenoble Univ Hosp, Dept Ophthalmol, Grenoble, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Ducreux, D (corresponding author), Univ Paris Sud, Bicetre Hosp, AP HP, Dept Neuroradiol, Le Kremlin Bicetre, France.	denis.ducreux@bct.aphp.fr; marc.labetoulle@bct.aphp.fr	Rousseau, Antoine/A-6667-2018; Labetoulle, Marc/AAC-6741-2022; Chiquet, Christophe/M-7426-2014	Chiquet, Christophe/0000-0002-7601-4885; rousseau, antoine/0000-0003-2355-2804				Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091; Belmonte Carlos, 2004, Ocul Surf, V2, P248; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Budrewicz S, 2012, NEUROL SCI, V33, P423, DOI 10.1007/s10072-011-0756-4; Chen DQ, 2011, NEUROSURGERY, V68, P1077, DOI 10.1227/NEU.0b013e31820c6cbe; de Melker H, 2006, VACCINE, V24, P3946, DOI 10.1016/j.vaccine.2006.02.017; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P967; Gallar J, 2010, INVEST OPHTH VIS SCI, V51, P4516, DOI 10.1167/iovs.10-5225; Hamrah P, 2013, OPHTHALMOLOGY, V120, P40, DOI 10.1016/j.ophtha.2012.07.036; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; Hartwig V, 2009, INT J ENV RES PUB HE, V6, P1778, DOI 10.3390/ijerph6061778; Herweh C, 2007, NEUROLOGY, V68, P776, DOI 10.1212/01.wnl.0000256340.16766.1d; Hill JM, 2008, J VIROL, V82, P8230, DOI 10.1128/JVI.00686-08; Hodaie M, 2013, J NEUROSURG SCI, V57, P13; Hodaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032745; Hodaie M, 2010, NEUROSURGERY, V66, P788, DOI 10.1227/01.NEU.0000367613.09324.DA; Hofling AA, 2009, NMR BIOMED, V22, P1100, DOI 10.1002/nbm.1420; Holland EJ, 1999, CORNEA, V18, P144, DOI 10.1097/00003226-199903000-00002; Hufner K, 2006, J NEUROPATH EXP NEUR, V65, P1022, DOI 10.1097/01.jnen.0000235852.92963.bf; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kabra Amit, 2006, Indian Journal of Ophthalmology, V54, P23; Keijser S, 2002, INVEST OPHTH VIS SCI, V43, P87; Kramer MF, 2003, J VIROL, V77, P9533, DOI 10.1128/JVI.77.17.9533-9541.2003; KRISTENSSON K, 1982, J NEUROL SCI, V53, P205, DOI 10.1016/0022-510X(82)90006-5; Kumar M, 2009, INVEST OPHTH VIS SCI, V50, P5601, DOI 10.1167/iovs.09-3729; Labetoulle M, 2005, OPHTHALMOLOGY, V112, P888, DOI 10.1016/j.ophtha.2004.11.052; Labetoulle M, 2003, INVEST OPHTH VIS SCI, V44, P217, DOI 10.1167/iovs.02-0464; Leal PRL, 2011, PAIN, V152, P2357, DOI 10.1016/j.pain.2011.06.029; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; LIESEGANG TJ, 1985, OPHTHALMOLOGY, V92, P316; Liu Y, 2013, EUR J RADIOL, V82, P783, DOI 10.1016/j.ejrad.2012.11.027; Lutz J, 2011, RADIOLOGY, V258, P524, DOI 10.1148/radiol.10100477; M'Garrech M, 2013, OPHTHALMOLOGY, V120, P1959, DOI 10.1016/j.ophtha.2013.02.037; MACKIE IA, 1978, T OPHTHAL SOC UK, V98, P343; Magone MT, 2005, AM J OPHTHALMOL, V139, P1135, DOI 10.1016/j.ajo.2004.12.014; Maillet S, 2006, J VIROL, V80, P9310, DOI 10.1128/JVI.02615-05; Moayedi M, 2012, PAIN, V153, P1467, DOI 10.1016/j.pain.2012.04.003; Mocan MC, 2012, CURR EYE RES, V37, P1099, DOI 10.3109/02713683.2012.707270; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2008, ORAL SURG ORAL MED O, V106, P270, DOI 10.1016/j.tripleo.2008.03.015; NORN MS, 1970, ACTA OPHTHALMOL, V48, P383; PAVANLANGSTON D, 1995, ARCH OPHTHALMOL-CHIC, V113, P1381, DOI 10.1001/archopht.1995.01100110041023; Pevenstein SR, 1999, J VIROL, V73, P10514, DOI 10.1128/JVI.73.12.10514-10518.1999; Richter ER, 2009, J INFECT DIS, V200, P1901, DOI 10.1086/648474; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; SHIMELD C, 1995, J NEUROIMMUNOL, V61, P7, DOI 10.1016/0165-5728(95)00068-D; Storey N, 2002, J CELL BIOL, V158, P1251, DOI 10.1083/jcb.200204010; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Upadhyay J, 2008, MAGN RESON MED, V60, P1037, DOI 10.1002/mrm.21682; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005; Wenkel H, 1998, OPHTHALMOLOGY, V105, P1323, DOI 10.1016/S0161-6420(98)97042-7; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Yen MT, 2001, AM J OPHTHALMOL, V131, P314, DOI 10.1016/S0002-9394(00)00822-9; Young RC, 2010, ARCH OPHTHALMOL-CHIC, V128, P1178, DOI 10.1001/archophthalmol.2010.187; Zaal MJW, 2003, GRAEF ARCH CLIN EXP, V241, P187, DOI 10.1007/s00417-002-0609-1; Zaal MJW, 2001, AM J OPHTHALMOL, V131, P25, DOI 10.1016/S0002-9394(00)00652-8	60	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122186	10.1371/journal.pone.0122186	http://dx.doi.org/10.1371/journal.pone.0122186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830672	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600101
J	Sordi, R; Chiazza, F; Patel, NSA; Doyle, RA; Collino, M; Thiemermann, C				Sordi, Regina; Chiazza, Fausto; Patel, Nimesh S. A.; Doyle, Rachel A.; Collino, Massimo; Thiemermann, Christoph			'Preconditioning' with Low Dose Lipopolysaccharide Aggravates the Organ Injury/Dysfunction Caused by Hemorrhagic Shock in Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTOXIN TOLERANCE; INJURY; ISCHEMIA; INHIBITION; PROTECTION; FAILURE; TRAUMA; MODEL; HYPORESPONSIVENESS	Methods Male rats were `pretreated' with phosphate-buffered saline (PBS; i.p.) or LPS (1 mg/kg; i.p.) 24 h prior to HS. Mean arterial pressure (MAP) was maintained at 30 +/- 2 mmHg for 90 min or until 25% of the shed blood had to be re-injected to sustain MAP. This was followed by resuscitation with the remaining shed blood. Four hours after resuscitation, parameters of organ dysfunction and systemic inflammation were assessed. Results HS resulted in renal dysfunction, and liver and muscular injury. At a first glance, LPS preconditioning attenuated organ dysfunction. However, we discovered that HS-rats that had been preconditioned with LPS (a) were not able to sustain a MAP at 30 mmHg for more than 50 min and (b) the volume of blood withdrawn in these animals was significantly less than in the PBS-control group. This effect was associated with an enhanced formation of the nitric oxide (NO) derived from inducible NO synthase (iNOS). Thus, a further control group in which all animals were resuscitated after 50 min of hemorrhage was performed. Then, LPS preconditioning aggravated both circulatory failure and organ dysfunction. Most notably, HS-rats pretreated with LPS exhibited a dramatic increase in NF-kappa B activation and pro-inflammatory cytokines. Conclusion In conclusion, LPS preconditioning predisposed animals to an earlier vascular decompensation, which may be mediated by an excess of NO production secondary to induction of iNOS and activation of NF-kappa B. Moreover, LPS preconditioning increased the formation of pro-inflammatory cytokines, which is likely to have contributed to the observed aggravation of organ injury/dysfunction caused by HS.	[Sordi, Regina; Patel, Nimesh S. A.; Doyle, Rachel A.; Thiemermann, Christoph] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Sordi, Regina] Minist Educ Brazil, Capes Fdn, Brasilia, DF, Brazil; [Chiazza, Fausto; Collino, Massimo] Univ Turin, Dept Drug Sci & Technol, Turin, Italy	University of London; Queen Mary University London; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of Turin	Thiemermann, C (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	c.thiemermann@qmul.ac.uk	Sordi, Regina/O-3377-2014; Chiazza, Fausto/I-5559-2015; Collino, Massimo/AAK-8532-2020	Sordi, Regina/0000-0003-0264-7062; Collino, Massimo/0000-0001-8782-3496; Thiemermann, Christoph/0000-0003-4228-9722; Chiazza, Fausto/0000-0001-7273-0051	Program Science without Borders, CAPES Foundation, Ministry of Education of Brazil, Brasilia/DF, Brazil; Bart's and The London Charity [753/1722]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) [608765]; William Harvey Research Foundation and University of Turin; Barts and The London Charity [753/1722]	Program Science without Borders, CAPES Foundation, Ministry of Education of Brazil, Brasilia/DF, Brazil; Bart's and The London Charity; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7); William Harvey Research Foundation and University of Turin; Barts and The London Charity	RS is supported by the Program Science without Borders, CAPES Foundation, Ministry of Education of Brazil, Brasilia/DF, Brazil; NSAP is, in part, supported by the Bart's and The London Charity (753/1722). The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 608765, from the William Harvey Research Foundation and University of Turin (Ricerca Locale ex-60%). This work contributes to the Organ Protection research theme of the Barts Centre for Trauma Sciences, supported by the Barts and The London Charity (Award 753/1722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Rosa F, 2002, CLIN EXP IMMUNOL, V128, P221, DOI 10.1046/j.1365-2249.2002.01828.x; Bahrami S, 1997, AM J PHYSIOL-HEART C, V272, pH2219, DOI 10.1152/ajpheart.1997.272.5.H2219; BEESON PB, 1946, P SOC EXP BIOL MED, V61, P248; BOND RF, 1985, FED PROC, V44, P281; Cabrales P, 2009, RESUSCITATION, V80, P707, DOI 10.1016/j.resuscitation.2009.03.001; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chang RM, 2014, INFLAMM RES, V63, P675, DOI 10.1007/s00011-014-0740-6; Collino M, 2005, KIDNEY INT, V68, P529, DOI 10.1111/j.1523-1755.2005.00430.x; Gong G, 2014, J MOL NEUROSCI, V54, P20, DOI 10.1007/s12031-014-0240-8; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Jiang H, 2012, ACTA PHARMACOL SIN, V33, P635, DOI 10.1038/aps.2012.5; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kan WH, 2008, J APPL PHYSIOL, V105, P1076, DOI 10.1152/japplphysiol.90495.2008; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kawano T, 2007, J CEREBR BLOOD F MET, V27, P1453, DOI 10.1038/sj.jcbfm.9600449; Kumral A, 2012, BRAIN RES, V1489, P81, DOI 10.1016/j.brainres.2012.10.015; Lausevic Z, 2008, CAN J SURG, V51, P97; Leung CH, 2014, ANN SURG IN PRESS; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032346; McDonald MC, 2002, J PHYSIOL PHARMACOL, V53, P555; Md S, 2005, J SURG RES, V123, P206, DOI 10.1016/j.jss.2004.07.243; Md S, 2003, LIFE SCI, V73, P1825, DOI 10.1016/S0024-3205(03)00510-1; Merry HE, 2010, J HEART LUNG TRANSPL, V29, P471, DOI 10.1016/j.healun.2009.11.005; Millar CGM, 1997, BRIT J PHARMACOL, V121, P1824, DOI 10.1038/sj.bjp.0701335; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; Park JH, 2014, CELL SIGNAL, V26, P849, DOI 10.1016/j.cellsig.2014.01.004; Pieber D, 1999, CARDIOVASC RES, V44, P166, DOI 10.1016/S0008-6363(99)00194-7; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Rao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065568; ROJAS A, 1993, BIOCHEM BIOPH RES CO, V191, P441, DOI 10.1006/bbrc.1993.1237; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Sato H, 2008, MED SCI MONITOR, V14, pBR79; Sivarajah A, 2005, J PHARMACOL EXP THER, V313, P896, DOI 10.1124/jpet.104.080598; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Wang YP, 2002, CARDIOVASC RES, V56, P33, DOI 10.1016/S0008-6363(02)00506-0; Zacharowski K, 1999, ARTERIOSCL THROM VAS, V19, P2276, DOI 10.1161/01.ATV.19.9.2276; Zager RA, 2007, KIDNEY INT, V71, P496, DOI 10.1038/sj.ki.5002092	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122096	10.1371/journal.pone.0122096	http://dx.doi.org/10.1371/journal.pone.0122096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830444	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600099
J	Sun, Y; George, J; Rocha, S				Sun, Yu; George, Jacob; Rocha, Sonia			Dose-Dependent Effects of Allopurinol on Human Foreskin Fibroblast Cells and Human Umbilical Vein Endothelial Cells under Hypoxia	PLOS ONE			English	Article							XANTHINE-OXIDASE; HIF-1-ALPHA; INHIBITION; METABOLISM	Allopurinol, an inhibitor of xanthine oxidase, has been used in clinical trials of patients with cardiovascular and chronic kidney disease. These are two pathologies with extensive links to hypoxia and activation of the transcription factor hypoxia inducible factor (HIF) family. Here we analysed the effects of allopurinol treatment in two different cellular models, and their response to hypoxia. We explored the dose-dependent effect of allopurinol on Human Foreskin Fibroblasts (HFF) and Human Umbilical Vein Endothelial Cells (HUVEC) under hypoxia and normoxia. Under normoxia and hypoxia, high dose allopurinol reduced the accumulation of HIF-1 alpha protein in HFF and HUVEC cells. Allopurinol had only marginal effects on HIF-1 alpha mRNA level in both cellular systems. Interestingly, allopurinol effects over the HIF system were independent of prolyl-hydroxylase activity. Finally, allopurinol treatment reduced angiogenesis traits in HUVEC cells in an in vitro model. Taken together these results indicate that high doses of allopurinol inhibits the HIF system and pro-angiogenic traits in cells.	[Sun, Yu; Rocha, Sonia] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland; [George, Jacob] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	George, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland.	j.george@dundee.ac.uk; s.rocha@dundee.ac.uk		George, Jacob/0000-0001-8154-8278	Anonymous Trust-Ninewells Medical School, Cancer Research UK [C99667/A12918]; Wellcome Trust [097945/B/11/Z]; Cancer Research UK [12918] Funding Source: researchfish	Anonymous Trust-Ninewells Medical School, Cancer Research UK; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was funded by a small grant from the Anonymous Trust-Ninewells Medical School, Cancer Research UK C99667/A12918, and the Wellcome Trust 097945/B/11/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abooali M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06307; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; AUGUSTIN AJ, 1994, INVEST OPHTH VIS SCI, V35, P3897; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Cantu-Medellin N, 2013, REDOX BIOL, V1, P353, DOI 10.1016/j.redox.2013.05.002; Collet G, 2014, MOL CANCER THER, V13, P165, DOI 10.1158/1535-7163.MCT-13-0637; Colpaert EE, 2000, BRIT J PHARMACOL, V130, P359, DOI 10.1038/sj.bjp.0703317; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; FEIGELSON P, 1957, J BIOL CHEM, V226, P993; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; KeuzenkampJansen CW, 1996, J PEDIAT HEMATOL ONC, V18, P145, DOI 10.1097/00043426-199605000-00009; Knight TR, 2001, TOXICOL SCI, V62, P212, DOI 10.1093/toxsci/62.2.212; LAFON SW, 1985, MOL BIOCHEM PARASIT, V14, P11, DOI 10.1016/0166-6851(85)90101-X; MADRI JA, 1986, J HISTOCHEM CYTOCHEM, V34, P85, DOI 10.1177/34.1.2416801; Melvin A, 2011, MOL BIOL CELL, V22, P4171, DOI 10.1091/mbc.E11-02-0163; MOORE EC, 1989, BIOCHEM PHARMACOL, V38, P4045; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Sen Banerjee S, 2012, TOXICOL MECH METHOD, V22, P347, DOI 10.3109/15376516.2012.673088; TRETYAKOV AV, 1995, J CLIN INVEST, V95, P738, DOI 10.1172/JCI117721; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yasinska IM, 2014, CELL MOL LIFE SCI, V71, P699, DOI 10.1007/s00018-013-1421-2; Yokomizo H, 2004, ANTICANCER RES, V24, P1131	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123649	10.1371/journal.pone.0123649	http://dx.doi.org/10.1371/journal.pone.0123649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830774	gold, Green Submitted, Green Published			2022-12-27	WOS:000352135600150
J	Alsahafi, N; Debbeche, O; Sodroski, J; Finzi, A				Alsahafi, Nirmin; Debbeche, Olfa; Sodroski, Joseph; Finzi, Andres			Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer	PLOS ONE			English	Article							GP120 INNER DOMAIN; INTERMOLECULAR DISULFIDE BOND; TYPE-1 GP41; DEPENDENT EPITOPE; ATOMIC-STRUCTURE; STRUCTURAL BASIS; CD4-BOUND STATE; RECEPTOR; FUSION; NEUTRALIZATION	The mature human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimer is produced by proteolytic cleavage of a precursor and consists of three gp120 exterior and three gp41 transmembrane subunits. The metastable Env complex is induced to undergo conformational changes required for virus entry by the binding of gp120 to the receptors, CD4 and CCR5/CXCR4. An isoleucine-to-proline change (I559P) in the gp41 ectodomain has been used to stabilize soluble forms of HIV-1 Env trimers for structural characterization and for use as immunogens. In the native membrane-anchored HIV-1(BG505) Env, the I559P change modestly decreased proteolytic maturation, increased the non-covalent association of gp120 with the Env trimer, and resulted in an Env conformation distinctly different from that of the wild-type HIV-1(BG505) Env. Compared with the wild-type Env, the I559P Env was recognized inefficiently by polyclonal sera from HIV-1-infected individuals, by several gp41-directed antibodies, by some antibodies against the CD4-binding site of gp120, and by antibodies that preferentially recognize the CD4-bound Env. Some of the gp120-associated antigenic differences between the wild-type HIV-1(BG505) Env and the I559P mutant were compensated by the SOS disulfide bond between gp120 and gp41, which has been used to stabilize cleaved soluble Env trimers. Nonetheless, regardless of the presence of the SOS changes, Envs with proline 559 were recognized less efficiently than Envs with isoleucine 559 by the VRC01 neutralizing antibody, which binds the CD4-binding site of gp120, and the PGT151 neutralizing antibody, which binds a hybrid gp120-gp41 epitope. The I559P change completely eliminated the ability of the HIV-1(BG505) Env to mediate cell-cell fusion and virus entry, and abolished the capacity of the SOS Env to support virus infection in the presence of a reducing agent. These results suggest that differences exist between the quaternary structures of functional Env spikes and I559P Envs.	[Alsahafi, Nirmin; Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Alsahafi, Nirmin; Debbeche, Olfa; Finzi, Andres] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Debbeche, Olfa; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Sodroski, Joseph] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Sodroski, Joseph] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	McGill University; Universite de Montreal; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	joseph_sodroski@dfci.harvard.edu; andres.finzi@umontreal.ca		Finzi, Andres/0000-0002-4992-5288	National Institutes of Health [AI24755, AI100645]; Canada Foundation [29866]; CIHR operating grants [119334, 134117]; FRQS Establishment of Young Scientist grant [26702]; Canada Research Chair on Retroviral Entry [950-229930]; King Abdullah scholarship for higher education from the Saudi Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024755, R37AI024755, UM1AI100645, R01AI093256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Foundation; CIHR operating grants(Canadian Institutes of Health Research (CIHR)); FRQS Establishment of Young Scientist grant; Canada Research Chair on Retroviral Entry; King Abdullah scholarship for higher education from the Saudi Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (AI24755 and AI100645) and by the late William F. McCarty-Cooper to JS and by a Canada Foundation for Innovation Program Leader grant #29866, by CIHR operating grants #119334 and #134117, by a FRQS Establishment of Young Scientist grant #26702 to AF. AF is the recipient of a Canada Research Chair on Retroviral Entry #950-229930. NA is the recipient of a King Abdullah scholarship for higher education from the Saudi Government.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Abrahamyan LG, 2003, J VIROL, V77, P5829, DOI 10.1128/JVI.77.10.5829-5836.2003; Acharya P, 2014, J VIROL, V88, P12895, DOI 10.1128/JVI.02194-14; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; [Anonymous], SCIENCE; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI 10.1089/AID.2010.0281; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doria-Rose NA, 2014, NATURE; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Haim H, 2013, CELL HOST MICROBE, V14, P547, DOI 10.1016/j.chom.2013.10.006; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Huang J, 2014, NATURE; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kassa A, 2009, J VIROL; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kesavardhana S, 2014, J VIROL, V88, P9590, DOI 10.1128/JVI.00494-14; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Korber B., 1998, HUMAN RETROVIRUSES A; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Mao Y, 2013, PROC NATL ACAD SCI U; Mao Y, 2012, NAT STRUCT MOL BIOL; Mo HM, 2004, VIROLOGY, V329, P319, DOI 10.1016/j.virol.2004.08.025; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Pancera M, 2014, NATURE; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RHO HM, 1981, VIROLOGY, V112, P355, DOI 10.1016/0042-6822(81)90642-5; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Veillette M, 2014, JOVE-J VIS EXP, DOI 10.3791/51995; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhang CWH, 2001, J BIOL CHEM, V276, P39577, DOI 10.1074/jbc.M107147200; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	93	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122111	10.1371/journal.pone.0122111	http://dx.doi.org/10.1371/journal.pone.0122111			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849367	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800099
J	Maestre-Reyna, M; Liu, WC; Jeng, WY; Lee, CC; Hsu, CA; Wen, TN; Wang, AHJ; Shyur, LF				Maestre-Reyna, Manuel; Liu, Wei-Chun; Jeng, Wen-Yih; Lee, Cheng-Chung; Hsu, Chih-An; Wen, Tuan-Nan; Wang, Andrew H. -J.; Shyur, Lie-Fen			Structural and Functional Roles of Glycosylation in Fungal Laccase from Lentinus sp.	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; FORCE-FIELD; SOFTWARE; VALIDATION; COMPONENT; ACCURACY; YEAST	Laccases are multi-copper oxidases that catalyze the oxidation of various organic and inorganic compounds by reducing O-2 to water. Here we report the crystal structure at 1.8 angstrom resolution of a native laccase (designated nLcc4) isolated from a white-rot fungus Lentinus sp. nLcc4 is composed of three cupredoxin-like domains D1-D3 each folded into a Greek key beta-barrel topology. T1 and T2/T3 copper binding sites and three N-glycosylated sites at Asn(75), Asn(238), and Asn(458) were elucidated. Initial rate kinetic analysis revealed that the k(cat), K-m, and k(cat)/K-m of nLcc4 with substrate ABTS were 3,382 s(-1), 65.0 +/- 6.5 mu M, and 52 s(-1) mu M-1, respectively; and the values with lignosulfonic acid determined using isothermal titration calorimetry were 0.234 s(-1), 56.7 +/- 3.2 mu M, and 0.004 s(-1) mu M-1, respectively. Endo H-deglycosylated nLcc4 (dLcc4), with only one GlcNAc residue remaining at each of the three N-glycosylation sites in the enzyme, exhibited similar kinetic efficiency and thermal stability to that of nLcc4. The isolated Lcc4 gene contains an open reading frame of 1563 bp with a deduced polypeptide of 521 amino acid residues including a predicted signaling peptide of 21 residues at the N-terminus. Recombinant wild-type Lcc4 and mutant enzymes N75D, N238D and N458D were expressed in Pichia pastoris cells to evaluate the effect on enzyme activity by single glycosylation site deficiency. The mutant enzymes secreted in the cultural media of P. pastoris cells were observed to maintain only 4-50% of the activity of the wildtype laccase. Molecular dynamics simulations analyses of various states of (de-) glycosylation in nLcc support the kinetic results and suggest that the local H-bond networks between the domain connecting loop D2-D3 and the glycan moieties play a crucial role in the laccase activity. This study provides new insights into the role of glycosylation in the structure and function of a Basidiomycete fungal laccase.	[Maestre-Reyna, Manuel; Hsu, Chih-An; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Liu, Wei-Chun; Lee, Cheng-Chung; Wang, Andrew H. -J.; Shyur, Lie-Fen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Jeng, Wen-Yih] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Jeng, Wen-Yih; Lee, Cheng-Chung; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Wen, Tuan-Nan] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wang, Andrew H. -J.] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Shyur, Lie-Fen] Kaohsiung Med Univ, PhD Program Translat Med, Kaohsiung, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University; Kaohsiung Medical University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; lfshyur@ccvax.sinica.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C. [NSC 102-2628-B-001-002-MY3, NSC 100-3111-Y-001-006, NSC 99-3113-B-001-001]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Ministry of Science and Technology (NSC 102-2628-B-001-002-MY3, NSC 100-3111-Y-001-006, and NSC 99-3113-B-001-001), Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berends E, 2009, TRENDS MICROBIOL, V17, P439, DOI 10.1016/j.tim.2009.07.002; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Chen SC, 2012, PROTEIN ENG DES SEL, V25, P761, DOI 10.1093/protein/gzs082; Christensen NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061985; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Fadda E, 2010, DRUG DISCOV TODAY, V15, P596, DOI 10.1016/j.drudis.2010.06.001; Ferraroni M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-60; Garg N, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-75; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hsu CA, 2012, ENVIRON SCI TECHNOL, V46, P5109, DOI 10.1021/es2047014; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kiiskinen LL, 2002, APPL MICROBIOL BIOT, V59, P198, DOI 10.1007/s00253-002-1012-x; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolasch A, 2009, APPL MICROBIOL BIOT, V82, P605, DOI 10.1007/s00253-009-1869-z; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sapay Nicolas, 2013, Methods Mol Biol, V924, P469, DOI 10.1007/978-1-62703-017-5_18; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sirim D, 2011, DATABASE; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Volkova N, 2012, ENZYME MICROB TECH, V50, P233, DOI 10.1016/j.enzmictec.2012.01.005; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	48	51	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120601	10.1371/journal.pone.0120601	http://dx.doi.org/10.1371/journal.pone.0120601			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849464	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800028
J	Shen, EY; Jiang, Y; Mao, WJ; Futai, K; Hock, H; Akbarian, S				Shen, Erica Y.; Jiang, Yan; Mao, Wenjie; Futai, Kensuke; Hock, Hanno; Akbarian, Schahram			Cognition and Mood-Related Behaviors in L3mbtl1 Null Mutant Mice	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; HISTONE METHYLATION; OPEN-FIELD; EPIGENETIC MECHANISMS; MOUSE MODEL; DEPRESSION; PROTEIN; EXPRESSION; DISORDER; STRESS	Alterations in histone lysine methylation and epigenetic regulators of gene expression could play a role in the neurobiology and treatment of patients diagnosed with mood spectrum disorder, including depression and anxiety. Mutations and altered expression of various lysine methyltransferases (KMTs) and demethylases (KDMs) have been linked to changes in motivational and emotional behaviors in preclinical model systems. However, it is not known whether regulators operating downstream of histone lysine methylation could affect mood-related behavior. Malignant Brain Tumor (MBT) domain 'chromatin reader' proteins bind to methylated histone lysine residues and associate with chromatin remodeling complexes to facilitate or repress gene expression. MBT proteins, including the founding member, L3mbtl1, maintain high levels of expression in neurons of the mature brain. Here, we exposed L3mbtl1 null mutant mice to a wide range of tests exploring cognition and mood-relevant behaviors at baseline and in the context of social isolation, as a stressor to elicit depression- related behavior in susceptible mice. L3mbtl1 loss-of-function was associated with significant decreases in depression and and anxiety in some of the behavioral paradigms. This was not associated with a more generalized neurological dysfunction because cognition and memory remained unaltered in comparison to controls. These findings warrant further investigations on the role of MBT chromatin reader proteins in the context of emotional and affective behaviors.	[Shen, Erica Y.; Jiang, Yan; Akbarian, Schahram] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA; [Mao, Wenjie; Futai, Kensuke] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; [Hock, Hanno] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Hock, Hanno] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Icahn School of Medicine at Mount Sinai; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Akbarian, S (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA.	schahram.akbarian@mssm.edu			National Institutes of Health [R01MH086509, P50MH096890]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086509, P50MH096890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants R01MH086509 and P50MH096890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Valles A, 2014, BIOL PSYCHIAT, V76, P57, DOI 10.1016/j.biopsych.2013.09.014; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Burman MA, 2014, J NEUROSCI METH, V222, P111, DOI 10.1016/j.jneumeth.2013.11.005; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chaudhury S, 2014, P NATL ACAD SCI USA, V111, P11834, DOI 10.1073/pnas.1411618111; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Chotiwat C, 2006, HORM BEHAV, V50, P489, DOI 10.1016/j.yhbeh.2006.06.007; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Cruceanu C, 2013, INT J NEUROPSYCHOPH, V16, P289, DOI 10.1017/S1461145712000363; Desai RI, 2005, PHARMACOL BIOCHEM BE, V81, P843, DOI 10.1016/j.pbb.2005.06.006; Ernst C, 2009, MOL PSYCHIATR, V14, P830, DOI 10.1038/mp.2009.35; Francis TC, 2015, BIOL PSYCHIAT, V77, P212, DOI 10.1016/j.biopsych.2014.07.021; Goto T, 2014, BEHAV BRAIN RES, V270, P339, DOI 10.1016/j.bbr.2014.05.040; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; Haghighi F, 2014, DIALOGUES CLIN NEURO, V16, P430; Heredia L, 2014, J PHARMACOL TOX MET, V69, P108, DOI 10.1016/j.vascn.2013.12.005; Hoya-Arias R, 2011, STEM CELLS DEV, V20, P1889, DOI 10.1089/scd.2010.0437; Hunter RG, 2009, P NATL ACAD SCI USA, V106, P20912, DOI 10.1073/pnas.0911143106; Ishikawa J, 2014, BEHAV BRAIN RES, V264, P197, DOI 10.1016/j.bbr.2014.02.007; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Jiang Y, 2010, J NEUROSCI, V30, P7152, DOI 10.1523/JNEUROSCI.1314-10.2010; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Kulesskaya N, 2014, PHYSIOL BEHAV, V133, P30, DOI 10.1016/j.physbeh.2014.05.006; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mahgoub M, 2013, NEUROTHERAPEUTICS, V10, P734, DOI 10.1007/s13311-013-0213-6; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Mellios N, 2014, P NATL ACAD SCI USA, V111, P9947, DOI 10.1073/pnas.1309426111; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Neumann ID, 2011, PROG NEURO-PSYCHOPH, V35, P1357, DOI 10.1016/j.pnpbp.2010.11.028; Oh G, 2015, BIOL PSYCHIAT, V77, P246, DOI 10.1016/j.biopsych.2014.06.016; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prusevich P, 2014, ACS CHEM BIOL, V9, P1284, DOI 10.1021/cb500018s; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Qin JZ, 2010, J BIOL CHEM, V285, P27767, DOI 10.1074/jbc.M110.115410; Qureshi IA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0506; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sabunciyan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034451; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Shen E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0514; Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043; TAKEUCHI H, 2014, FRONT PSYCHOL, V5, P56173, DOI DOI 10.3389/FNSYS.2014.00200; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Turecki G, 2014, NAT REV NEUROSCI, V15, P802, DOI 10.1038/nrn3839; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	60	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121252	10.1371/journal.pone.0121252	http://dx.doi.org/10.1371/journal.pone.0121252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849281	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800049
J	Li, RP; Liu, XP; Sidabras, JW; Paulson, ES; Jesmanowicz, A; Nencka, AS; Hudetz, AG; Hyde, JS				Li, Rupeng; Liu, Xiping; Sidabras, Jason W.; Paulson, Eric S.; Jesmanowicz, Andrzej; Nencka, Andrew S.; Hudetz, Anthony G.; Hyde, James S.			Restoring Susceptibility Induced MRI Signal Loss in Rat Brain at 9.4 T: A Step towards Whole Brain Functional Connectivity Imaging	PLOS ONE			English	Article							FOREPAW STIMULATION; AMYGDALOID NUCLEUS; HUMAN CONNECTOME; INSULAR CORTEX; FMRI; FEAR; PROJECTIONS; RESPONSES; MODEL; MOUSE	The aural cavity magnetic susceptibility artifact leads to significant echo planar imaging (EPI) signal dropout in rat deep brain that limits acquisition of functional connectivity fcMRI data. In this study, we provide a method that recovers much of the EPI signal in deep brain. Needle puncture introduction of a liquid-phase fluorocarbon into the middle ear allows acquisition of rat fcMRI data without signal dropout. We demonstrate that with seeds chosen from previously unavailable areas, including the amygdala and the insular cortex, we are able to acquire large scale networks, including the limbic system. This tool allows EPI-based neuroscience and pharmaceutical research in rat brain using fcMRI that was previously not feasible.	[Li, Rupeng; Sidabras, Jason W.; Jesmanowicz, Andrzej; Nencka, Andrew S.; Hyde, James S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Liu, Xiping] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Paulson, Eric S.] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA; [Hudetz, Anthony G.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Hyde, JS (corresponding author), Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA.	jshyde@mcw.edu		Sidabras, Jason/0000-0002-4537-7501	National Institutes of Health (NIH) [R01 EB000215]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000215] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grant R01 EB000215 from the National Institutes of Health, which was received by J.S.H. The National Institutes of Health (NIH) website can be accessed here: http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Brydges NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054197; Chen Y, 2013, MAGN RESON MED, V69, P1326, DOI 10.1002/mrm.24366; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; de Graaf RA, 2003, MAGNET RESON MED, V49, P409, DOI 10.1002/mrm.10404; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hettinger PC, 2011, J NEUROSCI METH, V200, P106, DOI 10.1016/j.jneumeth.2011.06.018; Hyde JS, 2014, BRAIN CONNECT, V4, P470, DOI 10.1089/brain.2014.0281; Juchem C, 2013, J MAGN RESON, V236, P95, DOI 10.1016/j.jmr.2013.08.015; Juchem C, 2010, J MAGN RESON, V204, P281, DOI 10.1016/j.jmr.2010.03.008; Komlosh ME, 2008, MAGN RESON MED, V59, P803, DOI 10.1002/mrm.21528; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lu HB, 2003, MAGNET RESON MED, V50, P1215, DOI 10.1002/mrm.10655; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mahankali S, 2000, MAGNET RESON MED, V43, P155, DOI 10.1002/(SICI)1522-2594(200001)43:1<155::AID-MRM20>3.0.CO;2-5; Malinverno G, 1996, FOOD CHEM TOXICOL, V34, P639, DOI 10.1016/0278-6915(96)00023-3; Mandeville JB, 2004, MAGNET RESON MED, V52, P1272, DOI 10.1002/mrm.20278; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Marota JJA, 2000, NEUROIMAGE, V11, P13, DOI 10.1006/nimg.1999.0520; Matsuura S, 2002, J UROLOGY, V168, P2035, DOI 10.1016/S0022-5347(05)64290-5; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Moussa MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044428; Niuwenhuys R, HUMAN CENTRAL NERVOU; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Peyron C, 1998, NEUROSCIENCE, V82, P443; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; RUBENS AB, 1985, NEUROLOGY, V35, P1019, DOI 10.1212/WNL.35.7.1019; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Sugar Jorgen, 2011, Front Neuroinform, V5, P7, DOI 10.3389/fninf.2011.00007; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Van Essen DC, 2012, NEUROIMAGE, V62, P1299, DOI 10.1016/j.neuroimage.2012.01.032; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	52	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0119450	10.1371/journal.pone.0119450	http://dx.doi.org/10.1371/journal.pone.0119450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844644	Green Submitted, gold, Green Published			2022-12-27	WOS:000352475700001
J	Calderon, FJ; Benjamin, J; Vigil, MF				Calderon, Francisco J.; Benjamin, Joseph; Vigil, Merle F.			A Comparison of Corn (Zea mays L.) Residue and Its Biochar on Soil C and Plant Growth	PLOS ONE			English	Article							MIDINFRARED SPECTROSCOPY; ORGANIC-MATTER; GAS EMISSIONS; DAIRY MANURE; CARBON; SEQUESTRATION; AVAILABILITY; PYROLYSIS; AMENDMENT; CELLULOSE	In order to properly determine the value of charring crop residues, the C use efficiency and effects on crop performance of biochar needs to be compared to the un-charred crop residues. In this study we compared the addition of corn stalks to soil, with equivalent additions of charred (300 degrees C and 500 degrees C) corn residues. Two experiments were conducted: a long term laboratory mineralization, and a growth chamber trial with proso millet plants. In the laboratory, we measured soil mineral N dynamics, C use efficiency, and soil organic matter (SOM) chemical changes via infrared spectroscopy. The 300 degrees C biochar decreased plant biomass relative to a nothing added control. The 500 degrees C biochar had little to no effect on plant biomass. With incubation we measured lower soil NO3 content in the corn stalk treatment than in the biochar-amended soils, suggesting that the millet growth reduction in the stalk treatment was mainly driven by N limitation, whereas other factors contributed to the biomass yield reductions in the biochar treatments. Corn stalks had a C sequestration use efficiency of up to 0.26, but charring enhanced C sequestration to values that ranged from 0.64 to 1.0. Infrared spectroscopy of the soils as they mineralized showed that absorbance at 3400, 2925-2850, 1737 cm(-1), and 1656 cm(-1) decreased during the incubation and can be regarded as labile SOM, corn residue, or biochar bands. Absorbances near 1600, 15001420, and 1345 cm(-1) represented the more refractory SOM moieties. Our results show that adding crop residue biochar to soil is a sound C sequestration technology compared to letting the crop residues decompose in the field. This is because the resistance to decomposition of the chars after soil amendment offsets any C losses during charring of the crop residues.	[Calderon, Francisco J.; Benjamin, Joseph; Vigil, Merle F.] USDA ARS, Cent Great Plains Res Stn, Akron, CO 80720 USA	United States Department of Agriculture (USDA)	Calderon, FJ (corresponding author), USDA ARS, Cent Great Plains Res Stn, 40335 Co Rd GG, Akron, CO 80720 USA.	francisco.calderon@ars.usda.gov						Almendros G, 2003, ORG GEOCHEM, V34, P1559, DOI 10.1016/S0146-6380(03)00152-9; Basso Andres S., 2013, GCB Bioenergy, V5, P132, DOI 10.1111/gcbb.12026; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; Calderon FJ, 2006, J ANAL APPL PYROL, V76, P14, DOI 10.1016/j.jaap.2005.06.009; Calderon F, 2013, SOIL SCI SOC AM J, V77, P1591, DOI 10.2136/sssaj2013.04.0131; Calderon FJ, 2011, SOIL SCI SOC AM J, V75, P568, DOI 10.2136/sssaj2009.0375; Chan KY, 2007, AUST J SOIL RES, V45, P629, DOI 10.1071/SR07109; Chan KY, BIOCHAR NUTR PROPERT, P67; Gaskin JW, 2010, AGRON J, V102, P623, DOI 10.2134/agronj2009.0083; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Laird DA, 2008, AGRON J, V100, P178, DOI 10.2134/agronj2007.0161; Lehmann J, 2010, ROLE BIOCHAR MITIGAT; Lentz RD, 2012, J ENVIRON QUAL, V41, P1033, DOI 10.2134/jeq2011.0126; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Malhi SS, 2001, SOIL TILL RES, V60, P101, DOI 10.1016/S0167-1987(01)00176-3; Mukome FND, 2013, J AGR FOOD CHEM, V61, P2196, DOI 10.1021/jf3049142; Parikh SJ, 2014, ADV AGRON, V126, P1, DOI 10.1016/B978-0-12-800132-5.00001-8; Peng X, 2011, SOIL TILL RES, V112, P159, DOI 10.1016/j.still.2011.01.002; Prendergast-Miller MT, 2011, SOIL BIOL BIOCHEM, V43, P2243, DOI 10.1016/j.soilbio.2011.07.019; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; Recous S, 1995, SOIL BIOL BIOCHEM, V27, P1529, DOI 10.1016/0038-0717(95)00096-W; Reeves JB, 2008, APPL SPECTROSC, V62, P182, DOI 10.1366/000370208783575618; Reeves JB, 2012, APPL SPECTROSC, V66, P689, DOI 10.1366/11-06478; Rutherford DW, 2012, BIOMASS BIOENERG, V46, P693, DOI 10.1016/j.biombioe.2012.06.026; Stewart CE, 2013, GCB BIOENERGY, V5, P153, DOI 10.1111/gcbb.12001; Swift RS, 2001, SOIL SCI, V166, P858, DOI 10.1097/00010694-200111000-00010; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Wang T, 2012, ORG GEOCHEM, V51, P45, DOI 10.1016/j.orggeochem.2012.07.009; Wang ZL, 2014, BIOL FERT SOILS, V50, P1109, DOI 10.1007/s00374-014-0933-8; Wu FP, 2013, BIOL FERT SOILS, V49, P555, DOI 10.1007/s00374-012-0745-7; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Zheng H, 2013, GEODERMA, V206, P32, DOI 10.1016/j.geoderma.2013.04.018; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	33	29	29	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121006	10.1371/journal.pone.0121006	http://dx.doi.org/10.1371/journal.pone.0121006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836653	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000037
J	Franco, PG; Pasquini, JM; Silvestroff, L				Franco, Paula G.; Pasquini, Juana M.; Silvestroff, Lucas			Optimizing Culture Medium Composition to Improve Oligodendrocyte Progenitor Cell Yields In Vitro from Subventricular Zone-Derived Neural Progenitor Cell Neurospheres	PLOS ONE			English	Article							WHITE-MATTER; STEM-CELLS; GLIAL PROGENITORS; ADULT-RAT; PDGF-AA; PRECURSOR; GENERATION; EXPRESSION; RECEPTOR; LINEAGE	Neural Stem and Progenitor Cells (NSC/NPC) are gathering tangible recognition for their uses in cell therapy and cell replacement therapies for human disease, as well as a model system to continue research on overall neural developmental processes in vitro. The Subventricular Zone is one of the largest NSC/NPC niches in the developing mammalian Central Nervous System, and persists through to adulthood. Oligodendrocyte progenitor cell (OPC) enriched cultures are usefull tools for in vitro studies as well as for cell replacement therapies for treating demyelination diseases. We used Subventricular Zone-derived NSC/NPC primary cultures from newborn mice and compared the effects of different growth factor combinations on cell proliferation and OPC yield. The Platelet Derived Growth Factor-AA and BB homodimers had a positive and significant impact on OPC generation. Furthermore, heparin addition to the culture media contributed to further increase overall culture yields. The OPC generated by this protocol were able to mature into Myelin Basic Protein-expressing cells and to interact with neurons in an in vitro co-culture system. As a whole, we describe an optimized in vitro method for increasing OPC.	[Silvestroff, Lucas] Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquim, RA-1053 Buenos Aires, DF, Argentina; Ciudad Autonoma Buenos Aires, UBA CONICET, Inst Quim & Fisicoquim Biol Profesor Alejandro C, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Silvestroff, L (corresponding author), Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquim, RA-1053 Buenos Aires, DF, Argentina.	lsilver81@yhoo.com.ar		Franco, Paula/0000-0002-0551-791X	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 1767, PIP 0711]; Agencia Nacionasl de Promocion Cientifica y Tecnologica [Prestamo BID PICT 2011-2040, Prestamo BID PICT 2008-0791]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacionasl de Promocion Cientifica y Tecnologica	This work was supported by PIP 1767-Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/) (PGF); PIP 0711-Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/) (PGF); Prestamo BID PICT 2011-2040-Agencia Nacionasl de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) (PGF); and Prestamo BID PICT 2008-0791)-Agencia Nacionasl de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) (JMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Azim K, 2012, GLIA, V60, P1977, DOI 10.1002/glia.22413; Ball SG, 2012, STEM CELLS, V30, P548, DOI 10.1002/stem.1015; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Belachew S, 2001, DEV NEUROSCI-BASEL, V23, P287, DOI 10.1159/000048712; Bilican B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002863; Broughton SK, 2007, J NEUROCHEM, V100, P628, DOI 10.1111/j.1471-4159.2006.04171.x; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chen PH, 2013, BBA-PROTEINS PROTEOM, V1834, P2176, DOI 10.1016/j.bbapap.2012.10.015; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Chojnacki A, 2004, J NEUROSCI, V24, P10888, DOI 10.1523/JNEUROSCI.3302-04.2004; Cohen RI, 1999, J EXP BIOL, V202, P461; Colello R J, 2001, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0312s03; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Erlandsson A, 2006, CANCER RES, V66, P8042, DOI 10.1158/0008-5472.CAN-06-0900; Furusho M, 2011, J NEUROSCI, V31, P5055, DOI 10.1523/JNEUROSCI.4800-10.2011; Gallagher S, 2000, CURR PROTOC CELL BIO; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; Gardner A, 2012, NAT PROTOC, V7, P1774, DOI 10.1038/nprot.2012.100; Gil-Perotin S, 2013, ANAT REC, V296, P1435, DOI 10.1002/ar.22746; Grade S, 2013, INT J DEV NEUROSCI, V31, P692, DOI 10.1016/j.ijdevneu.2013.01.004; GRINSPAN JB, 1990, ANN NY ACAD SCI, V605, P71, DOI 10.1111/j.1749-6632.1990.tb42382.x; He YT, 2009, NEUROSCI RES, V65, P272, DOI 10.1016/j.neures.2009.07.011; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu JG, 2004, J NEUROSCI RES, V78, P637, DOI 10.1002/jnr.20317; Hu JG, 2012, INT J MOL MED, V30, P1113, DOI 10.3892/ijmm.2012.1110; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; KELLY JD, 1991, J BIOL CHEM, V266, P8987; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kulbatski I, 2007, J HISTOCHEM CYTOCHEM, V55, P209, DOI 10.1369/jhc.6A7020.2006; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Masae N, 2006, DEV BIOL, V297, P262, DOI 10.1016/j.ydbio.2006.05.017; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Mirzadeh Z, 2010, J VIS EXP, P39; Moore L, 2014, ASN NEURO, V6, DOI [10.1042/AN20140004, DOI 10.1042/AN20140004]; Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207; Nakatsuji Y, 2001, J NEUROSCI RES, V66, P487, DOI 10.1002/jnr.1240; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Niu JQ, 2012, J NEUROSCI METH, V209, P241, DOI 10.1016/j.jneumeth.2012.05.032; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Silvestroff L, 2013, ASN NEURO, V5, P43, DOI 10.1042/AN20120075; Silvestroff L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033937; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Wang J, 2013, STEM CELLS DEV, V22, P2121, DOI 10.1089/scd.2013.0003; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Xu SY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/803930; Yang ZS, 2005, J NEUROSCI METH, V149, P50, DOI 10.1016/j.jneumeth.2005.05.003; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhang SC, 1998, J NEUROCYTOL, V27, P475, DOI 10.1023/A:1006953023845; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	72	8	9	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121774	10.1371/journal.pone.0121774	http://dx.doi.org/10.1371/journal.pone.0121774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837625	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000063
J	Fristedt, R; Martins, NF; Strenkert, D; Clarke, CA; Suchoszek, M; Thiele, W; Schottler, MA; Merchant, SS				Fristedt, Rikard; Martins, Nadia Figueira; Strenkert, Daniela; Clarke, Cornelia A.; Suchoszek, Monika; Thiele, Wolfram; Schoettler, Mark Aurel; Merchant, Sabeeha S.			The Thylakoid Membrane Protein CGL160 Supports CF1CF0 ATP Synthase Accumulation in Arabidopsis thaliana	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; COUPLING FACTOR; PHOTOSYSTEM-I; NUCLEAR GENE; BETA-SUBUNIT; COMPLEX; MITOCHONDRIAL; PLASTOCYANIN; PHOSPHORYLATION; IDENTIFICATION	The biogenesis of the major thylakoid protein complexes of the photosynthetic apparatus requires auxiliary proteins supporting individual assembly steps. Here, we identify a plant lineage specific gene, CGL160, whose homolog, atp1, co-occurs with ATP synthase subunits in an operon-like arrangement in many cyanobacteria. Arabidopsis thaliana T-DNA insertion mutants, which no longer accumulate the nucleus-encoded CGL160 protein, accumulate less than 25% of wild-type levels of the chloroplast ATP synthase. Severe cosmetic or growth phenotypes result under either short day or fluctuating light growth conditions, respectively, but this is ameliorated under long day constant light growth conditions where the growth, ATP synthase activity and photosynthetic electron transport of the mutants are less affected. Accumulation of other photosynthetic complexes is largely unaffected in cgl160 mutants, suggesting that CGL160 is a specific assembly or stability factor for the CF1CF0 complex. CGL160 is not found in the mature assembled complex but it does interact specifically with subunits of ATP synthase, predominantly those in the extrinsic CF1 sub-complex. We suggest therefore that it may facilitate the assembly of CF1 into the holocomplex.	[Fristedt, Rikard; Strenkert, Daniela; Clarke, Cornelia A.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Martins, Nadia Figueira; Suchoszek, Monika; Thiele, Wolfram; Schoettler, Mark Aurel] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; Max Planck Society; University of California System; University of California Los Angeles	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	merchant@chem.ucla.edu		Schottler, Mark Aurel/0000-0003-3210-0260; Strenkert, Daniela/0000-0002-3420-1332	U.S. Department of Energy [DE-FC02-02ER63421]; WennerGren Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); WennerGren Foundation	This work was supported by grants from the U.S. Department of Energy (Cooperative Agreement DE-FC02-02ER63421 to David Eisenberg at UCLA), and by a postdoctoral fellowship from the WennerGren Foundation (to R.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; ANDERSON JM, 1992, PHOTOSYNTH RES, V34, P341, DOI 10.1007/BF00029810; Armbruster U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6439; Avenson TJ, 2005, PLANT CELL ENVIRON, V28, P97, DOI 10.1111/j.1365-3040.2005.01294.x; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Benz M, 2009, MOL PLANT, V2, P1410, DOI 10.1093/mp/ssp095; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cramer WA, 2006, BBA-BIOENERGETICS, V1757, P339, DOI 10.1016/j.bbabio.2006.04.020; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; del Riego G, 2006, PHOTOSYNTH RES, V89, P11, DOI 10.1007/s11120-006-9078-4; Fristedt R, 2009, BIOCHEMISTRY-US, V48, P499, DOI 10.1021/bi8016334; Fristedt R, 2014, J BIOL CHEM, V289, P30657, DOI 10.1074/jbc.M114.587758; Fristedt R, 2014, PLANT PHYSIOL, V164, P201, DOI 10.1104/pp.113.228338; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Hansson M, 2007, J BIOL CHEM, V282, P16214, DOI 10.1074/jbc.M605833200; Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; LEONG TY, 1984, PHOTOSYNTH RES, V5, P117, DOI 10.1007/BF00028525; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyska D, 2013, PLANTA, V237, P413, DOI 10.1007/s00425-012-1752-5; MERCHANT S, 1983, EUR J BIOCHEM, V137, P373, DOI 10.1111/j.1432-1033.1983.tb07838.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MILLER KR, 1976, J CELL BIOL, V68, P30, DOI 10.1083/jcb.68.1.30; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Paul MF, 2000, J BIOL CHEM, V275, P29238, DOI 10.1074/jbc.M004546200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; RODERMEL SR, 1988, CELL, V55, P673, DOI 10.1016/0092-8674(88)90226-7; Rott M, 2011, PLANT CELL, V23, P304, DOI 10.1105/tpc.110.079111; Ruhle T, 2014, PLANT PHYSIOL, V165, P207, DOI 10.1104/pp.114.237883; Schottler MA, 2007, BIOCHEM J, V403, P251, DOI 10.1042/BJ20061573; Schottler MA, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00188, 10.3389/fpsyg.2014.00808]; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Schottler MA, 2004, PLANT PHYSIOL, V136, P4265, DOI 10.1104/pp.104.052324; Schottler MA, 2014, J EXP BOT; SELMANREIMER S, 1981, BIOCHEMISTRY-US, V20, P5476, DOI 10.1021/bi00522a020; SHARKEY TD, 1989, PLANT PHYSIOL, V91, P679, DOI 10.1104/pp.91.2.679; Shih PM, P NATL ACAD SCI US; Suzuki T, P NATL ACAD SCI US; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yamori W, 2011, PLANT PHYSIOL, V155, P956, DOI 10.1104/pp.110.168435; Zeng XM, 2008, MOL BIOL CELL, V19, P1366, DOI 10.1091/mbc.E07-08-0746	62	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121658	10.1371/journal.pone.0121658	http://dx.doi.org/10.1371/journal.pone.0121658			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835989	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000055
J	Houwink, EJF; Muijtjens, AMM; van Teeffelen, SR; Henneman, L; Rethans, JJ; Jacobi, F; van der Jagt, L; Stirbu, I; van Luijk, SJ; Stumpel, CTRM; Meijers-Heijboer, HE; van der Vleuten, C; Cornel, MC; Dinant, GJ				Houwink, Elisa J. F.; Muijtjens, Arno M. M.; van Teeffelen, Sarah R.; Henneman, Lidewij; Rethans, Jan Joost; Jacobi, Florijn; van der Jagt, Liesbeth; Stirbu, Irina; van Luijk, Scheltus J.; Stumpel, Connie T. R. M.; Meijers-Heijboer, Hanne E.; van der Vleuten, Cees; Cornel, Martina C.; Dinant, Geert Jan			Effect of Comprehensive Oncogenetics Training Interventions for General Practitioners, Evaluated at Multiple Performance Levels	PLOS ONE			English	Article							CONTINUING MEDICAL-EDUCATION; RANDOMIZED CONTROLLED-TRIAL; GENETICS EDUCATION; GENOMIC MEDICINE; PRIMARY-CARE; HEALTH-CARE; PROFESSIONALS; GPS	General practitioners (GPs) are increasingly called upon to identify patients at risk for hereditary cancers, and their genetic competencies need to be enhanced. This article gives an overview of a research project on how to build effective educational modules on genetics, assessed by randomized controlled trials (RCTs), reflecting the prioritized educational needs of primary care physicians. It also reports on an ongoing study to investigate long-term increase in genetic consultation skills (1-year follow-up) and interest in and satisfaction with a supportive website on genetics among GPs. Three oncogenetics modules were developed: an online Continuing Professional Development (G-eCPD) module, a live genetic CPD module, and a "GP and genetics" website (huisartsengenetica.nl) providing further genetics information applicable in daily practice. Three assessments to evaluate the effectiveness (1-year follow-up) of the oncogenetic modules were designed: 1.An online questionnaire on self-reported genetic competencies and changes in referral behaviour, 2. Referral rates from GPs to clinical genetics centres and 3. Satisfaction questionnaire and visitor count analytics of supportive genetics website. The setting was Primary care in the Netherlands and three groups of study participants were included in the reported studies:. Assessment 1.168 GPs responded to an email invitation and were randomly assigned to an intervention or control group, evaluating the G-eCPD module (n = 80) or the live module (n = 88). Assessment 2. Referral rates by GPs were requested from the clinical genetics centres, in the northern and southern parts of the Netherlands (Amsterdam and Maastricht), for the two years before (2010 [n = 2510] and 2011 [n = 2940]) and the year after (2012 [n = 2875]) launch of the oncogenetics CPD modules and the website. Assessment 3. Participants of the website evaluation were all recruited online. When they visited the website during the month of February 2013, a pop-up invitation came up. Of the 1350 unique visitors that month, only 38 completed the online questionnaire. Main outcomes measure showed long-term (self-reported) genetic consultation skills (i.e. increased genetics awareness and referrals to clinical genetics centres) among GPs who participated in the oncogenetic training course, and interest in and satisfaction with the supportive website. 42 GPs (52%) who previously participated in the G-eCPD evaluation study and 50 GPs (57%) who participated in the live training programme responded to the online questionnaire on long-term effects of educational outcome. Previous RCTs showed that the genetics CPD modules achieved sustained improvement of oncogenetic knowledge and consultation skills (3-months follow-up). Participants of these RCTs reported being more aware of genetic problems long term; this was reported by 29 GPs (69%) and 46 GPs (92%) participating in the G-eCPD and live module evaluation studies, respectively (Chisquare test, p<0.005). One year later, 68% of the respondents attending the live training reported that they more frequently referred patients to the clinical genetics centres, compared to 29% of those who attended the online oncogenetics training (Chisquare test, p<0.0005). However, the clinical genetics centres reported no significant change in referral numbers one year after the training. Website visitor numbers increased, as did satisfaction, reflected in a 7.7 and 8.1 (out of 10) global rating of the website (by G-eCPD and live module participants, respectively). The page most often consulted was "family tree drawing". Self-perceived genetic consultation skills increased long-term and GPs were interested in and satisfied with the supportive website. Further studies are necessary to see whether the oncogenetics CPD modules result in more efficient referral. The results presented suggest we have provided a flexible and effective framework to meet the need for effective educational programmes for non-geneticist healthcare providers, enabling improvement of genetic medical care.	[Houwink, Elisa J. F.; van Teeffelen, Sarah R.; Henneman, Lidewij; Cornel, Martina C.] Vrije Univ Amsterdam, Dept Clin Genet, Sect Community Genet, EMGO Inst Hlth & Care Res,Med Ctr, Amsterdam, Netherlands; [Houwink, Elisa J. F.; Dinant, Geert Jan] Maastricht Univ, Dept Family Med, Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands; [Muijtjens, Arno M. M.; van der Vleuten, Cees] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Educ Dev & Res, NL-6200 MD Maastricht, Netherlands; [Rethans, Jan Joost] Maastricht Univ, Fac Hlth Med & Life Sci, Skillslab, NL-6200 MD Maastricht, Netherlands; [Jacobi, Florijn; van der Jagt, Liesbeth] Dutch Coll Gen Practitioners NHG, Utrecht, Netherlands; [Stirbu, Irina] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Luijk, Scheltus J.] Maastricht Univ, Med Ctr, Dept Resident Training, NL-6200 MD Maastricht, Netherlands; [Stumpel, Connie T. R. M.] Maastricht UMC, Dept Clin Genet, Sch Oncol & Dev Biol, Maastricht, Netherlands; [Meijers-Heijboer, Hanne E.] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Maastricht University; Netherlands National Institute for Public Health & the Environment; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam	Houwink, EJF (corresponding author), Vrije Univ Amsterdam, Dept Clin Genet, Sect Community Genet, EMGO Inst Hlth & Care Res,Med Ctr, Amsterdam, Netherlands.	e.houwink@vumc.nl	Cornel, Martina/AAE-8955-2020	van der Vleuten, Cees/0000-0001-6802-3119; Cornel, Martina/0000-0002-5397-5544; Houwink, Isa/0000-0002-9927-7266; Henneman, Lidewij/0000-0003-3531-0597	Centre for Society and the Life Sciences in The Netherlands - Netherlands Genomics Initiative	Centre for Society and the Life Sciences in The Netherlands - Netherlands Genomics Initiative	This article is the result of a research project of the Centre for Society and the Life Sciences in The Netherlands, funded by the Netherlands Genomics Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalfs CM, 2003, FAM PRACT, V20, P135, DOI 10.1093/fampra/20.2.135; Akbari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471.pub2; Baars MJH, 2005, GENET MED, V7, P295, DOI 10.1097/01.GIM.0000162877.87333.9A; Creavin ST, 2011, FAM PRACT, V28, P461, DOI 10.1093/fampra/cmr001; Davis N, 2008, MED TEACH, V30, P652, DOI 10.1080/01421590802108323; Fernandez N, 2012, MED EDUC, V46, P357, DOI 10.1111/j.1365-2923.2011.04183.x; Gaff CL, 2007, GENET MED, V9, P451, DOI 10.1097/GIM.0b013e3180a6eb69; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Guttmacher Alan, 2010, Am J Med Genet A, V152A, pvii, DOI 10.1002/ajmg.a.33722; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Hocking JS, 2006, J CLIN EPIDEMIOL, V59, P521, DOI 10.1016/j.jclinepi.2005.10.009; Houwink EJF, 2014, EUR J HUM GENET, V22, P310, DOI 10.1038/ejhg.2013.163; Houwink EJF, 2014, GENET MED, V16, P45, DOI 10.1038/gim.2013.69; Houwink EJF, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-5; Houwink EJF, 2012, GENET MED, V14, P323, DOI 10.1038/gim.2011.15; Houwink EJF, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-5; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Kirkpatrick D., 1967, EVALUATION TRAINING; Lewis C, 2011, J GENET COUNS, V20, P80, DOI 10.1007/s10897-010-9327-8; Mansouri M, 2007, J CONTIN EDUC HEALTH, V27, P6, DOI 10.1002/chp.88; Moore D., 2008, CONTINUING ED HLTH P; Sargeant J, 2011, J CONTIN EDUC HEALTH, V31, P167, DOI 10.1002/chp.20123; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320	23	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122648	10.1371/journal.pone.0122648	http://dx.doi.org/10.1371/journal.pone.0122648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837634	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000104
J	Janjua, NZ; Mahmood, B; Bhatti, JA; Khan, MI				Janjua, Naveed Zafar; Mahmood, Bushra; Bhatti, Junaid A.; Khan, M. Imran			Association of Household and Community Socioeconomic Position and Urbanicity with Underweight and Overweight among Women in Pakistan	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CHILD UNDERNUTRITION; GLOBAL BURDEN; RISK-FACTORS; OBESITY; POPULATION; NUTRITION; OVERNUTRITION; COUNTRIES; URBANIZATION	Background Similar to other developing countries, Pakistan is going through a rapid nutrition transition where shift from underweight to overweight and obesity is occurring. In this paper, we report on the relationship of household socioeconomic position (SEP), community SEP and urbanicity with under- and over-weight categories of BMI among Pakistani women. Methods We analyzed data on 4,767 women ages 15-49 years enrolled in a nationally representative Pakistan Demographic Health Survey (PDHS) conducted in 2012-13 that employed a multistage, stratified cluster sampling design. We assessed the association of urbanicity, household and community SEP derived from household assets and utilities, with categories of body mass index (BMI) using multinomial regression analysis where normal weight (BMI 18.6-22.5) was the reference category. Results Thirteen percent of women were underweight (BMI <18.5), 15% pre-overweight (BMI: 22.6-24.9), 25% overweight (BMI: 25.0-29.9) and 14% were obese (BMI >= 30). Pre-overweight, overweight and obesity among women increased across household wealth quintiles (HWQs) in a graded fashion whereas there was no significant difference in underweight by household wealth. Women in urban areas were more likely to be obese. There was a pronounced increase in adjusted odds ratios (aORs) for overweight/obesity across HWQs within urban areas compared to rural areas. There was a steeper gradient in aORs for obesity from 1st to 5th HWQs in high income communities compared to the middle-and low income communities. In community-level analyses, communities in urban areas were more likely to have higher levels of obesity while in rural areas, especially in Sindh, more communities were more likely to have a higher level of underweight. Conclusion A shift to higher overweight and obesity than underweight in Pakistan is associated with high household and community wealth as well as living in urban areas. Clustering of obesity and underweight in distinct communities afford opportunity for tailored intervention programs.	[Janjua, Naveed Zafar] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Janjua, Naveed Zafar; Mahmood, Bushra] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Bhatti, Junaid A.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Bhatti, Junaid A.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Bhatti, Junaid A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Khan, M. Imran] Sabin Vaccine Inst, Washington, DC USA	University of British Columbia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Janjua, NZ (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.	Naveed.Janjua@bccdc.ca	Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X				Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4; Aloia CR, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-4; [Anonymous], 2005, PAK COUNTR GEND ASS; [Anonymous], 2009, BANGL DEM HLTH SURV, P1; [Anonymous], 2011, NUTR NAT DEV PAK INT; [Anonymous], 2007, NAT FAM HLTH SURV NF, P1; [Anonymous], 2013, BANGL DEM HLTH SURV, P1; [Anonymous], 2013, PAK DEM HLTH SURV 20, P1; Arambepola C, 2008, TROP MED INT HEALTH, V13, P448, DOI 10.1111/j.1365-3156.2008.02021.x; Ayesha Khan, 1999, Reproductive Health Matters, V7, P39; Balarajan Y, 2009, J NUTR, V139, P2139, DOI 10.3945/jn.109.112029; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Corsi DJ, 2011, J NUTR, V141, P631, DOI 10.3945/jn.110.131599; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; DURKIN MS, 1994, SOC SCI MED, V38, P1289, DOI 10.1016/0277-9536(94)90192-9; Feeney G, 2003, POPUL DEV REV, V29, P483, DOI 10.1111/j.1728-4457.2003.00483.x; Fernald LCH, 2008, J NUTR, V138, P2250, DOI 10.3945/jn.108.090506; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hilmers A, 2012, AM J PUBLIC HEALTH, V102, P1644, DOI 10.2105/AJPH.2012.300865; Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267; Jalil HH, 2010, PAKISTAN DEV REV, V49; Janjua NZ, 2011, AM J EPIDEMIOL, V173, pS116; Janjua NZ, 2011, ANN EPIDEMIOL, V21, P884, DOI 10.1016/j.annepidem.2011.08.006; Khan A, 2014, PAKISTAN EC SURVEY 2, P145; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mumtaz Z, 2005, SOC SCI MED, V60, P1751, DOI 10.1016/j.socscimed.2004.08.019; Naseer M, 2013, J PHYS ACT HEALTH, V10, P1039, DOI 10.1123/jpah.10.7.1039; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Pappas G, 2001, AM J PUBLIC HEALTH, V91, P93, DOI 10.2105/AJPH.91.1.93; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Raza Q, 2013, OBESITY FACTS, V6, P523, DOI 10.1159/000357176; Samir Nafisa, 2011, BMC Res Notes, V4, P174, DOI 10.1186/1756-0500-4-174; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Shera AS, 2010, PRIM CARE DIABETES, V4, P79, DOI 10.1016/j.pcd.2010.01.003; Song YM, 2006, INT J EPIDEMIOL, V35, P112, DOI 10.1093/ije/dyi227; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Thang NM, 2004, EUR J CLIN NUTR, V58, P145, DOI 10.1038/sj.ejcn.1601761; Uauy R, 2002, PUBLIC HEALTH NUTR, V5, P223, DOI 10.1079/PHN2001297; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Zahid N, 2011, J OBES, V2011, DOI 10.1155/2011/163749; Zhai FY, 2007, ASIA PAC J CLIN NUTR, V16, P374	52	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122314	10.1371/journal.pone.0122314	http://dx.doi.org/10.1371/journal.pone.0122314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835540	gold, Green Submitted, Green Published			2022-12-27	WOS:000352139000093
J	Mestres, G; Espanol, M; Xia, W; Persson, C; Ginebra, MP; Ott, MK				Mestres, Gemma; Espanol, Montserrat; Xia, Wei; Persson, Cecilia; Ginebra, Maria-Pau; Ott, Marjam Karlsson			Inflammatory Response to Nano- and Microstructured Hydroxyapatite	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENT; IN-VITRO; CELL RESPONSE; TRICALCIUM PHOSPHATE; PARTICLE-SIZE; BONE-MARROW; MACROPHAGES; BIOMATERIALS; TOPOGRAPHY; ACTIVATION	The proliferation and activation of leukocytes upon contact with a biomaterial play a crucial role in the degree of inflammatory response, which may then determine the clinical failure or success of an implanted biomaterial. The aim of this study was to evaluate whether nano-and microstructured biomimetic hydroxyapatite substrates can influence the growth and activation of macrophage-like cells. Hydroxyapatite substrates with different crystal morphologies consisting of an entangled network of plate-like and needle-like crystals were evaluated. Macrophage proliferation was evaluated on the material surface (direct contact) and also in extracts i.e. media modified by the material (indirect contact). Additionally, the effect of supplementing the extracts with calcium ions and/or proteins was investigated. Macrophage activation on the substrates was evaluated by quantifying the release of reactive oxygen species and by morphological observations. The results showed that differences in the substrate's microstructure play a major role in the activation of macrophages as there was a higher release of reactive oxygen species after culturing the macrophages on plate-like crystals substrates compared to the almost non-existent release on needle-like substrates. However, the difference in macrophage proliferation was ascribed to different ionic exchanges and protein adsorption/retention from the substrates rather than to the texture of materials.	[Mestres, Gemma; Xia, Wei; Persson, Cecilia; Ott, Marjam Karlsson] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden; [Espanol, Montserrat; Ginebra, Maria-Pau] Tech Univ Catalonia, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn, Barcelona, Spain	Uppsala University; Universitat Politecnica de Catalunya	Ott, MK (corresponding author), Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden.	marjam.ott@angstrom.uu.se	Ginebra, Maria-Pau/J-8149-2017; Espanol, Montserrat/J-8293-2017; Persson, Cecilia/E-9326-2013; Mestres, Gemma/E-3791-2016	Ginebra, Maria-Pau/0000-0002-4700-5621; Persson, Cecilia/0000-0001-6663-6536; Mestres, Gemma/0000-0001-7462-4236	Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth [GROWTH 291795]; Lars Hiertas Minne Foundation [FO2013-0337]; STINT [IG2011-2047]; Ollie och Elof Ericssons Stifelse for Vetenskaplig Forskning; Spanish Government [MAT2012-38438-003-01]; EU through European Regional Development Funds; prize "ICREA Academia'' for excellence in research - Generalitat de Catalunya	Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth; Lars Hiertas Minne Foundation; STINT; Ollie och Elof Ericssons Stifelse for Vetenskaplig Forskning; Spanish Government(Spanish GovernmentEuropean Commission); EU through European Regional Development Funds; prize "ICREA Academia'' for excellence in research - Generalitat de Catalunya(ICREA)	This work was funded by Marie Curie Actions FP7-PEOPLE-2011-COFUND (GROWTH 291795) via the VINNOVA programme Mobility for Growth, Lars Hiertas Minne Foundation (FO2013-0337 project), STINT (IG2011-2047 project), and Ollie och Elof Ericssons Stifelse for Vetenskaplig Forskning. The authors acknowledge the Spanish Government for financial support through project MAT2012-38438-003-01, co-funded by the EU through European Regional Development Funds. Support for the research of MPG was received through the prize "ICREA Academia'' for excellence in research, funded by the Generalitat de Catalunya. Part of this work was performed at the BioMat facility/Science for Life Laboratory at Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2009, TOXICOL IN VITRO, V23, P520, DOI 10.1016/j.tiv.2009.01.005; Ambrozova G, 2010, EUR J NUTR, V49, P133, DOI 10.1007/s00394-009-0057-3; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893; Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287; Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011; Espanol M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0037-7; FARLEY JR, 1994, J BONE MINER RES, V9, P497; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049; Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003; Gustavsson J, 2012, J MATER SCI-MATER M, V23, P2509, DOI 10.1007/s10856-012-4705-4; Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366; Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9; Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Lim JY, 2005, J R SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021; Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260; Muller KH, 2014, BIOMATERIALS, V35, P1074, DOI 10.1016/j.biomaterials.2013.10.041; Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005; Omar OM, 2011, BIOMATERIALS, V32, P8190, DOI 10.1016/j.biomaterials.2011.07.055; Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010; Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535; Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075; Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015; Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014; Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023; Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3; Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341; Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035; Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xing SM, 2002, MICROSC RES TECHNIQ, V57, P523, DOI 10.1002/jemt.10106; Yamaguchi T, 1998, J BONE MINER RES, V13, P1390, DOI 10.1359/jbmr.1998.13.9.1390	47	35	36	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120381	10.1371/journal.pone.0120381	http://dx.doi.org/10.1371/journal.pone.0120381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837264	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000020
J	Wendt, ER; Ferry, H; Greaves, DR; Keshav, S				Wendt, Emily R.; Ferry, Helen; Greaves, David R.; Keshav, Satish			Ratiometric Analysis of Fura Red by Flow Cytometry: A Technique for Monitoring Intracellular Calcium Flux in Primary Cell Subsets	PLOS ONE			English	Article							INFLAMMATORY PROTEIN 3-ALPHA; CC-CHEMOKINE RECEPTOR; HUMAN DENDRITIC CELLS; T-CELLS; EXPRESSION; RESPONSIVENESS; IMMUNITY; FLUO-3; BLOOD	Calcium flux is a rapid and sensitive measure of cell activation whose utility could be enhanced with better techniques for data extraction. We describe a technique to monitor calcium flux by flow cytometry, measuring Fura Red calcium dye by ratiometric analysis. This technique has several advantages: 1) using a single calcium dye provides an additional channel for surface marker characterization, 2) allows robust detection of calcium flux by minority cell populations within a heterogeneous population of primary T cells and monocytes 3) can measure total calcium flux and additionally, the proportion of responding cells, 4) can be applied to studying the effects of drug treatment, simultaneously stimulating and monitoring untreated and drug treated cells. Using chemokine receptor activation as an example, we highlight the utility of this assay, demonstrating that only cells expressing a specific chemokine receptor are activated by cognate chemokine ligand. Furthermore, we describe a technique for simultaneously stimulating and monitoring calcium flux in vehicle and drug treated cells, demonstrating the effects of the G alpha i inhibitor, pertussis toxin (PTX), on chemokine stimulated calcium flux. The described real time calcium flux assay provides a robust platform for characterizing cell activation within primary cells, and offers a more accurate technique for studying the effect of drug treatment on receptor activation in a heterogeneous population of primary cells.	[Wendt, Emily R.; Ferry, Helen; Keshav, Satish] Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Translat Gastroenterol Unit, Oxford, England; [Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	University of Oxford; University of Oxford	Keshav, S (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Translat Gastroenterol Unit, Oxford, England.	satish.keshav@ndm.ox.ac.uk		Greaves, David/0000-0003-2856-9410; Keshav, Satish/0000-0003-0508-8665	Oxford Biomedical Research Centre - United Kingdom National Institutes for Health Research [A93081]; ChemoCentryx, Inc., Mountain View, California, United States of America; MRC [G0200231] Funding Source: UKRI; British Heart Foundation [RG/10/15/28578] Funding Source: researchfish; Medical Research Council [G0200231] Funding Source: researchfish	Oxford Biomedical Research Centre - United Kingdom National Institutes for Health Research; ChemoCentryx, Inc., Mountain View, California, United States of America; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Oxford Biomedical Research Centre (http://oxfordbrc.nihr.ac.uk/), funded by the United Kingdom National Institutes for Health Research (grant number A93081, awarded to SK) and an unrestricted grant from ChemoCentryx, Inc., Mountain View, California, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Dustin LB, 2000, CLIN APPL IMMUNOL RE, V1, P5, DOI DOI 10.1016/S1529-1049(00)00002-7; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; June Carl H, 2004, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0505s64; Liao F, 1999, J IMMUNOL, V162, P186; Lohr C, 2003, CELL CALCIUM, V34, P295, DOI 10.1016/S0143-4160(03)00105-2; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Proudfoot A E, 2001, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1204s14; Rabin RL, 1999, J IMMUNOL, V162, P3840; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Sozzani S, 1997, J IMMUNOL, V159, P1993; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Zhang HH, 2010, J IMMUNOL, V185, P6646, DOI 10.4049/jimmunol.0904156; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	25	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119532	10.1371/journal.pone.0119532	http://dx.doi.org/10.1371/journal.pone.0119532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835294	Green Published, gold			2022-12-27	WOS:000352139000010
J	Fan, ZY; Chen, C; Pang, XY; Yu, Z; Qi, Y; Chen, XY; Liang, HH; Fang, XL; Sha, XY				Fan, Zhuoyang; Chen, Cheng; Pang, Xiaoying; Yu, Zhou; Qi, Yang; Chen, Xinyi; Liang, Huihui; Fang, Xiaoling; Sha, Xianyi			Adding Vitamin E-TPGS to the Formulation of Genexol-PM: Specially Mixed Micelles Improve Drug-Loading Ability and Cytotoxicity against Multidrug-Resistant Tumors Significantly	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-II; COPOLYMER MICELLES; CREMOPHOR-FREE; IN-VITRO; PACLITAXEL; DELIVERY; GLYCOPROTEIN; PHARMACOKINETICS; BIODISTRIBUTION	Genexol-PM, produced by Samyang Company (Korea) is an excellent preparation of paclitaxel (PTX) for clinical cancer treatment. However, it cannot resolve the issue of multidrug resistance (MDR)-a significant problem in the administration of PTX to cancer patients. To increase the efficacy of Genexol-PM against MDR tumors, a mixed micelle capable of serving as a vehicle for PTX was developed, and two substances were chosen as carrier materials: 1) Polyethylene glycol-polylactic acid (PEG-PLA), the original vehicle of Genexol-PM. 2) Vitamin E-TPGS, an inhibitor of P-glycoprotein (P-gp). P-gp has been proven to be the main cause of MDR. In vitro evaluation indicated that the mixed micelle was an ideal PTX delivery system for the treatment of MDR tumors; the mixed micelle also showed a significantly better drug-loading coefficient than Genexol-PM.	[Fan, Zhuoyang; Chen, Cheng; Pang, Xiaoying; Yu, Zhou; Qi, Yang; Chen, Xinyi; Liang, Huihui; Fang, Xiaoling; Sha, Xianyi] Fudan Univ, Sch Pharm, Dept Pharmaceut, Minist Educ & PLA,Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China	Fudan University	Sha, XY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmaceut, Minist Educ & PLA,Key Lab Smart Drug Delivery, Lane 826,Zhangheng Rd, Shanghai 201203, Peoples R China.	shaxy@fudan.edu.cn			National Natural Science Foundation of China [81273459]; National Basic Research Program of China [2013CB932500]; National Science and Technology Major Project [2012ZX09304004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project	This research was supported by the National Natural Science Foundation of China (81273459), National Basic Research Program of China (2013CB932500) and National Science and Technology Major Project (2012ZX09304004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger W, 2005, J CANCER RES CLIN, V131, P355, DOI 10.1007/s00432-004-0653-9; BJORNEBOE A, 1990, J NUTR, V120, P233, DOI 10.1093/jn/120.3.233; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; Chen LC, 2013, INT J NANOMED, V8, P73, DOI 10.2147/IJN.S38221; Collnot EM, 2007, MOL PHARM, V4, P465, DOI 10.1021/mp060121r; Collnot EM, 2010, MOL PHARMACEUT, V7, P642, DOI 10.1021/mp900191s; Filipits M, 2004, DRUG DISCOV TODAY, V1, P229, DOI DOI 10.1016/J.DDMEC.2004.10.001; GAISFORD S, 1995, J CHEM SOC CHEM COMM, P1843, DOI 10.1039/c39950001843; Gaisford S, 1997, LANGMUIR, V13, P2606, DOI 10.1021/la962033r; Han LM, 2006, ACTA PHARMACOL SIN, V27, P747, DOI 10.1111/j.1745-7254.2006.00340.x; Hugger ED, 2002, J PHARM SCI-US, V91, P1991, DOI 10.1002/jps.10176; Johnson BM, 2002, AAPS PHARMSCI, V4; Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P759, DOI 10.1016/S0169-409X(02)00047-9; Kang HK, 2005, MOL CANCER THER, V4, P1358, DOI 10.1158/1535-7163.MCT-05-0139; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Kim SC, 2001, J CONTROL RELEASE, V72, P191, DOI 10.1016/S0168-3659(01)00275-9; Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; Lee E, 2006, ARCH PHARM RES, V29, P1018, DOI 10.1007/BF02969286; Lee JL, 2012, INVEST NEW DRUG, V30, P1984, DOI 10.1007/s10637-011-9757-7; Letchford K, 2007, EUR J PHARM BIOPHARM, V65, P259, DOI 10.1016/j.ejpb.2006.11.009; Mayer LD, 2001, CANCER METAST REV, V20, P87, DOI 10.1023/A:1013108524062; McLeod AD, 1998, J PHARM SCI, V8, P704; Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4; Postma TJ, 2000, ANN ONCOL, V11, P409, DOI 10.1023/A:1008376123066; Prados MD, 1996, J CLIN ONCOL, V14, P2316, DOI 10.1200/JCO.1996.14.8.2316; Qiu LY, 2006, PHARM RES-DORDR, V23, P1, DOI 10.1007/s11095-005-9046-2; ROFSTAD EK, 1986, CELL TISSUE KINET, V19, P205, DOI 10.1111/j.1365-2184.1986.tb00731.x; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065; Saxena V, 2012, INT J NANOMED, V7, P713, DOI 10.2147/IJN.S28745; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Varma MVS, 2005, EUR J PHARM SCI, V25, P445, DOI 10.1016/j.ejps.2005.04.003; Wang YZ, 2008, ARCH PHARM RES, V31, P530, DOI 10.1007/s12272-001-1189-2; Wang YZ, 2007, INT J PHARM, V337, P63, DOI 10.1016/j.ijpharm.2006.12.033; WEISS RB, 1990, J CLIN ONCOL, V8, P1263, DOI 10.1200/JCO.1990.8.7.1263; Yamazaki T, 2000, CANCER LETT, V149, P153, DOI 10.1016/S0304-3835(99)00355-9; Zhang XC, 1996, INT J PHARM, V132, P195, DOI 10.1016/0378-5173(95)04386-1	38	33	34	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120129	10.1371/journal.pone.0120129	http://dx.doi.org/10.1371/journal.pone.0120129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831130	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600023
J	Fishman, MN; Tomshine, J; Fulp, WJ; Foreman, PK				Fishman, Mayer N.; Tomshine, Jin; Fulp, William J.; Foreman, Pamela K.			A Systematic Review of the Efficacy and Safety Experience Reported for Sorafenib in Advanced Renal Cell Carcinoma (RCC) in the Post-Approval Setting	PLOS ONE			English	Review							LARGE OPEN-LABEL; PHASE-II TRIAL; KINASE INHIBITOR SORAFENIB; EXPANDED ACCESS PROGRAM; LONG-TERM USE; JAPANESE PATIENTS; EUROPEAN PATIENTS; INTERFERON-ALPHA; 2ND-LINE TREATMENT; SUBGROUP ANALYSIS	Background Sorafenib was FDA approved in 2005 for treatment of renal cell carcinoma (RCC) based on the results of the pivotal phase 3 clinical trial, TARGET (Treatment Approaches in Renal Cancer Global Evaluation Trial). Since that time, numerous clinical studies have been undertaken that substantially broaden our knowledge of the use of sorafenib for this indication. Methods We systematically reviewed PubMed, Web of Science, Embase, Cochrane Library, and www.clinicaltrials.gov for prospective clinical studies using single agent sorafenib in RCC and published since 2005. Primary endpoints of interest were progression-free survival (PFS) and safety. PROSPERO International prospective register of systematic reviews #CRD42014010765. Results We identified 30 studies in which 2182 patients were treated with sorafenib, including 1575 patients who participated in randomized controlled phase 3 trials. In these trials, sorafenib was administered as first-, second- or third-line treatment. Heterogeneity among trial designs and reporting of data precluded statistical comparisons among trials or with TARGET. The PFS appeared shorter in second- vs. first-line treatment, consistent with the more advanced tumor status in the second-line setting. In some trials, incidences of grade 3/4 hypertension or hand-foot skin reaction (HFSR) were more than double that seen in TARGET (4% and 6%, respectively). These variances may be attributable to increased recognition of HFSR, or potentially differences in dose adjustments, that could be consequences of increased familiarity with sorafenib usage. Several small studies enrolled exclusively Asian patients. These studies reported notably longer PFS than was observed in TARGET. However, no obvious corresponding differences in disease control rate and overall survival were seen. Conclusions Collectively, more recent experiences using sorafenib in RCC are consistent with results reported for TARGET with no marked changes of response endpoints or new safety signals observed.	[Fishman, Mayer N.; Fulp, William J.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Fishman, Mayer N.; Fulp, William J.] Res Inst, Tampa, FL USA; [Tomshine, Jin; Foreman, Pamela K.] Blue Ocean Pharma LLC, Annandale, NJ USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Fishman, MN (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.	Mayer.Fishman@moffitt.org	Fulp, William/AAD-2369-2022; Fishman, Mayer/AAG-6640-2021	Fulp, William/0000-0001-6888-0794	Onyx Pharmaceuticals, an Amgen subsidiary; Blue Ocean Pharma LLC	Onyx Pharmaceuticals, an Amgen subsidiary; Blue Ocean Pharma LLC	Support for this manuscript was provided by Onyx Pharmaceuticals, an Amgen subsidiary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pamela Foreman and Jin Tomshine are employees of Blue Ocean Pharma LLC, which provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akaza H, 2007, EUR UROL SUPPL, V6, P237, DOI 10.1016/S1569-9056(07)60854-9; Akaza H, 2009, EJC SUPPL, V7, P437, DOI 10.1016/S1359-6349(09)71480-6; Akaza H, 2007, JPN J CLIN ONCOL, V37, P755, DOI 10.1093/jjco/hym095; Battaglia M, 2009, J CLIN ONCOL, V27; Bayer, PHASE III STUDY OF S; Bayer, SORAF ESC REN CELL C; Bayer, LONG TERM EXT RCC PH; Beck J, 2008, EUR UROL SUPPL, V7, P244, DOI 10.1016/S1569-9056(08)60692-2; Beck J, 2007, EJC SUPPL, V5, P300, DOI 10.1016/S1359-6349(07)71137-0; Beck J, 2011, ANN ONCOL, V22, P1812, DOI 10.1093/annonc/mdq651; Beck J, 2009, EJC SUPPL, V7, P434, DOI 10.1016/S1359-6349(09)71470-3; Beck J, 2008, J CLIN ONCOL, V26; Bhatt RS, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4557; Bokemeyer C, 2009, EJC SUPPL, V7, P433, DOI 10.1016/S1359-6349(09)71465-X; Bokemeyer C, 2008, ANN ONCOL, V19, P192; Bracarda S, 2015, BRIT J CANCER, V112, P14, DOI 10.1038/bjc.2014.240; Bracarda S, 2009, EUR UROL SUPPL, V8, P156, DOI 10.1016/S1569-9056(09)60148-2; Bukowski R, 2007, EUR UROL SUPPL, V6, P237, DOI 10.1016/S1569-9056(07)60853-7; Bukowski RM, 2008, ANN ONCOL, V19, P195; Bukowski RM, 2008, J CLIN ONCOL S, V26; Bukowski RM, 2010, ONCOLOGY-BASEL, V78, P340, DOI 10.1159/000320223; Case Comprehensive Cancer Center, SOR TREAT PAT MET KI; Cella D, 2013, BRIT J CANCER, V108, P1571, DOI 10.1038/bjc.2013.145; Cella D, 2011, EUR J CANCER, V47, pS224, DOI 10.1016/S0959-8049(11)71079-6; Cella D, 2011, J CLIN ONCOL S, V29; Davis I, 2011, ASIA PAC J CLIN O S4, V7, P151; del Muro XG, 2008, ANN ONCOL, V19, P193; Eisen T, 2012, BJU INT, V110, P16; Eisen T, 2008, ANN ONCOL, V19, P194; Eisen TQG, 2012, ANN ONCOL, V23, P262; Escudier B, 2007, ANN ONCOL, V18, P18; Escudier B, 2007, J CLIN ONCOL, V25; Escudier B, 2013, EUR J CANCER, V49, pS673; Escudier B, 2011, EUR J CANCER, V47, pS505, DOI 10.1016/S0959-8049(11)72018-4; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Escudier BJ, 2014, J CLIN ONCOL S4, V32; Garcia JA, 2010, CANCER-AM CANCER SOC, V116, P5383, DOI 10.1002/cncr.25327; Gernone A, 2009, ANN ONCOL S8, V20, pviii84; Gore ME, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4609; Gschwend J, 2013, J CLIN ONCOL, V31; Haas NB, 2012, J CLIN ONCOL S, V30; Henderson CA, 2008, EUR UROL SUPPL, V7, P245, DOI 10.1016/S1569-9056(08)60695-8; Herrmann E, 2009, GEN CANC S FEBR 26 2; Herrmann E, 2008, ONCOLOGY-BASEL, V74, P216, DOI 10.1159/000151369; Hutson T, 2012, PRESENTED AT ESMO CO; Hutson TE, 2013, J CLIN ONSOL S6, V31; Hutson TE, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.6_suppl.lba348; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Hutson TE, 2013, LANCET ONCOL, V14, P1287, DOI 10.1016/S1470-2045(13)70465-0; Imarisio I, 2012, FUTURE ONCOL, V8, P1051, DOI [10.2217/fon.12.74, 10.2217/FON.12.74]; Jonasch E, 2007, J CLIN ONCOL, V25; Jonasch E, 2010, CANCER-AM CANCER SOC, V116, P57, DOI 10.1002/cncr.24685; Kapoor A, 2008, J CLIN ONCOL S, V26; Kapoor A, 2008, INDIAN J UROL S22, V24; Knox JJ, 2007, J CLIN ONCOL, V25; Maroto JP, 2013, CLIN TRANSL ONCOL, V15, P698, DOI 10.1007/s12094-012-0991-z; Michel MS, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.4_suppl.393; Michel MS, 2012, J CLIN ONSOL S, V30; Motzer R, 2012, BJU INT, V110, P14; Motzer R, 2012, BJU INT, V109, P7; Motzer RJ, 2011, J CLIN ONCOL S1, V29; Motzer RJ, 2012, J CLIN ONSOL S, V30; MOTZER RJ, 2012, ANN ONCOL S9, V23, P262; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Motzer RJ, 2012, J CLIN ONCOL, V30; Naito S, 2008, J CLIN ONCOL S, V26; Naito S, 2011, BJU INT, V108, P1813, DOI 10.1111/j.1464-410X.2011.10281.x; Pfizer, AX AG 013736 2 LIN T; Pfizer, TEMS VERS SOR 2 LIN; Pfizer, AG013736 PFIZ; Porta C, 2008, ANN ONCOL, V19, P193; Procopio G, 2013, ANN ONCOL, V24, P2967, DOI 10.1093/annonc/mdt375; Procopio G, 2011, BRIT J CANCER, V104, P1256, DOI 10.1038/bjc.2011.103; Procopio G, 2009, J CLIN ONCOL, V27; Procopio G, 2009, EJC SUPPL, V7, P425, DOI 10.1016/S1359-6349(09)71440-5; Procopio G, 2009, ANN ONCOL S8, V20, pvii79; Procopio G, 2013, J CLIN ONCOL S6, V31; Procopio G, 2010, J CLIN ONCOL S, V28; Procopio G, 2007, ONCOLOGY-BASEL, V73, P204, DOI 10.1159/000127387; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Rini BI, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.7_suppl.309; Rini BI, 2012, ASCO M S, V30, P354; Rini BI, 2011, J CLIN ONCOL S, V29; Rini B, 2012, CANCER-AM CANCER SOC, V118, P6152, DOI 10.1002/cncr.27632; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Shepard DR, 2008, J CLIN ONCOL, V26, P5123, DOI DOI 10.1200/JCO.2008.26.15_SUPPL.5123; Stadler WM, 2010, CANCER-AM CANCER SOC, V116, P1272, DOI 10.1002/cncr.24864; Staehler M, 2009, EUR UROL SUPPL, V8, P184, DOI 10.1016/S1569-9056(09)60259-1; Sternberg CN, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.6_suppl.16; Sun Y, 2008, J CLIN ONCOL, V26; Szczylik C, 2008, J CLIN ONCOL S15, V26; Tafreshi A, 2012, ASIA-PAC J CLIN ONCO, V8, P57; Tafreshi A, 2012, ASIA PAC J CLIN O S3, V8, P162; Tafreshi A, 2014, ASIA-PAC J CLIN ONCO, V10, P60, DOI 10.1111/ajco.12122; Tafreshi A, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.6_suppl.465; Tannir NM, 2008, J CLIN ONCOL S, V26; Tomita Y, 2014, J CLIN ONSOL S4, V32; Ueda T, 2013, JPN J CLIN ONCOL, V43, P616, DOI 10.1093/jjco/hyt054; Uemura H, 2012, ANN ONCOL, V23, P6; von Weikersthal LF, 2012, ONKOLOGIE, V35, P237; Yang L, 2012, ONCOL LETT, V3, P935, DOI 10.3892/ol.2012.585; Zhang HL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-249; Zurita AJ, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mdr047	106	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120877	10.1371/journal.pone.0120877	http://dx.doi.org/10.1371/journal.pone.0120877			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830512	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600048
J	Uchida, H; Sumimoto, K; Ferriols, VME; Imou, K; Saga, K; Furuhashi, K; Matsunaga, S; Okada, S				Uchida, Hidenobu; Sumimoto, Koremitsu; Ferriols, Victor Marco Emmanuel; Imou, Kenji; Saga, Kiyotaka; Furuhashi, Kenichi; Matsunaga, Shigeki; Okada, Shigeru			Isolation and Characterization of Two Squalene Epoxidase Genes from Botryococcus braunii, Race B	PLOS ONE			English	Article							RNA-SEQ DATA; SACCHAROMYCES-CEREVISIAE; EUPHORBIA-TIRUCALLI; REFERENCE GENOME; BIOSYNTHESIS; CLONING; EXPRESSION; TRITERPENE; PLANT; IDENTIFICATION	The B race of the green microalga Botryococcus braunii produces triterpene hydrocarbons, botryococcenes and methylsqualenes that can be processed into jet fuels with high heating values. In this alga, squalene is also converted into membrane sterols after 2,3-epoxidation. In the present study, cDNA clones of two distinct squalene epoxidases (BbSQE-I and -II) were isolated. Predicted amino acid sequences encoded on these genes are 45% identical with each other. Introduction of BbSQE-I or -II into Saccharomyces cerevisie erg1 mutants resulted in the complementation of ergosterol auxotrophy. The relative expression level of SQE-II increased 3.5-fold from the early stage to the middle phase of a culture period of 42 days, while that of SQE-I was almost constant throughout the culture period. Southern blot analyses suggested that these genes are single-copied genes. This is the first report on the isolation of functional SQEs that are encoded in duplicated loci in the algal genome.	[Uchida, Hidenobu; Sumimoto, Koremitsu; Ferriols, Victor Marco Emmanuel; Matsunaga, Shigeki; Okada, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Uchida, Hidenobu; Sumimoto, Koremitsu; Matsunaga, Shigeki; Okada, Shigeru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan; [Ferriols, Victor Marco Emmanuel] Univ Philippines Visayas, Inst Aquaculture, Iloilo 5023, Philippines; [Imou, Kenji; Saga, Kiyotaka; Furuhashi, Kenichi] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biol & Mech Engn, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of the Philippines System; University of the Philippines Visayas; University of Tokyo	Okada, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Bunkyo Ku, Tokyo 1138657, Japan.	aokada@mail.ecc.u-tokyo.ac.jp	Uchida, Hidenobu/N-4218-2015; Okada, Shigeru/U-8305-2017	Uchida, Hidenobu/0000-0002-7714-0402; Okada, Shigeru/0000-0003-3663-7778; Ferriols, Victor Marco Emmanuel/0000-0002-7427-1298	Japan Science and Technology Agency, CREST; Strategic Development of Next-generation Bioenergy Utilization Technology entitled, "Efficient Production of Hydrocarbon from Microalgae", New Energy and Industrial Technology Development Organization (NEDO)	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Strategic Development of Next-generation Bioenergy Utilization Technology entitled, "Efficient Production of Hydrocarbon from Microalgae", New Energy and Industrial Technology Development Organization (NEDO)	This work was financially supported by Japan Science and Technology Agency (http://www.jst.go.jp/), CREST. The RNAseq was financially supported by the Strategic Development of Next-generation Bioenergy Utilization Technology entitled, "Efficient Production of Hydrocarbon from Microalgae" by the New Energy and Industrial Technology Development Organization (NEDO) (http://www.nedo.go.jp/english/index.html). All of the founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achitouv E, 2004, PHYTOCHEMISTRY, V65, P3159, DOI 10.1016/j.phytochem.2004.09.015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Favre B, 1997, GENE, V189, P119, DOI 10.1016/S0378-1119(96)00844-X; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P1467, DOI 10.1016/S0031-9422(00)97766-5; JANDROSITZ A, 1991, GENE, V107, P155, DOI 10.1016/0378-1119(91)90310-8; Kapraun DF, 2007, ANN BOT-LONDON, V99, P677, DOI 10.1093/aob/mcl294; KOSUGA K, 1995, BBA-GENE STRUCT EXPR, V1260, P345, DOI 10.1016/0167-4781(94)00245-X; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; Landl KM, 1996, YEAST, V12, P609, DOI 10.1002/(SICI)1097-0061(199605)12:6<609::AID-YEA949>3.0.CO;2-B; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lipinski M, 2009, CENT EUR J BIOL, V4, P163, DOI 10.2478/s11535-009-0002-8; LOPEZGOMEZ R, 1992, HORTSCIENCE, V27, P440, DOI 10.21273/HORTSCI.27.5.440; Matsushima D, 2012, PLANT SCI, V185, P309, DOI 10.1016/j.plantsci.2012.01.002; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2995, DOI 10.1016/0031-9422(85)80043-1; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; Metzger P, 1999, CHEM MICROALGAE, P205; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Niehaus TD, 2012, J BIOL CHEM, V287, P8163, DOI 10.1074/jbc.M111.316059; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Nonomura A., 1988, JPN J PHYCOL, V36, P285; Okada S, 2004, ARCH BIOCHEM BIOPHYS, V422, P110, DOI 10.1016/j.abb.2003.12.004; Okada S, 2000, ARCH BIOCHEM BIOPHYS, V373, P307, DOI 10.1006/abbi.1999.1568; POULTER CD, 1990, ACCOUNTS CHEM RES, V23, P70, DOI 10.1021/ar00171a003; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Ruckenstuhl C, 2005, BIOCHEM SOC T, V33, P1197, DOI 10.1042/BST0331197; SAKAKIBARA J, 1995, J BIOL CHEM, V270, P17, DOI 10.1074/jbc.270.1.17; Sato Y, 2003, TETRAHEDRON LETT, V44, P7035, DOI 10.1016/S0040-4039(03)01784-2; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Uchida H, 2007, PLANTA, V226, P1109, DOI 10.1007/s00425-007-0557-4; Uchida H, 2009, PLANTA, V229, P1243, DOI 10.1007/s00425-009-0906-6; Weiss TL, 2010, J PHYCOL, V46, P534, DOI 10.1111/j.1529-8817.2010.00820.x	38	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122649	10.1371/journal.pone.0122649	http://dx.doi.org/10.1371/journal.pone.0122649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830359	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600118
J	Yong, XY; Menon, C				Yong, Xinyi; Menon, Carlo			EEG Classification of Different Imaginary Movements within the Same Limb	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; MOTOR IMAGERY; CHRONIC STROKE; MENTAL PRACTICE; BCI; REHABILITATION; TRIAL; COMMUNICATION; RECOVERY; SYSTEM	The task of discriminating the motor imagery of different movements within the same limb using electroencephalography (EEG) signals is challenging because these imaginary movements have close spatial representations on the motor cortex area. There is, however, a pressing need to succeed in this task. The reason is that the ability to classify different same-limb imaginary movements could increase the number of control dimensions of a brain-computer interface (BCI). In this paper, we propose a 3-class BCI system that discriminates EEG signals corresponding to rest, imaginary grasp movements, and imaginary elbow movements. Besides, the differences between simple motor imagery and goal-oriented motor imagery in terms of their topographical distributions and classification accuracies are also being investigated. To the best of our knowledge, both problems have not been explored in the literature. Based on the EEG data recorded from 12 able-bodied individuals, we have demonstrated that same-limb motor imagery classification is possible. For the binary classification of imaginary grasp and elbow (goal-oriented) movements, the average accuracy achieved is 66.9%. For the 3-class problem of discriminating rest against imaginary grasp and elbow movements, the average classification accuracy achieved is 60.7%, which is greater than the random classification accuracy of 33.3%. Our results also show that goal-oriented imaginary elbow movements lead to a better classification performance compared to simple imaginary elbow movements. This proposed BCI system could potentially be used in controlling a robotic rehabilitation system, which can assist stroke patients in performing task-specific exercises.	[Yong, Xinyi; Menon, Carlo] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Menon, C (corresponding author), Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada.	cmenon@sfu.ca	Menon, Carlo/GZG-8210-2022; Coish, Elizabeth/AAU-1245-2020	Menon, Carlo/0000-0002-2309-9977; 	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	Funding provided by Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Institutes of Health Research (CIHR), and the Michael Smith Foundation for Health Research (MSFHR). The author who received the funding is CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Ang Kai Keng, 2014, Front Neuroeng, V7, P30, DOI 10.3389/fneng.2014.00030; Ang KK, 2009, IEEE ENG MED BIO, P5981, DOI 10.1109/IEMBS.2009.5335381; Ang KK, 2011, CLIN EEG NEUROSCI, V42, P253, DOI 10.1177/155005941104200411; Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Ang KK, 2008, IEEE IJCNN, P2390, DOI 10.1109/IJCNN.2008.4634130; Birbaumer N., 2004, P 2 INT BCI WORKSH T, P1; Bishop C. M, 2006, PATTERN RECOGNITION; Boyd LA, 2010, NEUROSCI LETT, V482, P21, DOI 10.1016/j.neulet.2010.06.082; Broetz D, 2010, NEUROREHAB NEURAL RE, V24, P674, DOI 10.1177/1545968310368683; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Chakraborti T., 2011, 2011 International Conference on Recent Trends in Information Systems (ReTIS), P203, DOI 10.1109/ReTIS.2011.6146868; Cincotti F, 2012, IEEE ENG MED BIO, P4112, DOI 10.1109/EMBC.2012.6346871; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Daly JJ, 2009, J NEUROL PHYS THER, V33, P203, DOI 10.1097/NPT.0b013e3181c1fc0b; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Deng J, 2005, J NEURAL ENG, V2, P131, DOI 10.1088/1741-2560/2/4/009; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G., 2005, ADV NEURAL INF P SYS, V18, P315; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; Electrical Geodesics I, NET AMPS 400 SERIES; Electrical Geodesics I, 2007, GEODESIC SENSOR NET; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Frisoli A, 2012, IEEE T SYST MAN CY C, V42, P1169, DOI 10.1109/TSMCC.2012.2226444; Ghani Farid, 2013, Journal of Next Generation Information Technology, V4, P29; Gomez-Rodriguez M, 2010, IEEE SYS MAN CYBERN; Gomez-Rodriguez M., 2011, P IEEE INT C REH ROB, P1; Hollander M., 2013, NONPARAMETRIC STATIS, V3rd; Hsu C. W., 2010, TECHNICAL REPORT; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; Jaakkola TS, 2000, STAT COMPUT, V10, P25, DOI 10.1023/A:1008932416310; Kai Keng Ang, 2013, Journal of Computing Science and Engineering, V7, P139, DOI 10.5626/JCSE.2013.7.2.139; Kaiser V, 2012, STROKE, V43, P2735, DOI 10.1161/STROKEAHA.112.665489; Lachenbruch PA, 1975, DISCRIMINANT ANALYSI; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Liao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085192; Looned R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-51; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Meng F, 2008, IEEE IJCNN, P4103, DOI 10.1109/IJCNN.2008.4634388; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Navarro I, 2005, P ANN INT IEEE EMBS, P2118, DOI 10.1109/IEMBS.2005.1616878; Ortner R, 2012, STUD HEALTH TECHNOL, V181, P319, DOI 10.3233/978-1-61499-121-2-319; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Plow EB, 2010, CORTEX, V46, P310, DOI 10.1016/j.cortex.2009.02.024; Prasad G, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-60; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Rensink M, 2009, J ADV NURS, V65, P737, DOI 10.1111/j.1365-2648.2008.04925.x; Royer AS, 2010, IEEE T NEUR SYS REH, V18, P581, DOI 10.1109/TNSRE.2010.2077654; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Scherer R, 2004, IEEE T BIO-MED ENG, V51, P979, DOI 10.1109/TBME.2004.827062; Shindo K, 2011, J REHABIL MED, V43, P951, DOI 10.2340/16501977-0859; Silvoni S, 2011, CLIN EEG NEUROSCI, V42, P245, DOI 10.1177/155005941104200410; Tam WK, 2011, IEEE T NEUR SYS REH, V19, P617, DOI 10.1109/TNSRE.2011.2168542; Tan HG, 2010, IEEE ENG MED BIO, P4234, DOI 10.1109/IEMBS.2010.5627381; Vaughan T M, 1996, IEEE Trans Rehabil Eng, V4, P425, DOI 10.1109/86.547945; Vuckovic A, 2008, MED BIOL ENG COMPUT, V46, P529, DOI 10.1007/s11517-008-0345-8; Wang YJ, 2005, P ANN INT IEEE EMBS, P5392; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Young BM, 2014, FRONTIERS NEUROENGIN, V7, P1; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028; Zhou J, 2009, COMPUT BIOL MED, V39, P443, DOI 10.1016/j.compbiomed.2009.02.004	68	49	51	7	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121896	10.1371/journal.pone.0121896	http://dx.doi.org/10.1371/journal.pone.0121896			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830611	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600088
J	Hu, SJ; Parker, J; Wright, JT				Hu, Shijia; Parker, Joel; Wright, John Timothy			Towards Unraveling the Human Tooth Transcriptome: The Dentome	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; GENE-EXPRESSION; MAMMALIAN TOOTH; MICRODISSECTION; MICROARRAY; COMPLEX; CELLS; GERM; MORPHOGENESIS; ORGANIZATION	The goal of the study was to characterize the transcriptome profiles of human ameloblasts and odontoblasts, evaluate molecular pathways and advance our knowledge of the human "dentome". Laser capture microdissection was used to isolate odontoblasts and ameloblasts from human tooth buds (15-20week gestational age) from 4 fetuses. RNA was examined using Agilent 41k whole genome arrays at 2 different stages of enamel formation, presecretory and secretory. Probe detection was considered against the array negative control to control for background noise. Differential expression was examined using Significance Analysis of Microarrays (SAM) 4.0 between different cell types and developmental stages with a false discovery rate of 20%. Pathway analysis was conducted using Ingenuity Pathway Analysis software. We found that during primary tooth formation, odontoblasts expressed 14,802 genes, presecretory ameloblasts 15,179 genes and secretory ameloblasts 14,526 genes. Genes known to be active during tooth development for each cell type (eg COL1A1, AMELX) were shown to be expressed by our approach. Exploring further into the list of differentially expressed genes between the motile odontoblasts and non-motile presecretory ameloblasts we found several genes of interest that could be involved in cell movement (FN1, LUM, ASTN1). Furthermore, our analysis indicated that the Phospholipase C and ERK5 pathways, that are important for cell movement, were activated in the motile odontoblasts. In addition our pathway analysis identified WNT3A and TGFB1 as important upstream contributors. Recent studies implicate these genes in the development of Schimke immuno-osseous dysplasia. The utility of laser capture microdissection can be a valuable tool in the examination of specific tissues or cell populations present in human tooth buds. Advancing our knowledge of the human dentome and related molecular pathways provides new insights into the complex mechanisms regulating odontogenesis and biomineralization. This knowledge could prove useful in future studies of odontogenic related pathologies.	[Hu, Shijia; Wright, John Timothy] Univ N Carolina, Pediat Dent, Chapel Hill, NC 27514 USA; [Hu, Shijia] Univ N Carolina, Oral Biol Curriculum, Chapel Hill, NC USA; [Parker, Joel] Univ N Carolina, Canc Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hu, SJ (corresponding author), Univ N Carolina, Pediat Dent, Chapel Hill, NC 27514 USA.	Shijia_Hu@unc.edu	Wright, John Timothy/AAX-5755-2020; Parker, Joel/AAG-1108-2019	Hu, Shijia/0000-0001-6136-9926	National Institute of Dental and Craniofacial Research [DE016079]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016079] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/), grant number: DE016079 for JTW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Bartlett JD, 2013, J DENT RES, V92, P10, DOI 10.1177/0022034512463397; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chokechanachaisakul U, 2012, MICROSC RES TECHNIQ, V75, P1341, DOI 10.1002/jemt.22072; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Couve E, 2013, J DENT RES, V92, P765, DOI 10.1177/0022034513495874; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; DeCarlo K, 2011, METHODS MOL BIOL, V755, P1, DOI 10.1007/978-1-61779-163-5_1; Deutsch D, 1995, CONNECT TISSUE RES, V32, P97, DOI 10.3109/03008209509013710; Ganter B, 2008, PHARMACOGENOMICS, V9, P35, DOI 10.2217/14622416.9.1.35; Gorlov IP, 2007, CANCER RES, V67, P8406, DOI 10.1158/0008-5472.CAN-06-4784; Guan X, 2013, J DENT RES, V92, P1123, DOI 10.1177/0022034513506581; Hayashi Y, 2010, J PERIODONTAL RES, V45, P618, DOI 10.1111/j.1600-0765.2010.01276.x; Heikinheimo K, 2002, J DENT RES, V81, P525, DOI 10.1177/154405910208100805; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kim KM, 2012, ARCH ORAL BIOL, V57, P1100, DOI 10.1016/j.archoralbio.2012.02.019; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Landin Maria A. dos Santos Silva, 2012, Frontiers in Genetics, V3, P139, DOI 10.3389/fgene.2012.00139; Lee DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029160; Lin DH, 2007, DEV DYNAM, V236, P1307, DOI 10.1002/dvdy.21127; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Matheson S, 2005, J PERIODONTAL RES, V40, P312, DOI 10.1111/j.1600-0765.2005.00800.x; Morimoto M, 2012, J DENT RES, V91, pS29, DOI 10.1177/0022034512450299; Nieminen P, 1998, EUR J ORAL SCI, V106, P7, DOI 10.1111/j.1600-0722.1998.tb02146.x; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; QVIST V, 1975, SCAND J DENT RES, V83, P54; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Rufini A, 2011, BIOCHEM PHARMACOL, V82, P1256, DOI 10.1016/j.bcp.2011.07.068; Salmon CR, 2012, DIAGN MOL PATHOL, V21, P120, DOI 10.1097/PDM.0b013e31823e9395; Schoner K, 2013, PRENATAL DIAG, V33, P75, DOI 10.1002/pd.4012; Shtutman M, 2011, P NATL ACAD SCI USA, V108, P12449, DOI 10.1073/pnas.1103842108; Simmer JP, 2012, INT J ORAL SCI, V4, P129, DOI 10.1038/ijos.2012.59; Sorkin BC, 2000, J HISTOCHEM CYTOCHEM, V48, P397, DOI 10.1177/002215540004800309; Sun JX, 2012, INT J ORAL SCI, V4, P7, DOI 10.1038/ijos.2012.15; Thesleff I, 2001, Adv Dent Res, V15, P14; Tranasi M, 2009, J ENDODONT, V35, P1211, DOI 10.1016/j.joen.2009.05.026; Van den Bossche J, 2012, BLOOD, V119, P1623, DOI 10.1182/blood-2011-10-384289; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010	45	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124801	10.1371/journal.pone.0124801	http://dx.doi.org/10.1371/journal.pone.0124801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849153	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800276
J	Mendivil, CO; Koziel, H; Brain, JD				Mendivil, Carlos O.; Koziel, Henry; Brain, Joseph D.			Metabolic Hormones, Apolipoproteins, Adipokines, and Cytokines in the Alveolar Lining Fluid of Healthy Adults: Compartmentalization and Physiological Correlates	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; ADIPONECTIN; BARRIER; UREA; PERMEABILITY; TRANSPORT; INSULIN; LEPTIN; ALPHA	Objectives Our current understanding of hormone regulation in lung parenchyma is quite limited. We aimed to quantify a diverse array of biologically relevant protein mediators in alveolar lining fluid (ALF), compared to serum concentrations, and explore factors associated with protein compartmentalization on either side of the air-blood barrier. Research Design and Methods Participants were 24 healthy adult non-smoker volunteers without respiratory symptoms or significant medical conditions, with normal lung exams and office spirometry. Cell-free bronchoalveolar lavage fluid and serum were analyzed for 24 proteins (including enteric and metabolic hormones, apolipoproteins, adipokines, and cytokines) using a highly sensitive multiplex ELISA. Measurements were normalized to ALF concentrations. The ALF: serum concentration ratios were examined in relation to measures of protein size, hydrophobicity, charge, and to participant clinical and spirometric values. Results ALF measurements from 24 individuals detected 19 proteins, including adiponectin, adipsin, apoA-I, apoA-II, apoB, apoC-II, apoC-III, apoE, C-reactive protein, ghrelin, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), glucagon, insulin, leptin, monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, resistin, and visfatin. C-peptide and serpin E1 were not detected in ALF for any individual, and IL-6, IL-10, and TNF-alpha were not detected in either ALF or serum for any individual. In general, ALF levels were similar or lower in concentration for most proteins compared to serum. However, ghrelin, resistin, insulin, visfatin and GLP-1 had ALF concentrations significantly higher compared to serum. Importantly, elevated ALF: serum ratios of ghrelin, visfatin and resistin correlated with protein net charge and isoelectric point, but not with molecular weight or hydrophobicity. Conclusions Biologically relevant enteric and metabolic hormones, apolipoproteins, adipokines, and cytokines can be detected in the ALF of healthy individuals. For the proteins measured, charge may influence trafficking and compartmentalization to the alveolar airspace more than molecular weight or hydrophobicity. These data may have implications for homeostasis and drug delivery to the lung.	[Mendivil, Carlos O.] Univ Los Andes, Sch Med, Bogota, Colombia; [Mendivil, Carlos O.] Hosp Univ Fdn Santa Fe Bogota, Endocrinol Sect, Bogota, Colombia; [Koziel, Henry] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Koziel, Henry] Harvard Univ, Sch Med, Boston, MA USA; [Brain, Joseph D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA	Universidad de los Andes (Colombia); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Brain, JD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.	brain@hsph.harvard.edu		Mendivil, Carlos O/0000-0001-5546-4206				Assad NA, 2012, BIOCHIMIE, V94, P2180, DOI 10.1016/j.biochi.2012.03.006; Bartlett JA, 2013, AM J PHYSIOL-LUNG C, V305, P1256, DOI 10.1152/ajplung.00056.2013; Bernotiene E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2004; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Brain JD, 2007, DIABETES TECHNOL THE, V9, pS4, DOI 10.1089/dia.2007.0228; BYRON PR, 1993, AEROSOL SCI TECH, V18, P223, DOI 10.1080/02786829308959599; CONHAIM RL, 1988, J APPL PHYSIOL, V64, P1134, DOI 10.1152/jappl.1988.64.3.1134; FENG NH, 1992, J APPL PHYSIOL, V72, P1081, DOI 10.1152/jappl.1992.72.3.1081; Foster MW, 2013, J PROTEOME RES, V12, P2194, DOI 10.1021/pr400066g; Garcia-Verdugo I, 2010, BIOCHIMIE, V92, P1608, DOI 10.1016/j.biochi.2010.05.010; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; HOLTER JF, 1986, J CLIN INVEST, V78, P1513, DOI 10.1172/JCI112743; Kolka CM, 2012, PHYSIOLOGY, V27, P237, DOI 10.1152/physiol.00012.2012; Koziel H, 1998, J CLIN INVEST, V102, P1332, DOI 10.1172/JCI560; Kwan R, 2010, J ELECTR COMPUT ENG, V2010, DOI [10.1097/TA.0b013e3181bb9878, 10.1155/2010/273486]; MARCY TW, 1987, AM REV RESPIR DIS, V135, P1276; Marino MT, 2010, CLIN PHARMACOL THER, V88, P243, DOI 10.1038/clpt.2010.85; Matej R, 2014, EXP THER MED, V8, P533, DOI 10.3892/etm.2014.1776; Mendivil CO, 2012, DIABETES TECHNOL THE, V14, P50, DOI 10.1089/dia.2011.0148; Merrill WW, 1999, EUR RESPIR REV, V9, P70; NIEDERMAN MS, 1984, AM REV RESPIR DIS, V129, P943; Patton JS, 2007, NAT REV DRUG DISCOV, V6, P67, DOI 10.1038/nrd2153; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; SCHNEEBE.EE, 1968, J CELL BIOL, V37, P781, DOI 10.1083/jcb.37.3.781; Summer R, 2009, AM J PHYSIOL-LUNG C, V297, pL432, DOI 10.1152/ajplung.90599.2008; SUTINEN S, 1995, RESP MED, V89, P85, DOI 10.1016/0954-6111(95)90189-2; Teirila L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102624; THEODORE J, 1975, AM J PHYSIOL, V229, P989, DOI 10.1152/ajplegacy.1975.229.4.989; Vara E, 2001, AM J RESP CRIT CARE, V163, P840, DOI 10.1164/ajrccm.163.4.9912132; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; WARD C, 1992, AM REV RESPIR DIS, V146, P444, DOI 10.1164/ajrccm/146.2.444; West JB, 1999, ANNU REV PHYSIOL, V61, P543, DOI 10.1146/annurev.physiol.61.1.543; Xu SQ, 2008, ARTERIOSCL THROM VAS, V28, P899, DOI 10.1161/ATVBAHA.108.163634	33	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123344	10.1371/journal.pone.0123344	http://dx.doi.org/10.1371/journal.pone.0123344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848795	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800226
J	Toivanen, H; Suominen, A				Toivanen, Hannes; Suominen, Arho			The Global Inventor Gap: Distribution and Equality of World-Wide Inventive Effort, 1990-2010	PLOS ONE			English	Article							ABSORPTIVE-CAPACITY; INNOVATION SYSTEMS; INDICATOR; SCIENCE; HEALTH	Applying distance-to-frontier analysis, we have used 2.9 million patents and population data to assess whether the relative capacity of world countries and major regions to create new knowledge and technology has become globally more equal or less equal between 1990 and 2010. We show with the Gini coefficient that the global distribution of inventors has become more equal between major countries and regions. However, this trend has been largely due to the improved performance of only two major countries, China and India. The worst performing regions, totalling a population of almost 2 billion, are actually falling behind. Our results suggest that substantial parts of the global population have fallen further behind countries at the global frontier in their ability to create new knowledge and inventions, and that the catch-up among the least developed and middle-income countries is highly uneven, prompting questions about the nature and future of the global knowledge economy.	[Toivanen, Hannes; Suominen, Arho] VTT Tech Res Ctr Finland, Innovat Policy & Econ, Espoo, Finland; [Toivanen, Hannes] Lappeenranta Univ Technol, Sch Business, Lappeenranta, Finland	VTT Technical Research Center Finland; Lappeenranta University of Technology	Toivanen, H (corresponding author), VTT Tech Res Ctr Finland, Innovat Policy & Econ, Espoo, Finland.	Hannes.Toivanen@vtt.fi	Suominen, Arho/AAA-5918-2022	Suominen, Arho/0000-0001-9844-7799; Toivanen, Hannes/0000-0003-2040-964X	Tekes-the Finnish Funding Agency for Technology and Innovation [2004/31/2011]	Tekes-the Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	Tekes-the Finnish Funding Agency for Technology and Innovation supported this work with the research grant (2004/31/2011) awarded for the project "Co-evolution of knowledge creation systems and innovation pipelines". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibugi D, 2004, WORLD DEV, V32, P629, DOI 10.1016/j.worlddev.2003.10.008; Castellacci F, 2013, RES POLICY, V42, P579, DOI 10.1016/j.respol.2012.10.006; Castellacci F, 2011, REV DEV ECON, V15, P180, DOI 10.1111/j.1467-9361.2010.00601.x; Castells M, 2000, END MILLENNIUM; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Confraria H, 2015, SCIENTOMETRICS, V102, P1241, DOI 10.1007/s11192-014-1463-8; Criscuolo P., 2008, EUR J DEV RES, V20, P56, DOI [DOI 10.1080/09578810701853181, 10.1080/09578810701853181]; de Rassenfosse G, 2013, RES POLICY, V42, P720, DOI 10.1016/j.respol.2012.11.002; Fagerberg J, 2002, RES POLICY, V31, P1291, DOI 10.1016/S0048-7333(02)00064-1; Fagerberg J, 2007, WORLD DEV, V35, P1595, DOI 10.1016/j.worlddev.2007.01.004; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Kemeny T, 2009, J ECON GEOGR, V11, P1; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; PAPAGEORGIOU C., 2002, REV DEV EC OXFORD, V6, P351; Ponomariov B, 2014, RES POLICY, V43, P588, DOI 10.1016/j.respol.2013.09.002; Radosevic S, 2014, SCIENTOMETRICS, V101, P1897, DOI 10.1007/s11192-014-1344-1; Rodrik Dani., 1997, HAS GLOBALIZATION GO; Sachs J, 2003, INNOV POLICY ECON, V3, P131, DOI 10.1086/ipe.3.25056155; Taiwan, 2013, NATL STAT STAT DATAB; UN Millennium Project, 2005, INV DEV PRACT PLAN A; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012	21	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122098	10.1371/journal.pone.0122098	http://dx.doi.org/10.1371/journal.pone.0122098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849202	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800097
J	Koehler, NKU; Stransky, E; Meyer, M; Gaertner, S; Shing, M; Schnaldt, M; Celej, MS; Jovin, TM; Leyhe, T; Laske, C; Batra, A; Buchkremer, G; Fallgatter, AJ; Wernet, D; Richartz-Salzburger, E				Koehler, Niklas K. U.; Stransky, Elke; Meyer, Mirjam; Gaertner, Susanne; Shing, Mona; Schnaldt, Martina; Celej, Maria S.; Jovin, Thomas M.; Leyhe, Thomas; Laske, Christoph; Batra, Anil; Buchkremer, Gerhard; Fallgatter, Andreas J.; Wernet, Dorothee; Richartz-Salzburger, Elke			Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; PARKINSONS-DISEASE; LEWY BODIES; PROTEIN-DEGRADATION; ALZHEIMERS-DISEASE; DEMENTIA; MICE; TAU; FIBRILLIZATION; MITOCHONDRIA	There is unequivocal evidence that alpha-synuclein plays a pivotal pathophysiological role in neurodegenerative diseases, and in particular in synucleinopathies. These disorders present with a variable extent of cognitive impairment and alpha-synuclein is being explored as a biomarker in CSF, blood serum and plasma. Considering key events of aging that include proteostasis, alpha-synuclein may not only be useful as a marker for differential diagnosis but also for aging per se. To explore this hypothesis, we developed a highly specific ELISA to measure alpha-synuclein. In healthy males plasma alpha-synuclein levels correlated strongly with age, revealing much lower concentrations in older (avg. 58.1 years) compared to younger (avg. 27.6 years) individuals. This difference between the age groups was enhanced after acidification of the plasmas (p<0.0001), possibly reflecting a decrease of alpha-synuclein-antibody complexes or chaperone activity in older individuals. Our results support the concept that alpha-synuclein homeostasis may be impaired early on, possibly due to disturbance of the proteostasis network, a key component of healthy aging. Thus, alpha-synuclein may be a novel biomarker of aging, a factor that should be considered when analyzing its presence in biological specimens.	[Koehler, Niklas K. U.; Stransky, Elke; Meyer, Mirjam; Gaertner, Susanne; Shing, Mona; Leyhe, Thomas; Laske, Christoph; Batra, Anil; Buchkremer, Gerhard; Fallgatter, Andreas J.; Richartz-Salzburger, Elke] Univ Tubingen, Dept Psychiat & Psychotherapy, D-72076 Tubingen, Germany; [Koehler, Niklas K. U.; Laske, Christoph] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Schnaldt, Martina; Wernet, Dorothee] Zentrum Klin Transfus Med, D-72076 Tubingen, Germany; [Leyhe, Thomas] Psychiat Univ Hosp, Ctr Old Age Psychiat, CH-4012 Basel, Switzerland; [Celej, Maria S.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany; [Celej, Maria S.] Natl Univ Cordoba, Sch Chem Sci, Dept Biol Chem, CIQUIBIC,CONICET, Cordoba, Argentina	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Koehler, NKU (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Calwerstr 14, D-72076 Tubingen, Germany.	niklaskoehler@yahoo.com	Celej, Maria Soledad/N-5709-2019; Demchuk, Andrew M/E-1103-2012	Celej, Maria Soledad/0000-0002-7831-9244; Demchuk, Andrew M/0000-0002-4930-7789	Eberhard-Karls-University Tubingen; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tubingen University	Eberhard-Karls-University Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University	The authors acknowledge support by internal funds from the Eberhard-Karls-University Tubingen and support by Deutsche Forschungsgemeinschaft, Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baba M, 1998, AM J PATHOL, V152, P879; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Bonsch D, 2005, ALCOHOL CLIN EXP RES, V29, P763, DOI 10.1097/01.ALC.0000164360.43907.24; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Brighina L, 2010, NEUROBIOL AGING, V31, P884, DOI 10.1016/j.neurobiolaging.2008.06.010; Chahine Lama M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS99, DOI 10.1016/S1353-8020(13)70025-7; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Colom-Cadena M, 2013, J NEUROPATH EXP NEUR, V72, P1203, DOI 10.1097/NEN.0000000000000018; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Darvin K, 2013, J GERONTOL A; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; del Campo M, 2012, BIOMARK MED, V6, P419, DOI [10.2217/bmm.12.46, 10.2217/BMM.12.46]; Dimant H, 2012, NEUROSCIENTIST, V18, P589, DOI 10.1177/1073858412441372; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Eller M, 2011, CLIN CHEM LAB MED, V49, P403, DOI 10.1515/CCLM.2011.077; Eriksen JL, 2005, TRENDS MOL MED, V11, P91, DOI 10.1016/j.molmed.2005.01.001; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Gardai SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071634; Giasson BI, 2003, NEUROMOL MED, V4, P49, DOI 10.1385/NMM:4:1-2:49; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Gorostidi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052312; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V237, P611, DOI 10.1006/bbrc.1997.6978; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kasten M, 2013, MOVEMENT DISORD, V28, P697, DOI 10.1002/mds.25499; Kasuga Kensaku, 2012, Int J Alzheimers Dis, V2012, P437025, DOI 10.1155/2012/437025; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040504; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kokhan VS, 2012, BEHAV BRAIN RES, V231, P226, DOI 10.1016/j.bbr.2012.03.026; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Li QY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-21; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Malek N, 2014, ACTA NEUROL SCAND, V130, P59, DOI 10.1111/ane.12247; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Mash DC, 2008, DRUG ALCOHOL DEPEN, V94, P246, DOI 10.1016/j.drugalcdep.2007.09.020; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; Michell AW, 2005, NEUROSCI LETT, V381, P294, DOI 10.1016/j.neulet.2005.02.030; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI 10.1038/nrneurol.2013.10; Richartz-Salzburger E, 2010, NERVENARZT, V81, P837, DOI 10.1007/s00115-009-2918-7; Rott R, 2013, CNS NEUROL DISORD-DR; Schapira AHV, 2013, CURR OPIN NEUROL, V26, P395, DOI 10.1097/WCO.0b013e3283633741; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; SCHULZ R, 1988, J GERONTOL, V43, pP113, DOI 10.1093/geronj/43.5.P113; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Simm A, 2008, BIOL CHEM, V389, P257, DOI 10.1515/BC.2008.034; Smith LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052285; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Sun ZF, 2013, MOVEMENT DISORD; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; van Geel WJA, 2008, J NEUROSCI METH, V168, P182, DOI 10.1016/j.jneumeth.2007.09.021; Fjorback AW, 2007, SCAND J CLIN LAB INV, V67, P431, DOI 10.1080/00365510601161497; Yung RL, 2008, AUTOIMMUNITY, V41, P329, DOI 10.1080/08916930802024889	80	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123444	10.1371/journal.pone.0123444	http://dx.doi.org/10.1371/journal.pone.0123444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844871	Green Published, gold, Green Submitted			2022-12-27	WOS:000352475700022
J	McAdams, RM; McPherson, RJ; Beyer, RP; Bammler, TK; Farin, FM; Juul, SE				McAdams, Ryan M.; McPherson, Ronald J.; Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.; Juul, Sandra E.			Dose-Dependent Effects of Morphine Exposure on mRNA and microRNA (miR) Expression in Hippocampus of Stressed Neonatal Mice	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; OXIDATIVE STRESS; CELLS; BRAIN; STEM; DIFFERENTIATION; INFLAMMATION; CYTOKINES; MOLECULE; DENSITY	Morphine is used to sedate critically ill infants to treat painful or stressful conditions associated with intensive care. Whether neonatal morphine exposure affects microRNA (miR) expression and thereby alters mRNA regulation is unknown. We tested the hypothesis that repeated morphine treatment in stress-exposed neonatal mice alters hippocampal mRNA and miR expression. C57BL/6 male mice were treated from postnatal day (P) 5 to P9 with morphine sulfate at 2 or 5 mg/kg ip twice daily and then exposed to stress consisting of hypoxia (100% N-2 1 min and 100% O-2 5 min) followed by 2h maternal separation. Control mice were untreated and dam-reared. mRNA and miR expression profiling was performed on hippocampal tissues at P9. Overall, 2 and 5 mg/kg morphine treatment altered expression of a total of 150 transcripts (>1.5 fold change, P<0.05) from which 100 unique mRNAs were recognized (21 genes were up- and 79 genes were down-regulated), and 5 mg/kg morphine affected 63 mRNAs exclusively. The most upregulated mRNAs were fidgetin, arginine vasopressin, and resistin-like alpha, and the most down-regulated were defensin beta 11, aquaporin 1, calmodulin-like 4, chloride intracellular channel 6, and claudin 2. Gene Set Enrichment Analysis revealed that morphine treatment affected pathways related to cell cycle, membrane function, signaling, metabolism, cell death, transcriptional regulation, and immune response. Morphine decreased expression of miR-204-5p, miR-455-3p, miR-448-5p, and miR-574-3p. Nine morphine-responsive mRNAs that are involved in neurodevelopment, neurotransmission, and inflammation are predicted targets of the aforementioned differentially expressed miRs. These data establish that morphine produces dose-dependent changes in both hippocampal mRNA and miR expression in stressed neonatal mice. If permanent, morphine-mediated neuroepigenetic effects may affect long-term hippocampal function, and this provides a mechanism for the neonatal morphine-related impairment of adult learning.	[McAdams, Ryan M.; McPherson, Ronald J.; Juul, Sandra E.] Univ Washington, Dept Pediat, Div Neonatol, Seattle, WA 98195 USA; [Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McAdams, RM (corresponding author), Univ Washington, Dept Pediat, Div Neonatol, Seattle, WA 98195 USA.	mcadams@uw.edu			Seattle Children's Hospital Academic Enrichment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER	Seattle Children's Hospital Academic Enrichment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a local award from the Seattle Children's Hospital Academic Enrichment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]; Adkins P, 2001, J IMMUNOL, V166, P918, DOI 10.4049/jimmunol.166.2.918; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Anand KJS, 2007, J PERINATOL, V27, pS4, DOI 10.1038/sj.jp.7211712; Barca-Mayo O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgart E, 1996, P NATL ACAD SCI USA, V93, P13748, DOI 10.1073/pnas.93.24.13748; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Boasen JF, 2009, NEONATOLOGY, V95, P230, DOI 10.1159/000165379; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Brown JN, 2012, MOL CELL PROTEOMICS, V11, P605, DOI 10.1074/mcp.M111.016121; Cacciagli P, 2014, EUR J HUM GENET, V22, P363, DOI 10.1038/ejhg.2013.135; Chavez-Valdez R, 2013, J PERINATOL, V33, P374, DOI 10.1038/jp.2012.124; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Cioni JM, 2013, CURR BIOL, V23, P850, DOI 10.1016/j.cub.2013.04.007; Cornwell WD, 2013, J NEUROIMMUNOL, V265, P43, DOI 10.1016/j.jneuroim.2013.09.013; Dave RS, 2010, J CELL BIOCHEM, V110, P834, DOI 10.1002/jcb.22592; Decaro MH, 2011, EARLY HUM DEV, V87, pS19, DOI 10.1016/j.earlhumdev.2011.01.005; Dorum G, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1418; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Filipczak-Bryniarska I, 2012, PHARMACOL REP, V64, P1200, DOI 10.1016/S1734-1140(12)70916-7; Fiore R, 2011, PROG MOL BIOL TRANSL, V102, P47, DOI 10.1016/B978-0-12-415795-8.00004-0; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghafari S, 2011, FOLIA NEUROPATHOL, V49, P328; GOODMAN RR, 1980, P NATL ACAD SCI-BIOL, V77, P6239, DOI 10.1073/pnas.77.10.6239; Hays SL, 2012, BEHAV BRAIN RES, V227, P7, DOI 10.1016/j.bbr.2011.10.033; He Ying, 2012, Frontiers in Genetics, V3, P110, DOI 10.3389/fgene.2012.00110; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Heimfarth L, 2013, METAB BRAIN DIS, V28, P429, DOI 10.1007/s11011-013-9379-1; Ji F, 2013, J GENET GENOMICS, V40, P61, DOI 10.1016/j.jgg.2012.12.008; Juul SE, 2011, PEDIATR RES, V69, P285, DOI 10.1203/PDR.0b013e31820bd165; Kahn L, 2005, EUR J NEUROSCI, V21, P493, DOI 10.1111/j.1460-9568.2005.03883.x; Kurokawa D, 2014, DEV BIOL, V387, P203, DOI 10.1016/j.ydbio.2014.01.011; Leviton A, 2005, ANN NEUROL, V58, P821, DOI 10.1002/ana.20662; Li YJ, 2013, NEUROSCI LETT, V545, P17, DOI 10.1016/j.neulet.2013.04.008; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Sanchez-Simon FM, 2010, MOL PHARMACOL, V78, P935, DOI 10.1124/mol.110.066837; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; McPherson RJ, 2007, NEONATOLOGY, V92, P33, DOI 10.1159/000100084; McPherson RJ, 2009, PEDIATR RES, V66, P278, DOI 10.1203/PDR.0b013e3181b1bd1b; Messmer D, 2006, MOL MED, V12, P284, DOI 10.2119/2006-00043.Messmer; Milner TA, 2013, SYNAPSE, V67, P757, DOI 10.1002/syn.21683; Mizota T, 2013, J ANESTH, V27, P80, DOI 10.1007/s00540-012-1472-9; Moghadam Paanteha K, 2013, Front Endocrinol (Lausanne), V4, P124, DOI 10.3389/fendo.2013.00124; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Peng XH, 2000, J LEUKOCYTE BIOL, V68, P723; Rodriguez Raquel E., 2012, Frontiers in Genetics, V3, P223, DOI 10.3389/fgene.2012.00223; Roy S, 2004, J NEUROIMMUNOL, V147, P78, DOI 10.1016/j.jneuroim.2003.10.016; Roy S, 2001, SURGERY, V130, P304, DOI 10.1067/msy.2001.116033; Roy S, 2011, J NEUROIMMUNE PHARM, V6, P442, DOI 10.1007/s11481-011-9292-5; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shao D, 2009, MOL CELL NEUROSCI, V42, P219, DOI 10.1016/j.mcn.2009.07.003; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Simeone A, 2011, MOL NEUROBIOL, V43, P107, DOI 10.1007/s12035-010-8148-y; Slamberova R, 2003, HIPPOCAMPUS, V13, P461, DOI 10.1002/hipo.10076; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudhof TC, 2013, NAT MED, V19, P1227, DOI 10.1038/nm.3338; Tapocik JD, 2013, ADDICT BIOL, V18, P480, DOI 10.1111/j.1369-1600.2012.00470.x; Tripathi PP, 2014, NEUROSCIENCE, V261, P173, DOI 10.1016/j.neuroscience.2013.12.045; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vien TN, 2009, NEONATOLOGY, V96, P235, DOI 10.1159/000220763; White R, 2012, FILM QUART, V65, P4, DOI 10.1525/FQ.2012.65.3.04; Williams WM, 2012, SCI WORLD J, DOI 10.1100/2012/905785; Wood Emily J., 2012, Frontiers in Genetics, V3, P241, DOI 10.3389/fgene.2012.00241; Wu QF, 2013, FASEB J, V27, P522, DOI 10.1096/fj.12-213439; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848; Zheng K, 2012, NEUROSCIENTIST, V18, P114, DOI 10.1177/1073858411398322	75	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123047	10.1371/journal.pone.0123047	http://dx.doi.org/10.1371/journal.pone.0123047			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844808	Green Published, Green Submitted, gold			2022-12-27	WOS:000352475700018
J	Siegl, D; Midura, EF; Annecke, T; Conzen, P; Caldwell, CC; Tschoep, J				Siegl, Daniel; Midura, Emily F.; Annecke, Thorsten; Conzen, Peter; Caldwell, Charles C.; Tschoep, Johannes			The Effect of Ghrelin upon the Early Immune Response in Lean and Obese Mice during Sepsis	PLOS ONE			English	Article							MURINE MODEL; CECAL LIGATION; PROTECTS MICE; PLASMA LEPTIN; ORGAN INJURY; MORTALITY; ACTIVATION; CYTOKINES; HYPOTHERMIA; EXPRESSION	Introduction It is well established that obesity-related hormones can have modulatory effects associated with the immune response. Ghrelin, a hormone mainly derived from endocrine cells of the gastric mucosa, regulates appetite, energy expenditure and body weight counteracting leptin, a hormone mainly derived from adipocytes. Additionally, receptors of both have been detected on immune cells and demonstrated an immune regulatory function during sepsis. Methods In the present study, the effect of peripheral ghrelin administration on early immune response and survival was investigated with lean mice and mice with diet-induced obesity using cecal ligation and puncture to induce sepsis. Results In the obese group, we found that ghrelin treatment improved survival, ameliorated hypothermia, and increased hyperleptinemia as compared to the lean controls. We also observed that ghrelin treatment divergently regulated serum IL-1 beta and TNF-alpha concentrations in both lean and obese septic mice. Ghrelin treatment initially decreased but later resulted in increased bacteriaemia in lean mice while having no impact upon obese mice. Similarly, ghrelin treatment increased early neutrophil oxidative burst while causing a decrease 48 hours after sepsis inducement. Conclusion In conclusion, as the immune response to sepsis temporally changes, ghrelin treatment differentially mediates this response. Specifically, we observed that ghrelin conferred protective effects during the early phase of sepsis, but during the later phase deteriorated immune response and outcome. These adverse effects were more pronounced upon lean mice as compared to obese mice.	[Siegl, Daniel] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Conzen, Peter; Tschoep, Johannes] Univ Hosp Munich LMU, Dept Anaesthesiol, Munich, Germany; [Midura, Emily F.; Caldwell, Charles C.] Univ Cincinnati, Coll Med, Dept Surg, Div Res, Cincinnati, OH USA; [Annecke, Thorsten] Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Cologne, Germany	University of Munich; University of Munich; University System of Ohio; University of Cincinnati; University of Cologne	Tschoep, J (corresponding author), Univ Hosp Munich LMU, Dept Anaesthesiol, Munich, Germany.	Johannes.Tschoep@med.uni-muenchen.de	Annecke, Thorsten/AAG-3909-2020	Annecke, Thorsten/0000-0002-2496-4432; Midura, Emily/0000-0002-7659-316X; Caldwell, Charles/0000-0003-1692-4550	Department of Anesthesiology, Ludwig-Maximilians-University Munich, Munich, Germany; Gesellschaft fur medizinische Forschung und Weiterbildung e.V., Munich, Germany; Metiphys (Munich Excellence Training Initiative for Physician Scientists) Program - Ludwig-Maximilians-University, Munich, Germany	Department of Anesthesiology, Ludwig-Maximilians-University Munich, Munich, Germany; Gesellschaft fur medizinische Forschung und Weiterbildung e.V., Munich, Germany; Metiphys (Munich Excellence Training Initiative for Physician Scientists) Program - Ludwig-Maximilians-University, Munich, Germany	The study was supported by an intramural grant of the Department of Anesthesiology, Ludwig-Maximilians-University Munich, Munich, Germany and by the Gesellschaft fur medizinische Forschung und Weiterbildung e.V., Munich, Germany (to JT) and by the Metiphys (Munich Excellence Training Initiative for Physician Scientists) Program awarded by Ludwig-Maximilians-University, Munich, Germany (to DS). No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami S, 1997, AM J PHYSIOL-HEART C, V272, pH2219, DOI 10.1152/ajpheart.1997.272.5.H2219; Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280; Chang L, 2003, ACTA PHARMACOL SIN, V24, P45; Chorny A, 2008, J IMMUNOL, V180, P8369, DOI 10.4049/jimmunol.180.12.8369; Disse E, 2011, PHYSIOL BEHAV, V102, P481, DOI 10.1016/j.physbeh.2010.12.006; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Jaeschke Roman Z, 2008, Pol Arch Med Wewn, V118, P92; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuperman EF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-377; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; Lin LG, 2012, METHOD ENZYMOL, V514, P355, DOI 10.1016/B978-0-12-381272-8.00022-2; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Marik PE, 2000, INTENS CARE MED, V26, P716, DOI 10.1007/s001340051237; Martignoni A, 2008, SHOCK, V29, P591, DOI 10.1097/SHK.0b013e318157f427; Maruna P, 2005, EUR SURG RES, V37, P354, DOI 10.1159/000090336; Medina E, 2010, METHODS MOL BIOL, V602, P411, DOI 10.1007/978-1-60761-058-8_23; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Murphey ED, 2004, SHOCK, V21, P415, DOI 10.1097/00024382-200405000-00004; Nieman DC, 1999, J AM DIET ASSOC, V99, P294, DOI 10.1016/S0002-8223(99)00077-2; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Peng ZY, 2012, INT IMMUNOPHARMACOL, V13, P440, DOI 10.1016/j.intimp.2012.04.006; PRUITT JH, 1995, SHOCK, V3, P235, DOI 10.1097/00024382-199504000-00001; Rajan D, 2012, SURGERY, V151, P37, DOI 10.1016/j.surg.2011.06.027; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Robertson CM, 2006, MICROBES INFECT, V8, P1382, DOI 10.1016/j.micinf.2005.12.016; Scumpia PO, 2005, CRIT CARE MED, V33, pS468, DOI 10.1097/01.CCM.0000186268.53799.67; Siegl D, 2014, ANESTHESIOLOGY, V121, P98, DOI 10.1097/ALN.0000000000000192; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Tschoep J, 2008, J LEUKOCYTE BIOL, V83, P581, DOI 10.1189/jlb.0707507; Tschoep Johannes, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P336; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Wang LX, 2006, AM J PHYSIOL-GASTR L, V291, pG611, DOI 10.1152/ajpgi.00533.2005; Wang W, 2009, AM J PHYSIOL-RENAL, V297, pF1032, DOI 10.1152/ajprenal.00044.2009; Waseern T, 2008, SURGERY, V143, P334, DOI 10.1016/j.surg.2007.09.039; Wiedmer P, 2011, PHYSIOL BEHAV, V105, P43, DOI 10.1016/j.physbeh.2011.03.027; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1296, DOI 10.1152/ajpheart.00852.2003; Xia Q, 2004, REGUL PEPTIDES, V122, P173, DOI 10.1016/j.regpep.2004.06.016; Yilmaz Z, 2008, CRIT CARE MED, V36, P828, DOI 10.1097/01.CCM.0B013E3181611F5AA	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122211	10.1371/journal.pone.0122211	http://dx.doi.org/10.1371/journal.pone.0122211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844479	Green Published, Green Submitted, gold			2022-12-27	WOS:000352475700012
J	Ahlin, C; Stupica, D; Strle, F; Lusa, L				Ahlin, Crt; Stupica, Dasa; Strle, Franc; Lusa, Lara			medplot: A Web Application for Dynamic Summary and Analysis of Longitudinal Medical Data Based on R	PLOS ONE			English	Article							FALSE DISCOVERY RATE; REGRESSION; SEPARATION	In biomedical studies the patients are often evaluated numerous times and a large number of variables are recorded at each time-point. Data entry and manipulation of longitudinal data can be performed using spreadsheet programs, which usually include some data plotting and analysis capabilities and are straightforward to use, but are not designed for the analyses of complex longitudinal data. Specialized statistical software offers more flexibility and capabilities, but first time users with biomedical background often find its use difficult. We developed medplot, an interactive web application that simplifies the exploration and analysis of longitudinal data. The application can be used to summarize, visualize and analyze data by researchers that are not familiar with statistical programs and whose knowledge of statistics is limited. The summary tools produce publication-ready tables and graphs. The analysis tools include features that are seldom available in spreadsheet software, such as correction for multiple testing, repeated measurement analyses and flexible non-linear modeling of the association of the numerical variables with the outcome. medplot is freely available and open source, it has an intuitive graphical user interface (GUI), it is accessible via the Internet and can be used within a web browser, without the need for installing and maintaining programs locally on the user's computer. This paper describes the application and gives detailed examples describing how to use the application on real data from a clinical study including patients with early Lyme borreliosis.	[Ahlin, Crt] Univ Ljubljana, Stat Programme, Ljubljana, Slovenia; [Stupica, Dasa; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Lusa, Lara] Univ Ljubljana, Inst Biostat & Med Informat, Ljubljana 61000, Slovenia	University of Ljubljana; University Medical Centre Ljubljana; University of Ljubljana	Lusa, L (corresponding author), Univ Ljubljana, Inst Biostat & Med Informat, Ljubljana 61000, Slovenia.	lara.lusa@mf.uni-lj.si	Lusa, Lara/C-6692-2015	Lusa, Lara/0000-0002-8981-2421	European Union; European Social Fund; Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development; Slovenian Research Agency [P3-0296]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This article is partly a result of doctoral research done by one of the authors, Crt Ahlin, which was in part financed by the European Union, European Social Fund and the Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development for the period 2007 - 2013. Franc Strle obtained grant from the Slovenian Research Agency (grant P3-0296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Browner W., 2013, DESIGNING CLIN RES, V4th, ppp65; Carro A, 2010, NUCLEIC ACIDS RES, V38, pW182, DOI 10.1093/nar/gkq441; Chang W, 2015, SHINY WEB APPL FRAME; Diaz-Uriarte R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000737; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2010, STAT MED, V29, P770, DOI 10.1002/sim.3794; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Ogrinc K, 2013, CLIN INFECT DIS, V57, P501, DOI 10.1093/cid/cit317; Petchey O. L., 2009, B BRIT ECOL SOC, V20, P55; R Core Team, 2021, R LANGUAGE ENV STAT; Sinha AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031690; Strle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082132; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; Swihart BJ, 2010, EPIDEMIOLOGY, V21, P621, DOI 10.1097/EDE.0b013e3181e5b06a; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wickham H, GGPLOT2 ELEGANT GRAP; Xie YH, 2014, IMPLEMENTING REPROD, P3	23	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121760	10.1371/journal.pone.0121760	http://dx.doi.org/10.1371/journal.pone.0121760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837352	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000060
J	Nygren, J; Shad, N; Kvarnheden, A; Westerbergh, A				Nygren, Jim; Shad, Nadeem; Kvarnheden, Anders; Westerbergh, Anna			Variation in Susceptibility to Wheat dwarf virus among Wild and Domesticated Wheat	PLOS ONE			English	Article							A-GENOME DONOR; NUCLEOTIDE DIVERSITY; GENETIC DIVERSITY; PLANT-RESISTANCE; POLYPLOID WHEAT; HOST-RANGE; B-GENOME; TRITICUM; AEGILOPS; ORIGIN	We investigated the variation in plant response in host-pathogen interactions between wild (Aegilops spp., Triticum spp.) and domesticated wheat (Triticum spp.) and Wheat dwarf virus (WDV). The distribution of WDV and its wild host species overlaps in Western Asia in the Fertile Crescent, suggesting a coevolutionary relationship. Bread wheat originates from a natural hybridization between wild emmer wheat (carrying the A and B genomes) and the wild D genome donor Aegilops tauschii, followed by polyploidization and domestication. We studied whether the strong selection during these evolutionary processes, leading to genetic bottlenecks, may have resulted in a loss of resistance in domesticated wheat. In addition, we investigated whether putative fluctuations in intensity of selection imposed on the hostpathogen interactions have resulted in a variation in susceptibility to WDV. To test our hypotheses we evaluated eighteen wild and domesticated wheat taxa, directly or indirectly involved in wheat evolution, for traits associated with WDV disease such as leaf chlorosis, different growth traits and WDV content. The plants were exposed to viruliferous leafhoppers (Psammotettix alienus) in a greenhouse trial and evaluated at two time points. We found three different plant response patterns: i) continuous reduction in growth over time, ii) weak response at an early stage of plant development but a much stronger response at a later stage, and iii) remission of symptoms over time. Variation in susceptibility may be explained by differences in the intensity of natural selection, shaping the coevolutionary interaction between WDV and the wild relatives. However, genetic bottlenecks during wheat evolution have not had a strong impact on WDV resistance. Further, this study indicates that the variation in susceptibility may be associated with the genome type and that the ancestor Ae. tauschii may be useful as genetic resource for the improvement of WDV resistance in wheat.	[Nygren, Jim; Shad, Nadeem; Kvarnheden, Anders; Westerbergh, Anna] Swedish Univ Agr Sci, Linnean Ctr Plant Biol Uppsala, Uppsala BioCtr, Dept Plant Biol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Westerbergh, A (corresponding author), Univ Punjab, Fac Life Sci, Inst Agr Sci, Lahore, Pakistan.	anna.westerbergh@slu.se			Swedish Research Council Formas; Royal Swedish Academy of Agriculture and Forestry; Higher Education Commission, Pakistan through University of the Punjab	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Royal Swedish Academy of Agriculture and Forestry; Higher Education Commission, Pakistan through University of the Punjab	This study has been funded by the Swedish Research Council Formas and the Royal Swedish Academy of Agriculture and Forestry. NS was supported by the Higher Education Commission, Pakistan through University of the Punjab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley S, 2014, GENE, V533, P142, DOI 10.1016/j.gene.2013.09.103; Baum BR, 2004, GENET RESOUR CROP EV, V51, P183, DOI 10.1023/B:GRES.0000020861.96294.f4; Behjatnia SAA, 2011, AUSTRALAS PLANT PATH, V40, P12, DOI 10.1007/s13313-010-0008-8; Benkovics AH, 2010, PLANT PATHOL, V59, P1144, DOI 10.1111/j.1365-3059.2010.02318.x; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bisnieks M, 2005, Z PFLANZENK PFLANZEN, V112, P521; BOULTON MI, 1991, VIROLOGY, V181, P312, DOI 10.1016/0042-6822(91)90497-Y; BOULTON MI, 1991, VIROLOGY, V183, P114, DOI 10.1016/0042-6822(91)90124-T; BOULTON RE, 1980, ANN APPL BIOL, V94, P69, DOI 10.1111/j.1744-7348.1980.tb03897.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; Brown JK, 2005, PHYTOPATHOLOGY, V95, P1217, DOI 10.1094/PHYTO-95-1217; Carrillo-Tripp J, 2007, PHYTOPATHOLOGY, V97, P51, DOI 10.1094/PHYTO-97-0051; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2004, J VIROL, V78, P7465, DOI 10.1128/JVI.78.14.7465-7477.2004; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; DVORAK J, 1993, GENOME, V36, P21, DOI 10.1139/g93-004; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Ekzayez AM, 2011, PLANT DIS, V95, P76, DOI 10.1094/PDIS-09-10-0628; Fargette D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000125; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Hagen C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029; Hall MD, 2009, EUPHYTICA, V169, P169, DOI 10.1007/s10681-009-9910-y; HAMMER K, 1980, Kulturpflanze, V28, P33; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Hohn T, 2011, BBA-GENE REGUL MECH, V1809, P588, DOI 10.1016/j.bbagrm.2011.06.002; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Kanyuka K, 2004, PLANT PATHOL, V53, P154, DOI 10.1111/j.0032-0862.2004.01000.x; Karagoz Alptekin, 2006, Turkish Journal of Agriculture and Forestry, V30, P387; Kilian B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P1, DOI 10.1007/978-3-642-14228-4_1; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; Koklu G, 2004, PHYTOPROTECTION, V85, P19, DOI 10.7202/008902ar; Koklu G, 2007, VIRUS GENES, V34, P359, DOI 10.1007/s11262-006-0029-0; Kvarnheden A, 2002, ARCH VIROL, V147, P205, DOI 10.1007/s705-002-8313-x; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Laine AL, 2011, J ECOL, V99, P96, DOI 10.1111/j.1365-2745.2010.01738.x; Laine AL, 2009, J EXP BOT, V60, P2957, DOI 10.1093/jxb/erp168; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Li WL, 2012, PLANT CELL REP, V31, P905, DOI 10.1007/s00299-011-1211-y; Lindblad M, 2004, CROP PROT, V23, P229, DOI 10.1016/j.cropro.2003.08.011; Lindblad M, 2002, AGR ECOSYST ENVIRON, V92, P115, DOI 10.1016/S0167-8809(01)00302-4; LINDSTEN K, 1991, ACTA PHYTOPATHOL HUN, V26, P175; LINDSTEN K, 1970, Statens Vaxtskyddsanstalt Meddelanden, V14, P285; Lindsten K., 1980, P 3 C VIR DIS GRAM E, P27; Liu Y, 2014, VIRUS RES, V190, P34, DOI 10.1016/j.virusres.2014.06.014; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Mochizuki T, 2014, VIROLOGY, V456, P292, DOI 10.1016/j.virol.2014.04.010; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Persson T, 2007, ACTA AGR SCAND B-S P, V57, P10, DOI 10.1080/09064710500487895; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Ramsell JNE, 2008, PLANT PATHOL, V57, P834, DOI 10.1111/j.1365-3059.2008.01862.x; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Sirlova Lenka, 2005, Plant Protection Science, V41, P1; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Thompson J. N., 2005, INTERSPEC INTERACT; Tsuda S, 2007, PHYTOPATHOLOGY, V97, P412, DOI 10.1094/PHYTO-97-4-0412; Vacke J., 2001, Czech Journal of Genetics and Plant Breeding, V37, P50; Vacke J., 2000, Czech Journal of Genetics and Plant Breeding, V36, P1; Vacke J., 1972, Vedecke Prace Vyzkumnych Ustavu Rostlinne Vyroby v Praze-Ruzyni, V17, P151; VACKE J, 1961, BIOL PLANTARUM, V3, P228, DOI 10.1007/BF02933566; Vacke J, 1964, P 5 C CZECH PLANT VI, P331; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Vuorinen AL, 2011, PLANT SCI, V181, P355, DOI 10.1016/j.plantsci.2011.06.008; WAINES JG, 1992, HEREDITAS, V116, P207, DOI 10.1111/j.1601-5223.1992.tb00143.x; Wang YJ, 2014, PHYTOPATHOLOGY, V104, P897, DOI 10.1094/PHYTO-09-13-0251-R; Wang YQ, 2014, J GEN VIROL, V95, P2082, DOI 10.1099/vir.0.064246-0; Ward E, 2005, NEW PHYTOL, V165, P875, DOI 10.1111/j.1469-8137.2004.01291.x; Wu BL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-335; Yazdkhasti E., 2012, THESIS SWEDISH U AGR; Zaharieva M, 2001, EUPHYTICA, V119, P33, DOI 10.1023/A:1017500728227; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	87	19	20	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121580	10.1371/journal.pone.0121580	http://dx.doi.org/10.1371/journal.pone.0121580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837893	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000048
J	Zhang, LQ; Polyansky, A; Buck, M				Zhang, Liqun; Polyansky, Anton; Buck, Matthias			Modeling Transmembrane Domain Dimers/Trimers of Plexin Receptors: Implications for Mechanisms of Signal Transmission across the Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GTPASE BINDING DOMAIN; HELIX ASSOCIATION; LIPID-BILAYERS; EGF RECEPTOR; PROTEINS; DIMERS; PREDICTION; PROGRAM; RND1	Single-pass transmembrane (TM) receptors transmit signals across lipid bilayers by helix association or by configurational changes within preformed dimers. The structure determination for such TM regions is challenging and has mostly been accomplished by NMR spectroscopy. Recently, the computational prediction of TM dimer structures is becoming recognized for providing models, including alternate conformational states, which are important for receptor regulation. Here we pursued a strategy to predict helix oligomers that is based on packing considerations (using the PREDDIMER webserver) and is followed by a refinement of structures, utilizing microsecond all-atom molecular dynamics simulations. We applied this method to plexin TM receptors, a family of 9 human proteins, involved in the regulation of cell guidance and motility. The predicted models show that, overall, the preferences identified by PREDDIMER are preserved in the unrestrained simulations and that TM structures are likely to be diverse across the plexin family. Plexin-B1 and -B3 TM helices are regular and tend to associate, whereas plexin-A1, -A2, -A3, -A4, -C1 and -D1 contain sequence elements, such as poly-Glycine or aromatic residues that distort helix conformation and association. Plexin-B2 does not form stable dimers due to the presence of TM prolines. No experimental structural information on the TM region is available for these proteins, except for plexin-C1 dimeric and plexin-B1 -trimeric structures inferred from X-ray crystal structures of the intracellular regions. Plexin-B1 TM trimers utilize Ser and Thr sidechains for interhelical contacts. We also modeled the juxtamembrane (JM) region of plexin-C1 and plexin-B1 and show that it synergizes with the TM structures. The structure and dynamics of the JM region and TM-JM junction provide determinants for the distance and distribution of the intracellular domains, and for their binding partners relative to the membrane. The structures suggest experimental tests and will be useful for the interpretation of future studies.	[Zhang, Liqun; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Polyansky, Anton] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, AT-1030 Vienna, Austria; [Polyansky, Anton] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Neurosci, Case Comprehens Canc Ctr,Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Case Comprehens Canc Ctr,Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; University of Vienna; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Case Western Reserve University; Case Western Reserve University	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Matthias.Buck@case.edu	Buck, Matthias/B-2106-2017; Zhang, Li/GWM-7501-2022; Polyansky, Anton A/J-2145-2018	Buck, Matthias/0000-0002-2958-0403; Polyansky, Anton A/0000-0002-1011-2706	NIH [1R01GM112491, R21EY022839]; Russian Scientific Foundation [14-1400871];  [NIH T32DK007470]; Russian Science Foundation [14-14-00871] Funding Source: Russian Science Foundation; NATIONAL EYE INSTITUTE [R21EY022839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112491, R01GM092851, RC2GM093307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Scientific Foundation(Russian Science Foundation (RSF)); ; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by grants to M.B. (partially by NIH 1R01GM112491, then R21EY022839 which were preceded by R01GM092851) and a postdoctoral fellowship to L.Z. (NIH T32DK007470). A.A.P. expresses his gratitude to the Russian Scientific Foundation (grant 14-1400871) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aci-Seche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097779; Adamian L, 2005, PROTEINS, V59, P496, DOI 10.1002/prot.20456; [Anonymous], PYM MOL GRAPH SYST V; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Azzarelli R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4405; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Bocharov EV, 2010, CELL ADHES MIGR, V4, P284, DOI 10.4161/cam.4.2.11930; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; Braun R, 2004, BIOPHYS J, V87, P754, DOI 10.1529/biophysj.104.040279; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2007, BIOPHYS J, V92, P854, DOI 10.1529/biophysj.106.095216; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; Dror RO, 2009, IEEE ENG MED BIO, P2340, DOI 10.1109/IEMBS.2009.5335057; Garman EF, 2014, SCIENCE, V343, P1102, DOI 10.1126/science.1247829; Hendrickson WA, 2005, Q REV BIOPHYS, V38, P321, DOI 10.1017/S0033583506004136; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Im W, 2012, BBA-BIOMEMBRANES, V1818, P252, DOI 10.1016/j.bbamem.2011.07.048; Jang H, 2006, BIOPHYS J, V91, P2848, DOI 10.1529/biophysj.106.084046; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Koldso H, 2014, MARK LIPID CLUSTERIN, DOI [10.1371/journal.pcbi.1003911, DOI 10.1371/JOURNAL.PCBI.1003911]; Kordyukova LV, 2011, BBA-BIOMEMBRANES, V1808, P1843, DOI 10.1016/j.bbamem.2011.03.005; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Li PC, 2014, J COMPUT CHEM, V35, P300, DOI 10.1002/jcc.23494; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Polyansky AA, 2012, J AM CHEM SOC, V134, P14390, DOI 10.1021/ja303483k; Reddy T, 2014, BIOCHEMISTRY-US, V53, P323, DOI 10.1021/bi401576k; Roney KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024795; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawma P, 2014, J MOL BIOL, DOI [10.1016/jmb.2014.10.007, DOI 10.1016/JMB.2014.10.007]; Sayadi M, 2010, BIOPHYS J, V98, P805, DOI 10.1016/j.bpj.2009.11.015; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Torres J, 2003, TRENDS BIOCHEM SCI, V28, P137, DOI 10.1016/S0968-0004(03)00026-4; Trigg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023519; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wang H, 2011, J BIOL CHEM, V286, P26093, DOI 10.1074/jbc.M110.197053; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zerbetto M, 2013, J PHYS CHEM B, V117, P174, DOI 10.1021/jp310142f; Zhang JM, 2009, BIOPHYS J, V96, P4418, DOI 10.1016/j.bpj.2009.03.008; Zhang LQ, 2013, PROTEINS, V81, P365, DOI 10.1002/prot.24192; Ziomkiewicz I, 2013, CYTOM PART A, V83, P794, DOI 10.1002/cyto.a.22311	54	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121513	10.1371/journal.pone.0121513	http://dx.doi.org/10.1371/journal.pone.0121513			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837709	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000046
J	Galik, A; Mohandesan, E; Forstenpointner, G; Scholz, UM; Ruiz, E; Krenn, M; Burger, P				Galik, Alfred; Mohandesan, Elmira; Forstenpointner, Gerhard; Scholz, Ute Maria; Ruiz, Emily; Krenn, Martin; Burger, Pamela			A Sunken Ship of the Desert at the River Danube in Tulln, Austria	PLOS ONE			English	Article							MEDICAL-TREATMENT; CAMELS; DROMEDARY; ANATOMY	Rescue excavations recovered a skeleton that resurrect the contemporary dramatic history of Austria in the 17th century as troops besieged Vienna in the second Osmanic-Habsburg war. Unique for Central Europe is the evidence of a completely preserved camel skeleton uncovered in a large refuse pit. The male individual of slender stature indicates a few but characteristic pathological changes revealing not a beast of burden but probably a valuable riding animal. Anatomical and morphometrical analyses suggest a hybrid confirmed by the ancient DNA analyses resulting in the presence of a dromedary in the maternal and a Bactrian camel in the paternal line.	[Galik, Alfred; Forstenpointner, Gerhard] Vetmeduni, Inst Anat Histol & Embryol, Vienna, Austria; [Mohandesan, Elmira; Scholz, Ute Maria; Ruiz, Emily; Burger, Pamela] Vetmeduni, Inst Populat Genet, Vienna, Austria; [Scholz, Ute Maria] Univ Vienna, Inst Prehist & Hist Archaeol, Vienna, Austria; [Krenn, Martin] Fed Off Protect Monuments Vienna, Vienna, Austria	University of Vienna	Galik, A (corresponding author), Vetmeduni, Inst Anat Histol & Embryol, Vienna, Austria.	alfred.galik@vetmeduni.ac.at	ANIKUZHIYIL, ANISH/Y-8609-2018	ANIKUZHIYIL, ANISH/0000-0001-9686-1283; Galik, Alfred/0000-0002-7070-1035; Burger, Pamela/0000-0002-6941-0257; Ruiz Puerta, Emily Johana/0000-0002-0129-9417; Scholz, Ute/0000-0003-0002-8807	Austrian Science Foundation FWF project [P24706-B25]; Austrian Academy of Sciences [11506]; Austrian Science Fund (FWF) [P 24706] Funding Source: researchfish	Austrian Science Foundation FWF project(Austrian Science Fund (FWF)); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	EM and RF were supported by the Austrian Science Foundation FWF project (P24706-B25) to P. Burger, who is recipient of an APART fellowship (11506) from the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mathen Charruau, UNPUB; Balasescu A, 2014, ANTHROPOZOOLOGICA, V49, P253, DOI 10.5252/az2014n2a07; Bartosiewicz L., 2003, HUNGARIAN ARCHAEOLOG, P60; Bartosiewicz L., 1995, ARCHAEOZOOLOGY NEAR, P119; Bartosiewicz L, 2014, ANTHROPOZOOLOGICA, V49, P297, DOI 10.5252/az2014n2a10; BEHRENSMEYER A K, 1975, Bulletin of the Museum of Comparative Zoology, V146, P473; Bello A., 2013, Scientific Journal of Animal Science, V2, P9; Biack O, 1982, GESCH STADT TULLN; Biack O, 1991, TULLNER HAUSERCHRONI; Bulliet Richard, 1990, CAMEL WHEEL; Cakirlar C, 2014, ANTHROPOZOOLOGICA, V49, P237, DOI 10.5252/az2014n2a06; Driesch von den A, 1976, PEABODY MUSEUM B, V1, P136; FAROQHI S, 1982, INT J MIDDLE E STUD, V14, P523, DOI 10.1017/S0020743800052193; Faye B., 2019, CAMELS ASIA N AFRICA, P28; Gauthier-Pilters H., 1981, CAMEL ITS EVOLUTION; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Honey J. G, 2007, EVOLUTION ARTIODACTY, P177; Inalcik Halil., 1994, EC SOCIAL HIST OTTOM; KOHLER-ROLLEFSON I U, 1991, Mammalian Species, P1, DOI 10.2307/3504297; KOHLER-ROLLEFSON I. U., 1989, PELLA DECAPOLIS, V2, P142; Lesbre FX, 1903, RECHERCHES ANATOMIQU; Mason I., 1984, EVOLUTION DOMESTICAT; Monfared A. L., 2013, Global Veterinaria, V10, P322; Moreno-Garcia M, 2007, ARCHAEOFAUNA, V16, P193; Morrison DG, 1974, HDB MARKETING RES; Mukasa-Mugerwa E, 1981, INT LIVESTOCK CTR AF, V5, P1; Naumann R., CAMELUS DROMEDARIUS; Onar V, 2013, TURK J VET ANIM SCI, V37, P81, DOI 10.3906/vet-1111-7; Peters J, 1997, TIERARZTL PRAX G N, V25, P559; Peters J, 1997, J ZOOL, V242, P651, DOI 10.1111/j.1469-7998.1997.tb05819.x; Peters J, 1998, Z SAUGETIERKD, V63, P372; Pigiere F, 2012, J ARCHAEOL SCI, V39, P1531, DOI 10.1016/j.jas.2011.11.014; Potts D.T., 2004, J ECON SOC HIST ORIE, V47, P143, DOI DOI 10.1163/1568520041262314; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Ruiz E, 2015, CONSERV GENET RESOUR, V7, P329, DOI 10.1007/s12686-015-0420-z; Scholz U, 2011, P 15 INT C CULT HER, P51; Smuts M., 1987, ANATOMY DROMEDARY; Stanc S., 2012, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies, V69, P203; Steiger C, 1990, THESIS; STUDER J., 2008, TRAVAUX MAISON ORIEN, V49, P581; Tapper R, CAM C SOAS 23 25 MAY; Uyar Mesut, 2009, MILITARY HIST OTTOMA; Vedat C, 2010, TURIZAM, V14, P22; VUKOVIC S., 2013, STARINAR, V63, P251, DOI DOI 10.2298/STA1363251V; Vukovic-Bogdanovic S, 2014, ANTHROPOZOOLOGICA, V49, P281, DOI 10.5252/az2014n2a09; Wilson RT, 1984, THE CAMEL; Yahaya A., 2012, Journal of Morphological Sciences, V29, P140; Yahaya Ahmed, 2012, Italian Journal of Anatomy and Embryology, V117, P34	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121235	10.1371/journal.pone.0121235	http://dx.doi.org/10.1371/journal.pone.0121235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831121	gold, Green Submitted, Green Published			2022-12-27	WOS:000352135600063
J	Hou, J; Wang, ZL; Xu, H; Yang, LN; Yu, XL; Yang, ZZ; Deng, Y; Meng, J; Feng, Y; Guo, XM; Yang, G				Hou, Jing; Wang, Ziliang; Xu, Han; Yang, Lina; Yu, Xiaoli; Yang, Zhaozhi; Deng, Yun; Meng, Jiao; Feng, Yan; Guo, Xiaomao; Yang, Gong			Stanniocalicin 2 Suppresses Breast Cancer Cell Migration and Invasion via the PKC/Claudin-1-Mediated Signaling	PLOS ONE			English	Article							GENE-EXPRESSION; EMT; PKC; CLAUDIN-1; FAMILY; PHOSPHORYLATION; OVEREXPRESSION; IDENTIFICATION; LOCALIZATION; PROGRESSION	Stanniocalcin (STC), a glycoprotein hormone, is expressed in a wide variety of tissues to regulate Ca2+ and PO4(-) homeostasis. STC2, a member of STC family, has been reported to be associated with tumor development. In this study, we investigated whether the expression of STC2 is associated with migration and invasion of breast cancer cells. We found that breast cancer cell line 231 HM transfected with STC2 shRNA displayed high motility, fibroblast morphology, and enhanced cell migration and invasion. Introduction of STC2 in 231 cells reduced cell migration and invasion. In response to irradiation, silencing of STC2 in 231 HM cells reduced apoptosis, whereas overexpression of STC2 in 231 cells promoted apoptosis, compared with in control cells. Mechanistic study showed that STC2 negatively regulated PKC to control the expression of Claudin-1, which subsequently induced the expressions of EMT-related factors including ZEB1, ZO-1, Slug, Twist, and MMP9. Suppression of PKC activity by using a PKC inhibitor (Go 6983) restored the normal motility of STC2-silenced cells. Furthermore, in vivo animal assay showed that STC2 inhibited tumorigenesis and metastasis of breast cancer cells. Collectively, these results indicate that STC2 may inhibit EMT at least partially through the PKC/Claudin-1-mediated signaling in human breast cancer cells. Thus, STC2 may be exploited as a biomarker for metastasis and targeted therapy in human breast cancer.	[Hou, Jing; Yu, Xiaoli; Yang, Zhaozhi; Feng, Yan; Guo, Xiaomao] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Hou, Jing; Wang, Ziliang; Xu, Han; Yang, Lina; Yu, Xiaoli; Yang, Zhaozhi; Deng, Yun; Meng, Jiao; Feng, Yan; Guo, Xiaomao; Yang, Gong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Hou, Jing; Wang, Ziliang; Yang, Lina; Deng, Yun; Meng, Jiao; Yang, Gong] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China; [Xu, Han] Fudan Univ, Shanghai Canc Ctr, Breast Surg, Shanghai 200433, Peoples R China; [Yang, Gong] Fudan Univ, Peoples Hosp Shanghai 1, Cent Lab, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Guo, XM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China.	guoxm1800@126.com; yanggong@fudan.edu.cn			National Nature Science Foundation of China [91129721, 81372430]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (#91129721) for Gong Yang, and by National Nature Science Foundation of China (#81372430) for Xiaomao Guo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouras T, 2002, CANCER RES, V62, P1289; Burgess DJ, 2013, NAT REV CANCER, V13, P148, DOI 10.1038/nrc3475; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; Chang ACM, 2008, ENDOCRINOLOGY, V149, P2403, DOI 10.1210/en.2007-1219; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Cowin P, 2007, J MAMMARY GLAND BIOL, V12, P99, DOI 10.1007/s10911-007-9041-9; Esseghir S, 2007, CLIN CANCER RES, V13, P3164, DOI 10.1158/1078-0432.CCR-07-0224; French AD, 2009, INT J MED SCI, V6, P93; Gagliardi AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE92, DOI 10.1152/ajpendo.00268.2004; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Ieta K, 2009, INT J CANCER, V125, P926, DOI 10.1002/ijc.24453; Ito D, 2004, MOL CELL BIOL, V24, P9456, DOI 10.1128/MCB.24.21.9456-9469.2004; Ivaska Johanna, 2011, Small GTPases, V2, P51; Iwao K, 2002, HUM MOL GENET, V11, P199, DOI 10.1093/hmg/11.2.199; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Law AYS, 2010, EXP CELL RES, V316, P3425, DOI 10.1016/j.yexcr.2010.06.026; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Li ZH, 2012, ONCOL REP, V27, P1879, DOI 10.3892/or.2012.1728; Low AYS, 2010, EXP CELL RES, V316, P466, DOI 10.1016/j.yexcr.2009.09.018; Madsen KL, 1998, AM J PHYSIOL-GASTR L, V274, pG96, DOI 10.1152/ajpgi.1998.274.1.G96; Okumura M, 2002, BBA-MOL CELL RES, V1592, P107, DOI 10.1016/S0167-4889(02)00276-8; Raulic S, 2008, J ENDOCRINOL, V197, P517, DOI 10.1677/JOE-08-0043; Sjo A, 2010, J MEMBRANE BIOL, V236, P181, DOI 10.1007/s00232-010-9289-7; Smit MA, 2008, CANCER CELL, V14, P5, DOI 10.1016/j.ccr.2008.06.012; Stebbing J, 2013, ONCOGENE, V32, P4871, DOI 10.1038/onc.2012.591; Tamura K, 2009, CANCER SCI, V100, P914, DOI 10.1111/j.1349-7006.2009.01117.x; Volland S, 2009, INT J CANCER, V125, P2049, DOI 10.1002/ijc.24564; Wagner GF, 1997, J BONE MINER RES, V12, P165, DOI 10.1359/jbmr.1997.12.2.165; Wagner GF, 2006, J EXP ZOOL PART A, V305A, P769, DOI 10.1002/jez.a.313; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Yamamura J, 2004, CANCER SCI, V95, P887, DOI 10.1111/j.1349-7006.2004.tb02198.x; Yang G, 2003, ONCOGENE, V22, P5694, DOI 10.1038/sj.onc.1206858; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang MY, 2010, J AGR FOOD CHEM, V58, P5806, DOI 10.1021/jf100718b; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zeiger W, 2011, MOL CELL BIOL, V31, P3710, DOI 10.1128/MCB.05140-11; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	41	37	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122179	10.1371/journal.pone.0122179	http://dx.doi.org/10.1371/journal.pone.0122179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830567	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600100
J	Kovac, J; Simunovic, K; Wu, ZW; Klancnik, A; Bucar, F; Zhang, QJ; Mozina, SS				Kovac, Jasna; Simunovic, Katarina; Wu, Zuowei; Klancnik, Anja; Bucar, Franz; Zhang, Qijing; Mozina, Sonja Smole			Antibiotic Resistance Modulation and Modes of Action of (-)-alpha-Pinene in Campylobacter jejuni	PLOS ONE			English	Article							ALPINIA-KATSUMADAI; EFFLUX INHIBITORS; ESSENTIAL OIL; ANTIBACTERIAL; CMEABC	The aim of the study was to investigate the mode of action of (-)-alpha-pinene in terms of its modulation of antibiotic resistance in Campylobacter jejuni. Broth microdilution and ethidium bromide accumulation assays were used to evaluate the (-)-alpha-pinene antimicrobial activity, modulation of antimicrobial resistance, and inhibition of antimicrobial efflux. The target antimicrobial efflux systems were identified using an insertion mutagenesis approach, and C. jejuni adaptation to (-)-alpha-pinene was evaluated using DNA microarrays. Knock-out mutants of the key up- regulated transcriptional regulators hspR and hrcA were constructed to investigate their roles in C. jejuni adaptation to several stress factors, including osmolytes, and pH, using Biolog phenotypical microarrays. Our data demonstrate that (-)-alpha-pinene efficiently modulates antibiotic resistance in C. jejuni by decreasing the minimum inhibitory concentrations of ciprofloxacin, erythromycin and triclosan by up to 512-fold. Furthermore, (-)-alpha-pinene promotes increased expression of cmeABC and another putative antimicrobial efflux gene, Cj1687. The ethidium bromide accumulation was greater in the wild-type strain than in the antimicrobial efflux mutant strains, which indicates that these antimicrobial efflux systems are a target of action of (-)-alpha-pinene. Additionally, (-)-alpha-pinene decreases membrane integrity, which suggests that enhanced microbial influx is a secondary mode of action of (-)-alpha-pinene. Transcriptomic analysis indicated that (-)-alpha-pinene disrupts multiple metabolic pathways, and particularly those involved in heat-shock responses. Thus, (-)-alpha-pinene has significant activity in the modulation of antibiotic resistance in C. jejuni, which appears to be mediated by multiple mechanisms that include inhibition of microbial efflux, decreased membrane integrity, and metabolic disruption. These data warrant further studies on (-)-alpha-pinene to develop its use in the control of antibiotic resistance in Campylobacter.	[Kovac, Jasna; Simunovic, Katarina; Klancnik, Anja; Mozina, Sonja Smole] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia; [Wu, Zuowei; Zhang, Qijing] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Bucar, Franz] Graz Univ, Inst Pharmaceut Sci, Dept Pharmacognosy, Graz, Austria	University of Ljubljana; Iowa State University; University of Graz	Mozina, SS (corresponding author), Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia.	sonja.smole-mozina@bf.uni-lj.si	Klančnik, Anja/I-4571-2012	Klančnik, Anja/0000-0003-1632-5785	European Commission through project PROMISE [FP7-265877]; Slovenian Research Agency ARRS [BI-US/11-12-043, WTZ SI 03/2011, BIA-500054]; EU European Social Fund; Republic of Slovenia, Ministry for Education, Science and Sport	European Commission through project PROMISE; Slovenian Research Agency ARRS(Slovenian Research Agency - Slovenia); EU European Social Fund(European Social Fund (ESF)European Commission); Republic of Slovenia, Ministry for Education, Science and Sport	This study was partially financed by the European Commission through project PROMISE (FP7-265877), and the Slovenian Research Agency ARRS (BI-US/11-12-043; WTZ SI 03/2011; BIA-500054). The research work of JK was supported by the EU European Social Fund and the Republic of Slovenia, Ministry for Education, Science and Sport, in the framework of the Operational programme for human resources development for the period 2007-2013.	Akiba M, 2006, J ANTIMICROB CHEMOTH, V57, P52, DOI 10.1093/jac/dki419; Cameron A, 2012, J BACTERIOL, V194, P6116, DOI 10.1128/JB.01409-12; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC, P1; Corcionivoschi N, 2012, CELL HOST MICROBE, V12, P47, DOI 10.1016/j.chom.2012.05.018; Dufour V, 2013, APPL ENVIRON MICROB, V79, P6958, DOI 10.1128/AEM.01967-13; European Center for Disease Prevention and Control EMA, 2009, THE BACTERIAL CHALLE; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Groblacher B, 2012, J NAT PROD, V75, P1393, DOI 10.1021/np300375t; Groblacher B, 2012, BIOORGAN MED CHEM, V20, P2701, DOI 10.1016/j.bmc.2012.02.039; Herrmann F, 2011, PHYTOMEDICINE, V18, P1191, DOI 10.1016/j.phymed.2011.08.070; Holmes CW, 2010, MICROBIOL-SGM, V156, P158, DOI 10.1099/mic.0.031708-0; Jeon B, 2011, J ANTIMICROB CHEMOTH, V66, P79, DOI 10.1093/jac/dkq418; Klancnik A, 2012, J APPL MICROBIOL, V113, P1249, DOI 10.1111/j.1365-2672.2012.05424.x; Klancnik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051800; Kovac J, 2014, EPIDEMIOLOGY AND INF, V13, P1; Kovac J, 2014, FOOD TECHNOL BIOTECH, V52, P248; Kurincic M, 2012, INT J ANTIMICROB AG, V40, P467, DOI 10.1016/j.ijantimicag.2012.07.015; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; da Silva ACR, 2012, MOLECULES, V17, P6305, DOI 10.3390/molecules17066305; Shiu WKP, 2013, INT J ANTIMICROB AG, V42, P513, DOI 10.1016/j.ijantimicag.2013.08.007; Simoes M, 2008, MED CHEM, V4, P616, DOI 10.2174/157340608786242016; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Teixeira B, 2013, IND CROP PROD, V43, P587, DOI 10.1016/j.indcrop.2012.07.069; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; Wang W, 2012, MOLECULES, V17, P2704, DOI 10.3390/molecules17032704; Wu ZW, 2013, GENOME BIOL EVOL, V5, P2217, DOI 10.1093/gbe/evt172; Xia QQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-133	30	66	69	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122871	10.1371/journal.pone.0122871	http://dx.doi.org/10.1371/journal.pone.0122871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830640	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600129
J	Ali, H; Al-Yatama, MK; Abu-Farha, M; Behbehani, K; Al Madhoun, A				Ali, Hamad; Al-Yatama, Majda K.; Abu-Farha, Mohamed; Behbehani, Kazem; Al Madhoun, Ashraf			Multi-Lineage Differentiation of Human Umbilical Cord Wharton's Jelly Mesenchymal Stromal Cells Mediates Changes in the Expression Profile of Stemness Markers	PLOS ONE			English	Article							BONE-MARROW; PROLIFERATION; SUPPRESSION; PHENOTYPE; MIGRATION; PROTEOMES; EXPANSION; RESPONSES; RECEPTOR; CAPACITY	Wharton's Jelly-derived Mesenchymal stem cells (WJ-MSCs) have gained interest as an alternative source of stem cells for regenerative medicine because of their potential for self-renewal, differentiation and unique immunomodulatory properties. Although many studies have characterized various WJ-MSCs biologically, the expression profiles of the commonly used stemness markers have not yet been addressed. In this study, WJ-MSCs were isolated and characterized for stemness and surface markers expression. Flow cytometry, immunofluorescence and qRT-PCR analysis revealed predominant expression of CD29, CD44, CD73, CD90, CD105 and CD166 in WJ-MSCs, while the hematopoietic and endothelial markers were absent. Differential expression of CD 29, CD90, CD105 and CD166 following adipogenic, osteogenic and chondrogenic induction was observed. Furthermore, our results demonstrated a reduction in CD44 and CD73 expressions in response to the tri-lineage differentiation induction, suggesting that they can be used as reliable stemness markers, since their expression was associated with undifferentiated WJ-MSCs only.	[Ali, Hamad; Behbehani, Kazem; Al Madhoun, Ashraf] Dasman Diabet Inst, Dept Basic Sci Res, Dasman 1180, Kuwait; [Ali, Hamad] Kuwait Univ, Fac Allied Hlth Sci, Hlth Sci Ctr, Dept Med Lab Sci MLS, Kuwait, Kuwait; [Al-Yatama, Majda K.] Dar Al Baraa Med Ctr, Hawally 3357, Kuwait; [Abu-Farha, Mohamed] Dasman Diabet Inst, Biochem & Mol Biol Unit, Dasman 1180, Kuwait	Kuwait University	Al Madhoun, A (corresponding author), Dasman Diabet Inst, Dept Basic Sci Res, Dasman 1180, Kuwait.	ashraf.madhoun@dasmaninstitute.org	Ali, Hamad/AAA-2192-2021	Yaseen Ali, Hamad/0000-0001-6623-3374; Al Madhoun, Ashraf/0000-0001-8593-3878; Abu-Farha, Mohamed/0000-0001-8357-1252	Kuwait Foundation for the Advancement of Sciences [RA-2013-009, 2012-1302-03]; OMICSRU grant [SRUL02/13]	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); OMICSRU grant	RA-2013-009 and 2012-1302-03, www.kfas.org, Kuwait Foundation for the Advancement of Sciences, for AAM and HA, respectively. OMICSRU grant SRUL02/13 for HA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075342; Al Madhoun AS, 2013, J MOL CELL CARDIOL, V60, P164, DOI 10.1016/j.yjmcc.2013.04.003; Al Madhoun AS, 2011, EMBO J, V30, P2477, DOI 10.1038/emboj.2011.153; Ali H, 2013, ACTA NEUROBIOL EXP, V73, P250; Ali H, 2012, STEM CELL REV REP, V8, P210, DOI 10.1007/s12015-011-9287-x; Ali H, 2009, ACTA NEUROBIOL EXP, V69, P11; Barker TH, 2009, BBA-MOL CELL RES, V1793, P921, DOI 10.1016/j.bbamcr.2008.10.004; Bassi Enio Jose, 2011, World J Stem Cells, V3, P1, DOI 10.4252/wjsc.v3.i1.1; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dorronsoro A, 2014, EUR J IMMUNOL, V44, P480, DOI 10.1002/eji.201343668; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Feldmann RE, 2005, ELECTROPHORESIS, V26, P2749, DOI 10.1002/elps.200410406; Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Han HS, 2010, J ORTHOP RES, V28, P1283, DOI 10.1002/jor.21129; Higuchi O, 2012, CELL REPROGRAM, V14, P448, DOI 10.1089/cell.2012.0020; Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485; Hu L., 2013, BIOMED RES INT; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Jarvinen L, 2008, J IMMUNOL, V181, P4389, DOI 10.4049/jimmunol.181.6.4389; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; Jiang Ranhua, 2011, Front Med, V5, P94, DOI 10.1007/s11684-011-0116-z; Jurga M, 2012, STEM CELLS DEV, V21, P923, DOI 10.1089/scd.2011.0224; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032350; Kowno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081552; Kurpinski K, 2009, CELL MOL BIOENG, V2, P606, DOI 10.1007/s12195-009-0090-6; Law S, 2013, AM J STEM CELLS, V2, P22; Lee HJ, 2009, ARTHRITIS RHEUM-US, V60, P2325, DOI 10.1002/art.24786; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Lindenmair Andrea, 2012, Cells, V1, P1061, DOI 10.3390/cells1041061; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Martins AA, 2009, TRANSPL P, V41, P943, DOI 10.1016/j.transproceed.2009.01.059; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mennan C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/916136; Mohammadian M, 2013, ADV PHARM BULL, V3, P433, DOI 10.5681/apb.2013.070; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Munoz J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.84; Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195; Nekanti U, 2010, STEM CELL RES, V5, P244, DOI 10.1016/j.scr.2010.08.005; Nekanti U, 2010, STEM CELLS DEV, V19, P117, DOI 10.1089/scd.2009.0177; Nguyen TM, 2013, STEM CELLS DEV, V22, P2751, DOI 10.1089/scd.2012.0676; Niehage C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020399; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Patel AN, 2013, CELL TRANSPLANT, V22, P513, DOI 10.3727/096368912X655064; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Seshareddy K, 2008, METHOD CELL BIOL, V86, P101, DOI 10.1016/S0091-679X(08)00006-X; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Voronova A, 2013, J BIOL CHEM, V288, P4389, DOI 10.1074/jbc.M112.400184; Wang HW, 2014, INT J MOL MED, V33, P263, DOI 10.3892/ijmm.2013.1572; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Xu YA, 2012, J TISSUE ENG REGEN M, V6, P645, DOI 10.1002/term.468; Zeddou M, 2010, CELL BIOL INT, V34, P693, DOI 10.1042/CBI20090414; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186	72	34	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122465	10.1371/journal.pone.0122465	http://dx.doi.org/10.1371/journal.pone.0122465			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848763	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800130
J	Choudhury, GR; Winters, A; Rich, RM; Ryou, MG; Gryczynski, Z; Yuan, F; Yang, SH; Liu, R				Choudhury, Gourav Roy; Winters, Ali; Rich, Ryan M.; Ryou, Myoung-Gwi; Gryczynski, Zygmunt; Yuan, Fang; Yang, Shao-Hua; Liu, Ran			Methylene Blue Protects Astrocytes against Glucose Oxygen Deprivation by Improving Cellular Respiration	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GLYCOGEN-METABOLISM; STROKE; DAMAGE; NEURODEGENERATION; PATHOPHYSIOLOGY; DYSFUNCTION; MECHANISMS; TRANSIENT; NEURONS	Astrocytes outnumber neurons and serve many metabolic and trophic functions in the mammalian brain. Preserving astrocytes is critical for normal brain function as well as for protecting the brain against various insults. Our previous studies have indicated that methylene blue (MB) functions as an alternative electron carrier and enhances brain metabolism. In addition, MB has been shown to be protective against neurodegeneration and brain injury. In the current study, we investigated the protective role of MB in astrocytes. Cell viability assays showed that MB treatment significantly protected primary astrocytes from oxygenglucose deprivation (OGD) & reoxygenation induced cell death. We also studied the effect of MB on cellular oxygen and glucose metabolism in primary astrocytes following OGD-reoxygenation injury. MB treatment significantly increased cellular oxygen consumption, glucose uptake and ATP production in primary astrocytes. In conclusion our study demonstrated that MB protects astrocytes against OGD-reoxygenation injury by improving astrocyte cellular respiration.	[Choudhury, Gourav Roy; Winters, Ali; Ryou, Myoung-Gwi; Yang, Shao-Hua; Liu, Ran] Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Rich, Ryan M.; Gryczynski, Zygmunt] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX USA; [Yuan, Fang; Yang, Shao-Hua] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Neurosurg, Beijing, Peoples R China	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Beijing Neurosurgical Institute; Capital Medical University	Yang, SH (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu; ran.liu@unthsc.edu	Choudhury, Gourav Roy/L-7707-2016	Choudhury, Gourav Roy/0000-0001-8664-7638; Liu, Ran/0000-0002-3882-0616	National Institutes of Health [NS054651, NS088596, NS087209]; AHA [SDG16960084]; National Natural Science Foundation of China [81228009]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087209, R01NS088596, R01NS054651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS054651, NS088596, NS087209, AHA SDG16960084, and National Natural Science Foundation of China Grant 81228009.	Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benarroch EE, 2010, NEUROLOGY, V74, P919, DOI 10.1212/WNL.0b013e3181d3e44b; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Di Malta C, 2012, P NATL ACAD SCI USA, V109, pE2334, DOI 10.1073/pnas.1209577109; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Fried R. FLW., 1974, IMETHODS ENZYMATIC A, P644; Haberg A, 2006, NEUROCHEM INT, V48, P531, DOI 10.1016/j.neuint.2005.12.025; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Huang YZ, 2004, CELL, V118, P665, DOI 10.1016/j.cell.2004.09.004; Ji J, 2002, J BIOMED OPT, V7, P404, DOI 10.1117/1.1483082; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nehlig A, 2004, J CEREBR BLOOD F MET, V24, P1004, DOI 10.1097/01.WCB.0000128533.84196.D8; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Pascual JM, 2007, ARCH NEUROL-CHICAGO, V64, P507, DOI 10.1001/archneur.64.4.noc60165; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Poteet E, 2013, J BIOL CHEM, V288, P9153, DOI 10.1074/jbc.M112.440354; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Rodriguez P, 2014, BRAIN RES; Roy Choudhury G, 2014, BRAIN RES; SAKAMOTO A, 1991, BRAIN RES, V554, P186, DOI 10.1016/0006-8993(91)90187-Z; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Stack C, 2014, HUM MOL GENET; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; Thoren AE, 2006, J NEUROCHEM, V97, P968, DOI 10.1111/j.1471-4159.2006.03778.x; Watts LT, 2014, J NEUROTRAUM; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307	48	20	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123096	10.1371/journal.pone.0123096	http://dx.doi.org/10.1371/journal.pone.0123096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848957	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800203
J	Zhang, CK; Zhai, SM; Wu, L; Bai, YH; Jia, JB; Zhang, Y; Zhang, B; Yan, B				Zhang, Chengke; Zhai, Shumei; Wu, Ling; Bai, Yuhong; Jia, Jianbo; Zhang, Yi; Zhang, Bin; Yan, Bing			Induction of Size-Dependent Breakdown of Blood-Milk Barrier in Lactating Mice by TiO2 Nanoparticles	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; WALLED CARBON NANOTUBES; OXIDATIVE STRESS; PHYSIOLOGICAL SIGNIFICANCE; GOLD NANOPARTICLES; ACUTE TOXICITY; SURFACE; PARTICLES; ACCUMULATION; LACTOFERRIN	This study aims to investigate the potential nanotoxic effects of TiO2 nanoparticles (TNPs) to dams and pups during lactation period. TiO2 nanoparticles are accumulated in mammary glands of lactating mice after i.v. administration. This accumulation of TiO2 NP likely causes a ROS-induced disruption of tight junction of the blood-milk barrier as indicated by the loss of tight junction proteins and the shedding of alveolar epithelial cells. Compared to larger TNPs (50 nm), smaller ones (8 nm) exhibit a higher accumulation in mammary glands and are more potent in causing perturbations to blood-milk barrier. An alarming finding is that the smaller TNPs (8 nm) are transferred from dams to pups through breastfeeding, likely through the disrupted blood-milk barrier. However, during the lactation period, the nutrient quality of milk from dams and the early developmental landmarks of the pups are not affected by above perturbations.	[Zhang, Chengke; Zhai, Shumei; Wu, Ling; Bai, Yuhong; Jia, Jianbo; Zhang, Yi; Zhang, Bin; Yan, Bing] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China	Shandong University	Yan, B (corresponding author), Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.	drbingyan@yahoo.com	Zhang, Bin/H-4942-2014	Zhang, Bin/0000-0002-1529-6356; Jia, Jianbo/0000-0002-1703-6734; Wu, Ling/0000-0002-5786-4315	National Natural Science Foundation of China [21137002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB14030401]; Natural Science Foundation of Shandong Province [ZR2014BM026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China (grant numbers: 21137002 to BY) (http://www.nsfc.gov.cn), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant numbers: XDB14030401 to BY) (http://www.cas.cn) and the Natural Science Foundation of Shandong Province (grant numbers: ZR2014BM026 to ZSM) (http://www.sdnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Bai YH, 2010, NAT NANOTECHNOL, V5, P683, DOI [10.1038/NNANO.2010.153, 10.1038/nnano.2010.153]; Bonazzi M, 2011, J CELL BIOL, V195, P348, DOI 10.1083/jcb.201106011; Burgoyne RD, 1998, J MAMMARY GLAND BIOL, V3, P275, DOI 10.1023/A:1018763427108; Burton JL, 2003, VET CLIN N AM-FOOD A, V19, P1, DOI 10.1016/S0749-0720(02)00073-7; Chen HH, 2012, CHEM REV, V112, P5919, DOI 10.1021/cr3002092; Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414; Chen XX, 2013, SMALL, V9, P1765, DOI 10.1002/smll.201201506; Cho WS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-9; D'Alessandro A, 2010, J PROTEOME RES, V9, P3339, DOI 10.1021/pr100123f; Deng XY, 2009, CARBON, V47, P1421, DOI 10.1016/j.carbon.2008.12.032; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; Dewey KG, 1998, AM J CLIN NUTR, V67, P10, DOI 10.1093/ajcn/67.1.10; Duan YM, 2010, BIOMATERIALS, V31, P894, DOI 10.1016/j.biomaterials.2009.10.003; Gao XY, 2011, BIOL TRACE ELEM RES, V143, P1616, DOI 10.1007/s12011-011-8990-4; Gosens I, 2014, NANOTOXICOLOGY, V8, P643, DOI 10.3109/17435390.2013.815814; He B, 2013, BIOMATERIALS, V34, P6082, DOI 10.1016/j.biomaterials.2013.04.053; Hougaard KS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-16; Jacoby WA, 1998, ENVIRON SCI TECHNOL, V32, P2650, DOI 10.1021/es980036f; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Labbok MH, 2004, NAT REV IMMUNOL, V4, P565, DOI 10.1038/nri1393; Li WQ, 2013, SMALL, V9, P1708, DOI 10.1002/smll.201201079; Liu Huiting, 2010, Toxicological and Environmental Chemistry, V92, P175, DOI 10.1080/02772240902732530; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lonnerdal B, 2003, NUTR REV, V61, P295, DOI 10.1301/nr.2003.sept.295-305; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Ma LL, 2010, BIOMATERIALS, V31, P99, DOI 10.1016/j.biomaterials.2009.09.028; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Mohammadipour A, 2016, TOXICOL IND HEALTH, V32, P221, DOI 10.1177/0748233713498440; Mutlu EA, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-19; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Pietroiusti A, 2011, ACS NANO, V5, P4624, DOI 10.1021/nn200372g; Project on Emerging Nanotechnologies, 2014, CONSUMER PRODUCTS IN; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Schilling K, 2010, PHOTOCH PHOTOBIO SCI, V9, P495, DOI 10.1039/b9pp00180h; Seo JW, 2007, SMALL, V3, P850, DOI 10.1002/smll.200600488; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; STELWAGEN K, 1994, J DAIRY SCI, V77, P426, DOI 10.3168/jds.S0022-0302(94)76969-1; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Su GX, 2012, J PHYS CHEM C, V116, P4993, DOI 10.1021/jp211041m; Sumner SCJ, 2010, J APPL TOXICOL, V30, P354, DOI 10.1002/jat.1503; Tian X, 2013, SMALL, V9, P2432, DOI 10.1002/smll.201300817; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang JX, 2008, TOXICOLOGY, V254, P82, DOI 10.1016/j.tox.2008.09.014; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; WHEELER TT, 1995, EXP CELL RES, V217, P346, DOI 10.1006/excr.1995.1096; WILLIAMSON DH, 1995, P NUTR SOC, V54, P165, DOI 10.1079/PNS19950046; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Xie GP, 2011, TOXICOL LETT, V205, P55, DOI 10.1016/j.toxlet.2011.04.034; Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]; Yang ST, 2008, TOXICOL LETT, V181, P182, DOI 10.1016/j.toxlet.2008.07.020; Ye D, 2013, NANOSCALE, V5, P11153, DOI 10.1039/c3nr02905k; Yeo MK, 2012, MOL CELL TOXICOL, V8, P317, DOI 10.1007/s13273-012-0039-z; Yoshida S, 2010, FERTIL STERIL, V93, P1695, DOI 10.1016/j.fertnstert.2009.03.094; Zhang CK, 2013, CURR PHARM DESIGN, V19, P6667; Zhang LL, 2011, TOXICOL LETT, V207, P73, DOI 10.1016/j.toxlet.2011.08.001; Zhu HY, 2004, J AM CHEM SOC, V126, P8380, DOI 10.1021/ja048204t; Zhu HY, 2005, J AM CHEM SOC, V127, P6730, DOI 10.1021/ja044689+	62	39	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122591	10.1371/journal.pone.0122591	http://dx.doi.org/10.1371/journal.pone.0122591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849145	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800144
J	Choong, E; Guo, J; Persson, A; Virding, S; Johansson, I; Mkrtchian, S; Ingelman-Sundberg, M				Choong, Eva; Guo, Jia; Persson, Anna; Virding, Susanne; Johansson, Inger; Mkrtchian, Souren; Ingelman-Sundberg, Magnus			Developmental Regulation and Induction of Cytochrome P450 2W1, an Enzyme Expressed in Colon Tumors	PLOS ONE			English	Article							COLORECTAL-CANCER; DNA METHYLATION; GENE-EXPRESSION; LINOLEIC-ACID; CYP2W1; CELLS; PROTEIN; CYP1B1; MOUSE; DIFFERENTIATION	Cytochrome P450 2W1 (CYP2W1) is expressed predominantly in colorectal and also in hepatic tumors, whereas the levels are insignificant in the corresponding normal human adult tissues. CYP2W1 has been proposed as an attractive target for colorectal cancer (CRC) therapy by exploiting its ability to activate duocarmycin prodrugs to cytotoxic metabolites. However, its endogenous function, regulation and developmental pattern of expression remain unexplored. Here we report the CYP2W1 developmental expression in the murine and human gastrointestinal tissues. The gene expression in the colon and small intestine commence at early stages of embryonic life and is completely silenced shortly after the birth. Immunohistochemical analysis of human fetal colon revealed that CYP2W1 expression is restricted to the crypt cells. The silencing of CYP2W1 after birth correlates with the increased methylation of CpG-rich regions in both murine and human CYP2W1 genes. Analysis of CYP2W1 expression in the colon adenocarcinoma cell line HCC2998 revealed that the gene expression can be induced by e.g. the antitumor agent imatinib, linoleic acid and its derivatives. The imatinib mediated induction of CYP2W1 suggests an adjuvant therapy to treatment with duocarmycins that thus would involve induction of tumor CYP2W1 levels followed by the CYP2W1 activated duocarmycin prodrugs. Taken together these data strongly support further exploration of CYP2W1 as a specific drug target in CRC.	[Choong, Eva; Guo, Jia; Persson, Anna; Virding, Susanne; Johansson, Inger; Mkrtchian, Souren; Ingelman-Sundberg, Magnus] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden	Karolinska Institutet	Ingelman-Sundberg, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden.	magnus.ingelman-sundberg@ki.se	Choong, Eva/F-1570-2019; Ingelman-Sundberg, Magnus/ABD-9302-2021	Choong, Eva/0000-0001-6776-4978; Mkrtchian, Souren/0000-0001-9801-2736	Swiss National Research Foundation [139821, 145578]; Swedish Cancer Society; Swedish Research Council; Karolinska Institutet	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swiss National Research Foundation (projects no: 139821, 145578) and by grants from the Swedish Cancer Society, the Swedish Research Council, the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; Barouki Robert, 2012, Drug Metabolism and Drug Interactions, V27, P3, DOI 10.1515/dmdi-2011-0035; Bazzi R, 2009, TOXICOL APPL PHARM, V237, P102, DOI 10.1016/j.taap.2009.02.015; Benjamin S, 2013, J ZHEJIANG UNIV-SC B, V14, P115, DOI 10.1631/jzus.B1200175; Bianco C, 2005, CURR TOP DEV BIOL, V67, P85, DOI 10.1016/S0070-2153(05)67003-2; Butura A, 2004, BIOCHEM PHARMACOL, V67, P1249, DOI 10.1016/j.bcp.2003.10.033; Carriere V, 2001, TOXICOL IN VITRO, V15, P373, DOI 10.1016/S0887-2333(01)00039-X; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Choudhary D, 2007, DRUG METAB DISPOS, V35, P987, DOI 10.1124/dmd.106.014282; Cui JH, 2014, CURR MED CHEM, V21, P519, DOI 10.2174/09298673113206660277; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edler D, 2009, EUR J CANCER, V45, P705, DOI 10.1016/j.ejca.2008.11.031; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Fraczek J, 2012, INVEST NEW DRUG, V30, P1715, DOI 10.1007/s10637-011-9659-8; Gao F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-716; Gomez A, 2007, PHARMACOGENOMICS, V8, P1315, DOI 10.2217/14622416.8.10.1315; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Ioannidis P, 2003, ANTICANCER RES, V23, P2179; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Karlgren M, 2006, BIOCHEM BIOPH RES CO, V341, P451, DOI 10.1016/j.bbrc.2005.12.200; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurje G, 2007, CLIN COLORECTAL CANC, V6, P683, DOI 10.3816/CCC.2007.n.037; Murray GI, 1997, CANCER RES, V57, P3026; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; Pierre AS, 2013, BBA-MOL CELL BIOL L, V1831, P759, DOI 10.1016/j.bbalip.2013.01.005; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rochat B, 2008, BIOPHARM DRUG DISPOS, V29, P103, DOI 10.1002/bdd.598; Sargsyan E, 2002, J BIOL CHEM, V277, P17009, DOI 10.1074/jbc.M200539200; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; Spelt L, 2012, EJSO-EUR J SURG ONC, V38, P16, DOI 10.1016/j.ejso.2011.10.013; STARZYNSKA T, 1992, BRIT J CANCER, V66, P867, DOI 10.1038/bjc.1992.375; Stenstedt K, 2014, ACTA ONCOL, V53, P885, DOI 10.3109/0284186X.2014.887224; Stenstedt K, 2013, PHARMACOGENOMICS, V14, P1615, DOI 10.2217/pgs.13.136; Stenstedt K, 2012, ANTICANCER RES, V32, P3869; Tan BS, 2011, MOL CANCER THER, V10, P1982, DOI 10.1158/1535-7163.MCT-11-0391; Travica S, 2013, CLIN CANCER RES, V19, P2952, DOI 10.1158/1078-0432.CCR-13-0238; Wang JH, 2013, CHEM PHYS LIPIDS, V175, P27, DOI 10.1016/j.chemphyslip.2013.07.009; Wang K, 2012, CHEM RES TOXICOL; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; Xiao Y, 2012, J LIPID RES; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Zhang K, 2014, TUMOR BIOL, V35, P7669, DOI 10.1007/s13277-014-2023-9	49	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122820	10.1371/journal.pone.0122820	http://dx.doi.org/10.1371/journal.pone.0122820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844926	Green Published, gold, Green Submitted			2022-12-27	WOS:000352475700015
J	Camargo, JF; Bhimji, A; Kumar, D; Kaul, R; Pavan, R; Schuh, A; Seftel, M; Lipton, JH; Gupta, V; Humar, A; Husain, S				Camargo, Jose F.; Bhimji, Alyajahan; Kumar, Deepali; Kaul, Rupert; Pavan, Rhea; Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas; Humar, Atul; Husain, Shahid			Impaired T Cell Responsiveness to Interleukin-6 in Hematological Patients with Invasive Aspergillosis	PLOS ONE			English	Article							STEM-CELL; TRANSPLANT RECIPIENTS; SINGLE-CELL; FUNGAL-INFECTIONS; FLOW-CYTOMETRY; THERAPY; PTX3; EPIDEMIOLOGY; DEFICIENCY	Invasive mold infections (IMI) are among the most devastating complications following chemotherapy and hematopoietic stem cell transplantation (HSCT), with high mortality rates. Yet, the molecular basis for human susceptibility to invasive aspergillosis (IA) and mucormycosis remain poorly understood. Herein, we aimed to characterize the immune profile of individuals with hematological malignancies (n = 18) who developed IMI during the course of chemotherapy or HSCT, and compared it to that of hematological patients who had no evidence of invasive fungal infection (n = 16). First, we measured the expression of the pattern recognition receptors pentraxin 3, dectin-1, and Toll-like receptors (TLR) 2 and 4 in peripheral blood of chemotherapy and HSCT recipients with IMI. Compared to hematological controls, individuals with IA and mucormycosis had defective expression of dectin-1; in addition, patients with mucormycosis had decreased TLR2 and increased TLR4 expression. Since fungal recognition via dectin-1 favors T helper 17 responses and the latter are highly dependent on activation of the signal transducer and activator of transcription (STAT) 3, we next used phospho-flow cytometry to measure the phosphorylation of the transcription factors STAT1 and STAT3 in response to interferon-gamma (IFN-gamma) and interleukin (IL)-6, respectively. While IFN-gamma/STAT1 signaling was similar between groups, naive T cells from patients with IA, but not those with mucormycosis, exhibited reduced responsiveness to IL-6 as measured by STAT3 phosphorylation. Furthermore, IL-6 increased Aspergillus-induced IL-17 production in culture supernatants from healthy and hematological controls but not in patients with IA. Altogether, these observations suggest an important role for dectin-1 and the IL-6/STAT3 pathway in protective immunity against Aspergillus.	[Camargo, Jose F.; Bhimji, Alyajahan; Kumar, Deepali; Pavan, Rhea; Humar, Atul; Husain, Shahid] Univ Toronto, Univ Hlth Network, Multiorgan Transplant Program, Transplant Infect Dis, Toronto, ON, Canada; [Camargo, Jose F.; Kumar, Deepali; Kaul, Rupert; Pavan, Rhea; Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas; Humar, Atul; Husain, Shahid] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Bhimji, Alyajahan] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas] Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Husain, S (corresponding author), Univ Toronto, Univ Hlth Network, Multiorgan Transplant Program, Transplant Infect Dis, Toronto, ON, Canada.	Shahid.Husain@uhn.ca	Seftel, Matthew/L-9607-2019	Gupta, Vikas/0000-0002-1419-8607; Husain, Shahid/0000-0002-9216-5229; Kaul, Rupert/0000-0002-1586-4093				Bellocchio S, 2005, J ANTIMICROB CHEMOTH, V55, P214, DOI 10.1093/jac/dkh542; Biagi E, 2008, J PEDIAT HEMATOL ONC, V30, P881, DOI 10.1097/MPH.0b013e318180bc1d; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Camargo JF, 2014, CLIN INFECT DIS, V59, P569, DOI 10.1093/cid/ciu337; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Chamilos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012955; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dohner H, 2013, HAEMATOLOGICA, V98, P233, DOI 10.3324/haematol.2012.072264; Huang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021671; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lee AW, 2008, J VIROL, V82, P3702, DOI 10.1128/JVI.01582-07; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Potenza L, 2011, BLOOD, V118, P5416, DOI 10.1182/blood-2011-07-366526; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Roilides E, 2012, CLIN INFECT DIS, V54, pS61, DOI 10.1093/cid/cir869; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Vinh DC, 2010, J ALLERGY CLIN IMMUN, V125, P1389, DOI 10.1016/j.jaci.2010.01.047	31	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123171	10.1371/journal.pone.0123171	http://dx.doi.org/10.1371/journal.pone.0123171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835547	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000133
J	Cheng, YQ; Liu, JF; Zhang, HD; Wang, J; Zhao, YX; Geng, WT				Cheng, Yunqing; Liu, Jianfeng; Zhang, Huidi; Wang, Ju; Zhao, Yixin; Geng, Wanting			Transcriptome Analysis and Gene Expression Profiling of Abortive and Developing Ovules during Fruit Development in Hazelnut	PLOS ONE			English	Article							REPRODUCTIVE GROWTH; CORYLUS	Background A high ratio of blank fruit in hazelnut (Corylus heterophylla Fisch) is a very common phenomenon that causes serious yield losses in northeast China. The development of blank fruit in the Corylus genus is known to be associated with embryo abortion. However, little is known about the molecular mechanisms responsible for embryo abortion during the nut development stage. Genomic information for C. heterophylla Fisch is not available; therefore, data related to transcriptome and gene expression profiling of developing and abortive ovules are needed. Methodology/Principal Findings In this study, de novo transcriptome sequencing and RNA-seq analysis were conducted using short-read sequencing technology (Illumina HiSeq 2000). The results of the transcriptome assembly analysis revealed genetic information that was associated with the fruit development stage. Two digital gene expression libraries were constructed, one for a full (normally developing) ovule and one for an empty (abortive) ovule. Transcriptome sequencing and assembly results revealed 55,353 unigenes, including 18,751 clusters and 36,602 singletons. These results were annotated using the public databases NR, NT, Swiss-Prot, KEGG, COG, and GO. Using digital gene expression profiling, gene expression differences in developing and abortive ovules were identified. A total of 1,637 and 715 unigenes were significantly upregulated and downregulated, respectively, in abortive ovules, compared with developing ovules. Quantitative real-time polymerase chain reaction analysis was used in order to verify the differential expression of some genes. Conclusions/Significance The transcriptome and digital gene expression profiling data of normally developing and abortive ovules in hazelnut provide exhaustive information that will improve our understanding of the molecular mechanisms of abortive ovule formation in hazelnut.	[Cheng, Yunqing; Liu, Jianfeng; Zhang, Huidi; Wang, Ju; Zhao, Yixin; Geng, Wanting] Jilin Normal Univ, Coll Life Sci, Siping 136000, Jilin Province, Peoples R China	Jilin Normal University	Liu, JF (corresponding author), Jilin Normal Univ, Coll Life Sci, Siping 136000, Jilin Province, Peoples R China.	jianfengliu1976@163.com			National Natural Science Foundation of China [31370683, 31070610]; China Scholarship Council Project [201208220004]; Science and Technology Project of Jilin Province [20130102052JC, 20140101145JC]; Scientific Items of Jilin Provincial Department of Education [2013202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council Project(China Scholarship Council); Science and Technology Project of Jilin Province; Scientific Items of Jilin Provincial Department of Education	The funders include the National Natural Science Foundation of China (31370683 and 31070610), China Scholarship Council Project (201208220004), Science and Technology Project of Jilin Province (20130102052JC and 20140101145JC), and Scientific Items of Jilin Provincial Department of Education (2013202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JS, 2006, J AGR FOOD CHEM, V54, P449, DOI 10.1021/jf052133f; Benjamini Y, 2001, ANN STAT, V29, P1165; Beyhan N, 2007, SCI HORTIC-AMSTERDAM, V113, P208, DOI 10.1016/j.scienta.2007.02.007; Cheng YQ, 2013, PLANT MOL BIOL REP, V31, P607, DOI 10.1007/s11105-012-0533-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Erdogan V, 2000, J AM SOC HORTIC SCI, V125, P489, DOI 10.21273/JASHS.125.4.489; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Liu JF, 2013, SCI HORTIC-AMSTERDAM, V150, P348, DOI 10.1016/j.scienta.2012.12.001; Liu JF, 2012, SCI HORTIC-AMSTERDAM, V136, P128, DOI 10.1016/j.scienta.2012.01.008; Ma H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-152; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olsen KM, 2013, ANNU REV PLANT BIOL, V64, P47, DOI 10.1146/annurev-arplant-050312-120048; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rowley ER, 2012, CROP SCI, V52, P2679, DOI 10.2135/cropsci2012.02.0065; Savage GP, 1997, J AM OIL CHEM SOC, V74, P755, DOI 10.1007/s11746-997-0214-x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029	22	18	23	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122072	10.1371/journal.pone.0122072	http://dx.doi.org/10.1371/journal.pone.0122072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836368	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000077
J	Delefosse, M; Kristensen, E; Crunelle, D; Braad, PE; Dam, JH; Thisgaard, H; Thomassen, A; Hoilund-Carlsen, PF				Delefosse, Matthieu; Kristensen, Erik; Crunelle, Diane; Braad, Poul Erik; Dam, Johan Hygum; Thisgaard, Helge; Thomassen, Anders; Hoilund-Carlsen, Poul Flemming			Seeing the Unseen-Bioturbation in 4D: Tracing Bioirrigation in Marine Sediment Using Positron Emission Tomography and Computed Tomography	PLOS ONE			English	Article							LUGWORM ARENICOLA-MARINA; BIOGENIC STRUCTURES; HYDRAULIC ACTIVITIES; AIDED TOMOGRAPHY; QUANTIFICATION; REWORKING; FLOW; VISUALIZATION; IRRIGATION; TRANSPORT	Understanding spatial and temporal patterns of bioirrigation induced by benthic fauna ventilation is critical given its significance on benthic nutrient exchange and biogeochemistry in coastal ecosystems. The quantification of this process challenges marine scientists because faunal activities and behaviors are concealed in an opaque sediment matrix. Here, we use a hybrid medical imaging technique, positron emission tomography and computed tomography (PET/CT) to provide a qualitative visual and fully quantitative description of bioirrigation in 4D (space and time). As a study case, we present images of porewater advection induced by the well-studied lugworm (Arenicola marina). Our results show that PET/CT allows more comprehensive studies on ventilation and bioirrigation than possible using techniques traditionally applied in marine ecology. We provide a dynamic three-dimensional description of bioirrigation by the lugworm at very high temporal and spatial resolution. Results obtained with the PET/CT are in agreement with literature data on lugworm ventilation and bioirrigation. Major advantages of PET/CT over methods commonly used are its non-invasive and non-destructive approach and its capacity to provide information that otherwise would require multiple methods. Furthermore, PET/CT scan is versatile as it can be used for a variety of benthic macrofauna species and sediment types and it provides information on burrow morphology or animal behavior. The lack of accessibility to the expensive equipment is its major drawback which can only be overcome through collaboration among several institutions.	[Delefosse, Matthieu; Kristensen, Erik; Crunelle, Diane] Univ Southern Denmark, Dept Biol, Odense, Denmark; [Braad, Poul Erik; Dam, Johan Hygum; Thisgaard, Helge; Thomassen, Anders; Hoilund-Carlsen, Poul Flemming] Odense Univ Hosp, Dept Nucl Med, DK-5000 Odense, Denmark; [Braad, Poul Erik; Dam, Johan Hygum; Thisgaard, Helge; Thomassen, Anders; Hoilund-Carlsen, Poul Flemming] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Delefosse, M (corresponding author), Univ Southern Denmark, Dept Biol, Odense, Denmark.	matthieu.delefosse@gmail.com	Thisgaard, Helge/B-9362-2017; Dam, Johan/B-7564-2018; Delefosse, Matthieu/C-5849-2008	Thisgaard, Helge/0000-0001-9492-448X; Dam, Johan/0000-0001-6577-7011; Delefosse, Matthieu/0000-0003-4422-9475; Braad, Poul-Erik/0000-0003-4906-5422; Kristensen, Erik/0000-0001-7259-0132	Danish Council for Independent Research [09-071369, 12-127012]; Danish Council for Strategic Research [09-063190, 12-132701]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was funded by the Danish Council for Independent Research (contract # 09-071369 and 12-127012 to EK), and by the Danish Council for Strategic Research (contract # 09-063190 and 12-132701 to EK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann T, 2000, ENVIRON SCI TECHNOL, V34, P4242, DOI 10.1021/es991124i; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; CADEE GC, 1976, NETH J SEA RES, V10, P440, DOI 10.1016/0077-7579(76)90020-X; Charbonneau P, 1997, LIMNOL OCEANOGR, V42, P1823, DOI 10.4319/lo.1997.42.8.1823; DAVEY JT, 1990, J EXP MAR BIOL ECOL, V139, P135, DOI 10.1016/0022-0981(90)90043-C; Delefosse M, 2012, J SEA RES, V71, P41, DOI 10.1016/j.seares.2012.04.006; Dorgan KM, 2005, NATURE, V433, P475, DOI 10.1038/433475a; Dufour SC, 2005, LIMNOL OCEANOGR-METH, V3, P372, DOI 10.4319/lom.2005.3.372; Kapoor V, 2004, RADIOGRAPHICS, V24, P523, DOI 10.1148/rg.242025724; Khalili A, 1999, ACTA MECH, V132, P221, DOI 10.1007/BF01186969; Kleinhans MG, 2008, SEDIMENT GEOL, V208, P69, DOI 10.1016/j.sedgeo.2008.07.002; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; KRISTENSEN E, 1987, J EXP MAR BIOL ECOL, V109, P15, DOI 10.1016/0022-0981(87)90182-1; Kristensen E, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00041; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Kristensen E, 2011, MAR ECOL PROG SER, V425, P125, DOI 10.3354/meps09007; Levin CS, 1999, PHYS MED BIOL, V44, P781, DOI 10.1088/0031-9155/44/3/019; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Magill J, 2006, KARLSRUBER NUKLIDKAR; Maire O, 2008, AQUAT BIOL, V2, P219, DOI 10.3354/ab00053; Mermillod-Blondin F, 2003, J EXP MAR BIOL ECOL, V287, P193, DOI 10.1016/S0022-0981(02)00548-8; Meysman FJR, 2007, BIOGEOSCIENCES, V4, P627, DOI 10.5194/bg-4-627-2007; Papaspyrou S, 2007, ESTUAR COAST SHELF S, V72, P213, DOI 10.1016/j.ecss.2006.10.020; Perez KT, 1999, ECOL APPL, V9, P1050, DOI 10.1890/1051-0761(1999)009[1050:AOCATC]2.0.CO;2; Pooley RA, 2005, RADIOGRAPHICS, V25, P1087, DOI 10.1148/rg.254055027; Quintana CO, 2011, J EXP MAR BIOL ECOL, V397, P179, DOI 10.1016/j.jembe.2010.12.006; Retraubun ASW, 1996, J EXP MAR BIOL ECOL, V202, P107, DOI 10.1016/0022-0981(96)00017-2; Riisgard HU, 2005, AQUAT ECOL, V39, P237, DOI 10.1007/s10452-004-1916-x; Riisgard HU, 1998, VIE MILIEU, V48, P243; Riisgard HU, 1996, MAR ECOL PROG SER, V138, P149, DOI 10.3354/meps138149; ROBBINS JA, 1984, J GREAT LAKES RES, V10, P335, DOI 10.1016/S0380-1330(84)71850-8; Rosenberg R, 2005, J EXP MAR BIOL ECOL, V326, P67, DOI 10.1016/j.jembe.2005.05.022; Rosenberg R, 2008, MAR ECOL PROG SER, V363, P171, DOI 10.3354/meps07463; Rosenberg R, 2007, MAR ECOL PROG SER, V331, P23, DOI 10.3354/meps331023; Roskosch A, 2011, FUND APPL LIMNOL, V178, P89, DOI 10.1127/1863-9135/2011/0178-0089; Roskosch A, 2010, APPL RADIAT ISOTOPES, V68, P1094, DOI 10.1016/j.apradiso.2010.02.004; Taina IA, 2008, CAN J SOIL SCI, V88, P1, DOI 10.4141/CJSS06027; Teras M, 2007, EUR J NUCL MED MOL I, V34, P1683, DOI 10.1007/s00259-007-0493-3; Townsend DW, 2008, J NUCL MED, V49, P938, DOI 10.2967/jnumed.108.051276; Volkenborn N, 2010, LIMNOL OCEANOGR, V55, P1231, DOI 10.4319/lo.2010.55.3.1231; WELLS GP, 1949, J MAR BIOL ASSOC UK, V28, P447, DOI 10.1017/S0025315400023328; Wethey DS, 2008, J MAR RES, V66, P255, DOI 10.1357/002224008785837121	42	5	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122201	10.1371/journal.pone.0122201	http://dx.doi.org/10.1371/journal.pone.0122201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837626	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000084
J	Herrero, L; Valcarcel, L; da Silva, CA; Albert, N; Diez-Noguera, A; Cambras, T; Serra, D				Herrero, Laura; Valcarcel, Lorea; Andressa da Silva, Crhistiane; Albert, Nerea; Diez-Noguera, Antoni; Cambras, Trinitat; Serra, Dolors			Altered Circadian Rhythm and Metabolic Gene Profile in Rats Subjected to Advanced Light Phase Shifts	PLOS ONE			English	Article							MOTOR-ACTIVITY RHYTHM; ADIPOSE-TISSUE; PPAR-ALPHA; CLOCK; DISRUPTION	The circadian clock regulates metabolic homeostasis and its disruption predisposes to obesity and other metabolic diseases. However, the effect of phase shifts on metabolism is not completely understood. We examined whether alterations in the circadian rhythm caused by phase shifts induce metabolic changes in crucial genes that would predispose to obesity. Three-month-old rats were maintained on a standard diet under lighting conditions with chronic phase shifts consisting of advances, delays or advances plus delays. Serum leptin, insulin and glucose levels decreased only in rats subjected to advances. The expression of the clock gene Bmal 1 increased in the hypothalamus, white adipose tissue (WAT), brown adipose tissue (BAT) and liver of the advanced group compared to control rats. The advanced group showed an increase in hypothalamic AgRP and NPY mRNA, and their lipid metabolism gene profile was altered in liver, WAT and BAT. WAT showed an increase in inflammation and ER stress and brown adipocytes suffered a brown-to-white transformation and decreased UCP-1 expression. Our results indicate that chronic phase advances lead to significant changes in neuropeptides, lipid metabolism, inflammation and ER stress gene profile in metabolically relevant tissues such as the hypothalamus, liver, WAT and BAT. This highlights a link between alteration of the circadian rhythm and metabolism at the transcriptional level.	[Herrero, Laura; Valcarcel, Lorea; Serra, Dolors] Univ Barcelona, Fac Farm, Dept Biochem & Mol Biol, IBUB, E-08028 Barcelona, Spain; [Herrero, Laura; Valcarcel, Lorea; Serra, Dolors] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obes & Nutr CIBE, Madrid, Spain; [Andressa da Silva, Crhistiane; Albert, Nerea; Diez-Noguera, Antoni; Cambras, Trinitat] Univ Barcelona, Fac Farm, Dept Physiol, E-08028 Barcelona, Spain; [Andressa da Silva, Crhistiane] Univ Fed Rio Grande do Norte, Dept Fisiol, Lab Neurobiol & Ritimicidade Biol, BR-59072970 Natal, RN, Brazil	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Universidade Federal do Rio Grande do Norte	Cambras, T (corresponding author), Univ Barcelona, Fac Farm, Dept Physiol, E-08028 Barcelona, Spain.	cambras@ub.edu; dserra@ub.edu	Valcarcel, Lorea/F-6747-2017; Serra, Dolors/L-3657-2014; Cambras, Trinitat/S-3881-2019; Herrero, Laura/D-4011-2014; Silva, Crhistiane/K-6479-2013	Valcarcel, Lorea/0000-0002-7309-9924; Serra, Dolors/0000-0002-4936-4206; Cambras, Trinitat/0000-0002-9009-4690; Herrero, Laura/0000-0003-4244-4673; Silva, Crhistiane/0000-0003-2637-162X; ALBERT COLOMER, NEREA/0000-0001-8893-1317	Spanish Ministry of Economy and Competitiveness [BFU2008-00199, SAF2013-45887-R, SAF2011-30520-C02-01]; Generalitat de Catalunya [2014SGR-465]; Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Instituto de Salud Carlos III [CB06/03/0026]; European Foundation for the Study of Diabetes (EFSD)/Lilly; European Foundation for the Study of Diabetes (EFSD)/Janssen; L'Oreal-UNESCO; Ministerio de Educacion y Ciencia [BFU2008-00199]; CAPES [BEX 4970/10-1]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Foundation for the Study of Diabetes (EFSD)/Lilly(Eli Lilly); European Foundation for the Study of Diabetes (EFSD)/Janssen; L'Oreal-UNESCO(L'Oreal Group); Ministerio de Educacion y Ciencia(Spanish Government); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Spanish Ministry of Economy and Competitiveness (Grant BFU2008-00199 to TC and AD, Grant SAF2013-45887-R to LH and Grant SAF2011-30520-C02-01 to DS), Generalitat de Catalunya (2014SGR-465 to DS), Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III (Grant CB06/03/0026 to DS), European Foundation for the Study of Diabetes (EFSD)/Lilly and European Foundation for the Study of Diabetes (EFSD)/Janssen (research fellowships to LH), L'Oreal-UNESCO (research fellowship to LH) and by the Ministerio de Educacion y Ciencia (BFU2008-00199). CAS was Bolsista da CAPES - Proc. no BEX 4970/10-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert N, 2013, BEHAV BRAIN RES, V252, P347, DOI 10.1016/j.bbr.2013.06.025; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Campuzano A, 1998, PHYSIOL BEHAV, V63, P171, DOI 10.1016/S0031-9384(97)00416-2; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2008, NEUROBIOL AGING, V29, P471, DOI 10.1016/j.neurobiolaging.2006.10.018; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Husse J, 2012, PLOS ONE, V7, DOI [10.1371/ journal. pone. 0052983, DOI 10.1371/J0URNAL.P0NE.0052983]; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kennaway DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065255; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lancha A, 2012, NUTR RES REV, V25, P223, DOI 10.1017/S0954422412000145; Li SM, 2009, J APPL PHYSIOL, V107, P1959, DOI 10.1152/japplphysiol.00467.2009; Lucas RJ, 2012, PROG BRAIN RES, V199, P1, DOI 10.1016/B978-0-444-59427-3.00001-0; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Madrid JA, 1998, AM J PHYSIOL-REG I, V275, pR372, DOI 10.1152/ajpregu.1998.275.2.R372; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P227, DOI 10.3109/07420528.2012.658127; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Salgado-Delgado RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060052; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Summa KC, 2014, ADV NUTR, V5, p312S, DOI 10.3945/an.113.005132; Szantoova K, 2011, MOL CELL BIOCHEM, V348, P53, DOI 10.1007/s11010-010-0636-x; Varcoe TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053800; Zafrir B, 2013, HORM METAB RES, V45, P774, DOI 10.1055/s-0033-1348264	37	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122570	10.1371/journal.pone.0122570	http://dx.doi.org/10.1371/journal.pone.0122570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837425	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000101
J	Ten Brink, AF; Nijboer, TCW; Bergsma, DP; Barton, JJS; Van der Stigchel, S				Ten Brink, Antonia F.; Nijboer, Tanja C. W.; Bergsma, Douwe P.; Barton, Jason J. S.; Van der Stigchel, Stefan			Lack of Multisensory Integration in Hemianopia: No Influence of Visual Stimuli on Aurally Guided Saccades to the Blind Hemifield	PLOS ONE			English	Article							PRIMATE SUPERIOR COLLICULUS; EYE-MOVEMENT TRAJECTORIES; SOMATOSENSORY CONVERGENCE; AUDIOVISUAL STIMULATION; TELL US; VISION; DISTRACTORS; ENHANCEMENT; CAPTURE; TARGET	In patients with visual hemifield defects residual visual functions may be present, a phenomenon called blindsight. The superior colliculus (SC) is part of the spared pathway that is considered to be responsible for this phenomenon. Given that the SC processes input from different modalities and is involved in the programming of saccadic eye movements, the aim of the present study was to examine whether multimodal integration can modulate oculomotor competition in the damaged hemifield. We conducted two experiments with eight patients who had visual field defects due to lesions that affected the retinogeniculate pathway but spared the retinotectal direct SC pathway. They had to make saccades to an auditory target that was presented alone or in combination with a visual stimulus. The visual stimulus could either be spatially coincident with the auditory target (possibly enhancing the auditory target signal), or spatially disparate to the auditory target (possibly competing with the auditory tar-get signal). For each patient we compared the saccade endpoint deviation in these two bi-modal conditions with the endpoint deviation in the unimodal condition (auditory target alone). In all seven hemianopic patients, saccade accuracy was affected only by visual stimuli in the intact, but not in the blind visual field. In one patient with a more limited quadrantano-pia, a facilitation effect of the spatially coincident visual stimulus was observed. We conclude that our results show that multisensory integration is infrequent in the blind field of patients with hemianopia.	[Ten Brink, Antonia F.; Nijboer, Tanja C. W.; Van der Stigchel, Stefan] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands; [Ten Brink, Antonia F.; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Brain Ctr, Utrecht, Netherlands; [Ten Brink, Antonia F.; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Ten Brink, Antonia F.; Nijboer, Tanja C. W.] Rehabil Ctr Hoogstr, Utrecht, Netherlands; [Bergsma, Douwe P.] Radboud Univ Nijmegen Med Ctr, Dept Cognit Neurosci, Nijmegen, Netherlands; [Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of British Columbia; University of British Columbia	Ten Brink, AF (corresponding author), Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands.	t.t.brink@dehoogstraat.nl	Ten Brink, Antonia/AAM-9341-2020; Barton, Jason JS/A-6362-2012	Ten Brink, Antonia/0000-0001-7634-0819; 	Netherlands Organization for Scientific Research [451-09-019, 451-10-013]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was funded by two grants from the Netherlands Organization for Scientific Research: (http://www.nwo.nl/), Grant Nos. 451-09-019 (to S.V.d.S.) and 451-10-013 (to T.C.W.N.). This organization had no other role in the conduct of the research or preparation of the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; Azzopardi P, 1998, CONSCIOUS COGN, V7, P292, DOI 10.1006/ccog.1998.0358; Barton Jason J S, 2011, Handb Clin Neurol, V102, P223, DOI 10.1016/B978-0-444-52903-9.00015-7; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; Bolognini N, 2005, BRAIN, V128, P2830, DOI 10.1093/brain/awh656; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; Carey DP, 2008, NEUROPSYCHOLOGIA, V46, P3053, DOI 10.1016/j.neuropsychologia.2008.06.015; Colonius H, 2001, PERCEPT PSYCHOPHYS, V63, P126, DOI 10.3758/BF03200508; CORBETTA M, 1990, BRAIN, V113, P603, DOI 10.1093/brain/113.3.603; COREN S, 1972, PERCEPT MOTOR SKILL, V34, P499, DOI 10.2466/pms.1972.34.2.499; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Corneil BD, 1996, J NEUROSCI, V16, P8193; Cowey A, 2004, Q J EXP PSYCHOL-A, V57, P577, DOI 10.1080/02724980343000882; Danckert J, 2005, NEUROSCI BIOBEHAV R, V29, P1035, DOI 10.1016/j.neubiorev.2005.02.001; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; Doyle MC, 2002, EXP BRAIN RES, V142, P116, DOI 10.1007/s00221-001-0919-2; EDWARDS SB, 1979, J COMP NEUROL, V184, P309, DOI 10.1002/cne.901840207; ENGELKEN EJ, 1989, AVIAT SPACE ENVIR MD, V60, P762; Fayel A, 2014, EXP BRAIN RES, V232, P903, DOI 10.1007/s00221-013-3803-y; FENDRICH R, 1992, SCIENCE, V258, P1489, DOI 10.1126/science.1439839; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Frassinetti F, 2005, J COGNITIVE NEUROSCI, V17, P1442, DOI 10.1162/0898929054985446; FRENS MA, 1995, EXP BRAIN RES, V107, P103, DOI 10.1007/BF00228022; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Klemen J, 2012, NEUROSCI BIOBEHAV R, V36, P111, DOI 10.1016/j.neubiorev.2011.04.015; Ladavas E, 2008, ANN NY ACAD SCI, V1124, P98, DOI 10.1196/annals.1440.008; Leh SE, 2006, BRAIN, V129, P1822, DOI 10.1093/brain/awl111; Leo F, 2008, BRAIN, V131, P855, DOI 10.1093/brain/awn003; Leopold DA, 2012, ANNU REV NEUROSCI, V35, P91, DOI 10.1146/annurev-neuro-062111-150356; Lewald J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031603; MARZI CA, 1986, NEUROPSYCHOLOGIA, V24, P749, DOI 10.1016/0028-3932(86)90074-6; MEREDITH MA, 1992, EXP BRAIN RES, V88, P181, DOI 10.1007/BF02259139; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Overgaard M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0209; Overgaard M, 2011, EXP BRAIN RES, V209, P473, DOI 10.1007/s00221-011-2578-2; Passamonti C, 2009, NEUROPSYCHOLOGIA, V47, P546, DOI 10.1016/j.neuropsychologia.2008.10.008; PERROTT DR, 1991, HUM FACTORS, V33, P389, DOI 10.1177/001872089103300402; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; RAFAL R, 1990, SCIENCE, V250, P118, DOI 10.1126/science.2218503; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; Sparks D L, 1989, Rev Oculomot Res, V3, P213; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Stanford T. R., 2004, CROSSMODAL SPACE CRO, P25; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE., 1993, MERGING SENSES; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Ten Brink AF, 2014, EXP BRAIN RES, V232, P1357, DOI 10.1007/s00221-014-3854-8; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Van der Stigchel S, 2010, BRAIN COGNITION, V74, P66, DOI 10.1016/j.bandc.2010.06.006; Van der Stigchel S, 2008, J COGNITIVE NEUROSCI, V20, P2025, DOI 10.1162/jocn.2008.20145; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; Van der Stigchel S, 2011, J EYE MOVEMENT RES, V4; Van der Stigchel S, 2010, CONSCIOUS COGN, V19, P186, DOI 10.1016/j.concog.2009.11.003; Walker R, 2000, P ROY SOC B-BIOL SCI, V267, P431, DOI 10.1098/rspb.2000.1018; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709	57	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122054	10.1371/journal.pone.0122054	http://dx.doi.org/10.1371/journal.pone.0122054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835952	Green Published, gold			2022-12-27	WOS:000352139000075
J	Zerrouki, H; Rizzati, V; Bernis, C; Negre-Salvayre, A; Sarrette, JP; Cousty, S				Zerrouki, Hayat; Rizzati, Virginie; Bernis, Corinne; Negre-Salvayre, Anne; Sarrette, Jean Philippe; Cousty, Sarah			Escherichia coli Morphological Changes and Lipid A Removal Induced by Reduced Pressure Nitrogen Afterglow Exposure	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ATMOSPHERIC-PRESSURE; NONCULTURABLE STATE; PLASMA; STERILIZATION; SURVIVAL; ROLES; ASSAY; HEAT; DRY	Lipid A is a major hydrophobic component of lipopolysaccharides (endotoxin) present in the membrane of most Gram-negative bacteria, and the major responsible for the bioactivity and toxicity of the endotoxin. Previous studies have demonstrated that the late afterglow region of flowing post-discharges at reduced pressure (1-20 Torr) can be used for the sterilization of surfaces and of the reusable medical instrumentation. In the present paper, we show that the antibacterial activity of a pure nitrogen afterglow can essentially be attributed to the large concentrations of nitrogen atoms present in the treatment area and not to the UV radiation of the afterglow. In parallel, the time variation of the inactivation efficiency quantified by the log reduction of the initial Escherichia coli (E. coli) population is correlated with morphologic changes observed on the bacteria by scanning electron microscopy (SEM) for increasing afterglow exposure times. The effect of the afterglow exposure is also studied on pure lipid A and on lipid A extracted from exposed E. coli bacteria. We report that more than 60% of lipid A (pure or bacteria-extracted) are lost with the used operating conditions (nitrogen flow Q(N2) = 1 standard liter per minute (slpm), pressure p = 5 Torr, microwave injected power P-MW = 200 W, exposure time: 40 minutes). The afterglow exposure also results in a reduction of the lipid A proinflammatory activity, assessed by the net decrease of the redox-sensitive NF kappa B transcription factor nuclear translocation in murine aortic endothelial cells stimulated with control vs afterglow-treated (pure and extracted) lipid A. Altogether these results point out the ability of reduced pressure nitrogen afterglows to neutralize the cytotoxic components in Gram-negative bacteria.	[Zerrouki, Hayat; Sarrette, Jean Philippe] Univ Toulouse, Lab Plasma & Convers Energie, LAPLACE, UPS,INPT, F-31062 Toulouse, France; [Zerrouki, Hayat; Sarrette, Jean Philippe] CNRS, LAPLACE, F-31062 Toulouse, France; [Rizzati, Virginie; Bernis, Corinne; Negre-Salvayre, Anne] Univ Toulouse, INSERM, UMR 1048, F-31062 Toulouse, France; [Cousty, Sarah] Univ Toulouse, Ctr Hosp, UPS, Fac Chirurg Dent Toulouse, F-31062 Toulouse, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sarrette, JP (corresponding author), Univ Toulouse, Lab Plasma & Convers Energie, LAPLACE, UPS,INPT, Bat 3R2, F-31062 Toulouse, France.	jean-philippe.sarrette@laplace.univ-tlse.fr	Cousty, Sarah/AGZ-6395-2022	Cousty, Sarah/0000-0003-4077-2796; Sarrette, Jean Philippe/0000-0001-7735-0576; Bernis, Corinne/0000-0002-2335-187X; Negre-Salvayre, Anne/0000-0003-2136-5706	french ANR program through the grant "PLASMAVIV" [ANR 2010 BLAN 0950 01]	french ANR program through the grant "PLASMAVIV"(French National Research Agency (ANR))	The work was supported by the french ANR program through the grant "PLASMAVIV", ANR 2010 BLAN 0950 01.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Alfa MJ, 1999, AM J INFECT CONTROL, V27, P392, DOI 10.1016/S0196-6553(99)70004-0; Auge N, 2002, ARTERIOSCLER THROMB, V22; Baxter RL, 2006, J HOSP INFECT, V63, P439, DOI 10.1016/j.jhin.2006.03.011; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Boudam MK, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/29/295202; BYRD JJ, 1991, APPL ENVIRON MICROB, V57, P875, DOI 10.1128/AEM.57.3.875-878.1991; Colwell RR, 1996, WORLD J MICROB BIOT, V12, P28, DOI 10.1007/BF00327795; DesCoteaux J G, 1995, AORN J, V62, P23, DOI 10.1016/S0001-2092(06)63680-6; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dolezalova E, 2015, BIOELECTROCHEMISTRY, V103, P7, DOI 10.1016/j.bioelechem.2014.08.018; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Kutasi K, 2007, J PHYS D APPL PHYS, V40, P5612, DOI 10.1088/0022-3727/40/18/017; Lerouge S., 2000, PLASMAS POLYM, V5, P31, DOI [10.1023/A:1009504209276, DOI 10.1023/A:1009504209276]; LINDBERG C, 1991, J PHOTOCH PHOTOBIO B, V11, P69, DOI 10.1016/1011-1344(91)80269-N; Lipscomb IP, 2006, J CLIN MICROBIOL, V44, P3728, DOI 10.1128/JCM.01280-06; Miller DM, 2001, ANAESTHESIA, V56, P1069, DOI 10.1046/j.1365-2044.2001.02277.x; Moesby L, 2005, EUR J PHARM SCI, V26, P318, DOI 10.1016/j.ejps.2005.07.003; Moisan M, 2013, EUR PHYS J-APPL PHYS, V63, DOI 10.1051/epjap/2013120510; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKATA T, 1993, J PARENT SCI TECHN, V47, P258; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Philip N, 2002, IEEE T PLASMA SCI, V30, P1429, DOI 10.1109/TPS.2002.804203; Pintassilgo CD, 2003, P 16 INT S PLASM CHE; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rossi F, 2006, PLASMA PROCESS POLYM, V3, P431, DOI 10.1002/ppap.200600011; ROTH WG, 1988, APPL ENVIRON MICROB, V54, P3142, DOI 10.1128/AEM.54.12.3142-3146.1988; Sifuentes-Osornio J, 2001, GAC MED MEX, V137, P191; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Vasselle A, 2006, 421 OPEPS; Villeger S, 2008, EUR PHYS J-APPL PHYS, V42, P25, DOI 10.1051/epjap:2007177; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Williams David, 2003, Med Device Technol, V14, P10; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Zerrouki H, 2013, CONTRIB PLASM PHYS, V53, P599, DOI 10.1002/ctpp.201300008	35	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0116083	10.1371/journal.pone.0116083	http://dx.doi.org/10.1371/journal.pone.0116083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837580	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000002
J	Zhang, JJ; Ren, A; Chen, H; Zhao, MW; Shi, L; Chen, MJ; Wang, H; Feng, ZY				Zhang, Jinjing; Ren, Ang; Chen, Hui; Zhao, Mingwen; Shi, Liang; Chen, Mingjie; Wang, Hong; Feng, Zhiyong			Transcriptome Analysis and Its Application in Identifying Genes Associated with Fruiting Body Development in Basidiomycete Hypsizygus marmoreus	PLOS ONE			English	Article							EDIBLE MUSHROOM; NADPH OXIDASE; SIGNAL-TRANSDUCTION; AGARICUS-BISPORUS; LENTINULA-EDODES; GROWTH; LIGHT; EXPRESSION; PHOTORECEPTOR; MYCELIUM	To elucidate the mechanisms of fruit body development in H. marmoreus, a total of 43609521 high-quality RNA-seq reads were obtained from four developmental stages, including the mycelial knot (H-M), mycelial pigmentation (H-V), primordium (H-P) and fruiting body (H-F) stages. These reads were assembled to obtain 40568 unigenes with an average length of 1074 bp. A total of 26800 (66.06%) unigenes were annotated and analyzed with the Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and Eukaryotic Orthologous Group (KOG) databases. Differentially expressed genes (DEGs) from the four transcriptomes were analyzed. The KEGG enrichment analysis revealed that the mycelium pigmentation stage was associated with the MAPK, cAMP, and blue light signal transduction pathways. In addition, expression of the two-component system members changed with the transition from H-M to H-V, suggesting that light affected the expression of genes related to fruit body initiation in Hypsizygus marmoreus. During the transition from H-V to H-P, stress signals associated with MAPK, cAMP and ROS signals might be the most important inducers. Our data suggested that nitrogen starvation might be one of the most important factors in promoting fruit body maturation, and nitrogen metabolism and mTOR signaling pathway were associated with this process. In addition, 30 genes of interest were analyzed by quantitative real-time PCR to verify their expression profiles at the four developmental stages. This study advances our understanding of the molecular mechanism of fruiting body development in Hypsizygus marmoreus by identifying a wealth of new genes that may play important roles in mushroom morphogenesis.	[Zhang, Jinjing; Ren, Ang; Zhao, Mingwen; Shi, Liang; Feng, Zhiyong] Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Zhang, Jinjing; Chen, Hui; Chen, Mingjie; Wang, Hong; Feng, Zhiyong] Shanghai Acad Agr Sci, Natl Res Ctr Edible Fungi Biotechnol & Engn, Key Lab Appl Mycol Resources & Utilizat,Inst Edib, Minist Agr,Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Shanghai Academy of Agricultural Sciences	Feng, ZY (corresponding author), Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China.	feng_zy@yahoo.com	Gulliver, Aaron/K-7925-2012; Zhao, Ming-Wen/AAS-1510-2020	Gulliver, Aaron/0000-0001-9919-0323; zhao, mingwen/0000-0002-9413-1743	National Natural Science Foundation of China [31401932]; Key Scientific Research Project of Shanghai [11391901003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Research Project of Shanghai	This work was supported by the National Natural Science Foundation of China (Project No. 31401932) and the Key Scientific Research Project of Shanghai (Project No. 11391901003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia Eden, 2006, International Journal of Medicinal Mushrooms, V8, P361, DOI 10.1615/IntJMedMushr.v8.i4.70; Aleksandrova EA, 1998, MICROBIOLOGY+, V67, P535; Bidartondo MI, 2001, NEW PHYTOL, V151, P543, DOI 10.1046/j.1469-8137.2001.00180.x; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cheng CK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-195; Chum WWY, 2008, MYCOL RES, V112, P950, DOI 10.1016/j.mycres.2008.01.028; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Groot PWJ, 1998, MYCOL RES, V102, P1297, DOI 10.1017/S0953756298007266; Eastwood DC, 2013, FUNGAL GENET BIOL, V55, P54, DOI 10.1016/j.fgb.2013.01.001; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hsu KH, 2011, INT J MED MUSHROOMS, V13, P513, DOI 10.1615/IntJMedMushr.v13.i6.30; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Jang MJ, 2013, MYCOBIOLOGY, V41, P63, DOI 10.5941/MYCO.2013.41.1.63; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katherine PD, 2000, PLANT CELL, V11, P2045; Krieg RC, 2005, J BIOCHEM BIOPH METH, V65, P13, DOI 10.1016/j.jbbm.2005.08.005; Kues U., 2004, Fungi in human and animal health, P431; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Kuratani M, 2010, FUNGAL GENET BIOL, V47, P152, DOI 10.1016/j.fgb.2009.10.006; Lalucque H, 2003, TRENDS MICROBIOL, V11, P9, DOI 10.1016/S0966-842X(02)00007-0; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; LEATHAM GF, 1987, T BRIT MYCOL SOC, V88, P9, DOI 10.1016/S0007-1536(87)80180-8; Lee CY, 2012, FEMS MICROBIOL LETT, V327, P54, DOI 10.1111/j.1574-6968.2011.02458.x; Lee YL, 2009, LWT-FOOD SCI TECHNOL, V42, P594, DOI 10.1016/j.lwt.2008.09.003; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li P, 2013, GENE, V532, P63, DOI 10.1016/j.gene.2013.09.014; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Masloff S, 1999, GENETICS, V152, P191; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu DS, 2014, ENVIRON MICROBIOL, V16, P1709, DOI 10.1111/1462-2920.12326; Muraguchi H, 2000, FUNGAL GENET BIOL, V29, P49, DOI 10.1006/fgbi.2000.1184; Nakazawa T, 2011, FUNGAL GENET BIOL, V48, P519, DOI 10.1016/j.fgb.2011.01.010; Palmer GE, 2006, FEMS MICROBIOL LETT, V262, P1, DOI 10.1111/j.1574-6968.2006.00341.x; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Park HY, 1999, CELL MOL BIOL, V45, P919; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez-Ferrer A., 1995, BIOCHIM BIOPHYS ACTA, V1, P1247; Sano H, 2007, BIOSCI BIOTECH BIOCH, V71, P2206, DOI 10.1271/bbb.70170; Sano H, 2009, FUNGAL GENET BIOL, V46, P333, DOI 10.1016/j.fgb.2009.01.001; Stamets P, 1993, GROWING GOURMET MED, V103, P242; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Tang LH, 2013, APPL MICROBIOL BIOT, V97, P4977, DOI 10.1007/s00253-013-4832-y; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Umar MH, 1998, MYCOL RES, V102, P719, DOI 10.1017/S0953756297005893; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083517; Weijn A, 2013, FUNGAL GENET BIOL, V55, P42, DOI 10.1016/j.fgb.2012.10.004; WESSELS JGH, 1993, NEW PHYTOL, V123, P397, DOI 10.1111/j.1469-8137.1993.tb03751.x; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhang H, 2014, FOOD CHEM, V147, P189, DOI 10.1016/j.foodchem.2013.09.118; Zhang JJ, 2014, MICROBIOL RES, V169, P741, DOI 10.1016/j.micres.2014.01.004	59	51	66	7	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123025	10.1371/journal.pone.0123025	http://dx.doi.org/10.1371/journal.pone.0123025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837428	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000121
J	Benstoem, C; Moza, A; Autschbach, R; Stoppe, C; Goetzenich, A				Benstoem, Carina; Moza, Ajay; Autschbach, Ruediger; Stoppe, Christian; Goetzenich, Andreas			Evaluating Outcomes Used in Cardiothoracic Surgery Interventional Research: A Systematic Review of Reviews to Develop a Core Outcome Set	PLOS ONE			English	Article								Background When planning clinical trials, it is a key element to choose appropriate outcomes that ensure the comparability of effects of interventions in ways that minimise bias. We hypothesise that outcome measures in cardiothoracic surgical trials are inconsistent and without standard. Therefore, comparing the relative effectiveness of interventions across studies is problematic. We surmise that cardiothoracic research has focused habitually on the identification of risk factors and on the reduction of adverse outcomes with less consideration of factors that contribute to well being and positive health outcomes (salutogenesis). Methods and Findings We conducted a systematic review of reviews to determine both the type and number of outcomes reported in current cardiothoracic surgery interventional research, in order to identify a list of potential outcomes for a minimum core outcome set (COS). Special focus was placed on outcomes that emphasise salutogenesis. We interpreted salutogenic outcomes as those relating to optimum and/or positive health and well being. We searched Issue 7 (July 2014) of the Cochrane Database of Systematic Reviews. Systematic reviews of randomised trials on non-minimal-invasive off-or on-pump cardiothoracic surgery (elective and emergency, excluding transplants) investigating pre-, intra-or postsurgical interventions related to the outcome of the procedure were eligible for inclusion. We excluded protocols and withdrawn systematic reviews. Two review authors extracted outcome data independently. Unique lists of salutogenically and non-salutogenically focused outcomes were established. 15 systematic reviews involving 371 randomized trials and 58,253 patients were included in this review. Applied definitions of single and composite endpoints varied significantly, and patient-centred, salutogenically focused outcomes were seldom reported. One third of included reviews did not assess patient-centred outcomes at all; all other reviews were unable to perform meta-analyses due to an absence of data or heterogeneity in outcome measures. This compares to 36 non-salutogenically focused outcome domains representing 121 individual non-salutogenically focused outcomes, whereof 50% were assessed only once. Measures of mortality, cerebrovascular complications and hospitalisation were reported most frequently. Two reviews chose a composite endpoint as primary outcome. Pooled analysis of composite endpoints was not possible, as the required data was not reported per patient in all components. Conclusion In cardiothoracic surgical trials, choice and definition of non-salutogenically focused single and composite outcomes are inconsistent. There is an absence of patient centred, salutogenically focused outcome parameters in cardiac trials. We recommend the development of a core outcome set of salutogenically focused and non-salutogenically focused outcomes for cardiothoracic surgical research.	[Benstoem, Carina; Moza, Ajay; Autschbach, Ruediger; Stoppe, Christian; Goetzenich, Andreas] Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, Aachen, Germany; [Stoppe, Christian] Univ Hosp RWTH Aachen, Dept Anaesthesiol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Benstoem, C (corresponding author), Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, Aachen, Germany.	cbenstoem@ukaachen.de		Stoppe, Christian/0000-0002-2028-2039	START-Program of the Faculty of Medicine, RWTH Aachen	START-Program of the Faculty of Medicine, RWTH Aachen(Austrian Science Fund (FWF))	This research project is supported by the START-Program of the Faculty of Medicine, RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonovsky A., 1988, UNRAVELING MYSTERY H; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fellahi JL, 2007, CRIT CARE, V11, DOI 10.1186/cc6126; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Karmali KN, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007131.pub3; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-21; Kirkham JJ, 2009, BMJ-BRIT MED J, V340, P1; Lindstrom B, 2010, HITCHHIKERS GUIDE SA; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Newman MF, 1996, CIRCULATION, V94, P74; Organization W.H, 1979, WHO HDB REP RES CANC; Paparella D, 2003, ANN THORAC SURG, V76, P1094, DOI 10.1016/S0003-4975(03)00833-6; Smith V, 2014, MIDWIFERY, V30, pE151, DOI 10.1016/j.midw.2013.11.002; Theologou Thomas, 2011, Cochrane Database Syst Rev, pCD004472, DOI 10.1002/14651858.CD004472.pub3; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; WHO, 1986, 1 INT C HLTH PROM OT, DOI DOI 10.1093/HEAPRO/1.4.405; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; World Health Organisation, 2014, CARD DIS CVD	24	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122204	10.1371/journal.pone.0122204	http://dx.doi.org/10.1371/journal.pone.0122204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830921	Green Submitted, gold, Green Published			2022-12-27	WOS:000352135600103
J	Dine, J; Ionescu, IA; Avrabos, C; Yen, YC; Holsboer, F; Landgraf, R; Schmidt, U; Eder, M				Dine, Julien; Ionescu, Irina A.; Avrabos, Charilaos; Yen, Yi-Chun; Holsboer, Florian; Landgraf, Rainer; Schmidt, Ulrike; Eder, Matthias			Intranasally Applied Neuropeptide S Shifts a High-Anxiety Electrophysiological Endophenotype in the Ventral Hippocampus towards a "Normal"-Anxiety One	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; TRAIT ANXIETY; MOUSE MODEL; EXPRESSING NEURONS; FEAR EXPRESSION; GLYOXALASE-I; LONG-TERM; BRAIN; ACTIVATION; RATS	The neurobiological basis of pathological anxiety and the improvement of its pharmacological treatment are a matter of intensive investigation. Here, using electrophysiological techniques in brain slices from animals of the high anxiety-related behavior (HAB) and normal anxiety-related behavior (NAB) mouse model, we show that basal neurotransmission at ventral hippocampal CA3-CA1 synapses is weaker in HAB compared to NAB mice. We further demonstrate that paired-pulse facilitation (PPF) and long-term potentiation (LTP) at these synapses are more pronounced in slices from HAB animals. Based on previous findings, we also examined whether intranasal delivery of neuropeptide S (NPS), which increasingly emerges as a potential novel treatment option for anxiety symptoms occurring in a variety of diseases like anxiety disorders, posttraumatic stress disorder, and major depression, impacts on the high-anxiety electrophysiological endophenotype in HAB mice. Strikingly, we detected enhanced basal neurotransmission and reduced PPF and LTP in slices from NPS-treated HAB animals. Collectively, our study uncovers a multifaceted high-anxiety neurophysiological endophenotype in the murine ventral hippocampus and provides the first evidence that an intranasally applied neuropeptide can shift such an endophenotype in an anxiety-regulating brain structure towards a "normal"-anxiety one.	[Dine, Julien; Ionescu, Irina A.; Avrabos, Charilaos; Yen, Yi-Chun; Holsboer, Florian; Landgraf, Rainer; Schmidt, Ulrike; Eder, Matthias] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Dine, Julien; Eder, Matthias] Max Planck Inst Psychiat, Dept Stress Neurobiol & Neurogenet, D-80804 Munich, Germany	Max Planck Society; Max Planck Society	Dine, J (corresponding author), Max Planck Inst Psychiat, D-80804 Munich, Germany.	dine@psych.mpg.de; eder@psych.mpg.de	Yen, Yi-Chun/GYD-3634-2022	Dine, Julien/0000-0001-6381-8916; Eder, Matthias/0000-0002-2579-2628				Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; Avrabos C, 2013, J NEUROSCI, V33, P16262, DOI 10.1523/JNEUROSCI.2397-13.2013; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Braga RJ, 2013, PSYCHIAT RES, V210, P1, DOI 10.1016/j.psychres.2013.07.030; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Clark SD, 2011, J COMP NEUROL, V519, P1867, DOI 10.1002/cne.22606; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Dine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060219; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Filiou MD, 2011, BIOL PSYCHIAT, V70, P1074, DOI 10.1016/j.biopsych.2011.06.009; Frank E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007821; Hariri AR, 2009, ANNU REV NEUROSCI, V32, P225, DOI 10.1146/annurev.neuro.051508.135335; Ionescu IA, 2012, NEUROPSYCHOPHARMACOL, V37, P1323, DOI 10.1038/npp.2011.317; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Jungling K, 2012, J PHYSIOL-LONDON, V590, P3701, DOI 10.1113/jphysiol.2011.226423; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Liu XB, 2011, J COMP NEUROL, V519, P1847, DOI 10.1002/cne.22603; Lukas M, 2012, NEUROPHARMACOLOGY, V62, P398, DOI 10.1016/j.neuropharm.2011.08.016; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Straube T, 2007, NEUROIMAGE, V37, P1427, DOI 10.1016/j.neuroimage.2007.06.023; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Zhang WN, 2014, BEHAV BRAIN RES, V262, P47, DOI 10.1016/j.bbr.2013.10.044; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	36	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120272	10.1371/journal.pone.0120272	http://dx.doi.org/10.1371/journal.pone.0120272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830625	Green Published, gold			2022-12-27	WOS:000352135600028
J	Aljedai, A; Buckle, AM; Hiwarkar, P; Syed, F				Aljedai, Abdullah; Buckle, Anne-Marie; Hiwarkar, Prashant; Syed, Farhatullah			Potential Role of Notch Signalling in CD34(+) Chronic Myeloid Leukaemia Cells: Cross-Talk between Notch and BCR-ABL	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; GAMMA-SECRETASE INHIBITORS; HEMATOPOIETIC STEM; INTRACELLULAR DOMAIN; PROGENITOR CELLS; KINASE-ACTIVITY; BLAST CRISIS; IN-VIVO; IMATINIB; CML	Notch signalling is critical for haemopoietic stem cell (HSC) self-renewal and survival. The role of Notch signalling has been reported recently in chronic myeloid leukaemia (CML) - a stem cell disease characterized by BCR-ABL tyrosine kinase activation. Therefore, we studied the relationship between BCR-ABL and Notch signalling and assessed the expression patterns of Notch and its downstream target Hes1 in CD34(+) stem and progenitor cells from chronic-phase CML patients and bone marrow (BM) from normal subjects (NBM). We found significant upregulation (p<0.05) of Notch1, Notch2 and Hes1 on the most primitive CD34(+)Thy(+) subset of CML CD34(+) cells suggesting that active Notch signalling in CML primitive progenitors. In addition, Notch1 was also expressed in distinct lymphoid and myeloid progenitors within the CD34(+) population of primary CML cells. To further delineate the possible role and interactions of Notch with BCR-ABL in CD34(+) primary cells from chronic-phase CML, we used P-crkl detection as a surrogate assay of BCR-ABL tyrosine kinase activity. Our data revealed that Imatinib (IM) induced BCR-ABL inhibition results in significant (p<0.05) upregulation of Notch activity, assessed by Hes1 expression. Similarly, inhibition of Notch leads to hyperactivation of BCR-ABL. This antagonistic relationship between Notch and BCR-ABL signalling was confirmed in K562 and ALL-SIL cell lines. In K562, we further validated this antagonistic relationship by inhibiting histone deacetylase (HDAC) - an effector pathway of Hes1, using valproic acid (VPA) - a HDAC inhibitor. Finally, we also confirmed the potential antagonism between Notch and BCR/ABL in In Vivo, using publically available GSE-database, by analysing gene expression profile of paired samples from chronic-phase CML patients pre- and post-Imatinib therapy. Thus, we have demonstrated an antagonistic relationship between Notch and BCR-ABL in CML. A combined inhibition of Notch and BCR-ABL may therefore provide superior clinical response over tyrosine-kinase inhibitor monotherapy by targeting both quiescent leukaemic stem cells and differentiated leukaemic cells and hence must be explored.	[Aljedai, Abdullah; Buckle, Anne-Marie; Syed, Farhatullah] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; [Hiwarkar, Prashant] Great Ormond St Hosp Sick Children, Dept Paediat Haematol, London, England; [Syed, Farhatullah] Univ Manchester, Manchester Inst Biotechnol, Inst Inflammat & Repair, Manchester, Lancs, England	University of Manchester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester	Aljedai, A (corresponding author), King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh 11451, Saudi Arabia.	aaljedai@ksu.edu.sa	ALJEDAI, ABDULLAH/HCH-6903-2022	Aljedai, Abdullah/0000-0002-8331-5651	Ministry of Saudi, Government of Saudi Arabia	Ministry of Saudi, Government of Saudi Arabia	For this work the funding was provided to A.A. by Ministry of Saudi, Government of Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2005, FEBS LETT, V579, P6199, DOI 10.1016/j.febslet.2005.09.093; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruennert D, 2009, LEUKEMIA, V23, P983, DOI 10.1038/leu.2008.337; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burthem J, 2007, LEUKEMIA, V21, P1708, DOI 10.1038/sj.leu.2404762; Chadwick N, 2007, STEM CELLS, V25, P203, DOI 10.1634/stemcells.2005-0303; Chadwick N, 2010, BLOOD CELL MOL DIS, V45, P201, DOI 10.1016/j.bcmd.2010.07.006; Chadwick N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-35; Chen YY, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-21; Chomel JC, 2014, M S-MED SCI, V30, P452, DOI 10.1051/medsci/20143004022; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; De Keersmaecker K, 2008, HAEMATOLOGICA, V93, P533, DOI 10.3324/haematol.11894; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Graux C, 2009, LEUKEMIA, V23, P125, DOI 10.1038/leu.2008.278; Guruharsha K, 2012, NATURE REV GENETICS; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; He F, 2009, LEUKEMIA RES, V33, P798, DOI 10.1016/j.leukres.2008.09.016; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Jamieson C, 2010, BLOOD, V115, P2726, DOI 10.1182/blood-2009-12-252585; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kinstrie R, 2013, CURR HEMATOL MALIG R, V8, P14, DOI 10.1007/s11899-012-0148-8; Kogoshi H, 2007, ONCOL REP, V18, P77; Kolb EA, 2012, PEDIATR BLOOD CANCER, V58, P815, DOI 10.1002/pbc.23290; Liu N, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-23; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; Mizuno T, 2008, ONCOGENE, V27, P3465, DOI 10.1038/sj.onc.1211007; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakahara F, 2014, BLOOD, V123, P3932, DOI 10.1182/blood-2013-01-476747; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Neumann F, 2005, LEUKEMIA, V19, P458, DOI 10.1038/sj.leu.2403615; ODA T, 1994, J BIOL CHEM, V269, P22925; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Pellicano F, 2011, LEUKEMIA, V25, P1159, DOI 10.1038/leu.2011.67; Pellicano F, 2009, BLOOD, V114, P4186, DOI 10.1182/blood-2009-05-219550; Petzer AL, 1996, BLOOD, V88, P2162, DOI 10.1182/blood.V88.6.2162.bloodjournal8862162; Portillo V, 2013, EUROPEAN J HAEMATOLO; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Samon JB, 2012, MOL CANCER THER, V11, P1565, DOI 10.1158/1535-7163.MCT-11-0938; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Suresh S, 2013, J PATHOL, V231, P378, DOI 10.1002/path.4246; Tejada FNH, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00054; Tickenbrock L, 2008, INT J ONCOL, V33, P1215, DOI 10.3892/ijo_00000111; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yang Chun-xiu, 2011, Chinese Journal of Biologicals, V24, P1278; Yang ZS, 2013, ONCOL LETT, V5, P1390, DOI 10.3892/ol.2013.1159; Yin DD, 2009, LEUKEMIA RES, V33, P109, DOI 10.1016/j.leukres.2008.06.023	63	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123016	10.1371/journal.pone.0123016	http://dx.doi.org/10.1371/journal.pone.0123016			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849484	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800196
J	Binelli, M; Scolari, SC; Pugliesi, G; Van Hoeck, V; Gonella-Diaza, AM; Andrade, SCS; Gasparin, GR; Coutinho, LL				Binelli, Mario; Scolari, Saara C.; Pugliesi, Guilherme; Van Hoeck, Veerle; Gonella-Diaza, Angela M.; Andrade, Sonia C. S.; Gasparin, Gustavo R.; Coutinho, Luiz L.			The Transcriptome Signature of the Receptive Bovine Uterus Determined at Early Gestation	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOMETRIAL RECEPTIVITY; UTERINE RECEPTIVITY; EARLY-PREGNANCY; EMBRYO; IMPLANTATION; PROGESTERONE; MARKERS; FERTILITY; CATTLE	Pregnancy success is critical to the profitability of cattle operations. However, the molecular events driving the uterine tissue towards embryo receptivity are poorly understood. This study aimed to characterize the uterine transcriptome profiles of pregnant (P) versus nonpregnant (NP) cows during early pregnancy and attempted to define a potential set of marker genes that can be valuable for predicting pregnancy outcome. Therefore, beef cows were synchronized (n=51) and artificially inseminated (n=36) at detected estrus. Six days after AI (D6), jugular blood samples and a biopsy from the uterine horn contralateral to the ovary containing the corpus luteum were collected. Based on pregnancy outcome on D30, samples were retrospectively allocated to the following groups: P (n=6) and NP (n=5). Both groups had similar plasma progesterone concentrations on D6. Uterine biopsies were submitted to RNA-Seq analysis in a Illumina platform. The 272,685,768 million filtered reads were mapped to the Bos Taurus reference genome and 14,654 genes were analyzed for differential expression between groups. Transcriptome data showed that 216 genes are differently expressed when comparing NP versus P uterine tissue (Padj <= 0.1). More specifically, 36 genes were up-regulated in P cows and 180 are up-regulated in NP cows. Functional enrichment and pathway analyses revealed enriched expression of genes associated with extracellular matrix remodeling in the NP cows and nucleotide binding, microsome and vesicular fraction in the P cows. From the 40 top-ranked genes, the transcript levels of nine genes were re-evaluated using qRT-PCR. In conclusion, this study characterized a unique set of genes, expressed in the uterus 6 days after insemination, that indicate a receptive state leading to pregnancy success. Furthermore, expression of such genes can be used as potential markers to efficiently predict pregnancy success.	[Binelli, Mario; Scolari, Saara C.; Pugliesi, Guilherme; Van Hoeck, Veerle; Gonella-Diaza, Angela M.; Andrade, Sonia C. S.] FMVZ USP, Dept Anim Reprod, Lab Fisiol & Endocrinol Mol, Sao Paulo, Brazil; [Gasparin, Gustavo R.; Coutinho, Luiz L.] ESALQ USP, Dept Zootecnia, Lab Genet Anim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Binelli, M (corresponding author), FMVZ USP, Dept Anim Reprod, Lab Fisiol & Endocrinol Mol, Sao Paulo, Brazil.	binelli@usp.br	Coutinho, Luiz L/C-8455-2012; pugliesi, Guilherme/A-9149-2013; Andrade, Sonia/GLS-1234-2022; Andrade, Sonia CS/F-8267-2014; Coutinho, Luiz/P-5233-2019; Pugliesi, Guilherme/AAK-9557-2020	Coutinho, Luiz L/0000-0002-7266-8881; Andrade, Sonia/0000-0002-1302-5261; Andrade, Sonia CS/0000-0002-1302-5261; Coutinho, Luiz/0000-0002-7266-8881; Pugliesi, Guilherme/0000-0001-5739-0677	LFEM (Laboratorio de Fisiologia e Endocrinologia Molecular) [211]; Fundacao de Amparo A Pesquisa do Estado de Sao Paulo [2011/03226-4, 2012/23532-5]; CNPq; CAPES	LFEM (Laboratorio de Fisiologia e Endocrinologia Molecular); Fundacao de Amparo A Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by LFEM (Laboratorio de Fisiologia e Endocrinologia Molecular)(Project #211), Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (2011/03226-4 and 2012/23532-5), CNPq and CAPES.	Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Baumann CG, 2007, MOL REPROD DEV, V74, P1345, DOI 10.1002/mrd.20604; Beltman ME, 2013, REPROD FERT DEVELOP, V25, P966, DOI 10.1071/RD12232; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Binelli M, 2014, ANIM REPROD, V11, P246; BRENNER CA, 1989, GENE DEV, V3, P848, DOI 10.1101/gad.3.6.848; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Clemente M, 2009, REPRODUCTION, V138, P507, DOI 10.1530/REP-09-0152; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; Fatemi HM, 2013, REPROD BIOMED ONLINE, V27, P530, DOI 10.1016/j.rbmo.2013.05.018; Favaro RR, 2013, PLACENTA, V34, P1128, DOI 10.1016/j.placenta.2013.09.012; Forde N, 2012, PHYSIOL GENOMICS, V44, P799, DOI 10.1152/physiolgenomics.00067.2012; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Forde N, 2012, J REPROD DEVELOP, V58, P189, DOI 10.1262/jrd.2011-021; Garrido-Gomez T, 2013, FERTIL STERIL, V99, P1078, DOI 10.1016/j.fertnstert.2012.12.005; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giudice LC, 1999, HUM REPROD, V14, P3, DOI 10.1093/humrep/14.suppl_2.3; Grimard B, 2006, ANIM REPROD SCI, V91, P31, DOI 10.1016/j.anireprosci.2005.03.003; Groothuis PG, 2007, HUM REPROD UPDATE, V13, P405, DOI 10.1093/humupd/dmm009; ILESANMI AO, 1993, MICROSC RES TECHNIQ, V25, P208, DOI 10.1002/jemt.1070250304; Kaloglu C, 2010, TISSUE CELL, V42, P301, DOI 10.1016/j.tice.2010.07.004; Kim JY, 2011, BIOL REPROD, V84, P62, DOI 10.1095/biolreprod.110.085738; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Llobat L, 2012, REPROD DOMEST ANIM, V47, P281, DOI 10.1111/j.1439-0531.2011.01855.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mesquita FS, 2014, THERIOGENOLOGY, V81, P861, DOI 10.1016/j.theriogenology.2013.12.022; Minten MA, 2013, PLOS ONE, DOI [10.1371/ journal. pone. 0069444, DOI 10.1371/J0URNAL.P0NE.0069444]; Murphy CR, 1995, HUM REPROD UPDATE, V1, P567, DOI 10.1093/humupd/1.6.567; Nissi R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-2; Pugliesi G, 2014, REPROD DOMEST ANIM, V49, pE35, DOI 10.1111/rda.12345; Rashid NA, 2011, AM J REPROD IMMUNOL, V66, P23, DOI 10.1111/j.1600-0897.2011.01048.x; Revel A, 2012, FERTIL STERIL, V97, P1028, DOI 10.1016/j.fertnstert.2012.03.039; Robert C, 2010, REPRODUCTION, V140, P787, DOI 10.1530/REP-10-0191; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Spencer T. E., 2004, J ANIM SCI, V82, P4; Ulbrich SE, 2009, BIOL REPROD, V81, P795, DOI 10.1095/biolreprod.108.075184; Walker CG, 2013, PHYSIOL GENOMICS, V45, P276, DOI 10.1152/physiolgenomics.00145.2012; Walker CG, 2012, PHYSIOL GENOMICS, V44, P47, DOI 10.1152/physiolgenomics.00254.2010	44	28	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122874	10.1371/journal.pone.0122874	http://dx.doi.org/10.1371/journal.pone.0122874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849079	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800168
J	Krychtiuk, KA; Kastl, SP; Pfaffenberger, S; Lenz, M; Hofbauer, SL; Wonnerth, A; Koller, L; Katsaros, KM; Pongratz, T; Goliasch, G; Niessner, A; Gaspar, L; Huber, K; Maurer, G; Dostal, E; Wojta, J; Oravec, S; Speidl, WS				Krychtiuk, Konstantin A.; Kastl, Stefan P.; Pfaffenberger, Stefan; Lenz, Max; Hofbauer, Sebastian L.; Wonnerth, Anna; Koller, Lorenz; Katsaros, Katharina M.; Pongratz, Thomas; Goliasch, Georg; Niessner, Alexander; Gaspar, Ludovit; Huber, Kurt; Maurer, Gerald; Dostal, Elisabeth; Wojta, Johann; Oravec, Stanislav; Speidl, Walter S.			Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease	PLOS ONE			English	Article							CD14(+)CD16(+) MONOCYTES; CD16(+) MONOCYTES; HEART-DISEASE; LIPOPROTEIN; RISK; SIZE; MEN; IDENTIFICATION; HETEROGENEITY; INFLAMMATION	Objective Atherosclerosis is considered to be an inflammatory disease in which monocytes and monocyte-derived macrophages play a key role. Circulating monocytes can be divided into three distinct subtypes, namely in classical monocytes (CM; CD14++CD16-), intermediate monocytes (IM; CD14++CD16+) and non-classical monocytes (NCM; CD14+CD16++). Low density lipoprotein particles are heterogeneous in size and density, with small, dense LDL (sdLDL) crucially implicated in atherogenesis. The aim of this study was to examine whether monocyte subsets are associated with sdLDL serum levels. Methods We included 90 patients with angiographically documented stable coronary artery disease and determined monocyte subtypes by flow cytometry. sdLDL was measured by an electrophoresis method on polyacrylamide gel. Results Patients with sdLDL levels in the highest tertile (sdLDL >= 4mg/dL; T3) showed the highest levels of pro-inflammatory NCM (15.2 +/- 7% vs. 11.4 +/- 6% and 10.9 +/- 4%, respectively; p<0.01) when compared with patients in the middle (sdLDL=2-3mg/dL; T2) and lowest tertile (sdLDL=0-1mg/dL; T1). Furthermore, patients in the highest sdLDL tertile showed lower CM levels than patients in the middle and lowest tertile (79.2 +/- 8% vs. 83.9 +/- 7% and 82.7 +/- 5%; p<0.01 for T3 vs. T2+T1). Levels of IM were not related to sdLDL levels (5.6 +/- 4% vs. 4.6 +/- 3% vs. 6.4 +/- 3% for T3, T2 and T1, respectively). In contrast to monocyte subset distribution, levels of circulating pro- and anti-inflammatory markers were not associated with sdLDL levels. Conclusion The atherogenic lipoprotein fraction sdLDL is associated with an increase of NCM and a decrease of CM. This could be a new link between lipid metabolism dysregulation, innate immunity and atherosclerosis.	[Krychtiuk, Konstantin A.; Kastl, Stefan P.; Pfaffenberger, Stefan; Lenz, Max; Hofbauer, Sebastian L.; Wonnerth, Anna; Koller, Lorenz; Katsaros, Katharina M.; Goliasch, Georg; Niessner, Alexander; Maurer, Gerald; Wojta, Johann; Speidl, Walter S.] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, A-1090 Vienna, Austria; [Krychtiuk, Konstantin A.; Huber, Kurt; Wojta, Johann] Ludwig Boltzmann Cluster Cardiovasc Res, A-1090 Vienna, Austria; [Pongratz, Thomas; Dostal, Elisabeth; Oravec, Stanislav] Krankenanstalten Dr Dostal, A-1190 Vienna, Austria; [Gaspar, Ludovit; Oravec, Stanislav] Comenius Univ, Fac Med, Dept Internal Med 2, Bratislava 81102, Slovakia; [Huber, Kurt] Wilhelminenhospital, Dept Med 3, A-1160 Vienna, Austria; [Wojta, Johann] Med Univ Vienna, Core Facil, A-1090 Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Comenius University Bratislava; Wilhelminenspital; Medical University of Vienna	Wojta, J (corresponding author), Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Waehringerguertel 18-20, A-1090 Vienna, Austria.	johann.wojta@meduniwien.ac.at	Kastl, Stefan P/B-2695-2009; Speidl, Walter S./AAU-8830-2020; Wojta, Johann/AAC-8433-2020	Kastl, Stefan P/0000-0002-9682-0200; Speidl, Walter S./0000-0002-7267-3138; Wojta, Johann/0000-0002-1282-9276; Maurer, Gerald/0000-0002-9043-7657; Goliasch, Georg/0000-0002-6219-6104; Lenz, Max/0000-0003-3539-994X; Krychtiuk, Konstantin/0000-0001-7792-2837	WF Austrian Science Fund [SFB-54]; Cellular Mediators Linking Inflammation and Thrombosis (Vienna, Austria); Association for the Promotion of Research on Arteriosclerosis, Thrombosis and Vascular Biology (Vienna, Austria); Ludwig Boltzmann Cluster for Cardiovascular Research (Vienna, Austria)	WF Austrian Science Fund; Cellular Mediators Linking Inflammation and Thrombosis (Vienna, Austria); Association for the Promotion of Research on Arteriosclerosis, Thrombosis and Vascular Biology (Vienna, Austria); Ludwig Boltzmann Cluster for Cardiovascular Research (Vienna, Austria)	This work was supported by the FWF Austrian Science Fund, Grant Number SFB-54, Cellular Mediators Linking Inflammation and Thrombosis (Vienna, Austria), the Association for the Promotion of Research on Arteriosclerosis, Thrombosis and Vascular Biology (Vienna, Austria) and the Ludwig Boltzmann Cluster for Cardiovascular Research (Vienna, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anber V, 1996, ATHEROSCLEROSIS, V124, P261, DOI 10.1016/0021-9150(96)05842-X; Arbab-Zadeh A, 2012, CIRCULATION, V125, P1147, DOI 10.1161/CIRCULATIONAHA.111.047431; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P187, DOI 10.1161/01.ATV.12.2.187; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Coen PM, 2010, METABOLISM, V59, P1775, DOI 10.1016/j.metabol.2010.05.002; DEJAGER S, 1993, J LIPID RES, V34, P295; Draude G, 1999, AM J PHYSIOL-HEART C, V276, pH1144, DOI 10.1152/ajpheart.1999.276.4.H1144; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Fildes JE, 2008, TRANSPL IMMUNOL, V19, P152, DOI 10.1016/j.trim.2008.02.002; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Ghattas A, 2013, J AM COLL CARDIOL, V62, P1541, DOI 10.1016/j.jacc.2013.07.043; Goliasch G, 2012, EUR J CLIN INVEST, V42, P631, DOI 10.1111/j.1365-2362.2011.02629.x; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Heine GH, 2008, KIDNEY INT, V73, P622, DOI 10.1038/sj.ki.5002744; Hoefner DM, 2001, CLIN CHEM, V47, P266; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; Horelt A, 2002, EUR J IMMUNOL, V32, P1319, DOI 10.1002/1521-4141(200205)32:5<1319::AID-IMMU1319>3.0.CO;2-2; Hristov M, 2011, THROMB HAEMOSTASIS, V106, P757, DOI 10.1160/TH11-07-0500; Imanishi T, 2010, ATHEROSCLEROSIS, V212, P628, DOI 10.1016/j.atherosclerosis.2010.06.025; Jaipersad AS, 2013, EUR J CLIN INVEST, V43, P1307, DOI 10.1111/eci.12183; Kapinsky M, 2001, ARTERIOSCL THROM VAS, V21, P1004, DOI 10.1161/01.ATV.21.6.1004; Kashiwagi M, 2010, ATHEROSCLEROSIS, V212, P171, DOI 10.1016/j.atherosclerosis.2010.05.004; Kirmizis D, 2010, J ATHEROSCLER THROMB, V17, P1256, DOI 10.5551/jat.5710; KRAUSS RM, 1982, J LIPID RES, V23, P97; Krychtiuk KA, 2013, HAMOSTASEOLOGIE, V33, P269, DOI 10.5482/HAMO-13-07-0039; Mosig S, 2009, FASEB J, V23, P866, DOI 10.1096/fj.08-118240; Packard CJ, 2006, CURR OPIN LIPIDOL, V17, P412, DOI 10.1097/01.mol.0000236367.42755.c1; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Rothe G, 1996, ARTERIOSCL THROM VAS, V16, P1437, DOI 10.1161/01.ATV.16.12.1437; Rothe G, 1999, ATHEROSCLEROSIS, V144, P251, DOI 10.1016/S0021-9150(99)00061-1; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; St-Pierre AC, 2003, AM J CARDIOL, V91, P555, DOI 10.1016/S0002-9149(02)03305-2; West SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052406; Zawada AM, 2012, IMMUNOBIOLOGY, V217, P1273, DOI 10.1016/j.imbio.2012.07.001; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	47	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123367	10.1371/journal.pone.0123367	http://dx.doi.org/10.1371/journal.pone.0123367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849089	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800228
J	Liu, W; Shi, XY; Yang, YD; Cheng, XM; Liu, Q; Han, H; Yang, BH; He, CY; Wang, YL; Jiang, B; Wang, ZT; Wang, CH				Liu, Wei; Shi, Xiaoyuan; Yang, Yadi; Cheng, Xuemei; Liu, Qing; Han, Han; Yang, Baohua; He, Chunyong; Wang, Yongli; Jiang, Bo; Wang, Zhengtao; Wang, Changhong			In Vitro and In Vivo Metabolism and Inhibitory Activities of Vasicine, a Potent Acetylcholinesterase and Butyrylcholinesterase Inhibitor	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; IDENTIFICATION; DRUG; TIME; ALKALOIDS; PEGANUM; DISCOVERY; SEEDS	Vasicine (VAS), a potential natural cholinesterase inhibitor, exhibited promising anticholinesterase activity in preclinical models and has been in development for treatment of Alzheimer's disease. This study systematically investigated the in vitro and in vivo metabolism of VAS in rat using ultra performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry. A total of 72 metabolites were found based on a detailed analysis of their H-1-NMR and C-13 NMR data. Six key metabolites were isolated from rat urine and elucidated as vasicinone, vasicinol, vasicinolone, 1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-yl hydrogen sulfate, 9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-yl hydrogen sulfate, and 1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-beta-D-glucuronide. The metabolic pathway of VAS in vivo and in vitro mainly involved monohydroxylation, dihydroxylation, trihydroxylation, oxidation, desaturation, sulfation, and glucuronidation. The main metabolic soft spots in the chemical structure of VAS were the 3-hydroxyl group and the C-9 site. All 72 metabolites were found in the urine sample, and 15, 25, 45, 18, and 11 metabolites were identified from rat feces, plasma, bile, rat liver micro-somes, and rat primary hepatocyte incubations, respectively. Results indicated that renal clearance was the major excretion pathway of VAS. The acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities of VAS and its main metabolites were also evaluated. The results indicated that although most metabolites maintained potential inhibitory activity against AChE and BChE, but weaker than that of VAS. VAS undergoes metabolic inactivation process in vivo in respect to cholinesterase inhibitory activity.	[Liu, Wei; Shi, Xiaoyuan; Yang, Yadi; Han, Han; Yang, Baohua; He, Chunyong; Wang, Yongli; Jiang, Bo; Wang, Zhengtao; Wang, Changhong] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Wang, Zhengtao; Wang, Changhong] MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China; [Wang, Zhengtao; Wang, Changhong] SATCM Key Lab New Resources & Qual Evaluat Chines, Shanghai, Peoples R China; [Cheng, Xuemei; Liu, Qing; Wang, Yongli; Wang, Zhengtao; Wang, Changhong] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Wang, CH (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China.	wchcxm@hotmail.com	han, han/HDL-7807-2022; Wang, Chang-hong/AAD-2543-2020; Wang, Zhengtao/AAH-7360-2019	Wang, Chang-hong/0000-0001-7578-4856; Wang, Zhengtao/0000-0003-2797-4625	Xinjiang Uygur Autonomous Region of China [U1130303]; National Natural Science Foundation of China [U1130303, 81173119]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2012ZX0910320-051]; Program of Shanghai Subject Chief Scientist [13XD1403500]	Xinjiang Uygur Autonomous Region of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China; Program of Shanghai Subject Chief Scientist	This work was financially supported by the Key Projects of Joint Funds of the National Natural Science Foundation of China and Xinjiang Uygur Autonomous Region of China (No. U1130303), the National Natural Science Foundation of China (Grant 81173119), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China (Grants 2012ZX0910320-051), and the Program of Shanghai Subject Chief Scientist (13XD1403500) awarded to Professor Chang-hong Wang for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atal C., 1983, INDIAN DRUGS, V20, P431; Bateman KP, 2007, RAPID COMMUN MASS SP, V21, P1485, DOI 10.1002/rcm.2996; Bhide M, 1976, B HAFFKIN I, V4, P45; Chattopadhyay N, 2011, CARBOHYD POLYM, V83, P1970, DOI 10.1016/j.carbpol.2010.11.002; Cheng CR, 2012, DRUG METAB DISPOS, V40, P2307, DOI 10.1124/dmd.112.047506; Cheng XM, 2010, PHYTOCHEM ANALYSIS, V21, P279, DOI 10.1002/pca.1198; Gao H, 2008, FOOD CHEM, V108, P965, DOI 10.1016/j.foodchem.2007.12.002; HANAI T, 1983, J HIGH RES CHROMATOG, V6, P20, DOI 10.1002/jhrc.1240060105; Holcapek M, 2008, ANAL BIOANAL CHEM, V391, P59, DOI 10.1007/s00216-008-1962-7; Hua HM, 2002, CHEM PHARM BULL, V50, P1393, DOI 10.1248/cpb.50.1393; Ibanez M, 2011, RAPID COMMUN MASS SP, V25, P3103, DOI 10.1002/rcm.5183; Joshi BS, 1996, TETRAHEDRON-ASYMMETR, V7, P25, DOI 10.1016/0957-4166(95)00412-2; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; Li LA, 2011, DRUG METAB DISPOS, V39, P472, DOI 10.1124/dmd.110.036723; Li SP, 2014, J PHARMACEUT BIOMED, V92, P53, DOI 10.1016/j.jpba.2014.01.003; Lin JH, 1997, PHARMACOL REV, V49, P403; Liu W, 2014, J PHARMACEUT BIOMED, V94, P215, DOI 10.1016/j.jpba.2014.02.004; [刘伟 Liu Wei], 2013, [国际药学研究杂志, Journal of International Pharmaceutical Research], V40, P386; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahindroo N, 2005, MED CHEM RES, V14, P347, DOI 10.1007/s00044-006-0141-7; Nepali K, 2013, MED CHEM RES, V22, P1, DOI 10.1007/s00044-012-0002-5; Niwa T, 2000, DRUG METAB DISPOS, V28, P1128; Rachana, 2011, Indo Global Journal of Pharmaceutical Sciences, V1, P85; Rashkes YV, 1983, CHEM NAT COMPD, V19, P64; Sayeed Ahmad, 2009, Natural Product Radiance, V8, P549; SCHRENK D, 1992, CARCINOGENESIS, V13, P453, DOI 10.1093/carcin/13.3.453; Singh B, 2013, PHYTOMEDICINE, V20, P441, DOI 10.1016/j.phymed.2012.12.015; Srinivasarao D., 2006, Indian Journal of Allergy, Asthma & Immunology, V20, P1; Swamy GYSK, 2005, J CHEM CRYSTALLOGR, V35, P183, DOI 10.1007/s10870-005-2955-4; Trunzer M, 2009, J MED CHEM, V52, P329, DOI 10.1021/jm8008663; Walsky RL, 2004, DRUG METAB DISPOS, V32, P647, DOI 10.1124/dmd.32.6.647; Wen Fang-fang, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2971; Zhang HY, 2009, J MASS SPECTROM, V44, P999, DOI 10.1002/jms.1610; Zhao T, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/717232; Zheng XY, 2011, JPC-J PLANAR CHROMAT, V24, P470, DOI 10.1556/JPC.24.2011.6.3; Zheng XY, 2009, ARCH PHARM RES, V32, P1245, DOI 10.1007/s12272-009-1910-x	36	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122366	10.1371/journal.pone.0122366	http://dx.doi.org/10.1371/journal.pone.0122366			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849329	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800122
J	Pollizzi, KN; Waickman, AT; Patel, CH; Sun, IH; Powell, JD				Pollizzi, Kristen N.; Waickman, Adam T.; Patel, Chirag H.; Sun, Im Hong; Powell, Jonathan D.			Cellular Size as a Means of Tracking mTOR Activity and Cell Fate of CD4+T Cells upon Antigen Recognition	PLOS ONE			English	Article							REGULATORY T-CELLS; MAMMALIAN TARGET; IN-VIVO; RESPIRATORY CAPACITY; DIFFERENTIATION; ACTIVATION; INDUCTION; RAPAMYCIN; MEMORY; GENE	mTOR is a central integrator of metabolic and immunological stimuli, dictating immune cell activation, proliferation and differentiation. In this study, we demonstrate that within a clonal population of activated T cells, there exist both mTOR(hi) and mTOR(lo) cells exhibiting highly divergent metabolic and immunologic functions. By taking advantage of the role of mTOR activation in controlling cellular size, we demonstrate that upon antigen recognition, mTORhi CD4+ T cells are destined to become highly glycolytic effector cells. Conversely, mTOR(lo) T cells preferentially develop into long-lived cells that express high levels of Bcl-2, CD25, and CD62L. Furthermore, mTOR(lo) T cells have a greater propensity to differentiate into suppressive Foxp3+ T regulatory cells, and this paradigm was also observed in human CD4+ T cells. Overall, these studies provide the opportunity to track the development of effector and memory T cells from naive precursors, as well as facilitate the interrogation of immunologic and metabolic programs that inform these fates.	[Pollizzi, Kristen N.; Waickman, Adam T.; Patel, Chirag H.; Sun, Im Hong; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA.	poweljo@jhmi.edu	Waickman, Adam/AHB-5028-2022	Sun, Im Hong/0000-0003-0288-2062; Waickman, Adam/0000-0002-4536-6714	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI072677, AI77610, AI091481]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247, R01AI077610, P01AI072677, R01AI091481] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases: AI072677, AI77610 and AI091481 to JDP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, MOL IMMUNOL, V46, P2694, DOI 10.1016/j.molimm.2009.05.185; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Powell JD, 2013, COLD SH Q B, V78, P125, DOI 10.1101/sqb.2013.78.020214; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Qiao GL, 2013, J IMMUNOL, V191, P632, DOI 10.4049/jimmunol.1202068; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Sauer S, 2008, P NATL ACAD SCI US; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Waickman AT, 2012, J IMMUNOL, V188, P4721, DOI 10.4049/jimmunol.1103143; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030592; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	49	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121710	10.1371/journal.pone.0121710	http://dx.doi.org/10.1371/journal.pone.0121710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849206	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800073
J	Yamashita, T; Sakamoto, T; Yoshihara, N; Terasaki, H; Kii, Y; Tanaka, M; Nakao, K				Yamashita, Takehiro; Sakamoto, Taiji; Yoshihara, Naoya; Terasaki, Hiroto; Kii, Yuya; Tanaka, Minoru; Nakao, Kumiko			Circumpapillary Course of Retinal Pigment Epithelium Can Be Fit to Sine Wave and Amplitude of Sine Wave Is Significantly Correlated with Ovality Ratio of Optic Disc	PLOS ONE			English	Article							NERVE-FIBER LAYER; COHERENCE TOMOGRAPHY; GLAUCOMATOUS EYES; MYOPIA; THICKNESS; TILT; PHOTOGRAPHY; POPULATION; PREVALENCE; JAPANESE	The purpose of this study was to develop a method of quantifying the degree of optic disc tilt in normal eyes. This was a prospective, observational cross sectional study of 126 right eyes of 126 healthy volunteers. The optic disc tilt was determined from the circular peripapillary optical coherence tomographic (OCT) scan images. The course of the retinal pigment epithelium (RPE) layer in the peripapillary cross sectional scan images was fit to a sine wave curve, and the amplitude of the sine curve was used to reflect the degree of the optic disc tilt in the optical axis. The repeatability of the amplitude determinations was calculated. The correlation between the amplitude and the ovality ratio of the optic disc was determined. The correlation between the amplitude and the body height was also calculated. The mean amplitudewas 36.6 +/- 17.5 pixels, which was significantly and inversely correlated with the ovality ratio of the optic disc (R = -0.59, P<0.001). The intra-rater and inter-rater correlation coefficients of the amplitude were significant high (P<0.001, both). The amplitude was significantly and inversely correlated with the body height (R = -0.38, P<0.001), but not with the axial length. In conclusion, a sine wave function can be used to describe the course of the RPE in the circumpapillary OCT images. The results indicate that the amplitude of the sine wave can be used to represent the degree of optic disc tilt. Thus, the sine wave analyses can be used as a quantifiable and repeatable method to determine the optic disc tilt.	[Yamashita, Takehiro; Sakamoto, Taiji; Yoshihara, Naoya; Terasaki, Hiroto; Kii, Yuya; Tanaka, Minoru; Nakao, Kumiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan	Kagoshima University	Sakamoto, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			Research Committee on Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare, Tokyo, Japan; Ministry of Education, Science, and Culture of the Japanese Government; Grants-in-Aid for Scientific Research [26462643] Funding Source: KAKEN	Research Committee on Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare, Tokyo, Japan; Ministry of Education, Science, and Culture of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Research Committee on Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare, Tokyo, Japan; and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bloom RI, 2010, CURR OPIN OPHTHALMOL, V21, P247, DOI 10.1097/ICU.0b013e328339f1dd; Blumenthal EZ, 2000, OPHTHALMOLOGY, V107, P2278, DOI 10.1016/S0161-6420(00)00341-9; Curtin BJ, 1985, MYOPIAS BASIC SCI CL, P301; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Hoh ST, 2006, OPHTHALMOLOGY, V113, P773, DOI 10.1016/j.ophtha.2006.01.058; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; Leitgeb R, 2003, OPT EXPRESS, V11, P889, DOI 10.1364/OE.11.000889; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Mistlberger A, 1999, OPHTHALMOLOGY, V106, P2027, DOI 10.1016/S0161-6420(99)90419-0; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Nangia V, 2010, GRAEF ARCH CLIN EXP, V248, P1657, DOI 10.1007/s00417-010-1448-0; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Spaide RF, 2014, PATHOLOGIC MYOPIA, P177; Takasaki H, 2013, JPN J OPHTHALMOL, V57, P34, DOI 10.1007/s10384-012-0193-9; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Tong L, 2002, OPHTHAL PHYSL OPT, V22, P32, DOI 10.1046/j.1475-1313.2002.00003.x; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Vizzeri G, 2009, OPT EXPRESS, V17, P4004, DOI 10.1364/OE.17.004004; Wang DC, 2011, INVEST OPHTH VIS SCI, V52, P7949, DOI 10.1167/iovs.11-7684; Yamashita T, 2013, INVEST OPHTH VIS SCI, V54, P5481, DOI 10.1167/iovs.12-11008; Yin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043172; Zangwill LM, 2000, OPHTHALMOLOGY, V107, P1309, DOI 10.1016/S0161-6420(00)00168-8	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122191	10.1371/journal.pone.0122191	http://dx.doi.org/10.1371/journal.pone.0122191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848777	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800106
J	Ye, CX; Zhao, W; Li, MH; Zhuang, JL; Yan, X; Lu, Q; Chang, CJ; Huang, XJ; Zhou, J; Xie, BX; Zhang, Z; Yao, X; Yan, J; Guo, HQ				Ye, Changxiao; Zhao, Wei; Li, Minghui; Zhuang, Junlong; Yan, Xiang; Lu, Qun; Chang, Cunjie; Huang, Xiaojing; Zhou, Ji; Xie, Bingxian; Zhang, Zhen; Yao, Xin; Yan, Jun; Guo, Hongqian			delta-Tocotrienol Induces Human Bladder Cancer Cell Growth Arrest, Apoptosis and Chemosensitization through Inhibition of STAT3 Pathway	PLOS ONE			English	Article							VITAMIN-E; TYROSINE KINASE; SIGNALING PATHWAY; TUMOR ANGIOGENESIS; GAMMA-TOCOTRIENOL; STEM-CELLS; ACTIVATION; INDUCTION; CARCINOMA; RISK	Vitamin E intake has been implicated in reduction of bladder cancer risk. However, the mechanisms remain elusive. Here we reported that d-tocotrienol (delta-T3), one of vitamin E isomers, possessed the most potent cytotoxic capacity against human bladder cancer cells, compared with other Vitamin E isomers. delta-T3 inhibited cancer cell proliferation and colonogenicity through induction of G1 phase arrest and apoptosis. Western blotting assay revealed that delta-T3 increased the expression levels of cell cycle inhibitors (p21, p27), proapoptotic protein (Bax) and suppressed expression levels of cell cycle protein (Cyclin D1), anti-apoptotic proteins (Bcl-2, Bcl-xL and Mcl-1), resulting in the Caspase-3 activation and cleavage of PARP. Moreover, the delta-T3 treatment inhibited ETK phosphorylation level and induced SHP-1 expression, which was correlated with downregulation of STAT3 activation. In line with this, delta-T3 reduced the STAT3 protein level in nuclear fraction, as well as its transcription activity. Knockdown of SHP-1 partially reversed delta-T3-induced cell growth arrest. Importantly, low dose of delta-T3 sensitized Gemcitabine-induced cytotoxic effects on human bladder cancer cells. Overall, our findings demonstrated, for the first time, the cytotoxic effects of delta-T3 on bladder cancer cells and suggest that delta-T3 might be a promising chemosensitization reagent for Gemcitabine in bladder cancer treatment.	[Ye, Changxiao; Zhao, Wei; Chang, Cunjie; Huang, Xiaojing; Xie, Bingxian; Yan, Jun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Ye, Changxiao; Li, Minghui; Zhuang, Junlong; Yan, Xiang; Lu, Qun; Guo, Hongqian] Nanjing Univ, Nanjing Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Guo, Hongqian] Nanjing Urol Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Ji; Yao, Xin] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Zhen] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University; Wenzhou Medical University	Yan, J (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.	yanjun@nicemice.cn; dr.ghq@163.com	Xie, Bingxian/Y-6487-2019; Zhao, Wei/AAC-6849-2020; Yan, Jun/Q-3031-2017	Zhao, Wei/0000-0003-2421-7311; Yan, Jun/0000-0002-1303-1952	Ministry of Science and Technology of the People's Republic of China [2011CB944104]; National Natural Science Foundation of China [81172009, 81372168]; Doctoral Fund of Ministry of Education of China [20110091120028]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by Ministry of Science and Technology of the People's Republic of China (2011CB944104), the National Natural Science Foundation of China (81172009, 81372168), Doctoral Fund of Ministry of Education of China (20110091120028) to Dr. J. Yan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Brinkman MT, 2010, CANCER CAUSE CONTROL, V21, P609, DOI 10.1007/s10552-009-9490-0; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen CL, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-78; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Guo SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017778; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Holopainen T, 2012, CANCER RES, V72, P3512, DOI 10.1158/0008-5472.CAN-11-1070; Husain K, 2011, MOL CANCER THER, V10, P2363, DOI 10.1158/1535-7163.MCT-11-0424; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Ji XM, 2011, J CELL BIOCHEM, V112, P2773, DOI 10.1002/jcb.23184; Jiang XN, 2007, J BIOL CHEM, V282, P32689, DOI 10.1074/jbc.M703412200; Kanai K, 2010, CANCER SCI, V101, P216, DOI 10.1111/j.1349-7006.2009.01362.x; Kannappan R, 2012, GENES NUTR, V7, P43, DOI 10.1007/s12263-011-0220-3; Kannappan R, 2010, J BIOL CHEM, V285, P33520, DOI 10.1074/jbc.M110.158378; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Michaud DS, 2002, BRIT J CANCER, V87, P960, DOI 10.1038/sj.bjc.6600604; Miyazawa T, 2009, J NUTR BIOCHEM, V20, P79, DOI 10.1016/j.jnutbio.2008.09.003; Neri B, 2002, ANTICANCER RES, V22, P2981; Oka T, 2002, CANCER RES, V62, P6390; Pathania AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110411; Pierpaoli E, 2010, LIFE SCI, V86, P668, DOI 10.1016/j.lfs.2010.02.018; Rajendran P, 2011, BRIT J PHARMACOL, V163, P283, DOI 10.1111/j.1476-5381.2010.01187.x; Sen CK, 2007, VITAM HORM, V76, P203, DOI 10.1016/S0083-6729(07)76008-9; Shin-Kang S, 2011, FREE RADICAL BIO MED, V51, P1164, DOI 10.1016/j.freeradbiomed.2011.06.008; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Svatek RS, 2014, EUR UROL, V66, P253, DOI 10.1016/j.eururo.2014.01.006; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yafi FA, 2011, CURR ONCOL, V18, pE25; Yap WN, 2010, CANCER LETT, V291, P187, DOI 10.1016/j.canlet.2009.10.012; Yeung C, 2014, PHARMACOECONOMICS, V32, P1093, DOI 10.1007/s40273-014-0194-2; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang JS, 2011, TOXICOLOGY, V285, P8, DOI 10.1016/j.tox.2011.03.011	38	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122712	10.1371/journal.pone.0122712	http://dx.doi.org/10.1371/journal.pone.0122712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849286	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800157
J	van der Logt, EMJ; Kuperus, DAJ; van Setten, JW; van den Heuvel, MC; Boers, JE; Schuuring, E; Kibbelaar, RE				van der Logt, Elise M. J.; Kuperus, Deborah A. J.; van Setten, Jan W.; van den Heuvel, Marius C.; Boers, James. E.; Schuuring, Ed; Kibbelaar, Robby E.			Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; AMPLIFICATION; TUMORIGENESIS; CHEMOTHERAPY; EXPRESSION; EFFICACY; SAFETY	HER2 assessment is routinely used to select patients with invasive breast cancer that might benefit from HER2-targeted therapy. The aim of this study was to validate a fully automated in situ hybridization (ISH) procedure that combines the automated Leica HER2 fluorescent ISH system for Bond with supervised automated analysis with the Visia imaging D-Sight digital imaging platform. HER2 assessment was performed on 328 formalin-fixed/paraffin-embedded invasive breast cancer tumors on tissue microarrays (TMA) and 100 (50 selected IHC 2+ and 50 random IHC scores) full-sized slides of resections/biopsies obtained for diagnostic purposes previously. For digital analysis slides were pre-screened at 20x and 100x magnification for all fluorescent signals and supervised-automated scoring was performed on at least two pictures (in total at least 20 nuclei were counted) with the D-Sight HER2 FISH analysis module by two observers independently. Results were compared to data obtained previously with the manual Abbott FISH test. The overall agreement with Abbott FISH data among TMA samples and 50 selected IHC 2+ cases was 98.8% (kappa = 0.94) and 93.8% (kappa = 0.88), respectively. The results of 50 additionally tested unselected IHC cases were concordant with previously obtained IHC and/or FISH data. The combination of the Leica FISH system with the D-Sight digital imaging platform is a feasible method for HER2 assessment in routine clinical practice for patients with invasive breast cancer.	[van der Logt, Elise M. J.; Kuperus, Deborah A. J.; van Setten, Jan W.; van den Heuvel, Marius C.; Kibbelaar, Robby E.] Dept Pathol Pathol Friesland, Leeuwarden, Netherlands; [van der Logt, Elise M. J.; Schuuring, Ed] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Boers, James. E.] Isala Klin, Dept Pathol, Zwolle, Netherlands	University of Groningen; Isala Clinics	van der Logt, EMJ (corresponding author), Dept Pathol Pathol Friesland, Leeuwarden, Netherlands.	e.van.der.logt@pathologiefriesland.nl						Baasner S, 1996, ONCOGENE, V13, P901; Baselga J, 1998, CANCER RES, V58, P2825; Boers J, 2012, VIRCHOWS ARCH, V461, pS236; Brugmann A, 2011, APPL IMMUNOHISTO M M, V19, P203, DOI 10.1097/PAI.0b013e3181f7118e; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Dekker TJA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3208; Del Bimbo A., 2010, 2010 IEEE International Conference on Imaging Systems and Techniques (IST 2010), P407, DOI 10.1109/IST.2010.5548461; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Furrer D, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-17; Goddard KAB, 2012, AM J MANAG CARE, V18, P704; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Konsti J, 2008, J CLIN PATHOL, V61, P278, DOI 10.1136/jcp.2007.048991; Moelans CB, 2010, CELL ONCOL, V32, P149, DOI 10.3233/CLO-2010-0514; Moerland E, 2006, CELL ONCOL, V28, P151; Netten H, 1997, CYTOMETRY, V28, P1; Nitta H, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-41; Ohlschlegel C, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-13; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Pajor G, 2012, CYTOM PART A, V81A, P649, DOI 10.1002/cyto.a.22082; Perez EA, 2014, CANCER TREAT REV, V40, P276, DOI 10.1016/j.ctrv.2013.09.001; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Sjogren S, 1998, J CLIN ONCOL, V16, P462; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Theodosiou Z, 2008, BREAST, V17, P80, DOI 10.1016/j.breast.2007.07.041; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972	30	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123201	10.1371/journal.pone.0123201	http://dx.doi.org/10.1371/journal.pone.0123201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844540	Green Published, gold, Green Submitted			2022-12-27	WOS:000352475700020
J	Sodring, M; Oostindjer, M; Egelandsdal, B; Paulsen, JE				Sodring, Marianne; Oostindjer, Marije; Egelandsdal, Bjorg; Paulsen, Jan Erik			Effects of Hemin and Nitrite on Intestinal Tumorigenesis in the A/J Min/ plus Mouse Model	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; COLON-CANCER; RED MEAT; DIETARY HEME; LIPID-PEROXIDATION; COLORECTAL-CANCER; SIGNAL-TRANSDUCTION; PROCESSED MEAT; IRON; APC	Red and processed meats are considered risk factors for colorectal cancer (CRC); however, the underlying mechanisms are still unclear. One cause for the potential link between CRC and meat is the heme iron in red meat. Two pathways by which heme and CRC promotion may be linked have been suggested: fat peroxidation and N-nitrosation. In the present work we have used the novel A/J Min/+ mouse model to test the effects of dietary hemin (a model of red meat), and hemin in combination with nitrite (a model of processed meat) on intestinal tumorigenesis. Mice were fed a low Ca2+ and vitamin D semi-synthetic diet with added hemin and/or nitrite for 8 weeks post weaning, before termination followed by excision and examination of the intestinal tract. Our results indicate that dietary hemin decreased the number of colonic lesions in the A/J Min/+ mouse. However, our results also showed that the opposite occurred in the small intestine, where dietary hemin appeared to stimulate tumor growth. Furthermore, we find that nitrite, which did not have an effect in the colon, appeared to have a suppressive effect on tumor growth in the small intestine.	[Sodring, Marianne; Paulsen, Jan Erik] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, N-0033 Oslo, Norway; [Oostindjer, Marije; Egelandsdal, Bjorg] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Sodring, M (corresponding author), Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, POB 8146 Dep, N-0033 Oslo, Norway.	marianne.sodring@nmbu.no		Sodring, Marianne/0000-0003-0236-8549; Oostindjer, Marije/0000-0002-0997-0041				Barnes CJ, 1998, GASTROENTEROLOGY, V114, P873, DOI 10.1016/S0016-5085(98)70305-1; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chen FP, 2013, NUTR CANCER, V65, P195, DOI 10.1080/01635581.2013.756532; Chin J, 1997, NUTR RES, V17, P1381, DOI 10.1016/S0271-5317(97)00121-8; Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009; Cross AJ, 2003, CANCER RES, V63, P2358; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Demeyer D, 2014, CRIT REV FO IN PRESS; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Fearnhead NS, 2001, ABC APC HUM MOL GENE, P10; Ferlay J, 2013, IARC CANCERBASE; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Fodde R, 2010, J PATHOL, V221, P239, DOI 10.1002/path.2718; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; IGNARRO LJ, 1990, HYPERTENSION, V16, P477, DOI 10.1161/01.HYP.16.5.477; Ijssennagger N, 2013, CARCINOGENESIS, V34, P1628, DOI 10.1093/carcin/bgt084; IJssennagger N, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043260, 10.1371/journal.pone.0049868]; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Ilyas M, 1999, EUR J CANCER, V35, P335, DOI 10.1016/S0959-8049(98)00431-6; Jacoby RF, 1996, CANCER RES, V56, P710; Kanner J, 2007, MOL NUTR FOOD RES, V51, P1094, DOI 10.1002/mnfr.200600303; Kelloff GJ, 2004, CLIN CANCER RES, V10, P3908, DOI 10.1158/1078-0432.CCR-03-0789; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Lai C, 1997, CANCER LETT, V112, P87, DOI 10.1016/S0304-3835(96)04549-1; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Olstorn HB., 2009, EFFECT ACRYLAMIDE GL; Oostindjer M, 2014, MEAT SCI, V97, P583, DOI 10.1016/j.meatsci.2014.02.011; Paulsen JE, 2005, CANCER RES, V65, P121; Paulsen JE, 2001, CANCER RES, V61, P5010; Paulsen JE, 2000, TOXICOL LETT, V112, P403, DOI 10.1016/S0378-4274(99)00262-3; PENCE BC, 1995, CARCINOGENESIS, V16, P1157, DOI 10.1093/carcin/16.5.1157; Petersson J, 2007, AM J PHYSIOL-GASTR L, V292, pG718, DOI 10.1152/ajpgi.00435.2006; Pierre F, 2007, CARCINOGENESIS, V28, P321, DOI 10.1093/carcin/bgl127; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S; Rimbach G, 1997, J TRACE ELEM MED BIO, V11, P99, DOI 10.1016/S0946-672X(97)80033-8; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Sawa T, 1998, CANCER EPIDEM BIOMAR, V7, P1007; Sesink ALA, 1999, CANCER RES, V59, P5704; Sesink ALA, 2000, CARCINOGENESIS, V21, P1909, DOI 10.1093/carcin/21.10.1909; Stimson J, 1997, NUTR RES, V17, P1683, DOI 10.1016/S0271-5317(97)00175-9; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Svendsen C, 2012, LAB ANIM-UK, V46, P207, DOI 10.1258/la.2012.011055; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; van Es JH, 2001, EXP CELL RES, V264, P126, DOI 10.1006/excr.2000.5142; Van Hecke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101122; Weitzberg E, 2013, ANNU REV NUTR, V33, P129, DOI 10.1146/annurev-nutr-071812-161159; Winter J, 2014, MOL NUTR FOOD RES, V58, P550, DOI 10.1002/mnfr.201300430; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/436307; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591	57	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122880	10.1371/journal.pone.0122880	http://dx.doi.org/10.1371/journal.pone.0122880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836260	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000352139000116
J	Abeliuk, A; Berbeglia, G; Cebrian, M; Van Hentenryck, P				Abeliuk, Andres; Berbeglia, Gerardo; Cebrian, Manuel; Van Hentenryck, Pascal			The Benefits of Social Influence in Optimized Cultural Markets	PLOS ONE			English	Article							SUCCESS; WISDOM	Social influence has been shown to create significant unpredictability in cultural markets, providing one potential explanation why experts routinely fail at predicting commercial success of cultural products. As a result, social influence is often presented in a negative light. Here, we show the benefits of social influence for cultural markets. We present a policy that uses product quality, appeal, position bias and social influence to maximize expected profits in the market. Our computational experiments show that our profit-maximizing policy leverages social influence to produce significant performance benefits for the market, while our theoretical analysis proves that our policy outperforms in expectation any policy not displaying social signals. Our results contrast with earlier work which focused on showing the unpredictability and inequalities created by social influence. Not only do we show for the first time that, under our policy, dynamically showing consumers positive social signals increases the expected profit of the seller in cultural markets. We also show that, in reasonable settings, our profit-maximizing policy does not introduce significant unpredictability and identifies "blockbusters". Overall, these results shed new light on the nature of social influence and how it can be leveraged for the benefits of the market.	[Abeliuk, Andres; Berbeglia, Gerardo; Cebrian, Manuel; Van Hentenryck, Pascal] Natl ICT Australia, Optimizat Res Grp, Melbourne, Vic, Australia; [Abeliuk, Andres; Cebrian, Manuel] Univ Melbourne, Melbourne Sch Engn, Melbourne, Vic, Australia; [Berbeglia, Gerardo] Univ Melbourne, Melbourne Business Sch, Ctr Business Analyt, Melbourne, Vic, Australia; [Van Hentenryck, Pascal] Australian Natl Univ, Res Sch Comp Sci, Canberra, ACT, Australia	NICTA; University of Melbourne; University of Melbourne; Australian National University	Van Hentenryck, P (corresponding author), Natl ICT Australia, Optimizat Res Grp, Melbourne, Vic, Australia.	pvh@nicta.com.au	Abeliuk, Andres/AAN-9174-2020; Berbeglia, Gerardo/R-1656-2017	Abeliuk, Andres/0000-0002-8158-4647; Berbeglia, Gerardo/0000-0003-0108-2936				BIELBY WT, 1994, AM J SOCIOL, V99, P1287, DOI 10.1086/230412; Caves RE, 2000, CREATIVE IND CONTRAC, P20; De Vany A, 2011, HOLLYWOOD EC EXTREME; Eliashberg J, 1997, J MARKETING, V61, P68, DOI 10.2307/1251831; Farrell S, 2011, P NATL ACAD SCI USA, V108, pE625, DOI 10.1073/pnas.1109947108; Hedstrom P, 2006, SCIENCE, V311, P786, DOI 10.1126/science.1124707; HIRSCH PM, 1972, AM J SOCIOL, V77, P639, DOI 10.1086/225192; JENSEN MC, 1978, J FINANC ECON, V6, P95, DOI 10.1016/0304-405X(78)90025-9; Kabadi SN, 2008, OPER RES LETT, V36, P402, DOI 10.1016/j.orl.2007.12.001; Krumme C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033785; Lerman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098914; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; PETERSON RA, 1971, ADMIN SCI QUART, V16, P97, DOI 10.2307/2391293; Rauhut H, 2011, P NATL ACAD SCI USA, V108, pE626, DOI 10.1073/pnas.1111007108; Rigney D, 2010, THE MATTHEW EFFECT; Salganik MJ, 2009, TOP COGN SCI, V1, P439, DOI 10.1111/j.1756-8765.2009.01030.x; Salganik MJ, 2008, SOC PSYCHOL QUART, V71, P338, DOI 10.1177/019027250807100404; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SHIGENO M, 1995, DISCRETE APPL MATH, V56, P333, DOI 10.1016/0166-218X(93)00094-G; Shiller R., 1992, MARKET VOLATILITY; Shleifer A., 2000, INEFFICIENT MARKETS; van de Rijt A, 2014, P NATL ACAD SCI USA, V111, P6934, DOI 10.1073/pnas.1316836111; Watts DJ, 2012, EVERYTHING IS OBVIOU	24	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121934	10.1371/journal.pone.0121934	http://dx.doi.org/10.1371/journal.pone.0121934			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25831093	Green Published, gold			2022-12-27	WOS:000352135600092
J	Dietrich, S; Hertrich, I; Kumar, V; Ackermann, H				Dietrich, Susanne; Hertrich, Ingo; Kumar, Vinod; Ackermann, Hermann			Experience-Related Structural Changes of Degenerated Occipital White Matter in Late-Blind Humans - A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; VISUAL-CORTEX; ACTIVATION PATTERNS; SENSITIVE PERIOD; ADAPTIVE-CHANGES; MENTAL-IMAGERY; SPEECH; FMRI; BRAILLE; REORGANIZATION	Late-blind humans can learn to understand speech at ultra-fast syllable rates (ca. 20 syllables/s), a capability associated with hemodynamic activation of the central-visual system. Thus, the observed functional cross-modal recruitment of occipital cortex might facilitate ultra-fast speech processing in these individuals. To further elucidate the structural prerequisites of this skill, diffusion tensor imaging (DTI) was conducted in late-blind subjects differing in their capability of understanding ultra-fast speech. Fractional anisotropy (FA) was determined as a quantitative measure of the directionality of water diffusion, indicating fiber tract characteristics that might be influenced by blindness as well as the acquired perceptual skills. Analysis of the diffusion images revealed reduced FA in late-blind individuals relative to sighted controls at the level of the optic radiations at either side and the right-hemisphere dorsal thalamus (pulvinar). Moreover, late-blind subjects showed significant positive correlations between FA and the capacity of ultra-fast speech comprehension within right-hemisphere optic radiation and thalamus. Thus, experience-related structural alterations occurred in late-blind individuals within visual pathways that, presumably, are linked to higher order frontal language areas.	[Dietrich, Susanne; Hertrich, Ingo; Ackermann, Hermann] Univ Tubingen, Hertie Inst Clin Brain Res, Ctr Neurol, Dept Gen Neurol, D-72076 Tubingen, Germany; [Kumar, Vinod] Univ Aachen, RWTH, Univ Hosp, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Dietrich, S (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Ctr Neurol, Dept Gen Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	susanne.dietrich@med.uni-tuebingen.de	Hertrich, Ingo/T-1154-2018	Hertrich, Ingo/0000-0001-8965-6249; kumar, vinod/0000-0001-9691-017X	German Research Foundation (DFG) [AC 55 09/01]; Hertie Institute for Clinical Brain Research, Tubingen	German Research Foundation (DFG)(German Research Foundation (DFG)); Hertie Institute for Clinical Brain Research, Tubingen	This work has been funded by the German Research Foundation (DFG; AC 55 09/01) and the Hertie Institute for Clinical Brain Research, Tubingen The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2004, NAT NEUROSCI, V7, P1266, DOI 10.1038/nn1328; Anurova I, 2015, CEREB CORTEX, V25, P2035, DOI 10.1093/cercor/bhu009; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bedny M, 2012, BRAIN LANG, V122, P162, DOI 10.1016/j.bandl.2011.10.005; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2006, HUM BRAIN MAPP, V27, P325, DOI 10.1002/hbm.20188; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cattaneo Z, 2011, NEUROSCIENCE VISUAL; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Collignon O, 2013, BRAIN, V136, P2769, DOI 10.1093/brain/awt176; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Dietrich S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00701; Dietrich S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-74; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Greenberg S, 2003, J PHONETICS, V31, P465, DOI 10.1016/j.wocn.2003.09.005; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hertrich I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00530; Hertrich I, 2013, BRAIN LANG, V124, P9, DOI 10.1016/j.bandl.2012.10.006; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kupers R, 2011, FRONT PSYCHOL, V2, P1; Lambert S, 2004, COGNITIVE BRAIN RES, V20, P1; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00170; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Maleki N, 2012, HUM BRAIN MAPP, V33, P75, DOI 10.1002/hbm.21194; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Mishra V, 2015, MAGN RESON MED, V74, P1768, DOI 10.1002/mrm.25548; Moos Anja, 2007, P 16 INT C PHON SCI, P667; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Noppeney U, 2007, NEUROSCI BIOBEHAV R, V31, P1169, DOI 10.1016/j.neubiorev.2007.04.012; Park HJ, 2007, NEUROREPORT, V18, P1757, DOI 10.1097/WNR.0b013e3282f13e66; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Pessoa L, 2004, CEREB CORTEX, V14, P511, DOI 10.1093/cercor/bhh013; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Romanski LM, 1997, J COMP NEUROL, V379, P313; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; SCHNEIDER F, 2006, SOC NEUR ABSTR, V240, P6; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schoth F, 2006, NEUROSCI LETT, V398, P178, DOI 10.1016/j.neulet.2005.12.088; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stevens AA, 2007, J NEUROSCI, V27, P10734, DOI 10.1523/JNEUROSCI.1669-07.2007; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; TUSA RJ, 1985, ANN NEUROL, V18, P583, DOI 10.1002/ana.410180512; Vagharchakian L, 2012, J NEUROSCI, V32, P9089, DOI 10.1523/JNEUROSCI.5685-11.2012; Vanlierde A, 2003, NEUROIMAGE, V19, P698, DOI 10.1016/S1053-8119(03)00153-8; Voss P, 2014, BRAIN, V137, P1224, DOI 10.1093/brain/awu030; Voss P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00664; Voss P, 2012, CEREB CORTEX, V22, P2455, DOI 10.1093/cercor/bhr311; Wang DW, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/128236; Weeks R, 2000, J NEUROSCI, V20, P2664; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yu CS, 2007, NEUROIMAGE, V36, P411, DOI 10.1016/j.neuroimage.2007.03.003; Zhang Y, 2012, BRAIN RES, V1458, P34, DOI 10.1016/j.brainres.2012.04.012	88	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122863	10.1371/journal.pone.0122863	http://dx.doi.org/10.1371/journal.pone.0122863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830371	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600127
J	Gomez, F; Qiu, DJ; Lopes, RM; Lin, SJ				Gomez, Fernando; Qiu, Dajun; Lopes, Rubens M.; Lin, Senjie			Fukuyoa paulensis gen. et sp nov., a New Genus for the Globular Species of the Dinoflagellate Gambierdiscus (Dinophyceae)	PLOS ONE			English	Article							TOXIC DINOFLAGELLATE; BENTHIC DINOFLAGELLATE; CIGUATERA; MORPHOLOGY; YASUMOTOI; GONYAULACALES; TAXONOMY; COOLIA; AREAS	The marine epiphytic dinoflagellate Gambierdiscus is a toxicologically important genus responsible for ciguatera fish poisoning, the principal cause of non-bacterial illness associated with fish consumption. The genus currently contains species exhibiting either globular or anterior-posteriorly compressed morphologies with marked differences in cell shape and plate arrangement. Here we report a third globular, epiphytic and tychoplanktonic species from the coasts of Ubatuba, Brazil. The new species can be distinguished from G. yasumotoi and G. ruetzleri by its broader first apical plate that occupies a larger portion of the epitheca. Accordingly, phylogenetic trees from small subunit (SSU) and large subunit (LSU) ribosomal DNA sequences also showed strongly supported separation of the new species from the G. yasumotoi / G. ruetzleri group albeit with short distance. The molecular phylogenies, which included new sequences of the planktonic species Goniodoma polyedricum, further indicated that the globular species of Gambierdiscus formed a tight clade, clearly separated (with strong bootstrap support) from the clade of lenticular species including the type for Gambierdiscus. The morphological and molecular data in concert support the split of Gambierdiscus sensu lato into two genera. Gambierdiscus sensu stricto should be reserved for the species with lenticular shapes, highly compressed anterioposteriorly, with short-shank fishhook apical pore plate, large 2' plate, low and ascending cingular displacement, and pouch-like sulcal morphology. The new genus name Fukuyoa gen. nov. should be applied to the globular species, slightly laterally compressed, with long-shank fishhook apical pore plate, large 1' plate, greater and descending cingular displacement, and not pouch-like vertically-oriented sulcal morphology. Fukuyoa contains the new species Fukuyoa paulensis gen. et sp. nov., and F. yasumotoi comb. nov. and F. ruetzleri comb. nov.	[Gomez, Fernando; Lopes, Rubens M.] Univ Sao Paulo, Oceanog Inst, Lab Plankton Syst, Sao Paulo, Brazil; [Qiu, Dajun] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci & Marine Biodiv, Xiamen, Peoples R China; [Lin, Senjie] Xiamen Univ, Global Change Res Ctr, Xiamen, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Universidade de Sao Paulo; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Xiamen University; Xiamen University; University of Connecticut	Gomez, F (corresponding author), Univ Sao Paulo, Oceanog Inst, Lab Plankton Syst, Sao Paulo, Brazil.	fernando.gomez@fitoplancton.com	Guo, chentao/G-7320-2016; Gomez, Fernando/B-2495-2009; Qiu, Dajun/I-5944-2019; Lin, Senjie/A-7466-2011; Lopes, Rubens M/C-6335-2012; Qiu, Dajun/D-3045-2017	Gomez, Fernando/0000-0002-5886-3488; Qiu, Dajun/0000-0003-2315-3432; Lopes, Rubens M/0000-0002-9709-073X; Qiu, Dajun/0000-0003-2315-3432	Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [BJT 370646/2013-14, 402759/2012-5, 311936/2013-0]; Natural Science Foundation of China [41129001, 41330959]; United States National Science Foundation [EF-0629624]	Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Science Foundation(National Science Foundation (NSF))	This research is supported by the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant numbers BJT 370646/2013-14 to F. G., and 402759/2012-5 and 311936/2013-0 to R. M. L.) and the Natural Science Foundation of China grants (41129001, 41330959 to S. L.), and United States National Science Foundation grant (EF-0629624 to S. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ADACHI R, 1979, B JPN SOC SCI FISH, V45, P67; ALFONSO A, 2005, BIOCHEM PHARMACOL, V69, P1543; BALECH E, 1979, Lilloa, V35, P97; Balech E, 1995, GENUS ALEXANDRIUM HA; Balech E., 1980, ANALES CTR CIENCIAS, V7, P57; BESADA EG, 1982, B MAR SCI, V32, P723; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Dickey RW, 2010, TOXICON, V56, P123, DOI 10.1016/j.toxicon.2009.09.008; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; Fraga S, 2008, J PHYCOL, V44, P1060, DOI 10.1111/j.1529-8817.2008.00555.x; Fraga S, 2014, PROTIST, V165, P839, DOI 10.1016/j.protis.2014.09.003; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Hernandez-Becerril DU, 2004, REV BIOL TROP, V52, P77; Holmes MJ, 1998, J PHYCOL, V34, P661, DOI 10.1046/j.1529-8817.1998.340661.x; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Litaker RW, 2010, TOXICON, V56, P711, DOI 10.1016/j.toxicon.2010.05.017; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; Murray S, 2014, HARMFUL ALGAE, V39, P242, DOI 10.1016/j.hal.2014.08.003; Nishimura T, 2014, J PHYCOL, V50, P506, DOI 10.1111/jpy.12175; Nishimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060882; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071346; Qiu DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029398; Rhodes L, 2014, NEW ZEAL J MAR FRESH, V48, P303, DOI 10.1080/00288330.2013.870220; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang L, 2014, HARMFUL ALGAE, V31, P100, DOI 10.1016/j.hal.2013.10.013; Xu YX, 2014, HARMFUL ALGAE, V34, P56, DOI 10.1016/j.hal.2014.02.007; YASUMOTO T, 1977, B JPN SOC SCI FISH, V43, P1021, DOI 10.2331/suisan.43.1021; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	32	77	79	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119676	10.1371/journal.pone.0119676	http://dx.doi.org/10.1371/journal.pone.0119676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831082	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600013
J	Grange, L; Loucoubar, C; Telle, O; Tall, A; Faye, J; Sokhna, C; Trape, JF; Sakuntabhai, A; Bureau, JF; Paul, R				Grange, Laura; Loucoubar, Cheikh; Telle, Olivier; Tall, Adama; Faye, Joseph; Sokhna, Cheikh; Trape, Jean-Francois; Sakuntabhai, Anavaj; Bureau, Jean-Francois; Paul, Richard			Risk Factors for Plasmodium falciparum Gametocyte Positivity in a Longitudinal Cohort	PLOS ONE			English	Article							MOSQUITO-BORNE DISEASE; POPULATION-DYNAMICS; HOLOENDEMIC AREA; SEVERE MALARIA; GENOME-WIDE; CHLOROQUINE; CARRIAGE; TRANSMISSION; RESISTANCE; CHILDREN	Malaria transmission intensity is highly heterogeneous even at a very small scale. Implementing targeted intervention in malaria transmission hotspots offers the potential to reduce the burden of disease both locally and in adjacent areas. Transmission of malaria parasites from man to mosquito requires the production of gametocyte stage parasites. Cluster analysis of a 19-year long cohort study for gametocyte carriage revealed spatially defined gametocyte hotspots that occurred during the time when chloroquine was the drug used for clinical case treatment. In addition to known risk factors for gametocyte carriage, notably young age (<15 years old) and associated with a clinical episode, blood groups B and O increased risk compared to groups A and AB. A hotspot of clinical P. falciparum clinical episodes that overlapped the gametocyte hotspots was also identified. Gametocyte positivity was found to be increased in individuals who had been treated with chloroquine, as opposed to other drug treatment regimens, for a clinical P. falciparum episode up to 30 days previously. It seems likely the hotspots were generated by a vicious circle of ineffective treatment of clinical cases and concomitant gametocyte production in a sub-population characterized by an increased prevalence of all the identified risk factors. While rapid access to treatment with an effective anti-malarial can reduce the duration of gametocyte carriage and onward parasite transmission, localised hotspots represent a challenge to malaria control and eventual eradication.	[Grange, Laura; Loucoubar, Cheikh; Telle, Olivier; Sakuntabhai, Anavaj; Bureau, Jean-Francois; Paul, Richard] Inst Pasteur, Unite Genet Fonct Malad Infect, F-75724 Paris 15, France; [Grange, Laura; Loucoubar, Cheikh; Telle, Olivier; Sakuntabhai, Anavaj; Bureau, Jean-Francois; Paul, Richard] CNRS, URA3012, F-75015 Paris, France; [Loucoubar, Cheikh; Tall, Adama; Faye, Joseph] Inst Pasteur, Unite Epidemiol Malad Infect UR 172, Dakar, Senegal; [Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Unite Pathogenie Afrotrop UMR 198, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD)	Paul, R (corresponding author), Inst Pasteur, Unite Genet Fonct Malad Infect, 28 Rue Docteur Roux, F-75724 Paris 15, France.	rpaul@pasteur.fr		Bureau, Jean-Francois/0000-0003-1945-1883; Paul, Richard/0000-0002-0665-5089; Telle, Olivier/0000-0002-9473-8406				Abdel-Wahab A, 2002, J INFECT DIS, V185, P1838, DOI 10.1086/340638; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; [Anonymous], GENSTAT FOR WINDOWS; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Bouganali C, 2009, 5TH MIM PAN AFRICAN; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CATTANI JA, 1986, PAPUA NEW GUINEA MED, V29, P11; Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628; Cottrell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028812; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drakeley CJ, 2004, TROP MED INT HEALTH, V9, P53, DOI 10.1046/j.1365-3156.2003.01169.x; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Ecker A, 2011, J INFECT DIS, V203, P228, DOI 10.1093/infdis/jiq036; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gouagna LC, 2010, NAT GENET, V42, P328, DOI 10.1038/ng.554; HASIBEDER G, 1988, THEOR POPUL BIOL, V33, P31, DOI 10.1016/0040-5809(88)90003-2; Herrant M, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2013-002835, DOI 10.1136/BMJOPEN-2013-002835]; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Machado A, 2012, MALARIA PARASITES, P267; Nacher M, 2002, J PARASITOL, V88, P97, DOI 10.1645/0022-3395(2002)088[0097:DHCHAS]2.0.CO;2; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; Paul REL, 2007, INFECT GENET EVOL, V7, P577, DOI 10.1016/j.meegid.2007.04.004; Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Robert V, 1996, AM J TROP MED HYG, V55, P350, DOI 10.4269/ajtmh.1996.55.350; Robert V, 2000, AM J TROP MED HYG, V62, P210, DOI 10.4269/ajtmh.2000.62.210; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Sokhna CS, 2001, PARASITE, V8, P243, DOI 10.1051/parasite/2001083243; Sowunmi A, 2004, PARASITOLOGY, V129, P255, DOI 10.1017/S0031182004005669; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; TRAGER W, 1992, J PROTOZOOL, V39, P429, DOI 10.1111/j.1550-7408.1992.tb01476.x; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Vallee J, 2006, INTERNATIONAL JOURNA, V2, P29; World Health Organization, WORLD MALARIA REPORT	58	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123102	10.1371/journal.pone.0123102	http://dx.doi.org/10.1371/journal.pone.0123102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830351	Green Submitted, gold, Green Published			2022-12-27	WOS:000352135600138
J	Dvashi, Z; Goldberg, M; Adir, O; Shapira, M; Pollack, A				Dvashi, Zeev; Goldberg, Mordechai; Adir, Orit; Shapira, Michal; Pollack, Ayala			TGF-beta 1 Induced Transdifferentiation of RPE Cells is Mediated by TAK1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RETINAL-PIGMENT EPITHELIUM; COLLAGEN GEL CONTRACTION; BETA SIGNAL-TRANSDUCTION; TGF-BETA; PROLIFERATIVE VITREORETINOPATHY; GROWTH-FACTOR; KINASE KINASE; MAPK KINASE; ACTIVATION	Background and Aim Proliferative vitreoretinopathy (PVR) is an active process that develops as a complication upon retinal detachment (RD), accompanied by formation of fibrotic tissue. The main cells involved in the development of fibrotic tissue during PVR are the retinal pigment epithelial (RPE) cells. The RPE cells undergo epithelial-mesenchymal transition (EMT) which leads to complex retinal detachment and loss of vision. Transforming growth factor-beta 1 (TGF-beta 1) is considered as the main player in the EMT of RPE cells, even though the mechanism is not fully understood. This study was performed to determine the possible involvement of transforming growth factor beta activated kinase 1 (TAK1) in the EMT process of the RPE cells. Methodology ARPE-19 Cells were treated with 5Z-7 oxozeaenol (TAK1 inhibitor) or SB431542 (TGF-beta 1 receptor kinase inhibitor) followed by TGF-beta 1 stimulation. Immunofluorescence, scratch assay Real time PCR and collagen contraction assay assessed the EMT features. The phosphorylation of Smad2/3 and p38 was examined using western blots analysis. Results This study demonstrates that stimulation of RPE cells with TGF-beta 1 increases alpha-SMA expression, cell migration and cell contractility, all of which are EMT features. Remarkably, addition of TAK1 inhibitor abolishes all these processes. Furthermore, we show hereby that TAK1 regulates not only the activation of the non-canonical cascade of TGF-beta 1 (p38), but also the canonical cascade, the Smad2/3 activation. Thus, the outcome of the TGF-beta response in RPE cells is TAK1 dependent. Conclusions/Significance This work demonstrated TAK1, a component of the non-canonical pathway of TGF-beta 1, is a key player in the EMT process, thus provides deep insight into the pathogenesis of PVR. The ability to halt the process of EMT in RPE cells may reduce the severity of the fibrotic response that occurs upon PVR, leading to a better prognosis and increase the probability of success in RD treatment.	[Dvashi, Zeev; Goldberg, Mordechai; Adir, Orit; Shapira, Michal; Pollack, Ayala] Hadassah Hebrew Univ Jerusalem, Kaplan Med Ctr, Rehovot, Israel	Hebrew University of Jerusalem; Kaplan Medical Center	Pollack, A (corresponding author), Hadassah Hebrew Univ Jerusalem, Kaplan Med Ctr, Rehovot, Israel.	ayala_p@clalit.org.il			Ministry of Industry and Trade (KAMIN)	Ministry of Industry and Trade (KAMIN)	This work was supported by grants to Ayala Pollack by the Chief Scientist at the Ministry of Industry and Trade (KAMIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cao LN, 2013, INVEST OPHTH VIS SCI, V54, P3738, DOI 10.1167/iovs.13-11612; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; He SK, 2008, INVEST OPHTH VIS SCI, V49, P4078, DOI 10.1167/iovs.07-1302; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; HO PC, 1985, BRIT J OPHTHALMOL, V69, P584, DOI 10.1136/bjo.69.8.584; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Lam CRI, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.339; Lambert H M, 1995, Semin Ophthalmol, V10, P49, DOI 10.3109/08820539509059979; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li HS, 2011, J NAT GAS CHEM, V20, P1, DOI 10.1016/S1003-9953(10)60156-9; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Ma J, 2012, CLIN EXP OPHTHALMOL, V40, pE76, DOI 10.1111/j.1442-9071.2011.02618.x; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Raviv S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004360; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Saika S, 2005, LAB INVEST, V85, P838, DOI 10.1038/labinvest.3700294; Saika S, 2008, PROG RETIN EYE RES, V27, P177, DOI 10.1016/j.preteyeres.2007.12.002; SAKAMOTO T, 1994, CURR EYE RES, V13, P451, DOI 10.3109/02713689408999873; Strippoli R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031492; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Symeonidis C, 2011, ACTA OPHTHALMOL, V89, P339, DOI 10.1111/j.1755-3768.2009.01701.x; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Umazume K, 2013, INVEST OPHTH VIS SCI, V54, P1150, DOI 10.1167/iovs.12-10418; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Yumoto K, 2013, J BIOL CHEM, V288, P13467, DOI 10.1074/jbc.M112.431775; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	50	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122229	10.1371/journal.pone.0122229	http://dx.doi.org/10.1371/journal.pone.0122229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849436	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800110
J	Forlano, PM; Ghahramani, ZN; Monestime, CM; Kurochkin, P; Chernenko, A; Milkis, D				Forlano, Paul M.; Ghahramani, Zachary N.; Monestime, Camillia M.; Kurochkin, Philip; Chernenko, Alena; Milkis, Dmitriy			Catecholaminergic Innervation of Central and Peripheral Auditory Circuitry Varies with Reproductive State in Female Midshipman Fish, Porichthys notatus	PLOS ONE			English	Article							GUINEA-PIG COCHLEA; VOCAL PLAINFIN MIDSHIPMAN; MESSENGER-RNA EXPRESSION; SEASONALLY BREEDING SONGBIRD; DOPAMINE-MELATONIN NEURONS; BRAIN TYROSINE-HYDROXYLASE; EEL ANGUILLA-ANGUILLA; TELEOST FISH; HAIR CELL; INNER-EAR	In seasonal breeding vertebrates, hormone regulation of catecholamines, which include dopamine and noradrenaline, may function, in part, to modulate behavioral responses to conspecific vocalizations. However, natural seasonal changes in catecholamine innervation of auditory nuclei is largely unexplored, especially in the peripheral auditory system, where encoding of social acoustic stimuli is initiated. The plainfin midshipman fish, Porichthys notatus, has proven to be an excellent model to explore mechanisms underlying seasonal peripheral auditory plasticity related to reproductive social behavior. Recently, we demonstrated robust catecholaminergic (CA) innervation throughout the auditory system in midshipman. Most notably, dopaminergic neurons in the diencephalon have widespread projections to auditory circuitry including direct innervation of the saccule, the main endorgan of hearing, and the cholinergic octavolateralis efferent nucleus (OE) which also projects to the inner ear. Here, we tested the hypothesis that gravid, reproductive summer females show differential CA innervation of the auditory system compared to non-reproductive winter females. We utilized quantitative immunofluorescence to measure tyrosine hydroxylase immunoreactive (TH-ir) fiber density throughout central auditory nuclei and the sensory epithelium of the saccule. Reproductive females exhibited greater density of TH-ir innervation in two forebrain areas including the auditory thalamus and greater density of TH-ir on somata and dendrites of the OE. In contrast, non-reproductive females had greater numbers of TH-ir terminals in the saccule and greater TH-ir fiber density in a region of the auditory hindbrain as well as greater numbers of TH-ir neurons in the preoptic area. These data provide evidence that catecholamines may function, in part, to seasonally modulate the sensitivity of the inner ear and, in turn, the appropriate behavioral response to reproductive acoustic signals.	[Forlano, Paul M.; Ghahramani, Zachary N.; Monestime, Camillia M.; Kurochkin, Philip; Chernenko, Alena; Milkis, Dmitriy] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Forlano, Paul M.] CUNY, Program Neurosci, New York, NY 10021 USA; [Forlano, Paul M.; Ghahramani, Zachary N.] CUNY, Program Ecol Evolutionary Biol & Behav, New York, NY 10021 USA; [Forlano, Paul M.] CUNY, Grad Ctr, Program Behav & Cognit Neurosci, New York, NY USA; [Forlano, Paul M.] CUNY Brooklyn Coll, Aquat Res & Environm Assessment Ctr, Brooklyn, NY 11210 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY)	Forlano, PM (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	pforlano@brooklyn.cuny.edu	Ghahramani, Zachary Nadar/Q-4844-2019	Ghahramani, Zachary Nadar/0000-0002-4136-7832; Forlano, Paul/0000-0003-4258-5708	National Institutes of Health (NIH) [SC2DA034996]; PSC-CUNY Award - Professional Staff Congress [64519-00 42]; City University of New York; NIH MARC [GM08078]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [SC2DA034996] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSC-CUNY Award - Professional Staff Congress; City University of New York; NIH MARC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (NIH) SC2DA034996 to PMF (www.nih.gov), PSC-CUNY Award 64519-00 42 jointly funded by The Professional Staff Congress and The City University of New York to PMF (www.rfcuny.org) and NIH MARC GM08078 to CMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; Bass AH, 2000, J COMP NEUROL, V419, P505, DOI 10.1002/(SICI)1096-9861(20000417)419:4<505::AID-CNE7>3.0.CO;2-3; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; Bass AH, 1996, AM SCI, V84, P352; BASS AH, 1994, J NEUROSCI, V14, P4025; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Boyle R, 2009, J NEUROPHYSIOL, V102, P1513, DOI 10.1152/jn.91367.2008; BRANTLEY RK, 1988, J COMP NEUROL, V275, P87, DOI 10.1002/cne.902750108; Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9; Caras ML, 2013, FRONT NEUROENDOCRIN, V34, P285, DOI 10.1016/j.yfrne.2013.07.006; Chagnaud BP, 2013, J NEUROSCI, V33, P18775, DOI 10.1523/JNEUROSCI.3140-13.2013; Chagnaud BP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1349; Chaube R, 2003, GEN COMP ENDOCR, V130, P29, DOI 10.1016/S0016-6480(02)00529-4; Chaube R, 2002, J EXP ZOOL, V293, P585, DOI 10.1002/jez.10185; Coffin AB, 2012, J NEUROSCI, V32, P1366, DOI 10.1523/JNEUROSCI.4928-11.2012; DALDIN C, 1995, HEARING RES, V90, P202, DOI 10.1016/0378-5955(95)00167-5; DALDIN C, 1995, EUR ARCH OTO-RHINO-L, V252, P270; Darrow KN, 2006, J COMP NEUROL, V498, P403, DOI 10.1002/cne.21050; Drescher MJ, 2010, NEUROSCIENCE, V171, P1054, DOI 10.1016/j.neuroscience.2010.09.051; Dufour S, 2010, J FISH BIOL, V76, P129, DOI 10.1111/j.1095-8649.2009.02499.x; Edds-Walton PL, 2010, HEARING RES, V262, P45, DOI 10.1016/j.heares.2010.01.008; El Halawani ME, 2009, GEN COMP ENDOCR, V163, P123, DOI 10.1016/j.ygcen.2008.11.030; EYBALIN M, 1993, NEUROSCIENCE, V54, P133, DOI 10.1016/0306-4522(93)90389-W; Falcon J, 2007, TRENDS ENDOCRIN MET, V18, P81, DOI 10.1016/j.tem.2007.01.002; Fergus DJ, 2013, J COMP NEUROL, V521, P2850, DOI 10.1002/cne.23320; Filippi A, 2014, J COMP NEUROL, V522, P2019, DOI 10.1002/cne.23524; Fontaine R, 2013, ENDOCRINOLOGY, V154, P807, DOI 10.1210/en.2012-1759; Forlano P. M., 2014, FRONT NEUROENDOCRINO; Forlano PM, 2006, FRONT NEUROENDOCRIN, V27, P247, DOI 10.1016/j.yfrne.2006.05.002; Forlano PM, 2014, J COMP NEUROL, V522, P2887, DOI 10.1002/cne.23596; Forlano PM, 2011, HORM BEHAV, V59, P616, DOI 10.1016/j.yhbeh.2010.10.006; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Forlano PM, 2005, J NEUROBIOL, V65, P37, DOI 10.1002/neu.20179; Forlano PM, 2005, J NEUROBIOL, V65, P50, DOI 10.1002/neu.20178; Forlano PM, 2005, J COMP NEUROL, V483, P91, DOI 10.1002/cne.20397; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203, DOI 10.1113/jphysiol.1981.sp013742; Gaborjan A, 1999, NEUROSCIENCE, V90, P131, DOI 10.1016/S0306-4522(98)00461-8; Garrett AR, 2011, AUDIOL NEURO-OTOL, V16, P145, DOI 10.1159/000316674; Goebrecht GKE, 2014, J CHEM NEUROANAT, V56, P13, DOI 10.1016/j.jchemneu.2014.01.001; Goodson JL, 2002, J COMP NEUROL, V448, P298, DOI 10.1002/cne.10258; Heimovics SA, 2011, NEUROSCIENCE, V182, P133, DOI 10.1016/j.neuroscience.2011.03.012; Heimovics SA, 2012, ENDOCRINOLOGY, V153, P1364, DOI 10.1210/en.2011-1525; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Kang SW, 2010, NEUROSCIENCE, V170, P200, DOI 10.1016/j.neuroscience.2010.06.082; Kapsimali M, 2000, J COMP NEUROL, V419, P320, DOI 10.1002/(SICI)1096-9861(20000410)419:3<320::AID-CNE5>3.0.CO;2-F; KHAN KM, 1991, NEUROSCI LETT, V131, P109, DOI 10.1016/0304-3940(91)90348-W; Kittelberger JM, 2013, J COMP NEUROL, V521, P791, DOI 10.1002/cne.23202; Koppl C, 2011, SPRINGER HANDB AUDIT, V38, P217, DOI 10.1007/978-1-4419-7070-1_8; LeBlanc MM, 2007, BRAIN RES, V1171, P93, DOI 10.1016/j.brainres.2007.06.086; Linard B, 1996, NEUROENDOCRINOLOGY, V63, P156, DOI 10.1159/000126952; LU Z, 1995, J COMP PHYSIOL A, V176, P747; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; Lynch KS, 2012, BRAIN BEHAV EVOLUT, V79, P252, DOI 10.1159/000337533; MA PM, 1994, J COMP NEUROL, V344, P256, DOI 10.1002/cne.903440207; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; Maison SF, 2012, J NEUROSCI, V32, P344, DOI 10.1523/JNEUROSCI.4720-11.2012; Mamta SK, 2014, GEN COMP ENDOCR, V197, P18, DOI 10.1016/j.ygcen.2013.11.022; Maney DL, 2001, NEUROSCI LETT, V311, P189, DOI 10.1016/S0304-3940(01)02157-7; Maney DL, 2013, HEARING RES, V305, P19, DOI 10.1016/j.heares.2013.04.011; Maney DL, 2011, FRONT NEUROENDOCRIN, V32, P287, DOI 10.1016/j.yfrne.2010.12.002; Matragrano LL, 2013, DEV NEUROBIOL, V73, P455, DOI 10.1002/dneu.22072; Matragrano LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039388; Matragrano LL, 2011, EUR J NEUROSCI, V34, P416, DOI 10.1111/j.1460-9568.2011.07751.x; Mazurais D, 1999, J COMP NEUROL, V409, P313, DOI 10.1002/(SICI)1096-9861(19990628)409:2<313::AID-CNE11>3.0.CO;2-1; McCormick CA, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P283; Mccormick C.A., 1999, COMP HEARING FISH AM, P155; McIver EL, 2014, J EXP BIOL, V217, P2377, DOI 10.1242/jeb.102772; McKibben JR, 1998, J ACOUST SOC AM, V104, P3520, DOI 10.1121/1.423938; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; NAKAJIMA Y, 1974, J COMP NEUROL, V156, P403, DOI 10.1002/cne.901560403; Niu X, 2006, NEUROSCIENCE, V137, P981, DOI 10.1016/j.neuroscience.2005.10.044; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Pasqualini C, 2009, ENDOCRINOLOGY, V150, P1377, DOI 10.1210/en.2008-0578; Pawlisch BA, 2012, GEN COMP ENDOCR, V179, P359, DOI 10.1016/j.ygcen.2012.09.007; Petersen CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070474; Rabbitt RD, 2011, CURR OPIN OTOLARYNGO, V19, P376, DOI 10.1097/MOO.0b013e32834a5be1; Remage-Healey L, 2014, HORM BEHAV, V66, P552, DOI 10.1016/j.yhbeh.2014.07.014; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Rohmann KN, 2013, CURR BIOL, V23, P678, DOI 10.1016/j.cub.2013.03.014; Rohmann KN, 2011, J EXP BIOL, V214, P1931, DOI 10.1242/jeb.054114; Ruel J, 2001, EUR J NEUROSCI, V14, P977, DOI 10.1046/j.0953-816x.2001.01721.x; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Sabban EL, 2010, PHYSIOL BEHAV, V99, P163, DOI 10.1016/j.physbeh.2009.07.011; Schweitzer J, 2012, DEV NEUROBIOL, V72, P256, DOI 10.1002/dneu.20911; Sebert ME, 2008, J NEUROENDOCRINOL, V20, P917, DOI 10.1111/j.1365-2826.2008.01744.x; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sisneros JA, 2004, GEN COMP ENDOCR, V136, P101, DOI 10.1016/j.ygcen.2003.12.007; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Sisneros JA, 2009, INTEGR ZOOL, V4, P33, DOI 10.1111/j.1749-4877.2008.00133.x; Sisneros JA, 2009, J NEUROPHYSIOL, V102, P1121, DOI 10.1152/jn.00236.2009; Sisneros JA, 2009, HEARING RES, V252, P9, DOI 10.1016/j.heares.2008.12.007; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Sugihara I, 2001, HEARING RES, V153, P91, DOI 10.1016/S0378-5955(00)00259-8; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Tomchik SM, 2006, J NEUROPHYSIOL, V95, P3562, DOI 10.1152/jn.00063.2006; Uz T, 2005, MOL BRAIN RES, V136, P45, DOI 10.1016/j.molbrainres.2005.01.002; Weeg MS, 2005, J NEUROSCI, V25, P5967, DOI 10.1523/JNEUROSCI.0019-05.2005; Weeg MS, 2002, J NEUROPHYSIOL, V88, P1252, DOI 10.1152/jn.2002.88.3.1252; Weeg MS, 2000, J COMP NEUROL, V418, P41; Weltzien FA, 2006, ENDOCRINOLOGY, V147, P2964, DOI 10.1210/en.2005-1477; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Zeddies DG, 2010, J ACOUST SOC AM, V127, P3104, DOI 10.1121/1.3365261; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	106	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121914	10.1371/journal.pone.0121914	http://dx.doi.org/10.1371/journal.pone.0121914			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849450	Green Published, gold			2022-12-27	WOS:000352477800087
J	Kalinowska, M; Castillo, C; Francesconi, A				Kalinowska, Magdalena; Castillo, Catherine; Francesconi, Anna			Quantitative Profiling of Brain Lipid Raft Proteome in a Mouse Model of Fragile X Syndrome	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; LEMLI-OPITZ-SYNDROME; DETERGENT-RESISTANT MEMBRANES; LONG-TERM DEPRESSION; DE-NOVO MUTATIONS; LARGE GENE LISTS; MESSENGER-RNAS; VISUAL-CORTEX; AMPA RECEPTOR; MICE LACKING	Fragile X Syndrome, a leading cause of inherited intellectual disability and autism, arises from transcriptional silencing of the FMR1 gene encoding an RNA-binding protein, Fragile X Mental Retardation Protein (FMRP). FMRP can regulate the expression of approximately 4% of brain transcripts through its role in regulation of mRNA transport, stability and translation, thus providing a molecular rationale for its potential pleiotropic effects on neuronal and brain circuitry function. Several intracellular signaling pathways are dysregulated in the absence of FMRP suggesting that cellular deficits may be broad and could result in homeostatic changes. Lipid rafts are specialized regions of the plasma membrane, enriched in cholesterol and glycosphingolipids, involved in regulation of intracellular signaling. Among transcripts targeted by FMRP, a subset encodes proteins involved in lipid biosynthesis and homeostasis, dysregulation of which could affect the integrity and function of lipid rafts. Using a quantitative mass spectrometry-based approach we analyzed the lipid raft proteome of Fmr1 knockout mice, an animal model of Fragile X syndrome, and identified candidate proteins that are differentially represented in Fmr1 knockout mice lipid rafts. Furthermore, network analysis of these candidate proteins reveals connectivity between them and predicts functional connectivity with genes encoding components of myelin sheath, axonal processes and growth cones. Our findings provide insight to aid identification of molecular and cellular dysfunctions arising from Fmr1 silencing and for uncovering shared pathologies between Fragile X syndrome and other autism spectrum disorders.	[Kalinowska, Magdalena; Castillo, Catherine; Francesconi, Anna] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA	Yeshiva University	Francesconi, A (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA.	anna.francesconi@einstein.yu.edu			Autism Speaks [7287]; NIH [MH082870]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082870] Funding Source: NIH RePORTER	Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a grant from Autism Speaks (grant # 7287), www.autismspeaks.org; and NIH grant MH082870 to A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Behan AT, 2009, MOL PSYCHIATR, V14, P601, DOI 10.1038/mp.2008.7; BERRYKRAVIS E, 1993, AM J MED GENET, V45, P81, DOI 10.1002/ajmg.1320450120; Bukelis I, 2007, AM J PSYCHIAT, V164, P1655, DOI 10.1176/appi.ajp.2007.07020315; Chadwick W., 2010, INT J ALZHEIMERS DIS, V2010, DOI [10.4061/2010/604792, DOI 10.4061/2010/604792]; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DeBruin LS, 2007, NEUROCHEM RES, V32, P213, DOI 10.1007/s11064-006-9137-4; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Donati RJ, 2008, J NEUROSCI, V28, P3042, DOI 10.1523/JNEUROSCI.5713-07.2008; Fagni L, 2012, ADV EXP MED BIOL, V970, P63, DOI 10.1007/978-3-7091-0932-8_3; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Giampetruzzi A, 2013, MOL CELL NEUROSCI, V56, P333, DOI 10.1016/j.mcn.2013.07.009; Gielen E, 2006, GLIA, V54, P499, DOI 10.1002/glia.20406; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Gross C, 2012, MOL MED, V18, P336, DOI 10.2119/molmed.2011.00363; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Hagerman RJ, 2005, CURR OPIN PSYCHIATR, V18, P490, DOI 10.1097/01.yco.0000179485.39520.b0; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hering H, 2003, J NEUROSCI, V23, P3262; Herrera-Molina R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034295; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeft F, 2010, P NATL ACAD SCI USA, V107, P9335, DOI 10.1073/pnas.1002762107; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Jia JY, 2006, MOL CELL PROTEOMICS, V5, P2060, DOI 10.1074/mcp.M600161-MCP200; JIANG L, 2008, NEUROBIOL AGING; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019; Kumari R, 2013, J BIOL CHEM, V288, P32004, DOI 10.1074/jbc.M113.475863; Kumari R, 2011, METHODS MOL BIOL, V746, P411, DOI 10.1007/978-1-61779-126-0_24; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; MAHANTHAPPA NK, 1992, DEV BIOL, V150, P47, DOI 10.1016/0012-1606(92)90006-3; Martosella J, 2006, J PROTEOME RES, V5, P1301, DOI 10.1021/pr060051g; Maurin T, 2014, NEUROSCI BIOBEHAV RE; Mayeux-Portas V, 2000, CURR BIOL, V10, P68, DOI 10.1016/S0960-9822(99)00278-X; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nakamura K, 2014, EPILEPSIA, V55, pE13, DOI 10.1111/epi.12508; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Pacey LKK, 2013, HUM MOL GENET, V22, P3920, DOI 10.1093/hmg/ddt246; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Rakheja D, 2008, PEDIATR DEVEL PATHOL, V11, P128, DOI 10.2350/06-10-0179.1; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Sikora DM, 2006, AM J MED GENET A, V140A, P1511, DOI 10.1002/ajmg.a.31294; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stam AJ, 2009, APPL CLIN GENET, V2, P7, DOI 10.2147/TACG.S4683; Straiker A, 2013, NEUROBIOL DIS, V56, P1, DOI 10.1016/j.nbd.2013.04.002; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Thevenon J, 2013, EUR J HUM GENET, V21, P82, DOI 10.1038/ejhg.2012.116; Thomsen MS, 2013, BRAIN STRUCT FUNCT; Tiede A, 1998, BIOCHEM J, V334, P609, DOI 10.1042/bj3340609; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Yamagata M, 2005, J NEUROSCI, V25, P8457, DOI 10.1523/JNEUROSCI.1976-05.2005; Yu HW, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-17; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	90	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121464	10.1371/journal.pone.0121464	http://dx.doi.org/10.1371/journal.pone.0121464			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849048	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800059
J	Li, J; Zeng, GF; Qi, YW; Tang, XD; Zhang, JJ; Wu, ZY; Liang, J; Shi, L; Liu, HW; Zhang, PH				Li, Jin; Zeng, Guofang; Qi, Yawei; Tang, Xudong; Zhang, Jingjing; Wu, Zeyong; Liang, Jie; Shi, Lei; Liu, Hongwei; Zhang, Peihua			Xenotransplantation of Human Adipose-Derived Stem Cells in Zebrafish Embryos	PLOS ONE			English	Article							IN-UTERO TRANSPLANTATION; CORD BLOOD; MODEL; DIFFERENTIATION; ENGRAFTMENT; XENOGRAFTS; EXPRESSION; MOUSE	Zebrafish is a widely used animal model with well-characterized background in developmental biology. The fate of human adipose-derived stem cells (ADSCs) after their xenotransplantation into the developing embryos of zebrafish is unknown. Therefore, human ADSCs were firstly isolated, and then transduced with lentiviral vector system carrying a green fluorescent protein (GFP) reporter gene, and followed by detection of their cell viability and the expression of cell surface antigens. These GFP-expressing human ADSCs were transplanted into the zebrafish embryos at 3.3-4.3 hour post-fertilization (hpf). Green fluorescent signal, the proliferation and differentiation of human ADSCs in recipient embryos were respectively examined using fluorescent microscopy and immunohistochemical staining. The results indicated that human ADSCs did not change their cell viability and the expression levels of cell surface antigens after GFP transduction. Microscopic examination demonstrated that green fluorescent signals of GFP expressed in the transplanted cells were observed in the embryos and larva fish at post-transplantation. The positive staining of Ki-67 revealed the survival and proliferation of human ADSCs in fish larvae after transplantation. The expression of CD105 was observable in the xenotransplanted ADSCs, but CD31 expression was undetectable. Therefore, our results indicate that human ADSCs xenotransplanted in the zebrafish embryos not only can survive and proliferate at across-species circumstance, but also seem to maintain their undifferentiation status in a short term. This xenograft model of zebrafish embryos may provide a promising and useful technical platform for the investigation of biology and physiology of stem cells in vivo.	[Li, Jin; Zeng, Guofang; Qi, Yawei; Wu, Zeyong; Liang, Jie; Zhang, Peihua] Guangdong Med Coll, Affiliated Hosp, Inst Plast Surg, Zhanjiang, Guangdong, Peoples R China; [Tang, Xudong] Guangdong Med Coll, Inst Biochem & Mol Biol, Zhanjiang, Guangdong, Peoples R China; [Zhang, Jingjing] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Guangdong, Peoples R China; [Shi, Lei] S China Univ Technol, Sch Light Ind & Food Sci, Guangzhou 510641, Guangdong, Peoples R China; [Liu, Hongwei] Jinan Univ, Affiliated Hosp 1, Dept Plast Surg, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; South China University of Technology; Jinan University	Liu, HW (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Plast Surg, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China.	liuhongwei0521@hotmail.com; Zhangpeihua128@126.com	Zhang, Jing/HII-4294-2022		Scientific Research Starting Foundation for the Doctors of Guangdong Medical College [B2012036]; Open Project Program of State Key Laboratory of Meat Products for Security and Production Technology in Xiamen [2011YXGZ008]	Scientific Research Starting Foundation for the Doctors of Guangdong Medical College; Open Project Program of State Key Laboratory of Meat Products for Security and Production Technology in Xiamen	This work was partly supported by the Scientific Research Starting Foundation for the Doctors of Guangdong Medical College (grant number: B2012036). GFZ received this funding. In addition, this work was also partly supported by the Open Project Program of State Key Laboratory of Meat Products for Security and Production Technology in Xiamen (grant number: 2011YXGZ008). PHZ received this funding. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abe T, 2012, EXP HEMATOL, V40, P436, DOI 10.1016/j.exphem.2012.01.018; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Bansal N, 2014, PROSTATE, V74, P187, DOI 10.1002/pros.22740; Bayati V, 2011, TISSUE CELL, V43, P359, DOI 10.1016/j.tice.2011.07.004; Bershteyn M, 2014, NATURE, V507, P99, DOI 10.1038/nature12923; Blackburn JS, 2014, DIS MODEL MECH, V7, P755, DOI 10.1242/dmm.015842; Chen CP, 2009, HUM REPROD, V24, P154, DOI 10.1093/humrep/den356; Chen X, 2009, EXP MOL PATHOL, V87, P173, DOI 10.1016/j.yexmp.2009.07.009; De Santis M, 2011, Minerva Ginecol, V63, P387; Efthymiou AG, 2014, EXPERT OPIN BIOL TH, V31, P1; Eguiara A, 2011, CELL CYCLE, V10, P3751, DOI 10.4161/cc.10.21.17921; Etchin J, 2011, METHOD CELL BIOL, V105, P309, DOI 10.1016/B978-0-12-381320-6.00013-8; Fisher JE, 2013, LIVER TRANSPLANT, V19, P328, DOI 10.1002/lt.23598; Flake AW, 1998, ANN NY ACAD SCI, V850, P300, DOI 10.1111/j.1749-6632.1998.tb10487.x; Gahremanpour A, 2013, XENOTRANSPLANTATION, V20, P110, DOI 10.1111/xen.12026; Harding MJ, 2014, DEVELOPMENT, V141, P2549, DOI 10.1242/dev.101444; Jung DW, 2012, MOL BIOSYST, V8, P1930, DOI 10.1039/c2mb05501e; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Liao XB, 2008, STEM CELLS DEV, V17, P303, DOI 10.1089/scd.2007.0086; Mazo M, 2012, CELL TRANSPLANT, V21, P2723, DOI 10.3727/096368912X638847; Mushtaq MY, 2013, BIOTECHNOL GENET ENG, V29, P187, DOI 10.1080/02648725.2013.801238; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Ripoll CB, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-3; Roubelakis MG, 2011, J CELL MOL MED, V15, P1896, DOI 10.1111/j.1582-4934.2010.01180.x; Sabaawy HE, 2006, P NATL ACAD SCI USA, V103, P15166, DOI 10.1073/pnas.0603349103; Saez-Lara MJ, 2006, XENOTRANSPLANTATION, V13, P529, DOI 10.1111/j.1399-3089.2006.00344.x; Santo VE, 2012, J CONTROL RELEASE, V162, P19, DOI 10.1016/j.jconrel.2012.06.001; Tat Jennifer, 2013, Drug Discov Today Technol, V10, pe83, DOI 10.1016/j.ddtec.2012.04.006; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061801, 10.1371/journal.pone.0062181]; Yoon IS, 2011, J BIOSCI BIOENG, V112, P402, DOI 10.1016/j.jbiosc.2011.06.018; Yu G, 2011, METHODS MOL BIOL, V702, P17, DOI 10.1007/978-1-61737-960-4_2; Zeng FY, 2006, P NATL ACAD SCI USA, V103, P7801, DOI 10.1073/pnas.0602646103; Zeng FY, 2005, DNA CELL BIOL, V24, P403, DOI 10.1089/dna.2005.24.403; Zeng GF, 2013, ORGANOGENESIS, V9, P287, DOI 10.4161/org.27153; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	36	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123264	10.1371/journal.pone.0123264	http://dx.doi.org/10.1371/journal.pone.0123264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849455	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800219
J	Nega, D; Dana, D; Tefera, T; Eshetu, T				Nega, Desalegn; Dana, Daniel; Tefera, Tamirat; Eshetu, Teferi			Prevalence and Predictors of Asymptomatic Malaria Parasitemia among Pregnant Women in the Rural Surroundings of Arbaminch Town, South Ethiopia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; TRANSMISSION; BURDEN; AREA; SPP.	Background In Sub-Saharan African countries, including Ethiopia, malaria in pregnancy is a major public health threat which results in significant morbidities and mortalities among pregnant women and their fetuses. In malaria endemic areas, Plasmodium infections tend to remain asymptomatic yet causing significant problems like maternal anemia, low birth weight, premature births, and still birth. This study was conducted to determine the prevalence and predictors of asymptomatic Plasmodium infection among pregnant women in the rural surroundings of Arba Minch Town, Southern Ethiopia. Methods A community based cross-sectional study comprising multistage sampling was conducted between April and June, 2013. Socio-demographic data were collected by using a semi-structured questionnaire. Plasmodium infection was diagnosed by using Giemsa-stained blood smear microscopy and a rapid diagnostic test (SD BIOLINE Malaria Ag Pf/Pv POCT, standard diagnostics, inc., Korea). Results Of the total 341 pregnant women participated in this study, 9.1% (31/341) and 9.7% (33/341) were confirmed to be infected with Plasmodium species by microscopy and rapid diagnostic tests (RDTs), respectively. The geometric mean of parasite density was 2392 parasites per microliter (mu l); 2275/mu l for P. falciparum and 2032/mu l for P. vivax. Parasitemia was more likely to occur in primigravidae (Adjusted odds ratio (AOR): 9.4, 95% confidence interval (CI): 4.3-60.5), secundigravidae (AOR: 6.3, 95% CI: 2.9-27.3), using insecticide treated bed net (ITN) sometimes (AOR: 3.2, 95% CI: 1.8-57.9), not using ITN at all (AOR: 4.6, 95% CI: 1.4-14.4) compared to multigravidae and using ITN always, respectively. Conclusion Asymptomatic malaria in this study is low compared to other studies' findings. Nevertheless, given the high risk of malaria during pregnancy, pregnant women essentially be screened for asymptomatic Plasmodium infection and be treated promptly via the antenatal care (ANC) services.	[Nega, Desalegn] Ethiopian Publ Hlth Inst, Directorate Parasit Bacterial & Zoonot Dis Res, Malaria & Other Parasit & Vector Borne Dis Res Te, Addis Ababa, Ethiopia; [Dana, Daniel; Tefera, Tamirat; Eshetu, Teferi] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Oromia, Ethiopia	Jimma University	Tefera, T (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Oromia, Ethiopia.	tamirat.tefera@ju.edu.et		Temesgen, Tamirat Tefera/0000-0002-6946-5055; Dana, Daniel/0000-0002-1941-5076	JIMMA UNIVERSITY	JIMMA UNIVERSITY	Funding was provided by JIMMA UNIVERSITY (www.ju.edu.et). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-174; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; [Anonymous], MAL OP PLAN FY 2012; [Anonymous], 2012, NAT MAL GUID; [Anonymous], PLOS ONE; [Anonymous], 2012, J DENT MED SCI; [Anonymous], 2013, WHO POL BRIEF IMPL I; [Anonymous], ETH NAT MAL IND SURV; [Anonymous], 13 WORLD C PUBL HLTH; Astatkie A, 2010, ETHIOP J HEALTH DEV, V24, P15; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Bouyou-Akotet MK, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-18; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Douamba Z, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/198317; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Getachew Million, 2013, BMC Res Notes, V6, P263, DOI 10.1186/1756-0500-6-263; Getachew M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-296; Isah AY, 2011, ANN AFR MED, V10, P171, DOI 10.4103/1596-3519.82070; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Cucunuba ZM, 2013, T ROY SOC TROP MED H, V107, P129, DOI 10.1093/trstmh/trs021; Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878; Nwagha UI, 2009, T ROY SOC TROP MED H, V103, P16, DOI 10.1016/j.trstmh.2008.07.016; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; Van Geertruyden JP, 2005, TROP MED INT HEALTH, V10, P681, DOI 10.1111/j.1365-3156.2005.01431.x; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, pS25, DOI 10.1080/00034989957718; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yavo W, 2002, B SOC PATHOL EXOT, V95, P238	31	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123630	10.1371/journal.pone.0123630	http://dx.doi.org/10.1371/journal.pone.0123630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849587	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800246
J	De Mukhopadhyay, K; Liu, Z; Bandyopadhyay, A; Kirma, NB; Tekmal, RR; Wang, S; Sun, LZ				De Mukhopadhyay, Keya; Liu, Zhao; Bandyopadhyay, Abhik; Kirma, Nameer B.; Tekmal, Rajeshwar R.; Wang, Shui; Sun, Lu-Zhe			Aromatase Expression Increases the Survival and Malignancy of Estrogen Receptor Positive Breast Cancer Cells	PLOS ONE			English	Article							ADIPOSE STROMAL CELLS; INHIBITORS; GENE; METASTASIS; INDUCTION; PROMOTER; ALPHA; MCF-7; CYP19	In postmenopausal women, local estrogen produced by adipose stromal cells in the breast is believed to support estrogen receptor alpha (ERa) positive breast cancer cell survival and growth. This raises the question of how the ERa positive metastatic breast cancer cells survive after they enter blood and lymph circulation, where estrogen level is very low in postmenopausal women. In this study, we show that the aromatase expression increased when ERa positive breast cancer cells were cultured in suspension. Furthermore, treatment with the aromatase substrate, testosterone, inhibited suspension culture-induced apoptosis whereas an aromatase inhibitor attenuated the effect of testosterone suggesting that suspended circulating ERa positive breast cancer cells may up-regulate intracrine estrogen activity for survival. Consistent with this notion, a moderate level of ectopic aromatase expression rendered a non-tumorigenic ERa positive breast cancer cell line not only tumorigenic but also metastatic in female nude mice without exogenous estrogen supplementation. The increased malignant phenotype was confirmed to be due to aromatase expression as the growth of orthotopic tumors regressed with systemic administration of an aromatase inhibitor. Thus, our study provides experimental evidence that aromatase plays an important role in the survival of metastatic ERa breast cancer cells by suppressing anoikis.	[De Mukhopadhyay, Keya; Liu, Zhao; Bandyopadhyay, Abhik; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Tekmal, Rajeshwar R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Kirma, Nameer B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Tekmal, Rajeshwar R.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Nanjing Medical University	Wang, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	ws0801@hotmail.com; sunl@uthscsa.edu	, LuZhe/AAW-4095-2021		National Natural Science Foundation of China [81172505]; National Institutes of Health [R01CA79683, R01ES022057]; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant [2 P30 CA054174]; NATIONAL CANCER INSTITUTE [R01CA079683, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022057] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by funding from the National Natural Science Foundation of China Grant #81172505 (SW), National Institutes of Health Grants R01CA79683 and R01ES022057 (LZS), and the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant 2 P30 CA054174.	Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Briest S, 2008, EXPERT REV ANTICANC, V8, P1, DOI 10.1586/14737140.8.1.1; Briest S, 2007, REV ENDOCR METAB DIS, V8, P215, DOI 10.1007/s11154-007-9039-z; Fierro FA, 2004, CLIN EXP METASTAS, V21, P313, DOI 10.1023/B:CLIN.0000046130.79363.33; Ghosh S, 2005, ONCOGENE, V24, P2236, DOI 10.1038/sj.onc.1208415; Ghosh S, 2007, AM J PHYSIOL-ENDOC M, V292, pE246, DOI 10.1152/ajpendo.00242.2006; Ghosh S, 2009, MOL ENDOCRINOL, V23, P662, DOI 10.1210/me.2008-0468; Guillemette C, 2004, BREAST CANCER RES, V6, P246, DOI 10.1186/bcr936; Kinoshita Y, 2003, CANCER RES, V63, P3546; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; MULDER KM, 1989, MOL ENDOCRINOL, V3, P1215, DOI 10.1210/mend-3-8-1215; Nair HB, 2005, CANCER RES, V65, P11164, DOI 10.1158/0008-5472.CAN-05-1087; Parker BS, 2003, CANCER BIOL THER, V2, P14; Rose D P, 2004, Obes Rev, V5, P153, DOI 10.1111/j.1467-789X.2004.00142.x; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Salhab M, 2006, BREAST CANCER RES TR, V99, P155, DOI 10.1007/s10549-006-9198-8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 2002, RECENT PROG HORM RES, V57, P317, DOI 10.1210/rp.57.1.317; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; STRAMM LE, 1987, EXP EYE RES, V44, P17, DOI 10.1016/S0014-4835(87)80021-0; TUBIANAHULIN M, 1991, BONE, V12, pS9, DOI 10.1016/8756-3282(91)90059-R; WANG TTY, 1995, CANCER RES, V55, P2487; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; YUE W, 1994, CANCER RES, V54, P5092	26	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121136	10.1371/journal.pone.0121136	http://dx.doi.org/10.1371/journal.pone.0121136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837259	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000039
J	Hajarizadeh, B; Grady, B; Page, K; Kim, AY; McGovern, BH; Cox, AL; Rice, TM; Sacks-Davis, R; Bruneau, J; Morris, M; Amin, J; Schinkel, J; Applegate, T; Maher, L; Hellard, M; Lloyd, AR; Prins, M; Dore, GJ; Grebely, J				Hajarizadeh, Behzad; Grady, Bart; Page, Kimberly; Kim, Arthur Y.; McGovern, Barbara H.; Cox, Andrea L.; Rice, Thomas M.; Sacks-Davis, Rachel; Bruneau, Julie; Morris, Meghan; Amin, Janaki; Schinkel, Janke; Applegate, Tanya; Maher, Lisa; Hellard, Margaret; Lloyd, Andrew R.; Prins, Maria; Dore, Gregory J.; Grebely, Jason		InC3 Study Grp	Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study	PLOS ONE			English	Article							SPONTANEOUS VIRAL CLEARANCE; INJECTION-DRUG USERS; NATURAL-HISTORY; HCV RNA; IL28B GENOTYPE; VIREMIA; EPIDEMIOLOGY; PERSISTENCE; EVOLUTION; DIAGNOSIS	Background Understanding the patterns of HCV RNA levels during acute hepatitis C virus (HCV) infection provides insights into immunopathogenesis and is important for vaccine design. This study evaluated patterns of HCV RNA levels and associated factors among individuals with acute infection. Methods Data were from an international collaboration of nine prospective cohorts of acute HCV (InC3 Study). Participants with well-characterized acute HCV infection (detected within three months post-infection and interval between the peak and subsequent HCV RNA levels <= 120 days) were categorised by a priori-defined patterns of HCV RNA levels: i) spontaneous clearance, ii) partial viral control with persistence (>= 1 log IU/mL decline in HCV RNA levels following peak) and iii) viral plateau with persistence (increase or < 1 log IU/mL decline in HCV RNA levels following peak). Factors associated with HCV RNA patterns were assessed using multinomial logistic regression. Results Among 643 individuals with acute HCV, 162 with well-characterized acute HCV were identified: spontaneous clearance (32%), partial viral control with persistence (27%), and viral plateau with persistence (41%). HCV RNA levels reached a high viraemic phase within two months following infection, with higher levels in the spontaneous clearance and partial viral control groups, compared to the viral plateau group (median: 6.0, 6.2, 5.3 log IU/mL, respectively; P=0.018). In the two groups with persistence, Interferon lambda 3 (IFNL3) CC genotype was independently associated with partial viral control compared to viral plateau (adjusted odds ratio [AOR]: 2.75; 95% CI: 1.08, 7.02). In the two groups with viral control, female sex was independently associated with spontaneous clearance compared to partial viral control (AOR: 2.86; 95% CI: 1.04, 7.83). Conclusions Among individuals with acute HCV, a spectrum of HCV RNA patterns is evident. IFNL3 CC genotype is associated with initial viral control, while female sex is associated with ultimate spontaneous clearance.	[Hajarizadeh, Behzad; Amin, Janaki; Applegate, Tanya; Maher, Lisa; Dore, Gregory J.; Grebely, Jason] Univ New S Wales, Kirby Inst, UNSW Australia, Sydney, NSW, Australia; [Grady, Bart; Prins, Maria] GGD Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands; [Page, Kimberly; Rice, Thomas M.; Morris, Meghan] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kim, Arthur Y.] Harvard Univ, Sch Med, Boston, MA USA; [McGovern, Barbara H.] Tufts Med Sch, Boston, MA USA; [McGovern, Barbara H.] Abbvie, Chicago, IL USA; [Cox, Andrea L.] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Sacks-Davis, Rachel; Hellard, Margaret] Burnet Inst, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bruneau, Julie] Univ Montreal, CRCHUM, Montreal, PQ, Canada; [Schinkel, Janke; Prins, Maria] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lloyd, Andrew R.] UNSW Australia, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; Public Health Service Amsterdam; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Tufts Medical Center; Tufts University; AbbVie; Johns Hopkins University; Johns Hopkins Medicine; Burnet Institute; Monash University; Universite de Montreal; University of Amsterdam; Academic Medical Center Amsterdam; University of New South Wales Sydney	Hajarizadeh, B (corresponding author), Univ New S Wales, Kirby Inst, UNSW Australia, Sydney, NSW, Australia.	bhajarizadeh@kirby.unsw.edu.au	Hajarizadeh, Behzad/AAY-9361-2021; Lloyd, Andrew/AAF-6071-2022; Dore, Gregory John/ABD-5665-2021; Lloyd, Andrew/AFJ-8960-2022; Lauer, Georg/J-1467-2018	Hajarizadeh, Behzad/0000-0003-2212-2028; Lloyd, Andrew/0000-0001-6277-8887; Dore, Gregory John/0000-0002-4741-2622; Lloyd, Andrew/0000-0001-6277-8887; Amin, Janaki/0000-0003-2161-9366; Lauer, Georg/0000-0002-9792-4271; Maher, Lisa/0000-0001-6020-6519; Page, Kimberly/0000-0002-7120-1673; Sacks-Davis, Rachel/0000-0003-0860-2762; Cox, Andrea/0000-0002-9331-2462; Applegate, Tanya/0000-0002-8657-4261	National Institute on Drug Abuse Award [R01DA031056]; Australian Government Department of Health and Ageing; Australian Postgraduate PhD Award; National Health and Medical Research Council (NHMRC) Career Development Fellowship; NHMRC Practitioner Research Fellowships; NHMRC Senior Research Fellowships; VicHealth Senior Research Fellowship; NHMRC postgraduate scholarship; Centre for Research Excellence into Injecting Drug Use postgraduate top-up scholarship; National Institutes of Health [RO1 DA 15999-01]; NIH [U19 AI088791, U19 AI066345, R01 DA033541, MOP-103138, MOP-210232]; Netherlands National Institute for Public Health and the Environment; NHMRC Project [630483]; Abbvie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI088791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016017, R01DA031056, R01DA033541, R01DA015999] Funding Source: NIH RePORTER; Alberta Innovates [201201140] Funding Source: researchfish	National Institute on Drug Abuse Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Postgraduate PhD Award; National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); VicHealth Senior Research Fellowship; NHMRC postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); Centre for Research Excellence into Injecting Drug Use postgraduate top-up scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands National Institute for Public Health and the Environment; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); Abbvie(AbbVie); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Alberta Innovates	The InC<INF>3</INF> Study is supported by the National Institute on Drug Abuse Award Number R01DA031056. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. BH is supported by an Australian Postgraduate PhD Award. JG is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship. GD and AL are supported by NHMRC Practitioner Research Fellowships. MH and LM are supported by NHMRC Senior Research Fellowships and MH additionally by a VicHealth Senior Research Fellowship. RSD was supported by an NHMRC postgraduate scholarship and a Centre for Research Excellence into Injecting Drug Use postgraduate top-up scholarship. ATAHC is supported by National Institutes of Health grant number: RO1 DA 15999-01. Other research support includes NIH U19 AI088791 (AC), NIH U19 AI066345 (AK, BM), R01 DA033541 (AK), MOP-103138, MOP-210232 (JB), the Netherlands National Institute for Public Health and the Environment (MP), and NHMRC Project Grant #630483 (LM). BM received funding in the form of salary from the commercial company Abbvie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel Golo, 2013, Immune Netw, V13, P168, DOI 10.4110/in.2013.13.5.168; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Busch MP, 2005, CLIN INFECT DIS, V40, P959, DOI 10.1086/428583; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Floreani A, 2011, EUR J GASTROEN HEPAT, V23, P997, DOI 10.1097/MEG.0b013e32834ae863; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Grady BPX, 2015, J VIRAL HEPATITIS, V22, P263, DOI 10.1111/jvh.12303; Grebely J, 2013, INT J EPIDEMIOL, V42, P1649, DOI 10.1093/ije/dys167; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Grebely J, 2011, NAT REV GASTRO HEPAT, V8, P265, DOI 10.1038/nrgastro.2011.32; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Hajarizadeh B, 2015, J VIRAL HEPATITIS, V22, P708, DOI 10.1111/jvh.12384; Hajarizadeh B, 2014, J CLIN VIROL, V61, P430, DOI 10.1016/j.jcv.2014.08.027; Hajarizadeh B, 2014, J MED VIROL, V86, P1722, DOI 10.1002/jmv.24010; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Harris HE, 2007, J VIRAL HEPATITIS, V14, P213, DOI 10.1111/j.1365-2893.2006.00795.x; Heller T, 2005, SEMIN LIVER DIS, V25, P7, DOI 10.1055/s-2005-864778; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Liu L, 2012, HEPATOLOGY, V55, P1684, DOI 10.1002/hep.25575; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Sacks-Davis R, 2013, 20 INT S HEP C VIR R; Smith JA, 2010, J INFECT DIS, V202, P1770, DOI 10.1086/657317; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thomson EC, 2011, J GEN VIROL, V92, P2227, DOI 10.1099/vir.0.033910-0; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Uccellini L, 2012, HEPATOLOGY, V56, P86, DOI 10.1002/hep.25652; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555; Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Zeuzem S, 2012, J VIRAL HEPATITIS, V19, P766, DOI 10.1111/j.1365-2893.2012.01624.x; Zhang MD, 2006, BLOOD, V107, P892, DOI 10.1182/blood-2005-07-2781	47	30	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122232	10.1371/journal.pone.0122232	http://dx.doi.org/10.1371/journal.pone.0122232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837807	Green Published, gold			2022-12-27	WOS:000352139000087
J	Mannheimer, B; Wagner, H; Otstenson, CG; Diczfalusy, U				Mannheimer, Buster; Wagner, Henrik; Otstenson, Claes-Goran; Diczfalusy, Ulf			No Impact of Vitamin D on the CYP3A Biomarker 4 beta-Hydroxycholesterol in Patients with Abnormal Glucose Regulation	PLOS ONE			English	Article							CYTOCHROME-P450 3A4; ANTIEPILEPTIC DRUGS; D SUPPLEMENTATION; IN-VIVO; EXPRESSION; MIDAZOLAM; MARKER; ITRACONAZOLE; METABOLISM; INCREASE	Purpose To investigate the effect of vitamin D3 on hepatic Cytochrome P450 enzyme (CYP) 3A4 in patients with abnormal glucose regulation using the endogenous marker 4 beta-hydroxycholesterol (4 beta-OHC): cholesterol ratio. Methods The present study took advantage of a trial primarily aiming to investigate the effect of vitamin D3 on beta cell function and insulin sensitivity in patients with abnormal glucose regulation. 44 subjects were randomized to receive vitamin D3, 30000 IU given orally once weekly or placebo for 8 weeks. The two sample t-test was used to test the means of the intra-individual differences of 4 beta-OHC:cholesterol ratio between the two groups. Results Mean (SD) 4 beta-OHC in the whole group of patients before and after the intervention was 26 (11) ng/ml and 26 (12). Mean (SD) 4 beta-OHC:cholesterol ratio in the whole group of patients before and after the intervention was 0.12 (0.046) and 0.13 (0.047). In the Vitamin D group mean (SD) serum 25-OH-vitamin D3 increased from 46 (16) to 85nM (13) during the corresponding time period. To investigate the impact of vitamin D3 on hepatic CYP3A4 we calculated the mean intra-individual differences in 4 beta-OHC:cholesterol ratio (delta 4 beta-OHC:cholesterol ratio) before versus after the intervention in the two treatment groups. The difference (95% CI) between delta 4 beta-OHC:cholesterol ratio in the control group and intervention group was -0.0010 (-0.0093, 0.0072), a difference being not statistically significant (p = 0.80). Conclusions We provide further evidence that vitamin D3 may not substantially affect hepatic CYP3A4. This does not exclude the possibility of an impact of intestinal first-pass metabolism of orally administered drugs which should be investigated.	[Mannheimer, Buster] Karolinska Inst, Dept Clin Sci & Educ Sodersjukhuset, SE-11882 Stockholm, Sweden; [Wagner, Henrik] Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Otstenson, Claes-Goran] Karolinska Inst, Karolinska Univ Hosp, Dept Diabet Endocrinol & Metab, SE-17176 Stockholm, Sweden; [Diczfalusy, Ulf] Karolinska Inst, Karolinska Univ Hosp, Div Clin Chem, Dept Lab Med, SE-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Mannheimer, B (corresponding author), Karolinska Inst, Dept Clin Sci & Educ Sodersjukhuset, SE-11882 Stockholm, Sweden.	buster.mannheimer@sodersjukhuset.se	Diczfalusy, Ulf/A-5336-2008	Diczfalusy, Ulf/0000-0001-6643-3763	Swedish Society for Medical Research; Diabetesfonden (Swedish Diabetes Association); Swedish Research Council	Swedish Society for Medical Research; Diabetesfonden (Swedish Diabetes Association); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by the Swedish Society for Medical Research, Diabetesfonden (Swedish Diabetes Association) and Swedish Research Council. In addition, we would like to thank Kajsa Sundkvist, Maria Warn, Lotta Larsson and Christina Hall for invaluable help throughout the study.	Backman JT, 1998, EUR J CLIN PHARMACOL, V54, P53, DOI 10.1007/s002280050420; Bjorkhem-Bergman L, 2013, DRUG METAB DISPOS, V41, P704, DOI 10.1124/dmd.113.051136; Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Diczfalusy U, 2008, PHARMACOGENET GENOM, V18, P201, DOI 10.1097/FPC.0b013e3282f50ee9; Diczfalusy U, 2011, BRIT J CLIN PHARMACO, V71, P183, DOI 10.1111/j.1365-2125.2010.03773.x; Dostalek M, 2011, BRIT J PHARMACOL, V163, P937, DOI 10.1111/j.1476-5381.2011.01270.x; Eichelbaum M, 2001, NAT MED, V7, P285, DOI 10.1038/85417; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Flockhart DA., 2007, DRUG INTERACTIONS CY; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Gorski JC, 1998, CLIN PHARMACOL THER, V64, P133, DOI 10.1016/S0009-9236(98)90146-1; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Kanebratt KP, 2008, CLIN PHARMACOL THER, V84, P589, DOI 10.1038/clpt.2008.132; Kantola T, 1998, CLIN PHARMACOL THER, V64, P177, DOI 10.1016/S0009-9236(98)90151-5; Kantola T, 1998, CLIN PHARMACOL THER, V64, P58, DOI 10.1016/S0009-9236(98)90023-6; Lindh JD, 2011, DRUG METAB DISPOS, V39, P933, DOI 10.1124/dmd.111.038125; LOWN KS, 1994, DRUG METAB DISPOS, V22, P947; Lutjohann D, 2009, INT J CLIN PHARM TH, V47, P709; Nylen H, 2014, BASIC CLIN PHARM TOX; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Paine MF, 2005, DRUG METAB DISPOS, V33, P426, DOI 10.1124/dmd.104.002469; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Pavek P, 2010, BIOCHEM PHARMACOL, V79, P277, DOI 10.1016/j.bcp.2009.08.017; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741, DOI 10.1124/mol.51.5.741; Schwartz JB, 2009, CLIN PHARMACOL THER, V85, P198, DOI 10.1038/clpt.2008.165; Suzuki Y, 2014, DRUG METAB DISPOS, V42, P105, DOI 10.1124/dmd.113.054171; Thirumaran RK, 2012, BIOCHEM PHARMACOL, V84, P104, DOI 10.1016/j.bcp.2012.03.017; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; Thummel KE, 1996, CLIN PHARMACOL THER, V59, P491, DOI 10.1016/S0009-9236(96)90177-0; WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156; Wide K, 2008, BRIT J CLIN PHARMACO, V65, P708, DOI 10.1111/j.1365-2125.2007.03078.x; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Xu Y, 2006, BIOCHEM PHARMACOL, V72, P385, DOI 10.1016/j.bcp.2006.04.033; Zhou CC, 2006, J CLIN INVEST, V116, P1703, DOI 10.1172/JCI27793	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121984	10.1371/journal.pone.0121984	http://dx.doi.org/10.1371/journal.pone.0121984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835492	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000072
J	Pardini, EA; Vickstrom, KE; Knight, TM				Pardini, Eleanor A.; Vickstrom, Kyle E.; Knight, Tiffany M.			Early Successional Microhabitats Allow the Persistence of Endangered Plants in Coastal Sand Dunes	PLOS ONE			English	Article							POPULATION VIABILITY; GRASSLAND MANAGEMENT; CONSERVATION; DISTURBANCE; BURIAL; BIODIVERSITY; DYNAMICS; REGIMES; KEY	Many species are adapted to disturbance and occur within dynamic, mosaic landscapes that contain early and late successional microhabitats. Human modification of disturbance regimes alters the availability of microhabitats and may affect the viability of species in these ecosystems. Because restoring historical disturbance regimes is typically expensive and requires action at large spatial scales, such restoration projects must be justified by linking the persistence of species with successional microhabitats. Coastal sand dune ecosystems worldwide are characterized by their endemic biodiversity and frequent disturbance. Dune-stabilizing invasive plants alter successional dynamics and may threaten species in these ecosystems. We examined the distribution and population dynamics of two federally endangered plant species, the annual Layia carnosa and the perennial Lupinus tidestromii, within a dune ecosystem in northern California, USA. We parameterized a matrix population model for L. tidestromii and examined the magnitude by which the successional stage of the habitat (early or late) influenced population dynamics. Both species had higher frequencies and L. tidestromii had higher frequency of seedlings in early successional habitats. Lupinus tidestromii plants in early successional microhabitats had higher projected rates of population growth than those associated with stabilized, late successional habitats, due primarily to higher rates of recruitment in early successional microhabitats. These results support the idea that restoration of disturbance is critical in historically dynamic landscapes. Our results suggest that large-scale restorations are necessary to allow persistence of the endemic plant species that characterize these ecosystems.	[Pardini, Eleanor A.; Vickstrom, Kyle E.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pardini, EA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	epardini@wustl.edu			National Science Foundation DEB Award [0743731]	National Science Foundation DEB Award	Funding for this project was provided by National Science Foundation DEB Award number 0743731 to TMK and EAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MARINE COASTAL ECOSY; BARBOUR MG, 1976, J BIOGEOGR, V3, P55; BOYD RS, 1988, AM J BOT, V75, P1540, DOI 10.2307/2444704; BRECKON G J, 1974, Madrono, V22, P333; Brunbjerg AK, 2014, BIOL CONSERV, V174, P101, DOI 10.1016/j.biocon.2014.04.002; Brys R, 2004, J APPL ECOL, V41, P1080, DOI 10.1111/j.0021-8901.2004.00981.x; Caswell, 2000, MATRIX POPULATION MO; Clarke K. R., 2009, PRIMER V6 USER MANUA; Cowles Henry C., 1899, ECOLOGICAL RELATIONS, V27, P95117; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Dangremond EM, 2010, ECOLOGY, V91, P2261, DOI 10.1890/09-0418.1; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Evens J.G., 2008, NATURAL HIST POINT R; Hacker SD, 2012, OIKOS, V121, P138, DOI 10.1111/j.1600-0706.2011.18887.x; Hilton MJ, 2006, NEW ZEAL GEOGR, V62, P105, DOI 10.1111/j.1745-7939.2006.00054.x; Hyland T, 2005, CONTR EUR BEACHGR AM; Kollmann J, 2007, BIOL INVASIONS, V9, P31, DOI 10.1007/s10530-006-9003-y; Kollmann J, 2011, RESTOR ECOL, V19, P371, DOI 10.1111/j.1526-100X.2009.00569.x; KRUCKEBERG AR, 1985, ANNU REV ECOL SYST, V16, P447, DOI 10.1146/annurev.es.16.110185.002311; Lennartsson T, 2001, J ECOL, V89, P451, DOI 10.1046/j.1365-2745.2001.00566.x; Liu H, 2005, ECOL APPL, V15, P210, DOI 10.1890/03-5382; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Martinez M., 2004, ECOL STUD, V171, P390; Math Works, 2012, MATLAB R2012B; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Maun MA, 2004, ECOL STU AN, V171, P119; MIYANISHI K, 2007, PLANT DISTURBANCE EC, P249; Muir JJ, 2010, CONDOR, V112, P507, DOI 10.1525/cond.2010.090196; Parsons L. P., 2012, ANN REPORT 2001 2011; Pascarella JB, 1998, ECOLOGY, V79, P547, DOI 10.2307/176952; Pickart AJ, 1998, ECOLOGY RESTORATION; Pickart AJ, 2007, CONTR EUR BEACHGR AM; Pickart AJ, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P155; Pickart Andrea J., 2008, Grasslands, V18, P4; Pitts WD, 1979, AM MIDL NAT, V10, P38; Quintana-Ascencio PF, 2003, CONSERV BIOL, V17, P433, DOI 10.1046/j.1523-1739.2003.01431.x; Skinner MW, 1994, CNPS SPECIAL PUBLICA, V1; Smith M, 2005, ECOL APPL, V15, P1036, DOI 10.1890/04-0434; USFWS, 2009, LUP TID CLOV LUP 5 Y, P22; USFWS, 2007, REC PLAN PAC COAST P; USFWS, 1998, 7 COAST PLANTS MYRTL, P141; vanderMeulen F, 1996, OCEAN COAST MANAGE, V30, P177, DOI 10.1016/0964-5691(95)00060-7; Wiedemann AM, 1996, LANDSCAPE URBAN PLAN, V34, P287, DOI 10.1016/0169-2046(95)00240-5	44	23	23	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119567	10.1371/journal.pone.0119567	http://dx.doi.org/10.1371/journal.pone.0119567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835390	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000011
J	Sarrou, S; Liakopoulos, A; Chasioti, M; Foka, A; Fthenakis, G; Billinis, C; Spyrou, V; Pantelidi, K; Roussaki-Schulze, A; Lachanas, V; Makaritsis, K; Skoulakis, C; Daikos, GL; Dalekos, G; Spiliopoulou, I; Petinaki, E				Sarrou, Styliani; Liakopoulos, Apostolos; Chasioti, Markella; Foka, Antigoni; Fthenakis, Georgios; Billinis, Charalampos; Spyrou, Vassiliki; Pantelidi, Kleoniki; Roussaki-Schulze, Angeliki; Lachanas, Vassilios; Makaritsis, Konstantinos; Skoulakis, Charalampos; Daikos, Georgios L.; Dalekos, Georgios; Spiliopoulou, Iris; Petinaki, Efthymia			Dissemination of Methicillin-Susceptible CC398 Staphylococcus aureus Strains in a Rural Greek Area	PLOS ONE			English	Article							PIG FARMERS; RESISTANT; GENES; BACTERIOPHAGES; ST398-T571; HOSPITALS; DIVERSITY; ERM(T)	A large collection of Staphylococcus aureus including a. 745 clinically significant isolates that were consecutively recovered from human infections during 2012-2013, b. 19 methicillin- susceptible (MSSA), randomly selected between 2006-2011 from our Staphylococcal Collection, c. 16 human colonizing isolates, and d. 10 strains from colonized animals was investigated for the presence and the molecular characteristics of CC398. The study was conducted in Thessaly, a rural region in Greece. The differentiation of livestock-associated clade from the human clade was based on canSNPs combined with the presence of the phi 3 bacteriophage and the tetM, scn, sak, and chp genes. Among the 745 isolates, two MRSA (0.8% of total MRSA) and thirteen MSSA (2.65% of total MSSA) were found to belong to CC398, while, between MSSA of our Staphylococcal Collection, one CC398, isolated in 2010, was detected. One human individual, without prior contact with animals, was found to be colonized by a MSSA CC398. No CC398 was identified among the 10 S. aureus isolated from animals. Based on the molecular markers, the 17 CC398 strains were equally placed in the livestock-associated and in the human clades. This is the first report for the dissemination of S. aureus CC398 among humans in Greece.	[Sarrou, Styliani; Liakopoulos, Apostolos; Petinaki, Efthymia] Univ Hosp Larissa, Dept Microbiol, Larisa, Greece; [Chasioti, Markella; Pantelidi, Kleoniki; Roussaki-Schulze, Angeliki] Univ Hosp Larissa, Dept Dermatol, Larisa, Greece; [Foka, Antigoni; Spiliopoulou, Iris] Univ Patras, Sch Med, Dept Microbiol, Natl Staphylococcal Reference Lab, GR-26110 Patras, Greece; [Fthenakis, Georgios; Billinis, Charalampos] Univ Thessaly, Fac Vet Med, Kardhitsa, Greece; [Spyrou, Vassiliki] Technol Educ Inst Thessaly, Larisa, Greece; [Lachanas, Vassilios; Skoulakis, Charalampos] Univ Hosp Larissa, Dept Otorhinolaryngol, Larisa, Greece; [Daikos, Georgios L.] Univ Athens, Dept Propaedeut Med 1, Athens, Greece; [Makaritsis, Konstantinos; Dalekos, Georgios] Univ Hosp Larissa, Dept Med, Larisa, Greece; [Makaritsis, Konstantinos; Dalekos, Georgios] Univ Hosp Larissa, Res Lab Internal Med, Larisa, Greece	General University Hospital of Larissa; General University Hospital of Larissa; University of Patras; University of Thessaly; General University Hospital of Larissa; National & Kapodistrian University of Athens; General University Hospital of Larissa; General University Hospital of Larissa	Petinaki, E (corresponding author), Univ Hosp Larissa, Dept Microbiol, Larisa, Greece.	petinaki@med.uth.gr	Lachanas, Vasileios A/H-6807-2019; Daikos, George L./ABD-8378-2021	Lachanas, Vasileios A/0000-0002-4501-3257; Skoulakis, Charalampos/0000-0003-1711-6811; Liakopoulos, Apostolos/0000-0002-3240-8444; Sarrou, Styliani/0000-0001-8134-9228				Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Camoez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072828; Chini V, 2006, CLIN MICROBIOL INFEC, V12, P29, DOI 10.1111/j.1469-0691.2005.01295.x; Chroboczek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068462; Drougka E, 2014, CLIN MICROBIOL INFEC, V20, pO796, DOI 10.1111/1469-0691.12624; Drougka E, 2012, Indian J Med Microbiol, V30, P232, DOI 10.4103/0255-0857.96706; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, BREAKPOINT TABLES IN; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Gomez-Sanz E, 2013, J ANTIMICROB CHEMOTH, V68, P471, DOI 10.1093/jac/dks411; Gomez-Sanz E, 2010, FOODBORNE PATHOG DIS, V7, P1269, DOI 10.1089/fpd.2010.0610; He WQ, 2013, INT J ANTIMICROB AG, V42, P211, DOI 10.1016/j.ijantimicag.2013.04.031; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kumagai R, 2007, VET MICROBIOL, V122, P190, DOI 10.1016/j.vetmic.2007.01.008; Lozano C, 2011, CLIN MICROBIOL INFEC, V17, P923, DOI 10.1111/j.1469-0691.2010.03437.x; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Yan XM, 2014, INT J MED MICROBIOL, V304, P379, DOI 10.1016/j.ijmm.2013.12.003; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	26	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122761	10.1371/journal.pone.0122761	http://dx.doi.org/10.1371/journal.pone.0122761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835293	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000110
J	Shaeib, F; Khan, SN; Ali, I; Najafi, T; Maitra, D; Abdulhamid, I; Saed, GM; Pennathur, S; Abu-Soud, HM				Shaeib, Faten; Khan, Sana N.; Ali, Iyad; Najafi, Tohid; Maitra, Dhiman; Abdulhamid, Ibrahim; Saed, Ghassan M.; Pennathur, Subramaniam; Abu-Soud, Husam M.			Melatonin Prevents Myeloperoxidase Heme Destruction and the Generation of Free Iron Mediated by Self-Generated Hypochlorous Acid	PLOS ONE			English	Article							NITRIC-OXIDE; MAMMALIAN PEROXIDASES; CATALYTIC-ACTIVITY; HYDROGEN-PEROXIDE; ANTIOXIDANT ACTIVITY; TAURINE CHLORAMINE; POTENTIAL ROLE; MECHANISM; CHLORIDE; OXIDATION	Myeloperoxidase (MPO) generated hypochlorous acid (HOCl) formed during catalysis is able to destroy the MPO heme moiety through a feedback mechanism, resulting in the accumulation of free iron. Here we show that the presence of melatonin (MLT) can prevent HOCl-mediated MPO heme destruction using a combination of UV-visible photometry, hydrogen peroxide (H2O2)-specific electrode, and ferrozine assay techniques. High performance liquid chromatography (HPLC) analysis showed that MPO heme protection was at the expense of MLT oxidation. The full protection of the MPO heme requires the presence of a 1:2 MLT to H2O2 ratio. Melatonin prevents HOCl-mediated MPO heme destruction through multiple pathways. These include competition with chloride, the natural co-substrate; switching the MPO activity from a two electron oxidation to a one electron pathway causing the buildup of the inactive Compound II, and its subsequent decay to MPO-Fe(III) instead of generating HOCl; binding to MPO above the heme iron, thereby preventing the access of H2O2 to the catalytic site of the enzyme; and direct scavenging of HOCl. Collectively, in addition to acting as an antioxidant and MPO inhibitor, MLT can exert its protective effect by preventing the release of free iron mediated by self-generated HOCl. Our work may establish a direct mechanistic link by which MLT exerts its antioxidant protective effect in chronic inflammatory diseases with MPO elevation.	[Shaeib, Faten; Khan, Sana N.; Ali, Iyad; Najafi, Tohid; Maitra, Dhiman; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet, Detroit, MI 48202 USA; [Shaeib, Faten; Khan, Sana N.; Ali, Iyad; Najafi, Tohid; Maitra, Dhiman; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Gynecol, Detroit, MI USA; [Ali, Iyad] An Najah Natl Univ, Fac Med, Dept Biochem & Genet, Nablus, Israel; [Najafi, Tohid; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Abdulhamid, Ibrahim] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA	Wayne State University; Wayne State University; An Najah National University; Wayne State University; Children's Hospital of Michigan; University of Michigan System; University of Michigan	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet, Detroit, MI 48202 USA.	habusoud@med.wayne.edu	; Ali, Imran/F-7710-2010	, dhiman/0000-0002-8775-2963; Ali, Iyad/0000-0002-3921-6859; Ali, Imran/0000-0001-6511-8374	National Institutes of Health [RO1 HL066367, HL094230, DK097153]; Children's Hospital of Michigan, Detroit, Michigan, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367, R01HL094230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan, Detroit, Michigan, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant to H. M.A-S. from National Institutes of Health RO1 HL066367, HL094230, and DK097153 and a grant from the Children's Hospital of Michigan, Detroit, Michigan, USA. I.A. is a Senior Fulbright Research Scholar in Dr. Abu-Soud lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Abu-Soud HM, 2012, FREE RADICAL BIO MED, V52, P616, DOI 10.1016/j.freeradbiomed.2011.10.496; Allegra M, 2001, BIOCHEM BIOPH RES CO, V282, P380, DOI 10.1006/bbrc.2001.4582; Allen RC, 2011, INFECT IMMUN, V79, P474, DOI 10.1128/IAI.00910-09; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973; Banerjee J, 2012, J PINEAL RES, V53, P122, DOI 10.1111/j.1600-079X.2012.00977.x; Bonini MG, 2007, FREE RADICAL BIO MED, V42, P530, DOI 10.1016/j.freeradbiomed.2006.11.019; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Carvalho LC, 2010, BIOORG MED CHEM LETT, V20, P6475, DOI 10.1016/j.bmcl.2010.09.067; Chau Lee-Young, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P151; Comai S, 2014, J PSYCHIATR NEUROSCI, V39, P6, DOI 10.1503/jpn.130009; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; Dellegar SM, 1999, BIOCHEM BIOPH RES CO, V257, P431, DOI 10.1006/bbrc.1999.0438; Furtmuller PG, 2000, REDOX REP, V5, P173, DOI 10.1179/135100000101535717; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Galijasevic S, 2004, J BIOL CHEM, V279, P39465, DOI 10.1074/jbc.M406003200; Galijasevic S, 2003, P NATL ACAD SCI USA, V100, P14766, DOI 10.1073/pnas.2435008100; Galijasevic S, 2008, FREE RADICAL BIO MED, V44, P1570, DOI 10.1016/j.freeradbiomed.2008.01.003; Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q; Galijasevic S, 2009, FREE RADICAL BIO MED, V47, P431, DOI 10.1016/j.freeradbiomed.2009.05.017; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Gulcin I, 2003, J PINEAL RES, V34, P278; Hallingback HR, 2006, BIOCHEMISTRY-US, V45, P2940, DOI 10.1021/bi051510e; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hardeland R, 2009, BIOFACTORS, V35, P183, DOI 10.1002/biof.23; Johnson S, 2000, MED HYPOTHESES, V55, P239, DOI 10.1054/mehy.2000.1051; Jung-Hynes B, 2010, J PINEAL RES, V49, P60, DOI 10.1111/j.1600-079X.2010.00767.x; Jung-Hynes B, 2010, J PINEAL RES, V48, P9, DOI 10.1111/j.1600-079X.2009.00729.x; Lu T, 2008, BRIT J PHARMACOL, V154, P1308, DOI 10.1038/bjp.2008.173; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Maitra D, 2012, J PINEAL RES, V53, P198, DOI 10.1111/j.1600-079X.2012.00988.x; Maitra D, 2011, FREE RADICAL BIO MED, V51, P374, DOI 10.1016/j.freeradbiomed.2011.04.011; Maitra D, 2011, FREE RADICAL BIO MED, V51, P364, DOI 10.1016/j.freeradbiomed.2011.03.040; Reiter RM, 2011, MEDIATED BUSINESS INTERACTIONS: INTERCULTURAL COMMUNICATION BETWEEN SPEAKERS OF SPANISH, P22; Marshall KA, 1996, FREE RADICAL BIO MED, V21, P307, DOI 10.1016/0891-5849(96)00046-9; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; MOHAMED AO, 1993, AM J TROP MED HYG, V49, P799, DOI 10.4269/ajtmh.1993.49.799; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Ogino T, 2009, ADV EXP MED BIOL, V643, P451, DOI 10.1007/978-0-387-75681-3_47; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004; Pennathur S, 2010, FREE RADICAL BIO MED, V49, P205, DOI 10.1016/j.freeradbiomed.2010.04.003; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Proteasa G, 2007, BIOCHEMISTRY-US, V46, P398, DOI 10.1021/bi0609725; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; REITER RJ, 1991, MOL CELL ENDOCRINOL, V79, pC153, DOI 10.1016/0303-7207(91)90087-9; Reiter RJ, 2013, MINI-REV MED CHEM, V13, P373; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; Rozov SV, 2003, J PINEAL RES, V35, P245, DOI 10.1034/j.1600-079X.2003.00081.x; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Schiller J, 2003, CURR MED CHEM, V10, P2123, DOI 10.2174/0929867033456828; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Tekbas OF, 2008, J PINEAL RES, V44, P222, DOI 10.1111/j.1600-079X.2007.00516.x; Tesoriere L, 1999, J PINEAL RES, V27, P95, DOI 10.1111/j.1600-079X.1999.tb00602.x; Trinder D, 2002, GUT, V51, P290, DOI 10.1136/gut.51.2.290; Tzikas S, 2014, J ALZHEIMERS DIS, V39, P557, DOI 10.3233/JAD-131469; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Gomez FJV, 2012, J PINEAL RES, V52, P349, DOI 10.1111/j.1600-079X.2011.00949.x; Wang L, 2007, J Burns Wounds, V6, pe5; Weinberg ED, 2000, MICROBES INFECT, V2, P85, DOI 10.1016/S1286-4579(00)00281-1; Weinberg ED, 2000, BIOMETALS, V13, P85, DOI 10.1023/A:1009293500209; Ximenes VF, 2010, J PINEAL RES, V49, P115, DOI 10.1111/j.1600-079X.2010.00772.x; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; Yang YTT, 2012, LIFE SCI, V90, P682, DOI 10.1016/j.lfs.2012.03.002	77	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120737	10.1371/journal.pone.0120737	http://dx.doi.org/10.1371/journal.pone.0120737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835505	gold, Green Submitted, Green Published			2022-12-27	WOS:000352139000032
J	Guo, QC; Wang, DQ; He, XB; Feng, QR; Lin, R; Xu, FQ; Fu, L; Luo, MM				Guo, Qingchun; Wang, Daqing; He, Xiaobin; Feng, Qiru; Lin, Rui; Xu, Fuqiang; Fu, Ling; Luo, Minmin			Whole-Brain Mapping of Inputs to Projection Neurons and Cholinergic Interneurons in the Dorsal Striatum	PLOS ONE			English	Article							TONICALLY ACTIVE NEURONS; GIANT ASPINY INTERNEURONS; BASAL GANGLIA; MIDBRAIN DOPAMINE; GENE-EXPRESSION; IN-VIVO; RAT; PATHWAY; REWARD; MOTOR	The dorsal striatum integrates inputs from multiple brain areas to coordinate voluntary movements, associative plasticity, and reinforcement learning. Its projection neurons consist of the GABAergic medium spiny neurons (MSNs) that express dopamine receptor type 1 (D1) or dopamine receptor type 2 (D2). Cholinergic interneurons account for a small portion of striatal neuron populations, but they play important roles in striatal functions by synapsing onto the MSNs and other local interneurons. By combining the modified rabies virus with specific Cre-mouse lines, a recent study mapped the monosynaptic input patterns to MSNs. Because only a small number of extrastriatal neurons were labeled in the prior study, it is important to reexamine the input patterns of MSNs with higher labeling efficiency. Additionally, the whole-brain innervation pattern of cholinergic interneurons remains unknown. Using the rabies virus-based transsynaptic tracing method in this study, we comprehensively charted the brain areas that provide direct inputs to D1-MSNs, D2-MSNs, and cholinergic interneurons in the dorsal striatum. We found that both types of projection neurons and the cholinergic interneurons receive extensive inputs from discrete brain areas in the cortex, thalamus, amygdala, and other subcortical areas, several of which were not reported in the previous study. The MSNs and cholinergic interneurons share largely common inputs from areas outside the striatum. However, innervations within the dorsal striatum represent a significantly larger proportion of total inputs for cholinergic interneurons than for the MSNs. The comprehensive maps of direct inputs to striatal MSNs and cholinergic interneurons shall assist future functional dissection of the striatal circuits.	[Guo, Qingchun; Fu, Ling] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China; [Guo, Qingchun] Huazhong Univ Sci & Technol, Dept Biomed Engn, MoE Key Lab Biomed Photon, Wuhan 430074, Peoples R China; [Wang, Daqing; Feng, Qiru; Lin, Rui; Luo, Minmin] Natl Inst Biol Sci, Beijing, Peoples R China; [Wang, Daqing; Luo, Minmin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [He, Xiaobin; Xu, Fuqiang] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; National Institute of Biological Sciences, Beijing; Tsinghua University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Luo, MM (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	luomm@tsinghua.edu.cn	Liu, Rebecca/F-3466-2014; xu, fuqiang/AAI-1571-2019	xu, fu qiang/0000-0002-4382-9797; Luo, Minmin/0000-0003-3535-6624	China Ministry of Science and Technology Science Fund for Creative Research Group of China [2012CB837701, 2012YQ03026005]; National Natural Science Foundation of China [61421064, 91432114, 61178077]	China Ministry of Science and Technology Science Fund for Creative Research Group of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	2012CB837701 and 2012YQ03026005 from China Ministry of Science and Technology Science Fund for Creative Research Group of China (http://www.973.gov.cn/AreaAppl.aspx) to Minmin Luo. 91432114, 61178077, and 61421064 from National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Minmin Luo, Ling Fu, and Ling Fu, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Arenkiel BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029423; Benhamou L, 2014, J NEUROSCI, V34, P2299, DOI 10.1523/JNEUROSCI.1798-13.2014; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gonzales KK, 2013, J COMP NEUROL, V521, P2502, DOI 10.1002/cne.23295; Graybiel A M, 1979, Prog Brain Res, V51, P237; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GRAYBIEL AM, 1995, TRENDS NEUROSCI, V18, P60; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Jaeger D, 2013, BASAL GANGLIA, V3, P15, DOI 10.1016/j.baga.2012.09.006; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KAWAGUCHI Y, 1992, J NEUROPHYSIOL, V67, P1669, DOI 10.1152/jn.1992.67.6.1669; KUNISHIO K, 1994, J COMP NEUROL, V350, P337, DOI 10.1002/cne.903500302; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Lim Sean Austin O, 2014, Front Synaptic Neurosci, V6, P22, DOI 10.3389/fnsyn.2014.00022; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MCGEORGE AJ, 1987, BRAIN RES, V423, P318, DOI 10.1016/0006-8993(87)90855-9; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; RAGSDALE CW, 1981, BRAIN RES, V208, P259, DOI 10.1016/0006-8993(81)90556-4; Reynolds JNJ, 2004, BRAIN RES, V1011, P115, DOI 10.1016/j.brainres.2004.03.026; SCHWAB M, 1977, BRAIN RES, V126, P211, DOI 10.1016/0006-8993(77)90722-3; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; STAINES WA, 1981, BRAIN RES, V206, P446, DOI 10.1016/0006-8993(81)90545-X; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Waselus M, 2006, J CHEM NEUROANAT, V31, P233, DOI 10.1016/j.jchemneu.2006.01.007; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WILSON CJ, 1990, J NEUROSCI, V10, P508; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	55	89	89	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123381	10.1371/journal.pone.0123381	http://dx.doi.org/10.1371/journal.pone.0123381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830919	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600143
J	Harris, DG; Benipal, PK; Cheng, XF; Burdorf, L; Azimzadeh, AM; Pierson, RN				Harris, Donald G.; Benipal, Prabhjot K.; Cheng, Xiangfei; Burdorf, Lars; Azimzadeh, Agnes M.; Pierson, Richard N., III			Four-Dimensional Characterization of Thrombosis in a Live-Cell, Shear-Flow Assay: Development and Application to Xenotransplantation	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR BINDING; REAL-TIME ANALYSIS; EX-VIVO MODEL; PLATELET-AGGREGATION; TISSUE FACTOR; SWINE LUNGS; CLINICAL XENOTRANSPLANTATION; HYPERACUTE REJECTION; MICROFLUIDIC DEVICES; P-SELECTIN	Background Porcine xenografts are a promising source of scarce transplantable organs, but stimulate intense thrombosis of human blood despite targeted genetic and pharmacologic interventions. Current experimental models do not enable study of the blood/endothelial interface to investigate adhesive interactions and thrombosis at the cellular level under physiologic conditions. The purpose of this study was to develop and validate a live-cell, shear-flow based thrombosis assay relevant to general thrombosis research, and demonstrate its potential in xenotransplantation applications. Methodology/Principal Findings Confluent wild-type (WT, n = 48) and Gal transferase knock-out (GalTKO, which resist hyper-acute rejection; n = 11) porcine endothelia were cultured in microfluidic channels. To mimic microcirculatory flow, channels were perfused at 5 dynes/cm(2) and 37 degrees C with human blood stained to fluorescently label platelets. Serial fluorescent imaging visualized percent surface area coverage (SA, for adhesion of labeled cells) and total fluorescence (a metric of clot volume). Aggregation was calculated by the fluorescence/SA ratio (FR). WT endothelia stimulated diffuse platelet adhesion (SA 65 +/- 2%) and aggregation (FR 120 +/- 1 a.u.), indicating high-grade thrombosis consistent with the rapid platelet activation and consumption seen in whole-organ lung xenotransplantation models. Experiments with antibody blockade of platelet aggregation, and perfusion of syngeneic and allo-incompatible endothelium was used to verify the biologic specificity and validity of the assay. Finally, with GalTKO endothelia thrombus volume decreased by 60%, due primarily to a 58% reduction in adhesion (P < 0.0001 each); importantly, aggregation was only marginally affected (11% reduction, P < 0.0001). Conclusions/Significance This novel, high-throughput assay enabled dynamic modeling of whole-blood thrombosis on intact endothelium under physiologic conditions, and allowed mechanistic characterization of endothelial and platelet interactions. Applied to xenogeneic thrombosis, it enables future studies regarding the effect of modifying the porcine genotype on sheer-stress-dependent events that characterize xenograft injury. This in-vitro platform is likely to prove broadly useful to study thrombosis and endothelial interactions under dynamic physiologic conditions.	[Harris, Donald G.] Univ Maryland, Sch Med, Dept Surg, Div Gen Surg, Baltimore, MD 21201 USA; [Harris, Donald G.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Benipal, Prabhjot K.; Cheng, Xiangfei; Burdorf, Lars; Azimzadeh, Agnes M.; Pierson, Richard N., III] Univ Maryland, Sch Med, Dept Surg, Div Cardiac Surg, Baltimore, MD 21201 USA; [Pierson, Richard N., III] VA Maryland Hlth Care Syst, Surg Care Clin Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Harris, DG (corresponding author), Univ Maryland, Sch Med, Dept Surg, Div Gen Surg, Baltimore, MD 21201 USA.	dharris@smail.umaryland.edu		Harris, Donald/0000-0002-5059-5597	NIH [5T32HL007698, U19AI090959, P01HL107152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698, P01HL107152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by: a) NIH 5T32HL007698 (Donald G. Harris), b) NIH U19AI090959 (Richard N. Pierson), c) NIH P01HL107152, and d) an unrestricted philanthropic gift from United Therapeutics, Inc. to the Pierson Lab (http://www.unither.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033; Alcaide P, 2009, MICROCIRCULATION, V16, P43, DOI 10.1080/10739680802273892; ALEVRIADOU BR, 1993, BLOOD, V81, P1263; Azimzadeh A, 1997, TRANSPLANTATION, V64, P1166, DOI 10.1097/00007890-199710270-00015; Budorf L, 2013, J HEART LUNG TRANSPL, V32, pS137, DOI 10.1016/j.healun.2013.01.307; Burdorf L, 2014, AM J TRANSPLANT, V14, P1084, DOI 10.1111/ajt.12673; Bush EL, 2011, XENOTRANSPLANTATION, V18, P6, DOI 10.1111/j.1399-3089.2011.00621.x; Cauwenberghs N, 2000, ARTERIOSCL THROM VAS, V20, P1347, DOI 10.1161/01.ATV.20.5.1347; Chen D, 2005, CURR OPIN ORGAN TRAN, V10, P240, DOI 10.1097/01.mot.0000174044.75567.d0; Chen DX, 1999, TRANSPLANTATION, V67, P467, DOI 10.1097/00007890-199902150-00021; Chen DX, 1999, TRANSPLANTATION, V68, P832, DOI 10.1097/00007890-199909270-00016; CHOW TW, 1992, BLOOD, V80, P113; COLLER BS, 1989, CIRCULATION, V80, P1766, DOI 10.1161/01.CIR.80.6.1766; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Conant CG, 2011, BIOTECHNOL BIOENG, V108, P2978, DOI 10.1002/bit.23243; Conant CG, 2010, J BIOMOL SCREEN, V15, P102, DOI 10.1177/1087057109353789; Dorling A, 1997, LANCET, V349, P867, DOI 10.1016/S0140-6736(96)09404-4; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Ezzelarab M, 2009, TRANSPLANTATION, V87, P805, DOI 10.1097/TP.0b013e318199c34f; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gaca JG, 2002, TRANSPLANTATION, V73, P1717, DOI 10.1097/00007890-200206150-00005; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Goto S, 1998, J CLIN INVEST, V101, P479, DOI 10.1172/JCI973; Gresele P., 2002, PLATELETS IN THROMBO; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; Hisashi Y, 2008, AM J TRANSPLANT, V8, P2516, DOI 10.1111/j.1600-6143.2008.02444.x; Joist JH, 1998, THROMB RES, V92, pS47; Joziasse DH, 1999, BBA-MOL BASIS DIS, V1455, P403, DOI 10.1016/S0925-4439(99)00056-3; Konstantopoulos K, 1998, CIRCULATION, V98, P873, DOI 10.1161/01.CIR.98.9.873; KUHNLE GEH, 1995, AM J RESP CRIT CARE, V152, P1221, DOI 10.1164/ajrccm.152.4.7551374; Lin CC, 2010, AM J TRANSPLANT, V10, P1556, DOI 10.1111/j.1600-6143.2010.03147.x; Lin SS, 1997, TRANSPL IMMUNOL, V5, P212, DOI 10.1016/S0966-3274(97)80040-8; Miyazaki Y, 1996, BLOOD, V88, P3456, DOI 10.1182/blood.V88.9.3456.bloodjournal8893456; Moroi M, 1996, BLOOD, V88, P2081, DOI 10.1182/blood.V88.6.2081.bloodjournal8862081; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Nguyen Bao H., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P255, DOI 10.2174/1568006054064753; Nguyen BNH, 2007, J THORAC CARDIOV SUR, V133, P1354, DOI 10.1016/j.jtcvs.2006.11.043; Nguyen BNH, 2011, XENOTRANSPLANTATION, V18, P94, DOI 10.1111/j.1399-3089.2011.00633.x; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Pfeiffer S, 2003, TRANSPLANTATION, V75, P953, DOI 10.1097/01.TP.0000058517.07194.90; Pierson RN, 2009, XENOTRANSPLANTATION, V16, P263, DOI 10.1111/j.1399-3089.2009.00534.x; Pierson RN, 2009, JAMA-J AM MED ASSOC, V301, P967, DOI 10.1001/jama.2009.237; Prabhakarpandian B, 2011, MICROVASC RES, V82, P210, DOI 10.1016/j.mvr.2011.06.013; Robson SC, 2000, XENOTRANSPLANTATION, V7, P166, DOI 10.1034/j.1399-3089.2000.00067.x; Robson SC, 1996, TRANSPLANTATION, V61, P862, DOI 10.1097/00007890-199603270-00003; Roussel JC, 2008, AM J TRANSPLANT, V8, P1101, DOI 10.1111/j.1600-6143.2008.02210.x; Ruggeri ZM, 1999, BLOOD, V94, P172, DOI 10.1182/blood.V94.1.172.413k17_172_178; SAKARIASSEN KS, 1980, THROMB RES, V19, P547, DOI 10.1016/0049-3848(80)90027-4; Schmelzle M, 2010, CURR OPIN ORGAN TRAN, V15, P212, DOI 10.1097/MOT.0b013e3283373ccc; Schroeder C, 2005, TRANSPL P, V37, P512, DOI 10.1016/j.transproceed.2004.12.133; Siegel JB, 1997, TRANSPLANTATION, V64, P888, DOI 10.1097/00007890-199709270-00017; Tovar-Lopez FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074123; Tsuji S, 1999, BLOOD, V94, P968, DOI 10.1182/blood.V94.3.968.415a13_968_975; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810	57	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123015	10.1371/journal.pone.0123015	http://dx.doi.org/10.1371/journal.pone.0123015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830912	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600131
J	Morrison, A; Chekaluk, Y; Bacares, R; Ladanyi, M; Zhang, LY				Morrison, Arianne; Chekaluk, Yvonne; Bacares, Ruben; Ladanyi, Marc; Zhang, Liying			BAP1 Missense Mutation c.2054 A > T (p.E685V) Completely Disrupts Normal Splicing through Creation of a Novel 5 ' Splice Site in a Human Mesothelioma Cell Line	PLOS ONE			English	Article							BRCA1-ASSOCIATED PROTEIN-1; MALIGNANT MESOTHELIOMA; PLEURAL MESOTHELIOMA; UBIQUITIN HYDROLASE; SIGNALS; UVEAL	BAP1 is a tumor suppressor gene that is lost or deleted in diverse cancers, including uveal melanoma, malignant pleural mesothelioma (MPM), clear cell renal carcinoma, and cholangiocarcinoma. Recently, BAP1 germline mutations have been reported in families with combinations of these same cancers. A particular challenge for mutation screening is the classification of non-truncating BAP1 sequence variants because it is not known whether these subtle changes can affect the protein function sufficiently to predispose to cancer development. Here we report mRNA splicing analysis on a homozygous substitution mutation, BAP1 c. 2054 A&T (p. Glu685Val), identified in an MPM cell line derived from a mesothelioma patient. The mutation occurred at the 3rd nucleotide from the 3' end of exon 16. RTPCR, cloning and subsequent sequencing revealed several aberrant splicing products not observed in the controls: 1) a 4 bp deletion at the end of exon 16 in all clones derived from the major splicing product. The BAP1 c. 2054 A&T mutation introduced a new 5' splice site (GU), which resulted in the deletion of 4 base pairs and presumably protein truncation; 2) a variety of alternative splicing products that led to retention of different introns: introns 1416; introns 15-16; intron 14 and intron 16; 3) partial intron 14 and 15 retentions caused by activation of alternative 3' splice acceptor sites (AG) in the introns. Taken together, we were unable to detect any correctly spliced mRNA transcripts in this cell line. These results suggest that aberrant splicing caused by this mutation is quite efficient as it completely abolishes normal splicing through creation of a novel 5' splice site and activation of cryptic splice sites. These data support the conclusion that BAP1 c. 2054 A&T (p.E685V) variant is a pathogenic mutation and contributes to MPM through disruption of normal splicing.	[Morrison, Arianne] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Chekaluk, Yvonne; Bacares, Ruben; Ladanyi, Marc; Zhang, Liying] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Wake Forest University; Memorial Sloan Kettering Cancer Center	Zhang, LY (corresponding author), Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA.	zhangl2@mskcc.org	Ladanyi, Marc/AAG-8585-2019		NATIONAL CANCER INSTITUTE [R25CA020449] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Buratti E, 2010, RNA BIOL, V7, P412, DOI 10.4161/rna.7.4.12153; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ladanyi M, 2012, CLIN CANCER RES, V18, P4485, DOI 10.1158/1078-0432.CCR-11-2375; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Murali R, 2013, PATHOLOGY, V45, P116, DOI 10.1097/PAT.0b013e32835d0efb; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Popova T, 2013, AM J HUM GENET; Ram O, 2008, MOL CELL BIOL, V28, P3513, DOI 10.1128/MCB.02279-07; REALE FR, 1987, CANCER RES, V47, P3199; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schwartz S, 2009, NUCLEIC ACIDS RES, V37, pW189, DOI 10.1093/nar/gkp320; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Wadt K, 2012, PIGM CELL MELANOMA R, V25, P815, DOI 10.1111/pcmr.12006; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang LY, 2011, BREAST CANCER RES TR, V130, P1051, DOI 10.1007/s10549-011-1732-7	31	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119224	10.1371/journal.pone.0119224	http://dx.doi.org/10.1371/journal.pone.0119224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830670	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600010
J	Tolosa, JM; Parsons, KS; Hansbro, PM; Smith, R; Wark, PAB				Tolosa, Jorge M.; Parsons, Kristy S.; Hansbro, Philip M.; Smith, Roger; Wark, Peter A. B.			The Placental Protein Syncytin-1 Impairs Antiviral Responses and Exaggerates Inflammatory Responses to Influenza	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; T-CELLS; ENDOGENOUS RETROVIRUSES; RESPIRATORY ILLNESS; AVIAN INFLUENZA; VIRUS-INFECTION; H1N1 INFLUENZA; HERV-W; PREGNANCY; EXPRESSION	Background Pregnancy increases susceptibility to influenza. The placenta releases an immunosuppressive endogenous retroviral protein syncytin-1. We hypothesised that exposure of peripheral monocytes (PBMCs) to syncytin-1 would impair responses to H1N1pdm09 influenza. Methods and Findings Recombinant syncytin-1 was produced. PBMCs from non-pregnant women (n=10) were exposed to H1N1pdm09 in the presence and absence of syncytin-1 and compared to responses of PBMCs from pregnant women (n=12). PBMCs were characterised using flow cytometry, release of interferon (IFN)-alpha, IFN-lambda, IFN-gamma, IL-10, IL-2, IL-6 and IL-1 beta were measured by cytometric bead array or ELISA. Exposure of PBMCs to H1N1pdm09 resulted in the release of IFN-alpha, (14,787 pg/mL, 95% CI 7311-22,264 pg/mL) IFN-lambda (1486 pg/mL, 95% CI 756-2216 pg/mL) and IFN-gamma (852 pg/mL, 95% CI 193-1511 pg/mL) after 48 hours. This was significantly impaired in pregnant women (IFN-alpha; p<0.0001 and IFN-lambda; p<0.001). Furthermore, in the presence of syncytin-1, PBMCs demonstrated marked reductions in IFN-alpha and IFN-lambda, while enhanced release of IL-10 as well as IL-6 and IL-1 beta. Conclusions Our data indicates that a placental derived protein, syncytin-1 may be responsible for the heightened vulnerability of pregnant women to influenza.	[Tolosa, Jorge M.; Smith, Roger] Univ Newcastle, Mothers & Babies Res Ctr, Newcastle, NSW 2300, Australia; [Tolosa, Jorge M.; Parsons, Kristy S.; Hansbro, Philip M.; Smith, Roger; Wark, Peter A. B.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Parsons, Kristy S.; Hansbro, Philip M.; Wark, Peter A. B.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Wark, Peter A. B.] John Hunter Hosp, Dept Resp & Sleep Med, New Lambton, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; John Hunter Hospital	Wark, PAB (corresponding author), Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia.	peter.wark@hnehealth.nsw.gov.au	Hansbro, Phil/G-7486-2013; Wark, Peter/G-7037-2013	Hansbro, Phil/0000-0002-4741-3035; Wark, Peter/0000-0001-5676-6126; Smith, Roger/0000-0003-4720-0280	National Health and Medical Research Council of Australia [APP1008924]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia APP1008924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Bachy V, 2008, J REPROD IMMUNOL, V78, P11, DOI 10.1016/j.jri.2007.09.004; Blois SM, 2008, J MOL MED, V86, P837, DOI 10.1007/s00109-008-0342-2; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Cerbulo-Vazquez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107900; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Denner J, 2014, AIDS; Denner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055199; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; GRAHAM MB, 1994, J EXP MED, V180, P1273, DOI 10.1084/jem.180.4.1273; Grutz G, 2005, J LEUKOCYTE BIOL, V77, P3, DOI 10.1189/jlb.0904484; HARAGUCHI S, 1995, P NATL ACAD SCI USA, V92, P3611, DOI 10.1073/pnas.92.8.3611; Haraguchi S, 1997, J LEUKOCYTE BIOL, V61, P654, DOI 10.1002/jlb.61.6.654; Haraguchi S, 2008, IMMUNOL RES, V41, P46, DOI 10.1007/s12026-007-0039-6; Horwitz DA, 2003, J LEUKOCYTE BIOL, V74, P471, DOI 10.1189/jlb.0503228; Hsu ACY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032947; Hsu ACY, 2011, AM J RESP CELL MOL, V44, P906, DOI 10.1165/rcmb.2010-0157OC; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; HUPRIKAR J, 1980, J VIROL METHODS, V1, P117, DOI 10.1016/0166-0934(80)90020-8; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Kay AW, 2014, P NATL ACAD SCI USA, V111, P14506, DOI 10.1073/pnas.1416569111; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Liu YX, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-37; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Marcelin G, 2011, J VIROL, V85, P11208, DOI 10.1128/JVI.00654-11; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moran TM, 1999, J INFECT DIS, V180, P579, DOI 10.1086/314952; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; MULLOOLY JP, 1986, PUBLIC HEALTH REP, V101, P205; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Piccinni MP, 2001, J REPROD IMMUNOL, V52, P35, DOI 10.1016/S0165-0378(01)00111-5; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Salomon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098667; Santner-Nanan B, 2013, J IMMUNOL, V191, P145, DOI 10.4049/jimmunol.1203165; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Urnovitz HB, 1996, CLIN MICROBIOL REV, V9, P72, DOI 10.1128/CMR.9.1.72; Vanders RL, 2013, J INFECT DIS, V208, P1062, DOI 10.1093/infdis/jit296; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wolf AI, 2009, J IMMUNOL, V182, P871, DOI 10.4049/jimmunol.182.2.871	55	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0118629	10.1371/journal.pone.0118629	http://dx.doi.org/10.1371/journal.pone.0118629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831059	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600003
J	Biscere, T; Rodolfo-Metalpa, R; Lorrain, A; Chauvaud, L; Thebault, J; Clavier, J; Houlbreque, F				Biscere, Tom; Rodolfo-Metalpa, Riccardo; Lorrain, Anne; Chauvaud, Laurent; Thebault, Julien; Clavier, Jacques; Houlbreque, Fanny			Responses of Two Scleractinian Corals to Cobalt Pollution and Ocean Acidification	PLOS ONE			English	Article							STYLOPHORA-PISTILLATA; FERTILIZATION SUCCESS; CLIMATE-CHANGE; NEW-CALEDONIA; CLADOCORA-CAESPITOSA; CARBONATE CHEMISTRY; METAL CONTAMINATION; PARTIAL-PRESSURE; SYMBIOTIC ALGAE; HEAVY-METALS	The effects of ocean acidification alone or in combination with warming on coral metabolism have been extensively investigated, whereas none of these studies consider that most coral reefs near shore are already impacted by other natural anthropogenic inputs such as metal pollution. It is likely that projected ocean acidification levels will aggravate coral reef health. We first investigated how ocean acidification interacts with one near shore locally abundant metal on the physiology of two major reef-building corals: Stylophora pistillata and Acropora muricata. Two pH levels (pH(T) 8.02; pCO(2) 366 mu atm and pH(T) 7.75; pCO(2) 1140 mu atm) and two cobalt concentrations (natural, 0.03 mu g L-1 and polluted, 0.2 mu g L-1) were tested during five weeks in aquaria. We found that, for both species, cobalt input decreased significantly their growth rates by 28% while it stimulated their photosystem II, with higher values of rETR(max) (relative Electron Transport Rate). Elevated pCO(2) levels acted differently on the coral rETR(max) values and did not affect their growth rates. No consistent interaction was found between pCO(2) levels and cobalt concentrations. We also measured in situ the effect of higher cobalt concentrations (1.06 +/- 0.16 mu g L-1) on A. muricata using benthic chamber experiments. At this elevated concentration, cobalt decreased simultaneously coral growth and photosynthetic rates, indicating that the toxic threshold for this pollutant has been reached for both host cells and zooxanthellae. Our results from both aquaria and in situ experiments, suggest that these coral species are not particularly sensitive to high pCO(2) conditions but they are to ecologically relevant cobalt concentrations. Our study reveals that some reefs may be yet subjected to deleterious pollution levels, and even if no interaction between pCO(2) levels and cobalt concentration has been found, it is likely that coral metabolism will be weakened if they are subjected to additional threats such as temperature increase, other heavy metals, and eutrophication.	[Biscere, Tom; Rodolfo-Metalpa, Riccardo; Houlbreque, Fanny] ENTROPIE UMR9220, Inst Rech Dev, Lab Excellence CORAIL, Noumea 98848, New Caledonia; [Lorrain, Anne] IRD Noumea, IRD R LEMAR 195, Noumea 98848, New Caledonia; [Chauvaud, Laurent; Thebault, Julien; Clavier, Jacques] Univ Brest, Inst Univ Europeen Mer, CNRS IRD UBO UMR6539, Lab Sci Environm Marin, F-29280 Plouzane, France	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Houlbreque, F (corresponding author), ENTROPIE UMR9220, Inst Rech Dev, Lab Excellence CORAIL, BP A5, Noumea 98848, New Caledonia.	fanny.houlbreque@ird.fr	Houlbreque, Fanny/L-9072-2017; Thébault, Julien/F-6198-2011; Lorrain, Anne/A-4152-2009; /AAL-3738-2021	Houlbreque, Fanny/0000-0002-3976-6690; Thébault, Julien/0000-0002-3111-4428; Lorrain, Anne/0000-0002-1289-2072; 	Laboratoire d'Excellence (LabEX Corail); Institut de Recherche pour le Developpement (IRD); Institut National des Sciences de l'Univers (INSU) through the PNEC/CITRIX IBANOE program of Initiative Structurante Ecosphere Continentale et Cotiere (EC2CO)	Laboratoire d'Excellence (LabEX Corail); Institut de Recherche pour le Developpement (IRD); Institut National des Sciences de l'Univers (INSU) through the PNEC/CITRIX IBANOE program of Initiative Structurante Ecosphere Continentale et Cotiere (EC2CO)	Part of this study was supported by the Laboratoire d'Excellence (LabEX Corail), the Institut de Recherche pour le Developpement (IRD) and the Institut National des Sciences de l'Univers (INSU) through the PNEC/CITRIX IBANOE program of Initiative Structurante Ecosphere Continentale et Cotiere (EC2CO).	Agostini S, 2012, CORAL REEFS, V31, P147, DOI 10.1007/s00338-011-0831-6; Agostini Sylvain, 2009, Galaxea - Tokyo, V11, P1; Ali AAM, 2010, HELGOLAND MAR RES, V65, P67; Atkinson MJ, 1995, CORAL REEFS, V14, P215, DOI 10.1007/BF00334344; Bielmyer GK, 2010, AQUAT TOXICOL, V97, P125, DOI 10.1016/j.aquatox.2009.12.021; BLANKENSHIP ML, 1975, J PHYCOL, V11, P211, DOI 10.1111/j.1529-8817.1975.tb02769.x; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; BROWN MT, 1998, METAL METABOLISM AQU, P185; BURRIS JE, 1983, MAR BIOL, V75, P113, DOI 10.1007/BF00405992; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2374; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DAVIES PS, 1989, MAR BIOL, V101, P389; Dickson A.G., 2007, GUIDE BEST PRACTICES; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Enriquez S, 2010, DEVEL APPL PHYCOL, V4, P187, DOI 10.1007/978-90-481-9268-7_9; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Ferrier-Pages C, 2005, CORAL REEFS, V24, P636, DOI 10.1007/s00338-005-0045-x; Ferrier-Pages C, 2001, J EXP MAR BIOL ECOL, V259, P249, DOI 10.1016/S0022-0981(01)00241-6; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Fichez R, 2005, AQUAT LIVING RESOUR, V18, P125, DOI 10.1051/alr:2005015; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fujita M, 2014, CHEMOSPHERE, V95, P628, DOI 10.1016/j.chemosphere.2013.10.023; Gattuso JP, 1999, AM ZOOL, V39, P160; Godinot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025024; GUZMAN HM, 1992, MAR POLLUT BULL, V24, P554, DOI 10.1016/0025-326X(92)90708-E; HARLAND AD, 1989, MAR POLLUT BULL, V20, P353, DOI 10.1016/0025-326X(89)90159-8; Hedouin L, 2006, SCI TOTAL ENVIRON, V366, P154, DOI 10.1016/j.scitotenv.2005.10.022; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Houlbreque F, 2012, CORAL REEFS, V31, P101, DOI 10.1007/s00338-011-0819-2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kennish R, 1997, OECOLOGIA, V109, P209, DOI 10.1007/s004420050075; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; LEDERMAN TC, 1981, BOT MAR, V24, P125, DOI 10.1515/botm.1981.24.3.125; Lewis C, 2013, MAR BIOL, V160, P2089, DOI 10.1007/s00227-012-2081-8; MARSH JA, 1970, ECOLOGY, V51, P254; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; Metian M, 2008, ENVIRON POLLUT, V152, P543, DOI 10.1016/j.envpol.2007.07.009; Mitchelmore CL, 2007, AQUAT TOXICOL, V85, P48, DOI 10.1016/j.aquatox.2007.07.015; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; Moreton BM, 2009, GEOSTAND GEOANAL RES, V33, P205, DOI 10.1111/j.1751-908X.2009.00899.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Panzeca C, 2009, ESTUAR COAST SHELF S, V85, P223, DOI 10.1016/j.ecss.2009.08.016; Pascal PY, 2010, MAR POLLUT BULL, V60, P2201, DOI 10.1016/j.marpolbul.2010.08.018; Point D, 2007, ESTUAR COAST SHELF S, V72, P457, DOI 10.1016/j.ecss.2006.11.013; PRICE NM, 1990, NATURE, V344, P658, DOI 10.1038/344658a0; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; REICHELT AJ, 1994, AUST J MAR FRESH RES, V45, P1237, DOI 10.1071/MF9941237; Reichelt-Brushett AJ, 1999, MAR POLLUT BULL, V38, P182, DOI 10.1016/S0025-326X(98)00183-0; Reichelt-Brushett AJ, 2005, CORAL REEFS, V24, P524, DOI 10.1007/s00338-005-0013-5; Reichelt-Brushett AJ, 2005, AQUAT TOXICOL, V74, P280, DOI 10.1016/j.aquatox.2005.05.011; Reichelt-Brushett AJ, 2000, MAR POLLUT BULL, V41, P385, DOI 10.1016/S0025-326X(00)00131-4; Reichelt-Brushett A, 2012, OCEANOGRAPHY, V25, P40, DOI 10.5670/oceanog.2012.66; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Ritz C, 2008, USE R, P1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Sabdono A., 2009, Research Journal of Environmental Sciences, V3, P96, DOI 10.3923/rjes.2009.96.102; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; STAMBLER N, 1991, Pacific Science, V45, P299; Tanaka K, 2013, APPL GEOCHEM, V37, P79, DOI 10.1016/j.apgeochem.2013.07.005; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Vermaat JE, 2009, PERSPECT PLANT ECOL, V11, P137, DOI 10.1016/j.ppees.2009.01.002; Wantiez L, 2008, REV ECOL-TERRE VIE, V63, P117; Whitall D, 2014, MAR POLLUT BULL, V80, P293, DOI 10.1016/j.marpolbul.2013.12.053	79	34	34	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122898	10.1371/journal.pone.0122898	http://dx.doi.org/10.1371/journal.pone.0122898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849317	Green Published, gold			2022-12-27	WOS:000352477800170
J	Ghali, JR; O'Sullivan, KM; Eggenhuizen, PJ; Holdsworth, SR; Kitching, AR				Ghali, Joanna R.; O'Sullivan, Kim M.; Eggenhuizen, Peter J.; Holdsworth, Stephen R.; Kitching, A. Richard			FMS-Like Tyrosine Kinase 3 Ligand Treatment Does Not Ameliorate Experimental Rapidly Progressive Glomerulonephritis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; T-REGULATORY CELLS; FLT3 LIGAND; CRESCENTIC GLOMERULONEPHRITIS; STEADY-STATE; GENERATION; RECEPTOR; MICE; INFLAMMATION; PROGENITORS	Fms-like tyrosine kinase 3-ligand (FL) is a growth factor that may expand dendritic cell and regulatory T cell populations. We hypothesised that FL-induced regulatory T cells would protect mice from experimental rapidly progressive glomerulonephritis. To determine if FL was able to enhance regulatory T cell populations, C57BL/6 mice received 10 days of daily intraperitoneal injections of either FL or phosphate buffered saline. To induce accelerated autologous-phase anti-mouse glomerular basement membrane glomerulonephritis, mice were sensitized to sheep globulin 4 days prior to the induction of glomerulonephritis with sheep anti-mouse glomerular basement membrane globulin, and experiments ended 10 days later. FL was administered before, throughout and during the sensitization phase of this glomerulonephritis model. Renal disease and systemic immunity to the nephritogenic antigen were assessed. FL increased regulatory T cell and plasmacytoid dendritic cell proportions within spleen and lymph nodes. FL administration prior to glomerulonephritis did not protect mice from renal injury. When FL was given throughout the model, FL treated mice had reduced survival, with more interstitial neutrophils and glomerular CD11c+ cells than controls. Systemic immune responses showed increased IL-17A production from splenocytes, with more CD11c+ cells, but reduced plasmacytoid dendritic cell proportions in spleen and lymph nodes, despite increased regulatory T cell proportions. Under homeostatic conditions, FL expanded regulatory T cell and plasmacytoid dendritic cell populations, but FL enhanced systemic inflammatory responses and conventional dendritic cell populations when given during experimental glomerulonephritis, suggesting selective attempts to suppress pathogenic immunity by dendritic cell manipulation may be harmful.	[Ghali, Joanna R.; O'Sullivan, Kim M.; Eggenhuizen, Peter J.; Holdsworth, Stephen R.; Kitching, A. Richard] Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [Ghali, Joanna R.; Holdsworth, Stephen R.; Kitching, A. Richard] Monash Hlth, Dept Nephrol, Clayton, Vic, Australia; [Kitching, A. Richard] Monash Hlth, Dept Paediat Nephrol, Clayton, Vic, Australia	Monash University	Ghali, JR (corresponding author), Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia.	joanna.ghali@monash.edu	Kitching, A Richard/B-6947-2013	Kitching, A Richard/0000-0002-2713-2391; Eggenhuizen, Peter/0000-0002-7102-3547; O'Sullivan, Kim Maree/0000-0002-3098-7948	National Health and Medical Research Council [1017559, 1048575]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JRG and ARK have been supported by the National Health and Medical Research Council Grant Numbers 1017559 and 1048575 respectively (https://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2001, INT IMMUNOPHARMACOL, V1, P2081, DOI 10.1016/S1567-5769(01)00122-9; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Coates PTH, 2004, TRANSPLANTATION, V77, P1080, DOI 10.1097/01.TP.0000122183.60680.C9; Collins CB, 2012, GUT, V61, P1154, DOI 10.1136/gutjnl-2011-300820; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Dehlin M, 2011, J LEUKOCYTE BIOL, V90, P811, DOI 10.1189/jlb.1110640; Diener KR, 2008, EXP HEMATOL, V36, P51, DOI 10.1016/j.exphem.2007.08.024; Edwan JH, 2004, J IMMUNOL, V172, P5016, DOI 10.4049/jimmunol.172.8.5016; Gonzalez IT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046755; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kitching AR, 2005, J AM SOC NEPHROL, V16, P2023, DOI 10.1681/ASN.2004121075; Kitching AR, 2000, J IMMUNOL, V165, P4649, DOI 10.4049/jimmunol.165.8.4649; Klein O, 2013, EUR J IMMUNOL, V43, P533, DOI 10.1002/eji.201242603; Li W, 2001, J IMMUNOL, V166, P5619, DOI 10.4049/jimmunol.166.9.5619; Liao GX, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00035; LIGLER FS, 1983, J CLIN IMMUNOL, V3, P368, DOI 10.1007/BF00915798; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Marroquin CE, 2002, J IMMUNOTHER, V25, P278, DOI 10.1097/00002371-200205000-00011; McGee HS, 2010, AM J RESP CELL MOL, V43, P520, DOI 10.1165/rcmb.2009-0241OC; Mcgee HS, 2010, AM J RESP CELL MOL, V42, P331, DOI 10.1165/rcmb.2008-0397OC; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miloud T, 2012, J IMMUNOL, V188, P1125, DOI 10.4049/jimmunol.1003920; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; O'Keeffe M, 2005, INT IMMUNOL, V17, P307, DOI 10.1093/intimm/dxh210; Ooi JD, 2012, P NATL ACAD SCI USA, V109, pE2615, DOI 10.1073/pnas.1210147109; Ooi JD, 2011, KIDNEY INT, V79, P977, DOI 10.1038/ki.2010.541; Ostmann A, 2013, J AM SOC NEPHROL, V24, P930, DOI 10.1681/ASN.2012070684; Papenfuss TL, 2007, J LEUKOCYTE BIOL, V82, P1510, DOI 10.1189/jlb.0406257; Paust HJ, 2011, KIDNEY INT, V80, P155, DOI 10.1038/ki.2011.108; Rini BI, 2002, J IMMUNOTHER, V25, P269, DOI 10.1097/00002371-200205000-00010; Rogers NM, 2013, AM J TRANSPLANT, V13, P1125, DOI 10.1111/ajt.12229; Salama AD, 2003, KIDNEY INT, V64, P1685, DOI 10.1046/j.1523-1755.2003.00259.x; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shurin MR, 1998, CYTOKINE GROWTH F R, V9, P37, DOI 10.1016/S1359-6101(97)00035-X; Shurin MR, 1997, CELL IMMUNOL, V179, P174, DOI 10.1006/cimm.1997.1152; Summers SA, 2011, AM J PATHOL, V178, P580, DOI 10.1016/j.ajpath.2010.10.013; Svensson MND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054884; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Tipping PG, 1997, EUR J IMMUNOL, V27, P530, DOI 10.1002/eji.1830270226; Van Belle TL, 2010, J AUTOIMMUN, V34, P445, DOI 10.1016/j.jaut.2009.11.010; Whartenby KA, 2005, P NATL ACAD SCI USA, V102, P16741, DOI 10.1073/pnas.0506088102; Wolf D, 2005, J AM SOC NEPHROL, V16, P1360, DOI 10.1681/ASN.2004100837; Yamano T, 2011, BLOOD, V117, P2640, DOI 10.1182/blood-2010-07-293860	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123118	10.1371/journal.pone.0123118	http://dx.doi.org/10.1371/journal.pone.0123118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849330	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800206
J	Jensen, TK; Andersen, LB; Kyhl, HB; Nielsen, F; Christesen, HT; Grandjean, P				Jensen, Tina Kold; Andersen, Louise Bjorkholt; Kyhl, Henriette Boye; Nielsen, Flemming; Christesen, Henrik Thybo; Grandjean, Philippe			Association between Perfluorinated Compound Exposure and Miscarriage in Danish Pregnant Women	PLOS ONE			English	Article							PERFLUOROOCTANOIC ACID EXPOSURE; SERUM-LEVELS; POPULATION; HEALTH	Perfluorinated alkylated substances (PFAS) have been extensively used in consumer products and humans are widely exposed to these persistent compounds. A recent study found no association between exposure to perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) and miscarriage, but no studies have examined adverse effect of the more recently introduced PFASs. We therefore conducted a case-control study within a population-based, prospective cohort during 2010-2012. Newly pregnant women residing in the Municipality of Odense, Denmark were invited to enroll in the Odense Child Cohort at their first antenatal visit before pregnancy week 12. Among a total of 2,874 participating women, 88 suffered a miscarriage and 59 had stored serum samples, of which 56 occurred before gestational week 12. They were compared to a random sample (N=336) of delivering women, who had also donated serum samples before week 12. Using a case-control design, 51 of the women suffering a miscarriage were matched on parity and gestational day of serum sampling with 204 delivering women. In a multiple logistic regression with adjustment for age, BMI, parity and gestational age at serum sampling, women with the highest tertile of exposure to perfluorononanoic acid (PFNA) and perfluorodecanoic acid (PFDA) in pregnancy had odds ratios for miscarriage of 16.5 (95% CI 7.4-36.6-36.5) and 2.67 (1.31-5.44), respectively, as compared to the lowest tertile. In the matched data set, the OR were 37.9 (9.9-145.2) and 3.71 (1.60-8.60), respectively. The association with perfluorohexane sulfonic acid (PFHxS) was in the same direction, but not statistically significant, while no association was found with PFOA and PFOS. Our findings require confirmation due to the possible public health importance, given that all pregnant women are exposed to these widely used compounds.	[Jensen, Tina Kold; Nielsen, Flemming; Grandjean, Philippe] Univ Southern Denmark, Dept Environm Med, Odense, Denmark; [Jensen, Tina Kold; Kyhl, Henriette Boye] Hans Christian Andersen Childrens Hosp, Odense Child Cohort, Odense, Denmark; [Jensen, Tina Kold] Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, DK-5000 Odense, Denmark; [Andersen, Louise Bjorkholt; Christesen, Henrik Thybo] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, DK-5000 Odense, Denmark; [Andersen, Louise Bjorkholt; Christesen, Henrik Thybo] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Jensen, TK (corresponding author), Univ Southern Denmark, Dept Environm Med, Odense, Denmark.	tkjensen@health.sdu.dk	Christesen, Henrik/AAR-9023-2021; Grandjean, Philippe/I-2962-2014	Christesen, Henrik/0000-0001-5330-6853; Jensen, Tina Kold/0000-0003-2311-5778; Bjorkholt Andersen, Louise/0000-0002-3331-7149; Grandjean, Philippe/0000-0003-4046-9658; Nielsen, Flemming/0000-0002-5657-405X	Danish Agency for Science, Technology and Innovation [09067180]; Danish Council for Strategic Research, Program Commission on Health, Food and Welfare [2101-08-0058]; Danish Ministry of Health; Danish Environmental Protection Agency; Municipality of Odense; Odense University Hospital	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research, Program Commission on Health, Food and Welfare; Danish Ministry of Health; Danish Environmental Protection Agency; Municipality of Odense; Odense University Hospital	This work was supported by the Danish Agency for Science, Technology and Innovation (09067180), the Danish Council for Strategic Research, Program Commission on Health, Food and Welfare (project 2101-08-0058), the Danish Ministry of Health and the Danish Environmental Protection Agency. The Municipality of Odense and Odense University Hospital provides core-funding support for the Odense Child Cohort study. Other contributors are: the Mental Health Service in the Region of Southern Denmark, K.A. Rohde's and wife's Foundation, the Ronald McDonald Child Foundation, the Health Insurance Foundation and the Odense University Hospital Research Fund. No funders had any influence on design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Agency UeP, 2013, PERFLUROOCTANOIC ACI; Andersen LB, 2013, CLIN ENDOCRINOL, V79, P333, DOI 10.1111/cen.12147; Berger U, 2011, ANAL BIOANAL CHEM, V400, P1625, DOI 10.1007/s00216-011-4823-8; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Darrow L. A., 2013, ENV HLTH PERSPECT, V121, P1207, DOI DOI 10.1289/EHP.1206372; Darrow LA, 2014, EPIDEMIOLOGY, V25, P505, DOI 10.1097/EDE.0000000000000103; Fromme H, 2010, ENVIRON SCI TECHNOL, V44, P7123, DOI 10.1021/es101184f; Guo W, 2014, CHEMOSPHERE, V116, P75, DOI 10.1016/j.chemosphere.2014.04.007; Haug LS, 2009, J CHROMATOGR A, V1216, P385, DOI 10.1016/j.chroma.2008.10.113; Kuklenyik Z, 2005, ANAL CHEM, V77, P6085, DOI 10.1021/ac050671l; Lau C, 2006, TOXICOL SCI, V90, P510, DOI 10.1093/toxsci/kfj105; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Savitz DA, 2012, ENVIRON HEALTH PERSP, V120, P1201, DOI 10.1289/ehp.1104752; Savitz DA, 2012, EPIDEMIOLOGY, V23, P386, DOI 10.1097/EDE.0b013e31824cb93b; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P1100, DOI 10.1289/ehp.0901827; Stein CR, 2009, AM J EPIDEMIOL, V170, P837, DOI 10.1093/aje/kwp212; Tefre de Renzy-Martin K FH, 2013, REPRODUCTION IN PRES; Whitworth KW, 2012, AM J EPIDEMIOL, V175, P1209, DOI 10.1093/aje/kwr459	19	62	64	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123496	10.1371/journal.pone.0123496	http://dx.doi.org/10.1371/journal.pone.0123496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848775	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800238
J	Jones, KT; Stephens, JA; Alam, M; Bikson, M; Berryhill, ME				Jones, Kevin T.; Stephens, Jaclyn A.; Alam, Mahtab; Bikson, Marom; Berryhill, Marian E.			Longitudinal Neurostimulation in Older Adults Improves Working Memory	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; AGE-RELATED DECLINE; PREFRONTAL CORTEX; MOTOR CORTEX; PHYSICAL-ACTIVITY; ELECTRICAL-STIMULATION; COGNITIVE DECLINE; DECISION-MAKING; TRAINING GAINS; TDCS	An increasing concern affecting a growing aging population is working memory (WM) decline. Consequently, there is great interest in improving or stabilizing WM, which drives expanded use of brain training exercises. Such regimens generally result in temporary WM benefits to the trained tasks but minimal transfer of benefit to untrained tasks. Pairing training with neurostimulation may stabilize or improve WM performance by enhancing plasticity and strengtheningWM-related cortical networks. We tested this possibility in healthy older adults. Participants received 10 sessions of sham (control) or active (anodal, 1.5 mA) tDCS to the right prefrontal, parietal, or prefrontal/parietal (alternating) cortices. After ten minutes of sham or active tDCS, participants performed verbal and visual WM training tasks. On the first, tenth, and follow-up sessions, participants performed transfer WM tasks including the spatial 2-back, Stroop, and digit span tasks. The results demonstrated that all groups benefited from WM training, as expected. However, at follow-up 1-month after training ended, only the participants in the active tDCS groups maintained significant improvement. Importantly, this pattern was observed for both trained and transfer tasks. These results demonstrate that tDCS-linked WM training can provide long-term benefits in maintaining cognitive training benefits and extending them to untrained tasks.	[Jones, Kevin T.; Stephens, Jaclyn A.; Berryhill, Marian E.] Univ Nevada, Dept Psychol, Memory & Brain Lab, Reno, NV 89557 USA; [Jones, Kevin T.] Georgetown Univ, Med Ctr, Dept Neurol, Cognit Neuropsychol Lab, Washington, DC 20007 USA; [Alam, Mahtab; Bikson, Marom] CUNY, Dept Biomed Engn, New York, NY 10021 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Georgetown University; City University of New York (CUNY) System	Berryhill, ME (corresponding author), Univ Nevada, Dept Psychol, Memory & Brain Lab, Reno, NV 89557 USA.	mberryhill@unr.edu		Berryhill, Marian/0000-0002-8218-6587	National Institute of Health under Centers of Biomedical Research Excellence Grant [1P20GM103650, R15EY022775]; Department of Defense; NATIONAL EYE INSTITUTE [R15EY022775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103650] Funding Source: NIH RePORTER	National Institute of Health under Centers of Biomedical Research Excellence Grant; Department of Defense(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health under Centers of Biomedical Research Excellence Grant 1P20GM103650 (PI Webster, Project Leader MEB) R15EY022775 (to MEB), and the Department of Defense (to MB) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2003, SUPPL CLIN NEUROPHYS, V56, P291; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Backman L, 2013, NEUROSCI BIOBEHAV R, V37, P2209, DOI 10.1016/j.neubiorev.2013.01.014; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Berryhill ME, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00800; Berryhill ME, 2012, NEUROSCI LETT, V521, P148, DOI 10.1016/j.neulet.2012.05.074; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; Boehringer A, 2013, BRAIN STIMUL, V6, P649, DOI 10.1016/j.brs.2012.10.001; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2012, BRAIN STIMUL, V5, P223, DOI 10.1016/j.brs.2011.06.006; Boggio PS, 2011, NEUROPSYCHOL REHABIL, V21, P703, DOI 10.1080/09602011.2011.617943; Boggio PS, 2010, EUR J NEUROSCI, V31, P593, DOI 10.1111/j.1460-9568.2010.07080.x; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Brunoni AR, 2011, PROG NEURO-PSYCHOPH, V35, P96, DOI 10.1016/j.pnpbp.2010.09.010; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Cabeza R, 2001, SCAND J PSYCHOL, V42, P277, DOI 10.1111/1467-9450.00237; Cassavaugh ND, 2009, APPL ERGON, V40, P943, DOI 10.1016/j.apergo.2009.02.001; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Chrysikou EG, 2013, COGN NEUROSCI-UK, V4, P81, DOI 10.1080/17588928.2013.768221; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dahlin E, 2009, RESTOR NEUROL NEUROS, V27, P405, DOI 10.3233/RNN-2009-0492; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Elmer S, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-29; Fabiani M, 2012, PSYCHOPHYSIOLOGY, V49, P283, DOI 10.1111/j.1469-8986.2011.01331.x; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Filmer HL, 2013, CORTEX, V49, P2845, DOI 10.1016/j.cortex.2013.08.015; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Fridriksson J, 2011, STROKE, V42, P819, DOI 10.1161/STROKEAHA.110.600288; Gajewski PD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00130; Galea JM, 2009, J NEUROPHYSIOL, V102, P294, DOI 10.1152/jn.00184.2009; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; Heimrath K, 2012, Front Psychiatry, V3, P56, DOI 10.3389/fpsyt.2012.00056; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; Iuculano T, 2013, J NEUROSCI, V33, P4482, DOI 10.1523/JNEUROSCI.4927-12.2013; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jeon SY, 2012, ANN REHABIL MED-ARM, V36, P585, DOI 10.5535/arm.2012.36.5.585; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Jones K, 2013, J COGNITIVE NEUROSCI, P82; Jones KT, 2015, NEUROIMAGE, V105, P238, DOI 10.1016/j.neuroimage.2014.11.012; Jones Kevin T, 2012, Front Psychiatry, V3, P81, DOI 10.3389/fpsyt.2012.00081; Kamegaya T, 2012, GERIATR GERONTOL INT, V12, P673, DOI 10.1111/j.1447-0594.2012.00840.x; Karbach J, 2014, PSYCHOL SCI; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Kim DY, 2009, AM J PHYS MED REHAB, V88, P829, DOI 10.1097/PHM.0b013e3181b811e3; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kuhn S, 2011, J COGNITIVE NEUROSCI, V23, P2147, DOI 10.1162/jocn.2010.21564; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Li SC, 2008, PSYCHOL AGING, V23, P731, DOI 10.1037/a0014343; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Marangolo P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00539; Margrett JA, 2006, AGING NEUROPSYCHOL C, V13, P173, DOI 10.1080/138255890969285; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Mendelsohn AR, 2011, REJUV RES, V14, P557, DOI 10.1089/rej.2011.1247; Miller KJ, 2012, AM J GERIAT PSYCHIAT, V20, P514, DOI 10.1097/JGP.0b013e318227f821; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Mylius V, 2012, EUR J PAIN, V16, P974, DOI 10.1002/j.1532-2149.2011.00105.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Noack H, 2009, RESTOR NEUROL NEUROS, V27, P435, DOI 10.3233/RNN-2009-0496; Nouchi R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-200; Nouchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029676; Nyberg L, 2009, SCAND J PSYCHOL, V50, P41, DOI 10.1111/j.1467-9450.2008.00678.x; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park SH, 2014, NEUROREPORT, V25, P122, DOI 10.1097/WNR.0000000000000080; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Peich MC, 2013, PSYCHOL AGING, V28, P729, DOI 10.1037/a0033236; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Richmond L, 2014, JOURNAL OF COGNITIVE; Richmond LL, 2011, PSYCHOL AGING, V26, P813, DOI 10.1037/a0023631; Rosenkranz K, 2000, NEUROSCI LETT, V296, P61, DOI 10.1016/S0304-3940(00)01621-9; Ross LA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00016; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Shatil E, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00008; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Snowball A, 2013, CURR BIOL, V23, P987, DOI 10.1016/j.cub.2013.04.045; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suzuki K, 2012, INT J NEUROSCI, V122, P675, DOI 10.3109/00207454.2012.707715; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; van Muijden J, 2012, FRONT HUM NEUROSCI, V6, P1, DOI 10.3389/fnhum.2012.00221; Verhaeghen P, 2004, J EXP PSYCHOL LEARN, V30, P1322, DOI 10.1037/0278-7393.30.6.1322; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243; Wechsler D., 2012, WAIS 4 KASIKIRJA; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2; Zimerman M, 2013, ANN NEUROL, V73, P10, DOI 10.1002/ana.23761	114	95	97	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121904	10.1371/journal.pone.0121904	http://dx.doi.org/10.1371/journal.pone.0121904			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849358	Green Published, gold			2022-12-27	WOS:000352477800086
J	Monteiro, S; Carreira, A; Freitas, R; Pinheiro, AM; Ferreira, RB				Monteiro, Sara; Carreira, Alexandra; Freitas, Regina; Pinheiro, Ana Margarida; Ferreira, Ricardo Boavida			A Nontoxic Polypeptide Oligomer with a Fungicide Potency under Agricultural Conditions Which Is Equal or Greater than That of Their Chemical Counterparts	PLOS ONE			English	Article							SEED STORAGE PROTEINS; CHITIN-BINDING PROTEINS; ANTIFUNGAL PROTEINS; CALLOSOBRUCHUS-MACULATUS; 3-DIMENSIONAL STRUCTURE; DISEASE RESISTANCE; VICILINS; AGGREGATION; RESOLUTION; PHASEOLIN	There are literally hundreds of polypeptides described in the literature which exhibit fungicide activity. Tens of them have had attempted protection by patent applications but none, as far as we are aware, have found application under real agricultural conditions. The reasons behind may be multiple where the sensitivity to the Sun UV radiation can come in first place. Here we describe a multifunctional glyco-oligomer with 210 kDa which is mainly composed by a 20 kDa polypeptide termed Blad that has been previously shown to be a stable intermediary product of beta-conglutin catabolism. This oligomer accumulates exclusively in the cotyledons of Lupinus species, between days 4 and 12 after the onset of germination. Blad-oligomer reveals a plethora of biochemical properties, like lectin and catalytic activities, which are not unusual per si, but are remarkable when found to coexist in the same protein molecule. With this vast range of chemical characteristics, antifungal activity arises almost as a natural consequence. The biological significance and potential technological applications of Blad-oligomer as a plant fungicide to agriculture, its uniqueness stems from being of polypeptidic in nature, and with efficacies which are either equal or greater than the top fungicides currently in the market are addressed.	[Monteiro, Sara; Freitas, Regina; Pinheiro, Ana Margarida; Ferreira, Ricardo Boavida] Univ Lisbon, Ctr Bot Aplicada Agr, Inst Super Agron, P-1699 Lisbon, Portugal; [Monteiro, Sara; Carreira, Alexandra] Converde, SA, Cantanhede, Portugal; [Ferreira, Ricardo Boavida] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa	Monteiro, S (corresponding author), Univ Lisbon, Ctr Bot Aplicada Agr, Inst Super Agron, P-1699 Lisbon, Portugal.	sam@cev.com.pt		Monteiro, Sara/0000-0002-7069-0591; Freitas, Regina/0000-0001-8605-2925; Ferreira, Ricardo Boavida/0000-0002-5027-7564	Fundacao para a Ciencia e a Tecnologia, Agencia de Inovacao: Project Resoidio [SFRH//BPD/5712/2001, SFRH/BD/87561/2012, PRAXIS/3/3.2/HORT/2140/95]; CONVERDE SA	Fundacao para a Ciencia e a Tecnologia, Agencia de Inovacao: Project Resoidio; CONVERDE SA	This work was funded by Fundacao para a Ciencia e a Tecnologia: Grant number: SFRH//BPD/5712/2001 to SM; Grant number: SFRH/BD/87561/2012 to AMP; Project number: PRAXIS/3/3.2/HORT/2140/95, Agencia de Inovacao: Project Resoidio. The funder CONVERDE SA provided support in the form of salaries for authors SM and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ABELES FB, 1970, PLANT PHYSIOL, V45, P395, DOI 10.1104/pp.45.4.395; [Anonymous], 2008, M38 A2 REFERENCE MET, DOI [10.1007/s11046-014-9730-z, DOI 10.1007/S11046-014-9730-Z]; ARGOS P, 1985, EMBO J, V4, P1111, DOI 10.1002/j.1460-2075.1985.tb03747.x; Austin AT, 2014, NEW PHYTOL, V204, P257, DOI 10.1111/nph.13062; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Blackwell J, 1988, METHOD ENZYMOL, V161, P465; Boucher I, 1995, J BIOL CHEM, V270, P31077, DOI 10.1074/jbc.270.52.31077; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Bruno J, 2010, CLIN EXP DERMATOL, V35, P658, DOI [10.1111/j.1365-2230.2009.03698.x, DOI 10.1111/J.1365-2230.2009.03698.X]; Casey R., 1986, Oxford surveys of plant molecular and cell biology. Volume 3., P1; Coultate TP, 1989, FOOD THE CHEMISTRY O; Barros MED, 2007, J MED MICROBIOL, V56, P514, DOI 10.1099/jmm.0.46542-0; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Faye L, 1985, ANAL BIOCHEM, V118, P131, DOI [10.1016/0003-2697(85)90498-1, DOI 10.1016/0003-2697(85)90498-1]; Ferreira RB, 2003, FEBS LETT, V534, P106, DOI 10.1016/S0014-5793(02)03801-2; Ferreira RB, 1999, J AGR FOOD CHEM, V47, P3009, DOI 10.1021/jf981151c; Ferreira RB, 2006, CRIT REV PLANT SCI, V25, P505, DOI 10.1080/07352680601054610; FERREIRA RMB, 1995, J EXP BOT, V46, P211, DOI 10.1093/jxb/46.2.211; Firmino F, 1996, BRAZ J MED BIOL RES, V29, P749; Gomes VM, 1997, J AGR FOOD CHEM, V45, P4110, DOI 10.1021/jf960942g; Hegedus N, 2013, FUNGAL BIOL REV, V26, P132, DOI 10.1016/j.fbr.2012.07.002; HIGGINS TJV, 1984, ANNU REV PLANT PHYS, V35, P191, DOI 10.1146/annurev.pp.35.060184.001203; ISELI B, 1993, PLANT PHYSIOL, V103, P221, DOI 10.1104/pp.103.1.221; Juliana M, 2012, PEPTIDE SCI, V98, P406, DOI [10.1002/bip.22068, DOI 10.1002/BIP.22068]; KO TP, 1993, PLANT PHYSIOL, V101, P729, DOI 10.1104/pp.101.3.729; Lamberth C, 2013, SCIENCE, V341, P742, DOI 10.1126/science.1237227; LAWRENCE MC, 1990, EMBO J, V9, P9, DOI 10.1002/j.1460-2075.1990.tb08074.x; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; MELO TS, 1994, PHYTOCHEMISTRY, V37, P641, DOI 10.1016/S0031-9422(00)90331-5; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Monteiro S, 2001, J AGR FOOD CHEM, V49, P3999, DOI 10.1021/jf0013914; Monteiro S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008542; Ng TB, 2004, PEPTIDES, V25, P1215, DOI 10.1016/j.peptides.2004.03.012; NICHOLS EJ, 1980, PLANT PHYSIOL, V66, P199, DOI 10.1104/pp.66.2.199; OECD, 1998, GUIDELINE FOR THE TE; Oliveira GB, 2014, COMP BIOCHEM PHYS B, V168, P45, DOI 10.1016/j.cbpb.2013.11.001; Patil DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063779; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; Ramos Paula Cristina Rodrigues Dos, 1997, Planta (Heidelberg), V203, P26; Sales MP, 1996, BRAZ J MED BIOL RES, V29, P319; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Santos CN, 1997, J AGR FOOD CHEM, V45, P3821, DOI 10.1021/jf970075v; Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200; Schulze-Lefert P, 2003, ANNU REV PHYTOPATHOL, V41, P641, DOI 10.1146/annurev.phyto.41.061002.083300; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Shutov AD, 1995, J MOL EVOL, V41, P1057, DOI 10.1007/BF00173187; Slavokhotova AA, 2014, FEBS J, V281, P4754, DOI 10.1111/febs.13015; Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4; UENO M, 1991, J BIOL CHEM, V266, P3146; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; Yunes ANA, 1998, J SCI FOOD AGR, V76, P111, DOI 10.1002/(SICI)1097-0010(199801)76:1&lt;111::AID-JSFA932&gt;3.0.CO;2-4	53	19	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122095	10.1371/journal.pone.0122095	http://dx.doi.org/10.1371/journal.pone.0122095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849076	Green Published, gold			2022-12-27	WOS:000352477800096
J	Poos, K; Smida, J; Maugg, D; Eckstein, G; Baumhoer, D; Nathrath, M; Korsching, E				Poos, Kathrin; Smida, Jan; Maugg, Doris; Eckstein, Gertrud; Baumhoer, Daniel; Nathrath, Michaela; Korsching, Eberhard			Genomic Heterogeneity of Osteosarcoma - Shift from Single Candidates to Functional Modules	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; TUMOR-SUPPRESSOR GENE; COPY-NUMBER; PROGNOSTIC-SIGNIFICANCE; ALLELIC IMBALANCES; CHROMOSOME 6Q; EXPRESSION; NETWORK; HYBRIDIZATION; REVEALS	Osteosarcoma (OS), a bone tumor, exhibit a complex karyotype. On the genomic level a highly variable degree of alterations in nearly all chromosomal regions and between individual tumors is observable. This hampers the identification of common drivers in OS biology. To identify the common molecular mechanisms involved in the maintenance of OS, we follow the hypothesis that all the copy number-associated differences between the patients are intercepted on the level of the functional modules. The implementation is based on a network approach utilizing copy number associated genes in OS, paired expression data and protein interaction data. The resulting functional modules of tightly connected genes were interpreted regarding their biological functions in OS and their potential prognostic significance. We identified an osteosarcoma network assembling well-known and lesserknown candidates. The derived network shows a significant connectivity and modularity suggesting that the genes affected by the heterogeneous genetic alterations share the same biological context. The network modules participate in several critical aspects of cancer biology like DNA damage response, cell growth, and cell motility which is in line with the hypothesis of specifically deregulated but functional modules in cancer. Further, we could deduce genes with possible prognostic significance in OS for further investigation (e.g. EZR, CDKN2A, MAP3K5). Several of those module genes were located on chromosome 6q. The given systems biological approach provides evidence that heterogeneity on the genomic and expression level is ordered by the biological system on the level of the functional modules. Different genomic aberrations are pointing to the same cellular network vicinity to form vital, but already neoplastically altered, functional modules maintaining OS. This observation, exemplarily now shown for OS, has been under discussion already for a longer time, but often in a hypothetical manner, and can here be exemplified for OS.	[Poos, Kathrin; Korsching, Eberhard] Univ Hosp Munster, Inst Bioinformat, Munster, Germany; [Smida, Jan; Maugg, Doris; Baumhoer, Daniel; Nathrath, Michaela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Osteosarcoma, Neuherberg, Germany; [Smida, Jan; Maugg, Doris; Nathrath, Michaela] Tech Univ Munich, Klinikum Rechts Isar, Childrens Canc Res Ctr, D-80290 Munich, Germany; [Smida, Jan; Maugg, Doris; Nathrath, Michaela] Tech Univ Munich, Klinikum Rechts Isar, Dept Pediat, D-80290 Munich, Germany; [Eckstein, Gertrud] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Baumhoer, Daniel] Univ Basel Hosp, Bone Tumor Reference Ctr, Inst Pathol, CH-4031 Basel, Switzerland	University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Basel	Korsching, E (corresponding author), Univ Hosp Munster, Inst Bioinformat, Munster, Germany.	korschi@uni-muenster.de	Smida, Jan/P-2486-2014	Smida, Jan/0000-0001-6055-8207	Translational Sarcoma Research Network [FKZ 01GM0870, FKZ 01GM0869]; BMBF [FZK 01KT1310]; Foundation for the Preservation of the Basel Bone Tumor Center; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of the University of Munster (WWU)	Translational Sarcoma Research Network; BMBF(Federal Ministry of Education & Research (BMBF)); Foundation for the Preservation of the Basel Bone Tumor Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster (WWU)	This work was funded by the Translational Sarcoma Research Network (FKZ 01GM0870 to JS, MN, DM and FKZ 01GM0869 to KP, EK), the European TRANSCAN I consortium - PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalized translational medicine both supported by the BMBF (FZK 01KT1310 to KP, EK) and the Foundation for the Preservation of the Basel Bone Tumor Center [to DB]. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of the University of Munster. Funding for open access charge: Deutsche Forschungsgemeinschaft (DFG) and Open Access Publication Fund of the University of Munster (WWU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2012, TUMOR SUPPRESSOR GEN; Angstadt AY, 2012, CANCER GENET-NY, V205, P572, DOI 10.1016/j.cancergen.2012.09.005; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batanian JR, 2002, J CLIN PATHOL-MOL PA, V55, P389, DOI 10.1136/mp.55.6.389; Baumhoer D, 2012, CANCER GENET-NY, V205, P212, DOI 10.1016/j.cancergen.2012.03.001; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Both J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115835; Both J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030907; Calvert George T., 2012, Sarcoma, V2012, P152382, DOI 10.1155/2012/152382; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chauveinc L, 2001, Ophthalmic Genet, V22, P77, DOI 10.1076/opge.22.2.77.2228; Cheng WH, 2012, BIOCHEM BIOPH RES CO, V420, P24, DOI 10.1016/j.bbrc.2012.02.104; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; COX PM, 1991, BRIT J CANCER, V63, P651, DOI 10.1038/bjc.1991.151; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dohi O, 2008, CANCER SCI, V99, P518, DOI 10.1111/j.1349-7006.2007.00673.x; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ferrari S, 2008, PEDIATR BLOOD CANCER, V50, P752, DOI 10.1002/pbc.21360; FITZSIMMONS RJ, 1995, J BONE MINER RES, V10, P812; Flores RJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-50; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman R, 2013, GRAPH PACKAGE HANDLE; Gkantsidis C., 2003, P 5 WORKSH ALG ENG E; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong Colin, 2009, Expert Opin Med Diagn, V3, P13; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Kusuzaki K, 1999, CANCER LETT, V137, P27, DOI 10.1016/S0304-3835(98)00336-X; Kusuzaki K, 1999, CANCER LETT, V141, P131, DOI 10.1016/S0304-3835(99)00092-0; Lafleur EA, 2004, CLIN CANCER RES, V10, P8114, DOI 10.1158/1078-0432.CCR-04-0353; Luo Y, 2013, ARCH MED SCI, V9, P569, DOI 10.5114/aoms.2012.30956; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Na KY, 2012, PATHOLOGY, V44, P540, DOI 10.1097/PAT.0b013e32835803bc; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Nathrath MH, 2002, ONCOGENE, V21, P5975, DOI 10.1038/sj.onc.1205764; Natrajan R, 2006, J PATHOL, V210, P49, DOI 10.1002/path.2021; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nielsen GP, 1998, AM J PATHOL, V153, P159, DOI 10.1016/S0002-9440(10)65556-3; Noviello C, 1996, CLIN CANCER RES, V2, P1601; Ohata N, 2006, INT J MOL MED, V18, P1153; ORPHANOS V, 1995, BRIT J CANCER, V71, P666, DOI 10.1038/bjc.1995.132; Ozaki T, 2002, INT J CANCER, V102, P355, DOI 10.1002/ijc.10709; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Poos K, 2014, STRUCTURING OSTEOSAR; Poos K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003210; PORTER DE, 1992, J BONE JOINT SURG BR, V74, P883; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rehman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030885; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Rosenberg A, 2013, WHO CLASSIFICATION T, V5; SALZERKUNTSCHIK M, 1983, PATHOLOGE, V4, P135; Sau A, 2012, MOL BIOSYST, V8, P994, DOI 10.1039/c1mb05295k; Savage Sharon A., 2011, Sarcoma, V2011, P548151, DOI 10.1155/2011/548151; Serra M, 2001, MODERN PATHOL, V14, P710, DOI 10.1038/modpathol.3880377; Smida J, 2010, CLIN CANCER RES, V16, P4256, DOI 10.1158/1078-0432.CCR-10-0284; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tarkkanen M, 1999, CANCER GENET CYTOGEN, V114, P35, DOI 10.1016/S0165-4608(99)00031-X; Tsuchiya T, 2000, CANCER GENET CYTOGEN, V120, P91, DOI 10.1016/S0165-4608(99)00255-1; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang ZZ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-80; Zielenska M, 2004, CYTOGENET GENOME RES, V107, P77, DOI 10.1159/000079574	77	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123082	10.1371/journal.pone.0123082	http://dx.doi.org/10.1371/journal.pone.0123082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848766	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800202
J	Rahaman, H; Khan, MKA; Hassan, MI; Islam, A; Moosavi-Movahedi, AA; Ahmad, F				Rahaman, Hamidur; Khan, Md. Khurshid Alam; Hassan, Md. Imtaiyaz; Islam, Asimul; Moosavi-Movahedi, Ali Akbar; Ahmad, Faizan			Heterogeneity of Equilibrium Molten Globule State of Cytochrome c Induced by Weak Salt Denaturants under Physiological Condition	PLOS ONE			English	Article							THERMODYNAMIC CHARACTERIZATION; GUANIDINE-HYDROCHLORIDE; CIRCULAR-DICHROISM; FERRICYTOCHROME-C; ANION-BINDING; ALKALINE TRANSITION; INTERMEDIATE STATE; HYDROGEN-EXCHANGE; INFRARED-SPECTRA; SURFACE-CHARGES	While many proteins are recognized to undergo folding via intermediate(s), the heterogeneity of equilibrium folding intermediate(s) along the folding pathway is less understood. In our present study, FTIR spectroscopy, far- and near-UV circular dichroism (CD), ANS and tryptophan fluorescence, near IR absorbance spectroscopy and dynamic light scattering (DLS) were used to study the structural and thermodynamic characteristics of the native (N), denatured (D) and intermediate state (X) of goat cytochorme c (cyt-c) induced by weak salt denaturants (LiBr, LiCl and LiClO4) at pH 6.0 and 25 degrees C. The LiBr-induced denaturation of cyt-c measured by Soret absorption (Delta epsilon(400)) and CD ([theta](409)), is a three-step process, N <-> X <-> D. It is observed that the X state obtained along the denaturation pathway of cyt-c possesses common structural and thermodynamic characteristics of the molten globule (MG) state. The MG state of cyt-c induced by LiBr is compared for its structural and thermodynamic parameters with those found in other solvent conditions such as LiCl, LiClO4 and acidic pH. Our observations suggest: (1) that the LiBr-induced MG state of cyt-c retains the native Met80-Fe(III) axial bond and Trp59-propionate interactions; (2) that LiBr-induced MG state of cyt-c is more compact retaining the hydrophobic interactions in comparison to the MG states induced by LiCl, LiClO4 and 0.5 M NaCl at pH 2.0; and (3) that there exists heterogeneity of equilibrium intermediates along the unfolding pathway of cyt-c as highly ordered (X1), classical (X2) and disordered (X3), i.e., D <-> X3 <-> X2 <-> X1 <-> N.	[Rahaman, Hamidur; Khan, Md. Khurshid Alam; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Moosavi-Movahedi, Ali Akbar] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran	Jamia Millia Islamia; University of Tehran	Ahmad, F (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	fahmad@jmi.ac.in	Hamidur, Rahaman Md/ABE-4554-2021; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Mohammad/GZA-7507-2022; Hassan, Md Imtaiyaz/G-7072-2017; Ahmad, Faizan/AGH-4493-2022; Islam, Asimul/V-4526-2019	Hamidur, Rahaman Md/0000-0001-5998-177X; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Ahmad, Faizan/0000-0001-7021-7502; Islam, Asimul/0000-0001-9060-7970; Khan, Md. Khurshid/0000-0002-3205-0729; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432	Council of Scientific and Industrial Research (CSIR); Department of Science and Technology (DST); University Grants Commission	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR) and the Department of Science and Technology (DST) to FA. HR and MKAK are thankful to the University Grants Commission and CSIR for their fellowships, respectively. MIH is thankful to the DST for the award of the Young Scientist grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1982, J BIOL CHEM, V257, P2935; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; BARRICK D, 1994, J MOL BIOL, V237, P588, DOI 10.1006/jmbi.1994.1257; Battistuzzi G, 2001, EUR J INORG CHEM, P2989; Battistuzzi G, 1997, ARCH BIOCHEM BIOPHYS, V339, P283, DOI 10.1006/abbi.1996.9862; BATTISTUZZI G, 1995, EUR J BIOCHEM, V233, P335, DOI 10.1111/j.1432-1033.1995.335_1.x; Battistuzzi G, 1996, EUR J BIOCHEM, V241, P208, DOI 10.1111/j.1432-1033.1996.0208t.x; BOWLER BE, 1994, BIOCHEMISTRY-US, V33, P2402, DOI 10.1021/bi00175a008; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Bychkova VE, 1996, BIOCHEMISTRY-US, V35, P6058, DOI 10.1021/bi9522460; Chamani J, 2006, J COLLOID INTERF SCI, V297, P561, DOI 10.1016/j.jcis.2005.11.035; Colon W, 1996, NAT STRUCT BIOL, V3, P1019, DOI 10.1038/nsb1296-1019; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Dev S, 2006, J BIOSCIENCES, V31, P551, DOI 10.1007/BF02708406; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; DONG AC, 1994, METHOD ENZYMOL, V232, P139; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; Dong AC, 2005, ARCH BIOCHEM BIOPHYS, V436, P154, DOI 10.1016/j.abb.2005.01.006; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Goldbeck RA, 2009, INT J MOL SCI, V10, P1476, DOI 10.3390/ijms10041476; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; HAGIHARA Y, 1994, J MOL BIOL, V237, P336, DOI 10.1006/jmbi.1994.1234; Haque MA, 2015, INT J BIOL MACROMOL, V72, P1406, DOI 10.1016/j.ijbiomac.2014.10.053; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0; KATAOKA M, 1993, J MOL BIOL, V229, P591, DOI 10.1006/jmbi.1993.1064; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khan MKA, 2010, J BIOL INORG CHEM, V15, P1319, DOI 10.1007/s00775-010-0691-5; Khan MKA, 2009, J BIOL INORG CHEM, V14, P751, DOI 10.1007/s00775-009-0488-6; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Kokai E, 2006, ARCH BIOCHEM BIOPHYS, V451, P59, DOI 10.1016/j.abb.2006.03.020; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; KURODA Y, 1992, J MOL BIOL, V223, P1139, DOI 10.1016/0022-2836(92)90265-L; Latypov RF, 2006, J MOL BIOL, V357, P1009, DOI 10.1016/j.jmb.2006.01.055; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042; MOENCH SJ, 1991, EUR J BIOCHEM, V197, P631, DOI 10.1111/j.1432-1033.1991.tb15953.x; Mok KH, 2005, P NATL ACAD SCI USA, V102, P8899, DOI 10.1073/pnas.0500661102; Moza B, 2006, BIOCHEMISTRY-US, V45, P4695, DOI 10.1021/bi052357r; Moza B, 2003, BBA-PROTEINS PROTEOM, V1646, P49, DOI 10.1016/S1570-9639(02)00548-4; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; NATH U, 1995, BIOCHEMISTRY-US, V34, P1702, DOI 10.1021/bi00005a027; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; POTEKHIN S, 1989, BIOPHYS CHEM, V34, P55, DOI 10.1016/0301-4622(89)80041-9; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Qureshi SH, 2003, BIOCHEMISTRY-US, V42, P1684, DOI 10.1021/bi0271042; Radivojac P, 2006, PROTEINS, V63, P398, DOI 10.1002/prot.20873; Rahaman H, 2008, BIOPHYS CHEM, V138, P23, DOI 10.1016/j.bpc.2008.08.008; Rahaman H, 2013, J CHEM THERMODYN, V58, P351, DOI 10.1016/j.jct.2012.11.024; Rao DK, 2006, BIOCHEMISTRY-US, V45, P3412, DOI 10.1021/bi051882n; Santucci R, 2000, BIOCHEMISTRY-US, V39, P12632, DOI 10.1021/bi000516v; Schechter E, 1967, BIOPOLYMERS, V5, P788; SCHEJTER A, 1984, BIOCHEMISTRY-US, V23, P1081, DOI 10.1021/bi00301a007; Schwartz R., 2014, NEW MEDIA SOC, V1, P1; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Silkstone GG, 2005, J AM CHEM SOC, V127, P92, DOI 10.1021/ja045719b; Sinibaldi F, 2003, J BIOL INORG CHEM, V8, P663, DOI 10.1007/s00775-003-0462-7; Sinibaldi F, 2003, BIOCHEMISTRY-US, V42, P7604, DOI 10.1021/bi034132r; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; TANEJA S, 1994, BIOCHEM J, V303, P147, DOI 10.1042/bj3030147; Thomas YG, 2000, BIOPOLYMERS, V57, P29, DOI 10.1002/(SICI)1097-0282(2000)57:1<29::AID-BIP5>3.0.CO;2-V; Tompa P, 2006, BIOPHYS J, V91, P2243, DOI 10.1529/biophysj.106.084723; TSONG TY, 1975, BIOCHEMISTRY-US, V14, P1542, DOI 10.1021/bi00678a031; Ubaid-Ullah S, 2014, J BIOMOL STRUCT DYN, V32, P2005, DOI 10.1080/07391102.2013.848826; UVERSKY VN, 1992, FEBS LETT, V314, P89, DOI 10.1016/0014-5793(92)81468-2; Verbaro D, 2009, BIOCHEMISTRY-US, V48, P2990, DOI 10.1021/bi802208f; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WILLIAMS G, 1982, FEBS LETT, V150, P293, DOI 10.1016/0014-5793(82)80754-0; Xu YJ, 1998, NAT STRUCT BIOL, V5, P774, DOI 10.1038/1810; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1	79	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120465	10.1371/journal.pone.0120465	http://dx.doi.org/10.1371/journal.pone.0120465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849212	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800025
J	Shivalli, S; Gururaj, N				Shivalli, Siddharudha; Gururaj, Nandihal			Postnatal Depression among Rural Women in South India: Do Socio-Demographic, Obstetric and Pregnancy Outcome Have a Role to Play?	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; RISK-FACTORS; MENTAL-DISORDER; PREVALENCE; COMMUNITY; COHORT; SCALE; GOA	Introduction Postnatal depression (PND) is one of the most common psychopathology and is considered as a serious public health issue because of its devastating effects on mother, family, and infant or the child. Objective To elicit socio-demographic, obstetric and pregnancy outcome predictors of Postnatal Depression (PND) among rural postnatal women in Karnataka state, India. Design Hospital based analytical cross sectional study Setting A rural tertiary care hospital of Mandya District, Karnataka state, India. Sample PND prevalence based estimated sample of 102 women who came for postnatal follow up from 4th to 10th week of lactation. Method Study participants were interviewed using validated kannada version of Edinburgh Postnatal Depression Scale (EPDS). Cut-off score of >= 13 was used as high risk of PND. The percentage of women at risk of PND was estimated, and differences according to socio-demographic, obstetric and pregnancy outcome were described. Logistic regression was applied to identify the independent predictors of PND risk. Main Outcome Measures Prevalence, Odds ratio (OR) and adjusted (adj) OR of PND Results Prevalence of PND was 31.4% (95% CI 22.7-41.4%). PND showed significant (P<0.05) association with joint family, working women, non-farmer husbands, poverty, female baby and pregnancy complications or known medical illness. In binomial logistic regression poverty (adjOR: 11.95, 95% CI: 1.36-105), birth of female baby (adjOR: 3.6, 95% CI: 1.26-10.23) and pregnancy complications or known medical illness (adjOR: 17.4, 95% CI: 2.5-121.2) remained as independent predictors of PND. Conclusion Risk of PND among rural postnatal women was high (31.4%). Birth of female baby, poverty and complications in pregnancy or known medical illness could predict the high risk of PND. PND screening should be an integral part of postnatal care. Capacity building of grass root level workers and feasibility trials for screening PND by them are needed.	[Shivalli, Siddharudha; Gururaj, Nandihal] Yenepoya Univ, Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India	Yenepoya (Deemed to be University)	Shivalli, S (corresponding author), Yenepoya Univ, Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India.	shivalli.bhu@gmail.com	Shivalli, Siddharudha/AAU-3907-2020	Shivalli, Siddharudha/0000-0003-1454-7114				Ali NS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-384; [Anonymous], 2012, CENS IND 2011; Anoop S, 2004, ARCH DIS CHILD, V89, P325, DOI 10.1136/adc.2002.009738; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Chaaya M, 2002, Arch Womens Ment Health, V5, P65, DOI 10.1007/s00737-002-0140-8; Chandran M, 2002, BRIT J PSYCHIAT, V181, P499, DOI 10.1192/bjp.181.6.499; Chaudron LH, 2003, PEDIATR REV, V24, P154, DOI 10.1542/pir.24-5-154; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Fernandes MC, 2011, ARCH WOMEN MENT HLTH, V14, P209, DOI 10.1007/s00737-010-0190-2; Ghubash R, 1997, BRIT J PSYCHIAT, V171, P65, DOI 10.1192/bjp.171.1.65; Golbasi Z, 2010, MATERN CHILD HLTH J, V14, P485, DOI 10.1007/s10995-009-0459-0; Hegde S, 2012, J WOMENS HLTH ISSUES, V1, P1, DOI DOI 10.4172/2325-9795.1000101; Husain N, 2006, ARCH WOMEN MENT HLTH, V9, P197, DOI 10.1007/s00737-006-0129-9; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S, DOI [10.1371/journal.pone.0071584, DOI 10.1371/JOURNAL.PONE.0071584]; Lwanga SK., 1991, SAMPLE SIZE DETERMIN, P25; Malik Geeta, 2009, Nurs J India, V100, P88; Mancini F, 2007, J MIDWIFERY WOM HEAL, V52, P429, DOI 10.1016/j.jmwh.2007.03.007; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Nhiwatiwa S, 1998, J EPIDEMIOL COMMUN H, V52, P262, DOI 10.1136/jech.52.4.262; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Park K, 2013, PARKS TXB PREVENTIVE, P620; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Pearlstein T, 2009, AM J OBSTET GYNECOL, V200, P357, DOI 10.1016/j.ajog.2008.11.033; Posmontier Barbara, 2004, J Transcult Nurs, V15, P34, DOI 10.1177/1043659603260032; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Regmi S, 2002, TROP MED INT HEALTH, V7, P378, DOI 10.1046/j.1365-3156.2002.00866.x; Savarimuthu RJS, 2010, INT J SOC PSYCHIATR, V56, P94, DOI 10.1177/0020764008097756; Sookhoo D., 2009, SOCIAL CONTEXT BIRTH, P85; Stewart RC, 2010, SOC PSYCH PSYCH EPID, V45, P551, DOI 10.1007/s00127-009-0094-5; Tannous L, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-1; World Health Organization, 2014, PRET BIRTH; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn	34	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122079	10.1371/journal.pone.0122079	http://dx.doi.org/10.1371/journal.pone.0122079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25848761	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800094
J	Tellez, G; Latorre, JD; Kuttappan, VA; Hargis, BM; Hernandez-Velasco, X				Tellez, Guillermo; Latorre, Juan D.; Kuttappan, Vivek A.; Hargis, Billy M.; Hernandez-Velasco, Xochitl			Rye Affects Bacterial Translocation, Intestinal Viscosity, Microbiota Composition and Bone Mineralization in Turkey Poults	PLOS ONE			English	Article							POLYSACCHARIDE-DEGRADING ENZYMES; CELIAC-DISEASE; GROWTH PROMOTERS; GUT MICROBIOTA; T-CELLS; BROILERS; DIET; PERFORMANCE; GLUTEN; HEALTH	Previously, we have reported that rye significantly increased both viscosity and Clostridium perfringens proliferation when compared with corn in an in vitro digestive model. Two independent trials were conducted to evaluate the effect of rye as a source of energy on bacterial translocation, intestinal viscosity, gut microbiota composition, and bone mineralization, when compared with corn in turkey poults. In each experiment, day-of-hatch, turkey poults were randomly assigned to either a corn or a rye diet (n = 0/group). At 10 d of age, in both experiments, 12 birds/group were given an oral gavage dose of fluorescein isothiocyanate dextran (FITC-d). After 2.5 h of oral gavage, blood and liver samples were collected to evaluate the passage of FITC-d and bacterial translocation (BT) respectively. Duodenum, ileum and cecum gut sections were collected to evaluate intestinal viscosity and to enumerate gut microbiota. Tibias were collected for observation of bone parameters. Broilers fed with a rye diet showed increased (p<0.05) intestinal viscosity, BT, and serum FITC-d. Bacterial enumeration revealed that turkey poults fed with rye had increased the number of total lactic acid bacteria (LAB) in all three sections of the gastrointestinal tract evaluated when compared to turkey poults fed with corn. Turkey poults fed with rye also had significantly higher coliforms in duodenum and ileum but not in the ceca, whereas the total number of anaer-obes increased only in duodenum. A significant reduction in bone strength and bone mineralization was observed in turkey poults fed with rye when compared with corn fed turkey poults. In conclusion, rye evoked mucosal damage in turkey poults that increased intestinal viscosity, increased leakage through the intestinal tract, and altered the microbiota composition and bone mineralization. Studies to evaluate dietary inclusion of selected Direct-Fed Microbial (DFM) candidates that produce exogenous enzymes in rye fed turkey poults are currently being evaluated.	[Tellez, Guillermo; Latorre, Juan D.; Kuttappan, Vivek A.; Hargis, Billy M.] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA; [Hernandez-Velasco, Xochitl] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico	University of Arkansas System; University of Arkansas Fayetteville; Universidad Nacional Autonoma de Mexico	Tellez, G (corresponding author), Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA.	gtellez@uark.edu	Latorre, Juan D/AAM-5522-2021	Latorre, Juan D/0000-0001-6250-566X				Annett CB, 2002, AVIAN PATHOL, V31, P599, DOI 10.1080/0307945021000024544; Assimakopoulos Stelios F, 2011, World J Gastrointest Pathophysiol, V2, P123, DOI 10.4291/wjgp.v2.i6.123; BEDFORD MR, 1993, POULTRY SCI, V72, P137, DOI 10.3382/ps.0720137; BEDFORD MR, 1991, POULTRY SCI, V70, P1571, DOI 10.3382/ps.0701571; Bedford MR, 1998, NUTR RES REV, V11, P91, DOI 10.1079/NRR19980007; Bianchi ML, 2008, OSTEOPOROSIS INT, V19, P1705, DOI 10.1007/s00198-008-0624-0; Bianchi ML, 2010, ARCH BIOCHEM BIOPHYS, V503, P54, DOI 10.1016/j.abb.2010.06.026; CAMPBELL GL, 1983, BRIT POULTRY SCI, V24, P191, DOI 10.1080/00071668308416730; Capriles VD, 2009, NUTR REV, V67, P599, DOI 10.1111/j.1753-4887.2009.00232.x; Caruso R, 2020, NAT REV IMMUNOL, V20, P411, DOI [10.4161/gmic.20228, 10.1038/s41577-019-0268-7]; CHOCT M, 1995, J NUTR, V125, P485; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; DUNSFORD BR, 1989, J ANIM SCI, V67, P1855; Hofacre C. L., 2001, Science and technology in the feed industry. Proceedings of Alltech's 17th Annual Symposium: a time for answers, P79; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Horwaitz W, 2000, OFFICIAL METHODS ANA, P1; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Ilan Y, 2012, WORLD J GASTROENTERO, V18, P2609, DOI 10.3748/wjg.v18.i21.2609; James SP, 2005, J ALLERGY CLIN IMMUN, V115, P25, DOI 10.1016/j.jaci.2004.11.011; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kiarie E, 2013, NUTR RES REV, V26, P71, DOI 10.1017/S0954422413000048; Kotake S, 2009, ARTHRITIS RHEUM-US, V60, P3158, DOI 10.1002/art.24886; Kupfer Sonia S, 2012, Gastrointest Endosc Clin N Am, V22, P639, DOI 10.1016/j.giec.2012.07.003; Latorre Juan D, 2014, Front Vet Sci, V1, P26, DOI 10.3389/fvets.2014.00026; Leffler D, 2011, JAMA-J AM MED ASSOC, V306, P1582, DOI [10.1001/jama.2011.1312, 10.1001/jama.306.14.1582]; MACAULIFFE T, 1971, POULTRY SCI, V50, P1130, DOI 10.3382/ps.0501130; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Murphy TC, 2009, BRIT POULTRY SCI, V50, P716, DOI 10.1080/00071660903389950; National Research Council, 1994, NUTR REQ POULTR; Ouwehand A., 2002, European Journal of Nutrition, V41; RENNIE JS, 1993, BRIT J NUTR, V69, P809, DOI 10.1079/BJN19930081; Salminen S, 2006, J PEDIATR-US, V149, pS115, DOI 10.1016/j.jpeds.2006.06.062; Salzman NH, 2011, CURR OPIN MICROBIOL, V14, P99, DOI 10.1016/j.mib.2010.09.018; SAS Institute Inc, 2002, SAS US GUID; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Shirzadi H, 2010, AFR J BIOTECHNOL, V9, P1517; Silva MA, 2012, DIGEST DIS SCI, V57, P38, DOI 10.1007/s10620-011-1847-z; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Strohle Alexander, 2013, Med Monatsschr Pharm, V36, P369; Teirlynck E, 2009, BRIT J NUTR, V102, P1453, DOI 10.1017/S0007114509990407; Tellez G, 2014, POULT SCI S1, V93, P214; Tellez G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00339; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; Van Leeuwen P, 2004, BRIT POULTRY SCI, V45, P41, DOI 10.1080/00071660410001668842; Wideman Robert F, 2012, Front Endocrinol (Lausanne), V3, P183, DOI 10.3389/fendo.2012.00183; Williamson D, 2002, MOL BIOTECHNOL, V22, P293, DOI 10.1385/MB:22:3:293; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091; Zhang BF, 1997, POULTRY SCI, V76, P1698, DOI 10.1093/ps/76.12.1698	55	32	32	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122390	10.1371/journal.pone.0122390	http://dx.doi.org/10.1371/journal.pone.0122390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849537	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800125
J	Hausmann, S; Brandt, E; Kochel, C; Einsele, H; Bargou, RC; Seggewiss-Bernhardt, R; Stuhmer, T				Hausmann, Stefan; Brandt, Evelyn; Koechel, Carolin; Einsele, Hermann; Bargou, Ralf C.; Seggewiss-Bernhardt, Ruth; Stuehmer, Thorsten			Loss of Serum and Glucocorticoid-Regulated Kinase 3 (SGK3) Does Not Affect Proliferation and Survival of Multiple Myeloma Cell Lines	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT; AKT; INHIBITION; CANCER; PHOSPHORYLATION; DOWNSTREAM; ACTIVATION; MECHANISM; ISOFORMS; PATHWAY	Multiple myeloma (MM) is a generally fatal plasma cell cancer that often shows activation of the phosphoinositide 3-kinase/Akt (PI3K/Akt) pathway. Targeted pharmacologic therapies, however, have not yet progressed beyond the clinical trial stage, and given the complexity of the PI3K/Akt signalling system (e.g. multiple protein isoforms, diverse feedback regulation mechanisms, strong variability between patients) it is mandatory to characterise its ramifications in order to better guide informed decisions about the best therapeutic approaches. Here we explore whether serum and glucocorticoid-regulated kinase 3 (SGK3), a potential downstream effector of PI3K, plays a role in oncogenic signalling in MM cells-either in concert with or independent of Akt. SGK3 was expressed in all MM cell lines and in all primary MM samples tested. Four MM cell lines representing a broad range of intrinsic Akt activation (very strong: MM. 1s, moderate: L 363 and JJN-3, absent: AMO-1) were chosen to test the effects of transient SGK3 knockdown alone and in combination with pharmacological inhibition of Akt, PI3K-p110a, or in the context of serum starvation. Although the electroporation protocol led to strong SGK3 depletion for at least 5 days its absence had no substantial effect on the activation status of potential downstream substrates, or on the survival, viability or proliferation of MM cells in all experimental contexts tested. We conclude that it is unlikely that SGK3 plays a significant role for oncogenic signalling in multiple myeloma.	[Hausmann, Stefan; Brandt, Evelyn; Koechel, Carolin; Einsele, Hermann; Stuehmer, Thorsten] Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany; [Bargou, Ralf C.; Seggewiss-Bernhardt, Ruth] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stuhmer, T (corresponding author), Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany.	stuehmer_t@ukw.de			Wilhelm Sander-Stiftung [2011.114.1]; Deutsche Forschungsgemeinschaft [KFO 216]	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Wilhelm Sander-Stiftung (www.sanst.de)(Grant No. 2011.114.1 to RS-B, TS) and the Deutsche Forschungsgemeinschaft (www.dfg.de)(KFO 216 (RCB, HE, TS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab F, 2014, BRIT J HAEMATOL, V165, P89, DOI 10.1111/bjh.12734; Bruhn Maressa A, 2013, Cancer Manag Res, V5, P281, DOI 10.2147/CMAR.S35178; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; De Marco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055362; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Fensterle J, 2014, ANTI-CANCER AGENT ME, V14, P629, DOI 10.2174/1871520614666140309225912; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hofmann C, 2014, BRIT J HAEMATOL, V166, P529, DOI 10.1111/bjh.12920; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Ismail SI, 2010, LEUKEMIA RES, V34, P824, DOI 10.1016/j.leukres.2009.11.018; Keane NA, 2014, EXPERT OPIN THER TAR, V18, P897, DOI 10.1517/14728222.2014.924507; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leich E, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2012.47; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mimura N, 2014, CANCER RES, V74, P4458, DOI 10.1158/0008-5472.CAN-13-3652; Moreau P, 2013, ANN ONCOL, V24, P133, DOI 10.1093/annonc/mdt297; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Munugalavadla V, 2014, ONCOGENE, V33, P316, DOI 10.1038/onc.2012.594; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Ramakrishnan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050005; Rehan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109705; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Sahin I, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.24; Spencer A, 2014, BLOOD, V124, P2190, DOI 10.1182/blood-2014-03-559963; Steinbrunn T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097443; Steinbrunn T, 2012, BRIT J HAEMATOL, V159, P430, DOI 10.1111/bjh.12039; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Tessier M, 2006, J BIOL CHEM, V281, P23978, DOI 10.1074/jbc.M604333200; Tu YP, 2000, CANCER RES, V60, P6763; Uphoff CC, 2004, METH MOLEC MED, V88, P319; Usmani SZ, 2013, LEUKEMIA, V27, P226, DOI 10.1038/leu.2012.160; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wang YZ, 2014, MOL ENDOCRINOL, V28, P935, DOI 10.1210/me.2013-1339; Wang YZ, 2014, J BIOL CHEM, V289, P4815, DOI 10.1074/jbc.M113.518480; Wang YZ, 2011, MOL ENDOCRINOL, V25, P72, DOI 10.1210/me.2010-0294; Yan L, 2009, P 100 ANN M AM ASS C; Zollinger A, 2008, BLOOD, V112, P3403, DOI 10.1182/blood-2007-11-119362	48	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122689	10.1371/journal.pone.0122689	http://dx.doi.org/10.1371/journal.pone.0122689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837824	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000106
J	Carter, GM; Indyk, D; Johnson, M; Andreae, M; Suslov, K; Busani, S; Esmaeili, A; Sacks, HS				Carter, George M.; Indyk, Debbie; Johnson, Matthew; Andreae, Michael; Suslov, Kathryn; Busani, Sudharani; Esmaeili, Aryan; Sacks, Henry S.			Micronutrients in HIV: A Bayesian Meta-Analysis	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; MULTIVITAMIN SUPPLEMENTATION; INFECTED INDIVIDUALS; DISEASE PROGRESSION; RANDOMIZED-TRIAL; FOOD INSECURITY; ALTERNATIVE MEDICINE; MORTALITY; NUTRITION	Background Approximately 28.5 million people living with HIV are eligible for treatment (CD4<500), but currently have no access to antiretroviral therapy. Reduced serum level of micronutrients is common in HIV disease. Micronutrient supplementation (MNS) may mitigate disease progression and mortality. Objectives We synthesized evidence on the effect of micronutrient supplementation on mortality and rate of disease progression in HIV disease. Methods We searched MEDLINE, EMBASE, the Cochrane Central, AMED and CINAHL databases through December 2014, without language restriction, for studies of greater than 3 micronutrients versus any or no comparator. We built a hierarchical Bayesian random effects model to synthesize results. Inferences are based on the posterior distribution of the population effects; posterior distributions were approximated by Markov chain Monte Carlo in OpenBugs. Principal Findings From 2166 initial references, we selected 49 studies for full review and identified eight reporting on disease progression and/or mortality. Bayesian synthesis of data from 2,249 adults in three studies estimated the relative risk of disease progression in subjects on MNS vs. control as 0.62 (95% credible interval, 0.37, 0.96). Median number needed to treat is 8.4 (4.8, 29.9) and the Bayes Factor 53.4. Based on data reporting on 4,095 adults reporting mortality in 7 randomized controlled studies, the RR was 0.84 (0.38, 1.85), NNT is 25 (4.3,1). Conclusions MNS significantly and substantially slows disease progression in HIV+ adults not on ARV, and possibly reduces mortality. Micronutrient supplements are effective in reducing progression with a posterior probability of 97.9%. Considering MNS low cost and lack of adverse effects, MNS should be standard of care for HIV+ adults not yet on ARV.	[Carter, George M.] Fdn Integrat AIDS Res, Brooklyn, NY USA; [Indyk, Debbie; Suslov, Kathryn; Busani, Sudharani; Esmaeili, Aryan; Sacks, Henry S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Johnson, Matthew] Columbia Univ, Teachers Coll, New York, NY 10027 USA; [Andreae, Michael] Albert Einstein Coll Med, Dept Anesthesiol, Bronx, NY 10467 USA	Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University Teachers College; Yeshiva University; Albert Einstein College of Medicine	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	Henry.Sacks@mountsinai.org	Andreae, Michael/AAE-5558-2022; Johnson, Matthew/A-4570-2019	Andreae, Michael/0000-0002-9052-0936; Johnson, Matthew/0000-0003-3157-4165; Carter, George/0000-0002-3508-8650	National Institutes of Health, National Center for Complementary and Alternative Medicine [1R01AT005824-01]; CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [1 UL1 TR001073-01, 1 TL1 TR001072-01, 1 KL2 TR001071-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001072, UL1TR001073, KL2TR000088, KL2TR001071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005824] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025749] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by grant no. 1R01AT005824-01 from National Institutes of Health, National Center for Complementary and Alternative Medicine. MA was supported in part by the CTSA Grant 1 UL1 TR001073-01, 1 TL1 TR001072-01, 1 KL2 TR001071-01 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).	ABRAMS B, 1993, J ACQ IMMUN DEF SYND, V6, P949; [Anonymous], 2004, TreatmentUpdate, V16, P4; [Anonymous], 2014, GLOB UPD HLTH SECT R; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Asdamongkol N, 2013, JPN J INFECT DIS, V66, P469, DOI 10.7883/yoken.66.469; Baum MK, 2013, JAMA-J AM MED ASSOC, V310, P2154, DOI 10.1001/jama.2013.280923; Baum MK, 2010, 17 INT AIDS C; Berhe N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-233; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Carter G, 2011, PROSPERO, V2011; Carter G, 2012, 19 INT AIDS C; Childs K, 2012, AIDS, V26, P253, DOI 10.1097/QAD.0b013e32834f324b; Cunningham-Rundles S, 2005, J ALLERGY CLIN IMMUN, V115, P1119, DOI 10.1016/j.jaci.2005.04.036; de Pee S, 2014, AIDS BEHAV; Deeks J J, 2003, Health Technol Assess, V7, piii; Doitsh G, 2013, NATURE; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472; Fawzi W, 2004, CLIN INFECT DIS, V38, P716, DOI 10.1086/381673; Fawzi WW, 2007, AM J CLIN NUTR, V85, P1335, DOI 10.1093/ajcn/85.5.1335; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Fawzi WW, 2002, AIDS, V16, P1935, DOI 10.1097/00002030-200209270-00011; Filteau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011165; Havens PL, 2012, J CLIN ENDOCR METAB, V97, P4004, DOI 10.1210/jc.2012-2600; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Irlam JH, 2010, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003650.PUB3; Isanaka S, 2012, JAMA-J AM MED ASSOC, V308, P1535, DOI 10.1001/jama.2012.13083; Jackson CH, 2008, AM STAT, V62, P340, DOI 10.1198/000313008X370843; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jiamto S, 2004, JAIDS-J ACQ IMM DEF, V37, P1216, DOI 10.1097/01.qai.0000136092.79153.ac; Jiamton S, 2003, AIDS, V17, P2461, DOI 10.1097/00002030-200311210-00008; Kaiser JD, 2006, JAIDS-J ACQ IMM DEF, V42, P523, DOI 10.1097/01.qai.0000230529.25083.42; Kapp C, 2005, LANCET, V366, P1837, DOI 10.1016/S0140-6736(05)67739-2; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keding GB, 2011, FOOD NUTR BULL, V32, P218, DOI 10.1177/156482651103200306; Kelly P, 2008, AM J CLIN NUTR, V88, P1010, DOI 10.1093/ajcn/88.4.1010; Kish L., 1987, STAT DESIGN RES; Kouanda S, 2012, AIDS CARE, V24, P478, DOI 10.1080/09540121.2011.630353; Kruschke J. K, 2010, DOING BAYESIAN DATA; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Lorenc A, 2013, AIDS PATIENT CARE ST, V27, P503, DOI 10.1089/apc.2013.0175; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Marston B, 2004, NEW ENGL J MED, V351, P78, DOI 10.1056/NEJMe048134; McClelland RS, 2004, JAIDS-J ACQ IMM DEF, V37, P1657, DOI 10.1097/00126334-200412150-00021; McGrath N, 2006, PEDIATRICS, V117, pE216, DOI 10.1542/peds.2004-1668; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Myers EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028437; Nunnari Giuseppe, 2012, Front Biosci (Elite Ed), V4, P2442; Olofin IO, 2014, JAIDS-J ACQ IMM DEF, V67, pS173, DOI 10.1097/QAI.0000000000000375; Peinemann F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085035; Range N, 2006, BRIT J NUTR, V95, P762, DOI 10.1079/BJN20051684; Semba RD, 2007, INT J TUBERC LUNG D, V11, P854; Semba RD, 2007, JAIDS-J ACQ IMM DEF, V45, P298; Shannon K, 2011, AIDS, V25, P2037, DOI 10.1097/QAD.0b013e32834b35c9; Shekelle PG, 2005, ANN INTERN MED, V142, P1042, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00003; Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189; Singhal Neera, 2002, J Int Assoc Physicians AIDS Care (Chic), V1, P63, DOI 10.1177/154510970200100205; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; Villamor E, 2008, J INFECT DIS, V197, P1499, DOI 10.1086/587846; Wagenmakers E.-J, 2008, BAYESIAN EVALUATION, P181, DOI [10.1007/978-0-387-09612-4_9, DOI 10.1007/978-0-387-09612-4_9, 10.1007/978-0-387-09612-4, DOI 10.1007/978-0-387-09612-4]; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; World Health Organization, 2013, GLOB SUMM AIDS EP 20	64	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120113	10.1371/journal.pone.0120113	http://dx.doi.org/10.1371/journal.pone.0120113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830916	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600021
J	Kang, X; Hu, DY; Li, CB; Li, XH; Fan, SL; Liu, Y; Tang, GY; Ai, ZS; Wu, TF; Mohan, C; Zhou, XJ; Liu, JY; Peng, A				Kang, Xin; Hu, Da-Yong; Li, Chang-Bin; Li, Xin-Hua; Fan, Shu-Ling; Liu, Yong; Tang, Guang-Yu; Ai, Zi-Sheng; Wu, Tianfu; Mohan, Chandra; Zhou, Xin J.; Liu, Jun-Yan; Peng, Ai			The Volume Ratio of Ground Glass Opacity in Early Lung CT Predicts Mortality in Acute Paraquat Poisoning	PLOS ONE			English	Article							SURVIVAL	Background Pulmonary injury is the main cause of death in acute paraquat (PQ) poisoning. However, whether quantitative lung computed tomography (CT) can be useful in predicting the outcome of PQ poisoning remains unknown. We aimed to identify early findings of quantitative lung CT as predictors of outcome in acute PQ poisoning. Methods Lung CT scanning (64-slide) and quantitative CT lesions were prospectively measured for patients after PQ intoxication within 5 days. The study outcome was mortality during 90 days follow-up. Survival curves were derived by the Kaplan-Meier method, and mortality risk factors were analyzed by the forward stepwise Cox regression analysis. Results Of 97 patients, 41 (42.3%) died. Among the eight different types of lung CT findings which appeared in the first 5-day of PQ intoxication, four ones discriminated between survivors and non-survivors including ground glass opacity (GGO), consolidation, pneumomediastinum and "no obvious lesion". With a cutoff value of 10.8%, sensitivity of 85.4% and specificity of 89.3%, GGO volume ratio is better than adopted outcome indicators in predicting mortality, such as estimated amount of PQ ingestion, plasma or urine PQ concentration, acute physiology and chronic health evaluation (APACHE) II and sequential organ failure assessment (SOFA) scores. GGO volume ratios above 10.8% were associated with increased mortality (hazard ratio, 5.82; 95% confidence interval, 4.77-7.09; P < 0.001). Conclusions The volume ratio of GGO exceeding 10.8% is a novel, reliable and independent predictors of outcome in acute PQ poisoning.	[Kang, Xin; Hu, Da-Yong; Li, Chang-Bin; Li, Xin-Hua; Fan, Shu-Ling; Liu, Jun-Yan; Peng, Ai] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nephrol & Rheumatol, Shanghai 200092, Peoples R China; [Liu, Yong; Tang, Guang-Yu] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Radiol, Shanghai 200092, Peoples R China; [Ai, Zi-Sheng] Tongji Univ, Sch Med, Coll Med, Dept Med Stat, Shanghai 200092, Peoples R China; [Wu, Tianfu; Mohan, Chandra] Univ Houston, Dept Biomed Engn & Pharm, Houston, TX 77004 USA; [Zhou, Xin J.] Baylor Univ, Med Ctr, Renal Path Diagnost Pathologists BioMed Labs, Dallas, TX USA; [Zhou, Xin J.] Baylor Univ, Med Ctr, Dept Pathol, Dallas, TX USA	Tongji University; Tongji University; Tongji University; University of Houston System; University of Houston; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Peng, A (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nephrol & Rheumatol, Shanghai 200092, Peoples R China.	pengai@tongji.edu.cn	Wu, Tianfu/G-6672-2019; LIU, JUNYAN/B-2515-2010; liu, junyan/HGV-1505-2022; Mohan, Chandra/GPX-8233-2022	LIU, JUNYAN/0000-0002-3018-0335; Ai, Zi-Sheng/0000-0001-8417-4160; Wu, Tianfu/0000-0001-8235-5929; Wu, Tianfu/0000-0003-4406-1449	National Natural Science Foundation of China [81270136, 81171792, 30871202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81270136, 81171792, and 30871202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKRILL P, 1978, BRIT MED J, V1, P1252, DOI 10.1136/bmj.1.6122.1252; Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P874, DOI 10.1513/pats.200810-118QC; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; HART TB, 1984, LANCET, V2, P1222; Hong SY, 2005, CHEST, V128, P1506, DOI 10.1378/chest.128.3.1506; Huang NC, 2006, CLIN TOXICOL, V44, P99, DOI 10.1080/15563650500514251; IM JG, 1991, AM J ROENTGENOL, V157, P697, DOI 10.2214/ajr.157.4.1892020; Kageyama J, 1990, Kokyu To Junkan, V38, P273; Kang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078160; Kim YT, 2009, J KOREAN MED SCI, V24, P636, DOI 10.3346/jkms.2009.24.4.636; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; LEE SH, 1995, RADIOLOGY, V195, P271, DOI 10.1148/radiology.195.1.7892484; Licker M, 1998, THORAX, V53, P620, DOI 10.1136/thx.53.7.620; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin T J, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V54, P363; Neves FF, 2010, J BRAS PNEUMOL, V36, P513, DOI 10.1590/S1806-37132010000400019; PROUDFOOT AT, 1979, LANCET, V2, P330; Ruiz-Bailen M, 2001, CHEST, V119, P1956, DOI 10.1378/chest.119.6.1956; SAWADA Y, 1988, LANCET, V1, P1333; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; SUZUKI K, 1989, HUM TOXICOL, V8, P33, DOI 10.1177/096032718900800106; Suzuki K, 2011, AM J ROENTGENOL, V197, pW706, DOI 10.2214/AJR.10.5958; Washko GR, 2012, RESPIROLOGY, V17, P432, DOI 10.1111/j.1440-1843.2011.02117.x; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Whitehead RD, 2010, J CHROMATOGR B, V878, P2548, DOI 10.1016/j.jchromb.2009.09.029; Wunnapuk K, 2013, TOXICOL LETT, V222, P280, DOI 10.1016/j.toxlet.2013.08.003; YAMAGUCHI H, 1990, HUM EXP TOXICOL, V9, P381, DOI 10.1177/096032719000900604; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x; Zhang H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130035	33	16	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121691	10.1371/journal.pone.0121691	http://dx.doi.org/10.1371/journal.pone.0121691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830638	gold, Green Submitted, Green Published			2022-12-27	WOS:000352135600079
J	Redden, JP; Mann, T; Vickers, Z; Mykerezi, E; Reicks, M; Elsbernd, S				Redden, Joseph P.; Mann, Tracl; Vickers, Zata; Mykerezi, Elton; Reicks, Marla; Elsbernd, Stephanie			Serving First in Isolation Increases Vegetable Intake among Elementary Schoolchildren	PLOS ONE			English	Article							FRUIT CONSUMPTION; DIETARY PATTERNS; PORTION SIZE; INTERVENTIONS; CHILDREN; FOOD; CHILDHOOD; OBESITY; HEALTH; RISK	Many people want to eat healthier, but they often fail in these attempts. We report two field studies in an elementary school cafeteria that each demonstrate children eat more of a vegetable (carrots, broccoli) when we provide it first in isolation versus alongside other more preferred foods. We propose this healthy first approach succeeds by triggering one's inherent motivation to eat a single food placed in front of them, and works even though they have prior knowledge of the full menu available and no real time constraints. Consistent with this theory, and counter to simple contrast effects, an additional lab study found that presenting a food first in isolation had the unique ability to increase intake whether the food was healthy (carrots) or less healthy (M&M's). Our findings demonstrate the effectiveness of this simple intervention in promoting healthier eating, which should interest consumers, food marketers, health professionals, and policy makers.	[Redden, Joseph P.] Univ Minnesota, Dept Mkt, Minneapolis, MN 55455 USA; [Mann, Tracl] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Vickers, Zata; Reicks, Marla; Elsbernd, Stephanie] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA; [Mykerezi, Elton] Univ Minnesota, Dept Appl Econ, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Redden, JP (corresponding author), Univ Minnesota, Dept Mkt, Minneapolis, MN 55455 USA.	jredden@umn.edu		Mykerezi, Elton/0000-0002-8131-1163	Economic Research Service United States Department of Agriculture [59-5000-0-0090]; Minnesota Agricultural Experiment Station under MAES Project [MIN-54-057]	Economic Research Service United States Department of Agriculture(United States Department of Agriculture (USDA)); Minnesota Agricultural Experiment Station under MAES Project	This publication was supported by an agreement with Cornell University, Department of Applied Engineering and Management, under 59-5000-0-0090 from the Economic Research Service United States Department of Agriculture (http://www.ers.usda.gov/). This research has also been supported in part by the Minnesota Agricultural Experiment Station (http://www.maes.umn.edu/) under MAES Project No. MIN-54-057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzman-Frasca S, 2012, APPETITE, V58, P543, DOI 10.1016/j.appet.2011.11.012; Baranowski T, 2002, PREV MED, V34, P353, DOI 10.1006/pmed.2001.0989; Blanchette L, 2005, J HUM NUTR DIET, V18, P431, DOI 10.1111/j.1365-277X.2005.00648.x; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; CLARK RA, 1976, CHILD DEV, V47, P1008, DOI 10.2307/1128437; Condon EM, 2009, J AM DIET ASSOC, V109, pS67, DOI 10.1016/j.jada.2008.10.062; COSTANZO PR, 1966, CHILD DEV, V37, P967, DOI 10.2307/1126618; Davis M, 2000, HEALTH EDUC BEHAV, V27, P167, DOI 10.1177/109019810002700203; de Mutsert R, 2014, AM J EPIDEMIOL, V179, P1353, DOI 10.1093/aje/kwu052; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Frederick S, 2009, J CONSUM RES, V36, P553, DOI 10.1086/599764; French SA, 2003, PREV MED, V37, P593, DOI 10.1016/j.ypmed.2003.09.007; Gao SK, 2008, AM J CLIN NUTR, V88, P64; Geier AB, 2006, PSYCHOL SCI, V17, P521, DOI 10.1111/j.1467-9280.2006.01738.x; Haynos AF, 2012, CLIN PSYCHOL REV, V32, P383, DOI 10.1016/j.cpr.2011.09.006; Helson H, 1964, ADAPTATION LEVEL THE; Hoppert K, 2012, APPETITE, V59, P949, DOI 10.1016/j.appet.2012.09.005; Just D. R., 2009, Choices. The Magazine of Food, Farm, and Resources Issues, V24, punpaginated; Kahneman Daniel, 2002, HEURISTICS BIASES PS, P48; Kimmons Joel, 2009, Medscape J Med, V11, P26; Knai C, 2006, PREV MED, V42, P85, DOI 10.1016/j.ypmed.2005.11.012; Kral TVE, 2010, OBESITY, V18, P521, DOI 10.1038/oby.2009.243; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Maes L, 2012, EUR J PUBLIC HEALTH, V22, P677, DOI 10.1093/eurpub/ckr098; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Parducci A., 1995, HAPPINES PLEASURE JU; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Raju S, 2010, J MARKETING, V74, P93, DOI 10.1509/jmkg.74.3.93; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; Reicks M, 2012, JAMA-J AM MED ASSOC, V307, P784, DOI 10.1001/jama.2012.170; Roberto CA, 2014, J CONSUM PSYCHOL, V24, P438, DOI 10.1016/j.jcps.2014.03.001; Roe LS, 2012, APPETITE, V58, P242, DOI 10.1016/j.appet.2011.10.003; Samieri C, 2013, ANN INTERN MED, V159, P584, DOI 10.7326/0003-4819-159-9-201311050-00004; Schwartz J, 2012, HEALTH AFFAIR, V31, P399, DOI 10.1377/hlthaff.2011.0224; SIEGEL PS, 1957, PSYCHOL REP, V3, P15, DOI 10.2466/pr0.1957.3.g.15; Slovic Paul, 1972, OREGON RES I RES MON, V12, P1; Stables GJ, 2005, J AM DIET ASSOC, V105, P252, DOI 10.1016/j.jada.2004.11.031; Stevens J, 2011, PUBLIC HEALTH NUTR, V14, P314, DOI 10.1017/S1368980010001837; Tande DL, 2010, PUBLIC HEALTH NUTR, V13, P208, DOI 10.1017/S1368980009990723; Thomson CA, 2011, J AM DIET ASSOC, V111, P1523, DOI 10.1016/j.jada.2011.07.013; van Stralen MM, 2011, INT J OBESITY, V35, P1251, DOI 10.1038/ijo.2011.68; Wansink B, 2004, ANNU REV NUTR, V24, P341	44	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121283	10.1371/journal.pone.0121283	http://dx.doi.org/10.1371/journal.pone.0121283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830337	gold, Green Published			2022-12-27	WOS:000352135600066
J	Amorim, CEG; Daub, JT; Salzano, FM; Foll, M; Excoffier, L				Amorim, Carlos Eduardo G.; Daub, Josephine T.; Salzano, Francisco M.; Foll, Matthieu; Excoffier, Laurent			Detection of Convergent Genome-Wide Signals of Adaptation to Tropical Forests in Humans	PLOS ONE			English	Article							EPITHELIAL CHEMOKINE MEC/CCL28; AFRICAN RAIN-FORESTS; GENETIC-STRUCTURE; EVOLUTION; LOCI; DIVERSITY; SELECTION; HISTORY; ASSOCIATION; POPULATIONS	Tropical forests are believed to be very harsh environments for human life. It is unclear whether human beings would have ever subsisted in those environments without external resources. It is therefore possible that humans have developed recent biological adaptations in response to specific selective pressures to cope with this challenge. To understand such biological adaptations we analyzed genome-wide SNP data under a Bayesian statistics framework, looking for outlier markers with an overly large extent of differentiation between populations living in a tropical forest, as compared to genetically related populations living outside the forest in Africa and the Americas. The most significant positive selection signals were found in genes related to lipid metabolism, the immune system, body development, and RNA Polymerase III transcription initiation. The results are discussed in the light of putative tropical forest selective pressures, namely food scarcity, high prevalence of pathogens, difficulty to move, and inefficient thermoregulation. Agreement between our results and previous studies on the pygmy phenotype, a putative prototype of forest adaptation, were found, suggesting that a few genetic regions previously described as associated with short stature may be evolving under similar positive selection in Africa and the Americas. In general, convergent evolution was less pervasive than local adaptation in one single continent, suggesting that Africans and Amerindians may have followed different routes to adapt to similar environmental selective pressures.	[Amorim, Carlos Eduardo G.; Daub, Josephine T.; Excoffier, Laurent] Inst Ecol & Evolut, Computat & Mol Populat Genet Lab, Bern, Switzerland; [Amorim, Carlos Eduardo G.; Daub, Josephine T.; Foll, Matthieu; Excoffier, Laurent] Swiss Inst Bioinformat, Lausanne, Switzerland; [Amorim, Carlos Eduardo G.; Salzano, Francisco M.] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Porto Alegre, RS, Brazil; [Amorim, Carlos Eduardo G.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Foll, Matthieu] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Foll, Matthieu] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France	Swiss Institute of Bioinformatics; Universidade Federal do Rio Grande do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; World Health Organization; International Agency for Research on Cancer (IARC)	Amorim, CEG (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	cg2827@columbia.edu	Foll, Matthieu/A-8561-2014; Salzano, Francisco M/L-7916-2015; Excoffier, Laurent/D-3498-2013; Daub, Josephine/H-8488-2015	Foll, Matthieu/0000-0001-9006-8436; Excoffier, Laurent/0000-0002-7507-6494; Daub, Josephine/0000-0003-1424-6602	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Programa de Apoio a Nucleos de Excelencia (FAPERGS/PRONEX); CAPES Foundation [BEX 8279/11-0]; Swiss NSF grants [31003A-143393, PDFMP3_130309]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Programa de Apoio a Nucleos de Excelencia (FAPERGS/PRONEX); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swiss NSF grants	This research was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to CEGA and FMS . Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Programa de Apoio a Nucleos de Excelencia (FAPERGS/PRONEX) to FMS . CAPES Foundation grant (BEX 8279/11-0) to CEGA . Swiss NSF grants (31003A-143393 and PDFMP3_130309) to LE . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; BAILEY RC, 1989, AM ANTHROPOL, V91, P59, DOI 10.1525/aa.1989.91.1.02a00040; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cann HM, 2002, SCIENCE, V296, P261; Castelletti E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000969; Chung SY, 2009, CANCER SCI, V100, P2109, DOI 10.1111/j.1349-7006.2009.01277.x; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080; Doll A, 2001, CYTOGENET CELL GENET, V95, P20, DOI 10.1159/000057012; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Ezzat MHM, 2009, INT J DERMATOL, V48, P822, DOI 10.1111/j.1365-4632.2009.04069.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2014, AM J HUM GENET, V95, P394, DOI 10.1016/j.ajhg.2014.09.002; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; HART TB, 1986, HUM ECOL, V14, P29, DOI 10.1007/BF00889209; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Hunemeier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038862; ISA-Instituto Socioambiental, 2013, POV IND BRAS; Kaindl AM, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9357; Kriska T, 2010, J LIPID RES, V51, P3174, DOI 10.1194/jlr.M008342; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lee Richard, 2004, CAMBRIDGE ENCY HUNTE, pxiii; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Mendizabal I, 2012, HUM GENET, V131, P1305, DOI 10.1007/s00439-012-1157-3; Mercader J, 2002, EVOL ANTHROPOL, V11, P117, DOI 10.1002/evan.10022; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Micale L, 2008, EUR J HUM GENET, V16, P1038, DOI 10.1038/ejhg.2008.68; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Migliano AB, 2013, HUM BIOL, V85, P251, DOI 10.3378/027.085.0313; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Umemura M, 2007, MOL BIOL CELL, V18, P4304, DOI 10.1091/mbc.E07-05-0482; Walker RS, 2008, CURR ANTHROPOL, V49, P115, DOI 10.1086/524763; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zhang W, 2007, REPRODUCTION, V133, P511, DOI 10.1530/REP-06-0125	56	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121557	10.1371/journal.pone.0121557	http://dx.doi.org/10.1371/journal.pone.0121557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849546	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800064
J	Lin, YH; Wei, J; Fan, LL; Cheng, DY				Lin, Yihua; Wei, Jia; Fan, Lili; Cheng, Deyun			BTNL2 Gene Polymorphism and Sarcoidosis Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							MOLECULE; VARIANT; RISK	Background Butyrophilin-like 2 (BTNL2) rs2076530 gene polymorphism has been implicated in susceptibility to sarcoidosis. However, results from previous studies are not consistent. To assess the association of BTNL2 polymorphism and sarcoidosis susceptibility, a meta-analysis was performed. Methods PubMed, Embase were searched for eligible case-control studies. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. Results Ten studies involving a total of 3303 cases and 2514 controls were included in this meta-analysis. Combined data indicated that BTNL2 rs2076530 polymorphism was associated with sarcoidosis susceptibility in allelic model (A vs. G, OR = 1.59, 95% CI: 1.47-1.72), dominant model (AA + AG vs. GG, OR = 2.10, 95% CI: 1.67-2.65), and recessive model (AA vs. AG + GG, OR = 1.93, 95% CI: 1.49-2.50). Conclusions This meta-analysis indicates that BTNL2 rs2076530 polymorphism contributes to the risk of sarcoidosis.	[Lin, Yihua; Wei, Jia; Fan, Lili; Cheng, Deyun] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China; [Lin, Yihua] Xiamen Univ, Affiliated Hosp 1, Dept Resp Med, Xiamen, Fujian, Peoples R China	Sichuan University; Xiamen University	Cheng, DY (corresponding author), Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China.	chengdeyunSCU@163.com		Lin, Yihua/0000-0002-9354-7704				Adrianto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043907; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gaillot-Drevon M, 2014, SARCOIDOSIS VASC DIF, V31, P136; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Li Y, 2006, THORAX, V61, P273, DOI 10.1136/thx.2005.056564; Milman N, 2011, CLIN RESPIR J, V5, P105, DOI 10.1111/j.1752-699X.2010.00206.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morais A, 2012, RESP MED, V106, P1771, DOI 10.1016/j.rmed.2012.08.009; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Ozdemir M, 2014, TURK J MED SCI, V44, P590, DOI 10.3906/sag-1306-16; Rybicki BA, 2005, AM J HUM GENET, V77, P491, DOI 10.1086/444435; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Spagnolo P, 2007, TISSUE ANTIGENS, V70, P219, DOI 10.1111/j.1399-0039.2007.00879.x; Suzuki H, 2012, INVEST OPHTH VIS SCI, V53, P7109, DOI 10.1167/iovs.12-10491; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wijnen PA, 2011, HUM IMMUNOL, V72, P342, DOI 10.1016/j.humimm.2011.01.011; Ziegenhagen MW, 2003, J INTERN MED, V253, P18, DOI 10.1046/j.1365-2796.2003.01074.x	24	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122639	10.1371/journal.pone.0122639	http://dx.doi.org/10.1371/journal.pone.0122639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849037	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800155
J	Xu, HD; Zhao, MF; Lou, GH; Zheng, M; Cao, QY; Chen, Z				Xu, Hangdi; Zhao, Mingfei; Lou, Guohua; Zheng, Min; Cao, Qingyi; Chen, Zhi			New Point Mutations in Surface and Core Genes of Hepatitis B Virus Associated with Acute on Chronic Liver Failure Identified by Complete Genomic Sequencing	PLOS ONE			English	Article							ASYMPTOMATIC CARRIER STATE; E-ANTIGEN; GENOTYPE; PRECORE; MUTANTS; DOMAINS	The objective of this study was to identify new viral biomarkers associated with acute on chronic liver failure (ACLF) by complete genomic sequencing of HBV. Hepatitis B virus mutations associated with ACLF were screened by Illumina high-throughput sequencing in twelve ACLF cases and twelve age-matched mild chronic hepatitis B patients, which were validated in 438 chronic hepatitis B patients (80 asymptomatic carriers, 152 mild chronic hepatitis B patients, 102 severe chronic hepatitis B patients and 104 ACLF patients) by direct sequencing. The results of Illumina sequencing showed that the mutations at 7 sites (T216C, G285A, A1846T, G1896A, C1913A/G, A2159G, and A2189C) of 12 ACLF patients were significantly higher than those of 12 controls. In the validation cohorts, a significantly higher ratio of genotype B to C was found in patients with ACLF than in patients with nonACLF. Multivariate analysis showed that T216C, G1896A, C1913A/G and A2159G/C were independent risk factors for ACLF. C216 in any combination, A/G1913 in any combination, and G/C2159 in any combination had high specificity for ACLF. In summary, T216C and A2159G/C mutations were novel factors independently associated with ACLF. Combined mutations in hepatitis B cases could play important roles in ACLF development.	[Xu, Hangdi] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Mingfei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Lou, Guohua; Zheng, Min; Cao, Qingyi; Chen, Zhi] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Inst Infect Dis,State Key Lab Diag & Trea, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Chen, Z (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Inst Infect Dis,State Key Lab Diag & Trea, Hangzhou 310003, Zhejiang, Peoples R China.	zju.zhichen@gmail.com			National Natural Science Foundation of China [81272679]; 12-5 State S&T Projects of China [2012ZX10002005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12-5 State S&T Projects of China(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (81272679), and the 12-5 State S&T Projects of China (2012ZX10002005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; Dai CY, 2011, HEPATOLOGY, V54, P1108, DOI 10.1002/hep.24328; Frelin L, 2009, J VIROL, V83, P1379, DOI 10.1128/JVI.01902-08; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liaw YF, 2011, HEPATOLOGY, V54, P91, DOI 10.1002/hep.24361; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu Q, 2007, J GASTROEN HEPATOL, V22, P2101, DOI 10.1111/j.1440-1746.2006.04362.x; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Ni YH, 2003, GUT, V52, P122, DOI 10.1136/gut.52.1.122; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Ren X, 2010, J VIRAL HEPATITIS, V17, P887, DOI 10.1111/j.1365-2893.2009.01254.x; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Siegler VD, 2013, J VIROL, V87, P1491, DOI 10.1128/JVI.02500-12; Sonneveld MJ, 2012, HEPATOLOGY, V56, P67, DOI 10.1002/hep.25636; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Taylor BC, 2009, HEPATOLOGY, V49, pS85, DOI 10.1002/hep.22929; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Xiao L, 2011, J MED VIROL, V83, P1544, DOI 10.1002/jmv.22159; Yan T, 2011, J MED VIROL, V83, P996, DOI 10.1002/jmv.22067; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Zhu Y, 2010, CANCER EPIDEM BIOMAR, V19, P2623, DOI 10.1158/1055-9965.EPI-10-0469; 吴光华, 2008, [自然科学进展, Progress in Natural Science], V18, P121	29	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123139	10.1371/journal.pone.0123139	http://dx.doi.org/10.1371/journal.pone.0123139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849554	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800209
J	Zhu, D; Xie, H; Wang, XY; Yu, HY; Gao, W				Zhu, Dan; Xie, Hong; Wang, Xinyu; Yu, Haiyi; Gao, Wei			Correlation of Plasma Catestatin Level and the Prognosis of Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							INHIBITORY PEPTIDE CATESTATIN; CHROMOGRANIN-A FRAGMENT; CATECHOLAMINE RELEASE; HEART-FAILURE; IN-VIVO; ACTIVATION; MECHANISM; HUMANS; ACTS; TERM	Catestatin is a peptide which is a potent inhibitor of catecholamine secretion and played essential functions in the cardiovascular system. Previous research found that dramatic changes of catestatin were associated with hemodynamics in acute myocardial infarction (AMI) during the first week after the AMI symptoms onset, but whether catestatin is also involved in the pathophysiological progression after AMI and then a predictor for outcomes is not clear. The aim of this study is to determine the correlation of plasma catestatin levels at different time points and the prognosis of AMI. 100 participants recruited were all patients with AMI, all of who received successful primary percutaneous coronary intervention (PCI) within 12h from the AMI symptom onset in our center; the concentrations of plasma catestatin were evaluated from blood samples of those 100 participants. Subsequent 65 months' follow-up was performed after discharging to evaluate cardiac adverse events and the association between catestatin levels and prognosis of AMI was examined. We confirmed the dramatic change of catestatin concentrations in the first week of AMI, and the levels of catestatin on D3 were much higher in adverse events group than those in non-adverse events group (p<0.0001), but the ratio of D7/D3 was significantly lower. In addition, the Kaplan-Meier analysis showed that the groups in which the levels on D3 were higher (p<0.0001) and the ratios of D7/D3 were lower (p<0.0001), patients trended to be more susceptive to adverse events after AMI. Furthermore, according to the analysis, we surmised catestatin level on D3 as an appropriate predictor for outcomes in patients with AMI with good specificity as well as sensitivity. All of the evidence confirmed that catestatin plays an important role in the progress of AMI, and may act as a promising target for prognostic prediction.	[Zhu, Dan; Xie, Hong; Wang, Xinyu; Yu, Haiyi; Gao, Wei] Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptided, Beijing, Peoples R China	Peking University	Xie, H (corresponding author), Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptided, Beijing, Peoples R China.	ycy2255@sohu.com		Gao, Wei/0000-0003-3541-9568	National Natural Science Foundation of China [81200167]; Ph.D. Programs Foundation of the Ministry of Education of China [20120001120131]; International cooperation projects of the Ministry of Science and Technology [2013DFG32940]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); International cooperation projects of the Ministry of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (No. 81200167) and the Ph.D. Programs Foundation of the Ministry of Education of China (No. 20120001120131), and the International cooperation projects of the Ministry of Science and Technology (No. 2013DFG32940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Brar BK, 2010, REGUL PEPTIDES, V165, P63, DOI 10.1016/j.regpep.2010.07.153; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Durakoglugil ME, 2015, ANATOL J CARDIOL, V15, P577, DOI 10.5152/akd.2014.5536; FOY SG, 1995, EUR HEART J, V16, P770, DOI 10.1093/oxfordjournals.eurheartj.a060995; Fung MM, 2010, CLIN EXP HYPERTENS, V32, P278, DOI 10.3109/10641960903265246; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Husebye T, 2013, EUR J HEART FAIL, V15, P565, DOI 10.1093/eurjhf/hfs215; Jansson AM, 2009, EUR HEART J, V30, P25, DOI 10.1093/eurheartj/ehn513; JEWITT DE, 1969, LANCET, V1, P635; Jons C, 2011, HEART RHYTHM, V8, P342, DOI 10.1016/j.hrthm.2010.09.090; Kennedy BP, 1998, PEPTIDES, V19, P1241, DOI 10.1016/S0196-9781(98)00086-2; Kruger PG, 2003, REGUL PEPTIDES, V114, P29, DOI 10.1016/S0167-0115(03)00069-7; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Mahata SK, 1999, J BIOL CHEM, V274, P2920, DOI 10.1074/jbc.274.5.2920; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mahata SK, 2010, REGUL PEPTIDES, V165, P52, DOI 10.1016/j.regpep.2010.09.007; Meng L, 2013, POSTGRAD MED J, V89, P193, DOI 10.1136/postgradmedj-2012-131060; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Omland T, 2003, AM J MED, V114, P25, DOI 10.1016/S0002-9343(02)01425-0; Penna C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102536; Penna C, 2010, CELL MOL NEUROBIOL, V30, P1171, DOI 10.1007/s10571-010-9598-5; Perrelli MG, 2013, PFLUG ARCH EUR J PHY, V465, P1031, DOI 10.1007/s00424-013-1217-0; Petersen CL, 2003, CARDIOLOGY, V100, P23, DOI 10.1159/000072388; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; SIGURDSSON A, 1993, AM HEART J, V126, P1068, DOI 10.1016/0002-8703(93)90656-T; Taylor CV, 2000, J BIOL CHEM, V275, P22905, DOI 10.1074/jbc.M001232200; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Zhu D, 2011, BIOMARKERS, V16, P691, DOI 10.3109/1354750X.2011.629058	32	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122993	10.1371/journal.pone.0122993	http://dx.doi.org/10.1371/journal.pone.0122993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848973	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800191
J	Giabicani, E; Lemaire, P; Brauner, R				Giabicani, Eloise; Lemaire, Pierre; Brauner, Raja			Models for Predicting the Adult Height and Age at First Menstruation of Girls with Idiopathic Central Precocious Puberty	PLOS ONE			English	Article							LONG-TERM TREATMENT; BODY-MASS INDEX; FINAL HEIGHT; HORMONE ANALOGS; GNRH AGONIST; FOLLOW-UP; GROWTH; DIAGNOSIS; PATTERN; ONSET	Background It is difficult to determine whether to treat a given girl who has idiopathic central precocious puberty (CPP) with gonadotropin-releasing hormone analog (GnRHa) in terms of adult height (AH). The objective was to provide an easy tool for predicting AH and age at first menstruation at initial evaluation to help guide the decision regarding whether to treat. Methods Data analysis using multiple linear regression models was performed in 134 girls with CPP. Among them 78 were given GnRHa because of low predicted AH (n=45), pubertal luteinising hormone (LH)/follicle-stimulating hormone peaks (FSH) ratio (n=50) and/or high plasma estradiol concentration (n=45). 56 girls were followed without treatment. Results In the whole population, the actual AH (162.1 +/- 5.61 cm) was similar to target height (161.7 +/- 4.91 cm) and to AH predicted by the Bayley and Pinneau method (161.9 +/- 7.98 cm). Separated models for treated and untreated girls provide very close estimations, leading to a unique formula for both groups. The AH (cm) could be calculated at the initial evaluation: 2.21 (height at initial evaluation, SD) + 2.32 (target height, SD) -1.83 (LH/FSH peaks ratio) + 159.68. The actual AH was lower than the calculated AH by more than 1 SD (5.6 cm) in 11 girls (8.0%). The time between onset of puberty and first menstruation (in untreated girls) can be estimated with: 10.9 - 0.57 (LH/FSH peaks ratio). The formulae are available at http://www.kamick.org/lemaire/med/girls-cpp15.html. Conclusions We established formulae that can be used at an initial evaluation to predict the AH, and the time between onset of puberty and first menstruation after spontaneous puberty. The similarity of the formulae for both groups suggests that the treatment had no significant effect on	[Giabicani, Eloise; Brauner, Raja] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Lemaire, Pierre] Univ Grenoble Alpes, F-38000 Grenoble, France; [Lemaire, Pierre] CNRS, G SCOP, F-38000 Grenoble, France; [Brauner, Raja] Univ Paris 05, Paris, France	Fondation Adolphe de Rothschild; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	raja.brauner@wanadoo.fr	Giabicani, Eloïse/AAM-8783-2020	GIABICANI, Eloise/0000-0001-5360-8616				Adan L, 2002, CLIN ENDOCRINOL, V56, P297, DOI 10.1046/j.1365-2265.2002.01488.x; Allali S, 2011, MED SCI MONITOR, V17, pPH41, DOI 10.12659/MSM.881794; Armengaud JB, 2009, J CLIN ENDOCR METAB, V94, P2835, DOI 10.1210/jc.2009-0314; Arrigo T, 1999, EUR J ENDOCRINOL, V141, P140, DOI 10.1530/eje.0.1410140; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; BRAUNER R, 1994, J CLIN ENDOCR METAB, V79, P415, DOI 10.1210/jc.79.2.415; BRAUNER R, 1991, HORM RES, V36, P116, DOI 10.1159/000182143; Brauner R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011282; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Cassio A, 1999, ARCH DIS CHILD, V81, P329, DOI 10.1136/adc.81.4.329; Chalumeau M, 2003, J PEDIATR-US, V143, P445, DOI 10.1067/S0022-3476(03)00328-7; de Vries L, 2004, J CLIN ENDOCR METAB, V89, P1794, DOI 10.1210/jc.2003-030361; FONTOURA M, 1989, ARCH DIS CHILD, V64, P1170, DOI 10.1136/adc.64.8.1170; Giabicani E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070931; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Klein KO, 2001, J CLIN ENDOCR METAB, V86, P4711, DOI 10.1210/jc.86.10.4711; Lazar L, 2007, J CLIN ENDOCR METAB, V92, P3483, DOI 10.1210/jc.2007-0321; Lemaire P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-172; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; OERTER KE, 1990, J CLIN ENDOCR METAB, V71, P1251, DOI 10.1210/jcem-71-5-1251; Oostdijk W, 1996, ARCH DIS CHILD, V75, P292, DOI 10.1136/adc.75.4.292; Palmert MR, 1999, J CLIN ENDOCR METAB, V84, P415, DOI 10.1210/jc.84.2.415; Pasquino AM, 2008, J CLIN ENDOCR METAB, V93, P190, DOI 10.1210/jc.2007-1216; PERIGNON F, 1992, J CLIN ENDOCR METAB, V75, P1170, DOI 10.1210/jc.75.4.1170; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Sempe A, 1979, AUXOLOGIE METHODE SE; Tanaka T, 2005, J CLIN ENDOCR METAB, V90, P1371, DOI 10.1210/jc.2004-1863; Tanner J M, 1970, Arch Dis Child, V45, P819; Willemsen RH, 2014, NAT REV ENDOCRINOL, V10, P352, DOI 10.1038/nrendo.2014.40; Witten I.H., 2000, DATA MINING PRACTICA	30	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120588	10.1371/journal.pone.0120588	http://dx.doi.org/10.1371/journal.pone.0120588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837693	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000026
J	Ramel, F; Brasseur, G; Pieulle, L; Valette, O; Hirschler-Rea, A; Fardeau, ML; Dolla, A				Ramel, Fanny; Brasseur, Gael; Pieulle, Laetitia; Valette, Odile; Hirschler-Rea, Agnes; Fardeau, Marie Laure; Dolla, Alain			Growth of the Obligate Anaerobe Desulfovibrio vulgaris Hildenborough under Continuous Low Oxygen Concentration Sparging: Impact of the Membrane- Bound Oxygen Reductases	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; PYRUVATE-FERREDOXIN OXIDOREDUCTASE; SP STRAIN MB; CYTOCHROME BD; MICROBIAL MAT; VULGATIS HILDENBOROUGH; AZOTOBACTER-VINELANDII; OXIDATIVE STRESS; DEPENDENT GROWTH; SP. NOV	Although obligate anaerobe, the sulfate-reducing bacterium Desulfovibrio vulgaris Hilden-borough (DvH) exhibits high aerotolerance that involves several enzymatic systems, including two membrane-bound oxygen reductases, a bd-quinol oxidase and a cc(b/o)o(3) cytochrome oxidase. Effect of constant low oxygen concentration on growth and morphology of the wild-type, single (Delta bd,Delta cox) and double deletion (Delta coxbd) mutant strains of the genes encoding these oxygen reductases was studied. When both wild-type and deletion mutant strains were cultured in lactate/sulfate medium under constant 0.02% O-2 sparging, they were able to grow but the final biomasses and the growth yield were lower than that obtained under anaerobic conditions. At the end of the growth, lactate was not completely consumed and when conditions were then switched to anaerobic, growth resumed. Time-lapse microscopy revealed that a large majority of the cells were then able to divide (over 97%) but the time to recover a complete division event was longer for single deletion mutant Delta bd than for the three other strains. Determination of the molar growth yields on lactate suggested that a part of the energy gained from lactate oxidation was derived toward cells protection/repairing against oxidative conditions rather than biosynthesis, and that this part was higher in the single deletion mutant Delta bd and, to a lesser extent, Delta cox strains. Our data show that when DvH encounters oxidative conditions, it is able to stop growing and to rapidly resume growing when conditions are switched to anaerobic, suggesting that it enters active dormancy sate under oxidative conditions. We propose that the pyruvate-ferredoxin oxidoreductase (PFOR) plays a central role in this phenomenon by reversibly switching from an oxidative-sensitive fully active state to an oxidative-insensitive inactive state. The oxygen reductases, and especially the bd-quinol oxidase, would have a crucial function by maintaining reducing conditions that permit PFOR to stay in its active state.	[Ramel, Fanny; Brasseur, Gael; Pieulle, Laetitia; Valette, Odile; Dolla, Alain] Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France; [Hirschler-Rea, Agnes; Fardeau, Marie Laure] Aix Marseille Univ, Univ Toulon, CNRS, IRD,MIO,UM110, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Dolla, A (corresponding author), Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France.	dolla@imm.cnrs.fr			French national Research Agency (ANR) [2011BSV601201]	French national Research Agency (ANR)(French National Research Agency (ANR))	AD, GB, LP and FR were funded by the French national Research Agency (ANR grant #2011BSV601201). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarten A, 2001, ARCH MICROBIOL, V176, P306, DOI 10.1007/s002030100329; Belevich I, 2007, BIOCHEMISTRY-US, V46, P11177, DOI 10.1021/bi700862u; Blaabjerg V, 1998, AQUAT MICROB ECOL, V15, P311, DOI 10.3354/ame015311; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; CHEN L, 1993, BIOCHEM BIOPH RES CO, V193, P100, DOI 10.1006/bbrc.1993.1595; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; CYPIONKA H, 1985, FEMS MICROBIOL ECOL, V31, P39, DOI 10.1016/0378-1097(85)90045-X; DANNENBERG S, 1992, ARCH MICROBIOL, V158, P93, DOI 10.1007/BF00245211; DILLING W, 1990, FEMS MICROBIOL LETT, V71, P123; Eschemann A, 1999, ENVIRON MICROBIOL, V1, P489, DOI 10.1046/j.1462-2920.1999.00057.x; Figueiredo MCO, 2012, ANAEROBE, V18, P454, DOI 10.1016/j.anaerobe.2012.06.001; Fournier M, 2004, J BIOL CHEM, V279, P1787, DOI 10.1074/jbc.M307965200; Fournier M, 2006, BIOCHIMIE, V88, P85, DOI 10.1016/j.biochi.2005.06.012; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; FRUND C, 1992, APPL ENVIRON MICROB, V58, P70; HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873; Johnson MS, 1997, J BACTERIOL, V179, P5598, DOI 10.1128/jb.179.17.5598-5601.1997; JORGENSEN BB, 1991, APPL ENVIRON MICROB, V57, P847; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Krekeler D, 1998, FEMS MICROBIOL ECOL, V25, P89, DOI 10.1016/S0168-6496(97)00085-8; Krekeler D, 1997, ARCH MICROBIOL, V167, P369, DOI 10.1007/s002030050457; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; KUO J, 1993, AUST J MAR FRESH RES, V44, P75; Kusel K, 1999, APPL ENVIRON MICROB, V65, P5117; Lamrabet O, 2011, MICROBIOL-SGM, V157, P2720, DOI 10.1099/mic.0.049171-0; LeGall J, 1996, ANAEROBE, V2, P1, DOI 10.1006/anae.1996.0001; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Machado P, 2006, CURR MICROBIOL, V52, P274, DOI 10.1007/s00284-005-0165-0; MARSCHALL C, 1993, ARCH MICROBIOL, V159, P168, DOI 10.1007/BF00250278; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Nielsen LB, 2001, ENVIRON MICROBIOL, V3, P63, DOI 10.1046/j.1462-2920.2001.00160.x; Okabe S, 1999, APPL ENVIRON MICROB, V65, P5107; Pereira PM, 2008, ANTON LEEUW INT J G, V93, P347, DOI 10.1007/s10482-007-9212-0; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Pieulle L, 2011, J BIOL CHEM, V286, P7812, DOI 10.1074/jbc.M110.197988; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Postgate J.R., 1979, SULFATE REDUCING BAC; Postgate J.R., 1984, SULFATE REDUCING BAC, V2nd; Ramel F, 2013, MICROBIOL-SGM, V159, P2663, DOI 10.1099/mic.0.071282-0; RISATTI JB, 1994, P NATL ACAD SCI USA, V91, P10173, DOI 10.1073/pnas.91.21.10173; Saas H, 1997, FEMS MICROBIOL ECOL, V22, P245; Santana M, 2008, ANAEROBE, V14, P145, DOI 10.1016/j.anaerobe.2008.03.001; Santegoeds CM, 1998, APPL ENVIRON MICROB, V64, P3731; Sass H, 1998, SYST APPL MICROBIOL, V21, P212, DOI 10.1016/S0723-2020(98)80025-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sigalevich P, 2000, APPL ENVIRON MICROB, V66, P5019, DOI 10.1128/AEM.66.11.5019-5023.2000; Sigalevich P, 2000, APPL ENVIRON MICROB, V66, P5013, DOI 10.1128/AEM.66.11.5013-5018.2000; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P6492, DOI 10.1021/bi0473049; STAMS AJM, 1982, FEMS MICROBIOL LETT, V13, P389, DOI 10.1016/0378-1097(82)90197-5; Teske A, 1996, APPL ENVIRON MICROB, V62, P1405, DOI 10.1128/AEM.62.4.1405-1415.1996; VANDIJK C, 1983, FEBS LETT, V156, P340, DOI 10.1016/0014-5793(83)80525-0; VISSCHER PT, 1992, FEMS MICROBIOL ECOL, V86, P283, DOI 10.1016/0378-1097(92)90792-M; Vita N, 2008, BIOCHEMISTRY-US, V47, P957, DOI 10.1021/bi7014713; Wildschut JD, 2006, J BACTERIOL, V188, P6253, DOI 10.1128/JB.00425-06; Yurkiw MA, 2012, ENVIRON MICROBIOL, V14, P2711, DOI 10.1111/j.1462-2920.2012.02859.x; Zhang WW, 2006, ANTON LEEUW INT J G, V89, P221, DOI 10.1007/s10482-005-9024-z; Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62	60	21	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123455	10.1371/journal.pone.0123455	http://dx.doi.org/10.1371/journal.pone.0123455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837676	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000145
J	Srivastava, P; Sinha-Mahapatra, SK; Ghosh, A; Srivastava, I; Dhingra, NK				Srivastava, Prerna; Sinha-Mahapatra, Sumit K.; Ghosh, Abhinaba; Srivastava, Ipsit; Dhingra, Narender K.			Differential Alterations in the Expression of Neurotransmitter Receptors in Inner Retina following Loss of Photoreceptors in rd1 Mouse	PLOS ONE			English	Article							BIPOLAR CELLS EXPRESS; OSCILLATORY ACTIVITY; GLUTAMATE RECEPTORS; GLYCINE RECEPTORS; ALPHA-1 SUBUNIT; GANGLION-CELLS; RHO SUBUNITS; RAT RETINA; MODEL; LOCALIZATION	Loss of photoreceptors leads to significant remodeling in inner retina of rd1 mouse, a widely used model of retinal degeneration. Several morphological and physiological alterations occur in the second-and third-order retinal neurons. Synaptic activity in the excitatory bipolar cells and the predominantly inhibitory amacrine cells is enhanced. Retinal ganglion cells (RGCs) exhibit hyperactivity and aberrant spiking pattern, which adversely affects the quality of signals they can carry to the brain. To further understand the pathophysiology of retinal degeneration, and how it may lead to aberrant spiking in RGCs, we asked how loss of photoreceptors affects some of the neurotransmitter receptors in rd1 mouse. Using Western blotting, we measured the levels of several neurotransmitter receptors in adult rd1 mouse retina. We found significantly higher levels of AMPA, glycine and GABAa receptors, but lower levels of GABAc receptors in rd1 mouse than in wild-type. Since GABAa receptor is expressed in several retinal layers, we employed quantitative immunohistochemistry to measure GABAa receptor levels in specific retinal layers. We found that the levels of GABAa receptors in inner plexiform layer of wild-type and rd1 mice were similar, whereas those in outer plexiform layer and inner nuclear layer combined were higher in rd1 mouse. Specifically, we found that the number of GABAa-immunoreactive somas in the inner nuclear layer of rd1 mouse retina was significantly higher than in wild-type. These findings provide further insights into neurochemical remodeling in the inner retina of rd1 mouse, and how it might lead to oscillatory activity in RGCs.	[Srivastava, Prerna; Sinha-Mahapatra, Sumit K.; Ghosh, Abhinaba; Srivastava, Ipsit; Dhingra, Narender K.] Natl Brain Res Ctr, Manesar Gurgaon, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dhingra, NK (corresponding author), Natl Brain Res Ctr, Manesar Gurgaon, Haryana, India.	naren@nbrc.ac.in	Ghosh, Abhinaba/AAU-4280-2021	Srivastava, Prerna/0000-0002-3429-7039	National Brain Research Centre	National Brain Research Centre	This work was supported by funds from National Brain Research Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Boudard DL, 2009, EUR J NEUROSCI, V30, P1527, DOI 10.1111/j.1460-9568.2009.06935.x; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Choi H, 2014, J NEUROPHYSIOL, V112, P1491, DOI 10.1152/jn.00437.2014; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Delyfer MN, 2005, MOL VIS, V11, P688; Enz R, 1999, EUR J NEUROSCI, V11, P41, DOI 10.1046/j.1460-9568.1999.00423.x; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Haverkamp S, 2004, J COMP NEUROL, V477, P399, DOI 10.1002/cne.20267; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Koulen P, 1996, J NEUROSCI, V16, P2127; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Liu LO, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-7; Lukasiewicz PD, 2004, VISION RES, V44, P3289, DOI 10.1016/j.visres.2004.07.023; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/507037; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; MURASHIMA YL, 1990, J NEUROCHEM, V54, P893, DOI 10.1111/j.1471-4159.1990.tb02335.x; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Poria D, 2015, J NEUROPHYSIOL, V113, P420, DOI 10.1152/jn.00702.2014; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Sterling P., 2004, SYNAPTIC ORG BRAIN, P217; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Toychiev AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077658; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Varela C, 2003, VISION RES, V43, P879, DOI 10.1016/S0042-6989(02)00493-5; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; WOODFORD BJ, 1989, CELL TISSUE RES, V256, P495; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yazulla S, 1997, VISION RES, V37, P3471, DOI 10.1016/S0042-6989(96)00223-4; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008	44	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123896	10.1371/journal.pone.0123896	http://dx.doi.org/10.1371/journal.pone.0123896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835503	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000152
J	Tung, WP; Chen, YH; Cheng, WC; Chuang, MF; Hsu, WT; Kam, YC; Lehtinen, RM				Tung, Wan-Ping; Chen, Yi-Huey; Cheng, Wei-Chun; Chuang, Ming-Feng; Hsu, Wan-Tso; Kam, Yeong-Choy; Lehtinen, Richard M.			Parentage of Overlapping Offspring of an Arboreal-Breeding Frog with No Nest Defense: Implications for Nest Site Selection and Reproductive Strategy	PLOS ONE			English	Article							CHIRIXALUS-EIFFINGERI ANURA; HEMIDACTYLIUM-SCUTATUM CAUDATA; EXTRA-PAIR PATERNITY; OOPHAGOUS TADPOLES; CLUTCH OVERLAP; MATE FIDELITY; FITNESS CONSEQUENCES; MOVEMENT PATTERNS; BROODING BEHAVIOR; NATURAL-HISTORY	Overlapping offspring occurs when eggs are laid in a nest containing offspring from earlier reproduction. Earlier studies showed that the parentage is not always obvious due to difficulties in field observation and/or alternative breeding tactics. To unveil the parentage between overlapping offspring and parents is critical in understanding oviposition site selection and the reproductive strategies of parents. Amplectant pairs of an arboreal-breeding frog, Kurixalus eiffingeri, lay eggs in tadpole-occupied nests where offspring of different life stages (embryos and tadpoles) coexist. We used five microsatellite DNA markers to assess the parentage between parents and overlapping offspring. We also tested the hypothesis that the male or female frog would breed in the same breeding site because of the scarcity of nest sites. Results showed varied parentage patterns, which may differ from the phenomenon of overlapping egg clutches reported earlier. Parentage analyses showed that only 58 and 25% of the tadpole-occupied stumps were reused by the same male and female respectively, partially confirming our prediction. Re-nesting by the same individual was more common in males than females, which is most likely related to the cost of tadpole feeding and/or feeding schemes of females. On the other hand, results of parentage analyses showed that about 42 and 75% of male and female respectively bred in tadpole-occupied stumps where tadpoles were genetically unrelated. Results of a nest-choice experiment revealed that 40% of frogs chose tadpole-occupied bamboo cups when we presented identical stumps, without or with tadpoles, suggesting that the habitat saturation hypothesis does not fully explain why frogs used the tadpole-occupied stumps. Several possible benefits of overlapping offspring with different life stages were proposed. Our study highlights the importance of integrating molecular data with field observations to better understand the reproductive biology and nest site selection of anuran amphibians.	[Tung, Wan-Ping; Cheng, Wei-Chun; Chuang, Ming-Feng; Hsu, Wan-Tso; Kam, Yeong-Choy] Tunghai Univ, Dept Life Sci, Taichung 407, Taiwan; [Chen, Yi-Huey] Chinese Culture Univ, Dept Life Sci, Taipei, Taiwan; [Lehtinen, Richard M.] Coll Wooster, Dept Biol, Wooster, OH 44691 USA	Tunghai University; Chinese Culture University; College of Wooster	Kam, YC (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 407, Taiwan.	biyckam@thu.edu.tw	Chuang, Ming-Feng/GWQ-6299-2022	Chuang, Ming-Feng/0000-0002-7328-2577	National Science Council grant (NSC) [101-2621-B-029-002-MY3]	National Science Council grant (NSC)	This study was supported by a National Science Council grant to YCK (NSC 101-2621-B-029-002-MY3).	[Anonymous], 2008, STAPFIA; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; BACHMANN MD, 1984, HERPETOLOGICA, V40, P436; BARCLAY RMR, 1988, AUK, V105, P53, DOI 10.1093/auk/105.1.53; BREITENBACH GL, 1982, J HERPETOL, V16, P341, DOI 10.2307/1563563; Bried J, 2003, ANIM BEHAV, V65, P235, DOI 10.1006/anbe.2002.2045; BURLEY N, 1980, AM NAT, V115, P223, DOI 10.1086/283556; Burrowes PA, 2000, HERPETOLOGICA, V56, P375; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Carreno CA, 1998, COPEIA, P183; Cezilly F, 2000, ANIM BEHAV, V59, P1143, DOI 10.1006/anbe.2000.1422; Chen YH, 2001, HERPETOLOGICA, V57, P438; Chen YH, 2007, ZOOL SCI, V24, P434, DOI 10.2108/zsj.24.434; Chen YH, 2011, BEHAV ECOL SOCIOBIOL, V65, P2329, DOI 10.1007/s00265-011-1243-x; Cheng WC, 2013, ETHOLOGY, V119, P286, DOI 10.1111/eth.12062; Chiu CT, 2006, BEHAVIOUR, V143, P123, DOI 10.1163/156853906775133605; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Crump Martha L., 1995, Amphibian Biology, V2, P518; DAUGHERTY CH, 1982, HERPETOLOGICA, V38, P468; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doody JS, 2009, Q REV BIOL, V84, P229, DOI 10.1086/605078; DOW H, 1983, J ANIM ECOL, V52, P681, DOI 10.2307/4447; Edgerly JS, 1998, J ANIM ECOL, V67, P805, DOI 10.1046/j.1365-2656.1998.00243.x; Ewen JG, 2004, NEW ZEAL J ECOL, V28, P233; FORESTER DC, 1979, COPEIA, P332; FORESTER DC, 1983, COPEIA, P1098; GROSS MR, 1985, AM ZOOL, V25, P807; Gruter C, 2011, NEOTROP ENTOMOL, V40, P55, DOI 10.1590/S1519-566X2011000100008; HARRIS RN, 1995, ANIM BEHAV, V50, P1309, DOI 10.1016/0003-3472(95)80046-8; HARRIS RN, 1980, HERPETOLOGICA, V36, P141; Heg D, 2003, ANIM BEHAV, V66, P175, DOI 10.1006/anbe.2003.2188; Hetmanski T, 2005, POL J ECOL, V53, P523; HOM CL, 1990, HERPETOLOGICA, V46, P304; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Johannesen E, 2002, EMU, V102, P241, DOI 10.1071/MU01061; Johnson M, 2008, AUK, V125, P76, DOI 10.1525/auk.2008.125.1.76; Junca FA, 1996, J HERPETOL, V30, P292, DOI 10.2307/1565530; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kam YC, 1997, ZOOL STUD, V36, P186; Kam YC, 2000, ZOOL STUD, V39, P67; Kam YC, 1998, HERPETOLOGICA, V54, P425; Kam YC, 1998, PHYSIOL ZOOL, V71, P534, DOI 10.1086/515957; Kam YC, 1996, J HERPETOL, V30, P52, DOI 10.2307/1564706; Kam YC, 2000, BEHAVIOUR, V137, P137, DOI 10.1163/156853900501917; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Knouft JH, 2004, COPEIA, P915, DOI 10.1643/CE-03-169R1; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Lannoo J.M., 1987, FIELDIANA ZOOL, V38, P1, DOI DOI 10.5962/BHL.TITLE.2932; Laurila A, 1998, BIOL J LINN SOC, V63, P221; Lehtinen RM, 2004, MISC PUBL MUS ZOOL, V193, P1; Liang MF, 2002, J ZOOL, V256, P207, DOI 10.1017/S0952836902000249; Lin YS, 2008, ZOOL STUD, V47, P129; Lin YS, 2008, HERPETOLOGICA, V64, P413, DOI 10.1655/08-020R1.1; LOWTHER P E, 1979, Bird-Banding, V50, P160; MacDougallShackleton EA, 1996, ANIM BEHAV, V52, P1177, DOI 10.1006/anbe.1996.0265; Manica A, 2004, AM NAT, V164, P517, DOI 10.1086/423792; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McCarthy MA, 2004, J APPL ECOL, V41, P780, DOI 10.1111/j.0021-8901.2004.00919.x; Mokany A, 2003, AUSTRAL ECOL, V28, P33, DOI 10.1046/j.1442-9993.2003.01239.x; MOLLER AP, 1990, ANIM BEHAV, V40, P1070, DOI 10.1016/S0003-3472(05)80173-3; Murphy PJ, 2003, BEHAV ECOL, V14, P626, DOI 10.1093/beheco/arg042; Naves LC, 2006, OIKOS, V115, P263; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Redmond LJ, 2009, WILSON J ORNITHOL, V121, P1, DOI 10.1676/07-166.1; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Roberts JD, 2011, ADV STUD BEHAV, V43, P1, DOI 10.1016/B978-0-12-380896-7.00001-0; Rowe KMC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1283, DOI 10.1007/s00265-007-0359-5; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; SAS, 2001, SAS STAT US GUID; Schulte L, 2014, ANIM COGN, V17, P267, DOI 10.1007/s10071-013-0659-2; Schulte LM, 2010, SALAMANDRA, V46, P180; Shang K- S, 2009, FIELD GUIDE AMPHIBIA; SMITH C, 1995, REV FISH BIOL FISHER, V5, P7, DOI 10.1007/BF01103363; SONERUD GA, 1987, ORNIS SCAND, V18, P323, DOI 10.2307/3676904; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; TESSIER C, 1991, J HERPETOL, V25, P213, DOI 10.2307/1564652; TRAVIS J, 1987, ECOLOGY, V68, P611, DOI 10.2307/1938466; UEDA H, 1986, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V8, P109; Vergara P, 2006, IBIS, V148, P672, DOI 10.1111/j.1474-919X.2006.00565.x; Vieites DR, 2004, NATURE, V431, P305, DOI 10.1038/nature02879; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ECOLOGY, V58, P750, DOI 10.2307/1936211; WESTMORELAND D, 1989, ANIM BEHAV, V38, P1062, DOI 10.1016/S0003-3472(89)80145-9; WESTMORELAND D, 1986, AUK, V103, P196; WOODRUFF DS, 1977, HERPETOLOGICA, V33, P296; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; [No title captured]	89	3	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123221	10.1371/journal.pone.0123221	http://dx.doi.org/10.1371/journal.pone.0123221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835716	Green Published, gold			2022-12-27	WOS:000352139000134
J	Wong, LP; Shakir, SMM; Atefi, N; AbuBakar, S				Wong, Li Ping; Shakir, Sharina Mahavera Mohamad; Atefi, Narges; AbuBakar, Sazaly			Factors Affecting Dengue Prevention Practices: Nationwide Survey of the Malaysian Public	PLOS ONE			English	Article							KNOWLEDGE; FEVER; ATTITUDES; BELIEFS; URBAN; MODEL	Background Efforts to stamp dengue in many dengue endemic countries has met little success. There is a need to re-examine and understand how the public at large view the dengue prevention efforts. This study aimed to examine the demographic factors, theoretical constructs of the Health Belief Model and knowledge about dengue and how these influence the practice of dengue prevention. Methods A national telephone survey was carried out with 2,512 individuals of the Malaysian public aged 18-60 years. Results The majority (73%) of the Malaysian public had a total dengue prevention score of 51-100 (of a possible score of 1-100). Multivariate analysis suggests significant correlates of higher dengue prevention practices with demographic background, perception of susceptibility to dengue, perceived density of mosquitoes in the neighbourhood and knowledge about dengue. Households of lower income of which the majority (40.7%) were from the rural areas, were associated with the highest odds [OR = 1.33; 95% CI = 1.09-1.67; p = 0.004] of dengue prevention. Dengue prevention practices were also less likely to be undertaken in neighbourhoods where the responders perceived there is no and/or low density of mosquitoes. Dengue prevention practices are also less likely to be practiced by skilled workers [OR = 0.78; 95% CI = 0.63-0.95; p = 0.029] compared to those unemployed. Higher perceived susceptibility to dengue was associated with higher dengue prevention practices and participants with higher dengue knowledge were found to have a higher level of involvement in dengue prevention practices. Conclusion Results from the study suggest that in formulating approaches to contain dengue, strategies should be developed to cultivate dengue prevention practices among urban population and target areas with low density of mosquitoes where public perceived a less likely chance of getting dengue. Dengue prevention campaigns should focus on messages highlighting the risk of contracting dengue and education to increase knowledge about dengue.	[Wong, Li Ping; Shakir, Sharina Mahavera Mohamad; Atefi, Narges] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Wong, Li Ping] Univ Malaya, Julius Ctr Univ Malaya, Kuala Lumpur, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Wong, LP (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	wonglp@ummc.edu.my	WONG, LI PING/B-2782-2010; abubakar, sazaly/B-3957-2010	WONG, LI PING/0000-0002-0107-0532; abubakar, sazaly/0000-0002-9267-1420; Mohamad Shakir, Sharina Mahavera/0000-0001-8649-3800	Ministry of Higher Education, Malaysia Long Term Research Grant Scheme (LRGS) for Infectious Disease	Ministry of Higher Education, Malaysia Long Term Research Grant Scheme (LRGS) for Infectious Disease	This study was solely funded by Ministry of Higher Education, Malaysia Long Term Research Grant Scheme (LRGS) for Infectious Disease. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dubai SAR, 2013, SE ASIAN J TROP MED, V44, P37; Artwanichakul K., 2012, European Journal of Social Sciences, V32, P485; Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51; Boland M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-208; GLANZ K, 1997, HLTH BEHAV HLTH ED T; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Isa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002401; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Lam S. K., 1993, Tropical Medicine, V35, P303; Lennon J. L., 2005, Dengue Bulletin, V29, P217; Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1; Nalongsack S, 2009, NAGOYA J MED SCI, V71, P29; Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005; Phuanukoonnon S, 2006, ACTA TROP, V99, P6, DOI 10.1016/j.actatropica.2006.05.012; Pulford J, 2012, SOC SCI MED, V75, P2283, DOI 10.1016/j.socscimed.2012.08.030; Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009; Samuelsen H, 2004, SOC SCI MED, V59, P2361, DOI 10.1016/j.socscimed.2004.03.031; Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853; Shepard D.S., 2013, BURDEN DENGUE MALAYS; Shuaib F, 2010, W INDIAN MED J, V59, P139; Thompson F, 2009, INT J HLTH PROMOTION, V48; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; WHO, 2014, EM DIS SURV RESP WPR; WHO, 2014, DENG SEV DENG 2014; Wong LP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002789; Yboa BC, 2013, AM J PUBLIC HLTH RES, V1, P47, DOI [10.12691/ajphr-1-2-2, DOI 10.12691/AJPHR-1-2-2]	26	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122890	10.1371/journal.pone.0122890	http://dx.doi.org/10.1371/journal.pone.0122890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25836366	gold, Green Published			2022-12-27	WOS:000352139000117
J	Zhang, JY; Ding, TD; Zhang, ZJ; Xu, LP; Zhang, CL				Zhang, Jianying; Ding, Tengda; Zhang, Zhijian; Xu, Liping; Zhang, Chunlong			Enhanced Adsorption of Trivalent Arsenic from Water by Functionalized Diatom Silica Shells	PLOS ONE			English	Article							ACTIVATED ALUMINA; AQUEOUS-SOLUTION; WASTE-WATER; REMOVAL; XPS; OXIDE; KINETICS; SURFACE; EQUILIBRIUM; COPPER(II)	The potential of porous diatom silica shells as a naturally abundant low-cost sorbent for the removal of arsenic in aqueous solutions was investigated in a batch study. The objective of this work was to chemically modify the silica shells of a diatom Melosira sp. with bifunctional (thiol and amino) groups to effectively remove arsenic in its toxic As(III) form (arsenite) predominant in the aquatic environment. Sorption experiments with this novel sorbent were conducted under varying conditions of pH, time, dosage, and As(III) concentration. A maximum adsorption capacity of 10.99 mg g(-1) was achieved within 26 h for a solution containing 12 mg L-1 As(III) at pH 4 and sorbent dosage of 2 g L-1. The functionalized diatom silica shells had a surface morphological change which was accompanied by increased pore size at the expense of reduced specific surface area and total pore volume. As(III) adsorption was best fitted with the Langmuir-Freundlich model, and the adsorption kinetic data using pore surface diffusion model showed that both the external (film) and internal (intraparticle) diffusion can be rate-determining for As(III) adsorption. Fourier transform infrared spectroscopy (FTIR) indicated that the thiol and amino groups potentially responsible for As(III) adsorption were grafted on the surface of diatom silica shells. X-ray photoelectron spectroscopy (XPS) further verified that this unique sorbent proceeded via a chemisorption mechanism through the exchange between oxygen-containing groups of neutral As(III) and thiol groups, and through the surface complexation between As(III) and protonated nitrogen and hydroxyl groups. Results indicate that this functionalized bioadsorbent with a high As(III) adsorption capacity holds promise for the treatment of As(III) containing wastewater.	[Zhang, Jianying; Ding, Tengda; Zhang, Zhijian; Xu, Liping] Zhejiang Univ, Inst Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jianying] Zhejiang Prov Key Lab Organ Pollut Proc & Control, Hangzhou, Zhejiang, Peoples R China; [Ding, Tengda] Jiangxi Acad Sci, Inst Sci & Technol Strategy, Nanchang, Jiangxi, Peoples R China; [Zhang, Chunlong] Univ Houston Clear Lake City, Dept Environm Sci, Houston, TX 77058 USA	Zhejiang University; University of Houston System; University of Houston; University of Houston Clear Lake	Zhang, JY (corresponding author), Zhejiang Univ, Inst Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zjy@zju.edu.cn	Ding, Tengda/GWM-8175-2022; Zhang, Jianying/I-9351-2014; Zhang, Chunlong/N-2564-2014; Ding, Tengda/ABG-1481-2021	Zhang, Jianying/0000-0002-1636-5544; Zhang, Chunlong/0000-0003-4782-5424; 	National Natural Science Foundation of China [21177106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant 21177106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2013, APPL SURF SCI, V273, P507, DOI 10.1016/j.apsusc.2013.02.070; Albarelli JQ, 2012, ADSORPT SCI TECHNOL, V30, P227, DOI 10.1260/0263-6174.30.3.227; Alves CCO, 2013, LWT-FOOD SCI TECHNOL, V51, P1, DOI 10.1016/j.lwt.2012.11.012; Benhamou A, 2013, J COLLOID INTERF SCI, V404, P135, DOI 10.1016/j.jcis.2013.04.026; Chang CF, 2012, WATER RES, V46, P2869, DOI 10.1016/j.watres.2012.02.041; Chang FF, 2009, J COLLOID INTERF SCI, V338, P353, DOI 10.1016/j.jcis.2009.06.049; Chen JP, 2006, LANGMUIR, V22, P8906, DOI 10.1021/la060770+; Cui H, 2013, WATER RES, V47, P6258, DOI 10.1016/j.watres.2013.07.040; DRIEHAUS W, 1995, WATER RES, V29, P297, DOI 10.1016/0043-1354(94)E0089-O; Gimenez J, 2007, J HAZARD MATER, V141, P575, DOI 10.1016/j.jhazmat.2006.07.020; Gong B, 1999, SURF INTERFACE ANAL, V28, P126, DOI 10.1002/(SICI)1096-9918(199908)28:1<126::AID-SIA633>3.0.CO;2-V; Goswami B, 2012, LUMINESCENCE, V27, P16, DOI 10.1002/bio.1315; Hao JM, 2009, MICROPOR MESOPOR MAT, V124, P1, DOI 10.1016/j.micromeso.2009.03.021; Heredia A, 2012, PHYCOL RES, V60, P229, DOI 10.1111/j.1440-1835.2012.00652.x; Huang CP, 2007, J CHEM TECHNOL BIOT, V82, P289, DOI 10.1002/jctb.1671; Knoerr R, 2013, MICROPOR MESOPOR MAT, V169, P185, DOI 10.1016/j.micromeso.2012.09.036; Kumar PS, 2010, DESALINATION, V261, P52, DOI 10.1016/j.desal.2010.05.032; Liang XF, 2009, COLLOID SURFACE A, V349, P61, DOI 10.1016/j.colsurfa.2009.07.052; Lim SF, 2009, LANGMUIR, V25, P4973, DOI 10.1021/la802974x; Lin TF, 2001, WATER RES, V35, P2049, DOI 10.1016/S0043-1354(00)00467-X; Deng LP, 2007, J HAZARD MATER, V143, P220, DOI 10.1016/j.jhazmat.2006.09.009; Lu P, 2011, ENVIRON EARTH SCI, V62, P1673, DOI 10.1007/s12665-010-0652-x; Mertens J, 2012, ENVIRON SCI TECHNOL, V46, P7310, DOI 10.1021/es204508t; Mirji SA, 2006, SURF INTERFACE ANAL, V38, P158, DOI 10.1002/sia.2309; Mudhoo A, 2011, CRIT REV ENV SCI TEC, V41, P435, DOI 10.1080/10643380902945771; Nakamura N, 2004, SURF COAT TECH, V186, P339, DOI 10.1016/j.surfcoat.2003.12.005; Pena M, 2006, ENVIRON SCI TECHNOL, V40, P1257, DOI 10.1021/es052040e; Petit C, 2010, CARBON, V48, P1779, DOI 10.1016/j.carbon.2010.01.024; Rahman MS, 2009, CHEM ENG J, V149, P273, DOI 10.1016/j.cej.2008.11.029; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Sari A, 2011, CHEM ENG J, V167, P155, DOI 10.1016/j.cej.2010.12.014; Sharma VK, 2009, ENVIRON INT, V35, P743, DOI 10.1016/j.envint.2009.01.005; Sumper M, 2006, ADV FUNCT MATER, V16, P17, DOI 10.1002/adfm.200500616; Teixeira MC, 2005, ENVIRON SCI TECHNOL, V39, P895, DOI 10.1021/es049513m; Tesson B, 2010, J STRUCT BIOL, V169, P62, DOI 10.1016/j.jsb.2009.08.013; Travlou NA, 2013, LANGMUIR, V29, P1657, DOI 10.1021/la304696y; Wang GJ, 2009, ADV FUNCT MATER, V19, P2768, DOI 10.1002/adfm.200900402; Weng CH, 2007, SEP PURIF TECHNOL, V54, P187, DOI 10.1016/j.seppur.2006.09.009; Wu K, 2011, J ENVIRON ENG-ASCE, V137, P1122, DOI 10.1061/(ASCE)EE.1943-7870.0000432; Wu YH, 2010, WORLD J MICROB BIOT, V26, P249, DOI 10.1007/s11274-009-0167-3; Yagi S, 2013, APPL SURF SCI, V267, P45, DOI 10.1016/j.apsusc.2012.05.098; Yu Y, 2012, SCI TECHNOL ADV MAT, P13	42	30	31	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123395	10.1371/journal.pone.0123395	http://dx.doi.org/10.1371/journal.pone.0123395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837498	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000142
J	de Assis, VR; Titon, SCM; Barsotti, AMG; Titon, B; Gomes, FR				de Assis, Vania Regina; Monteiro Titon, Stefanny Christie; Giorgi Barsotti, Adriana Maria; Titon, Braz, Jr.; Gomes, Fernando Ribeiro			Effects of Acute Restraint Stress, Prolonged Captivity Stress and Transdermal Corticosterone Application on Immunocompetence and Plasma Levels of Corticosterone on the Cururu Toad (Rhinella icterica)	PLOS ONE			English	Article							BASE-LINE CORTICOSTERONE; FROG PLATYMANTIS-VITIANA; IMMUNE FUNCTION; LYMPHOCYTE MITOGENESIS; LOCOMOTOR PERFORMANCE; RESPONSES; GLUCOCORTICOIDS; HYDROCORTISONE; INDICATORS; MORTALITY	Glucocorticoid steroids modulate immunocompetence in complex ways with both immunoenhancing and immunosuppressive effects in vertebrates exposed to different stressors. Such bimodal effects have been associated with variation in duration and intensity of the stress response. Given that natural populations have been exposed to a multitude of stressors, a better understanding of the functional association between duration and intensity of the stress response, the resulting changes in glucocorticoid plasma levels and their impact on different aspects of immunocompetence emerges as a cornerstone for vertebrate conservation strategies. We investigated the effects of a restraint challenge (with and without movement restriction), long-term captivity, and transdermal corticosterone application on plasma levels of corticosterone (hereinafter referred to as CORT) and different parameters of innate immunocompetence in the male cururu toads (Rhinella icterica). We show that for Rhinella icterica restraint for 24h proved to be a stressful condition, increasing CORT by 3-fold without consistent immunological changes. However, the application of a more intense stressor (restraint with movement restriction), for the same period, potentiated this response resulting in a 9-fold increase in CORT, associated with increase Neutrophil/Lymphocyte ratio (N:L) and a lower bacterial killing ability (BKA). Transdermal application of corticosterone efficiently mimics repeated acute stress response events, without changing the immune parameters even after 13 days of treatment. Interestingly, long-term captivity did not mitigate the stress response, since the toads maintained 3-fold increased CORT even after 3 months under these conditions. Moreover, long-term captivity in the same condition increased total leukocyte count (TLC) and generated an even greater decrease in BKA, suggesting that consequences of the stress response can be aggravated by time in captivity.	[de Assis, Vania Regina; Monteiro Titon, Stefanny Christie; Giorgi Barsotti, Adriana Maria; Titon, Braz, Jr.; Gomes, Fernando Ribeiro] Univ Sao Paulo, Dept Fisiol, Inst Biociencias, BR-05508900 Sao Paulo, SP, Brazil	Universidade de Sao Paulo	de Assis, VR (corresponding author), Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Rua Matao,Trav 14,101, BR-05508900 Sao Paulo, SP, Brazil.	v.regina.a@gmail.com	Gomes, Fernando Ribeiro/C-5997-2012; Titon, Stefanny CM/AAL-2887-2021; Assis, Vania R/F-8310-2013	Titon, Stefanny CM/0000-0002-1351-6546; Assis, Vania R/0000-0003-0326-4397; Gomes, Fernando/0000-0003-2244-6161	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through Young Researcher support [2006/54699-1]; FRG, Regular grant for FRG [2013/00900-1]; PhD scholarship [2011/10560-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a PhD scholarship [140272/2011-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through Young Researcher support(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FRG, Regular grant for FRG; PhD scholarship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a PhD scholarship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	The study design, data collection and analysis, decision to publish, or preparation of the manuscript study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through Young Researcher support (2006/54699-1) conducted by FRG, Regular grant for FRG (2013/00900-1) and PhD scholarship (2011/10560-8) for VRA (http://www.fapesp.br), and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a PhD scholarship (140272/2011-9 GD) for VRA (http://www.cnpq.br).	Barriga C, 2002, J NEUROENDOCRINOL, V14, P691, DOI 10.1046/j.1365-2826.2002.00823.x; Bennett AF, 1987, NEW DIRECTIONS ECOLO, P147, DOI DOI 10.1002/MUS.880150105; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berzins LL, 2008, PHYSIOL BIOCHEM ZOOL, V81, P383, DOI 10.1086/529461; BISHOP CR, 1968, J CLIN INVEST, V47, P249, DOI 10.1172/JCI105721; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Brown GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099734; Brown GP, 2011, METHODS ECOL EVOL, V2, P341, DOI 10.1111/j.2041-210X.2011.00090.x; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Campbell T.W., 2006, HEMATOLOGIA BIOQUIMI, P291; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Casto JM, 2001, AM NAT, V157, P408, DOI 10.1086/319318; COHEN JJ, 1972, J IMMUNOL, V108, P841; Cree A, 2003, GEN COMP ENDOCR, V134, P316, DOI 10.1016/S0016-6480(03)00282-X; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Davis AK, 2008, COPEIA, P613, DOI 10.1643/CP-07-133; de Assis VR, 2013, S AM J HERPETOL, V8, P155, DOI 10.2994/SAJH-D-13-00007.1; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Dickens MJ, 2013, GEN COMP ENDOCR, V191, P177, DOI 10.1016/j.ygcen.2013.06.014; Dohm MR, 2002, FUNCT ECOL, V16, P273; FAUCI AS, 1975, IMMUNOLOGY, V28, P669; Fernandes PACM, 2009, THESIS U SAO PAULO; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Fisher JW, 1998, ANNU REV PHARMACOL, V38, P1, DOI 10.1146/annurev.pharmtox.38.1.1; FISHER JW, 1958, P SOC EXP BIOL MED, V97, P502; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; Gilbertson MK, 2003, ENVIRON TOXICOL CHEM, V22, P101, DOI [10.1002/etc.5620220113, 10.1897/1551-5028(2003)022&lt;0101:IITNLF&gt;2.0.CO;2]; Gomes Fernando Ribeiro, 2012, South American Journal of Herpetology, V7, P1; Graham SP, 2012, HORM BEHAV, V62, P146, DOI 10.1016/j.yhbeh.2012.06.001; Hopkins WA, 2011, GEN COMP ENDOCR, V174, P107, DOI 10.1016/j.ygcen.2011.08.006; HUEY RB, 1987, EVOLUTION, V41, P1116, DOI 10.1111/j.1558-5646.1987.tb05880.x; Jain NC, 1986, SCHALMS VET HAEMATOL, P1168; Janin A, 2012, CONSERV BIOL, V26, P923, DOI 10.1111/j.1523-1739.2012.01910.x; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Kinney KS, 1999, MICROB PATHOGENESIS, V26, P85, DOI 10.1006/mpat.1998.0251; Klukowski M, 2011, GEN COMP ENDOCR, V173, P295, DOI 10.1016/j.ygcen.2011.06.006; Maciel NM, 2010, MOL PHYLOGENET EVOL, V57, P787, DOI 10.1016/j.ympev.2010.08.025; Markham JA, 2006, PSYCHONEUROENDOCRINO, V31, P781, DOI 10.1016/j.psyneuen.2006.02.008; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; McCormick GL, 2014, GEN COMP ENDOCR, V204, P135, DOI 10.1016/j.ygcen.2014.04.037; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McMahon TA, 2014, NATURE, V511, P224, DOI 10.1038/nature13491; MEINTS RH, 1973, GEN COMP ENDOCR, V21, P9, DOI 10.1016/0016-6480(73)90151-2; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Mendonca MT, 1996, HORM BEHAV, V30, P153, DOI 10.1006/hbeh.1996.0019; Meylan S, 2003, COMP BIOCHEM PHYS A, V134, P497, DOI 10.1016/S1095-6433(02)00343-4; Mueller C, 2006, GEN COMP ENDOCR, V148, P163, DOI 10.1016/j.ygcen.2006.02.012; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Narayan E, 2011, AUST J ZOOL, V59, P79, DOI 10.1071/ZO11030; Narayan Edward, 2009, Pacific Conservation Biology, V15, P47; Narayan EJ, 2014, J THERM BIOL, V41, P72, DOI 10.1016/j.jtherbio.2014.02.011; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; Patchev Vladimir K, 2006, Dialogues Clin Neurosci, V8, P417; Reynolds SJ, 2009, J HERPETOL, V43, P326, DOI 10.1670/08-062R2.1; Rich EL, 2005, AM J PHYSIOL-REG I, V288, pR1628, DOI 10.1152/ajpregu.00484.2004; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM, 1992, STRESS AGING BRAIN M; Seddon RJ, 2012, J EXP ZOOL PART A, V9999A, P1; Taylor SK, 1999, J WILDLIFE DIS, V35, P49, DOI 10.7589/0090-3558-35.1.49; Titon B, 2010, COMP BIOCHEM PHYS A, V156, P129, DOI 10.1016/j.cbpa.2010.01.009; Wack CL, 2012, COMP BIOCHEM PHYS A, V161, P153, DOI 10.1016/j.cbpa.2011.10.017; Wack CL, 2010, GEN COMP ENDOCR, V169, P269, DOI 10.1016/j.ygcen.2010.09.004; WIEGERS GJ, 1994, ENDOCRINOLOGY, V135, P2351, DOI 10.1210/en.135.6.2351; WIEGERS GJ, 1995, J IMMUNOL, V155, P1893; Wiegers GJ, 1998, TRENDS PHARMACOL SCI, V19, P317, DOI 10.1016/S0165-6147(98)01229-2; WIEGERS GJ, 1993, AM J PHYSIOL, V265, pE825, DOI 10.1152/ajpendo.1993.265.6.E825; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Wingfield John C., 1997, P95; Zamudio SR, 2009, BRAIN RES BULL, V80, P331, DOI 10.1016/j.brainresbull.2009.09.005; ZERANI M, 1993, HORM BEHAV, V27, P29, DOI 10.1006/hbeh.1993.1003	76	54	54	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121005	10.1371/journal.pone.0121005	http://dx.doi.org/10.1371/journal.pone.0121005			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831055	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600052
J	Peng, HK; Marculescu, R				Peng, Huan-Kai; Marculescu, Radu			Multi-Scale Compositionality: Identifying the Compositional Structures of Social Dynamics Using Deep Learning	PLOS ONE			English	Article								Objective Social media exhibit rich yet distinct temporal dynamics which cover a wide range of different scales. In order to study this complex dynamics, two fundamental questions revolve around (1) the signatures of social dynamics at different time scales, and (2) the way in which these signatures interact and form higher-level meanings. Method In this paper, we propose the Recursive Convolutional Bayesian Model (RCBM) to address both of these fundamental questions. The key idea behind our approach consists of constructing a deep-learning framework using specialized convolution operators that are designed to exploit the inherent heterogeneity of social dynamics. RCBM's runtime and convergence properties are guaranteed by formal analyses. Results Experimental results show that the proposed method outperforms the state-of-the-art approaches both in terms of solution quality and computational efficiency. Indeed, by applying the proposed method on two social network datasets, Twitter and Yelp, we are able to identify the compositional structures that can accurately characterize the complex social dynamics from these two social media. We further show that identifying these patterns can enable new applications such as anomaly detection and improved social dynamics forecasting. Finally, our analysis offers new insights on understanding and engineering social media dynamics, with direct applications to opinion spreading and online content promotion.	[Peng, Huan-Kai; Marculescu, Radu] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Peng, HK (corresponding author), Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA.	pumbaapeng@cmu.edu	Marculescu, Radu/AAR-5320-2021	Marculescu, Radu/0000-0003-1826-7646	United States National Science Foundation [CCF-1314876]	United States National Science Foundation(National Science Foundation (NSF))	HP and RM are both funded by the United States National Science Foundation Grant CCF-1314876, Website: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ADV NEURAL INF PROCE, DOI DOI 10.1109/ICIP.2001.958968; Asur S, 2011, P ICWSM; Boureau Y, 2008, ADV NEURAL INFORM PR, P1; Boyd S., 2004, CONVEX OPTIMIZATION; Chen JR, 2007, P 6 AUSTR DAT MIN C; Collobert R., 2011, INT C ART INT STAT; Grosse R, 2007, P UAI; Hinton G. E., 2006, SCIENCE; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; James D, 2012, TIME SERIES ANAL STA; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Kleinberg Jon, 2002, P KDD; Lee H., 2009, P ANN INT C MACH LEA, P609; Lehmann J., 2012, P WWW; Leskovec J., 2005, P KDD; Lin Y, 2008, P WWW; Mitchell T.M, 2003, MACH LEARN; Mueen J, 2012, INT C DAT MIN ICDM; Naaman M, 2011, J AM SOC INF SCI TEC, V62, P902, DOI 10.1002/asi.21489; Nesterov Y, 2007, GRADIENT METHODS MIN; Olshausen BA, 1998, NATURE; Peng HK, 2014, ASE INT C SOC COMP; Peng HK, 2013, P ASONAM; Rakthanmanon T, 2013, P 13 SIAM C; Rakthanmanon T, 2011, INT C DAT MIN ICDM; Romero D. M., 2011, P WWW; Smyth G, 1998, P 3 KDD; Sochard R, 2011, INT C MACH LEARN ICM; Sumi R, 2011, IEEE INT C SOC COMP; Taylor G, 2010, COMP VISIONECCV 2010; Vieweg S, 2010, P CHI; Yang Jaewon, 2011, P WSDM; Yelp, 2014, YELP DAT CHALL; Zeiler MD, 2010, PROC CVPR IEEE, P2528, DOI 10.1109/CVPR.2010.5539957	34	21	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0118309	10.1371/journal.pone.0118309	http://dx.doi.org/10.1371/journal.pone.0118309			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830775	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600001
J	Rahmati, M; Davarynejad, GH; Genard, M; Bannayan, M; Azizi, M; Vercambre, G				Rahmati, Mitra; Davarynejad, Gholam Hossein; Genard, Michel; Bannayan, Mohammad; Azizi, Majid; Vercambre, Gilles			Peach Water Relations, Gas Exchange, Growth and Shoot Mortality under Water Deficit in Semi-Arid Weather Conditions	PLOS ONE			English	Article							MESOPHYLL DIFFUSION CONDUCTANCE; CARBOHYDRATE REQUIREMENTS; VEGETATIVE GROWTH; HIGH-TEMPERATURE; PRUNUS-PERSICA; RAPID GROWTH; FINAL STAGE; DROUGHT; TREE; STRESS	In this study the sensitivity of peach tree (Prunus persica L.) to three water stress levels from mid-pit hardening until harvest was assessed. Seasonal patterns of shoot and fruit growth, gas exchange (leaf photosynthesis, stomatal conductance and transpiration) as well as carbon (C) storage/mobilization were evaluated in relation to plant water status. A simple C balance model was also developed to investigate sink-source relationship in relation to plant water status at the tree level. The C source was estimated through the leaf area dynamics and leaf photosynthesis rate along the season. The C sink was estimated for maintenance respiration and growth of shoots and fruits. Water stress significantly reduced gas exchange, and fruit, and shoot growth, but increased fruit dry matter concentration. Growth was more affected by water deficit than photosynthesis, and shoot growth was more sensitive to water deficit than fruit growth. Reduction of shoot growth was associated with a decrease of shoot elongation, emergence, and high shoot mortality. Water scarcity affected tree C assimilation due to two interacting factors: (i) reduction in leaf photosynthesis (-23% and -50% under moderate (MS) and severe (SS) water stress compared to low (LS) stress during growth season) and (ii) reduction in total leaf area (-57% and -79% under MS and SS compared to LS at harvest). Our field data analysis suggested Psi(stem) threshold of -1.5 MPa below which daily net C gain became negative, i.e. C assimilation became lower than C needed for respiration and growth. Negative C balance under MS and SS associated with decline of trunk carbohydrate reserves -may have led to drought-induced vegetative mortality.	[Rahmati, Mitra; Genard, Michel; Vercambre, Gilles] INRA, Plantes & Syst Culture Horticoles UR1115, Avignon, France; [Rahmati, Mitra; Davarynejad, Gholam Hossein; Bannayan, Mohammad; Azizi, Majid] Ferdowsi Univ Mashhad, Fac Agr, Mashhad, Iran	INRAE; Ferdowsi University Mashhad	Vercambre, G (corresponding author), INRA, Plantes & Syst Culture Horticoles UR1115, Site Agroparc, Avignon, France.	Gilles.vercambre@avignon.inra.fr	Aval, Mohammad Bannayan/P-7996-2019; Bannayan, Mohammad/A-2554-2009; davarynrjad, gholamhossein/M-2851-2018; Azizi, Majid/AAA-3124-2020; Rahmati, Mitra/Q-1140-2019	Bannayan, Mohammad/0000-0001-6076-6196; davarynrjad, gholamhossein/0000-0001-9931-1623; Azizi, Majid/0000-0002-8813-4518; Rahmati, Mitra/0000-0001-9079-5262	Institut national de la recherche agronomique (INRA) Grant [ACCAFCAQ40]; Agricultural Research In the Mediterranean area (ARIMNET) - Apple and Peach in Mediterranean orchards (APMED) Grant [ANR-12-AGRI-0001]	Institut national de la recherche agronomique (INRA) Grant; Agricultural Research In the Mediterranean area (ARIMNET) - Apple and Peach in Mediterranean orchards (APMED) Grant	This research was supported by the Institut national de la recherche agronomique (INRA) Grant no. ACCAFCAQ40, and Agricultural Research In the Mediterranean area (ARIMNET) - Apple and Peach in Mediterranean orchards (APMED) Grant no. ANR-12-AGRI-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Ben Mimoun M., 1999, Fruits (Paris), V54, P129; Besset J, 2001, SCI HORTIC-AMSTERDAM, V91, P289, DOI 10.1016/S0304-4238(01)00272-2; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Centritto M, 2002, TREE PHYSIOL, V22, P699, DOI 10.1093/treephys/22.10.699; Choat B, 2013, TREE PHYSIOL, V33, P669, DOI 10.1093/treephys/tpt046; Cui NB, 2009, AGR WATER MANAGE, V96, P1237, DOI 10.1016/j.agwat.2009.03.015; Da Silva D, 2013, 7 INT WORKSH FUNCT S, P258; Da Silva D, 2011, ANN BOT-LONDON, V108, P1135, DOI 10.1093/aob/mcr072; DeJong T. M., 2008, The peach: botany, production and uses, P244, DOI 10.1079/9781845933869.0244; DEJONG TM, 1989, TREE PHYSIOL, V5, P329, DOI 10.1093/treephys/5.3.329; Egea G, 2013, IRRIGATION SCI, V31, P445, DOI 10.1007/s00271-012-0322-8; Egea G, 2011, AGR FOREST METEOROL, V151, P1370, DOI 10.1016/j.agrformet.2011.05.019; Esparza G, 2001, TREE PHYSIOL, V21, P1073, DOI 10.1093/treephys/21.14.1073; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; Gomez L, 2007, J SCI FOOD AGR, V87, P1893, DOI 10.1002/jsfa.2924; Griffiths H, 2013, PLANT CELL ENVIRON, V36, P733, DOI 10.1111/pce.12075; GROSSMAN YL, 1995, ANN BOT-LONDON, V76, P473, DOI 10.1006/anbo.1995.1122; GROSSMAN YL, 1994, TREE PHYSIOL, V14, P37, DOI 10.1093/treephys/14.1.37; Hartmann H, 2013, FUNCT ECOL, V27, P413, DOI 10.1111/1365-2435.12046; HIGGINS SS, 1992, SCI HORTIC-AMSTERDAM, V52, P313, DOI 10.1016/0304-4238(92)90032-8; HIPPS NA, 1995, TREE PHYSIOL, V15, P95, DOI 10.1093/treephys/15.2.95; Hsiao TC, 2000, J EXP BOT, V51, P1595, DOI 10.1093/jexbot/51.350.1595; Johnson R. S., 2008, The peach: botany, production and uses, P303, DOI 10.1079/9781845933869.0303; Jordan MO, 1996, J EXP BOT, V47, P79, DOI 10.1093/jxb/47.1.79; Lescourret F, 1998, EUR J AGRON, V9, P173, DOI 10.1016/S1161-0301(98)00035-5; LI SH, 1989, J HORTIC SCI, V64, P541, DOI 10.1080/14620316.1989.11515989; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Mercier V, 2009, IRRIGATION SCI, V27, P297, DOI 10.1007/s00271-009-0146-3; Miras-Avalos JM, 2011, TREES-STRUCT FUNCT, V25, P785, DOI 10.1007/s00468-011-0555-9; Muller B, 2011, J EXP BOT, V62, P1715, DOI 10.1093/jxb/erq438; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; Penning de Vries FWT, 1989, SIMULATION ECOPHYSIO; Quilot B, 2004, J HORTIC SCI BIOTECH, V79, P546, DOI 10.1080/14620316.2004.11511803; Rieger M, 2003, TREE PHYSIOL, V23, P51, DOI 10.1093/treephys/23.1.51; Romero P, 2006, TREE PHYSIOL, V26, P1537, DOI 10.1093/treephys/26.12.1537; Rosati A, 2006, J HORTIC SCI BIOTECH, V81, P415, DOI 10.1080/14620316.2006.11512082; Sala A, 2012, TREE PHYSIOL, V32, P764, DOI 10.1093/treephys/tpr143; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Vico G, 2008, PLANT SOIL, V313, P187, DOI 10.1007/s11104-008-9691-4; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Walcroft AS, 2004, TREE PHYSIOL, V24, P313, DOI 10.1093/treephys/24.3.313; Woodruff DR, 2011, PLANT CELL ENVIRON, V34, P1920, DOI 10.1111/j.1365-3040.2011.02388.x; Yadollahi A, 2011, SCI HORTIC-AMSTERDAM, V129, P403, DOI 10.1016/j.scienta.2011.04.007; Yuan JH, 2009, PLANT SCI, V177, P691, DOI 10.1016/j.plantsci.2009.09.006; Zhao JB, 2013, NEW PHYTOL, V200, P330, DOI 10.1111/nph.12400; Zweifel R, 2006, J EXP BOT, V57, P1445, DOI 10.1093/jxb/erj125	50	36	39	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120246A	10.1371/journal.pone.0120246	http://dx.doi.org/10.1371/journal.pone.0120246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830350	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600026
J	Tuhebwe, D; Bagonza, J; Kiracho, EE; Yeka, A; Elliott, AM; Nuwaha, F				Tuhebwe, Doreen; Bagonza, James; Kiracho, Elizabeth Ekirapa; Yeka, Adoke; Elliott, Alison M.; Nuwaha, Fred			Uptake of Mass Drug Administration Programme for Schistosomiasis Control in Koome Islands, Central Uganda	PLOS ONE			English	Article							SOIL-TRANSMITTED HELMINTHS; NEGLECTED TROPICAL DISEASES; MANSONI; PRAZIQUANTEL	Introduction Schistosomiasis is one of the neglected tropical diseases targeted for elimination in Uganda through the Mass Drug Administration (MDA) programme. Praziquantel has been distributed using community resource persons in fixed sites and house-to-house visits; however the uptake is still below target coverage. In 2011/2012 MDA exercise, uptake stood at 50% yet WHO target coverage is 75% at community level. We assessed the uptake of MDA and the associated factors in Koome Islands, Central Uganda. Methods In March 2013, we conducted a mixed methods cross sectional study in 15 randomly selected villages. We interviewed a total of 615 respondents aged 18 years and above using semi structured questionnaires and five key informants were also purposively selected. Univariate and multivariate analysis was done. MDA uptake was defined as self reported swallowing of praziquantel during the last (2012) MDA campaign. We conducted key informant interviews with Ministry of Health, district health personnel and community health workers. Results Self reported uptake of praziquantel was 44.7% (275/615), 95% confidence interval (CI) 40.8-48.7%. Of the 275 community members who said they had swallowed praziquantel, 142 (51.6%) reported that they had developed side effects. Uptake of MDA was more likely if the respondent was knowledgeable about schistosomiasis transmission and prevention (adjusted odds ratio [AOR] 1.85, 95% CI 1.22-2.81) and reported to have received health education from the health personnel (AOR 5.95, 95% CI 3.67-9.65). Service delivery challenges such as drug shortages and community health worker attrition also influenced MDA in Koome Islands. Conclusions Uptake of MDA for schistosomiasis control in Koome was sub optimal. Lack of knowledge about schistosomiasis transmission and prevention, inadequate health education and drug shortages are some of the major factors associated with low uptake. These could be addressed through routine health education and systematic drug supply for the successful elimination of schistosomiasis on the islands.	[Tuhebwe, Doreen; Bagonza, James; Kiracho, Elizabeth Ekirapa] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Yeka, Adoke; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Elliott, Alison M.] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Elliott, Alison M.] London Sch Hyg & Trop Med, London WC1, England	Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Tuhebwe, D (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda.	tuhereen@yahoo.com		Elliott, Alison/0000-0003-2818-9549	Wellcome Trust Uganda Masters Fellowship - Wellcome Trust Strategic Award [084344]	Wellcome Trust Uganda Masters Fellowship - Wellcome Trust Strategic Award	This work was supported by a Wellcome Trust Uganda Masters Fellowship in Infection and Immunity held by Doreen Tuhebwe (DT), funded by a Wellcome Trust Strategic Award, grant number 084344. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; DHO, 2011, DISTR ANN REP; Doris Njomo W, 2012, AFRICAN J HLTH SCI, V20, P1; French MD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000897; HSSIP, 2010, UG HLTH SECT STRAT I; Kabatereine NB, 2006, TRENDS PARASITOL, V22, P332, DOI 10.1016/j.pt.2006.05.001; Kabatereine NB, 2003, T ROY SOC TROP MED H, V97, P599, DOI 10.1016/S0035-9203(03)80044-5; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; Kish L., 1965, SURVEY SAMPLING POPU; Kolaczinski JH, 2006, NEGLECTED TROPICAL D; Likert R., 1931, ARCH PSYCHOL; MoH, 2010, UG HLTH SECT STRAT I; MOH, 2010, VILL HLTH TEAM VHT H; Montresor A, 2002, HELMINTHS CONTROL SC; Muhumuza S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063438; Nsowah-Nuamah NNN, 2001, AM J TROP MED HYG, V65, P484, DOI 10.4269/ajtmh.2001.65.484; Odongkara K, 2006, CONTRIBUTION LAKE VI; Omedo MO, 2012, AM J TROP MED HYG; Park B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-218; Parker M, 2008, J BIOSOC SCI, V40, P161, DOI 10.1017/S0021932007002301; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Utzinger J, 2003, LANCET, V362, P1932, DOI 10.1016/S0140-6736(03)14968-9; WHO, 2008, PHARMAFORUM 0121; WHO, 2012, SCHIST PROGR REP 200, DOI [10.1016/j.parint.2011.10.006, DOI 10.1016/J.PARINT.2011.10.006]; World Health Organization, 2002, WHO TECHN REP SER; World Health Organization, 2001, WORLD HLTH REP; World Health Organization (WHO), 2012, WPRRC636 WHO	30	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123673	10.1371/journal.pone.0123673	http://dx.doi.org/10.1371/journal.pone.0123673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830917	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000352135600151
J	Bachas, C; Schuurhuls, GJ; Zwaan, CM; van den Heuvel-Eibrink, MM; den Boer, ML; de Bont, ESJM; Kwidama, ZJ; Reinhardt, D; Creutzig, U; de Haas, V; Kaspers, GJL; Cloos, J				Bachas, Costa; Schuurhuls, Gerrit Jan; Zwaan, C. Michel; van den Heuvel-Eibrink, Marry M.; den Boer, Monique L.; de Bont, Eveline S. J. M.; Kwidama, Zinia J.; Reinhardt, Dirk; Creutzig, Ursula; de Haas, Valerie; Kaspers, Gertjan J. L.; Cloos, Jacqueline			Gene Expression Profiles Associated with Pediatric Relapsed AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; C/EBP-ALPHA; INTEGRATIVE ANALYSIS; CLONAL EVOLUTION; DRUG-RESISTANCE; CEBPA MUTATIONS; HIGH-FREQUENCY; 1ST RELAPSE; DIAGNOSIS; SATB1	Development of relapse remains a problem for further improvements in the survival of pediatric AML patients. While virtually all patients show a good response to initial treatment, more patients respond poorly when treated at relapse. The cellular characteristics of leukemic blast cells that allow survival of initial treatment, relapse development and subsequent resistance to salvage treatment remain largely elusive. Therefore, we studied if leukemic blasts at relapse biologically resemble their initial diagnosis counterparts. We performed microarray gene expression profiling on paired initial and relapse samples of 23 pediatric AML patients. In 11 out of 23 patients, gene expression profiles of initial and corresponding relapse samples end up in different clusters in unsupervised analysis, indicating altered gene expression profiles. In addition, shifts in type I/II mutational status were found in 5 of these 11 patients, while shifts were found in 3 of the remaining 12 patients. Although differentially expressed genes varied between patients, they were commonly related to hematopoietic differentiation, encompassed genes involved in chromatin remodeling and showed associations with similar transcription factors. The top five were CEBPA, GFI1, SATB1, KLF2 and TBP. In conclusion, the leukemic blasts at relapse are biologically different from their diagnosis counterparts. These differences may be exploited for further development of novel treatment strategies.	[Bachas, Costa; Kwidama, Zinia J.; Kaspers, Gertjan J. L.; Cloos, Jacqueline] Vrije Univ Amsterdam Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands; [Bachas, Costa; Schuurhuls, Gerrit Jan; Cloos, Jacqueline] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands; [Zwaan, C. Michel; van den Heuvel-Eibrink, Marry M.; den Boer, Monique L.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Div Pediat Oncol Hematol, Groningen, Netherlands; [Reinhardt, Dirk; Creutzig, Ursula] Hannover Med Sch, Dept Pediat Hematol Oncol, AML BFM Study Grp, Hannover, Germany; [de Haas, Valerie; Kaspers, Gertjan J. L.] DCOG, The Hague, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Groningen; Hannover Medical School; Dutch Childhood Oncology Group	Cloos, J (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands.	j.cloos@vumc.nl	Bachas, Costa/AAO-6608-2020; Reinhardt, Dirk/N-7003-2016; Kaspers, Gertjan/ABC-5334-2020	Bachas, Costa/0000-0001-5983-6193; Reinhardt, Dirk/0000-0002-7027-4483; Kaspers, Gertjan/0000-0001-7716-8475; den Boer, Monique/0000-0002-5795-2921; Cloos, Jacqueline/0000-0001-9150-8026	Dutch Cancer Society [VU 2005-3666]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was financially supported by the Dutch Cancer Society (VU 2005-3666, J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson J, 2011, J CLIN ONCOL, V29, P310, DOI 10.1200/JCO.2010.30.6829; Bachas C, 2012, LEUKEMIA, V26, P1313, DOI 10.1038/leu.2011.383; Bachas C, 2010, BLOOD, V116, P2752, DOI 10.1182/blood-2010-03-276519; Baer MR, 2001, BLOOD, V97, P3574, DOI 10.1182/blood.V97.11.3574; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P1478, DOI 10.3324/haematol.2010.038976; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P221, DOI 10.3324/haematol.2010.029660; Balgobind BV, 2009, BLOOD, V114, P2489, DOI 10.1182/blood-2009-04-215152; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Capizzi RL, 1996, INVEST NEW DRUG, V14, P249, DOI 10.1007/BF00194527; Cloos J, 2006, LEUKEMIA, V20, P1217, DOI 10.1038/sj.leu.2404246; Creutzig U, 2012, BLOOD, V120, P3187, DOI 10.1182/blood-2012-03-362608; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dufour A, 2010, J CLIN ONCOL, V28, P570, DOI 10.1200/JCO.2008.21.6010; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; ESTEY E, 1995, LEUKEMIA, V9, P972; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Guillemin C, 2009, STEM CELLS, V27, P108, DOI 10.1634/stemcells.2008-0755; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Helbling D, 2004, P NATL ACAD SCI USA, V101, P13312, DOI 10.1073/pnas.0404731101; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Ho PA, 2009, BLOOD, V113, P6558, DOI 10.1182/blood-2008-10-184747; Hollink IHIM, 2011, HAEMATOL-HEMATOL J, V96, P384, DOI 10.3324/haematol.2010.031336; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jan M, 2013, ONCOGENE, V32, P135, DOI 10.1038/onc.2012.48; Ji Q, 2014, BRIT J CANCER, P1, DOI [10.1038/bjc.2014.144, DOI 10.1038/BJC.2014.144]; Kaspers CJL, 1999, KLIN PADIATR, V211, P239, DOI 10.1055/s-2008-1043795; Kaspers GJL, 2013, J CLIN ONCOL, V31, P599, DOI 10.1200/JCO.2012.43.7384; Kaspers GJL, 2005, LEUKEMIA, V19, P2025, DOI 10.1038/sj.leu.2403958; KASPERS GJL, 1994, BRIT J CANCER, V70, P1047, DOI 10.1038/bjc.1994.446; Kato N, 2011, BLOOD, V117, P221, DOI 10.1182/blood-2010-02-270181; Kern W, 2002, LEUKEMIA, V16, P2084, DOI 10.1038/sj.leu.2402654; Kohwi-Shigematsu T, 2012, SEMIN CANCER BIOL; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Langebrake C, 2005, CYTOM PART B-CLIN CY, V63B, P1, DOI 10.1002/cyto.b.20037; Leopold LH, 2002, LEUKEMIA LYMPHOMA, V43, P1715, DOI 10.1080/1042819021000006529; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; MANNIRONI C, 1988, CANCER RES, V48, P3670; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rockova V, 2011, BLOOD, V118, P1069, DOI 10.1182/blood-2011-02-334748; Rubnitz JE, 2007, CANCER, V109, P157, DOI 10.1002/cncr.22385; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sander A, 2010, LEUKEMIA, V24, P1422, DOI 10.1038/leu.2010.127; Staal FJT, 2003, LEUKEMIA, V17, P1324, DOI 10.1038/sj.leu.2402974; Staffas A, 2011, BLOOD, V118, P5905, DOI 10.1182/blood-2011-05-353185; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Taskesen E, 2011, BLOOD, V117, P2469, DOI 10.1182/blood-2010-09-307280; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Webb DKH, 1999, BRIT J HAEMATOL, V106, P851, DOI 10.1046/j.1365-2141.1999.01629.x; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Wheat JC, 2014, THE COREPRESSOR TLE4, P9; Wheatley K, 1999, BRIT J HAEMATOL, V107, P69, DOI 10.1046/j.1365-2141.1999.01684.x; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Yamaguchi H, 2006, J BIOL CHEM, V281, P5319, DOI 10.1074/jbc.M510933200; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zeppezauer M, 2007, ASH ANNU MEET ABSTR, V110, P918	69	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121730	10.1371/journal.pone.0121730	http://dx.doi.org/10.1371/journal.pone.0121730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849371	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800075
J	Benchimol, EI; Manuel, DG; To, T; Mack, DR; Nguyen, GC; Gommerman, JL; Croitoru, K; Mojaverian, N; Wang, X; Quach, P; Guttmann, A				Benchimol, Eric I.; Manuel, Douglas G.; To, Teresa; Mack, David R.; Nguyen, Geoffrey C.; Gommerman, Jennifer L.; Croitoru, Kenneth; Mojaverian, Nassim; Wang, Xuesong; Quach, Pauline; Guttmann, Astrid			Asthma, Type 1 and Type 2 Diabetes Mellitus, and Inflammatory Bowel Disease amongst South Asian Immigrants to Canada and Their Children: A Population-Based Cohort Study	PLOS ONE			English	Article							ADMINISTRATIVE DATA ALGORITHM; ULCERATIVE-COLITIS; BRITISH-COLUMBIA; PREVALENCE; ONTARIO; RISK; LEICESTERSHIRE; VALIDATION; WHITE; UK	BACKGROUND There is a high and rising rate of immune-mediated diseases in the Western world. Immigrants from South Asia have been reported to be at higher risk upon arrival to the West. We determined the risk of immune-mediated diseases in South Asian and other immigrants to Ontario, Canada, and their Ontario-born children. METHODS Population-based cohorts of patients with asthma, type 1 diabetes (T1DM), type 2 diabetes (T2DM), and inflammatory bowel disease (IBD) were derived from health administrative data. We determined the standardized incidence, and the adjusted risk of these diseases in immigrants from South Asia, immigrants from other regions, compared with non-immigrant residents of Ontario. The risk of these diseases in the Ontario-born children of immigrants were compared to the children of non-immigrants. RESULTS Compared to non-immigrants, adults from South Asia had higher risk of asthma (IRR 1.56, 95%CI 1.51-1.61) and T2DM (IRR 2.59, 95%CI 2.53-2.65). Adults from South Asia had lower incidence of IBD than non-immigrants (IRR 0.32, 95%CI 0.22-0.49), as did immigrants from other regions (IRR 0.29, 95%CI 0.20-0.42). Compared to non-immigrant children, the incidence of asthma (IRR 0.66, 95%CI 0.62-0.71) and IBD (IRR 0.47, 95%CI 0.33-0.67) was low amongst immigrant children from South Asia. However, the risk in Ontario-born children of South Asian immigrants relative to the children of non-immigrants was higher for asthma (IRR 1.75, 95%CI 1.69-1.81) and less attenuated for IBD (IRR 0.90, 95%CI 0.65-1.22). CONCLUSION Early-life environmental exposures may trigger a genetic predisposition to the development of asthma and IBD in South Asian immigrants and their Canada-born children.	[Benchimol, Eric I.; Mack, David R.; Quach, Pauline] Childrens Hosp Eastern Ontario, Ctr Inflammatory Bowel Dis, Div Gastroenterol Hepatol & Nutr, Ottawa, ON K1H 8L1, Canada; [Benchimol, Eric I.; Mack, David R.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Benchimol, Eric I.] Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON K1N 6N5, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Benchimol, Eric I.; Manuel, Douglas G.; Nguyen, Geoffrey C.; Mojaverian, Nassim; Wang, Xuesong; Quach, Pauline; Guttmann, Astrid] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [To, Teresa] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Guttmann, Astrid] Hosp Sick Children, Div Pediat Med, Toronto, ON M5G 1X8, Canada; [Nguyen, Geoffrey C.; Croitoru, Kenneth] Mt Sinai Ctr Inflammatory Bowel Dis, Toronto, ON, Canada; [To, Teresa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Nguyen, Geoffrey C.; Croitoru, Kenneth] Univ Toronto, Dept Med, Toronto, ON, Canada; [To, Teresa; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Nguyen, Geoffrey C.; Guttmann, Astrid] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Guttmann, Astrid] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Benchimol, EI (corresponding author), Childrens Hosp Eastern Ontario, Ctr Inflammatory Bowel Dis, Div Gastroenterol Hepatol & Nutr, Ottawa, ON K1H 8L1, Canada.	ebenchimol@cheo.on.ca	Croitoru, Kenneth/C-4604-2015; Benchimol, Eric Ian/A-7711-2010; Nguyen, Geoffrey C/C-4614-2015; Manuel, Doug/D-7100-2014	Croitoru, Kenneth/0000-0003-1231-0180; Benchimol, Eric Ian/0000-0001-8855-3598; Nguyen, Geoffrey C/0000-0001-7083-7429; Manuel, Doug/0000-0003-0912-0845; Gommerman, Jennifer/0000-0003-4576-6168	Ontario Ministry of Health and Long-Term Care Academic Health Sciences Centre Alternate Funding Plan Innovation Fund; Faculty of Medicine, University of Toronto	Ontario Ministry of Health and Long-Term Care Academic Health Sciences Centre Alternate Funding Plan Innovation Fund; Faculty of Medicine, University of Toronto(University of Toronto)	Funding from: (1) Ontario Ministry of Health and Long-Term Care Academic Health Sciences Centre Alternate Funding Plan Innovation Fund. The funders had no role in the study design or conduct, interpretation of the results, or authorship of the manuscript. Researchers were considered independent from the funders. (2) Faculty of Medicine, University of Toronto. The funders had no role in the study design or conduct, interpretation of the results, or authorship of the manuscript. Researchers were considered independent from the funders.	Agrawal S, 2013, INT J TUBERC LUNG D, V17, P275, DOI 10.5588/ijtld.12.0438; Amed S, 2010, DIABETES CARE, V33, P786, DOI 10.2337/dc09-1013; [Anonymous], 2013, WORLD BANK COUNTR LE; Aujnarain Amiirah, 2013, Curr Gastroenterol Rep, V15, P326, DOI 10.1007/s11894-013-0326-4; Barreiro-de Acosta M, 2011, J CROHNS COLITIS, V5, P566, DOI 10.1016/j.crohns.2011.05.009; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Carlsson AC, 2013, DIABETES RES CLIN PR, V100, P404, DOI 10.1016/j.diabres.2013.03.014; Carr I, 1999, AM J GASTROENTEROL, V94, P2918, DOI 10.1016/S0002-9270(99)00494-3; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; GUJRAL JS, 1994, DIABETIC MED, V11, P570, DOI 10.1111/j.1464-5491.1994.tb02037.x; Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x; HAWTHORNE K, 1993, DIABETIC MED, V10, P8, DOI 10.1111/j.1464-5491.1993.tb01989.x; Huang YJ, 2013, CURR ALLERGY ASTHM R, V13, P453, DOI 10.1007/s11882-013-0355-y; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Mangat BK, 2011, CAN J GASTROENTEROL, V25, P73, DOI 10.1155/2011/640920; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; Milan A., 2010, PORTRAIT COUPLES MIX; PARTRIDGE MR, 1979, CLIN ALLERGY, V9, P489, DOI 10.1111/j.1365-2222.1979.tb02513.x; Penno MAS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-124; Pinsk V, 2007, AM J GASTROENTEROL, V102, P1077, DOI 10.1111/j.1572-0241.2007.01124.x; Ranasinghe P, 2013, J DIABETES, V5, P34, DOI 10.1111/1753-0407.12003; Raymond NT, 2001, DIABETOLOGIA, V44, pB32, DOI 10.1007/PL00002951; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587; Statistics Canada, POP DWELL COUNTS CAN; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; Tsironi E, 2004, AM J GASTROENTEROL, V99, P1749, DOI 10.1111/j.1572-0241.2004.30445.x; Wandell PE, 2010, CURR DIABETES REV, V6, P126, DOI 10.2174/157339910790909404	31	36	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123599	10.1371/journal.pone.0123599	http://dx.doi.org/10.1371/journal.pone.0123599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849480	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800244
J	Hildebrand, A; Kasuga, T; Fan, ZL				Hildebrand, Amanda; Kasuga, Takao; Fan, Zhiliang			Production of Cellobionate from Cellulose Using an Engineered Neurospora crassa Strain with Laccase and Redox Mediator Addition	PLOS ONE			English	Article							LACTOBIONIC ACID PRODUCTION; PAPER PULP; DEHYDROGENASE; PURIFICATION; WHEY; EXPRESSION; INDUCTION; COPPER	We report a novel production process for cellobionic acid from cellulose using an engineered fungal strain with the exogenous addition of laccase and a redox mediator. A previously engineered strain of Neurospora crassa (F5 Delta ace-1 Delta cre-1 Delta ndvB) was shown to produce cellobionate directly from cellulose without the addition of exogenous cellulases. Specifically, N. crassa produces cellulases, which hydrolyze cellulose to cellobiose, and cellobiose dehydrogenase (CDH), which oxidizes cellobiose to cellobionate. However, the conversion of cellobiose to cellobionate is limited by the slow re-oxidation of CDH by molecular oxygen. By adding low concentrations of laccase and a redox mediator to the fermentation, CDH can be efficiently oxidized by the redox mediator, with in-situ re-oxidation of the redox mediator by laccase. The conversion of cellulose to cellobionate was optimized by evaluating pH, buffer, and laccase and redox mediator addition time on the yield of cellobionate. Mass and material balances were performed, and the use of the native N. crassa laccase in such a conversion system was evaluated against the exogenous Pleurotus ostreatus laccase. This paper describes a working concept of cellobionate production from cellulose using the CDH-ATBS-laccase system in a fermentation system.	[Hildebrand, Amanda; Fan, Zhiliang] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA; [Kasuga, Takao] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Kasuga, Takao] USDA ARS, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Fan, ZL (corresponding author), Univ Calif Davis, Dept Biol & Agr Engn, One Shields Ave, Davis, CA 95616 USA.	jzfan@ucdavis.edu			Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-67009-20060]; EPA Star fellowship; Cota-Robles fellowship; ARS [ARS-0423014] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; EPA Star fellowship(United States Environmental Protection Agency); Cota-Robles fellowship; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The project was supported by the Agriculture and Food Research Initiative Competitive Grant No. 2011-67009-20060 from the USDA National Institute of Food and Agriculture. The authors also acknowledge funding support to Amanda Hildebrand from EPA Star fellowship and Cota-Robles fellowship.	Alonso S, 2013, BIOTECHNOL ADV, V31, P1275, DOI 10.1016/j.biotechadv.2013.04.010; Alonso S, 2012, BIORESOURCE TECHNOL, V109, P140, DOI 10.1016/j.biortech.2012.01.045; Alonso S, 2011, BIORESOURCE TECHNOL, V102, P9730, DOI 10.1016/j.biortech.2011.07.089; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Baminger U, 2001, J MOL CATAL B-ENZYM, V11, P541, DOI 10.1016/S1381-1177(00)00034-5; Baminger U, 1999, J MICROBIOL METH, V35, P253, DOI 10.1016/S0167-7012(99)00022-6; BAO WJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P705, DOI 10.1006/abbi.1993.1098; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Camarero S, 2007, ENZYME MICROB TECH, V40, P1264, DOI 10.1016/j.enzmictec.2006.09.016; Canas AI, 2007, ENVIRON SCI TECHNOL, V41, P2964, DOI 10.1021/es062328j; Demain AL, 2007, IND BIOTECHNOL, V3, P269, DOI DOI 10.1089/IND.2007.3.269; Fan ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031693; FROEHNER SC, 1974, J BACTERIOL, V120, P450, DOI 10.1128/JB.120.1.450-457.1974; GESSNER MO, 1991, MICROBIAL ECOL, V22, P285, DOI 10.1007/BF02540230; Gutierrez A, 2007, ENVIRON SCI TECHNOL, V41, P4124, DOI 10.1021/es062723+; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hildebrand A, 2015, APPL ENVIRON MICROB, V81, P597, DOI 10.1128/AEM.02885-14; HUBER M, 1987, FEBS LETT, V219, P335, DOI 10.1016/0014-5793(87)80247-8; Jang YS, 2012, BIOTECHNOL BIOENG, V109, P2437, DOI 10.1002/bit.24599; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; LINDEN RM, 1991, CURR GENET, V19, P375; Luke AK, 2001, ENZYME MICROB TECH, V29, P348, DOI 10.1016/S0141-0229(01)00390-8; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Madhavi V, 2009, BIORESOURCES, V4, P1694; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Miyamoto Y, 2000, BIOTECHNOL LETT, V22, P427, DOI 10.1023/A:1005617903152; More S.S., 2011, ENZYM RES; Murakami H., 2003, Journal of Applied Glycoscience, V50, P117; Okamoto Kenji, 2000, Mycoscience, V41, P7, DOI 10.1007/BF02464380; Roy BP, 1996, APPL ENVIRON MICROB, V62, P4417, DOI 10.1128/AEM.62.12.4417-4427.1996; Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006; SCHILLING B, 1992, CURR GENET, V22, P197, DOI 10.1007/BF00351726; TAMARU H, 1989, J BACTERIOL, V171, P6288, DOI 10.1128/jb.171.11.6288-6293.1989; Van Hecke W, 2009, BIOTECHNOL BIOENG, V102, P1475, DOI 10.1002/bit.22165; Wu WH, 2013, ENZYME MICROB TECH, V52, P184, DOI 10.1016/j.enzmictec.2012.12.010; Zhang RF, 2011, PROTEIN EXPRES PURIF, V75, P63, DOI 10.1016/j.pep.2010.08.003	36	11	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123006	10.1371/journal.pone.0123006	http://dx.doi.org/10.1371/journal.pone.0123006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849253	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800193
J	Liu, YS; Cai, JF; Zhan, ZF; Guo, D; Ye, J; Chen, Z; Qu, XB				Liu, Yunsong; Cai, Jian-Feng; Zhan, Zhifang; Guo, Di; Ye, Jing; Chen, Zhong; Qu, Xiaobo			Balanced Sparse Model for Tight Frames in Compressed Sensing Magnetic Resonance Imaging	PLOS ONE			English	Article							RECONSTRUCTION; REPRESENTATIONS; MRI; RESTORATION; ALGORITHMS	Compressed sensing has shown to be promising to accelerate magnetic resonance imaging. In this new technology, magnetic resonance images are usually reconstructed by enforcing its sparsity in sparse image reconstruction models, including both synthesis and analysis models. The synthesis model assumes that an image is a sparse combination of atom signals while the analysis model assumes that an image is sparse after the application of an analysis operator. Balanced model is a new sparse model that bridges analysis and synthesis models by introducing a penalty term on the distance of frame coefficients to the range of the analysis operator. In this paper, we study the performance of the balanced model in tight frame based compressed sensing magnetic resonance imaging and propose a new efficient numerical algorithm to solve the optimization problem. By tuning the balancing parameter, the new model achieves solutions of three models. It is found that the balanced model has a comparable performance with the analysis model. Besides, both of them achieve better results than the synthesis model no matter what value the balancing parameter is. Experiment shows that our proposed numerical algorithm constrained split augmented Lagrangian shrinkage algorithm for balanced model (C-SALSA-B) converges faster than previously proposed algorithms accelerated proximal algorithm (APG) and alternating directional method of multipliers for balanced model (ADMM-B).	[Liu, Yunsong; Zhan, Zhifang; Ye, Jing; Chen, Zhong; Qu, Xiaobo] Xiamen Univ, Fujian Prov Key Lab Plasma & Magnet Resonance, Dept Elect Sci, Xiamen, Peoples R China; [Cai, Jian-Feng] Univ Iowa, Dept Math, Iowa City, IA USA; [Guo, Di] Xiamen Univ Technol, Sch Comp & Informat Engn, Xiamen, Peoples R China	Xiamen University; University of Iowa; Xiamen University of Technology	Qu, XB (corresponding author), Xiamen Univ, Fujian Prov Key Lab Plasma & Magnet Resonance, Dept Elect Sci, Xiamen, Peoples R China.	quxiaobo@xmu.edu.cn	Cai, Jian-Feng/L-1808-2016; Chen, Zhong/G-4601-2010; Qu, Xiaobo/D-5017-2009; Cai, Jianfeng/AAB-9478-2019; Guo, Di/HGA-5929-2022; Liu, Yunsong/W-5029-2019	Cai, Jian-Feng/0000-0003-2571-570X; Qu, Xiaobo/0000-0002-8675-5820; chen, zhong/0000-0002-1473-2224	National Natural Science Foundation of China [61201045, 61302174, 11375147]; Fundamental Research Funds for the Central Universities [2013SH002]; Open Fund from Key Lab of Digital Signal and Image Processing of Guangdong Province [54600321, 2013GDDSIPL-07]; Scientific Research Foundation for the Introduction of Talent at Xiamen University of Technology [YKJ12021R]; Simons Foundation [281384]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Fund from Key Lab of Digital Signal and Image Processing of Guangdong Province; Scientific Research Foundation for the Introduction of Talent at Xiamen University of Technology; Simons Foundation	This work was partially supported by the National Natural Science Foundation of China (61201045, 61302174 and 11375147) (http://www.nsfc.gov.cn/), Fundamental Research Funds for the Central Universities (2013SH002 (http://www.moe.gov.cn/), Open Fund from Key Lab of Digital Signal and Image Processing of Guangdong Province (54600321 and 2013GDDSIPL-07)(http://imagelab.stu.edu.cn/), Scientific Research Foundation for the Introduction of Talent at Xiamen University of Technology (YKJ12021R)(http://ky.xmut.edu.cn/), and a grant from the Simons Foundation (#281384 to J.-F. Cai). (http://www.simonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso MV, 2011, IEEE T IMAGE PROCESS, V20, P681, DOI 10.1109/TIP.2010.2076294; Baraniuk R, 1993, RICE WAVELET TOOLBOX; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bertsekas D., 1996, CONSTRAINED OPTIMIZA; Cai JF, 2008, SIAM J SCI COMPUT, V30, P1205, DOI 10.1137/040615298; Cai JF, 2008, APPL COMPUT HARMON A, V24, P131, DOI 10.1016/j.acha.2007.10.002; Cai JF, 2014, APPL COMPUT HARMON A, V37, P89, DOI 10.1016/j.acha.2013.10.001; Cai JF, 2010, J COMPUT MATH, V28, P289, DOI [10.4208/jcm.2009.10-m1002, 10.4208/jcm.1001-m1002]; Cai JF, 2009, MULTISCALE MODEL SIM, V8, P337, DOI 10.1137/090753504; Cai JF, 2009, ADV COMPUT MATH, V31, P87, DOI 10.1007/s10444-008-9084-5; Candes EJ, 2004, COMMUN PUR APPL MATH, V57, P219, DOI 10.1002/cpa.10116; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2003, ANN STAT, V31, P1561, DOI 10.1214/aos/1065705119; Candes EJ, 2008, CR MATH, V346, P589, DOI 10.1016/j.crma.2008.03.014; Candes EJ, 2011, APPL COMPUT HARMON A, V31, P59, DOI 10.1016/j.acha.2010.10.002; Chang HC, 2013, QUANT IMAGING MED SU, V3, P73, DOI 10.3978/j.issn.2223-4292.2013.03.05; Chen C., 2012, ADV NEURAL INFORM PR, P1124; Chen C, 2014, MED IMAGE ANAL, V18, P834, DOI 10.1016/j.media.2013.12.004; Chen HJ, 2013, QUANT IMAGING MED SU, V3, P298, DOI 10.3978/j.issn.2223-4292.2013.12.01; Combettes PL, 2005, MULTISCALE MODEL SIM, V4, P1168, DOI 10.1137/050626090; Daubechies I, 2003, APPL COMPUT HARMON A, V14, P1, DOI 10.1016/S1063-5203(02)00511-0; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Elad M, 2007, INVERSE PROBL, V23, P947, DOI 10.1088/0266-5611/23/3/007; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Guerquin-Kern M, 2011, IEEE T MED IMAGING, V30, P1649, DOI 10.1109/TMI.2011.2140121; Haacke E. M., 1999, MAGNETIC RESONANCE I; Huang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079709; Huang JZ, 2011, MED IMAGE ANAL, V15, P670, DOI 10.1016/j.media.2011.06.001; Huang Y, 2013, ARXIV13022712; Kayvanrad MH, 2014, MAGNETIC RESONANCE I; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; Liang D, 2012, MAGN RESON MED, V68, P41, DOI 10.1002/mrm.23197; Lu YM, 2007, IEEE T IMAGE PROCESS, V16, P918, DOI 10.1109/TIP.2007.891785; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Ma S., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587391; Majumdar A, 2012, SIGNAL PROCESS-IMAGE, V27, P1035, DOI 10.1016/j.image.2012.08.002; Mallat S, 2009, APPL COMPUT HARMON A, V26, P161, DOI 10.1016/j.acha.2008.03.004; Nam S, 2013, APPL COMPUT HARMON A, V34, P30, DOI 10.1016/j.acha.2012.03.006; Pang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056098; Qu XB, 2014, MED IMAGE ANAL, V18, P843, DOI 10.1016/j.media.2013.09.007; Qu XB, 2012, MAGN RESON IMAGING, V30, P964, DOI 10.1016/j.mri.2012.02.019; Qu XB, 2010, INVERSE PROBL SCI EN, V18, P737, DOI 10.1080/17415977.2010.492509; Rauhut H, 2008, IEEE T INFORM THEORY, V54, P2210, DOI 10.1109/TIT.2008.920190; Ravishankar S, 2011, IEEE T MED IMAGING, V30, P1028, DOI 10.1109/TMI.2010.2090538; Selesnick IW, 2009, P SPIE; Shen ZW, 2011, SIAM J IMAGING SCI, V4, P573, DOI 10.1137/090779437; Vetterli M., 2014, FDN SIGNAL PROCESSIN; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Xie SL, 2012, IEEE T IMAGE PROCESS, V21, P4557, DOI 10.1109/TIP.2012.2206043; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; Yin WT, 2008, SIAM J IMAGING SCI, V1, P143, DOI 10.1137/070703983; Zhao B, 2012, IEEE T MED IMAGING, V31, P1809, DOI 10.1109/TMI.2012.2203921; Zhu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045302	58	30	32	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119584	10.1371/journal.pone.0119584	http://dx.doi.org/10.1371/journal.pone.0119584			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849209	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800013
J	Mennecozzi, M; Landesmann, B; Palosaari, T; Harris, G; Whelan, M				Mennecozzi, Milena; Landesmann, Brigitte; Palosaari, Taina; Harris, Georgina; Whelan, Maurice			Sex Differences in Liver Toxicity-Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro?	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ADVERSE DRUG-REACTIONS; GENDER-DIFFERENCES; GENE-EXPRESSION; AGE; DICLOFENAC; INJURY; CELL; PHARMACOKINETICS; METABOLITES	There is increasing amount of evidence for sex variation in drug efficiency and toxicity profiles. Women are more susceptible than men to acute liver injury from xenobiotics. In general, this is attributed to sex differences at a physiological level as well as differences in pharmacokinetics and pharmacodynamics, but neither of these can give a sufficient explanation for the diverse responses to xenobiotics. Existing data are mainly based on animal models and limited data exist on in vitro sex differences relevant to humans. To date, male and female human hepatocytes have not yet been compared in terms of their responses to hepatotoxic drugs. We investigated whether sex-specific differences in acute hepatotoxicity can be observed in vitro by comparing hepatotoxic drug effects in male and female primary human hepatocytes. Significant sex-related differences were found for certain parameters and individual drugs, showing an overall higher sensitivity of female primary hepatocytes to hepatotoxicants. Moreover, our work demonstrated that high content screening is feasible with pooled primary human hepatocytes in suspension.	[Mennecozzi, Milena; Landesmann, Brigitte; Palosaari, Taina; Whelan, Maurice] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Varese, Italy; [Harris, Georgina] Johns Hopkins Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD USA	European Commission Joint Research Centre; EC JRC ISPRA Site; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Landesmann, B (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Varese, Italy.	brigitte.landesmann@ec.europa.eu						Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; [Anonymous], 2001, GAO 01 286R; Aydin S, 2010, BIOGERONTOLOGY, V11, P335, DOI 10.1007/s10522-009-9257-8; BANKS AT, 1995, HEPATOLOGY, V22, P820, DOI 10.1016/0270-9139(95)90303-8; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Boelsterli UA, 2003, TOXICOL APPL PHARM, V192, P307, DOI 10.1016/S0041-008X(03)00368-5; Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Csete M, 2008, ANESTH ANALG, V107, P232, DOI 10.1213/ane.0b013e318163feaf; de Mirecki-Garrido M, 2012, PHARMACEUTICALS, V5, P758, DOI 10.3390/ph5070758; Dever JT, 2009, TOXICOL APPL PHARM, V236, P358, DOI 10.1016/j.taap.2009.02.009; Faria G, 2009, TOXICOL APPL PHARM, V234, P256, DOI 10.1016/j.taap.2008.10.012; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Federman DD, 2006, NEW ENGL J MED, V354, P1507, DOI 10.1056/NEJMra052529; FLETCHER CV, 1994, J ADOLESCENT HEALTH, V15, P619, DOI 10.1016/S1054-139X(94)90628-9; Flynn TJ, 2010, TOXICOL LETT, V198, P232, DOI 10.1016/j.toxlet.2010.07.003; Food and Drug Administration, 1977, GUID GEN CONS CLIN E, P77; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Gendered Innovations, 2019, GENDERED INNOVATIONS; Gochfeld M, 2007, ENVIRON RES, V104, P4, DOI 10.1016/j.envres.2005.12.005; Gray J, 2007, CLIN PHARMACOL THER, V82, P15, DOI 10.1038/sj.clpt.6100261; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hammes SR, 2014, MOL ENDOCRINOL, V28, P1209, DOI 10.1210/me.2014-1209; Hayden EC, 2010, NATURE, V464, P332, DOI 10.1038/464332b; Henderson VW, 2010, PROG BRAIN RES, V182, P77, DOI 10.1016/S0079-6123(10)82003-5; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; KAHN D, 1993, DIGEST DIS SCI, V38, P1485, DOI 10.1007/BF01308608; Kanazawa H, 2002, J CHROMATOGR A, V949, P1, DOI 10.1016/S0021-9673(01)01508-4; Lacroix I, 2004, FUND CLIN PHARMACOL, V18, P201, DOI 10.1111/j.1472-8206.2004.00224.x; Lahita RG, 2010, PRINCIPLES GENDER SP; Lash LH, 2001, J PHARMACOL EXP THER, V297, P155; Liu L, 2010, TOXICOLOGY, V271, P57, DOI 10.1016/j.tox.2010.03.004; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Manda G., 2009, CURR CHEM BIOL, V3, P22, DOI [10.2174/187231309787158271, DOI 10.2174/187231309787158271, DOI 10.2174/22127968109030]; Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1016/0270-9139(95)90202-3; Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x; Masubuchi Y, 2002, HEPATOLOGY, V35, P544, DOI 10.1053/jhep.2002.31871; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Miller MA, 2001, INT J TOXICOL, V20, P149, DOI 10.1080/109158101317097728; Miller VM, 2012, AM J PHYSIOL-LUNG C, V302, pL801, DOI 10.1152/ajplung.00095.2012; Nicolson TJ, 2010, TRENDS PHARMACOL SCI, V31, P108, DOI 10.1016/j.tips.2009.12.001; O'connor N, 2003, QJM-INT J MED, V96, P787, DOI 10.1093/qjmed/hcg138; Oliveira PJ, 2012, J LIPIDS, V2012, P1; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pauli-Magnus C, 2000, J PHARMACOL EXP THER, V293, P376; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; PILLAY P, 1990, DIGEST DIS SCI, V35, P686, DOI 10.1007/BF01540167; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Rustgi VK, 2002, LIVER TRANSPLANT, V8, P514, DOI 10.1053/jlts.2002.33457; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; Sari FR, 2011, CARDIOVASC PATHOL, V20, P281, DOI 10.1016/j.carpath.2010.07.006; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226; Soldin OP, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/187103; Straface Elisabetta, 2012, Handb Exp Pharmacol, P49, DOI 10.1007/978-3-642-30726-3_3; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tadic SD, 2002, J APPL PHYSIOL, V93, P1057, DOI 10.1152/japplphysiol.00568.2001; Tang W, 2003, CURR DRUG METAB, V4, P319, DOI 10.2174/1389200033489398; Taylor K Efua, 2011, Biol Sex Differ, V2, P11, DOI 10.1186/2042-6410-2-11; Torgrimson BN, 2005, J APPL PHYSIOL, V99, P785, DOI 10.1152/japplphysiol.00376.2005; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uhl K, 2007, CLIN PHARMACOL THER, V81, P600, DOI 10.1038/sj.clpt.6100112; Vahter M, 2007, ENVIRON RES, V104, P70, DOI 10.1016/j.envres.2006.10.001; Vickers AEM, 2009, CHEM-BIOL INTERACT, V179, P9, DOI 10.1016/j.cbi.2008.10.010; Wald C, 2010, SCIENCE, V327, P1571, DOI 10.1126/science.327.5973.1571; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; World Health Organization, WHAT DO WE MEAN SEX; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Lun, 2012, J Drug Metab Toxicol, V3, P1000119, DOI 10.4172/2157-7609.1000119; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6; Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a	79	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122786	10.1371/journal.pone.0122786	http://dx.doi.org/10.1371/journal.pone.0122786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849576	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800161
J	von Bondorff, MB; Tormakangas, T; Salonen, M; von Bonsdorff, ME; Osmond, C; Kajantie, E; Eriksson, JG				von Bondorff, Mikaela B.; Tormakangas, Timo; Salonen, Minna; von Bonsdorff, Monika E.; Osmond, Clive; Kajantie, Eero; Eriksson, Johan G.			Early Life Origins of All-Cause and Cause-Specific Disability Pension: Findings from the Helsinki Birth Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOLLOW-UP; FETAL-GROWTH; AGE 60; RISK; WEIGHT; CHILDHOOD; DETERMINANTS; STRESS; SIZE	Background There is some evidence linking sub-optimal prenatal development to an increased risk of disability pension (DP). Our aim was to investigate whether body size at birth was associated with transitioning into all-cause and cause-specific DP during the adult work career. Methods 10 682 people born in 1934-44 belonging to the Helsinki Birth Cohort Study had data on birth weight extracted from birth records, and on time, type and reason of retirement between 1971 and 2011 extracted from the Finnish Centre for Pensions. Results Altogether 21.3% transitioned into DP during the 40-year follow-up, mainly due to mental disorders, musculoskeletal disorders and cardiovascular disease. Average age of transitioning into DP was 51.3 (SD 8.4) for men and 52.2 (SD 7.6) for women. Cohort members who did not transition into DP retired 10 years later on average. Among men, higher birth weight was associated with a lower hazard of transitioning into DP, adjusted hazard ratio (HR) being 0.94 (95% confidence interval [CI] 0.88-0.99 for 1 SD increase in birth weight). For DP due to mental disorders the adjusted HR was 0.90, 95% CI 0.81, 0.99. A similar but non-significant trend was found for DP due to cardiovascular disease. Among women there were no associations between body size at birth and all-cause DP (p for interaction gender*birth weight on DP p = 0.007). Conclusions Among men disability pension, particularly due to mental disorders, may have its origins in prenatal development. Given that those who retire due to mental health problems are relatively young, the loss to the workforce is substantial.	[von Bondorff, Mikaela B.; Tormakangas, Timo; von Bonsdorff, Monika E.] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; [von Bondorff, Mikaela B.; Tormakangas, Timo; von Bonsdorff, Monika E.] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Salonen, Minna; Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Div Welf & Hlth Promot, Diabet Prevent Unit, Helsinki, Finland; [Salonen, Minna; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Osmond, Clive] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland	University of Jyvaskyla; University of Jyvaskyla; Finland National Institute for Health & Welfare; Folkhalsan Research Center; University of Southampton; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital	von Bondorff, MB (corresponding author), Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland.	mikaela.vonbonsdorff@jyu.fi	; von Bonsdorff, Mikaela/A-5218-2015; von Bonsdorff, Monika/D-3049-2014	Tormakangas, Timo/0000-0001-7268-5297; von Bonsdorff, Mikaela/0000-0001-8530-5230; Osmond, Clive/0000-0002-9054-4655; von Bonsdorff, Monika/0000-0002-4689-2126; Eriksson, Johan/0000-0002-2516-2060	Emil Aaltonen Foundation; Finnish Foundation for Diabetes Research; Novo Nordisk Foundation; Signe; Ane Gyllenberg Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; Liv och Halsa; Finnish Foundation for Cardiovascular Research; Academy of Finland MBvB [257239]; Academy of Finland MEvB [250681, 127437, 129306, 130326, 134791, 2639249, 129369, 129907, 135072, 129255, 126775]; European Commission [278603]; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Emil Aaltonen Foundation; Finnish Foundation for Diabetes Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe; Ane Gyllenberg Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; Liv och Halsa; Finnish Foundation for Cardiovascular Research; Academy of Finland MBvB(Academy of Finland); Academy of Finland MEvB(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Fonden(Novo Nordisk Foundation)	HBCS was supported by Emil Aaltonen Foundation, Finnish Foundation for Diabetes Research, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Samfundet Folkhalsan, Finska Lakaresallskapet, Liv och Halsa, Finnish Foundation for Cardiovascular Research. The Academy of Finland supported MBvB (grant no. 257239); MEvB (grant no. 250681) EK (grant no. 127437, 129306, 130326, 134791 and 2639249) JGE (grant no. 129369, 129907, 135072, 129255 and 126775). The research leading to these results has received funding from the European Commission within the 7th Framework Programme (DORIAN, grant agreement no 278603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SICKN DIS WORK BREAK; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 1998, MOTHERS BABIES HLTH; Central Statistical Office of Finland, 1989, CLASS SOC GROUPS HDB, V17; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Gravseth HM, 2007, EUR J EPIDEMIOL, V22, P533, DOI 10.1007/s10654-007-9139-9; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Harkonmaki K, 2007, J EPIDEMIOL COMMUN H, V61, P479, DOI 10.1136/jech.2006.052670; Helgertz J, 2014, SOC SCI MED, V119, P249, DOI 10.1016/j.socscimed.2013.11.052; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; ILMARINEN J, 1991, SCAND J WORK ENV HEA, V17, P12; Jones A, 2006, J CLIN ENDOCR METAB, V91, P1868, DOI 10.1210/jc.2005-2077; Kajantie E, 2007, J CLIN ENDOCR METAB, V92, P4094, DOI 10.1210/jc.2007-1539; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lahti M, 2013, J PERS SOC PSYCHOL, V105, P154, DOI 10.1037/a0032300; Laine S, 2009, J EPIDEMIOL COMMUN H, V63, P24, DOI 10.1136/jech.2007.071407; Lampl M, 2010, AM J HUM BIOL, V22, P431, DOI 10.1002/ajhb.21014; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Muller M, 2014, PEDIATRICS, V134, P761, DOI 10.1542/peds.2014-1108; OECD, 2011, PENS GLANC 2011 RET; OECD, 2003, TRANSF DIS AB POL PR; Official Statistics of Finland, 2013, PENS INS FINL 2011; Osler M, 2005, BRIT J PSYCHIAT, V186, P400, DOI 10.1192/bjp.186.5.400; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Phillips DIW, 2006, J PHYSIOL-LONDON, V572, P45, DOI 10.1113/jphysiol.2005.104695; Raikkonen K, 2007, BRIT J PSYCHIAT, V190, P469, DOI 10.1192/bjp.bp.106.022145; Rees S, 2004, NEUROSCI LETT, V361, P111, DOI 10.1016/j.neulet.2004.02.002; Siipi J, 1962, HELSINGIN KAUPUNGIN, P137; Steunenberg B, 2010, J AFFECT DISORDERS, V123, P164, DOI 10.1016/j.jad.2009.08.002; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; von Bonsdorff MB, 2011, AM J EPIDEMIOL, V174, P1336, DOI 10.1093/aje/kwr270; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	38	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122134	10.1371/journal.pone.0122134	http://dx.doi.org/10.1371/journal.pone.0122134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849578	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000352477800102
J	Wilkie, R; Hay, EM; Croft, P; Pransky, G				Wilkie, Ross; Hay, Elaine M.; Croft, Peter; Pransky, Glenn			Exploring How Pain Leads to Productivity Loss in Primary Care Consulters for Osteoarthritis: A Prospective Cohort Study	PLOS ONE			English	Article							LOW-BACK-PAIN; COPING STRATEGIES; WORK; DISABILITY; ARTHRITIS; RISK; PARTICIPATION; POPULATION; MANAGEMENT; INJURIES	Objective Osteoarthritis pain has become a leading cause of decreased productivity and work disability in older workers, a major concern in primary care. How osteoarthritis pain leads to decreased productivity at work is unclear; the aim of this study was to elucidate causal mechanisms and thus identify potential opportunities for intervention. Methods Population-based prospective cohort study of primary care consulters with osteoarthritis. Path analysis was used to test proposed mechanisms by examining the association between pain at baseline, and onset of work productivity loss at three years for mediation by physical limitation, depression, poor sleep and poor coping mechanisms. Results High pain intensity was associated with onset of work productivity loss (Adjusted Odds Ratio 2.5; 95% CI 1.3, 4.8). About half of the effect of pain on work productivity was a direct effect, and half was mediated by the impact of pain on physical function. Depression, poor sleep quality and poor coping did not mediate the association between high pain intensity and onset of work productivity loss. Conclusions As pain is a major cause of work productivity loss, results suggest that decreasing pain should be a major focus. However, successfully improving function may have an indirect effect by decreasing the impact of pain on work productivity, especially important as significant pain reduction is often difficult to achieve. Although depression, sleep problems, and coping strategies may be directly related to work productivity loss, addressing these issues may not have much effect on the significant impact of pain on work productivity.	[Wilkie, Ross; Hay, Elaine M.; Croft, Peter] Keele Univ, Primary Care Sci, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Pransky, Glenn] Liberty Mutual Res Inst, Ctr Disabil Res, Hopkinton, MA 01748 USA	Keele University	Wilkie, R (corresponding author), Keele Univ, Primary Care Sci, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	r.wilkie@keele.ac.uk			Medical Research Council, United Kingdom [G9900220]; North Staffordshire Primary Care R D Consortium; MRC [G0501798, G0900038] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500579/1] Funding Source: researchfish; Medical Research Council [G0501798, G0900038] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10183] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); North Staffordshire Primary Care R D Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is supported financially by the Medical Research Council, United Kingdom (grant code: G9900220) and by the North Staffordshire Primary Care R & D Consortium.	Altman RD, 2010, AM J MANAG CARE, V16, pS41; Bieleman HJ, 2011, J RHEUMATOL, V38, P1835, DOI 10.3899/jrheum.101210; Buis ML, 2010, STATA J, V10, P11, DOI 10.1177/1536867X1001000104; Burton Wayne N, 2006, Dis Manag, V9, P131, DOI 10.1089/dis.2006.9.131; Carroll LJ, 2013, DISABIL REHABIL, V35, P1182, DOI 10.3109/09638288.2012.723791; Chaparro LE, 2013, COCHRANE DATABASE SY, P8; Chou R, 2014, ANN INTERN MED, V160, DOI 10.7326/0003-4819-160-11-201406030-01006; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; DiBonaventura MD, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-30; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Gignac MAM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1753, DOI 10.1002/art.24889; Golightly YM, 2015, INT J BEHAV MED, V22, P101, DOI 10.1007/s12529-013-9365-3; Hayward RA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-8; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jensen MP, 2003, PAIN, V104, P453, DOI 10.1016/S0304-3959(03)00076-9; Jordan K, 2007, BRIT J GEN PRACT, V57, P7; Karlson KB, 2011, RES SOC STRAT MOBIL, V29, P221, DOI 10.1016/j.rssm.2010.12.005; Lacey RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083948; Li X, 2006, MED CARE, V44, P304, DOI 10.1097/01.mlr.0000204257.25875.04; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Loisel P, 1997, SPINE, V22, P2911, DOI 10.1097/00007632-199712150-00014; Manchikanti L, 2001, PAIN PHYSICIAN, V4, P101; Mody GM, 2012, BEST PRACT RES CL RH, V26, P237, DOI 10.1016/j.berh.2012.03.002; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NHS Information, 2000, CLIN TERMS VERS 3 RE; Pransky GS, 2005, AM J IND MED, V47, P104, DOI 10.1002/ajim.20122; Ricci JA, 2005, ARTHRIT RHEUM-ARTHR, V53, P673, DOI 10.1002/art.21453; Shaw WS, 2009, J OCCUP ENVIRON MED, V51, P185, DOI 10.1097/JOM.0b013e318192bcf8; Shaw WS, 2005, SPINE, V30, P572, DOI 10.1097/01.brs.0000154628.37515.ef; Stewart WF, 2003, J OCCUP ENVIRON MED, V45, P1234, DOI 10.1097/01.jom.0000099999.27348.78; Streiner DL, 2005, CAN J PSYCHIAT, V50, P115, DOI 10.1177/070674370505000207; Tang K, 2011, J RHEUMATOL, V38, P1776, DOI 10.3899/jrheum.110405; Tang NKY, 2012, SLEEP, V35, P675, DOI 10.5665/sleep.1830; Vasseljen O, 2013, PAIN, V154, P1237, DOI 10.1016/j.pain.2013.03.032; Ware J., 1993, SF 36 HLTH SURVEY MA; Wilkie R, 2014, RHEUMATOLOGY, V53, P459, DOI 10.1093/rheumatology/ket336; Wilkie R, 2013, ARTHRIT CARE RES, V65, P910, DOI 10.1002/acr.21918; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120042	10.1371/journal.pone.0120042	http://dx.doi.org/10.1371/journal.pone.0120042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849594	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800018
J	Dovis, S; Van der Oord, S; Wiers, RW; Prins, PJM				Dovis, Sebastiaan; Van der Oord, Saskia; Wiers, Reinout W.; Prins, Pier J. M.			Improving Executive Functioning in Children with ADHD: Training Multiple Executive Functions within the Context of a Computer Game. A Randomized Double-Blind Placebo Controlled Trial	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; QUALITY-OF-LIFE; WORKING-MEMORY; CLINICAL-SIGNIFICANCE; RESPONSE-INHIBITION; COGNITIVE CONTROL; TASK; RELIABILITY; REWARD	Introduction Executive functions (EFs) training interventions aimed at ADHD-symptom reduction have yielded mixed results. Generally, these interventions focus on training a single cognitive domain (e.g., working memory [WM], inhibition, or cognitive-flexibility). However, evidence suggests that most children with ADHD show deficits on multiple EFs, and that these EFs are largely related to different brain regions. Therefore, training multiple EFs might be a potentially more effective strategy to reduce EF-related ADHD symptoms. Methods Eighty-nine children with a clinical diagnosis of ADHD (aged 8-12) were randomized to either a full-active-condition where visuospatial WM, inhibition and cognitive-flexibility were trained, a partially-active-condition where inhibition and cognitive-flexibility were trained and the WM-training task was presented in placebo-mode, or to a full placebo-condition. Short-term and long-term (3-months) effects of this gamified, 25-session, home-based computer-training were evaluated on multiple outcome domains. Results During training compliance was high (only 3% failed to meet compliance criteria). After training, only children in the full-active condition showed improvement on measures of visuospatial short-term-memory (STM) and WM. Inhibitory performance and interference control only improved in the full-active- and the partially-active condition. No Treatment-condition x Time interactions were found for cognitive-flexibility, verbal WM, complex-reasoning, nor for any parent-, teacher-, or child-rated ADHD behaviors, EF-behaviors, motivational behaviors, or general problem behaviors. Nonetheless, almost all measures showed main Time-effects, including the teacher-ratings. Conclusions Improvements on inhibition and visuospatial STM and WM were specifically related to the type of treatment received. However, transfer to untrained EFs and behaviors was mostly nonspecific (i.e., only interference control improved exclusively in the two EF training conditions). As such, in this multiple EF-training, mainly nonspecific treatment factors - as opposed to the specific effects of training EFs-seem related to far transfer effects found on EF and behavior.	[Dovis, Sebastiaan; Van der Oord, Saskia; Wiers, Reinout W.; Prins, Pier J. M.] Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [Dovis, Sebastiaan; Wiers, Reinout W.] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol Adapt Lab, Amsterdam, Netherlands; [Dovis, Sebastiaan; Van der Oord, Saskia] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Van der Oord, Saskia] Leuven Univ, Dept Clin Psychol, Leuven, Belgium	University of Amsterdam; University of Amsterdam; University of Amsterdam; KU Leuven	Dovis, S (corresponding author), Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands.	S.Dovis@uva.nl	Wiers, Reinout/AAB-4008-2021; Dovis, Sebastiaan/A-7944-2015	Wiers, Reinout/0000-0002-4312-9766; Dovis, Sebastiaan/0000-0002-6448-795X				Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; [Anonymous], 2000, DSM4TR AM PSYCH ASS; Barkley R.A., 1987, ADV BEHAVIORAL ASSES, V3, P157; Barkley RA, 2006, HDB DIAGNOSIS TREATM; Bastiaansen D, 2004, QUAL LIFE RES, V13, P489, DOI 10.1023/B:QURE.0000018483.01526.ab; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Burgess GC, 2010, BIOL PSYCHIAT, V67, P632, DOI 10.1016/j.biopsych.2009.10.036; Chacko A, 2014, J CHILD PSYCHOL PSYC, V55, P247, DOI 10.1111/jcpp.12146; Chacko A, 2013, J CLIN CHILD ADOLESC, V42, P769, DOI 10.1080/15374416.2013.787622; Colder CR, 2004, J ABNORM CHILD PSYCH, V32, P435, DOI 10.1023/B:JACP.0000030296.54122.b6; Corsi PM, 1972, DISS ABSTR INT, V34, p819B; Costenbader V, 2001, SCHOOL PSYCHOL INT, V22, P258, DOI 10.1177/0143034301223003; Crosbie J, 2013, J ABNORM CHILD PSYCH, V41, P497, DOI 10.1007/s10802-012-9693-9; Cunningham CE, 2002, J ABNORM CHILD PSYCH, V30, P555, DOI 10.1023/A:1020855429085; De Vries M, 2014, J CHILD PSY IN PRESS; DELANEY HD, 1981, MULTIVAR BEHAV RES, V16, P105, DOI 10.1207/s15327906mbr1601_6; Dovis S, 2014, J CLIN CHIL IN PRESS; Dovis S, 2008, EXECUTIVE FUNCTION T; Dovis S, 2013, J ABNORM CHILD PSYCH, V41, P901, DOI 10.1007/s10802-013-9729-9; Dovis S, 2012, J ABNORM CHILD PSYCH, V40, P669, DOI 10.1007/s10802-011-9601-8; Durston S, 2011, BIOL PSYCHIAT, V69, P1178, DOI 10.1016/j.biopsych.2010.07.037; Egberink IJL, 2014, COTAN REV 2002; Egeland J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075660; Evans SW, 2014, J CLIN CHILD ADOLESC, V43, P527, DOI 10.1080/15374416.2013.850700; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; FELSON RB, 1989, J MARRIAGE FAM, V51, P727, DOI 10.2307/352171; Gathercole SE, 2014, J CHILD PSYCHOL PSYC, V55, P256, DOI 10.1111/jcpp.12196; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P836, DOI 10.1111/j.1469-7610.2004.00276.x; Gioia GA, 2000, BEHAV RATING INVENTO; Gray P. O., 2010, PSYCHOLOGY; Green CT, 2012, NEUROTHERAPEUTICS, V9, P639, DOI 10.1007/s13311-012-0124-y; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Greenhill L. L., 1998, GUIDE TREATMENTS WOR, P42; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Halperin JM, 2013, J ATTEN DISORD, V17, P711, DOI 10.1177/1087054711435681; Hammes J., 1978, STROOP KLEUR WOORD T; Hinshaw SP, 2007, J PEDIATR PSYCHOL, V32, P664, DOI 10.1093/jpepsy/jsl055; Hoekzema E, 2011, HUM BRAIN MAPP, V32, P1741, DOI 10.1002/hbm.21143; Hoekzema E, 2010, HUM BRAIN MAPP, V31, P1942, DOI 10.1002/hbm.20988; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnstone SJ, 2012, ADHD-ATTEND DEFICIT, V4, P11, DOI 10.1007/s12402-011-0069-8; Johnstone SJ, 2010, ADHD-ATTEND DEFICIT, V2, P31, DOI 10.1007/s12402-009-0017-z; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kessels RPC, 2008, ASSESSMENT, V15, P426, DOI 10.1177/1073191108315611; Kittler Jennifer E, 2007, Eat Behav, V8, P115, DOI 10.1016/j.eatbeh.2006.02.006; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kofler MJ, 2010, J ABNORM CHILD PSYCH, V38, P149, DOI 10.1007/s10802-009-9357-6; Kort W., 2002, WISC 3 NL; Kramer J.H, 2007, DELIS KAPLAN EXECUTI; Kray J, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00180; Kuhn S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.53; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2012, J ABNORM CHILD PSYCH, V40, P145, DOI 10.1007/s10802-011-9547-x; Luman M, 2010, NEUROSCI BIOBEHAV R, V34, P744, DOI 10.1016/j.neubiorev.2009.11.021; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Nigg J. T., 2006, WHAT CAUSES ADHD UND; Oosterlaan J, 2000, VRAGENLIJST VOOR GED; Pelham WE, 1992, J CLIN CHILD PSYCHOL, V8, P259; Prins PJM, 2013, GAMES HEALTH J, V2, P44, DOI 10.1089/g4h.2013.0004; Prins PJM, 2011, CYBERPSYCH BEH SOC N, V14, P115, DOI 10.1089/cyber.2009.0206; Raiker JS, 2012, J ABNORM CHILD PSYCH, V40, P699, DOI 10.1007/s10802-011-9607-2; Rapport MD, 2013, CLIN PSYCHOL REV, V33, P1237, DOI 10.1016/j.cpr.2013.08.005; Rapport MD, 2009, J ABNORM CHILD PSYCH, V37, P521, DOI 10.1007/s10802-008-9287-8; Rapport MD, 2001, J CLIN CHILD PSYCHOL, V30, P48, DOI 10.1207/S15374424JCCP3001_6; Raven JC., 1995, COLOURED PROGR MATRI; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rutledge KJ, 2012, NEUROTHERAPEUTICS, V9, P542, DOI 10.1007/s13311-012-0134-9; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Sattler, 2018, ASSESSMENT CHILDREN; SCHACHAR RJ, 1993, CLIN PSYCHOL REV, V13, P721, DOI 10.1016/S0272-7358(05)80003-0; Schecklmann M, 2013, J ATTEN DISORD, V17, P470, DOI 10.1177/1087054711429702; Schellig D., 1997, BLOCK TAPPING TEST; Sergeant J.A., 1999, HDB DISRUPTIVE BEHAV, P75, DOI DOI 10.1007/978-1-4615-4881-2_4; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shaw Rebecca, 2005, J Atten Disord, V8, P160, DOI 10.1177/1087054705278771; Shaw-Zirt Barbara, 2005, J Atten Disord, V8, P109; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Smidts D.P., 2009, BRIEF EXECUTIEVE FUN; Smith AB, 2006, AM J PSYCHIAT, V163, P1044, DOI 10.1176/appi.ajp.163.6.1044; Sonuga-Barke EJS, 2011, J CHILD PSYCHOL PSYC, V52, P917, DOI 10.1111/j.1469-7610.2011.02444.x; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Soreni N, 2009, J ATTEN DISORD, V13, P137, DOI 10.1177/1087054708326110; Strand MT, 2012, J ABNORM CHILD PSYCH, V40, P1193, DOI 10.1007/s10802-012-9627-6; Thompson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063614; Tillman C, 2011, DEV NEUROPSYCHOL, V36, P181, DOI 10.1080/87565641.2010.549981; Titz C, 2014, PSYCHOL RES-PSYCH FO, V78, P852, DOI 10.1007/s00426-013-0537-1; Toplak ME, 2008, CLIN PSYCHOL REV, V28, P801, DOI 10.1016/j.cpr.2007.10.008; van der Oord S, 2014, J ATTEN DISORD, V18, P699, DOI 10.1177/1087054712453167; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; White Holly A, 2006, J Atten Disord, V10, P44, DOI 10.1177/1087054705286063; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Wise EA, 2004, J PERS ASSESS, V82, P50, DOI 10.1207/s15327752jpa8201_10; Wong CG, 2012, BIOL PSYCHIAT, V71, P458, DOI 10.1016/j.biopsych.2011.11.011	99	106	111	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121651	10.1371/journal.pone.0121651	http://dx.doi.org/10.1371/journal.pone.0121651			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VA	25844638	Green Published, Green Submitted, gold			2022-12-27	WOS:000352475700009
J	Kimura, M; Tamura, Y; Takei, M; Yamamoto, T; Ono, T; Kuwana, M; Fukuda, K; Satoh, T				Kimura, Mai; Tamura, Yuichi; Takei, Makoto; Yamamoto, Tsunehisa; Ono, Tomohiko; Kuwana, Masataka; Fukuda, Keiichi; Satoh, Toru			Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients with Advanced Pulmonary Arterial Hypertension	PLOS ONE			English	Article							VASCULAR-RESISTANCE; THERAPY; PROSTACYCLIN; SURVIVAL; REDUCTION; TRIAL	Background Intravenous infusion (IVI) of epoprostenol is an effective treatment for patients with advanced pulmonary arterial hypertension (PAH). However, there is no widely accepted standard method for initiating the IVI therapy. This study evaluated the hemodynamic improvements achieved with IVI epoprostenol to determine the optimal protocol for treatment initiation. Methods and Results We retrospectively analyzed 42 consecutive PAH patients who underwent IVI epoprostenol in Keio University Hospital from 2001 to 2013. The study group comprised 30 women with a mean age of 34.3 +/- 1.9 years. The etiology of PAH was idiopathic or heritable PAH (I/HPAH) in 38 cases, PAH associated with connective tissue disease in 3, and Eissenmenger's syndrome in the remaining case. We divided the patients into rapid-and slow-initiation therapy groups according to the cumulative epoprostenol dose administered during the first 180 days, and compared the hemodynamic changes between the groups. The median cumulative doses were 6142 +/- 165 mu g/kg and 3998 +/- 132 mu g/kg epoprostenol, respectively. While there were no significant differences in mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), or cardiac index (CI) between the groups before the IVI epoprostenol therapy, the rapid-initiation therapy group achieved significant improvements in these hemodynamic data compared with the slow-initiation therapy group (P < 0.005) at the follow-up right-heart catheterization (RHC). Conclusion Rapid initiation of IVI epoprostenol therapy achieved the optimal hemodynamic improvements in patients with severe PAH.	[Kimura, Mai; Tamura, Yuichi; Takei, Makoto; Yamamoto, Tsunehisa; Ono, Tomohiko; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Kuwana, Masataka] Nippon Med Sch, Dept Rheumatol, Tokyo 113, Japan; [Satoh, Toru] Kyorin Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Keio University; Nippon Medical School; Kyorin University	Tamura, Y (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	u1@ta-mu.net	Fukuda, Keiichi/L-3777-2013	Yamamoto, Tsunehisa/0000-0002-5241-9482; Tamura, Yuichi/0000-0002-4437-8019	Health and Labor Sciences Research Grants in Japan; Health and Labor Sciences Research Grants in Japan	Health and Labor Sciences Research Grants in Japan; Health and Labor Sciences Research Grants in Japan	This work was supported by Health and Labor Sciences Research Grants in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2010, CIRC J, V74, P2200, DOI 10.1253/circj.CJ-10-0190; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Badesch DB, 2004, CHEST, V126, p35S, DOI 10.1378/chest.126.1_suppl.35S; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Homma S, 2010, CIRC J, V74, P2062, DOI 10.1253/circj.CJ-10-0854; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; RUBIN LJ, 1990, ANN INTERN MED, V112, P485, DOI 10.7326/0003-4819-112-7-485; Sakuma M, 2009, CIRC J, V73, P523, DOI 10.1253/circj.CJ-07-1020; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313	16	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121894	10.1371/journal.pone.0121894	http://dx.doi.org/10.1371/journal.pone.0121894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844932	gold, Green Published, Green Submitted			2022-12-27	WOS:000352475700011
J	Musella, V; Callari, M; Di Buduo, E; Scuro, M; Dugo, M; Miodini, P; Bianchini, G; Paolini, B; Gianni, L; Daidone, MG; Cappelletti, V				Musella, Valeria; Callari, Maurizio; Di Buduo, Eleonora; Scuro, Manuela; Dugo, Matteo; Miodini, Patrizia; Bianchini, Giampaolo; Paolini, Biagio; Gianni, Luca; Daidone, Maria Grazia; Cappelletti, Vera			Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients	PLOS ONE			English	Article							ARCHIVAL MATERIAL; RNA; TISSUES; CLASSIFICATION; AMPLIFICATION; PERFORMANCE; VALIDATION; ESTROGEN; SURVIVAL; SUBTYPE	To obtain gene expression profiles from samples collected in clinical trials, we conducted a pilot study to assess feasibility and estimate sample attrition rates when profiling formalin-fixed, paraffin-embedded specimens. Ten matched fresh-frozen and fixed breast cancer samples were profiled using the Illumina HT-12 and Ref-8 chips, respectively. The profiles obtained with Ref 8, were neither technically nor biologically reliable since they failed to yield the expected separation between estrogen receptor positive and negative samples. With the use of Affymetrix HG-U133 2.0 Plus chips on fixed samples and a quantitative polymerase chain reaction -based sample pre-assessment step, results were satisfactory in terms of biological reliability, despite the low number of present calls (M = 21%+/- 5). Compared with the Illumina DASL WG platform, Affymetrix data showed a wider interquartile range (1.32 vs 0.57, P<2.2 E-16,) and larger fold changes. The Affymetrix chips were used to run a pilot study on 60 fixed breast cancers. By including in the workflow the sample pre-assessment steps, 96% of the samples predicted to give good results (44/46), were in fact rated as satisfactory from the point of view of technical and biological meaningfulness. Our gene expression profiles showed strong agreement with immunohistochemistry data, were able to reproduce breast cancer molecular subtypes, and allowed the validation of an estrogen receptor status classifier derived in frozen samples. The approach is therefore suitable to profile formalin-fixed paraffin-embedded samples collected in clinical trials, provided that quality controls are run both before (sample pre-assessment) and after hybridization on the array.	[Musella, Valeria; Callari, Maurizio; Di Buduo, Eleonora; Dugo, Matteo; Miodini, Patrizia; Daidone, Maria Grazia; Cappelletti, Vera] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Scuro, Manuela; Paolini, Biagio] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Bianchini, Giampaolo; Gianni, Luca] Univ Milan, Osped San Raffaele, Dept Med Oncol, I-20127 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Daidone, MG (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	mariagrazia.daidone@istitutotumori.mi.it	Cappelletti, Vera/B-9310-2017; Callari, Maurizio/AAF-7089-2019; Daidone, Maria Grazia/E-9232-2017; Musella, Valeria/H-4458-2016; Dugo, Matteo/H-6860-2014; Paolini, Biagio/E-9240-2017; Miodini, Patrizia/B-1054-2019	Cappelletti, Vera/0000-0002-9709-0676; Callari, Maurizio/0000-0001-5239-0918; Daidone, Maria Grazia/0000-0002-4786-1321; Musella, Valeria/0000-0001-9517-2670; Dugo, Matteo/0000-0001-9786-2763; Paolini, Biagio/0000-0001-7535-7715; Miodini, Patrizia/0000-0001-5815-211X; GIANNI, LUCA/0000-0002-2372-9625; Bianchini, Giampaolo/0000-0002-6790-6267	Italian Association for Cancer Research (AIRC) [IG 4915, IG 10611]; Ministero della Salute (Progetto Oncologico di Medicina Molecolare: I Tumori Femminili)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute (Progetto Oncologico di Medicina Molecolare: I Tumori Femminili)	This work was supported by: the Italian Association for Cancer Research (AIRC) [IG 4915 to LG] and [IG 10611 to MGD] and the Ministero della Salute (Progetto Oncologico di Medicina Molecolare: I Tumori Femminili). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Allen WL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-687; Bianchini G, 2013, J CLIN ONCOL; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11; Budczies J, 2011, J HISTOCHEM CYTOCHEM, V59, P146, DOI 10.1369/jhc.2010.956607; Callari M, 2014, MOL ONCOL, V8, P1278, DOI 10.1016/j.molonc.2014.04.010; Callari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086511; Conway C, 2009, CLIN CANCER RES, V15, P6939, DOI 10.1158/1078-0432.CCR-09-1631; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Deben C, 2013, DIAGN MOL PATHOL, V22, P59, DOI 10.1097/PDM.0b013e318269de3b; Dressler LG, 1999, BREAST CANCER RES TR, V58, P31, DOI 10.1023/A:1006354627669; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fountzilas E, 2012, ANN ONCOL, V23, P2146, DOI 10.1093/annonc/mdr576; Frank M, 2007, VIRCHOWS ARCH, V450, P699, DOI 10.1007/s00428-007-0412-9; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Kim S, 2014, ANN HEMATOL, V93, P437, DOI 10.1007/s00277-013-1884-0; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mehta R, 2011, CLIN BREAST CANCER, V11, P20, DOI 10.3816/CBC.2011.n.004; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Musella V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053406; Paik S, 2006, CLIN CANCER RES, V12, p1019S, DOI 10.1158/1078-0432.CCR-05-2296; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pentheroudakis G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-111; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Ribeiro-Silva A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-118; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; RONCHI E, 1986, TUMORI, V72, P251, DOI 10.1177/030089168607200305; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Sfakianos GP, 2013, GYNECOL ONCOL, V129, P159, DOI 10.1016/j.ygyno.2012.12.030; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Thomas Marlene, 2013, J Clin Bioinforma, V3, P10, DOI 10.1186/2043-9113-3-10; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; von AS, 2007, PLOS ONE, V2, pe1261; Waldron L, 2012, CLIN CANCER RES, V18, P6136, DOI 10.1158/1078-0432.CCR-12-1915; Williams PM, 2010, J MOL DIAGN, V12, P680, DOI 10.2353/jmoldx.2010.090164	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123194	10.1371/journal.pone.0123194	http://dx.doi.org/10.1371/journal.pone.0123194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844937	Green Submitted, gold, Green Published			2022-12-27	WOS:000352475700019
J	Ryndak, MB; Singh, KK; Peng, ZY; Laal, S				Ryndak, Michelle B.; Singh, Krishna K.; Peng, Zhengyu; Laal, Suman			Transcriptional Profile of Mycobacterium tuberculosis Replicating in Type II Alveolar Epithelial Cells	PLOS ONE			English	Article							RESUSCITATION-PROMOTING FACTORS; STREPTOCOCCUS-PNEUMONIAE; GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; VIRULENCE FACTORS; CALMETTE-GUERIN; GUINEA-PIGS; IN-VIVO; INVASION; LUNG	Mycobacterium tuberculosis (Mycobacterium tuberculosis) infection is initiated by the few bacilli inhaled into the alveolus. Studies in lungs of aerosol-infected mice provided evidence for extensive replication of Mycobacterium tuberculosis in non-migrating, non-antigen-presenting cells in the alveoli during the first 2-3 weeks post-infection. Alveoli are lined by type II and type I alveolar epithelial cells (AEC) which outnumber alveolar macrophages by several hundred-fold. Mycobacterium tuberculosis DNA and viable Mycobacterium tuberculosis have been demonstrated in AEC and other non-macrophage cells of the kidney, liver, and spleen in autopsied tissues from latently-infected subjects from TB-endemic regions indicating systemic bacterial dissemination during primary infection. Mycobacterium tuberculosis have also been demonstrated to replicate rapidly in A549 cells (type II AEC line) and acquire increased invasiveness for endothelial cells. Together, these results suggest that AEC could provide an important niche for bacterial expansion and development of a phenotype that promotes dissemination during primary infection. In the current studies, we have compared the transcriptional profile of Mycobacterium tuberculosis replicating intracellularly in A549 cells to that of Mycobacterium tuberculosis replicating in laboratory broth, by microarray analysis. Genes significantly upregulated during intracellular residence were consistent with an active, replicative, metabolic, and aerobic state, as were genes for tryptophan synthesis and for increased virulence (ESAT-6, and ESAT-6-like genes, esxH, esxJ, esxK, esxP, and esxW). In contrast, significant downregulation of the DevR (DosR) regulon and several hypoxia-induced genes was observed. Stress response genes were either not differentially expressed or were downregulated with the exception of the heat shock response and those induced by low pH. The intra-type II AEC Mycobacterium tuberculosis transcriptome strongly suggests that AEC could provide a safe haven in which Mycobacterium tuberculosis can expand dramatically and disseminate from the lung prior to the elicitation of adaptive immune responses.	[Ryndak, Michelle B.; Singh, Krishna K.; Laal, Suman] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Peng, Zhengyu] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Laal, Suman] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	New York University; NYU Langone Medical Center; Fudan University	Laal, S (corresponding author), NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	Suman.Laal@nyumc.org			Veterans Affairs Research Career Scientist Award; National Institutes of Health (NIH)/Fogarty International Center training grant [D43 TW001409]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; FOGARTY INTERNATIONAL CENTER [D43TW001409] Funding Source: NIH RePORTER	Veterans Affairs Research Career Scientist Award(US Department of Veterans Affairs); National Institutes of Health (NIH)/Fogarty International Center training grant; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The work was supported by the Veterans Affairs Research Career Scientist Award and the National Institutes of Health (NIH)/Fogarty International Center training grant (D43 TW001409) both awarded to SL. This material is also based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development with salary support to Research Microbiologist and Research Career Scientist, SL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Aggarwal NR, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25248; Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; Andersen P, 2014, TRENDS IMMUNOL; Bajaj D, 2012, UNDERSTANDING TUBERCULOSIS - DECIPHERING THE SECRET LIFE OF THE BACILLI, P257; Barrios-Payan J, 2012, J INFECT DIS, V206, P1194, DOI 10.1093/infdis/jis381; Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7; Bermudez LE, 2002, INFECT IMMUN, V70, P140, DOI 10.1128/IAI.70.1.140-146.2002; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Birkness KA, 1999, INFECT IMMUN, V67, P653, DOI 10.1128/IAI.67.2.653-658.1999; Blumenthal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037314; Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087; Both D, 2014, BIOCHEM J, V457, P33, DOI 10.1042/BJ20131227; Bruns H, 2014, FUTURE MICROBIOL, V9, P327, DOI 10.2217/fmb.13.164; Bukka A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00266; Butcher PD, 1998, METH MOL B, V101, P285, DOI 10.1385/0-89603-471-2:285; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Castro-Garza J, 2002, FEMS MICROBIOL LETT, V212, P145, DOI 10.1111/j.1574-6968.2002.tb11258.x; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chapeton-Montes JA, 2008, FRONT BIOSCI-LANDMRK, V13, P650, DOI 10.2741/2709; Chen SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-320; Chung HS, 2013, BIOORGAN MED CHEM, V21, P6359, DOI 10.1016/j.bmc.2013.08.045; Crandall ED, 1991, LUNG SCI FDN; CRYSTAL RG, 1991, LUNG SCI FDN, P527; Deng XB, 2014, APOPTOSIS, V19, P1099, DOI 10.1007/s10495-014-0980-5; Dobos KM, 2000, INFECT IMMUN, V68, P6300, DOI 10.1128/IAI.68.11.6300-6310.2000; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Dudoit D, 2000, 578 U CAL DEP STAT; Evans TG, 2013, VACCINE, V31, pB223, DOI 10.1016/j.vaccine.2012.11.081; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Ferry Tristan, 2005, Curr Infect Dis Rep, V7, P420, DOI 10.1007/s11908-005-0043-8; Fine KL, 2012, CELL MICROBIOL, V14, P1402, DOI 10.1111/j.1462-5822.2012.01804.x; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; Guadiz G, 1997, AM J RESP CELL MOL, V17, P60, DOI 10.1165/ajrcmb.17.1.2730; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; He BM, 2013, MOL MED REP, V8, P1683, DOI 10.3892/mmr.2013.1724; He XY, 2003, MICROBES INFECT, V5, P851, DOI 10.1016/S1286-4579(03)00179-5; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Heseler K, 2008, FEMS IMMUNOL MED MIC, V52, P273, DOI 10.1111/j.1574-695X.2007.00374.x; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Ilghari D, 2009, BIOMOL NMR ASSIGN, V3, P171, DOI 10.1007/s12104-009-9167-3; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kallio A, 2014, INFECT IMMUN, V82, P1683, DOI 10.1128/IAI.00699-13; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Krishnan V, 2011, ADV EXP MED BIOL, V715, P175, DOI 10.1007/978-94-007-0940-9_11; Kuo CJ, 2013, J BIOL CHEM, V288, P3886, DOI 10.1074/jbc.M112.415679; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Lewinsohn DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067016; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Mahmood A, 2011, FEBS J, V278, P341, DOI 10.1111/j.1742-4658.2010.07958.x; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Mehra A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003734; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Minch K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035935; Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6; NARDONE LL, 1979, BIOCHIM BIOPHYS ACTA, V573, P276, DOI 10.1016/0005-2760(79)90061-4; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; NOLL H, 1956, BIOCHIM BIOPHYS ACTA, V20, P299, DOI 10.1016/0006-3002(56)90289-X; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Parthasarathy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043429; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; Podinovskaia M, 2013, CELL MICROBIOL, V15, P843, DOI 10.1111/cmi.12092; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rindi L, 1999, BIOCHEM BIOPH RES CO, V258, P94, DOI 10.1006/bbrc.1999.0591; Rindi L, 2001, MICROBIOLOGICA, V24, P289; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Ryndak MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094939; Sanchez CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026587; Schlingemann J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni029; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schneeberger E. E., 1991, LUNG SCI FDN, P229; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Soong G, 2011, J BIOL CHEM, V286, P35891, DOI 10.1074/jbc.M111.295386; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613; Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wang JH, 2013, J MICROBIOL, V51, P644, DOI 10.1007/s12275-013-3040-x; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094701; Wang X, 2014, MICROBES INFECT, V16, P178, DOI 10.1016/j.micinf.2013.11.003; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140	120	42	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123745	10.1371/journal.pone.0123745	http://dx.doi.org/10.1371/journal.pone.0123745			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844539	Green Submitted, gold, Green Published			2022-12-27	WOS:000352475700024
J	Cascella, K; Jollivet, D; Papot, C; Leger, N; Corre, E; Ravaux, J; Clark, MS; Toullec, JY				Cascella, Kevin; Jollivet, Didier; Papot, Claire; Leger, Nelly; Corre, Erwan; Ravaux, Juliette; Clark, Melody S.; Toullec, Jean-Yves			Diversification, Evolution and Sub-Functionalization of 70kDa Heat-Shock Proteins in Two Sister Species of Antarctic Krill: Differences in Thermal Habitats, Responses and Implications under Climate Change	PLOS ONE			English	Article							EUPHAUSIA-CRYSTALLOROPHIAS; DROSOPHILA-MELANOGASTER; RIMICARIS-EXOCULATA; RELAXED SELECTION; GENE-EXPRESSION; TERMINAL DOMAIN; SOUTH GEORGIA; HSP70; ADAPTATION; LIMITS	Background A comparative thermal tolerance study was undertaken on two sister species of Euphausiids (Antarctic krills) Euphausia superba and Euphausia crystallorophias. Both are essential components of the Southern Ocean ecosystem, but occupy distinct environmental geographical locations with slightly different temperature regimes. They therefore provide a useful model system for the investigation of adaptations to thermal tolerance. Methodology/Principal Finding Initial CTmax studies showed that E. superba was slightly more thermotolerant than E. crystallorophias. Five Hsp70 mRNAs were characterized from the RNAseq data of both species and subsequent expression kinetics studies revealed notable differences in induction of each of the 5 orthologues between the two species, with E. crystallorophias reacting more rapidly than E. superba. Furthermore, analyses conducted to estimate the evolutionary rates and selection strengths acting on each gene tended to support the hypothesis that diversifying selection has contributed to the diversification of this gene family, and led to the selective relaxation on the inducible C form with its possible loss of function in the two krill species. Conclusions The sensitivity of the epipelagic species E. crystallorophias to temperature variations and/or its adaptation to cold is enhanced when compared with its sister species, E. superba. These results indicate that ice krill could be the first of the two species to be impacted by the warming of coastal waters of the Austral ocean in the coming years due to climate change.	[Cascella, Kevin; Jollivet, Didier; Toullec, Jean-Yves] Univ Paris 06, Sorbonne Univ, CNRS, Equipe ABICE,Stn Biol Roscoff,UMR 7144, F-29680 Roscoff, France; [Cascella, Kevin; Jollivet, Didier; Toullec, Jean-Yves] CNRS, Stn Biol Roscoff, Adaptat & Div Milieu Marin, UMR 7144, F-29680 Roscoff, France; [Papot, Claire] Univ Lille 1, CNRS, Ecoimmunol Marine Annelids, UMR8198, F-59655 Villeneuve Dascq, France; [Leger, Nelly; Ravaux, Juliette] Univ Paris 06, Sorbonne Univ, CNRS, Equipe AMEX,UMR 7208, F-75005 Paris, France; [Leger, Nelly; Ravaux, Juliette] Univ Paris 06, CNRS 7208, BOREA, F-75005 Paris, France; [Corre, Erwan] Univ Paris 06, Sorbonne Univ, CNRS,ABiMS,FR 2424, Anal & Bioinformat Marine Sci,Stn Biol Roscoff, F-29680 Roscoff, France; [Corre, Erwan] CNRS, Stn Biol Roscoff, FR 2424, F-29680 Roscoff, France; [Clark, Melody S.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Toullec, JY (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, Equipe ABICE,Stn Biol Roscoff,UMR 7144, F-29680 Roscoff, France.	jean-yves.toullec@sb-roscoff.fr	corre, erwan/O-4669-2019; Clark, Melody S/D-7371-2014	corre, erwan/0000-0001-6354-2278; Clark, Melody S/0000-0002-3442-3824; Papot, Claire/0000-0002-8324-2261	Emergence-UPMC research program; Region Bretagne; Institut Paul Emile Victor (IPEV) (KREVET program); "Region Bretagne" (SAD-1 - DRAKAR program); Polar Sciences for Planet Earth programme; British Antarctic Survey; Natural Environment Research Council; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Emergence-UPMC research program; Region Bretagne(Region Bretagne); Institut Paul Emile Victor (IPEV) (KREVET program); "Region Bretagne" (SAD-1 - DRAKAR program); Polar Sciences for Planet Earth programme; British Antarctic Survey; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KC received a PhD grant by the Emergence-UPMC 2011 research program and the "Region Bretagne". JYT benefited from funding provided by Institut Paul Emile Victor (IPEV) (KREVET program) and also by the "Region Bretagne" (SAD-1 - DRAKAR program). MSC was funded by the Polar Sciences for Planet Earth programme, by the British Antarctic Survey and the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Bedulina DS, 2013, MOL ECOL, V22, P1416, DOI 10.1111/mec.12136; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Bettencourt BR, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-5; Blamowska M, 2012, J CELL BIOL, V199, P125, DOI 10.1083/jcb.201205012; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Clark MS, 2008, CELL STRESS CHAPERON, V13, P39, DOI 10.1007/s12192-008-0014-8; Clark MS, 2008, CELL STRESS CHAPERON, V13, P51, DOI 10.1007/s12192-008-0015-7; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Clark MS, 2009, CELL STRESS CHAPERON, V14, P649, DOI 10.1007/s12192-009-0117-x; Clarke A, 1996, TRENDS ECOL EVOL, V11, P212, DOI 10.1016/0169-5347(96)10029-X; Clarke A, 2008, CURR BIOL, V18, P282, DOI 10.1016/j.cub.2008.01.059; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Cottin D, 2010, J EXP MAR BIOL ECOL, V393, P9, DOI 10.1016/j.jembe.2010.06.008; Cui ZX, 2010, FISH SHELLFISH IMMUN, V28, P56, DOI 10.1016/j.fsi.2009.09.018; D'Amico S, 2001, J BIOL CHEM, V276, P25791, DOI 10.1074/jbc.M102741200; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Fuertes MA, 2004, BBA-PROTEINS PROTEOM, V1699, P45, DOI 10.1016/j.bbapap.2003.12.007; Gojobori J, 2009, TRENDS GENET, V25, P198, DOI 10.1016/j.tig.2009.03.008; Guglielmo L, 2009, POLAR BIOL, V32, P347, DOI 10.1007/s00300-008-0546-5; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hill SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072246; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hofmann GE, 2000, J EXP BIOL, V203, P2331; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Jarman SN, 2000, MOL PHYLOGENET EVOL, V17, P26, DOI 10.1006/mpev.2000.0823; Jarman SN, 2001, BIOL J LINN SOC, V73, P199, DOI 10.1006/bjls.2001.0538; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Koshi JM, 1996, J MOL EVOL, V42, P313, DOI 10.1007/BF02198858; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Laursen JR, 1997, J INVERTEBR PATHOL, V70, P226, DOI 10.1006/jipa.1997.4686; Liu J, 2004, CELL STRESS CHAPERON, V9, P313, DOI 10.1379/CSC-40R.1; Luan W, 2010, CELL STRESS CHAPERON, V15, P83, DOI 10.1007/s12192-009-0124-y; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Mackey AP, 2012, DEEP-SEA RES PT II, V59, P130, DOI 10.1016/j.dsr2.2011.08.011; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; Morley SA, 2010, ANTARCT SCI, V22, P774, DOI 10.1017/S0954102010000465; Morris JP, 2013, MOL ECOL, V22, P1494, DOI 10.1111/mec.12216; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pakhomov EA, 1996, DEEP-SEA RES PT I, V43, P59, DOI 10.1016/0967-0637(95)00094-1; Pakhomov EA, 1998, J MARINE SYST, V17, P313, DOI 10.1016/S0924-7963(98)00046-3; Park H, 2007, CELL STRESS CHAPERON, V12, P275, DOI 10.1379/CSC-271.1; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patarnello T, 1996, MAR BIOL, V126, P603, DOI 10.1007/BF00351327; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Ravaux J, 2007, GENE, V386, P162, DOI 10.1016/j.gene.2006.09.001; Ravaux J, 2012, J COMP PHYSIOL B, V182, P899, DOI 10.1007/s00360-012-0666-7; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schiermeier Q, 2010, NATURE, V467, P15, DOI 10.1038/467015a; Schoville SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-170; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Smith WO, 2014, ANNU REV MAR SCI, V6, P469, DOI 10.1146/annurev-marine-010213-135114; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zuiderweg ER, 2012, TOP CURR CHEM	79	34	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121642	10.1371/journal.pone.0121642	http://dx.doi.org/10.1371/journal.pone.0121642			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835552	Green Published, Green Accepted, gold			2022-12-27	WOS:000352139000053
J	Huynh, TP; Barwe, SP; Lee, SJ; McSpadden, R; Franco, OE; Hayward, SW; Damoiseaux, R; Grubbs, SS; Petrelli, NJ; Rajasekaran, AK				Huynh, Thu P.; Barwe, Sonali P.; Lee, Seung J.; McSpadden, Ryan; Franco, Omar E.; Hayward, Simon W.; Damoiseaux, Robert; Grubbs, Stephen S.; Petrelli, Nicholas J.; Rajasekaran, Ayyappan K.			Glucocorticoids Suppress Renal Cell Carcinoma Progression by Enhancing Na, K-ATPase Beta-1 Subunit Expression	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; IN-VIVO; ANTITUMOR-ACTIVITY; NA,K-ATPASE; DEXAMETHASONE; CANCER; GENE; PHARMACOKINETICS; BETA(1)-SUBUNIT; NA+,K+-ATPASE	Glucocorticoids are commonly used as palliative or chemotherapeutic clinical agents for treatment of a variety of cancers. Although steroid treatment is beneficial, the mechanisms by which steroids improve outcome in cancer patients are not well understood. Na, K-ATPase beta-subunit isoform 1 (NaK-beta(1)) is a cell-cell adhesion molecule, and its expression is down-regulated in cancer cells undergoing epithelial-to mesenchymal-transition (EMT), a key event associated with cancer progression to metastatic disease. In this study, we performed high-throughput screening to identify small molecules that could up-regulate NaK-beta(1) expression in cancer cells. Compounds related to the glucocorticoids were identified as drug candidates enhancing NaK-beta(1) expression. Of these compounds, triamcinolone, dexamethasone, and fluorometholone were validated to increase NaK-beta(1) expression at the cell surface, enhance cell-cell adhesion, attenuate motility and invasiveness and induce mesenchymal to epithelial like transition of renal cell carcinoma (RCC) cells in vitro. Treatment of NaK-beta(1) knockdown cells with these drug candidates confirmed that these compounds mediate their effects through up-regulating NaK-beta(1). Furthermore, we demonstrated that these compounds attenuate tumor growth in subcutaneous RCC xenografts and reduce local invasiveness in orthotopically-implanted tumors. Our results strongly indicate that the addition of glucocorticoids in the treatment of RCC may improve outcome for RCC patients by augmenting NaK-beta(1) cell-cell adhesion function.	[Huynh, Thu P.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Damoiseaux, Robert] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Huynh, Thu P.; Barwe, Sonali P.; Lee, Seung J.; McSpadden, Ryan] Alfred I DuPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE USA; [Franco, Omar E.; Hayward, Simon W.] Vanderbilt Univ, Dept Urol Surg, Nashville, TN 37235 USA; [Grubbs, Stephen S.; Petrelli, Nicholas J.; Rajasekaran, Ayyappan K.] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE 19718 USA; [Rajasekaran, Ayyappan K.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Rajasekaran, Ayyappan K.] Therapy Architects, Wilmington, DE USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Nemours Alfred I. duPont Hospital for Children; Vanderbilt University; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; University of Delaware	Rajasekaran, AK (corresponding author), Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE 19718 USA.	arakaran687@gmail.com	Damoiseaux, Robert/F-1086-2011; Damoiseaux, Robert/S-6712-2019	Damoiseaux, Robert/0000-0002-7611-7534; Damoiseaux, Robert/0000-0002-7611-7534; Barwe, Sonali/0000-0003-4162-3004; McSpadden, Ryan/0000-0002-6249-6772; Hayward, Simon/0000-0002-6059-6550; Lee, Seung Joon/0000-0001-6690-2830	National Institutes of Health [DK56216, P20GM103464, F31CA117050]; NATIONAL CANCER INSTITUTE [F31CA117050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health Grants DK56216, P20GM103464 and F31CA117050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPRO MS, 1983, CANCER TREAT REP, V67, P1013; ABBOTT A, 1993, BIOCHEMISTRY-US, V32, P3511, DOI 10.1021/bi00064a040; Arafa HMM, 2006, TOXICOLOGY, V222, P103, DOI 10.1016/j.tox.2006.02.007; Arai Y, 2008, CANCER INVEST, V26, P35, DOI 10.1080/07357900701638418; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Avila J, 1997, ANN NY ACAD SCI, V834, P653, DOI 10.1111/j.1749-6632.1997.tb52341.x; Bab-Dinitz E, 2009, BIOCHEMISTRY-US, V48, P8684, DOI 10.1021/bi900868e; Barwe SP, 2006, CELL MOL BIOL, V52, P41, DOI 10.1170/T759; Barwe SP, 2007, J MOL BIOL, V365, P706, DOI 10.1016/j.jmb.2006.10.029; Barwe SP, 2012, J CELL SCI, V125, P5711, DOI 10.1242/jcs.108795; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BRADY ME, 1987, EUR J CLIN PHARMACOL, V32, P593, DOI 10.1007/BF02455994; Chalaka S, 1999, AM J PHYSIOL-LUNG C, V277, pL197, DOI 10.1152/ajplung.1999.277.1.L197; Demoe JH, 2009, CANCER RES, V69, P1509, DOI 10.1158/0008-5472.CAN-08-3133; Derfoul A, 1998, J BIOL CHEM, V273, P20702, DOI 10.1074/jbc.273.33.20702; Eble JN, 2004, PATHOLOGY GENETICS T; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Gassler N, 2005, BRIT J CANCER, V92, P1084, DOI 10.1038/sj.bjc.6602453; Gorospe M, 1999, MOL CELL BIOL, V19, P1289; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao H, 2003, BBA-GENE STRUCT EXPR, V1630, P55, DOI 10.1016/j.bbaexp.2003.09.003; Hao H, 2003, AM J PHYSIOL-LUNG C, V285, pL593, DOI 10.1152/ajplung.00037.2003; Hayward SW, 1999, PROSTATE, V39, P205; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Jang YH, 2013, LAB INVEST, V93, P194, DOI 10.1038/labinvest.2012.166; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamata M, 2006, BIOCHEM BIOPH RES CO, V348, P1101, DOI 10.1016/j.bbrc.2006.07.158; Kitamura N, 2005, P NATL ACAD SCI USA, V102, P2796, DOI 10.1073/pnas.0409344102; Murphy AM, 2009, UROLOGY, V73, P1293, DOI 10.1016/j.urology.2008.12.072; Piette C, 2009, J BIOL CHEM, V284, P32483, DOI 10.1074/jbc.M109.014589; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Reeves DJ, 2009, CANCER CHEMOTH PHARM, V64, P11, DOI 10.1007/s00280-009-0983-z; Selvakumar P, 2014, EPIGENETICS-US, V9, P579, DOI 10.4161/epi.27795; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; Siemann DW, 2009, INT J RADIAT ONCOL, V73, P897, DOI 10.1016/j.ijrobp.2008.10.031; SUN Y, 1992, AM J PHYSIOL, V262, pC1491, DOI 10.1152/ajpcell.1992.262.6.C1491; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tummala R, 2009, CANCER CHEMOTH PHARM, V64, P1187, DOI 10.1007/s00280-009-0985-x; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wang H, 2004, CLIN CANCER RES, V10, P1633, DOI 10.1158/1078-0432.CCR-0829-3; Xu JQ, 2009, NATL VITAL STAT REPO, V58; Yu WD, 1998, J NATL CANCER I, V90, P134, DOI 10.1093/jnci/90.2.134; Zhang LA, 2010, FEBS LETT, V584, P4646, DOI 10.1016/j.febslet.2010.10.038; Zhang Q, 2009, EXPERT OPIN THER PAT, V19, P731, DOI 10.1517/13543770902967674	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122442	10.1371/journal.pone.0122442	http://dx.doi.org/10.1371/journal.pone.0122442			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836370	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000097
J	Johnson, AMF; Costanzo, A; Gareau, MG; Armando, AM; Quehenberger, O; Jameson, JM; Olefsky, JM				Johnson, Andrew M. F.; Costanzo, Anne; Gareau, Melanie G.; Armando, Aaron M.; Quehenberger, Oswald; Jameson, Julie M.; Olefsky, Jerrold M.			High Fat Diet Causes Depletion of Intestinal Eosinophils Associated with Intestinal Permeability	PLOS ONE			English	Article							INSULIN-RESISTANCE; INDUCED OBESITY; GUT MICROBIOTA; PROBIOTIC TREATMENT; METABOLIC SYNDROME; INFLAMMATION; MICE; HOMEOSTASIS; ENDOTOXEMIA; ADIPOSE	The development of intestinal permeability and the penetration of microbial products are key factors associated with the onset of metabolic disease. However, the mechanisms underlying this remain unclear. Here we show that, unlike liver or adipose tissue, high fat diet (HFD)/obesity in mice does not cause monocyte/macrophage infiltration into the intestine or pro-inflammatory changes in gene expression. Rather HFD causes depletion of intestinal eosinophils associated with the onset of intestinal permeability. Intestinal eosinophil numbers were restored by returning HFD fed mice to normal chow and were unchanged in leptin-deficient (Ob/Ob) mice, indicating that eosinophil depletion is caused specifically by a high fat diet and not obesity per se. Analysis of different aspects of intestinal permeability in HFD fed and Ob/Ob mice shows an association between eosinophil depletion and ileal paracelullar permeability, as well as leakage of albumin into the feces, but not overall permeability to FITC dextran. These findings provide the first evidence that a high fat diet causes intestinal eosinophil depletion, rather than inflammation, which may contribute to defective barrier integrity and the onset of metabolic disease.	[Johnson, Andrew M. F.; Quehenberger, Oswald; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, San Diego, CA 92103 USA; [Armando, Aaron M.; Quehenberger, Oswald] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Gareau, Melanie G.] Univ Calif San Diego, Dept Gastroenterol, San Diego, CA 92103 USA; [Costanzo, Anne; Jameson, Julie M.] Calif State Univ San Marcos, Dept Biol, San Marcos, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; California State University San Marcos	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, San Diego, CA 92103 USA.	jolefsky@ucsd.edu			A.D.A mentor-based fellowship [7-09-MN-37];  [D.K.0033651];  [D.K.074868];  [D.K.063491];  [D.K.09062]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	A.D.A mentor-based fellowship; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the following grants D.K.0033651, D.K.074868, D.K.063491 and D.K.09062 (J.O.). A.M.F.J. was supported by an A.D.A mentor-based fellowship (7-09-MN-37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brignardello J, 2010, ALIMENT PHARM THER, V32, P1307, DOI 10.1111/j.1365-2036.2010.04475.x; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hogan SP, 2001, NAT IMMUNOL, V2, P353, DOI 10.1038/86365; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Lee JJ, 2010, CLIN EXP ALLERGY, V40, P563, DOI 10.1111/j.1365-2222.2010.03484.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Liu ZH, 2012, J NUTR BIOCHEM, V23, P1207, DOI 10.1016/j.jnutbio.2011.07.002; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Suzuki T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-19; Svensson-Frej M, 2011, J INNATE IMMUN, V3, P565, DOI 10.1159/000328799; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Teixeira TFS, 2012, NUTR RES, V32, P637, DOI 10.1016/j.nutres.2012.07.003; Teixeira TFS, 2012, CLIN NUTR, V31, P735, DOI 10.1016/j.clnu.2012.02.009; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen T, 2013, P NATL ACAD SCI USA, V110, P6067, DOI 10.1073/pnas.1220572110; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	42	88	92	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122195	10.1371/journal.pone.0122195	http://dx.doi.org/10.1371/journal.pone.0122195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837594	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000083
J	Piao, HL; Takahashi, K; Yamaguchi, Y; Wang, C; Liu, KX; Naruse, K				Piao, Hulin; Takahashi, Ken; Yamaguchi, Yohei; Wang, Chen; Liu, Kexiang; Naruse, Keiji			Transient Receptor Potential Melastatin-4 Is Involved in Hypoxia-Reoxygenation Injury in the Cardiomyocytes	PLOS ONE			English	Article							MYOCARDIAL REPERFUSION; SMOOTH-MUSCLE; CELL-DEATH; TRPM4; CHANNELS; PATHOPHYSIOLOGY; INHIBITION; MECHANISMS; ISCHEMIA; SYSTEM	Ischemic heart disease still remains the most common cause of cardiac death. During ischemia-reperfusion (I/R), reactive oxygen species (ROS) are produced in excess in cardiac tissue, where they induce cell death. Our previous study showed that 9-phenanthrol (9-Phe), a specific inhibitor of the TRPM4 channel, preserves cardiac contractile function and protects the heart from I/R injury-related infarction in the excised rat heart. Accordingly, we hypothesized that TRPM4 channels are involved in the 9-Phe-mediated cardioprotection against ROS-induced injury. In rats, intravenous 9-Phe mitigated the development of myocardial infarction caused by the occlusion of the left anterior descending artery. Immunohistochemical analysis indicated that TRPM4 proteins are expressed in ventricular myocytes susceptible to I/R injury. Hydrogen peroxide (H2O2) is among the main ROS overproduced during I/R. In the cardiomyocyte cell line H9c2, pretreatment with 9-Phe prevented cell death induced by conditions mimicking I/R, namely 200 mu M H2O2 and hypoxia-reoxygenation. Gene silencing of TRPM4 preserved the viability of H9c2 cardiomyocytes exposed to 200 mu M H2O2. These results suggest that the cardioprotective effects of 9-Phe are mediated through the inhibition of the TRPM4 channels.	[Piao, Hulin; Liu, Kexiang] Jilin Univ, Affiliated Hosp 2, Dept Cardiovasc Surg, Changchun, Peoples R China; [Piao, Hulin; Takahashi, Ken; Yamaguchi, Yohei; Naruse, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama, Japan; [Wang, Chen] Dalian Med Univ, Grad Sch, Dept Cardiol, Dalian, Peoples R China	Jilin University; Okayama University; Dalian Medical University	Takahashi, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama, Japan.	takah-k2@okayama-u.ac.jp	Sokabe, Masahiro/I-1565-2012; TAKAHASHI, Ken/B-1622-2011	TAKAHASHI, Ken/0000-0002-7580-8691; naruse, keiji/0000-0003-4100-6444; Wang, Chen/0000-0002-7143-811X	China Scholarship Council; Okayama University	China Scholarship Council(China Scholarship Council); Okayama University	The work of Hulin Piao was supported by a scholarship from the China Scholarship Council. This work was funded by a Grant-in-Aid for Strategic Research Promotion by the Okayama University.	Abriel H, 2012, BIOCHEM PHARMACOL, V84, P873, DOI 10.1016/j.bcp.2012.06.021; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; BOLLI R, 1988, J AM COLL CARDIOL, V12, P239, DOI 10.1016/0735-1097(88)90381-6; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Goel M, 2007, AM J PHYSIOL-HEART C, V292, pH874, DOI 10.1152/ajpheart.00785.2006; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Jang Y, 2012, ARCH PHARM RES, V35, P1823, DOI 10.1007/s12272-012-1016-8; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Matsushima S, 2014, TRENDS CARDIOVAS MED, V24, P202, DOI 10.1016/j.tcm.2014.03.003; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sarmiento D, 2014, MICROVASC RES; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serafini N, 2012, J IMMUNOL, V189, P3689, DOI 10.4049/jimmunol.1102969; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; SLEZAK J, 1995, AM J PATHOL, V147, P772; Tullio F, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0392-7; Visovatti S., 2010, HURSTS THE HEART, P1316; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070587; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Yoo JC, 2010, BIOCHEM BIOPH RES CO, V391, P806, DOI 10.1016/j.bbrc.2009.11.142	25	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121703	10.1371/journal.pone.0121703	http://dx.doi.org/10.1371/journal.pone.0121703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836769	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000058
J	Shi, YL; Soderlund, M; Xiang, JH; Lu, YN				Shi, Yingli; Soderlund, Marcus; Xiang, Jianhai; Lu, Yuanan			Function and Regulation Domains of a Newly Isolated Putative beta-Actin Promoter from Pacific White Shrimp	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; TRANSGENE INHERITANCE; PENAEUS-MONODON; GENE-TRANSFER; TIGER SHRIMP; EXPRESSION; CLONING; IDENTIFICATION; SEQUENCES; ENHANCER	Current development of transgenic shrimp research has been hampered due to the lack of the suitable promoters and efficient transfection methods for crustaceans. A 1642 bp sequence, containing 5'-upstream sequence, exon 1, intron 1 and partial exon 2, which is responsible for transcriptional initiation of the newly reported shrimp beta-actin (actinT1), has been isolated from the Pacific white shrimp (Litopenaeus vannamei) and named as SbaP. To determine its function and potential application in marine biotechnology, the sequence and functional domains were examined by constitutive expression of the luciferase reporter gene. We have identified 5' regions that play a central role in the expression of the mu-actin gene. The proximal promoter (-1642/-1325) contains two highly conserved transcriptional sites, CCAAT box and CArG motif. Two negative (-1140/-924, -222/-21) and one positive (-810/-425) regulatory elements have been identified in intron1. Transient transfection assay with a construct containing proximal promoter and enhancer (SbaP Delta-222/+1 Delta-1325/-924) regions of the shrimp beta-actin coupled with luciferase and EGFP (enhanced green fluorescent protein) showed that the promoter was not only functional in sf21 cells, but promoter activity was more than 8-fold higher than a viral-origin promoter (ie1, white spot syndrome virus immediate early gene promoter). Furthermore, SbaP Delta-222/+1 Delta-1325/924 drove a successful expression of luciferase injection assay in vivo injection and also showed higher promoter activity than the ie1 promoter, suggesting that the expression vectors constructed with SbaP Delta-222/+1 Delta-1325/-924 have important potential in gene transfer studies for shrimp and other crustacean species.	[Shi, Yingli; Soderlund, Marcus; Lu, Yuanan] Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA; [Shi, Yingli; Xiang, Jianhai] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Shandong, Peoples R China; [Shi, Yingli] Univ Chinese Acad Sci, Beijing, Peoples R China	University of Hawaii System; University of Hawaii Manoa; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, YN (corresponding author), Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA.	yuanan@hawaii.edu	xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787	University of Hawaii at Manoa OVCRGE [399767]; University of Hawaii Sea Grant [661160]	University of Hawaii at Manoa OVCRGE; University of Hawaii Sea Grant	This work was supported in part by a University of Hawaii at Manoa OVCRGE grant (No. 399767) and University of Hawaii Sea Grant (661160). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 1996, MOL REPROD DEV, V45, P117, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;117::AID-MRD2&gt;3.0.CO;2-W; Arenal Amilcar, 2000, Biotecnologia Aplicada, V17, P247; Beckmann S, 2007, EXP PARASITOL, V117, P292, DOI 10.1016/j.exppara.2007.04.007; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Cho YS, 2011, TRANSGENIC RES, V20, P1333, DOI 10.1007/s11248-011-9501-2; FAO, 2012, FISH AQ STAT, P18; Flegel T.W., 2008, DIS ASIAN AQUACULTUR, V6, P355; Green MR, 2012, MOL CLONING LAB MANU, V1; Hanley S, 1998, MOL MAR BIOL BIOTECH, V7, P165; Huang XD, 2010, VIROLOGY, V406, P176, DOI 10.1016/j.virol.2010.06.046; KAWAMOTO T, 1988, MOL CELL BIOL, V8, P267, DOI 10.1128/MCB.8.1.267; Kosuga M, 2000, CELL TRANSPLANT, V9, P675, DOI 10.1177/096368970000900513; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; LARSEN NI, 1995, NUCLEIC ACIDS RES, V23, P1223, DOI 10.1093/nar/23.7.1223; Lee SY, 2009, FISH AQUAT SCI, V12, P90; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; LIU ZJ, 1991, GENE, V108, P211, DOI 10.1016/0378-1119(91)90436-F; LIU ZJ, 1990, MOL CELL BIOL, V10, P3432, DOI 10.1128/MCB.10.7.3432; Liu ZY, 2001, CHINESE SCI BULL, V46, P766, DOI 10.1007/BF03187219; MIWA T, 1987, P NATL ACAD SCI USA, V84, P6702, DOI 10.1073/pnas.84.19.6702; Musthaq SS, 2009, VIROLOGY, V391, P315, DOI 10.1016/j.virol.2009.06.017; NG SY, 1989, NUCLEIC ACIDS RES, V17, P601, DOI 10.1093/nar/17.2.601; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; Noh JK, 2003, MAR BIOTECHNOL, V5, P244, DOI 10.1007/s10126-002-0066-1; Pawlowski WP, 1996, MOL BIOTECHNOL, V6, P17, DOI 10.1007/BF02762320; PENMAN DJ, 1991, MOL REPROD DEV, V30, P201, DOI 10.1002/mrd.1080300306; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; QUITSCHKE WW, 1989, J BIOL CHEM, V264, P9539; Rattanachai A, 2004, FISHERIES SCI, V70, P765, DOI 10.1111/j.1444-2906.2004.00869.x; SANDS AT, 1993, MOL REPROD DEV, V34, P117, DOI 10.1002/mrd.1080340202; Sun PS, 2007, MAR BIOL, V151, P2145, DOI 10.1007/s00227-007-0646-8; Sun PS, 2005, AQUACULTURE, V243, P19, DOI 10.1016/j.aquaculture.2004.09.037; Tseng FS, 2000, THERIOGENOLOGY, V54, P1421, DOI 10.1016/S0093-691X(00)00464-7; Yazawa R, 2005, J EXP ZOOL PART A, V303A, P1104, DOI 10.1002/jez.a.235; Zhang JQ, 2006, J BIOTECHNOL, V125, P173, DOI 10.1016/j.jbiotec.2006.03.010; Zhao C, 2013, FISH SHELLFISH IMMUN, V34, P397, DOI 10.1016/j.fsi.2012.09.022	36	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122262	10.1371/journal.pone.0122262	http://dx.doi.org/10.1371/journal.pone.0122262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835297	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000090
J	Simonit, S; Connors, JP; Yoo, J; Kinzig, A; Perrings, C				Simonit, Silvio; Connors, John P.; Yoo, James; Kinzig, Ann; Perrings, Charles			The Impact of Forest Thinning on the Reliability of Water Supply in Central Arizona	PLOS ONE			English	Article							ECOSYSTEM SERVICES; CLIMATE-CHANGE; SUSTAINABILITY; MANAGEMENT; YIELD; US; BIODIVERSITY; CONSERVATION; WILDFIRE; MARKETS	Economic growth in Central Arizona, as in other semiarid systems characterized by low and variable rainfall, has historically depended on the effectiveness of strategies to manage water supply risks. Traditionally, the management of supply risks includes three elements: hard infrastructures, landscape management within the watershed, and a supporting set of institutions of which water markets are frequently the most important. In this paper we model the interactions between these elements. A forest restoration initiative in Central Arizona (the Four Forest Restoration Initiative, or 4FRI) will result in thinning of ponderosa pine forests in the upper watershed, with potential implications for both sedimentation rates and water delivery to reservoirs. Specifically, we model the net effect of ponderosa pine forest thinning across the Salt and Verde River watersheds on the reliability and cost of water supply to the Phoenix metropolitan area. We conclude that the sediment impacts of forest thinning (up to 50% of canopy cover) are unlikely to compromise the reliability of the reservoir system while thinning has the potential to increase annual water supply by 8%. This represents an estimated net present value of surface water storage of $104 million, considering both water consumption and hydropower generation.	[Simonit, Silvio; Connors, John P.; Kinzig, Ann; Perrings, Charles] Arizona State Univ, Sch Life Sci, EcoServ Grp, Tempe, AZ 85281 USA; [Simonit, Silvio] IUCN, Reg Off Mexico, Cent Amer & Caribbean, San Jose, Costa Rica; [Connors, John P.] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ USA; [Yoo, James] Calif Baptist Univ, Riverside, CA USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; California Baptist University	Simonit, S (corresponding author), Arizona State Univ, Sch Life Sci, EcoServ Grp, Tempe, AZ 85281 USA.	silvio.simonit@iucn.org			Biodiversity and Ecosystem Services Research Training Network (BESTNet) [0639252]; National Science Foundation	Biodiversity and Ecosystem Services Research Training Network (BESTNet); National Science Foundation(National Science Foundation (NSF))	The authors acknowledge support from the Biodiversity and Ecosystem Services Research Training Network (BESTNet) for research coordination Grant 0639252, from the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADWR, 2010, DEM SUPPL A IN PRESS; ADWR, 2009, REG GROUNDW FLOW MOD; Arizona Department of Water Resources, 2014, AR NEXT CENT STRAT V; Arizona Department of Water Resources, 2009, CTR HIGHL PLANN AR, V5; AZ Department of Administration Office of Employment and Population Statistics, 2014, POP PROJ; BAKER MB, 1986, WATER RESOUR RES, V22, P67, DOI 10.1029/WR022i001p00067; Barbier EB, 2011, ANNU REV RESOUR ECON, V3, P337, DOI 10.1146/annurev-resource-083110-120115; BASSOW SL, 1994, ECOL APPL, V4, P593, DOI 10.2307/1941960; BAZZAZ FA, 1996, GLOBAL CHANGE TERRES, P43; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Brewer J., 2006, U MICH J L REFORM, V40, P1021; Cayan DR, 2010, P NATL ACAD SCI USA, V107, P21271, DOI 10.1073/pnas.0912391107; Claassen R, 2008, ECOL ECON, V65, P737, DOI 10.1016/j.ecolecon.2007.07.032; Clark EHI, 1986, ERODING SOILS OFF FA; Conte M, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P89; Covington W. W., 1994, Journal of Sustainable Forestry, V2, P153, DOI 10.1300/J091v02n01_07; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Dore S, 2010, ECOL APPL, V20, P663, DOI 10.1890/09-0934.1; DUNNE T, 1979, J HYDROL, V42, P281, DOI 10.1016/0022-1694(79)90052-0; Gober P, 2010, P NATL ACAD SCI USA, V107, P21295, DOI 10.1073/pnas.0911113107; Gould BW, 1964, WATER RESOURCES USE, P161; Grafton RQ, 2012, WATER POLICY, V14, P175, DOI 10.2166/wp.2011.016; Grafton RQ, 2011, REV ENV ECON POLICY, V5, P219, DOI 10.1093/reep/rer002; Huffaker R, 2006, J ECON DYN CONTROL, V30, P2553, DOI 10.1016/j.jedc.2005.08.003; Jacobs KL, 2004, HYDROGEOL J, V12, P52, DOI 10.1007/s10040-003-0308-y; MacDonald GM, 2010, P NATL ACAD SCI USA, V107, P21256, DOI 10.1073/pnas.0909651107; McMahon TA, 1986, RIVER RESERVOIR YIEL; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Reclamation Bo., 1995, THEODORE ROOSEVELT R; Sabo JL, 2010, P NATL ACAD SCI USA, V107, P21263, DOI 10.1073/pnas.1009734108; Sahin V, 1996, J HYDROL, V178, P293, DOI 10.1016/0022-1694(95)02825-0; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Selig M, 2010, REPORT 4 FOREST REST; Simonit S, 2013, P NATL ACAD SCI USA, V110, P9326, DOI 10.1073/pnas.1112242110; Strand RI, 1982, RESERVOIR SEDIMENTAT; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Turpie JK, 2008, ECOL ECON, V65, P788, DOI 10.1016/j.ecolecon.2007.12.024; van Noordwijk M., 1998, P223; Vogel RM, 1999, J WATER RES PL-ASCE, V125, P245, DOI 10.1061/(ASCE)0733-9496(1999)125:5(245); Vogel RM, 1996, HYDROLOG SCI J, V41, P75, DOI 10.1080/02626669609491480; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Winnett SM, 1998, CLIMATE RES, V11, P39, DOI 10.3354/cr011039; Worster Donald, 1985, RIVERS EMPIRE WATER; Yoo J, 2014, APPLIED ECONOMICS PE, V91, P57	46	12	12	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121596	10.1371/journal.pone.0121596	http://dx.doi.org/10.1371/journal.pone.0121596			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835003	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000049
J	Edwards, W; Moles, AT; Chong, C				Edwards, Will; Moles, Angela T.; Chong, Caroline			Generalised Extreme Value Distributions Provide a Natural Hypothesis for the Shape of Seed Mass Distributions	PLOS ONE			English	Article							GLOBAL PATTERNS; PLANT; EVENTS; DEFINITION; EVOLUTION; VARY	Among co-occurring species, values for functionally important plant traits span orders of magnitude, are uni-modal, and generally positively skewed. Such data are usually log-transformed "for normality" but no convincing mechanistic explanation for a log-normal expectation exists. Here we propose a hypothesis for the distribution of seed masses based on generalised extreme value distributions (GEVs), a class of probability distributions used in climatology to characterise the impact of event magnitudes and frequencies; events that impose strong directional selection on biological traits. In tests involving datasets from 34 locations across the globe, GEVs described log10 seed mass distributions as well or better than conventional normalising statistics in 79% of cases, and revealed a systematic tendency for an overabundance of small seed sizes associated with low latitudes. GEVs characterise disturbance events experienced in a location to which individual species' life histories could respond, providing a natural, biological explanation for trait expression that is lacking from all previous hypotheses attempting to describe trait distributions in multispecies assemblages. We suggest that GEVs could provide a mechanistic explanation for plant trait distributions and potentially link biology and climatology under a single paradigm.	[Edwards, Will; Chong, Caroline] James Cook Univ, Coll Marine & Environm Sci, Cairns, Qld, Australia; [Edwards, Will; Chong, Caroline] James Cook Univ, Ctr Trop Biodivers & Climate Change, Cairns, Qld, Australia; [Moles, Angela T.] UNSW, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	James Cook University; James Cook University; University of New South Wales Sydney	Edwards, W (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Cairns, Qld, Australia.	will.edwards@jcu.edu.au	Moles, Angela T/C-3083-2008; Edwards, Will/GRS-5509-2022; Edwards, Will/M-6652-2015	Moles, Angela T/0000-0003-2041-7762; Edwards, Will/0000-0001-8981-7479				Anderson PL, 1998, WATER RESOUR RES, V34, P2271, DOI 10.1029/98WR01449; Araya YN, 2011, NEW PHYTOL, V189, P253, DOI 10.1111/j.1469-8137.2010.03475.x; Arthington AH, 2011, ECOHYDROLOGY, V4, P708, DOI 10.1002/eco.221; Buishand T., 1989, STAT NEERL, V43, P1, DOI DOI 10.1111/J.1467-9574.1989.TB01244.X; Burhnam K.P., 1998, MODEL SELECTION INFE; Chong C, 2013, AM J BOT, V100, P2250, DOI 10.3732/ajb.1200614; Cilas C, 2010, TREE GENET GENOMES, V6, P219, DOI 10.1007/s11295-009-0242-9; Combes C, 2008, CR GEOSCI, V340, P591, DOI 10.1016/j.crte.2008.01.003; Dorland C, 1999, CLIMATIC CHANGE, V43, P513, DOI 10.1023/A:1005492126814; Falster DS, 2003, NEW PHYTOL, V158, P509, DOI 10.1046/j.1469-8137.2003.00765.x; Gilleland E., 2011, EOS T AM GEOPHYS UN, V92, P1314, DOI [10.1029/2011EO020001, DOI 10.1029/2011EO020001, https://doi.org/10.1029/2011EO020001]; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Katz RW, 2010, CLIMATIC CHANGE, V100, P71, DOI 10.1007/s10584-010-9834-5; Katz RW, 2002, DO WEATHER CLIMATE V, P13; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Krockenberger AK, 2012, OECOLOGIA, V168, P889, DOI 10.1007/s00442-011-2146-2; Leishman M. R., 2000, SEEDS ECOLOGY REGENE, P31, DOI [DOI 10.1126/science.1156831, DOI 10.1079/9780851994321.0031]; Mcgarrigle E, 2011, FORESTRY, V84, P431, DOI 10.1093/forestry/cpr033; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Murphy BP, 2013, J BIOGEOGR, V40, P1048, DOI 10.1111/jbi.12065; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Rees M, 1997, OIKOS, V78, P116, DOI 10.2307/3545807; Rootzen H., 1997, SCANDINAVIAN ACTUARI, V1, P70, DOI DOI 10.1080/03461238.1997; Schymanski SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054231; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Smith R, 2001, ENV STAT, V8, P300; Viglione A., 2011, NSRFA NONSUPERVISED; Villarini G, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008395; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	36	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121724	10.1371/journal.pone.0121724	http://dx.doi.org/10.1371/journal.pone.0121724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830773	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000352135600080
J	Fletcher, K; Issa, R; Lockwood, DNJ				Fletcher, Kate; Issa, Rita; Lockwood, D. N. J.			Visceral Leishmaniasis and Immunocompromise as a Risk Factor for the Development of Visceral Leishmaniasis: A Changing Pattern at The Hospital for Tropical Diseases, London	PLOS ONE			English	Article							COINFECTION	Visceral leishmaniasis (VL) is a parasitic protozoon infection caused by the Leishmania species and transmitted by sandflies. Patients acquire VL in five main tropical areas and the Mediterranean basin, and clinicians from non-endemic regions regularly see infected patients. We describe the population presenting with VL to the Hospital for Tropical Diseases (HTD), London and identify risk factors for developing VL. Methods and Principal Findings A retrospective study of imported VL to the HTD, London including patients diagnosed and/or managed at the HTD between January 1995 and July 2013. We analyse patient demographics, risk factors for developing VL, diagnosis, investigation, management and outcome. Twenty-eight patients were treated for VL at the HTD over an 18 year period. The median age at VL diagnosis was 44 years (range 4-87 years) with a male to female ratio of 2: 1. Most patients were British and acquired their infection in the Mediterranean basin. The median time from first symptom to diagnosis was six months with a range of 1-12 months and diagnosis included microscopic visualisation of leishmania amastigotes, positive serological tests (DAT and k39 antibody) or identification of leishmania DNA. Nineteen patients had some form of immunocompromise and this has increased proportionally compared to previously described data. Within the immunocompromised group, the ratio of those with autoimmune disease has increased. Immunocompromised patients had lower cure and higher relapse rates. Conclusions The rise of VL in patients with immunocompromise secondary to autoimmune disease on immunomodulatory drugs presents new diagnostic and therapeutic challenges. VL should be a differential diagnosis in immunocompromised patients with pyrexia of unknown origin returning from travel in leishmania endemic areas.	[Fletcher, Kate; Issa, Rita; Lockwood, D. N. J.] Hosp Trop Dis, London NW1 0PE, England; [Fletcher, Kate; Issa, Rita; Lockwood, D. N. J.] London Sch Hyg & Trop Med, London WC1, England; [Lockwood, D. N. J.] Univ Coll Fdn Trust, Hosp Trop Dis, London WC1E 6AU, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Fletcher, K (corresponding author), Hosp Trop Dis, London NW1 0PE, England.	hs08kmf@doctors.org.uk		Issa, Rita/0000-0002-0051-5595	Special Trustees of the Hospital for Tropical Diseases	Special Trustees of the Hospital for Tropical Diseases	This study was supported by the Special Trustees of the Hospital for Tropical Diseases. Margaret Armstrong is supported by The Special Trustees of the Hospital for Tropical Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Argaw D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002543; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; Bogdan C, 2012, ANN RHEUM DIS, V71, P60, DOI 10.1136/annrheumdis-2011-200596; Mabey D, 2013, PRINCIPLES MED AFRIC; Malik ANJ, 2006, EMERG INFECT DIS, V12, P8; Monge-Maillo B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003021; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; Rosenthal E, 2001, AIDS, V15, P1184, DOI 10.1097/00002030-200106150-00017; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Venizelos Ioannis, 2009, Int J Infect Dis, V13, pe169, DOI 10.1016/j.ijid.2008.09.012; Wall EC, 2012, AM J TROP MED HYG, V86, P115, DOI 10.4269/ajtmh.2012.10-0558; Weisser M, 2007, CLIN MICROBIOL INFEC, V13, P751, DOI 10.1111/j.1469-0691.2007.01755.x; World Health Organization, LEISHM DIS BURD	18	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121418	10.1371/journal.pone.0121418	http://dx.doi.org/10.1371/journal.pone.0121418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831056	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352135600072
J	Li, YL; Pin, P; Wu, C				Li, Yongli; Pin, Paolo; Wu, Chong			A Network Centrality Method for the Rating Problem	PLOS ONE			English	Article							WEIGHTED NETWORKS; GENERATION	We propose a new method for aggregating the information of multiple users rating multiple items. Our approach is based on the network relations induced between items by the rating activity of the users. Our method correlates better than the simple average with respect to the original rankings of the users, and besides, it is computationally more efficient than other methods proposed in the literature. Moreover, our method is able to discount the information that would be obtained adding to the system additional users with a systematically biased rating activity.	[Li, Yongli] Northeastern Univ, Sch Business Adm, Shenyang 110819, Peoples R China; [Pin, Paolo] Univ Siena, Dipartimento Econ Polit & Stat, I-53100 Siena, Italy; [Wu, Chong] Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China	Northeastern University - China; University of Siena; Harbin Institute of Technology	Pin, P (corresponding author), Univ Siena, Dipartimento Econ Polit & Stat, Via Laterina 8, I-53100 Siena, Italy.	paolo.pin@unisi.it		LI, Yongli/0000-0002-5617-8866; Li, Yongli/0000-0002-1979-9057; Wu, Chong/0000-0003-1017-4496; Pin, Paolo/0000-0001-9907-4947				Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Ahuja RK, 2003, MANAGE SCI, V49, P950, DOI 10.1287/mnsc.49.7.950.16384; Amestoy PR, 2012, SIAM J SCI COMPUT, V34, pA1975, DOI 10.1137/100799411; Arrow K., 1963, SOCIAL CHOICE INDIVI; Ba SL, 2002, MIS QUART, V26, P243, DOI 10.2307/4132332; Basili M, 2014, STRUCT SAF, V52, P144; Boldi P, 2014, INTERNET MATH, V10, P222, DOI 10.1080/15427951.2013.865686; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Bramoulle Y, 2014, AM ECON REV, V104, P898, DOI 10.1257/aer.104.3.898; Cao Q., 2012, 9 USENIX S NETW SYST, P197; Girotra K, 2010, MANAGE SCI, V56, P591, DOI 10.1287/mnsc.1090.1144; Hochbaum DS, 2006, MANAGE SCI, V52, P1394, DOI 10.1287/mnsc.1060.0540; Hochbaum DS, 2011, OPER RES, V59, P1171, DOI 10.1287/opre.1110.0963; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; KEENER JP, 1993, SIAM REV, V35, P80, DOI 10.1137/1035004; Markines B., 2009, P 18 INT C WORLD WID, P641, DOI DOI 10.1145/1526709.1526796; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Park DH, 2008, ELECTRON COMMER R A, V7, P399, DOI 10.1016/j.elerap.2007.12.001; Pavlou PA, 2004, INFORM SYST RES, V15, P37, DOI 10.1287/isre.1040.0015; Pavlou PA, 2007, MIS QUART, V31, P105; RESNICK P, 1994, 1994 ACM C COMPUTER, P175, DOI [DOI 10.1145/192844.192905, 10.1145/192844.192905]; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Sarwar B., 2001, P 10 INT C WORLD WID, P285, DOI [DOI 10.1145/371920.372071, 10.1145/371920.372071]; Snell, 1962, MATH MODELS SOCIAL S, P9; Trevisiol M, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P445, DOI 10.1145/2348283.2348345; Vanhoucke M, 2010, OMEGA-INT J MANAGE S, V38, P359, DOI 10.1016/j.omega.2009.10.001; Wang G., 2012, P 21 INT C WORLD WID, P679, DOI [10.1145/2187836.2187928, DOI 10.1145/2187836.2187928]; Wang G., 2013, P 20 NETW DISTR SYST, P1; Williams VV, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P887; Yang Z, 2014, ACM T KNOWL DISCOV D, V8, P5, DOI 10.1145/2556609	33	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120247	10.1371/journal.pone.0120247	http://dx.doi.org/10.1371/journal.pone.0120247			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830502	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600027
J	Zinyama-Gutsire, RBL; Chasela, C; Madsen, HO; Rusakaniko, S; Kallestrup, P; Christiansen, M; Gomo, E; Ullum, H; Erikstrup, C; Munyati, ES; Kurewa, EN; Stray-Pedersen, B; Garred, P; Mduluza, T				Zinyama-Gutsire, Rutendo B. L.; Chasela, Charles; Madsen, Hans O.; Rusakaniko, Simbarashe; Kallestrup, Per; Christiansen, Michael; Gomo, Exnevia; Ullum, Henrik; Erikstrup, Christian; Munyati, Shungu; Kurewa, Edith N.; Stray-Pedersen, Babill; Garred, Peter; Mduluza, Takafira			Role of Mannose-Binding Lectin Deficiency in HIV-1 and Schistosoma Infections in a Rural Adult Population in Zimbabwe	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENE POLYMORPHISM; COMPLEMENT ACTIVATION; VERTICAL TRANSMISSION; AFRICAN POPULATIONS; GLOBAL BURDEN; SERUM-LEVEL; PROTEIN; SUSCEPTIBILITY; ASSOCIATION	Background Polymorphism in the MBL2 gene lead to MBL deficiency, which has been shown to increase susceptibility to various bacterial, viral and parasitic infections. We assessed role of MBL deficiency in HIV-1 and schistosoma infections in Zimbabwean adults enrolled in the Mupfure Schistosomiasis and HIV Cohort (MUSH Cohort). Methods HIV-1, S. haematobium and S. mansoni infections were determined at baseline. Plasma MBL concentration was measured by ELISA and MBL2 genotypes determined by PCR. We calculated and compared the proportions of plasma MBL deficiency, MBL2 structural variant alleles B (codon 54A>G), C (codon 57A>G), and D (codon 52T>C) as well as MBL2 promoter variants -550(H/L), -221(X/Y) and + 4(P/Q) between HIV-1 and schistosoma co-infection and control groups using Chi Square test. Results We assessed 379 adults, 80% females, median age (IQR) 30 (17-41) years. HIV-1, S. haematobium and S. mansoni prevalence were 26%, 43% and 18% respectively in the MUSH baseline survey. Median (IQR) plasma MBL concentration was 800 mu g/L (192-1936 mu g/L). Prevalence of plasma MBL deficiency was 18% with high frequency of the C (codon 57G>A) mutant allele (20%). There was no significant difference in median plasma MBL levels between HIV negative (912 mu g/L) and HIV positive (688 mu g/L), p = 0.066. However plasma MBL levels at the assay detection limit of 20 mu g/L were more frequent among the HIV-1 infected (p = 0.007). S. haematobium and S. mansoni infected participants had significantly higher MBL levels than uninfected. All MBL2 variants were not associated with HIV1 infection but promoter variants LY and LL were significantly associated with S. haematobium infection. Conclusion Our data indicate high prevalence of MBL deficiency, no evidence of association between MBL deficiency and HIV-1 infection. However, lower plasma MBL levels were protective against both S. haematobium and S. mansoni infections and MBL2 promoter and variants LY and LL increased susceptibility to S. haematobium infection.	[Zinyama-Gutsire, Rutendo B. L.; Chasela, Charles] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Zinyama-Gutsire, Rutendo B. L.] Med Res Council Zimbabwe, Minist Hlth & Child Welf, Harare, Zimbabwe; [Zinyama-Gutsire, Rutendo B. L.; Kurewa, Edith N.; Stray-Pedersen, Babill] Letten Res Fdn, Harare, Zimbabwe; [Madsen, Hans O.; Erikstrup, Christian] Rigshosp, Dept Clin Immunol, Tissue Typing Lab, DK-2100 Copenhagen, Denmark; [Rusakaniko, Simbarashe; Kurewa, Edith N.; Stray-Pedersen, Babill] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Kallestrup, Per] Aarhus Univ, Ctr Global Hlth, Dept Publ Hlth, Aarhus, Denmark; [Christiansen, Michael] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Gomo, Exnevia; Ullum, Henrik] Univ Zimbabwe, Dept Med Lab Sci, Coll Hlth Sci, Harare, Zimbabwe; [Garred, Peter] Univ Copenhagen, Rigshosp, Dept Clin Immunol, Mol Med Lab, DK-2100 Copenhagen, Denmark; [Munyati, Shungu] Biomed Res & Training Inst, Harare, Zimbabwe; [Stray-Pedersen, Babill] Oslo Univ Hosp, Div Women & Children, Rigshosp, Oslo, Norway; [Stray-Pedersen, Babill] Univ Oslo, Oslo, Norway; [Mduluza, Takafira] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe; [Mduluza, Takafira] Univ KwaZulu Natal, Dept Lab Med & Med Sci, Durban, South Africa	University of Witwatersrand; Rigshospitalet; University of Copenhagen; University of Zimbabwe; Aarhus University; Statens Serum Institut; University of Zimbabwe; Rigshospitalet; University of Copenhagen; Biomedical Research Training Institute; University of Oslo; National Hospital Norway; University of Oslo; University of Zimbabwe; University of Kwazulu Natal	Zinyama-Gutsire, RBL (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	gutsirerbl@yahoo.com	Madsen, Hans O/Q-2035-2015; Kallestrup, Per/AAA-8313-2022	Madsen, Hans O/0000-0001-5551-4787; Kallestrup, Per/0000-0001-6041-4510; Gomo, Exnevia/0000-0003-0891-6251; Ullum, Henrik/0000-0001-7306-9058; Garred, Peter/0000-0002-2876-8586; Erikstrup, Christian/0000-0001-6551-6647	Research Foundation of the Capital Region of Denmark; Sven Andersen Research Foundation; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) through a grant for R Zinyama-Gutsire [A30670]; Essential National Health Research Fund of the Ministry of Health and Child Welfare of Zimbabwe [P355]; Fogarty International Centre, National Institutes of Health (NIH-USA) through the International Clinical, Operational and Health Services and Training Award (ICOHRTA) Programme; Danish AIDS Foundation [F01-18, F01-19]; Danish Embassy in Zimbabwe; DANIDA Health Programme in Zimbabwe; US Centres for Disease Control and Prevention Programme in Zimbabwe; SA AIDS conference [A2288739]; Letten Research Foundation; University of Oslo Norway/Zimbabwe Collaborative PMTCT BHAMC Programme	Research Foundation of the Capital Region of Denmark; Sven Andersen Research Foundation; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) through a grant for R Zinyama-Gutsire; Essential National Health Research Fund of the Ministry of Health and Child Welfare of Zimbabwe; Fogarty International Centre, National Institutes of Health (NIH-USA) through the International Clinical, Operational and Health Services and Training Award (ICOHRTA) Programme; Danish AIDS Foundation; Danish Embassy in Zimbabwe; DANIDA Health Programme in Zimbabwe; US Centres for Disease Control and Prevention Programme in Zimbabwe; SA AIDS conference; Letten Research Foundation; University of Oslo Norway/Zimbabwe Collaborative PMTCT BHAMC Programme	Funding was provided by the Research Foundation of the Capital Region of Denmark and the Sven Andersen Research Foundation (Peter Garred and Hans O. Madsen), UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) through a grant for R Zinyama-Gutsire, grant No A30670, the Essential National Health Research Fund of the Ministry of Health and Child Welfare of Zimbabwe (P355) and a study fellowship for RBL Zinyama-Gutsire from The Fogarty International Centre, National Institutes of Health (NIH-USA) through the International Clinical, Operational and Health Services and Training Award (ICOHRTA) Programme (2008-2010). Per Kallestrup received funding from the Danish AIDS Foundation (F01-18, F01-19), The Danish Embassy in Zimbabwe (2001), The DANIDA Health Programme in Zimbabwe (2001), The US Centres for Disease Control and Prevention Programme in Zimbabwe. The Letten Research Foundation, University of Oslo Norway/Zimbabwe Collaborative PMTCT BHAMC Programme special mention Professor Letten F. Saugstad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. An abstract of the results of this study was accepted and presented in Durban at the 6th South Africa AIDS conference as a poster, 18-21 June 2013, funded by the SA AIDS conference, abstract number A2288739 and the Letten Research Foundation, University of Oslo Norway/Zimbabwe Collaborative PMTCT BHAMC Programme.	Alonso DP, 2007, J INFECT DIS, V195, P1212, DOI 10.1086/512683; [Anonymous], 2012, REPORT GLOBAL AIDS E; Antony JS, 2013, J INFECT DIS, V207, P1675, DOI 10.1093/infdis/jit081; Bentwich Z, 2000, AIDS, V14, P2071, DOI 10.1097/00002030-200009290-00002; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-21; Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Catano G, 2008, J INFECT DIS, V198, P72, DOI 10.1086/588712; Chatterjee A, 2011, TISSUE ANTIGENS, V77, P18, DOI 10.1111/j.1399-0039.2010.01563.x; Chirundu D, 2007, CENTRAL AFRICAN J ME, V53, P6; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; da Silva GK, 2011, AIDS, V25, P411, DOI 10.1097/QAD.0b013e328342fef1; Das JK, 2014, CURR OPIN INFECT DIS, V27, P451, DOI 10.1097/QCO.0000000000000096; de Messias-Reason IJ, 2007, J INFECT DIS, V196, P1379, DOI 10.1086/521627; DEELDER AM, 1994, TROP GEOGR MED, V46, P233; DOEHRING E, 1985, KIDNEY INT, V27, P667, DOI 10.1038/ki.1985.62; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Egli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051983; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Eisen S, 2008, FUTURE VIROL, V3, P225, DOI 10.2217/17460794.3.3.225; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Garcia-Laorden MI, 2006, MOL IMMUNOL, V43, P2143, DOI 10.1016/j.molimm.2006.01.008; Garred P, 1997, SCAND J IMMUNOL, V46, P204, DOI 10.1046/j.1365-3083.1997.d01-111.x; Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2003, INFECT IMMUN, V71, P5245, DOI 10.1128/IAI.71.9.5245-5253.2003; GARRED P, 1992, EUR J IMMUNOGENET, V19, P403, DOI 10.1111/j.1744-313X.1992.tb00083.x; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HAURUM JS, 1993, AIDS, V7, P1307, DOI 10.1097/00002030-199310000-00002; Heggelund L, 2003, JAIDS-J ACQ IMM DEF, V32, P354, DOI 10.1097/00126334-200304010-00002; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Hokke CH, 2005, PARASITE IMMUNOL, V27, P257, DOI 10.1111/j.1365-3024.2005.00781.x; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Jambo KC, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-42; Jha AN, 2014, INFECT IMMUN, V82, P52, DOI 10.1128/IAI.01041-13; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; Kallestrup P, 2006, CLIN INFECT DIS, V42, P1781, DOI 10.1086/504380; Kallestrup P, 2005, J INFECT DIS, V192, P1956, DOI 10.1086/497696; Kallestrup P, 2005, J INFECT DIS, V191, P1311, DOI 10.1086/428907; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; Klabunde J, 2000, EXP PARASITOL, V95, P231, DOI 10.1006/expr.2000.4539; KNIGHT WB, 1976, AM J TROP MED HYG, V25, P818, DOI 10.4269/ajtmh.1976.25.818; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Kristensen IA, 2004, SCAND J IMMUNOL, V60, P184, DOI 10.1111/j.0300-9475.2004.01466.x; Kruse C, 2002, AM J OBSTET GYNECOL, V187, P1313, DOI 10.1067/mob.2002.126846; Kuhn L, 2006, AM J CLIN NUTR, V84, P610, DOI 10.1093/ajcn/84.3.610; Li H, 2013, INFECT GENET EVOL, V20, P163, DOI 10.1016/j.meegid.2013.09.010; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Lipscombe RJ, 1996, EUR J HUM GENET, V4, P13; LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; MALHOTRA R, 1990, BIOCHEM SOC T, V18, P1145, DOI 10.1042/bst0181145; Malik S, 2003, IMMUNOGENETICS, V55, P49, DOI 10.1007/s00251-003-0550-4; Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498; Mass J, 1998, AIDS, V12, P2275, DOI 10.1097/00002030-199817000-00008; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Mduluza T, 2001, MEM I OSWALDO CRUZ, V96, P157, DOI 10.1590/S0074-02762001000900024; Mhandire K, 2014, OMICS, V18, P454, DOI 10.1089/omi.2013.0131; Midzi N, 2008, T ROY SOC TROP MED H, V102, P1039, DOI 10.1016/j.trstmh.2008.05.024; Midzi N, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Mombo LE, 2003, AM J TROP MED HYG, V68, P186, DOI 10.4269/ajtmh.2003.68.186; Mombo LE, 2003, GENES IMMUN, V4, P362, DOI 10.1038/sj.gene.6363979; MOTT KE, 1982, TROPENMED PARASITOL, V33, P227; Mwanakasale V, 2003, AM J TROP MED HYG, V69, P420, DOI 10.4269/ajtmh.2003.69.420; Mwinzi PNM, 2001, J INFECT DIS, V184, P488, DOI 10.1086/322783; NIELSEN SL, 1995, CLIN EXP IMMUNOL, V100, P219; Pastinen T, 1998, AIDS RES HUM RETROV, V14, P695, DOI 10.1089/aid.1998.14.695; Petersen SV, 2001, MOL IMMUNOL, V38, P133; Prohaszka Z, 1997, IMMUNOL LETT, V58, P171, DOI 10.1016/S0165-2478(97)00084-9; Santos IKFD, 2001, INFECT IMMUN, V69, P5212, DOI 10.1128/IAI.69.8.5212-5215.2001; SCHMIDT J, 1995, PARASITOLOGY, V111, P325, DOI 10.1017/S0031182000081877; Sekine H, 2013, ADV EXP MED BIOL, V735, P41, DOI 10.1007/978-1-4614-4118-2_3; SENALDI G, 1990, J INFECT DIS, V162, P1227, DOI 10.1093/infdis/162.6.1227; SENALDI G, 1995, J INFECTION, V31, P145, DOI 10.1016/S0163-4453(95)92185-0; Sheng A, 2010, INT J IMMUNOGENET, V37, P445, DOI 10.1111/j.1744-313X.2010.00946.x; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Steffensen R, 2003, J IMMUNOL METHODS, V241, P33; Tan YJ, 2009, MOL IMMUNOL, V47, P632, DOI 10.1016/j.molimm.2009.08.020; Tang Jianming, 2003, AIDS, V17 Suppl 4, pS51, DOI 10.1097/00002030-200317004-00006; TURNER M W, 1991, Clinical and Experimental Immunology, V86, P53; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; UNAIDS. UNAIDS Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, 2013 REP GLOB HIV AI; Valles X, 2010, EUR RESPIR J, V36, P856, DOI 10.1183/09031936.00171409; Valles X, 2009, TISSUE ANTIGENS, V74, P298, DOI 10.1111/j.1399-0039.2009.01328.x; Vallinoto A.C., 2011, REV SOC BRAS MED TRO, V44, P1; Vallinoto ACR, 2008, MEM I OSWALDO CRUZ, V103, P645, DOI 10.1590/S0074-02762008000700003; Vengen IT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042113; WEBER M C, 1969, Central African Journal of Medicine, V15, P27; Wong NKH, 1999, MOL IMMUNOL, V36, P853, DOI 10.1016/S0161-5890(99)00106-6; XU XF, 1994, EXP PARASITOL, V79, P399, DOI 10.1006/expr.1994.1102; Zimbabwe National AIDS Council, 2014, NAT HIV AIDS REP	100	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122659	10.1371/journal.pone.0122659	http://dx.doi.org/10.1371/journal.pone.0122659			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830474	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600119
J	Bianchi, R; Teijeira, A; Proulx, ST; Christiansen, AJ; Seidel, CD; Rulicke, T; Makinen, T; Hagerling, R; Halin, C; Detmar, M				Bianchi, Roberta; Teijeira, Alvaro; Proulx, Steven T.; Christiansen, Ailsa J.; Seidel, Catharina D.; Ruelicke, Thomas; Maekinen, Taija; Haegerling, Rene; Halin, Cornelia; Detmar, Michael			A Transgenic Prox1-Cre-tdTomato Reporter Mouse for Lymphatic Vessel Research	PLOS ONE			English	Article							DENDRITIC CELL-MIGRATION; RED FLUORESCENT PROTEIN; VALVE FORMATION; INFLAMMATION; LYMPHANGIOGENESIS; PROX1; MICE; EXPRESSION; GENE; ENDOTHELIUM	The lymphatic vascular system plays an active role in immune cell trafficking, inflammation and cancer spread. In order to provide an in vivo tool to improve our understanding of lymphatic vessel function in physiological and pathological conditions, we generated and characterized a tdTomato reporter mouse and crossed it with a mouse line expressing Cre recombinase under the control of the lymphatic specific promoter Prox1 in an inducible fashion. We found that the tdTomato fluorescent signal recapitulates the expression pattern of Prox1 in lymphatic vessels and other known Prox1-expressing organs. Importantly, tdTomato co-localized with the lymphatic markers Prox1, LYVE-1 and podoplanin as assessed by whole-mount immunofluorescence and FACS analysis. The tdTomato reporter was brighter than a previously established red fluorescent reporter line. We confirmed the applicability of this animal model to intravital microscopy of dendritic cell migration into and within lymphatic vessels, and to fluorescence-activated single cell analysis of lymphatic endothelial cells. Additionally, we were able to describe the early morphological changes of the lymphatic vasculature upon induction of skin inflammation. The Prox1-Cre-tdTomato reporter mouse thus shows great potential for lymphatic research.	[Bianchi, Roberta; Teijeira, Alvaro; Proulx, Steven T.; Christiansen, Ailsa J.; Seidel, Catharina D.; Halin, Cornelia; Detmar, Michael] ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Vienna, Austria; [Maekinen, Taija] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Haegerling, Rene] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Mammalian Cell Signaling Lab, D-48149 Munster, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Veterinary Medicine Vienna; Uppsala University; Max Planck Society	Detmar, M (corresponding author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Makinen, Taija/C-5765-2014; Teijeira, Alvaro/I-6903-2017; Makinen, Taija/CAI-2233-2022	Makinen, Taija/0000-0002-9338-1257; Teijeira, Alvaro/0000-0002-7339-4464; Makinen, Taija/0000-0002-9338-1257; Hagerling, Rene/0000-0002-6830-2043; Proulx, Steven/0000-0003-2154-8502; Halin, Cornelia/0000-0002-7899-2850; Christiansen, Ailsa/0000-0002-8151-7444	Swiss National Science Foundation [31003A-130627]; Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich(Leducq Foundation)	This work was supported by Swiss National Science Foundation grant 31003A-130627, Advanced European Research Council Grant LYVICAM, the Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich (to M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer D, 2014, ANGIOGENESIS, V17, P383, DOI 10.1007/s10456-013-9404-3; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; CLARK AJ, 1994, REPROD FERT DEVELOP, V6, P589, DOI 10.1071/RD9940589; Dieterich LC, 2014, ANGIOGENESIS, V17, P359, DOI 10.1007/s10456-013-9406-1; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Hagerling R, 2011, BIOCHEM SOC T, V39, P1674, DOI 10.1042/BST20110722; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Jurisic G, 2009, CELL TISSUE RES, V335, P97, DOI 10.1007/s00441-008-0644-2; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Martinez-Corral I, 2012, P NATL ACAD SCI USA, V109, P6223, DOI 10.1073/pnas.1115542109; Mumprecht V, 2010, CANCER RES, V70, P8842, DOI 10.1158/0008-5472.CAN-10-0896; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Onder L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00050; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Proulx ST, 2013, BIOMATERIALS, V34, P5128, DOI 10.1016/j.biomaterials.2013.03.034; Proulx ST, 2010, CANCER RES, V70, P7053, DOI 10.1158/0008-5472.CAN-10-0271; Sawicki JA, 1998, EXP CELL RES, V244, P367, DOI 10.1006/excr.1998.4175; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Truman LA, 2013, LYMPHAT RES BIOL, V11, P187, DOI 10.1089/lrb.2013.0013; Truman LA, 2012, AM J PATHOL, V180, P1715, DOI 10.1016/j.ajpath.2011.12.026; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1	35	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122976	10.1371/journal.pone.0122976	http://dx.doi.org/10.1371/journal.pone.0122976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849579	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800186
J	Buchholz, M; Honstein, T; Kirchhoff, S; Kreider, R; Schmidt, H; Sipos, B; Gress, TM				Buchholz, Malte; Honstein, Tatjana; Kirchhoff, Sandra; Kreider, Ramona; Schmidt, Harald; Sipos, Bence; Gress, Thomas M.			A Multistep High-Content Screening Approach to Identify Novel Functionally Relevant Target Genes in Pancreatic Cancer	PLOS ONE			English	Article							CELL-LINES; EXPRESSION PROFILES; CARCINOMA CELLS; DIFFERENTIATION; OVEREXPRESSION; IDENTIFICATION; GEMCITABINE; INVASION; ADENOCARCINOMA; ESTABLISHMENT	In order to foster the systematic identification of novel genes with important functional roles in pancreatic cancer, we have devised a multi-stage screening strategy to provide a rational basis for the selection of highly relevant novel candidate genes based on the results of functional high-content analyses. The workflow comprised three consecutive stages: 1) serial gene expression profiling analyses of primary human pancreatic tissues as well as a number of in vivo and in vitro models of tumor-relevant characteristics in order to identify genes with conspicuous expression patterns; 2) use of 'reverse transfection array' technology for large-scale parallelized functional analyses of potential candidate genes in cell-based assays; and 3) selection of individual candidate genes for further in-depth examination of their cellular roles. A total of 14 genes, among them 8 from "druggable" gene families, were classified as high priority candidates for individual functional characterization. As an example to demonstrate the validity of the approach, comprehensive functional data on candidate gene ADRBK1/GRK2, which has previously not been implicated in pancreatic cancer, is presented.	[Buchholz, Malte; Honstein, Tatjana; Kirchhoff, Sandra; Kreider, Ramona; Schmidt, Harald; Gress, Thomas M.] Univ Marburg, Clin Gastroenterol Endocrinol Metab & Infectiol, Marburg, Germany; [Sipos, Bence] Univ Tubingen Hosp, Dept Pathol & Neuropathol, Tubingen, Germany	Philipps University Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Buchholz, M (corresponding author), Univ Marburg, Clin Gastroenterol Endocrinol Metab & Infectiol, Marburg, Germany.	malte.buchholz@staff.uni-marburg.de		Gress, Thomas/0000-0002-9333-5461	EU [LSHB-CT-2006-018771, 602783]; German federal ministry of education and research (BMBF) [PKB-01GS08, 01GS08178]; German Research Foundation (DFG) [Bu 1536/3-1]	EU(European Commission); German federal ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded in part by EU FP6 grant LSHB-CT-2006-018771 (Integrated Project "MolDiag-Paca"), the German federal ministry of education and research (BMBF) within the framework of the program of medical genome research (PaCaNet; project ID PKB-01GS08 and 01GS08178), the German Research Foundation (DFG; grant Bu 1536/3-1 to M.B.), and EU FP7 grant no. 602783 (large-scale integrated project "CAM-PaC"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Buchholz M, 2003, CANCER RES, V63, P4945; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; DREXLER HG, 1995, LEUKEMIA RES, V19, P681, DOI 10.1016/0145-2126(95)00036-N; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Evron T, 2012, TRENDS PHARMACOL SCI, V33, P154, DOI 10.1016/j.tips.2011.12.003; Fensterer H, 2004, GENE CHROMOSOME CANC, V39, P224, DOI 10.1002/gcc.20000; Gress TM, 2012, J MOL MED, V90, P457, DOI 10.1007/s00109-011-0832-5; Gress TM, 1996, ONCOGENE, V13, P1819; Gress TM, 1997, GENE CHROMOSOME CANC, V19, P97, DOI 10.1002/(SICI)1098-2264(199706)19:2<97::AID-GCC5>3.0.CO;2-V; Han HY, 2002, CANCER RES, V62, P2890; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5; Iwamura T, 1997, CANCER RES, V57, P1206; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kuhnemuth B, 2015, ONCOGENE, V34, P177, DOI 10.1038/onc.2013.530; Lehnert L, 1999, ANN NY ACAD SCI, V880, P83, DOI 10.1111/j.1749-6632.1999.tb09512.x; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Logsdon CD, 2003, CANCER RES, V63, P2649; Mannherz O, 2006, GENOMICS, V87, P665, DOI 10.1016/j.ygeno.2005.12.009; Maurice JP, 1999, AM J PHYSIOL-HEART C, V276, pH1853, DOI 10.1152/ajpheart.1999.276.6.H1853; Metaye T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Plath T, 2002, J NATL CANCER I, V94, P129, DOI 10.1093/jnci/94.2.129; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Rivas V, 2013, J CLIN INVEST, V123, P4714, DOI 10.1172/JCI67333; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; VILA MR, 1995, LAB INVEST, V72, P395; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wei ZY, 2012, J CELL PHYSIOL, V227, P2371, DOI 10.1002/jcp.22972; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114; ZUR HAUSEN HARALD, 1967, J VIROL, V1, P1174	51	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122946	10.1371/journal.pone.0122946	http://dx.doi.org/10.1371/journal.pone.0122946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849100	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800180
J	de Paola, I; Pirone, L; Palmieri, M; Balasco, N; Esposito, L; Russo, L; Mazza, D; Di Marcotullio, L; Di Gaetano, S; Malgieri, G; Vitagliano, L; Pedone, E; Zaccaro, L				de Paola, Ivan; Pirone, Luciano; Palmieri, Maddalena; Balasco, Nicole; Esposito, Luciana; Russo, Luigi; Mazza, Daniela; Di Marcotullio, Lucia; Di Gaetano, Sonia; Malgieri, Gaetano; Vitagliano, Luigi; Pedone, Emilia; Zaccaro, Laura			Cullin3-BTB Interface: A Novel Target for Stapled Peptides	PLOS ONE			English	Article							HISTONE DEACETYLASE; SECONDARY STRUCTURE; ESSENTIAL DYNAMICS; UBIQUITIN LIGASES; PROTEIN; DOMAIN; TETRAMERIZATION; PROGRAM; FAMILY; IDENTIFICATION	Cullin3 (Cul3), a key factor of protein ubiquitination, is able to interact with dozens of different proteins containing a BTB (Bric-a-brac, Tramtrack and Broad Complex) domain. We here targeted the Cul3-BTB interface by using the intriguing approach of stabilizing the alpha-helical conformation of Cul3-based peptides through the "stapling" with a hydrocarbon cross-linker. In particular, by combining theoretical and experimental techniques, we designed and characterized stapled Cul3-based peptides embedding the helix 2 of the protein (residues 49-68). Intriguingly, CD and NMR experiments demonstrate that these stapled peptides were able to adopt the helical structure that the fragment assumes in the parent protein. We also show that some of these peptides were able to bind to the BTB of the tetrameric KCTD11, a substrate adaptor involved in HDAC1 degradation, with high affinity (similar to 300-600 nM). Cul3-derived staple peptides are also able to bind the BTB of the pentameric KCTD5. Interestingly, the affinity of these peptides is of the same order of magnitude of that reported for the interaction of full-length Cul3 with some BTB containing proteins. Moreover, present data indicate that stapling endows these peptides with an increased serum stability. Altogether, these findings indicate that the designed stapled peptides can efficiently mimic protein-protein interactions and are potentially able to modulate fundamental biological processes involving Cul3.	[de Paola, Ivan; Balasco, Nicole; Esposito, Luciana; Di Gaetano, Sonia; Vitagliano, Luigi; Pedone, Emilia; Zaccaro, Laura] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Pirone, Luciano] CNR, Inst Crystallog, I-70126 Bari, Italy; [Palmieri, Maddalena; Balasco, Nicole; Russo, Luigi; Malgieri, Gaetano] Univ Naples 2, Caserta, Italy; [Esposito, Luciana; Di Gaetano, Sonia; Vitagliano, Luigi; Pedone, Emilia; Zaccaro, Laura] Interuniv Ctr Res Bioact Peptides CIRPEB, Naples, Italy; [Mazza, Daniela; Di Marcotullio, Lucia] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Universita della Campania Vanvitelli; Sapienza University Rome	Pedone, E (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	empedone@unina.it; lzaccaro@unina.it	Pedone, Emilia/HDN-2342-2022; Malgieri, Gaetano/N-1678-2016; esposito, luciana/Q-3182-2017; Pirone, Luciano/ABG-2892-2020; Pedone, Emilia Maria/K-2229-2015; Pirone, Luciano/G-7256-2015; Mazzà, Daniela/AAK-3687-2021; de Paola, Ivan/B-6867-2017	Pedone, Emilia/0000-0003-0203-8611; esposito, luciana/0000-0001-6431-2677; Pirone, Luciano/0000-0002-7014-4689; Pedone, Emilia Maria/0000-0003-0203-8611; Pirone, Luciano/0000-0002-7014-4689; Mazzà, Daniela/0000-0003-4754-9394; de Paola, Ivan/0000-0003-1508-6591; RUSSO, Luigi/0000-0002-1577-176X; Di Gaetano, Sonia/0000-0001-5523-3619; Balasco, Nicole/0000-0001-7862-9448; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178; MALGIERI, Gaetano/0000-0002-4070-9458	Italian MIUR [FIRB RBAP114AMK 006]	Italian MIUR(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Italian MIUR for financial support (FIRB RBAP114AMK 006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Azizieh R, 2011, MOL NEUROBIOL, V44, P111, DOI 10.1007/s12035-011-8194-0; Balasco N, 2014, BIOCH BIOPHYS ACTA; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bernal F, 2007, J AM CHEM SOC, V129, P5298, DOI 10.1021/ja076886p; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bird GH, 2014, ACS CHEM BIOL, V9, P831, DOI 10.1021/cb4003305; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; De Smaele E, 2011, NEOPLASIA, V13, P374, DOI 10.1593/neo.101630; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Di Marcotullio L, 2011, BBA-REV CANCER, V1815, P241, DOI 10.1016/j.bbcan.2011.01.002; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hu X, 2012, MOL BIOL REP, V39, P9911, DOI 10.1007/s11033-012-1858-7; Huang T, 2012, BIOCHEM BIOPH RES CO, V417, P182, DOI 10.1016/j.bbrc.2011.11.081; Joseph TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043985; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Merlino A, 2002, BIOPOLYMERS, V65, P274, DOI 10.1002/bip.10225; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pirone L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/162674; Pirone L, 2011, J PEPT SCI, V17, P373, DOI 10.1002/psc.1366; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sviridov DO, 2011, BIOCHEM BIOPH RES CO, V410, P446, DOI 10.1016/j.bbrc.2011.05.154; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2014, J MED CHEM; Williams MJ, 2012, CELL MOL LIFE SCI, V69, P3819, DOI 10.1007/s00018-012-1022-5; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010	48	24	24	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121149	10.1371/journal.pone.0121149	http://dx.doi.org/10.1371/journal.pone.0121149			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848797	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800046
J	Memarian, N; Madsen, SK; Macey, PM; Fried, I; Engel, J; Thompson, PM; Staba, RJ				Memarian, Negar; Madsen, Sarah K.; Macey, Paul M.; Fried, Itzhak; Engel, Jerome, Jr.; Thompson, Paul M.; Staba, Richard J.			Ictal Depth EEG and MRI Structural Evidence for Two Different Epileptogenic Networks in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							SEIZURE-ONSET PATTERNS; HIPPOCAMPAL SCLEROSIS; CORTICAL EFFERENTS; ENTORHINAL CORTEX; RHESUS-MONKEY; ATROPHY; ABNORMALITIES; CONNECTIONS; RECORDINGS; SUBTYPES	Hypersynchronous (HYP) and low voltage fast (LVF) activity are two separate ictal depth EEG onsets patterns often recorded in presurgical patients with MTLE. Evidence suggests the mechanisms generating HYP and LVF onset seizures are distinct, including differential involvement of hippocampal and extra-hippocampal sites. Yet the extent of extra-hippocampal structural alterations, which could support these two common seizures, is not known. In the current study, preoperative MRI from 24 patients with HYP or LVF onset seizures were analyzed to determine changes in cortical thickness and relate structural changes to spatiotemporal properties of the ictal EEG. Overall, onset and initial ipsilateral spread of HYP onset seizures involved mesial temporal structures, whereas LVF onset seizures involved mesial and lateral temporal as well as orbitofrontal cortex. MRI analysis found reduced cortical thickness correlated with longer duration of epilepsy. However, in patients with HYP onsets, the most affected areas were on the medial surface of each hemisphere, including parahippocampal regions and cingulate gyrus, whereas in patients with LVF onsets, the lateral surface of the anterior temporal lobe and orbitofrontal cortex showed the greatest effect. Most patients with HYP onset seizures were seizure-free after resective surgery, while a higher proportion of patients with LVF onset seizures had only worthwhile improvement. Our findings confirm the view that recurrent seizures cause progressive changes in cortical thickness, and provide information concerning the structural basis of two different epileptogenic networks responsible for MTLE. One, identified by HYP ictal onsets, chiefly involves hippocampus and is associated with excellent outcome after standardized anteromedial temporal resection, while the other also involves lateral temporal and orbitofrontal cortex and a seizure-free surgical outcome occurs less after this procedure. These results suggest that a more extensive tailored resection may be required for patients with the second type of MTLE.	[Memarian, Negar; Engel, Jerome, Jr.; Staba, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Madsen, Sarah K.; Thompson, Paul M.] Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Dept Neurol,Imaging Genet Ctr, Los Angeles, CA 90033 USA; [Macey, Paul M.] Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA USA; [Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Staba, RJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	rstaba@mednet.ucla.edu	Macey, Paul M./B-5037-2008; Staba, Richard/AAN-3149-2021; Thompson, Paul M/C-4194-2018	Macey, Paul M./0000-0003-4093-7458; Thompson, Paul M/0000-0002-4720-8867	National Institute of Neurological Disorders and Stroke [071048, 033310]; Natural Sciences and Engineering Research Council of Canada	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) grants 071048 (RS) and 033310 (JE), and a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) fellowship (NM).	Abbie AA, 1940, J COMP NEUROL, V72, P429, DOI 10.1002/cne.900720302; Akiake H, 1974, IEEE T AUTOMATIC CON, V19, P716; Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 1999, CLIN NEUROPHYSIOL, V110, P1741, DOI 10.1016/S1388-2457(99)00107-8; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bartolomei F, 2010, EPILEPSIA, V51, P2147, DOI 10.1111/j.1528-1167.2010.02690.x; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Bernhardt BC, 2012, NEUROLOGY, V78, P129, DOI 10.1212/WNL.0b013e31823efd0d; Blumcke I, 2007, ACTA NEUROPATHOL, V113, P235, DOI 10.1007/s00401-006-0187-0; Bonilha L, 2003, J NEUROL NEUROSUR PS, V74, P1627, DOI 10.1136/jnnp.74.12.1627; Bonilha L, 2006, NEUROIMAGE, V32, P1070, DOI 10.1016/j.neuroimage.2006.05.038; Bonilha L, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2011.03298.x; Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x; Bragin A, 2005, EPILEPSIA, V46, P59, DOI 10.1111/j.1528-1167.2005.01010.x; Bragin A, 2007, EPILEPSIA, V48, P1883, DOI 10.1111/j.1528-1167.2007.01149.x; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Chabardes S, 2005, BRAIN, V128, P1818, DOI 10.1093/brain/awh512; Chassoux F, 2004, BRAIN, V127, P164, DOI 10.1093/brain/awh014; Coan AC, 2014, EPILEPSIA, V55, P1187, DOI 10.1111/epi.12670; Coan AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085843; de Curtis M, 2009, EPILEPSIA, V50, P2514, DOI 10.1111/j.1528-1167.2009.02249.x; EBEL RL, 1951, PSYCHOMETRIKA, V16, P407; ENGEL J, 1983, TRENDS NEUROSCI, V6, P60, DOI 10.1016/0166-2236(83)90027-9; Engel J Jr, 1989, Acta Neurochir Suppl (Wien), V46, P3; Engel Jr J, 1993, SURG TREATMENT EPILE, P727; Fahoum F, 2012, EPILEPSIA, V53, P1618, DOI 10.1111/j.1528-1167.2012.03533.x; Fried I, 1993, Neurosurg Clin N Am, V4, P233; IBM Corp, 2013, SPSS TWOSTEP CLUST C; Isnard J, 2000, ANN NEUROL, V48, P614, DOI 10.1002/1531-8249(200010)48:4<614::AID-ANA8>3.0.CO;2-S; Jehi LE, 2010, J NEUROSURG, V113, P1186, DOI 10.3171/2010.8.JNS10180; Joshi SH, 2012, IEEE T MED IMAGING, V31, P1195, DOI 10.1109/TMI.2012.2186975; Kahane P, 2002, EPILEPTIC DISORD, V4, pS51; Kahane P, 2010, EPILEPSIA, V51, P59, DOI 10.1111/j.1528-1167.2009.02448.x; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Kobayashi Y, 2007, J COMP NEUROL, V502, P810, DOI 10.1002/cne.21346; LIEB JP, 1991, EPILEPSIA, V32, P822, DOI 10.1111/j.1528-1157.1991.tb05539.x; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Liu RSN, 2003, ANN NEUROL, V53, P312, DOI 10.1002/ana.10463; Maillard L, 2004, EPILEPSIA, V45, P1590, DOI 10.1111/j.0013-9580.2004.09704.x; McDonald CR, 2008, EPILEPSIA, V49, P794, DOI 10.1111/j.1528-1167.2008.01539.x; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Mueller SG, 2009, NEUROIMAGE, V46, P353, DOI 10.1016/j.neuroimage.2009.02.020; Munoz M, 2005, EUR J NEUROSCI, V22, P1368, DOI 10.1111/j.1460-9568.2005.04299.x; Ogren JA, 2009, EPILEPSIA, V50, P1361, DOI 10.1111/j.1528-1167.2008.01881.x; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Perucca P, 2013, BRAIN; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ryvlin P, 2005, CURR OPIN NEUROL, V18, P125, DOI 10.1097/01.wco.0000162852.22026.6f; Sanides F., 1970, PRIMATE BRAIN ADV PR, P137; Scanlon C, 2013, J NEUROL, V260, P2320, DOI 10.1007/s00415-013-6974-3; SPENCER SS, 1992, ELECTROEN CLIN NEURO, V83, P104, DOI 10.1016/0013-4694(92)90023-B; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Spencer SS, 1996, EPILEPSIA, V37, P455, DOI 10.1111/j.1528-1157.1996.tb00591.x; Talairach J., 1973, PROGR NEUROL SURG, V5, P297, DOI [DOI 10.1159/000394343, 10.1159/000394343]; Thom M, 2010, ANN NEUROL, V68, P424, DOI 10.1002/ana.22142; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Van Paesschen W, 2003, BRAIN, V126, P1103, DOI 10.1093/brain/awg108; Velasco AL, 2000, NEURAL PLAST, V7, P49, DOI 10.1155/NP.2000.49; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x	64	24	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123588	10.1371/journal.pone.0123588	http://dx.doi.org/10.1371/journal.pone.0123588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849340	Green Published, gold			2022-12-27	WOS:000352477800242
J	Song, YL; Yu, MH				Song, Yinglei; Yu, Menghong			On the Treewidths of Graphs of Bounded Degree	PLOS ONE			English	Article							TREE-WIDTH; MINORS; ALGORITHMS	In this paper, we develop a new technique to study the treewidth of graphs with bounded degree. We show that the treewidth of a graph G = (V, E) with maximum vertex degree d is at most (1-Ce-(4.06 root d))vertical bar V vertical bar for sufficiently large d, where C is a constant.	[Song, Yinglei; Yu, Menghong] Jiangsu Univ Sci & Technol Zhenjiang, Sch Elect & Informat Sci, Zhenjiang 212003, Jiangsu, Peoples R China	Jiangsu University of Science & Technology	Song, YL (corresponding author), Jiangsu Univ Sci & Technol Zhenjiang, Sch Elect & Informat Sci, Zhenjiang 212003, Jiangsu, Peoples R China.	yingleisong@gmail.com; ymhzj2691@163.com			New Faculty Start-up Funding at Jiangsu University of Science and Technology, China [635301202]	New Faculty Start-up Funding at Jiangsu University of Science and Technology, China	This work is fully supported by the New Faculty Start-up Funding at Jiangsu University of Science and Technology, China, under the funding number 635301202. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNBORG S, 1989, DISCRETE APPL MATH, V23, P11, DOI 10.1016/0166-218X(89)90031-0; ARNBORG S, 1987, SIAM J ALGEBRA DISCR, V8, P277, DOI 10.1137/0608024; BAKER BS, 1994, J ACM, V41, P153, DOI 10.1145/174644.174650; Bodlaender HL, 2004, LECT NOTES COMPUT SC, V3221, P628; Bodlaender HL, 1997, DISCRETE APPL MATH, V79, P45, DOI 10.1016/S0166-218X(97)00031-0; BODLAENDER HL, 1991, LECT NOTES COMPUT SC, V510, P544; Bodlaender HL, 1996, SIAM J COMPUT, V25, P1305, DOI 10.1137/S0097539793251219; COURCELLE B, 1990, INFORM COMPUT, V85, P12, DOI 10.1016/0890-5401(90)90043-H; Eppstein D., 1999, Journal of Graph Algorithms and Applications, V3; Kneis J, 2005, LECT NOTES COMPUT SC, V3787, P385; Kosowski A, 2012, LECT NOTES COMPUT SC, V7392, P610, DOI 10.1007/978-3-642-31585-5_54; Lucena B, 2003, SIAM J DISCRETE MATH, V16, P345, DOI 10.1137/S0895480101397773; ROBERTSON N, 1995, J COMB THEORY B, V63, P65, DOI 10.1006/jctb.1995.1006; ROBERTSON N, 1990, J COMB THEORY B, V48, P227, DOI 10.1016/0095-8956(90)90120-O; ROBERTSON N, 1986, J COMB THEORY B, V41, P92, DOI 10.1016/0095-8956(86)90030-4; ROBERTSON N, 1984, J COMB THEORY B, V36, P49, DOI 10.1016/0095-8956(84)90013-3; ROBERTSON N, 1991, J COMB THEORY B, V52, P153, DOI 10.1016/0095-8956(91)90061-N; ROBERTSON N, 1986, J ALGORITHM, V7, P309, DOI 10.1016/0196-6774(86)90023-4	18	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120880	10.1371/journal.pone.0120880	http://dx.doi.org/10.1371/journal.pone.0120880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849278	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800037
J	Wang, JY; Mao, Y; Li, J; Xiong, Z; Wang, WX				Wang, Jingyuan; Mao, Yu; Li, Jing; Xiong, Zhang; Wang, Wen-Xu			Predictability of Road Traffic and Congestion in Urban Areas	PLOS ONE			English	Article							AIR-POLLUTION; PREDICTION; MODEL; LAWS	Mitigating traffic congestion on urban roads, with paramount importance in urban development and reduction of energy consumption and air pollution, depends on our ability to foresee road usage and traffic conditions pertaining to the collective behavior of drivers, raising a significant question: to what degree is road traffic predictable in urban areas? Here we rely on the precise records of daily vehicle mobility based on GPS positioning device installed in taxis to uncover the potential daily predictability of urban traffic patterns. Using the mapping from the degree of congestion on roads into a time series of symbols and measuring its entropy, we find a relatively high daily predictability of traffic conditions despite the absence of any priori knowledge of drivers' origins and destinations and quite different travel patterns between weekdays and weekends. Moreover, we find a counterintuitive dependence of the predictability on travel speed: the road segment associated with intermediate average travel speed is most difficult to be predicted. We also explore the possibility of recovering the traffic condition of an inaccessible segment from its adjacent segments with respect to limited observability. The highly predictable traffic patterns in spite of the heterogeneity of drivers' behaviors and the variability of their origins and destinations enables development of accurate predictive models for eventually devising practical strategies to mitigate urban road congestion.	[Wang, Jingyuan; Mao, Yu; Li, Jing; Xiong, Zhang] Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China; [Wang, Jingyuan] Beihang Univ, Res Inst Shenzhen, Shenzhen, Peoples R China; [Wang, Wen-Xu] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beihang University; Beihang University; Beijing Normal University	Wang, JY (corresponding author), Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China.	jywang@buaa.edu.cn			National High Technology Research and Development Program of China [2013AA01A601]; National Natural Science Foundation of China [61272350]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National High Technology Research and Development Program of China (No. 2013AA01A601) http://www.863.gov.cn/, National Natural Science Foundation of China (No. 61272350) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kadi O, 2014, FRONT COMPUT SCI-CHI, V8, P619, DOI 10.1007/s11704-014-3156-0; [Anonymous], RING ROADS BEIJ; [Anonymous], FLOAT CAR DAT; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Brabazon A, 2008, STUD COMPUT INTELL, V185, P1; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chin ATH, 1996, ATMOS ENVIRON, V30, P787, DOI 10.1016/1352-2310(95)00173-5; Cover T. M., 1991, Elements of information theory, DOI 10.1002/0471200611; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; HAUTUS MLJ, 1969, P K NED AKAD A MATH, V72, P443; Helbing D, 2003, J PHYS A-MATH GEN, V36, pL593, DOI 10.1088/0305-4470/36/46/L03; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Herrera JC, 2007, DYNAMIC ESTIMATION O; Herrera JC, 2010, TRANSPORT RES C-EMER, V18, P568, DOI 10.1016/j.trc.2009.10.006; Hornsey R, 2010, MODERN TRAFFIC IS LO; Jia T, 2012, ISPRS INT J GEO-INF, V1, P89, DOI 10.3390/ijgi1010089; Kolbl R, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/348; Leng B, 2013, FRONT COMPUT SCI-CHI, V7, P195, DOI 10.1007/s11704-013-2057-y; Li RH, 2013, FRONT COMPUT SCI-CHI, V7, P185, DOI 10.1007/s11704-013-3902-8; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lou Y., 2009, P 17 ACM SIGSPATIAL, P352, DOI DOI 10.1145/1653771.1653820; MAYER-SCHONBERGER VIKTOR, 2013, BIG DATA A REVOLUTIO; Ortuzar JD, 2011, MODELLING TRANSPORT, 4TH EDITION; Rosenlund M, 2008, J EXPO SCI ENV EPID, V18, P192, DOI 10.1038/sj.jes.7500571; Schrank D, 2004, URBAN MOBILITY REPOR; Thomas JM, 2006, J PLAN LIT, V21, P153, DOI 10.1177/0885412206292259; Wang J, 2014, SCI REP, V4; Wang P, 2012, SCI REP, V2; Wynter L, 2012, PROCEEDINGS OF TRANS, P12; Yousaf J, 2014, FRONT COMPUT SCI-CHI, V8, P100, DOI 10.1007/s11704-013-3021-6; Yu KF, 2014, FRONT COMPUT SCI-CHI, V8, P316, DOI 10.1007/s11704-014-3258-8; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; Zhang XY, 2012, ATMOS CHEM PHYS, V12, P779, DOI 10.5194/acp-12-779-2012; Zheng Y, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1436, DOI 10.1145/2487575.2488188	37	27	30	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121825	10.1371/journal.pone.0121825	http://dx.doi.org/10.1371/journal.pone.0121825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849534	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800077
J	Zhang, JB; Lin, J; Zhao, XD				Zhang, Jian Bo; Lin, Ji; Zhao, Xiao Dong			Analysis of Bias in Measurements of Potassium, Sodium and Hemoglobin by an Emergency Department-Based Blood Gas Analyzer Relative to Hospital Laboratory Autoanalyzer Results	PLOS ONE			English	Article							HEPARIN; POINT	Objective The emergency departments (EDs) of Chinese hospitals are gradually being equipped with blood gas machines. These machines, along with the measurement of biochemical markers by the hospital laboratory, facilitate the care of patients with severe conditions who present to the ED. However, discrepancies have been noted between the Arterial Blood Gas (ABG) analyzers in the ED and the hospital laboratory autoanalyzer in relation to electrolyte and hemoglobin measurements. The present study was performed to determine whether the ABG and laboratory measurements of potassium, sodium, and hemoglobin levels are equivalent, and whether ABG analyzer results can be used to guide clinical care before the laboratory results become available. Materials and Methods Study power analyses revealed that 200 consecutive patients who presented to our ED would allow this prospective single-center cohort study to detect significant differences between ABG- and laboratory-measured potassium, sodium, and hemoglobin levels. Paired arterial and venous blood samples were collected within 30 minutes. Arterial blood samples were measured in the ED by an ABL 90 FLEX blood gas analyzer. The biochemistry and blood cell counts of the venous samples were measured in the hospital laboratory. The potassium, sodium, and hemoglobin concentrations obtained by both methods were compared by using paired Student's t-test, Spearman's correlation, Bland-Altman plots, and Deming regression. Results The mean ABG and laboratory potassium values were 3.77 +/- 0.44 and 4.2 +/- 0.55, respectively (P<0.0001). The mean ABG and laboratory sodium values were 137.89 +/- 5.44 and 140.93 +/- 5.50, respectively (P<0.0001). The mean ABG and laboratory Hemoglobin values were 12.28 +/- 2.62 and 12.35 +/- 2.60, respectively (P = 0.24). Conclusion Although there are the statistical difference and acceptable biases between ABG- and laboratory-measured potassium and sodium, the biases do not exceed USCLIA-determined limits. In parallel, there are no statistical differences and biases beyond USCLIA-determined limits between ABG- and laboratory-measured hemoglobin. Therefore, all three variables measured by ABG were reliable.	[Zhang, Jian Bo; Zhao, Xiao Dong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Emergency Dept, Beijing 100048, Peoples R China; [Lin, Ji] Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Zhao, XD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Emergency Dept, Beijing 100048, Peoples R China.	zxd63715@126.com						Arthurs O, 2010, POINT CARE, V9, P21, DOI 10.1097/POC.0b013e3181d2d6b0; Bloom BM, 2013, EUROPEAN J EMERGENCY; Chacko B, 2011, INDIAN J CRIT CARE M, V15, P24, DOI 10.4103/0972-5229.78219; Chhapola V, 2013, INDIAN J PEDIATR, V80, P731, DOI 10.1007/s12098-013-0977-z; De Koninck AS, 2012, CLIN CHEM LAB MED, V50, P1083, DOI 10.1515/cclm-2011-0685; Jain A, 2009, INT J EMERG MED, V2, P117, DOI 10.1007/s12245-009-0091-1; Price CP, 2002, CLIN CHEM LAB MED, V40, P246, DOI 10.1515/CCLM.2002.040; van Berkel M, 2011, CLIN CHEM LAB MED, V49, P249, DOI 10.1515/CCLM.2011.047; Yip PM, 2006, CLIN BIOCHEM, V39, P391, DOI 10.1016/j.clinbiochem.2005.12.006	9	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122383	10.1371/journal.pone.0122383	http://dx.doi.org/10.1371/journal.pone.0122383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849375	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800123
J	Houede, N; Leutenegger, E; Lomma, M; Bellera, C				Houede, Nadine; Leutenegger, Eric; Lomma, Mariella; Bellera, Carine			Formal Consensus Method to Evaluate the Conformity of Prescription of a Recently Approved Chemotherapy Treatment in an Observatory Study	PLOS ONE			English	Article							DOCETAXEL TREATMENT; PROSTATE; CABAZITAXEL; DEFINITION; THERAPY	Cabazitaxel is a second line chemotherapy drug recently approved for the treatment of metastatic castration-resistant prostate cancer. A first panel of French experts and a second independent panel of European experts were convened to assess the conformity of prescription of cabazitaxel with a Delphi consensus method. A two-round modified Delphi consensus process was conducted. This methodology is based on experts' opinion obtained in a systematic manner. The process was divided into five steps: (i) elaboration of the questionnaire, (ii) rating, (iii) analysis, (iv) discussion of the points with absence of consensus following rating of the questionnaire, and (v) final reporting. Consensus was defined according to RAND method and all analyses were conducted according to the same methodology. At the end of the two rounds of rating and a synthesis meeting, of the 26 items included in the Summary of Product Characteristics (SPC), 11 items were judged appropriate with strong consensus by the two independent panels of experts. These items can therefore be considered of prime importance to evaluate conformity of cabazitaxel prescription in the context of observatory studies as well as in further clinical trials using this new taxane. Our findings further provide important evidence about the value of the Delphi consensus and highlight a requirement for "conformity" standards to assist practitioners in a safe chemotherapy drug prescription.	[Houede, Nadine] Univ Nimes Hosp, Dept Med Oncol, F-30000 Nimes, France; [Houede, Nadine] Inst Rech Cancerol Montpellier, INSERM U1194, Montpellier, France; [Leutenegger, Eric] Gecem, Late Phase Studies, Paris, France; [Lomma, Mariella] Univ Nimes Hosp, Dept Clin Epidemiol, F-30000 Nimes, France; [Bellera, Carine] Ctr Comprehens Canc, Inst Bergonie, Clin Res & Clin Epidemiol Unit, Bordeaux, France; [Bellera, Carine] INSERM, CIC 1401, Clin Epidemiol, Bordeaux, France	Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; UNICANCER; Centre Eugene Marquis; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Houede, N (corresponding author), Univ Nimes Hosp, Dept Med Oncol, Pl Pr R Debre, F-30000 Nimes, France.	nadine.houede@chu-nimes.fr		Bellera, Carine/0000-0001-7926-4671	Sanofi	Sanofi(Sanofi-Aventis)	This work was supported by Sanofi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Eric Leutenegger is employed by Late Phase Studies, Gecem. Late Phase Studies, Gecem provided support in the form of salary for author EL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abdel-Wahab M, 2012, J AM COLL RADIOL, V9, P233, DOI 10.1016/j.jacr.2011.12.030; Bellera CA, 2013, EUR J CANCER, V49, P769, DOI 10.1016/j.ejca.2012.09.035; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Eberhardt SC, 2013, J AM COLL RADIOL, V10, P83, DOI 10.1016/j.jacr.2012.10.021; European Medicines Agency, JEVT SUMM PROD CHAR; Fitch K, 2001, RAND UCLA APPROPRIAT, DOI [10.1016/j.seizure.2011.09.007, DOI 10.1016/J.SEIZURE.2011.09.007]; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; Haute Autorite de Sante, 2010, EL REC BONN PRAT MET; Hong TS, 2014, GASTROINTEST CANC RE, V7, P4; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lee LJ, 2013, ONCOLOGY-NY, V27, P1166; Mitchell DG, 2013, J AM COLL RADIOL, V10, P822, DOI 10.1016/j.jacr.2013.07.017; Pouessel D, 2012, B CANCER, V99, P731, DOI 10.1684/bdc.2012.1608; Prot-Labarthe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101171; Thomas SK, 2013, BRIT J CLIN PHARMACO, V76, P797, DOI 10.1111/bcp.12087; Tombal B, 2014, BJU INT, V113, P189, DOI 10.1111/bju.12469; van den Bos W, 2014, EUR UROL, V65, P1078, DOI 10.1016/j.eururo.2014.01.001	17	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123035	10.1371/journal.pone.0123035	http://dx.doi.org/10.1371/journal.pone.0123035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837603	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000123
J	James, BD; Boyle, PA; Yu, L; Han, SD; Bennett, DA				James, Bryan D.; Boyle, Patricia A.; Yu, Lei; Han, S. Duke; Bennett, David A.			Cognitive Decline Is Associated with Risk Aversion and Temporal Discounting in Older Adults without Dementia	PLOS ONE			English	Article							DECISION-MAKING; RUSH MEMORY; HEALTH; CONNECTIVITY; INTELLIGENCE; PREFERENCES; IMPATIENCE; ABILITY	Risk aversion and temporal discounting are preferences that are strongly linked to suboptimal financial and health decision making ability. Prior studies have shown they differ by age and cognitive ability, but it remains unclear whether differences are due to age-related cognitive decline or lower cognitive abilities over the life span. We tested the hypothesis that cognitive decline is associated with higher risk aversion and temporal discounting in 455 older persons without dementia from the Memory and Aging Project, a longitudinal cohort study of aging in Chicago. All underwent repeated annual cognitive evaluations using a detailed battery including 19 tests. Risk aversion was measured using standard behavioral economics questions: participants were asked to choose between a certain monetary payment versus a gamble in which they could gain more or nothing; potential gamble gains varied across questions. Temporal discounting: participants were asked to choose between an immediate, smaller payment and a delayed, larger one; two sets of questions addressed small and large stakes based on payment amount. Regression analyses were used to examine whether prior rate of cognitive decline predicted level of risk aversion and temporal discounting, controlling for age, sex, and education. Over an average of 5.5 (SD = 2.9) years, cognition declined at an average of 0.016 units per year (SD = 0.03). More rapid cognitive decline predicted higher levels of risk aversion (p = 0.002) and temporal discounting (small stakes: p = 0.01, high stakes: p = 0.006). Further, associations between cognitive decline and risk aversion (p = 0.015) and large stakes temporal discounting (p = 0.026) persisted in analyses restricted to persons without any cognitive impairment (i.e., no dementia or mild cognitive impairment); the association of cognitive decline and small stakes temporal discounting was no longer statistically significant (p = 0.078). These findings are consistent with the hypothesis that subtle age-related changes in cognition can detrimentally affect individual preferences that are critical for maintaining health and well being.	[James, Bryan D.; Boyle, Patricia A.; Yu, Lei; Han, S. Duke; Bennett, David A.] Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [James, Bryan D.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Boyle, Patricia A.; Han, S. Duke] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Yu, Lei; Han, S. Duke; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Han, S. Duke] VA Long Beach Healthcare Syst, Dept Mental Hlth, Long Beach, CA USA	Rush University; Rush University; Rush University; Rush University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	James, BD (corresponding author), Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.	Bryan_James@rush.edu	Han/N-1246-2019; Yu, Lei/AAT-3685-2020	James, Bryan/0000-0003-1932-151X	National Institutes of Health [R01AG17917, R01AG34374, R01AG33678, K23AG40625]; Robert C. Borwell Endowment Fund; NATIONAL INSTITUTE ON AGING [R01AG033678, R01AG034374, K23AG040625, R01AG017917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert C. Borwell Endowment Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding is provided by National Institutes of Health grants R01AG17917, R01AG34374, R01AG33678, and K23AG40625, and the Robert C. Borwell Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARP, 1999, AARP POLL NEARL ONE; Agarwal S., 2009, AGE REASON FINANCIAL; Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; [Anonymous], 2009, SAS 9 2 HELP DOC; Barsky RB, 1997, Q J ECON, V112, P537, DOI 10.1162/003355397555280; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Boyle PA, 2013, PSYCHOL AGING, V28, P614, DOI 10.1037/a0033103; Boyle PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067376; Boyle PA, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-48; Boyle PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043647; Boyle PA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00205; Boyle PA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-53; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; COHN RA, 1975, J FINANC, V30, P605, DOI 10.2307/2978738; Cramer JS, 2002, J ECON BEHAV ORGAN, V48, P29, DOI 10.1016/S0167-2681(01)00222-0; Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; Donkers B, 1999, SUBJECTIVE MEASURES; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Guiso L., 2004, ROLE RISK AVERSION P; Han SD, 2013, EXP GERONTOL, V48, P1489, DOI 10.1016/j.exger.2013.10.003; Han SD, 2012, BEHAV BRAIN RES, V227, P233, DOI 10.1016/j.bbr.2011.10.026; Harrison GW, 2007, ECONOMETRICA, V75, P433, DOI 10.1111/j.1468-0262.2006.00753.x; Harrison GW, 2008, RES EXP ECON, V12, P41, DOI 10.1016/S0193-2306(08)00003-3; Hatfield J, 2009, ACCIDENT ANAL PREV, V41, P25, DOI 10.1016/j.aap.2008.08.023; Hesketh B, 1998, J VOCAT BEHAV, V52, P89, DOI 10.1006/jvbe.1996.1570; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Hsu M, 2008, ADV HEALTH ECON HEAL, V20, P203, DOI 10.1016/S0731-2199(08)20009-9; Kimball MS, 2009, AM ECON REV, V99, P363, DOI 10.1257/aer.99.2.363; Kirby KN, 1997, J EXP PSYCHOL GEN, V126, P54, DOI 10.1037/0096-3445.126.1.54; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Kirby KN, 2005, LEARN INDIVID DIFFER, V15, P213, DOI 10.1016/j.lindif.2005.01.003; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; Roberto K., 2011, METLIFE STUDY ELDER; Samanez-Larkin Gregory R, 2013, APS Obs, V26, P30; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Shamosh NA, 2008, INTELLIGENCE, V36, P289, DOI 10.1016/j.intell.2007.09.004; Skarupski KA, 2009, GERONTOLOGIST, V49, P828, DOI 10.1093/geront/gnp055; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292; Willner P, 2010, AJIDD-AM J INTELLECT, V115, P157, DOI 10.1352/1944-7558-115.2.157; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wilson RS, 2005, J INT NEUROPSYCH SOC, V11, P400, DOI 10.1017/S1355617705050459	52	33	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121900	10.1371/journal.pone.0121900	http://dx.doi.org/10.1371/journal.pone.0121900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25838074	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000067
J	Kim, JK; Won, CI; Cha, J; Lee, K; Kim, DS				Kim, Jae-Kwan; Won, Chung-In; Cha, Jehyun; Lee, Kichun; Kim, Deok-Soo			Optimal Ligand Descriptor for Pocket Recognition Based on the Beta-Shape	PLOS ONE			English	Article							VORONOI-DIAGRAM; BINDING-SITES; PROTEIN SURFACES; DOCKING; INHIBITORS; CAVITIES; SEARCH; IDENTIFICATION; VISUALIZATION; COMPUTATION	Structure-based virtual screening is one of the most important and common computational methods for the identification of predicted hit at the beginning of drug discovery. Pocket recognition and definition is frequently a prerequisite of structure-based virtual screening, reducing the search space of the predicted protein-ligand complex. In this paper, we present an optimal ligand shape descriptor for a pocket recognition algorithm based on the beta-shape, which is a derivative structure of the Voronoi diagram of atoms. We investigate six candidates for a shape descriptor for a ligand using statistical analysis: the minimum enclosing sphere, three measures from the principal component analysis of atoms, the van der Waals volume, and the beta-shape volume. Among them, the van der Waals volume of a ligand is the optimal shape descriptor for pocket recognition and best tunes the pocket recognition algorithm based on the beta-shape for efficient virtual screening. The performance of the proposed algorithm is verified by a benchmark test.	[Kim, Jae-Kwan; Won, Chung-In; Kim, Deok-Soo] Hanyang Univ, Voronoi Diagram Res Ctr, Seoul 133791, South Korea; [Cha, Jehyun; Kim, Deok-Soo] Hanyang Univ, Sch Mech Engn, Seoul 133791, South Korea; [Lee, Kichun] Hanyang Univ, Dept Ind Engn, Seoul 133791, South Korea	Hanyang University; Hanyang University; Hanyang University	Kim, DS (corresponding author), Hanyang Univ, Voronoi Diagram Res Ctr, Seoul 133791, South Korea.	dskim@hanyang.ac.kr	Kim, Deok-Soo/K-8661-2015		National Research Foundation grant - MSIP, Republic of Korea [2012R1A2A1A05026395]; Small and Medium Business Administration (SMBA), Republic of Korea [201400000002667]	National Research Foundation grant - MSIP, Republic of Korea; Small and Medium Business Administration (SMBA), Republic of Korea	J-KK, C-IW, JC, and D-SK were supported by the National Research Foundation grant funded by MSIP (No. 2012R1A2A1A05026395), Republic of Korea. KL was supported by the grant (201400000002667) funded by Small and Medium Business Administration (SMBA), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 2004, CURR OPIN CHEM BIOL, V8, P365, DOI 10.1016/j.cbpa.2004.05.001; [Anonymous], 2006, J ZHEJIANG UNIV-SC A, DOI DOI 10.1631/JZUS.2006.A1492; Blundell TL, 2004, CURR OPIN PHARMACOL, V4, P490, DOI 10.1016/j.coph.2004.04.007; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; CambridgeSoft, 2004, TECHNICAL REPORT; Campbell SJ, 2003, CURR OPIN STRUC BIOL, V13, P389, DOI 10.1016/S0959-440X(03)00075-7; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; CHERFILS J, 1993, CURR OPIN STRUC BIOL, V3, P265, DOI 10.1016/S0959-440X(05)80162-9; Cho Y, 2012, J ADV MECH DES SYST, V6, P389, DOI 10.1299/jamdsm.6.389; Coleman RG, 2010, J CHEM INF MODEL, V50, P589, DOI 10.1021/ci900397t; Davis J., 2006, P 23 INT C MACH LEAR, V23, P233, DOI DOI 10.1145/1143844.1143874; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Edelsbrunner H., 1992, Weighted alpha shapes; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finn PW, 1999, ALGORITHMICA, V25, P347, DOI 10.1007/PL00008282; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Ghosh S, 2006, CURR OPIN CHEM BIOL, V10, P194, DOI 10.1016/j.cbpa.2006.04.002; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hardy L.W., 2003, CURR DRUG DISCOV, V3, P15; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; HO CMW, 1990, J COMPUT AID MOL DES, V4, P337, DOI 10.1007/BF00117400; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim CM, 2006, COMPUT AIDED DESIGN, V38, P1192, DOI 10.1016/j.cad.2006.07.007; Kim DS, 2006, COMPUT AIDED DESIGN, V38, P808, DOI 10.1016/j.cad.2006.04.008; Kim Deok-Soo, 2014, Biodesign, V2, P26; Kim DS, 2012, J COMPUT CHEM, V33, P1252, DOI 10.1002/jcc.22956; Kim DS, 2011, J BIOMOL STRUCT DYN, V29, P219, DOI 10.1080/07391102.2011.10507384; Kim DS, 2010, COMPUT AIDED DESIGN, V42, P911, DOI 10.1016/j.cad.2010.06.004; Kim DS, 2010, COMPUT AIDED DESIGN, V42, P874, DOI 10.1016/j.cad.2010.06.002; Kim D, 2008, J MOL GRAPH MODEL, V26, P1104, DOI 10.1016/j.jmgm.2007.10.002; Kim DS, 2005, COMPUT AIDED DESIGN, V37, P1412, DOI 10.1016/j.cad.2005.02.013; Kim JK, 2014, J COMPUT DES ENG, V1, P79, DOI 10.7315/JCDE.2014.008; Kim JK, 2014, PROTEINS, V82, P1829, DOI 10.1002/prot.24537; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Lee C., 2010, THESIS HANYANG U SEO; LEVITT DG, 1992, J MOL GRAPH MODEL, V10, P229, DOI 10.1016/0263-7855(92)80074-N; Lewis D. D., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P3; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Linn S, 2006, EPIDEMIOLOGIC PERSPE, V3; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Mehio W, 2010, BIOINFORMATICS, V26, P2549, DOI 10.1093/bioinformatics/btq490; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Neyman J, 1928, BIOMETRIKA, V20A, P175, DOI 10.2307/2331945; Peters KP, 1996, J MOL BIOL, V256, P201, DOI 10.1006/jmbi.1996.0077; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Politi A, 2010, J MOL GRAPH MODEL, V29, P425, DOI 10.1016/j.jmgm.2010.08.003; Saranya N, 2009, BIOORG MED CHEM LETT, V19, P5769, DOI 10.1016/j.bmcl.2009.07.140; Scheswohl DM, 2008, J MOL SIGNALING, P3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schulz-Gasch T, 2003, J MOL MODEL, V9, P47, DOI 10.1007/s00894-002-0112-y; Shin WH, 2013, J COMPUT CHEM, V34, P2647, DOI 10.1002/jcc.23438; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Taha MO, 2010, J MOL GRAPH MODEL, V28, P383, DOI 10.1016/j.jmgm.2009.09.005; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; VOORINTHOLT R, 1989, J MOL GRAPHICS, V7, P243, DOI 10.1016/0263-7855(89)80010-4; Wickens TD, 1989, MULTIWAY CONTIGENCY; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	68	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122787	10.1371/journal.pone.0122787	http://dx.doi.org/10.1371/journal.pone.0122787			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835497	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000112
J	Piludu, M; Piras, M; Pichiri, G; Coni, P; Orru, G; Cabras, T; Messana, I; Faa, G; Castagnola, M				Piludu, Marco; Piras, Monica; Pichiri, Giuseppina; Coni, Pierpaolo; Orru, Germano; Cabras, Tiziana; Messana, Irene; Faa, Gavino; Castagnola, Massimo			Thymosin Beta 4 May Translocate from the Cytoplasm in to the Nucleus in HepG2 Cells following Serum Starvation. An Ultrastructural Study	PLOS ONE			English	Article							F-ACTIN; TRANSPORT; COMPLEX; EXPRESSION; ENVELOPE; BINDING; TISSUES; PROTEIN; PEPTIDE; CAPG	Due to its actin-sequestering properties, thymosin beta-4 (T beta 4) is considered to play a significant role in the cellular metabolism. Several physiological properties of T beta 4 have been reported;, however, many questions concerning its cellular function remain to be ascertained. To better understand the role of this small peptide we have analyzed by means of transmission immunoelectron microscopy techniques the ultrastructural localization of T beta 4 in HepG2 cells. Samples of HepG2 cells were fixed in a mixture of 3% formaldehyde and 0.1% glutaraldehyde in 0.1 M cacodylate buffer and processed for standard electron microscopic techniques. The samples were dehydrated in a cold graded methanol series and embedded in LR gold resin. Ultrathin sections were labeled with rabbit antibodies to T beta 4, followed by gold-labeled goat anti-rabbit, stained with uranyl acetate and bismuth subnitrate, observed and photographed in a JEOL 100S transmission electron microscope. Highresolution electron microscopy showed that T beta 4 was mainly restricted to the cytoplasm of HepG2 growing in complete medium. A strong T beta 4 reactivity was detected in the perinuclear region of the cytoplasmic compartment where gold particles appeared strictly associated to the nuclear membrane. In the nucleus specific T beta 4 labeling was observed in the nucleolus. The above electron microscopic results confirm and extend previous observations at light microscopic level, highlighting the subcellular distribution of T beta 4 in both cytoplasmic and nuclear compartments of HepG2 cells. The meaning of T beta 4 presence in the nucleolus is not on the best of our knowledge clarified yet. It could account for the interaction of T beta 4 with nucleolar actin and according with this hypothesis, T beta 4 could contribute together with the other nucleolar acting binding proteins to modulate the transcription activity of the RNA polymerases.	[Piludu, Marco] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Piras, Monica; Pichiri, Giuseppina; Coni, Pierpaolo; Faa, Gavino] Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy; [Cabras, Tiziana; Messana, Irene] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [Orru, Germano] Univ Cagliari, Dept Surg Sci, OBL, Cagliari, Italy; [Castagnola, Massimo] Univ Cattolica, Ist Biochim & Biochim Clin, Rome, Italy; [Castagnola, Massimo] CNR, Ist Chim Riconoscimento Mol, Ist Sci, Int ISI, Rome, Italy	University of Cagliari; University of Cagliari; University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Pichiri, G (corresponding author), Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy.	pichiri@unica.it	Castagnola, Massimo/AAM-6355-2021; Castagnola, Massimo/AAB-2825-2019; Piras, M/AAW-6255-2020; Messana, Irene/L-2478-2019; Cabras, Tiziana/AAF-6231-2020	Castagnola, Massimo/0000-0002-0959-7259; Messana, Irene/0000-0002-1436-6105; Coni, Pierpaolo/0000-0001-5602-8887; Pichiri, Giuseppina/0000-0001-8700-8854; Orru, Germano/0000-0003-1032-4431; Piras, Monica/0000-0002-1068-1781; Faa, Gavino/0000-0002-6129-0975	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy(Fondazione Banco di Sardegna)	The authors acknowledge the financial support of Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; Durzynska J, 2014, ONCOL REP, V32, P893, DOI 10.3892/or.2014.3329; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Goldstein AL, 2007, ANN NY ACAD SCI, V1112, P1, DOI 10.1196/annals.1415.045; Hubert T, 2008, BIOCHEM BIOPH RES CO, V377, P699, DOI 10.1016/j.bbrc.2008.10.048; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCormack SA, 1999, AM J PHYSIOL-CELL PH, V276, pC459, DOI 10.1152/ajpcell.1999.276.2.C459; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nemolato S, 2012, CANCER BIOL THER, V13, DOI 10.4161/cbt.13.4.18691; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Pichiri G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067999; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; WATTS JD, 1990, EUR J BIOCHEM, V192, P643, DOI 10.1111/j.1432-1033.1990.tb19271.x; Wirsching HG, 2014, BRAIN, V137, P433, DOI 10.1093/brain/awt333; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; YU FX, 1994, CELL MOTIL CYTOSKEL, V27, P13, DOI 10.1002/cm.970270103; Zoubek RE, 2007, ANN NY ACAD SCI, V1112, P442, DOI 10.1196/annals.1415.031	25	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119642	10.1371/journal.pone.0119642	http://dx.doi.org/10.1371/journal.pone.0119642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835495	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000012
J	Shi, H; Chen, X; Lu, C; Gu, CM; Jiang, HW; Meng, RW; Niu, X; Huang, YX; Lu, MX				Shi, Hao; Chen, Xiong; Lu, Cheng; Gu, Changmei; Jiang, Hongwei; Meng, RuiWei; Niu, Xun; Huang, Yangxin; Lu, Meixia			Association between P16(INK4a) Promoter Methylation and HNSCC: A Meta-Analysis of 21 Published Studies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; HUMAN-PAPILLOMAVIRUS; QUANTITATIVE-EVALUATION; HEAD; P16; CANCER; HYPERMETHYLATION; DNA; EXPRESSION	Background The p16(INK4a) is an important tumor suppressor gene (TSG) and aberrant methylation of promoter is known to be a major inactivation mechanism of the tumor suppressor and tumor-related genes. Aberrant TSG methylation was considered an important epigenetic silencing mechanism in the progression of head and neck squamous cell carcinoma (HNSCC). However, some studies have reported differences in the methylation frequencies of P16(INK4a) promoter between cancer and the corresponding control group. Therefore, we conducted a meta-analysis to better identify the association. Methods PubMed, Ovid, ISI Web of Science, and EMBASE were searched to identify eligible studies to evaluate the association of p16(INK4a) promoter methylation and HNSCC. Odds ratio (ORs) and 95% confidence intervals (95% CI) were calculated to evaluate the strength of association between p16(INK4a) promoter methylation and HNSCC. Results A total of twenty-one studies with 1155 cases and 1017 controls were included in the meta-analysis. The frequencies of p16(INK4a) promoter methylation in the cancer group were significantly higher than those in the control group (cancer group: median: 46.67%, range = 7.84%-95.12%; control group: median: 18.37%, range = 0-83.33%; respectively). The pooled odds ratio was 3.37 (95% CI = 2.32-4.90) in the cancer group versus the corresponding control group under the random-effects model. Conclusion This meta-analysis of 21 published studies identified that aberrant methylation of p16(INK4a) promoter was found to be significantly associated with HNSCC.	[Shi, Hao; Gu, Changmei; Jiang, Hongwei; Meng, RuiWei; Lu, Meixia] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Epidemiol & Biostat, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Shi, Hao; Gu, Changmei; Jiang, Hongwei; Meng, RuiWei; Lu, Meixia] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Chen, Xiong; Niu, Xun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otolaryngol, Wuhan 430074, Hubei, Peoples R China; [Lu, Cheng] Nanchang Univ, Coll Med, Dept Anat, Nanchang, Jiangxi, Peoples R China; [Huang, Yangxin] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Publ Hlth, Tampa, FL USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Nanchang University; State University System of Florida; University of South Florida	Lu, MX (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Epidemiol & Biostat, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	mlu@hust.edu.cn			National Natural Science Foundation of China [81373092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81373092).	Ai LB, 2003, MODERN PATHOL, V16, P944, DOI 10.1097/01.MP.0000085760.74313.DD; [Anonymous], 1979, PSYCHOL BULL, P638; Askari M, 2013, MOL BIOL REP, V40, P4921, DOI 10.1007/s11033-013-2592-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Belinsky SA, 2005, CLIN CANCER RES, V11, P6505, DOI 10.1158/1078-0432.CCR-05-0625; Bhatia V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/248419; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; Dang J, 2013, J ORAL PATHOL MED, V42, P315, DOI 10.1111/jop.12012; Demokan S, 2012, HEAD NECK-J SCI SPEC, V34, P1470, DOI 10.1002/hed.21949; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Naggar AK, 1999, HUM PATHOL, V30, P1013, DOI 10.1016/S0046-8177(99)90217-4; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464; Hasegawa M, 2002, ONCOGENE, V21, P4231, DOI 10.1038/sj.onc.1205528; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsu LS, 2006, ONCOL REP, V15, P507; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaur J, 2010, INT J CANCER, V127, P2367, DOI 10.1002/ijc.25377; Kis A, 2014, PATHOL ONCOL RES, V20, P923, DOI 10.1007/s12253-014-9775-9; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Kulkarni V, 2004, ORAL ONCOL, V40, P145, DOI 10.1016/S1368-8375(03)00143-X; Laytragoon-Lewin N, 2010, ANTICANCER RES, V30, P4643; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lim AM, 2014, INT J CANCER, V135, P887, DOI 10.1002/ijc.28727; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Martone T, 2007, CLIN CANCER RES, V13, P5089, DOI 10.1158/1078-0432.CCR-07-0119; Maruya SI, 2004, CLIN CANCER RES, V10, P3825, DOI 10.1158/1078-0432.CCR-03-0370; Mino A, 2006, ONCOL REP, V15, P615; de Assis LVM, 2014, BBA-REV CANCER, V1845, P232, DOI 10.1016/j.bbcan.2014.01.008; Nakahara Y, 2001, CANCER LETT, V163, P221, DOI 10.1016/S0304-3835(00)00699-6; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; O'Regan EM, 2008, HUM PATHOL, V39, P452, DOI 10.1016/j.humpath.2007.08.004; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Pande P, 1998, ORAL ONCOL, V34, P396, DOI 10.1016/S1368-8375(98)00024-4; Piepkorn M, 2000, J AM ACAD DERMATOL, V42, P705, DOI 10.1067/mjd.2000.104687; Righini CA, 2007, CLIN CANCER RES, V13, P1179, DOI 10.1158/1078-0432.CCR-06-2027; Rosas SLB, 2001, CANCER RES, V61, P939; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Song BB, 2013, PAK J MED SCI, V29, P1338; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Su PF, 2010, ORAL ONCOL, V46, P734, DOI 10.1016/j.oraloncology.2010.07.002; Toyota M, 1999, CANCER RES, V59, P2307; Weber A, 2003, PATHOL RES PRACT, V199, P391, DOI 10.1078/0344-0338-00435; Weiss D, 2011, MOL CARCINOGEN, V50, P680, DOI 10.1002/mc.20798; Wong TS, 2003, EUR J CANCER, V39, P1881, DOI 10.1016/S0959-8049(03)00428-3; Wong YK, 2011, J DENT SCI, V6, P158, DOI 10.1016/j.jds.2011.05.006; Wu CL, 1999, GENE CHROMOSOME CANC, V25, P16, DOI 10.1002/(SICI)1098-2264(199905)25:1<16::AID-GCC3>3.3.CO;2-U; Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209	54	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122302	10.1371/journal.pone.0122302	http://dx.doi.org/10.1371/journal.pone.0122302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835498	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000092
J	van Beek, N; Patsatsi, A; Gupta, Y; Moller, S; Freitag, M; Lemcke, S; Recke, A; Zillikens, D; Schmidt, E; Ibrahim, S				van Beek, Nina; Patsatsi, Aikaterini; Gupta, Yask; Moeller, Steffen; Freitag, Miriam; Lemcke, Susanne; Recke, Andreas; Zillikens, Detlef; Schmidt, Enno; Ibrahim, Saleh			A Family with Atypical Hailey Hailey Disease-Is There More to the Underlying Genetics than ATP2C1?	PLOS ONE			English	Article							CALCIUM-PUMP; GOLGI; LOCALIZES; MUTATIONS	The autosomal dominant Hailey Hailey disease (HHD) is caused by mutations in the ATP2C1 gene encoding for human secretory pathway Ca2+/Mn2+ ATPase protein (hSPCA1) in the Golgi apparatus. Clinically, HHD presents with erosions and hyperkeratosis predominantly in the intertrigines. Here we report an exome next generation sequencing (NGS) based analysis of ATPase genes in a Greek family with 3 HHD patients presenting with clinically atypical lesions mainly localized on the neck and shoulders. By NGS of one HHD-patient and in silico SNP calling and SNP filtering we identified a SNP in the expected ATP2C1 gene and SNPs in further ATPase genes. Verification in all 3 affected family members revealed a heterozygous frameshift deletion at position 2355_2358 in exon 24 of ATP2C1 in all three patients. 7 additional SNPs in 4 ATPase genes (ATP9B, ATP11A, ATP2B3 and ATP13A5) were identified. The SNPs rs138177421 in the ATP9B gene and rs2280268 in the ATP13A5 gene were detected in all 3 affected, but not in 2 non affected family members. The SNPs in the ATP2B3 and ATP11A gene as well as further SNPs in the ATP13A5 gene could not be confirmed in all affected family members. One may speculate that besides the level of functional hSPCA1 protein, levels of other ATPase proteins may influence expressivity of the disease and might also contribute, as in this case, to atypical presentations.	[van Beek, Nina; Gupta, Yask; Moeller, Steffen; Freitag, Miriam; Lemcke, Susanne; Recke, Andreas; Zillikens, Detlef; Schmidt, Enno; Ibrahim, Saleh] Med Univ Lubeck, Dept Dermatol Allergol & Venerol, D-23538 Lubeck, Germany; [Patsatsi, Aikaterini] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Gen Hosp, Dept Dermatol 2, GR-54006 Thessaloniki, Greece	University of Lubeck; Aristotle University of Thessaloniki; Papageorgiou Hospital	Ibrahim, S (corresponding author), Med Univ Lubeck, Dept Dermatol Allergol & Venerol, D-23538 Lubeck, Germany.	saleh.ibrahim@uksh.de	Schmidt, Enno/C-4008-2009; van Beek, Nina/D-4121-2019; Zillikens, Detlef/C-8572-2011; Recke, Andreas/C-8963-2009; Lemcke, Susanne/L-2991-2013; Ibrahim, Saleh/AAO-9541-2020; Patsatsi, Aikaterini/ABB-5223-2020; Möller, Steffen/B-5368-2013	Schmidt, Enno/0000-0002-1206-8913; van Beek, Nina/0000-0002-3265-0011; Recke, Andreas/0000-0002-7674-1804; Möller, Steffen/0000-0002-7187-4683; Ibrahim, Saleh/0000-0001-7827-2290; Lemcke, Susanne/0000-0002-5945-4862				Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; BURGE SM, 1992, BRIT J DERMATOL, V126, P275, DOI 10.1111/j.1365-2133.1992.tb00658.x; De La Hera DP, 2013, BIOCHEM J, V450, P47, DOI 10.1042/BJ20120739; Foggia L, 2004, AM J MED GENET C, V131C, P20, DOI 10.1002/ajmg.c.30031; Hashimoto K, 1995, J CUTAN PATHOL, V22, P488, DOI 10.1111/j.1600-0560.1995.tb01145.x; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Kellermayer R, 2008, CELL CALCIUM, V43, P105, DOI 10.1016/j.ceca.2007.06.005; Shull GE, 2011, BIOFACTORS, V37, P150, DOI 10.1002/biof.141; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Szigeti R, 2006, J INVEST DERMATOL, V126, P2370, DOI 10.1038/sj.jid.5700447; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121253	10.1371/journal.pone.0121253	http://dx.doi.org/10.1371/journal.pone.0121253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837627	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000043
J	Lauer, SA; Kleinman, KP; Reich, NG				Lauer, Stephen A.; Kleinman, Ken P.; Reich, Nicholas G.			The Effect of Cluster Size Variability on Statistical Power in Cluster-Randomized Trials	PLOS ONE			English	Article							SAMPLE-SIZE; RELATIVE EFFICIENCY	The frequency of cluster-randomized trials (CRTs) in peer-reviewed literature has increased exponentially over the past two decades. CRTs are a valuable tool for studying interventions that cannot be effectively implemented or randomized at the individual level. However, some aspects of the design and analysis of data from CRTs are more complex than those for individually randomized controlled trials. One of the key components to designing a successful CRT is calculating the proper sample size (i.e. number of clusters) needed to attain an acceptable level of statistical power. In order to do this, a researcher must make assumptions about the value of several variables, including a fixed mean cluster size. In practice, cluster size can often vary dramatically. Few studies account for the effect of cluster size variation when assessing the statistical power for a given trial. We conducted a simulation study to investigate how the statistical power of CRTs changes with variable cluster sizes. In general, we observed that increases in cluster size variability lead to a decrease in power.	[Lauer, Stephen A.; Reich, Nicholas G.] Univ Massachusetts, Div Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Kleinman, Ken P.] Harvard Univ, Sch Med, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA	University of Massachusetts System; University of Massachusetts Amherst; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Lauer, SA (corresponding author), Univ Massachusetts, Div Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.	slauer@schoolph.umass.edu	Reich, Nicholas/L-1168-2019	Reich, Nicholas/0000-0003-3503-9899; Kleinman, Ken/0000-0002-5600-5834	Centers for Disease Control [CDC IAA 09FED905876]; United States Department of Veterans Affairs [CDC IAA 09FED905876]	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs)	This project was funded by the ResPECT study (clinicaltrials.gov, ID: NCT01249625) through an interagency agreement between the Centers for Disease Control and the United States Department of Veterans Affairs (CDC IAA 09FED905876). The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell MJ, 2007, STAT MED, V26, P2, DOI 10.1002/sim.2731; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Candel MJJM, 2010, STAT MED, V29, P1488, DOI 10.1002/sim.3857; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Hemming K, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-102; Kerry SM, 2001, STAT MED, V20, P377, DOI 10.1002/1097-0258(20010215)20:3<377::AID-SIM799>3.0.CO;2-N; Murray DM, 1998, DESIGN ANAL GROUP RA; Platt R, 2010, MED CARE, V48, pS52, DOI 10.1097/MLR.0b013e3181dbebcf; R Core Team, 2021, R LANGUAGE ENV STAT; Reich NG, 2012, CLUSTERPOWER POWER C; Reich NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035564; van Breukelen GJP, 2007, STAT MED, V26, P2589, DOI 10.1002/sim.2740; Xie Y, 2013, DYNAMIC DOCUMENTS R; Xie Y., 2013, KNITR GEN PURPOSE PA; You ZY, 2011, CLIN TRIALS, V8, P27, DOI 10.1177/1740774510391492	16	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119074	10.1371/journal.pone.0119074	http://dx.doi.org/10.1371/journal.pone.0119074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830416	gold, Green Submitted, Green Published			2022-12-27	WOS:000352135600008
J	Avila-Pedretti, G; Tornero, J; Fernandez-Nebro, A; Blanco, F; Gonzalez-Alvaro, I; Canete, JD; Maymo, J; Alperiz, M; Fernandez-Gutienrez, B; Olive, A; Corominas, H; Erra, A; Aterido, A; Lasanta, ML; Tortosa, R; Julia, A; Marsal, S				Avila-Pedretti, Gabriela; Tornero, Jesus; Fernandez-Nebro, Antonio; Blanco, Francisco; Gonzalez-Alvaro, Isidoro; Canete, Juan D.; Maymo, Joan; Alperiz, Mercedes; Fernandez-Gutierrez, Benjamin; Olive, Alex; Corominas, Hector; Erra, Alba; Aterido, Adria; Lopez Lasanta, Maria; Tortosa, Rauel; Julia, Antonio; Marsal, Sara			Variation at FCGR2A and Functionally Related Genes Is Associated with the Response to Anti-TNF Therapy in Rheumatoid Arthritis	PLOS ONE			English	Article							C-RECEPTOR POLYMORPHISMS; FC-GAMMA RECEPTORS; DENDRITIC CELLS; EXPRESSION; IGG; RNA; VALIDATION; ACTIVATION; RITUXIMAB; CRITERIA	Objective Anti-TNF therapies have been highly efficacious in the management of rheumatoid arthritis (RA), but 25-30% of patients do not show a significant clinical response. There is increasing evidence that genetic variation at the Fc receptor FCGR2A is associated with the response to anti-TNF therapy. We aimed to validate this genetic association in a patient cohort from the Spanish population, and also to identify new genes functionally related to FCGR2A that are also associated with anti-TNF response. Methods A total of 348 RA patients treated with an anti-TNF therapy were included and genotyped for FCGR2A polymorphism rs1081274. Response to therapy was determined at 12 weeks, and was tested for association globally and independently for each anti-TNF drug (infliximab, etanercept and adalimumab). Using gene expression profiles from macrophages obtained from synovial fluid of RA patients, we searched for genes highly correlated with FCGR2A expression. Tag SNPs were selected from each candidate gene and tested for association with the response to therapy. Results We found a significant association between FCGR2A and the response to adalimumab (P=0.022). Analyzing the subset of anti-CCP positive RA patients (78%), we also found a significant association between FCGR2A and the response to infliximab (P=0.035). DHX32 and RGS12 were the most consistently correlated genes with FCGR2A expression in RA synovial fluid macrophages (P<0.001). We found a significant association between the genetic variation at DHX32 (rs12356233, corrected P=0.019) and a nominally significant association between RGS12 and the response to adalimumab (rs4690093, uncorrected P=0.040). In the anti-CCP positive group of patients, we also found a nominally significant association between RGS12 and the response to infliximab (rs2857859, uncorrected P=0.042). Conclusions In the present study we have validated the FCGR2A association in an independent population, and we have identified new genes associated with the response to anti-TNF therapy in RA.	[Avila-Pedretti, Gabriela; Aterido, Adria; Lopez Lasanta, Maria; Tortosa, Rauel; Julia, Antonio; Marsal, Sara] Vall dHebron Hosp, Res Inst, Rheumatol Res Group, Barcelona, Spain; [Tornero, Jesus] Hosp Univ Guadalajara, Dept Rheumatol, Guadalajara, Spain; [Fernandez-Nebro, Antonio] Univ Malaga, Hosp Reg, Inst Invest Biomed Malaga, UGC Reumatol, E-29071 Malaga, Spain; [Blanco, Francisco] INIBIC Hosp Univ A Coruna, Dept Rheumatol, La Coruna, Spain; [Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, Dept Rheumatol, IIS La Princesa, Madrid, Spain; [Canete, Juan D.] Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain; [Maymo, Joan] Hosp del Mar, Dept Rheumatol, Barcelona, Spain; [Alperiz, Mercedes] Hosp Univ Cent Asturias, Dept Rheumatol, Oviedo, Spain; [Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Olive, Alex] Hosp Badalona Germans Trias & Pujol, Dept Rheumatol, Madrid, Spain; [Corominas, Hector] Hosp Moises Broggi, Dept Rheumatol, Barcelona, Spain; [Erra, Alba] Hosp St Rafael, Dept Rheumatol, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Universidad de Malaga; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Central University Hospital Asturias; Hospital Clinico San Carlos; Hospital Germans Trias i Pujol	Marsal, S (corresponding author), Vall dHebron Hosp, Res Inst, Rheumatol Res Group, Barcelona, Spain.	sara.marsal@vhir.org	Fernandez-Nebro, Antonio/K-7628-2012; Corominas, Hèctor/P-5045-2019; Cañete, Juan D/AAV-8910-2021; Blanco Garcia, Francisco J/C-3192-2014	Fernandez-Nebro, Antonio/0000-0002-2962-9844; Corominas, Hèctor/0000-0002-7738-6787; Cañete, Juan D/0000-0003-2606-0573; Lopez Lasanta, Maria/0000-0002-8462-8406; marsal, sara/0000-0001-5515-3854; Blanco Garcia, Francisco J/0000-0001-9821-7635; Julia Cano, Antonio/0000-0001-6064-3620; Avila-Pedretti, Gabriela/0000-0002-6526-6278	Spanish Ministry of Economy and Competitiveness [PSE-010000-2006-6, IPT-010000-2010-36]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness grants (PSE-010000-2006-6 and IPT-010000-2010-36). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2005, ANTICANCER RES, V25, P2645; Abdelhaleem M, 2002, LEUKEMIA RES, V26, P945, DOI 10.1016/S0145-2126(02)00040-1; Acosta-Colman I, 2013, PHARMACOGENOMICS, V14, P727, DOI [10.2217/PGS.13.60, 10.2217/pgs.13.60]; Alli Z, 2005, CELL IMMUNOL, V237, P141, DOI 10.1016/j.cellimm.2005.12.003; Alli Z, 2007, ANTICANCER RES, V27, P373; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bossini-Castillo L, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204591; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Burska AN, 2014, PHARMACOGENOMICS J, V14, P93, DOI 10.1038/tpj.2013.48; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Criswell LA, 2004, ARTHRITIS RHEUM-US, V50, P2750, DOI 10.1002/art.20469; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Ivan E, 2006, HUM IMMUNOL, V67, P479, DOI 10.1016/j.humimm.2005.12.001; Krintel SB, 2012, PHARMACOGENET GENOM, V22, P577, DOI 10.1097/FPC.0b013e3283544043; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Mimoto F, 2014, MOL IMMUNOL, V58, P132, DOI 10.1016/j.molimm.2013.11.017; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Montes A, 2014, PHARMACOGENET GENOM, V24, P238, DOI 10.1097/FPC.0000000000000042; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Narendra SC, 2014, J LEUKOCYTE BIOL, V95, P661, DOI 10.1189/jlb.0613320; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Paiva M, 2008, CANCER GENET CYTOGEN, V183, P35, DOI 10.1016/j.cancergencyto.2008.02.001; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Salliot C, 2011, ANN RHEUM DIS, V70, P266, DOI 10.1136/ard.2010.132134; Siberil S, 2006, IMMUNOL LETT, V106, P111, DOI 10.1016/j.imlet.2006.05.009; Smolen JS, 2006, CLIN EXP RHEUMATOL, V24, pS7; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	49	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122088	10.1371/journal.pone.0122088	http://dx.doi.org/10.1371/journal.pone.0122088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848939	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800095
J	Chen, QQ; Ma, QJ; Chen, ML; Chen, B; Wen, Q; Jia, B; Wang, F; Sun, BT; Gao, S				Chen, Qianqian; Ma, Qingjie; Chen, Minglong; Chen, Bin; Wen, Qiang; Jia, Bing; Wang, Fan; Sun, Butong; Gao, Shi			An Exploratory Study on Tc-99m-RGD-BBN Peptide Scintimammography in the Assessment of Breast Malignant Lesions Compared to Tc-99m-3P4-RGD2	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; POSITRON-EMISSION-TOMOGRAPHY; BOMBESIN ANALOGS; INTERNATIONAL-COMMISSION; RECEPTOR; EXPRESSION; CANCER; PROTECTION; MODEL	Purpose This study aimed to explore the diagnostic performance of single photon emission computed tomography / computerized tomography (SPECT/CT) using a new radiotracer Tc-99m-RGD-BBN for breast malignant tumor compared with Tc-99m-3P4-RGD(2). Methods 6 female patients with breast malignant tumors diagnosed by fine needle aspiration cytology biopsy (FNAB) who were scheduled to undergo surgery were included in the study. Tc-99m-3P4-RGD(2) and 99mTc-RGD-BBN were performed with single photon emission computed tomography (SPECT) at 1 hour after intravenous injection of 299 +/- 30 MBq and 293 +/- 32 MBq of radiotracers respectively at separate day. The results were evaluated by the Tumor to non-Tumor ratios (T/NT). Tc-99m-RGD-BBN and Tc-99m-3P4-RGD(2) SPECT/CT images were interpreted independently by 3 experienced nuclear medicine physicians using a 3-point scale system. All of the samples were analyzed immunohistochemically to evaluate the integrin alpha v beta 3 and gastrin-releasing peptide receptor (GRPR) expression. The safety, biodistribution and radiation dosimetry of Tc-99m-RGD-BBN were also evaluated in the healthy volunteers. Results No serious adverse events were reported in any of the patients during the study. The effective radiation dose entirely conformed to the relevant standards. A total of 6 palpable malignant lesions were detected using Tc-99m-RGD-BBN SPECT/CT with clear uptake. All malignant lesions were also detected using Tc-99m-3P4-RGD(2) SPECT/CT. The results showed that five malignant lesions were with clear uptake and the other one with barely an uptake. 4 malignant cases were found with both alpha v beta 3 and GRPR expression, 1 case with only GRPR positive expression (integrin alpha v beta 3 negative) and 1 case with only integrin alpha nu beta 3 positive expression (GRPR negative). Conclusion Tc-99m-RGD-BBN is a safe agent for detecting breast cancer. Tc-99m-RGD-BBN may have the potential to make up for the deficiency of Tc-99m-3P4-RGD(2) in the detection of breast cancer with only GRPR positive expression (integrin alpha(v)beta(3) negative). The preliminary application of Tc-99m-RGD-BBN has demonstrated its powerful potential in breast cancer diagnosis and therapy.	[Chen, Qianqian; Ma, Qingjie; Chen, Minglong; Chen, Bin; Wen, Qiang; Sun, Butong; Gao, Shi] Jilin Univ, China Japan Union Hosp, Dept Nucl Med, Changchun 130033, Peoples R China; [Jia, Bing; Wang, Fan] Peking Univ, Med Isotopes Res Ctr, Beijing 100191, Peoples R China	Jilin University; Peking University	Gao, S (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Nucl Med, Changchun 130033, Peoples R China.	gaoshi@jlu.edu.cn	Jia, Bing/C-3796-2008		National Natural Science Foundation of China (NSFC) projects [81271606]; Research Fund of Science and Technology Department of Jilin Province [201015185, 201115088]	National Natural Science Foundation of China (NSFC) projects(National Natural Science Foundation of China (NSFC)); Research Fund of Science and Technology Department of Jilin Province	This research was supported by the National Natural Science Foundation of China (NSFC) projects (Grant number: 81271606), Research Fund of Science and Technology Department of Jilin Province (Grant number: 201015185, 201115088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Mohand S, 2011, BIOCONJUGATE CHEM, V22, P1729, DOI 10.1021/bc2002665; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Beer AJ, 2007, CLIN CANCER RES, V13, P6610, DOI 10.1158/1078-0432.CCR-07-0528; Beer AJ, 2006, CLIN CANCER RES, V12, P3942, DOI 10.1158/1078-0432.CCR-06-0266; Cheng GH, 2012, NUCL SCI TECH, V23, P349; de Visser M, 2007, J NUCL MED, V48, P88; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Gao S, 2014, MOL IMAGING, P13; Ji SD, 2013, THERANOSTICS, V3, P816, DOI 10.7150/thno.6989; Kehoe T, 2007, CLIN ONCOL-UK, V19, P539, DOI 10.1016/j.clon.2007.05.003; KUBO A, 1991, Kaku Igaku, V28, P1133; Liu S, 2007, BIOCONJUGATE CHEM, V18, P438, DOI 10.1021/bc0603081; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P1483, DOI 10.1007/s00259-009-1123-z; Liu ZF, 2009, BIOCONJUGATE CHEM, V20, P1016, DOI 10.1021/bc9000245; Liu ZM, 2012, ANAL CHEM, V84, P10338, DOI 10.1021/ac3023907; Ma QJ, 2011, EUR J NUCL MED MOL I, V38, P2145, DOI 10.1007/s00259-011-1901-2; Marrone BF, 2013, CLIN EXP DERMATOL, V38, P707, DOI 10.1111/ced.12058; Okarvi SM, 2004, MED RES REV, V24, P357, DOI 10.1002/med.20002; Pradhan AS, 2007, J MED PHYS, V32, P89, DOI 10.4103/0971-6203.35719; Scott N, 2004, J CLIN PATHOL, V57, P189, DOI 10.1136/jcp.2003.10660; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Strande V, 2009, PROTEOM CLIN APPL, V3, P41, DOI 10.1002/prca.200800083; Wiegrebe L, 2008, BIOL CYBERN, V98, P587, DOI 10.1007/s00422-008-0216-2; Yang YS, 2006, NUCL MED BIOL, V33, P371, DOI 10.1016/j.nucmedbio.2005.12.011; Yu ZL, 2013, CURR PHARM DESIGN, V19, P3329, DOI 10.2174/1381612811319180015; Zhang XZ, 2006, J NUCL MED, V47, P492; Zhu ZH, 2012, J NUCL MED, V53, P716, DOI 10.2967/jnumed.111.098988	27	20	22	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123401	10.1371/journal.pone.0123401	http://dx.doi.org/10.1371/journal.pone.0123401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849333	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800230
J	de Vries, NJ; Reis, R; Moscato, P				de Vries, Natalie Jane; Reis, Rodrigo; Moscato, Pablo			Clustering Consumers Based on Trust, Confidence and Giving Behaviour: Data-Driven Model Building for Charitable Involvement in the Australian Not-For-Profit Sector	PLOS ONE			English	Article							RELATIONSHIP COMMITMENT	Organisations in the Not-for-Profit and charity sector face increasing competition to win time, money and efforts from a common donor base. Consequently, these organisations need to be more proactive than ever. The increased level of communications between individuals and organisations today, heightens the need for investigating the drivers of charitable giving and understanding the various consumer groups, or donor segments, within a population. It is contended that 'trust' is the cornerstone of the not-for-profit sector's survival, making it an inevitable topic for research in this context. It has become imperative for charities and not-for-profit organisations to adopt for-profit's research, marketing and targeting strategies. This study provides the not-for-profit sector with an easily-interpretable segmentation method based on a novel unsupervised clustering technique (MST-kNN) followed by a feature saliency method (the CM1 score). A sample of 1,562 respondents from a survey conducted by the Australian Charities and Not-for-profits Commission is analysed to reveal donor segments. Each cluster's most salient features are identified using the CM1 score. Furthermore, symbolic regression modelling is employed to find cluster-specific models to predict 'low' or 'high' involvement in clusters. The MST-kNN method found seven clusters. Based on their salient features they were labelled as: the 'non-institutionalist charities supporters', the 'resource allocation critics', the 'information-seeking financial sceptics', the 'non-questioning charity supporters', the 'non-trusting sceptics', the 'charity management believers' and the 'institutionalist charity believers'. Each cluster exhibits their own characteristics as well as different drivers of 'involvement'. The method in this study provides the not-for-profit sector with a guideline for clustering, segmenting, understanding and potentially targeting their donor base better. If charities and not-for-profit organisations adopt these strategies, they will be more successful in today's competitive environment.	[de Vries, Natalie Jane; Reis, Rodrigo; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Information, Callaghan, NSW 2308, Australia; [Reis, Rodrigo] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil	University of Newcastle; Universidade de Sao Paulo	Moscato, P (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Information, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au		Moscato, Pablo/0000-0003-2570-5966				[Anonymous], 2008, DATABASE MARKETING A; Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Arefin AS, 2012, INT CONF COMP SCI ED, P585, DOI 10.1109/ICCSE.2012.6295143; Aviad B, 2012, DECIS SUPPORT SYST, V54, P292, DOI 10.1016/j.dss.2012.05.037; Bekkers R, 2009, NONPROF VOLUNT SEC Q, V38, P884, DOI 10.1177/0899764008324516; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; De Vries NJ, 2014, J BRAND MANAG, V21, P495, DOI 10.1057/bm.2014.18; de Vries NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102768; Filiou MD, 2014, NEUROGENETICS, V15, P201, DOI 10.1007/s10048-014-0409-x; Gneezy U, 2014, SCIENCE, V346, P632, DOI 10.1126/science.1253932; Herlocker JL, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P230, DOI 10.1145/312624.312682; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, V4828, P156; Inostroza-Ponta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014468; Maenpaa K, 2006, INTERNET RES, V16, P304, DOI 10.1108/10662240610673718; Marsden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066813; Nutonian, 2014, EUR PROD AC; Polonsky, 2002, INT J NONPROFIT VOLU, V7, P19, DOI [DOI 10.1002/NVSM.164, 10.1002/nvsm.164]; Polonsky M.J., 2002, J NONPROFIT PUBLIC S, V10, P67, DOI [10.1300/J054v10n02_04, DOI 10.1300/J054V10N02_04]; Sargeant A, 2004, PSYCHOL MARKET, V21, P613, DOI 10.1002/mar.20021; Sargeant A, 2004, NONPROF VOLUNT SEC Q, V33, P185, DOI 10.1177/0899764004263321; SCHLEGELMILCH BB, 1988, EUR J MARKETING, V22, P31, DOI 10.1108/EUM0000000005265; SMITH WR, 1956, J MARKETING, V21, P3, DOI 10.2307/1247695; Smits GF, 2005, GENET PROGR SER, V8, P283, DOI 10.1007/0-387-23254-0_17; Srnka K. J., 2003, AUSTRALAS MARK J, V11, P70, DOI DOI 10.1016/S1441-3582(03)70119-0; Yavas U, 1981, J ACAD MARKET SCI, V9, P52, DOI [10.1007/BF02723565, DOI 10.1007/BF02723565]	26	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122133	10.1371/journal.pone.0122133	http://dx.doi.org/10.1371/journal.pone.0122133			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849547	Green Published, gold			2022-12-27	WOS:000352477800101
J	Li, L; Chen, ZH; Bei, WC; Su, ZP; Huang, Q; Zhang, L; Chen, HC; Zhou, R				Li, Lu; Chen, Zhaohui; Bei, Weicheng; Su, Zhipeng; Huang, Qi; Zhang, Liang; Chen, Huanchun; Zhou, Rui			Catecholamines Promote Actinobacillus pleuropneumoniae Growth by Regulating Iron Metabolism	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; OUTER-MEMBRANE PROTEIN; TRANSCRIPTIONAL RESPONSE; SALMONELLA-ENTERICA; MOLECULAR-CLONING; GENE-EXPRESSION; NOREPINEPHRINE; RESTRICTION; TRANSFERRIN; VIRULENCE	Catecholamines are host stress hormones that can induce the growth of many bacteria by facilitating iron utilization and/or regulate the expression of virulence genes through specific hormone receptors. Whether these two responsive pathways are interconnected is unknown. In our previous study, it was found that catecholamines can regulate the expression of a great number of genes of Actinobacillus pleuropneumoniae, an important swine respiratory pathogen. However, bacterial growth was not affected by catecholamines in rich medium. In this study, it was discovered that catecholamines affected A. pleuropneumoniae growth in chemically defined medium (CDM). We found that serum inhibited A. pleuropneumoniae growth in CDM, while epinephrine, norepinephrine and dopamine promoted A. pleuropneumoniae growth in the CDM containing serum. The known bacterial hormone receptor QseC didn't play roles in this process. Ion-supplementation and transcriptome analysis indicated that serum addition resulted in iron-restricted conditions which were alleviated by the addition of catecholamines. Transferrin, one of the components in serum, inhibited the growth of A. pleuropneumoniae in CDM, an effect reversed by addition of catecholamines in a TonB2-dependent manner. Our data demonstrate that catecholamines promote A. pleuropneumoniae growth by regulating iron-acquisition and metabolism, which is independent of the adrenergic receptor QseC.	[Li, Lu; Chen, Zhaohui; Bei, Weicheng; Su, Zhipeng; Huang, Qi; Zhang, Liang; Chen, Huanchun; Zhou, Rui] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Li, L (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	lilu@mail.hzau.edu.cn; rzhou@mail.hzau.edu.cn		Huang, Qi/0000-0002-1600-1169	National Natural Science Foundation of China [31201932]; National Basic Research Program of China (973 Program) [2012CB518802]; Special Fund for Agro-scientific Research in the Public Interest [201303034-11]; Fundamental Research Funds for the Central Universities [2662014BQ021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31201932) (http://www.nsfc.gov.cn/, National Basic Research Program of China (973 Program, 2012CB518802) (http://www.973.gov.cn/Default_3.aspx, Special Fund for Agro-scientific Research in the Public Interest (201303034-11) (http://www.moa.gov.cn/) and Fundamental Research Funds for the Central Universities (2662014BQ021) (http://www.hzau.edu.cn/2014/ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MT, 2006, J BACTERIOL, V188, P5731, DOI 10.1128/JB.00495-06; Archambault M, 2003, CAN J VET RES, V67, P271; Armstrong SK, 2012, MOL MICROBIOL, V84, P446, DOI 10.1111/j.1365-2958.2012.08032.x; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Bearson BL, 2008, MICROBES INFECT, V10, P807, DOI 10.1016/j.micinf.2008.04.011; Beddek AJ, 2004, INFECT IMMUN, V72, P701, DOI 10.1128/IAI.72.2.701-708.2004; Bei WC, 2005, FEMS MICROBIOL LETT, V243, P21, DOI 10.1016/j.femsle.2004.11.033; Belay T, 2003, LIFE SCI, V73, P1527, DOI 10.1016/S0024-3205(03)00472-7; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Burton CL, 2002, INFECT IMMUN, V70, P5913, DOI 10.1128/IAI.70.11.5913-5923.2002; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Chin N, 1996, FEMS MICROBIOL LETT, V143, P1, DOI 10.1111/j.1574-6968.1996.tb08452.x; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; DENEER HG, 1989, INFECT IMMUN, V57, P798, DOI 10.1128/IAI.57.3.798-804.1989; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; Diarra MS, 1996, APPL ENVIRON MICROB, V62, P853, DOI 10.1128/AEM.62.3.853-859.1996; Dowd SE, 2007, FEMS MICROBIOL LETT, V273, P214, DOI 10.1111/j.1574-6968.2007.00800.x; DSILVA CG, 1995, VET MICROBIOL, V44, P11, DOI 10.1016/0378-1135(94)00109-A; Freestone PPE, 2003, FEMS MICROBIOL LETT, V222, P39, DOI 10.1016/S0378-1097(03)00243-X; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Freestone PPE, 2007, FEMS MICROBIOL LETT, V269, P221, DOI 10.1111/j.1574-6968.2006.00619.x; Freestone PPE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-8; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Jacques M, 2004, CAN J VET RES, V68, P81; Karavolos MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-458; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; Kinney KS, 1999, MICROB PATHOGENESIS, V26, P85, DOI 10.1006/mpat.1998.0251; Klitgaard K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-698; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031121; Li L, 2011, MICROB PATHOGENESIS, V50, P293, DOI 10.1016/j.micpath.2011.02.002; Lone AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006139; Lyte M, 1996, J LAB CLIN MED, V128, P392, DOI 10.1016/S0022-2143(96)80011-4; Lyte M, 1997, BIOCHEM BIOPH RES CO, V232, P682, DOI 10.1006/bbrc.1997.6356; LYTE M, 1992, MED HYPOTHESES, V37, P255, DOI 10.1016/0306-9877(92)90197-K; Mikael LG, 2002, MICROBIOL-SGM, V148, P2869, DOI 10.1099/00221287-148-9-2869; NIVEN DF, 1989, MOL MICROBIOL, V3, P1083, DOI 10.1111/j.1365-2958.1989.tb00258.x; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Sandrini SM, 2010, J BACTERIOL, V192, P587, DOI 10.1128/JB.01028-09; Srikumar R, 2004, MICROBIOL-SGM, V150, P1723, DOI 10.1099/mic.0.27046-0; Wagner TK, 2006, FEMS IMMUNOL MED MIC, V48, P192, DOI 10.1111/j.1574-695X.2006.00147.x; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10	44	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121887	10.1371/journal.pone.0121887	http://dx.doi.org/10.1371/journal.pone.0121887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849041	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800083
J	Zhu, JW; Lu, DH; Sveinsson, O; Wirdefeldt, K; Fall, K; Piehl, F; Valdimarsdottir, U; Fang, F				Zhu, Jianwei; Lu, Donghao; Sveinsson, Olafur; Wirdefeldt, Karin; Fall, Katja; Piehl, Fredrik; Valdimarsdottir, Unnur; Fang, Fang			Is a Cancer Diagnosis Associated with Subsequent Risk of Transient Global Amnesia?	PLOS ONE			English	Article							CARDIOVASCULAR DEATH; EMOTIONAL AROUSAL; SUICIDE; PREVALENCE; DISORDERS; DISTRESS; THERAPY	Background Psychological stress has been associated with transient global amnesia (TGA). Whether a cancer diagnosis, a severely stressful life event, is associated with subsequent risk of TGA has not been studied. Methods Based on the Swedish Cancer Register and Patient Register, we conducted a prospective cohort study including 5,365,608 Swedes at age 30 and above during 2001-2009 to examine the relative risk of TGA among cancer patients, as compared to cancer-free individuals. Incidence rate ratios (IRRs) and their 95% confidence intervals (CIs) derived from Poisson regression were used as estimates of the association between cancer diagnosis and the risk of TGA. Results During the study 322,558 individuals (6.01%) received a first diagnosis of cancer. We identified 210 cases of TGA among the cancer patients (incidence rate, 0.22 per 1000 person-years) and 4,887 TGA cases among the cancer-free individuals (incidence rate, 0.12 per 1000 person-years). Overall, after adjustment for age, sex, calendar year, socioeconomic status, education and civil status, cancer patients had no increased risk of TGA than the cancer-free individuals (IRR, 0.99; 95% CI, 0.86-1.13). The IRRs did not differ over time since cancer diagnosis or across individual cancer types. The null association was neither modified by sex, calendar period or age. Conclusion Our study did not provide support for the hypothesis that patients with a new diagnosis of cancer display a higher risk of TGA than cancer-free individuals.	[Zhu, Jianwei; Lu, Donghao; Wirdefeldt, Karin; Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sveinsson, Olafur; Piehl, Fredrik] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Wirdefeldt, Karin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Fall, Katja] Univ Orebro, Clin Epidemiol & Biostat Unit, SE-70182 Orebro, Sweden; [Valdimarsdottir, Unnur] Univ Iceland, Ctr Publ Hlth, Reykjavik, Iceland; [Zhu, Jianwei] Shandong Univ, Shandong Prov Hosp, Dept Orthoped, Jinan 250100, Peoples R China	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University; University of Iceland; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhu, JW (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Jianwei.zhu@ki.se	Fall, Katja/AAE-1876-2021	Fall, Katja/0000-0002-3649-2639; Lu, Donghao/0000-0002-4186-8661; Piehl, Fredrik/0000-0001-8329-5219; Valdimarsdottir, Unnur/0000-0001-5382-946X; Fang, Fang/0000-0002-3310-6456; Zhu, Jianwei/0000-0002-6236-6628	Swedish Research Council for Health, Working Life and Welfare [2012-0498]; Swedish Research Council [SIMSAM 80748301, 340-2013-5867]; China Scholarship Council [201309370015]; Swedish Society for Medical Research; Lindhes Advokatbyra AB [LA2014-0352]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Swedish Society for Medical Research; Lindhes Advokatbyra AB	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (No. 2012-0498), URL: http://www.forte.se/en/; Swedish Research Council (SIMSAM 80748301 and 340-2013-5867), URL: http://www.vr.se/inenglish/researchfunding.4.12fff4451215cbd83e4800021418.html; China Scholarship Council (No. 201309370015), URL: http://www.csc.edu.cn/; Swedish Society for Medical Research, URL: http://www.ssmf.se/; Karolinska Institutet, URL: http://ki.se/start; Lindhes Advokatbyra AB (LA2014-0352), URL: http://www.lindhes.se/hem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bartsch T, 2013, NAT REV NEUROL, V9, P86, DOI 10.1038/nrneurol.2012.264; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Brigo F, 2014, ACTA NEUROL BELG; Carlson LE, 2010, J CLIN ONCOL, V28, P4884, DOI 10.1200/JCO.2009.27.3698; Dohring J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00287; Dropkin MJ, 1999, CANCER PRACT, V7, P309, DOI 10.1046/j.1523-5394.1999.76006.x; EVANS J, 1993, J NEUROL NEUROSUR PS, V56, P1227, DOI 10.1136/jnnp.56.11.1227; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2012, NEW ENGL J MED, V366, P1310, DOI 10.1056/NEJMoa1110307; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; FISHER CM, 1982, ARCH NEUROL-CHICAGO, V39, P605, DOI 10.1001/archneur.1982.00510220003001; FISHER CM, 1964, ACTA NEUROL SCAND, V40, P7; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; HODGES JR, 1990, BRAIN, V113, P639, DOI 10.1093/brain/113.3.639; Inzitari D, 1997, ARCH NEUROL-CHICAGO, V54, P866, DOI 10.1001/archneur.1997.00550190056015; Johnson TV, 2012, PSYCHO-ONCOLOGY, V21, P351, DOI 10.1002/pon.1905; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Kirshner HS, 2011, CURR NEUROL NEUROSCI, V11, P578, DOI 10.1007/s11910-011-0224-9; KOSKI KJ, 1990, ACTA NEUROL SCAND, V81, P358; Lu D, 2013, ANN ONCOL, V24, P3112, DOI 10.1093/annonc/mdt415; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; MERRIAM AE, 1992, PSYCHOSOMATICS, V33, P109, DOI 10.1016/S0033-3182(92)72029-5; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; Mouridsen H, 2007, J CLIN ONCOL, V25, P5715, DOI 10.1200/JCO.2007.12.1665; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; Pantoni L, 2000, ACTA NEUROL SCAND, V102, P275, DOI 10.1034/j.1600-0404.2000.102005275.x; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Salvo N, 2012, CLIN ONCOL-UK, V24, P139, DOI 10.1016/j.clon.2011.05.003; Sander D, 2000, LANCET, V356, P1982, DOI 10.1016/S0140-6736(00)03313-4; Sander K, 2005, LANCET NEUROL, V4, P437, DOI 10.1016/S1474-4422(05)70121-6; Steginga SK, 2004, UROLOGY, V63, P751, DOI 10.1016/j.urology.2003.11.017; Wade J, 2013, J CLIN ONCOL, V31, P4235, DOI 10.1200/JCO.2012.45.4801; ZORZON M, 1995, STROKE, V26, P1536, DOI 10.1161/01.STR.26.9.1536	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122960	10.1371/journal.pone.0122960	http://dx.doi.org/10.1371/journal.pone.0122960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849383	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800183
J	Wujcicka, W; Paradowska, E; Studzinska, M; Gaj, Z; Wilczynski, J; Lesnikowski, Z; Nowakowska, D				Wujcicka, Wioletta; Paradowska, Edyta; Studzinska, Miroslawa; Gaj, Zuzanna; Wilczynski, Jan; Lesnikowski, Zbigniew; Nowakowska, Dorota			TLR9 2848 GA Heterozygotic Status Possibly Predisposes Fetuses and Newborns to Congenital Infection with Human Cytomegalovirus	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR-4 POLYMORPHISMS; TOXOPLASMA-GONDII; HYPORESPONSIVENESS; SEROPREVALENCE; EXPRESSION; MANAGEMENT; RESPONSES; GENOTYPE; MOTHER; WOMEN	Background Some single nucleotide polymorphisms (SNP), located in Toll-like receptor (TLR) genes, were reported to be associated with human cytomegalovirus (HCMV) infections. The study was aimed to assess the correlation of SNPs at TLR4 and TLR9 genes with the occurrence of congenital cytomegaly, based on available samples. Methods Reported case-control study included both HCMV infected and non-infected fetuses and newborns. The specimens were classified to the molecular analyses, based on serological features of the recent infection and HCMV DNAemia in body fluids. TLR SNPs were studied, using multiplex nested PCR-RFLP assay, and determined genotypes were confirmed by sequencing. Hardy-Weinberg equilibrium was assessed for the identified genotypes. The linkage disequilibrium was also estimated for TLR4 SNPs. A relationship between the status of TLR genotypes and congenital cytomegaly development was estimated, using a logistic regression model. Results Hardy Weinberg equilibrium was observed for almost all SNPs, both infected and non-infected patients, with exception of TLR4 896 A>G polymorphism in the control group (P <= 0.050). TLR4 896 A>G and 1196 C>T SNPs were found in linkage disequilibrium in both study groups (P <= 0.050). The CC genotype at TLR4 1196 SNP and the GA variant at TLR9 2848 G>A SNP were significantly associated with HCMV infection (P <= 0.050). The risk of congenital cytomegaly was higher in heterozygotes at TLR9 SNP than in the carriers of other genotypic variants at the reported locus (OR 4.81; P <= 0.050). The GC haplotype at TLR4 SNPs and GCA variants at TLR4 and TLR9 SNPs were significantly associated with HCMV infection (P <= 0.0001). The ACA variants were more frequent among fetuses and neonates with symptomatic, rather than asymptomatic cytomegaly (P <= 0.0001). Conclusions TLR4 and TLR9 polymorphisms may contribute to the development of congenital infection with HCMV in fetuses and neonates. The TLR9 2848 GA heterozygotic status possibly predisposes to HCMV infection, increasing the risk of congenital cytomegaly development.	[Wujcicka, Wioletta; Gaj, Zuzanna] Polish Mothers Mem Hosp, Res Inst, Ctr Med Lab Diagnost, Sci Lab, Lodz, Poland; [Wilczynski, Jan; Nowakowska, Dorota] Polish Mothers Mem Hosp, Res Inst, Dept Perinatol & Gynecol, Lodz, Poland; [Paradowska, Edyta; Studzinska, Miroslawa; Lesnikowski, Zbigniew] Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland	Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Nowakowska, D (corresponding author), Polish Mothers Mem Hosp, Res Inst, Dept Perinatol & Gynecol, Lodz, Poland.	dnowakowska@yahoo.com	Lesnikowski, Zbigniew/AAG-7006-2020; Gaj, Zuzanna/O-3749-2014	Lesnikowski, Zbigniew/0000-0003-3158-5796; Paradowska, Edyta/0000-0001-9446-0136; Wujcicka, Wioletta/0000-0002-2907-1414; Gaj, Zuzanna/0000-0002-1803-1935; Studzinska, Miroslawa/0000-0002-4851-2190	Polish Ministry of Science & Higher Education, Polish Mother's Memorial Hospital-Research Institute-Young Researcher Internal Grant [2012/63-MN]	Polish Ministry of Science & Higher Education, Polish Mother's Memorial Hospital-Research Institute-Young Researcher Internal Grant	Sponsor: the Polish Ministry of Science & Higher Education, Polish Mother's Memorial Hospital-Research Institute-Young Researcher Internal Grant No. 2012/63-MN.	Arav-Boger Ravit, 2012, BMC Res Notes, V5, P140, DOI 10.1186/1756-0500-5-140; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Benoist G, 2013, FETAL DIAGN THER, V33, P203, DOI 10.1159/000342752; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Britt W, 2011, INFECT DIS FETUS NEW, P707; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; De Paschale Massimo, 2009, Infect Dis Obstet Gynecol, V2009, P206505, DOI 10.1155/2009/206505; Ducloux D, 2005, KIDNEY INT, V67, P2454, DOI 10.1111/j.1523-1755.2005.00354.x; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; Harwani SC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-133; Hassan-Walker AF, 2001, J MED VIROL, V64, P283, DOI 10.1002/jmv.1048; Hollier LM, 2005, CLIN PERINATOL, V32, P671, DOI 10.1016/j.clp.2005.05.003; Iversen AC, 2009, J IMMUNOL, V182, P5672, DOI 10.4049/jimmunol.0801268; Jablonska A, 2014, INT J INFECT DIS, V25, P11, DOI 10.1016/j.ijid.2014.04.001; Kirchner M, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-9; Kruger B, 2010, CLIN SCI, V119, P535, DOI 10.1042/CS20100190; Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346; Meena NK, 2013, J CLIN GASTROENTEROL, V47, P773, DOI 10.1097/MCG.0b013e31828a6e93; Nelson CT, 1997, CLIN PERINATOL, V24, P151, DOI 10.1016/S0095-5108(18)30189-1; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Pandey S, 2011, MOL BIOL REP, V38, P4715, DOI 10.1007/s11033-010-0607-z; Paradowska E, 2006, APMIS, V114, P764, DOI 10.1111/j.1600-0463.2006.apm_31.x; Pedraza-Sanchez S, 2013, CLIN VACCINE IMMUNOL, V20, P962, DOI 10.1128/CVI.00609-12; Peixoto-Rangel AL, 2009, MEM I OSWALDO CRUZ, V104, P1187, DOI 10.1590/S0074-02762009000800019; Renneson J, 2009, EUR J IMMUNOL, V39, P2789, DOI 10.1002/eji.200939414; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Ricci E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-49; Roszak A, 2012, MOL BIOL REP, V39, P8425, DOI 10.1007/s11033-012-1695-8; Rycel M, 2014, EUR J CLIN IN PRESS; Rycel Magdalena, 2013, Ginekol Pol, V84, P1005; Sanders MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-112; Tamer GS, 2009, CLIN INVEST MED, V32, pE43; Taniguchi R, 2013, INT J INFECT DIS, V17, pE1092, DOI 10.1016/j.ijid.2013.06.004; Temperton NJ, 2003, J MED VIROL, V70, P86, DOI 10.1002/jmv.10357; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; Wujcicka W, 2014, EUR J CLIN MICROBIOL, V33, P1951, DOI 10.1007/s10096-014-2170-3; Wujcicka W, 2014, EUR J CLIN MICROBIOL, V33, P703, DOI 10.1007/s10096-013-2017-3; Wujcicka W, 2013, EUR J CLIN MICROBIOL, V32, P503, DOI 10.1007/s10096-012-1763-y; Wujcicka W, 2014, PATHOG DIS, V70, P3, DOI 10.1111/2049-632X.12083; Yamakawa N, 2013, INT IMMUNOL, V25, P45, DOI 10.1093/intimm/dxs084; Yew KH, 2011, ACTA VIROL, V55, P243, DOI 10.4149/av_2011_03_243; Yew KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044500; Yew KH, 2010, MOL IMMUNOL, V47, P883, DOI 10.1016/j.molimm.2009.10.009	47	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122831	10.1371/journal.pone.0122831	http://dx.doi.org/10.1371/journal.pone.0122831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844529	gold, Green Published, Green Submitted			2022-12-27	WOS:000352475700016
J	Marshall, JK; Lindner, P; Tait, N; Maddocks, T; Riepsamen, A; van der Linden, J				Marshall, Jean K.; Lindner, Pernilla; Tait, Noel; Maddocks, Tracy; Riepsamen, Angelique; van der Linden, Jan			Intra-Operative Tissue Oxygen Tension Is Increased by Local Insufflation of Humidified-Warm CO2 during Open Abdominal Surgery in a Rat Model	PLOS ONE			English	Article							CONTROLLED RESPIRATORY SUPPORT; CARDIOTHORACIC WOUND CAVITY; SURGICAL SITE INFECTION; SUPPLEMENTAL PERIOPERATIVE OXYGEN; CARBON-DIOXIDE PNEUMOPERITONEUM; RANDOMIZED CLINICAL-TRIAL; GAS-DIFFUSER; POSTOPERATIVE-PATIENTS; TEMPERATURE; HYPERCAPNIA	Introduction Maintenance of high tissue oxygenation (PtO2) is recommended during surgery because PtO2 is highly predictive of surgical site infection and colonic anastomotic leakage. However, surgical site perfusion is often sub-optimal, creating an obstructive hurdle for traditional, systemically applied therapies to maintain or increase surgical site PtO2. This research tested the hypothesis that insufflation of humidified-warm CO2 into the abdominal cavity would increase sub-peritoneal PtO2 during open abdominal surgery. Materials and Methods 15 Wistar rats underwent laparotomy under general anesthesia. Three sets of randomized cross-over experiments were conducted in which the abdominal cavity was subjected to alternating exposure to 1) humidified-warm CO2 & ambient air; 2) humidified-warm CO2 & dry-cold CO2; and 3) dry-cold CO2 & ambient air. Sub-peritoneal PtO2 and tissue temperature were measured with a polarographic oxygen probe. Results Upon insufflation of humidified-warm CO2, PtO2 increased by 29.8 mmHg (SD 13.3; p<0.001), or 96.6%(SD 51.9), and tissue temperature by 3.0 degrees C (SD 1.7 p<0.001), in comparison with exposure to ambient air. Smaller, but significant, increases in PtO2 were seen in experiments 2 and 3. Tissue temperature decreased upon exposure to dry-cold CO2 compared with ambient air (-1.4 degrees C, SD 0.5, p = 0.001). Conclusions In a rat model, insufflation of humidified-warm CO2 into the abdominal cavity during open abdominal surgery causes an immediate and potentially clinically significant increase in PtO2. The effect is an additive result of the delivery of CO2 and avoidance of evaporative cooling via the delivery of the CO2 gas humidified at body temperature.	[Marshall, Jean K.; Maddocks, Tracy] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Marshall, Jean K.] Univ Wollongong, Grad Sch Med, Wollongong, NSW, Australia; [Lindner, Pernilla; van der Linden, Jan] Karolinska Univ Hosp, Karolinska Inst, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Tait, Noel] Moruya Dist Hosp, Moruya, Australia; [Riepsamen, Angelique] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; Karolinska Institutet; Karolinska University Hospital; University of New South Wales Sydney	Marshall, JK (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	jkm972@uow.edu.au		Riepsamen, Angelique/0000-0002-7633-6294	Fisher & Paykel Healthcare Ltd (Auckland, New Zealand)	Fisher & Paykel Healthcare Ltd (Auckland, New Zealand)	This research was funded by Fisher & Paykel Healthcare Ltd (Auckland, New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akca O, 2006, BRIT J ANAESTH, V96, P708, DOI 10.1093/bja/ael093; Akca O, 2003, ANAESTHESIA, V58, P536, DOI 10.1046/j.1365-2044.2003.03193.x; Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Akca O, 2002, ANESTHESIOLOGY, V97, P801, DOI 10.1097/00000542-200210000-00009; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; [Anonymous], 2013, BRIT J ANAESTH, DOI DOI 10.1093/BJA/AET233; Arkilic CF, 2003, SURGERY, V133, P49, DOI 10.1067/msy.2003.80; BABIOR BM, 1978, NEW ENGL J MED, V298, P721, DOI 10.1056/NEJM197803302981305; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Bakri MH, 2008, ANESTH ANALG, V106, P1619, DOI 10.1213/ane.0b013e3181732e82; Bourdel N, 2007, HUM REPROD, V22, P1149, DOI 10.1093/humrep/del482; Buggy DJ, 2002, ANESTHESIOLOGY, V97, P952, DOI 10.1097/00000542-200210000-00030; Cater JE, 2014, MED ENG PHYS; CHANG N, 1983, ANN SURG, V197, P470, DOI 10.1097/00000658-198304000-00017; Davis B, 2013, SURG CLIN N AM, V93, P61, DOI 10.1016/j.suc.2012.09.014; de Vries A, 2013, INT J SURG, V11, P1118, DOI 10.1016/j.ijsu.2013.09.005; DIJI A, 1959, J APPL PHYSIOL, V14, P414, DOI 10.1152/jappl.1959.14.3.414; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Frey JM, 2012, ANESTH ANALG, V115, P1204, DOI 10.1213/ANE.0b013e31826ac49f; Frey JM, 2010, WOUND REPAIR REGEN, V18, P378, DOI 10.1111/j.1524-475X.2010.00602.x; Frey JMK, 2012, WORLD J SURG, V36, P2567, DOI 10.1007/s00268-012-1735-5; Gianotti L, 2011, SURG ENDOSC, V25, P1835, DOI 10.1007/s00464-010-1475-2; Govinda R, 2010, ANESTH ANALG, V111, P946, DOI 10.1213/ANE.0b013e3181e80a94; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Hager H, 2006, ANESTH ANALG, V103, P677, DOI 10.1213/01.ane.0000229715.71464.90; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; HARTMANN M, 1992, EUR J SURG, V158, P521; Hopf HW, 2007, ANTIOXID REDOX SIGN, V9, P1183, DOI 10.1089/ars.2007.1641; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; HUNT TK, 2008, ANGIOGENESIS INTEGRA, P541; Ikeda T, 1998, AM J SURG, V175, P33, DOI 10.1016/S0002-9610(97)00237-7; JENSEN JA, 1991, ARCH SURG-CHICAGO, V126, P1131; JONSSON K, 1987, BRIT J SURG, V74, P263, DOI 10.1002/bjs.1800740413; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; JONSSON K, 1986, Surgical Forum (Chicago), V37, P86; Kabon B, 2003, ANESTH ANALG, V97, P1812, DOI 10.1213/01.ANE.0000087040.48267.54; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Matsuzaki S, 2007, HUM REPROD, V22, P2702, DOI 10.1093/humrep/dem114; Matsuzaki S, 2010, SURG ENDOSC, V24, P2871, DOI 10.1007/s00464-010-1069-z; Minamiyama Motomu, 2010, Journal of Biorheology, V24, P42, DOI 10.1007/s12573-010-0023-y; Mynbaev OA, 2014, INT J SURG, V12, P190, DOI 10.1016/j.ijsu.2013.11.009; National Health and Medical Research Council, 2008, GUID PROM WELLB AN U; Neudecker J, 2002, SURG ENDOSC, V16, P1121, DOI 10.1007/s00464-001-9166-7; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Persson M, 2004, J CARDIOTHOR VASC AN, V18, P180, DOI 10.1053/j.jvca.2004.01.024; Persson M, 2003, J HOSP INFECT, V55, P152, DOI 10.1016/S0195-6701(03)00288-3; Persson M, 2003, J CARDIOTHOR VASC AN, V17, P329, DOI 10.1016/S1053-0770(03)00050-8; Persson M, 2008, MED HYPOTHESES, V71, P8, DOI 10.1016/j.mehy.2007.12.016; Qadan M, 2009, EXPERT REV ANTI-INFE, V7, P1043, DOI 10.1586/ERI.09.88; Reshef A, 2013, SURG ENDOSC, V27, P1717, DOI 10.1007/s00464-012-2663-z; ROE CF, 1971, AM J SURG, V122, P13, DOI 10.1016/0002-9610(71)90338-2; Saklani AP, 2013, COLORECTAL DIS, V15, P80, DOI 10.1111/j.1463-1318.2012.03098.x; Sammour T, 2010, MINIM INVASIV THER, V19, P219, DOI 10.3109/13645701003644475; Sessler Daniel I, 2006, Anesthesiol Clin, V24, P279, DOI 10.1016/j.atc.2006.01.005; Sheffield Clark W., 1996, Wound Repair and Regeneration, V4, P339, DOI 10.1046/j.1524-475X.1996.40310.x; SHERIDAN WG, 1987, DIS COLON RECTUM, V30, P867, DOI 10.1007/BF02555426; Svenarud P, 2003, J THORAC CARDIOV SUR, V125, P1043, DOI 10.1067/mtc.2003.50; Svenarud P, 2003, ANESTH ANALG, V96, P321, DOI 10.1097/00000539-200302000-00005; Taflampas P, 2009, SURG TODAY, V39, P183, DOI 10.1007/s00595-008-3835-2; Treschan TA, 2003, ANESTH ANALG, V96, P1553, DOI 10.1213/01.ANE.0000063824.43113.DB; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Yoshida Makiko, 2007, J Surg Educ, V64, P302, DOI 10.1016/j.jsurg.2007.08.003	62	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122838	10.1371/journal.pone.0122838	http://dx.doi.org/10.1371/journal.pone.0122838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835954	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000115
J	Momosaki, R; Abo, M; Watanabe, S; Kakuda, W; Yamada, N; Kinoshita, S				Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji			Effects of Ankle-Foot Orthoses on Functional Recovery after Stroke: A Propensity Score Analysis Based on Japan Rehabilitation Database	PLOS ONE			English	Article							BALANCE; INDEX; RISK	Objectives The purpose of the present study was to investigate potential effects of ankle-foot orthoses (AFOs) on the functional recovery of post-acute stroke patients following rehabilitation. Subjects and Methods This study is a retrospective cohort study. Participants were in-hospital stroke patients registered in the Japan Rehabilitation Database between 2005 and 2012. A total of 1862 patients were eligible after applying exclusion criteria. Propensity score analysis was applied to adjust for potential bias and to create two comparable groups. An additional subset analysis focused on Functional Independence Measure (FIM) scores on admission. Results In this sample, 30.7% of 1863 eligible patients were prescribed AFOs. Propensity score matched analysis showed that patients with AFOs had significantly higher scores than those without them for discharge FIM (mean: 91.3 vs 85.8; p=0.02), FIM gain (mean: 28.9 vs 23.5; p<0.001), and FIM efficiency (mean: 0.27 vs 0.22; p<0.001). Inverse probability weighting analysis showed similar results. In the subset analysis, patients with AFOs had significantly higher discharge FIM compared with those without them in the low admission FIM subgroup only. In addition, patients with AFOs performed independent exercise more than those without them (p<0.001). Conclusions These data suggest that stroke survivors may have better functional recovery if they are prescribed an AFO than if they are not prescribed an AFO. The use of AFOs is considered to be a feasible option to improve functional recovery of stroke rehabilitation patients.	[Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan	Jikei University	Momosaki, R (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan.	momosakiryo@gmail.com	Kinoshita, Shoji/K-5408-2019; Momosaki, Ryo/H-6486-2018	Kinoshita, Shoji/0000-0001-8670-4241; Momosaki, Ryo/0000-0003-3274-3952; Abo, Masahiro/0000-0001-6701-4974				Austin PC, 2013, MULTIVARIATE BEHAV R, V46, P399; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Bowers R, 2010, PROSTHET ORTHOT INT, V34, P245, DOI 10.3109/03093646.2010.486392; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cakar E, 2010, EUR J PHYS REHAB MED, V46, P363; Chisholm AE, 2012, DISABIL REHABIL-ASSI, V7, P437, DOI 10.3109/17483107.2012.680940; Chumney D, 2010, J REHABIL RES DEV, V47, P17, DOI 10.1682/JRRD.2009.08.0140; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Indurkhya A, 2006, STAT MED, V25, P1561, DOI 10.1002/sim.2267; Jeong S, 2010, CLIN AUDIT, V2, P59, DOI [10.2147/CA.S7970, DOI 10.2147/CA.S7970]; Koh GCH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003483; Miyai I, 2011, NEUROREHAB NEURAL RE, V25, P540, DOI 10.1177/1545968311402696; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Safaz I, 2009, INT J REHABIL RES, V32, P228, DOI 10.1097/MRR.0b013e32832a62ad; Sonoda S, 2004, AM J PHYS MED REHAB, V83, P88, DOI 10.1097/01.PHM.0000107481.69424.E1; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Teasell RT, 2001, ARCH PHYS MED REHAB, V82, P1047, DOI 10.1053/apmr.2001.25078; Tyson SF, 2013, CLIN REHABIL, V27, P879, DOI 10.1177/0269215513486497; Tyson SF, 2013, ARCH PHYS MED REHAB, V94, P1377, DOI 10.1016/j.apmr.2012.12.025; Westreich D, 2011, PHARMACOEPIDEM DR S, V20, P317, DOI 10.1002/pds.2074; Xu S, 2010, VALUE HEALTH, V13, P273, DOI 10.1111/j.1524-4733.2009.00671.x; Yusuke Inoue, 2011, CLIN AUDIT, V3, P17	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122688	10.1371/journal.pone.0122688	http://dx.doi.org/10.1371/journal.pone.0122688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837720	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000105
J	Oertel, D; Schmitz, S; Freudl, R				Oertel, Dan; Schmitz, Sabrina; Freudl, Roland			A TatABC-Type Tat Translocase Is Required for Unimpaired Aerobic Growth of Corynebacterium glutamicum ATCC13032	PLOS ONE			English	Article							SEC-INDEPENDENT PROTEIN; TWIN-ARGININE TRANSLOCASE; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; RESPIRATORY-CHAIN; EXPORT PATHWAY; FUNCTIONAL-ANALYSIS; SIGNAL PEPTIDES; SYSTEM; TRANSPORT	The twin-arginine translocation (Tat) system transports folded proteins across the cytoplasmic membrane of bacteria and the thylakoid membrane of plant chloroplasts. Escherichia coli and other Gram-negative bacteria possess a TatABC-type Tat translocase in which each of the three inner membrane proteins TatA, TatB, and TatC performs a mechanistically distinct function. In contrast, low-GC Gram-positive bacteria, such as Bacillus subtilis, use a TatAC-type minimal Tat transiocase in which the TatB function is carried out by a bifunctional TatA. In high-GC Gram-positive Actinobacteria, such as Mycobacterium tuberculosis and Corynebacterium glutamicum, tatA, tatB, and tatC genes can be identified, suggesting that these organisms, just like E. coli, might use TatABC-type Tat translocases as well. However, since contrary to this view a previous study has suggested that C. glutamicum might in fact use a TatAC translocase with TatB only playing a minor role, we reexamined the requirement of TatB for Tat-dependent protein translocation in this microorganism. Under aerobic conditions, the misassembly of the Rieske iron-sulfur protein QcrA was identified as a major reason for the severe growth defect of Tat-defective C. glutamicum mutant strains. Furthermore, our results clearly show that TatB, besides TatA and TatC, is strictly required for unimpaired aerobic growth. In addition, TatB was also found to be essential for the secretion of a heterologous Tat-dependent model protein into the C. glutamicum culture supernatant. Together with our finding that expression of the C. glutamicum TatB in an E. coli Delta tatB mutant strain resulted in the formation of an active Tat translocase, our results clearly indicate that a TatABC translocase is used as the physiologically relevant functional unit for Tat-dependent protein translocation in C. glutamicum and, most likely, also in other TatB-containing Actinobacteria.	[Oertel, Dan; Schmitz, Sabrina; Freudl, Roland] Forschungszentrum Julich, Biotechnol IBG1, Inst Bio & Geowissensch 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Freudl, R (corresponding author), Forschungszentrum Julich, Biotechnol IBG1, Inst Bio & Geowissensch 1, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279	Bio.NRW; local government of North Rhine Westphalia [w0805wb003c]	Bio.NRW; local government of North Rhine Westphalia	This research was supported by Bio.NRW, a funding initiative of the local government of North Rhine Westphalia (ExpressO: grant no. w0805wb003c). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; De Keersmaeker S, 2005, BIOCHEM BIOPH RES CO, V335, P973, DOI 10.1016/j.bbrc.2005.07.165; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Desvaux M, 2004, TRENDS MICROBIOL, V12, P306, DOI 10.1016/j.tim.2004.05.002; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; EIKMANNS BJ, 1991, GENE, V102, P93, DOI 10.1016/0378-1119(91)90545-M; EIKMANNS BJ, 1994, MICROBIOL-SGM, V140, P1817, DOI 10.1099/13500872-140-8-1817; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, J BIOL CHEM, V289, P13124, DOI 10.1074/jbc.M113.529677; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; Goosens VJ, 2013, J PROTEOME RES, V12, P796, DOI 10.1021/pr300866f; Hicks MG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-64; Hopkins A, 2014, J BACTERIOL, V196, P50, DOI 10.1128/JB.00776-13; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Kikuchi Y., 2002, International Patent Cooperation Treaty patent, Patent No. [WO2002/081694, 2002081694]; Kikuchi Y, 2006, APPL ENVIRON MICROB, V72, P7183, DOI 10.1128/AEM.01528-06; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2; Koch-Koerfges A, 2013, BBA-BIOENERGETICS, V1827, P699, DOI 10.1016/j.bbabio.2013.02.004; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Meissner D, 2007, APPL MICROBIOL BIOT, V76, P633, DOI 10.1007/s00253-007-0934-8; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Okibe N, 2011, J MICROBIOL METH, V85, P155, DOI 10.1016/j.mimet.2011.02.012; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sambrook J., 2001, MOL CLONING LAB MANU; Samorski M, 2005, BIOTECHNOL BIOENG, V92, P61, DOI 10.1002/bit.20573; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Scherr N, 2009, CURR OPIN MICROBIOL, V12, P699, DOI 10.1016/j.mib.2009.10.003; Simone D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078742; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Willemse J, 2012, J BACTERIOL, V194, P6272, DOI 10.1128/JB.01425-12	55	10	11	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123413	10.1371/journal.pone.0123413	http://dx.doi.org/10.1371/journal.pone.0123413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837592	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000143
J	Schepisi, MS; Sotgiu, G; Contini, S; Puro, V; Ippolito, G; Girardi, E				Schepisi, Monica Sane; Sotgiu, Giovanni; Contini, Silvia; Puro, Vincenzo; Ippolito, Giuseppe; Girardi, Enrico			Tuberculosis Transmission from Healthcare Workers to Patients and Co-workers: A Systematic Literature Review and Meta-Analysis	PLOS ONE			English	Review							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; ACTIVE PULMONARY TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; NURSERY EXPOSURE; NEONATAL EXPOSURE; OUTBREAK; MANAGEMENT; NEWBORNS; PEDIATRICIAN; EXPERIENCE	Healthcare workers (HCWs) are at risk of becoming infected with tuberculosis (TB), and potentially of being infectious themselves when they are ill. To assess the magnitude of healthcare-associated TB (HCA-TB) transmission from HCWs to patients and colleagues, we searched three electronic databases up to February 2014 to select primary studies on HCA-TB incidents in which a HCW was the index case and possibly exposed patients and co-workers were screened. We identified 34 studies out of 2,714 citations. In 29 individual investigations, active TB was diagnosed in 3/6,080 (0.05%) infants, 18/3,167 (0.57%) children, 1/3,600 (0.03%) adult patients and 0/2,407 HCWs. The quantitative analysis of 28 individual reports showed that combined proportions of active TB among exposed individuals were: 0.11%(95% CI 0.04-0.21) for infants, 0.38% (95% CI 0.01-1.60) for children, 0.09% (95% CI 0.02-0.22) for adults and 0.00% (95% CI 0.00-0.38) for HCWs. Combined proportions of individuals who acquired TB infection were: 0.57%(95% CI 7.28E-03-2.02) for infants, 0.9%(95% CI 0.40-1.60) for children, 4.32% (95% CI 1.43-8.67) for adults and 2.62% (95% CI 1.05-4.88) for HCWs. The risk of TB transmission from HCWs appears to be lower than that recorded in other settings or in the healthcare setting when the index case is not a HCW. To provide a firm evidence base for the screening strategies, more and better information is needed on the infectivity of the source cases, the actual exposure level of screened contacts, and the environmental characteristics of the healthcare setting.	[Schepisi, Monica Sane; Contini, Silvia; Puro, Vincenzo; Girardi, Enrico] L Spallanzani Natl Inst Infect Dis, Dept Epidemiol & Preclin Res, Rome, Italy; [Sotgiu, Giovanni] Univ Sassari, Dept Biomed Sci, Epidemiol & Med Stat Unit, Med Educ & Profess Dev Unit,AOU Sassari, I-07100 Sassari, Italy; [Ippolito, Giuseppe] L Spallanzani Natl Inst Infect Dis, Rome, Italy	IRCCS Lazzaro Spallanzani; University of Sassari; IRCCS Lazzaro Spallanzani	Schepisi, MS (corresponding author), L Spallanzani Natl Inst Infect Dis, Dept Epidemiol & Preclin Res, Rome, Italy.	monica.saneschepisi@inmi.it	Ippolito, Giuseppe/J-7207-2017; Sotgiu, Giovanni/N-1032-2017; Schepisi, Monica Sane/H-2962-2019	Sotgiu, Giovanni/0000-0002-1600-4474; Sane Schepisi, Monica/0000-0001-7283-8062; puro, vincenzo/0000-0003-0291-4490; Ippolito, Giuseppe/0000-0002-1076-2979; Girardi, Enrico/0000-0001-8182-5896	Italian Ministry of Health - "Ricerca Finalizzata" [RF-2009-1499157]; "Ricerca Corrente" INMI Spallanzani; Specialisation School of Hygiene and Preventive Medicine, Tor Vergata University, Rome, Italy	Italian Ministry of Health - "Ricerca Finalizzata"(Ministry of Health, Italy); "Ricerca Corrente" INMI Spallanzani; Specialisation School of Hygiene and Preventive Medicine, Tor Vergata University, Rome, Italy	This work was supported by the Italian Ministry of Health - "Ricerca Finalizzata" Grant no. RF-2009-1499157 and "Ricerca Corrente" INMI Spallanzani. The funder had no role in planning or conducting the review or in the decision to publish its results. Monica Sane Schepisi is a post-graduate student and the recipient of a scholarship from the Specialisation School of Hygiene and Preventive Medicine, Tor Vergata University, Rome, Italy. The funders had no role in study design, data collection	Aivazis V, 2004, ACTA PAEDIATR, V93, P140, DOI 10.1080/08035250310021677; Anderson C, 2007, J PUBLIC HEALTH-UK, V29, P292, DOI 10.1093/pubmed/fdm042; [Anonymous], 2001, Nurs Times, V97, P7; Askew GL, 1997, PEDIATRICS, V100, P19, DOI 10.1542/peds.100.1.19; BECKSAGUE C, 1992, JAMA-J AM MED ASSOC, V268, P1280, DOI 10.1001/jama.268.10.1280; BELFIELD PW, 1984, BRIT J DIS CHEST, V78, P313; Berlioz M, 2008, ARCH PEDIATRIE, V15, P1637, DOI 10.1016/j.arcped.2008.08.017; Bock NN, 1999, INFECT CONT HOSP EP, V20, P421, DOI 10.1086/501644; Borgia P, 2011, EURO SURVEILL, V16; Bradshaw L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020770; Brassard P, 2000, PEDIATR INFECT DIS J, V19, P968, DOI 10.1097/00006454-200010000-00006; BURK JR, 1978, SOUTHERN MED J, V71, P7, DOI 10.1097/00007611-197801000-00004; Carbonne A, 2005, INT J TUBERC LUNG D, V9, P848; Dewan PK, 2006, PEDIATRICS, V117, P863, DOI 10.1542/peds.2005-1380; DOOLEY SW, 1992, JAMA-J AM MED ASSOC, V267, P2632, DOI 10.1001/jama.267.19.2632; DROBNIEWSKI FA, 1995, THORAX, V50, P863, DOI 10.1136/thx.50.8.863; Dubrulle S, 2010, ARCH PEDIATRIE, V17, P1491, DOI 10.1016/j.arcped.2010.06.027; Fisher KE, 2013, INFECT CONT HOSP EP, V34, P754, DOI 10.1086/670995; Fitzpatrick F., 2005, Morbidity and Mortality Weekly Report, V54, P1280; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Fraser TG, 2009, INFECT CONT HOSP EP, V30, P80, DOI 10.1086/592706; Gaensbauer JT, 2009, ARCH DIS CHILD, V94, P392, DOI 10.1136/adc.2008.145755; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Grime PR, 2011, OCCUP MED-OXFORD, V61, P274, DOI 10.1093/occmed/kqr033; Harris TG, 2013, AM J INFECT CONTROL, V41, P155, DOI 10.1016/j.ajic.2012.02.015; Hickstein L., 2004, Morbidity and Mortality Weekly Report, V53, P873; Hillarus M, 2003, BEH, V10-11, P54; Huang WL, 2007, J FORMOS MED ASSOC, V106, P520, DOI 10.1016/S0929-6646(07)60002-3; Jonsson J, 2013, J HOSP INFECT, V83, P321, DOI 10.1016/j.jhin.2012.11.028; KAUPAS V, 1974, JAMA-J AM MED ASSOC, V228, P851, DOI 10.1001/jama.228.7.851; KEIM LW, 1974, AM REV RESPIR DIS, V110, P522; LEGGIADRO RJ, 1989, PEDIATR INFECT DIS J, V8, P52, DOI 10.1097/00006454-198901000-00015; LIGHT IJ, 1974, AM REV RESPIR DIS, V109, P415; Linquist JA, 2002, AM J INFECT CONTROL, V30, P307, DOI 10.1067/mic.2002.123394; Magnin D, 2007, B EPIDEMIOL HEBDO, V17, P137; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Migueres B, 2010, MED MALADIES INFECT, V40, P524, DOI 10.1016/j.medmal.2010.02.007; Millership SE, 2009, PEDIATR INFECT DIS J, V28, P915, DOI 10.1097/INF.0b013e3181a3d289; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore M, 1998, J PEDIATR-US, V133, P108, DOI 10.1016/S0022-3476(98)70188-X; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Munoz FM, 2002, INFECT CONT HOSP EP, V23, P568, DOI 10.1086/501972; Nania JJ, 2007, INFECT CONT HOSP EP, V28, P661, DOI 10.1086/517975; Nivin B, 1998, CLIN INFECT DIS, V26, P303, DOI 10.1086/516296; Noel D, 2009, B EPIDEMIOL HEBDO, V18-19, P187; NOLAN CM, 1987, PEDIATRICS, V79, P630; Ohno Hitoshi, 2008, Journal of Infection and Chemotherapy, V14, P66, DOI 10.1007/s10156-007-0565-0; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; Perry A, 2012, ARCH PEDIATRIE, V19, P396, DOI [10.1016/j.arcped.2012.01.017, 10.1016/.arcped.2012.01.017]; Public Health England, TB INC OUTBR SURV TB; RAO VR, 1980, BRIT MED J, V281, P187, DOI 10.1136/bmj.281.6234.187; Roberts JR, 2012, PEDIATR INFECT DIS J, V31, P82, DOI 10.1097/INF.0b013e31823378c9; Sen M, 2005, CAN MED ASSOC J, V172, P1453, DOI 10.1503/cmaj.1031052; Singhatiraj E, 2009, INFECT CONT HOSP EP, V30, P502, DOI 10.1086/597230; SMITH WHR, 1982, LANCET, V1, P842; STEINER P, 1976, AM REV RESPIR DIS, V113, P267; Sterling TR, 2006, NEW ENGL J MED, V355, P118, DOI 10.1056/NEJMp068015; STEWART CJ, 1976, BRIT MED J, V1, P30, DOI 10.1136/bmj.1.6000.30; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Trueba F, 2006, REV MAL RESPIR, V23, P339, DOI 10.1016/S0761-8425(06)71599-6; van der Zanden AGM, 2001, NETH J MED, V59, P152, DOI 10.1016/S0300-2977(01)00153-X; Wells G.A., NEWCASTLE OTTAWA SCA; World Health Organization, 2009, WHO POL TB INF CONTR; ZAZA S, 1995, J INFECT DIS, V172, P1542, DOI 10.1093/infdis/172.6.1542	64	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121639	10.1371/journal.pone.0121639	http://dx.doi.org/10.1371/journal.pone.0121639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835507	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000052
J	Stinca, A; Chirico, GB; Incerti, G; Bonanomi, G				Stinca, Adriano; Chirico, Giovanni Battista; Incerti, Guido; Bonanomi, Giuliano			Regime Shift by an Exotic Nitrogen-Fixing Shrub Mediates Plant Facilitation in Primary Succession	PLOS ONE			English	Article							SOIL-WATER REPELLENCY; NURSE PLANTS; INVASION; IMPACTS; FOREST; DECOMPOSITION; FEEDBACKS; DYNAMICS; TREES; RESTORATION	Ecosystem invasion by non-native, nitrogen-fixing species is a global phenomenon with serious ecological consequences. However, in the Mediterranean basin few studies addressed the impact of invasion by nitrogen-fixing shrubs on soil quality and hydrological properties at local scale, and the possible effects on succession dynamics and ecosystem invasibility by further species. In this multidisciplinary study we investigated the impact of Genista aetnensis (Biv.) DC., an exotic nitrogen-fixing shrub, on the Vesuvius Grand Cone (Southern Italy). Specifically, we tested the hypotheses that the invasion of Genista aetnensis has a significant impact on soil quality, soil hydrological regime, local microclimate and plant community structure, and that its impact increases during the plant ontogenetic cycle. We showed that Genista aetnensis, in a relatively short time-span (i.e. similar to 40 years), has been able to build-up an island of fertility under its canopy, by accumulating considerable stocks of C, N, and P in the soil, and by also improving the soil hydrological properties. Moreover, Genista aetnensis mitigates the daily range of soil temperature, reducing the exposure of coexisting plants to extremely high temperatures and water loss by soil evaporation, particularly during the growing season. Such amelioration of soil quality, coupled with the mitigation of below-canopy microclimatic conditions, has enhanced plant colonization of the barren Grand Cone slopes, by both herbaceous and woody species. These results suggest that the invasion of Genista aetnensis could eventually drive to the spread of other, more resource-demanding exotic species, promoting alternative successional trajectories that may dramatically affect the local landscape. Our study is the first record of the invasion of Genista aetnensis, an additional example of the regime shifts driven by N-fixing shrubs in Mediterranean region. Further studies are needed to identity specific management practices that can limit the spread and impacts of this species.	[Stinca, Adriano; Chirico, Giovanni Battista; Incerti, Guido; Bonanomi, Giuliano] Univ Naples Federico II, Dept Agr, Naples, Italy	University of Naples Federico II	Stinca, A (corresponding author), Univ Naples Federico II, Dept Agr, Via Univ 100, Naples, Italy.	adriano.stinca@unina.it	Chirico, Giovanni Battista/E-7330-2016; Incerti, Guido/B-5106-2017; Incerti, Guido/O-5870-2019	Chirico, Giovanni Battista/0000-0002-9536-4741; Incerti, Guido/0000-0003-1288-8708; Incerti, Guido/0000-0003-1288-8708; BONANOMI, Giuliano/0000-0002-1831-4361; Stinca, Adriano/0000-0002-8275-0184	Piante Aliene della Regione Campania (Regione Campania, Servizio Fitosanitario Regionale, Italy); MED For Climadapt (Vesuvius National Park, Italy)	Piante Aliene della Regione Campania (Regione Campania, Servizio Fitosanitario Regionale, Italy); MED For Climadapt (Vesuvius National Park, Italy)	This research was partly founded by projects Piante Aliene della Regione Campania (Regione Campania, Servizio Fitosanitario Regionale, Italy) and MED For Climadapt (Vesuvius National Park, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTINI R, 1975, Archivio Botanico e Biogeografico Italiano, V51, P11; AGOSTINI RENZO, 1959, DELPINOA N S, V1, P42; Aguilera LE, 1999, J ARID ENVIRON, V42, P61, DOI 10.1006/jare.1999.0503; Alef K., 1995, METHODS APPL SOIL MI, DOI 10.1016/B978-0-12-513840-6.X5014-9; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; BAUMGARDNER MF, 1985, ADV AGRON, V38, P1, DOI 10.1016/S0065-2113(08)60672-0; BELSKY AJ, 1993, J APPL ECOL, V30, P143, DOI 10.2307/2404278; Berg B, 1996, CAN J BOT, V74, P659, DOI 10.1139/b96-084; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Birken AS, 2006, ECOL APPL, V16, P1103, DOI 10.1890/1051-0761(2006)016[1103:POTIAF]2.0.CO;2; Bloem J., 2006, MICROBIOLOGICAL METH; Bonanomi G, 2005, OIKOS, V111, P311, DOI 10.1111/j.0030-1299.2005.13975.x; Bonanomi G, 2008, PLANT ECOL, V197, P207, DOI 10.1007/s11258-007-9371-0; Bonanomi G, 2013, SOIL BIOL BIOCHEM, V56, P40, DOI 10.1016/j.soilbio.2012.03.003; Bonanomi G, 2012, J VEG SCI, V23, P236, DOI 10.1111/j.1654-1103.2011.01353.x; Bonanomi G, 2011, PLANT ECOL, V212, P1777, DOI 10.1007/s11258-011-9948-5; Bonanomi G, 2011, APPL SOIL ECOL, V47, P184, DOI 10.1016/j.apsoil.2010.12.007; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; Carrillo-Garcia A, 1999, RESTOR ECOL, V7, P321, DOI 10.1046/j.1526-100X.1999.72027.x; Cass A, 1999, SOIL ANAL INTERPRETA, P95; Castro J, 2004, RESTOR ECOL, V12, P352, DOI 10.1111/j.1061-2971.2004.0316.x; Castro SA, 2005, DIVERS DISTRIB, V11, P183, DOI 10.1111/j.1366-9516.2005.00145.x; Castroviejo S., 1986, FLORA IBRICA PLANTAS; Chirico GB, 2003, HYDROL PROCESS, V17, P2239, DOI 10.1002/hyp.1330; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; Conti F., 2007, NAT VICENTINA, V10, P5; CORNEJO FH, 1994, OIKOS, V70, P183, DOI 10.2307/3545629; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeBano L. F., 1981, PSW46 USDA FOR SERV; Diamantopoulos E, 2013, J HYDROL, V486, P175, DOI 10.1016/j.jhydrol.2013.01.020; DiTomaso JM, 2007, WEEDS CALIFORNIA OTH, V1; Doerr SH, 2000, EARTH-SCI REV, V51, P33, DOI 10.1016/S0012-8252(00)00011-8; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; El-Keblawy A, 2007, PLANT ECOL, V190, P23, DOI 10.1007/s11258-006-9188-2; Facelli JM, 2000, ECOGRAPHY, V23, P479, DOI 10.1034/j.1600-0587.2000.230410.x; FRANCO AC, 1989, J ECOL, V77, P870, DOI 10.2307/2260991; Gaertner M, 2014, DIVERS DISTRIB, V20, P733, DOI 10.1111/ddi.12182; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Geerts S, 2013, S AFR J BOT, V87, P134, DOI 10.1016/j.sajb.2013.03.019; Gessner Mark O., 2005, P115, DOI 10.1007/1-4020-3466-0_17; Godinez-Alvarez H, 1998, J ARID ENVIRON, V39, P21, DOI 10.1006/jare.1998.0376; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gotelli NJ, 2013, ECOSIMR 1 00; Haubensak KA, 2004, PLANT ECOL, V175, P71, DOI 10.1023/B:VEGE.0000048088.32708.58; Incerti G, 2013, ACTA OECOL, V49, P116, DOI 10.1016/j.actao.2013.03.012; Kamijo T, 2002, FOLIA GEOBOT, V37, P71, DOI 10.1007/BF02803192; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; LONSDALE WM, 1993, J ECOL, V81, P513, DOI 10.2307/2261529; Marchante E, 2008, APPL SOIL ECOL, V40, P210, DOI 10.1016/j.apsoil.2008.04.004; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Mataix-Solera J, 2007, HYDROL PROCESS, V21, P2300, DOI 10.1002/hyp.6750; Mazzoleni S, 2007, COMMUNITY ECOL, V8, P103, DOI 10.1556/ComEc.8.2007.1.12; Mazzoleni S., 1993, PRIMARY SUCCESSION L, P101; Mazzoleni S, 1989, ANN BOT ROMA S6, V47, P97; MCGHIE DA, 1981, AUST J AGR RES, V32, P609, DOI 10.1071/AR9810609; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Mooney H.A., 2000, INVASIVE SPECIES CHA; Moro MJ, 1997, ECOGRAPHY, V20, P175, DOI 10.1111/j.1600-0587.1997.tb00360.x; Motti R, 2009, LAB MONITORAGGIO BIO, P17; Munzbergova Z, 2002, J VEG SCI, V13, P227, DOI 10.1658/1100-9233(2002)013[0227:ATAKSI]2.0.CO;2; Nossov DR, 2011, J ECOL, V99, P621, DOI 10.1111/j.1365-2745.2010.01792.x; Piccolo F., 2005, ADV GEOSCI, V2, P151, DOI [10.5194/adgeo-2-151-2005, DOI 10.5194/ADGEO-2-151-2005]; Pickart AJ, 1998, RESTOR ECOL, V6, P59, DOI 10.1046/j.1526-100x.1998.00618.x; Pignatti S., 1982, FLORA DITALIA, VVolume I; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rawls WJ, 2003, GEODERMA, V116, P61, DOI 10.1016/S0016-7061(03)00094-6; Rejmanek M, 2013, DIVERS DISTRIB, V19, P1093, DOI 10.1111/ddi.12075; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Ricciardi M, 1988, B SOC NAT NAPOLI, V96, P3; Rillig MC, 2005, PEDOBIOLOGIA, V49, P395, DOI 10.1016/j.pedobi.2005.04.004; Romano N, 2011, HYDROL EARTH SYST SC, V15, P3877, DOI 10.5194/hess-15-3877-2011; Sanjurjo MJF, 2003, GEODERMA, V115, P223, DOI 10.1016/S0016-7061(03)00013-2; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Soliveres S, 2010, PERSPECT PLANT ECOL, V12, P227, DOI 10.1016/j.ppees.2010.02.003; Sparks D.L., 1996, SSSA BOOK SERIES, V5, P437; Sparks D. L, 1996, SSSA BOOK SERIES, V5; Stinca A., 2013, Informatore Botanico Italiano, V45, P35; Stinca A, 2013, THESIS U NAPLES FEDE; Stinca Adriano, 2014, Hacquetia, V13, P355, DOI 10.2478/hacq-2014-0011; Stinca Adriano, 2009, Webbia, V64, P235; Tutin T.G., 1964, FLORA EUROPAEA, V1-5; Tutin TG, 1993, FLORA EUROPAEA, V1; VANDERPUTTEN WH, 1993, NATURE, V362, P53; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; WORKNEH F, 1993, PHYTOPATHOLOGY, V83, P581, DOI 10.1094/Phyto-83-581; York CA, 2000, J HYDROL, V231, P126, DOI 10.1016/S0022-1694(00)00189-X; [No title captured], DOI DOI 10.2307/2937039; [No title captured]	95	25	27	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123128	10.1371/journal.pone.0123128	http://dx.doi.org/10.1371/journal.pone.0123128			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835015	Green Published, gold			2022-12-27	WOS:000352139000129
J	Zorn, JA; Wang, Q; Fujimura, E; Barros, T; Kuriyan, J				Zorn, Julie A.; Wang, Qi; Fujimura, Eric; Barros, Tiago; Kuriyan, John			Crystal Structure of the FLT3 Kinase Domain Bound to the Inhibitor Quizartinib (AC220)	PLOS ONE			English	Article							TYROSINE KINASE; STI-571 INHIBITION; AUTOINHIBITION; COMPLEX	More than 30% of acute myeloid leukemia (AML) patients possess activating mutations in the receptor tyrosine kinase FMS-like tyrosine kinase 3 or FLT3. A small-molecule inhibitor of FLT3 (known as quizartinib or AC220) that is currently in clinical trials appears promising for the treatment of AML. Here, we report the co-crystal structure of the kinase domain of FLT3 in complex with quizartinib. FLT3 with quizartinib bound adopts an "Abl-like" inactive conformation with the activation loop stabilized in the "DFG-out" orientation and folded back onto the kinase domain. This conformation is similar to that observed for the uncomplexed intracellular domain of FLT3 as well as for related receptor tyrosine kinases, except for a localized induced fit in the activation loop. The co-crystal structure reveals the interactions between quizartinib and the active site of FLT3 that are key for achieving its high potency against both wild-type FLT3 as well as a FLT3 variant observed in many AML patients. This co-complex further provides a structural rationale for quizartinib-resistance mutations.	[Zorn, Julie A.; Wang, Qi; Fujimura, Eric; Barros, Tiago; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zorn, Julie A.; Wang, Qi; Barros, Tiago; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Barros, Tiago; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Barros, Tiago/B-8455-2014	Barros, Tiago/0000-0002-9807-7625	National Institutes of Health National Cancer Institute [F32 CA177087-02]; Cancer Research Institute; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [F32CA177087] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JAZ is supported by a postdoctoral fellowship from the National Institutes of Health National Cancer Institute (F32 CA177087-02). QW is supported by an Irvington Institute postdoctoral fellowship from the Cancer Research Institute. JK and TB are funded by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albers C, 2013, LEUKEMIA, V27, P1416, DOI 10.1038/leu.2013.14; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chao Q, 2009, J MED CHEM, V52, P7808, DOI 10.1021/jm9007533; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gunawardane RN, 2013, MOL CANCER THER, V12, P438, DOI 10.1158/1535-7163.MCT-12-0305; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Laham LE, 2000, ONCOGENE, V19, P3961, DOI 10.1038/sj.onc.1203738; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levis M, 2005, INT J HEMATOL, V82, P100, DOI 10.1532/IJH97.05079; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel HK, 2009, BIOORG MED CHEM LETT, V19, P5182, DOI 10.1016/j.bmcl.2009.07.024; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schlessinger J, 2014, COLD SPRING HARB PER, V6, P3, DOI DOI 10.1101/CSHPERSPECT.A008912; Schwartz PA, 2011, BIOORG CHEM, V39, P192, DOI 10.1016/j.bioorg.2011.07.004; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Smith CC, 2014, P NATL ACAD SCI USA, V111, P5319, DOI 10.1073/pnas.1320661111; Solowiej J, 2009, BIOCHEMISTRY-US, V48, P7019, DOI 10.1021/bi900522y; Sudhindra A, 2014, CURR HEMATOL MALIG R, V9, P174, DOI 10.1007/s11899-014-0203-8; Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532; Wang Q, 2014, METHOD ENZYMOL, V548, P23, DOI 10.1016/B978-0-12-397918-6.00002-1; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t	39	62	63	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121177	10.1371/journal.pone.0121177	http://dx.doi.org/10.1371/journal.pone.0121177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837374	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000040
J	Heijmen, L; ter Voert, EEGW; Oyen, WJG; Punt, CJA; van Spronsen, DJ; Heerschap, A; de Geus-Oei, LF; van Laarhoven, HWM				Heijmen, Linda; ter Voert, Edwin E. G. W.; Oyen, Wim J. G.; Punt, Cornelis J. A.; van Spronsen, Dick Johan; Heerschap, Arend; de Geus-Oei, Lioe-Fee; van Laarhoven, Hanneke W. M.			Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; LIVER METASTASES; TUMOR RESPONSE; F-18-FDG PET; FDG-PET/CT; CHEMOTHERAPY; BEVACIZUMAB; GRADE	Aim Aim of this study was to investigate the potential of F-18-FDG PET, diffusion weighted imaging (DWI) and susceptibility-weighted (T2*) MRI to predict response to systemic treatment in patients with colorectal liver metastases. The predictive values of pretreatment measurements and of early changes one week after start of therapy, were evaluated. Methods Imaging was performed prior to and one week after start of first line chemotherapy in 39 patients with colorectal liver metastases. F-18-FDG PET scans were performed on a PET/CT scanner and DWI and T2* were performed on a 1.5T MR scanner. The maximum standardized uptake values (SUV), total lesion glycolysis (TLG), apparent diffusion coefficient (ADC) and T2* value were assessed in the same lesions. Up to 5 liver metastases per patient were analyzed. Outcome measures were progression free survival (PFS), overall survival (OS) and size response. Results Pretreatment, high SUVmax, high TLG, low ADC and high T2* were associated with a shorter OS. Low pretreatment ADC value was associated with shorter PFS. After 1 week a significant drop in SUVmax and rise in ADC were observed. The drop in SUV was correlated with the rise in ADC (r=-0.58, p=0.002). Neither change in ADC nor in SUV was predictive of PFS or OS. T2* did not significantly change after start of treatment. Conclusion Pretreatment SUVmax, TLG, ADC, and T2* values in colorectal liver metastases are predictive of patient outcome. Despite sensitivity of DWI and F-18-FDG PET for early treatment effects, change in these parameters was not predictive of long term outcome.	[Heijmen, Linda; van Laarhoven, Hanneke W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands; [Heijmen, Linda; ter Voert, Edwin E. G. W.; Oyen, Wim J. G.; Heerschap, Arend; de Geus-Oei, Lioe-Fee] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, NL-6525 ED Nijmegen, Netherlands; [Punt, Cornelis J. A.; van Laarhoven, Hanneke W. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Nijmegen, Netherlands; [van Spronsen, Dick Johan] Canisius Wilhelmina Hosp, Dept Med Oncol, Nijmegen, Netherlands; [de Geus-Oei, Lioe-Fee] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Canisius-Wilhelmina Hospital; University of Twente	Heijmen, L (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands.	Linda.Heijmen@radboudumc.nl	Heerschap, Arend/G-5228-2010; van Spronsen, Dick Johan/D-6101-2018; de Geus-Oei, L.F./B-2716-2014; van Laarhoven, Hanneke/AAW-3464-2021; Oyen, Wim J.G./D-4178-2009; Oyen, Wim J.G./AAD-3373-2020	de Geus-Oei, L.F./0000-0003-1817-2743; Oyen, Wim J.G./0000-0001-8235-7078; Oyen, Wim J.G./0000-0001-8235-7078; van Laarhoven, H.W.M./0000-0003-1274-5643; ter Voert, Edwin/0000-0001-8877-338X; Heijmen, Linda/0000-0003-1453-3337	Dutch Cancer Society (KWF Kankerbestrijding) [KUN 2008-4098]	Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding)	This work was supported by a grant from the Dutch Cancer Society (KWF Kankerbestrijding), no. KUN 2008-4098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; De Bruyne S, 2012, BRIT J CANCER, V106, P1926, DOI 10.1038/bjc.2012.184; de Geus-Oei LF, 2006, ANN ONCOL, V17, P1650, DOI 10.1093/annonc/mdl180; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Desar IME, 2009, CANCER TREAT REV, V35, P309, DOI 10.1016/j.ctrv.2008.12.001; Desar IM, ASCO ANN M 2010; Dimitrakopoulou-Strauss A, 2004, J NUCL MED, V45, P1480; Fan B, 2011, MAGN RESON IMAGING, V29, P153, DOI 10.1016/j.mri.2010.08.014; Findlay M, 1996, J CLIN ONCOL, V14, P700, DOI 10.1200/JCO.1996.14.3.700; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Gruenberger T, 2012, SURG ONCOL, V21, P309, DOI 10.1016/j.suronc.2012.07.003; Hambrock T, 2011, RADIOLOGY, V259, P453, DOI 10.1148/radiol.11091409; Heijmen L, 2014, CONTRAST MEDIA MOL I, V9, P237, DOI 10.1002/cmmi.1564; Heijmen L, 2012, CRIT REV ONCOL HEMAT, V83, P194, DOI 10.1016/j.critrevonc.2011.12.008; Hendlisz A, 2012, ANN ONCOL, V23, P1687, DOI 10.1093/annonc/mdr554; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Koh DM, 2007, AM J ROENTGENOL, V188, P1001, DOI 10.2214/AJR.06.0601; Li SP, 2010, RADIOLOGY, V257, P643, DOI 10.1148/radiol.10100421; Liu CJ, 2011, HEPATO-GASTROENTEROL, V58, P1495, DOI 10.5754/hge11082; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Nanni O, 2002, BRIT J CANCER, V87, P868, DOI 10.1038/sj.bjc.6600569; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; ter Voert EEGW, 2014, NUCL MED COMMUN, V35, P472, DOI 10.1097/MNM.0000000000000086; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tol J, 2010, CLIN THER, V32, P437, DOI 10.1016/j.clinthera.2010.03.012; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Woodfield CA, 2010, AM J ROENTGENOL, V194, pW316, DOI 10.2214/AJR.09.2651; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520	31	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120823	10.1371/journal.pone.0120823	http://dx.doi.org/10.1371/journal.pone.0120823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831053	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600043
J	Schepers, E; Houthuys, E; Dhondt, A; De Meyer, G; Neirynck, N; Bernaert, P; Van den Bergh, R; Brouckaert, P; Vanholder, R; Glorieux, G				Schepers, Eva; Houthuys, Erica; Dhondt, Annemieke; De Meyer, Grim; Neirynck, Nathalie; Bernaert, Pascale; Van den Bergh, Rafael; Brouckaert, Peter; Vanholder, Raymond; Glorieux, Griet			Transcriptome Analysis in Patients with Chronic Kidney Disease on Hemodialysis Disclosing a Key Role for CD16(+)CX3CR1(+) Monocytes	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SYMMETRIC DIMETHYLARGININE; CD14(++)CD16(+) MONOCYTES; CD14+CD16+ MONOCYTES; RHEUMATOID-ARTHRITIS; PROFILING REVEALS; CD16(+) MONOCYTES; INFLAMMATION; DIALYSIS; ATHEROSCLEROSIS	The risk for cardiovascular morbidity and mortality is increased in chronic kidney disease; in this process micro-inflammation plays an essential role. Responsible mechanisms remain to a large extent unidentified. In this pilot study transcriptome analysis of peripheral blood monocytes was used to identify in an unprejudiced manner which factors could be discriminative for cardiovascular disease in patients with chronic kidney disease on hemodialysis. Forty gender- and age-matched, non-diabetic, non-smoking subjects with CRP < 20 mg/L were recruited: 9 healthy controls, 11 patients with eGFR > 60 mL/min/1.73m(2) and a history of cardiovascular event (CVE), 10 patients with chronic kidney disease stage 5 on hemodialysis without previous cardiovascular event (CKD5HD) and 10 with a previous cardiovascular event (CKD5HD/CVE). Monocytes were isolated and their mRNA was submitted to focused transcriptome analysis using a macroarray platform containing ca. 700 genes associated with macrophage functional capacity. The macroarray data indicated 9 genes ( 8 upregulated and 1 downregulated) with a significant differential expression in CKD5HD/CVE vs. CVE alone, after excluding genes differentially expressed in CKD5HD vs. control. For FCGR3A (CD16) and CX3CR1 (chemokine receptor) the upregulation vs. control and vs. CVE could be confirmed by quantitative RT-PCR for all CKD5HD patients. Furthermore, CX3CR1 relative expression on monocytes correlated with CRP. Flow cytometric analysis of purified monocytes confirmed a significant increase in the percentage of CD16 positive monocytes in all CKD5HD patients vs. control and CVE. The present study indicates the importance of a specific pro-inflammatory monocyte subpopulation, positive for CD16 and the co-expressed chemokine receptor, CX3CR1, discriminative for CKD5HD patients.	[Schepers, Eva; Dhondt, Annemieke; Vanholder, Raymond] Ghent Univ Hosp, Div Nephrol, Dept Internal Med, Ghent, Belgium; [Houthuys, Erica] Univ Ghent, VIB, IRC, Unit Med Biotechnol, B-9000 Ghent, Belgium; [Houthuys, Erica] Univ Ghent, Dept Biochem & Microbiol, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [De Meyer, Grim; Neirynck, Nathalie] Ghent Univ Hosp, Div Cardiol, Dept Internal Med, Ghent, Belgium; [Bernaert, Pascale] AZ Maria Middelares, Div Renal, Ghent, Belgium; [Van den Bergh, Rafael] Vrije Univ Brussel VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Van den Bergh, Rafael] Vrije Univ Brussel, Lab Cellular & Mol Immunol, B-1050 Brussels, Belgium; [Brouckaert, Peter] Univ Ghent, Dept Biomed & Mol Biol, Zwijnaarde, Belgium	Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Ghent University	Schepers, E (corresponding author), Ghent Univ Hosp, Div Nephrol, Dept Internal Med, Ghent, Belgium.	Eva.Schepers@UGent.be		Van den Bergh, Rafael/0000-0001-6277-8713				Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Ancuta P, 2006, J LEUKOCYTE BIOL, V80, P1156, DOI 10.1189/jlb.0206125; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boonefaes T, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-97; Cohen G, 2011, NEPHROL DIAL TRANSPL, V26, P2271, DOI 10.1093/ndt/gfq731; Glorieux G, 2012, NEPHROL DIAL TRANSPL, V27, P4010, DOI 10.1093/ndt/gfs306; Glorieux G, 2009, SEMIN DIALYSIS, V22, P423, DOI 10.1111/j.1525-139X.2009.00593.x; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Heine GH, 2008, KIDNEY INT, V73, P622, DOI 10.1038/sj.ki.5002744; Ikejima H, 2010, CIRC J, V74, P337, DOI 10.1253/circj.CJ-09-0484; Krane V, 2011, NAT REV NEPHROL, V7, P385, DOI 10.1038/nrneph.2011.62; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Merino A, 2008, CONTRIB NEPHROL, V161, P83, DOI 10.1159/000130412; Merino A, 2010, CLIN J AM SOC NEPHRO, V5, P227, DOI 10.2215/CJN.03260509; Mobley JL, 2007, INFLAMMATION, V30, P189, DOI 10.1007/s10753-007-9036-0; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Nockher WA, 1998, INFECT IMMUN, V66, P2782, DOI 10.1128/IAI.66.6.2782-2790.1998; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Ramirez R, 2011, CONTRIB NEPHROL, V171, P57, DOI 10.1159/000327134; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P1568, DOI 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1; Sardenberg C, 2006, NEPHROL DIAL TRANSPL, V21, P160, DOI 10.1093/ndt/gfi095; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Sester U, 2001, NEPHROL DIAL TRANSPL, V16, P1402, DOI 10.1093/ndt/16.7.1402; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2002, SEMIN DIALYSIS, V15, P329, DOI 10.1046/j.1525-139X.2002.00083.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; Van Biesen W, 2007, NEPHROL DIAL TRANSPL, V22, P53, DOI 10.1093/ndt/gfl601; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Van Roy N, 2001, GENE CHROMOSOME CANC, V32, P126, DOI 10.1002/gcc.1174; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; West SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052406; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zaza G, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-17	47	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121750	10.1371/journal.pone.0121750	http://dx.doi.org/10.1371/journal.pone.0121750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830914	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600081
J	Vasquez, D; Willoughby, A; Davis, AK				Vasquez, David; Willoughby, Anna; Davis, Andrew K.			Fighting while Parasitized: Can Nematode Infections Affect the Outcome of Staged Combat in Beetles?	PLOS ONE			English	Article							DISJUNCTUS ILLIGER COLEOPTERA; HEMOLYMPH COMPOSITION; SEXUAL SELECTION; BEHAVIOR; HOST; REPRODUCTION; POPULATION; AGGRESSION; DIMORPHISM; DYNAMICS	The effects of non-lethal parasites may be felt most strongly when hosts engage in intense, energy-demanding behaviors. One such behavior is fighting with conspecifics, which is common among territorial animals, including many beetle species. We examined the effects of parasites on the fighting ability of a saproxylic beetle, the horned passalus (Odontotaenius disjunctus, Family: Passalidae), which is host to a non-lethal nematode, Chondronema passali. We pitted pairs of randomly-chosen (but equally-weighted) beetles against each other in a small arena and determined the winner and aggression level of fights. Then we examined beetles for the presence, and severity of nematode infections. There was a nonsignificant tendency (p = 0.065) for the frequency of wins, losses and draws to differ between beetles with and without C. passali; non-parasitized individuals (n = 104) won 47% of their fights while those with the parasite (n = 88) won 34%, a 13% difference in wins. The number of nematodes in a beetle affected the outcome of fights between infected and uninfected individuals in an unexpected fashion: fighting ability was lowest in beetles with the lowest (p = 0.033), not highest (p = 0.266), nematode burdens. Within-fight aggression was highest when both beetles were uninfected and lowest when both were infected (p = 0.034). Collectively, these results suggest the nematode parasite, C. passali, is associated with a modest reduction in fighting ability in horned passalus beetles, consistent with the idea that parasitized beetles have lower energy available for fighting. This study adds to a small but growing body of evidence showing how parasites negatively influence fighting behavior in animals.	[Vasquez, David] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Willoughby, Anna] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Davis, Andrew K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	Virginia Polytechnic Institute & State University; Duke University; University System of Georgia; University of Georgia	Davis, AK (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	akdavis@uga.edu		Willoughby, Anna/0000-0002-0504-0605	National Science Foundation [DBI-1156707]; University of Georgia; Div Of Biological Infrastructure [1156707] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Georgia; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted as a part of the Population Biology of Infectious Diseases REU Site, a program funded by the National Science Foundation (Grant #DBI-1156707) and the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, J INSECT PHYSIOL, V41, P269, DOI 10.1016/0022-1910(94)00095-X; Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Benowitz Kyle M., 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1; Benowitz KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042738; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Broussard DR, 2003, J ANIM ECOL, V72, P212, DOI 10.1046/j.1365-2656.2003.00691.x; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; Christie J. R., 1931, Journal of the Washington Academy of Sciences, V21, P356; Cox D, 2013, COLEOPTS BULL, V67, P179, DOI 10.1649/0010-065X-67.2.179; Cremer S, 1998, ETHOLOGY, V104, P1, DOI 10.1111/j.1439-0310.1998.tb00025.x; Davis AK, 2013, J ENTOMOL SCI, V48, P1; Davis AK, 2014, J INSECT BEHAV, V27, P496, DOI 10.1007/s10905-014-9444-6; Davis AK, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.10701; Eberhard, 1978, PSYCHE, V83, P292; Eoff M, 1968, P OKLA ACAD SCI, V48, P29; GRAY IE, 1946, AM MIDL NAT, V35, P728, DOI 10.2307/2421554; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HAMILTON WJ, 1995, J FISH BIOL, V47, P302, DOI 10.1111/j.1095-8649.1995.tb01897.x; Holmstad PR, 2005, OIKOS, V111, P377, DOI 10.1111/j.0030-1299.2005.13640.x; Huang F, 2008, INSECT SCI, V15, P237, DOI 10.1111/j.1744-7917.2008.00206.x; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Inoue A, 2013, J ETHOL, V31, P55, DOI 10.1007/s10164-012-0350-0; Karino K, 2005, J INSECT BEHAV, V18, P805, DOI 10.1007/s10905-005-8741-5; King A, 2007, J INSECT BEHAV, V20, P527, DOI 10.1007/s10905-007-9094-z; Kolluru GR, 2011, BEHAV PROCESS, V88, P184, DOI 10.1016/j.beproc.2011.09.004; Kruse KC, 2007, J INSECT SCI, V7; Lee VE, 2014, BEHAV ECOL, V25, P172, DOI 10.1093/beheco/art101; Maksimowich DS, 2000, ETHOLOGY, V106, P319, DOI 10.1046/j.1439-0310.2000.00526.x; Mikheev VN, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-17; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; MULLEN V T, 1973, Journal of the Georgia Entomological Society, V8, P115; NICKLE WR, 1969, P HELM SOC WASH, V36, P190; Okada K, 2004, ANN ENTOMOL SOC AM, V97, P1342, DOI 10.1603/0013-8746(2004)097[1342:SDIMAM]2.0.CO;2; PALMER TJ, 1978, NATURE, V274, P583, DOI 10.1038/274583a0; Pearse A. S., 1936, Ecological Monographs, V6, P455; REINERT J A, 1973, Florida Entomologist, V56, P273, DOI 10.2307/3493803; SCHMIDT SP, 1980, J INVERTEBR PATHOL, V36, P240, DOI 10.1016/0022-2011(80)90030-0; Schutz D, 2011, ETHOLOGY, V117, P1101, DOI 10.1111/j.1439-0310.2011.01965.x; Schuster J, 1975, THESIS U FLORIDA; THOMPSON SN, 1982, COMP BIOCHEM PHYS B, V72, P233, DOI 10.1016/0305-0491(82)90040-2; THONG CHS, 1975, J INVERTEBR PATHOL, V26, P91, DOI 10.1016/0022-2011(75)90173-1; Tierney AJ, 2013, BEHAV PROCESS, V99, P47, DOI 10.1016/j.beproc.2013.06.001; Tsai YJJ, 2014, ANIM BEHAV, V91, P151, DOI 10.1016/j.anbehav.2014.03.010; Valenzuela-Gonzalez J., 1986, FOLIA ENTOMOL MEX, V70, P53; Wicknick JA, 2009, COLEOPTS BULL, V63, P108, DOI 10.1649/0010-065X-63.1.108	45	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121614	10.1371/journal.pone.0121614	http://dx.doi.org/10.1371/journal.pone.0121614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830367	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600077
J	Choi, L; Blume, JD; Dupont, WD				Choi, Leena; Blume, Jeffrey D.; Dupont, William D.			Elucidating the Foundations of Statistical Inference with 2 x 2 Tables	PLOS ONE			English	Article							YATES CONTINUITY CORRECTION; FISHER EXACT TEST; MARGINAL TOTALS; LIKELIHOOD METHODS; CONDITIONAL TESTS; DISPRAISE; INFORMATION; PROBABILITY; EQUALITY; REASONS	To many, the foundations of statistical inference are cryptic and irrelevant to routine statistical practice. The analysis of 2 x 2 contingency tables, omnipresent in the scientific literature, is a case in point. Fisher's exact test is routinely used even though it has been fraught with controversy for over 70 years. The problem, not widely acknowledged, is that several different p-values can be associated with a single table, making scientific inference inconsistent. The root cause of this controversy lies in the table's origins and the manner in which nuisance parameters are eliminated. However, fundamental statistical principles (e.g., sufficiency, ancillarity, conditionality, and likelihood) can shed light on the controversy and guide our approach in using this test. In this paper, we use these fundamental principles to show how much information is lost when the tables origins are ignored and when various approaches are used to eliminate unknown nuisance parameters. We present novel likelihood contours to aid in the visualization of information loss and show that the information loss is often virtually non-existent. We find that problems arising from the discreteness of the sample space are exacerbated by p-value-based inference. Accordingly, methods that are less sensitive to this discreteness - likelihood ratios, posterior probabilities and mid-p-values lead to more consistent inferences.	[Choi, Leena; Blume, Jeffrey D.; Dupont, William D.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37235 USA	Vanderbilt University	Choi, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA.	leena.choi@vanderbilt.edu			NIH [AG034412]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Brian S. Caffo, Frank E. Harrell, Jr., Bryan Shepherd, the editor and reviewers for their helpful suggestions. This work was supported in part by NIH grant AG034412.	Agresti A, 2003, STAT METHODS MED RES, V12, P3, DOI 10.1191/0962280203sm311ra; Agresti A, 2001, STAT MED, V20, P2709, DOI 10.1002/sim.738; [Anonymous], 2012, CATEGORICAL DATA ANA; [Anonymous], 1965, LOGIC STAT INFERENCE; [Anonymous], 2000, LIKELIHOOD METHODS S; BARNARD GA, 1949, J ROY STAT SOC B, V11, P115; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; BARNARD GA, 1979, J STAT PLAN INFER, V3, P181, DOI 10.1016/0378-3758(79)90009-0; Barndorff-Nielsen O. E., 1987, J R STAT SOC B, V49, P18; BARNDORFFNIELSEN O, 1983, BIOMETRIKA, V70, P343; BASU D, 1979, J STAT PLAN INFER, V3, P189, DOI 10.1016/0378-3758(79)90010-7; Berger JO, 1999, STAT SCI, V14, P1; BERKSON J, 1978, J STAT PLAN INFER, V2, P27, DOI 10.1016/0378-3758(78)90019-8; BIRNBAUM A, 1962, J AM STAT ASSOC, V57, P269, DOI 10.2307/2281640; Blume J, 2003, J AM ASSOC GYN LAP, V10, P439, DOI 10.1016/S1074-3804(05)60143-0; Blume JD, 2002, STAT MED, V21, P2563, DOI 10.1002/sim.1216; Blume JD, 2011, HBK PHILOS SCI, V7, P493; Brazzale A. R., 2007, APPL ASYMPTOTICS CAS; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Casella G., 2002, STAT INFERENCE, V2nd; Choi L, 2008, STAT MED, V27, P4874, DOI 10.1002/sim.3334; CHOI Leena, 2011, PROFILE LIKELIHOOD P; CONOVER WJ, 1974, J AM STAT ASSOC, V69, P374, DOI 10.2307/2285661; CORMACK RS, 1991, J ROY STAT SOC D-STA, V40, P27; CORNFIELD J, 1966, AM STAT, V20, P18, DOI 10.2307/2682711; CORSTEN LCA, 1979, J STAT PLAN INFER, V3, P193, DOI 10.1016/0378-3758(79)90011-9; COX D, 2000, THEORETICAL STAT; COX DR, 1958, ANN MATH STAT, V29, P357, DOI 10.1214/aoms/1177706618; COX DR, 1987, J ROY STAT SOC B MET, V49, P1; Cox DR, 1984, J R STATIST SOC A, V147, P451; DAGOSTINO RB, 1988, AM STAT, V42, P198, DOI 10.2307/2685002; DUPONT WD, 1986, STAT MED, V5, P629, DOI 10.1002/sim.4780050610; EVANS MJ, 1986, CAN J STAT, V14, P181, DOI 10.2307/3314794; Fraser DAS, 2003, BIOMETRIKA, V90, P327, DOI 10.1093/biomet/90.2.327; FRASER DAS, 1989, BIOMETRIKA, V76, P477, DOI 10.1093/biomet/76.3.477; GONG G, 1981, ANN STAT, V9, P861, DOI 10.1214/aos/1176345526; GOODMAN SN, 1993, AM J EPIDEMIOL, V137, P485, DOI 10.1093/oxfordjournals.aje.a116700; GREENLAND S, 1991, AM STAT, V45, P248, DOI 10.2307/2684304; GRIZZLE JE, 1967, AM STAT, V21, P28, DOI 10.2307/2682103; HABER M, 1989, COMMUN STAT THEORY, V18, P147, DOI 10.1080/03610928908829889; HAVILAND MG, 1990, STAT MED, V9, P363, DOI 10.1002/sim.4780090403; Howard JV, 1998, STAT SCI, V13, P351; KALBFLEISH JD, 1973, SANKHYA SER A, V35, P311; KEMPTHORNE O, 1979, J STAT PLAN INFER, V3, P199, DOI 10.1016/0378-3758(79)90012-0; LANCASTER HO, 1952, BIOMETRIKA, V39, P419, DOI 10.2307/2334035; LITTLE RJA, 1989, AM STAT, V43, P283, DOI 10.2307/2685390; MCCULLAGH P, 1990, J ROY STAT SOC B MET, V52, P325; McCullagh P., 1999, GEN LINEAR MODELS; PEARSON ES, 1947, BIOMETRIKA, V34, P139, DOI 10.1093/biomet/34.1-2.139; PLACKETT RL, 1964, BIOMETRIKA, V51, P327, DOI 10.1093/biomet/51.3-4.327; PLACKETT RL, 1977, BIOMETRIKA, V64, P37, DOI 10.1093/biomet/64.1.37; Reid N, 1995, STAT SCI, V10, P138, DOI 10.1214/ss/1177010027; Rothman KJe, 1998, MODERN EPIDEMIOLOGY; Royall R., 1997, STAT EVIDENCE LIKELI; Sartori N, 2003, J STAT PLAN INFER, V110, P1, DOI 10.1016/S0378-3758(01)00290-7; Severini TA, 1998, BIOMETRIKA, V85, P507, DOI 10.1093/biomet/85.3.507; Staicu AM, 2008, CAN J STAT, V36, P613, DOI 10.1002/cjs.5550360408; STARMER CF, 1974, J AM STAT ASSOC, V69, P376, DOI 10.2307/2285662; STONE M, 1969, BIOMETRIKA, V56, P485, DOI 10.2307/2334654; TOCHER KD, 1950, BIOMETRIKA, V37, P130, DOI 10.2307/2332156; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; ZHU YL, 1994, CAN J STAT, V22, P111, DOI 10.2307/3315827	65	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121263	10.1371/journal.pone.0121263	http://dx.doi.org/10.1371/journal.pone.0121263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849515	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800052
J	Hsu, WH; Chang, CC; Huang, KW; Chen, YC; Hsu, SL; Wu, LC; Tsou, AP; Lai, JM; Huang, CYF				Hsu, Wei-Hsiang; Chang, Chia-Chuan; Huang, Kai-Wen; Chen, Yi-Chen; Hsu, Shih-Lan; Wu, Li-Chen; Tsou, Ann-Ping; Lai, Jin-Mei; Huang, Chi-Ying F.			Evaluation of the Medicinal Herb Graptopetalum paraguayense as a Treatment for Liver Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; WALTHER,E. EXTRACTS; SIGNALING PATHWAYS; OXIDATIVE STRESS; HEPATOMA-CELLS; TUMOR-GROWTH; AURORA-A; APOPTOSIS; SORAFENIB; PTEN	Background Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third most common cause of cancer-related death worldwide. Sorafenib is the only drug for patients with advanced-stage hepatocellular carcinoma (HCC) that has been shown to confer a survival benefit to patients with HCC; however, it has many side effects. Thus, alternate therapeutic strategies with improved safety and therapeutic efficacy for the management of HCC should be developed. Methods and Findings We demonstrate that an extract of Graptopetalum paraguayense (GP) down-regulated the expression levels of several onco-proteins, including AURKA, AURKB, and FLJ10540, in HCC cells. To isolate the active components in the GP extracts, we prepared extracts fractions and assessed their effects on the expression of onco-proteins in HCC cells. The fraction designated HH-F3 was enriched in active ingredients, exhibited cytotoxic effects, and suppressed the expression of the onco-proteins in HCC cells. The structure of the main active compound in HH-F3 was found to be similar to that of the proanthocyanidin compounds derived from Rhodiola rosea. In addition, a distinct new compound rich in 3, 4, 5-trihydroxy benzylic moieties was identified in the HH-F3 preparations. Mechanistic studies indicated that HH-F3 induced apoptosis in HCC cells by promoting the loss of mitochondrial membrane potential and the production of reactive oxygen species. HH-F3 also enhanced PTEN expression and decreased AKT phosphorylation at Ser473 in a concentration-dependent manner in HCC cells. Moreover combination of GP or HH-F3 and sorafenib synergistically inhibits the proliferation of Huh7 cells. The treatment of a rat model with diethylnitrosamine DEN)-induced liver cancer with extracts of GP and HH-F3 decreased hepatic collagen contents and inhibited tumor growth. Conclusions These results indicate that GP extracts and HH-F3 can protect the liver by suppressing tumor growth; consequently, these compounds could be considered for the treatment of HCC.	[Hsu, Wei-Hsiang; Chen, Yi-Chen; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Chang, Chia-Chuan] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ, Dept Surg, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei 10764, Taiwan; [Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Wu, Li-Chen] Natl Chi Nan Univ, Dept Appl Chem, Puli, Nantou, Taiwan; [Wu, Li-Chen] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Puli, Nantou, Taiwan; [Tsou, Ann-Ping; Huang, Chi-Ying F.] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taichung Veterans General Hospital; National Chi Nan University; National Chi Nan University; National Yang Ming Chiao Tung University; Fu Jen Catholic University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	cyhuang5@ym.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022; Chang, Chia-Chuan/A-5518-2009	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Chang, Chia-Chuan/0000-0002-1297-9602; HUANG, KAI-WEN/0000-0001-6375-8714	Taiwan National Science Council [NSC102-2627-B-010-001-, MOST103-2627-B-010-001-, MOST103-2627-B-030-001-]; Taiwan Ministry of Economic Affairs [99-EC-17- A-S1-152, 100-EC-17-A-S1-152, 101-EC-17-A-S1-152]; Ministry of Education, Aim for the Top University Plan [103AC-T503]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Economic Affairs(Ministry of Economic Affairs, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by the Taiwan National Science Council under grant numbers NSC102-2627-B-010-001-, MOST103-2627-B-010-001-, and MOST103-2627-B-030-001-; the Taiwan Ministry of Economic Affairs grant numbers 99-EC-17- A-S1-152, 100-EC-17-A-S1-152, and 101-EC-17-A-S1-152); and by a grant from the Ministry of Education, Aim for the Top University Plan (103AC-T503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen SJ, 2008, AM J CHINESE MED, V36, P369, DOI 10.1142/S0192415X08005837; Chen SJ, 2007, FOOD CHEM, V100, P1032, DOI 10.1016/j.foodchem.2005.10.053; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chung YC, 2005, FOOD CHEM, V91, P419, DOI 10.1016/j.foodchem.2004.06.022; Croswell JM, 2009, J HEPATOL, V50, P817, DOI 10.1016/j.jhep.2009.01.005; Duh PD, 2011, J ETHNOPHARMACOL, V134, P379, DOI 10.1016/j.jep.2010.12.029; Dulundu E, 2007, J GASTROEN HEPATOL, V22, P885, DOI 10.1111/j.1440-1746.2007.04875.x; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; Ha KT, 2004, PHARMACOL RES, V50, P279, DOI 10.1016/j.phrs.2004.02.006; Hata T, 2005, CANCER RES, V65, P2899, DOI 10.1158/0008-5472.CAN-04-3981; He W, 2013, AM J TRANSL RES, V5, P359; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Huang KW, 2008, MOL THER, V16, P1681, DOI 10.1038/mt.2008.160; Huang KF, 2005, FOOD CHEM, V89, P583, DOI 10.1016/j.foodchem.2004.03.022; Jacotot E, 2006, BBA-BIOENERGETICS, V1757, P1312, DOI 10.1016/j.bbabio.2006.07.002; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Juan YC, 2011, J ETHNOPHARMACOL, V137, P592, DOI 10.1016/j.jep.2011.06.007; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kwon YW, 2012, MOL CANCER RES, V10, P834, DOI 10.1158/1541-7786.MCR-12-0025; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Long M, 2012, CANCER GENE THER, V19, P271, DOI 10.1038/cgt.2011.89; Muntane J, ANTICANCER AGENTS ME, V11, P576; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Neuwirt H, 2008, PROSTATE, V68, P1647, DOI 10.1002/pros.20829; Paquet P, 2007, INT J MOL MED, V19, P3; Peyrou M, 2010, WORLD J GASTROENTERO, V16, P4627, DOI 10.3748/wjg.v16.i37.4627; Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326; Ray SD, 2005, MUTAT RES-FUND MOL M, V579, P81, DOI 10.1016/j.mrfmmm.2005.02.017; Shi DY, 2008, FEBS LETT, V582, P1667, DOI 10.1016/j.febslet.2008.04.021; Shin MO, 2010, ARCH PHARM RES, V33, P167, DOI 10.1007/s12272-010-2239-1; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Su LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053988; Su LJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/256561; Suchankova G, VNITR LEK, V57, P485; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tsuchiya M, 2008, INT J CANCER, V123, P2503, DOI 10.1002/ijc.23828; van Malenstein H, 2011, EUR J CANCER, V47, P1789, DOI 10.1016/j.ejca.2011.04.027; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Vullierme MP, 2010, J VISC SURG, V147, pE1, DOI 10.1016/j.jviscsurg.2010.02.003; Wang ZQ, 2010, J CELL PHYSIOL, V224, P559, DOI 10.1002/jcp.22160; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wu JJ, 2013, INT J ONCOL, V43, P1643, DOI 10.3892/ijo.2013.2085; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015; Zucman-Rossi J, 2010, DIGEST LIVER DIS, V42, pS235, DOI 10.1016/S1590-8658(10)60511-7	52	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121298	10.1371/journal.pone.0121298	http://dx.doi.org/10.1371/journal.pone.0121298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849560	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800053
J	Ibinda, F; Bauni, E; Kariuki, SM; Fegan, G; Lewa, J; Mwikamba, M; Boga, M; Odhiambo, R; Mwagandi, K; Seale, AC; Berkley, JA; Dorfman, JR; Newton, CRJC				Ibinda, Fredrick; Bauni, Evasius; Kariuki, Symon M.; Fegan, Greg; Lewa, Joy; Mwikamba, Monica; Boga, Mwanamvua; Odhiambo, Rachael; Mwagandi, Kiponda; Seale, Anna C.; Berkley, James A.; Dorfman, Jeffrey R.; Newton, Charles R. J. C.			Incidence and Risk Factors for Neonatal Tetanus in Admissions to Kilifi County Hospital, Kenya	PLOS ONE			English	Article							MATERNAL HIV-INFECTION; PLACENTAL MALARIA; ANTIBODY TRANSFER; MORTALITY; IMMUNOGLOBULIN; IMMUNITY; NIGERIA	Background Neonatal Tetanus (NT) is a preventable cause of mortality and neurological sequelae that occurs at higher incidence in resource-poor countries, presumably because of low maternal immunisation rates and unhygienic cord care practices. We aimed to determine changes in the incidence of NT, characterize and investigate the associated risk factors and mortality in a prospective cohort study including all admissions over a 15-year period at a County hospital on the Kenyan coast, a region with relatively high historical NT rates within Kenya. Methods We assessed all neonatal admissions to Kilifi County Hospital in Kenya (1999-2013) and identified cases of NT (standard clinical case definition) admitted during this time. Poisson regression was used to examine change in incidence of NT using accurate denominator data from an area of active demographic surveillance. Logistic regression was used to investigate the risk factors for NT and factors associated with mortality in NT amongst were tested for anti-tetanus antibodies. Results There were 191 NT admissions, of whom 187 (98%) were home deliveries. Incidence of NT declined significantly (Incidence Rate Ratio: 0.85 (95% Confidence interval 0.81-0.89), P < 0.001) but the case fatality (62%) did not change over the study period (P = 0.536). Younger infant age at admission (P = 0.001) was the only independent predictor of mortality. Compared to neonatal hospital admittee controls, the proportion of home births was higher among the cases. Sera tested for antitetanus antibodies showed most mothers (50/61, 82%) had undetectable levels of antitetanus antibodies, and most (8/9, 89%) mothers with detectable antibodies had a neonate without protective levels. Conclusions Incidence of NT in Kilifi County has significantly reduced, with reductions following immunisation campaigns. Our results suggest immunisation efforts are effective if sustained and efforts should continue to expand coverage.	[Ibinda, Fredrick; Bauni, Evasius; Kariuki, Symon M.; Fegan, Greg; Lewa, Joy; Mwikamba, Monica; Boga, Mwanamvua; Odhiambo, Rachael; Mwagandi, Kiponda; Seale, Anna C.; Berkley, James A.; Newton, Charles R. J. C.] Ctr Geog Med Res Coast, KEMRI, Wellcome Trust Res Programme, Kilifi, Kenya; [Fegan, Greg; Seale, Anna C.; Berkley, James A.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England; [Dorfman, Jeffrey R.] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Dorfman, Jeffrey R.] Univ Cape Town, Div Immunol, ZA-7925 Cape Town, South Africa; [Newton, Charles R. J. C.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Oxford	Ibinda, F (corresponding author), Ctr Geog Med Res Coast, KEMRI, Wellcome Trust Res Programme, Kilifi, Kenya.	fibinda@.kemri-wellcome.org	Newton, Charles RJC/B-7578-2014; Dorfman, Jeffrey R/B-4854-2011; Fegan, Greg W/O-8079-2018; Dorfman, Jeffrey R/M-4218-2017; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Dorfman, Jeffrey R/0000-0001-9938-8911; Fegan, Greg W/0000-0002-2663-2765; Newton, Charles/0000-0002-6999-5507; Seale, Anna/0000-0002-0129-3146	Wellcome Trust [083744, 099782, 101140, 083579]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Wellcome Trust Senior Clinical Fellowship to Professor Charles Newton (No. 083744). Symon Kariuki was supported by the Wellcome Trust training fellowship (099782), Fredrick Ibinda by the Wellcome Trust masters training fellowship (101140), and James Berkley by the Wellcome Trust intermediate clinical fellowship (083579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MAT NEON TET MNT EL; [Anonymous], 1993, IMMUNOLOGICAL BASIS; BAGCCHI S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F5808; Barlow JL, 2001, TROP MED INT HEALTH, V6, P305, DOI 10.1046/j.1365-3156.2001.00705.x; Beltran A, 2007, SOUTH MED J, V100, P83, DOI 10.1097/SMJ.0b013e31802e2717; BJERREGAARD P, 1993, INT J EPIDEMIOL, V22, P163, DOI 10.1093/ije/22.1.163; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Borrow R, 2006, IMMUNIZATION VACCINE; BRAIR ME, 1994, LANCET, V343, P208, DOI 10.1016/S0140-6736(94)90991-1; CRONE NE, 1992, NEUROLOGY, V42, P761, DOI 10.1212/WNL.42.4.761; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Dey A C, 2011, Mymensingh Med J, V20, P54; Dietz V, 1996, B WORLD HEALTH ORGAN, V74, P619; El Arifeen S, 2012, LANCET, V379, P1022, DOI 10.1016/S0140-6736(11)61848-5; Fetuga BM, 2010, WORLD J PEDIATR, V6, P71, DOI 10.1007/s12519-010-0010-9; Galazka A. M., 1998, THERMOSTABILITY VACC; HLADY WG, 1992, AM J PUBLIC HEALTH, V82, P1365, DOI 10.2105/AJPH.82.10.1365; Jacobsen Geir W, 2011, Tidsskr Nor Laegeforen, V131, P701, DOI 10.4045/tidsskr.10.1023; Kenya National Bureau of statistics, 2010, KEN DEM HLTH SURV 20; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liu L.L., 2005, P AS PAC MICR C SUZH, VVol. 4, DOI DOI 10.1177/105122840528286416385023; Lum S H, 2009, Med J Malaysia, V64, P80; Maitha E, 2009, P 26 IUSSP INT POP C; Mwaniki Michael K, 2010, BMC Public Health, V10, P591, DOI 10.1186/1471-2458-10-591; Naik Ashish K, 2013, Int J Prev Med, V4, P1395; Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808; Onalo R, 2011, J INFECT DEV COUNTR, V5, P255, DOI 10.3855/jidc.1666; Poudel P, 2008, Nepal Med Coll J, V10, P170; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; SESARDIC D, 1993, BIOLOGICALS, V21, P67, DOI 10.1006/biol.1993.1048; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; SOKAL DC, 1988, B WORLD HEALTH ORGAN, V66, P69; Soofi S, 2012, LANCET, V379, P1029, DOI 10.1016/S0140-6736(11)61877-1; STANFIELD JP, 1984, B WORLD HEALTH ORGAN, V62, P647; Taylor AM, 2006, BJA EDUC, V6, P101, DOI 10.1093/bjaceaccp/mkl014; Thwaites CL, 2014, LANCET; UNICEF WHO UNFPA., 2000, MAT NEON TET EL 2005; WHO, 2006, WEEKL EP REC, P197	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122606	10.1371/journal.pone.0122606	http://dx.doi.org/10.1371/journal.pone.0122606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849440	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000352477800147
J	Jin, SS; Chang, CQ; Zhang, LT; Liu, Y; Huang, XR; Chen, ZM				Jin, Shasha; Chang, Cuiqing; Zhang, Lantao; Liu, Yang; Huang, Xianren; Chen, Zhimin			Chlorogenic Acid Improves Late Diabetes through Adiponectin Receptor Signaling Pathways in db/db Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR-BETA; COFFEE CONSUMPTION; DECAFFEINATED COFFEE; GLUT4 TRANSLOCATION; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; LONG-TERM; METABOLISM; RISK	The aim of this study was to examine the effects of chlorogenic acid (CGA) on glucose and lipid metabolism in late diabetic db/db mice, as well as on adiponectin receptors and their signaling molecules, to provide evidence for CGA in the prevention of type 2 diabetes. We randomly divided 16 female db/db mice into db/db-CGA and db/db-control (CON) groups equally; db/m mice were used as control mice. The mice in both the db/db-CGA and db/m-CGA groups were administered 80 mg/kg/d CGA by lavage for 12 weeks, whereas the mice in both CON groups were given equal volumes of phosphate-buffered saline (PBS) by lavage. At the end of the intervention, we assessed body fat and the parameters of glucose and lipid metabolism in the plasma, liver and skeletal muscle tissues as well as the levels of aldose reductase (AR) and transforming growth factor-beta 1 (TGF-beta 1) in the kidneys and measured adiponectin receptors and the protein expression of their signaling molecules in liver and muscle tissues. After 12 weeks of intervention, compared with the db/db-CON group, the percentage of body fat, fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) in the db/db-CGA group were all significantly decreased; TGF-beta 1 protein expression and AR activity in the kidney were both decreased; and the adiponectin level in visceral adipose was increased. The protein expression of adiponectin receptors (ADPNRs), the phosphorylation of AMP-activated protein kinase (AMPK) in the liver and muscle, and the mRNA and protein levels of peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the liver were all significantly greater. CGA could lower the levels of fasting plasma glucose and HbA1c during late diabetes and improve kidney fibrosis to some extent through the modulation of adiponectin receptor signaling pathways in db/db mice.	[Jin, Shasha; Chang, Cuiqing; Zhang, Lantao; Liu, Yang; Huang, Xianren; Chen, Zhimin] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China	Peking University	Chang, CQ (corresponding author), Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China.	changcuiqing@126.com			National Natural Sciences Foundation of China [30872112]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Natural Sciences Foundation of China (30872112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidov M, 2006, Georgian Med News, P66; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444; Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Chen XL, 2008, METABOLISM, V57, P1516, DOI 10.1016/j.metabol.2008.06.005; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; CHOI ME, 1993, KIDNEY INT, V44, P948, DOI 10.1038/ki.1993.336; de Oliveira RB, 2011, J ETHNOPHARMACOL, V133, P434, DOI 10.1016/j.jep.2010.10.019; de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0; Herrera-Arellano A, 2004, PHYTOMEDICINE, V11, P561, DOI 10.1016/j.phymed.2004.01.006; Hosch SE, 2006, CELL METAB, V4, P5, DOI 10.1016/j.cmet.2006.06.003; Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5; Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23; Kawano Y, 2013, OBES SURG, V23, P1947, DOI 10.1007/s11695-013-1035-7; Kim CS, 2011, ARCH PHARM RES, V34, P847, DOI 10.1007/s12272-011-0519-z; Kim YS, 2011, BIOL PHARM BULL, V34, P925, DOI 10.1248/bpb.34.925; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lafontan M, 2008, DIABETES METAB, V34, P317, DOI 10.1016/j.diabet.2008.04.001; Li BQ, 2010, DRUG CHEM TOXICOL, V33, P415, DOI 10.3109/01480540903580055; Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9; LIKE AA, 1972, AM J PATHOL, V66, P193; Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x; Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10; Olthof MR, 2001, AM J CLIN NUTR, V73, P532; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311; Peters KE, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-15; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620; TOMLINSON DR, 1994, TRENDS PHARMACOL SCI, V15, P293, DOI 10.1016/0165-6147(94)90010-8; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207; VANDERJAGT DL, 1990, J BIOL CHEM, V265, P20982; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952; Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang Lan-tao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; 郭晓红, 2010, [生理科学进展, Progress in Physiological Sciences], V41, P471	47	69	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120842	10.1371/journal.pone.0120842	http://dx.doi.org/10.1371/journal.pone.0120842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849026	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800035
J	Lai, CL; Wu, CF; Kuo, RNC; Yang, YY; Chen, MF; Chan, KA; Lai, MS				Lai, Chao-Lun; Wu, Ching-Fen; Kuo, Raymond Nien-Chen; Yang, Yen-Yun; Chen, Ming-Fong; Chan, K. Arnold; Lai, Mei-Shu			Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database	PLOS ONE			English	Article							BARE-METAL STENTS; RANDOMIZED-TRIALS; TAIWAN SOCIETY; FOLLOW-UP; SCANDINAVIAN ORGANIZATION; BALLOON ANGIOPLASTY; CARDIOLOGY TSOC; 2012 GUIDELINES; EFFICACY; SAFETY	The clinical outcomes of different limus-based drug-eluting stents (DES) in a real-world setting have not been well defined. The aim of this study was to investigate the clinical outcomes of three different limus-based DES, namely sirolimus-eluting stent (SES), Endeavor zotarolimus-eluting stent (E-ZES) and everolimus-eluting stent (EES), using a national insurance claims database. We identified all patients who received implantation of single SES, E-ZES or EES between January 1, 2007 and December 31, 2009 from the National Health Insurance claims database, Taiwan. Follow-up was through December 31, 2011 for all selected clinical outcomes. The primary end-point was all-cause mortality. Secondary end-points included acute coronary events, heart failure needing hospitalization, and cerebrovascular disease. Cox regression model adjusting for baseline characteristics was used to compare the relative risks of different outcomes among the three different limus-based DES. Totally, 6584 patients were evaluated (n=2142 for SES, n=3445 for E-ZES, and n=997 for EES). After adjusting for baseline characteristics, we found no statistically significant difference in the risk of all-cause mortality in three DES groups (adjusted hazard ratio [HR]: 1.14, 95% confidence interval [CI]: 0.94-1.38, p=0.20 in E-ZES group compared with SES group; adjusted HR: 0.77, 95% CI: 0.54-1.10, p=0.15 in EES group compared with SES group). Similarly, we found no difference in the three stent groups in risks of acute coronary events, heart failure needing hospitalization, and cerebrovascular disease. In conclusion, we observed no difference in all-cause mortality, acute coronary events, heart failure needing hospitalization, and cerebrovascular disease in patients treated with SES, E-ZES, and EES in a real-world population-based setting in Taiwan.	[Lai, Chao-Lun] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lai, Chao-Lun] Natl Taiwan Univ Hosp, Hsin Chu Branch, Ctr Crit Care Med, Hsinchu, Taiwan; [Lai, Chao-Lun] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Lai, Chao-Lun; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wu, Ching-Fen] Mennonite Christian Hosp, Dept Internal Med, Hualien, Taiwan; [Kuo, Raymond Nien-Chen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Kuo, Raymond Nien-Chen; Yang, Yen-Yun; Lai, Mei-Shu] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Ctr Comparat Effectiveness Res, Taipei, Taiwan; [Chen, Ming-Fong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lai, MS (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	mslai@ntu.edu.tw	Chen, Ming/GVU-8412-2022; Kuo, Raymond N./N-2558-2018	Kuo, Raymond N./0000-0003-4980-853X; Chan, Kinwei/0000-0001-8161-1986; Lai, Chao-Lun/0000-0002-0362-245X; Lai, Mei-shu/0000-0001-6130-3468	Science and Technology Unit, Ministry of Health and Welfare, Executive Yuan, Taiwan [DOH101-TD-B-111-001, DOH102-TD-B-111-001]	Science and Technology Unit, Ministry of Health and Welfare, Executive Yuan, Taiwan	This study was supported by grants from the Science and Technology Unit, Ministry of Health and Welfare, Executive Yuan, Taiwan (DOH101-TD-B-111-001 and DOH102-TD-B-111-001). The funding agency did not have any input in study design, data analysis, and interpretation of findings, or in the decision to submit the manuscript for publication.	Caixeta A, 2009, J AM COLL CARDIOL, V54, P894, DOI 10.1016/j.jacc.2009.04.077; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Cassese S, 2011, INT J CARDIOL, V150, P84, DOI 10.1016/j.ijcard.2011.01.015; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Fu HH, 2004, HEALTH POLICY, V70, P185, DOI 10.1016/j.healthpol.2004.02.006; Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007; Hofma SH, 2012, J AM COLL CARDIOL, V60, P381, DOI 10.1016/j.jacc.2012.01.073; Jensen LO, 2012, J AM COLL CARDIOL, V60, P1140, DOI 10.1016/j.jacc.2012.07.004; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Kaltoft A, 2009, J AM COLL CARDIOL, V53, P658, DOI 10.1016/j.jacc.2008.09.058; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Leon MB, 2010, JACC-CARDIOVASC INTE, V3, P1043, DOI 10.1016/j.jcin.2010.07.008; Li YH, 2012, ACTA CARDIOL SIN, V28, P63; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; Maeng M, 2012, JACC-CARDIOVASC INTE, V5, P812, DOI 10.1016/j.jcin.2012.04.008; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park KW, 2013, AM HEART J, V165, P241, DOI 10.1016/j.ahj.2012.08.007; Park KW, 2011, J AM COLL CARDIOL, V58, P1844, DOI 10.1016/j.jacc.2011.07.031; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Simsek C, 2010, CATHETER CARDIO INTE, V76, P41, DOI 10.1002/ccd.22533; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2009, CIRCULATION, V119, P680, DOI 10.1161/CIRCULATIONAHA.108.803528; Townsend JC, 2012, VASC HEALTH RISK MAN, V8, P393, DOI 10.2147/VHRM.S23388; Wang CC, 2012, ACTA CARDIOL SIN, V28, P161	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122860	10.1371/journal.pone.0122860	http://dx.doi.org/10.1371/journal.pone.0122860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848942	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800167
J	Golle, J; Probst, F; Mast, FW; Lobmaier, JS				Golle, Jessika; Probst, Fabian; Mast, Fred W.; Lobmaier, Janek S.			Preference for Cute Infants Does Not Depend on Their Ethnicity or Species: Evidence from Hypothetical Adoption and Donation Paradigms	PLOS ONE			English	Article							LOW BODY-WEIGHT; PHYSICAL ATTRACTIVENESS; BABY SCHEMA; FACIAL CUES; ADULT; PERCEPTIONS; SEX; DETERMINANTS; BEAUTIFUL; BEHOLDER	Results of previous work suggest a preference of adult observers for cute compared to less cute infants. In Study 1 we investigated whether the preference for cute infants depends on the ethnicity and species of the infant. We simultaneously presented two faces (one cute and one less cute) and asked Caucasian participants to choose the infant to whom they would rather give a toy (Task 1) and which infant they would rather adopt (Task 2). The infants were Caucasian or African human babies or dog puppies. For all face categories and in both tasks we found a strong preference for cute infants. A possible reason for preferring cute infants may be that cute infants look healthier than less cute infants. To investigate whether cuteness is associated with the assessment of health we conducted Study 2. Faces of Caucasian and African infants and dog puppies were rated for cuteness and health. The findings revealed a significant relationship between health and cuteness evaluation across all stimuli. We suggest that one reason why cute infants are preferred might be because they are perceived as being healthier.	[Golle, Jessika; Probst, Fabian; Mast, Fred W.; Lobmaier, Janek S.] Univ Bern, Dept Psychol, Bern, Switzerland; [Golle, Jessika; Probst, Fabian; Mast, Fred W.; Lobmaier, Janek S.] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland; [Golle, Jessika] Univ Tubingen, Hector Res Inst Educ Sci & Psychol, Tubingen, Germany	University of Bern; University of Bern; Eberhard Karls University of Tubingen	Lobmaier, JS (corresponding author), Univ Bern, Dept Psychol, Bern, Switzerland.	janek.lobmaier@psy.unibe.ch	Mast, Fred/B-5058-2013; Golle, Jessika/AAO-3924-2020	Mast, Fred/0000-0002-0665-4457; Lobmaier, Janek/0000-0001-8025-1616; Golle, Jessika/0000-0002-8507-7079	Swiss National Science Foundation award [PDFMP1_127238, PZ00P1_121622/1]	Swiss National Science Foundation award	Jessika Golle was supported by a grant from the Pro*Doc program of the Swiss National Science Foundation awarded to Fred W. Mast (PDFMP1_127238). Fabian Probst and Janek S. Lobmaier were supported by a grant from the Swiss National Science Foundation awarded to Janek S. Lobmaier (grant number PZ00P1_121622/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; Badr LK, 2001, INFANT BEHAV DEV, V24, P129; Bosker R, 2011, MULTILEVEL ANAL INTR; Cardenas RA, 2013, EVOL HUM BEHAV, V34, P280, DOI 10.1016/j.evolhumbehav.2013.04.001; Charles NE, 2013, EVOL HUM BEHAV, V34, P373, DOI 10.1016/j.evolhumbehav.2013.06.005; Chin SF., 2006, J CULTURAL EVOLUTION, V4, P215, DOI [10.1556/JCEP.4.2006.3-4.2, DOI 10.1556/JCEP.4.2006.3-4.2]; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; DION KK, 1974, DEV PSYCHOL, V10, P772, DOI 10.1037/h0037030; ELDER GH, 1985, CHILD DEV, V56, P361, DOI 10.2307/1129726; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Golle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058248; Hahn AC, 2013, Q J EXP PSYCHOL, V66, P200, DOI 10.1080/17470218.2012.705860; HILDEBRANDT KA, 1977, PERCEPT MOTOR SKILL, V45, P472, DOI 10.2466/pms.1977.45.2.472; HILDEBRANDT KA, 1979, INFANT BEHAV DEV, V2, P329, DOI 10.1016/S0163-6383(79)80043-0; HILDEBRANDT KA, 1978, BEHAV PROCESS, V3, P159, DOI 10.1016/0376-6357(78)90042-6; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; KARRAKER KH, 1990, BASIC APPL SOC PSYCH, V11, P371, DOI 10.1207/s15324834basp1104_2; Karraker KH, 1995, SEX ROLES, V33, P687, DOI 10.1007/BF01547725; LANGLOIS JH, 1995, DEV PSYCHOL, V31, P464, DOI 10.1037/0012-1649.31.3.464; Little AC, 2012, ETHOLOGY, V118, P775, DOI 10.1111/j.1439-0310.2012.02068.x; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Luo LZ, 2011, J EXP CHILD PSYCHOL, V110, P115, DOI 10.1016/j.jecp.2011.04.002; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; Nittono H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046362; Parsons CE, 2011, PLOS ONE, V6; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; RITTER JM, 1988, DEV PSYCHOL, V24, P254, DOI 10.1037/0012-1649.24.2.254; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; Sprengelmeyer R., 2013, PLOS ONE, V8; STEPHAN CW, 1984, CHILD DEV, V55, P576, DOI 10.2307/1129969; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Volk A, 2002, HUM NATURE-INT BIOS, V13, P437, DOI 10.1007/s12110-002-1002-9; Volk A.A., 2009, J EVOL PSYCHOL, V7, P225, DOI DOI 10.1556/JEP.7.2009.3.3; Volk AA, 2005, INFANT MENT HEALTH J, V26, P459, DOI 10.1002/imhj.20064; Volk AA., 2001, INFLUENCE INFANT FAC, P92; Volk AA, 2006, THESCIENTIFICWORLDJO, V6, P1574, DOI 10.1100/tsw.2006.261; Waller KL, 2003, HUMAN NATURE, V15, P101; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042; ZEBROWITZ LA, 1993, J PERS SOC PSYCHOL, V65, P85, DOI 10.1037/0022-3514.65.1.85	45	19	19	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121554	10.1371/journal.pone.0121554	http://dx.doi.org/10.1371/journal.pone.0121554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VA	25844526	Green Published, Green Submitted, gold			2022-12-27	WOS:000352475700008
J	Mariani, S; Di Bello, C; Bonello, L; Tondat, F; Pacchioni, D; Molinaro, L; Barreca, A; Macri, L; Chiusa, L; di Celle, PF; Cassoni, P; Sapino, A				Mariani, Sara; Di Bello, Cristiana; Bonello, Lisa; Tondat, Fabrizio; Pacchioni, Donatella; Molinaro, Luca; Barreca, Antonella; Macri, Luigia; Chiusa, Luigi; di Celle, Paola Francia; Cassoni, Paola; Sapino, Anna			Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; KRAS; EGFR; DNA; ADENOCARCINOMA; FLUOROURACIL; PANITUMUMAB; LEUCOVORIN; PERCENTAGE	The selection of proper tissues from formalin-fixed and paraffin-embedded tumors before diagnostic molecular testing is responsibility of the pathologist and represents a crucial step to produce reliable test results. The international guidelines suggest two cut-offs, one for the percentage and one for the number of tumor cells, in order to enrich the tumor content before DNA extraction. The aim of the present work was two-fold: to evaluate to what extent a low percentage or absolute number of tumor cells can be qualified for somatic mutation testing; and to determine how assay sensitivities can guide pathologists towards a better definition of morphology-based adequacy cut-offs. We tested 1797 tumor specimens from melanomas, colorectal and lung adenocarcinomas. Respectively, their BRAF, K-RAS and EGFR genes were analyzed at specific exons by mutation-enriched PCR, pyrosequencing, direct sequencing and real-time PCR methods. We demonstrate that poorly cellular specimens do not modify the frequency distribution of either mutated or wild-type DNA samples nor that of specific mutations. This observation suggests that currently recommended cutoffs for adequacy of specimens to be processed for molecular assays seem to be too much stringent in a laboratory context that performs highly sensitive routine analytical methods. In conclusion, new cut-offs are needed based on test sensitivities and documented tumor heterogeneity.	[Mariani, Sara; Barreca, Antonella; Cassoni, Paola; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Di Bello, Cristiana; Pacchioni, Donatella; Molinaro, Luca; Macri, Luigia; Chiusa, Luigi; di Celle, Paola Francia] Univ Citta Salute & Sci, Azienda Osped, Turin, Italy; [Di Bello, Cristiana; Pacchioni, Donatella; Molinaro, Luca; Macri, Luigia; Chiusa, Luigi; di Celle, Paola Francia] Presidio Osped Molinette Torino, Turin, Italy; [Bonello, Lisa; Tondat, Fabrizio] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Sapino, A (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	anna.sapino@unito.it	Sapino, Anna/AGY-9901-2022; Cassoni, Paola/I-8544-2018; Sapino, Anna/J-4113-2018	Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571; MARIANI, Sara/0000-0003-3761-3612	Lanzavecchia-Lastretti Foundation for "Progetto Melanoma"	Lanzavecchia-Lastretti Foundation for "Progetto Melanoma"	This study was supported by the Lanzavecchia-Lastretti Foundation for "Progetto Melanoma." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awada A, 2013, CURR OPIN ONCOL, V25, P296, DOI 10.1097/CCO.0b013e32835ff318; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Fuery CJ, 2000, CLIN CHEM, V46, P620; Heinzerling L, 2013, BRIT J CANCER, V109, P2833, DOI 10.1038/bjc.2013.622; Hlinkova K, 2013, DIAGN MOL PATHOL, V22, P70, DOI 10.1097/PDM.0b013e31827e6984; Jancik S, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-79; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaneda H, 2004, LUNG CANCER, V46, P247, DOI 10.1016/j.lungcan.2004.04.032; Kirkham A, 2013, FORENSIC SCI INT-GEN, V7, P92, DOI 10.1016/j.fsigen.2012.07.003; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Lewandowska MA, 2013, MOL DIAGN THER, V17, P193, DOI 10.1007/s40291-013-0025-8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Mixich F, 2007, J GASTROINTEST LIVER, V16, P5; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; RANEK L, 1976, ACTA CYTOL, V20, P151; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Smits AJJ, 2014, MODERN PATHOL, V27, P168, DOI 10.1038/modpathol.2013.134; Snedecor GW, 1980, STAT METHODS, V7th; Sun LN, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-30; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Vignot S, 2013, B CANCER, V100, P561, DOI 10.1684/bdc.2013.1767; Vucic EA, 2012, GENOME RES, V22, P188, DOI 10.1101/gr.124354.111; Yu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068022	27	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121815	10.1371/journal.pone.0121815	http://dx.doi.org/10.1371/journal.pone.0121815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844806	Green Published, Green Submitted, gold			2022-12-27	WOS:000352475700010
J	Amagloh, FK; Chiridza, T; Lemercier, ME; Broomfield, A; Morel, PCH; Coad, J				Amagloh, Francis Kweku; Chiridza, Tracy; Lemercier, Marie-Eve; Broomfield, Anne; Morel, Patrick C. H.; Coad, Jane			Sweetpotato- and Cereal-Based Infant Foods: Protein Quality Assessment, and Effect on Body Composition Using Sprague Dawley Rats as a Model	PLOS ONE			English	Article							VITAMIN-A; COMPLEMENTARY FOODS; DIGESTIBILITY; CHILDREN	The Protein Digestibility Corrected Amino Acid Score (PDCAAS) of sweetpotato-based complementary foods (OFSP ComFa and CFSP ComFa) and cereal-based infant products (Weanimix and Cerelac) was assessed using 3 wk-old male Sprague Dawley rats weighing between 53-67 g as a model for human infants. Also, the effect of consumption of the infant formulations on lean mass, bone mass content and fat mass was evaluated by Dual-Energy X-ray Absorptiometry (DEXA) using 6 wk-old Sprague Dawley rats (initial weight, 206-229 g). The ComFa products and Weanimix are household-level formulations, and Cerelac is a commercial infant cereal. The true protein digestibility score for Cerelac was 96.27%, and about 1.8% (P<0.0001) higher than that for OFSP ComFa, CFSP ComFa and Weanimix. However, OFSP ComFa had the highest un-truncated PDCAAS by a difference of 4.1%, than CFSP ComFa, and about 20% difference compared with both the Weanimix and Cerelac. All the products investigated had PDCAAS greater than 70%, the minimum protein quality requirement for complementary foods. Among the rats assigned to the four formulations, their bone mass and fat mass composition were not significantly different (P=0.08 and P=0.85, respectively). However, the rats on CFSP ComFa had higher lean mass than those on Cerelac (321.67 vs. 297.19 g; P=0.03). The findings from the PDCAAS and the DEXA-measured body composition studies indicate that complementary foods could be formulated from readily available agricultural resources at the household-level to support growth as would a nutritionally adequate industrial-manufactured infant cereal. Nonetheless, it should be noted that the findings of our studies are based on an animal model.	[Amagloh, Francis Kweku] Univ Dev Studies, Fac Agr, Dept Biotechnol, Food Proc & Technol Unit, Nyankpala, Ghana; [Chiridza, Tracy; Broomfield, Anne; Coad, Jane] Massey Univ, Coll Hlth, Te Kura Hauora Tangata, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Lemercier, Marie-Eve] Inst Polytech LaSalle Beauvais, Beauvais, France; [Morel, Patrick C. H.] Massey Univ, Inst Vet Anim & Biomed Sci, Coll Sci, Palmerston North, New Zealand	University for Development Studies; Massey University; UniLaSalle; Massey University	Coad, J (corresponding author), Massey Univ, Coll Hlth, Te Kura Hauora Tangata, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand.	J.Coad@massey.ac.nz	Amagloh, Francis Kweku/J-6219-2014	Amagloh, Francis Kweku/0000-0001-7243-0972	Nutricia Research Foundation, the Netherlands [2012-E6]	Nutricia Research Foundation, the Netherlands(Netherlands Government)	This work was supported by the Nutricia Research Foundation, the Netherlands (Project number: 2012-E6).	Agble R, 1997, SCN NEWS, P9; Amagloh FK, 2012, MATERN CHILD NUTR, V8, P512, DOI 10.1111/j.1740-8709.2011.00343.x; Amagloh FK, 2014, FOOD NUTR BULL, V35, P51, DOI 10.1177/156482651403500107; Amagloh FK, 2012, FOOD NUTR BULL, V33, P3, DOI 10.1177/156482651203300101; Amuna P., 2000, Nutrition & Food Science, P116, DOI 10.1108/00346650010319688; AOAC, 2006, OFFICIAL METHODS ANA, V18th ed.; AOAC, 2005, OFFICIAL METHODS ANA; Bertin E, 1998, J NUTR, V128, P1550, DOI 10.1093/jn/128.9.1550; Codex Alimentarius Commission, 2006, 022006 CACMRL, P1; Dewey KG, 2003, DIV HLTH PROM PROT F; Ejigui J, 2011, INT J FOOD SCI NUTR, V62, P484, DOI 10.3109/09637486.2010.547461; FAO/WHO, 1991, REP JOINT FAO WHO EX, P51; FAO/WHO/UNU (Expert Consultation), 2007, WHO TECHN REP SER, V935; Hotz C, 2012, J NUTR; Kannan S, 2001, J AGR FOOD CHEM, V49, P5070, DOI 10.1021/jf010323u; Lartey A, 1999, AM J CLIN NUTR, V70, P391; Low JW, 2007, J NUTR, V137, P1320; Mensa-Wilmot Y, 2001, NUTR RES, V21, P849, DOI 10.1016/S0271-5317(01)00302-5; Mouquet C, 2003, FOOD CHEM, V82, P249, DOI 10.1016/S0308-8146(02)00545-9; Nnam NM, 2000, PLANT FOOD HUM NUTR, V55, P255, DOI 10.1023/A:1008176903750; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Schaafsma G, 2000, J NUTR, V130, p1865S, DOI 10.1093/jn/130.7.1865S; Serrem CA, 2011, J SCI FOOD AGR, V91, P1814, DOI 10.1002/jsfa.4389; Sun MJ, 2012, J FOOD COMPOS ANAL, V26, P104, DOI 10.1016/j.jfca.2012.03.008; Tizazu S., 2011, African Journal of Food, Agriculture, Nutrition and Development, V11, P5083; van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080	26	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120121	10.1371/journal.pone.0120121	http://dx.doi.org/10.1371/journal.pone.0120121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836365	Green Published, gold			2022-12-27	WOS:000352139000017
J	Guix, S; Perez-Bosque, A; Miro, L; Moreto, M; Bosch, A; Pinto, RM				Guix, Susana; Perez-Bosque, Anna; Miro, Lluisa; Moreto, Miquel; Bosch, Albert; Pinto, Rosa M.			Type I Interferon Response Is Delayed in Human Astrovirus Infections	PLOS ONE			English	Article							TERMINAL NSP1A PROTEIN; VIRUS; INDUCTION; APOPTOSIS; IMMUNITY; REPLICATION; ASSOCIATION; INHIBITION; COMPLEMENT; PATHWAY	Type I interferon (IFN) activation and its subsequent effects are important in the response to viral infections. Here we show that human astroviruses (HAstVs), which are important agents of acute gastroenteritis in children, induce a mild and delayed IFN response upon infecting CaCo-2 cells. Although IFN-beta mRNA is detected within infected cells and supernatant from infected cells show antiviral activity against the replication of other well-known IFN-sensitive viruses, these responses occur at late stages of infection once genome replication has taken place. On the other hand, HAstV replication can be partially reduced by the addition of exogenous IFN, and inhibition of IFN activation by BX795 enhances viral replication, indicating that HAstVs are IFN-sensitive viruses. Finally, different levels of IFN response were observed in cells infected with different HAstV mutants with changes in the hypervariable region of nsP1a/4, suggesting that nsP1a/4 genotype may potentially have clinical implications due to its correlation with the viral replication phenotype and the antiviral responses induced within infected cells.	[Guix, Susana; Bosch, Albert; Pinto, Rosa M.] Univ Barcelona, Dept Microbiol, Enter Virus Grp, Barcelona, Spain; [Guix, Susana; Perez-Bosque, Anna; Miro, Lluisa; Moreto, Miquel; Bosch, Albert; Pinto, Rosa M.] Univ Barcelona, Nutr & Food Safety Res Inst INSA UB, Santa Coloma de Gramenet, Spain; [Perez-Bosque, Anna; Miro, Lluisa; Moreto, Miquel] Univ Barcelona, Dept Physiol, Digest Physiol & Nutr Adaptat Grp, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona	Guix, S (corresponding author), Univ Barcelona, Dept Microbiol, Enter Virus Grp, Barcelona, Spain.	susanaguix@ub.edu	Perez-Bosque, Anna/R-6383-2019; Guix, Susana/D-4318-2014; Pinto, Rosa M/K-2859-2014	Perez-Bosque, Anna/0000-0003-2175-9684; Guix, Susana/0000-0002-1588-3198; Pinto, Rosa M/0000-0003-1382-6648	Projectes de recerca per potenciar els grups de recerca consolidats, Agencia de Gestio d'Ajuts Universitaris i de Recerca. Generalitat de Catalunya [2009SGR00024]; Institute of Nutrition and Food Safety, University of Barcelona [FRI-2011]; XRB-Biotechnology Reference Network (Generalitat de Catalunya)	Projectes de recerca per potenciar els grups de recerca consolidats, Agencia de Gestio d'Ajuts Universitaris i de Recerca. Generalitat de Catalunya; Institute of Nutrition and Food Safety, University of Barcelona; XRB-Biotechnology Reference Network (Generalitat de Catalunya)(Generalitat de Catalunya)	This work was supported by the following grants: 2009SGR00024 (Projectes de recerca per potenciar els grups de recerca consolidats, Agencia de Gestio d'Ajuts Universitaris i de Recerca. Generalitat de Catalunya; www.gencat.cat/agaur), FRI-2011 (Institute of Nutrition and Food Safety, University of Barcelona; www.ub.edu/insa), and XRB-Biotechnology Reference Network (Generalitat de Catalunya; www.gencat.cat/agaur).	Abad FX, 2001, APPL ENVIRON MICROB, V67, P3904, DOI 10.1128/AEM.67.9.3904-3907.2001; Appleton H, 1975, Lancet, V1, P1297; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14; Caballero S, 2003, J MED VIROL, V71, P245, DOI 10.1002/jmv.10476; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Geigenmuller U, 1997, J VIROL, V71, P1713; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Guix S, 2004, J VIROL, V78, P13627, DOI 10.1128/JVI.78.24.13627-13636.2004; Guix S, 2005, VIROLOGY, V333, P124, DOI 10.1016/j.virol.2004.12.023; Guix S, 2004, VIROLOGY, V319, P249, DOI 10.1016/j.virol.2003.10.036; Guix S, 2002, J CLIN MICROBIOL, V40, P133, DOI 10.1128/JCM.40.1.133-139.2002; Hair PS, 2010, MOL IMMUNOL, V47, P792, DOI 10.1016/j.molimm.2009.10.006; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Koci MD, 2005, VIRAL IMMUNOL, V18, P11, DOI 10.1089/vim.2005.18.11; Koci MD, 2004, J VIROL, V78, P1564, DOI 10.1128/JVI.78.3.1564-1574.2004; Kotla S, 2008, VIROLOGY, V374, P399, DOI 10.1016/j.virol.2008.01.022; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Mendez E, 2004, J VIROL, V78, P8601, DOI 10.1128/JVI.78.16.8601-8608.2004; Mendez E., 2007, FIELDS VIROLOGY, V5, P981; Mendez E, 2007, J VIROL, V81, P10649, DOI 10.1128/JVI.00785-07; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Moser LA, 2007, J VIROL, V81, P11937, DOI 10.1128/JVI.00942-07; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nighot PK, 2010, VIROLOGY, V401, P146, DOI 10.1016/j.virol.2010.02.004; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Sano D, 2010, ENVIRON SCI TECHNOL, V44, P808, DOI 10.1021/es9018964; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz-Cherry S., 2013, ASTROVIRUS RES ESSEN; Tam JCH, 2014, SCIENCE, V345, P1134, DOI 10.1126/science.1256070; THOUVENELLE ML, 1995, AVIAN DIS, V39, P343, DOI 10.2307/1591877; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; WILLCOCKS MM, 1994, J VIROL, V68, P6057, DOI 10.1128/JVI.68.9.6057-6058.1994; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	47	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123087	10.1371/journal.pone.0123087	http://dx.doi.org/10.1371/journal.pone.0123087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837699	gold, Green Submitted, Green Published			2022-12-27	WOS:000352139000126
J	Hipp, JF; Siegel, M				Hipp, Joerg F.; Siegel, Markus			Accounting for Linear Transformations of EEG and MEG Data in Source Analysis	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SIGNAL-SPACE PROJECTION; GAMMA-BAND ACTIVITY; MUSCLE ARTIFACTS; EYE ACTIVITY; BRAIN; SEPARATION; REMOVAL; IDENTIFICATION; LOCALIZATION	Analyses of electro- and magnetoencephalography (EEG, MEG) data often involve a linear modification of signals at the sensor level. Examples include re-referencing of the EEG, computation of synthetic gradiometer in MEG, or the removal of artifactual independent components to clean EEG and MEG data. A question of practical relevance is, if such modifications must be accounted for by adapting the physical forward model (leadfield) before subsequent source analysis. Here, we show that two scenarios need to be differentiated. In the first scenario, which corresponds to re-referencing the EEG and synthetic gradiometer computation in MEG, the leadfield must be adapted before source analysis. In the second scenario, which corresponds to removing artifactual components to 'clean' the data, the leadfield must not be changed. We demonstrate and discuss the consequences of wrongly modifying the leadfield in the latter case for an example. Future EEG and MEG studies employing source analyses should carefully consider whether and, if so, how the leadfield must be modified as explicated here.	[Hipp, Joerg F.; Siegel, Markus] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Hipp, Joerg F.; Siegel, Markus] Univ Tubingen, MEG Ctr, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hipp, JF (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany.	joerg.hipp@cin.uni-tuebingen.de; markus.siegel@uni-tuebingen.de	Hipp, Joerg F/D-8936-2014; Siegel, Markus/H-5225-2012	Hipp, Joerg F/0000-0002-7875-2988; Siegel, Markus/0000-0001-5115-936X	Deutsche Forschungsgemeinschaft [EXC 307]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft, EXC 307 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Haufe S, 2014, NEUROIMAGE, V101, P583, DOI 10.1016/j.neuroimage.2014.06.073; He B, 1997, IEEE T BIO-MED ENG, V44, P529, DOI 10.1109/10.594893; HE B, 1987, IEEE T BIO-MED ENG, V34, P406, DOI 10.1109/TBME.1987.326056; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Lins Otavio G., 1993, Brain Topography, V6, P65, DOI 10.1007/BF01234128; Mantini D, 2008, NEUROIMAGE, V40, P160, DOI 10.1016/j.neuroimage.2007.11.022; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Nolte G, 1999, IEEE T BIO-MED ENG, V46, P400, DOI 10.1109/10.752937; Nunez P. L, 2006, ELECTRIC FIELDS OF T; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Siegel M, 2007, CEREB CORTEX, V17, P732, DOI 10.1093/cercor/bhk025; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vigario R, 1998, ADV NEUR IN, V10, P229; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024	37	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121048	10.1371/journal.pone.0121048	http://dx.doi.org/10.1371/journal.pone.0121048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836951	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000038
J	Kwan, P; Ding, J; Tredget, EE				Kwan, Peter; Ding, Jie; Tredget, Edward E.			MicroRNA 181b Regulates Decorin Production by Dermal Fibroblasts and May Be a Potential Therapy for Hypertrophic Scar	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTIONAL CONTROL; FIBROTIC RESPONSE; EXPRESSION; TARGETS; CELLS; DIFFERENTIATION; PROTEOGLYCAN; SKIN; IDENTIFICATION	Hypertrophic scarring is a frequent fibroproliferative complication following deep dermal burns leading to impaired function and lifelong disfigurement. Decorin reduces fibrosis and induces regeneration in many tissues, and is significantly downregulated in hypertrophic scar and normal deep dermal fibroblasts. It was hypothesized that microRNAs in these fibroblasts downregulate decorin and blocking them would increase decorin and may prevent hypertrophic scarring. Lower decorin levels were found in hypertrophic scar as compared to normal skin, and in deep as compared to superficial dermis. A decorin 3' un-translated region reporter assay demonstrated microRNA decreased decorin in deep dermal fibroblasts, and microRNA screening predicted miR-24, 181b, 421, 526b, or 543 as candidates. After finding increased levels of mir-181b in deep dermal fibroblasts, it was demonstrated that TGF-beta(1) stimulation decreased miR-24 but increased miR-181b and that hypertrophic scar and deep dermis contained increased levels of miR-181b. By blocking miR-181b with an antagomiR, it was possible to increase decorin protein expression in dermal fibroblasts. This suggests miR-181b is involved in the differential expression of decorin in skin and wound healing. Furthermore, blocking miR-181b reversed TGF-beta(1) induced decorin down-regulation and myofibroblast differentiation in hypertrophic scar fibroblasts, suggesting a potential therapy for hypertrophic scar.	[Kwan, Peter; Tredget, Edward E.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Plast Surg, Edmonton, AB, Canada; [Kwan, Peter; Ding, Jie; Tredget, Edward E.] Univ Alberta, Wound Healing Res Grp, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada; [Tredget, Edward E.] Univ Alberta Hosp, Dept Med, Div Crit Care, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta; University of Alberta	Tredget, EE (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Div Plast Surg, Edmonton, AB, Canada.	etredget@ualberta.ca			Canadian Institutes of Health Research; Firefighters' Burn Trust Fund of the University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Firefighters' Burn Trust Fund of the University of Alberta(University of Alberta)	The funding source for this work has been the Canadian Institutes of Health Research and the Firefighters' Burn Trust Fund of the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0005610; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Arnold CP, 2011, GENOME RES, V21, P798, DOI 10.1101/gr.111385.110; Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; Boutla A, 2003, NUCLEIC ACIDS RES, V31, P4973, DOI 10.1093/nar/gkg707; BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Dunkin CSJ, 2007, PLAST RECONSTR SURG, V119, P1722, DOI 10.1097/01.prs.0000258829.07399.f0; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gangemi EN, 2008, ARCH FACIAL PLAST S, V10, P93, DOI 10.1001/archfaci.10.2.93; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kwan P, 2009, HAND CLIN, V25, P511, DOI 10.1016/j.hcl.2009.06.007; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; LINARES HA, 1972, J INVEST DERMATOL, V59, P323, DOI 10.1111/1523-1747.ep12627386; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Pfaffl M. W., 2004, QUANTIFICATION STRAT; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Rittie L, 2005, METH MOLEC MED, V117, P83; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; SANTRA M, 1994, J BIOL CHEM, V269, P579; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Scott PG, 1998, CLIN SCI, V94, P541, DOI 10.1042/cs0940541; Scott PG, 1996, CLIN SCI, V90, P417, DOI 10.1042/cs0900417; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tredget EE, 1997, SURG CLIN N AM, V77, P701, DOI 10.1016/S0039-6109(05)70576-4; Vial C, 2011, J BIOL CHEM, V286, P24242, DOI 10.1074/jbc.M110.189365; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang HJ, 2005, EXP MOL PATHOL, V78, P17, DOI 10.1016/j.yexmp.2004.07.006; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wang Ting-Fang, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4189; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang Z, 2007, BURNS, V33, P634, DOI 10.1016/j.burns.2006.08.018; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021	59	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123054	10.1371/journal.pone.0123054	http://dx.doi.org/10.1371/journal.pone.0123054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837671	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000125
J	Rensberger, JM; Martinez, RN				Rensberger, John M.; Martinez, Ricardo N.			Bone Cells in Birds Show Exceptional Surface Area, a Characteristic Tracing Back to Saurischian Dinosaurs of the Late Triassic	PLOS ONE			English	Article							GROWTH-RATES; FLUID-FLOW; PERIOSTEAL BONE; FINE-STRUCTURE; LAMELLAR BONE; OSTEOCYTES; MODEL; CANALICULI; MICROSTRUCTURE; MINERALIZATION	Background Dinosaurs are unique among terrestrial tetrapods in their body sizes, which range from less than 3 gm in hummingbirds to 70,000 kg or more in sauropods. Studies of the microstructure of bone tissue have indicated that large dinosaurs, once believed to be slow growing, attained maturity at rates comparable to or greater than those of large mammals. A number of structural criteria in bone tissue have been used to assess differences in rates of osteogenesis in extinct taxa, including counts of lines of arrested growth and the density of vascular canals. Methodology/Principal Findings Here, we examine the density of the cytoplasmic surface of bone-producing cells, a feature which may set an upper limit to the rate of osteogenesis. Osteocyte lacunae and canaliculi, the cavities in bone containing osteocytes and their extensions, were measured in thin-sections of primary (woven and parallel fibered) bone in a diversity of tetrapods. The results indicate that bone cell surfaces are more densely organized in the Saurischia (extant birds, extinct Mesozoic Theropoda and Sauropodomorpha) than in other tetrapods, a result of denser branching of the cell extensions. The highest postnatal growth rates among extant tetrapods occur in modern birds, the only surviving saurischians, and the finding of exceptional cytoplasmic surface area of the cells that produce bone in this group suggests a relationship with bone growth rate. In support of this relationship is finding the lowest cell surface density among the saurischians examined in Dinornis, a member of a group of ratites that evolved in New Zealand in isolation from mammalian predators and show other evidence of lowered maturation rates.	[Rensberger, John M.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Martinez, Ricardo N.] Univ Nacl San Juan, Museo Ciencias Nat, San Juan, Argentina	University of Washington; University of Washington Seattle; Universidad Nacional de San Juan	Rensberger, JM (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	rensb@u.washington.edu			Department of Earth and Space Sciences, (UW); Department of Orthodontics (UW); Burke Museum of Naturlal History and Culture (UW); Museo de Ciencias Naturales Universidad Nacional de San Juan, Argentina	Department of Earth and Space Sciences, (UW); Department of Orthodontics (UW); Burke Museum of Naturlal History and Culture (UW); Museo de Ciencias Naturales Universidad Nacional de San Juan, Argentina	This project benefited from contributions by many people, including the individuals and institutions which made bone tissue samples available for study and the reviewers whose comments helped improve this manuscript. Facilities and support were provided by the Department of Earth and Space Sciences, (UW), the Department of Orthodontics (UW), the Burke Museum of Naturlal History and Culture (UW), and the Museo de Ciencias Naturales Universidad Nacional de San Juan, Argentina.	Amprino R., 1947, ARCH BIOL SCI, V58, P315; Barragan-Adjemian C, 2006, CALCIFIED TISSUE INT, V79, P340, DOI 10.1007/s00223-006-0107-2; Boyde A., 1980, METAB BONE DIS REL S, P69; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; COWIN SC, 1995, J BIOMECH, V28, P1281, DOI 10.1016/0021-9290(95)00058-P; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 1960, Q J MICROSC SCI, V101, P351; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; D'Emic MD, 2013, BONE, V57, P300, DOI 10.1016/j.bone.2013.08.010; Davies S., 2002, RATITES AND TINAMOUS; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P411; de Ricqles A, 1977, Annales de Paleontologie Vertebres, V63, P133; DUDLEY HR, 1961, J BIOPHYS BIOCHEM CY, V11, P627, DOI 10.1083/jcb.11.3.627; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Ferretti Marzia, 1999, Italian Journal of Anatomy and Embryology, V104, P121; Francillon-Vieillot H., 1990, P471; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; MAROTTI G, 1985, BONE, V6, P335, DOI 10.1016/8756-3282(85)90325-4; MAROTTI G, 1979, METAB BONE DIS RELAT, V1, P325, DOI 10.1016/0221-8747(79)90027-4; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Martin RB., 1989, STRUCTURE FUNCTION; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; OWEN M, 1963, J CELL BIOL, V19, P19, DOI 10.1083/jcb.19.1.19; PALUMBO C, 1986, CELL TISSUE RES, V246, P125; PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0; Remaggi Francesca, 1998, Italian Journal of Anatomy and Embryology, V103, P145; Rensberger JM, 2000, NATURE, V406, P619, DOI 10.1038/35020550; Ricklefs RE, 2010, FUNCT ECOL, V24, P588, DOI 10.1111/j.1365-2435.2009.01684.x; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; SALZSTEIN RA, 1987, J BIOMECH, V20, P261, DOI 10.1016/0021-9290(87)90293-4; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Stein K, 2014, BIOL REV, V89, P24, DOI 10.1111/brv.12041; Tate MLK, 1998, AM J MED SCI, V316, P189, DOI 10.1097/00000441-199809000-00007; Tate MLK, 2000, J BIOMECH, V33, P247, DOI 10.1016/S0021-9290(99)00143-8; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; You LD, 2004, ANAT REC PART A, V278A, P505, DOI 10.1002/ar.a.20050; ZENG Y, 1994, ANN BIOMED ENG, V22, P280, DOI 10.1007/BF02368235	55	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119083	10.1371/journal.pone.0119083	http://dx.doi.org/10.1371/journal.pone.0119083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830561	Green Published, gold			2022-12-27	WOS:000352135600009
J	Zhao, YT; Liu, YH; Wu, XQ; Harding, SP; Zheng, YL				Zhao, Yitian; Liu, Yonghuai; Wu, Xiangqian; Harding, Simon P.; Zheng, Yalin			Retinal Vessel Segmentation: An Efficient Graph Cut Approach with Retinex and Local Phase	PLOS ONE			English	Article							BLOOD-VESSELS; COLOR IMAGES; FLUORESCEIN; ENHANCEMENT	Our application concerns the automated detection of vessels in retinal images to improve understanding of the disease mechanism, diagnosis and treatment of retinal and a number of systemic diseases. We propose a new framework for segmenting retinal vasculatures with much improved accuracy and efficiency. The proposed framework consists of three technical components: Retinex-based image inhomogeneity correction, local phase-based vessel enhancement and graph cut-based active contour segmentation. These procedures are applied in the following order. Underpinned by the Retinex theory, the inhomogeneity correction step aims to address challenges presented by the image intensity inhomogeneities, and the relatively low contrast of thin vessels compared to the background. The local phase enhancement technique is employed to enhance vessels for its superiority in preserving the vessel edges. The graph cut-based active contour method is used for its efficiency and effectiveness in segmenting the vessels from the enhanced images using the local phase filter. We have demonstrated its performance by applying it to four public retinal image datasets (3 datasets of color fundus photography and 1 of fluorescein angiography). Statistical analysis demonstrates that each component of the framework can provide the level of performance expected. The proposed framework is compared with widely used unsupervised and supervised methods, showing that the overall framework outperforms its competitors. For example, the achieved sensitivity (0:744), specificity (0:978) and accuracy (0:953) for the DRIVE dataset are very close to those of the manual annotations obtained by the second observer.	[Zhao, Yitian; Harding, Simon P.; Zheng, Yalin] Univ Liverpool, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Liu, Yonghuai] Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3FG, Dyfed, Wales; [Wu, Xiangqian] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China; [Harding, Simon P.; Zheng, Yalin] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England	University of Liverpool; Aberystwyth University; Harbin Institute of Technology; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Zheng, YL (corresponding author), Univ Liverpool, Dept Eye & Vis Sci, Liverpool, Merseyside, England.	yalin.zheng@liverpool.ac.uk	Zheng, Yalin/N-6432-2017; Liu, Yonghuai/ABF-3794-2020	Zheng, Yalin/0000-0002-7873-0922; Harding, Simon/0000-0003-4676-1158	Wellcome Trust [092668/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant number 092668/Z/10/Z). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Anijeet DR, 2012, INVEST OPHTH VIS SCI, V53, P650, DOI 10.1167/iovs.11-8014; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Azzopardi G, 2013, PATTERN RECOGN LETT, V34, P922, DOI 10.1016/j.patrec.2012.11.002; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Boukerroui D, 2004, J MATH IMAGING VIS, V21, P53, DOI 10.1023/B:JMIV.0000026557.50965.09; Boykov Y, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P26; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chaudhuri S, 1989, IEEE T MED IMAGING, V25, P203; Danek O, 2012, PATTERN RECOGN LETT, V33, P1405, DOI 10.1016/j.patrec.2012.03.013; Elad M, 2005, LECT NOTES COMPUT SC, V3459, P217; Fadzil MHA, 2009, ICDIP 2009: INTERNATIONAL CONFERENCE ON DIGITAL IMAGE PROCESSING, PROCEEDINGS, P137, DOI 10.1109/ICDIP.2009.32; Felsberg M, 2001, IEEE T SIGNAL PROCES, V49, P3136, DOI 10.1109/78.969520; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Hong X, 2007, IEEE T NEURAL NETWOR, V18, P28, DOI 10.1109/TNN.2006.882812; Jobson DJ, 1997, IEEE T IMAGE PROCESS, V6, P965, DOI 10.1109/83.597272; LAND EH, 1986, VISION RES, V26, P7, DOI 10.1016/0042-6989(86)90067-2; Lathen G, 2010, PATTERN RECOGN LETT, V31, P762, DOI 10.1016/j.patrec.2009.09.020; Li HQ, 2005, IEEE T BIO-MED ENG, V52, P1352, DOI 10.1109/TBME.2005.847402; Luo G, 2008, IEEE T BIOMED ENG, V49, P168; Lupascu CA, 2010, IEEE T INF TECHNOL B, V14, P1267, DOI 10.1109/TITB.2010.2052282; MacCormick IJC, 2014, BRAIN, V137, P2119, DOI 10.1093/brain/awu001; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez ME, 2007, MED IMAGE ANAL, V11, P47, DOI 10.1016/j.media.2006.11.004; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Narasimha-Iyer H, 2008, IEEE T INF TECHNOL B, V12, P406, DOI 10.1109/TITB.2007.897782; Nguyen UTV, 2013, PATTERN RECOGN, V46, P703, DOI 10.1016/j.patcog.2012.08.009; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Orlando JI, 2014, LECT NOTES COMPUT SC, V8673, P634, DOI 10.1007/978-3-319-10404-1_79; Palomera-Perez MA, 2010, IEEE T INF TECHNOL B, V14, P500, DOI 10.1109/TITB.2009.2036604; Park YK, 2008, SIGNAL PROCESS, V88, P1929, DOI 10.1016/j.sigpro.2008.01.028; Perez-Rovira A, 2011, IEEE ENG MED BIO, P2614, DOI 10.1109/IEMBS.2011.6090721; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Poon K, 2007, LECT NOTES COMPUT SC, V4792, P444; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Setiawan A, 2009, P INT C HIGH PERF CO, P1; Sinthanayothin C, 1999, BRIT J OPHTHALMOL, V83, P902, DOI 10.1136/bjo.83.8.902; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Sun KQ, 2012, IEEE T BIO-MED ENG, V59, P464, DOI 10.1109/TBME.2011.2174362; Vazquez M, 2001, THESIS CALIFORNIA ST; Vazquez SC, 2010, LECT NOTES COMPUT SC, V6112, P50, DOI 10.1007/978-3-642-13775-4_6; Wang YF, 2013, PATTERN RECOGN, V46, P2117, DOI 10.1016/j.patcog.2012.12.014; Wink O, 2004, IEEE T MED IMAGING, V23, P130, DOI 10.1109/TMI.2003.819920; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Xu N, 2007, COMPUT VIS IMAGE UND, V107, P210, DOI 10.1016/j.cviu.2006.11.004; Yin Y, 2012, PATTERN RECOGN, V45, P1235, DOI 10.1016/j.patcog.2011.09.019; You XG, 2011, PATTERN RECOGN, V44, P2314, DOI 10.1016/j.patcog.2011.01.007; Zhang B, 2010, COMPUT BIOL MED, V40, P438, DOI 10.1016/j.compbiomed.2010.02.008; Zhao YT, 2011, INT SYMP IMAGE SIG, P230; Zheng YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109765, 10.1371/journal.pone.0093624]; ZHOU LA, 1994, IEEE T MED IMAGING, V13, P619, DOI 10.1109/42.363106	55	63	67	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122332	10.1371/journal.pone.0122332	http://dx.doi.org/10.1371/journal.pone.0122332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830353	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600107
J	Chadwick, AC; Holme, RL; Chen, YL; Thomas, MJ; Sorci-Thomas, MG; Silverstein, RL; Pritchard, KA; Sahoo, D				Chadwick, Alexandra C.; Holme, Rebecca L.; Chen, Yiliang; Thomas, Michael J.; Sorci-Thomas, Mary G.; Silverstein, Roy L.; Pritchard, Kirkwood A., Jr.; Sahoo, Daisy			Acrolein Impairs the Cholesterol Transport Functions of High Density Lipoproteins	PLOS ONE			English	Article							RECEPTOR CLASS-B; APOLIPOPROTEIN-A-I; SCAVENGER RECEPTOR; SR-BI; OXIDATIVE STRESS; APOA-I; SELECTIVE UPTAKE; HEART-DISEASE; HDL; PLASMA	High density lipoproteins (HDL) are considered athero-protective, primarily due to their role in reverse cholesterol transport, where they transport cholesterol from peripheral tissues to the liver for excretion. The current study was designed to determine the impact of HDL modification by acrolein, a highly reactive aldehyde found in high abundance in cigarette smoke, on the cholesterol transport functions of HDL. HDL was chemically-modified with acrolein and immunoblot and mass spectrometry analyses confirmed apolipoprotein crosslinking, as well as acrolein adducts on apolipoproteins A-I and A-II. The ability of acrolein-modified HDL (acro-HDL) to serve as an acceptor of free cholesterol (FC) from COS-7 cells transiently expressing SR-BI was significantly decreased. Further, in contrast to native HDL, acroHDL promotes higher neutral lipid accumulation in murine macrophages as judged by Oil Red O staining. The ability of acro-HDL to mediate efficient selective uptake of HDL-cholesteryl esters (CE) into SR-BI-expressing cells was reduced compared to native HDL. Together, the findings from our studies suggest that acrolein modification of HDL produces a dysfunctional particle that may ultimately promote atherogenesis by impairing functions that are critical in the reverse cholesterol transport pathway.	[Silverstein, Roy L.; Sahoo, Daisy] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Chadwick, Alexandra C.; Holme, Rebecca L.; Sahoo, Daisy] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Chen, Yiliang; Silverstein, Roy L.] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Thomas, Michael J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA; [Sorci-Thomas, Mary G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA; [Pritchard, Kirkwood A., Jr.] Childrens Res Inst, Dept Surg, Milwaukee, WI USA; [Sahoo, Daisy] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Medical College of Wisconsin	Sahoo, D (corresponding author), Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.	dsahoo@mcw.edu		Sorci-Thomas, Mary/0000-0002-6464-5006; Chen, Yiliang/0000-0001-9786-8305	National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI) [R01HL58012, R01HL112270, R01HL112276, PO1HL087018, R01HL111614]; American Heart Association (AHA) Predoctoral Fellowship [AHA14PRE185800221]; AHA Postdoctoral Fellowship [AHA13POST14800034]; NIH Shared Instrumentation [1S10RR17846]; North Carolina Biotechnology [2007-IDG-1021]; National Cancer Institute center grant [5P30CA12197]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112270, P01HL087018, R01HL127649, R01HL111614, R01HL112276, R01HL058012] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA) Predoctoral Fellowship(American Heart Association); AHA Postdoctoral Fellowship(American Heart Association); NIH Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology; National Cancer Institute center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI) (R01HL58012 to D. S., R01HL112270 to K.A.P., R01HL112276 to M.G.T., and PO1HL087018 and R01HL111614 to R.L.S.), as well as an American Heart Association (AHA) Predoctoral Fellowship (AHA14PRE185800221 to A.C.C.) and AHA Postdoctoral Fellowship (AHA13POST14800034 to Y.C.). Mass spectrometers were acquired with funds (to M.J.T.) from several agencies: Waters Q-TOF mass spectrometer from NIH Shared Instrumentation Grant 1S10RR17846 and Advion Nanomate from the North Carolina Biotechnology Grant 2007-IDG-1021. MS analyses were performed in the Mass Spectrometer Facility of the Comprehensive Cancer Center of Wake Forest University School of Medicine supported in part by National Cancer Institute center grant 5P30CA12197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Aseervatham GSB, 2013, ENVIRON SCI POLLUT R, V20, P4356, DOI 10.1007/s11356-013-1748-0; Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf; BONNEFONTROUSSELOT D, 1995, BBA-LIPID LIPID MET, V1255, P23, DOI 10.1016/0005-2760(94)00211-G; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Chadwick AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045660; Conklin DJ, 2010, TOXICOL APPL PHARM, V243, P1, DOI 10.1016/j.taap.2009.12.010; Connelly MA, 2003, J BIOL CHEM, V278, P25773, DOI 10.1074/jbc.M302820200; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; de Beer MC, 2001, J LIPID RES, V42, P309; DeJarnett N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000934; FERON VJ, 1991, MUTAT RES, V259, P363, DOI 10.1016/0165-1218(91)90128-9; Ferretti G, 2006, ATHEROSCLEROSIS, V184, P1, DOI 10.1016/j.atherosclerosis.2005.08.008; Fullana A, 2004, J AGR FOOD CHEM, V52, P5207, DOI 10.1021/jf035241f; Gillard BK, 2005, BIOCHEMISTRY-US, V44, P471, DOI 10.1021/bi048591j; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; GLASS C, 1985, J BIOL CHEM, V260, P744; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gugliucci A, 2007, CLIN CHIM ACTA, V384, P105, DOI 10.1016/j.cca.2007.06.012; Ishii T, 2007, FREE RADICAL RES, V41, P1253, DOI 10.1080/10715760701678652; IZARD C, 1977, MUTAT RES, V47, P115; Jairam VU, 2012, BIOCH GEN MOL BIOL, P383; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; JOHNSTONE RAW, 1959, CHEM REV, V59, P885, DOI 10.1021/cr50029a004; Larach DB, 2012, CURR CARDIOL REP, V14, P684, DOI 10.1007/s11886-012-0317-3; Li HH, 2001, J LIPID RES, V42, P2084; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACALA LJ, 1983, J LIPID RES, V24, P1243; MAZIERE JC, 1993, ATHEROSCLEROSIS, V104, P213, DOI 10.1016/0021-9150(93)90192-W; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; MCCALL MR, 1994, ARTERIOSCLER THROMB, V14, P248, DOI 10.1161/01.ATV.14.2.248; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Nieland TJF, 2011, BIOCHEMISTRY-US, V50, P1818, DOI 10.1021/bi101657j; Obama T, 2007, PROTEOMICS, V7, P2132, DOI 10.1002/pmic.200700111; Otocka-Kmiecik A, 2012, PROG LIPID RES, V51, P314, DOI 10.1016/j.plipres.2012.03.003; Papale GA, 2010, ARCH BIOCHEM BIOPHYS, V496, P132, DOI 10.1016/j.abb.2010.02.011; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Parathath S, 2007, J LIPID RES, V48, P1386, DOI 10.1194/jlr.M700086-JLR200; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; PITTMAN RC, 1984, J LIPID RES, V25, P1577; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Raveh O, 2000, FREE RADICAL BIO MED, V29, P131, DOI 10.1016/S0891-5849(00)00332-4; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; SALMON S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P230, DOI 10.1016/0005-2760(92)90050-6; Shao BH, 2012, BBA-MOL CELL BIOL L, V1821, P490, DOI 10.1016/j.bbalip.2011.11.011; Shao BH, 2011, J PROTEOMICS, V74, P2289, DOI 10.1016/j.jprot.2011.04.001; Shao B, 2009, J LIPID RES, V50, P599, DOI 10.1194/jlr.E900001-JLR200; Shao BH, 2005, ANN NY ACAD SCI, V1043, P396, DOI 10.1196/annals.1333.046; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; SorciThomas MG, 1996, J LIPID RES, V37, P673; Srivastava S, 2011, ATHEROSCLEROSIS, V215, P301, DOI 10.1016/j.atherosclerosis.2011.01.001; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Tamamizu-Kato S, 2007, BIOCHEMISTRY-US, V46, P8392, DOI 10.1021/bi700289k; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Watanabe K, 2013, ATHEROSCLEROSIS, V227, P51, DOI 10.1016/j.atherosclerosis.2012.12.020; WITZ G, 1989, FREE RADICAL BIO MED, V7, P333, DOI 10.1016/0891-5849(89)90137-8; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yoshida M, 2010, ATHEROSCLEROSIS, V211, P475, DOI 10.1016/j.atherosclerosis.2010.03.031; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	66	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123138	10.1371/journal.pone.0123138	http://dx.doi.org/10.1371/journal.pone.0123138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849485	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800208
J	Drovetski, SV; Semenov, G; Red'kin, YA; Sotnikov, VN; Fadeev, IV; Koblik, EA				Drovetski, Sergei V.; Semenov, Georgy; Red'kin, Yaroslav A.; Sotnikov, Vladimir N.; Fadeev, Igor V.; Koblik, Evgeniy A.			Effects of Asymmetric Nuclear Introgression, Introgressive Mitochondrial Sweep, and Purifying Selection on Phylogenetic Reconstruction and Divergence Estimates in the Pacific Clade of Locustella Warblers	PLOS ONE			English	Article							GENETIC CONSEQUENCES; SPECIATION; EVOLUTION	When isolated but reproductively compatible populations expand geographically and meet, simulations predict asymmetric introgression of neutral loci from a local to invading taxon. Genetic introgression may affect phylogenetic reconstruction by obscuring topology and divergence estimates. We combined phylogenetic analysis of sequences from one mtDNA and 12 nuDNA loci with analysis of gene flow among 5 species of Pacific Locustella warblers to test for presence of genetic introgression and its effects on tree topology and divergence estimates. Our data showed that nuDNA introgression was substantial and asymmetrical among all members of superspecies groups whereas mtDNA showed no introgression except a single species pair where the invader's mtDNA was swept by mtDNA of the local species. This introgressive sweep of mtDNA had the opposite direction of the nuDNA introgression and resulted in the paraphyly of the local species' mtDNA haplotypes with respect to those of the invader. he multilocus nuDNA species tree resolved all inter- and intraspecific relationships despite substantial introgression. However, the node ages on the species tree may be underestimated as suggested by the differences in node age estimates based on non-introgressing mtDNA and introgressing nuDNA. In turn, the introgressive sweep and strong purifying selection appear to elongate internal branches in the mtDNA gene tree.	[Drovetski, Sergei V.] Univ Tromso Arctic Univ Norway, Tromso Univ Museum, Dept Nat Hist, Tromso, Norway; [Semenov, Georgy] Russian Acad Sci, Inst Systemat & Ecol Anim, Themat Grp Bird Ecol, Siberian Branch, Novosibirsk, Russia; [Red'kin, Yaroslav A.; Koblik, Evgeniy A.] Moscow MV Lomonosov State Univ, Dept Ornithol, Zool Museum, Moscow, Russia; [Sotnikov, Vladimir N.] Kirov City Zool Museum, Kirov, Russia; [Fadeev, Igor V.] State Darwin Museum, Dept Collect, Moscow, Russia	UiT The Arctic University of Tromso; Russian Academy of Sciences; Lomonosov Moscow State University	Drovetski, SV (corresponding author), Univ Tromso Arctic Univ Norway, Tromso Univ Museum, Dept Nat Hist, Tromso, Norway.	sdrovetski@gmail.com	Red'kin, Yaroslav/AAE-4218-2021; Koblik, Evgeny/AAE-4252-2021; Drovetski, Sergei/A-6002-2011	Drovetski, Sergei/0000-0002-1832-5597	CIBIO, Centro de Investigacao em Biodiversidade e Recursos Geneticos, Portugal	CIBIO, Centro de Investigacao em Biodiversidade e Recursos Geneticos, Portugal	This study was supported by the startup funds to SVD from CIBIO, Centro de Investigacao em Biodiversidade e Recursos Geneticos, Portugal. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2011, MOL PHYLOGENET EVOL, V58, P513, DOI 10.1016/j.ympev.2010.12.012; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clements JF, 2013, EBIRD CLEMENTS CHECK; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Drovetski SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087570; Drovetski SV, 2013, ECOL EVOL, V3, P1518, DOI 10.1002/ece3.539; Drovetski SV, 2005, CONSERV GENET, V6, P875, DOI 10.1007/s10592-005-9074-9; Drovetski SV, 2004, J AVIAN BIOL, V35, P105; Drummond A.J., 2012, MOL BIOL EVOL; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gill F., IOC WORLD BIRD LIST; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; HUDSON RR, 1987, GENETICS, V116, P153; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Kalyakin MV, 1993, P ZOOLOGICAL MUSEUM, V30, P164; Kutschera VE, 2014, MOL BIOL EVOL, V31, P2004, DOI 10.1093/molbev/msu186; Leache AD, 2014, SYST BIOL, V63, P17, DOI 10.1093/sysbio/syt049; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Peters JL, 2014, MOL ECOL, V23, P2961, DOI 10.1111/mec.12799; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; STEPANYAN L S, 1972, Zoologicheskii Zhurnal, V51, P1896; Stepanyan L. S., 2003, CONSPECTUS ORNITHOLO; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tyrberg T., 1998, PLEISTOCENE BIRDS PA	36	18	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122590	10.1371/journal.pone.0122590	http://dx.doi.org/10.1371/journal.pone.0122590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849039	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800143
J	Jin, PY; Peng, JJ; Zou, HD; Wang, WW; Fu, J; Shen, BJ; Bai, XL; Xu, X; Zhang, X				Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin; Xu, Xun; Zhang, Xi			A Five-Year Prospective Study of Diabetic Retinopathy Progression in Chinese Type 2 Diabetes Patients with "Well-Controlled" Blood Glucose	PLOS ONE			English	Article							MACULAR EDEMA; RISK-FACTORS; PREVALENCE; REGRESSION; DISEASE; SYSTEM	Purpose To determine the progression rate and risk factors for diabetic retinopathy (DR) in Chinese type 2 diabetic patients who have reached the target hemoglobin A1c (HbA1c) level recommended by the American Diabetes Association. Methods This was a 5-year community-based prospective study. The study population consisted of patients with type 2 diabetes with HbA1c less than 7.0%. Demographic information, systemic examination results and ophthalmological test results for each participant were collected. The outcome of this study was the progression of DR, which was defined as an increase in DR grade in one or both eyes at the final visit in comparison to the baseline status. The association between each potential risk factor and DR progression was studied. Results A total of 453 patients with HbA1c less than 7.0% were included in the study group. In 146 patients (32.22%), DR developed or progressed during the five-year follow-up. Baseline HbA1c level was the only independent risk factor for DR progression (p<0.01, OR = 2.84, 95%CI: 2.11 similar to 3.82). The logistic regression function suggested that the possibility of DR progression increased fastest when baseline HbA1c increased from 5.2% to 6.4%. The 5-year DR progression rate in patients with baseline HbA1c less than 5.2%, between 5.2% and 6.4%, and over 6.4% were 19.62%, 24.41%, and 76.83%, respectively. Conclusions To slow the progression of DR in Chinese patients with type 2 diabetes, more intensive glucose control is recommended.	[Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Xu, Xun; Zhang, Xi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China; [Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai 200040, Peoples R China; [Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin] Beixinjing Community Hlth Serv Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China.	zouhaidong@hotmail.com	Dagdelen, Selcuk/A-9432-2017	Dagdelen, Selcuk/0000-0002-0513-1750; Zou, Haidong/0000-0002-6831-7560	Chinese National Nature Science Foundation [81371069]; Shanghai Pujiang Program [0001652]; Shanghai New Hundred Talents Program from Shanghai Medical and Family Planning Commitee [13B141]	Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai New Hundred Talents Program from Shanghai Medical and Family Planning Commitee	This study was funded by the Chinese National Nature Science Foundation (project number 81371069), Shanghai Pujiang Program (project number PJ(2012) 0001652), Shanghai New Hundred Talents Program from Shanghai Medical and Family Planning Commitee (project number 13B141). The sponsor or funding organization had no role in the design or conduct of this research.	Association AD, 2008, CLIN PRACT REC 2008; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Beulens JWJ, 2009, DIABETOLOGIA, V52, P2027, DOI 10.1007/s00125-009-1457-x; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Consultation WHO, 1999, DEF DIAGN CLASS DIAB; GERRITZEN FM, 1973, DIABETES, V22, P122, DOI 10.2337/diab.22.2.122; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gibbins RL, 1998, DIABETOLOGIA, V41, P59, DOI 10.1007/s001250050867; Giordano C, 2011, EUR J INTERN MED, V22, P266, DOI 10.1016/j.ejim.2011.02.009; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Han Jae Ryong, 2004, Korean J Ophthalmol, V18, P41; Hellstedt T, 1996, BRIT J OPHTHALMOL, V80, P135, DOI 10.1136/bjo.80.2.135; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Lopez F, 2007, EUROPEAN OPHTHALMIC, P68; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Peng JJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-250; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; ROY S, 1990, P NATL ACAD SCI USA, V87, P404, DOI 10.1073/pnas.87.1.404; Rudnisky CJ, 2012, CAN J OPHTHALMOL, V47, P365, DOI 10.1016/j.jcjo.2012.04.006; Ruggenenti P, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/106384; Schoenlau Frank, 2001, International Ophthalmology, V24, P161, DOI 10.1023/A:1021160924583; Sjolie AK, 2011, DIABETIC MED, V28, P345, DOI 10.1111/j.1464-5491.2010.03210.x; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Steigerwalt R, 2009, J OCUL PHARMACOL TH, V25, P537, DOI 10.1089/jop.2009.0023; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; VANEWIJK PH, 1994, J R STAT SOC C-APPL, V43, P477; Wang N, 2008, OPHTHALMOLOGICA, V222, P32, DOI 10.1159/000109276; WHITE MC, 1981, BRIT J OPHTHALMOL, V65, P307, DOI 10.1136/bjo.65.5.307; White NH, 2010, DIABETES, V59, P1244, DOI 10.2337/db09-1216; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xie XW, 2009, EUR J OPHTHALMOL, V19, P91, DOI 10.1177/112067210901900114; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zavrelova H, 2011, DIABETES CARE, V34, P867, DOI 10.2337/dc10-1741; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524; [邹海东 ZOU Hai dong], 2006, [中华眼底病杂志, Chinese Journal of Ocular Fundus Diseases], V22, P31	39	12	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123449	10.1371/journal.pone.0123449	http://dx.doi.org/10.1371/journal.pone.0123449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849536	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800233
J	Oyebode, O; Pape, UJ; Laverty, AA; Lee, JT; Bhan, N; Millett, C				Oyebode, Oyinlola; Pape, Utz J.; Laverty, Anthony A.; Lee, John T.; Bhan, Nandita; Millett, Christopher			Rural, Urban and Migrant Differences in NonCommunicable Disease Risk-Factors in Middle Income Countries: A Cross-Sectional Study of WHO-SAGE Data	PLOS ONE			English	Article							LIFE-YEARS; HEALTH; SMOKING; URBANIZATION; MIGRATION	Background Understanding how urbanisation and rural-urban migration influence risk-factors for noncommunicable disease (NCD) is crucial for developing effective preventative strategies globally. This study compares NCD risk-factor prevalence in urban, rural and migrant populations in China, Ghana, India, Mexico, Russia and South Africa. Methods Study participants were 39,436 adults within the WHO Study on global AGEing and adult health (SAGE), surveyed 2007-2010. Risk ratios (RR) for each risk-factor were calculated using logistic regression in country-specific and all country pooled analyses, adjusted for age, sex and survey design. Fully adjusted models included income quintile, marital status and education. Results Regular alcohol consumption was lower in migrant and urban groups than in rural groups (pooled RR and 95% CI: 0.47 (0.31-0.68); 0.58, (0.46-0.72), respectively). Occupational physical activity was lower (0.86 (0.72-0.98); 0.76 (0.65-0.85)) while active travel and recreational physical activity were higher (pooled RRs for urban groups; 1.05 (1.00-1.09), 2.36 (1.95-2.83), respectively; for migrant groups: 1.07 (1.0 -1.12), 1.71 (1.11-2.53), respectively). Overweight, raised waist circumference and diagnosed diabetes were higher in urban groups (1.19 (1.04-1.35), 1.24 (1.07-1.42), 1.69 (1.15-2.47), respectively). Exceptions to these trends exist: obesity indicators were higher in rural Russia; active travel was lower in urban groups in Ghana and India; and in South Africa, urban groups had the highest alcohol consumption. Conclusion Migrants and urban dwellers had similar NCD risk-factor profiles. These were not consistently worse than those seen in rural dwellers. The variable impact of urbanisation on NCD risk must be considered in the design and evaluation of strategies to reduce the growing burden of NCDs globally.	[Oyebode, Oyinlola; Pape, Utz J.; Laverty, Anthony A.; Lee, John T.; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Reynolds Bldg,St Dunstands Rd, London, England; [Bhan, Nandita; Millett, Christopher] Publ Hlth Fdn India, New Delhi, India	Imperial College London; Public Health Foundation of India	Oyebode, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Reynolds Bldg,St Dunstands Rd, London, England.	o.oyebode@imperial.ac.uk	Oyebode, Oyinlola/ABE-1256-2021	Oyebode, Oyinlola/0000-0003-0925-9839; Laverty, Anthony/0000-0003-1318-8439; Millett, Christopher/0000-0002-0793-9884	United States National Institute on Aging's Division of Behavioral and Social Research; World Health Organization's Department of Health Statistics and Information Systems; London, Kent, Surrey Sussex Public Health Training Programme; Education Funding Council for England; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Wellcome Trust [084674/Z/08/Z]; Career Development Award under the PHFI-UKC Wellcome Trust Capacity Building Programme [084754/Z/08/A]; United States National Institute on Aging's Division of Behavioral and Social Research; World Health Organization's Department of Health Statistics and Information Systems; London, Kent, Surrey Sussex Public Health Training Programme; Education Funding Council for England; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Wellcome Trust [084674/Z/08/Z]; Career Development Award under the PHFI-UKC Wellcome Trust Capacity Building Programme [084754/Z/08/A]	United States National Institute on Aging's Division of Behavioral and Social Research; World Health Organization's Department of Health Statistics and Information Systems; London, Kent, Surrey Sussex Public Health Training Programme; Education Funding Council for England; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Wellcome Trust(Wellcome TrustEuropean Commission); Career Development Award under the PHFI-UKC Wellcome Trust Capacity Building Programme; United States National Institute on Aging's Division of Behavioral and Social Research; World Health Organization's Department of Health Statistics and Information Systems; London, Kent, Surrey Sussex Public Health Training Programme; Education Funding Council for England; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Wellcome Trust(Wellcome TrustEuropean Commission); Career Development Award under the PHFI-UKC Wellcome Trust Capacity Building Programme	This article uses data from WHO Study on Global Ageing and Adult Health (SAGE) Wave 1 version 1.1.0. SAGE is supported by the United States National Institute on Aging's Division of Behavioral and Social Research and the World Health Organization's Department of Health Statistics and Information Systems. OO is funded by the London, Kent, Surrey Sussex Public Health Training Programme. CM is funded by the Higher Education Funding Council for England and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme. The South Asia Network for Chronic Disease (CM, NB) is supported by a Wellcome Trust strategic award 084674/Z/08/Z. NB is funded by a Career Development Award under the PHFI-UKC Wellcome Trust Capacity Building Programme (084754/Z/08/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; [Anonymous], 2014, LANCET; Bobrova N, 2010, ALCOHOL ALCOHOLISM, V45, P573, DOI 10.1093/alcalc/agq069; Chen XG, 2004, PREV MED, V39, P666, DOI 10.1016/j.ypmed.2004.02.033; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Hernandez AV, 2012, HEART, V98, P185, DOI 10.1136/heartjnl-2011-300599; Justin M, 2012, HEART, V98, P271, DOI 10.1136/heartjnl-2011-301200; Kinra S, 2011, AM J EPIDEMIOL, V174, P154, DOI 10.1093/aje/kwr053; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kyobutungi C, 2010, GLOBAL HLTH ACTION, V3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu Y, 2008, SOC SCI MED, V67, P1331, DOI 10.1016/j.socscimed.2008.06.017; Millett C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001459; MISCH KA, 1988, CARDIOLOGY, V75, P71, DOI 10.1159/000174351; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Mou J, 2013, NICOTINE TOB RES, V15, P69, DOI 10.1093/ntr/nts085; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nguyen LT, 2012, THE JOURNAL OF ADOLE, V50, DOI [10.1016/j.jadohealth.2011.12.010, DOI 10.1016/J.JADOHEALTH.2011.12.010]; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Peer N, 2013, GLOBAL HLTH ACTION, V6; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/annotation/4c5252d3-2fd5-4ff2-b3d9-ed197690f877, DOI 10.1371/ANNOTATION/4C5252D3-2FD5-4FF2-B3D9-ED197690F877]; The United Nations Department of Economic and Social Affairs, WORLD URB PROSP 2011; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; United Nations General Assembly, 2011, 3 PLEN M 19 SEPT; Vearey J, 2010, HEALTH PLACE, V16, P694, DOI 10.1016/j.healthplace.2010.02.007; Vorster HH, 2002, PUBLIC HEALTH NUTR, V5, P239, DOI 10.1079/PHN2001299; Wagner KHH, 2012, PREVENTIVE MED S, V54; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2013, NCD GLOB MON FRAM; Williams CT, 2008, J URBAN HEALTH, V85, P472, DOI 10.1007/s11524-008-9286-7; Yang T, 2009, PUBLIC HEALTH, V123, P743, DOI 10.1016/j.puhe.2009.09.021; Yusuf F, 2008, CHINA URBANIZES CONS; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	35	47	50	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122747	10.1371/journal.pone.0122747	http://dx.doi.org/10.1371/journal.pone.0122747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849356	Green Published, gold			2022-12-27	WOS:000352477800158
J	Abascal, JFPJ; Abella, M; Sisniega, A; Vaquero, JJ; Desco, M				Abascal, Juan F. P. J.; Abella, Monica; Sisniega, Alejandro; Jose Vaquero, Juan; Desco, Manuel			Investigation of Different Sparsity Transforms for the PICCS Algorithm in Small-Animal Respiratory Gated CT	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; COMPRESSED SENSING PICCS; DIFFUSE OPTICAL TOMOGRAPHY; SPLIT BREGMAN METHOD; IMAGE-RECONSTRUCTION; MICRO-CT; TEMPORAL RESOLUTION; PERFORMANCE; REGULARIZATION; PROJECTIONS	Respiratory gating helps to overcome the problem of breathing motion in cardiothoracic small-animal imaging by acquiring multiple images for each projection angle and then assigning projections to different phases. When this approach is used with a dose similar to that of a static acquisition, a low number of noisy projections are available for the reconstruction of each respiratory phase, thus leading to streak artifacts in the reconstructed images. This problem can be alleviated using a prior image constrained compressed sensing (PICCS) algorithm, which enables accurate reconstruction of highly undersampled data when a prior image is available. We compared variants of the PICCS algorithm with different transforms in the prior penalty function: gradient, unitary, and wavelet transform. In all cases the problem was solved using the Split Bregman approach, which is efficient for convex constrained optimization. The algorithms were evaluated using simulations generated from data previously acquired on a micro-CT scanner following a high-dose protocol (four times the dose of a standard static protocol). The resulting data were used to simulate scenarios with different dose levels and numbers of projections. All compressed sensing methods performed very similarly in terms of noise, spatiotemporal resolution, and streak reduction, and filtered back-projection was greatly improved. Nevertheless, the wavelet domain was found to be less prone to patchy cartoon-like artifacts than the commonly used gradient domain.	[Abascal, Juan F. P. J.; Abella, Monica; Sisniega, Alejandro; Jose Vaquero, Juan; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain; [Abascal, Juan F. P. J.; Abella, Monica; Sisniega, Alejandro; Jose Vaquero, Juan; Desco, Manuel] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Desco, Manuel] Ctr Invest Red Salud Mental CIBERSAM, Madrid, Spain	Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Abella, M (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain.	monica.abella@uc3m.es	ABASCAL, JUAN FPJ/L-7062-2014; Desco, Manuel/AAD-7137-2019; Vaquero, Juan José/D-3033-2009; ABELLA, MONICA/AAE-7616-2019	ABASCAL, JUAN FPJ/0000-0002-2757-8676; Desco, Manuel/0000-0003-0989-3231; Vaquero, Juan José/0000-0001-9200-361X; ABELLA, MONICA/0000-0002-4847-7233; Sisniega, Alejandro/0000-0003-2030-2711	RIC-RETIC network from the Ministerio de Economia y Competitividad [RD12/0042/0057]; Ministerio de Ciencia e Innovacion [TEC2010-21619-C04-01, PI11/00616]; Innovative Medicines Initiative [115337]; European Union's Seventh Framework Programme (FP7); EFPIA companies	RIC-RETIC network from the Ministerio de Economia y Competitividad; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Innovative Medicines Initiative; European Union's Seventh Framework Programme (FP7); EFPIA companies	This work was partially funded by the RIC-RETIC network (RD12/0042/0057) from the Ministerio de Economia y Competitividad (www.mineco.gob.es/) and projects TEC2010-21619-C04-01 and PI11/00616 from Ministerio de Ciencia e Innovacion (www.micinn.es/). The research leading to these results was supported by funding from the Innovative Medicines Initiative (www.imi.europa.eu) Joint Undertaking under grant agreement no 115337, the resources of which comprise financial contributions from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies ("in kind contribution"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JFPJ, 2011, MED PHYS, V38, P6275, DOI 10.1118/1.3656063; Abascal J, 2012, IEEE NUCL SCI CONF R, P3344; Abella M, 2012, COMPUT METH PROG BIO, V107, P218, DOI 10.1016/j.cmpb.2011.06.008; Bruckstein AM, 2009, SIAM REV, V51, P34, DOI 10.1137/060657704; Buckheit JB, 1995, WAVELAB REFERENCE MA; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2005, P SPIE C WAV APPL SI, P5914; Candes E, 2007, INVERSE PROBL, V23, P969, DOI 10.1088/0266-5611/23/3/008; Chamorro-Servent J, 2011, OPT EXPRESS, V19, P11490, DOI 10.1364/OE.19.011490; Chavarrias C, 2008, PHYS MED BIOL, V53, P4683, DOI 10.1088/0031-9155/53/17/015; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Dong B, 2012, J SCI COMPUTING, P1; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; Lauzier PT, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2461; Lee H, 2012, PHYS MED BIOL, V57, P2287, DOI 10.1088/0031-9155/57/8/2287; Leng S, 2008, PHYS MED BIOL, V53, P5653, DOI 10.1088/0031-9155/53/20/006; Leng S, 2008, MED PHYS, V35, P4649, DOI 10.1118/1.2977736; MCKINNON GC, 1981, IEEE T BIO-MED ENG, V28, P123, DOI 10.1109/TBME.1981.324785; Montesinos P, 2013, MAGNETIC RESONANCE M; Moscato P, 2003, HDB METAHEURISTICS I; Nett BE, 2010, PHYS MED BIOL, V55, P2333, DOI 10.1088/0031-9155/55/8/014; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pan XC, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123009; Qi ZH, 2011, PHYS MED BIOL, V56, P6709, DOI 10.1088/0031-9155/56/20/013; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; Ramirez-Giraldo JC, 2011, MED PHYS, V38, P2157, DOI 10.1118/1.3560878; Ritschl L, 2011, PHYS MED BIOL, V56, P1545, DOI 10.1088/0031-9155/56/6/003; Sawall S, 2011, MED PHYS, V38, P1416, DOI 10.1118/1.3551993; Setzer S, 2010, J VIS COMMUN IMAGE R, V21, P193, DOI 10.1016/j.jvcir.2009.10.006; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Song J, 2007, MED PHYS, V34, P4476, DOI 10.1118/1.2795830; Starck JL, 2005, IEEE T IMAGE PROCESS, V14, P1570, DOI 10.1109/TIP.2005.852206; Stayman JW, 2011, SPIE MED IMAGING, V7961; Tang J, 2010, MED PHYS, V37, P4377, DOI 10.1118/1.3460318; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Vandeghinste B, 2012, SPIE MED IMAGING; Vaquero JJ, 2008, IEEE T NUCL SCI, V55, P898, DOI 10.1109/TNS.2008.922814; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Yang SY, 2013, INFORM SCIENCES, V252, P144, DOI 10.1016/j.ins.2013.06.029; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Zhang QH, 2007, MED PHYS, V34, P4772, DOI 10.1118/1.2804576; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460	43	9	10	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120140	10.1371/journal.pone.0120140	http://dx.doi.org/10.1371/journal.pone.0120140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836670	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000018
J	Hayashi, Y; Yasugi, F; Arai, M				Hayashi, Yuuki; Yasugi, Fumitaka; Arai, Munehito			Role of Cysteine Residues in the Structure, Stability, and Alkane Producing Activity of Cyanobacterial Aldehyde Deformylating Oxygenase	PLOS ONE			English	Article							SHORT-CHAIN ALKANES; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; BIOSYNTHESIS; DECARBONYLATION; PROTEIN; OXIDATION; KINETICS; ENZYMES; FORMATE	Aldehyde deformylating oxygenase (AD) is a key enzyme for alkane biosynthesis in cyanobacteria, and it can be used as a catalyst for alkane production in vitro and in vivo. However, three free Cys residues in AD may impair its catalytic activity by undesired disulfide bond formation and oxidation. To develop Cys-deficient mutants of AD, we examined the roles of the Cys residues in the structure, stability, and alkane producing activity of AD from Nostoc punctiforme PCC 73102 by systematic Cys-to-Ala/Ser mutagenesis. The C71A/S mutations reduced the hydrocarbon producing activity of AD and facilitated the formation of a dimer, indicating that the conserved Cys71, which is located in close proximity to the substrate-binding site, plays crucial roles in maintaining the activity, structure, and stability of AD. On the other hand, mutations at Cys107 and Cys117 did not affect the hydrocarbon producing activity of AD. Therefore, we propose that the C107A/C117A double mutant is preferable to wild type AD for alkane production and that the double mutant may be used as a pseudo-wild type protein for further improvement of the alkane producing activity of AD.	[Hayashi, Yuuki; Yasugi, Fumitaka; Arai, Munehito] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Arai, Munehito] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Arai, M (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	arai@bio.c.u-tokyo.ac.jp	Arai, Munehito/A-1258-2012; Hayashi, Yuuki/Q-7515-2019	Arai, Munehito/0000-0002-1223-2242; Hayashi, Yuuki/0000-0002-7073-0151	Precursory Research for Embryonic Science and Technology (PRESTO), Japan; Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Hokuto Foundation for Bioscience; Tonen General Sekiyu Research & Development Encouragement & Assistance Foundation; Yazaki Memorial Foundation for Science and Technology; Grants-in-Aid for Scientific Research [25117504] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan; Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Tonen General Sekiyu Research & Development Encouragement & Assistance Foundation; Yazaki Memorial Foundation for Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (MA), Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (MA, YH), Hokuto Foundation for Bioscience (YH), Tonen General Sekiyu Research & Development Encouragement & Assistance Foundation (YH), and Yazaki Memorial Foundation for Science and Technology (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arai M, 2005, J MOL BIOL, V347, P337, DOI 10.1016/j.jmb.2005.01.033; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Das D, 2011, ANGEW CHEM INT EDIT, V50, P7148, DOI 10.1002/anie.201101552; DENNIS MW, 1991, ARCH BIOCHEM BIOPHYS, V287, P268, DOI 10.1016/0003-9861(91)90478-2; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; Harger M, 2013, ACS SYNTH BIOL, V2, P59, DOI 10.1021/sb300061x; Hari SB, 2010, PROTEIN SCI, V19, P670, DOI 10.1002/pro.342; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; IWAKURA M, 1995, J BIOCHEM, V117, P480, DOI 10.1093/oxfordjournals.jbchem.a124733; Khara B, 2013, CHEMBIOCHEM, V14, P1204, DOI 10.1002/cbic.201300307; KOLATTUKUDY PE, 1968, SCIENCE, V159, P498, DOI 10.1126/science.159.3814.498; KOLATTUKUDY PE, 1968, PLANT PHYSIOL, V43, P1466, DOI 10.1104/pp.43.9.1466; Kong B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085890; Krebs C, 2011, CURR OPIN CHEM BIOL, V15, P291, DOI 10.1016/j.cbpa.2011.02.019; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PERRY LJ, 1987, PROTEIN ENG, V1, P101, DOI 10.1093/protein/1.2.101; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takenawa T, 2009, J BIOCHEM, V145, P517, DOI 10.1093/jb/mvp003; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002	28	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122217	10.1371/journal.pone.0122217	http://dx.doi.org/10.1371/journal.pone.0122217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837679	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000085
J	Murshid, A; Gong, JL; Prince, T; Borges, TJ; Calderwood, SK				Murshid, Ayesha; Gong, Jianlin; Prince, Thomas; Borges, Thiago J.; Calderwood, Stuart K.			Scavenger Receptor SREC-I Mediated Entry of TLR4 into Lipid Microdomains and Triggered Inflammatory Cytokine Release in RAW 264.7 Cells upon LPS Activation	PLOS ONE			English	Article							NF-KAPPA-B; GPI-ANCHORED PROTEINS; HEAT-SHOCK PROTEINS; DENDRITIC CELLS; RECOGNITION; ANTIGEN; PATHWAYS; INTERNALIZATION; MACROPHAGES; SIGNALS	Scavenger receptor associated with endothelial cells I (SREC-I) was shown to be expressed in immune cells and to play a role in the endocytosis of peptides and antigen presentation. As our previous studies indicated that SREC-I required intact Toll-like receptor 4 (TLR4) expression for its functions in tumor immunity, we examined potential interactions between these two receptors. We have shown here that SREC-I became associated with TLR4 on binding bacterial lipopolysaccharides (LPS) in RAW 264.7 and HEK 293 cells overexpressing these two receptors. The receptors then became internalized together in intracellular endosomes. SREC-I promoted TLR4-induced signal transduction through the NF-kB and MAP kinase pathways, leading to enhanced inflammatory cytokine release. Activation of inflammatory signaling through SREC-I/TLR4 complexes appeared to involve recruitment of the receptors into detergent-insoluble, cholesterol-rich lipid microdomains that contained the small GTPase Cdc42 and the non-receptor tyrosine kinase c-src. Under conditions of SREC-I activation by LPS, TLR4 activity required Cdc42 as well as cholesterol and actin polymerization for signaling through NF-kB and MAP kinase pathways in RAW 264.7 cells. SREC-I appeared to respond differently to another ligand, the molecular chaperone Hsp90 that, while triggering SREC-I-TLR4 binding caused only faint activation of the NF-kB pathway. Our experiments therefore indicated that SREC-I could bind LPS and might be involved in innate inflammatory immune responses to extracellular danger signals in RAW 264.7 cells or bone marrow-derived macrophages.	[Murshid, Ayesha; Prince, Thomas; Borges, Thiago J.; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Life Sci,Mol & Cellular Radiat Oncol, Boston, MA 02215 USA; [Gong, Jianlin] Boston Univ, Med Ctr, Stress Response Ctr, Boston, MA USA; [Borges, Thiago J.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Biosci, Porto Alegre, RS, Brazil; [Borges, Thiago J.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Biomed Res Inst, Porto Alegre, RS, Brazil	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Calderwood, SK (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Life Sci,Mol & Cellular Radiat Oncol, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu	Borges, Thiago/Q-3711-2019	Borges, Thiago/0000-0002-6554-0169	 [NIHRO1CA47407-25];  [NIHRO1CA176326-01];  [NIHRO1CA119045]; NATIONAL CANCER INSTITUTE [R01CA047407, R01CA176326, R01CA119045] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by NIHRO1CA47407-25, NIHRO1CA176326-01, NIHRO1CA119045, www.cancer.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2002, J BIOL CHEM, V277, P24014, DOI 10.1074/jbc.M201854200; Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Beauvillain C, 2010, J HEPATOL, V52, P644, DOI 10.1016/j.jhep.2009.11.031; Berwin B, 2004, J BIOL CHEM, V279, P51250, DOI 10.1074/jbc.M406202200; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Calderwood SK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00075; Chen YY, 2010, EUR J IMMUNOL, V40, P1451, DOI 10.1002/eji.200939891; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Dziarski R, 2000, J ENDOTOXIN RES, V6, P401, DOI 10.1179/096805100101532243; Enomoto Y, 2006, J IMMUNOL, V177, P5946, DOI 10.4049/jimmunol.177.9.5946; Facciponte JG, 2007, EUR J IMMUNOL, V37, P2268, DOI 10.1002/eji.200737127; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gong JL, 2009, J IMMUNOL, V183, P3092, DOI 10.4049/jimmunol.0901235; Guo CQ, 2012, IMMUNOL CELL BIOL, V90, P101, DOI 10.1038/icb.2011.10; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Murshid A, 2012, MOL CHAPERONES SCAVE, P215; Murshid Ayesha, 2013, Methods Mol Biol, V960, P209, DOI 10.1007/978-1-62703-218-6_17; Murshid A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00063; Murshid A, 2010, J IMMUNOL, V185, P2903, DOI 10.4049/jimmunol.0903635; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Pfistershammer K, 2008, J LEUKOCYTE BIOL, V83, P131, DOI 10.1189/jlb.0407231; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Todt JC, 2008, J LEUKOCYTE BIOL, V84, P510, DOI 10.1189/jlb.0307135; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Tuyt LML, 1999, J IMMUNOL, V162, P4893; Uto T, 2007, J IMMUNOL, V178, P2979, DOI 10.4049/jimmunol.178.5.2979; Vogel SN, 1998, PROG CLIN BIOL RES, V397, P137; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060078; Yi H, 2013, CANCER RES, V71, P6611; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105; Zietara N, 2009, J IMMUNOL, V183, P1099, DOI 10.4049/jimmunol.0803214; Zuo D, 2011, HEPATOLOGY, V57, P228	55	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122529	10.1371/journal.pone.0122529	http://dx.doi.org/10.1371/journal.pone.0122529			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836976	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000099
J	Smith, EL; Rashidi, H; Kanczler, JM; Shakesheff, KM; Oreffo, ROC				Smith, Emma L.; Rashidi, Hassan; Kanczler, Janos M.; Shakesheff, Kevin M.; Oreffo, Richard O. C.			The Effects of 1 alpha, 25-dihydroxyvitamin D-3 and Transforming Growth Factor-beta 3 on Bone Development in an Ex Vivo Organotypic Culture System of Embryonic Chick Femora	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; VITAMIN-D-RECEPTOR; FACTOR-BETA; ENDOCHONDRAL OSSIFICATION; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN-D3; DIFFERENTIATION; CARTILAGE; FETAL; STIMULATION	Transforming growth factor-beta3 (TGF-beta 3) and 1 alpha, 25-dihydroxyvitamin D-3 (1 alpha, 25 (OH) D-2(3)) are essential factors in chondrogenesis and osteogenesis respectively. These factors also play a fundamental role in the developmental processes and the maintenance of skeletal integrity, but their respective direct effects on these processes are not fully understood. Using an organotypic bone rudiment culture system the current study has examined the direct roles the osteotropic factors 1 alpha, 25 (OH) D-2(3) and TGF-beta 3 exert on the development and modulation of the three dimensional structure of the embryonic femur. Isolated embryonic chick femurs (E11) were organotypically cultured for 10 days in basal media, or basal media supplemented with either 1 alpha, 25 (OH) D-2(3) (25 nM) or TGF-beta 3 (5 ng/mL & 15 ng/mL). Analyses of the femurs were undertaken using micro-computed tomography (mu CT), histology and immunohistochemistry. 1 alpha, 25 (OH)(2)D-3 supplemented cultures enhanced osteogenesis directly in the developing femurs with elevated levels of osteogenic markers such as type 1 collagen. In marked contrast organotypic femur cultures supplemented with TGF-beta 3 (5 ng/mL & 15 ng/mL) demonstrated enhanced chondrogenesis with a reduction in osteogenesis. These studies demonstrate the efficacy of the ex vivo organotypic embryonic femur culture employed to elucidate the direct roles of these molecules, 1 alpha, 25 (OH) 2D3 and TGF-beta 3 on the structural development of embryonic bone within a three dimensional framework. We conclude that 1 alpha, 25(OH)(2)D and TGF-beta 3 modify directly the various cell populations in bone rudiment organotypic cultures effecting tissue metabolism resulting in significant changes in embryonic bone growth and modulation. Understanding the roles of osteotropic agents in the process of skeletal development is integral to developing new strategies for the recapitulation of bone tissue in later life.	[Smith, Emma L.; Kanczler, Janos M.; Oreffo, Richard O. C.] Univ Southampton, Human Dev & Hlth, Bone & Joint Res Grp, Southampton, Hants, England; [Rashidi, Hassan; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham, England	University of Southampton; University of Nottingham	Oreffo, ROC (corresponding author), Univ Southampton, Human Dev & Hlth, Bone & Joint Res Grp, Southampton, Hants, England.	roco@soton.ac.uk	Rashidi, Hassan/N-9313-2014; Shakesheff, Kevin/AAR-6603-2021; Shakesheff, Kevin M/O-6371-2018; Oreffo, Richard OC/A-4615-2011	Rashidi, Hassan/0000-0001-8078-6688; Shakesheff, Kevin M/0000-0003-3236-2439; Oreffo, Richard OC/0000-0001-5995-6726; Kanczler, Janos/0000-0001-7249-0414	Biotechnology and Biological Sciences Research Council, UK [BB/G010579/1]; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish; BBSRC [BB/G010579/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the strategic longer and larger grant (sLOLA) from the Biotechnology and Biological Sciences Research Council, UK-grant number BB/G010579/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; BAGI CM, 1992, J BONE MINER RES, V7, P29; BERESFORD JN, 1986, ENDOCRINOLOGY, V119, P1776, DOI 10.1210/endo-119-4-1776; Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013; Brady K, 2014, STEM CELLS DEV, V23, P541, DOI 10.1089/scd.2013.0301; Cheah FSH, 2010, MECH DEVELOP, V127, P329, DOI 10.1016/j.mod.2010.04.003; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Curtis KM, 2014, MOL ENDOCRINOL, V28, P644, DOI 10.1210/me.2013-1241; Davies JH, 2011, J PEDIATR ORTHOPED, V31, P798, DOI 10.1097/BPO.0b013e31822f1af1; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Endo H, 1980, VITAMIN D3 METABOLIT; Farquharson C, 1996, J ENDOCRINOL, V149, P277, DOI 10.1677/joe.0.1490277; GRYNPAS MD, 1988, J BONE MINER RES, V3, P159; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Harvey Nicholas, 2004, J Br Menopause Soc, V10, P14, DOI 10.1258/136218004322986726; Hechavarria D, 2010, MED ENG PHYS, V32, P1065, DOI 10.1016/j.medengphy.2010.07.010; Hewison M, 2010, J BONE MINER RES, V25, P11, DOI 10.1002/jbmr.2; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kanczler JM, 2012, TISSUE ENG PART C-ME, V18, P747, DOI 10.1089/ten.tec.2012.0033; Kovacs Christopher S, 2011, Curr Osteoporos Rep, V9, P274, DOI 10.1007/s11914-011-0073-0; Lanske B, 2007, J NUTR BIOCHEM, V18, P771, DOI 10.1016/j.jnutbio.2007.02.002; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; Longaker MT, 2001, J CRANIOFAC SURG, V12, P389, DOI 10.1097/00001665-200107000-00016; Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; MATSUMOTO T, 1991, BONE, V12, P27, DOI 10.1016/8756-3282(91)90051-J; Matsunaga S, 1999, INT J ONCOL, V14, P1063; Mehlhorn AT, 2006, TISSUE ENG, V12, P1393, DOI 10.1089/ten.2006.12.1393; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Mrugala D, 2008, ANN RHEUM DIS, V67, P288, DOI 10.1136/ard.2007.076620; NARBAITZ R, 1989, CALCIFIED TISSUE INT, V44, P348, DOI 10.1007/BF02556316; Opperman L, 1998, J CRANIOFACIAL GENET, V19, P164; Opperman LA, 2000, DEV DYNAM, V219, P237, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1044>3.0.CO;2-F; Park JS, 2009, J BIOMED MATER RES A, V91A, P408, DOI 10.1002/jbm.a.32271; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poisson E, 2009, TRANSFORMING GROWTH; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; Smith EL, 2013, EUR CELLS MATER, V26, P91, DOI 10.22203/eCM.v026a07; Smith EL, 2012, TISSUE ENG PART C-ME, V18, P984, DOI [10.1089/ten.tec.2012.0132, 10.1089/ten.TEC.2012.0132]; St-Arnaud R, 2010, J STEROID BIOCHEM, V121, P254, DOI 10.1016/j.jsbmb.2010.02.002; SUDA S, 1985, CALCIFIED TISSUE INT, V37, P82, DOI 10.1007/BF02557684; Tang QO, 2009, TGF BETA3 POTENTIAL; THORP BH, 1992, DEVELOPMENT, V114, P907; THORP BH, 1994, BONE, V15, P59, DOI 10.1016/8756-3282(94)90892-3; Turner NJ, 2013, BIRTH DEFECTS RES C, V99, P149, DOI 10.1002/bdrc.21040; Woeckel VJ, 2013, GENE, V512, P438, DOI 10.1016/j.gene.2012.07.051; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542; Yoshida T, 2012, ENDOCRIN METAB CLIN, V41, P557, DOI 10.1016/j.ecl.2012.04.003	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121653	10.1371/journal.pone.0121653	http://dx.doi.org/10.1371/journal.pone.0121653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835745	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352139000054
J	Mohamed, RH; Sutoh, Y; Itoh, Y; Otsuka, N; Miyatake, Y; Ogasawara, K; Kasahara, M				Mohamed, Rania Hassan; Sutoh, Yoichi; Itoh, Yasushi; Otsuka, Noriyuki; Miyatake, Yukiko; Ogasawara, Kazumasa; Kasahara, Masanori			The SKINT1-Like Gene Is Inactivated in Hominoids But Not in All Primate Species: Implications for the Origin of Dendritic Epidermal T Cells	PLOS ONE			English	Article							GAMMA-DELTA; BOVINE SKIN; RECEPTOR; EXPRESSION; DIVERSITY; SELECTION; PHYLOGENOMICS; REPERTOIRE; GENERATION; MECHANISM	Dendritic epidermal T cells, which express an invariant V.5V delta 1 T-cell receptor and account for 95% of all resident T cells in the mouse epidermis, play a critical role in skin immune surveillance. These gamma delta T cells are generated by positive selection in the fetal thymus, after which they migrate to the skin. The development of dendritic epidermal T cells is critically dependent on the Skint1 gene expressed specifically in keratinocytes and thymic epithelial cells, suggesting an indispensable role for Skint1 in the selection machinery for specific intraepithelial lymphocytes. Phylogenetically, rodents have functional SKINT1 molecules, but humans and chimpanzees have a SKINT1-like (SKINT1L) gene with multiple inactivating mutations. In the present study, we analyzed SKINT1L sequences in representative primate species and found that all hominoid species have a common inactivating mutation, but that Old World monkeys such as olive baboons, green monkeys, cynomolgus macaques and rhesus macaques have apparently functional SKINT1L sequences, indicating that SKINT1L was inactivated in a common ancestor of hominoids. Interestingly, the epidermis of cynomolgus macaques contained a population of dendritic-shaped gamma delta T cells expressing a semi-invariant V.10/V delta 1 T-cell receptor. However, this population of macaque T cells differed from rodent dendritic epidermal T cells in that their V.10/V delta 1 T-cell receptors displayed junctional diversity and expression of V.10 was not epidermis-specific. Therefore, macaques do not appear to have rodent-type dendritic epidermal T cells despite having apparently functional SKINT1L. Comprehensive bioinformatics analysis indicates that SKINT1L emerged in an ancestor of placental mammals but was inactivated or lost multiple times in mammalian evolution and that Skint1 arose by gene duplication in a rodent lineage, suggesting that authentic dendritic epidermal T cells are presumably unique to rodents.	[Mohamed, Rania Hassan; Sutoh, Yoichi; Otsuka, Noriyuki; Miyatake, Yukiko; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Itoh, Yasushi; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga 52021, Japan	Hokkaido University; Shiga University of Medical Science	Kasahara, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	mkasaha@med.hokudai.ac.jp	Kasahara, Masanori/G-7651-2011; Sutoh, Yoichi/AAA-5516-2020	Sutoh, Yoichi/0000-0002-1607-9759; Mohamed, Rania/0000-0001-7391-9550; Itoh, Yasushi/0000-0001-7462-2193; Miyatake, Yukiko/0000-0001-9591-0151	JSPS KAKENHI [24390091]; Ministry of Higher Education and Scientific Research of Egypt	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Higher Education and Scientific Research of Egypt(Ministry of Higher Education & Scientific Research (MHESR))	This work was supported by JSPS KAKENHI Grant Number 24390091. RHM was supported by a stipend from the Ministry of Higher Education and Scientific Research of Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; Afrache H, 2012, IMMUNOGENETICS, V64, P781, DOI 10.1007/s00251-012-0619-z; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; FOSTER CA, 1990, J EXP MED, V171, P997, DOI 10.1084/jem.171.4.997; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Hein WR, 1997, IMMUNOLOGY, V91, P58, DOI 10.1046/j.1365-2567.1997.00224.x; HUCK S, 1988, EMBO J, V7, P719, DOI 10.1002/j.1460-2075.1988.tb02868.x; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Kazen AR, 2011, P NATL ACAD SCI USA, V108, pE332, DOI 10.1073/pnas.1105105108; KLEIN MH, 1987, P NATL ACAD SCI USA, V84, P6884, DOI 10.1073/pnas.84.19.6884; Kuhnlein P, 1996, EUR J IMMUNOL, V26, P3092, DOI 10.1002/eji.1830261240; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spetz AL, 1996, AM J PATHOL, V149, P665; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Van Rhijn I, 2007, J LEUKOCYTE BIOL, V81, P968, DOI 10.1189/jlb.0506331; Witherden DA, 2011, TRENDS IMMUNOL, V32, P265, DOI 10.1016/j.it.2011.03.005; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x; Yoshida S, 2012, J IMMUNOL, V188, P3972, DOI 10.4049/jimmunol.1102886	35	8	11	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123258	10.1371/journal.pone.0123258	http://dx.doi.org/10.1371/journal.pone.0123258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830554	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600140
J	Baglioni, M; Russo, F; Geraci, F; Rizzo, M; Rainaldi, G; Pellegrini, M				Baglioni, Miriam; Russo, Francesco; Geraci, Filippo; Rizzo, Milena; Rainaldi, Giuseppe; Pellegrini, Marco			A New Method for Discovering Disease-Specific MiRNA-Target Regulatory Networks	PLOS ONE			English	Article							CENTRALITY; GENES; EXPRESSION; IDENTIFICATION; RESOURCE; INVASION; FAMILY; CELLS	Genes and their expression regulation are among the key factors in the comprehension of the genesis and development of complex diseases. In this context, microRNAs (miRNAs) are post-transcriptional regulators that play an important role in gene expression since they are frequently deregulated in pathologies like cardiovascular disease and cancer. In vitro validation of miRNA -targets regulation is often too expensive and time consuming to be carried out for every possible alternative. As a result, a tool able to provide some criteria to prioritize trials is becoming a pressing need. Moreover, before planning in vitro experiments, the scientist needs to evaluate the miRNA-target genes interaction network. In this paper we describe the miRable method whose purpose is to identify new potentially relevant genes and their interaction networks associate to a specific pathology. To achieve this goal miRable follows a system biology approach integrating together general-purpose medical knowledge (literature, Protein-Protein Interaction networks, prediction tools) and pathology specific data (gene expression data). A case study on Prostate Cancer has shown that miRable is able to: 1) find new potential miRNA-targets pairs, 2) highlight novel genes potentially involved in a disease but never or little studied before, 3) reconstruct all possible regulatory subnetworks starting from the literature to expand the knowledge on the regulation of miRNA regulatory mechanisms.	[Baglioni, Miriam; Geraci, Filippo] CNR, Inst Informat & Telemat, I-56124 Pisa, Italy; [Russo, Francesco; Rainaldi, Giuseppe; Pellegrini, Marco] CNR, Inst Informat & Telemat, Lab Integrat Syst Med, I-56124 Pisa, Italy; [Russo, Francesco; Rizzo, Milena; Rainaldi, Giuseppe; Pellegrini, Marco] CNR, Inst Clin Physiol IFC, I-56124 Pisa, Italy; [Russo, Francesco] Univ Pisa, Dept Comp Sci, I-56127 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa	Russo, F (corresponding author), CNR, Inst Informat & Telemat, Lab Integrat Syst Med, Via G Moruzzi 1, I-56124 Pisa, Italy.	francesco.russo@iit.cnr.it	Pellegrini, Marco/AAX-9568-2020; Rizzo, Milena/L-1481-2016; Baglioni, Miriam/AAL-5697-2021; Russo, Francesco/X-3055-2018	Rizzo, Milena/0000-0001-5924-8615; GERACI, FILIPPO/0000-0001-6993-6761; Russo, Francesco/0000-0001-9257-4359; Baglioni, Miriam/0000-0002-2273-9004; Pellegrini, Marco/0000-0003-3151-9481	Progetto Istituto Toscano Tumori Grant [2012 Prot.A00GRT]; Flagship project InterOmics - Italian MIUR organization [PB.P05]; Flagship project InterOmics - CNR organization [PB.P05]; joint IIT-IFC Laboratory of Integrative Systems Medicine (LISM)	Progetto Istituto Toscano Tumori Grant; Flagship project InterOmics - Italian MIUR organization; Flagship project InterOmics - CNR organization; joint IIT-IFC Laboratory of Integrative Systems Medicine (LISM)	FR has been supported by a fellowship sponsored by Progetto Istituto Toscano Tumori Grant 2012 Prot.A00GRT. The present work is partially supported by the Flagship project InterOmics(PB.P05), funded by the Italian MIUR and CNR organizations, and by the joint IIT-IFC Laboratory of Integrative Systems Medicine (LISM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2000, CELL, V136, P25; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bisognin A, 2012, NUCLEIC ACIDS RES, V40, pW13, DOI 10.1093/nar/gks460; Boldi P, 2014, AXIOMS CENTRALITY; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Fioretti FM, 2014, J MOL ENDOCRINOL, V52, pR257, DOI 10.1530/JME-14-0030; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fu C, 2014, TUMOUR BIOL; HAGE P, 1995, SOC NETWORKS, V17, P57, DOI 10.1016/0378-8733(94)00248-9; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jourquin J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S20; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Kwak SY, 2014, BBA-MOL CELL RES, V1843, P508, DOI 10.1016/j.bbamcr.2013.11.021; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang TM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/679563; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Ries J, 2014, ONCOL REP, V31, P1429, DOI 10.3892/or.2014.2983; Russo F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S3-S4; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Tang YF, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S3-S6; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang LG, 2009, AM J TRANSL RES, V1, P62; Xiao J, 2012, PROSTATE, V72, P1514, DOI 10.1002/pros.22501	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122473	10.1371/journal.pone.0122473	http://dx.doi.org/10.1371/journal.pone.0122473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848944	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800131
J	Balanovsky, O; Zhabagin, M; Agdzhoyan, A; Chukhryaeva, M; Zaporozhchenko, V; Utevska, O; Highnam, G; Sabitov, Z; Greenspan, E; Dibirova, K; Skhalyakho, R; Kuznetsova, M; Koshel, S; Yusupov, Y; Nymadawa, P; Zhumadilov, Z; Pocheshkhova, E; Haber, M; Zalloua, PA; Yepiskoposyan, L; Dybo, A; Tyler-Smith, C; Balanovska, E				Balanovsky, Oleg; Zhabagin, Maxat; Agdzhoyan, Anastasiya; Chukhryaeva, Marina; Zaporozhchenko, Valery; Utevska, Olga; Highnam, Gareth; Sabitov, Zhaxylyk; Greenspan, Elliott; Dibirova, Khadizhat; Skhalyakho, Roza; Kuznetsova, Marina; Koshel, Sergey; Yusupov, Yuldash; Nymadawa, Pagbajabyn; Zhumadilov, Zhaxybay; Pocheshkhova, Elvira; Haber, Marc; Zalloua, Pierre A.; Yepiskoposyan, Levon; Dybo, Anna; Tyler-Smith, Chris; Balanovska, Elena			Deep Phylogenetic Analysis of Haplogroup G1 Provides Estimates of SNP and STR Mutation Rates on the Human Y-Chromosome and Reveals Migrations of Iranic Speakers	PLOS ONE			English	Article							MTDNA VARIATION; EAST-ASIA; POPULATION; ORIGIN; HERITAGE	Y-chromosomal haplogroup G1 is a minor component of the overall gene pool of South-West and Central Asia but reaches up to 80% frequency in some populations scattered within this area. We have genotyped the G1-defining marker M285 in 27 Eurasian populations (n = 5,346), analyzed 367 M285-positive samples using 17 Y-STRs, and sequenced similar to 11 Mb of the Y-chromosome in 20 of these samples to an average coverage of 67X. This allowed detailed phylogenetic reconstruction. We identified five branches, all with high geographical specificity: G1-L1323 in Kazakhs, the closely related G1-GG1 in Mongols, G1-GG265 in Armenians and its distant brother clade G1-GG162 in Bashkirs, and G1-GG362 in West Indians. The haplotype diversity, which decreased from West Iran to Central Asia, allows us to hypothesize that this rare haplogroup could have been carried by the expansion of Iranic speakers northwards to the Eurasian steppe and via founder effects became a predominant genetic component of some populations, including the Argyn tribe of the Kazakhs. The remarkable agreement between genetic and genealogical trees of Argyns allowed us to calibrate the molecular clock using a historical date (1405 AD) of the most recent common genealogical ancestor. The mutation rate for Y-chromosomal sequence data obtained was 0.78x10(-9) per bp per year, falling within the range of published rates. The mutation rate for Y-chromosomal STRs was 0.0022 per locus per generation, very close to the so-called genealogical rate. The "clan-based" approach to estimating the mutation rate provides a third, middle way between direct farther-to-son comparisons and using archeologically known migrations, whose dates are subject to revision and of uncertain relationship to genetic events.	[Balanovsky, Oleg; Zhabagin, Maxat; Agdzhoyan, Anastasiya; Chukhryaeva, Marina; Dibirova, Khadizhat; Skhalyakho, Roza] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Balanovsky, Oleg; Chukhryaeva, Marina; Zaporozhchenko, Valery; Dibirova, Khadizhat; Skhalyakho, Roza; Kuznetsova, Marina; Balanovska, Elena] Russian Acad Sci, Med Genet Res Ctr, Moscow, Russia; [Zhabagin, Maxat; Sabitov, Zhaxylyk] Nazarbayev Univ, Ctr Life Sci, Astana, Kazakhstan; [Utevska, Olga] Kharkov Natl Univ, Dept Genet & Citol, Kharkov, Ukraine; [Highnam, Gareth; Greenspan, Elliott] Gene Gene Ltd, Houston, TX USA; [Sabitov, Zhaxylyk] Gumilov Eurasian Natl Univ, Astana, Kazakhstan; [Koshel, Sergey] Moscow MV Lomonosov State Univ, Fac Geog, Moscow, Russia; [Yusupov, Yuldash] Inst Humanitarian Res Republ Bashkortostan, Ufa, Russia; [Nymadawa, Pagbajabyn] Mongolian Acad Med Sci, Ulaanbaatar, Mongolia; [Zhumadilov, Zhaxybay] Krasnodar State Med Univ, Krasnodar, Russia; [Pocheshkhova, Elvira; Haber, Marc; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Zalloua, Pierre A.] Lebanese Amer Univ, Beirut, Lebanon; [Yepiskoposyan, Levon] Natl Acad Sci Republ Armenia, Inst Mol Biol, Yerevan, Armenia; [Dybo, Anna] Russian Acad Sci, Inst Linguist, Moscow, Russia	Russian Academy of Sciences; Vavilov Institute of General Genetics; Research Centre for Medical Genetics; Russian Academy of Sciences; Nazarbayev University; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; L.N. Gumilyov Eurasian National University; Lomonosov Moscow State University; Mongolian Academy of Sciences; Kuban State Medical University; Wellcome Trust Sanger Institute; Lebanese American University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Institute of Linguistics, Russian Academy of Sciences; Russian Academy of Sciences	Balanovsky, O (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	balanovsky@inbox.ru	Pocheshkhova, Elvira/P-2207-2017; Zhabagin, Maxat/P-9956-2015; Sabitov, Zhaxylyk M./P-7576-2014; Nymadawa, Pagbajab/AAE-7344-2019; Haber, Marc/Y-5090-2019; Koshel, Sergey M/B-2662-2012; Agdzhoyan, Anastasia/G-1540-2014; Dybo, Anna/F-8623-2016	Pocheshkhova, Elvira/0000-0002-8991-7194; Zhabagin, Maxat/0000-0003-3414-0610; Sabitov, Zhaxylyk M./0000-0001-7186-156X; Nymadawa, Pagbajab/0000-0002-3189-2772; Haber, Marc/0000-0003-1000-1448; Koshel, Sergey M/0000-0002-4540-2922; Agdzhoyan, Anastasia/0000-0002-8776-2934; Dybo, Anna/0000-0002-6077-7183; Shalaho, Roza/0000-0002-4005-1887; zalloua, pierre/0000-0002-8494-5081; Utevska, Olga/0000-0002-5787-0467; Yusupov, Yuldash/0000-0002-7210-7136	Russian Scientific Foundation [14-14-00827]; Center for Life Sciences of Nazarbayev University; RFBR [13-04-01711]; Wellcome Trust [098051]; Russian Science Foundation [14-14-00827] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Center for Life Sciences of Nazarbayev University; RFBR(Russian Foundation for Basic Research (RFBR)); Wellcome Trust(Wellcome TrustEuropean Commission); Russian Science Foundation(Russian Science Foundation (RSF))	This study received primary support from the Russian Scientific Foundation grant 14-14-00827, including funding for genotyping, data analysis, and completing the paper. MZ and his research has been funded by research project and research grant from Center for Life Sciences of Nazarbayev University. Analyses related to Indo-European problem were funded by RFBR grant 13-04-01711. CTS is supported by The Wellcome Trust (grant 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-59; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; BANDELT HJ, 1995, GENETICS, V141, P743; Biro AZ, 2009, AM J PHYS ANTHROPOL, V139, P305, DOI 10.1002/ajpa.20984; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Chennakrishnaiah S, 2013, GENE, V526, P96, DOI 10.1016/j.gene.2013.04.074; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Di Cristofaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076748; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eaaswarkhanth M, 2010, EUR J HUM GENET, V18, P354, DOI 10.1038/ejhg.2009.168; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Ge JY, 2009, FORENSIC SCI INT-GEN, V3, P179, DOI 10.1016/j.fsigen.2009.01.007; Ginzburg V, 1956, WORKS KIRGHIZ ARCHAE, V1, P85; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Gusmao L, 2005, HUM MUTAT, V26, P520, DOI 10.1002/humu.20254; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; Haber M, 2011, EUR J HUM GENET, V19, P334, DOI 10.1038/ejhg.2010.177; Heath T., 2008, THESIS; Herrera KJ, 2012, EUR J HUM GENET, V20, P313, DOI 10.1038/ejhg.2011.192; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kazarnitskiy A. A., 2012, POPULATION AZOV CASP; Khachikyan L, 1969, B YEREVAN STATE U, V2, P115; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Koshel S.M., 2012, SOVREMENNAYA GEOGRAF, P158; Lashgary Z, 2011, ANN HUM BIOL, V38, P364, DOI 10.3109/03014460.2010.535562; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; Margaryan A, 2012, HUM BIOL, V84, P405, DOI 10.3378/027.084.0404; Masanov N, 2011, NOMADIC KAZAKHS CIVI, P740; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Nei M., 1987, MOL EVOLUTIONARY GEN; Oransky I, 1960, INTRO IRANIAN PHILOL, P62; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Rootsi S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3928; Rootsi S, 2012, EUR J HUM GENET, V20, P1275, DOI 10.1038/ejhg.2012.86; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sanchez-Diz P, 2008, INT J LEGAL MED, V122, P529, DOI 10.1007/s00414-008-0265-z; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Torlakian BG, 1981, ETHNOGRAPHY FOLKLORE, V13, P24; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	55	32	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122968	10.1371/journal.pone.0122968	http://dx.doi.org/10.1371/journal.pone.0122968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849548	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800185
J	Braicu, C; Pileczki, V; Pop, L; Petric, RC; Chira, S; Pointiere, E; Achimas-Cadariu, P; Berindan-Neagoe, I				Braicu, Cornelia; Pileczki, Valentina; Pop, Laura; Petric, Roxana Cojocneanu; Chira, Sergiu; Pointiere, Eve; Achimas-Cadariu, Patriciu; Berindan-Neagoe, Ioana			Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model	PLOS ONE			English	Article							MUTANT P53; GREEN TEA; APOPTOSIS; AUTOPHAGY; PROLIFERATION; INHIBITION; MIGRATION	Triple-negative breast cancer (TNBC) is a highly aggressive phenotype that is resistant to standard therapy. Thus, the development of alternative therapeutic strategies for TNBC is essential. The purpose of our in vitro study was to evaluate the impact of p53 gene silencing in conjunction with the administration of a natural compound, epigallocatechingallate (EGCG). RT(2)Profiler PCR Array technology was used to evaluate the impact of dual treatment on the main genes involved in apoptosis in the Hs578T cell culture model of TNBC. Gene expression analysis revealed 28 genes were significantly altered (16 upregulated and 12 downregulated) in response to combined p53 siRNA and EGCG treatment. Further analysis revealed that p53 siRNA and EGCG dual therapy leads to the activation of pro-apoptotic genes and the inhibition of pro-survival genes, autophagy, and cell network formation. These results indicate that this dual therapy targets both the apoptotic and angiogenic pathways, which may improve treatment effectiveness for tumors resistant to conventional treatment.	[Braicu, Cornelia; Pileczki, Valentina; Pop, Laura; Petric, Roxana Cojocneanu; Chira, Sergiu; Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania; [Pileczki, Valentina] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Cluj Napoca, Romania; [Petric, Roxana Cojocneanu] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania; [Pointiere, Eve] Haute Ecole Louvain Hainaut, Fleurus, Belgium; [Achimas-Cadariu, Patriciu] Oncol Inst Prof Dr Ion Chiricuta, Dept Surg, Cluj Napoca, Romania; [Achimas-Cadariu, Patriciu] Iuliu Hatieganu Univ Med & Pharm, Dept Surg Oncol & Gynaecol Oncol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Dept Immunol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] Oncol Inst Prof Dr Ion Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] MD Anderson Canc Ctr Houston, Dept Expt Therapeut, Houston, TX USA	Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Babes Bolyai University from Cluj; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Oncology Institute Prof. Dr. Ion Chiricuta; University of Texas System; UTMD Anderson Cancer Center	Achimas-Cadariu, P (corresponding author), Oncol Inst Prof Dr Ion Chiricuta, Dept Surg, Cluj Napoca, Romania.	pachimas@umfcluj.ro; ioananeagoe29@gmail.com	Pop, Laura/AAY-8349-2020; Berindan-Neagoe, Ioana/AAH-9854-2019; Chira, Sergiu/AAD-4885-2020; Pileczki, Valentina/ABB-6273-2020; Pop, Laura A/B-8218-2012	Pop, Laura/0000-0002-5806-0220; Chira, Sergiu/0000-0001-6075-7468; Pop, Laura A/0000-0002-5806-0220; Cojocneanu, Roxana-Maria/0000-0002-7450-9454	Sectoral Operational Program for Increasing the Economic Competitiveness (POSCCE) [709/2010]; NATIONAL PLAN FOR RESEARCH, DEVELOPMENT AND INNOVATION (PNII); European Social Fund; Human Resources Development Operational Programme [POSDRU/159/1.5/S/138776]	Sectoral Operational Program for Increasing the Economic Competitiveness (POSCCE); NATIONAL PLAN FOR RESEARCH, DEVELOPMENT AND INNOVATION (PNII); European Social Fund(European Social Fund (ESF)); Human Resources Development Operational Programme	This work was financed by the Sectoral Operational Program for Increasing the Economic Competitiveness (POSCCE) 709/2010 grant with the title: "Clinical and economical impact of proteom and transcriptom molecular profiling in neoadjuvant therapy of triple negative breast cancer (BREASTIMPACT)". Cornelia Braicu has received a research grant financed by THE NATIONAL PLAN FOR RESEARCH, DEVELOPMENT AND INNOVATION 2007-2013 (PNII) with title: "Modulation of pro/anticarcinogenic effect of toxic chemical agents in breast cancer multitargeted therapy (CANCERTER-p53). Valentina Pileczki, Laura Pop, and Roxana Cojocneanu Petric has received a fellowships under the frame of European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/138776 with title: "Model colaborativ institutional pentru translatarea cercetarii stiintifice biomedicale in practica clinica-TRANCENT". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencio IA, 2006, CANCER GENE THER, V13, P169, DOI 10.1038/sj.cgt.7700870; Berindan-Neagoe I, 2012, INT J NANOMED, V7, P6035, DOI 10.2147/IJN.S36523; Braicu C, 2013, MOL CELL BIOCHEM, V381, P61, DOI 10.1007/s11010-013-1688-5; Braicu C, 2013, J NANOSCI NANOTECHNO, V13, P632, DOI 10.1166/jnn.2013.6882; Braicu C, 2013, J DRUG TARGET, V21, P250, DOI 10.3109/1061186X.2012.740673; Chen CA, 2008, CANCER BIOL THER, V7, P303, DOI 10.4161/cbt.7.2.5333; Chen WC, 2014, FOOD FUNCT, V5, P1856, DOI [10.1039/c4fo00145a, 10.1039/C4FO00145A]; Chiorean R, 2013, BREAST, V22, P1026, DOI 10.1016/j.breast.2013.08.007; Chittaranjan S, 2014, CLIN CANCER RES, V20, P3159, DOI 10.1158/1078-0432.CCR-13-2060; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dai FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052162; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Jiang Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.200; Johnson R, 2013, PHARMACEUTICS, V1, DOI [10.3390/pharmaceutics5020329, DOI 10.3390/PHARMACEUTICS5020329]; Kanwar Jyoti, 2012, Front Biosci (Elite Ed), V4, P111; Liu K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.51; Liu K, 2013, LIVER INT, V33, P1566, DOI 10.1111/liv.12238; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Sharma C, 2012, ASIAN PAC J CANCER P, V13, P4815, DOI 10.7314/APJCP.2012.13.9.4815; Storvold Gro Leite, 2006, Critical Reviews in Oncogenesis, V12, P127; Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88; Tachibana H, 2011, P JPN ACAD B-PHYS, V87, P66, DOI 10.2183/pjab.87.66; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Yadav BS, 2014, WORLD J CLIN ONCOL, V5, P125, DOI 10.5306/wjco.v5.i2.125	27	22	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120936	10.1371/journal.pone.0120936	http://dx.doi.org/10.1371/journal.pone.0120936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849487	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800040
J	Hashimoto, M; Yamazaki, T; Hamaguchi, M; Morimoto, T; Yamori, M; Asai, K; Isobe, Y; Furu, M; Ito, H; Fujii, T; Terao, C; Mori, M; Matsuo, T; Yoshitomi, H; Yamamoto, K; Yamamoto, W; Bessho, K; Mimori, T				Hashimoto, Motomu; Yamazaki, Toru; Hamaguchi, Masahide; Morimoto, Takeshi; Yamori, Masashi; Asai, Keita; Isobe, Yu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Terao, Chikashi; Mori, Masato; Matsuo, Takashi; Yoshitomi, Hiroyuki; Yamamoto, Keiichi; Yamamoto, Wataru; Bessho, Kazuhisa; Mimori, Tsuneyo			Periodontitis and Porphyromonas gingivalis in Preclinical Stage of Arthritis Patients	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SHARED EPITOPE; RISK-FACTOR; TOOTH LOSS; DISEASE; ASSOCIATION; RECOMMENDATIONS; AUTOIMMUNITY; INFECTIONS; MICROBIOTA	Purpose To determine whether the presence of periodontitis (PD) and Porphyromonas gingivalis (Pg) in the subgingival biofilm associates with the development of rheumatoid arthritis (RA) in treatment naive preclinical stage of arthritis patients. Methods We conducted a prospective cohort study of 72 consecutive patients with arthralgia who had never been treated with any anti-rheumatic drugs or glucocorticoids. Periodontal status at baseline was assessed by dentists. PD was defined stringently by the maximal probing depth. 4 mm, or by the classification by the 5th European Workshop in Periodontology (EWP) in 2005 using attachment loss. Up to eight plaque samples were obtained from each patient and the presence of Pg was determined by Taqman PCR. The patients were followed up for 2 years and introduction rate of methotrexate (MTX) treatment on the diagnosis of RA was compared in patients with or without PD or Pg. Results Patients with PD (probing depth >= 4mm) had higher arthritis activity (p = 0.02) and higher risk for future introduction of MTX treatment on the diagnosis of RA during the follow up than patients without PD (Hazard ratio 2.68, p = 0.03). Arthritis activity and risk for MTX introduction increased with the severity of PD assessed by EWP, although not statistically significant. On the other hand, presence of Pg was not associated with arthritis activity (p = 0.72) or the risk for MTX introduction (p = 0.45). Conclusion In treatment naive arthralgia patients, PD, but not the presence of Pg, associates with arthritis activity and future requirement of MTX treatment on the diagnosis of RA.	[Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Yamazaki, Toru; Yamori, Masashi; Asai, Keita; Isobe, Yu; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Hamaguchi, Masahide] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Gen Med, Kobe, Hyogo, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Fujii, Takao; Mori, Masato; Matsuo, Takashi; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Yoshitomi, Hiroyuki] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Kyoto, Japan; [Yamamoto, Keiichi] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Osaka, Japan; [Yamamoto, Wataru] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan	Kyoto University; Kyoto University; Kyoto Prefectural University of Medicine; Hyogo College of Medicine; University of Hyogo; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Osaka University	Hashimoto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan.	mohashim@kuhp.kyoto-u.ac.jp	Yamamoto, Keiichi/AFQ-9006-2022	Yamamoto, Keiichi/0000-0003-3278-5001; Hamaguchi, Masahide/0000-0002-8651-4445; , Hiroyuki/0000-0001-7339-9030	Ministry of Education, Culture, Sports, Science in Japan [23791113]	Ministry of Education, Culture, Sports, Science in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid (23791113) for Scientific Research from the Ministry of Education, Culture, Sports, Science in Japan (M. Hashimoto) http://kaken.nii.ac.jp/d/p/23791113.ja.html.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; de Pablo P, 2008, J RHEUMATOL, V35, P70; Demmer RT, 2011, J CLIN PERIODONTOL, V38, P998, DOI 10.1111/j.1600-051X.2011.01776.x; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Kennish L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001117; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Machado P, 2011, ANN RHEUM DIS, V70, P15, DOI 10.1136/ard.2010.130625; Marotte H, 2006, ANN RHEUM DIS, V65, P905, DOI 10.1136/ard.2005.036913; Martinez-Martinez RE, 2009, J CLIN PERIODONTOL, V36, P1004, DOI 10.1111/j.1600-051X.2009.01496.x; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mikuls TR, 2012, ARTHRITIS RHEUM-US, V64, P3522, DOI 10.1002/art.34595; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Ozmeric N, 2000, ACTA ODONTOL SCAND, V58, P183, DOI 10.1080/000163500429190; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Spahr A, 2006, ARCH INTERN MED, V166, P554, DOI 10.1001/archinte.166.5.554; Suzuki N, 2005, CLIN MED RES, V3, P176, DOI 10.3121/cmr.3.3.176; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wolff B, 2014, RHEUMATOLOGY, V53, P526, DOI 10.1093/rheumatology/ket362; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xiong X, 2013, J PUBLIC HEALTH DENT, V73, P41, DOI 10.1111/jphd.12004	38	33	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122121	10.1371/journal.pone.0122121	http://dx.doi.org/10.1371/journal.pone.0122121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849461	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800100
J	Kaur, S; Jobling, S; Jones, CS; Noble, LR; Routledge, EJ; Lockyer, AE				Kaur, Satwant; Jobling, Susan; Jones, Catherine S.; Noble, Leslie R.; Routledge, Edwin J.; Lockyer, Anne E.			The Nuclear Receptors of Biomphalaria glabrata and Lottia gigantea: Implications for Developing New Model Organisms	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTOR; VERTEBRATE SEX STEROIDS; LIGAND-BINDING DOMAIN; FRESH-WATER SNAIL; SCHISTOSOMA-MANSONI; HORMONE-RECEPTOR; ENDOCRINE DISRUPTION; MARISA-CORNUARIETIS; EXPRESSION ANALYSIS; SIGNALING PATHWAYS	Nuclear receptors (NRs) are transcription regulators involved in an array of diverse physiological functions including key roles in endocrine and metabolic function. The aim of this study was to identify nuclear receptors in the fully sequenced genome of the gastropod snail, Biomphalaria glabrata, intermediate host for Schistosoma mansoni and compare these to known vertebrate NRs, with a view to assessing the snail's potential as a invertebrate model organism for endocrine function, both as a prospective new test organism and to elucidate the fundamental genetic and mechanistic causes of disease. For comparative purposes, the genome of a second gastropod, the owl limpet, Lottia gigantea was also investigated for nuclear receptors. Thirty-nine and thirty-three putative NRs were identified from the B. glabrata and L. gigantea genomes respectively, based on the presence of a conserved DNA-binding domain and/or ligand-binding domain. Nuclear receptor transcript expression was confirmed and sequences were subjected to a comparative phylogenetic analysis, which demonstrated that these molluscs have representatives of all the major NR subfamilies (1-6). Many of the identified NRs are conserved between vertebrates and invertebrates, however differences exist, most notably, the absence of receptors of Group 3C, which includes some of the vertebrate endocrine hormone targets. The mollusc genomes also contain NR homologues that are present in insects and nematodes but not in vertebrates, such as Group 1J (HR48/DAF12/HR96). The identification of many shared receptors between humans and molluscs indicates the potential for molluscs as model organisms; however the absence of several steroid hormone receptors indicates snail endocrine systems are fundamentally different.	[Kaur, Satwant; Jobling, Susan; Routledge, Edwin J.; Lockyer, Anne E.] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England; [Jones, Catherine S.; Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Brunel University; University of Aberdeen	Lockyer, AE (corresponding author), Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England.	anne.lockyer@brunel.ac.uk	Lockyer, Anne/AAO-4327-2021; Routledge, Edwin John/V-2336-2019; Routledge, Edwin/AGI-0283-2022	Routledge, Edwin/0000-0001-7695-364X; Kaur, Satwant/0000-0002-8653-6791; Lockyer, Anne/0000-0002-3498-2423; Noble, leslie/0000-0003-3076-0759	National Centre for the Replacement, Refinement and Reduction of Animals in Research [G0900802]; National Centre for the Replacement [G0900802/1] Funding Source: researchfish	National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This work was funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research, Grant Ref: G0900802 to CSJ, LRN, SJ & EJR [www.nc3rs.org.uk]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antebi A, 2000, GENE DEV, V14, P1512; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Auwerx J, 1999, CELL, V97, P161; Baker ME, 2004, MOL CELL ENDOCRINOL, V215, P55, DOI 10.1016/j.mce.2003.11.007; Baker ME, 2008, BIOCHEM BIOPH RES CO, V375, P623, DOI 10.1016/j.bbrc.2008.08.047; Bannister R, 2007, ENVIRON SCI TECHNOL, V41, P2643, DOI 10.1021/es062565m; Bannister R, 2013, AQUAT TOXICOL, V140, P19, DOI 10.1016/j.aquatox.2013.05.002; Bardet PL, 2006, TRENDS ENDOCRIN MET, V17, P166, DOI 10.1016/j.tem.2006.03.005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benoit G, 2004, TRENDS CELL BIOL, V14, P369, DOI 10.1016/j.tcb.2004.05.007; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Bonneton F, 2008, INSECT BIOCHEM MOLEC, V38, P416, DOI 10.1016/j.ibmb.2007.10.006; Bouton D, 2005, J MOL ENDOCRINOL, V34, P567, DOI 10.1677/jme.1.01766; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Carter CJ, 2010, DEV BIOL, V343, P124, DOI 10.1016/j.ydbio.2010.03.023; Castro LFC, 2007, AQUAT TOXICOL, V85, P57, DOI 10.1016/j.aquatox.2007.07.016; Castro LFC, 2007, AQUAT TOXICOL, V84, P465, DOI 10.1016/j.aquatox.2007.07.008; Chen LM, 2008, MOL ENDOCRINOL, V22, P858, DOI 10.1210/me.2007-0181; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Chung Arthur C, 2003, Nucl Recept Signal, V1, pe007; Daniel A, 1999, DEVELOPMENT, V126, P2945; de Groot A, 2005, J MOL BIOL, V354, P841, DOI 10.1016/j.jmb.2005.09.090; Ding XF, 2013, J ZHEJIANG UNIV-SC B, V14, P171, DOI 10.1631/jzus.B1200357; Eick GN, 2011, MOL CELL ENDOCRINOL, V334, P31, DOI 10.1016/j.mce.2010.09.003; Enmark E, 2001, TRENDS PHARMACOL SCI, V22, P611, DOI 10.1016/S0165-6147(00)01859-9; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030; GARCIA M, 1995, GEN COMP ENDOCR, V97, P76, DOI 10.1006/gcen.1995.1008; Glass CK, 2000, GENE DEV, V14, P121; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Greenspan RJ, 2005, CURR BIOL, V15, pR671, DOI 10.1016/j.cub.2005.08.018; Gutierrez-Mazariegos J, 2014, ENDOCRINOLOGY, V155, P4275, DOI 10.1210/en.2014-1181; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Hanington PC, 2010, INT J PARASITOL, V40, P819, DOI 10.1016/j.ijpara.2009.12.005; Hertel LA, 2005, DEV COMP IMMUNOL, V29, P295, DOI 10.1016/j.dci.2004.08.003; Heyland A, 2005, J EXP BIOL, V208, P4355, DOI 10.1242/jeb.01877; Hultin CL, 2014, GENE, V540, P26, DOI 10.1016/j.gene.2014.02.039; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang YG, 2006, DEV COMP IMMUNOL, V30, P855, DOI 10.1016/j.dci.2005.12.004; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kajiwara M, 2006, GEN COMP ENDOCR, V148, P315, DOI 10.1016/j.ygcen.2006.03.016; Katsu Y, 2010, ENDOCRINOLOGY, V151, P639, DOI 10.1210/en.2009-0766; Keay J, 2006, ENDOCRINOLOGY, V147, P3861, DOI 10.1210/en.2006-0363; Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Knight M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001212; Kohler HR, 2007, ECOTOXICOLOGY, V16, P131, DOI 10.1007/s10646-006-0111-3; Kumkate S, 2009, J PARASITOL, V95, P1391, DOI 10.1645/GE-2080.1; Lafont R, 2007, ECOTOXICOLOGY, V16, P109, DOI 10.1007/s10646-006-0113-1; Laguerre M, 2010, FEBS LETT, V584, P4458, DOI 10.1016/j.febslet.2010.10.004; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; Li TR, 2000, DEVELOPMENT, V127, P2897; Lima D, 2011, AQUAT TOXICOL, V101, P221, DOI 10.1016/j.aquatox.2010.09.022; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Lockyer AE, 2004, CAN J ZOOL, V82, P251, DOI [10.1139/z03-215, 10.1139/Z03-215]; Lockyer AE, 2007, DEV COMP IMMUNOL, V31, P763, DOI 10.1016/j.dci.2006.11.004; Lockyer AE, 2007, MOL BIOCHEM PARASIT, V151, P18, DOI 10.1016/j.molbiopara.2006.09.009; Lockyer AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051102; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Markov GV, 2011, MOL CELL ENDOCRINOL, V334, P21, DOI 10.1016/j.mce.2010.10.017; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Matsumoto T, 2007, GEN COMP ENDOCR, V151, P195, DOI 10.1016/j.ygcen.2007.01.016; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; Matthiessen Peter, 2008, Integrated Environmental Assessment and Management, V4, P274, DOI 10.1897/IEAM_2008-003.1; Mitta G, 2005, DEV COMP IMMUNOL, V29, P393, DOI 10.1016/j.dci.2004.10.002; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Oehlmann J, 2003, PURE APPL CHEM, V75, P2207, DOI 10.1351/pac200375112207; Omran NEE, 2012, REPROD BIOL, V12, P301, DOI 10.1016/j.repbio.2012.10.002; Pascoal S, 2013, MOL ECOL, V22, P1589, DOI 10.1111/mec.12137; Pawlak M, 2012, CURR TOP MED CHEM, V12, P486, DOI 10.2174/156802612799436641; Puinean AM, 2006, AQUAT TOXICOL, V79, P376, DOI 10.1016/j.aquatox.2006.07.006; Raghavan N, 2006, TRENDS PARASITOL, V22, P148, DOI 10.1016/j.pt.2006.02.008; Rapado LN, 2014, MOLECULES, V19, P5205, DOI 10.3390/molecules19045205; Robinson-Rechavi M, 2005, J MOL EVOL, V60, P577, DOI 10.1007/s00239-004-0175-8; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schiffelers MJWA, 2014, REGUL TOXICOL PHARM, V69, P41, DOI 10.1016/j.yrtph.2014.02.007; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Scott AP, 2013, STEROIDS, V78, P268, DOI 10.1016/j.steroids.2012.11.006; Scott AP, 2012, STEROIDS, V77, P1450, DOI 10.1016/j.steroids.2012.08.009; SHIFF CJ, 1991, TROP MED PARASITOL, V42, P11; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Snow MI, 2000, BBA-GENE STRUCT EXPR, V1494, P104, DOI 10.1016/S0167-4781(00)00224-4; Stange D, 2012, ECOTOX ENVIRON SAFE, V75, P94, DOI 10.1016/j.ecoenv.2011.09.003; Sternberg RM, 2008, GEN COMP ENDOCR, V156, P15, DOI 10.1016/j.ygcen.2007.12.002; Sternberg RM, 2010, ECOTOXICOLOGY, V19, P4, DOI 10.1007/s10646-009-0397-z; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; Tallarico LDF, 2014, ECOTOX ENVIRON SAFE, V110, P208, DOI 10.1016/j.ecoenv.2014.09.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Thomson SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-500; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tillmann M, 2001, ECOTOXICOLOGY, V10, P373, DOI 10.1023/A:1012279231373; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; UEDA H, 1992, MOL CELL BIOL, V12, P5667, DOI 10.1128/MCB.12.12.5667; Urushitani H, 2013, AQUAT TOXICOL, V142, P403, DOI 10.1016/j.aquatox.2013.09.008; Velarde RA, 2006, INSECT MOL BIOL, V15, P583, DOI 10.1111/j.1365-2583.2006.00679.x; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; WHITEHEAD DL, 1982, EXPERIENTIA, V38, P1249, DOI 10.1007/BF01959769; Wu W, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-150; Wu WJ, 2011, MOL CELL ENDOCRINOL, V334, P56, DOI 10.1016/j.mce.2010.06.011; Wu WJ, 2006, GENE, V366, P303, DOI 10.1016/j.gene.2005.09.013; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Zhang H, 2012, COMP BIOCHEM PHYS C, V156, P51, DOI 10.1016/j.cbpc.2012.03.007; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004	124	36	37	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121259	10.1371/journal.pone.0121259	http://dx.doi.org/10.1371/journal.pone.0121259			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849443	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800051
J	Kim, DY; Abdelwahab, MG; Lee, SH; O'Neill, D; Thompson, RJ; Duff, HJ; Sullivan, PG; Rho, JM				Kim, Do Young; Abdelwahab, Mohammed G.; Lee, Soo Han; O'Neill, Derek; Thompson, Roger J.; Duff, Henry J.; Sullivan, Patrick G.; Rho, Jong M.			Ketones Prevent Oxidative Impairment of Hippocampal Synaptic Integrity through K-ATP Channels	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; KETOGENIC DIET; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; GRANULE NEURONS; TAU PATHOLOGIES; ROS PRODUCTION; MOUSE MODEL; STRESS	Dietary and metabolic therapies are increasingly being considered for a variety of neurological disorders, based in part on growing evidence for the neuroprotective properties of the ketogenic diet (KD) and ketones. Earlier, we demonstrated that ketones afford hippocampal synaptic protection against exogenous oxidative stress, but the mechanisms underlying these actions remain unclear. Recent studies have shown that ketones may modulate neuronal firing through interactions with ATP-sensitive potassium (K-ATP) channels. Here, we used a combination of electrophysiological, pharmacological, and biochemical assays to determine whether hippocampal synaptic protection by ketones is a consequence of K-ATP channel activation. Ketones dose-dependently reversed oxidative impairment of hippocampal synaptic integrity, neuronal viability, and bioenergetic capacity, and this action was mirrored by the K-ATP channel activator diazoxide. Inhibition of K-ATP channels reversed ketoneevoked hippocampal protection, and genetic ablation of the inwardly rectifying K+ channel subunit Kir6.2, a critical component of K-ATP channels, partially negated the synaptic protection afforded by ketones. This partial protection was completely reversed by co-application of the KATP blocker, 5-hydoxydecanoate (5HD). We conclude that, under conditions of oxidative injury, ketones induce synaptic protection in part through activation of K-ATP channels.	[Kim, Do Young; Abdelwahab, Mohammed G.; Lee, Soo Han; O'Neill, Derek] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Kim, Do Young; Abdelwahab, Mohammed G.; Lee, Soo Han; O'Neill, Derek] St Josephs Hosp, Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ USA; [Thompson, Roger J.] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol, Calgary, AB, Canada; [Thompson, Roger J.] Univ Calgary, Hotchkiss Brain Inst, Dept Anat, Calgary, AB, Canada; [Duff, Henry J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Rho, Jong M.] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Rho, Jong M.] Alberta Childrens Prov Gen Hosp, Dept Clin Neurosci, Calgary, AB, Canada	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Kentucky; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Kim, DY (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA.	doyoung.kim@dignityhealth.org	Lee, Soohan/AAP-6976-2020; Thompson, Roger/L-3930-2016	Thompson, Roger/0000-0002-7019-7246	NIH [NS 070261]; Canadian Institutes of Health Research; Barrow Neurological Foundation; Arizona Biomedical Research Commission; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Barrow Neurological Foundation; Arizona Biomedical Research Commission; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant NS 070261 (DYK/JMR), the Canadian Institutes of Health Research (JMR), the Barrow Neurological Foundation and the Arizona Biomedical Research Commission (DYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; Avshalumov MV, 2002, J NEUROPHYSIOL, V87, P2896, DOI 10.1152/jn.2002.87.6.2896; BENARI Y, 1990, NEUROSCIENCE, V37, P55, DOI 10.1016/0306-4522(90)90191-6; Betourne A, 2009, NEUROPHARMACOLOGY, V56, P615, DOI 10.1016/j.neuropharm.2008.11.001; Busija DW, 2004, BRAIN RES REV, V46, P282, DOI 10.1016/j.brainresrev.2004.06.011; Chen Y, 1996, NEUROSCI LETT, V218, P204, DOI 10.1016/S0304-3940(96)13149-9; Choeiri C, 2006, BEHAV BRAIN RES, V172, P233, DOI 10.1016/j.bbr.2006.05.005; Costa ADT, 2009, J BIOENERG BIOMEMBR, V41, P123, DOI 10.1007/s10863-009-9213-y; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971; Domoki F, 2005, AM J PHYSIOL-HEART C, V289, pH368, DOI 10.1152/ajpheart.00887.2004; Drose S, 2009, BBA-GEN SUBJECTS, V1790, P558, DOI 10.1016/j.bbagen.2009.01.011; Hartman AL, 2007, PEDIATR NEUROL, V36, P281, DOI 10.1016/j.pediatrneurol.2007.02.008; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; HONORE E, 1993, PFLUG ARCH EUR J PHY, V424, P113, DOI 10.1007/BF00374601; Huang CW, 2007, J NEUROSCI RES, V85, P1468, DOI 10.1002/jnr.21284; Ienco EC, 2011, J ALZHEIMERS DIS, V24, P111, DOI 10.3233/JAD-2011-110164; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Kamsler A, 2003, J NEUROSCI, V23, P269; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x; KIRSCH GE, 1990, AM J PHYSIOL, V259, pH820, DOI 10.1152/ajpheart.1990.259.3.H820; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Liang HW, 2005, BRAIN RES, V1042, P169, DOI 10.1016/j.brainres.2005.02.031; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu B, 2010, MOL CELL BIOCHEM, V337, P25, DOI 10.1007/s11010-009-0283-2; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Lund TM, 2015, J NEUROCHEM, V132, P520, DOI 10.1111/jnc.12975; Lund TM, 2009, J NEUROCHEM, V110, P80, DOI 10.1111/j.1471-4159.2009.06115.x; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2008, J NEUROSCI RES, V86, P3322, DOI 10.1002/jnr.21782; Milder J, 2012, EPILEPSY RES, V100, P295, DOI 10.1016/j.eplepsyres.2011.09.021; Nagy K, 2004, J NEUROSCI RES, V76, P697, DOI 10.1002/jnr.20120; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Nordli DR, 1997, EPILEPSIA, V38, P743, DOI 10.1111/j.1528-1157.1997.tb01460.x; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Sakurai T, 2000, Nihon Ronen Igakkai Zasshi, V37, P962; Schroder UH, 2004, EUR J PHARMACOL, V502, P99, DOI 10.1016/j.ejphar.2004.08.046; Simao F, 2011, J NUTR BIOCHEM, V22, P921, DOI 10.1016/j.jnutbio.2010.07.013; Smith SL, 2005, CNS DRUG REV, V11, P113; Sun XL, 2010, CLIN EXP PHARMACOL P, V37, P243, DOI 10.1111/j.1440-1681.2009.05190.x; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Teshima Y, 2003, STROKE, V34, P1796, DOI 10.1161/01.STR.0000077017.60947.AE; Thio LL, 2000, NEUROLOGY, V54, P325, DOI 10.1212/WNL.54.2.325; Wang L, 2011, NEUROSCI LETT, V491, P63, DOI 10.1016/j.neulet.2010.12.065; Won YJ, 2013, J NEUROSCI, V33, P19314, DOI 10.1523/JNEUROSCI.3102-13.2013; Xie J, 2010, J NEUROSCI RES, V88, P428, DOI 10.1002/jnr.22213	56	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119316	10.1371/journal.pone.0119316	http://dx.doi.org/10.1371/journal.pone.0119316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848768	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800010
J	Negmadjanov, U; Godic, Z; Rizvi, F; Emelyanova, L; Ross, G; Richards, J; Holmuhamedov, EL; Jahangir, A				Negmadjanov, Ulugbek; Godic, Zarko; Rizvi, Farhan; Emelyanova, Larisa; Ross, Gracious; Richards, John; Holmuhamedov, Ekhson L.; Jahangir, Arshad			TGF-beta 1-Mediated Differentiation of Fibroblasts Is Associated with Increased Mitochondrial Content and Cellular Respiration	PLOS ONE			English	Article							PRESSURE WOUND THERAPY; HEART-DISEASE; MYOFIBROBLASTS; ATP; EXPOSURE; MYOCYTES	Objectivs Cytokine-dependent activation of fibroblasts to myofibroblasts, a key event in fibrosis, is accompanied by phenotypic changes with increased secretory and contractile properties dependent on increased energy utilization, yet changes in the energetic profile of these cells are not fully described. We hypothesize that the TGF-beta 1-mediated transformation of myofibroblasts is associated with an increase in mitochondrial content and function when compared to naive fibroblasts. Methods Cultured NIH/3T3 mouse fibroblasts treated with TGF-beta 1, a profibrotic cytokine, or vehicle were assessed for transformation to myofibroblasts (appearance of alpha-smooth muscle actin [alpha-SMA] stress fibers) and associated changes in mitochondrial content and functions using laser confocal microscopy, Seahorse respirometry, multi-well plate reader and biochemical protocols. Expression of mitochondrial-specific proteins was determined using western blotting, and the mitochondrial DNA quantified using Mitochondrial DNA isolation kit. Results Treatment with TGF-beta 1 (5 ng/mL) induced transformation of naive fibroblasts into myofibroblasts with a threefold increase in the expression of alpha-SMA (6.85 +/- 0.27 RU) compared to cells not treated with TGF-beta 1 (2.52 +/- 0.11 RU). TGF-beta 1 exposure increased the number of mitochondria in the cells, as monitored by membrane potential sensitive dye tetramethylrhodamine, and expression of mitochondria-specific proteins; voltage-dependent anion channels (0.54 +/- 0.05 vs. 0.23 +/- 0.05 RU) and adenine nucleotide transporter (0.61 +/- 0.11 vs. 0.22 +/- 0.05 RU), as well as mitochondrial DNA content (530 +/- 12 mu g DNA/10(6) cells vs. 307 +/- 9 mu g DNA/10(6) cells in control). TGF-beta 1 treatment was associated with an increase in mitochondrial function with a twofold increase in baseline oxygen consumption rate (2.25 +/- 0.03 vs. 1.13 +/- 0.1 nmol O-2/min/10(6) cells) and FCCP-induced mitochondrial respiration (2.87 +/- 0.03 vs. 1.46 +/- 0.15 nmol O-2/min/10(6) cells). Conclusions TGF-beta 1 induced differentiation of fibroblasts is accompanied by energetic remodeling of myofibroblasts with an increase in mitochondrial respiration and mitochondrial content.	[Negmadjanov, Ulugbek; Godic, Zarko; Rizvi, Farhan; Emelyanova, Larisa; Ross, Gracious; Holmuhamedov, Ekhson L.; Jahangir, Arshad] Aurora Hlth Care, Sheikh Khalifa bin Hamad Al Thani Ctr Integrat Re, Aurora Res Inst, Milwaukee, WI 53215 USA; [Richards, John] Aurora Hlth Care, Immunol Lab, Aurora, WI 53215 USA; [Jahangir, Arshad] Aurora Hlth Care, Aurora Cardiovasc Serv, Aurora, WI 53215 USA		Jahangir, A (corresponding author), Aurora Hlth Care, Sheikh Khalifa bin Hamad Al Thani Ctr Integrat Re, Aurora Res Inst, Milwaukee, WI 53215 USA.	Publishing44@aurora.org	Holmuhamedov, Ekhson L/P-5228-2016; Jahangir, Arshad/M-7916-2016	Holmuhamedov, Ekhson L/0000-0002-0809-350X; 	National Heart, Lung, and Blood Institute [HL089542, HL101240]; Aurora Health Care, Cardiovascular Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089542, R01HL101240] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Aurora Health Care, Cardiovascular Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute (HL089542 and HL101240) and intramural support from Aurora Health Care, Cardiovascular Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baracca A, 2013, INT J BIOCHEM CELL B, V45, P1356, DOI 10.1016/j.biocel.2013.03.013; Baudino TA, 2008, MICROSC MICROANAL, V14, P117, DOI 10.1017/S1431927608080021; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Baum JR, 2012, AM J PHYSIOL-HEART C, V302, pH790, DOI 10.1152/ajpheart.00498.2011; Biovision Inc. Mitochondrial DNA Isolation Kit, MIT DNA IS KIT; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Chiang B, 2007, AM J SURG, V193, P213, DOI 10.1016/j.amjsurg.2006.08.069; Corradi D, 2008, NAT CLIN PRACT CARD, V5, P782, DOI 10.1038/ncpcardio1370; Daskalopoulos EP, 2013, METHODS MOL BIOL, V1037, P355, DOI 10.1007/978-1-62703-505-7_21; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; Dzeja PP, 2001, CIRC RES, V89, P744, DOI 10.1161/res.89.9.744; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Furuya S, 2013, INT REV CEL MOL BIO, V304, P133, DOI 10.1016/B978-0-12-407696-9.00003-8; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Holmuhamedov E, 2009, ARCH BIOCHEM BIOPHYS, V481, P226, DOI 10.1016/j.abb.2008.10.036; Holmuhamedov EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044667; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; Honda E, 2013, TOHOKU J EXP MED, V230, P67, DOI 10.1620/tjem.230.67; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Langevin HM, 2005, AM J PHYSIOL-CELL PH, V288, pC747, DOI 10.1152/ajpcell.00420.2004; McNulty AK, 2007, WOUND REPAIR REGEN, V15, P838, DOI 10.1111/j.1524-475X.2007.00287.x; McNulty AK, 2009, WOUND REPAIR REGEN, V17, P192, DOI 10.1111/j.1524-475X.2009.00460.x; Moruzzi N, 2014, INT J BIOCHEM CELL B, V53, P66, DOI 10.1016/j.biocel.2014.04.026; Nemutlu E, 2012, PHYSIOL GENOMICS, V44, P386, DOI 10.1152/physiolgenomics.00152.2011; Noseda M, 2009, DEV CELL, V16, P161, DOI 10.1016/j.devcel.2009.01.020; Pereira SL, 2011, CARDIOVASC TOXICOL, V11, P180, DOI 10.1007/s12012-011-9112-4; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOLMI R, 1994, BIOCHEM MOL BIOL INT, V33, P477; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Zhou LF, 2008, AM J PHYSIOL-HEART C, V295, pH939, DOI 10.1152/ajpheart.00561.2008	42	57	57	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123046	10.1371/journal.pone.0123046	http://dx.doi.org/10.1371/journal.pone.0123046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849590	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800198
J	Will, U; Clayton, M; Wertheim, I; Leante, L; Berg, E				Will, Udo; Clayton, Martin; Wertheim, Ira; Leante, Laura; Berg, Eric			Pulse and Entrainment to Non-Isochronous Auditory Stimuli: The Case of North Indian Alap	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; TIME; PERFORMANCE; PERCEPTION; ATTENTION; TEMPO; BEAT	Pulse is often understood as a feature of a (quasi-) isochronous event sequence that is picked up by an entrained subject. However, entrainment does not only occur between quasiperiodic rhythms. This paper demonstrates the expression of pulse by subjects listening to non-periodic musical stimuli and investigates the processes behind this behaviour. The stimuli are extracts from the introductory sections of North Indian (Hindustani) classical music performances (alap, jor and jhala). The first of three experiments demonstrates regular motor responses to both irregular alap and more regular jor sections: responses to alap appear related to individual spontaneous tempi, while for jor they relate to the stimulus event rate. A second experiment investigated whether subjects respond to average periodicities of the alap section, and whether their responses show phase alignment to the musical events. In the third experiment we investigated responses to a broader sample of performances, testing their relationship to spontaneous tempo, and the effect of prior experience with this music. Our results suggest an entrainment model in which pulse is understood as the experience of one's internal periodicity: it is not necessarily linked to temporally regular, structured sensory input streams; it can arise spontaneously through the performance of repetitive motor actions, or on exposure to event sequences with rather irregular temporal structures. Greater regularity in the external event sequence leads to entrainment between motor responses and stimulus sequence, modifying subjects' internal periodicities in such a way that they are either identical or harmonically related to each other. This can be considered as the basis for shared (rhythmic) experience and may be an important process supporting 'social' effects of temporally regular music.	[Will, Udo; Wertheim, Ira; Berg, Eric] Ohio State Univ, SoM, Cognit Ethnomusicol, Columbus, OH 43210 USA; [Clayton, Martin; Leante, Laura] Univ Durham, Mus Dept, Durham, England	University System of Ohio; Ohio State University; Durham University	Will, U (corresponding author), Ohio State Univ, SoM, Cognit Ethnomusicol, Columbus, OH 43210 USA.	will.51@osu.edu	Clayton, Martin/AAU-8333-2020	Clayton, Martin/0000-0002-9670-5077; Will, Udo/0000-0002-2593-1827	UK's Arts and Humanities Research Council [RGST/6186/APN19244, SG/AN6186/APN19110]; British Academy's International Networks scheme	UK's Arts and Humanities Research Council; British Academy's International Networks scheme	The research was funded by the UK's Arts and Humanities Research Council (grants RGST/6186/APN19244 and SG/AN6186/APN19110), and the British Academy's International Networks scheme.	Batschelet E, 1981, CIRCULAR STAT BIOL; Berg ET, 2004, THESIS OSU COLUMBUS; Clayton M., 2000, TIME INDIAN MUSIC RH; Clayton M, 2005, ESEM COUNTERPOINT SE, V11; Clayton MRL, 2007, MUSIC SCI, V11, P27, DOI 10.1177/102986490701100102; COLLYER CE, 1994, PERCEPT PSYCHOPHYS, V55, P443, DOI 10.3758/BF03205301; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Fisher NI, 1995, STAT ANAL CIRCULAR D; Foote J, 2002, P INT C MUS INF RETR, P265; Fraisse P., 1974, CHRONOBIOLOGY, P517; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Jones M. R., 1990, PSYCHOMUSICOLOGY, V9, P193, DOI DOI 10.1037/H0094147; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; Kreuz T, 2004, NIC SERIES, V21; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Madison G, 2002, PSYCHOL RES-PSYCH FO, V66, P201, DOI 10.1007/s00426-001-0085-y; Mardia K.V., 2000, STAT DIRECTIONAL DAT, Vsecond; Moelants D, 2002, P 7 INT C MUSIC PERC, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Oda GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023895; Parlitz U, 1996, PHYS REV E, V54, P2115, DOI 10.1103/PhysRevE.54.2115; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Pikovsky A.S., 1985, SOV J COMMUN TECHNOL, V30, P85; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2004, Q J EXP PSYCHOL-A, V57, P499, DOI 10.1080/02724980343000369; Riley MA, 2003, NEUROSCI LETT, V342, P45, DOI 10.1016/S0304-3940(03)00229-5; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; Wallin JEW, 1911, PSYCHOL REV, V18, P100, DOI 10.1037/h0070543; Webber Jr C.L., 2005, TUTORIALS CONT NONLI, V94, P26; WIDDESS R, 1994, ETHNOMUSICOLOGY, V38, P59, DOI 10.2307/852268; Will U., 2011, MUSIC SCI RHYTHMIC B, P86; Will U, 2007, NEUROSCI LETT, V424, P55, DOI 10.1016/j.neulet.2007.07.036	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123247	10.1371/journal.pone.0123247	http://dx.doi.org/10.1371/journal.pone.0123247			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849357	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000352477800218
J	Ho, CY; Li, PC; Chiang, YC; Young, ST; Chu, WC				Ho, Cheng-Yu; Li, Pei-Chun; Chiang, Yuan-Chuan; Young, Shuenn-Tsong; Chu, Woei-Chyn			The Binaural Masking-Level Difference of Mandarin Tone Detection and the Binaural Intelligibility-Level Difference of Mandarin Tone Recognition in the Presence of Speech-Spectrum Noise	PLOS ONE			English	Article							INFORMATION; CUES	Binaural hearing involves using information relating to the differences between the signals that arrive at the two ears, and it can make it easier to detect and recognize signals in a noisy environment. This phenomenon of binaural hearing is quantified in laboratory studies as the binaural masking-level difference (BMLD). Mandarin is one of the most commonly used languages, but there are no publication values of BMLD or BILD based on Mandarin tones. Therefore, this study investigated the BMLD and BILD of Mandarin tones. The BMLDs of Mandarin tone detection were measured based on the detection threshold differences for the four tones of the voiced vowels /i/(i. e., /i1/, /i2/, /i3/, and /i4/) and /u/(i. e., /u1/, /u2/, /u3/, and /u4/) in the presence of speech-spectrum noise when presented interaurally in phase (S0N0) and interaurally in antiphase (S pi N0). The BILDs of Mandarin tone recognition in speech-spectrum noise were determined as the differences in the target-to-masker ratio (TMR) required for 50% correct tone recognitions between the S0N0 and SpN(0) conditions. The detection thresholds for the four tones of /i/ and /u/ differed significantly (p<0.001) between the S0N0 and SpN(0) conditions. The average detection thresholds of Mandarin tones were all lower in the SpN(0) condition than in the S0N0 condition, and the BMLDs ranged from 7.3 to 11.5 dB. The TMR for 50% correct Mandarin tone recognitions differed significantly (p<0.001) between the S(0)N0 and SpN(0) conditions, at -13.4 and -18.0 dB, respectively, with a mean BILD of 4.6 dB. The study showed that the thresholds of Mandarin tone detection and recognition in the presence of speech- spectrum noise are improved when phase inversion is applied to the target speech. The average BILDs of Mandarin tones are smaller than the average BMLDs of Mandarin tones.	[Ho, Cheng-Yu; Young, Shuenn-Tsong; Chu, Woei-Chyn] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Engn, Taipei 112, Taiwan; [Ho, Cheng-Yu; Young, Shuenn-Tsong] Mackay Med Coll, Holist Educ Ctr, New Taipei City, Taiwan; [Li, Pei-Chun] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan; [Chiang, Yuan-Chuan] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech & Hearing Disorders & Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College; National Taipei University of Nursing & Health Science (NTUNHS)	Li, PC (corresponding author), Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan.	ankhli@gmail.com; woeichyn@gmail.com			Taiwan National Science Council [NSC 101-2220-E-715-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the Taiwan National Science Council (# NSC 101-2220-E-715-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute, 2004, S36 ANSI; Blauert J, 1997, SPATIAL HEARING PSYC, P262; CAMBRON NK, 1991, EAR HEARING, V12, P64, DOI 10.1097/00003446-199102000-00009; CARHART R, 1966, J ACOUST SOC AM, V39, P1037, DOI 10.1121/1.1909990; Fu Q-J, 2000, ASIA PAC J SPEECH LA, V5, P45, DOI DOI 10.1179/136132800807547582; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; Howie J. M., 1976, ACOUSTICAL STUDIES M; Hugo Fastl, 2006, PSYCHOACOUSTICS FACT, P296; Johansson MSK, 2002, INT J AUDIOL, V41, P279, DOI 10.3109/14992020209077187; Kong YY, 2006, J ACOUST SOC AM, V120, P2830, DOI 10.1121/1.2346009; Lawson G, 2011, SPEECH AUDIOMETRY, P23; Lee CY, 2000, LEXICAL TONE SPOKEN; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LEVITT H, 1967, J ACOUST SOC AM, V42, P601, DOI 10.1121/1.1910629; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; Lin M., 1988, J CHINESE LINGUIST, V204, P182; Liu SY, 2004, LANG SPEECH, V47, P109, DOI 10.1177/00238309040470020101; Moore BCJ, 2003, INTRO PSYCHOL HEARIN, P267; Musiek FE, 1999, CONT PERSPECTIVES HE, P380; NOFFSINGER D, 1972, ACTA OTO-LARYNGOL, P1; OLSEN WO, 1976, AUDIOLOGY, V15, P287; QUARANTA A, 1977, ARCH OTOLARYNGOL, V103, P482; Rosners B., 2006, FUNDAMENTALS BIOSTAT, P492; STEVENS KN, 1955, J ACOUST SOC AM, V27, P484, DOI 10.1121/1.1907943; Sun CF, 2006, CHINESE: A LINGUISTIC INTRODUCTION, P34, DOI 10.1017/CBO9780511755019.006; Tsai KS, 2009, EAR HEARING, V30, P90, DOI 10.1097/AUD.0b013e31818f28a6; Tseng CY, 1990, ACOUSTIC PHONETIC ST; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; WILSON RH, 1982, J SPEECH HEAR RES, V25, P235, DOI 10.1044/jshr.2502.235	31	1	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120977	10.1371/journal.pone.0120977	http://dx.doi.org/10.1371/journal.pone.0120977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835987	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000035
J	Ohtsu, I; Kawano, Y; Suzuki, M; Morigasaki, S; Saiki, K; Yamazaki, S; Nonaka, G; Takagi, H				Ohtsu, Iwao; Kawano, Yusuke; Suzuki, Marina; Morigasaki, Susumu; Saiki, Kyohei; Yamazaki, Shunsuke; Nonaka, Gen; Takagi, Hiroshi			Uptake of L-cystine via an ABC transporter contributes defense of oxidative stress in the L-cystine export-dependent manner in Escherichia coli	PLOS ONE			English	Article							SERINE ACETYLTRANSFERASE; FLUORESCEINS	Intracellular thiols like L-cystine and L-cystine play a critical role in the regulation of cellular processes. Here we show that Escherichia coli has two L-cystine transporters, the symporter YdjN and the ATP-binding cassette importer FliY-YecSC. These proteins import L-cystine, an oxidized product of L-cystine from the periplasm to the cytoplasm. The symporter YdjN, which is expected to be a new member of the L-cystine regulon, is a low affinity L-cystine transporter (K-m = 1.1 mu M) that is mainly involved in L-cystine uptake from outside as a nutrient. E. coli has only two L-cystine importers because.ydjN.yecS mutant cells are not capable of growing in the minimal medium containing L-cystine as a sole sulfur source. Another protein YecSC is the FliY-dependent L-cystine transporter that functions cooperatively with the L-cystine transporter YdeD, which exports L-cystine as reducing equivalents from the cytoplasm to the periplasm, to prevent E. coli cells from oxidative stress. The exported L-cystine can reduce the periplasmic hydrogen peroxide to water, and then generated L-cystine is imported back into the cytoplasm via the ATP-binding cassette transporter YecSC with a high affinity to L-cystine (K-m = 110 nM) in a manner dependent on FliY, the periplasmic L-cystine-binding protein. The double disruption of ydeD and fliY increased cellular levels of lipid peroxides. From these findings, we propose that the hydrogen peroxide-inducible L-cystine/L-cystine shuttle system plays a role of detoxification of hydrogen peroxide before lipid peroxidation occurs, and then might specific prevent damage to membrane lipids.	[Ohtsu, Iwao; Kawano, Yusuke; Suzuki, Marina; Morigasaki, Susumu; Saiki, Kyohei; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan; [Yamazaki, Shunsuke; Nonaka, Gen] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan	Nara Institute of Science & Technology; Ajinomoto Co Inc	Ohtsu, I (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan.	iohtsu@bs.naist.jp	Morigasaki, Susumu/Q-6981-2017	Morigasaki, Susumu/0000-0002-6938-5119; Takagi, Hiroshi/0000-0002-1786-3174; Ohtsu, Iwao/0000-0002-3553-0306; Kawano, Yusuke/0000-0002-6845-8902	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Ajinomoto Co., Inc	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ajinomoto Co., Inc	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to IO). This work was also supported by KAKENHI [Grant-in-Aid for Young Scientists on priority areas (B)] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to IO) and by a grant from Ajinomoto Co., Inc (to IO and HT). This work was supported by the funds described in manuscript, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; DENK D, 1987, J GEN MICROBIOL, V133, P515; Hindson VJ, 2003, BIOCHEM J, V375, P745, DOI 10.1042/BJ20030429; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kawano Y, 2015, J BIOSCI BIOENG, V119, P176, DOI 10.1016/j.jbiosc.2014.07.006; LEIVE L, 1965, J BIOL CHEM, V240, P4370; Lo R, 2009, J BACTERIOL, V191, P1827, DOI 10.1128/JB.01553-08; Maeda H, 2005, ANGEW CHEM INT EDIT, V44, P2922, DOI 10.1002/anie.200500114; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Maeda H, 2007, CHEM-EUR J, V13, P1946, DOI 10.1002/chem.200600522; Manchado M, 2000, J BACTERIOL, V182, P6842, DOI 10.1128/JB.182.23.6842-6844.2000; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Tani A, 2008, MICROBIOL-SGM, V154, P3437, DOI 10.1099/mic.0.2007/016048-0; Wiriyathanawudhiwong N, 2009, APPL MICROBIOL BIOT, V81, P903, DOI 10.1007/s00253-008-1686-9	20	39	41	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120619	10.1371/journal.pone.0120619	http://dx.doi.org/10.1371/journal.pone.0120619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837721	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000027
J	Li, CZ; Fu, WJ; Zhang, Y; Zhou, L; Mao, Z; Lv, WR; Li, J; Zhou, Y				Li, Changzheng; Fu, Weijun; Zhang, Yu; Zhou, Liang; Mao, Zhi; Lv, Weiran; Li, Juan; Zhou, Ye			Meta-Analysis of MicroRNA-146a rs2910164 G>C Polymorphism Association with Autoimmune Diseases Susceptibility, an Update Based on 24 Studies	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ETS-1 GENE POLYMORPHISMS; RHEUMATOID-ARTHRITIS; MIR-146A RS2910164; PROSTATE-CANCER; KINASE IRAK1; RISK; EXPRESSION; VARIANTS; PRE-MIR-146A	Background Published data showed that the susceptibility of autoimmune diseases (ADs) was associated with the polymorphism rs2910164 in microRNA-146a (miR-146a). However, the results remain controversial so far. Two meta-analyses published in 2013 and 2014 came to opposite conclusions. In order to derive a more precise estimation of the relationship, we performed this meta-analysis. Methods We searched the PubMed, OvidSP and CNKI databases (published prior to September 8th, 2014) and extracted data from eligible studies. The procedure of meta-analysis was performed by using the Stata 12.0 software. Random effect model or fixed effect model were chosen respectively, according to the between study heterogeneities. Results A total of 24 case-control studies, 11 more than previous meta-analysis on this topic, were involved. We took stratified analyses by different ethnicities and different types of diseases in different genetic models. In Caucasian subgroup, significant increased risks of GC genotype and GC+CC genotype with ADs susceptibility were found in heterozygote model (GC vs GG, OR = 1.38, 95% CI 1.04-1.83, p = 0.024) and dominant model (GC+CC vs GG, OR = 1.37, 95% CI 1.01-1.85, p = 0.041), respectively. Meanwhile, in other disease subgroup, significant increased risks of C allele, CC genotype and GC+CC genotype were found in allele model (C vs G, OR = 1.16, 95% CI 1.04-1.31, p = 0.010), homozygote model (CC vs GG, OR = 1.42, 95% CI 1.10-1.84, p = 0.006) and dominant model (GC+CC vs GG, OR = 1.25, 95% CI 1.04-1.51, p = 0.020), respectively. Conclusions MiR-146a rs2910164 G>C polymorphism was associated with the susceptibility of ADs.	[Li, Changzheng; Fu, Weijun; Lv, Weiran; Li, Juan] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Li, Changzheng; Li, Juan] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Yu; Zhou, Liang] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA; [Mao, Zhi] Chinese Peoples Liberat Army Gen Hosp, Dept Intens Care Unit, Beijing 100853, Peoples R China; [Zhou, Ye] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Virginia Commonwealth University; Chinese People's Liberation Army General Hospital; Southern Medical University - China	Li, J (corresponding author), Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	lj40038@126.com; lzhouye@126.com	Mao, Zhi/AAZ-1629-2020		Natural Science Foundation of China [31100661]; Specialized Research Fund for the Doctoral Program of Higher Education [20114433120019, 20124433120002]; Natural Science Foundation of Guangdong Province [S2011040002748, S2012040006972]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Natural Science Foundation of China (NO. 31100661), Specialized Research Fund for the Doctoral Program of Higher Education (NO. 20114433120019, NO. 20124433120002) and the Natural Science Foundation of Guangdong Province (NO. S2011040002748, NO. S2012040006972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Autoimmune Related Diseases Association National Coalition of Autoimmune Patient Groups, 2011, THE COST BURDEN OF A; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chatzikyriakidou A, 2010, SCAND J IMMUNOL, V71, P382, DOI 10.1111/j.1365-3083.2010.02381.x; Chatzikyriakidou A, 2010, JOINT BONE SPINE, V77, P411, DOI 10.1016/j.jbspin.2010.05.013; Chen HF, 2013, GENE, V521, P259, DOI 10.1016/j.gene.2013.03.073; El-Shal AS, 2013, JOINT BONE SPINE, V80, P626, DOI 10.1016/j.jbspin.2013.03.005; Fenoglio C, 2011, NEUROSCI LETT, V504, P9, DOI 10.1016/j.neulet.2011.08.021; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gazouli M, 2013, DIGEST DIS SCI, V58, P2324, DOI 10.1007/s10620-013-2640-y; Goris A, 2012, COLD SPRING HARB PER, P4; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; Hashemi M, 2013, MOL MED REP, V7, P287, DOI 10.3892/mmr.2012.1176; Iizuka T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-249; Jimenez-Morales S, 2012, TISSUE ANTIGENS, V80, P317, DOI 10.1111/j.1399-0039.2012.01929.x; Li K, 2014, HUM IMMUNOL, V75, P602, DOI 10.1016/j.humimm.2014.05.002; Lin JH, 2014, PEDIATR NEPHROL, V29, P1979, DOI 10.1007/s00467-014-2818-3; Liu M, 2011, PROSTATE, V71, P1023, DOI 10.1002/pros.21317; Liu M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-37; Lofgren SE, 2012, GENES IMMUN, V13, P268, DOI 10.1038/gene.2011.84; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Meisgen F, 2014, J INVEST DERMATOL, V134, P1931, DOI 10.1038/jid.2014.89; Miller FW, 2011, ADV EXP MED BIOL, V711, P61; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Okada Y, 2014, INT J DERMATOL, V53, P300, DOI 10.1111/j.1365-4632.2012.05739.x; Okubo M, 2011, J CLIN IMMUNOL, V31, P69, DOI 10.1007/s10875-010-9461-y; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qian Long, 2012, Zhonghua Weishengwuxue He Mianyixue Zazhi, V32, P253, DOI 10.3760/cma.j.issn.0254-5101.2012.03.016; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Sakoguchi A, 2013, CLIN EXP DERMATOL, V38, P99, DOI 10.1111/j.1365-2230.2012.04453.x; Singh S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/215748; Suzuki M, 2011, CLIN GENITOURIN CANC, V9, P46, DOI 10.1016/j.clgc.2011.04.004; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091199; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Yang B, 2011, MOL BIOL REP, V38, P4913, DOI 10.1007/s11033-010-0633-x; Yang Y, 2014, IMMUNOL INVEST, V43, P13, DOI 10.3109/08820139.2013.822389; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zhang JL, 2011, MOL BIOL REP, V38, P1463, DOI 10.1007/s11033-010-0252-6; Zhao HF, 2014, AUTOIMMUNITY, V47, P173, DOI 10.3109/08916934.2014.883503; Zheng RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04731; Zhou QY, 2014, ANN RHEUM DIS, V73, P170, DOI 10.1136/annrheumdis-2012-201627; Zhou QY, 2012, MOL VIS, V18, P426	44	21	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121918	10.1371/journal.pone.0121918	http://dx.doi.org/10.1371/journal.pone.0121918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830862	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600090
J	Li, K; Zhao, H; Liu, WJ; Yin, ZY				Li, Kui; Zhao, Hui; Liu, Wenjun; Yin, Zhiyong			Material Properties and Constitutive Modeling of Infant Porcine Cerebellum Tissue in Tension at High Strain Rate	PLOS ONE			English	Article							BRAIN-TISSUE; MECHANICAL-PROPERTIES; IN-VIVO; DEFORMATION; COMPRESSION; ELASTICITY; WHITE	Background The mechanical characterization of infant porcine cerebellum tissue in tension at high strain rate is crucial for modeling traumatic cerebellum injury, which is in turn helpful for understanding the biomechanics of such injuries suffered in traffic accidents. Material and Method In this study, the infant porcine cerebellum tissue was given three loading velocities, ie, 2s(-1), 20s(-1) and 100s(-1) with up to 30% strain to investigate the tensile properties. At least six tensile tests for each strain rate were validly performed. Fung, Gent, Ogden and exponential models were applied to fit the constitutive equations, so as to obtain material parameters from the experimental data. Results The Lagrange stress of infant porcine cerebellum tissue in tension appeared to be no more than 3000Pa at each loading velocity. More specifically, the Lagrange stress at 30% strain was (393.7 +/- 84.4) Pa, (928.3 +/- 56.3) Pa and (2582.4 +/- 282.2) Pa at strain rates of 2s(-1), 20s(-1) and 100s(-1), respectively. Fung (0.833 <= R-2 <= 0.924), Gent (0.797 <= R-2 <= 0.875), Ogden (0.859 <= R-2 <= 0.944) and exponential (0.930 <= R-2 <= 0.972) models provided excellent fitting to experimental data up to 30% strain. Conclusions The infant cerebellum tissue shows a stiffer response with increase of the loading speed, indicating a strong strain-rate sensitivity. This study will enrich the knowledge on the material properties of infant brain tissue, which may augment the biofidelity of finite element model of human pediatric cerebellum.	[Li, Kui; Zhao, Hui; Liu, Wenjun; Yin, Zhiyong] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Inst Traff Med,Dept 4, Chongqing 400042, Peoples R China	Army Medical University	Yin, ZY (corresponding author), Third Mil Med Univ, Inst Surg Res, Daping Hosp, Inst Traff Med,Dept 4, Chongqing 400042, Peoples R China.	yinzhiyong86@126.com		Zhao, Hui/0000-0001-5074-0128	National Natural Science Foundation of China [1271006, 31470913]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This paper was supported by grants from National Natural Science Foundation of China (No. 1271006, No. 31470913), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, J BIOMECH SCI ENG, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bilston LE, 2011, BIOL MED PHYS BIOMED, P69, DOI 10.1007/978-1-4419-9997-9_4; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; FUNG YC, 1979, AM J PHYSIOL, V237, pH620, DOI 10.1152/ajpheart.1979.237.5.H620; FUNG YCB, 1967, AM J PHYSIOL, V213, P1532, DOI 10.1152/ajplegacy.1967.213.6.1532; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Margulies SS, 2013, PEDIAT INJURY BIOMEC, P157; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2001, J BIOMECH, V34, P651, DOI 10.1016/S0021-9290(00)00236-0; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Ogden R.W., 1997, NONLINEAR ELASTIC DE; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2013, J BIOMECH, V46, P1276, DOI 10.1016/j.jbiomech.2013.02.014; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Tamura A., 2008, J BIOMECHANICAL SCI, V3, P263, DOI [10.1299/jbse.3.263, DOI 10.1299/JBSE.3.263]; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	28	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123506	10.1371/journal.pone.0123506	http://dx.doi.org/10.1371/journal.pone.0123506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830545	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600148
J	Liu, LJ; Sun, CL; Liu, SR; Chai, RS; Huang, WQ; Liu, XX; Tang, CX; Zhang, YS				Liu, Lijuan; Sun, Chengliang; Liu, Shuangri; Chai, Rushan; Huang, Weiqing; Liu, Xingxing; Tang, Caixian; Zhang, Yongsong			Bioorganic Fertilizer Enhances Soil Suppressive Capacity against Bacterial Wilt of Tomato	PLOS ONE			English	Article							RALSTONIA-SOLANACEARUM; BORNE PATHOGENS; BIOCONTROL; MANAGEMENT; SOLARIZATION; BIOVAR-2; SURVIVAL; INVASION; BIOMASS; POTATO	Tomato bacterial wilt caused by Ralstonia solanacearum is one of the most destructive soilborne diseases. Many strategies have been taken to improve soil suppressiveness against this destructive disease, but limited success has been achieved. In this study, a novel bioorganic fertilizer revealed a higher suppressive ability against bacterial wilt compared with several soil management methods in the field over four growing seasons from March 2011 to July 2013. The application of the bioorganic fertilizer significantly (P<0.05) reduced disease incidence of tomato and increased fruit yields in four independent trials. The association among the level of disease incidence, soil physicochemical and biological properties was investigated. The soil treated with the bioorganic fe(r)tilizer increased soil pH value, electric conductivity, organic carbon, NH4+-N, NO3--N and available K content, microbial activities and microbial biomass carbon content, which were positively related with soil suppressiveness. Bacterial and actinomycete populations assessed using classical plate counts were highest, whereas R. solanacearum and fungal populations were lowest in soil applied with the bioorganic fertilizer. Microbial community diversity and richness were assessed using denaturing gel gradient electrophoresis profile analysis. The soil treated with the bioorganic fertilizer exhibited higher bacterial community diversity but lower fungal community diversity. Redundancy analysis showed that bacterial community diversity and richness negatively related with bacterial wilt suppressiveness, while fungal community richness positively correlated with R. solanacearum population. We concluded that the alteration of soil physicochemical and biological properties in soil treated with the bioorganic fertilizer induced the soil suppressiveness against tomato bacterial wilt.	[Liu, Lijuan; Sun, Chengliang; Liu, Shuangri; Chai, Rushan; Huang, Weiqing; Zhang, Yongsong] Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Xingxing] Zhejiang Univ, Coll Environm & Resource Sci, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Tang, Caixian] La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic, Australia	Zhejiang University; Zhejiang University; La Trobe University	Zhang, YS (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	yszhang@zju.edu.cn	Tang, Caixian/S-8702-2019	Tang, Caixian/0000-0002-9138-8770	Chinese Ministry of Agriculture [201103004]; National Key Project on Science and Technology of China [2012BAC17B02]; Project of Scientific Emissary of Zhejiang Province [2012T2T209]	Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); National Key Project on Science and Technology of China; Project of Scientific Emissary of Zhejiang Province	This work was financially supported by the Chinese Ministry of Agriculture (201103004), the National Key Project on Science and Technology of China (2012BAC17B02) and the Project of Scientific Emissary of Zhejiang Province (2012T2T209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G, 2001, SOIL BIOL BIOCHEM, V33, P943, DOI 10.1016/S0038-0717(00)00244-3; Akila R, 2011, BIOL CONTROL, V57, P175, DOI 10.1016/j.biocontrol.2011.02.010; Bailey KL, 2003, SOIL TILL RES, V72, P169, DOI 10.1016/S0167-1987(03)00086-2; Boukaew S, 2011, BIOCONTROL, V56, P365, DOI 10.1007/s10526-010-9336-4; Boulter JI, 2002, WORLD J MICROB BIOT, V18, P661, DOI 10.1023/A:1016827929432; BREMNER JM, 1983, COMMUN SOIL SCI PLAN, V14, P905, DOI 10.1080/00103628309367418; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Chet I, 1979, BIOL CONTROL SOIL BO, P585; Dalal N. R., 1999, Journal of Soils and Crops, V9, P223; Davis JR, 2001, AM J POTATO RES, V78, P291, DOI 10.1007/BF02875694; Ding CY, 2013, PLANT SOIL, V366, P453, DOI 10.1007/s11104-012-1425-y; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; French E. R., 1995, Fitopatologia, V30, P126; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghorbani R, 2008, ENVIRON CHEM LETT, V6, P149, DOI 10.1007/s10311-008-0147-0; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; Gorissen A, 2004, CAN J MICROBIOL, V50, P587, DOI 10.1139/w04-042; Guo JH, 2004, BIOL CONTROL, V29, P66, DOI 10.1016/S1049-9644(03)00124-5; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Helmke P. A., 1996, Methods of soil analysis. Part 3 - chemical methods., P551; Hoper H, 1996, EUR J SOIL BIOL, V32, P41; King SR, 2008, HORTSCIENCE, V43, P1673, DOI 10.21273/HORTSCI.43.6.1673; Knudsen IMB, 1999, APPL SOIL ECOL, V12, P61, DOI 10.1016/S0929-1393(98)00156-5; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; Michel VV, 1998, PHYTOPATHOLOGY, V88, P300, DOI 10.1094/PHYTO.1998.88.4.300; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Padel S, 2009, FOOD POLICY, V34, P245, DOI 10.1016/j.foodpol.2009.03.008; Pankhurst CE, 1995, AUST J EXP AGR, V35, P1015, DOI 10.1071/EA9951015; Pradhanang PM, 2003, PLANT DIS, V87, P423, DOI 10.1094/PDIS.2003.87.4.423; Rivard CL, 2012, PLANT DIS, V96, P973, DOI 10.1094/PDIS-12-10-0877; Scherf JM, 2010, APPL ENVIRON MICROB, V76, P7061, DOI 10.1128/AEM.01580-10; Shannon C., 1963, MATH THEORY COMMUNIC; Shi K, 2009, CHEMOSPHERE, V75, P872, DOI 10.1016/j.chemosphere.2009.01.054; Sullivan P., 2001, SUSTAINABLE MANAGEME; Swanson JK, 2005, PHYTOPATHOLOGY, V95, P136, DOI 10.1094/PHYTO-95-0136; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Tabatabai M. A., 1972, Soil Biology and Biochemistry, V4, P479, DOI 10.1016/0038-0717(72)90064-8; Tamietti G, 2006, CROP PROT, V25, P389, DOI 10.1016/j.cropro.2005.07.002; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; van Os GJ, 2001, SOIL BIOL BIOCHEM, V33, P1447, DOI 10.1016/S0038-0717(01)00053-0; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang JF, 1998, BACTERIAL WILT DISEASE, P269; Wei Z, 2013, BIOL CONTROL, V65, P278, DOI 10.1016/j.biocontrol.2012.12.010; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wollum A. G. II, 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P781; Yilmaz S, 2011, INT J PLANT PROD, V5, P95; Yin S, 2001, BIOL FERT SOILS, V47, P303; Yuan SF, 2014, APPL SOIL ECOL, V75, P86, DOI 10.1016/j.apsoil.2013.11.004	50	32	35	8	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121304	10.1371/journal.pone.0121304	http://dx.doi.org/10.1371/journal.pone.0121304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830639	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600069
J	Maulik, U; Mallik, S; Mukhopadhyay, A; Bandyopadhyay, S				Maulik, Ujjwal; Mallik, Saurav; Mukhopadhyay, Anirban; Bandyopadhyay, Sanghamitra			Analyzing Large Gene Expression and Methylation Data Profiles Using StatBicRM: Statistical Biclustering-Based Rule Mining	PLOS ONE			English	Article							NORMALITY	Microarray and beadchip are two most efficient techniques for measuring gene expression and methylation data in bioinformatics. Biclustering deals with the simultaneous clustering of genes and samples. In this article, we propose a computational rule mining framework, StatBicRM (i.e., statistical biclustering-based rule mining) to identify special type of rules and potential biomarkers using integrated approaches of statistical and binary inclusion-maximal biclustering techniques from the biological datasets. At first, a novel statistical strategy has been utilized to eliminate the insignificant/low-significant/redundant genes in such way that significance level must satisfy the data distribution property (viz., either normal distribution or non-normal distribution). The data is then discretized and post-discretized, consecutively. Thereafter, the biclustering technique is applied to identify maximal frequent closed homogeneous itemsets. Corresponding special type of rules are then extracted from the selected itemsets. Our proposed rule mining method performs better than the other rule mining algorithms as it generates maximal frequent closed homogeneous itemsets instead of frequent itemsets. Thus, it saves elapsed time, and can work on big dataset. Pathway and Gene Ontology analyses are conducted on the genes of the evolved rules using David database. Frequency analysis of the genes appearing in the evolved rules is performed to determine potential biomarkers. Furthermore, we also classify the data to know how much the evolved rules are able to describe accurately the remaining test (unknown) data. Subsequently, we also compare the average classification accuracy, and other related factors with other rule-based classifiers. Statistical significance tests are also performed for verifying the statistical relevance of the comparative results. Here, each of the other rule mining methods or rule-based classifiers is also starting with the same post-discretized data-matrix. Finally, we have also included the integrated analysis of gene expression and methylation for determining epigenetic effect (viz., effect of methylation) on gene expression level.	[Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [Mallik, Saurav; Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India; [Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India	Jadavpur University; Indian Statistical Institute; Indian Statistical Institute Kolkata; Kalyani University	Bandyopadhyay, S (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India.	sanghami@isical.ac.in	Bandyopadhyay, Sanghamitra/AAO-7010-2020; Maulik, Ujjwal/AAO-8754-2020; Bandyopadhyay, Sanghamitra/A-6597-2010; mallik, saurav/R-4977-2019; Bandyopadhyay, Sanghamitra/AAP-4578-2020; Mukhopadhyay, Anirban/H-3220-2012; Mallik, Saurav/D-1608-2014; Mukhopadhyay, Anirban/ABB-5739-2021	mallik, saurav/0000-0003-4107-6784; Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Mukhopadhyay, Anirban/0000-0001-8128-3521; Maulik, Ujjwal/0000-0003-1167-0774				AGRAWAL R, 1993, IEEE T KNOWL DATA EN, V5, P914, DOI 10.1109/69.250074; Agrawal R., 1993, P 1993 ACM SIGMOD IN, P207; Baba A.I, 2007, COMP ONCOLOGY 2; Bandyopadhyay S., 2007, ANAL BIOL DATA SOFT; Bandyopadhyay S, 2014, IEEE ACM T COMPUT BI, V11, P95, DOI 10.1109/TCBB.2013.147; Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Creighton C, 2003, BIOINFORMATICS, V19, P79, DOI 10.1093/bioinformatics/19.1.79; Devasena C, 2011, BONFRING INT J MAN M; Dudoit S, 2002, STAT SINICA, V12, P111; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; Geng LQ, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1132960.1132963; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Kim SY, 2006, STAT METHODS MED RES, V15, P3, DOI 10.1191/0962280206sm423oa; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lange MM, 2014, THESIS U CALIFORNIA; Mallik S, 2013, P IEEE S COMP INT BI; Maulik U., 2010, COMPUTATIONAL INTELL; Maulik U, 2011, APPL SOFT COMPUT, V11, P4152, DOI 10.1016/j.asoc.2011.03.004; Mishra SK, 2010, J QUANTITATIVE EC, V8, P165; Mukhopadhyay A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032289; Navarro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033284; NOWAK RA, 1993, J CLIN ENDOCR METAB, V76, P1308, DOI 10.1210/jc.76.5.1308; Pei J, 2007, IIE TRANS, V39, P593, DOI 10.1080/07408170600897460; Pieters BFI, P PREF LEARN WORKSH, V10, P1; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Rainho CA, 1999, GYNECOL ONCOL, V74, P375, DOI 10.1006/gyno.1999.5483; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tan PN, 2004, INFORM SYST, V29, P293, DOI 10.1016/S0306-4379(03)00072-3; Tao F, 2003, P ACM SIGKDD WASH DC; Thadewald T, 2007, J APPL STAT, V34, P87, DOI 10.1080/02664760600994539; Toh SH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S24; Vickers A, 2005, BMC MED RES METHODOL; Wan Q, 2012, ONCOTARGETS THER, V5, P171, DOI 10.2147/OTT.S33550; Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112; Wu Q, 2012, LUNG CANCER, V77, P407, DOI 10.1016/j.lungcan.2012.04.007; Zaki MJ, 2000, IEEE T KNOWL DATA EN, V12, P372, DOI 10.1109/69.846291	38	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119448	10.1371/journal.pone.0119448	http://dx.doi.org/10.1371/journal.pone.0119448			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830807	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600011
J	Drouin, MA; Fleet, R; Poitras, J; Archambault, P; Chauny, JM; Levesque, JF; Ouimet, M; Dupuis, G; Tanguay, A; Simard-Racine, G; Gauthier, J; Tounkara, FK; Gilbert, MH; Legare, F				Drouin, Melodie-Anne; Fleet, Richard; Poitras, Julien; Archambault, Patrick; Chauny, Jean-Marc; Levesque, Jean-Frederic; Ouimet, Mathieu; Dupuis, Gilles; Tanguay, Alain; Simard-Racine, Genevieve; Gauthier, Josee; Tounkara, Fatoumata Korika; Gilbert, Marie-Helene; Legare, France			The Quebec Rural Emergency Department Project: A Cross-Sectional Study of a Potential Two-Pronged Strategy in the Knowledge Transfer Process	PLOS ONE			English	Article							BARRIERS	Introduction Health services research generates useful knowledge. Promotion of implementation of this knowledge in medical practice is essential. Prior to initiation of a major study on rural emergency departments (EDs), we deployed two knowledge transfer strategies designed to generate interest and engagement from potential knowledge users. The objective of this paper was to review: 1) a combined project launch and media press release strategy, and 2) a pre-study survey designed to survey potential knowledge users' opinions on the proposed study variables. Materials and Methods We evaluated the impact of the project launch (presentation at two conferences hosted by key stakeholders) and media press release via a survey of participants/stakeholders and by calculating the number of media interview requests and reports generated. We used a pre- study survey to collect potential key stakeholder' opinions on the study variables. Results Twenty-one of Quebec's 26 rural EDs participated in the pre-study survey (81% participation rate). The press release about the study generated 51 press articles and 20 media request for interviews, and contributed to public awareness of a major rural research initiative. In the pre-study survey, thirteen participants (46%) mentioned prior knowledge of the research project. Results from the pre-study survey revealed that all of the potential study variables were considered to be relevant for inclusion in the research project. Respondents also proposed additional variables of interest, including factors promoting retention of human resources. Conclusions The present study demonstrated the potential utility of a two-pronged knowledge transfer strategy, including a combined formal launch and press release, and a pre-study survey designed to ensure that the included variables were of interest to participants and stakeholders.	[Drouin, Melodie-Anne; Fleet, Richard; Poitras, Julien; Archambault, Patrick; Tanguay, Alain] Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada; [Drouin, Melodie-Anne; Fleet, Richard; Archambault, Patrick; Tounkara, Fatoumata Korika; Gilbert, Marie-Helene] Univ Laval, CHAU Hotel Dieu, Levis Hosp, Res Chair Emergency Med, Levis City, PQ, Canada; [Chauny, Jean-Marc] Univ Montreal, Dept Family & Emergency Med, Montreal, PQ H3C 3J7, Canada; [Chauny, Jean-Marc] Hop Sacre Coeur Montreal, Dept Emergency Med, Montreal, PQ, Canada; [Levesque, Jean-Frederic] Univ New S Wales, Ctr Primary Hlth Care & Equity, Sydney, NSW 2052, Australia; [Ouimet, Mathieu] Univ Laval, Dept Sci Polit, Quebec City, PQ, Canada; [Dupuis, Gilles] Univ Quebec, Dept Psychol, Montreal, PQ, Canada; [Simard-Racine, Genevieve] CSSS La Matapadia, Dept Emergency Med, Quebec City, PQ, Canada; [Gauthier, Josee] Univ Quebec, Inst Natl Sante Publ Quebec, Direct Anal & Evaluat Syst Soins & Serv, Rimouski, PQ, Canada; [Legare, France] Univ Laval, Unite Rech Evaluat, CHUQ Res Ctr CRCHUQ, Dept Family Med & Emergency Med,Knowledge Transfe, Quebec City, PQ, Canada	Laval University; Laval University; Universite de Montreal; Universite de Montreal; University of New South Wales Sydney; Laval University; University of Quebec; University of Quebec Montreal; Institut national de sante publique du Quebec (INSPQ); University of Quebec; Laval University	Fleet, R (corresponding author), Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada.	rfleet@videotron.ca	Levesque, Jean-Frederic/ABH-7122-2020	Levesque, Jean-Frederic/0000-0002-5418-8593; Legare, France/0000-0002-2296-6696	FRQS; Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital; Hotel-Dieu de Levis Hospital research fund	FRQS; Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital; Hotel-Dieu de Levis Hospital research fund	The research project was supported in part by a Junior 1 Clinician-Scientist award from the FRQS (RF), the Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital and the Hotel-Dieu de Levis Hospital research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson M, 2008, J NURS CARE QUAL, V23, P362, DOI 10.1097/01.NCQ.0000336675.48466.37; Baker T, 2009, AUST J RURAL HEALTH, V17, P291, DOI 10.1111/j.1440-1584.2009.01082.x; Bala MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub3; BOROSH I, 1966, MATH COMPUT, V20, P107, DOI 10.2307/2004274; Brazil K, 2013, RURAL REMOTE HEALTH, V13; Canadian Institute for Health Information [CIHI], 2006, HLTH AR RUR CAN ASS; Canadian Institute for Health Information (CIHI), 2005, GEOGR DISTR PHYS CAN; Canadian Institute for Health Information (CIHI), 2012, NAT HLTH EXP TRENDS; Chan GK, 2011, J EMERG NURS, V37, P24, DOI 10.1016/j.jen.2009.11.016; Chen TM, 2010, RURAL REMOTE HEALTH, V10; Choo EK, 2011, WEST J EMERG MED, V12, P178; Choo EK, 2010, J RURAL HEALTH, V26, P361, DOI 10.1111/j.1748-0361.2010.00307.x; Dagenais C, 2013, GLOB HEALTH PROMOT, V20, P70, DOI 10.1177/1757975912462416; Fleet R, 2012, CAEP 2012 ANN C NIAG; Fleet R, 2013, BMJ OPEN, V3; Glazebrook Roz M, 2006, Rural Remote Health, V6, P502; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Masino C, 2010, TELEMED J E-HEALTH, V16, P273, DOI 10.1089/tmj.2010.0057; McKenna C, 2013, VANCOUVER SUN; Ministere de la Sante et des Services sociaux du Quebec, 2006, GUID GEST URG; Pannell DJ, 1997, AGR ECON, V16, P139, DOI 10.1016/S0169-5150(96)01217-0; Rajic A, 2013, FOODBORNE PATHOG DIS, V10, P397, DOI 10.1089/fpd.2012.1349; Statistics Canada, 2012, HLTH IND PROF ANN ES; The Canadian Institute for Health Information (CIHI), 2007, UND EM DEP WAIT TIM; Thompson MJ, 2005, ARCH SURG-CHICAGO, V140, P74, DOI 10.1001/archsurg.140.1.74; Wears RL, 2010, APPL ERGON, V41, P695, DOI 10.1016/j.apergo.2009.12.006	28	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120523	10.1371/journal.pone.0120523	http://dx.doi.org/10.1371/journal.pone.0120523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849328	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800026
J	Guan, LL; Liu, J; Wu, XM; Chen, DF; Wang, X; Ma, N; Wang, Y; Good, B; Ma, H; Yu, X; Good, MJ				Guan, Lili; Liu, Jin; Wu, Xia Min; Chen, Dafang; Wang, Xun; Ma, Ning; Wang, Yan; Good, Byron; Ma, Hong; Yu, Xin; Good, Mary-Jo			Unlocking Patients with Mental Disorders Who Were in Restraints at Home: A National Follow-Up Study of China's New Public Mental Health Initiatives	PLOS ONE			English	Article							LOW-INCOME; HUMAN-RIGHTS; SCALE-UP; SERVICES; ILL	Background In 2005, China implemented a demonstration program known as "686" to scale-up nationwide basic mental health services designed to improve access to evidence-based care and to promote human rights for people with severe mental disorders. As part of the 686 Program, teams "unlocked" and provided continuous mental health care to people with severe mental disorders who were found in restraints and largely untreated in their family homes. We implemented a nation-wide two-stage follow-up study to measure the effectiveness and sustainability of the "unlocking and treatment" intervention and its impact on the well-being of patients' families. Methods 266 patients unlocked from 2005 in "686" demonstration sites across China were recruited in Stage One of the study in 2009. In 2012, 230 of the 266 cases were re-interviewed (the Stage Two study). Outcome measures included the patient medication adherence and social functioning, family burden ratings, and relocking rate. We utilized pre-post tests to analyze the changes over time following the unlocking efforts. Results 96% of patients were diagnosed with schizophrenia. Prior to unlocking, their total time locked ranged from two weeks to 28 years, with 32% having been locked multiple times. The number of persons regularly taking medicines increased from one person at the time of unlocking to 74% in 2009 and 76% in 2012. Pre-post tests showed sustained improvement in patient social functioning and significant reductions in family burden. Over 92% of patients remained free of restraints in 2012. Conclusion Practice-based evidence from our study suggests an important model for protecting the human rights of people with mental disorders and keeping them free of restraints can be achieved by providing accessible, community based mental health services with continuity of care. China's "686" Program can inform similar efforts in low-resource settings where community locking of patients is practiced.	[Guan, Lili; Liu, Jin; Wu, Xia Min; Wang, Xun; Ma, Ning; Ma, Hong; Yu, Xin] Peking Univ, Hosp 2, Inst Mental Hlth, Key Lab Mental Hlth,Minist Hlth, Beijing 100871, Peoples R China; [Chen, Dafang; Wang, Yan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Good, Byron; Good, Mary-Jo] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Peking University; Peking University; Harvard University; Harvard Medical School	Yu, X (corresponding author), Peking Univ, Hosp 2, Inst Mental Hlth, Key Lab Mental Hlth,Minist Hlth, Beijing 100871, Peoples R China.	yuxin@bjmu.edu.cn			World Health Organization Representative Office in China [WP/2008/CHN/01]; Fogarty International Center of the National Institutes of Health in the United States [D43TW009081]; FOGARTY INTERNATIONAL CENTER [D43TW009081] Funding Source: NIH RePORTER	World Health Organization Representative Office in China; Fogarty International Center of the National Institutes of Health in the United States; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported in part by grants from the World Health Organization Representative Office in China (WP/2008/CHN/01) and Fogarty International Center of the National Institutes of Health in the United States (D43TW009081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biehl Joao, 2005, VITA LIFE ZONE SOCIA; Bureau of Disease Control and Prevention MoH China, 2012, MAN TREATM GUID PSYC; Chen Hh, 2012, Shanghai Arch Psychiatry, V24, P305, DOI 10.3969/j.issn.1002-0829.2012.06.001; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Drew N, 2011, LANCET, V378, P1664, DOI 10.1016/S0140-6736(11)61458-X; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Good Byron J, 2012, Shanghai Arch Psychiatry, V24, P175, DOI 10.3969/j.issn.1002-0829.2012.03.008; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Kuntz K, 2013, LOST PARADISE CHAINE; Liu J, 2011, WORLD PSYCHIATRY, V10, P210; Lund C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001359; Ma Hong, 2012, Shanghai Arch Psychiatry, V24, P172, DOI 10.3969/j.issn.1002-0829.2012.03.007; Maj M, 2008, WORLD PSYCHIATRY, V7, P129; Malik SB, 2001, PSYCHIAT B, V25, P273, DOI [DOI 10.1192/pb.25.7.273, DOI 10.1192/PB.25.7.273]; Mari JD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000165; Marrow J, 2012, CULT MED PSYCHIAT, V36, P493, DOI 10.1007/s11013-012-9266-y; Ndetei DM, 2010, AFR J PSYCHIATRY, V13, P3; Padmavati R, 2005, INT J SOC PSYCHIATR, V51, P139, DOI 10.1177/0020764005056761; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Puteh I, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-10; Read UM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-13; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Sky, 2013, MENT ILL MAN CAG DEC; Suryani LK, 2011, EUR ARCH PSY CLIN N, V261, P140, DOI 10.1007/s00406-011-0238-y; Thara R, 2013, WORLD PSYCHIATRY, V12, P176, DOI 10.1002/wps.20042; Thornicroft G, 2010, WORLD PSYCHIATRY, V9, P67; Xiang YT, 2012, LANCET, V379, P780, DOI 10.1016/S0140-6736(11)61704-2; Xin Yu, 2010, Int Psychiatry, V7, P3; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	32	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121425	10.1371/journal.pone.0121425	http://dx.doi.org/10.1371/journal.pone.0121425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25848800	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800058
J	Hedman, E; Lekander, M; Ljotsson, B; Lindefors, N; Ruck, C; Andersson, G; Andersson, E				Hedman, Erik; Lekander, Mats; Ljotsson, Brjann; Lindefors, Nils; Ruck, Christian; Andersson, Gerhard; Andersson, Erik			Optimal Cut-Off Points on the Health Anxiety Inventory, Illness Attitude Scales and Whiteley Index to Identify Severe Health Anxiety	PLOS ONE			English	Article							SOMATOFORM DISORDERS; HYPOCHONDRIASIS; PREVALENCE; VALIDATION; FEARS	Background Health anxiety can be viewed as a dimensional phenomenon where severe health anxiety in form of DSM-IV hypochondriasis represents a cut-off where the health anxiety becomes clinically significant. Three of the most reliable and used self-report measures of health anxiety are the Health Anxiety Inventory (HAI), the Illness Attitude Scales (IAS) and the Whiteley Index (WI). Identifying the optimal cut-offs for classification of presence of a diagnosis of severe health anxiety on these measures has several advantages in clinical and research settings. The aim of this study was therefore to investigate the HAI, IAS and WI as proximal diagnostic instruments for severe health anxiety defined as DSM-IV hypochondriasis. Methods We investigated sensitivity, specificity and predictive value on the HAI, IAS and WI using a total of 347 adult participants of whom 158 had a diagnosis of severe health anxiety, 97 had obsessive-compulsive disorder and 92 were healthy non-clinical controls. Diagnostic assessments were conducted using the Anxiety Disorder Interview Schedule. Results Optimal cut-offs for identifying a diagnosis of severe health anxiety was 67 on the HAI, 47 on the IAS, and 5 on the WI. Sensitivity and specificity were high, ranging from 92.6 to 99.4%. Positive and negative predictive values ranged from 91.6 to 99.4% using unadjusted prevalence rates. Conclusions The HAI, IAS and WI have very good properties as diagnostic indicators of severe health anxiety and can be used as cost-efficient proximal estimates of the diagnosis.	[Hedman, Erik; Ljotsson, Brjann; Andersson, Erik] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Hedman, Erik; Lekander, Mats] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, Stockholm, Sweden; [Lindefors, Nils; Ruck, Christian; Andersson, Gerhard; Andersson, Erik] Karolinska Inst, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Linkoping University; Stockholm University	Hedman, E (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden.	kire.hedman@ki.se	Andersson, Gerhard/J-8529-2012	Andersson, Gerhard/0000-0003-4753-6745; Hedman-Lagerlof, Erik/0000-0002-7939-9848; Andersson, Erik/0000-0003-0088-8719; Ruck, Christian/0000-0002-8742-0168	Karolinska Insititutet; Stockholm County Council	Karolinska Insititutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	The main funding organizations (Karolinska Insititutet and Stockholm County Council) is a public institution and had no role in the design and conduct of the study; in the collection, management, and analysis of the data; or in the preparation, review and approval of the manuscript. All authors report that they have no competing interests.	Abramowitz JS, 2008, PSYCHOL TREATMENT HL; Alberts NM, 2013, J ANXIETY DISORD, V27, P68, DOI 10.1016/j.janxdis.2012.10.009; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barsky AJ, 1998, ARCH GEN PSYCHIAT, V55, P737, DOI 10.1001/archpsyc.55.8.737; Barsky AJ, 2001, MED CARE, V39, P705, DOI 10.1097/00005650-200107000-00007; Conradt M, 2006, J PSYCHOSOM RES, V60, P137, DOI 10.1016/j.jpsychores.2005.07.003; DINARDO PA, 1983, ARCH GEN PSYCHIAT, V40, P1070; Faravelli C, 1997, SOC PSYCH PSYCH EPID, V32, P24, DOI 10.1007/BF00800664; Furr Mike, 2011, SCALE CONSTRUCTION P; Hadjistavropoulos HD, 1999, BEHAV RES THER, V37, P671, DOI 10.1016/S0005-7967(98)00159-4; Hedman E, 2014, BR J PSYCHIAT; Hedman E, PSYCHOMETRIC PROPERT; Hiller W, 2003, ACTA NEUROPSYCHIATR, V15, P167, DOI 10.1034/j.1601-5215.2003.00031.x; Hiller W, 2002, PSYCHOL MED, V32, P707, DOI 10.1017/S0033291702005524; Hofling V, 2013, J PSYCHOSOM RES, V75, P526, DOI 10.1016/j.jpsychores.2013.10.011; KELLNER R, 1987, J NERV MENT DIS, V175, P20, DOI 10.1097/00005053-198701000-00004; PILOWSKY I, 1967, BRIT J PSYCHIAT, V113, P89, DOI 10.1192/bjp.113.494.89; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sirri L, 2008, PSYCHOTHER PSYCHOSOM, V77, P337, DOI 10.1159/000151387; Sirri L, 2014, CURR PSYCHIATRY REV, V10, P50, DOI 10.2174/1573400509666131119005346; Speckens AEM, 1996, J PSYCHOSOM RES, V40, P95, DOI 10.1016/0022-3999(95)00561-7; Sunderland M, 2013, BRIT J PSYCHIAT, V202, P56, DOI 10.1192/bjp.bp.111.103960; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Tyrer P, 2011, J PSYCHOSOM RES, V71, P392, DOI 10.1016/j.jpsychores.2011.07.004; Weck F, 2010, J PERS ASSESS, V92, P260, DOI 10.1080/00223891003670216; Welch PG, 2009, J ANXIETY DISORD, V23, P1002, DOI 10.1016/j.janxdis.2009.05.006	29	35	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123412	10.1371/journal.pone.0123412	http://dx.doi.org/10.1371/journal.pone.0123412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849477	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800232
J	Jones, MS; Tadepalli, S; Bridges, DF; Wu, VCH; Drummond, F				Jones, Matthew S.; Tadepalli, Shravani; Bridges, David F.; Wu, Vivian C. H.; Drummond, Frank			Suppression of Escherichia coli O157:H7 by Dung Beetles (Coleoptera: Scarabaeidae) Using the Lowbush Blueberry Agroecosystem as a Model System	PLOS ONE			English	Article							CONTAMINATED MANURE; O157-H7 INFECTIONS; FOOD SAFETY; OUTBREAK; CATTLE; TRANSMISSION; SALMONELLA; SURVIVAL; SPINACH; FIELDS	Wildlife as a source of microbial contamination is a food safety concern. Deer feces (scat) have been determined as a point source for Escherichia coli O157:H7 contamination of fresh produce. The ecological role of the scooped scarab (Onthophagus hecate (Panzer)), a generalist dung beetle species common in Maine blueberry fields, was explored as a biological control agent and alternatively as a pathogen vector between deer scat and food. A large-scale field survey of wildlife scat indicated that pathogenic E. coli O157: H7 was present, albeit at a low prevalence (1.9% of samples, n = 318), in the Maine lowbush blueberry agroecosystem. A manipulative field experiment verified that, should contact occur between deer scat and blueberry plants and fruit during the summer, contamination with E. coli O157: H7 can occur and persist for more than 72 h. For both the positive control and an experimental scat inoculation treatment, the levels of the bacterial population decreased over time, but at different rates (treatment x time interaction: F ((1.9,18.8)) = 358.486, P < 0.0001). The positive control inoculation, which resulted in a higher initial E. coli level on fruit, decayed at a faster rate than inoculation of fruit via scat in the experimental treatment. We conducted 2 laboratory studies to elucidate aspects of dung beetle feeding ecology as it relates to suppression of E. coli O157:H7 from deer scat to lowbush blueberry fruit. In both experiments, dung beetles buried the same amount of scat whether or not the scat was inoculated with the pathogen (F-(1,F-6) = 0.001; P = 0.999 and (F ((2,17)) = 4.10, P = 0.147). Beetles feeding on E. coli inoculated deer scat were not found to vector the pathogen to fruit. In two studies, beetles lowered the amount of pathogenic E. coli persisting in soils compared to soils without beetles (F ((2,9)) = 7.757; P = 0.05 and F ((2,17)) = 8.0621, P = 0.004). Our study suggests that the dung beetle species, Onthophagus hecate, has the potential to contribute to the suppression of E. coli O157:H7 in agricultural landscapes.	[Jones, Matthew S.; Bridges, David F.; Drummond, Frank] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [Jones, Matthew S.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Tadepalli, Shravani; Wu, Vivian C. H.] Univ Maine, Sch Food & Agr, Orono, ME USA; [Drummond, Frank] Univ Maine, Cooperat Extens, Orono, ME USA	University of Maine System; University of Maine Orono; Washington State University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Jones, MS (corresponding author), Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA.	matthew.s.jones@wsu.edu; vivian.wu@umit.maine.edu; frank.drummond@umit.maine.edu		Bridges, David/0000-0002-8507-6498; Wu, Vivian C.H./0000-0002-1525-1078	Center for Produce Safety; Maine Agricultural and Forest Experiment Station at the University of Maine [3406]; USDA National Institute of Food and Agriculture [ME08562-10]	Center for Produce Safety; Maine Agricultural and Forest Experiment Station at the University of Maine; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was supported by the Center for Produce Safety and the Maine Agricultural and Forest Experiment Station at the University of Maine with external publication number 3406. This work is based upon research supported in part by Hatch Grant number ME08562-10 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 1998, J INFECT DIS, V177, P1588, DOI 10.1086/515323; ANDERSON JR, 1978, CALIF AGR, V32, P31; Atwill ER, 2008, P 23 VERT PEST C SAN, P5; Bertone M, 2006, NCSU COOP EXT; BESSER RE, 1993, JAMA-J AM MED ASSOC, V269, P2217, DOI 10.1001/jama.269.17.2217; Bialka KL, 2007, J FOOD SCI, V72, pM391, DOI 10.1111/j.1750-3841.2007.00517.x; Bugguide. net, 2004, SPECIES ONTHOPHAGUS; Cody SH, 1999, ANN INTERN MED, V130, P202, DOI 10.7326/0003-4819-130-3-199902020-00005; Collins JD, 2004, REV SCI TECH OIE, V23, P685, DOI 10.20506/rst.23.2.1510; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Feng P., 2011, BACTERIOLOGICAL ANAL; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; FINCHER GT, 1981, J GEORGIA ENTOMOL SO, V16, P316; Fischer JR, 2001, APPL ENVIRON MICROB, V67, P1218, DOI 10.1128/AEM.67.3.1218-1224.2001; Franz E, 2005, APPL ENVIRON MICROB, V71, P6165, DOI 10.1128/AEM.71.10.6165-6174.2005; Gillespie JR, 2000, J AM VET MED ASSOC, V216, P662, DOI 10.2460/javma.2000.216.662; Han Y, 2004, J FOOD PROTECT, V67, P2450, DOI 10.4315/0362-028X-67.11.2450; Holldobler B., 1990, pi; HOLTER P, 1979, OIKOS, V32, P393, DOI 10.2307/3544751; Howden H. F., 1963, Proceedings of the United States National Museum, V114, P1; Hwang JS, 2008, EUR J ENTOMOL, V105, P355, DOI 10.14411/eje.2008.042; Islam M, 2005, FOOD MICROBIOL, V22, P63, DOI 10.1016/j.fm.2004.04.007; Janisiewicz WJ, 1999, APPL ENVIRON MICROB, V65, P1; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Johannessen GS, 2005, APPL ENVIRON MICROB, V71, P2221, DOI 10.1128/AEM.71.5.2221-2225.2005; Jones M. J, 2013, THESIS; Koehler S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-3; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Laidler MR, 2013, CLIN INFECT DIS, P1; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Moyne AL, 2011, FOOD MICROBIOL, V28, P1417, DOI 10.1016/j.fm.2011.02.001; NEALIS VG, 1977, CAN J ZOOL, V55, P138, DOI 10.1139/z77-017; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Rasmussen MA, 2001, CRIT REV MICROBIOL, V27, P57, DOI 10.1080/20014091096701; Renter DG, 2006, J WILDLIFE DIS, V42, P699, DOI 10.7589/0090-3558-42.3.699; Renter DG, 2001, J WILDLIFE DIS, V37, P755, DOI 10.7589/0090-3558-37.4.755; ROGERS LL, 1987, J WILDLIFE MANAGE, V51, P330, DOI 10.2307/3801011; Ryan U, 2011, EXP PARASITOL, V129, P1, DOI 10.1016/j.exppara.2011.06.009; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Wheater P.C., 2011, PRACTICAL FIELD ECOL; Xu JG, 2003, MICROBIOL IMMUNOL, V47, P45, DOI 10.1111/j.1348-0421.2003.tb02784.x; Yarborough DE, 2013, COMMUNICATION	45	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120904	10.1371/journal.pone.0120904	http://dx.doi.org/10.1371/journal.pone.0120904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849430	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800039
J	Kim, MH; Kim, MS; Kim, W; Kang, MA; Cacalano, NA; Kang, SB; Shin, YJ; Jeong, JH				Kim, Moon-Hong; Kim, Moon-Sun; Kim, Wonwoo; Kang, Mi Ae; Cacalano, Nicholas A.; Kang, Soon-Beom; Shin, Young-Joo; Jeong, Jae-Hoon			Suppressor of Cytokine Signaling (SOCS) Genes Are Silenced by DNA Hypermethylation and Histone Deacetylation and Regulate Response to Radiotherapy in Cervical Cancer Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; JAK/STAT PATHWAY; GROWTH; METHYLATION; EXPRESSION; STRATEGIES	Suppressor of cytokine signaling (SOCS) family is an important negative regulator of cytokine signaling and deregulation of SOCS has been involved in many types of cancer. All cervical cancer cell lines tested showed lower expression of SOCS1, SOCS3, and SOCS5 than normal tissue or cell lines. The immunohistochemistry result for SOCS proteins in human cervical tissue also confirmed that normal tissue expressed higher level of SOCS proteins than neighboring tumor. Similar to the regulation of SOCS in other types of cancer, DNA methylation contributed to SOCS1 downregulation in CaSki, ME- 180, and HeLa cells. However, the expression of SOCS3 or SOCS5 was not recovered by the inhibition of DNA methylation. Histone deacetylation may be another regulatory mechanism involved in SOCS1 and SOCS3 expression, however, SOCS5 expression was neither affected by DNA methylation nor histone deacetylation. Ectopic expression of SOCS1 or SOCS3 conferred radioresistance to HeLa cells, which implied SOCS signaling regulates the response to radiation in cervical cancer. In this study, we have shown that SOCS expression repressed by, in part, epigenetically and altered SOCS1 and SOCS3 expression could contribute to the radiosensitive phenotype in cervical cancer.	[Kim, Moon-Hong] Korea Inst Radiol & Med Sci, Korea Canc Ctr Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Moon-Hong; Kim, Moon-Sun; Kim, Wonwoo; Kang, Mi Ae; Jeong, Jae-Hoon] Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul, South Korea; [Cacalano, Nicholas A.] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA; [Kang, Soon-Beom] Konkuk Univ, Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Shin, Young-Joo] Inje Univ, Sanggye Paik Hosp, Dept Radiat Oncol, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; National Cancer Center - Korea (NCC); Korea Institute of Radiological & Medical Sciences; University of California System; University of California Los Angeles; Konkuk University; Konkuk University Medical Center; Inje University	Jeong, JH (corresponding author), Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul, South Korea.	jeongj@kirams.re.kr	Kim, Moon-Hong/J-2380-2019	Kim, Moon-Hong/0000-0001-9456-8147	National Nuclear R & D Program of the Ministry of Science, ICT and Future Planning, Republic of Korea (KIRAMS RTR) [504580-2012]	National Nuclear R & D Program of the Ministry of Science, ICT and Future Planning, Republic of Korea (KIRAMS RTR)	This work was supported by the National Nuclear R & D Program of the Ministry of Science, ICT and Future Planning, Republic of Korea (KIRAMS RTR: 504580-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooney RN, 2002, SHOCK, V17, P83, DOI 10.1097/00024382-200202000-00001; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Francipane MG, 2009, CANCER RES, V69, P6141, DOI 10.1158/0008-5472.CAN-09-0994; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jo H, 2007, ACTA ONCOL, V46, P852, DOI 10.1080/02841860601134493; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kim MH, 2003, GYNECOL ONCOL, V90, P83, DOI 10.1016/S0090-8258(03)00224-5; Linke A, 2010, J INVEST DERMATOL, V130, P866, DOI 10.1038/jid.2009.345; Mallette FA, 2010, AGING-US, V2, P445, DOI 10.18632/aging.100163; McIntyre GJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-1; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Park SH, 2003, DNA CELL BIOL, V22, P131, DOI 10.1089/104454903321515931; Puhr M, 2009, CANCER RES, V69, P7375, DOI 10.1158/0008-5472.CAN-09-0806; Rottapel R, 2002, ONCOGENE, V21, P4351, DOI 10.1038/sj.onc.1205537; Sobti RC, 2011, CELL ONCOL, V34, P533, DOI 10.1007/s13402-011-0056-2; Suo GJ, 2010, TRANSPL P, V42, P2658, DOI 10.1016/j.transproceed.2010.04.039; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303; Zhu YQ, 2013, INT J ONCOL, V43, P1151, DOI 10.3892/ijo.2013.2027	22	39	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123133	10.1371/journal.pone.0123133	http://dx.doi.org/10.1371/journal.pone.0123133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849377	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800207
J	Maubant, S; Tesson, B; Maire, V; Ye, ML; Rigaill, G; Gentien, D; Cruzalegui, F; Tucker, GC; Roman-Roman, S; Dubois, T				Maubant, Sylvie; Tesson, Bruno; Maire, Virginie; Ye, Mengliang; Rigaill, Guillem; Gentien, David; Cruzalegui, Francisco; Tucker, Gordon C.; Roman-Roman, Sergio; Dubois, Thierry			Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							WNT/BETA-CATENIN PATHWAY; WNT SIGNALING PATHWAY; MAMMARY EPITHELIAL-CELLS; BETA-CATENIN; TARGET GENES; CANDIDATE TARGETS; UP-REGULATION; STEM-CELLS; EXPRESSION; ACTIVATION	The canonical Wnt/beta-catenin pathway is activated in triple-negative breast cancer (TNBC). The activation of this pathway leads to the expression of specific target genes depending on the cell/tissue context. Here, we analyzed the transcriptome of two different TNBC cell lines to define a comprehensive list of Wnt target genes. The treatment of cells with Wnt3a for 6h up-regulated the expression (fold change > 1.3) of 59 genes in MDA-MB-468 cells and 241 genes in HCC38 cells. Thirty genes were common to both cell lines. Beta-catenin may also be a transcriptional repressor and we found that 18 and 166 genes were down-regulated in response to Wnt3a treatment for 6h in MDA-MB-468 and HCC38 cells, respectively, of which six were common to both cell lines. Only half of the activated and the repressed transcripts have been previously described as Wnt target genes. Therefore, our study reveals 137 novel genes that may be positively regulated by Wnt3a and 104 novel genes that may be negatively regulated by Wnt3a. These genes are involved in the Wnt pathway itself, and also in TGF beta, p53 and Hedgehog pathways. Thorough characterization of these novel potential Wnt target genes may reveal new regulators of the canonical Wnt pathway. The comparison of our list of Wnt target genes with those published in other cellular contexts confirms the notion that Wnt target genes are tissue-, cell line-and treatment-specific. Genes up-regulated in Wnt3a-stimulated cell lines were more strongly expressed in TNBC than in luminal A breast cancer samples. These genes were also overexpressed, but to a much lesser extent, in HER2+ and luminal B tumors. We identified 72 Wnt target genes higher expressed in TNBCs (17 with a fold change >1.3) which may reflect the chronic activation of the canonical Wnt pathway that occurs in TNBC tumors.	[Maubant, Sylvie; Tesson, Bruno; Maire, Virginie; Ye, Mengliang; Dubois, Thierry] Inst Curie, Ctr Rech, Translat Res Dept, Breast Canc Biol Grp, Paris, France; [Tesson, Bruno] Inst Curie, Ctr Rech, Bioinformat Biostat Epidemiol & Computat Syst Bio, INSERM U900, Paris, France; [Tesson, Bruno] Mines ParisTech, Fontainebleau, France; [Rigaill, Guillem] Univ Evry Val Essonne, CNRS, INRA, Unite Rech Genom Vegetale, Evry, France; [Gentien, David] Inst Curie, Ctr Rech, Translat Res Dept, Platform Mol Biol Facil, Paris, France; [Cruzalegui, Francisco; Tucker, Gordon C.] Inst Rech SERVIER, Pole Innovat Therapeut Oncol, Croissy Sur Seine, France; [Roman-Roman, Sergio] Inst Curie, Ctr Rech, Translat Res Dept, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Servier; Institut de Recherches Internationales Servier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Dubois, T (corresponding author), Inst Curie, Ctr Rech, Translat Res Dept, Breast Canc Biol Grp, Paris, France.	thierry.dubois@curie.fr	Gentien, David/L-7757-2017; Roman-Roman, Sergio/K-9993-2014; Gentien, David/O-9356-2019; Dubois, Thierry/D-2852-2017	Gentien, David/0000-0001-8317-5188; Roman-Roman, Sergio/0000-0001-6459-2613; Dubois, Thierry/0000-0003-4739-6164; Rigaill, Guillem/0000-0002-7176-7511	Institut de Recherches Servier; Institut Curie; Institut de Recherche Servier	Institut de Recherches Servier; Institut Curie; Institut de Recherche Servier	This work was supported by Institut de Recherches Servier and Institut Curie. Co-authors Francisco Cruzalegui and Gordon C. Tucker are employed by Institut de Recherche Servier. Institut de Recherche Servier provided support in the form of salaries for authors FC and GCT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Angonin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074666; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Hoverter NP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pe43; INGHAM PW, 2012, GENE DEV, V4, DOI DOI 10.1101/CSHPERSPECT.A011221; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; Kamiya N, 2011, BIOCHEM BIOPH RES CO, V414, P326, DOI 10.1016/j.bbrc.2011.09.060; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Katoh M, 2007, INT J MOL MED, V19, P273; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim JS, 2002, CANCER RES, V62, P2744; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Lee HS, 2007, LIFE SCI, V80, P690, DOI 10.1016/j.lfs.2006.10.024; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2012, CANCER RES, V72, P1568, DOI 10.1158/0008-5472.CAN-11-3668; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Oderup C, 2013, J IMMUNOL, V190, P6126, DOI 10.4049/jimmunol.1203002; Pecina-Slaus N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-22; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Railo A, 2009, EXP CELL RES, V315, P2690, DOI 10.1016/j.yexcr.2009.06.021; Reichling T, 2005, CANCER RES, V65, P166; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Rohrs S, 2009, CELL BIOL INT, V33, P501, DOI 10.1016/j.cellbi.2009.01.016; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Schwartz DR, 2003, CANCER RES, V63, P2913; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Shin H, 2010, J DERMATOL SCI, V58, P91, DOI 10.1016/j.jdermsci.2010.02.011; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; So EY, 2010, INT J BIOL SCI, V6, P675; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Takahashi M, 2002, CANCER RES, V62, P5651; Takahashi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086582; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Tomimaru Y, 2013, LIVER INT, V33, P1100, DOI 10.1111/liv.12188; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Van Raay TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018650; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; Wan XH, 2012, CLIN CANCER RES, V18, P726, DOI 10.1158/1078-0432.CCR-11-2521; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhou YH, 2013, J MOL HISTOL, V44, P555, DOI 10.1007/s10735-013-9504-9; Ziegler S, 2005, FEBS J, V272, P1600, DOI 10.1111/j.1742-4658.2005.04581.x; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	98	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122333	10.1371/journal.pone.0122333	http://dx.doi.org/10.1371/journal.pone.0122333			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848952	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800119
J	Piccoli, T; Valente, G; Linden, DEJ; Re, M; Esposito, F; Sack, AT; Di Salle, F				Piccoli, Tommaso; Valente, Giancarlo; Linden, David E. J.; Re, Marta; Esposito, Fabrizio; Sack, Alexander T.; Di Salle, Francesco			The Default Mode Network and the Working Memory Network Are Not Anti-Correlated during All Phases of a Working Memory Task	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; RESTING-STATE; CINGULATE CORTEX; PARIETAL CORTEX; BRAIN-FUNCTION; FLUCTUATIONS; RETRIEVAL; MODULATION; ALZHEIMERS; COMPONENT	Introduction The default mode network and the working memory network are known to be anti-correlated during sustained cognitive processing, in a load-dependent manner. We hypothesized that functional connectivity among nodes of the two networks could be dynamically modulated by task phases across time. Methods To address the dynamic links between default mode network and the working memory network, we used a delayed visuo-spatial working memory paradigm, which allowed us to separate three different phases of working memory (encoding, maintenance, and retrieval), and analyzed the functional connectivity during each phase within and between the default mode network and the working memory network networks. Results We found that the two networks are anti-correlated only during the maintenance phase of working memory, i.e. when attention is focused on a memorized stimulus in the absence of external input. Conversely, during the encoding and retrieval phases, when the external stimulation is present, the default mode network is positively coupled with the working memory network, suggesting the existence of a dynamically switching of functional connectivity between "task-positive" and "task-negative" brain networks. Conclusions Our results demonstrate that the well-established dichotomy of the human brain (anti-correlated networks during rest and balanced activation-deactivation during cognition) has a more nuanced organization than previously thought and engages in different patterns of correlation and anti-correlation during specific sub-phases of a cognitive task. This nuanced organization reinforces the hypothesis of a direct involvement of the default mode network in cognitive functions, as represented by a dynamic rather than static interaction with specific task-positive networks, such as the working memory network.	[Piccoli, Tommaso; Valente, Giancarlo; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; [Piccoli, Tommaso] Univ Palermo, Dept Biomed & Clin Neurosci, Palermo, Italy; [Linden, David E. J.] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Re, Marta] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Esposito, Fabrizio; Di Salle, Francesco] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy	Maastricht University; University of Palermo; Cardiff University; Polytechnic University of Milan; University of Salerno	Piccoli, T (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands.	tommaso.piccoli@unipa.it	Re, Marta/K-2548-2018; Linden, David/C-7355-2013; Esposito, Fabrizio/M-8555-2015	Re, Marta/0000-0002-6971-3725; Piccoli, Tommaso/0000-0003-3410-2067; Linden, David/0000-0002-5638-9292; Sack, Alexander/0000-0002-1471-0885; Esposito, Fabrizio/0000-0002-5099-9786	Netherlands Organization for Scientific Research (NWO) [400-09195]; Medical Research Council [MR/L010305/1] Funding Source: researchfish	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the Netherlands Organization for Scientific Research (NWO; grant number 400-09195; awarded to FdS and ATS).	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluhm RL, 2011, HUM BRAIN MAPP, V32, P1029, DOI 10.1002/hbm.21090; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chiu YC, 2012, NEUROPSYCHOLOGIA, V50, P479, DOI 10.1016/j.neuropsychologia.2011.07.007; Daselaar SM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.013.2009; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Esposito F, 2009, MAGN RESON IMAGING, V27, P1120, DOI 10.1016/j.mri.2009.01.007; Finocchiaro C, 2006, NEUROCASE, V12, P317, DOI 10.1080/13554790601126203; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Krawczyk DC, 2013, HUM BRAIN MAPP, V34, P762, DOI 10.1002/hbm.21472; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Ljubisavljevic MR, 2013, CURR ALZHEIMER RES, V10, P578; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Metzak P, 2011, HUM BRAIN MAPP, V32, P856, DOI 10.1002/hbm.21072; Morgan HM, 2010, CEREB CORTEX, V20, P187, DOI 10.1093/cercor/bhp094; Mottaghy FM, 2002, CEREB CORTEX, V12, P369, DOI 10.1093/cercor/12.4.369; Nardone Raffaele, 2012, Int J Alzheimers Dis, V2012, P687909, DOI 10.1155/2012/687909; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pena-Gomez C, 2012, BRAIN STIMUL, V5, P252, DOI 10.1016/j.brs.2011.08.006; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vannini P, 2011, CEREB CORTEX, V21, P22, DOI 10.1093/cercor/bhq051; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Wendelken C, 2012, HUM BRAIN MAPP, V33, P1952, DOI 10.1002/hbm.21336; Woodward TS, 2013, NEUROIMAGE, V65, P529, DOI 10.1016/j.neuroimage.2012.09.070	46	72	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123354	10.1371/journal.pone.0123354	http://dx.doi.org/10.1371/journal.pone.0123354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848951	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800227
J	Shaw, AJ; Ingham, SA; Atkinson, G; Folland, JP				Shaw, Andrew J.; Ingham, Stephen A.; Atkinson, Greg; Folland, Jonathan P.			The Correlation between Running Economy and Maximal Oxygen Uptake: Cross-Sectional and Longitudinal Relationships in Highly Trained Distance Runners	PLOS ONE			English	Article							INVERSE RELATIONSHIP; PERFORMANCE; EXERCISE; EFFICIENCY; VO2MAX; TIME; COST	A positive relationship between running economy and maximal oxygen uptake ((V) over dotO(2max)) has been postulated in trained athletes, but previous evidence is equivocal and could have been confounded by statistical artefacts. Whether this relationship is preserved in response to running training (changes in running economy and (V) over dotO(2max)) has yet to be explored. This study examined the relationships of (i) running economy and (V) over dotO(2max) between runners, and (ii) the changes in running economy and (V) over dotO(2max) that occur within runners in response to habitual training. 168 trained distance runners (males, n = 98, (V) over dotO(2max) 73.0 +/- 6.3 mL.kg(-1).min(-1); females, n = 70, (V) over dotO(2max) 65.2 +/- 5.9 mL.kg(-1).min(-1)) performed a discontinuous submaximal running test to determine running economy (kcal.km(-1)). A continuous incremental treadmill running test to volitional exhaustion was used to determine (V) over dotO(2max) 54 participants (males, n = 27; females, n = 27) also completed at least one follow up assessment. Partial correlation analysis revealed small positive relationships between running economy and (V) over dotO(2max) (males r = 0.26, females r = 0.25; P<0.006), in addition to moderate positive relationships between the changes in running economy and VO2max in response to habitual training (r = 0.35; P<0.001). In conclusion, the current investigation demonstrates that only a small to moderate relationship exists between running economy and (V) over dotO(2max) in highly trained distance runners. With >85% of the variance in these parameters unexplained by this relationship, these findings reaffirm that running economy and (V) over dotO(2max) are primarily determined independently.	[Shaw, Andrew J.; Ingham, Stephen A.] Univ Loughborough, English Inst Sport, Loughborough, Leics, England; [Shaw, Andrew J.; Folland, Jonathan P.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Atkinson, Greg] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England	Loughborough University; Loughborough University; University of Teesside	Shaw, AJ (corresponding author), Univ Loughborough, English Inst Sport, Loughborough, Leics, England.	a.shaw@lboro.ac.uk	Atkinson, Greg/ABA-2278-2021	Atkinson, Greg/0000-0002-5459-9042				Atkinson G, 2003, MED SCI SPORT EXER, V35, P1242, DOI 10.1249/01.MSS.0000074560.08128.5D; Bishop D, 1998, MED SCI SPORT EXER, V30, P1270, DOI 10.1097/00005768-199808000-00014; Bland JM, 2009, BMJ-BRIT MED J, V446, P1; BLOMQVIST CG, 1983, ANNU REV PHYSIOL, V45, P169, DOI 10.1146/annurev.ph.45.030183.001125; BRANDON LJ, 1995, SPORTS MED, V19, P268, DOI 10.2165/00007256-199519040-00004; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; Di Michele R, 2014, J SCI MED SPORT, V17, P414, DOI 10.1016/j.jsams.2013.05.012; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; Fletcher JR, 2009, J APPL PHYSIOL, V107, P1918, DOI 10.1152/japplphysiol.00307.2009; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; Helgerud J, 2010, EUR J APPL PHYSIOL, V108, P1099, DOI 10.1007/s00421-009-1218-z; Hopker J, 2012, INT J SPORTS MED, V33, P789, DOI 10.1055/s-0032-1304640; Hopker J, 2009, MED SCI SPORT EXER, V41, P912, DOI 10.1249/MSS.0b013e31818f2ab2; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hunter GR, 2011, MED SCI SPORT EXER, V43, P1492, DOI 10.1249/MSS.0b013e318210464a; Iaia FM, 2009, J APPL PHYSIOL, V106, P73, DOI 10.1152/japplphysiol.90676.2008; Ingham SA, 2008, MED SCI SPORT EXER, V40, P345, DOI 10.1249/mss.0b013e31815a83dc; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Mclaughlin JE, 2010, MED SCI SPORT EXER, V42, P991, DOI 10.1249/MSS.0b013e3181c0669d; MORGAN DW, 1994, INT J SPORTS MED, V15, P426, DOI 10.1055/s-2007-1021082; Moya-Larano Jordi, 2008, Web Ecology, V8, P35; Noakes TD, 2004, MED SCI SPORT EXER, V36, P1083, DOI 10.1249/01.MSS.0000128140.85727.2D; PATE RR, 1992, MED SCI SPORT EXER, V24, P1128; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Peronnet F., 1991, CANAD J SPORT SCI, V9, P16; PUGH LGCE, 1970, J PHYSIOL-LONDON, V207, P823, DOI 10.1113/jphysiol.1970.sp009097; Rietjens GJWM, 2001, INT J SPORTS MED, V22, P291, DOI 10.1055/s-2001-14342; Santalla A, 2009, MED SCI SPORT EXER, V41, P1096, DOI 10.1249/MSS.0b013e318191c802; Sawyer BJ, 2010, MED SCI SPORT EXER, V42, P2122, DOI 10.1249/MSS.0b013e3181de2da7; Schmidt W, 2008, SCAND J MED SCI SPOR, V18, P57, DOI 10.1111/j.1600-0838.2008.00833.x; Scholz MN, 2008, J EXP BIOL, V211, P3266, DOI 10.1242/jeb.018812; Shaw AJ, 2014, MED SCI SPORT EXER, V46, P1968, DOI 10.1249/MSS.0000000000000311; Shaw AJ, 2013, APPL PHYSIOL NUTR ME, V38, P1268, DOI 10.1139/apnm-2013-0055; Tartaruga MP, 2012, RES Q EXERCISE SPORT, V83, P367; Wagner P D, 2000, Exerc Sport Sci Rev, V28, P10	38	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123101	10.1371/journal.pone.0123101	http://dx.doi.org/10.1371/journal.pone.0123101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849090	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800204
J	Stanifer, JW; Patel, UD; Karia, F; Thielman, N; Maro, V; Shimbi, D; Kilaweh, H; Lazaro, M; Matemu, O; Omolo, J; Boyd, D				Stanifer, John W.; Patel, Uptal D.; Karia, Francis; Thielman, Nathan; Maro, Venance; Shimbi, Dionis; Kilaweh, Humphrey; Lazaro, Matayo; Matemu, Oliver; Omolo, Justin; Boyd, David		Comprehensive Kidney Dis Assessmen	The Determinants of Traditional Medicine Use in Northern Tanzania: A Mixed-Methods Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH-CARE; HEALERS; COMPLEMENTARY; HIV/AIDS; BEHAVIOR; DISEASE	Introduction Traditional medicines are an important part of healthcare in sub-Saharan Africa, and building successful disease treatment programs that are sensitive to traditional medicine practices will require an understanding of their current use and roles, including from a biomedical perspective. Therefore, we conducted a mixed-method study in Northern Tanzania in order to characterize the extent of and reasons for the use of traditional medicines among the general population so that we can better inform public health efforts in the region. Methods Between December 2013 and June 2014 in Kilimanjaro, Tanzania, we conducted 5 focus group discussions and 27 in-depth interviews of key informants. The data from these sessions were analyzed using an inductive framework method with cultural insider-outsider coding. From these results, we developed a structured survey designed to test different aspects of traditional medicine use and administered it to a random sample of 655 adults from the community. The results were triangulated to explore converging and diverging themes. Results Most structured survey participants (68%) reported knowing someone who frequently used traditional medicines, and the majority (56%) reported using them themselves in the previous year. The most common uses were for symptomatic ailments (42%), chronic diseases (15%), reproductive problems (11%), and malaria/febrile illnesses (11%). We identified five major determinants for traditional medicine use in Northern Tanzania: biomedical healthcare delivery, credibility of traditional practices, strong cultural identities, individual health status, and disease understanding. Conclusions In order to better formulate effective local disease management programs that are sensitive to TM practices, we described the determinants of TM use. Additionally, we found TM use to be high in Northern Tanzania and that its use is not limited to lower-income areas or rural settings. After symptomatic ailments, chronic diseases were reported as the most common reason for TM use which may be particularly important in Northern Tanzania where non-communicable diseases are a rapidly growing burden.	[Stanifer, John W.; Patel, Uptal D.; Thielman, Nathan] Duke Univ, Dept Med, Durham, NC 27708 USA; [Stanifer, John W.; Thielman, Nathan; Boyd, David] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Karia, Francis; Maro, Venance; Shimbi, Dionis; Kilaweh, Humphrey; Lazaro, Matayo; Matemu, Oliver] Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Omolo, Justin] Tanga AIDS Working Grp, Tanga, Tanzania	Duke University; Duke University; Duke University	Stanifer, JW (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.	john.stanifer@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879	NIH - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; International Society of Nephrology (ISN) Global Outreach Committee; Masters of Science research stipend - Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER	NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Society of Nephrology (ISN) Global Outreach Committee; Masters of Science research stipend - Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported by an NIH Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology (ISN) Global Outreach Committee; and a Masters of Science research stipend funded by the Duke Global Health Institute.	Abbo C, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7117; Abdullahi, 2011, AFR J TRADIT COMPLEM, V8, P115, DOI 10.4314/ajtcam.v8i5S.5; Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Aderibigbe S A, 2013, J Prev Med Hyg, V54, P35; Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Babb Dale A, 2007, Psychol Health Med, V12, P314, DOI 10.1080/13548500600621511; Bodeker G, 2006, J ALTERN COMPLEM MED, V12, P563, DOI 10.1089/acm.2006.12.563; Cooper M, 2012, ETHNIC HEALTH, V17, P597, DOI 10.1080/13557858.2012.740003; de-Graft Aikins Ama, 2014, BMC Public Health, V14 Suppl 2, pS3, DOI 10.1186/1471-2458-14-S2-S3; Dillip A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-113; Ensink K., 1999, TRANSCULT PSYCHIATRY, V36, P23, DOI [DOI 10.1177/13634615990, 10.1177/136346159903600102, DOI 10.1177/136346159903600102]; FARRAND D, 1984, S AFR MED J, V66, P779; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gearhart R, 2014, J TRANSCULT NURS, V25, P218, DOI 10.1177/1043659613515713; Gessler MC, 1995, J ETHNOPHARMACOL, V48, P145, DOI 10.1016/0378-8741(95)01295-O; Gyasi RM, 2013, AM INT J CONT RES, V3, P1; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Joint United Nations Programme on HIV/ AIDS, 2002, ANC REM NEW DIS INV; Kayombo EJ, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-5; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Langwick SA, 2008, AM ETHNOL, V35, P428, DOI 10.1111/j.1548-1425.2008.00044.x; Liwa AC, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0437-9; Malangu N, 2007, AFR J TRADIT COMPLEM, V4, P273; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mhame PP, 2010, WHO CLIN PRACT AFR T; Mushi D, 2011, EPILEPSY BEHAV, V20, P338, DOI 10.1016/j.yebeh.2010.11.016; Nyamongo IK, 2002, SOC SCI MED, V54, P377, DOI 10.1016/S0277-9536(01)00036-3; Peltzer K, 2006, Curationis, V29, P54; Peltzer K, 2008, AFR J TRADIT COMPLEM, V5, P370; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; Semenya SS, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-4; Sorsdahl K, 2009, J NERV MENT DIS, V197, P434, DOI 10.1097/NMD.0b013e3181a61dbc; Stangeland T, 2008, J ETHNOPHARMACOL, V117, P290, DOI 10.1016/j.jep.2008.02.008; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Stekelenburg J, 2005, HEALTH POLICY, V71, P67, DOI 10.1016/j.healthpol.2004.05.008; Tabuti JRS, 2003, J ETHNOPHARMACOL, V85, P119, DOI 10.1016/S0378-8741(02)00378-1; Taylor KD, 2012, ETHNIC HEALTH, V17, P615, DOI 10.1080/13557858.2013.771151; The United Republic of Tanzania, 2013, POPULATION DISTRIBUT; Ulin PR, 2005, QUALITATIVE METHODS; United Republic of Tanzanian Ministry of Health, 2000, NAT BIRTH ATT IMPL P; World Heath Organisation, 2013, TRAD MED STRAT 2014; Wreford J, 2008, SOCIAL DYNAMICS, V31, P55	42	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122638	10.1371/journal.pone.0122638	http://dx.doi.org/10.1371/journal.pone.0122638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25848762	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800154
J	Su, JJ; Zhou, HG; Tao, YH; Guo, JC; Guo, ZL; Zhang, S; Zhang, Y; Huang, YY; Tang, YP; Dong, Q; Hu, RM				Su, Jingjing; Zhou, Houguang; Tao, Yinghong; Guo, Jingchun; Guo, Zhuangli; Zhang, Shuo; Zhang, Yu; Huang, Yanyan; Tang, Yuping; Dong, Qiang; Hu, Renming			G-CSF Protects Human Brain Vascular Endothelial Cells Injury Induced by High Glucose, Free Fatty Acids and Hypoxia through MAPK and Akt Signaling	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; PROGENITOR CELLS; BONE-MARROW; NEURONAL APOPTOSIS; DIABETES-MELLITUS; OXIDATIVE STRESS; MOBILIZATION; MODEL; PHOSPHORYLATION	Granulocyte-colony stimulating factor (G-CSF) has been shown to play a neuroprotective role in ischemic stroke by mobilizing bone marrow (BM)-derived endothelial progenitor cells (EPCs), promoting angiogenesis, and inhibiting apoptosis. Impairments in mobilization and function of the BM-derived EPCs have previously been reported in animal and human studies of diabetes where there is both reduction in the levels of the BM-derived EPCs and its ability to promote angiogenesis. This is hypothesized to account for the pathogenesis of diabetic vascular complications such as stroke. Here, we sought to investigate the effects of GCSF on diabetes-associated cerebral vascular defect. We observed that pretreatment of the cultured human brain vascular endothelial cells (HBVECs) with G-CSF largely prevented cell death induced by the combination stimulus with high glucose, free fatty acids (FFA) and hypoxia by increasing cell viability, decreasing apoptosis and caspase-3 activity. Cell ultrastructure measured by transmission electron microscope (TEM) revealed that G-CSF treatment nicely reduced combination stimulus-induced cell apoptosis. The results from fluorescent probe Fluo-3/AM showed that G-CSF greatly suppressed the levels of intracellular calcium ions under combination stimulus. We also found that G-CSF enhanced the expression of cell cycle proteins such as human cell division cycle protein 14A (hCdc14A), cyclinB and cyclinE, inhibited p53 activity, and facilitated cell cycle progression following combination stimulus. In addition, activation of extracellular signal-regulated kinase1/2 (ERK1/2) and Akt, and deactivation of c-Jun N terminal kinase (JNK) and p38 were proved to be required for the pro-survival effects of G-CSF on HBVECs exposed to combination stimulus. Overall, G-CSF is capable of alleviating HBVECs injury triggered by the combination administration with high glucose, FFA and hypoxia involving the mitogen-activated protein kinases (MAPK) and Akt signaling cascades. G-CSF may represent a promising therapeutic agent for diabetic stroke.	[Su, Jingjing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Neurol, Shanghai 200011, Peoples R China; [Zhou, Houguang; Zhang, Yu; Huang, Yanyan] Fudan Univ, Huashan Hosp, Dept Geriatr Neurol, Shanghai 200040, Peoples R China; [Tao, Yinghong] Ouyang Hosp, Dept Gen Med, Shanghai, Peoples R China; [Guo, Jingchun] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, State Key Lab Med Neurobiol,Dept Neurobiol, Shanghai 200032, Peoples R China; [Guo, Zhuangli] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Emergency Neurol, Qingdao 266100, Peoples R China; [Zhang, Shuo; Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrine, Shanghai 200040, Peoples R China; [Tang, Yuping; Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Qingdao University; Fudan University; Fudan University	Zhou, HG (corresponding author), Fudan Univ, Huashan Hosp, Dept Geriatr Neurol, Shanghai 200040, Peoples R China.	zhg7376@163.com; renminghu@fudan.edu.cn	huang, yan/GWM-4747-2022		National Natural Scientific Foundation of China [81170322, 81200941]; Shanghai Natural Scientific Foundation of China [11ZR1405300]; Shanghai Municipal Outstanding Talent Development Foundation [2012052]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Scientific Foundation of China; Shanghai Municipal Outstanding Talent Development Foundation	This work was supported by National Natural Scientific Foundation of China (81170322, 81200941), Shanghai Natural Scientific Foundation of China (11ZR1405300) and Shanghai Municipal Outstanding Talent Development Foundation (2012052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albiero M, 2013, VASC PHARMACOL, V58, P253, DOI 10.1016/j.vph.2013.01.003; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barthelmes D, 2013, BLOOD CELL MOL DIS, V51, P163, DOI 10.1016/j.bcmd.2013.05.002; Bejot Y, 2010, DIABETES METAB, V36, pS84, DOI 10.1016/S1262-3636(10)70472-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen WF, 2008, NEUROSCIENCE, V153, P31, DOI 10.1016/j.neuroscience.2008.01.062; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; de la Puente P, 2013, CLIN CANCER RES, V19, P3360, DOI 10.1158/1078-0432.CCR-13-0462; DEMETRI GD, 1991, BLOOD, V78, P2791; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2014, STEM CELL TRANSL MED, V3, P949, DOI 10.5966/sctm.2014-0052; Fadini Gian Paolo, 2012, Exp Diabetes Res, V2012, P742976, DOI 10.1155/2012/742976; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fan B, 2013, METABOLISM, V62, P1168, DOI 10.1016/j.metabol.2013.02.013; Floel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019767; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; Kong T, 2009, J NEUROSURG, V111, P155, DOI 10.3171/2008.12.JNS08172; Lan XF, 2008, TOHOKU J EXP MED, V216, P117, DOI 10.1620/tjem.216.117; Lee ST, 2008, BRAIN RES, V1194, P130, DOI 10.1016/j.brainres.2007.11.058; Li B, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt67; Li C, 2012, CLIN EXP PHARMACOL P, V39, P739, DOI 10.1111/j.1440-1681.2012.05700.x; Li JM, 2012, MOL BIOL REP, V39, P5, DOI 10.1007/s11033-011-0703-8; Lu CZ, 2006, BIOCHEM SOC T, V34, P1327, DOI 10.1042/BST0341327; Mukherjee D, 2009, BEST PRACT RES CL EN, V23, P335, DOI 10.1016/j.beem.2008.10.015; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; OConnor PM, 1997, CANCER SURV, V29, P151; Ohtsuki F, 1997, BRIT J HAEMATOL, V98, P520, DOI 10.1046/j.1365-2141.1997.2643079.x; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Qiu CL, 2014, CELL PHYSIOL BIOCHEM, V33, P784, DOI 10.1159/000358652; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shah QA, 2014, CELL PROLIFERAT, V47, P290, DOI 10.1111/cpr.12111; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sicinska E, 2006, MOL CELL BIOL, V26, P8052, DOI 10.1128/MCB.00800-06; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Song SJ, 2011, NEUROSCI LETT, V487, P153, DOI 10.1016/j.neulet.2010.10.012; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Su JJ, 2014, CNS NEUROSCI THER, V20, P264, DOI 10.1111/cns.12206; Su JJ, 2015, CELL SIGNAL, V27, P47, DOI 10.1016/j.cellsig.2014.10.003; Sugiyama Y, 2011, STROKE, V42, P770, DOI 10.1161/STROKEAHA.110.597799; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tousoulis D, 2013, INT J CARDIOL, V168, P4769, DOI 10.1016/j.ijcard.2013.07.229; Ueda K, 2006, ARTERIOSCL THROM VAS, V26, pE108, DOI 10.1161/01.ATV.0000219697.99134.10; Wolf G, 1999, KIDNEY INT, V56, P1262, DOI 10.1046/j.1523-1755.1999.00695.x; Zhan KH, 2013, MICROVASC RES, V90, P1, DOI 10.1016/j.mvr.2013.06.010; Zhou HG, 2013, CNS NEUROSCI THER, V19, P252, DOI 10.1111/cns.12068; Zhou WJ, 2009, HYPERTENS RES, V32, P306, DOI 10.1038/hr.2009.16	51	21	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120707	10.1371/journal.pone.0120707	http://dx.doi.org/10.1371/journal.pone.0120707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849550	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800029
J	Sugimori, N; Espinoza, JL; Trung, LQ; Takami, A; Kondo, Y; An, DT; Sasaki, M; Wakayama, T; Nakao, S				Sugimori, Naomi; Espinoza, J. Luis; Ly Quoc Trung; Takami, Akiyoshi; Kondo, Yukio; Dao Thi An; Sasaki, Motoko; Wakayama, Tomohiko; Nakao, Shinji			Paraptosis Cell Death Induction by the Thiamine Analog Benfotiamine in Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; DOUBLE-BLIND; LINE; INHIBITION; METABOLISM; EXPRESSION; PROGENITOR; RELEVANCE; MEDIATION; DAMAGE	Benfotiamine is a synthetic thiamine analogue that stimulates transketolase, a cellular enzyme essential for glucose metabolism. Currently, benfotiamine is used to treat diabetic neuropathy. We recently reported that oral benfotiamine induced a temporary but remarkable recovery from acute myeloid leukemia in an elderly patient who was ineligible for standard chemotherapy due to dementia and renal failure. In the present study we present evidences that benfotiamine possess antitumor activity against leukemia cells. In a panel of nine myeloid leukemia cell lines benfotiamine impaired the viability of HL-60, NB4, K562 and KG1 cells and also inhibited the growing of primary leukemic blasts. The antitumor activity of benfotiamine is not mediated by apoptosis, necrosis or autophagy, but rather occurs though paraptosis cell death induction. Mechanistic studies revealed that benfotiamine inhibited the activity of constitutively active ERK1/2 and concomitantly increased the phosphorylation of JNK1/2 kinase in leukemic cells. In addition, benfotiamine induced the down regulation of the cell cycle regulator CDK3 which resulted in G1 cell cycle arrest in the sensitive leukemic cells. Moreover, combination index studies showed that benfotiamine enhanced the antiproliferative activities of cytarabine against leukemia cells. These findings suggest that benfotiamine has antitumor therapeutic potential.	[Sugimori, Naomi; Espinoza, J. Luis; Ly Quoc Trung; Takami, Akiyoshi; Kondo, Yukio; Dao Thi An; Nakao, Shinji] Kanazawa Univ, Dept Hematol Oncol, Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Takami, Akiyoshi] Aichi Med Univ, Sch Med, Dept Hematol Oncol, Nagakute, Aichi 48011, Japan; [Sasaki, Motoko] Kanazawa Univ, Dept Pathol, Kanazawa, Ishikawa, Japan; [Wakayama, Tomohiko] Kanazawa Univ, Dept Anat & Histol, Kanazawa, Ishikawa, Japan	Kanazawa University; Aichi Medical University; Kanazawa University; Kanazawa University	Espinoza, JL (corresponding author), Kanazawa Univ, Dept Hematol Oncol, Kanazawa Univ Hosp, Japan Takaramachi 13-1, Kanazawa, Ishikawa, Japan.	luis@staff.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015; Takami, Akiyoshi/O-5677-2019; Espinoza, Luis/L-1586-2013	Sasaki, Motoko/0000-0003-2514-760X; Takami, Akiyoshi/0000-0002-1822-9976; Espinoza, Luis/0000-0002-1794-6666	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research [24591418] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports and Technology of Japan. The grant sources played no role in the study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Alkhalaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040427; Alkhalaf A, 2010, DIABETES CARE, V33, P1598, DOI 10.2337/dc09-2241; Ariyoshi-Kishino K, 2010, ANTICANCER RES, V30, P5069; Balakumar P, 2010, PHARMACOL RES, V61, P482, DOI 10.1016/j.phrs.2010.02.008; Beltramo E, 2008, ACTA DIABETOL, V45, P131, DOI 10.1007/s00592-008-0042-y; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Doepfner KT, 2007, CRIT REV ONCOL HEMAT, V63, P215, DOI 10.1016/j.critrevonc.2007.05.005; Edwards LG, 1996, LEUKEMIA RES, V20, P17, DOI 10.1016/0145-2126(95)00095-X; Eleni LD, 2010, J ONCOL, V2010, DOI 10.1155/2010/943823; Espinoza JL, 2013, CANCER SCI, V104, P657, DOI 10.1111/cas.12141; Espinoza JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051306; Fey MF, 2010, ANN ONCOL, V21, pv158, DOI 10.1093/annonc/mdq179; Fraser DA, 2011, GENES NUTR; Fraser DA, 2012, DIABETES CARE, V35, P1095, DOI 10.2337/dc11-1895; FURUKAWA T, 1994, LEUKEMIA, V8, P171; KITAMURA T, 1991, INT IMMUNOL, V3, P571, DOI 10.1093/intimm/3.6.571; KOCHI M, 1985, CANCER TREAT REP, V69, P533; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; LANOTTE M, 1991, BLOOD, V77, P1080; Marchetti V, 2006, DIABETES, V55, P2231, DOI 10.2337/db06-0369; Motyckova G, 2011, CURR TREAT OPTION ON, V12, P341, DOI 10.1007/s11864-011-0162-4; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Sanchez-Ramirez GM, 2006, EUR J PHARMACOL, V530, P48, DOI 10.1016/j.ejphar.2005.11.016; Scheibe RJ, 2000, J CELL BIOCHEM, V76, P420, DOI 10.1002/(SICI)1097-4644(20000301)76:3<420::AID-JCB10>3.0.CO;2-F; Schmid U, 2008, DIABETES-METAB RES, V24, P371, DOI 10.1002/dmrr.860; Schupp N, 2008, N-S ARCH PHARMACOL, V378, P283, DOI 10.1007/s00210-008-0310-y; Shoeb M, 2012, FREE RADICAL BIO MED, V52, P182, DOI 10.1016/j.freeradbiomed.2011.10.444; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; T Hoa N, 2007, LAB INVEST, V87, P115, DOI 10.1038/labinvest.3700506; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; Volvert Marie-Laure, 2008, BMC Pharmacology, V8, P10, DOI 10.1186/1471-2210-8-10; Yanada M, 2012, INT J HEMATOL, V96, P186, DOI 10.1007/s12185-012-1137-3; Ziems M., 2000, Biofactors, V11, P109	34	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120709	10.1371/journal.pone.0120709	http://dx.doi.org/10.1371/journal.pone.0120709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849583	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800030
J	Sun, Y; Wang, C; Hao, Z; Dai, J; Chen, DY; Xu, ZH; Shi, DQ; Mao, P; Teng, HJ; Gao, X; Hu, ZB; Shen, HB; Jiang, Q				Sun, Ye; Wang, Cheng; Hao, Zheng; Dai, Jin; Chen, Dongyang; Xu, Zhihong; Shi, Dongquan; Mao, Ping; Teng, Huajian; Gao, Xiang; Hu, Zhibin; Shen, Hongbing; Jiang, Qing			A Common Variant Of Ubiquinol-Cytochrome c Reductase Complex Is Associated with DDH	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; DEVELOPMENTAL DYSPLASIA; HIP; OSTEOARTHRITIS; EXPRESSION; CHONDROGENESIS; PROLIFERATION; CHONDROCYTES; HEIGHT; MODEL	Purpose Genetic basis of Developmental dysplasia of the hip (DDH) remains largely unknown. To find new susceptibility genes for DDH, we carried out a genome-wide association study (GWAS) for DDH. Methods We enrolled 386 radiology confirmed DDH patients and 558 healthy controls (Set A) to conduct a genome-wide association study (GWAS). Quality-control was conducted at both the sample and single nucleotide polymorphism (SNP) levels. We then conducted a subsequent case-control study to replicate the association between a promising loci, rs6060373 in UQCC gene and DDH in an independent set of 755 cases and 944 controls (set B). Results In the DDH GWAS discovering stage, 51 SNPs showed significance of less than 10(-4), and another 577 SNPs showed significance of less than 10(-3). In UQCC, all the 12 genotyped SNPs showed as promising risk loci. Genotyping of rs6060373 in set A showed the minor allele A as a promising risk allele (p = 4.82*10(-7)). In set A, the odds ratio of allele A was 1.77. Genotyping of rs6060373 in Set B produced another significant result (p = 0.0338) with an odds ratio of 1.18 for risk allele A. Combining set A and set B, we identified a total p value of 3.63*10(-6) with the odds ratio of 1.35 (1.19-1.53) for allele A. Conclusion Our study demonstrates common variants of UQCC, specifically rs6060373, are associated with DDH in Han Chinese population.	[Sun, Ye; Hao, Zheng; Dai, Jin; Chen, Dongyang; Xu, Zhihong; Shi, Dongquan; Mao, Ping; Jiang, Qing] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Ye; Dai, Jin; Shi, Dongquan; Teng, Huajian; Jiang, Qing] Nanjing Univ, Lab Bone & Joint Dis, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Wang, Cheng; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing Medical University	Jiang, Q (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing 210008, Jiangsu, Peoples R China.	jiangqing112@hotmail.com	shi, dongquan/AAE-9956-2020; Dai, Jin/GVT-2414-2022; shi, dongquan/ABH-3078-2021; Shi, Dongquan/ABG-6949-2021	Dai, Jin/0000-0003-3063-746X; shi, dongquan/0000-0002-4769-7816; Shen, Hongbing/0000-0002-2581-5906	China National Natural Science Funds for Youths [81101338, 30901570]; China National Funds for Distinguished Young Scientists [81125013]	China National Natural Science Funds for Youths; China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC))	This work was supported by China National Natural Science Funds for Youths (No. 81101338, No. 30901570) and China National Funds for Distinguished Young Scientists (No. 81125013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter C O, 1964, Clin Orthop Relat Res, V33, P119; Chan A, 1997, ARCH DIS CHILD-FETAL, V76, pF94, DOI 10.1136/fn.76.2.F94; Chia SL, 2009, ARTHRITIS RHEUM-US, V60, P2019, DOI 10.1002/art.24654; Cook MB, 2011, INT J EPIDEMIOL, V40, P731, DOI 10.1093/ije/dyq260; Dai J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2540; Deng FY, 2013, BONE, V53, P129, DOI 10.1016/j.bone.2012.11.028; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Imabayashi H, 2003, EXP CELL RES, V288, P35, DOI 10.1016/S0014-4827(03)00130-7; Jacobsen S, 2005, RHEUMATOLOGY, V44, P211, DOI 10.1093/rheumtology/keh436; Jia JY, 2012, OSTEOARTHR CARTILAGE, V20, P60, DOI 10.1016/j.joca.2011.10.004; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Laurence M, 1987, Biol Soc, V4, P61; Madry H, 2004, J GENE MED, V6, P238, DOI 10.1002/jgm.488; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; Marie PJ, 2005, J CELL BIOCHEM, V96, P888, DOI 10.1002/jcb.20582; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Sahni M, 2001, DEVELOPMENT, V128, P2119; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Shi DQ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3252; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sollazzo V, 2000, ANN HUM GENET, V64, P51, DOI 10.1017/S0003480000007958; Stein-Zamir C, 2008, PEDIATR INT, V50, P341, DOI 10.1111/j.1442-200X.2008.02575.x; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; Vetter K, 2001, MECH DEVELOP, V100, P123, DOI 10.1016/S0925-4773(00)00511-6; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2010, OSTEOARTHR CARTILAGE, V18, P1592, DOI 10.1016/j.joca.2010.09.008; WU M, 1989, J BIOL CHEM, V264, P11122	28	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120212	10.1371/journal.pone.0120212	http://dx.doi.org/10.1371/journal.pone.0120212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848760	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800022
J	Aeinehband, S; Lindblom, RPF; Al Nimer, F; Vijayaraghavan, S; Sandholm, K; Khademi, M; Olsson, T; Nilsson, B; Ekdahl, KN; Darreh-Shori, T; Piehl, F				Aeinehband, Shahin; Lindblom, Rickard P. F.; Al Nimer, Faiez; Vijayaraghavan, Swetha; Sandholm, Kerstin; Khademi, Mohsen; Olsson, Tomas; Nilsson, Bo; Ekdahl, Kristina Nilsson; Darreh-Shori, Taher; Piehl, Fredrik			Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; REGULATOR FACTOR-H; CEREBROSPINAL-FLUID; BIOLOGICAL MARKERS; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; INHIBITION; ACTIVATION; PROGRESSION; EXPRESSION	Dysregulation of the complement system is evident in many CNS diseases but mechanisms regulating complement activation in the CNS remain unclear. In a recent large rat genomewide expression profiling and linkage analysis we found co-regulation of complement C3 immediately downstream of butyrylcholinesterase (BuChE), an enzyme hydrolyzing acetylcholine (ACh), a classical neurotransmitter with immunoregulatory effects. We here determined levels of neurofilament-light (NFL), a marker for ongoing nerve injury, C3 and activity of the two main ACh hydrolyzing enzymes, acetylcholinesterase (AChE) and BuChE, in cerebrospinal fluid (CSF) from patients with MS (n = 48) and non-inflammatory controls (n = 18). C3 levels were elevated in MS patients compared to controls and correlated both to disability and NFL. C3 levels were not induced by relapses, but were increased in patients with >= 9 cerebral lesions on magnetic resonance imaging and in patients with progressive disease. BuChE activity did not differ at the group level, but was correlated to both C3 and NFL levels in individual samples. In conclusion, we show that CSF C3 correlates both to a marker for ongoing nerve injury and degree of disease disability. Moreover, our results also suggest a potential link between intrathecal cholinergic activity and complement activation. These results motivate further efforts directed at elucidating the regulation and effector functions of the complement system in MS, and its relation to cholinergic tone.	[Aeinehband, Shahin; Lindblom, Rickard P. F.; Al Nimer, Faiez; Khademi, Mohsen; Olsson, Tomas; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Vijayaraghavan, Swetha; Darreh-Shori, Taher] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Alzheimer Neurobiol Ctr, Stockholm, Sweden; [Nilsson, Bo; Ekdahl, Kristina Nilsson] Uppsala Univ, Dept Immunol Genet & Pathol, Div Clin Immunol, Uppsala, Sweden; [Sandholm, Kerstin; Ekdahl, Kristina Nilsson] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Linnaeus University	Aeinehband, S (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	shahin.aeinehband@ki.se	DARREH-SHORI, TAHER/G-3931-2013; Nimer, Faiez Al/ABB-9465-2020; Nilsson, Bo/B-3102-2012; Ekdahl, Kristina Nilsson/B-5301-2012	Nilsson, Bo/0000-0003-0057-2730; Olsson, Tomas/0000-0002-2938-1877; Darreh-Shori, Taher/0000-0003-1176-6258; Khademi, Mohsen/0000-0003-0801-1444; Lindblom, Rickard/0000-0001-7913-4981; Al Nimer, Faiez/0000-0003-0937-5995; Piehl, Fredrik/0000-0001-8329-5219				Antonelli T, 2013, NEUROL SCI, V34, P769, DOI 10.1007/s10072-012-1265-9; Axelsson M, 2014, MULT SCLER J, V20, P43, DOI 10.1177/1352458513490544; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Darreh-Shori T, 2008, NEUROBIOL AGING, V29, P168, DOI 10.1016/j.neurobiolaging.2006.09.020; Darreh-Shori T, 2006, NEUROBIOL DIS, V24, P326, DOI 10.1016/j.nbd.2006.07.013; Darreh-Shori T, 2013, NEUROBIOL AGING, V34, P2465, DOI 10.1016/j.neurobiolaging.2013.04.027; Darvesh S, 2003, NAT REV NEUROSCI, V4, P131, DOI 10.1038/nrn1035; Darvesh S, 1998, J COMP NEUROL, V393, P374; Darvesh S, 2001, CELL MOL NEUROBIOL, V21, P285, DOI 10.1023/A:1010947205224; Darvesh S, 2010, CHEM-BIOL INTERACT, V187, P425, DOI 10.1016/j.cbi.2010.01.037; De Simone R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-4; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Henningsson AJ, 2007, J NEUROIMMUNOL, V183, P200, DOI 10.1016/j.jneuroim.2006.10.022; Holton P, 2013, ANN HUM GENET, V77, P85, DOI 10.1111/ahg.12000; Iacobaeus E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019138; Ingram G, 2012, MULT SCLER J, V18, P1401, DOI 10.1177/1352458512438238; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Ingram G, 2011, J CELL BIOCHEM, V112, P2653, DOI 10.1002/jcb.23204; Ingram G, 2010, BRAIN, V133, P1602, DOI 10.1093/brain/awq085; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Kooi EJ, 2011, ACTA NEUROPATHOL, V122, P313, DOI 10.1007/s00401-011-0849-4; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lehmann DJ, 1997, HUM MOL GENET, V6, P1933, DOI 10.1093/hmg/6.11.1933; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Li Y, 2011, J CELL BIOCHEM, V112, P1930, DOI 10.1002/jcb.23113; Lindblom RPF, 2014, J IMMUNOL, V192, P1138, DOI 10.4049/jimmunol.1301233; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Malmsten L, 2014, J CELL MOL MED, V18, P1874, DOI 10.1111/jcmm.12343; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nizri E, 2006, NEUROPHARMACOLOGY, V50, P540, DOI 10.1016/j.neuropharm.2005.10.013; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; RUBERG M, 1987, J NEUROL NEUROSUR PS, V50, P538, DOI 10.1136/jnnp.50.5.538; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Sifringer M, 2013, DEV NEUROSCI-BASEL, V35, P255, DOI 10.1159/000346723; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Swanberg M, 2006, NEUROBIOL DIS, V24, P67, DOI 10.1016/j.nbd.2006.05.016; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vijayaraghavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065936; Wang Y, 2011, AM J PATHOL, V178, P1509, DOI 10.1016/j.ajpath.2011.01.006; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	56	41	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122048	10.1371/journal.pone.0122048	http://dx.doi.org/10.1371/journal.pone.0122048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835709	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000074
J	Dvey-Aharon, Z; Fogelson, N; Peled, A; Intrator, N				Dvey-Aharon, Zack; Fogelson, Noa; Peled, Avi; Intrator, Nathan			Schizophrenia Detection and Classification by Advanced Analysis of EEG Recordings Using a Single Electrode Approach	PLOS ONE			English	Article							CONTEXTUAL PROCESSING DEFICITS; FUNCTIONAL CONNECTIVITY	Electroencephalographic (EEG) analysis has emerged as a powerful tool for brain state interpretation and diagnosis, but not for the diagnosis of mental disorders; this may be explained by its low spatial resolution or depth sensitivity. This paper concerns the diagnosis of schizophrenia using EEG, which currently suffers from several cardinal problems: it heavily depends on assumptions, conditions and prior knowledge regarding the patient. Additionally, the diagnostic experiments take hours, and the accuracy of the analysis is low or unreliable. This article presents the "TFFO" (Time-Frequency transformation followed by Feature-Optimization), a novel approach for schizophrenia detection showing great success in classification accuracy with no false positives. The methodology is designed for single electrode recording, and it attempts to make the data acquisition process feasible and quick for most patients.	[Dvey-Aharon, Zack; Intrator, Nathan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Fogelson, Noa] Chaim Sheba Med Ctr, Joseph Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel; [Fogelson, Noa] Univ A Coruna, Dept Psychol, La Coruna, Spain; [Peled, Avi] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, IL-32000 Haifa, Israel; [Peled, Avi] Shaar Menashe Mental Hlth Ctr, Inst Psychiat Studies, Hadera, Israel	Tel Aviv University; Chaim Sheba Medical Center; Universidade da Coruna; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Dvey-Aharon, Z (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	zackdvey@tau.ac.il		Fogelson, Noa/0000-0003-2239-2212	regional government of Galicia, Spain [INCITE09 106 232 PR, 2009/013, 2009/002]; Spanish Ministry of Science and Innovation [PSI2012-34212]	regional government of Galicia, Spain; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the regional government of Galicia, Spain [INCITE09 106 232 PR to NF, 2009/013, 2009/002] and by the Spanish Ministry of Science and Innovation [PSI2012-34212 to NF]".	ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; [Anonymous], 2006, PHYSIOL MEAS; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Berger H, 1940, PSYCHE, V6; Bestelmeyer PEG, 2009, PSYCHIAT RES, V169, P212, DOI 10.1016/j.psychres.2008.06.035; Carretie L, 1997, ELECTROEN CLIN NEURO, V103, P298, DOI 10.1016/S0013-4694(96)96565-7; FENTON GW, 1980, BRIT J PSYCHIAT, V136, P445, DOI 10.1192/bjp.136.5.445; Fogelson N, 2011, PSYCHOPHYSIOLOGY, V48, P1217, DOI 10.1111/j.1469-8986.2011.01195.x; Fogelson N, 2011, CLIN NEUROPHYSIOL, V122, P539, DOI 10.1016/j.clinph.2010.07.017; Fogelson N, 2010, CORTEX, V46, P498, DOI 10.1016/j.cortex.2009.05.007; Fogelson N, 2009, BRAIN, V132, P3002, DOI 10.1093/brain/awp230; Geva AB, 1998, IEEE T BIO-MED ENG, V45, P1205, DOI 10.1109/10.720198; Halkidi M, 2002, CLUSTERING VALIDITY, P237; Jeon YW, 2003, PSYCHOPHYSIOLOGY, V40, P684, DOI 10.1111/1469-8986.00070; Koenig T, 2001, SCHIZOPHR RES, V50, P55, DOI 10.1016/S0920-9964(00)00154-7; Laton J, 2014, J NEUROL SCI, V347, P262, DOI 10.1016/j.jns.2014.10.015; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Neuhaus AH, 2014, SCHIZOPHRENIA BULL, V40, P1062, DOI 10.1093/schbul/sbt151; Neuhaus AH, 2011, NEUROIMAGE, V55, P514, DOI 10.1016/j.neuroimage.2010.12.038; Oude DB, 2007, EGG BASED EMOTION RE; Peled A, 2001, INT J NEUROSCI, V106, P47, DOI 10.3109/00207450109149737; Petrantonakis PC, 2010, IEEE T INF TECHNOL B, V14, P186, DOI 10.1109/TITB.2009.2034649; Podlipsky I, 2012, J NEUROSCI METH, V203, P377, DOI 10.1016/j.jneumeth.2011.10.015; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Tomioka R., 2007, NIPS, V19, P1377, DOI DOI 10.1109/ISMS.2014.46; Zhdanov A, 2007, INFERRING FUNCTIONAL; Zhdanov A, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P393, DOI 10.1007/978-1-4020-8387-7_67	28	45	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123033	10.1371/journal.pone.0123033	http://dx.doi.org/10.1371/journal.pone.0123033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837521	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000122
J	Guiro, K; Patel, SA; Greco, SJ; Rameshwar, P; Arinzeh, TL				Guiro, Khadidiatou; Patel, Shyam A.; Greco, Steven J.; Rameshwar, Pranela; Arinzeh, Treena L.			Investigating Breast Cancer Cell Behavior Using Tissue Engineering Scaffolds	PLOS ONE			English	Article							DRUG-RESISTANCE; MESENCHYMAL TRANSITION; MAMMOGRAPHIC DENSITY; BONE-MARROW; IN-VITRO; 3D; CULTURE; METASTASIS; MIGRATION; MATRIX	Despite early detection through the use of mammograms and aggressive intervention, breast cancer (BC) remains a clinical dilemma. BC can resurge after > 10 years of remission. Studies indicate that BC cells (BCCs) with self-renewal and chemoresistance could be involved in dormancy. The majority of studies use in vitro, two-dimensional (2-D) monolayer cultures, which do not recapitulate the in vivo microenvironment. Thus, to determine the effect of three-dimensional (3-D) microenvironment on BCCs, this study fabricated tissue engineering scaffolds made of poly (e-caprolactone) (PCL) having aligned or random fibers. Random and aligned fibers mimic, respectively, the random and highly organized collagen fibers found in the tumor extracellular matrix. Chemoresistant BCCs were obtained by treating with carboplatin. Western blot analysis of carboplatin resistant (treated) MDA-MB-231 (highly invasive, basal-like) and T47D (low-invasive, luminal) BCCs showed an increase in Bcl-2, Oct-4 and Sox-2, suggesting protection from apoptosis and increase in stem-like markers. Further studies with MDA-MB-231 BCCs seeded on the scaffolds showed little to no change in cell number over time for non-treated BCCs whereas on tissue culture polystyrene (TCP), non-treated BCCs displayed a significant increase in cell number at days 4 and 7 as compared to day 1 (p<0.05). Treated BCCs did not proliferate on TCP and the fibrous scaffolds. Little to no cyclin D1 was expressed for non-treated BCCs on TCP. On fibrous scaffolds, non-treated BCCs stained for cyclin D1 during the 7-day culture period. Treated BCCs expressed cyclin D1 on TCP and fibrous scaffolds during the 7-day culture period. Proliferation, viability and cell cycle analysis indicated that this 3-D culture prompted the aggressive BCCs to adopt a dormant phenotype, while the treated BCCs retained their phenotype. The findings indicate that random and aligned fibrous PCL scaffolds may provide a useful system to study how the 3-D microenvironment affects the behavior of BCCs.	[Guiro, Khadidiatou; Arinzeh, Treena L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Patel, Shyam A.; Greco, Steven J.; Rameshwar, Pranela] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA	New Jersey Institute of Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center	Arinzeh, TL (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	arinzeh@njit.edu			Department of Defense; Wallace H. Coulter Foundation	Department of Defense(United States Department of Defense); Wallace H. Coulter Foundation	This work was funded by the Department of Defense and the Wallace H. Coulter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Beck MT, 2002, ONCOGENE, V21, P5047, DOI 10.1038/sj.onc.1205637; Becker S, 2006, BREAST CANCER RES TR, V97, P91, DOI 10.1007/s10549-005-9095-6; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Box C, 2010, SEMIN CANCER BIOL, V20, P128, DOI 10.1016/j.semcancer.2010.06.004; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Braun S, 2009, CANCER INVEST, V27, P598, DOI 10.1080/07357900802574496; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen AA, 2009, BIOMATERIALS, V30, P1113, DOI 10.1016/j.biomaterials.2008.10.055; Cheng N, 2008, TISSUE ENG PT A, V14, P1, DOI 10.1089/ten.a.2007.0131; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Cichon MA, 2012, INTEGR BIOL-UK, V4, P440, DOI 10.1039/c1ib00090j; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; ELIOPOULOS AG, 1995, ONCOGENE, V11, P1217; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; FISHER RF, 1982, Q J EXP PHYSIOL CMS, V67, P213; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Foroni L, 2013, EXP CELL RES, V319, P1515, DOI 10.1016/j.yexcr.2013.03.035; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002; Grant CA, 2009, BIOPHYS J, V97, P2985, DOI 10.1016/j.bpj.2009.09.010; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hartman O, 2009, BIOMACROMOLECULES, V10, P2019, DOI 10.1021/bm8012764; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hitomi M, 1999, CURR BIOL, V9, P1075, DOI 10.1016/S0960-9822(99)80476-X; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001; Jorgensen HG, 2005, LEUKEMIA, V19, P1184, DOI 10.1038/sj.leu.2403785; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; KEELY PJ, 1995, DIFFERENTIATION, V59, P1, DOI 10.1046/j.1432-0436.1995.5910001.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; LAMMIE GA, 1991, CANCER CELL-MON REV, V3, P413; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee YS, 2011, ACTA BIOMATER, V7, P3877, DOI 10.1016/j.actbio.2011.07.013; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li D, 2004, ADV MATER, V16, P361, DOI 10.1002/adma.200306226; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lu JY, 2003, CLIN EXP METASTAS, V20, P121, DOI 10.1023/A:1022645116030; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; McLane JS, 2014, ACTA BIOMATER, V10, P4811, DOI 10.1016/j.actbio.2014.07.016; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Morris SR, 2007, REV ENDOCR METAB DIS, V8, P185, DOI 10.1007/s11154-007-9035-3; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patel SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00906; Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Richardson Alan, 2008, Curr Mol Pharmacol, V1, P244; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Wolf K, 2005, BIOCHIMIE, V87, P315, DOI 10.1016/j.biochi.2004.10.016; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	94	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0118724	10.1371/journal.pone.0118724	http://dx.doi.org/10.1371/journal.pone.0118724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837691	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000005
J	Johnson, VA; Kemp, AH; Heard, R; Lennings, CJ; Hickie, IB				Johnson, Vicki A.; Kemp, Andrew H.; Heard, Robert; Lennings, Christopher J.; Hickie, Ian B.			Childhood- versus Adolescent-Onset Antisocial Youth with Conduct Disorder: Psychiatric Illness, Neuropsychological and Psychosocial Function	PLOS ONE			English	Article							MENTAL-HEALTH-SERVICES; LIFE-COURSE-PERSISTENT; BRAIN-DYSFUNCTION; SUBSTANCE MISUSE; LARGE-SAMPLE; COMORBIDITY; BEHAVIOR; CANTAB; SCALE; EXPERIENCES	Objective The present study investigates whether youths with childhood-onset antisocial behavior have higher rates of psychiatric illness, neuropsychological and psychosocial dysfunction than youths who engage in antisocial behavior for the first time in adolescence. Prior studies have generally focused on single domains of function in heterogeneous samples. The present study also examined the extent to which adolescent-onset antisocial behavior can be considered normative, an assumption of Moffitt's dual taxonomy model. Method Forty-three subjects (34 males, 9 females, mean age = 15.31, age range 12-21) with a diagnosis of conduct disorder (CD) were recruited through Headspace Services and the Juvenile Justice Community Centre. We compared childhood-onset antisocial youths (n = 23) with adolescent-onset antisocial youths (n = 20) with a conduct disorder, across a battery of psychiatric, neuropsychological and psychosocial measures. Neuropsychological function of both groups was also compared with normative scores from control samples. Results The childhood-onset group displayed deficits in verbal learning and memory, higher rates of psychosis, childhood maltreatment and more serious violent behavior, all effects associated with a large effect size. Both groups had impaired executive function, falling within the extremely low range (severely impaired). Conclusions Childhood-onset CD displayed greater cognitive impairment, more psychiatric symptoms and committed more serious violent offences. The finding of severe executive impairment in both childhood- and adolescent-onset groupings challenges the assumption that adolescent-onset antisocial behavior is a normative process.	[Johnson, Vicki A.; Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2050, Australia; [Kemp, Andrew H.] Univ Sao Paulo, Univ Hosp, Sao Paulo, Brazil; [Kemp, Andrew H.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [Kemp, Andrew H.; Heard, Robert] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Kemp, Andrew H.; Heard, Robert] Univ Sydney, Discipline Psychiat, Sydney, NSW 2006, Australia; [Lennings, Christopher J.] Lennings Seidler Collins Psychol Clin & Foren Psy, Sydney, NSW, Australia; [Lennings, Christopher J.] Charles Sturt Univ, Fac Policing & Law Enforcement, Sydney, NSW, Australia	University of Sydney; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Sydney; University of Sydney; Charles Sturt University	Johnson, VA (corresponding author), Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, 100 Mallet St, Sydney, NSW 2050, Australia.	vickisoco@iprimus.com.au	Kemp, Andrew Haddon/C-7984-2012; Hickie, Ian B/K-8975-2015	Kemp, Andrew Haddon/0000-0003-1146-3791; Hickie, Ian B/0000-0001-8832-9895	Pfizer; Servier; Astra Zeneca; NHMRC funding	Pfizer(Pfizer); Servier(Servier); Astra Zeneca(AstraZeneca); NHMRC funding(National Health and Medical Research Council (NHMRC) of Australia)	Vicki Johnson, Andrew Kemp, Robert Heard, Christopher Lennings and Ian Hickie report no financial interests or potential conflicts of interest. Ian B. Hickie is a Board Member of Psychosis Australia Trust. From 2012, he is a Commissioner in Australia's new National Mental Health Commission. He was until January 2012 a director of headspace: the national youth mental health foundation. He has received honoraria for presentations of his own work at educational seminars supported by a number of nongovernment organisations and the pharmaceutical industry (including Pfizer, Servier and Astra Zeneca). He has served on advisory boards convened by the pharmaceutical industry in relation to specific antidepressants, including nefazodone, duloxetine and desvenlafaxine. He leads an investigator-initiated study of the effects of agomelatine on circadian parameters (supported in part by Servier but also by other NHMRC funding) and has participated in a multicentre clinical trial of the effects of agomelatine on sleep architecture in depression. Andrew Kemp is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Acosta María Rocío, 2012, Psychol. Neurosci., V5, P047, DOI 10.3922/j.psns.2012.1.07; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; ANGOLD A, 1993, AM J PSYCHIAT, V150, P1779; [Anonymous], 2000, DIAGN STAT MAN 4 TR; Baksheev GN, 2010, AUST NZ J PSYCHIAT, V44, P1043, DOI 10.1080/00048674.2010.503650; Benton AL., 1983, MULTILINGUAL APHASIA; Cambridge Cognition (n.d.), COGN ASS SOFTW CANTA; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dawe S, 2002, REV DIAGNOSTIC SCREE; Duff K, 2005, ARCH CLIN NEUROPSYCH, V20, P111, DOI 10.1016/j.acn.2004.03.003; ELLIOTT FA, 1976, PRACTITIONER, V217, P51; ELLIOTT FA, 1992, ARCH NEUROL-CHICAGO, V49, P595, DOI 10.1001/archneur.1992.00530300027006; ELLIOTT FA, 1982, J NERV MENT DIS, V170, P680, DOI 10.1097/00005053-198211000-00007; Fairchild G, 2008, BIOL PSYCHIAT, V63, P279, DOI 10.1016/j.biopsych.2007.06.019; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P924, DOI 10.1111/jcpp.12102; Farrington D. P., 1986, UNDERSTANDING CONTRO; Fazel S, 2004, AM J PSYCHIAT, V161, P2129, DOI 10.1176/appi.ajp.161.11.2129; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fonagy P, 2004, ANN NY ACAD SCI, V1036, P181, DOI 10.1196/annals.1330.012; Fray PJ, 1996, INT J GERIATR PSYCH, V11, P329; Golden CJ, 1996, AGGRESS VIOLENT BEH, V1, P3, DOI 10.1016/1359-1789(95)00002-X; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Headspace, 2020, HEADSP NAT YOUTH MEN; Hedlund JL, 1980, J OPERAT PSYCHIATRY, V11, P48; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hodgins S, 2003, BEHAV SCI LAW, V21, P523, DOI 10.1002/bsl.540; Jastak J.J., 1984, MANUAL WIDE RANGE AC; Jeglum-Bartusch D., 1997, CRIMINOLOGY, V35, P13, DOI DOI 10.1111/J.1745-; Kenny DT, 2007, COMTEMPORARY ISSUES, V107, P1; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 1996, KESSLERS 10 PSYCHOL; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Kroll L, 2002, LANCET, V359, P1975, DOI 10.1016/S0140-6736(02)08829-3; Leucht S, 2005, BRIT J PSYCHIAT, V187, P366, DOI 10.1192/bjp.187.4.366; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; LOEBER R, 1994, CLIN PSYCHOL REV, V14, P497, DOI 10.1016/0272-7358(94)90015-9; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; MCCONAUGHY SH, 1993, SCHOOL PSYCHOL REV, V22, P421; MILIN R, 1991, J AM ACAD CHILD PSY, V30, P569, DOI 10.1097/00004583-199107000-00007; Miller E, 2002, THE NEUROBIOLOGY OF, P134, DOI [10.1007/978-1-4615-0943-1_6, DOI 10.1007/978-1-4615-0943-1_6]; Moffitt T., 1990, NEUROPSYCHOLOGY DELI, V12; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Mofitt T., 1988, BIOL CONTRIBUTIONS C, P93; Morcillo C, 2012, J PSYCHIATR RES, V46, P323, DOI 10.1016/j.jpsychires.2011.10.012; Narhi V, 2010, SCAND J PSYCHOL, V51, P278, DOI 10.1111/j.1467-9450.2009.00767.x; Nielssen OB, 2007, MED J AUSTRALIA, V186, P301, DOI 10.5694/j.1326-5377.2007.tb00905.x; Olvera RL, 2005, BIPOLAR DISORD, V7, P57, DOI 10.1111/j.1399-5618.2004.00167.x; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pajer K, 2008, J AM ACAD CHILD PSY, V47, P416, DOI 10.1097/CHI.0b013e3181640828; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; ROBINS LN, 1991, PSYCHIATRY, V54, P116; Roisman GI, 2010, DEV PSYCHOPATHOL, V22, P295, DOI 10.1017/S0954579410000076; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; Scott H, 1998, BRIT J PSYCHIAT, V172, P345, DOI 10.1192/bjp.172.4.345; Soyka M, 2000, BRIT J PSYCHIAT, V176, P345, DOI 10.1192/bjp.176.4.345; Spreen O, 1998, COMPENDIUM NEUROPSYC; Taylor PJ, 1998, SOC PSYCH PSYCH EPID, V33, pS47, DOI 10.1007/s001270050209; Teichner G, 2000, AGGRESS VIOLENT BEH, V5, P509, DOI 10.1016/S1359-1789(98)00035-4; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; The Psychological Corporation, 1997, WAIS 3 WMS 2 TECHN M; Ulzen TPM, 1998, CAN J PSYCHIAT, V43, P57, DOI 10.1177/070674379804300106; Vreugdenhil C, 2004, J AM ACAD CHILD PSY, V43, P97, DOI 10.1097/00004583-200401000-00019; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; ZOCCOLILLO M, 1992, J AM ACAD CHILD PSY, V31, P547, DOI 10.1097/00004583-199205000-00024	73	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121627	10.1371/journal.pone.0121627	http://dx.doi.org/10.1371/journal.pone.0121627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835393	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000051
J	Li, Z; Jing, W; Peng, Y; Zhang, XQ; Ma, X; Huang, LK; Yan, YH				Li, Zhou; Jing, Wen; Peng, Yan; Zhang, Xin Quan; Ma, Xiao; Huang, Lin Kai; Yan, Yan-hong			Spermine Alleviates Drought Stress in White Clover with Different Resistance by Influencing Carbohydrate Metabolism and Dehydrins Synthesis	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; WATER-STRESS; GENE-EXPRESSION; ABIOTIC STRESS; ABSCISIC-ACID; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; TOLERANCE; ARABIDOPSIS; POLYAMINES	The objective of this research was to analyse whether ameliorating drought stress through exogenously applied spermine (Spm) was related to carbohydrate metabolism, dehydrins accumulation and the transcription of genes encoding dehydrins in two white clovers (drought-susceptible cv. 'Ladino' and drought-resistant cv. 'Haifa') under controlled drying conditions for 10 days. The results show that the application of Spm effectively alleviates negative effects caused by drought stress in both cultivars. Exogenous Spm led to accumulation of more water-soluble carbohydrates (WSC), sucrose, fructose and sorbitol in both cultivars under drought stress, and also significantly elevated glucose content in leaves of drought-resistant cv. 'Haifa', but had no effect on drought-susceptible cv. 'Ladino'. Accordingly, the key enzyme activities of sucrose and sorbitol metabolism changed along with the application of Spm under drought stress. Spm induced a significant increase in sucrose phosphate synthase (SPS) or sorbitol dehydrogenase (SDH) activity, but decrease in sucrose synthetase (SS) activity when two cultivars were subjected to drought. In addition, the improved accumulation of dehydrins induced by exogenous Spm coincided with three genes expression which was responsible for dehydrins synthesis. But Spm-induced transcript level of dehydrin genes increased earlier in cv. 'Ladino' than that in cv. 'Haifa'. Thus, these results suggest that ameliorating drought stress through exogenously applied Spm may be associated with increased carbohydrate accumulation and dehydrins synthesis. There are differences between drought-susceptible and - resistant white clover cultivars related to Spm regulation of WSC metabolism and dehydrins expression.	[Li, Zhou; Jing, Wen; Peng, Yan; Zhang, Xin Quan; Ma, Xiao; Huang, Lin Kai; Yan, Yan-hong] Sichuan Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Peng, Y (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Chengdu 611130, Peoples R China.	pengyanlee@163.com			National Science Foundation of China [31372371]; National Support Program [2011BAD17B03]; Sichuan Province Breeding Program [2011NZ0098-11]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Support Program; Sichuan Province Breeding Program	This study was funded by the National Science Foundation of China (Grant No. 31372371), National Support Program (Grant No. 2011BAD17B03), and Sichuan Province Breeding Program (Grant No. 2011NZ0098-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hakimi A., 1995, Journal of Genetics and Breeding, V49, P237; Alcazar R, 2006, PHYSIOL PLANTARUM, V128, P448, DOI 10.1111/j.1399-3054.2006.00780.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Bian HW, 2002, J PLANT PHYSIOL, V159, P1139, DOI 10.1078/0176-1617-00824; BLACKMAN SA, 1992, PLANT PHYSIOL, V100, P225, DOI 10.1104/pp.100.1.225; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; CASTRILLO M, 1992, J EXP BOT, V43, P1557, DOI 10.1093/jxb/43.12.1557; Cerny M, 2011, J EXP BOT, V62, P921, DOI 10.1093/jxb/erq322; CLOSE TJ, 1993, PLANT MOL BIOL, V23, P279, DOI 10.1007/BF00029004; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Cona A, 2006, J EXP BOT, V57, P2277, DOI 10.1093/jxb/erj195; Cui SM, 2004, J JPN SOC HORTIC SCI, V73, P25, DOI 10.2503/jjshs.73.25; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Farooq M, 2009, ACTA PHYSIOL PLANT, V31, P937, DOI 10.1007/s11738-009-0307-2; Aguayo MF, 2013, PLANT SCI, V205, P63, DOI 10.1016/j.plantsci.2013.01.012; Fresneau C, 2007, J EXP BOT, V58, P2983, DOI 10.1093/jxb/erm150; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; Fu JM, 2009, J AM SOC HORTIC SCI, V134, P41, DOI 10.21273/JASHS.134.1.41; GONZALEZ EM, 1995, J EXP BOT, V46, P1515, DOI 10.1093/jxb/46.10.1515; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Gupta AK, 2005, J BIOSCIENCES, V30, P761, DOI 10.1007/BF02703574; Gupta K, 2013, ACTA PHYSIOL PLANT, V35, P2015, DOI 10.1007/s11738-013-1239-4; Han B, 1996, J EXP BOT, V47, P933, DOI 10.1093/jxb/47.7.933; He LX, 2002, PLANT CELL PHYSIOL, V43, P196, DOI 10.1093/pcp/pcf021; Heyen BJ, 2002, PLANT PHYSIOL, V130, P675, DOI 10.1104/pp.002550; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Jain M, 2010, PLANT SOIL ENVIRON, V56, P263, DOI 10.17221/233/2009-PSE; Jang SJ, 2012, MOL CELLS, V34, P251, DOI 10.1007/s10059-012-0067-5; Jie Zhang, 2010, African Journal of Biotechnology, V9, P5320; Karlsson BH, 1999, J AM SOC HORTIC SCI, V124, P245, DOI 10.21273/JASHS.124.3.245; Kasukabe Y, 2004, PLANT CELL PHYSIOL, V45, P712, DOI 10.1093/pcp/pch083; Kaur K, 2007, INDIAN J BIOCHEM BIO, V44, P223; KHAYAT E, 1987, PLANT PHYSIOL, V84, P447, DOI 10.1104/pp.84.2.447; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Kubis J, 2008, J PLANT PHYSIOL, V165, P397, DOI 10.1016/j.jplph.2007.02.005; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Lalonde S, 2003, PLANT CELL ENVIRON, V26, P37, DOI 10.1046/j.1365-3040.2003.00847.x; LEE SP, 1993, PLANT PHYSIOL, V101, P1089, DOI 10.1104/pp.101.3.1089; Legay S, 2011, FUNCT INTEGR GENOMIC, V11, P275, DOI 10.1007/s10142-010-0206-z; Li CZ, 2004, PLANT SCI, V166, P303, DOI 10.1016/j.plantsci.2003.09.019; Li F, 2012, PLANT GROWTH REGUL, V68, P475, DOI 10.1007/s10725-012-9737-8; Li F, 2012, PLANT MOL BIOL REP, V30, P123, DOI 10.1007/s11105-011-0323-4; Li TH, 2005, TREE PHYSIOL, V25, P495, DOI 10.1093/treephys/25.4.495; Li Zhou, 2014, Plant Omics, V7, P517; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Lo Bianco R, 1999, J AM SOC HORTIC SCI, V124, P381, DOI 10.21273/JASHS.124.4.381; Lo Bianco R, 2000, PHYSIOL PLANTARUM, V108, P71, DOI 10.1034/j.1399-3054.2000.108001071.x; Lo Bianco R, 2002, J AM SOC HORTIC SCI, V127, P115, DOI 10.21273/JASHS.127.1.115; Marco F, 2011, OMICS, V15, P775, DOI 10.1089/omi.2011.0084; MENDICINO J, 1960, J BIOL CHEM, V235, P3347; Naya L, 2007, PLANT PHYSIOL, V144, P1104, DOI 10.1104/pp.107.099648; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Oufir M, 2008, PLANT SCI, V175, P839, DOI 10.1016/j.plantsci.2008.08.010; Parmentier-Line CM, 2002, PLANT SCI, V162, P273, DOI 10.1016/S0168-9452(01)00563-5; Radhakrishnan R, 2013, J PLANT GROWTH REGUL, V32, P22, DOI 10.1007/s00344-012-9274-8; Robyt JF, 1987, BIOCH TECHNIQUES THE, P267; Sagor GHM, 2013, TRANSGENIC RES, V22, P595, DOI 10.1007/s11248-012-9666-3; Scott P, 2000, ANN BOT-LONDON, V85, P159, DOI 10.1006/anbo.1999.1006; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shen Ye, 2004, Agricultural Sciences in China, V3, P575; Takahama U, 1997, PHYSIOL PLANTARUM, V101, P845; Tang W, 2005, PLANT GROWTH REGUL, V46, P31, DOI 10.1007/s10725-005-6395-0; TING SV, 1956, J AGR FOOD CHEM, V4, P263, DOI 10.1021/jf60061a009; Tun NN, 2006, PLANT CELL PHYSIOL, V47, P346, DOI 10.1093/pcp/pci252; Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021; Walters C, 1997, SEED SCI RES, V7, P125, DOI 10.1017/S0960258500003469; Wang XJ, 2002, J EXP BOT, V53, P551, DOI 10.1093/jexbot/53.368.551; Wi SJ, 2014, PLANTA, V239, P979, DOI 10.1007/s00425-014-2027-0; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y; Yang JC, 2002, PLANTA, V215, P645, DOI 10.1007/s00425-002-0789-2; Yang ZM, 2013, J AM SOC HORTIC SCI, V138, P24, DOI 10.21273/JASHS.138.1.24; Zhao WC, 2009, CHINESE AGR SCI B, V25, P148; Zhou Q, 2010, PLANT PHYSIOL BIOCH, V48, P417, DOI 10.1016/j.plaphy.2010.03.003	77	35	39	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120708	10.1371/journal.pone.0120708	http://dx.doi.org/10.1371/journal.pone.0120708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835290	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000030
J	Kurobe, H; Maxfield, MW; Tara, S; Rocco, KA; Bagi, PS; Yi, T; Udelsman, B; Zhuang, ZW; Cleary, M; Iwakiri, Y; Breuer, CK; Shinoka, T				Kurobe, Hirotsugu; Maxfield, Mark W.; Tara, Shuhei; Rocco, Kevin A.; Bagi, Paul S.; Yi, Tai; Udelsman, Brooks; Zhuang, Zhen W.; Cleary, Muriel; Iwakiri, Yasuko; Breuer, Christopher K.; Shinoka, Toshiharu			Development of Small Diameter Nanofiber Tissue Engineered Arterial Grafts	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR GRAFTS; ENDOTHELIUM; MACROPHAGES; ACTIVATION; VESSELS	The surgical repair of heart and vascular disease often requires implanting synthetic grafts. While synthetic grafts have been successfully used for medium-to-large sized arteries, applications for small diameter arteries (< 6 mm) is limited due to high rates of occlusion by thrombosis. Our objective was to develop a tissue engineered vascular graft (TEVG) for small diameter arteries. TEVGs composed of polylactic acid nanofibers with inner luminal diameter between 0.5 and 0.6 mm were surgically implanted as infra-renal aortic interposition conduits in 25 female C17SCID/bg mice. Twelve mice were given sham operations. Survival of mice with TEVG grafts was 91.6% at 12 months post-implantation (sham group: 83.3%). No instances of graft stenosis or aneurysmal dilatation were observed over 12 months post-implantation, assessed by Doppler ultrasound and microCT. Histologic analysis of explanted TEVG grafts showed presence of CD31-positive endothelial monolayer and F4/80-positive macrophages after 4, 8, and 12 months in vivo. Cells positive for alpha-smooth muscle actin were observed within TEVG, demonstrating presence of smooth muscle cells (SMCs). Neo-extracellular matrix consisting mostly of collagen types I and III were observed at 12 months post-implantation. PCR analysis supports histological observations. TEVG group showed significant increases in expressions of SMC marker, collagen-I and III, matrix metalloproteinases-2 and 9, and itgam (a macrophage marker), when compared to sham group. Overall, patency rates were excellent at 12 months after implantation, as structural integrity of these TEVG. Tissue analysis also demonstrated vessel remodeling by autologous cell.	[Kurobe, Hirotsugu; Tara, Shuhei; Yi, Tai; Breuer, Christopher K.; Shinoka, Toshiharu] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Maxfield, Mark W.; Rocco, Kevin A.; Bagi, Paul S.; Udelsman, Brooks; Zhuang, Zhen W.; Cleary, Muriel; Iwakiri, Yasuko] Yale Univ, Sch Med, New Haven, CT USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Yale University	Shinoka, T (corresponding author), Nationwide Childrens Hosp, Columbus, OH 43205 USA.	Toshiharu.Shinoka@nationwidechildrens.org	KUROBE, Hirotsugu/ABC-8384-2021	KUROBE, Hirotsugu/0000-0002-5789-5402; Breuer, Christopher/0000-0003-0987-3898; Rocco, Kevin/0000-0001-5570-6236; Udelsman, Brooks/0000-0001-8482-5218; Maxfield, Mark Webster/0000-0003-1559-5935	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082600]; OHSE Committee (Department of Surgery, Yale University School of Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082600, P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OHSE Committee (Department of Surgery, Yale University School of Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	YI received grant support from National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082600). Funding for this study was provided by the OHSE Committee (Department of Surgery, Yale University School of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712; DAS A, 1990, ARCH OPHTHALMOL-CHIC, V108, P421, DOI 10.1001/archopht.1990.01070050119045; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Drilling S, 2009, J BIOMED MATER RES A, V88A, P923, DOI 10.1002/jbm.a.31926; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; He W, 2009, J BIOMED MATER RES A, V90A, P205, DOI 10.1002/jbm.a.32081; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hibino N, 2011, FASEB J, V25, P2731, DOI 10.1096/fj.11-182246; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; JAG R, 1980, ARCHITECTURE VESSEL; Kuwano H, 2012, GEN THORAC CARDIOVAS, V60, P680, DOI 10.1007/s11748-012-0119-y; Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287; Martinez-Lemus LA, 2012, BASIC CLIN PHARMACOL, V110, P5, DOI 10.1111/j.1742-7843.2011.00813.x; Naito Y, 2012, CELLS TISSUES ORGANS, V195, P60, DOI 10.1159/000331405; Naito Y, 2011, ADV DRUG DELIVER REV, V63, P312, DOI 10.1016/j.addr.2011.03.001; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Rocco KA, 2014, TISSUE ENG B; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Tara S, 2014, J VASCULAR SURG; Thum T, 2000, FASEB J, V14, P740, DOI 10.1096/fasebj.14.5.740; Wu HJ, 2010, J MATER SCI-MATER M, V21, P3207, DOI 10.1007/s10856-010-4164-8; Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zee RYL, 2010, REJUV RES, V13, P411, DOI 10.1089/rej.2009.0975; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098	34	42	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120328	10.1371/journal.pone.0120328	http://dx.doi.org/10.1371/journal.pone.0120328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830942	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600031
J	Williams, ID; Baum, JK; Heenan, A; Hanson, KM; Nadon, MO; Brainard, RE				Williams, Ivor D.; Baum, Julia K.; Heenan, Adel; Hanson, Katharine M.; Nadon, Marc O.; Brainard, Russell E.			Human, Oceanographic and Habitat Drivers of Central and Western Pacific Coral Reef Fish Assemblages	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BASE-LINES; POPULATION-DENSITY; HAWAIIAN-ISLANDS; STRIP TRANSECT; BIOMASS; DEGRADATION; PHYTOPLANKTON; NORTHWESTERN; ABUNDANCE	Coral reefs around US-and US-affiliated Pacific islands and atolls span wide oceanographic gradients and levels of human impact. Here we examine the relative influence of these factors on coral reef fish biomass, using data from a consistent large-scale ecosystem monitoring program conducted by scientific divers over the course of >2,000 hours of underwater observation at 1,934 sites, across similar to 40 islands and atolls. Consistent with previous smaller-scale studies, our results show sharp declines in reef fish biomass at relatively low human population density, followed by more gradual declines as human population density increased further. Adjusting for other factors, the highest levels of oceanic productivity among our study locations were associated with more than double the biomass of reef fishes (including similar to 4 times the biomass of planktivores and piscivores) compared to islands with lowest oceanic productivity. Our results emphasize that coral reef areas do not all have equal ability to sustain large reef fish stocks, and that what is natural varies significantly amongst locations. Comparisons of biomass estimates derived from visual surveys with predicted biomass in the absence of humans indicated that total reef fish biomass was depleted by 61% to 69% at populated islands in the Mariana Archipelago; by 20% to 78% in the Main Hawaiian islands; and by 21% to 56% in American Samoa.	[Williams, Ivor D.; Heenan, Adel; Brainard, Russell E.] Natl Oceanog & Atmospher Adm, Coral Reef Ecosyst Div, Pacif Islands Fisheries Sci Ctr, Honolulu, HI 96814 USA; [Baum, Julia K.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Heenan, Adel; Nadon, Marc O.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Hanson, Katharine M.] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Nadon, Marc O.] Natl Oceanog & Atmospher Adm, Fisheries Res & Monitoring Div, Pacif Islands Fisheries Sci Ctr, Honolulu, HI USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Victoria; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA	Williams, ID (corresponding author), Natl Oceanog & Atmospher Adm, Coral Reef Ecosyst Div, Pacif Islands Fisheries Sci Ctr, Honolulu, HI 96814 USA.	ivor.williams@noaa.gov		Baum, Julia/0000-0002-9827-1612; Hanson, Katharine/0000-0002-3972-8520; Williams, Ivor/0000-0002-9444-1020	NOAA's Coral Reef Conservation Program; Natural Sciences and Engineering Research Council of Canada	NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for surveys and to support program operation was provided by NOAA's Coral Reef Conservation Program (http://coralreef.noaa.gov). JKB acknowledges funding from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold TW., 2010, J WILDLIFE MANAGE, V74, P1937; Ayotte PM, 2011, CORAL REET ECOSYSTEM; Baker JD, 2012, MAR ECOL PROG SER, V469, P175, DOI 10.3354/meps09987; Barton K., 2013, MUMIN MULTIMODEL INT; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Brandt ME, 2009, NPSSFCNRR2009150; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Brewer TD, 2009, BIOL CONSERV, V142, P1797, DOI 10.1016/j.biocon.2009.03.021; Bruno JF, 2014, MAR POLLUT BULL, V80, P24, DOI 10.1016/j.marpolbul.2014.01.010; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; DeMartini EE, 1996, B MAR SCI, V58, P804; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Dulvy NK, 2002, J EXP MAR BIOL ECOL, V278, P1, DOI 10.1016/S0022-0981(02)00327-1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Frisch AJ, 2014, MAR BIOL, V161, P61, DOI 10.1007/s00227-013-2315-4; Genin A, 2009, LIMNOL OCEANOGR, V54, P938, DOI 10.4319/lo.2009.54.3.0938; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Grace-McCaskey C., 2014, H1401 PAC ISL FISH S, P69; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; HAMNER WM, 1988, B MAR SCI, V42, P459; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; JENNINGS S, 1995, J FISH BIOL, V47, P733, DOI 10.1111/j.1095-8649.1995.tb01938.x; JENNINGS S, 1996, REEF FISHERIES, P193; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 2005, CYBIUM, V29, P235; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Max LM, 2013, MAR ECOL PROG SER, V482, P181, DOI 10.3354/meps10259; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Parrish FA, 2000, MAR MAMMAL SCI, V16, P392, DOI 10.1111/j.1748-7692.2000.tb00932.x; Pinnegar JK, 2006, MAR BIOL, V148, P1089, DOI 10.1007/s00227-005-0141-z; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; ROBERTSON DR, 1982, MAR ECOL PROG SER, V7, P253, DOI 10.3354/meps007253; Rodgers KS, 2010, AQUAT CONSERV, V20, P93, DOI 10.1002/aqc.1048; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SMITH MPL, 1988, MAR ECOL PROG SER, V43, P223, DOI 10.3354/meps043223; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Sorokin YI, 2009, J MAR BIOL ASSOC UK, V89, P235, DOI 10.1017/S0025315409003063; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Taylor BM, 2014, ECOGRAPHY COP; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Williams ID, 2011, J MAR BIOL; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wood S., 2012, MGCV GAMS GCV AIC RE; Woodworth-Jefcoats PA, 2013, GLOBAL CHANGE BIOL, V19, P724, DOI 10.1111/gcb.12076; Wyatt ASJ, 2012, CORAL REEFS, V31, P1029, DOI 10.1007/s00338-012-0923-y; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; Zuur A. F., 2012, BEGINNERS GUIDE GEN	58	104	105	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120516	10.1371/journal.pone.0120516	http://dx.doi.org/10.1371/journal.pone.0120516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831196	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600033
J	Berlin, I; Hakes, JK; Hu, MC; Covey, LS				Berlin, Ivan; Hakes, Jahn K.; Hu, Mei-Chen; Covey, Lirio S.			Tobacco Use and Suicide Attempt: Longitudinal Analysis with Retrospective Reports	PLOS ONE			English	Article							PSYCHIATRIC DIAGNOSTIC MODULES; NATIONAL EPIDEMIOLOGIC SURVEY; ALCOHOL-USE-DISORDER; IV AUDADIS-IV; CIGARETTE-SMOKING; COMPLETED SUICIDE; MENTAL-DISORDERS; RISK; IDEATION; ALTITUDE	Background Suicide has been associated with smoking/tobacco use but its association of and change in smoking/tobacco use status with suicide attempt (SA) is not well established. Methods We investigated whether persistent, former tobacco use, initiation, quitting tobacco use, relapse to tobacco use, and DSM-IV nicotine dependence predict independently SA using Wave 1 and 2 data of the National Epidemiologic Survey of Alcohol and Related Conditions. Data from 34,653 US adults interviewed at Wave 1 (2001-02) and Wave 2 (2004-05) were analyzed. The main outcome measure was SA between Wave 1 and Wave 2 as reported at Wave 2. Results Among the 1,673 respondents reporting lifetime SA at Wave 2, 328 individuals reported SA between Wave 1 and Wave 2. Current and former tobacco use at Wave 1 predicted Wave 2 SA independently of socio-demographic characteristics, psychiatric history, and prior SA (Adjusted Odds Ratio (AOR): 1.49; 95% CI: 1.13-1.95, AOR: 1.31; 95% CI: 1.01-1.69, respectively versus never tobacco users). The strongest association with SA was observed among former tobacco users who relapsed after Wave 1 (AOR: 4.66; 95% CI: 3.49-6.24) and among tobacco use initiators after Wave 1 (AOR: 3.16; 95% CI: 2.23-4.49). Persistent tobacco use (current tobacco use at both Wave 1 and Wave 2) also had an increased risk of SA (AOR: 1.89; 95% CI: 1.47-2.42). However, former tobacco users in both Waves 1 and 2 did not show a significantly elevated risk for SA in Wave 2 (AOR: 1.09, 95% CI: 0.78-1.52) suggesting that the risk resided mainly in Wave 1 former tobacco users who relapsed to tobacco use by Wave 2. DSM-IV nicotine dependence did not predict SA at Wave 2. Conclusion In a representative sample of US adults, relapse, tobacco use initiation, and persistent tobacco use, which are amenable to intervention, were associated with risk of SA.	[Berlin, Ivan] Univ Paris 06, AP HP, Hop Pitie Salpetriere, Fac Med,INSERM U1178,Dept Pharmacol, Paris, France; [Hakes, Jahn K.] US Census Bur, Ctr Adm Records Res & Applicat, Suitland, MD USA; [Hu, Mei-Chen; Covey, Lirio S.] Columbia Univ, Med Ctr, New York State Psychiat Inst, Dept Psychiat, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Columbia University; New York State Psychiatry Institute	Berlin, I (corresponding author), Univ Paris 06, AP HP, Hop Pitie Salpetriere, Fac Med,INSERM U1178,Dept Pharmacol, Paris, France.	ivan.berlin@psl.aphp.fr						American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Aubin HJ, 2011, AM J PSYCHIAT, V168, P326, DOI 10.1176/appi.ajp.2010.10101501; Baek JH, 2013, J AFFECT DISORDERS, V150, P1158, DOI 10.1016/j.jad.2013.05.082; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Berlin I., 2007, MEDICATION TREATMENT, P109; Berlin I, 2011, NICOTINE TOB RES, V13, P887, DOI 10.1093/ntr/ntr089; Boden JM, 2008, PSYCHOL MED, V38, P433, DOI 10.1017/S0033291707001547; Bolton JM, 2010, AM J PUBLIC HEALTH, V100, P2473, DOI 10.2105/AJPH.2010.192252; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P328, DOI 10.1001/archpsyc.62.3.328; Bronisch T, 2008, J AFFECT DISORDERS, V108, P135, DOI 10.1016/j.jad.2007.10.010; Center for Disease Control and Prevention, 2004, CURRENT CIGARETTE SM, V60, P1305, DOI 10.4278/ajhp.120604-ARB-283; Chung JH, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.94; Clarke DE, 2010, SUICIDE LIFE-THREAT, V40, P307, DOI 10.1521/suli.2010.40.4.307; Covey LS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000876; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Doshi A, 2005, ANN EMERG MED, V46, P369, DOI 10.1016/j.annemergmed.2005.04.018; Erhardt S, 2013, NEUROPSYCHOPHARMACOL, V38, P743, DOI 10.1038/npp.2012.248; Galfalvy H, 2009, INT J NEUROPSYCHOPH, V12, P1327, DOI 10.1017/S1461145709990228; Grant BF, 2009, MOL PSYCHIATR, V14, P1051, DOI 10.1038/mp.2008.41; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant BF, 2005, SOURCE AND ACCURACY; Grucza RA, 2014, NICOTINE TOB RES, V16, P1487, DOI 10.1093/ntr/ntu106; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Haws CA, 2009, MED HYPOTHESES, V73, P587, DOI 10.1016/j.mehy.2009.05.040; Jenkins GR, 2002, BRIT MED J, V325, P1155, DOI 10.1136/bmj.325.7373.1155; Kessler RC, 2009, MOL PSYCHIATR, V14, P1132, DOI 10.1038/mp.2008.78; Kessler RC, 2007, J NERV MENT DIS, V195, P369, DOI 10.1097/NMD.0b013e3180303eb8; Kim N, 2011, AM J PSYCHIAT, V168, P49, DOI 10.1176/appi.ajp.2010.10020289; Li DJ, 2012, J PSYCHIATR RES, V46, P1257, DOI 10.1016/j.jpsychires.2012.03.013; Malone KM, 2003, AM J PSYCHIAT, V160, P773, DOI 10.1176/appi.ajp.160.4.773; McGee R, 2005, AM J PSYCHIAT, V162, P619, DOI 10.1176/appi.ajp.162.3.619; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Nordentoft M, 2007, DAN MED BULL, V54, P306; Passamonti L, 2006, BIOL PSYCHIAT, V59, P334, DOI 10.1016/j.biopsych.2005.07.027; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4; Riala K, 2009, ANN EPIDEMIOL, V19, P329, DOI 10.1016/j.annepidem.2008.12.004; Ruan WJ, 2008, DRUG ALCOHOL DEPEN, V92, P27, DOI 10.1016/j.drugalcdep.2007.06.001; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Theil H, 1971, PRINCIPLES EC, P179; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS53, DOI 10.1016/j.drugalcdep.2004.08.007; World Health Organization, 2012, PUBLIC HEALTH ACTION, V2012; Young SN, 2013, J PSYCHIATR NEUROSCI, V38, P423, DOI 10.1503/jpn.130002	47	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122607	10.1371/journal.pone.0122607	http://dx.doi.org/10.1371/journal.pone.0122607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849514	gold, Green Published			2022-12-27	WOS:000352477800148
J	Cocho, G; Flores, J; Gershenson, C; Pineda, C; Sanchez, S				Cocho, Germinal; Flores, Jorge; Gershenson, Carlos; Pineda, Carlos; Sanchez, Sergio			Rank Diversity of Languages: Generic Behavior in Computational Linguistics	PLOS ONE			English	Article							EVOLUTION; LAW; COMPLEX; DISTRIBUTIONS; CULTURE; WORDS	Statistical studies of languages have focused on the rank-frequency distribution of words. Instead, we introduce here a measure of how word ranks change in time and call this distribution rank diversity. We calculate this diversity for books published in six European languages since 1800, and find that it follows a universal lognormal distribution. Based on the mean and standard deviation associated with the lognormal distribution, we define three different word regimes of languages: "heads" consist of words which almost do not change their rank in time, "bodies" are words of general use, while "tails" are comprised by context-specific words and vary their rank considerably in time. The heads and bodies reflect the size of language cores identified by linguists for basic communication. We propose a Gaussian random walk model which reproduces the rank variation of words in time and thus the diversity. Rank diversity of words can be understood as the result of random variations in rank, where the size of the variation depends on the rank itself. We find that the core size is similar for all languages studied.	[Cocho, Germinal; Flores, Jorge; Pineda, Carlos] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 04510, DF, Mexico; [Cocho, Germinal; Gershenson, Carlos] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Gershenson, Carlos] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Mexico City 04510, DF, Mexico; [Sanchez, Sergio] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Gershenson, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico.	cgg@unam.mx	Gershenson, Carlos/F-2241-2010	Gershenson, Carlos/0000-0003-0193-3067; Pineda, Carlos/0000-0002-7306-0894	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica of the Universidad Nacional Autonoma de Mexico [IN107414, IA101713]; SNI membership of Consejo Nacional de Ciencia y Tecnologia, Mexico [47907]; Consejo Nacional de Ciencia y Tecnologia [153190]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica of the Universidad Nacional Autonoma de Mexico; SNI membership of Consejo Nacional de Ciencia y Tecnologia, Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	GC received support from project IN107414 from the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica of the Universidad Nacional Autonoma de Mexico. CG was supported by SNI membership 47907 of Consejo Nacional de Ciencia y Tecnologia, Mexico. CP received support from the projects 153190 from Consejo Nacional de Ciencia y Tecnologia and IA101713 from the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica of the Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059030; Auerbach F, 1913, PETERMANNS MITT, V59, P74; Baek SK, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043004; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; Beare K, 2014, VOICE AM SPECIAL ENG; Beuls K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058960; Blumm N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128701; Bochkarev V, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0841; BOOTH AD, 1967, INFORM CONTROL, V10, P386, DOI 10.1016/S0019-9958(67)90201-X; Braha D, 2006, COMPLEXITY, V12, P59, DOI 10.1002/cplx.20156; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Cancho RFI., 2001, J QUANT LINGUIST, V8, P165, DOI [10.1076/jqul.8.3.165.4101, DOI 10.1076/JQUL.8.3.165.4101]; Chater N, 2009, P NATL ACAD SCI USA, V106, P1015, DOI 10.1073/pnas.0807191106; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corominas-Murtra B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036115; Febres G, 2014, COMPLEXITY MEASUREME; Ferrer i Cancho R., 2002, ADV COMPLEX SYST, V5, P1, DOI [10.1142/S0219525902000468, DOI 10.1142/S0219525902000468]; Font-Clos F, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093033; Gautreau A, 2009, P NATL ACAD SCI USA, V106, P8847, DOI 10.1073/pnas.0811113106; Gell-Mann M, 2011, P NATL ACAD SCI USA, V108, P17290, DOI 10.1073/pnas.1113716108; Gerlach M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021006; Ha LQ, 2002, P 19 INT C COMP LING, P315; Hall RobertA., 1953, HAITIAN CREOLE GRAMM; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hausmann R., 2014, ATLAS EC COMPLEXITY, DOI [10.7551/mitpress/9647.001.0001, DOI 10.7551/MITPRESS/9647.001.0001]; Hawkins JA, 1992, EV HUM LANG P WORKSH; Hernandez H, 1988, ACT 1 C NAC ASELE, P159; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hornby Albert Sydney, 2005, OXFORD ADV LEARNERS, P1620; Kirby S, 2007, P NATL ACAD SCI USA, V104, P5241, DOI 10.1073/pnas.0608222104; Mandelbrot B., 1953, COMMUN THEOR, P486; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Montemurro MA, 2001, PHYSICA A, V300, P567, DOI 10.1016/S0378-4371(01)00355-7; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nowak MA, 1999, P NATL ACAD SCI USA, V96, P8028, DOI 10.1073/pnas.96.14.8028; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Perra N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00469; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Petruszewycz M, 1973, MATH SCI HUMAINES, V44, P41; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Romaine S, 1988, PIDGIN CREOLE LANGUA; Sandler W, 2005, P NATL ACAD SCI USA, V102, P2661, DOI 10.1073/pnas.0405448102; Serra J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00521; Steels L., 1997, EVOL COMMUN, V1, P1, DOI [DOI 10.1075/E0C.1.1.02STE, 10.1075/eoc.1.1.02ste, DOI 10.1075/EOC.1.1.02STE]; Steels Luc, 1995, Artificial Life, V2, P319; Takala S., 1985, PRACTICE PROBLEMS LA, P157; Wijaya Derry Tanti, 2011, P 2011 INT WORKSHOP, P35, DOI DOI 10.1145/2064448.2064475; Zipf GK, 1932, SELECTIVE STUDIES PR	51	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121898	10.1371/journal.pone.0121898	http://dx.doi.org/10.1371/journal.pone.0121898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849150	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800084
J	Dangor, Z; Lala, SG; Cutland, CL; Koen, A; Jose, L; Nakwa, F; Ramdin, T; Fredericks, J; Wadula, J; Madhi, SA				Dangor, Ziyaad; Lala, Sanjay G.; Cutland, Clare L.; Koen, Anthonet; Jose, Lisa; Nakwa, Firdose; Ramdin, Tanusha; Fredericks, Joy; Wadula, Jeannette; Madhi, Shabir A.			Burden of Invasive Group B Streptococcus Disease and Early Neurological Sequelae in South African Infants	PLOS ONE			English	Article							UNITED-STATES; PREGNANT-WOMEN; MENINGITIS; PREVENTION; EPIDEMIOLOGY; POPULATION; INFECTION; ENGLAND; VACCINE; DENVER	Introduction Group B Streptococcus (GBS) is a leading cause of neonatal sepsis and meningitis. We aimed to evaluate the burden of invasive early-onset (0-6 days of life, EOD) and late-onset (7-89 days, LOD) GBS disease and subsequent neurological sequelae in infants from a setting with a high prevalence (29.5%) of HIV among pregnant women. Methods A case-control study was undertaken at three secondary-tertiary care public hospitals in Johannesburg. Invasive cases in infants < 3 months age were identified by surveillance of laboratories from November 2012 to February 2014. Neurodevelopmental screening was done in surviving cases and controls at 3 and 6 months of age. Results We identified 122 cases of invasive GBS disease over a 12 month period. Although the incidence (per 1,000 live births) of EOD was similar between HIV-exposed and HIV-unexposed infants (1.13 vs. 1.46; p = 0.487), there was a 4.67-fold (95% CI: 2.24-9.74) greater risk for LOD in HIV-exposed infants (2.27 vs. 0.49; p<0.001). Overall, serotypes Ia, Ib and III constituted 75.8% and 92.5% of EOD and LOD, respectively. Risk factors for EOD included offensive draining liquor (adjusted Odds Ratio: 27.37; 95% CI: 1.94-386.50) and maternal GBS bacteriuria (aOR: 8.41; 95% CI: 1.44-49.15), which was also a risk-factor for LOD (aOR: 3.49; 95% CI: 1.17-10.40). The overall case fatality rate among cases was 18.0%. The adjusted odds for neurological sequelae at 6 months age was 13.18-fold (95% CI: 1.44-120.95) greater in cases (13.2%) than controls (0.4%). Discussion The high burden of invasive GBS disease in South Africa, which is also associated with high case fatality rates and significant neurological sequelae among survivors, is partly due to the heightened risk for LOD in infants born to HIV-infected women. An effective trivalent GBS conjugate vaccine targeted at pregnant women could prevent invasive GBS disease in this setting.	[Dangor, Ziyaad; Cutland, Clare L.; Koen, Anthonet; Jose, Lisa; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, Gauteng, South Africa; [Dangor, Ziyaad; Cutland, Clare L.; Koen, Anthonet; Jose, Lisa; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, Gauteng, South Africa; [Dangor, Ziyaad; Lala, Sanjay G.; Nakwa, Firdose; Ramdin, Tanusha; Fredericks, Joy] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, Johannesburg, Gauteng, South Africa; [Wadula, Jeannette] Univ Witwatersrand, Dept Clin Microbiol & Infect Dis, Natl Hlth Lab Serv, Johannesburg, Gauteng, South Africa; [Madhi, Shabir A.] Natl Inst Communicable Dis, Ctr Vaccines & Immunol, Johannesburg, Gauteng, South Africa	South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Madhi, SA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, Gauteng, South Africa.	shabirm@nicd.ac.za	Cutland, Clare L./GXE-9967-2022	Cutland, Clare L./0000-0001-8250-8307; Dangor, Ziyaad/0000-0003-4089-147X	Carnegie Corporation of New York [B8749]; Discovery Foundation [20289/1]; Medical Research Council of South Africa; National Research Foundation/Department of Science and Technology: South African Research Chair Initiative in Vaccine Preventable Diseases and Medical Research Council of South Africa	Carnegie Corporation of New York; Discovery Foundation; Medical Research Council of South Africa(South African Medical Research Council); National Research Foundation/Department of Science and Technology: South African Research Chair Initiative in Vaccine Preventable Diseases and Medical Research Council of South Africa	ZD is funded in part by the Carnegie Corporation (Grant number B8749) of New York and the Discovery Foundation (Grant number 20289/1). SGL is funded in part by a career development award from the Medical Research Council of South Africa. SAM is funded in part by National Research Foundation/Department of Science and Technology: South African Research Chair Initiative in Vaccine Preventable Diseases and Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afran L, 2014, CLIN EXP IMMUNOL, V176, P11, DOI 10.1111/cei.12251; Afshar B, 2011, J CLIN MICROBIOL, V49, P1475, DOI 10.1128/JCM.02365-10; Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; Bedford H, 2001, BRIT MED J, V323, P533, DOI 10.1136/bmj.323.7312.533; Dagnew AF, 2012, CLIN INFECT DIS, V55, P91, DOI 10.1093/cid/cis395; District Research Committee, 2014, BIRTH STAT; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; EDWARDS MS, 1985, J PEDIATR-US, V106, P717, DOI 10.1016/S0022-3476(85)80342-5; Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183; Eyre J. A., 2003, Neural Plasticity, V10, P93, DOI 10.1155/NP.2003.93; Fluegge K, 2011, PEDIATR INFECT DIS J, V30, P1027, DOI 10.1097/INF.0b013e31822a2a1f; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; GLASCOE FP, 1992, PEDIATRICS, V89, P1221; HAFFEJEE IE, 1991, J INFECTION, V22, P225, DOI 10.1016/S0163-4453(05)80003-9; Heyderman R, 2014, SAFETY AND IMMUNOGEN; Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kwatra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098778; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Landes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047337; Levent F, 2010, PEDIATR INFECT DIS J, V29, P1009, DOI 10.1097/INF.0b013e3181e74c83; Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Madhi SA, 2013, VACCINE, V31, pD52, DOI 10.1016/j.vaccine.2013.02.029; Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861; National Department of Health, 2010, CLIN GUID PMTCT PREV; National Department of Health, 2013, S AFR ANT TREATM GUI, P8; National Health and Medical Research Council, 2011, NCCN CLIN PRACT GUID, P12; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Steinhoff MC, 2013, VACCINE, V31, pD27, DOI 10.1016/j.vaccine.2013.02.031; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; WALD ER, 1986, PEDIATRICS, V77, P217; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; World Health Organization, 2005, IMCI INT MANG CHILDH; Zaleznik DF, 2000, CLIN INFECT DIS, V30, P276, DOI 10.1086/313665	42	58	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123014	10.1371/journal.pone.0123014	http://dx.doi.org/10.1371/journal.pone.0123014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849416	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800195
J	Mapelli, J; Gandolfi, D; Giuliani, E; Prencipe, FP; Pellati, F; Barbieri, A; D'Angelo, E; Bigiani, A				Mapelli, Jonathan; Gandolfi, Daniela; Giuliani, Enrico; Prencipe, Francesco P.; Pellati, Federica; Barbieri, Alberto; D'Angelo, Egidio; Bigiani, Albertino			The Effect of Desflurane on Neuronal Communication at a Central Synapse	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; VOLATILE ANESTHETICS; RELEVANT CONCENTRATIONS; VESTIBULOOCULAR REFLEX; INHALED ANESTHETICS; POTASSIUM CHANNELS; INFORMATION-THEORY; MOLECULAR TARGETS; SODIUM-CHANNELS	Although general anesthetics are thought to modify critical neuronal functions, their impact on neuronal communication has been poorly examined. We have investigated the effect induced by desflurane, a clinically used general anesthetic, on information transfer at the synapse between mossy fibers and granule cells of cerebellum, where this analysis can be carried out extensively. Mutual information values were assessed by measuring the variability of postsynaptic output in relationship to the variability of a given set of presynaptic inputs. Desflurane synchronized granule cell firing and reduced mutual information in response to physiologically relevant mossy fibers patterns. The decrease in spike variability was due to an increased postsynaptic membrane excitability, which made granule cells more prone to elicit action potentials, and to a strengthened synaptic inhibition, which markedly hampered membrane depolarization. These concomitant actions on granule cells firing indicate that desflurane re-shapes the transfer of information between neurons by providing a less informative neurotransmission rather than completely silencing neuronal activity.	[Mapelli, Jonathan; Gandolfi, Daniela; Bigiani, Albertino] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Modena, Italy; [Gandolfi, Daniela; D'Angelo, Egidio] Univ Pavia, Dipartimento Sci Sistema Nervoso & Comportamento, I-27100 Pavia, Italy; [Giuliani, Enrico; Barbieri, Alberto] Univ Modena & Reggio Emilia, Dipartimento Med Diagnost Clin & Sanita Pubbl, Modena, Italy; [Prencipe, Francesco P.; Pellati, Federica] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Modena, Italy; [D'Angelo, Egidio] C Mondino Natl Neurol Inst, Brain Connect Ctr, Pavia, Italy	Universita di Modena e Reggio Emilia; University of Pavia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; IRCCS Fondazione Casimiro Mondino	Mapelli, J (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Modena, Italy.	jonathan.mapelli@unimore.it	Pellati, Federica/H-5846-2015; D'Angelo, Egidio/AAC-3846-2022; Giuliani, Enrico/L-2158-2016; Barbieri, Alberto/L-1427-2016; Bigiani, Albertino/G-3024-2015	Pellati, Federica/0000-0002-9822-6862; D'Angelo, Egidio/0000-0002-6007-7187; Giuliani, Enrico/0000-0001-7140-7850; Barbieri, Alberto/0000-0002-3904-1323; Bigiani, Albertino/0000-0001-6987-488X; mapelli, jonathan/0000-0002-0381-1576	Fondazione di Vignola	Fondazione di Vignola	This work was financed by a grant of Fondazione di Vignola (www.fondazionedivignola.it/) to JM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Arleo A, 2010, NEURAL COMPUT, V22, P2031, DOI 10.1162/NECO_a_00006-Arleo; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Benkwitz C, 2004, ANESTHESIOLOGY, V101, P924, DOI 10.1097/00000542-200410000-00018; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Bower JM, 1997, PROG BRAIN RES, V114, P463; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Cesana E, 2013, J NEUROSCI, V33, P12430, DOI 10.1523/JNEUROSCI.4897-11.2013; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00093; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DANGELO E, 1993, NEUROSCIENCE, V53, P121, DOI 10.1016/0306-4522(93)90290-V; Dayan P, 2001, COMPUTATIONAL NEUROS; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Eckenhoff RG, 1999, ANESTHESIOLOGY, V91, P856, DOI 10.1097/00000542-199909000-00039; Eger EI, 2001, ANESTHESIOLOGY, V94, P915, DOI 10.1097/00000542-200105000-00032; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; Flohr H, 1998, TOXICOL LETT, V101, P23, DOI 10.1016/S0378-4274(98)00161-1; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Friederich P, 2001, ANESTHESIOLOGY, V95, P954, DOI 10.1097/00000542-200110000-00026; Gandolfi D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00092; Gandolfi D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00064; Goldfarb M, 2012, CELL MOL LIFE SCI, V69, P1067, DOI 10.1007/s00018-011-0832-1; Huang JJ, 2014, CEREBELLUM, V13, P97, DOI 10.1007/s12311-013-0523-6; Jenkins A, 1999, ANESTHESIOLOGY, V90, P484, DOI 10.1097/00000542-199902000-00024; Joho RH, 2009, CEREBELLUM, V8, P323, DOI 10.1007/s12311-009-0098-4; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; Kofke WA, 2010, CURR OPIN ANESTHESIO, V23, P391, DOI 10.1097/ACO.0b013e328339250b; Lim BG, 2014, ASN NEURO, V6, DOI 10.1042/AN20140004; Lioudyno MI, 2013, J NEUROSCI, V33, P16310, DOI 10.1523/JNEUROSCI.0344-13.2013; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P764, DOI 10.1152/jn.1978.41.3.764; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Macario A, 2005, AM J HEALTH-SYST PH, V62, P63, DOI 10.1093/ajhp/62.1.63; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Mapelli J, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00014; Mapelli J, 2010, J NEUROPHYSIOL, V103, P250, DOI 10.1152/jn.00642.2009; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Mayer J, 2006, ANESTH ANALG, V102, P400, DOI 10.1213/01.ane.0000189561.44016.99; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Nieus T, 2006, J NEUROPHYSIOL, V95, P686, DOI 10.1152/jn.00696.2005; Nieus TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00246; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Nishikawa K, 2000, ANESTHESIOLOGY, V92, P228, DOI 10.1097/00000542-200001000-00035; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Ogawa SK, 2011, NEUROPHARMACOLOGY, V60, P701, DOI 10.1016/j.neuropharm.2010.11.016; Ordek G, 2013, J NEUROPHYSIOL, V109, P1435, DOI 10.1152/jn.00455.2012; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prestori F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064828; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rehberg B, 1996, ANESTHESIOLOGY, V84, P1223, DOI 10.1097/00000542-199605000-00025; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sola E, 2004, J PHYSIOL-LONDON, V557, P843, DOI 10.1113/jphysiol.2003.060285; Strong S P, 1998, Pac Symp Biocomput, P621; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Tiesinga PHE, 2002, NETWORK-COMP NEURAL, V13, P41, DOI 10.1088/0954-898X/13/1/302; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	79	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123534	10.1371/journal.pone.0123534	http://dx.doi.org/10.1371/journal.pone.0123534			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849222	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800241
J	Nam, J; Choo, KKR; Han, S; Kim, M; Paik, J; Won, D				Nam, Junghyun; Choo, Kim-Kwang Raymond; Han, Sangchul; Kim, Moonseong; Paik, Juryon; Won, Dongho			Efficient and Anonymous Two-Factor User Authentication in Wireless Sensor Networks: Achieving User Anonymity with Lightweight Sensor Computation	PLOS ONE			English	Article							MUTUAL AUTHENTICATION; KEY AGREEMENT; E-SAP; PROTOCOL; SECURITY; SCHEME; CRYPTANALYSIS; IMPROVEMENTS	A smart-card-based user authentication scheme for wireless sensor networks (hereafter referred to as a SCA-WSN scheme) is designed to ensure that only users who possess both a smart card and the corresponding password are allowed to gain access to sensor data and their transmissions. Despite many research efforts in recent years, it remains a challenging task to design an efficient SCA-WSN scheme that achieves user anonymity. The majority of published SCA-WSN schemes use only lightweight cryptographic techniques (rather than public-key cryptographic techniques) for the sake of efficiency, and have been demonstrated to suffer from the inability to provide user anonymity. Some schemes employ elliptic curve cryptography for better security but require sensors with strict resource constraints to perform computationally expensive scalar-point multiplications; despite the increased computational requirements, these schemes do not provide user anonymity. In this paper, we present a new SCA-WSN scheme that not only achieves user anonymity but also is efficient in terms of the computation loads for sensors. Our scheme employs elliptic curve cryptography but restricts its use only to anonymous user-to-gateway authentication, thereby allowing sensors to perform only lightweight cryptographic operations. Our scheme also enjoys provable security in a formal model extended from the widely accepted Bellare-Pointcheval- Rogaway (2000) model to capture the user anonymity property and various SCA-WSN specific attacks (e.g., stolen smart card attacks, node capture attacks, privileged insider attacks, and stolen verifier attacks).	[Nam, Junghyun; Han, Sangchul] Konkuk Univ, Dept Comp Engn, Chungju, Chungcheongbukd, South Korea; [Choo, Kim-Kwang Raymond] Univ S Australia, Sch Informat Technol & Math Sci, Mawson Lakes, SA, Australia; [Kim, Moonseong] Korean Intellectual Property Off, Informat Management Div, Taejon, South Korea; [Paik, Juryon; Won, Dongho] Sungkyunkwan Univ, Dept Comp Engn, Suwon, Gyeonggido, South Korea	Konkuk University; University of South Australia; Sungkyunkwan University (SKKU)	Han, S (corresponding author), Konkuk Univ, Dept Comp Engn, Chungju, Chungcheongbukd, South Korea.	schan@kku.ac.kr	Choo, Kim-Kwang Raymond/A-3634-2009	Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Paik, Juryon/0000-0002-0564-6412	Konkuk University	Konkuk University	This work was supported by Konkuk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellare M, 2000, LECT NOTES COMPUT SC, V1807, P139; Chen TH, 2010, ETRI J, V32, P704, DOI 10.4218/etrij.10.1510.0134; Chi L, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/637684; Choi Y, 2014, SENSORS-BASEL, V14, P10081, DOI 10.3390/s140610081; Das ML, 2009, IEEE T WIREL COMMUN, V8, P1086, DOI 10.1109/TWC.2008.080128; GOLDWASSER S, 1984, J COMPUT SYST SCI, V28, P270, DOI 10.1016/0022-0000(84)90070-9; Han W, 2011, IACR CRYPTOLOGY EPRI; He D, 2013, MULTIMEDIA SYSTEMS; He DJ, 2010, AD HOC SENS WIREL NE, V10, P361; He DB, 2014, IEEE T CONSUM ELECTR, V60, P30, DOI 10.1109/TCE.2014.6780922; He DB, 2014, WIRELESS PERS COMMUN, V74, P229, DOI 10.1007/s11277-013-1282-x; He DB, 2013, IEEE T CONSUM ELECTR, V59, P811, DOI 10.1109/TCE.2013.6689693; Jiang Q, 2015, PEER PEER NETW APPL, V8, P1070, DOI 10.1007/s12083-014-0285-z; Khan MK, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/347169; Khan MK, 2013, KSII T INTERNET INF, V7, P967, DOI 10.3837/tiis.2013.05.002; Khan MK, 2012, SECUR COMMUN NETW, V5, P1260, DOI 10.1002/sec.573; Khan MK, 2010, SENSORS-BASEL, V10, P2450, DOI 10.3390/s100302450; Kim J, 2014, SENSORS-BASEL, V14, P6443, DOI 10.3390/s140406443; Kocher P., 1999, Advances in Cryptology - CRYPTO'99. 19th Annual International Cryptology Conference. Proceedings, P388; Kumar P, 2013, ETRI J, V35, P889, DOI 10.4218/etrij.13.0113.0103; Kumar P, 2012, SENSORS-BASEL, V12, P1625, DOI 10.3390/s120201625; Kumar P, 2011, SENSORS-BASEL, V11, P5020, DOI 10.3390/s110505020; Li CT, 2013, SENSORS-BASEL, V13, P9589, DOI 10.3390/s130809589; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; NIST: National Institute of Standards and Technology, 1999, REC ELL CURV FED GOV; Rawat P, 2014, J SUPERCOMPUT, V68, P1, DOI 10.1007/s11227-013-1021-9; Shi WB, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/730831; Vaidya B, 2012, SECURITY COMMUNICATI; Wang D, 2014, COMPUT NETW, V73, P41, DOI 10.1016/j.comnet.2014.07.010; Wang D, 2014, AD HOC NETW, V20, P1, DOI 10.1016/j.adhoc.2014.03.003; Xie Q, 2014, WIRELESS PERS COMMUN, V74, P601, DOI 10.1007/s11277-013-1309-3; Xue KP, 2013, J NETW COMPUT APPL, V36, P316, DOI 10.1016/j.jnca.2012.05.010; Yeh HL, 2011, SENSORS-BASEL, V11, P4767, DOI 10.3390/s110504767; Yoo SG, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/382810	34	50	52	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0116709	10.1371/journal.pone.0116709	http://dx.doi.org/10.1371/journal.pone.0116709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849359	gold, Green Published, Green Accepted			2022-12-27	WOS:000352477800002
J	Wang, ZH; Slipicevic, A; Forsund, M; Trope, CG; Nesland, JM; Holm, R				Wang, Zhihui; Slipicevic, Ana; Forsund, Mette; Trope, Claes G.; Nesland, Jahn M.; Holm, Ruth			Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (Total) and pCyclin B1(Ser126) in Vulvar Squamous Cell Carcinoma and Their Relations with Clinicopatological Features and Prognosis	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CLINICAL-SIGNIFICANCE; PROTEIN EXPRESSION; DEPENDENT KINASES; GASTRIC-CANCER; LUNG-CANCER; IN-SITU; TRENDS; OVEREXPRESSION; ACTIVATION	Cyclin B1-CDK1 complex plays an important role in the regulation of cell cycle. Activation of Cyclin B1 and CDK1 and the formation of the complex in G2/ M are under multiple regulations involving many regulators such as isoforms of 14-3-3 and CDC25 and Wee1. Abnormal expression of Cyclin B1 and CDK1 has been detected in various tumors. However, to our knowledge no previous study has investigated Cyclin B1 and CDK1 in vulvar cancer. Therefore, we evaluated the statuses of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in 297 cases of vulvar squamous cell carcinomas by immunohistochemistry. Statistical analyses were performed to explore their clinicopathological and prognostic values. In at least 25% of tumor cases high expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1Ser126 was observed, compared to the low levels in normal vulvar squamous epithelium. Elevated levels of CDK1Tyr15, pCDK1Thr161, Cyclin B1 (total) and pCyclin B1Ser126 were correlated with advanced tumor behaviors and aggressive features. Although CDK1Tyr15, pCDK1Thr161, Cyclin B1 (total) and pCyclin B1Ser126 could not be identified as prognostic factors, combinations of (pCDK1(Thr161 C+ N) + 14-3-3 sigma(N)), (pCDK1(Thr161 C) (+N) + 14-3-3 eta(C)), (pCDK1(Thr161 C+ N) + Wee1(C)) and (pCDK1(Thr161 C+ N) + 14-3-3 sigma(N) + 14-3-3 eta(C) + Wee1(C)) were correlated with disease-specific survival (p = 0.036, p = 0.029, p = 0.042 and p = 0.007, respectively) in univariate analysis. The independent prognostic significance of (pCDK1(Thr161 C+ N) + 14-3-3 sigma(N) + 14-3-3 eta(C) + Wee1(C)) was confirmed by multivariate analysis. In conclusion, CDK1Tyr15, pCDK1Thr161, Cyclin B1 (total) and pCyclin B1Ser126 may be involved in progression of vulvar squamous cell carcinoma. The combination of pCDK1Thr161, 14-3-3s, 14-3-3. and Wee1 was a statistically independent prognostic factor.	[Wang, Zhihui; Slipicevic, Ana; Forsund, Mette; Nesland, Jahn M.; Holm, Ruth] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Trope, Claes G.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Obstet & Gynecol, Oslo, Norway; [Nesland, Jahn M.] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Wang, ZH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	zhihui.wang@rr-research.no			Inger and John Fredriksen Foundation for Ovarian Cancer Research; Norwegian Cancer Society	Inger and John Fredriksen Foundation for Ovarian Cancer Research; Norwegian Cancer Society(Norwegian Cancer Society)	This study was financially supported by The Inger and John Fredriksen Foundation for Ovarian Cancer Research and The Norwegian Cancer Society (ULR: https://kreftforeningen.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baandrup L, 2011, GYNECOL ONCOL, V122, P45, DOI 10.1016/j.ygyno.2011.03.016; Begnami MD, 2010, HUM PATHOL, V41, P1120, DOI 10.1016/j.humpath.2010.01.007; Bhattacharya A, 2013, ONCOGENE, V32, P3175, DOI 10.1038/onc.2012.324; Canavan TP, 2002, AM FAM PHYSICIAN, V66, P1269; CONNELLCROWLEY L, 1993, MOL BIOL CELL, V4, P79, DOI 10.1091/mbc.4.1.79; Dittmer C, 2011, ARCH GYNECOL OBSTET, V284, P169, DOI 10.1007/s00404-011-1850-9; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; Endo M, 2011, CLIN CANCER RES, V17, P3771, DOI 10.1158/1078-0432.CCR-10-2393; Eom M, 2012, KOREAN J PATHOL, V46, P324, DOI 10.4132/KoreanJPathol.2012.46.4.324; Fujita A, 2012, VIRCHOWS ARCH, V460, P163, DOI 10.1007/s00428-011-1181-z; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Hashiguchi Y, 2004, HUM PATHOL, V35, P165, DOI 10.1016/j.humpath.2003.07.018; Hassan KA, 2001, CLIN CANCER RES, V7, P2458; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Holm R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061273; Iversen T, 1998, OBSTET GYNECOL, V91, P969, DOI 10.1016/S0029-7844(98)00101-X; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; Joura EA, 2000, J REPROD MED, V45, P613; Judson PL, 2006, OBSTET GYNECOL, V107, P1018, DOI 10.1097/01.AOG.0000210268.57527.a1; Kleihues P., 2003, PATHOLOGY GENETICS T, P316; Knopp S, 2006, AM J CLIN PATHOL, V126, P266, DOI 10.1309/E9E8Y9WG5QE3LK29; Korenaga D, 2002, SURGERY, V131, pS114, DOI 10.1067/msy.2002.119362; Kuhling H, 2003, J PATHOL, V199, P424, DOI 10.1002/path.1322; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Magnussen GI, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-288; Magrina JF, 1998, GYNECOL ONCOL, V71, P116, DOI 10.1006/gyno.1998.5149; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nakamura N, 2005, HUM PATHOL, V36, P828, DOI 10.1016/j.humpath.2005.03.012; Nozoe T, 2002, CLIN CANCER RES, V8, P817; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Rothblum-Oviatt CJ, 2001, CELL GROWTH DIFFER, V12, P581; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Schuurman MS, 2013, EUR J CANCER, V49, P3872, DOI 10.1016/j.ejca.2013.08.003; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; Soria JC, 2000, CANCER RES, V60, P4000; Suzuki T, 2007, CANCER SCI, V98, P644, DOI 10.1111/j.1349-7006.2007.00444.x; Takeno S, 2002, CANCER, V94, P2874, DOI 10.1002/cncr.10542; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Wang ZH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-233; Wang ZH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-308; Watson M, 2009, J WOMENS HEALTH, V18, P1731, DOI 10.1089/jwh.2009.1570; Yasuda M, 2002, J CANCER RES CLIN, V128, P412, DOI 10.1007/s00432-002-0359-9; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073	48	4	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121398	10.1371/journal.pone.0121398	http://dx.doi.org/10.1371/journal.pone.0121398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849598	Green Published, gold			2022-12-27	WOS:000352477800054
J	Chung, EML; Banahan, C; Patel, N; Janus, J; Marshall, D; Horsfield, MA; Rousseau, C; Keelan, J; Evans, DH; Hague, JP				Chung, Emma M. L.; Banahan, Caroline; Patel, Nikil; Janus, Justyna; Marshall, David; Horsfield, Mark A.; Rousseau, Clement; Keelan, Jonathan; Evans, David H.; Hague, James P.			Size Distribution of Air Bubbles Entering the Brain during Cardiac Surgery	PLOS ONE			English	Article							CARBON-DIOXIDE INSUFFLATION; GASEOUS EMBOLI; BYPASS; TRIAL; BLOOD	Background Thousands of air bubbles enter the cerebral circulation during cardiac surgery, but whether high numbers of bubbles explain post-operative cognitive decline is currently controversial. This study estimates the size distribution of air bubbles and volume of air entering the cerebral arteries intra-operatively based on analysis of transcranial Doppler ultrasound data. Methods Transcranial Doppler ultrasound recordings from ten patients undergoing heart surgery were analysed for the presence of embolic signals. The backscattered intensity of each embolic signal was modelled based on ultrasound scattering theory to provide an estimate of bubble diameter. The impact of showers of bubbles on cerebral blood-flow was then investigated using patient-specific Monte-Carlo simulations to model the accumulation and clearance of bubbles within a model vasculature. Results Analysis of Doppler ultrasound recordings revealed a minimum of 371 and maximum of 6476 bubbles entering the middle cerebral artery territories during surgery. This was estimated to correspond to a total volume of air ranging between 0.003 and 0.12 mL. Based on analysis of a total of 18667 embolic signals, the median diameter of bubbles entering the cerebral arteries was 33 mu m (IQR: 18 to 69 mu m). Although bubble diameters ranged from similar to 5 mu m to 3.5 mm, the majority (85%) were less than 100 mu m. Numerous small bubbles detected during cardiopulmonary bypass were estimated by Monte-Carlo simulation to be benign. However, during weaning from bypass, showers containing large macro-bubbles were observed, which were estimated to transiently affect up to 2.2% of arterioles. Conclusions Detailed analysis of Doppler ultrasound data can be used to provide an estimate of bubble diameter, total volume of air, and the likely impact of embolic showers on cerebral blood flow. Although bubbles are alarmingly numerous during surgery, our simulations suggest that the majority of bubbles are too small to be harmful.	[Chung, Emma M. L.; Banahan, Caroline; Patel, Nikil; Janus, Justyna; Marshall, David; Horsfield, Mark A.; Evans, David H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Chung, Emma M. L.; Banahan, Caroline] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Chung, Emma M. L.; Patel, Nikil; Marshall, David; Rousseau, Clement] Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Keelan, Jonathan; Hague, James P.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Open University - UK	Chung, EML (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	emlc1@le.ac.uk; Jim.Hague@open.ac.uk	Horsfield, Mark A/C-6569-2013; Evans, David/AAN-1100-2020	Horsfield, Mark A/0000-0002-0815-6697; Rousseau, Clement/0000-0002-8063-0584; Chung, Emma/0000-0003-3723-9085; Hague, James/0000-0002-5760-8696; Patel, Nikil/0000-0003-2888-9668	British Heart Foundation [FS/10/46/288350]; National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit; EPSRC [EP/L025884/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1146445] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by the British Heart Foundation (FS/10/46/288350) and the National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banahan C, 2012, ULTRASOUND MED BIOL, V38, P824, DOI 10.1016/j.ultrasmedbio.2012.01.008; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Chaudhuri K, 2012, J THORAC CARDIOV SUR, V144, P646, DOI 10.1016/j.jtcvs.2012.04.010; Chaudhuri K, 2011, J CARDIAC SURG, V26, P189, DOI 10.1111/j.1540-8191.2011.01217.x; Chung EML, 2007, PHYS MED BIOL, V52, P7153, DOI 10.1088/0031-9155/52/23/025; Gerriets T, 2010, EUR HEART J, V31, P360, DOI 10.1093/eurheartj/ehp178; Hague JP, 2013, PHYS MED BIOL, V58, P4381, DOI 10.1088/0031-9155/58/13/4381; Hague JP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051912; Haines DE, 2013, CIRC-ARRHYTHMIA ELEC, V6, P23, DOI 10.1161/CIRCEP.112.973461; Kruis RWJ, 2010, SEMIN CARDIOTHORAC V, V14, P111, DOI 10.1177/1089253210370903; Lynch JE, 2008, PERFUSION-UK, V23, P23, DOI 10.1177/0267659108094350; Mitchell Simon, 2002, J Extra Corpor Technol, V34, P18; MOEHRING MA, 1994, IEEE T BIO-MED ENG, V41, P35, DOI 10.1109/10.277269; MOODY DM, 1995, ANN THORAC SURG, V59, P1304, DOI 10.1016/0003-4975(95)00057-R; Ringelstein EB, 1998, STROKE, V29, P725	15	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122166	10.1371/journal.pone.0122166	http://dx.doi.org/10.1371/journal.pone.0122166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837519	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000352139000082
J	Ogasawara, Y; Yackley, BJ; Greenberg, JA; Rogelj, S; Melancon, CE				Ogasawara, Yasushi; Yackley, Benjamin J.; Greenberg, Jacob A.; Rogelj, Snezna; Melancon, Charles E., III			Expanding our Understanding of Sequence-Function Relationships of Type II Polyketide Biosynthetic Gene Clusters: Bioinformatics-Guided Identification of Frankiamicin A from Frankia sp EAN1pec	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; TETRACENOMYCIN-F2 CYCLASE; ENGINEERED BIOSYNTHESIS; CRYSTAL-STRUCTURE; SP STRAINS; CLONING; SYNTHASE; MONOOXYGENASE; DISCOVERY; PURIFICATION	A large and rapidly increasing number of unstudied " orphan" natural product biosynthetic gene clusters are being uncovered in sequenced microbial genomes. An important goal of modern natural products research is to be able to accurately predict natural product structures and biosynthetic pathways from these gene cluster sequences. This requires both development of bioinformatic methods for global analysis of these gene clusters and experimental characterization of select products produced by gene clusters with divergent sequence characteristics. Here, we conduct global bioinformatic analysis of all available type II polyketide gene cluster sequences and identify a conserved set of gene clusters with unique ketosynthase a/a sequence characteristics in the genomes of Frankia species, a group of Actinobacteria with underexploited natural product biosynthetic potential. Through LC-MS profiling of extracts from several Frankia species grown under various conditions, we identified Frankia sp. EAN1pec as producing a compound with spectral characteristics consistent with the type II polyketide produced by this gene cluster. We isolated the compound, a pentangular polyketide which we named frankiamicin A, and elucidated its structure by NMR and labeled precursor feeding. We also propose biosynthetic and regulatory pathways for frankiamicin A based on comparative genomic analysis and literature precedent, and conduct bioactivity assays of the compound. Our findings provide new information linking this set of Frankia gene clusters with the compound they produce, and our approach has implications for accurate functional prediction of the many other type II polyketide clusters present in bacterial genomes.	[Ogasawara, Yasushi; Yackley, Benjamin J.; Greenberg, Jacob A.; Melancon, Charles E., III] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Melancon, Charles E., III] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Melancon, Charles E., III] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Rogelj, Snezna] New Mexico Inst Min & Technol, Dept Chem, Socorro, NM 87801 USA; [Rogelj, Snezna] New Mexico Inst Min & Technol, Dept Biol, Socorro, NM 87801 USA	University of New Mexico; University of New Mexico; University of New Mexico; New Mexico Institute of Mining Technology; New Mexico Institute of Mining Technology	Melancon, CE (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	cemelanc@unm.edu	Ogasawara, Yasushi/ABG-5942-2020	Ogasawara, Yasushi/0000-0002-3144-3985	University of New Mexico start-up funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	University of New Mexico start-up funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by University of New Mexico start-up funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; AOYAMA T, 1993, J ANTIBIOT, V46, P914, DOI 10.7164/antibiotics.46.914; Banskota AH, 2009, J ANTIBIOT, V62, P565, DOI 10.1038/ja.2009.77; Bao WL, 1998, BIOCHEMISTRY-US, V37, P8132, DOI 10.1021/bi980466i; Benson DR, 2011, MOL PLANT MICROBE IN, V24, P1310, DOI 10.1094/MPMI-06-11-0150; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bologa CG, 2013, CURR OPIN PHARMACOL, V13, P678, DOI 10.1016/j.coph.2013.07.002; Chen J, 2011, J CELL BIOCHEM, V112, P2694, DOI 10.1002/jcb.23219; Chung JY, 2002, J BACTERIOL, V184, P6115, DOI 10.1128/JB.184.22.6115-6122.2002; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; Dairi T, 1997, BIOSCI BIOTECH BIOCH, V61, P1445, DOI 10.1271/bbb.61.1445; Feng ZY, 2012, J AM CHEM SOC, V134, P2981, DOI 10.1021/ja207662w; Fritzsche K, 2008, J AM CHEM SOC, V130, P8307, DOI 10.1021/ja800251m; Frolova LV, 2013, J MED CHEM, V56, P6886, DOI 10.1021/jm400711t; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Helfrich EJN, 2014, CURR OPIN BIOTECH, V29, P107, DOI 10.1016/j.copbio.2014.03.004; Hertweck C, 2004, CHEM BIOL, V11, P461, DOI 10.1016/j.chembiol.2004.03.018; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hutchinson CR, 1997, CHEM REV, V97, P2525, DOI 10.1021/cr960022x; Ishida K, 2010, J AM CHEM SOC, V132, P13966, DOI 10.1021/ja105003g; Kang HS, 2014, ACS CHEM BIOL, V9, P1267, DOI 10.1021/cb500141b; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Kendrew SG, 1997, J BACTERIOL, V179, P4305, DOI 10.1128/jb.179.13.4305-4310.1997; Kim BC, 2007, J MICROBIOL BIOTECHN, V17, P830; Kim J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-169; Klika KD, 2001, J ORG CHEM, V66, P4065, DOI 10.1021/jo001789z; Komatsu M, 2006, MOL MICROBIOL, V62, P1534, DOI 10.1111/j.1365-2958.2006.05461.x; Kudo F, 2011, J ANTIBIOT, V64, P123, DOI 10.1038/ja.2010.145; Lackner G, 2007, J AM CHEM SOC, V129, P9306, DOI 10.1021/ja0718624; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lechner A, 2011, CHEM BIOL, V18, P1527, DOI 10.1016/j.chembiol.2011.10.014; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Lopez P, 2010, GENE, V461, P5, DOI 10.1016/j.gene.2010.03.016; Martin R, 2001, J ANTIBIOT, V54, P239, DOI 10.7164/antibiotics.54.239; Matharu AL, 1998, CHEM BIOL, V5, P699, DOI 10.1016/S1074-5521(98)90663-9; MATSUDA Y, 1987, J ANTIBIOT, V40, P1104, DOI 10.7164/antibiotics.40.1104; Mayer A, 2005, CHEMBIOCHEM, V6, P2312, DOI 10.1002/cbic.200500205; MCDANIEL R, 1994, P NATL ACAD SCI USA, V91, P11542, DOI 10.1073/pnas.91.24.11542; MCDANIEL R, 1995, J AM CHEM SOC, V117, P6805, DOI 10.1021/ja00131a001; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Napan KL, 2012, BIOORG MED CHEM LETT, V22, P606, DOI 10.1016/j.bmcl.2011.10.075; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Oves-Costales D, 2012, RSC DRUG DISCOV, V25, P140, DOI 10.1039/9781849734950-00140; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RICKARDS RW, 1989, J ANTIBIOT, V42, P336, DOI 10.7164/antibiotics.42.336; Romero D, 2011, CHEM REV, V111, P5492, DOI 10.1021/cr2000509; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; SHEN B, 1993, BIOCHEMISTRY-US, V32, P11149, DOI 10.1021/bi00092a026; SHEN B, 1993, BIOCHEMISTRY-US, V32, P6656, DOI 10.1021/bi00077a019; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Thompson TB, 2004, J BIOL CHEM, V279, P37956, DOI 10.1074/jbc.M406144200; Tsukamoto M, 1998, Jpn Kokai Tokkyo Koho, Patent No. [JP 10017527, 10017527]; Udwary DW, 2011, APPL ENVIRON MICROB, V77, P3617, DOI 10.1128/AEM.00038-11; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zaleta-Rivera K, 2010, J AM CHEM SOC, V132, P9122, DOI 10.1021/ja102519v; Zawada RJX, 1999, CHEM BIOL, V6, P607; Zhan JX, 2008, CHEMBIOCHEM, V9, P1710, DOI 10.1002/cbic.200800178; Zhan JX, 2009, CHEMBIOCHEM, V10, P1447, DOI 10.1002/cbic.200900082; Zhang WK, 2012, CHEM BIOL, V19, P422, DOI 10.1016/j.chembiol.2012.01.016; Zhang X, 2008, ANTIMICROB AGENTS CH, V52, P574, DOI 10.1128/AAC.00717-07; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275	72	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121505	10.1371/journal.pone.0121505	http://dx.doi.org/10.1371/journal.pone.0121505			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837682	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000045
J	Baillot, A; Romain, AJ; Boisvert-Vigneault, K; Audet, M; Baillargeon, JP; Dionne, IJ; Valiquette, L; Abou Chakra, CN; Avignon, A; Langlois, MF				Baillot, Aurelie; Romain, Ahmed J.; Boisvert-Vigneault, Katherine; Audet, Melisa; Baillargeon, Jean Patrice; Dionne, Isabelle J.; Valiquette, Louis; Abou Chakra, Claire Nour; Avignon, Antoine; Langlois, Marie-France			Effects of Lifestyle Interventions That Include a Physical Activity Component in Class II and III Obese Individuals: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CARDIOVASCULAR RISK-FACTORS; WEIGHT REDUCTION PROGRAM; QUALITY-OF-LIFE; GASTRIC BYPASS-SURGERY; SEVERELY OBESE; BARIATRIC SURGERY; BODY-COMPOSITION; MORBID-OBESITY; MUSCLE PERFORMANCE; EATING BEHAVIOR	Background In class II and III obese individuals, lifestyle intervention is the first step to achieve weight loss and treat obesity-related comorbidities before considering bariatric surgery. A systematic review, meta-analysis, and meta-regression were performed to assess the impact of lifestyle interventions incorporating a physical activity (PA) component on health outcomes of class II and III obese individuals. Methods An electronic search was conducted in 4 databases (Medline, Scopus, CINAHL and Sport-discus). Two independent investigators selected original studies assessing the impact of lifestyle interventions with PA components on anthropometric parameters, cardiometabolic risk factors (fat mass, blood pressure, lipid and glucose metabolism), behaviour modification (PA and nutritional changes), and quality of life in adults with body mass index (BMI) >= 35 kg/m(2). Estimates were pooled using a random-effect model (DerSimonian and Laird method). Heterogeneity between studies was assessed by the Cochran's chi-square test and quantified through an estimation of the I-2. Results Of the 3,170 identified articles, 56 met our eligibility criteria, with a large majority of uncontrolled studies (80%). The meta-analysis based on uncontrolled studies showed significant heterogeneity among all included studies. The pooled mean difference in weight loss was 8.9 kg (95% CI, 10.2-7.7; p < 0.01) and 2.8 kg/m(2) in BMI loss (95% CI, 3.4-2.2; p < 0.01). Long-term interventions produced superior weight loss (11.3 kg) compared to short-term (7.2 kg) and intermediate-term (8.0 kg) interventions. A significant global effect of lifestyle intervention on fat mass, waist circumference, blood pressure, total cholesterol, LDL-C, triglycerides and fasting insulin was found (p<0.01), without significant effect on HDL-C and fasting blood glucose. Conclusions Lifestyle interventions incorporating a PA component can improve weight and various cardiometabolic risk factors in class II and III obese individuals. However, further high quality trials are needed to confirm this evidence, especially beyond weight loss.	[Baillot, Aurelie; Baillargeon, Jean Patrice; Langlois, Marie-France] Univ Sherbrooke, Res Ctr, Ctr Hosp, Sherbrooke, PQ J1K 2R1, Canada; [Baillot, Aurelie; Baillargeon, Jean Patrice; Langlois, Marie-France] Univ Sherbrooke, Dept Med, Div Endocrinol, Sherbrooke, PQ J1K 2R1, Canada; [Romain, Ahmed J.; Avignon, Antoine] Univ Hosp, Unit Nutr & Diabet, Dept Endocrinol Nutr & Diabet, Montpellier, France; [Boisvert-Vigneault, Katherine; Audet, Melisa; Dionne, Isabelle J.] Univ Sherbrooke, Res Ctr Aging, Hlth & Social Serv Ctr, Inst Geriatr, Sherbrooke, PQ J1K 2R1, Canada; [Boisvert-Vigneault, Katherine; Audet, Melisa; Dionne, Isabelle J.] Univ Sherbrooke, Fac Phys Educ & Sports, Sherbrooke, PQ J1K 2R1, Canada; [Valiquette, Louis; Abou Chakra, Claire Nour] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada; [Avignon, Antoine] Univ Montpellier, INSERM U1046, Physiol & Expt Med Heart & Muscles, F-34059 Montpellier, France	University of Sherbrooke; University of Sherbrooke; Universite de Montpellier; CHU de Montpellier; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Langlois, MF (corresponding author), Univ Sherbrooke, Res Ctr, Ctr Hosp, Sherbrooke, PQ J1K 2R1, Canada.	Marie-France.Langlois@usherbrooke.ca	Romain, Ahmed Jerome/AAP-5893-2020; Avignon, Antoine/AAD-5441-2020	Romain, Ahmed Jerome/0000-0003-1690-1375; Baillot, Aurelie/0000-0003-4874-0481; Baillargeon, Jean-Patrice/0000-0002-1336-081X	Canadian Institutes of Health Research (CIHR) [NRF - 124607]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR, NRF - 124607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland E, 2012, J OBES, V2012; Ahmadi N, 2011, AM J MED, V124, P978, DOI 10.1016/j.amjmed.2011.02.032; ANDERSON JW, 1994, J AM COLL NUTR, V13, P256, DOI 10.1080/07315724.1994.10718406; Annesi J. J., 2012, Open Public Health Journal, V5, P10, DOI 10.2174/1874944501205010010; Annesi James J, 2012, Perm J, V16, P7; Annesi JJ, 2011, BEHAV MED, V37, P71, DOI 10.1080/08964289.2011.579643; Annesi JJ, 2010, J OBES, V2010, DOI 10.1155/2010/171957; Annesi JJ, 2010, SOUTH MED J, V103, P1119, DOI 10.1097/SMJ.0b013e3181f6d3d4; Annesi JJ, 2010, HEALTH EDUC BEHAV, V37, P593, DOI 10.1177/1090198109331671; Annesi JJ, 2008, OBESITY FACTS, V1, P88, DOI 10.1159/000125194; Annesi JJ, 2012, INT J BEHAV MED, P1; Aucott L, 2005, HYPERTENSION, V45, P1035, DOI 10.1161/01.HYP.0000165680.59733.d4; Aucott LS, 2008, P NUTR SOC, V67, P54, DOI 10.1017/S0029665108006022; Bader D S, 2001, J Cardiopulm Rehabil, V21, P210, DOI 10.1097/00008483-200107000-00003; Baillot A, 2014, OBES REV, V15, P721, DOI 10.1111/obr.12171; Benson GA, 2011, ACSMS HEALTH FIT J, V15, P13, DOI 10.1249/FIT.0b013e318201c8df; BJORVELL H, 1985, BRIT MED J, V291, P379, DOI 10.1136/bmj.291.6492.379; Borenstein M, 2009, INTRO META ANAL; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brumley DW, 2007, DIS MANAGE, V10, pS18, DOI 10.1089/dis.2007.7715; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cancello R, 2012, INT J OBESITY, V36, P1552, DOI 10.1038/ijo.2011.275; Carlin AM, 2008, SURG OBES RELAT DIS, V4, P481, DOI 10.1016/j.soard.2007.09.010; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Clini E, 2006, Monaldi Arch Chest Dis, V65, P89; Cuntz U, 2001, INT J OBESITY, V25, pS99, DOI 10.1038/sj.ijo.0801710; Dalle Grave R, 2007, OBESITY, V15, P2320, DOI 10.1038/oby.2007.275; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Duval K, 2006, OBES SURG, V16, P574, DOI 10.1381/096089206776944968; Facchini M, 2003, J ENDOCRINOL INVEST, V26, P138, DOI 10.1007/BF03345142; FACHNIE J D, 1987, Henry Ford Hospital Medical Journal, V35, P216; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Fontaine Kevin R, 2004, Eat Behav, V5, P85, DOI 10.1016/S1471-0153(03)00059-X; Formiguera Sala X, 1991, Med Clin (Barc), V96, P401; Fortin MMR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-69; Galani C, 2007, INT J PUBLIC HEALTH, V52, P348, DOI 10.1007/s00038-007-7015-8; Golay A, 2004, Eat Weight Disord, V9, P29; Gondoni LA, 2003, NUTR METAB CARDIOVAS, V13, P232, DOI 10.1016/S0939-4753(03)80016-9; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gourlan MJ, 2011, OBES REV, V12, pE633, DOI 10.1111/j.1467-789X.2011.00874.x; Hardman AE, 1999, INT J OBESITY, V23, pS64, DOI 10.1038/sj.ijo.0800886; Heath GW, 2009, J PHYS ACT HEALTH, V6, P403, DOI 10.1123/jpah.6.4.403; Helge JW, 2011, ACTA PHYSIOL, V201, P357, DOI 10.1111/j.1748-1716.2010.02180.x; Hemmingsson E, 2008, OBESITY, V16, P1308, DOI 10.1038/oby.2008.204; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofso D, 2011, EUR J ENDOCRINOL, V164, P231, DOI 10.1530/EJE-10-0804; Hofso D, 2010, EUR J ENDOCRINOL, V163, P735, DOI 10.1530/EJE-10-0514; Huerta S, 2010, OBES SURG, V20, P173, DOI 10.1007/s11695-009-0001-x; Hulens M, 2003, SCAND J MED SCI SPOR, V13, P98, DOI 10.1034/j.1600-0838.2003.10273.x; Jakicic JM, 2011, PSYCHIAT CLIN N AM, V34, P829, DOI 10.1016/j.psc.2011.08.009; Jensen MD, 2013, J AM COLL CARDIOL; Karlsen TI, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-165; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; Konopko-Zubrzycka M, 2009, J CLIN ENDOCR METAB, V94, P1644, DOI 10.1210/jc.2008-1083; Lafortuna CL, 2003, J ENDOCRINOL INVEST, V26, P197; Larsson U, 2002, INT J OBESITY, V26, P417, DOI 10.1038/sj.ijo.0801919; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Levy RL, 2007, AM J GASTROENTEROL, V102, P2314, DOI 10.1111/j.1572-0241.2007.01342.x; Maehlum S, 2012, BRIT J SPORT MED, V46, P91, DOI 10.1136/bjsm.2010.071894; Maffiuletti NA, 2005, EUR J CLIN NUTR, V59, P685, DOI 10.1038/sj.ejcn.1602130; Malone M, 2012, ANN PHARMACOTHER, V46, P779, DOI 10.1345/aph.1Q556; Martins C, 2011, OBES SURG, V21, P841, DOI 10.1007/s11695-010-0131-1; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mercier Jacques, 1999, Molecular Aspects of Medicine, V20, P319, DOI 10.1016/S0098-2997(00)00002-9; Merrill RM, 2010, EAT WEIGHT DISORD-ST, V15, pE52, DOI 10.1007/BF03325280; Moher David, 2009, Open Med, V3, pe123; Morpurgo PS, 2003, J ENDOCRINOL INVEST, V26, P723, DOI 10.1007/BF03347353; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Institute for Health and Clinical Excellence: Guidance, 2006, OBESITY THE PREVENTI; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Oksanen L, 1996, INT J OBESITY, V20, P1055; Parikh M, 2012, SURG ENDOSC, V26, P853, DOI 10.1007/s00464-011-1966-9; PERRI MG, 1989, J CONSULT CLIN PSYCH, V57, P450, DOI 10.1037/0022-006X.57.3.450; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Ramage S, 2014, APPL PHYSIOL NUTR ME, V39, P1, DOI 10.1139/apnm-2013-0026; Ramani GV, 2008, CLIN CARDIOL, V31, P516, DOI [10.1002/clc.20315, 10.1002/ClC.20315]; Reis LO, 2012, REPROD SCI, V19, P1057, DOI 10.1177/1933719112440747; RICHMAN RM, 1992, MED J AUSTRALIA, V156, P768, DOI 10.5694/j.1326-5377.1992.tb121558.x; Roffey DM, 2011, SPINE J, V11, P197, DOI 10.1016/j.spinee.2011.01.031; Sartorio A, 2005, J ENDOCRINOL INVEST, V28, P494, DOI 10.1007/BF03347236; Sartorio A, 2003, Eat Weight Disord, V8, P107; Sartorio A, 2004, EUR J ENDOCRINOL, V150, P511, DOI 10.1530/eje.0.1500511; Sartorio A, 2003, J ENDOCRINOL INVEST, V26, P250, DOI 10.1007/BF03345165; Sartorio A, 2003, Eat Weight Disord, V8, P36; Sartorio A, 2003, DIABETES NUTR METAB, V16, P88; Sartorio A, 2002, DIABETES NUTR METAB, V15, P252; Sartorio A, 2001, DIABETES NUTR METAB, V14, P51; Sarwer DB, 2011, SURG OBES RELAT DIS, V7, P644, DOI 10.1016/j.soard.2011.06.016; Seres L, 2003, REV ESP CARDIOL, V56, P594, DOI 10.1157/13048157; Shields Margot, 2011, NCHS Data Brief, P1; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Strommen M, 2009, OBES RES CLIN PRACT, V3, P193, DOI 10.1016/j.orcp.2009.04.004; Sturm R, 2013, INT J OBESITY, V37, P889, DOI 10.1038/ijo.2012.159; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Tsigos C, 2008, OBESITY FACTS, V1, P106, DOI 10.1159/000126822; Tur JJ, 2013, CLIN ENDOCRINOL, V79, P791, DOI 10.1111/cen.12109; Unick JL, 2011, DIABETES CARE, V34, P2152, DOI 10.2337/dc11-0874; Valderas JP, 2010, J CLIN ENDOCR METAB, V95, P1069, DOI 10.1210/jc.2009-0983; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Weinstein AR, 2006, EXERC SPORT SCI REV, V34, P10, DOI 10.1097/00003677-200601000-00004; WHO, 2014, OB OV; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x; YOSHIDA T, 1994, INT J CLIN PHARM RES, V14, P125; Yumuk V, 2014, OBESITY FACTS, V7, P96, DOI 10.1159/000362191	111	73	74	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119017	10.1371/journal.pone.0119017	http://dx.doi.org/10.1371/journal.pone.0119017			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830342	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600007
J	Hohsfield, LA; Humpel, C				Hohsfield, Lindsay A.; Humpel, Christian			Intravenous Infusion of Monocytes Isolated from 2-Week-Old Mice Enhances Clearance of Beta-Amyloid Plaques in an Alzheimer Mouse Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VIVO; MACROPHAGES; MICROGLIA; DISEASE; BRAIN; CELLS; AGE; INFLAMMATION; DIFFERENTIATION	Alzheimer's disease (AD) is characterized by the deposition of beta-amyloid (A beta) senile plaques and tau-associated neurofibrillary tangles. Other disease features include neuroinflammation and cholinergic neurodegeneration, indicating their possible importance in disease propagation. Recent studies have shown that monocytic cells can migrate into the AD brain toward A beta plaques and reduce plaque burden. The purpose of this study was to evaluate whether the administration of intravenous infusions of 'young' CD11b-positive (+) monocytes into an AD mouse model can enhance A beta plaque clearance and attenuate cognitive deficits. Peripheral monocytes were isolated from two-week-old wildtype mice using the Pluriselect CD11b+ isolation method and characterized by FACS analysis for surface marker expression and effective phagocytosis of 1 mu m fluorescent microspheres, FITC-Dextran or FITC-A beta(1-42). The isolated monocytes were infused via the tail vein into a transgenic AD mouse model, which expresses the Swedish, Dutch/Iowa APP mutations (APPSwDI). The infusions began when animals reached 5 months of age, when little plaque deposition is apparent and were repeated again at 6 and 7 months of age. At 8 months of age, brains were analyzed for A beta+ plaques, inflammatory processes and microglial (Iba1) activation. Our data show that infusions of two-week-old CD11b+ monocytes into adult APPSwDI mice results in a transient improvement of memory function, a reduction (30%) in A beta plaque load and significantly in small (< 20 mu m) and large (> 40 mu m) plaques. In addition, we observe a reduction in Iba1+ cells, as well as no marked elevations in cytokine levels or other indicators of inflammation. Taken together, our findings indicate that young CD11b+ monocytes may serve as therapeutic candidates for improved A beta clearance in AD.	[Hohsfield, Lindsay A.; Humpel, Christian] Med Univ Innsbruck, Lab Psychiat & Expt Alzheimers Res, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Tyrol, Austria	Medical University of Innsbruck	Humpel, C (corresponding author), Med Univ Innsbruck, Lab Psychiat & Expt Alzheimers Res, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Tyrol, Austria.	christian.humpel@i-med.ac.at			Austrian Science Funds [P24541-B24]; Austrian Science Fund (FWF) [P 24541] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study has been supported by the Austrian Science Funds (P24541-B24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V32, P777, DOI 10.1016/0091-3057(89)90033-6; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Gate D, 2010, J NEURAL TRANSM, V117, P961, DOI 10.1007/s00702-010-0422-7; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Hohsfield LA, 2013, NEUROBIOL LEARN MEM, V106, P154, DOI 10.1016/j.nlm.2013.08.007; Hohsfield LA, 2010, CURR NEUROVASC RES, V7, P192; Khandelwal PJ, 2011, J NEUROIMMUNOL, V238, P1, DOI 10.1016/j.jneuroim.2011.07.002; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; Lampron A, 2013, J COMP NEUROL, V521, P3863, DOI 10.1002/cne.23363; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Majerova P, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0161-z; Malm T, 2010, GLIA, V58, P889, DOI 10.1002/glia.20973; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; Naert G, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00051; Pinke KH, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-22; Pirchl M, 2010, EUR J NEUROSCI, V32, P1516, DOI 10.1111/j.1460-9568.2010.07434.x; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Strohacker K, 2012, J BIOSCIENCES, V37, P55, DOI 10.1007/s12038-011-9169-z; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Ullrich C, 2010, MOL CELL NEUROSCI, V45, P408, DOI 10.1016/j.mcn.2010.08.001; Ullrich C, 2009, NEUROCHEM RES, V34, P2147, DOI 10.1007/s11064-009-0014-9; Verschoor CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104522; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Yong VW, 2009, NEURON, V64, P55, DOI 10.1016/j.neuron.2009.09.035; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	54	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121930	10.1371/journal.pone.0121930	http://dx.doi.org/10.1371/journal.pone.0121930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830951	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600091
J	Ngeow, YF; Wong, YL; Tan, JL; Hong, KW; Ng, HF; Ong, BL; Chan, KG				Ngeow, Yun Fong; Wong, Yan Ling; Tan, Joon Liang; Hong, Kar Wai; Ng, Hien Fuh; Ong, Bee Lee; Chan, Kok Gan			Identification of New Genomospecies in the Mycobacterium terrae Complex	PLOS ONE			English	Article							SP NOV.; CLINICAL ISOLATE; SEQUENCE; ALIGNMENT; ARUPENSE; IDENTITY; PROGRAM; MODEL	Members of the Mycobacterium terrae complex are slow-growing, non-chromogenic acid-fast bacilli found in the natural environment and occasionally in clinical material. These genetically closely-related members are difficult to differentiate by conventional phenotypic and molecular tests. In this paper we describe the use of whole genome data for the identification of four strains genetically similar to Mycobacterium sp. JDM601, a newly identified member of the M. terrae complex. Phylogenetic information from the alignment of genome-wide orthologous genes and single nucleotide polymorphisms show consistent clustering of the four strains together with M. sp. JDM601 into a distinct clade separate from other rapid and slow growing mycobacterial species. More detailed inter-strain comparisons using average nucleotide identity, tetra-nucleotide frequencies and analysis of synteny indicate that our strains are closely related to but not of the same species as M. sp. JDM601. Besides the 16S rRNA signature described previously for the M. terrae complex, five more hypothetical proteins were found that are potentially useful for the rapid identification of mycobacterial species belonging to the M. terrae complex. This paper illustrates the versatile utilization of whole genome data for the delineation of new bacterial species and introduces four new genomospecies to add to current members in the M. terrae complex.	[Ngeow, Yun Fong; Wong, Yan Ling; Tan, Joon Liang; Ng, Hien Fuh] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Hong, Kar Wai; Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia; [Ong, Bee Lee] Univ Putra Malaysia, Fac Vet Med, Serdang 43400, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia	Ngeow, YF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	yunngeow@yahoo.com	Tan, Joon Liang/M-4291-2019; Chan, Kok Gan/B-8347-2010; HONG, Kar Wai/G-4465-2012; NGEOW, YUN FONG/B-9237-2010; Tan, Joon Liang/K-6377-2015; Ong, Bee Lee/I-2254-2016	Tan, Joon Liang/0000-0002-8241-1879; Chan, Kok Gan/0000-0002-1883-1115; HONG, Kar Wai/0000-0002-3489-9056; Tan, Joon Liang/0000-0002-8241-1879; Ong, Bee Lee/0000-0003-4663-4327; Ngeow, Yun Fong/0000-0002-1011-762X	High Impact Research, University of Malaya, Kuala Lumpur, Malaysia [UM.C/625/1/HIR/MOHE/CHAN/14/4, H50001-00-A000038]	High Impact Research, University of Malaya, Kuala Lumpur, Malaysia	This work was supported by research grant UM.C/625/1/HIR/MOHE/CHAN/14/4 (account number: H50001-00-A000038) from the High Impact Research (http://www.hir.um.edu.my/), University of Malaya, Kuala Lumpur, Malaysia. YFN received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cloud JL, 2006, INT J SYST EVOL MICR, V56, P1413, DOI 10.1099/ijs.0.64194-0; Dai JL, 2011, J CLIN MICROBIOL, V49, P2296, DOI 10.1128/JCM.02602-10; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; KAZDA J, 1993, INT J SYST BACTERIOL, V43, P352, DOI 10.1099/00207713-43-2-352; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882, DOI 10.1128/JCM.31.11.2882-2889.1993; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; KUBICA G P, 1970, International Journal of Systematic Bacteriology, V20, P161; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee H, 2010, MICROBIOL IMMUNOL, V54, P46, DOI 10.1111/j.1348-0421.2009.00184.x; Lin J, 2000, GENOME RES, V10, P808, DOI 10.1101/gr.10.6.808; Masaki T, 2006, MICROBIOL IMMUNOL, V50, P889, DOI 10.1111/j.1348-0421.2006.tb03865.x; Milne B W, 2009, J Orthop Surg (Hong Kong), V17, P103; Mun HS, 2008, INT J SYST EVOL MICR, V58, P641, DOI 10.1099/ijs.0.65374-0; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ong BL, 2013, EPIDEMIOL INFECT, V141, P1481, DOI 10.1017/S0950268813000265; RICHMOND L, 1950, AM REV TUBERC PULM, V62, P632; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Smith DS, 2000, CLIN INFECT DIS, V30, P444, DOI 10.1086/313693; STAHL DA, 1990, J BACTERIOL, V172, P116, DOI 10.1128/JB.172.1.116-124.1990; Takahashi M, 2009, GENOMICS, V93, P525, DOI 10.1016/j.ygeno.2009.01.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TASLER GRW, 1981, VET PATHOL, V18, P122, DOI 10.1177/030098588101800115; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Tortoli E, 2013, INT J SYST EVOL MICR, V63, P401, DOI 10.1099/ijs.0.038737-0; Tortoli E, 2012, INFECT GENET EVOL, V12, P827, DOI 10.1016/j.meegid.2011.05.025; TSUKAMURA M, 1983, MICROBIOL IMMUNOL, V27, P219, DOI 10.1111/j.1348-0421.1983.tb03585.x; Zhang ZY, 2013, CLIN MICROBIOL INFEC, V19, P91, DOI 10.1111/j.1469-0691.2012.03818.x; Zhang ZY, 2011, J BACTERIOL, V193, P4300, DOI 10.1128/JB.05291-11; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	48	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120789	10.1371/journal.pone.0120789	http://dx.doi.org/10.1371/journal.pone.0120789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830768	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600041
J	De Martino, D; Mori, M; Parisi, V				De Martino, Daniele; Mori, Matteo; Parisi, Valerio			Uniform Sampling of Steady States in Metabolic Networks: Heterogeneous Scales and Rounding	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECONSTRUCTION; MODELS; SPACES	The uniform sampling of convex polytopes is an interesting computational problem with many applications in inference from linear constraints, but the performances of sampling algorithms can be affected by ill-conditioning. This is the case of inferring the feasible steady states in models of metabolic networks, since they can show heterogeneous time scales. In this work we focus on rounding procedures based on building an ellipsoid that closely matches the sampling space, that can be used to define an efficient hit-and-run (HR) Markov Chain Monte Carlo. In this way the uniformity of the sampling of the convex space of interest is rigorously guaranteed, at odds with non markovian methods. We analyze and compare three rounding methods in order to sample the feasible steady states of metabolic networks of three models of growing size up to genomic scale. The first is based on principal component analysis (PCA), the second on linear programming (LP) and finally we employ the Lovazs ellipsoid method (LEM). Our results show that a rounding procedure dramatically improves the performances of the HR in these inference problems and suggest that a combination of LEM or LP with a subsequent PCA perform the best. We finally compare the distributions of the HR with that of two heuristics based on the Artificially Centered hit-andrun (ACHR), gpSampler and optGpSampler. They show a good agreement with the results of the HR for the small network, while on genome scale models present inconsistencies.	[De Martino, Daniele] CLNS, IIT, I-00185 Rome, Italy; [Mori, Matteo; Parisi, Valerio] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy	Sapienza University Rome	De Martino, D (corresponding author), CLNS, IIT, Ple A Moro 2, I-00185 Rome, Italy.	daniele.demartino@roma1.infn.it	de martino, daniele/L-6519-2017; De Martino, Daniele/GQA-9589-2022; Mori, Matteo/Q-6717-2018; Parisi, Valerio/B-1492-2008	Mori, Matteo/0000-0002-6263-8021; De Martino, Daniele/0000-0002-5214-4706	DREAM Seed Project of the Italian Institute of Technology (IIT)	DREAM Seed Project of the Italian Institute of Technology (IIT)	This work is supported by the DREAM Seed Project of the Italian Institute of Technology (IIT). The IIT Platform Computation is gratefully acknowledged.	Abordbar N, 2010, MOL SYS BIO, V6, P422; Massucci FA, 2013, METABOLITES, V3, P838, DOI 10.3390/metabo3030838; Alu-Pentini F, 1985, ANNU REV AUTOMAT PR, V13, P19; Ball K., 1997, FLAVORS GEOMETRY, P31; Bland RG, 1981, OPER RES, V29, P1039, DOI [10.1287/opre.29.6.1039, DOI 10.1287/0PRE.29.6.1039]; Braunstein A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-240; De Martino D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052108; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Kapfer S, 2013, SAMPLING POLYTOPE HA; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Kolmogorov AN, 1933, G IST ITAL ATTURI, V4, P8391; Krauth W, 1998, LECT NOTES PHYS, V501, P1; Krzakala F, 2011, PHYS REV X, V2; Lovasz L, 1999, MATH PROGRAM, V86, P443, DOI 10.1007/s101070050099; Lovasz L, 1992, FDN COMPUT SCI, P482; Lovazs L, 1986, CBMS NSF C S SIAM, P50; Lubini M, 2012, MON NOT R ASTRON SOC, V425, P3077, DOI 10.1111/j.1365-2966.2012.21673.x; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Megchelenbrink W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086587; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; Simonovits M, 2003, MATH PROGRAM, V97, P337, DOI 10.1007/s10107-003-0447-x; SMITH RL, 1984, OPER RES, V32, P1296, DOI 10.1287/opre.32.6.1296; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; TURCHIN VF, 1971, THEOR PROBAB APPL+, V16, P720, DOI 10.1137/1116083	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122670	10.1371/journal.pone.0122670	http://dx.doi.org/10.1371/journal.pone.0122670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849140	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800156
J	Di Giacomo, C; Vanella, L; Sorrenti, V; Santangelo, R; Barbagallo, I; Calabrese, G; Genovese, C; Mastrojeni, S; Ragusa, S; Acquaviva, R				Di Giacomo, Claudia; Vanella, Luca; Sorrenti, Valeria; Santangelo, Rosa; Barbagallo, Ignazio; Calabrese, Giovanna; Genovese, Carlo; Mastrojeni, Silvana; Ragusa, Salvatore; Acquaviva, Rosaria			Effects of Tithonia diversifolia (Hemsl.) A. Gray Extract on Adipocyte Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AY DIABETIC MICE; NF-KAPPA-B; HEME OXYGENASE-1; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; SESQUITERPENE LACTONES; LIPID-ACCUMULATION; HYDROGEN-PEROXIDE; ADIPOSE-TISSUE	Tithonia diversifolia (Hemsl.) A. Gray (Asteraceae) is widely used in traditional medicine. There is increasing interest on the in vivo protective effects of natural compounds contained in plants against oxidative damage caused from reactive oxygen species. In the present study the total phenolic and flavonoid contents of aqueous, methanol and dichloromethane extracts of leaves of Tithonia diversifolia (Hemsl.) A. Gray were determined; furthermore, free radical scavenging capacity of each extract and the ability of these extracts to inhibit in vitro plasma lipid peroxidation were also evaluated. Since oxidative stress may be involved in trasformation of pre-adipocytes into adipocytes, to test the hypothesis that Tithonia extract may also affect adipocyte differentiation, human mesenchymal stem cell cultures were treated with Tithonia diversifolia aqueous extract and cell viability, free radical levels, Oil-Red O staining and western bolt analysis for heme oxygenase and 5'-adenosine mono-phoshate-activated protein kinase were carried out. Results obtained in the present study provide evidence that Tithonia diversifolia (Hemsl.) A. Gray exhibits interesting health promoting properties, resulting both from its free radical scavenger capacity and also by induction of protective cellular systems involved in cellular stress defenses and in adipogenesis of mesenchymal cells.	[Di Giacomo, Claudia; Vanella, Luca; Sorrenti, Valeria; Santangelo, Rosa; Barbagallo, Ignazio; Acquaviva, Rosaria] Univ Catania, Dept Drug Sci, Biochem Sect, Catania, Italy; [Calabrese, Giovanna] IOM Ric SRL, Catania, Italy; [Genovese, Carlo; Mastrojeni, Silvana] Univ Catania, Dept Biomed Sci, Microbiol Sect, Catania, Italy; [Ragusa, Salvatore] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Catania; Magna Graecia University of Catanzaro	Acquaviva, R (corresponding author), Univ Catania, Dept Drug Sci, Biochem Sect, Catania, Italy.	racquavi@unict.it	Sorrenti, Valeria/AAC-6099-2022; Acquaviva, Rosaria/A-6750-2018; GENOVESE, Carlo/D-7837-2012; Vanella, Luca/J-7354-2016	Acquaviva, Rosaria/0000-0002-3139-1177; GENOVESE, Carlo/0000-0003-2463-9047; Vanella, Luca/0000-0002-6314-6029; Calabrese, Giovanna/0000-0003-1937-5403; Di Giacomo, Claudia/0000-0002-2665-0007; Barbagallo, Ignazio/0000-0002-7761-0662	IOM Ricerca SRL	IOM Ricerca SRL	IOM Ricerca SRL provided support in the form of salaries for author GC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Acquaviva R, 2005, CURR NEUROVASC RES, V2, P141, DOI 10.2174/1567202053586820; Acquaviva R, 2013, MOLECULES, V18, P3241, DOI 10.3390/molecules18033241; Acquaviva R, 2013, NAT PROD RES, V27, P475, DOI 10.1080/14786419.2012.695364; Acquaviva R, 2012, INT J ONCOL, V41, P31, DOI 10.3892/ijo.2012.1428; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Ballard TS, 2010, FOOD CHEM, V120, P1185, DOI 10.1016/j.foodchem.2009.11.063; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Chagas-Paula DA, 2012, CHEM BIODIVERS, V9, P210, DOI 10.1002/cbdv.201100019; Cho HS, 2008, NEUROTOXICOLOGY, V29, P656, DOI 10.1016/j.neuro.2008.03.004; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; CRUSE I, 1988, J BIOL CHEM, V263, P3348; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; Goffin E, 2002, PLANTA MED, V68, P543, DOI 10.1055/s-2002-32552; Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011; Gu JQ, 2002, J NAT PROD, V65, P532, DOI 10.1021/np010545m; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Imhoff BR, 2011, CELL MOL BIOL LETT, V16, P149, DOI 10.2478/s11658-010-0042-0; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim SK, 2010, CHEM-BIOL INTERACT, V186, P24, DOI 10.1016/j.cbi.2010.04.003; Kuroda M, 2007, CHEM PHARM BULL, V55, P1240, DOI 10.1248/cpb.55.1240; LAUTIER D, 1992, CARCINOGENESIS, V13, P227, DOI 10.1093/carcin/13.2.227; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee MY, 2011, J AGR FOOD CHEM, V59, P2347, DOI 10.1021/jf105003n; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Miura T, 2005, BIOL PHARM BULL, V28, P2152, DOI 10.1248/bpb.28.2152; Miura T, 2002, AM J CHINESE MED, V30, P81, DOI 10.1142/S0192415X02000090; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Novo G, 2011, TRANSL RES, V157, P285, DOI 10.1016/j.trsl.2011.01.003; Owoyele VB, 2004, J ETHNOPHARMACOL, V90, P317, DOI 10.1016/j.jep.2003.10.010; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; RAJU VS, 1994, BBA-GENE STRUCT EXPR, V1217, P273, DOI 10.1016/0167-4781(94)90286-0; Rungeler P, 1998, PLANTA MED, V64, P588, DOI 10.1055/s-2006-957527; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sacerdoti D, 2005, CELL MOL BIOL, V51, P363, DOI 10.1170/T639; Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811; Scapagnini G, 2002, MOL PHARMACOL, V61, P554, DOI 10.1124/mol.61.3.554; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Siedle B, 2004, J MED CHEM, V47, P6042, DOI 10.1021/jm049937r; Sorisky A, 1999, CRIT REV CL LAB SCI, V36, P1, DOI 10.1080/10408369991239169; Tona L, 2000, PHYTOMEDICINE, V7, P31, DOI 10.1016/S0944-7113(00)80019-7; TRAKSHEL GM, 1989, J BIOL CHEM, V264, P1323; Tyrrell R, 1999, FREE RADICAL RES, V31, P335, DOI 10.1080/10715769900300901; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Volti GL, 2008, WORLD J GASTROENTERO, V14, P6122, DOI 10.3748/wjg.14.6122; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Yuan HD, 2010, BIOSCI BIOTECH BIOCH, V74, P322, DOI 10.1271/bbb.90651; Zhao GJ, 2012, FITOTERAPIA, V83, P1590, DOI 10.1016/j.fitote.2012.09.007; Zhou Y, 2009, BIOL PHARM BULL, V32, P993, DOI 10.1248/bpb.32.993; Zhu YZ, 2004, NAT PROD REP, V21, P478, DOI 10.1039/b304821g	72	25	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122320	10.1371/journal.pone.0122320	http://dx.doi.org/10.1371/journal.pone.0122320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848759	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800118
J	Lee, S; Gregor, J; Kennel, SJ; Osborne, DR; Wall, J				Lee, Sanghyeb; Gregor, Jens; Kennel, Stephen J.; Osborne, Dustin R.; Wall, Jonathan			GATE Validation of Standard Dual Energy Corrections in Small Animal SPECT-CT	PLOS ONE			English	Article								This paper addresses I-123 and I-125 dual isotope SPECT imaging, which can be challenging because of spectrum overlap in the low energy spectrums of these isotopes. We first quantify the contribution of low-energy photons from each isotope using GATE-based Monte Carlo simulations for the MOBY mouse phantom. We then describe and analyze a simple, but effective method that uses the ratio of detected low and high energy I-123 activity to separate the mixed low energy I-123 and I-125 activities. Performance is compared with correction methods used in conventional tissue biodistribution techniques. The results indicate that the spectrum overlap effects can be significantly reduced, if not entirely eliminated, when attenuation and scatter is either absent or corrected for using standard methods. In particular, we show that relative activity levels of the two isotopes can be accurately estimated for a wide range of organs and provide quantitative validation that standard methods for spectrum overlap correction provide reasonable estimates for reasonable corrections in smallanimal SPECT/CT imaging.	[Lee, Sanghyeb; Gregor, Jens] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA; [Lee, Sanghyeb; Kennel, Stephen J.; Osborne, Dustin R.; Wall, Jonathan] Univ Tennessee, Grad Sch Med, Dept Radiol, Knoxville, TN 37920 USA; [Kennel, Stephen J.; Wall, Jonathan] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37920 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Osborne, DR (corresponding author), Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA.	dosborne@utmck.edu	Osborne, Dustin R/B-1585-2012	Osborne, Dustin R/0000-0003-1324-5464; Wall, Jonathan/0000-0002-5516-8578	National Institutes of Health [1R01DK079984]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was sponsored by the National Institutes of Health under grant 1R01DK079984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du Y, 2003, IEEE T NUCL SCI, V50, P1556, DOI 10.1109/TNS.2003.817404; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Lee S, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00058; Mok GSP, 2009, IEEE T NUCL SCI, V56, P2636, DOI 10.1109/TNS.2009.2023444; Ogawa K, IEEE T MED IMAGING, P10; Salmon L, 1961, NUCL INSTRUMENTS MET, V14, DOI [10.1016/0029-554X(61)90071-4, DOI 10.1016/0029-554X(61)90071-4]; Song X, 2004, IEEE T NUCL SCI, V51, P72, DOI 10.1109/TNS.2003.823017; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066181; Wall JS, 2012, MOL IMAGING BIOL, V14, P402, DOI 10.1007/s11307-011-0524-0; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Wall JS, 2005, AMYLOID, V12, P149, DOI 10.1080/13506120500222359	12	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122780	10.1371/journal.pone.0122780	http://dx.doi.org/10.1371/journal.pone.0122780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849544	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800160
J	Pulito, C; Terrenato, I; Di Benedetto, A; Korita, E; Goeman, F; Sacconi, A; Biagioni, F; Blandino, G; Strano, S; Muti, P; Mottolese, M; Falvo, E				Pulito, Claudio; Terrenato, Irene; Di Benedetto, Anna; Korita, Etleva; Goeman, Frauke; Sacconi, Andrea; Biagioni, Francesca; Blandino, Giovanni; Strano, Sabrina; Muti, Paola; Mottolese, Marcella; Falvo, Elisabetta			Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas	PLOS ONE			English	Article							CYP24A1 EXPRESSION; GENE POLYMORPHISMS; VDR GENE; RISK; PROGRESSION; ASSOCIATION; GROWTH; METAANALYSIS; MECHANISMS; PREVENTION	Vitamin D plays a role in cancer development and acts through the vitamin D receptor (VDR). It regulates the action of hormone responsive genes and is involved in cell cycle regulation, differentiation and apoptosis. VDR is a critical component of the vitamin D pathway and different common single nucleotide polymorphisms have been identified. Cdx2 VDR polymorphism can play an important role in breast cancer, modulating the activity of VDR. The objective of this study is to assess the relationship between the Cdx2 VDR polymorphism and the activities of VDR in human breast cancer cell lines and carcinomas breast patients. Cdx2 VDR polymorphism and antiproliferative effects of vitamin D treatment were investigated in a panel of estrogen receptor-positive (MCF7 and T-47D) and estrogen receptor-negative (MDA-MB-231, SUM 159PT, SK-BR-3, BT549, MDA-MB-468, HCC1143, BT20 and HCC1954) human breast cancer cell lines. Furthermore, the potential relationship among Cdx2 VDR polymorphism and a number of biomarkers used in clinical management of breast cancer was assessed in an ad hoc set of breast cancer cases. Vitamin D treatment efficacy was found to be strongly dependent on the Cdx2 VDR status in ER-negative breast cancer cell lines tested. In our series of breast cancer cases, the results indicated that patients with variant homozygote AA were associated with bio-pathological characteristics typical of more aggressive tumours, such as ER negative, HER2 positive and G3. Our results may suggest a potential effect of Cdx2 VDR polymorphism on the efficacy of vitamin D treatment in aggressive breast cancer cells (estrogen receptor negative). These results suggest that Cdx2 polymorphism may be a potential biomarker for vitamin D treatment in breast cancer, independently of the VDR receptor expression.	[Pulito, Claudio; Korita, Etleva; Strano, Sabrina] Regina Elena Inst Canc Res, Mol Chemoprevent Unit, Rome, Italy; [Terrenato, Irene] Regina Elena Inst Canc Res, Dept Epidemiol, Rome, Italy; [Di Benedetto, Anna; Mottolese, Marcella] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Goeman, Frauke; Sacconi, Andrea; Biagioni, Francesca; Blandino, Giovanni] Regina Elena Inst Canc Res, Translat Oncogen Unit, Rome, Italy; [Muti, Paola] McMaster Univ, Dept Oncol, Juravinski Canc Ctr, Hamilton, ON L8V 5C2, Canada; [Falvo, Elisabetta] Regina Elena Inst Canc Res, Lab Pharmacogen, Area Mol Med, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; McMaster University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Falvo, E (corresponding author), CNR Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy.	elisabettafalvo@libero.it	Goeman, Frauke/GVS-9135-2022; Biagioni, Francesca/AAH-2618-2019; Muti, Paola/AAD-9108-2020; sacconi, andrea/J-3669-2018; Terrenato, Irene/B-1308-2017; Strano, Sabrina/K-9654-2016; Goeman, Frauke/K-9307-2016; pulito, claudio/K-6713-2016	sacconi, andrea/0000-0002-8276-0438; Terrenato, Irene/0000-0002-0187-9323; Goeman, Frauke/0000-0002-7803-8821; pulito, claudio/0000-0002-0921-6962; Di Benedetto, Anna/0000-0002-9853-8671; Falvo, Elisabetta/0000-0001-9584-8669; strano, sabrina/0000-0002-6341-4230; Biagioni, Francesca/0000-0002-1529-6313	Progetto oncologico di medicina molecolare tumori femminili - IEO/Ministero della salute [RF-IEO-2007-1128384]	Progetto oncologico di medicina molecolare tumori femminili - IEO/Ministero della salute	This study was supported by the Progetto oncologico di medicina molecolare tumori femminili RF-IEO-2007-1128384 (to P.M. and G.B.) awarded by IEO/Ministero della salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1994; Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; Bortman P, 2002, BRAZ J MED BIOL RES, V35, P1, DOI 10.1590/S0100-879X2002000100001; Brozyna AA, 2014, INT J MOL SCI, V15, P19000, DOI 10.3390/ijms151019000; Brozyna AA, 2014, ANTICANCER RES, V34, P2735; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; BURAS RR, 1994, BREAST CANCER RES TR, V31, P191, DOI 10.1007/BF00666153; Chen WY, 2005, CANCER EPIDEM BIOMAR, V14, P2335, DOI 10.1158/1055-9965.EPI-05-0283; Colston KW, 2008, BEST PRACT RES CL EN, V22, P587, DOI 10.1016/j.beem.2008.08.002; Colston KW, 2002, ENDOCR-RELAT CANCER, V9, P45, DOI 10.1677/erc.0.0090045; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; ELSTNER E, 1995, CANCER RES, V55, P2822; Flanagan L, 2003, J STEROID BIOCHEM, V84, P181, DOI 10.1016/S0960-0760(03)00028-1; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Garcia-Martin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065487; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Huang J, 2013, MOL BIOL REP, V40, P4219, DOI 10.1007/s11033-013-2503-9; Huang QQ, 2014, ASIAN PAC J CANCER P, V15, P847, DOI 10.7314/APJCP.2014.15.2.847; Kostner K, 2009, ANTICANCER RES, V29, P3511; Krishnan AV, 2012, STEROIDS, V77, P1107, DOI 10.1016/j.steroids.2012.06.005; Krishnan AV, 2010, ENDOCRIN METAB CLIN, V39, P401, DOI 10.1016/j.ecl.2010.02.011; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lopes N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3178; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; Marsh S, 2005, METH MOL B, V311, P97; McCullough ML, 2009, ANNU REV NUTR, V29, P111, DOI 10.1146/annurev-nutr-080508-141248; Muti P, 2011, OMICS, V15, P337, DOI 10.1089/omi.2010.0086; Peng XJ, 2007, CARCINOGENESIS, V28, P1000, DOI 10.1093/carcin/bgl230; REMMELE W, 1987, PATHOLOGE, V8, P138; Rose AAN, 2013, BREAST CANCER RES TR, V141, P331, DOI 10.1007/s10549-013-2713-9; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Swami S, 2010, CLIN CANCER RES, V6, P3371; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Tavassoli FA, 2003, WHO PATHOLOGY GENETI; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Wang D, 2013, TUMOR BIOL, V34, P3509, DOI 10.1007/s13277-013-0929-2; Welsh J, 2012, ARCH BIOCHEM BIOPHYS, V523, P107, DOI 10.1016/j.abb.2011.10.019; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zhou ZC, 2013, TUMOR BIOL, V34, P3437, DOI 10.1007/s13277-013-0919-4; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	45	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124894	10.1371/journal.pone.0124894	http://dx.doi.org/10.1371/journal.pone.0124894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849303	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800277
J	Su, Y; Blazey, TM; Snyder, AZ; Raichle, ME; Hornbeck, RC; Aldea, P; Morris, JC; Benzinger, TLS				Su, Yi; Blazey, Tyler M.; Snyder, Abraham Z.; Raichle, Marcus E.; Hornbeck, Russ C.; Aldea, Patricia; Morris, John C.; Benzinger, Tammie L. S.			Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; GRAPHICAL ANALYSIS; COMPARTMENTAL ANALYSIS; COGNITIVE IMPAIRMENT; C-11 FLUMAZENIL; PRION DISEASE; HUMAN BRAIN; PET DATA	Amyloid PET imaging is an indispensable tool widely used in the investigation, diagnosis and monitoring of Alzheimer's disease (AD). Currently, a reference region based approach is used as the mainstream quantification technique for amyloid imaging. This approach assumes the reference region is amyloid free and has the same tracer influx and washout kinetics as the regions of interest. However, this assumption may not always be valid. The goal of this work is to evaluate an amyloid imaging quantification technique that uses arterial region of interest as the reference to avoid potential bias caused by specific binding in the reference region. 21 participants, age 58 and up, underwent Pittsburgh compound B (PiB) PET imaging and MR imaging including a time-of-flight (TOF) MR angiography (MRA) scan and a structural scan. FreeSurfer based regional analysis was performed to quantify PiB PET data. Arterial input function was estimated based on coregistered TOF MRA using a modeling based technique. Regional distribution volume (V-T) was calculated using Logan graphical analysis with estimated arterial input function. Kinetic modeling was also performed using the estimated arterial input function as a way to evaluate PiB binding (DVRkinetic) without a reference region. As a comparison, Logan graphical analysis was also performed with cerebellar cortex as reference to obtain DVRREF. Excellent agreement was observed between the two distribution volume ratio measurements (r>0.89, ICC>0.80). The estimated cerebellum V-T was in line with literature reported values and the variability of cerebellum V-T in the control group was comparable to reported variability using arterial sampling data. This study suggests that image-based arterial input function is a viable approach to quantify amyloid imaging data, without the need of arterial sampling or a reference region. This technique can be a valuable tool for amyloid imaging, particularly in population where reference normalization may not be accurate.	[Su, Yi; Blazey, Tyler M.; Snyder, Abraham Z.; Raichle, Marcus E.; Hornbeck, Russ C.; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Su, Yi; Hornbeck, Russ C.; Aldea, Patricia; Morris, John C.; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr ADRC, St Louis, MO 63110 USA; [Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Su, Y (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	suy@mir.wustl.edu	Benzinger, Tammie/L-6104-2013	Benzinger, Tammie/0000-0002-8114-0552; Su, Yi/0000-0002-1946-8063	Knight Alzheimer's Disease Research Center; Washington University Institute of Clinical and Translational Sciences Pilot Grant by the Clinical and Translational Science Award (CTSA) program of National Institute of Health [UL1TR000448]; McDonnell Center for Systems Neuroscience New Resource Proposal award; National Institute of Neurological Disorders and Stroke [P30NS048056, P01NS080675]; National Institute of Ageing [P01AG026276, U19AG032438, P50AG005681, P01AG003991]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048056, P01NS080675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681, U19AG032438, P01AG026276] Funding Source: NIH RePORTER	Knight Alzheimer's Disease Research Center; Washington University Institute of Clinical and Translational Sciences Pilot Grant by the Clinical and Translational Science Award (CTSA) program of National Institute of Health; McDonnell Center for Systems Neuroscience New Resource Proposal award; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YS received funds from the Knight Alzheimer's Disease Research Center (http://knightadrc.wustl.edu/) pilot award, Washington University Institute of Clinical and Translational Sciences (http://icts.wustl.edu/) Pilot Grant supported by the Clinical and Translational Science Award (CTSA) program (https://www.ctsacentral.org/) of National Institute of Health (http://www.nih.gov/): UL1TR000448, McDonnell Center for Systems Neuroscience (http://centerserv.wustl.edu/) New Resource Proposal award; AZS received fund from National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/): P30NS048056; MER received fund from National Institute of Neurological Disorders and Stroke: P01NS080675; JCM and TLSB received funds from National Institute of Ageing (http://www.nia.nih.gov/): P01AG026276, U19AG032438, P50AG005681, P01AG003991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Aisen PS, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt2; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benzinger TL, 2014, P NATL ACAD SCI US; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Croteau E, 2010, EUROPEAN J NUCL MED; Derdeyn CP, 1999, RADIOLOGY, V212, P499, DOI 10.1148/radiology.212.2.r99au27499; Edison P, 2012, NEUROIMAGE, V60, P1716, DOI 10.1016/j.neuroimage.2012.01.099; Edison P, 2009, NEUROIMAGE, V48, P329, DOI 10.1016/j.neuroimage.2009.06.079; El Fakhri G, 2005, J NUCL MED, V46, P1264; Fang YHD, 2008, J NUCL MED, V49, P606, DOI 10.2967/jnumed.107.047613; Feng D, 1997, IEEE Trans Inf Technol Biomed, V1, P243, DOI 10.1109/4233.681168; HAJNAL JV, 1995, J COMPUT ASSIST TOMO, V19, P289, DOI 10.1097/00004728-199503000-00022; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; HOUSTON AS, 1984, PHYS MED BIOL, V29, P1109, DOI 10.1088/0031-9155/29/9/007; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Joshi A, 2009, NEUROIMAGE, V46, P154, DOI 10.1016/j.neuroimage.2009.01.057; Kaufer DI, 2008, ALZHEIMERS DEMANTIA, V4, pT290; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; Koeppe RA, 1997, J CEREBR BLOOD F MET, V17, P919, DOI 10.1097/00004647-199709000-00001; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lippa CF, 1996, NEUROLOGY, V46, P406, DOI 10.1212/WNL.46.2.406; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Lowe VJ, 2009, J NUCL MED, V50, P878, DOI 10.2967/jnumed.108.058529; Mann DMA, 2001, AM J PATHOL, V158, P2165, DOI 10.1016/S0002-9440(10)64688-3; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Mead S, 2006, BRAIN, V129, P2297, DOI 10.1093/brain/awl226; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Mourik JEM, 2008, NEUROIMAGE, V39, P1041, DOI 10.1016/j.neuroimage.2007.10.022; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Sitek A, 2002, IEEE T MED IMAGING, V21, P216, DOI 10.1109/42.996340; Su Y, 2008, PHYS MED BIOL, V53, P5899, DOI 10.1088/0031-9155/53/21/001; Su Y, 2007, IEEE NUCL SCI CONF R, P4481, DOI 10.1109/NSSMIC.2007.4437106; Su Y, 2007, PHYS MED BIOL, V52, P2313, DOI 10.1088/0031-9155/52/8/018; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073377; Su Y, 2013, J CEREBR BLOOD F MET, V33, P115, DOI 10.1038/jcbfm.2012.143; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; WATANABE R, 1993, NEUROPATH APPL NEURO, V19, P253, DOI 10.1111/j.1365-2990.1993.tb00435.x; Wilson DL, 1999, IEEE T MED IMAGING, V18, P938, DOI 10.1109/42.811277; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Zanotti-Fregonara P, 2009, J CEREBR BLOOD F MET, V29, P1825, DOI 10.1038/jcbfm.2009.93; Zanotti-Fregonara P, 2009, J NUCL MED, V50, P461, DOI 10.2967/jnumed.108.059642	53	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122920	10.1371/journal.pone.0122920	http://dx.doi.org/10.1371/journal.pone.0122920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849581	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800174
J	Suyundikov, A; Stevens, JR; Corcoran, C; Herrick, J; Wolff, RK; Slattery, ML				Suyundikov, Anvar; Stevens, John R.; Corcoran, Christopher; Herrick, Jennifer; Wolff, Roger K.; Slattery, Martha L.			Accounting for Dependence Induced by Weighted KNN Imputation in Paired Samples, Motivated by a Colorectal Cancer Study	PLOS ONE			English	Article							MISSING VALUE ESTIMATION; SUPPRESSOR; MICRORNAS; VALUES	Missing data can arise in bioinformatics applications for a variety of reasons, and imputation methods are frequently applied to such data. We are motivated by a colorectal cancer study where miRNA expression was measured in paired tumor-normal samples of hundreds of patients, but data for many normal samples were missing due to lack of tissue availability. We compare the precision and power performance of several imputation methods, and draw attention to the statistical dependence induced by K-Nearest Neighbors (KNN) imputation. This imputation-induced dependence has not previously been addressed in the literature. We demonstrate how to account for this dependence, and show through simulation how the choice to ignore or account for this dependence affects both power and type I error rate control.	[Suyundikov, Anvar; Stevens, John R.; Corcoran, Christopher] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA; [Herrick, Jennifer; Wolff, Roger K.; Slattery, Martha L.] Univ Utah, Sch Med, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84108 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; University of Utah	Stevens, JR (corresponding author), Utah State Univ, Dept Math & Stat, 3900 Old Main Hill, Logan, UT 84322 USA.	john.r.stevens@usu.edu		Herrick, Jennifer/0000-0001-9257-8843	National Institutes of Health [1R01CA163683-01A1]; NATIONAL CANCER INSTITUTE [R01CA163683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Institutes of Health, award number 1R01CA163683-01A1; MLS principal investigator, with subaward to JRS.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; [Anonymous], 1908, BIOMETRIKA, V6, P1; Batista G, 2001, ARG S ART INT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bo TH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh026; Bolstad BM, 2004, THESIS U CALIFORNIA; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Duda P. E., 1973, HART PATTERN CLASSIF; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Jonsson P, 2004, 10TH INTERNATIONAL SYMPOSIUM ON SOFTWARE METRICS, PROCEEDINGS, P108, DOI 10.1109/METRIC.2004.1357895; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Kim KY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-160; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Little R.J.A., 2002, STAT ANAL MISSING DA; Michael MZ, 2003, MOL CANCER RES, V1, P882; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Oh S, 2011, BIOINFORMATICS, V27, P78, DOI 10.1093/bioinformatics/btq613; Ouyang M, 2004, BIOINFORMATICS, V20, P917, DOI 10.1093/bioinformatics/bth007; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Schafer JL, 2010, ANAL INCOMPLETE MULT; Seber G., 2003, LINEAR REGRESSION AN; Stevens JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-281; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Visalakshi NK, 2009, INT J SOFT COMPUT, V4, P168; Yang LD, 2009, WORLD J SURG, V33, P638, DOI 10.1007/s00268-008-9865-5; Yuan Y, 2010, MULTIPLE IMPUTATION	30	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119876	10.1371/journal.pone.0119876	http://dx.doi.org/10.1371/journal.pone.0119876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849489	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800016
J	Ashida, G; Funabiki, K; Kretzberg, J				Ashida, Go; Funabiki, Kazuo; Kretzberg, Jutta			Minimal Conductance-Based Model of Auditory Coincidence Detector Neurons	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; MEDIAL SUPERIOR OLIVE; TO-NOISE RATIO; BRAIN-STEM; NUCLEUS-LAMINARIS; PHASE-LOCKING; SOUND LOCALIZATION; BARN OWL; PRINCIPAL NEURONS; FIRE MODELS	Sound localization is a fundamental sensory function of a wide variety of animals. The interaural time difference (ITD), an important cue for sound localization, is computed in the auditory brainstem. In our previous modeling study, we introduced a two-compartment Hodgkin-Huxley type model to investigate how cellular and synaptic specializations may contribute to precise ITD computation of the barn owl's auditory coincidence detector neuron. Although our model successfully reproduced fundamental physiological properties observed in vivo, it was unsuitable for mathematical analyses and large scale simulations because of a number of nonlinear variables. In the present study, we reduce our former model into three types of conductance-based integrate-and-fire (IF) models. We test their electrophysiological properties using data from published in vivo and in vitro studies. Their robustness to parameter changes and computational efficiencies are also examined. Our numerical results suggest that the single-compartment active IF model is superior to other reduced models in terms of physiological reproducibility and computational performance. This model will allow future theoretical studies that use more rigorous mathematical analysis and network simulations.	[Ashida, Go; Kretzberg, Jutta] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Oldenburg, Germany; [Funabiki, Kazuo] Osaka Biosci Inst, Syst Biol, Suita, Osaka 565, Japan	Carl von Ossietzky Universitat Oldenburg	Ashida, G (corresponding author), Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Oldenburg, Germany.	go.ashida@uni-oldenburg.de		Ashida, Go/0000-0002-8886-1213	Cluster of Excellence "Hearing4all" at the University of Oldenburg; US-JAPAN Brain Research Cooperative Program	Cluster of Excellence "Hearing4all" at the University of Oldenburg; US-JAPAN Brain Research Cooperative Program	This work was supported by the Cluster of Excellence "Hearing4all" at the University of Oldenburg (GA, JK), by Grant-in-Aid for Scientific Research (B) (KF), and the US-JAPAN Brain Research Cooperative Program (KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu A, 2010, THE D PROGRAMMING LA; Ashida G, 2010, FRONT CELL NEUROSCI, V4, P100; Ashida G, 2007, J NEUROPHYSIOL, V97, P2267, DOI 10.1152/jn.00399.2006; Ashida G, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00151; Ashida G, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00102; Ashida G, 2011, CURR OPIN NEUROBIOL, V21, P745, DOI 10.1016/j.conb.2011.05.008; Aviel Y, 2003, NEURAL COMPUT, V15, P1321, DOI 10.1162/089976603321780290; Borgers C, 2013, SIAM J SCI COMPUT, V35, pB623, DOI 10.1137/120883657; Boettcher FA, 2002, J SPEECH LANG HEAR R, V45, P1249, DOI 10.1044/1092-4388(2002/100); Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brughera AR, 1996, AUDIT NEUROSCI, V2, P219; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; BUGMANN G, 1991, NETWORK-COMP NEURAL, V2, P489, DOI 10.1088/0954-898X/2/4/010; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Carr CE, 2009, J NEUROSCI, V29, P7978, DOI 10.1523/JNEUROSCI.6154-08.2009; CARR CE, 1993, J COMP NEUROL, V334, P337, DOI 10.1002/cne.903340302; CARR CE, 1993, BRAIN RES, V628, P330, DOI 10.1016/0006-8993(93)90975-S; CARR CE, 1990, J NEUROSCI, V10, P3227; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Fischer BJ, 2011, P NATL ACAD SCI USA, V108, P18138, DOI 10.1073/pnas.1108921108; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Funabiki K, 2011, J NEUROSCI, V31, P15245, DOI 10.1523/JNEUROSCI.2127-11.2011; Gai Y, 2009, J NEUROPHYSIOL, V102, P3447, DOI 10.1152/jn.00538.2009; Gedeon T, 2004, J MATH BIOL, V49, P577, DOI 10.1007/s00285-004-0268-4; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W, 2002, SPIKING NEURON MODEL; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Golding NL, 2012, J PHYSIOL-LONDON, V590, P5563, DOI 10.1113/jphysiol.2012.229328; Golomb D, 1999, P NATL ACAD SCI USA, V96, P13480, DOI 10.1073/pnas.96.23.13480; Grau-Serrat V, 2003, BIOL CYBERN, V89, P388, DOI 10.1007/s00422-003-0444-4; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Herz AVM, 2006, SCIENCE, V314, P80, DOI 10.1126/science.1127240; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; KEENER JP, 1981, SIAM J APPL MATH, V41, P503, DOI 10.1137/0141042; Kempter R, 1998, NEURAL COMPUT, V10, P1987, DOI 10.1162/089976698300016945; Khurana S, 2011, J NEUROSCI, V31, P8936, DOI 10.1523/JNEUROSCI.1079-11.2011; Klump GM, 2000, SPR HDB AUD, V13, P249; Koppl C, 2008, BIOL CYBERN, V98, P541, DOI 10.1007/s00422-008-0220-6; KONISHI M, 1993, SCI AM, V268, P66, DOI 10.1038/scientificamerican0493-66; Koppl C, 1997, J NEUROSCI, V17, P3312; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Kuokkanen PT, 2010, J NEUROPHYSIOL, V104, P2274, DOI 10.1152/jn.00395.2010; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; Mathews PJ, 2010, NAT NEUROSCI, V13, P601, DOI 10.1038/nn.2530; Mc Laughlin M, 2010, J NEUROSCI, V30, P13472, DOI 10.1523/JNEUROSCI.0294-10.2010; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; Pena JL, 1996, J NEUROSCI, V16, P7046; Rathouz M, 1998, J NEUROPHYSIOL, V80, P2824, DOI 10.1152/jn.1998.80.6.2824; REYES AD, 1994, J NEUROSCI, V14, P5352; Reyes AD, 1996, J NEUROSCI, V16, P993; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; Rotter S, 1999, BIOL CYBERN, V81, P381, DOI 10.1007/s004220050570; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Svirskis G, 2003, NETWORK-COMP NEURAL, V14, P137, DOI 10.1088/0954-898X/14/1/308; Svirskis G, 2002, J NEUROSCI, V22, P11019; van der Heijden M, 2013, NEURON, V78, P936, DOI 10.1016/j.neuron.2013.04.028; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; Zhou Y, 2005, J NEUROSCI, V25, P3046, DOI 10.1523/JNEUROSCI.3064-04.2005	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122796	10.1371/journal.pone.0122796	http://dx.doi.org/10.1371/journal.pone.0122796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844803	Green Submitted, Green Published, gold			2022-12-27	WOS:000352475700014
J	Zhang, CF; Dai, LS; Wang, L; Qian, C; Wei, GQ; Li, J; Zhu, BJ; Liu, CL				Zhang, Congfen; Dai, Lishang; Wang, Lei; Qian, Cen; Wei, Guoqing; Li, Jun; Zhu, Baojian; Liu, Chaoliang			Inhibitors of Eicosanoid Biosynthesis Influencing the Transcripts Level of sHSP21.4 Gene Induced by Pathogen Infections, in Antheraea pernyi	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; IMMUNE-RESPONSE; SILKWORM; EXPRESSION; LOCALIZATION; INVOLVEMENT	Small heat shock proteins (sHSPs) can regulate protein folding and protect cells from stress. To investigate the role of sHSPs in the silk-producing insect Antheraea pernyi response to microorganisms, a sHsp gene termed as Ap-sHSP21.4, was identified. This gene encoded a 21.4 kDa protein which shares the conserved structure of insect sHsps and belongs to sHSP21.4 family. Ap-sHSP21.4 was highly expressed in fat body and up-regulated in midgut and fat body of Antheraea pernyi challenged with Escherichia coli, Beauveria bassiana and nuclear polyhedrosis virus (NPV), which was determined by quantitative real-time PCR. Meanwhile, knock down of Ap-sHSP21.4 with dsRNA result in the decrease at the expression levels of several immune response-related genes (defensin, Dopa decarboxylase, Toll1, lysozyme and Kazal-type serine protease inhibitor). Additionally, the impact of eicosanoid biosynthesis on the expression of Ap-sHSP21.4 response to NPV was determined using qPCR, inhibitors of eicosanoid biosynthesis significantly suppress Ap-HSP21.4 expression upon NPV challenge. All together, Ap-sHSP21.4 was involved in the immunity of Antheraea pernyi against microorganism and possibly mediated by eicosanoids pathway. These results will shed light in the understanding of the pathogen-host interaction in Antheraea pernyi.	[Zhang, Congfen; Dai, Lishang; Wang, Lei; Qian, Cen; Wei, Guoqing; Li, Jun; Zhu, Baojian; Liu, Chaoliang] Anhui Agr Univ, Coll Life Sci, Hefei 230036, Anhui, Peoples R China; [Zhang, Congfen] Wannan Med Coll, Dept Pharmacol, Wuhu 241002, Anhui, Peoples R China	Anhui Agricultural University; Wannan Medical College	Zhu, BJ (corresponding author), Anhui Agr Univ, Coll Life Sci, Hefei 230036, Anhui, Peoples R China.	zhubaojian@ahau.edu.cn; clliu@ahau.edu.cn	Zhu, Baojian/ABG-4522-2021		earmarked fund for modern Argo-industry Technology Research System [CARS-22 SYZ10]; Anhui High Schools Natural Science Foundation [KJ2013B320]; National 863 plans projects of China [2011AA100306]; Sericulture Biotechnology Innovation Team [2013xkdt-05]; Ph.D. programs in Biochemistry and Molecular Biology [xk2013042]	earmarked fund for modern Argo-industry Technology Research System; Anhui High Schools Natural Science Foundation; National 863 plans projects of China(National High Technology Research and Development Program of China); Sericulture Biotechnology Innovation Team; Ph.D. programs in Biochemistry and Molecular Biology	This work was supported by the earmarked fund for modern Argo-industry Technology Research System (CARS-22 SYZ10), Anhui High Schools Natural Science Foundation (KJ2013B320), National 863 plans projects of China (2011AA100306), Sericulture Biotechnology Innovation Team (2013xkdt-05), Ph.D. programs in Biochemistry and Molecular Biology (xk2013042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; ARRIGO AP, 1981, MOL GEN GENET, V184, P73, DOI 10.1007/BF00271198; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bundey S, 2003, ARCH INSECT BIOCHEM, V52, P183, DOI 10.1002/arch.10081; Buyukguzel E, 2007, J INSECT PHYSIOL, V53, P99, DOI 10.1016/j.jinsphys.2006.10.012; Carton Y, 2002, J PARASITOL, V88, P405, DOI 10.1645/0022-3395(2002)088[0405:DIOTCI]2.0.CO;2; Chen KK, 2014, DEV COMP IMMUNOL, V45, P1, DOI 10.1016/j.dci.2014.01.017; Durmus Y, 2008, J INSECT PHYSIOL, V54, P17, DOI 10.1016/j.jinsphys.2007.03.019; Harlow E., 1999, USING ANTIBODIES LAB; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Kokolakis G, 2008, INSECT MOL BIOL, V17, P699, DOI 10.1111/j.1365-2583.2008.00840.x; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Kristensen N.P., 1999, Lepidoptera: Moths and Butterflies. 1. Handbook of Zoology, Vol. IV, part 35. New York: De Gruyter, P7; Li J, 2012, MOL BIOL REP, V39, P3915, DOI 10.1007/s11033-011-1170-y; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Liang D, 2007, MOL MED, V13, P229, DOI 10.2119/2007-00004.Liang; Liu QN, 2013, J INSECT PHYSIOL, V59, P848, DOI 10.1016/j.jinsphys.2013.06.001; Liu ZH, 2012, CELL STRESS CHAPERON, V17, P539, DOI 10.1007/s12192-012-0330-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mikkelsen UR, 2013, EUR J APPL PHYSIOL, V113, P1883, DOI 10.1007/s00421-013-2606-y; Morishima I, 1997, FEBS LETT, V419, P83, DOI 10.1016/S0014-5793(97)01418-X; Park JA, 2012, CELL IMMUNOL, V279, P117, DOI 10.1016/j.cellimm.2012.11.005; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Sakano D, 2006, BIOSCI BIOTECH BIOCH, V70, P2443, DOI 10.1271/bbb.60176; Stanley David, 2012, Insects, V3, P492, DOI 10.3390/insects3020492; Stanley David, 2011, Front Endocrinol (Lausanne), V2, P105, DOI 10.3389/fendo.2011.00105; Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x; StanleySamuelson DW, 1997, COMP BIOCHEM PHYS A, V118, P93, DOI 10.1016/S0300-9629(96)00447-1; STANLEYSAMUELSON DW, 1991, P NATL ACAD SCI USA, V88, P1064, DOI 10.1073/pnas.88.3.1064; Surajit SARKAR, 2011, [Frontiers in Biology, 生物学前沿], V6, P312; Tang T, 2012, J INSECT PHYSIOL, V58, P1226, DOI 10.1016/j.jinsphys.2012.06.007; VELAZQUEZ JM, 1980, CELL, V20, P679, DOI 10.1016/0092-8674(80)90314-1; Wei ZJ, 2011, MOL BIOL REP, V38, P1121, DOI 10.1007/s11033-010-0209-9; Yang JH, 2014, CELL STRESS CHAPERON, V19, P33, DOI 10.1007/s12192-013-0432-0; Zhou J, 2006, FOOD CHEM TOXICOL, V44, P1123, DOI 10.1016/j.fct.2006.01.009	35	21	24	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121296	10.1371/journal.pone.0121296	http://dx.doi.org/10.1371/journal.pone.0121296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844646	Green Submitted, Green Published, gold			2022-12-27	WOS:000352475700005
J	Lanini, S; Costa, AN; Puro, V; Procaccio, F; Grossi, PA; Vespasiano, F; Ricci, A; Vesconi, S; Ison, MG; Carmeli, Y; Ippolito, G				Lanini, Simone; Costa, Alessandro Nanni; Puro, Vincenzo; Procaccio, Francesco; Grossi, Paolo Antonio; Vespasiano, Francesca; Ricci, Andrea; Vesconi, Sergio; Ison, Michael G.; Carmeli, Yehuda; Ippolito, Giuseppe		Donor-Recipient Infection DRIn Col	Incidence of Carbapenem-Resistant Gram Negatives in Italian Transplant Recipients: A Nationwide Surveillance Study	PLOS ONE			English	Article							INFECTION; PNEUMONIAE; ENTEROBACTERIACEAE; PREVALENCE; CARE	Background Bacterial infections remain a challenge to solid organ transplantation. Due to the alarming spread of carbapenem-resistant gram negative bacteria, these organisms have been frequently recognized as cause of severe infections in solid organ transplant recipients. Methods and Findings Between 15 May and 30 September 2012 we enrolled 887 solid organ transplant recipients in Italy with the aim to describe the epidemiology of gram negative bacteria spreading, to explore potential risk factors and to assess the effect of early isolation of gram negative bacteria on recipients' mortality during the first 90 days after transplantation. During the study period 185 clinical isolates of gram negative bacteria were reported, for an incidence of 2.39 per 1000 recipient-days. Positive cultures for gram negative bacteria occurred early after transplantation (median time 26 days; incidence rate 4.33, 1.67 and 1.14 per 1,000 recipient- days in the first, second and third month after SOT, respectively). Forty-nine of these clinical isolates were due to carbapenem-resistant gram negative bacteria (26.5%; incidence 0.63 per 1000 recipient-days). Carbapenems resistance was particularly frequent among Klebsiella spp. isolates (49.1%). Recipients with longer hospital stay and those who received either heart or lung graft were at the highest risk of testing positive for any gram negative bacteria. Moreover recipients with longer hospital stay, lung recipients and those admitted to hospital for more than 48h before transplantation had the highest probability to have culture(s) positive for carbapenem-resistant gram negative bacteria. Forty-four organ recipients died (0.57 per 1000 recipient-days) during the study period. Recipients with at least one positive culture for carbapenem-resistant gram negative bacteria had a 10.23-fold higher mortality rate than those who did not. Conclusion The isolation of gram-negative bacteria is most frequent among recipient with hospital stays >48 hours prior to transplant and in those receiving either heart or lung transplants. Carbapenem-resistant gram negative isolates are associated with significant mortality.	[Lanini, Simone; Puro, Vincenzo; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol & Preclin Res, Rome, Italy; [Costa, Alessandro Nanni; Procaccio, Francesco; Vespasiano, Francesca; Ricci, Andrea] Italian Natl Inst Hlth ISS, Italian Natl Transplant Ctr, Rome, Italy; [Grossi, Paolo Antonio] Univ Insubria, Osped Circolo, Dept Surg & Morphol Sci, Div Infect Dis, Varese, Italy; [Vesconi, Sergio] Direz Gen Salute Lombardia, Reg Lombardia, Milan, Italy; [Ison, Michael G.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA; [Ison, Michael G.] Northwestern Univ, Feinberg Sch Med, Div Organ Transplantat, Chicago, IL 60611 USA; [Carmeli, Yehuda] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Lab Mol Epidemiol & Antibiot Res, IL-69978 Tel Aviv, Israel	IRCCS Lazzaro Spallanzani; Istituto Superiore di Sanita (ISS); Ospedale Circolo & Fondazione Macchi; University of Insubria; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Lanini, S (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol & Preclin Res, Rome, Italy.	simone.lanini@inmi.it	Vespasiano, Francesca/AFO-2093-2022; Grossi, Paolo Antonio/A-6158-2013; Ippolito, Giuseppe/J-7207-2017; Vespasiano, Francesca/G-5970-2015; Lanini, Simone/C-7523-2012	Grossi, Paolo Antonio/0000-0003-2883-5061; Vespasiano, Francesca/0000-0002-3820-1508; Lanini, Simone/0000-0002-6743-4001; Ippolito, Giuseppe/0000-0002-1076-2979; Ricci, Andrea/0000-0001-8824-4867; puro, vincenzo/0000-0003-0291-4490	Italian Health Ministry; Ricerca Corrente "Lazzaro Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS	Italian Health Ministry(Ministry of Health, Italy); Ricerca Corrente "Lazzaro Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS	This study has been funded by the Italian Health Ministry (CCM 2012 program) and by Ricerca Corrente "Lazzaro Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS.	Ariza-Heredia EJ, 2012, TRANSPL INFECT DIS, V14, P229, DOI 10.1111/j.1399-3062.2012.00742.x; Bergamasco MD, 2012, TRANSPL INFECT DIS, V14, P198, DOI 10.1111/j.1399-3062.2011.00688.x; Burguete SR, 2013, RESPIROLOGY, V18, P22, DOI 10.1111/j.1440-1843.2012.02196.x; Chaparro C, 2001, AM J RESP CRIT CARE, V163, P43, DOI 10.1164/ajrccm.163.1.9811076; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; European Centre for Disease Prevention and Control, 2011, ANT RES SURV EUR 201; European Centre for Disease Prevention and Control, 2013, CARB PROD BACT EUR I; Fishman JA, 2009, AM J TRANSPLANT, V9, pS3, DOI 10.1111/j.1600-6143.2009.02887.x; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Giani T, 2013, EUROSURVEILLANCE, V18, pe22; Joe H, 2008, COMPUT STAT DATA AN, V52, P5066, DOI 10.1016/j.csda.2008.05.002; Kalpoe JS, 2012, LIVER TRANSPLANT, V18, P468, DOI 10.1002/lt.23374; Lanini S, 2009, INFECT CONT HOSP EP, V30, P659, DOI 10.1086/597596; Pham AD, 2013, ANN THORAC SURG, V96, P596, DOI 10.1016/j.athoracsur.2013.04.023; Raviv Y, 2012, CLIN TRANSPLANT, V26, pE388, DOI 10.1111/j.1399-0012.2012.01671.x; Speich R, 2001, CLIN INFECT DIS, V33, pS58, DOI 10.1086/320906; Stata Multilevel mixed-effects Poisson regression (QR decomposition), 2013, STATA MULTILEVEL MIX, P258; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; Venettoni Sante, 2007, Ann Ist Super Sanita, V43, P279; Wszola M, 2013, TRANSPLANTATION, V95, P878, DOI 10.1097/TP.0b013e318281b953	20	44	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123706	10.1371/journal.pone.0123706	http://dx.doi.org/10.1371/journal.pone.0123706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835018	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000149
J	Swain, R; Berger, A; Bongard, J; Hines, P				Swain, Robert; Berger, Alex; Bongard, Josh; Hines, Paul			Participation and Contribution in Crowdsourced Surveys	PLOS ONE			English	Article								This paper identifies trends within and relationships between the amount of participation and the quality of contributions in three crowdsourced surveys. Participants were asked to perform a collective problem solving task that lacked any explicit incentive: they were instructed not only to respond to survey questions but also to pose new questions that they thought might-if responded to by others-predict an outcome variable of interest to them. While the three surveys had very different outcome variables, target audiences, methods of advertisement, and lengths of deployment, we found very similar patterns of collective behavior. In particular, we found that: the rate at which participants submitted new survey questions followed a heavy-tailed distribution; the distribution in the types of questions posed was similar; and many users posed non-obvious yet predictive questions. By analyzing responses to questions that contained a built-in range of valid response we found that less than 0.2% of responses lay outside of those ranges, indicating that most participants tend to respond honestly to surveys of this form, even without explicit incentives for honesty. While we did not find a significant relationship between the quantity of participation and the quality of contribution for both response submissions and question submissions, we did find several other more nuanced participant behavior patterns, which did correlate with contribution in one of the three surveys. We conclude that there exists an optimal time for users to pose questions early on in their participation, but only after they have submitted a few responses to other questions. This suggests that future crowdsourced surveys may attract more predictive questions by prompting users to pose new questions at specific times during their participation and limiting question submission at non-optimal times.	[Swain, Robert] Univ Vermont, Comp Sci Dept Grad, Burlington, VT 05405 USA; [Berger, Alex] Univ Vermont, Sch Business Adm, Burlington, VT USA; [Bongard, Josh] Univ Vermont, Dept Comp Sci, Burlington, VT USA; [Hines, Paul] Univ Vermont, Sch Engn, Burlington, VT USA; [Bongard, Josh; Hines, Paul] Univ Vermont, Ctr Complex Syst, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont; University of Vermont	Hines, P (corresponding author), Univ Vermont, Comp Sci Dept Grad, Burlington, VT 05405 USA.	paul.hines@uvm.edu			National Science Foundation Integrative Graduate Education and Research Traineeship program at the University of Vermont [1144388]; Div Of Electrical, Commun & Cyber Sys [1254549] Funding Source: National Science Foundation	National Science Foundation Integrative Graduate Education and Research Traineeship program at the University of Vermont; Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	RS: National Science Foundation Integrative Graduate Education and Research Traineeship program at the University of Vermont Grant #1144388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKER A, 2012, THE 8TH INT CONF ON, P1456; Banzhaf W, 1998, GENETIC PROGRAMMING, V1; Bevelander KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087756; Bongard JC, 2013, IEEE T SYST MAN CY-S, V43, P176, DOI 10.1109/TSMCA.2012.2195168; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Callison-Burch C, 2010, P NAACL HLT 2010 WOR, P1; Castillo M, 2013, AM J NEURORADIOL, V34, P1863, DOI 10.3174/ajnr.A3417; Chandler D, 2013, J ECON BEHAV ORGAN, V90, P123, DOI 10.1016/j.jebo.2013.03.003; Doan A, 2011, COMMUN ACM, V54, P86, DOI 10.1145/1924421.1924442; Downs JS, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2399; Fang Wu, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P409, DOI 10.1109/CSE.2009.430; Heer J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P203; Howe J., 2006, WIRED MAG, V14, P1; Hsueh P.Y., 2009, P NAACL HLT WORKSH A, P27, DOI DOI 10.3115/1564131.1564137; Kazai G, 2011, LECT NOTES COMPUT SC, V6611, P165, DOI 10.1007/978-3-642-20161-5_17; Kittur A, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P453; Marge M, 2010, INT CONF ACOUST SPEE, P5270, DOI 10.1109/ICASSP.2010.5494979; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Nam KK, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P779; Nielsen Jakob, 2006, PARTICIPATION INEQUA; Rogers F, 2009, WHITE PAPERS; Schmidt M., 2013, EUREQA VERSION 0 98; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sorokin A, 2008, URBANA, V51, P820; Van Mieghem P, 2011, IEEE T MULTIMEDIA, V13, P1404, DOI 10.1109/TMM.2011.2165054; Voss J, 2005, PROC OF THE 10TH INT; Zaidan Omar, 2011, P 49 ANN M ASS COMP, P1220; Zook M, 2010, WORLD MED HEALTH POL, V2, P7, DOI 10.2202/1948-4682.1069	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120521	10.1371/journal.pone.0120521	http://dx.doi.org/10.1371/journal.pone.0120521			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837602	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000023
J	Timrott, K; Vondran, FWR; Bektas, H; Klempnauer, J; Jager, MD				Timrott, Kai; Vondran, Florian W. R.; Bektas, Hueseyin; Klempnauer, Juergen; Jaeger, Mark D.			Application of Allogeneic Bone Marrow Cells in View of Residual Alloreactivity: Sirolimus but Not Cyclosporine Evolves Tolerogenic Properties	PLOS ONE			English	Article							MIXED CHIMERISM; TRANSPLANTATION TOLERANCE; ALLOGRAFT TOLERANCE; T-CELLS; IMMUNOLOGICAL-TOLERANCE; THYMOCYTE MATURATION; RAPAMYCIN; RAT; INDUCTION; APOPTOSIS	Background Application of bone marrow cells (BMC) is a promising strategy for tolerance induction, but usually requires strong depletion of the host immune system. This study evaluates the ability of immunosuppressants to evolve tolerogenic properties of BMC in view of residual alloreactivity. Methods The rat model used a major histocompatibility complex (MHC) class II disparate bone marrow transplantation (BMT) setting (LEW.1AR1 (RT1(auu))-> LEW.1AR2 (RT1(aau))). Heart grafts (LEW.1WR1 (RT1(uua))) were disparate for the complete MHC to recipients and for MHC class I to BMC donors. Limited conditioning was performed by total body irradiation of 6 Gy. Cyclosporine (CsA) or Sirolimus (Srl) were administered for 14 or 28 days. Transplantation of heart grafts (HTx) was performed at day 16 or at day 100 after BMT. Chimerism and changes in the T cell pool were detected by flow cytometry. Results Mixed chimeras accepted HTx indefinitely, although the composition of the regenerated T cell pool was not changed to a basically donor MHC class II haplotype. Non-chimeric animals rejected HTx spontaneously. BMC recipients, who received HTx during T cell recovery at day 16, accepted HTx only after pre-treatment with Srl, although chimerism was lost. CsA pre-treatment led to accelerated HTx rejection as did isolated application of BMC. Conclusion Srl evolves tolerogenic properties of allogeneic BMC to achieve indefinite acceptance of partly MHC disparate HTx despite residual alloreactivity and in particular loss of chimerism.	[Timrott, Kai; Vondran, Florian W. R.; Bektas, Hueseyin; Klempnauer, Juergen; Jaeger, Mark D.] Klin Allgemein Viszeral & Transplantat Chirurg, Med Hsch, Hannover, Germany		Timrott, K (corresponding author), Klin Allgemein Viszeral & Transplantat Chirurg, Med Hsch, Hannover, Germany.	timrott.kai@mh-hannover.de						Abraham RT, 1998, CURR OPIN IMMUNOL, V10, P330, DOI 10.1016/S0952-7915(98)80172-6; Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Bektas H, 2005, J HEART LUNG TRANSPL, V24, P614, DOI 10.1016/j.healun.2004.01.016; Buhler LH, 2002, TRANSPLANTATION, V74, P1405, DOI 10.1097/01.TP.0000034627.37442.A4; Coenen JJA, 2006, BLOOD, V107, P1018, DOI 10.1182/blood-2005-07-3032; Damoiseaux JGMC, 2002, SCAND J IMMUNOL, V56, P353, DOI 10.1046/j.1365-3083.2002.01110.x; Domenig C, 2005, J IMMUNOL, V175, P51, DOI 10.4049/jimmunol.175.1.51; FARNSWORTH A, 1988, TRANSPLANTATION, V46, P418, DOI 10.1097/00007890-198809000-00017; Fitzhugh CD, 2013, BONE MARROW TRANSPL, V48, P1335, DOI 10.1038/bmt.2013.60; Hale DA, 2002, TRANSPLANTATION, V74, P477, DOI 10.1097/00007890-200208270-00008; Homma M, 1997, TRANSPLANT P, V29, P1743, DOI 10.1016/S0041-1345(97)00039-0; Huang CA, 2000, J CLIN INVEST, V105, P173, DOI 10.1172/JCI7913; ILDSTAD ST, 1984, NATURE, V307, P168, DOI 10.1038/307168a0; Issa F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00254; Jager MD, 2001, TRANSPLANT P, V33, P176, DOI 10.1016/S0041-1345(00)01962-X; KAWAI T, 1995, TRANSPLANTATION, V59, P256, DOI 10.1097/00007890-199501270-00018; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; KLEMPNAUER J, 1989, IMMUNOGENETICS, V30, P81, DOI 10.1007/BF02421535; Ko S, 1999, NAT MED, V5, P1292, DOI 10.1038/15248; Kurtz J, 2004, TRENDS IMMUNOL, V25, P518, DOI 10.1016/j.it.2004.08.007; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LoCascio SA, 2010, TRANSPLANTATION, V90, P1607, DOI 10.1097/TP.0b013e3181ffbaff; Loren AW, 2003, BONE MARROW TRANSPL, V31, P145, DOI 10.1038/sj.bmt.1703806; LUO HY, 1994, EUR J IMMUNOL, V24, P692, DOI 10.1002/eji.1830240331; Neujahr D, 2005, CONTRIB NEPHROL, V146, P65, DOI 10.1159/000082066; Nikolic B, 1998, TRANSPLANTATION, V65, P1216, DOI 10.1097/00007890-199805150-00013; Pasquet L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00080; Powell JD, 2005, TRANSPLANTATION, V80, P1541, DOI 10.1097/01.tp.0000185299.72295.90; Sachs DH, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015529; Sachs DH, 2011, SEMIN IMMUNOL, V23, P165, DOI 10.1016/j.smim.2011.07.001; SMITH CV, 1992, TRANSPLANTATION, V53, P438; STEPKOWSKI SM, 1991, TRANSPLANTATION, V51, P22, DOI 10.1097/00007890-199101000-00002; Taniguchi H, 1995, J IMMUNOL, V155; Tian LN, 2004, TRANSPLANTATION, V77, P183, DOI 10.1097/01.TP.0000101005.44661.3E; TORRESNAGEL NE, 1994, INT IMMUNOL, V6, P1367, DOI 10.1093/intimm/6.9.1367; Umemura A, 2000, J IMMUNOL, V164, P4452, DOI 10.4049/jimmunol.164.9.4452; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Xu H, 2012, TRANSPLANTATION, V93, P469, DOI 10.1097/TP.0b013e318242bddf	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119950	10.1371/journal.pone.0119950	http://dx.doi.org/10.1371/journal.pone.0119950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836261	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000016
J	Phillips, SP; Carver, L				Phillips, Susan P.; Carver, Lisa			Early Parental Loss and Self-Rated Health of Older Women and Men: A Population-Based, Multi-Country Study	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; ADULTS; RESILIENCE; PATHWAYS; ABUSE	Objective Death of a parent in childhood can diminish both the nurturing that promotes healthy development, and household income. We consider, for the first time, whether this adverse childhood experience is associated with self-rated health decades later, among seniors and whether this lifelong effect is different for women and men. Methods The International Mobility in Aging (IMIAS) study is a prospective cohort with survey information and biophysical measures and markers from 2000 community-dwelling 65-74 year olds in Canada, Colombia, Brazil and Albania. We assessed the independent impact of death of a parent, early hunger, and witnessing violence, while controlling for current income sufficiency and other early adversities on self-rated health using baseline (2012) IMIAS data. Regressions grouping and then separating women and men were compared. Results Approximately 17% of the 1991 participants had experienced early parental loss. Overall 56% rated their health as good however parental loss predicted poorer adult health, as did early hunger but not witnessing violence. Disaggregated analyses revealed that the health consequences of parental loss were significant only among men (p = 0.000 versus p = 0.210 for women) whereas early hunger predicted poor self-rated health for both (p = 0.000). Conclusion Parental loss should be considered as a potent adverse childhood experience with life-long consequences for health. The gender difference in its effect, speaks to unidentified and modifiable traits that appear to be more common among women and that may build resilience to long-term harms of early parental death.	[Phillips, Susan P.] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Phillips, Susan P.] Umea Univ, Umea Ctr Gender Studies, Umea, Sweden; [Carver, Lisa] Queens Univ, Dept Sociol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Umea University; Queens University - Canada	Phillips, SP (corresponding author), Queens Univ, Dept Family Med, Kingston, ON, Canada.	phillip@queensu.ca		Phillips, Susan/0000-0003-4798-1742; Carver, L.F./0000-0002-7695-7939	Canadian Institutes of Health Research [108751]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (#108751). SPP a PI on grant, LC funded as research assistant (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowes L, 2013, TRAUMA VIOLENCE ABUS, V14, P195, DOI 10.1177/1524838013487807; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Crimmins EM, 2011, EUR J PUBLIC HEALTH, V21, P81, DOI 10.1093/eurpub/ckq022; Cuijpers P, 2011, CHILD ABUSE NEGLECT, V35, P937, DOI 10.1016/j.chiabu.2011.06.005; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Freire AN, 2012, J AGING HEALTH, V24, P863, DOI 10.1177/0898264312438551; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Hagan MJ, 2011, PSYCHOPHARMACOLOGY, V214, P231, DOI 10.1007/s00213-010-1889-5; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Li J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001679; Luecken LJ, 2012, SOC PERSONAL PSYCHOL, V6, P243, DOI 10.1111/j.1751-9004.2011.00422.x; Miller GE, 2011, PSYCHOL SCI, V22, P1591, DOI 10.1177/0956797611419170; Pinquart M, 2001, PSYCHOL AGING, V16, P414, DOI 10.1037//0882-7974.16.3.414; Rose SMSF, 2014, PM&R, V6, P670, DOI 10.1016/j.pmrj.2014.01.013; Singh L, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013487914; Thompson MP, 2004, AM J PUBLIC HEALTH, V94, P599, DOI 10.2105/AJPH.94.4.599; Tyrka AR, 2008, BIOL PSYCHIAT, V63, P1147, DOI 10.1016/j.biopsych.2008.01.011	22	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120762	10.1371/journal.pone.0120762	http://dx.doi.org/10.1371/journal.pone.0120762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830511	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600039
J	Shearman, JR; Sangsrakru, D; Jomchai, N; Ruang-Areerate, P; Sonthirod, C; Naktang, C; Theerawattanasuk, K; Tragoonrung, S; Tangphatsornruang, S				Shearman, Jeremy R.; Sangsrakru, Duangjai; Jomchai, Nukoon; Ruang-Areerate, Panthita; Sonthirod, Chutima; Naktang, Chaiwat; Theerawattanasuk, Kanikar; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke			SNP Identification from RNA Sequencing and Linkage Map Construction of Rubber Tree for Anchoring the Draft Genome	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; MICROCYCLUS-ULEI; LATEX YIELD; GENE; RESISTANCE; DIVERSITY; POLYMORPHISMS; INVOLVEMENT; DISCOVERY; ALIGNMENT	Hevea brasiliensis, or rubber tree, is an important crop species that accounts for the majority of natural latex production. The rubber tree nuclear genome consists of 18 chromosomes and is roughly 2.15 Gb. The current rubber tree reference genome assembly consists of 1,150,326 scaffolds ranging from 200 to 531,465 bp and totalling 1.1 Gb. Only 143 scaffolds, totalling 7.6 Mb, have been placed into linkage groups. We have performed RNA-seq on 6 varieties of rubber tree to identify SNPs and InDels and used this information to perform target sequence enrichment and high throughput sequencing to genotype a set of SNPs in 149 rubber tree offspring from a cross between RRIM 600 and RRII 105 rubber tree varieties. We used this information to generate a linkage map allowing for the anchoring of 24,424 contigs from 3,009 scaffolds, totalling 115 Mb or 10.4% of the published sequence, into 18 linkage groups. Each linkage group contains between 319 and 1367 SNPs, or 60 to 194 non-redundant marker positions, and ranges from 156 to 336 cM in length. This linkage map includes 20,143 of the 69,300 predicted genes from rubber tree and will be useful for mapping studies and improving the reference genome assembly.	[Shearman, Jeremy R.; Sangsrakru, Duangjai; Jomchai, Nukoon; Ruang-Areerate, Panthita; Sonthirod, Chutima; Naktang, Chaiwat; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke] Natl Ctr Genet Engn & Biotechnol, Khlong Luang 12120, Pathumthani, Thailand; [Theerawattanasuk, Kanikar] RRIT, Minist Agr & Cooperat, Dept Agr, Bangkok 10900, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Ministry of Agriculture & Cooperatives - Thailand	Tangphatsornruang, S (corresponding author), Natl Ctr Genet Engn & Biotechnol, 113 Thailand Sci Pk,Paholyothin Rd, Khlong Luang 12120, Pathumthani, Thailand.	sithichoke.tan@biotec.or.th	Shearman, Jeremy/F-1618-2010; Tangphatsornruang, Sithichoke/G-3633-2010	Tangphatsornruang, Sithichoke/0000-0003-2673-0012	Rubber Research Institute of Thailand (RRIT)	Rubber Research Institute of Thailand (RRIT)	Samples and funding for this work were supplied by the Rubber Research Institute of Thailand (RRIT). The funders participated in study design and data collection.	Adams M. D., 1994, AUTOMATED DNA SEQUEN; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Berthelot K, 2014, BBA-PROTEINS PROTEOM, V1844, P473, DOI 10.1016/j.bbapap.2013.10.017; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Guen V, 2007, NEW PHYTOL, V173, P335, DOI 10.1111/j.1469-8137.2006.01911.x; Le Guen V, 2011, PLANT BREEDING, V130, P294, DOI 10.1111/j.1439-0523.2010.01774.x; Le Guen V, 2003, THEOR APPL GENET, V108, P160, DOI 10.1007/s00122-003-1407-9; Le Guen V, 2011, TREE GENET GENOMES, V7, P877, DOI 10.1007/s11295-011-0381-7; Leonforte A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-161; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pootakham W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116028; Pramoolkit P, 2014, PLANT PHYSIOL BIOCH, V84, P203, DOI 10.1016/j.plaphy.2014.09.016; Priyadarshan PM, 2004, ADV GENET, V52, P51, DOI 10.1016/S0065-2660(04)52003-5; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shearman JR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-45; Silva CC, 2014, MOL BREEDING, V34, P1035, DOI 10.1007/s11032-014-0095-2; Souza LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061238; Tangphatsornruang S, 2011, GENE, V475, P104, DOI 10.1016/j.gene.2011.01.002; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Wang XC, 2013, J PROTEOME RES, V12, P5146, DOI 10.1021/pr400378c; Wang Y, 2013, PLANT PHYSIOL BIOCH, V71, P283, DOI 10.1016/j.plaphy.2013.07.020; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Webster CC, 1989, BURNT MILL HARLOW; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77	37	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121961	10.1371/journal.pone.0121961	http://dx.doi.org/10.1371/journal.pone.0121961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831195	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600093
J	Suter, RS; Pachur, T; Hertwig, R; Endestad, T; Biele, G				Suter, Renata S.; Pachur, Thorsten; Hertwig, Ralph; Endestad, Tor; Biele, Guido			The Neural Basis of Risky Choice with Affective Outcomes	PLOS ONE			English	Article							DECISION-MAKING; PROSPECT-THEORY; AFFECTIVE PSYCHOLOGY; UNCERTAINTY; REWARD; BRAIN; PROBABILITY; AVOIDANCE; REGRET; MODEL	Both normative and many descriptive theories of decision making under risk are based on the notion that outcomes are weighted by their probability, with subsequent maximization of the (subjective) expected outcome. Numerous investigations from psychology, economics, and neuroscience have produced evidence consistent with this notion. However, this research has typically investigated choices involving relatively affect-poor, monetary outcomes. We compared choice in relatively affect-poor, monetary lottery problems with choice in relatively affect-rich medical decision problems. Computational modeling of behavioral data and model-based neuroimaging analyses provide converging evidence for substantial differences in the respective decision mechanisms. Relative to affect-poor choices, affect-rich choices yielded a more strongly curved probability weighting function of cumulative prospect theory, thus signaling that the psychological impact of probabilities is strongly diminished for affect-rich outcomes. Examining task-dependent brain activation, we identified a region-by-condition interaction indicating qualitative differences of activation between affect-rich and affect-poor choices. Moreover, brain activation in regions that were more active during affect-poor choices (e.g., the supramarginal gyrus) correlated with individual trial-by-trial decision weights, indicating that these regions reflect processing of probabilities. Formal reverse inference Neurosynth meta-analyses suggested that whereas affect-poor choices seem to be based on brain mechanisms for calculative processes, affect-rich choices are driven by the representation of outcomes' emotional value and autobiographical memories associated with them. These results provide evidence that the traditional notion of expectation maximization may not apply in the context of outcomes laden with affective responses, and that understanding the brain mechanisms of decision making requires the domain of the decision to be taken into account.	[Suter, Renata S.; Pachur, Thorsten; Hertwig, Ralph] Max Planck Inst Human Dev, Ctr Adapt Rational, Berlin, Germany; [Endestad, Tor; Biele, Guido] Univ Oslo, Dept Psychol, Oslo, Norway; [Biele, Guido] Norwegian Inst Publ Hlth, Oslo, Norway	Max Planck Society; University of Oslo; Norwegian Institute of Public Health (NIPH)	Suter, RS (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rational, Berlin, Germany.	suter@mpib-berlin.mpg.de	Biele, Guido/D-2265-2011; Hertwig, Ralph/B-3468-2015; Pachur, Thorsten/AAC-7980-2019	Biele, Guido/0000-0002-4225-9024; Hertwig, Ralph/0000-0002-9908-9556; Endestad, Tor/0000-0002-4403-6887; Pachur, Thorsten/0000-0001-6391-4107	German Research Foundation [HE 2768/7-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by a grant of the German Research Foundation to RH and TP (HE 2768/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; [Anonymous], 1974, Health Education Monograph, V2, P324; Bates D, 2012, LME4 LINEAR MIXED EF; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139; Galesic M, 2009, HEALTH PSYCHOL, V28, P210, DOI 10.1037/a0014474; Goldstein WM, 1995, PSYCHOL LEARN MOTIV, V32, P83, DOI DOI 10.1016/S0079-7421(08)60308-4; Gonzalez R, 1999, COGNITIVE PSYCHOL, V38, P129, DOI 10.1006/cogp.1998.0710; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Henson R, 2006, TRENDS COGN SCI, V10, P64, DOI 10.1016/j.tics.2005.12.005; HOLM S, 1979, SCAND J STAT, V6, P65; Hsee CK, 2004, J EXP PSYCHOL GEN, V133, P23, DOI 10.1037/0096-3445.133.1.23; Hsu M, 2009, J NEUROSCI, V29, P2231, DOI 10.1523/JNEUROSCI.5296-08.2009; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Levy AG, 2005, MEM COGNITION, V33, P1399, DOI 10.3758/BF03193372; Loewenstein G, 2008, ANNU REV PSYCHOL, V59, P647, DOI 10.1146/annurev.psych.59.103006.093710; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Loomes G, 2002, J RISK UNCERTAINTY, V24, P103, DOI 10.1023/A:1014094209265; McGraw AP, 2011, ORGAN BEHAV HUM DEC, V115, P25, DOI 10.1016/j.obhdp.2011.01.004; Mellers BA, 2000, PSYCHOL BULL, V126, P910, DOI 10.1037/0033-2909.126.6.910; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nygren TE, 1996, ORGAN BEHAV HUM DEC, V66, P59, DOI 10.1006/obhd.1996.0038; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Pachur T., 2014, DECISION, V1, P64, DOI [10.1037/dec0000006, DOI 10.1037/DEC0000006]; Pachur T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00646; Pachur T, 2013, J BEHAV DECIS MAKING, V26, P260, DOI 10.1002/bdm.1757; Palminteri S, 2012, NEURON, V76, P998, DOI 10.1016/j.neuron.2012.10.017; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Qiu JY, 2011, MANAGE SCI, V57, P193, DOI 10.1287/mnsc.1100.1260; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rieskamp J, 2008, J EXP PSYCHOL LEARN, V34, P1446, DOI 10.1037/a0013646; Rottenstreich Y, 2001, PSYCHOL SCI, V12, P185, DOI 10.1111/1467-9280.00334; Rotter J.B., 1954, SOCIAL LEARNING CLIN; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SOKAL RR, 1994, BIOMETRY; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Sunstein CR, 2002, YALE LAW J, V112, P61, DOI 10.2307/1562234; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Trepel C, 2005, COGNITIVE BRAIN RES, V23, P34, DOI 10.1016/j.cogbrainres.2005.01.016; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Vroom V., 1964, WORK MOTIVATION; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	63	20	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122475	10.1371/journal.pone.0122475	http://dx.doi.org/10.1371/journal.pone.0122475			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830918	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600112
J	Takayasu, M; Sato, K; Sano, Y; Yamada, K; Miura, W; Takayasu, H				Takayasu, Misako; Sato, Kazuya; Sano, Yukie; Yamada, Kenta; Miura, Wataru; Takayasu, Hideki			Rumor Diffusion and Convergence during the 3.11 Earthquake: A Twitter Case Study	PLOS ONE			English	Article								We focus on Internet rumors and present an empirical analysis and simulation results of their diffusion and convergence during emergencies. In particular, we study one rumor that appeared in the immediate aftermath of the Great East Japan Earthquake on March 11, 2011, which later turned out to be misinformation. By investigating whole Japanese tweets that were sent one week after the quake, we show that one correction tweet, which originated from a city hall account, diffused enormously. We also demonstrate a stochastic agentbased model, which is inspired by contagion model of epidemics SIR, can reproduce observed rumor dynamics. Our model can estimate the rumor infection rate as well as the number of people who still believe in the rumor that cannot be observed directly. For applications, rumor diffusion sizes can be estimated in various scenarios by combining our model with the real data.	[Takayasu, Misako; Sato, Kazuya; Miura, Wataru; Takayasu, Hideki] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Sano, Yukie] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba, Japan; [Sano, Yukie] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Yamada, Kenta] Waseda Inst Adv Study, Shinjuku Ku, Tokyo, Japan; [Yamada, Kenta] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Yamada, Kenta] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Takayasu, Hideki] Sony Comp Sci Labs Inc, Shinagawa, Tokyo, Japan; [Takayasu, Hideki] Meiji Inst Adv Study Math Sci, Kawasaki, Kanagawa, Japan	Tokyo Institute of Technology; Nihon University; University of Tsukuba; University of Tokyo; Japan Science & Technology Agency (JST); Sony Corporation	Takayasu, M (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan.	takayasu@dis.titech.ac.jp; sano@sk.tsukuba.ac.jp	Sano, Yukie/AAD-4791-2020; Takayasu, Misako/H-9890-2014	Sano, Yukie/0000-0001-8670-1024; Takayasu, Misako/0000-0002-2467-614X	JSPS KAKENHI [24540395, 26310207, 25750130]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Number 24540395 (MT), 26310207 (MT), and 25750130 (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport GW, 1948, PSYCHOL RUMOR; [Anonymous], 2011, REPORT JAPAN MINISTR; [Anonymous], 2005, P 11 ACM SIGKDD INT, DOI DOI 10.1145/1081870.1081883; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064679; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; DiFonzo N., 2008, WATERCOOLER EFFECT I; DiFonzo N, 2013, NATURE, V493, P135, DOI 10.1038/493135a; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Ettredge M, 2005, COMMUN ACM, V48, P87, DOI 10.1145/1096000.1096010; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; GOFFMAN W, 1964, NATURE, V204, P225, DOI 10.1038/204225a0; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lu LY, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123005; Maki DP, 1973, MTH MODELS APPL EMPH; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Ni SJ, 2011, PHYSICA A, V390, P4528, DOI 10.1016/j.physa.2011.07.042; OConnor B., 2010, ICWSM, P122; Piccardi C, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026113; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Sadilek A, 2012, P 26 AAAI C ART INT, P136; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shigyo Ayako, 2011, GREAT E JAPAN EARTHQ, P28; Starbird K, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P241; Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Yamada K, UNDERSTANDING UNPUB	30	59	60	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121443	10.1371/journal.pone.0121443	http://dx.doi.org/10.1371/journal.pone.0121443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831122	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600073
J	Elmore, MRP; Lee, RJ; West, BL; Green, KN				Elmore, Monica R. P.; Lee, Rafael J.; West, Brian L.; Green, Kim N.			Characterizing Newly Repopulated Microglia in the Adult Mouse: Impacts on Animal Behavior, Cell Morphology, and Neuroinflammation	PLOS ONE			English	Article							MORRIS WATER MAZE; ALZHEIMERS-DISEASE; IMMUNE-SYSTEM; AGED MICE; BRAIN; INFLAMMATION; NEUROGENESIS; MACROPHAGES; ACTIVATION; INFECTION	Microglia are the primary immune cell in the brain and are postulated to play important roles outside of immunity. Administration of the dual colony-stimulating factor 1 receptor (CSF1R)/c-Kit kinase inhibitor, PLX3397, to adult mice results in the elimination of similar to 99% of microglia, which remain eliminated for as long as treatment continues. Upon removal of the inhibitor, microglia rapidly repopulate the entire adult brain, stemming from a central nervous system (CNS) resident progenitor cell. Using this method of microglial elimination and repopulation, the role of microglia in both healthy and diseased states can be explored. Here, we examine the responsiveness of newly repopulated microglia to an inflammatory stimulus, as well as determine the impact of these cells on behavior, cognition, and neuroinflammation. Two month-old wild-type mice were placed on either control or PLX3397 diet for 21 d to eliminate microglia. PLX3397 diet was then removed in a subset of animals to allow microglia to repopulate and behavioral testing conducted beginning at 14 d repopulation. Finally, inflammatory profiling of the microglia-repopulated brain in response to lipopolysaccharide (LPS; 0.25 mg/kg) or phosphate buffered saline (PBS) was determined 21 d after inhibitor removal using quantitative real time polymerase chain reaction (RT-PCR), as well as detailed analyses of microglial morphologies. We find mice with repopulated microglia to perform similarly to controls by measures of behavior, cognition, and motor function. Compared to control/resident microglia, repopulated microglia had larger cell bodies and less complex branching in their processes, which resolved over time after inhibitor removal. Inflammatory profiling revealed that the mRNA gene expression of repopulated microglia was similar to normal resident microglia and that these new cells appear functional and responsive to LPS. Overall, these data demonstrate that newly repopulated microglia function similarly to the original resident microglia without any apparent adverse effects in healthy adult mice.	[Elmore, Monica R. P.; Lee, Rafael J.; Green, Kim N.] Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders UCI MI, Irvine, CA 92697 USA; [West, Brian L.] Plexxikon Inc, Berkeley, CA USA	University of California System; University of California Irvine; Plexxikon	Green, KN (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders UCI MI, Irvine, CA 92697 USA.	kngreen@uci.edu		West, Brian/0000-0002-5320-3691	Plexxikon Inc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000096] Funding Source: NIH RePORTER	Plexxikon Inc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Plexxikon Inc provided support in the form of salaries for authors (to BLW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2014, J BONE MINER RES, V29, P304, DOI 10.1002/jbmr.2038; Bastos GN, 2008, NEUROSCIENCE, V155, P454, DOI 10.1016/j.neuroscience.2008.06.020; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; Burton MD, 2012, BRAIN BEHAV IMMUN, V26, P732, DOI 10.1016/j.bbi.2011.10.008; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Chitu V, 2012, BLOOD, V120, P3126, DOI 10.1182/blood-2012-04-425595; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Grafen A., 2002, MODERN STAT LIFE SCI; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; He Y., 2012, E HLTH TELECOMM SYST, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0046900; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jenkins SJ, 2014, TRENDS IMMUNOL, V35, P358, DOI 10.1016/j.it.2014.06.006; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Lamprea MR, 2008, BRAZ J MED BIOL RES, V41, P135, DOI 10.1590/S0100-879X2008000200010; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Neely KM, 2011, J NEUROSCI, V31, P2781, DOI 10.1523/JNEUROSCI.5156-10.2010; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann H, 2013, NAT NEUROSCI, V16, P253, DOI 10.1038/nn.3338; Nicholson AM, 2013, NEUROLOGY, V80, P1033, DOI 10.1212/WNL.0b013e31828726a7; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patel S, 2009, CURR TOP MED CHEM, V9, P599, DOI 10.2174/156802609789007327; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Prada CE, 2013, ACTA NEUROPATHOL, V125, P159, DOI 10.1007/s00401-012-1056-7; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Serpente M, 2014, NEUROIMMUNOMODULAT, V21, P79, DOI 10.1159/000356529; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Ueno M, 2014, CURR OPIN NEUROBIOL, V27, P8, DOI 10.1016/j.conb.2014.02.004; Varvel NH, 2012, PNAS, P2; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641	66	125	129	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122912	10.1371/journal.pone.0122912	http://dx.doi.org/10.1371/journal.pone.0122912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849463	Green Published, gold			2022-12-27	WOS:000352477800172
J	Guo, ZQ; Wang, HQ; Yang, J; Miller, DJ				Guo, Zhiqiang; Wang, Huaiqing; Yang, Jie; Miller, David J.			A Stock Market Forecasting Model Combining Two-Directional Two-Dimensional Principal Component Analysis and Radial Basis Function Neural Network	PLOS ONE			English	Article							ALGORITHM; SYSTEM	In this paper, we propose and implement a hybrid model combining two-directional two-dimensional principal component analysis ((2D)(2)PCA) and a Radial Basis Function Neural Network (RBFNN) to forecast stock market behavior. First, 36 stock market technical variables are selected as the input features, and a sliding window is used to obtain the input data of the model. Next, (2D)(2)PCA is utilized to reduce the dimension of the data and extract its intrinsic features. Finally, an RBFNN accepts the data processed by (2D)(2)PCA to forecast the next day's stock price or movement. The proposed model is used on the Shanghai stock market index, and the experiments show that the model achieves a good level of fitness. The proposed model is then compared with one that uses the traditional dimension reduction method principal component analysis (PCA) and independent component analysis (ICA). The empirical results show that the proposed model outperforms the PCA-based model, as well as alternative models based on ICA and on the multilayer perceptron.	[Guo, Zhiqiang; Yang, Jie] Wuhan Univ Technol, Key Lab Fiber Opt Sensing Technol & Informat Proc, Sch Informat Engn, Wuhan 430070, Peoples R China; [Wang, Huaiqing] South Univ Sci & Technol China, Dept Financial Math & Financial Engn, Shenzhen, Peoples R China; [Miller, David J.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA	Wuhan University of Technology; Southern University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Guo, ZQ (corresponding author), Wuhan Univ Technol, Key Lab Fiber Opt Sensing Technol & Informat Proc, Sch Informat Engn, Wuhan 430070, Peoples R China.	guozhiqiang@whut.edu.cn			National Natural Science Foundation of China [51479159]; National Natural Science Foundation of Hubei province, China [2014CFB868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei province, China	This work is partially supported by the National Natural Science Foundation of China (grant no. 51479159) and National Natural Science Foundation of Hubei province, China (grant no. 2014CFB868).	Ajith A, 2003, P INT C COMP SCI, P337; Ao SI, 2011, SOFT COMPUT, V15, P1041, DOI 10.1007/s00500-010-0580-4; Atsalakis GS, 2009, EXPERT SYST APPL, V36, P5932, DOI 10.1016/j.eswa.2008.07.006; Bartlett MS, 2002, IEEE T NEURAL NETWOR, V13, P1450, DOI 10.1109/TNN.2002.804287; Bin Sun, 2010, 2010 IEEE 17th International Conference on Industrial Engineering and Engineering Management (IE&EM2010), P424, DOI 10.1109/ICIEEM.2010.5646582; Cao Q, 2005, COMPUT OPER RES, V32, P2499, DOI 10.1016/j.cor.2004.03.015; CHEN S, 1991, IEEE T NEURAL NETWOR, V2, P302, DOI 10.1109/72.80341; Dai WS, 2012, EXPERT SYST APPL, V39, P4444, DOI 10.1016/j.eswa.2011.09.145; Ettes D., 2000, Proceedings of the IEEE/IAFE/INFORMS 2000 Conference on Computational Intelligence for Financial Engineering (CIFEr) (Cat. No.00TH8520), P22, DOI 10.1109/CIFER.2000.844591; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Guo C, 2001, SYSTEMS ENG THEORY P, V31, P1921; Guo K., 2012, J MANAGEMENT SCI CHI, V1; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; Guo ZQ, 2013, SOFT COMPUT, V17, P805, DOI 10.1007/s00500-012-0953-y; Hassan R, 2005, 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, PROCEEDINGS, P192; Haugen R. A., 1999, NEW FINANCE CASE EFF, V2nd; Hsu CW, 2003, TECHNICAL REPORT, P1; Huang CJ, 2008, EXPERT SYST APPL, V34, P2870, DOI 10.1016/j.eswa.2007.05.035; Huang L, 2006, APSCC: 2006 IEEE ASIA-PACIFIC CONFERENCE ON SERVICES COMPUTING, PROCEEDINGS, P572; Huang SC, 2010, SMART INNOV SYST TEC, V4, P163; Huang W, 2005, COMPUT OPER RES, V32, P2513, DOI 10.1016/j.cor.2004.03.016; [黄颖 HUANG Ying], 2007, [数学的实践与认识, Mathematics in Practice and Theory], V37, P23; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Kao LJ, 2013, NEUROCOMPUTING, V99, P534, DOI 10.1016/j.neucom.2012.06.037; Lam SS, 2001, IEEE C EVOL COMPUTAT, P410, DOI 10.1109/CEC.2001.934420; Los CA, 2000, ADV ECONOMETRICS, V14, P329; Lu CJ, 2010, EXPERT SYST APPL, V37, P7056, DOI 10.1016/j.eswa.2010.03.012; Powell M., 1987, RADIAL BASIS FUNCTIO; Ravi V, 2008, APPL SOFT COMPUT, V8, P305, DOI 10.1016/j.asoc.2007.02.001; Teixeira LA, 2010, EXPERT SYST APPL, V37, P6885, DOI 10.1016/j.eswa.2010.03.033; Tiantian Xie, 2011, 2011 IEEE 20th International Symposium on Industrial Electronics (ISIE 2011), P1194, DOI 10.1109/ISIE.2011.5984328; Tsai CF, 2010, DECIS SUPPORT SYST, V50, P258, DOI 10.1016/j.dss.2010.08.028; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Versace M, 2004, EXPERT SYST APPL, V27, P417, DOI 10.1016/j.eswa.2004.05.018; Wang XL, 2009, INT C MANAGE SCI ENG, P1389, DOI 10.1109/ICMSE.2009.5317961; White H., 1988, IEEE International Conference on Neural Networks (IEEE Cat. No.88CH2632-8), P451, DOI 10.1109/ICNN.1988.23959; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang Yiwen, 2000, Proceedings of the IEEE/IAFE/INFORMS 2000 Conference on Computational Intelligence for Financial Engineering (CIFEr) (Cat. No.00TH8520), P155, DOI 10.1109/CIFER.2000.844615; Yee PV, 2001, ADAPT LEARN SYST SIG; Yeh CC, 2009, 29 ANN INT S FOR HON, P21; Zhang Defu., 2004, INT C COMP INT ICCI, P392; Zhang DQ, 2005, NEUROCOMPUTING, V69, P224, DOI 10.1016/j.neucom.2005.06.004; Zorin A, 2000, P INT C TRAD INN SUS, P312	43	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122385	10.1371/journal.pone.0122385	http://dx.doi.org/10.1371/journal.pone.0122385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849483	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800124
J	Maji, P; Roy, S				Maji, Pradipta; Roy, Shaswati			Rough-Fuzzy Clustering and Unsupervised Feature Selection for Wavelet Based MR Image Segmentation	PLOS ONE			English	Article							BRAIN-TUMOR SEGMENTATION; AUTOMATIC SEGMENTATION; FEATURE-EXTRACTION; TEXTURE ANALYSIS; CLASSIFICATION; VOLUME	Image segmentation is an indispensable process in the visualization of human tissues, particularly during clinical analysis of brain magnetic resonance (MR) images. For many human experts, manual segmentation is a difficult and time consuming task, which makes an automated brain MR image segmentation method desirable. In this regard, this paper presents a new segmentation method for brain MR images, integrating judiciously the merits of rough-fuzzy computing and multiresolution image analysis technique. The proposed method assumes that the major brain tissues, namely, gray matter, white matter, and cerebrospinal fluid from the MR images are considered to have different textural properties. The dyadic wavelet analysis is used to extract the scale-space feature vector for each pixel, while the rough-fuzzy clustering is used to address the uncertainty problem of brain MR image segmentation. An unsupervised feature selection method is introduced, based on maximum relevance-maximum significance criterion, to select relevant and significant textural features for segmentation problem, while the mathematical morphology based skull stripping preprocessing step is proposed to remove the non-cerebral tissues like skull. The performance of the proposed method, along with a comparison with related approaches, is demonstrated on a set of synthetic and real brain MR images using standard validity indices.	[Maji, Pradipta; Roy, Shaswati] Indian Stat Inst, Machine Intelligence Unit, Biomed Imaging & Bioinformat Lab, Kolkata 700108, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Maji, P (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Biomed Imaging & Bioinformat Lab, 203 BT Rd, Kolkata 700108, India.	pmaji@isical.ac.in	Maji, Pradipta/AAZ-3478-2020; Maji, Pradipta/HHR-9037-2022	Maji, Pradipta/0000-0002-8288-8917; 	Indian National Science Academy, New Delhi [SP/YSP/68/2012]	Indian National Science Academy, New Delhi	This work is partially supported by the Indian National Science Academy, New Delhi (grant no. SP/YSP/68/2012). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya M, 2002, IEEE T CIRC SYST VID, V12, P1117, DOI 10.1109/TCSVT.2002.806812; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Atkins MS, 1998, IEEE T MED IMAGING, V17, P98, DOI 10.1109/42.668699; Barra V, 2000, JMRI-J MAGN RESON IM, V11, P267, DOI 10.1002/(SICI)1522-2586(200003)11:3<267::AID-JMRI5>3.0.CO;2-8; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; BEZDEK JC, 1993, MED PHYS, V20, P1033, DOI 10.1118/1.597000; BOVIK AC, 1990, IEEE T PATTERN ANAL, V12, P55, DOI 10.1109/34.41384; Bullitt E, 2003, IEEE T MED IMAGING, V22, P1163, DOI 10.1109/TMI.2003.816964; Chang T, 1993, IEEE T IMAGE PROCESS, V2, P429, DOI 10.1109/83.242353; Chen CC, 1996, PATTERN RECOGN LETT, V17, P1069, DOI 10.1016/0167-8655(96)00065-7; Clark MC, 1998, IEEE T MED IMAGING, V17, P187, DOI 10.1109/42.700731; COIFMAN RR, 1992, IEEE T INFORM THEORY, V38, P713, DOI 10.1109/18.119732; Fletcher-Heath LM, 2001, ARTIF INTELL MED, V21, P43, DOI 10.1016/S0933-3657(00)00073-7; Fukuda S, 1999, IEEE T GEOSCI REMOTE, V37, P2282, DOI 10.1109/36.789624; Gao J, 2009, 2009 IEEE INT S COMP, P1; Gibbs P, 1996, PHYS MED BIOL, V41, P2437, DOI 10.1088/0031-9155/41/11/014; Haralick R. M., 1985, Proceedings of the SPIE - The International Society for Optical Engineering, V548, P2, DOI [10.1016/S0734-189X(85)90153-7, 10.1117/12.948400]; Huang K, 2006, SIGNAL PROCESS, V86, P1410, DOI 10.1016/j.sigpro.2005.07.032; Huang K, 2008, IEEE T IMAGE PROCESS, V17, P1709, DOI 10.1109/TIP.2008.2001050; JAIN AK, 1990, 1990 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN, AND CYBERNETICS, P14, DOI 10.1016/0031-3203(91)90143-S; Joe BN, 1999, RADIOLOGY, V212, P811, DOI 10.1148/radiology.212.3.r99se22811; JUST M, 1988, MAGN RESON IMAGING, V6, P463, DOI 10.1016/0730-725X(88)90482-1; Kaus MR, 2001, RADIOLOGY, V218, P586, DOI 10.1148/radiology.218.2.r01fe44586; Krishnapuram R., 1993, IEEE Transactions on Fuzzy Systems, V1, P98, DOI 10.1109/91.227387; Lindsay RW, 1996, IEEE T GEOSCI REMOTE, V34, P771, DOI 10.1109/36.499782; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Maji P., 2012, ROUGH FUZZY PATTERN; Maji P, 2007, IEEE T SYST MAN CY B, V37, P1529, DOI 10.1109/TSMCB.2007.906578; Maji P, 2013, IEEE ACM T COMPUT BI, V10, P286, DOI 10.1109/TCBB.2012.103; Maji P, 2011, INT J APPROX REASON, V52, P408, DOI 10.1016/j.ijar.2010.09.006; Maji P, 2008, FUND INFORM, V88, P161; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Meyer FG, 2003, IEEE T MED IMAGING, V22, P933, DOI 10.1109/TMI.2003.815869; Nie JX, 2009, COMPUT MED IMAG GRAP, V33, P431, DOI 10.1016/j.compmedimag.2009.04.006; Noreen N., 2011, WORLD APPL SCI J, V13, P34; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Pal SK, 1983, PATTERN RECOGN LETT, V1, P141, DOI 10.1016/0167-8655(83)90053-3; Park JG, 2009, NEUROIMAGE, V47, P1394, DOI 10.1016/j.neuroimage.2009.04.047; Pawlak Z., 2012, ROUGH SETS THEORETIC, DOI [10.1007/978-94-011-3534-4_7, DOI 10.1007/978-94-011-3534-4]; Prastawa M, 2004, MED IMAGE ANAL, V8, P275, DOI 10.1016/j.media.2004.06.007; Prastawa M, 2003, ACAD RADIOL, V10, P1341, DOI 10.1016/S1076-6332(03)00506-3; Rangayyan RM, 2004, BIOMEDICAL IMAGE ANA; REED TR, 1990, IEEE T PATTERN ANAL, V12, P1, DOI 10.1109/34.41379; Rosenfeld A., 1982, DIGITAL PICTURE PROC; SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9; Saito N, 2002, PATTERN RECOGN, V35, P2841, DOI 10.1016/S0031-3203(02)00019-5; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Suetens P, 2002, FUNDAMENTALS OF MEDI; TURNER MR, 1986, BIOL CYBERN, V55, P71; UNSER M, 1989, IEEE T PATTERN ANAL, V11, P717, DOI 10.1109/34.192466; UNSER M, 1995, IEEE T IMAGE PROCESS, V4, P1549, DOI 10.1109/83.469936; VELTHUIZEN RP, 1995, JMRI-J MAGN RESON IM, V5, P594, DOI 10.1002/jmri.1880050520; Xie K, 2005, EUR J RADIOL, V56, P12, DOI 10.1016/j.ejrad.2005.03.028	57	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123677	10.1371/journal.pone.0123677	http://dx.doi.org/10.1371/journal.pone.0123677			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848961	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800251
J	Yang, XJ; Zhao, YW; Yang, XL; Kan, FWK				Yang, Xiaojing; Zhao, Yuewen; Yang, Xiaolong; Kan, Frederick W. K.			Recombinant Hamster Oviductin Is Biologically Active and Exerts Positive Effects on Sperm Functions and Sperm-Oocyte Binding	PLOS ONE			English	Article							BABOON PAPIO-ANUBIS; ESTROGEN-DEPENDENT GLYCOPROTEIN; ESTRUS-ASSOCIATED PROTEIN; IN-VITRO FERTILIZATION; ZONA-PELLUCIDA; GOLDEN-HAMSTER; MOLECULAR CHARACTERIZATION; TYROSINE PHOSPHORYLATION; IMMUNOCYTOCHEMICAL LOCALIZATION; ULTRASTRUCTURAL EVIDENCE	Studies carried out in several mammalian species suggest that oviductin, also known as oviduct-specific glycoprotein or OVGP1, plays a key role in sperm capacitation, fertilization, and development of early embryos. In the present study, we used recombinant DNA technology to produce, for the first time, recombinant hamster OVGP1 (rHamOVGP1) in human embryonic kidney 293 (HEK293) cells. rHamOVGP1 secreted in the culture medium was purified by affinity chromatography. The resulting protein migrated as a poly-dispersed band of 160-350 kDa on SDS-PAGE corresponding to the molecular mass of the native HamOVGP1. Subsequent mass spectrometric analysis of the purified rHamOVGP1 confirmed its identity as HamOVGP1. Immunocytochemistry demonstrated binding of rHamOVGP1 to the mid-piece and head of hamster sperm and to the zona pellucida (ZP) of ovarian oocytes. In vitro functional experiments showed that addition of rHamOVGP1 in the capacitation medium further enhanced tyrosine phosphorylation of two sperm proteins of approximately 75 kDa and 83 kDa in a time-dependent manner. After 3 hours of incubation in the presence of rHamOVGP1, a significant increase in acrosome reaction was measured. Pretreatment of either sperm or oocyte with 20 mu g/ml of rHamOVGP1 prior to sperm-egg binding assay significantly increased the number of sperm bound to the ZP. Addition of rHamOVGP1 in the medium during sperm-egg binding with either oocyte or sperm pretreated with rHamOVGP1 also saw an increase in the number of sperm bound to ZP. In all experimental conditions, the effect of rHamOVGP1 on sperm-oocyte binding was negated by the addition of monoclonal anti-HamOVGP1 antibody. The successful production and purification of a biologically active rHamOVGP1 will allow further exploration of the function of this glycoprotein in reproductive function.	[Yang, Xiaojing; Zhao, Yuewen; Kan, Frederick W. K.] Queens Univ, Fac Hlth Sci, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Yang, Xiaolong] Queens Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Kingston, ON, Canada	Queens University - Canada; McMaster University; Queens University - Canada	Kan, FWK (corresponding author), Queens Univ, Fac Hlth Sci, Dept Biomed & Mol Sci, Kingston, ON, Canada.	kanfwk@queensu.ca		Zhao, Yuewen/0000-0002-8765-1839	Discover Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC)	Discover Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by a Discover Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to FWKK.	ABE H, 1990, J EXP ZOOL, V256, P210, DOI 10.1002/jez.1402560211; Aitken RJ, 2013, MOL HUM REPROD, V19, P785, DOI 10.1093/molehr/gat067; Araki Y, 2003, BIOCHEM J, V374, P551, DOI 10.1042/BJ20030466; ARAKI Y, 1987, J REPROD IMMUNOL, V11, P193, DOI 10.1016/0165-0378(87)90057-X; ARIAS EB, 1994, BIOL REPROD, V51, P685, DOI 10.1095/biolreprod51.4.685; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Bailey JL, 2010, SYST BIOL REPROD MED, V56, P334, DOI 10.3109/19396368.2010.512377; BAVISTER BD, 1989, GAMETE RES, V23, P139, DOI 10.1002/mrd.1120230202; BOATMAN DE, 1995, BIOL REPROD, V52, P199, DOI 10.1095/biolreprod52.1.199; BOICE ML, 1990, BIOL REPROD, V43, P457, DOI 10.1095/biolreprod43.3.457; BUHI WC, 1990, BIOL REPROD, V43, P929, DOI 10.1095/biolreprod43.6.929; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; Buhi WC, 1996, BIOL REPROD, V55, P1305, DOI 10.1095/biolreprod55.6.1305; Buhi WC, 2000, CELLS TISSUES ORGANS, V166, P165, DOI 10.1159/000016731; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chow A, 2010, INT J CANCER, V126, P2079, DOI 10.1002/ijc.24878; Coy P, 2012, REPRODUCTION, V144, P649, DOI 10.1530/REP-12-0279; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; DESOUZA MM, 1995, ENDOCRINOLOGY, V136, P2485, DOI 10.1210/en.136.6.2485; Fraser LR, 2010, MOL REPROD DEV, V77, P197, DOI 10.1002/mrd.21124; Jaffe RC, 1996, BIOL REPROD, V55, P421, DOI 10.1095/biolreprod55.2.421; Jha KN, 2002, MOL REPROD DEV, V61, P258, DOI 10.1002/mrd.1155; Kan FWK, 2006, MOL REPROD DEV, V73, P756, DOI 10.1002/mrd.20459; KAN FWK, 1989, BIOL REPROD, V40, P585, DOI 10.1095/biolreprod40.3.585; KAPUR RP, 1986, J EXP ZOOL, V238, P249, DOI 10.1002/jez.1402380215; KAPUR RP, 1988, ANAT REC, V221, P720, DOI 10.1002/ar.1092210307; Killian G, 2011, J ANIM SCI, V89, P1315, DOI 10.2527/jas.2010-3349; Killian GJ, 2004, ANIM REPROD SCI, V82-3, P141, DOI 10.1016/j.anireprosci.2004.04.028; KING RS, 1994, BIOL REPROD, V51, P34, DOI 10.1095/biolreprod51.1.34; KING RS, 1994, J ANDROL, V15, P468; LEESE HJ, 1988, J REPROD FERTIL, V82, P843, DOI 10.1530/jrf.0.0820843; Lyng R, 2009, J CELL SCI, V122, P3894, DOI 10.1242/jcs.058776; MALETTE B, 1993, BIOCHEM J, V295, P437, DOI 10.1042/bj2950437; Mugnier S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-129; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; ODayBowman MB, 1996, BIOL REPROD, V54, P60, DOI 10.1095/biolreprod54.1.60; OIKAWA T, 1988, GAMETE RES, V19, P113, DOI 10.1002/mrd.1120190202; OKO R, 1988, BIOL REPROD, V39, P169, DOI 10.1095/biolreprod39.1.169; OLIPHANT G, 1984, BIOL REPROD, V31, P165, DOI 10.1095/biolreprod31.1.165; PAQUETTE Y, 1995, MOL REPROD DEV, V42, P388, DOI 10.1002/mrd.1080420404; Pradeep MA, 2011, THERIOGENOLOGY, V75, P1005, DOI 10.1016/j.theriogenology.2010.11.007; ROBITAILLE G, 1988, BIOL REPROD, V38, P687, DOI 10.1095/biolreprod38.3.687; Saccary L, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109314; SENDAI Y, 1995, BIOL REPROD, V53, P285, DOI 10.1095/biolreprod53.2.285; SENDAI Y, 1994, BIOL REPROD, V50, P927, DOI 10.1095/biolreprod50.4.927; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; Siva AB, 2006, REPROD TOXICOL, V22, P702, DOI 10.1016/j.reprotox.2006.04.013; STJACQUES S, 1988, J REPROD IMMUNOL, V12, P247, DOI 10.1016/0165-0378(88)90011-3; SUZUKI K, 1995, BIOL REPROD, V53, P345, DOI 10.1095/biolreprod53.2.345; VERHAGE HG, 1988, ENDOCRINOLOGY, V122, P1639, DOI 10.1210/endo-122-4-1639; Verhage HG, 1997, BIOL REPROD, V57, P525, DOI 10.1095/biolreprod57.3.525; VERHAGE HG, 1989, ENDOCRINOLOGY, V124, P2464, DOI 10.1210/endo-124-5-2464; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129	55	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123003	10.1371/journal.pone.0123003	http://dx.doi.org/10.1371/journal.pone.0123003			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849110	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800192
J	Zhang, J; He, J; Zeng, XH; Ge, SJ; Huang, Y; Su, J; Ding, XM; Yang, JQ; Cao, YJ; Chen, H; Zhang, YH; Zhu, BS				Zhang, Jie; He, Jing; Zeng, Xiao-Hong; Ge, Shi-Jun; Huang, Yu; Su, Jie; Ding, Xue-Mei; Yang, Ji-Qing; Cao, Yong-Jiu; Chen, Hong; Zhang, Ying-Hong; Zhu, Bao-Sheng			Genetic Heterogeneity of the beta-Globin Gene in Various Geographic Populations of Yunnan in Southwestern China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGIC SURVEY; THALASSEMIA MUTATIONS; CHAIN VARIANTS; SOUTH CHINA; PROVINCE; SPECTRUM; HEMOGLOBINOPATHIES; HAPLOTYPES; MALARIA; REGION	Objectives The aim of this study was to investigate the geographic distribution of beta-globin gene mutations in different ethnic groups in Yunnan province. Methods From 2004 to 2014, 1,441 subjects with hemoglobin disorders, identified by PCR-reverse dot blot and DNA sequencing, were studied according to ethnicity and geographic origin. Haplotypes were examined among 41 unrelated thalassemia chromosomes. Results Eighteen beta-thalassemia mutations and seven hemoglobin variants were identified for 1,616 alleles in 22 different ethnic groups from all 16 prefecture-level divisions of Yunnan. The prevalence of beta-thalassemia was heterogeneous and regionally specific. CD 41-42 (-TCTT) was the most prevalent mutation in the populations of northeastern Yunnan. CD 17 (A > T) was the most common mutation in the populations of southeastern Yunnan, especially for the Zhuang minority, whereas Hb E (CD 26, G > A) was the most prevalent mutation in populations of southwestern Yunnan, especially for the Dai minority. Among the seven types of haplotypes identified, CD 17 (A > T) was mainly linked to haplotype VII (+ - - - - - +) and IVSII-654 (C > T) was only linked to haplotype I (+ - - - - + +). Conclusion Our data underline the heterogeneity of beta-globin gene mutations in Yunnan. This distribution of beta-globin mutations in the geographic regions and ethnic populations provided a detailed ethnic basis and evolutionary view of humans in southern China, which will be beneficial for genetic counseling and prevention strategies.	[Zhang, Jie; He, Jing; Zeng, Xiao-Hong; Su, Jie; Ding, Xue-Mei; Yang, Ji-Qing; Cao, Yong-Jiu; Chen, Hong; Zhang, Ying-Hong; Zhu, Bao-Sheng] First Peoples Hosp Yunnan Prov, Genet Diag Ctr, Yunnan Prov Key Lab Birth Defects & Genet Dis, Kunming, Peoples R China; [Zhang, Jie; He, Jing; Zeng, Xiao-Hong; Su, Jie; Ding, Xue-Mei; Yang, Ji-Qing; Cao, Yong-Jiu; Chen, Hong; Zhang, Ying-Hong; Zhu, Bao-Sheng] Kunming Univ Sci & Technol, Dept Genet, Kunming, Peoples R China; [Ge, Shi-Jun] Peoples Hosp Dehong Autonam Prefecture Dai & Jing, Dept Clin Lab, Mangshi, Peoples R China; [Huang, Yu] Maternal & Child Hlth Hosp Menghai, Dept Clin Lab, Menghai, Peoples R China	Kunming University of Science & Technology	Zhu, BS (corresponding author), First Peoples Hosp Yunnan Prov, Genet Diag Ctr, Yunnan Prov Key Lab Birth Defects & Genet Dis, Kunming, Peoples R China.	bszhu@aliyun.com	Ge, Shi-Jun/U-2499-2019		Fund of National Natural Science Foundation [81260415, 30760241]; key Natural Science Foundation of Yunnan Province [2011FB164]; Natural Science Foundation of Yunnan Province [2011FB224]	Fund of National Natural Science Foundation; key Natural Science Foundation of Yunnan Province; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This study was conducted between the years 2012 and 2013 under the "the prevention and control programme of thalassemia in Yunnan". And this study was partially funded by the Fund of National Natural Science Foundation (81260415, 30760241), by key Natural Science Foundation of Yunnan Province (2011FB164), and by Natural Science Foundation of Yunnan Province (2011FB224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 1999, HUM HERED, V49, P232, DOI 10.1159/000022880; Bi Y, 2013, AM J TROP MED HYG, V88, P526, DOI 10.4269/ajtmh.2012.12-0217; CHAN V, 1987, AM J HUM GENET, V41, P678; Edison ES, 2008, CLIN GENET, V73, P331, DOI 10.1111/j.1399-0004.2008.00973.x; Flatz G, 2004, HEMOGLOBIN, V28, P197, DOI 10.1081/HEM-120040334; GIRODON E, 1992, ANN HEMATOL, V65, P188, DOI 10.1007/BF01703113; Hu Hong, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P191; Huang SW, 2013, CLIN BIOCHEM, V46, P1865, DOI 10.1016/j.clinbiochem.2013.09.014; JANKOVIC L, 1990, HEMOGLOBIN, V14, P169, DOI 10.3109/03630269009046958; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; LAIG M, 1989, HUM GENET, V84, P47, DOI 10.1007/BF00210669; Lau EHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081846; LIEINJO LE, 1989, AM J HUM GENET, V45, P971; Lin M, 2013, HEMOGLOBIN, V37, P454, DOI 10.3109/03630269.2013.807285; Nicholas Tarling, 2008, THE EARLY KINGDOMS, P168; O'Donnell A, 2009, P NATL ACAD SCI USA, V106, P18716, DOI 10.1073/pnas.0910142106; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Park SS, 2002, INT J HEMATOL, V76, P93, DOI 10.1007/BF03165096; Saetung R, 2013, SE ASIAN J TROP MED, V44, P1055; SICK K, 1967, BIOCHIM BIOPHYS ACTA, V140, P231, DOI 10.1016/0005-2795(67)90463-1; Svasti MLS, 2002, AM J HEMATOL, V71, P85, DOI 10.1002/ajh.10193; Than AM, 2005, INT J HEMATOL, V82, P119, DOI 10.1532/IJH97.05028; Tritipsombut J, 2012, HEMOGLOBIN, V36, P47, DOI 10.3109/03630269.2011.637149; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Yao HX, 2014, BLOOD CELL MOL DIS, V53, P16, DOI 10.1016/j.bcmd.2014.01.003; Yin AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089855; ZENG YT, 1987, J MED GENET, V24, P578, DOI 10.1136/jmg.24.10.578; Zhang J, 2012, HEMOGLOBIN, V36, P464, DOI 10.3109/03630269.2012.717327; ZHANG JZ, 1988, HUM GENET, V78, P37, DOI 10.1007/BF00291231	30	19	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122956	10.1371/journal.pone.0122956	http://dx.doi.org/10.1371/journal.pone.0122956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849334	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800182
J	Mascali, D; DiNuzzo, M; Gili, T; Moraschi, M; Fratini, M; Maraviglia, B; Serra, L; Bozzali, M; Giove, F				Mascali, Daniele; DiNuzzo, Mauro; Gili, Tommaso; Moraschi, Marta; Fratini, Michela; Maraviglia, Bruno; Serra, Laura; Bozzali, Marco; Giove, Federico			Intrinsic Patterns of Coupling between Correlation and Amplitude of Low-Frequency fMRI Fluctuations Are Disrupted in Degenerative Dementia Mainly due to Functional Disconnection	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; BRAIN ACTIVITY; BOLD SIGNAL; CONNECTIVITY	Low frequency fluctuations (LFFs) of the BOLD signal are a major discovery in the study of the resting brain with functional magnetic resonance imaging (fMRI). Two fMRI-based measures, functional connectivity (FC), a measure of signal synchronicity, and the amplitude of LFFs (ALFF), a measure of signal periodicity, have been proved to be sensitive to changes induced by several neurological diseases, including degenerative dementia. In spite of the increasing use of these measures, whether and how they are related to each other remains to be elucidated. In this work we used voxel-wise FC and ALFF computed in different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.073 Hz; and full-band: 0.01-0.073 Hz), in order to assess their relationship in healthy elderly as well as the relevant changes induced by Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI). We found that in healthy elderly subjects FC and ALFF are positively correlated in anterior and posterior cingulate cortex (full-band, slow-4 and slow-5), temporal cortex (full-band and slow-5), and in a set of subcortical regions (full-band and slow-4). These correlation patterns between FC and ALFF were absent in either AD or MCI patients. Notably, the loss of correlation between FC and ALFF in the AD group was primarily due to changes in FC rather than in ALFF. Our results indicate that degenerative dementia is characterized by a loss of global connection rather than by a decrease of fluctuation amplitude.	[Mascali, Daniele; DiNuzzo, Mauro; Moraschi, Marta; Fratini, Michela; Maraviglia, Bruno; Giove, Federico] Museo Stor Fis, Rome, Italy; [Mascali, Daniele; DiNuzzo, Mauro; Moraschi, Marta; Fratini, Michela; Maraviglia, Bruno; Giove, Federico] Ctr Studi & Ric Enrico Fermi, Rome, Italy; [Mascali, Daniele; DiNuzzo, Mauro] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Gili, Tommaso; Moraschi, Marta; Maraviglia, Bruno; Serra, Laura; Bozzali, Marco; Giove, Federico] Fdn Santa Lucia, IRCCS, Rome, Italy; [Fratini, Michela] Univ Roma Tre, Dipartimento Sci, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; Roma Tre University	Giove, F (corresponding author), Museo Stor Fis, Rome, Italy.	federico.giove@roma1.infn.it	Fratini, Michela/AAC-1048-2019; Giove, Federico/C-3295-2008; Bozzali, Marco/AAC-1031-2022; DiNuzzo, Mauro/D-2494-2009; Serra, Laura/K-5637-2016; Mascali, Daniele/O-1936-2015; Mascali, Daniele/AAB-7591-2019	Fratini, Michela/0000-0003-3118-4335; Giove, Federico/0000-0002-6934-3146; DiNuzzo, Mauro/0000-0003-0181-5597; Serra, Laura/0000-0002-2717-1286; Mascali, Daniele/0000-0003-1269-6060; Mascali, Daniele/0000-0003-1269-6060; Maraviglia, Bruno/0000-0003-2354-8039; Gili, Tommaso/0000-0001-9154-1758; Moraschi, Marta/0000-0003-4789-6636; Bozzali, Marco/0000-0002-0568-2026				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2007, MAGN RESON IMAGING, V25, P1358, DOI 10.1016/j.mri.2007.03.022; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00118; Di X, 2013, CEREB CORTEX, V23, P255, DOI 10.1093/cercor/bhs001; DiNuzzo M, 2011, J NEUROPHYSIOL, V106, P3010, DOI 10.1152/jn.00416.2011; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hiltunen T, 2014, J NEUROSCI, V34, P356, DOI 10.1523/JNEUROSCI.0276-13.2014; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang PP, 2014, CURR ALZHEIMER RES, V11, P389, DOI 10.2174/1567205011666140331225335; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liu XN, 2014, J ALZHEIMERS DIS, V40, P387, DOI 10.3233/JAD-131322; Luchinger R, 2012, NEUROIMAGE, V60, P1426, DOI 10.1016/j.neuroimage.2012.01.031; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Serra L, 2013, J ALZHEIMERS DIS, V33, P1157, DOI 10.3233/JAD-2012-121663; Song XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086818; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Xi Q, 2013, CHINESE MED J-PEKING, V126, P2912, DOI 10.3760/cma.j.issn.0366-6999.20130431; Xi Q, 2012, CHINESE MED J-PEKING, V125, P858, DOI 10.3760/cma.j.issn.0366-6999.2012.05.023; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yu RJ, 2014, HUM BRAIN MAPP, V35, P627, DOI 10.1002/hbm.22203; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang JQ, 2013, BEHAV BRAIN RES, V252, P18, DOI 10.1016/j.bbr.2013.05.039; Zhao ZL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/920902; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	64	34	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0120988	10.1371/journal.pone.0120988	http://dx.doi.org/10.1371/journal.pone.0120988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844531	Green Published, gold, Green Submitted			2022-12-27	WOS:000352475700004
J	Romann, M; Cobley, S				Romann, Michael; Cobley, Stephen			Relative Age Effects in Athletic Sprinting and Corrective Adjustments as a Solution for Their Removal	PLOS ONE			English	Article							YOUTH SOCCER; SUCCESS; FOOTBALL; DROPOUT	Relative Age Effects (RAEs) refer to the selection and performance differentials between children and youth who are categorized in annual-age groups. In the context of Swiss 60m athletic sprinting, 7761 male athletes aged 8 - 15 years were analysed, with this study examining whether: (i) RAE prevalence changed across annual age groups and according to performance level (i.e., all athletes, Top 50%, 25% & 10%); (ii) whether the relationship between relative age and performance could be quantified, and corrective adjustments applied to test if RAEs could be removed. Part one identified that when all athletes were included, typical RAEs were evident, with smaller comparative effect sizes, and progressively reduced with older age groups. However, RAE effect sizes increased linearly according to performance level (i.e., all athletes - Top 10%) regardless of age group. In part two, all athletes born in each quartile, and within each annual age group, were entered into linear regression analyses. Results identified that an almost one year relative age difference resulted in mean expected performance differences of 10.1% at age 8, 8.4% at 9, 6.8% at 10, 6.4% at 11, 6.0% at 12, 6.3% at 13, 6.7% at 14, and 5.3% at 15. Correction adjustments were then calculated according to day, month, quarter, and year, and used to demonstrate that RAEs can be effectively removed from all performance levels, and from Swiss junior sprinting more broadly. Such procedures could hold significant implications for sport participation as well as for performance assessment, evaluation, and selection during athlete development.	[Romann, Michael] Swiss Fed Inst Sport, Dept Elite Sport, Magglingen, Switzerland; [Cobley, Stephen] Univ Sydney, Fac Hlth Sci, Exercise & Sport Sci, Sydney, NSW 2006, Australia	University of Sydney	Cobley, S (corresponding author), Univ Sydney, Fac Hlth Sci, Exercise & Sport Sci, Sydney, NSW 2006, Australia.	stephen.cobley@sydney.edu.au	Cobley, Stephen P/I-5686-2017; Romann, Michael/H-3571-2019	Cobley, Stephen P/0000-0001-6099-392X; Romann, Michael/0000-0003-4139-2955				Astrand PO, 2003, TEXTBOOK OF WORK PHY; Baker J, 2014, EUR J SPORT SCI, V14, pS183, DOI 10.1080/17461391.2012.671369; Barnsley R. H., 1985, CANADIAN ASS HLTH PH, V51, P23, DOI [10.1177/1012690210371560, DOI 10.1177/1012690210371560]; Beunen G, 1988, Exerc Sport Sci Rev, V16, P503; Bogin B, 1999, PATTERNS OF HUMAN GR; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Cobley S, 2008, J SPORT SCI, V26, P1531, DOI 10.1080/02640410802298250; Costa AM, 2013, EUR J SPORT SCI, V13, P437, DOI 10.1080/17461391.2012.742571; Cote J, 2006, J SPORT SCI, V24, P1065, DOI 10.1080/02640410500432490; Deaner RO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057753; Delorme N, 2010, J SPORT SCI, V28, P717, DOI 10.1080/02640411003663276; Edgar S, 2005, J SPORT SCI, V23, P1013, DOI 10.1080/02640410400021468; Fraser-Thomas J, 2008, PSYCHOL SPORT EXERC, V9, P645, DOI 10.1016/j.psychsport.2007.08.003; Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310; Hopkins WG., NEW VIEW STAT; Malina RM, 2004, EUR J APPL PHYSIOL, V91, P555, DOI 10.1007/s00421-003-0995-z; Malina RM, 2007, BRIT J SPORT MED, V41, P290, DOI 10.1136/bjsm.2006.031294; Moesch K, 2011, SCAND J MED SCI SPOR, V21, pE282, DOI 10.1111/j.1600-0838.2010.01280.x; Piacentini MF, 2014, J SPORT MED PHYS FIT, V54, P410; Raschner C, 2012, BR J SPORTS MED; Romann M, 2014, PERCEPT MOTOR SKILL, V118, P1; Romann M, 2014, INT J SPORTS SCI COA, V9, P347, DOI 10.1260/1747-9541.9.2.347; Schorer J, 2009, SCAND J MED SCI SPOR, V19, P720, DOI 10.1111/j.1600-0838.2008.00838.x; Swiss Athletics Federation, 2014, RESULTS DATABASE; Swiss Federal Office of Sport, 2014, STATISTICS OF YOUTH; Swiss Federal Office of Statistics, 2013, PERMANANT RESIDENTIA; THOMPSON AH, 1991, SOCIOL SPORT J, V8, P146, DOI 10.1123/ssj.8.2.146; Till K, 2010, SCAND J MED SCI SPOR, V20, P320, DOI 10.1111/j.1600-0838.2009.00884.x; Vaeyens R, 2008, SPORTS MED, V38, P703, DOI 10.2165/00007256-200838090-00001; Van Den Tillaar R, 2012, J SPORT SCI, V30, P807, DOI 10.1080/02640414.2012.671529; Viru A., 1999, EUR J PHYS ED, V4, P75, DOI DOI 10.1080/1740898990040106	31	72	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122988	10.1371/journal.pone.0122988	http://dx.doi.org/10.1371/journal.pone.0122988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844642	Green Published, gold, Green Submitted			2022-12-27	WOS:000352475700017
J	Cruet-Hennequart, S; Drougard, C; Shaw, G; Legendre, F; Demoor, M; Barry, F; Lefaix, JL; Galera, P				Cruet-Hennequart, Severine; Drougard, Carole; Shaw, Georgina; Legendre, Florence; Demoor, Magali; Barry, Frank; Lefaix, Jean-Louis; Galera, Philippe			Radiation-Induced Alterations of Osteogenic and Chondrogenic Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; IONIZING-RADIATION; STROMAL CELLS; CARTILAGE REPAIR; MATRIX SYNTHESIS; MARROW; HYPOXIA; BREAKS; RECRUITMENT; EXPRESSION	While human mesenchymal stem cells (hMSCs), either in the bone marrow or in tumour microenvironment could be targeted by radiotherapy, their response is poorly understood. The oxic effects on radiosensitivity, cell cycle progression are largely unknown, and the radiation effects on hMSCs differentiation capacities remained unexplored. Here we analysed hMSCs viability and cell cycle progression in 21% O-2 and 3% O-2 conditions after medical Xrays irradiation. Differentiation towards osteogenesis and chondrogenesis after irradiation was evaluated through an analysis of differentiation specific genes. Finally, a 3D culture model in hypoxia was used to evaluate chondrogenesis in conditions mimicking the natural hMSCs microenvironment. The hMSCs radiosensitivity was not affected by O-2 tension. A decreased number of cells in S phase and an increase in G2/M were observed in both O-2 tensions after 16 hours but hMSCs released from the G2/M arrest and proliferated at day 7. Osteogenesis was increased after irradiation with an enhancement of mRNA expression of specific osteogenic genes (alkaline phosphatase, osteopontin). Osteoblastic differentiation was altered since matrix deposition was impaired with a decreased expression of collagen I, probably through an increase of its degradation by MMP-3. After induction in monolayers, chondrogenesis was altered after irradiation with an increase in COL1A1 and a decrease in both SOX9 and ACAN mRNA expression. After induction in a 3D culture in hypoxia, chondrogenesis was altered after irradiation with a decrease in COL2A1, ACAN and SOX9 mRNA amounts associated with a RUNX2 increase. Together with collagens I and II proteins decrease, associated to a MMP-13 expression increase, these data show a radiation-induced impairment of chondrogenesis. Finally, a radiation-induced impairment of both osteogenesis and chondrogenesis was characterised by a matrix composition alteration, through inhibition of synthesis and/or increased degradation. Alteration of osteogenesis and chondrogenesis in hMSCs could potentially explain bone/joints defects observed after radiotherapy.	[Cruet-Hennequart, Severine; Drougard, Carole; Legendre, Florence; Demoor, Magali; Galera, Philippe] Normandy Univ, Caen, France; [Cruet-Hennequart, Severine; Drougard, Carole; Legendre, Florence; Demoor, Magali; Galera, Philippe] UNICAEN, Lab Microenvironm Cellulaire & Pathol MILPAT, Caen, France; [Cruet-Hennequart, Severine; Lefaix, Jean-Louis] CEA, DSV, IRCM, LARIA, Caen 5, France; [Cruet-Hennequart, Severine; Shaw, Georgina; Barry, Frank] Natl Univ Ireland Galway, Regenerat Med Inst REMEDI, Galway, Ireland	Universite de Caen Normandie; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Ollscoil na Gaillimhe-University of Galway	Galera, P (corresponding author), Normandy Univ, Caen, France.	philippe.galera@unicaen.fr		Barry, Frank/0000-0002-5535-002X; Drougard, Carole/0000-0001-6526-104X; legendre, florence/0000-0002-9951-1585	Regional Council of Lower-Normandy (France); French Ministry of Research; French National Agency of Research (ANR, PROMOCART grant)	Regional Council of Lower-Normandy (France)(Region Normandie); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French National Agency of Research (ANR, PROMOCART grant)(French National Research Agency (ANR))	This project was funded by the Regional Council of Lower-Normandy (France, Programme Emergence to SCH), another Programme Emergence to Christophe Denoyelle (BioTICLA, Caen, France) and PG, the French Ministry of Research and the French National Agency of Research (ANR, PROMOCART grant) to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio N, 2013, CELL MOL LIFE SCI, V70, P1637, DOI 10.1007/s00018-012-1224-x; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Chen MF, 2006, INT J RADIAT ONCOL, V66, P244, DOI 10.1016/j.ijrobp.2006.03.062; Claus S, 2010, J CELL BIOCHEM, V111, P1642, DOI 10.1002/jcb.22897; Cmielova J, 2013, INT J RADIAT BIOL, V89, P501, DOI 10.3109/09553002.2013.775530; Cruet-Hennequart S, 2010, CURR CANCER DRUG TAR, V10, P411, DOI 10.2174/156800910791208553; Damour O., 2012, Patent No. [WO 2012/ 038668, 2012038668, 2012/038668]; Delanian S, 2007, SEMIN RADIAT ONCOL, V17, P99, DOI 10.1016/j.semradonc.2006.11.006; Delanian S, 2011, INT J RADIAT ONCOL, V80, P832, DOI 10.1016/j.ijrobp.2010.03.029; Demoor M, 2012, PATHOL BIOL, V60, P199, DOI 10.1016/j.patbio.2012.03.003; Dikomey E, 2000, INT J RADIAT BIOL, V76, P773, DOI 10.1080/09553000050028922; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freyria AM, 2009, TISSUE ENG PT A, V15, P1233, DOI 10.1089/ten.tea.2008.0114; Galera P, 2010, Brevet francais, Patent No. [FR 2965278 du 23/ 09/ 2010, 2965278]; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Gilbert S.F., 2000, DEV BIOL; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Habrand J L, 1997, Cancer Radiother, V1, P810, DOI 10.1016/S1278-3218(97)82962-9; Hall EJ, 2006, RADIOBIOLOGY RADIOBI, V6th; Harada H, 2011, J RADIAT RES, V52, P545, DOI 10.1269/jrr.11056; Harfouche G, 2010, MUTAT RES-REV MUTAT, V704, P167, DOI 10.1016/j.mrrev.2010.01.007; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534; Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338; Kim YH, 2012, STEM CELLS DEV, V21, P2958, DOI 10.1089/scd.2011.0349; Kurpinski K, 2009, INT J RADIAT ONCOL, V73, P869, DOI 10.1016/j.ijrobp.2008.10.002; Laurent C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085158; Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]; Li J, 2007, PEDIATR TRANSPLANT, V11, P379, DOI 10.1111/j.1399-3046.2006.00663.x; Liao JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089025; Logovskaya LV, 2013, B EXP BIOL MED+, V155, P145, DOI 10.1007/s10517-013-2100-x; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moussavi-Harami F, 2006, BIOCHEM BIOPH RES CO, V346, P379, DOI 10.1016/j.bbrc.2006.05.158; Mutsaers A.J., 2014, BONE; Nicolay NH, 2013, INT J RADIAT ONCOL, V87, P1171, DOI 10.1016/j.ijrobp.2013.09.003; Nyman JS, 2005, MICRON, V36, P566, DOI 10.1016/j.micron.2005.07.004; Oliver L, 2013, STEM CELLS, V31, P800, DOI 10.1002/stem.1336; Oliver L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019820; Ollitrault D, 2014, TISSUE ENG C; Palomaki S, 2013, STEM CELLS, V31, P1902, DOI 10.1002/stem.1435; Paulino AC, 2004, INT J RADIAT ONCOL, V60, P265, DOI 10.1016/j.ijrobp.2004.02.001; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prendergast AM, 2011, CELL CYCLE, V10, P3768, DOI 10.4161/cc.10.21.17972; Prockop Darwin J, 2008, Methods Mol Biol, V449, pv; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Sokolov M, 2013, INT J MOL SCI, V14, P15695, DOI 10.3390/ijms140815695; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Titorencu I, 2007, CYTOTHERAPY, V9, P682, DOI 10.1080/14653240701561329; Titorencu I, 2014, CELL TISSUE RES, V355, P23, DOI 10.1007/s00441-013-1750-3; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Willey JS, 2013, INT J RADIAT BIOL, V89, P268, DOI 10.3109/09553002.2013.747015; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	61	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119334	10.1371/journal.pone.0119334	http://dx.doi.org/10.1371/journal.pone.0119334			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837977	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000008
J	Lim, N; Lidofsky, SD				Lim, Nicholas; Lidofsky, Steven D.			Impact of Physician Specialty on Quality Care for Patients Hospitalized with Decompensated Cirrhosis	PLOS ONE			English	Article							OF-CARE; AMERICAN ASSOCIATION; VARICEAL HEMORRHAGE; PRACTICE GUIDELINE; LIVER-DISEASES; ADULT PATIENTS; ORDER SET; MANAGEMENT; MORTALITY; OUTCOMES	Background Decompensated cirrhosis is a common precipitant for hospitalization, and there is limited information concerning factors that influence the delivery of quality care in cirrhotic inpatients. We sought to determine the relation between physician specialty and inpatient quality care for decompensated cirrhosis. Design We reviewed 247 hospital admissions for decompensated cirrhosis, managed by hospitalists or intensivists, between 2009 and 2013. The primary outcome was quality care delivery, defined as adherence to all evidence-based specialty society practice guidelines pertaining to each specific complication of cirrhosis. Secondary outcomes included new complications, length-of-stay, and in-hospital death. Results Overall, 147 admissions (59.5%) received quality care. Quality care was given more commonly by intensivists, compared with hospitalists (71.7% vs. 53.1%, P = .006), and specifically for gastrointestinal bleeding (72% vs. 45.8%, P = .03) and hepatic encephalopathy (100% vs. 63%, P = .005). Involvement of gastroenterology consultation was also more common in admissions in which quality care was administered (68.7% vs. 54.0%, P = .023). Timely diagnostic paracentesis was associated with reduced new complications in admissions for refractory ascites (9.5% vs. 46.6%, P = .02), and reduced length-of-stay in admissions for spontaneous bacterial peritonitis (5 days vs. 13 days, P = .02). Conclusions Adherence to quality indicators for decompensated cirrhosis is suboptimal among hospitalized patients. Although quality care adherence appears to be higher among cirrhotic patients managed by intensivists than by hospitalists, opportunities for improvement exist in both groups. Rational and cost-effective strategies should be sought to achieve this end.	[Lim, Nicholas; Lidofsky, Steven D.] Univ Vermont, Coll Med, Div Gastroenterol & Hepatol, Burlington, VT 05405 USA; [Lim, Nicholas; Lidofsky, Steven D.] Univ Vermont, Coll Med, Burlington, VT USA	University of Vermont; University of Vermont	Lidofsky, SD (corresponding author), Univ Vermont, Coll Med, Div Gastroenterol & Hepatol, Burlington, VT 05405 USA.	steven.lidofsky@uvm.edu		Lim, Nicholas/0000-0001-9740-8923				Bini EJ, 2001, HEPATOLOGY, V34, P1089, DOI 10.1053/jhep.2001.29204; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Buchanan PM, 2014, AM J GASTROENTEROL, V109, P934, DOI 10.1038/ajg.2013.487; Carretta HJ, 2013, AM J MED QUAL, V28, P46, DOI 10.1177/1062860612444459; Desai AP, 2014, J CLIN GASTROENTEROL, V48, pE30, DOI 10.1097/MCG.0b013e3182a87f70; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Ghaoui R, 2014, LIVER INT, V34, P204, DOI 10.1111/liv.12225; Gupta R, 2013, J CRIT CARE, V28, P1042, DOI 10.1016/j.jcrc.2013.06.010; Jairath V, 2014, DIGEST LIVER DIS, V46, P419, DOI 10.1016/j.dld.2013.12.010; Jungerwirth R, 2014, J HOSP MED, V9, P1, DOI 10.1002/jhm.2118; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kanwal F, 2012, GASTROENTEROLOGY, V143, P70, DOI 10.1053/j.gastro.2012.03.038; Kanwal F, 2011, GASTROENTEROLOGY, V140, P1182, DOI 10.1053/j.gastro.2010.12.032; Kanwal F, 2010, CLIN GASTROENTEROL H, V8, P709, DOI 10.1016/j.cgh.2010.03.028; Mayorga CA, 2013, CLIN GASTROENTEROL H, V11, P1342, DOI 10.1016/j.cgh.2013.04.021; Orman ES, 2014, CLIN GASTROENTEROL H, V12, P496, DOI 10.1016/j.cgh.2013.08.025; Panzer RJ, 2013, JAMA-J AM MED ASSOC, V310, P1971, DOI 10.1001/jama.2013.282047; Pastores SM, 2014, CRIT CARE MED, V42, P1272, DOI 10.1097/CCM.0000000000000250; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Siegal EM, 2012, CRIT CARE MED, V40, P1952, DOI 10.1097/CCM.0b013e318258eef7; Thiel SW, 2009, CRIT CARE MED, V37, P819, DOI 10.1097/CCM.0b013e318196206b; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314; Wilcox ME, 2013, CRIT CARE MED, V41, P2253, DOI 10.1097/CCM.0b013e318292313a; Wise KR, 2012, J HOSP MED, V7, P183, DOI 10.1002/jhm.972	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123490	10.1371/journal.pone.0123490	http://dx.doi.org/10.1371/journal.pone.0123490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837700	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000146
J	DeSimone, JC; Everling, S; Heath, M				DeSimone, Jesse C.; Everling, Stefan; Heath, Matthew			The Antisaccade Task: Visual Distractors Elicit a Location-Independent Planning 'Cost'	PLOS ONE			English	Article							COMPETITIVE INTEGRATION; SUPERIOR COLLICULUS; SACCADES; ACCURACY; SIGNALS; LATENCY; TARGET; MODEL; DIRECTION; STIMULI	The presentation of a remote - but not proximal - distractor concurrent with target onset increases prosaccade reaction times (RT) (i.e., the remote distractor effect: RDE). The competitive integration model asserts that the RDE represents the time required to resolve the conflict for a common saccade threshold between target- and distractor-related saccade generating commands in the superior colliculus. To our knowledge however, no previous research has examined whether remote and proximal distractors differentially influence antisaccade RTs. This represents a notable question because antisaccades require decoupling of the spatial relations between stimulus and response (SR) and therefore provide a basis for determining whether the sensory- and/or motor-related features of a distractor influence response planning. Participants completed pro- and antisaccades in a target-only condition and conditions wherein the target was concurrently presented with a proximal or remote distractor. As expected, prosaccade RTs elicited a reliable RDE. In contrast, antisaccade RTs were increased independent of the distractor's spatial location and the magnitude of the effect was comparable across each distractor location. Thus, distractor-related antisaccade RT costs are not accounted for by a competitive integration between conflicting saccade generating commands. Instead, we propose that a visual distractor increases uncertainty related to the evocation of the response-selection rule necessary for decoupling SR relations.	[DeSimone, Jesse C.; Heath, Matthew] Univ Western Ontario, Sch Kinesiol, London, ON, Canada; [Everling, Stefan] Univ Western Ontario, Dept Physiol & Pharmacol, Dept Psychol, Robarts Res Inst, London, ON, Canada; [Everling, Stefan; Heath, Matthew] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Heath, M (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON, Canada.	mheath2@uwo.ca	Everling, Stefan/K-5208-2013; Everling, Stefan/AAR-8687-2020	Everling, Stefan/0000-0001-9714-9757; DeSimone, Jesse/0000-0002-3823-8765	Natural Sciences and Engineering Research Council of Canada; Faculty Scholar Award from the University of Western Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Faculty Scholar Award from the University of Western Ontario	Supported by a grant from the Natural Sciences and Engineering Research Council of Canada and a Faculty Scholar Award from the University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson V, 2008, EXP PSYCHOL, V55, P334, DOI 10.1027/1618-3169.55.5.334; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Casteau S, 2012, J VISION, V12, DOI 10.1167/12.12.14; COREN S, 1972, PERCEPT MOTOR SKILL, V34, P499, DOI 10.2466/pms.1972.34.2.499; Cumming G., 2011, UNDERSTANDING NEW ST UNDERSTANDING NEW ST; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dafoe JM, 2007, EXP BRAIN RES, V179, P563, DOI 10.1007/s00221-006-0817-8; DeSimone JC, 2014, VISION RES, V96, P17, DOI 10.1016/j.visres.2013.12.005; Deubel H., 1984, THEORETICAL APPL ASP, P55, DOI DOI 10.1016/S0166-4115(08)61818-X; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 2007, J NEUROSCI, V27, P5053, DOI 10.1523/JNEUROSCI.4212-06.2007; Doyle D, 2001, EXP BRAIN RES, V139, P333, DOI 10.1007/s002210100742; Evdokimidis I, 2006, EXP BRAIN RES, V174, P304, DOI 10.1007/s00221-006-0462-2; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; FISCHER B, 1992, EXP BRAIN RES, V89, P415; Gaveau V, 2003, NEUROREPORT, V14, P875, DOI 10.1097/00001756-200305060-00020; Gillen C, 2014, VISION RES, V105, P151, DOI 10.1016/j.visres.2014.10.010; Gillen C, 2014, EXP BRAIN RES, V232, P3201, DOI 10.1007/s00221-014-4010-1; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HALLETT PE, 1980, VISION RES, V20, P329, DOI 10.1016/0042-6989(80)90019-X; Heath M, 2011, EXP BRAIN RES, V209, P117, DOI 10.1007/s00221-010-2525-7; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Irwin DE, 2007, PERCEPT PSYCHOPHYS, V69, P450, DOI 10.3758/BF03193765; Kloft L, 2012, EXP BRAIN RES, V222, P345, DOI 10.1007/s00221-012-3218-1; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; Krappmann P, 1998, VISION RES, V38, P2979, DOI 10.1016/S0042-6989(98)00101-1; Kveraga K, 2002, EXP BRAIN RES, V146, P307, DOI 10.1007/s00221-002-1168-8; Lawrence BM, 2010, EXP BRAIN RES, V204, P115, DOI 10.1007/s00221-010-2301-8; LEVYSCHO.A, 1969, ANN PSYCHOL, V69, P373; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Olk B, 2003, NEUROREPORT, V14, P151, DOI 10.1097/00001756-200301200-00028; OTTES FP, 1985, VISION RES, V25, P849, DOI 10.1016/0042-6989(85)90193-2; Pashler HE, 1998, PSYCHOL ATTENTION; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; Takahashi M, 2005, J NEUROPHYSIOL, V94, P1707, DOI 10.1152/jn.00347.2005; Tipper SP, 2001, EXP BRAIN RES, V136, P241, DOI 10.1007/s002210000577; Tipper SP, 2000, PHILOS TRANS R SOC L, V353, P1385; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Van der Stigchel S, 2011, J EYE MOVEMENT RES, V4; VANGISBERGEN JAM, 1987, NEUROSCIENCE, V21, P541, DOI 10.1016/0306-4522(87)90140-0; VANOPSTAL AJ, 1989, BIOL CYBERN, V60, P171, DOI 10.1007/BF00207285; Viswanathan J, 2013, EXP BRAIN RES, V225, P247, DOI 10.1007/s00221-012-3366-3; Walker R, 1997, J NEUROPHYSIOL, V78, P1108, DOI 10.1152/jn.1997.78.2.1108; Walker R, 2008, J EYE MOVEMENT RES, V2, P1, DOI DOI 10.16910/JEMR.2.3.7; Weiler J, 2014, J NEUROPHYSIOL, V112, P2176, DOI 10.1152/jn.00352.2014; West GL, 2009, J MOTOR BEHAV, V41, P117, DOI 10.3200/JMBR.41.2.117-127; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	50	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122345	10.1371/journal.pone.0122345	http://dx.doi.org/10.1371/journal.pone.0122345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830383	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600108
J	Fan, XW; Chen, F; Chen, Y; Chen, GH; Liu, HH; Guan, SK; Deng, Y; Liu, Y; Zhang, SJ; Peng, WJ; Jiang, GL; Wu, KL				Fan, Xing-Wen; Chen, Fu; Chen, Yan; Chen, Guan-Hao; Liu, Huan-Huan; Guan, Shi-Kuo; Deng, Yun; Liu, Yong; Zhang, Sheng-Jian; Peng, Wei-Jun; Jiang, Guo-Liang; Wu, Kai-Liang			Electroacupuncture Prevents Cognitive Impairments by Regulating the Early Changes after Brain Irradiation in Rats	PLOS ONE			English	Article							RADIATION-INDUCED CHANGES; HIPPOCAMPAL NEUROGENESIS; MICROGLIAL ACTIVATION; SUPEROXIDE-DISMUTASE; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; RECEPTOR; BARRIER; ACUPUNCTURE; EXPRESSION	Cognitive impairments severely affect the quality of life of patients who undergo brain irradiation, and there are no effective preventive strategies. In this study, we examined the therapeutic potential of electroacupuncture (EA) administered immediately after brain irradiation in rats. We detected changes in cognitive function, neurogenesis, and synaptic density at different time points after irradiation, but found that EA could protect the blood-brain barrier (BBB), inhibit neuroinflammatory cytokine expression, upregulate angiogenic cytokine expression, and modulate the levels of neurotransmitter receptors and neuropeptides in the early phase. Moreover, EA protected spatial memory and recognition in the delayed phase. At the cellular/molecular level, the preventative effect of EA on cognitive dysfunction was not dependent on hippocampal neurogenesis; rather, it was related to synaptophysin expression. Our results suggest that EA applied immediately after brain irradiation can prevent cognitive impairments by protecting against the early changes induced by irradiation and may be a novel approach for preventing or ameliorating cognitive impairments in patients with brain tumors who require radiotherapy.	[Fan, Xing-Wen; Chen, Guan-Hao; Guan, Shi-Kuo; Deng, Yun; Liu, Yong; Jiang, Guo-Liang; Wu, Kai-Liang] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200032, Peoples R China; [Chen, Fu; Chen, Yan] Fudan Univ, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Liu, Huan-Huan] Shanghai Jiao Tong Univ, Dept Radiol, Ruijin Hosp, Shanghai 200032, Peoples R China; [Zhang, Sheng-Jian; Peng, Wei-Jun] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200032, Peoples R China; [Fan, Xing-Wen; Chen, Guan-Hao; Jiang, Guo-Liang; Wu, Kai-Liang] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Wu, KL (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200032, Peoples R China.	wukailiang@aliyun.com		Wu, Kai-Liang/0000-0003-2808-3234	National Natural Scientific Foundation of China [8137243]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (8137243, http://www.nsfc.gov.cn/).	ALAOUI F, 1995, EUR J PHARMACOL, V276, P55, DOI 10.1016/0014-2999(95)00006-7; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Brown PD, 2013, NEURO-ONCOLOGY, V15, P1429, DOI 10.1093/neuonc/not114; Cao Y, 2009, CLIN CANCER RES, V15, P1747, DOI 10.1158/1078-0432.CCR-08-1420; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chen Y, 2012, BRAIN RES, V1432, P36, DOI 10.1016/j.brainres.2011.11.002; Conner KR, 2011, RADIAT RES, V176, P71, DOI 10.1667/RR2560.1; Corniola R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049367; Dong ZQ, 2005, NEUROSCI LETT, V376, P143, DOI 10.1016/j.neulet.2004.11.044; Ferreira R, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-169; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Greene-Schloesser D, 2014, RADIAT RES, V181, P33, DOI 10.1667/RR13202.1; Greene-Schloesser D, 2013, CLIN CANCER RES, V19, P2294, DOI 10.1158/1078-0432.CCR-11-2903; Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Lee M, 2013, CURR PROTEIN PEPT SC, V14, P21, DOI 10.2174/1389203711314010005; Lee TC, 2012, RADIAT RES, V178, P46, DOI 10.1667/RR2731.1; Li YQ, 2003, CANCER RES, V63, P5950; Li YQ, 2010, INT J RADIAT ONCOL, V77, P1213, DOI 10.1016/j.ijrobp.2010.01.015; Liu XY, 2004, EXP NEUROL, V189, P189, DOI 10.1016/j.expneurol.2004.05.028; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Molassiotis A, 2012, J CLIN ONCOL, V30, P4470, DOI 10.1200/JCO.2012.41.6222; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Parihar VK, 2013, P NATL ACAD SCI USA, V110, P12822, DOI 10.1073/pnas.1307301110; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Robbins ME, 2009, INT J RADIAT ONCOL, V73, P499, DOI 10.1016/j.ijrobp.2008.09.058; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Roughton K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.423; Schnegg CI, 2013, FREE RADICAL BIO MED, V61, P1, DOI 10.1016/j.freeradbiomed.2013.03.002; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; Shen PF, 2012, AM J CHINESE MED, V40, P685, DOI 10.1142/S0192415X12500516; Simcock R, 2013, ANN ONCOL, V24, P776, DOI 10.1093/annonc/mds515; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Warrington JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030444; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; Wu KL, 2010, INT J RADIAT ONCOL, V76, P220, DOI 10.1016/j.ijrobp.2009.08.017; Wu XD, 2001, ACUPUNCTURE ELECTRO, V26, P1; Yuan H, 2006, INT J RADIAT ONCOL, V66, P860, DOI 10.1016/j.ijrobp.2006.06.043; Zhang LY, 2013, J RADIAT RES, V54, P235, DOI 10.1093/jrr/rrs095; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]; Zhao WL, 2007, INT J RADIAT ONCOL, V67, P6, DOI 10.1016/j.ijrobp.2006.09.036; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zou YN, 2012, P NATL ACAD SCI USA, V109, P21522, DOI 10.1073/pnas.1216913110	50	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122087	10.1371/journal.pone.0122087	http://dx.doi.org/10.1371/journal.pone.0122087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830357	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600098
J	Gopinath, B; Harris, IA; Nicholas, M; Casey, P; Blyth, F; Maher, CG; Cameron, ID				Gopinath, Bamini; Harris, Ian A.; Nicholas, Michael; Casey, Petrina; Blyth, Fiona; Maher, Christopher G.; Cameron, Ian D.			A Comparison of Health Outcomes in Older versus Younger Adults following a Road Traffic Crash Injury: A Cohort Study	PLOS ONE			English	Article							PAIN; AUSTRALIA; FRAGILITY; DRIVERS; INDEX; COSTS	Background Given the aging demographics of most developed countries, understanding the public health impact of mild/moderate road traffic crash injuries in older adults is important. We aimed to determine whether health outcomes (pain severity and quality of life measures) over 24 months differ significantly between older (65+) and younger adults (18-64). Methods Prospective cohort study of 364, 284 and 252 participants with mild/moderate injury following a vehicle collision at baseline, 12 and 24 months, respectively. A telephone-administered questionnaire obtained information on socio-economic, pre-and post-injury psychological and heath characteristics. Results At baseline, there were 55 (15.1%) and 309 (84.9%) participants aged >= 65 and 18-64 years, respectively. At 12- and 24-month follow-up, older compared to younger participants who had sustained a mild/moderate musculoskeletal injury had lower physical functioning (3.9-units lower Short Form-12 Physical Composite Score, multivariable-adjusted p = 0.03 at both examinations). After multivariable adjustment, older (n = 45) versus younger (n = 207) participants had lower self-perceived health status (8.1-units lower European Quality of Life-5 Dimensions Visual Acuity Scale scores at 24 months, p = 0.03), 24 months later. Conclusions Older compared to younger participants who sustained a mild/moderate injury following a road-traffic crash demonstrated poorer physical functioning and general health at 24 months.	[Gopinath, Bamini; Casey, Petrina; Cameron, Ian D.] Univ Sydney, Sydney Med Sch, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia; [Harris, Ian A.] Univ New S Wales, Ingham Inst Appl Med Res, Kensington, NSW 2033, Australia; [Harris, Ian A.] Univ New S Wales, South Western Sydney Clin Sch, Kensington, NSW 2033, Australia; [Nicholas, Michael; Blyth, Fiona] Univ Sydney, Sydney Med Sch, Pain Management Res Inst, Sydney, NSW 2006, Australia; [Blyth, Fiona] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Maher, Christopher G.] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2006, Australia	University of Sydney; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; George Institute for Global Health; University of Sydney	Gopinath, B (corresponding author), Univ Sydney, Sydney Med Sch, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia.	bamini.gopinath@sydney.edu.au	Maher, Christopher/AAC-6267-2019; Gopinath, Bamini/K-4286-2019	Maher, Christopher/0000-0002-1628-7857; Gopinath, Bamini/0000-0003-3573-359X; Blyth, Fiona/0000-0003-1128-6756	Motor Accidents Authority of New South Wales; Australian Research Council; Australian National Health and Medical Research Council; Motor Accidents Authority of New South Wales; Australian Research Council; Australian National Health and Medical Research Council	Motor Accidents Authority of New South Wales; Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Accidents Authority of New South Wales; Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study is funded by the Motor Accidents Authority of New South Wales. The funder participates in the Steering Group for the study but has no direct involvement with the scientific aspects of the study. Professor Maher's fellowship is funded by the Australian Research Council. Professor Cameron's fellowship is funded by the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Daniel, 2010, Ann Adv Automot Med, V54, P359; Avery J., 2004, POPULATION RES OUTCO; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; EuroQol-a new facility for the measurement of health-related quality of life, 1990, HLTH POLICY AMSTERDA, V16, P199; FLOR H, 1993, BEHAV RES THER, V31, P63, DOI 10.1016/0005-7967(93)90044-U; Freeman M D, 2006, Pain Res Manag, V11, P79; Hijioka A, 2001, ARCH ORTHOP TRAUM SU, V121, P490, DOI 10.1007/s004020100284; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Leung Lawrence, 2012, Indian J Psychol Med, V34, P204, DOI 10.4103/0253-7176.106012; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Linton SJ, 2011, SPINE, V36, P1891, DOI 10.1097/BRS.0b013e3181f8f775; Littleton SM, 2011, INJURY, V42, P927, DOI 10.1016/j.injury.2010.02.011; McPhail S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-48; Meuleners LB, 2009, ACCIDENT ANAL PREV, V38, P1006; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nicholas MK, 2008, PAIN, V134, P158, DOI 10.1016/j.pain.2007.04.007; Ruscheweyh R, 2011, CLIN J PAIN, V27, P578, DOI 10.1097/AJP.0b013e31820fde1b; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Ware J., 1993, SF 36 HLTH SURVEY MA; Wood BM, 2010, PAIN MED, V11, P1780, DOI 10.1111/j.1526-4637.2010.01005.x	23	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122732	10.1371/journal.pone.0122732	http://dx.doi.org/10.1371/journal.pone.0122732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830702	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600121
J	Cao, PB; Azar, S; SanClemente, H; Mounet, F; Dunand, C; Marque, G; Marque, C; Teulieres, C				Cao, P. B.; Azar, S.; SanClemente, H.; Mounet, F.; Dunand, C.; Marque, G.; Marque, C.; Teulieres, C.			Genome-Wide Analysis of the AP2/ERF Family in Eucalyptus grandis: An Intriguing Over-Representation of Stress-Responsive DREB1/CBF Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; DNA-BINDING PROTEINS; APETALA2-LIKE GENE; REGULATORY GENES; AP2 DOMAIN; EXPRESSION; ARABIDOPSIS; TOLERANCE; SUPERFAMILY; ANNOTATION	Background The AP2/ERF family includes a large number of developmentally and physiologically important transcription factors sharing an AP2 DNA-binding domain. Among them DREB1/CBF and DREB2 factors are known as master regulators respectively of cold and heat/osmotic stress responses. Experimental Approaches The manual annotation of AP2/ERF family from Eucalyptus grandis, Malus, Populus and Vitis genomes allowed a complete phylogenetic study for comparing the structure of this family in woody species and the model Arabidopsis thaliana. Expression profiles of the whole groups of EgrDREB1 and EgrDREB2 were investigated through RNAseq database survey and RT-qPCR analyses. Results The structure and the size of the AP2/ERF family show a global conservation for the plant species under comparison. In addition to an expansion of the ERF subfamily, the tree genomes mainly differ with respect to the group representation within the subfamilies. With regard to the E. grandis DREB subfamily, an obvious feature is the presence of 17 DREB1/CBF genes, the maximum reported to date for dicotyledons. In contrast, only six DREB2 have been identified, which is similar to the other plants species under study, except for Malus. All the DREB1/CBF and DREB2 genes from E. grandis are expressed in at least one condition and all are heat-responsive. Regulation by cold and drought depends on the genes but is not specific of one group; DREB1/CBF group is more cold-inducible than DREB2 which is mainly drought responsive. Conclusion These features suggest that the dramatic expansion of the DREB1/CBF group might be related to the adaptation of this evergreen tree to climate changes when it expanded in Australia.	[Cao, P. B.; Azar, S.; SanClemente, H.; Mounet, F.; Dunand, C.; Marque, G.; Marque, C.; Teulieres, C.] Univ Toulouse, UPS, LRSV, UMR 5546, F-31326 Castanet Tolosan, France; [Cao, P. B.; Azar, S.; SanClemente, H.; Mounet, F.; Dunand, C.; Marque, G.; Marque, C.; Teulieres, C.] CNRS, LRSV, UMR 5546, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Teulieres, C (corresponding author), Univ Toulouse, UPS, LRSV, UMR 5546, 24 Chemin Borde Rouge,BP 42617, F-31326 Castanet Tolosan, France.	teulieres@lrsv.ups-tlse.fr	Dunand, Christophe/I-6424-2012; Mounet, Fabien/F-3614-2011; CAO, Phi Bang/A-7688-2016	Dunand, Christophe/0000-0003-1637-4042; Mounet, Fabien/0000-0001-6632-3070; CAO, Phi Bang/0000-0001-9374-3839	Fibre Excellence (31 St Gaudens, France); French Ministry for Scientific Research (University Toulouse III (UPS); CNRS; Labex Tulip [ANR-10-LABX-41]; Vietnamese Government; Midi Pyrenees Regional Council (France)	Fibre Excellence (31 St Gaudens, France); French Ministry for Scientific Research (University Toulouse III (UPS); CNRS(Centre National de la Recherche Scientifique (CNRS)); Labex Tulip; Vietnamese Government; Midi Pyrenees Regional Council (France)(Region Occitanie)	This work was funded by Fibre Excellence (31, St Gaudens, France) associated with the Midi Pyrenees Regional Council (France) and also supported by the French Ministry for Scientific Research (University Toulouse III (UPS), CNRS and Labex Tulip (ANR-10-LABX-41); the Vietnamese Government provided the PBC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], BMC P; Artlip TS, 2013, TREE PHYSIOL, V33, P866, DOI 10.1093/treephys/tpt056; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen YL, 2013, SCI WORLD J, DOI 10.1155/2013/954640; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; FAO, 2007, STAT WORLDS FOR 2007; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Florence R.G, 1996, ECOLOGY SILVICULTURE; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Girardi CL, 2013, SCI HORTIC-AMSTERDAM, V151, P112, DOI 10.1016/j.scienta.2012.12.017; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hefer C, 2011, BMC P; Hinchee M., 2011, BMC P, V5, P124, DOI DOI 10.1186/1753-6561-5-S7-I24; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; JONES JDG, 1985, EMBO J, V4, P2411, DOI 10.1002/j.1460-2075.1985.tb03949.x; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Keller G, 2013, TREES-STRUCT FUNCT, V27, P1713, DOI 10.1007/s00468-013-0918-5; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lawton-Rauh A, 2003, MOL PHYLOGENET EVOL, V29, P396, DOI 10.1016/j.ympev.2003.07.004; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Lee SJ, 2009, MOL CELLS, V27, P409, DOI 10.1007/s10059-009-0058-3; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Lin HN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r41; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Moss PT, 2000, PALAEOGEOGR PALAEOCL, V155, P155, DOI 10.1016/S0031-0182(99)00099-1; Myburg AA, 2003, THEOR APPL GENET, V107, P1028, DOI 10.1007/s00122-003-1347-4; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Navarro M, 2011, PLANT BIOTECHNOL J, V9, P50, DOI 10.1111/j.1467-7652.2010.00530.x; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sandve SR, 2010, MOL ECOL, V19, P2075, DOI 10.1111/j.1365-294X.2010.04629.x; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Song J, 2013, GENE, V513, P118, DOI 10.1016/j.gene.2012.10.058; Song YP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-111; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tayeh N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-814; Tong Z, 2009, PLANT MOL BIOL, V71, P115, DOI 10.1007/s11103-009-9513-y; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Xiao H, 2008, PLANT CELL ENVIRON, V31, P1, DOI 10.1111/j.1365-3040.2007.01741.x; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Zhang W, 2011, PLANT BIOLOGY, V13, P343, DOI 10.1111/j.1438-8677.2010.00375.x; Zhao T, 2012, MOL GENET GENOMICS, V287, P423, DOI 10.1007/s00438-012-0687-7; Zhou M-L, 2013, BIOINFORMATICS, V7, DOI [10.2174/157489312802460776, DOI 10.2174/157489312802]; Zhou ML, 2012, CURR BIOINFORM, V7, P324, DOI 10.2174/157489312802460776; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002	73	31	35	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121041	10.1371/journal.pone.0121041	http://dx.doi.org/10.1371/journal.pone.0121041			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849589	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800042
J	Eguchi, A; Mulya, A; Lazic, M; Radhakrishnan, D; Berk, MP; Povero, D; Gornicka, A; Feldstein, AE				Eguchi, Akiko; Mulya, Anny; Lazic, Milos; Radhakrishnan, Deepa; Berk, Michael P.; Povero, Davide; Gornicka, Agnieszka; Feldstein, Ariel E.			Microparticles Release by Adipocytes Act as "Find-Me" Signals to Promote Macrophage Migration	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; APOPTOTIC CELLS; HEPATIC STEATOSIS; METABOLIC SYNDROME; OBESITY; INFLAMMATION; CLEARANCE; FAT; DEATH	Macrophage infiltration of adipose tissue during weight gain is a central event leading to the metabolic complications of obesity. However, what are the mechanisms attracting professional phagocytes to obese adipose tissue remains poorly understood. Here, we demonstrate that adipocyte-derived microparticles (MPs) are critical "find-me" signals for recruitment of monocytes and macrophages. Supernatants from stressed adipocytes stimulated the attraction of monocyte cells and primary macrophages. The activation of caspase 3 was required for release of these signals. Adipocytes exposed to saturated fatty acids showed marked release of MPs into the supernatant while common genetic mouse models of obesity demonstrate high levels of circulating adipocyte-derived MPs. The release of MPs was highly regulated and dependent on caspase 3 and Rho-associated kinase. Further analysis identified these MPs as a central chemoattractant in vitro and in vivo. In addition, intravenously transplanting circulating MPs from the ob/ob mice lead to activation of monocytes in circulation and adipose tissue of the wild type mice. These data identify adipocyte-derived MPs as novel "find me" signals that contributes to macrophage infiltration associated with obesity.	[Eguchi, Akiko; Lazic, Milos; Povero, Davide; Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Mulya, Anny; Radhakrishnan, Deepa; Berk, Michael P.; Gornicka, Agnieszka; Feldstein, Ariel E.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA	University of California System; University of California San Diego; Cleveland Clinic Foundation	Feldstein, AE (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	afeldstein@ucsd.edu	Berk, Michael/M-3585-2019; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946	NIH grant [U01 AA022489, DK082451]; Gilead research scholars program in liver disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA022489] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead research scholars program in liver disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant (U01 AA022489) and (DK082451) to AEF, and Gilead research scholars program in liver disease to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Diehl Anna Mae, 2003, Endocr Pract, V9 Suppl 2, P93; Dinkla S, 2013, NANOMEDICINE-UK, V8, P1657, DOI [10.2217/NNM.13.149, 10.2217/nnm.13.149]; Eguchi A, 2013, ADIPOCYTE, V2, P170, DOI 10.4161/adip.24144; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gornicka A, 2012, AM J PHYSIOL-ENDOC M, V303, pE597, DOI 10.1152/ajpendo.00022.2012; Gregory C, 2009, NATURE, V461, P181, DOI 10.1038/461181a; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nagaosa K, 2003, DEV GROWTH DIFFER, V45, P351; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Povero D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004512; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08	43	60	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123110	10.1371/journal.pone.0123110	http://dx.doi.org/10.1371/journal.pone.0123110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849214	Green Published, gold			2022-12-27	WOS:000352477800205
J	Farrell, B; Tsang, C; Raman-Wilms, L; Irving, H; Conklin, J; Pottie, K				Farrell, Barbara; Tsang, Corey; Raman-Wilms, Lalitha; Irving, Hannah; Conklin, James; Pottie, Kevin			What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process	PLOS ONE			English	Article							BENZODIAZEPINE USE; OLDER-ADULTS; POLYPHARMACY; MEDICATIONS; APPROPRIATENESS; OVERDIAGNOSIS; THERAPY; HEALTH; IMPACT; TRIALS	Polypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it difficult to carry out. Deprescribing guidelines would facilitate this process. The aim of this paper is to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review to identify potentially inappropriate medications for the elderly, an expert panel to develop survey content and three survey rounds to seek consensus on priorities. Panel participants included three pharmacists, two family physicians and one social scientist. Sixty-five Canadian geriatrics experts (36 pharmacists, 19 physicians and 10 nurse practitioners) participated in the survey. Twenty-nine drugs/drug classes were included in the first survey with 14 reaching the required (>= 70%) level of consensus, and 2 new drug classes added from qualitative comments. Fifty-three participants completed round two, and 47 participants completed round three. The final five priorities were benzodiazepines, atypical antipsychotics, statins, tricyclic antidepressants, and proton pump inhibitors; nine other drug classes were also identified as being in need of evidence-based deprescribing guidelines. The Delphi consensus process identified five priority drug classes for which expert clinicians felt guidance is needed for deprescribing. The classes of drugs that emerged strongly from the rankings dealt with mental health, cardiovascular, gastroenterological, and neurological conditions. The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based deprescribing guidelines are a priority in the care of the elderly.	[Farrell, Barbara; Tsang, Corey; Irving, Hannah; Conklin, James; Pottie, Kevin] Bruyere Res Inst, Ottawa, ON, Canada; [Farrell, Barbara; Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Farrell, Barbara; Tsang, Corey] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada; [Raman-Wilms, Lalitha] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Conklin, James] Concordia Univ, Dept Appl Human Sci, Montreal, PQ, Canada	University of Ottawa; University of Ottawa; University of Waterloo; University of Toronto; Concordia University - Canada	Farrell, B (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.	bfarrell@bruyere.org	Pottie, Kevin/ABC-4385-2020	Tsang, Corey/0000-0002-2087-1888	Ontario Ministry of Health and Long-Term Care	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by the Ontario Ministry of Health and Long-Term Care (http://www.health.gov.on.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BF is the principal investigator; JC is the co-principal investigator.	American Geriatrics Society, 2012, AGS UPD BEERS CRIT P; [Anonymous], 2010, DELPHI TECHNIQUE NUR; [Anonymous], 2007, PRACTICAL ASSESSMENT, DOI [DOI 10.1576/T0AG.7.2.120.27071, DOI 10.7275/PDZ9-TH90]; Anthierens S, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-65; Bain KT, 2008, J AM GERIATR SOC, V56, P1946, DOI 10.1111/j.1532-5415.2008.01916.x; Bierman Arlene S, 2007, Am J Geriatr Pharmacother, V5, P147, DOI 10.1016/j.amjopharm.2007.06.005; Borghesani PR, 2011, J AM GERIATR SOC, V59, P376, DOI 10.1111/j.1532-5415.2011.03252.x; bpacnz, 2010, BEST PRACTICE J, V27; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Byatt Kit, 2014, Evid Based Med, V19, P121, DOI 10.1136/eb-2013-101646; Canadian Institute for Health Information, 2007, DRUG CLAIMS SEN AN F; Canadian Institute for Health Information, 2012, US SEL PSYCH DRUGS S; Canadian Institute for Health Information (CIHI), 2013, ADVERSE DRUG REACT T; Chokshi NP, 2012, AM J CARDIOL, V110, P1477, DOI 10.1016/j.amjcard.2012.06.058; Declercq T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007726.pub2; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Field A., 2009, DISCOVERING STAT USI, P539, DOI DOI 10.1111/J.1365-2648.2007.04270_1.X; Garfinkel D, 2007, ISR MED ASSOC J, V9, P430; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gnjidic D, 2012, CLIN GERIATR MED, V28, P237, DOI 10.1016/j.cger.2012.01.006; Godlee F., 2012, BMJ-BRIT MED J, V344, pe3783, DOI [10.1136/bmj.e3783, DOI 10.1136/BMJ.E3783]; Gokula M, 2012, CLIN GERIATR MED, V28, P323, DOI 10.1016/j.cger.2012.01.011; Gould RL, 2014, BRIT J PSYCHIAT, V204, P98, DOI 10.1192/bjp.bp.113.126003; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hamilton Hilary J, 2009, BMC Geriatr, V9, P5, DOI 10.1186/1471-2318-9-5; Hardy James E., 2011, Journal of Pharmacy Practice and Research, V41, P146; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Heath I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6361; Heidelbaugh JJ, 2010, AM J MANAG CARE, V16, pE228; Heidelbaugh JJ, 2009, AM J GASTROENTEROL, V104, pS27, DOI 10.1038/ajg.2009.49; Holey EA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-52; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Iyer S, 2008, DRUG AGING, V25, P1021, DOI 10.2165/0002512-200825120-00004; Jyrkka J, 2009, DRUG AGING, V26, P1039, DOI 10.2165/11319530-000000000-00000; Lane CJ, 2004, J AM GERIATR SOC, V52, P861, DOI 10.1111/j.1532-5415.2004.52250.x; Le Couteur D, 2011, AUST PRESCR, V34, P182; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; Ontario Drug Benefit Program, 2012, 2010 11 REP CARD ONT; Ott SM, 2011, CLEV CLIN J MED, V78, P619, DOI 10.3949/ccjm.78a.11022; Pare G, 2013, INFORM MANAGE-AMSTER, V50, P207, DOI 10.1016/j.im.2013.03.003; Patton M. Q, 2002, QUALITATIVE RES EVAL, P431; Reason B, 2012, FAM PRACT, V29, P427, DOI 10.1093/fampra/cmr124; Reeve E, 2013, DRUG AGING, V30, P793, DOI 10.1007/s40266-013-0106-8; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; Sergi G, 2011, DRUG AGING, V28, P509, DOI 10.2165/11592010-000000000-00000; Sithamparanathan K., 2012, ASIAN J GERONTOL GER, V7, P107; Spijker-Huiges Antje, 2006, Eur J Gen Pract, V12, P10, DOI 10.1080/13814780600757120; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Swinkels H, 2011, CAN MED ASSOC J, V183, pE928, DOI 10.1503/cmaj.090290; Sykes L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005398.pub3; Voshaar RCO, 2006, BRIT J PSYCHIAT, V189, P213, DOI 10.1192/bjp.189.3.213; Welch GH, 2011, OVER DIAGNOSED MAKIN; Woodward MC., 2003, J PHARM PRACT RES, V33, P323, DOI [10.1002/jppr2003334323, DOI 10.1002/JPPR2003334323]; Wu C, 2012, DRUG SAFETY, V35, P769, DOI 10.2165/11599540-000000000-00000; Ziere G, 2006, BRIT J CLIN PHARMACO, V61, P218, DOI 10.1111/j.1365-2125.2005.02543.x; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	63	108	112	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122246	10.1371/journal.pone.0122246	http://dx.doi.org/10.1371/journal.pone.0122246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849568	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800112
J	Gerards, SMPL; Dagnelie, PC; Gubbels, JS; van Buuren, S; Hamers, FJM; Jansen, MWJ; van der Goot, OHM; de Vries, NK; Sanders, MR; Kremers, SPJ				Gerards, Sanne M. P. L.; Dagnelie, Pieter C.; Gubbels, Jessica S.; van Buuren, Stef; Hamers, Femke J. M.; Jansen, Maria W. J.; van der Goot, Odilia H. M.; de Vries, Nanne K.; Sanders, Matthew R.; Kremers, Stef P. J.			The Effectiveness of Lifestyle Triple P in the Netherlands: A Randomized Controlled Trial	PLOS ONE			English	Article							BODY-MASS INDEX; PSYCHOLOGICAL CONTROL; FAMILY INTERVENTION; OVERWEIGHT CHILDREN; PREVENT OBESITY; PARENTS; BEHAVIOR; PROGRAM; IMPACT; ISSUES	Introduction Lifestyle Triple P is a general parenting intervention which focuses on preventing further excessive weight gain in overweight and obese children. The objective of the current study was to assess the effectiveness of the Lifestyle Triple P intervention in the Netherlands. Method We used a parallel randomized controlled design to test the effectiveness of the intervention. In total, 86 child-parent triads (children 4-8 years old, overweight or obese) were recruited and randomly assigned (allocation ratio 1: 1) to the Lifestyle Triple P intervention or the control condition. Parents in the intervention condition received a 14-week intervention consisting of ten 90-minute group sessions and four individual telephone sessions. Primary outcome measure was the children's body composition (BMI z-scores, waist circumference and skinfolds). The research assistant who performed the measurements was blinded for group assignment. Secondary outcome measures were the children's dietary behavior and physical activity level, parenting practices, parental feeding style, parenting style, and parental self-efficacy. Outcome measures were assessed at baseline and 4 months (short-term) and 12 months (long-term) after baseline. Multilevel multiple regression analyses were conducted to determine the effect of the intervention on primary and secondary outcome measures. Results No intervention effects were found on children's body composition. Analyses of secondary outcomes showed positive short-term intervention effects on children's soft-drink consumption and parental responsibility regarding physical activity, encouragement to eat, psychological control, and efficacy and satisfaction with parenting. Longer-term intervention effects were found on parent's report of children's time spent on sedentary behavior and playing outside, parental monitoring food intake, and responsibility regarding nutrition. Conclusion Although the Lifestyle Triple P intervention showed positive effects on some parent reported child behaviors and parenting measures, no effects were visible on children's body composition or objectively measured physical activity. Several adjustments of the intervention content are recommended, for example including a booster session.	[Gerards, Sanne M. P. L.; Gubbels, Jessica S.; Hamers, Femke J. M.; de Vries, Nanne K.; Kremers, Stef P. J.] Maastricht Univ, Dept Hlth Promot, NL-6200 MD Maastricht, Netherlands; [Gerards, Sanne M. P. L.; Gubbels, Jessica S.; Hamers, Femke J. M.; de Vries, Nanne K.; Kremers, Stef P. J.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, NL-6200 MD Maastricht, Netherlands; [Dagnelie, Pieter C.] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; [Dagnelie, Pieter C.; Jansen, Maria W. J.; de Vries, Nanne K.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands; [Dagnelie, Pieter C.] Maastricht Univ, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands; [van Buuren, Stef] Netherlands Org Appl Sci Res TNO, Leiden, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands; [Jansen, Maria W. J.] Publ Hlth Serv, Acad Collaborat Ctr Publ Hlth Limburg, Geleen, Netherlands; [van der Goot, Odilia H. M.] Publ Hlth Serv, Dept Youth Hlth Care, Geleen, Netherlands; [Sanders, Matthew R.] Univ Queensland, Sch Psychol, Parenting & Family Support Ctr, Brisbane, Qld, Australia	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Netherlands Organization Applied Science Research; Utrecht University; University of Queensland	Gerards, SMPL (corresponding author), Maastricht Univ, Dept Hlth Promot, NL-6200 MD Maastricht, Netherlands.	sanne.gerards@maastrichtuniversity.nl	Sanders, Matthew R/C-1941-2013	Sanders, Matthew R/0000-0003-3479-6337; Gubbels, Jessica Sophia/0000-0002-9284-1725; van Buuren, Stef/0000-0003-1098-2119	Netherlands Organization for Health Research and Development (ZonMW) [120520009]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The present study was funded by the Netherlands Organization for Health Research and Development (ZonMW), project number 120520009. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.2307/1131780; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Block J.H., 1965, CHILD REARING PRACTI; Brants H., 2006, VOEDING NU, V2, P25; Brotman LM, 2012, PEDIATRICS, V129, pE621, DOI 10.1542/peds.2011-1568; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; Dekovic M, 1989, MEASURING DIMENSIONS; Dutman AE, 2011, PUBLIC HEALTH NUTR, V14, P410, DOI 10.1017/S1368980010002119; Eurostat, 2007, TAKSF COR SOC VAR FI; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Foster N, 2012, BRIT J GEN PRACT, V62, P10, DOI 10.3399/bjgp12X616238; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Gerards SMPL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-267; Gerards SMPL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-37; Gerards SMPL, 2011, INT J PEDIATR OBES, V6, pE28, DOI 10.3109/17477166.2011.575147; Golan M, 2006, BRIT J NUTR, V95, P1008, DOI 10.1079/BJN20061757; Golley RK, 2011, OBES REV, V12, P114, DOI 10.1111/j.1467-789X.2010.00745.x; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; Gubbels JS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-18; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hughes SO, 2013, CHILD OBES, V9, pS95, DOI 10.1089/chi.2013.0032; JOHNSTON C, 1989, J CLIN CHILD PSYCHOL, V18, P167, DOI 10.1207/s15374424jccp1802_8; Knowlden AP, 2012, OBES REV, V13, P499, DOI 10.1111/j.1467-789X.2011.00976.x; Koepsell TD, 2011, AM J PREV MED, V40, P191, DOI 10.1016/j.amepre.2010.10.022; Lipsey MW., 1990, DESIGN SENSITIVITY; Magarey AM, 2011, PEDIATRICS, V127, P214, DOI 10.1542/peds.2009-1432; Moens E, 2012, BEHAV COGN PSYCHOTH, V40, P1, DOI 10.1017/S1352465811000403; Ostbye T, 2012, PREV MED, V55, P188, DOI 10.1016/j.ypmed.2012.06.005; Robertson W, 2008, ARCH DIS CHILD, V93, P921, DOI 10.1136/adc.2008.139162; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rodenburg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050642; Rodenburg G, 2011, INT J PEDIATR OBES, V6, P442, DOI 10.3109/17477166.2011.590203; Sanders M.R., 2003, PARENTING RES PRACTI, V1, P1; Sanders MR, 2012, ANNU REV CLIN PSYCHO, V8, P345, DOI 10.1146/annurev-clinpsy-032511-143104; Sandler IN, 2011, ANNU REV PSYCHOL, V62, P299, DOI 10.1146/annurev.psych.121208.131619; Sleddens EFC, 2014, APPETITE, V79, P42, DOI 10.1016/j.appet.2014.04.004; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Sleddens EFC, 2010, APPETITE, V54, P30, DOI 10.1016/j.appet.2009.09.002; Stark LJ, 2011, OBESITY, V19, P134, DOI 10.1038/oby.2010.87; Turner MT, 2007, HANDLEIDING BEGELEID; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; Visscher TLS, 2004, INT J OBESITY, V28, P1309, DOI 10.1038/sj.ijo.0802761; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; West F., 2010, FACILITATORS MANUAL; West F, 2010, BEHAV RES THER, V48, P1170, DOI 10.1016/j.brat.2010.08.008; World Health Organization, 2013, CHILDH OV OB	51	38	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122240	10.1371/journal.pone.0122240	http://dx.doi.org/10.1371/journal.pone.0122240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849523	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800111
J	Gutmann, J; Kuhbeck, F; Berberat, PO; Fischer, MR; Engelhardt, S; Sarikas, A				Gutmann, Joanna; Kuehbeck, Felizian; Berberat, Pascal O.; Fischer, Martin R.; Engelhardt, Stefan; Sarikas, Antonio			Use of Learning Media by Undergraduate Medical Students in Pharmacology: A Prospective Cohort Study	PLOS ONE			English	Article							DIGITAL NATIVES; GENDER; INFORMATION; TECHNOLOGY; SMARTPHONE; RESOURCES; EDUCATION; PATTERNS	The ubiquity of the internet and computer-based technologies has an increasing impact on higher education and the way students access information for learning. Moreover, there is a paucity of information about the quantitative and qualitative use of learning media by the current student generation. In this study we systematically analyzed the use of digital and non-digital learning resources by undergraduate medical students. Daily online surveys and semi-structured interviews were conducted with a cohort of 338 third year medical students enrolled in a general pharmacology course. Our data demonstrate a predominant use of digital over non-digital learning resources (69 +/- 7% vs. 31 +/- 7%; p < 0.01) by students. Most used media for learning were lecture slides (26.8 +/- 3.0%), apps (22.0 +/- 3.7%) and personal notes (15.5 +/- 2.7%), followed by textbooks (> 300 pages) (10.6 +/- 3.3%), internet search (7.9 +/- 1.6%) and e-learning cases (7.6 +/- 3.0%). When comparing learning media use of teaching vs. pre-exam self-study periods, textbooks were used significantly less during self-study (-55%; p < 0.01), while exam questions (+334%; p < 0.01) and e-learning cases (+176%; p < 0.01) were utilized more. Taken together, our study revealed a high prevalence and acceptance of digital learning resources by undergraduate medical students, in particular mobile applications.	[Gutmann, Joanna; Kuehbeck, Felizian; Engelhardt, Stefan; Sarikas, Antonio] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80290 Munich, Bavaria, Germany; [Berberat, Pascal O.] Tech Univ Munich, TUM Med Ctr Med Educ, D-80290 Munich, Bavaria, Germany; [Fischer, Martin R.] Univ Munich, Klinikum, Inst Didakt & Ausbildungsforsch Med, Munich, Bavaria, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Sarikas, A (corresponding author), Tech Univ Munich, Inst Pharmacol & Toxicol, D-80290 Munich, Bavaria, Germany.	sarikas@ipt.med.tum.de	Engelhardt, Stefan/AAA-9329-2019	Engelhardt, Stefan/0000-0001-5378-8661	Technische Universitat Munchen	Technische Universitat Munchen	This work was supported by a teaching fund (to A.S.) of Technische Universitat Munchen (http://www.tum.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, STATISTICAL YEARBOOK; Baudains C, 2013, EDUC PRIM CARE, V24, P340, DOI 10.1080/14739879.2013.11494198; Baumgart DC, 2011, ARCH INTERN MED, V171, P1294, DOI 10.1001/archinternmed.2011.320; Bennett S, 2008, BRIT J EDUC TECHNOL, V39, P775, DOI 10.1111/j.1467-8535.2007.00793.x; Brennan N, 2014, HEALTH INFO LIBR J, V31, P204, DOI 10.1111/hir.12072; Briscoe GW, 2006, ACAD PSYCHIATR, V30, P470, DOI 10.1176/appi.ap.30.6.470; Broos A, 2005, CYBERPSYCHOL BEHAV, V8, P21, DOI 10.1089/cpb.2005.8.21; Cooper AL, 2011, CLIN TEACH, V8, P43, DOI 10.1111/j.1743-498X.2010.00393.x; Davies BS, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-1; Ellaway RH, 2014, MED TEACH, V36, P130, DOI 10.3109/0142159X.2013.849800; Frand J, 2000, EDUCAUSE REV, P15; Glaser, 1967, INT J QUAL METH, DOI [DOI 10.2307/588533, 10.2307/588533]; Harley D, 2006, STUD HIGH EDUC, V94720, P326; Imhof M, 2007, COMPUT HUM BEHAV, V23, P2823, DOI 10.1016/j.chb.2006.05.007; KOZMA RB, 1991, REV EDUC RES, V61, P179, DOI 10.2307/1170534; Kuhbeck F, 2014, GMS Z MED AUSBILD, V31, P1; Leff B, 2006, ACAD MED, V81, P489, DOI 10.1097/01.ACM.0000222273.90705.a6; Lust G, 2011, COMPUT EDUC, V57, P2135, DOI 10.1016/j.compedu.2011.05.010; Maykut P, 1994, BEGINNING QUALITATIV, DOI [10.4324/9780203485781, DOI 10.4324/9780203485781]; Nguyen L, 2014, BR J EDUC TECHNOL; Oblinger D., 2005, EDUCATING THE NET GE; Pander T, 2014, GMS Z MED AUSBILD, V31, P1; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Payne KFB, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-121; Peterson MW, 2004, ACAD MED, V79, P89, DOI 10.1097/00001888-200401000-00019; Prensky Marc., 2001, HORIZON, V5, P1, DOI [10.1108/10748120110424816, DOI 10.1108/10748120110424816]; Robinson T, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9936-5; Sanchez-Franco MJ, 2006, BEHAV INFORM TECHNOL, V25, P19, DOI 10.1080/01449290500124536; Sandars J, 2007, MED TEACH, V29, P85, DOI 10.1080/01421590601176380; Sandars J, 2008, MED TEACH, V30, P308, DOI 10.1080/01421590701798729; Tapscott D, 1999, EDUC LEADERSHIP, V56, P6; Tapscott D, 1998, GROWING UP DIGITAL T; Thompson P, 2013, COMPUT EDUC, V65, P12, DOI 10.1016/j.compedu.2012.12.022; Wallace S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001099; Woody W., 2010, COMPUT EDUC, V55, P1, DOI [10.1016/j.compedu.2010.04.005, DOI 10.1016/J.C0MPEDU.2010.04.005]	35	32	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122624	10.1371/journal.pone.0122624	http://dx.doi.org/10.1371/journal.pone.0122624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849565	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800149
J	Matthews, AGW; Briggs, CE; Yamanaka, K; Small, TN; Mooster, JL; Bonilla, FA; Oettinger, MA; Butte, MJ				Matthews, Adam G. W.; Briggs, Christine E.; Yamanaka, Keiichi; Small, Trudy N.; Mooster, Jana L.; Bonilla, Francisco A.; Oettinger, Marjorie A.; Butte, Manish J.			Compound Heterozygous Mutation of Rag1 Leading to Omenn Syndrome	PLOS ONE			English	Article							ACTIVATING GENE-1 DEFICIENCY; V(D)J RECOMBINATION ACTIVITY; COMBINED IMMUNE-DEFICIENCY; PRIMARY IMMUNODEFICIENCIES; PLANT HOMEODOMAIN; IN-VIVO; LYSINE-4; PROTEINS; CLEAVAGE; DISEASE	Omenn syndrome is a primary immunodeficiency disorder, featuring susceptibility to infections and autoreactive T cells and resulting from defective genomic rearrangement of genes for the T cell and B cell receptors. The most frequent etiologies are hypomorphic mutations in "non-core" regions of the Rag1 or Rag2 genes, the protein products of which are critical members of the cellular apparatus for V(D)J recombination. In this report, we describe an infant with Omenn syndrome with a previously unreported termination mutation (p.R142*) in Rag1 on one allele and a partially characterized substitution mutation (p.V779M) in a "core" region of the other Rag1 allele. Using a cellular recombination assay, we found that while the p.R142* mutation completely abolished V(D) J recombination activity, the p.V779M mutation conferred a severe, but not total, loss of V(D) J recombination activity. The recombination defect of the V779 mutant was not due to overall misfolding of Rag1, however, as this mutant supported wild-type levels of V(D) J cleavage. These findings provide insight into the role of this poorly understood region of Rag1 and support the role of Rag1 in a post-cleavage stage of recombination.	[Matthews, Adam G. W.; Oettinger, Marjorie A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Matthews, Adam G. W.; Oettinger, Marjorie A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Matthews, Adam G. W.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02481 USA; [Briggs, Christine E.] Childrens Hosp, Mol Genet Core Facil, Boston, MA 02115 USA; [Yamanaka, Keiichi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 5148507, Japan; [Small, Trudy N.] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant Serv, New York, NY 10065 USA; [Mooster, Jana L.; Bonilla, Francisco A.] Boston Childrens Hosp, Div Immunol Allergy & Rheumatol, Dept Pediat, Boston, MA 02115 USA; [Butte, Manish J.] Stanford Univ, Dept Pediat, Div Immunol Allergy & Rheumatol, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Wellesley College; Harvard University; Boston Children's Hospital; Mie University; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Stanford University	Butte, MJ (corresponding author), Stanford Univ, Dept Pediat, Div Immunol Allergy & Rheumatol, 300 Pasteur Dr, Stanford, CA 94305 USA.	manish.butte@stanford.edu	Butte, Manish/T-8860-2019; Butte, Manish/AAM-8604-2020	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595	National Institutes of Health [K08 AI079268]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health K08 AI079268 (MJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle JL, 2001, J BIOL CHEM, V276, P37093, DOI 10.1074/jbc.M105988200; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Chen K, 2014, J ALLERGY CLIN IMMUN, V133, P880, DOI 10.1016/j.jaci.2013.11.038; Corneo B, 2000, J BIOL CHEM, V275, P12672, DOI 10.1074/jbc.275.17.12672; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Dalal I, 2005, CLIN IMMUNOL, V115, P70, DOI 10.1016/j.clim.2004.08.016; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; DESAINTBASILE G, 1991, J CLIN INVEST, V87, P1352, DOI 10.1172/JCI115139; Ege M, 2005, BLOOD, V105, P4179, DOI 10.1182/blood-2004-12-4861; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; GAUSS GH, 1993, MOL CELL BIOL, V13, P3900, DOI 10.1128/MCB.13.7.3900; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gennery AR, 2005, CLIN IMMUNOL, V116, P246, DOI 10.1016/j.clim.2005.04.014; Giliani S, 2006, J PEDIATR-US, V148, P272, DOI 10.1016/j.jpeds.2005.10.004; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; Gwyn LM, 2009, J MOL BIOL, V390, P863, DOI 10.1016/j.jmb.2009.05.076; Henderson LA, 2013, J ALLERGY CLIN IMMUN, V132, P969, DOI 10.1016/j.jaci.2013.06.032; Honig M, 2006, CURR OPIN RHEUMATOL, V18, P383; Kim DR, 1998, MOL CELL BIOL, V18, P4679, DOI 10.1128/MCB.18.8.4679; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Marrella V, 2011, CURR OPIN ALLERGY CL, V11, P525, DOI 10.1097/ACI.0b013e32834c311a; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Matthews AGW, 2004, EMBO J, V23, P1198, DOI 10.1038/sj.emboj.7600131; Niehues T, 2010, CLIN IMMUNOL, V135, P183, DOI 10.1016/j.clim.2010.01.013; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OMENN GS, 1965, NEW ENGL J MED, V273, P427, DOI 10.1056/NEJM196508192730806; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Roifman CM, 2006, J ALLERGY CLIN IMMUN, V117, P897, DOI 10.1016/j.jaci.2006.01.003; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Santagata S, 2000, P NATL ACAD SCI USA, V97, P14572, DOI 10.1073/pnas.97.26.14572; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Schuetz C, 2014, J ALLERGY CLIN IMMUN, V133, P1211, DOI 10.1016/j.jaci.2013.10.021; Schultz HY, 2001, MOL CELL, V7, P65, DOI 10.1016/S1097-2765(01)00155-1; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Simkus C, 2007, J IMMUNOL, V179, P8332, DOI 10.4049/jimmunol.179.12.8332; Sobacchi C, 2006, HUM MUTAT, V27, P1174, DOI 10.1002/humu.20408; Somech R, 2009, J ALLERGY CLIN IMMUN, V124, P793, DOI 10.1016/j.jaci.2009.06.048; Spanopoulou E, 1995, IMMUNITY, V3, P715, DOI 10.1016/1074-7613(95)90061-6; Tsai CL, 2002, GENE DEV, V16, P1934, DOI 10.1101/gad.984502; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Villa A, 1999, J CLIN IMMUNOL, V19, P87, DOI 10.1023/A:1020550432126; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Yawalkar N, 2003, BLOOD, V102, P4059, DOI 10.1182/blood-2003-04-1044	52	8	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121489	10.1371/journal.pone.0121489	http://dx.doi.org/10.1371/journal.pone.0121489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849362	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800062
J	Xing, K; Zhu, F; Zhai, LW; Liu, HJ; Wang, Y; Wang, ZJ; Chen, SK; Hou, ZC; Wang, CD				Xing, Kai; Zhu, Feng; Zhai, Liwei; Liu, Huijie; Wang, Yuan; Wang, Zhijun; Chen, Shaokang; Hou, Zhuocheng; Wang, Chuduan			Integration of Transcriptome and Whole Genomic Resequencing Data to Identify Key Genes Affecting Swine Fat Deposition	PLOS ONE			English	Article							PORCINE ADIPOSE-TISSUE; DIFFERENTIAL EXPRESSION; ACID SYNTHESIS; RETINOID METABOLISM; EXTREME PHENOTYPES; BACKFAT THICKNESS; NUCLEAR RECEPTORS; NATIVE PIG; MUSCLE; LIVER	Fat deposition is highly correlated with the growth, meat quality, reproductive performance and immunity of pigs. Fatty acid synthesis takes place mainly in the adipose tissue of pigs; therefore, in this study, a high-throughput massively parallel sequencing approach was used to generate adipose tissue transcriptomes from two groups of Songliao black pigs that had opposite backfat thickness phenotypes. The total number of paired-end reads produced for each sample was in the range of 39.29-49.36 millions. Approximately 188 genes were differentially expressed in adipose tissue and were enriched for metabolic processes, such as fatty acid biosynthesis, lipid synthesis, metabolism of fatty acids, etinol, caffeine and arachidonic acid and immunity. Additionally, many genetic variations were detected between the two groups through pooled whole-genome resequencing. Integration of transcriptome and whole-genome resequencing data revealed important genomic variations among the differentially expressed genes for fat deposition, for example, the lipogenic genes. Further studies are required to investigate the roles of candidate genes in fat deposition to improve pig breeding programs.	[Xing, Kai; Zhu, Feng; Zhai, Liwei; Liu, Huijie; Wang, Yuan; Hou, Zhuocheng; Wang, Chuduan] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; [Wang, Zhijun] China Agr Univ, Dept Anim Genet & Breeding, MOA Key Lab Anim Genet & Breeding, Beijing 100193, Peoples R China; [Wang, Zhijun] Tianjin Ninghe Primary Pig Breeding Farm, Tianjin 301500, Peoples R China; [Chen, Shaokang] Anim Husb & Vet Stn Beijing, Beijing 100125, Peoples R China	China Agricultural University; China Agricultural University	Hou, ZC (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	zchou@cau.edu.cn; cdwang@cau.edu.cn		Xing, Kai/0000-0002-2556-6946	Beijing team of the Pig Industry Technology System Innovation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAD28B01]; Tianjin Ninghe primary pig breeding farm	Beijing team of the Pig Industry Technology System Innovation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Tianjin Ninghe primary pig breeding farm	This research was financially supported by the Beijing team of the Pig Industry Technology System Innovation and National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2011BAD28B01). Tianjin Ninghe primary pig breeding farm provided support in the form of a salary for author ZW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions' section.	Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Choi KM, 2008, ASIAN AUSTRAL J ANIM, V21, P967, DOI 10.5713/ajas.2008.80059; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Corominas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053687; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Doran O, 2006, BRIT J NUTR, V95, P609, DOI 10.1079/BJN20051526; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fam BC, 2012, ADIPOCYTE, V1, P259, DOI 10.4161/adip.21448; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOUPT KA, 1979, YALE J BIOL MED, V52, P307; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kopecky J, 2004, PHYSIOL RES, V53, pS225; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XJ, 2012, ANIM GENET, V43, P144, DOI 10.1111/j.1365-2052.2011.02240.x; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moon JK, 2009, ANIM GENET, V40, P115, DOI 10.1111/j.1365-2052.2008.01798.x; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ren ZQ, 2008, GENET SEL EVOL, V40, P625, DOI 10.1051/gse:2008024; Roman J, 2008, J INVEST MED, V56, P528, DOI 10.2310/JIM.0b013e3181659932; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Sodhi SS, 2014, MOL BIOL REP, V41, P6305, DOI 10.1007/s11033-014-3513-y; Stachowiak M, 2013, MEAT SCI, V95, P64, DOI 10.1016/j.meatsci.2013.04.021; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Suzuki K, 2009, J ANIM SCI, V87, P2209, DOI 10.2527/jas.2008-0866; Taniguchi M, 2008, COMP BIOCHEM PHYS D, V3, P251, DOI 10.1016/j.cbd.2008.06.002; Tarazona S, 2013, NOISEQ DIFFERENTIAL; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tummaruk P, 2009, ANIM REPROD SCI, V110, P108, DOI 10.1016/j.anireprosci.2008.01.004; Vidal O, 2006, ANIM GENET, V37, P28, DOI 10.1111/j.1365-2052.2005.01366.x; WAKIL SJ, 1960, BIOCHIM BIOPHYS ACTA, V41, P122, DOI 10.1016/0006-3002(60)90377-2; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang T, 2013, INT J BIOL SCI, V9, P550, DOI 10.7150/ijbs.6257; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Xing K, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-32; Zempleni J, 2012, ADV NUTR, V3, P213, DOI 10.3945/an.111.001305; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou SL, 2012, GENET MOL RES, V11, P1254, DOI 10.4238/2012.May.9.4; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081	58	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122396	10.1371/journal.pone.0122396	http://dx.doi.org/10.1371/journal.pone.0122396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849573	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800126
J	Yan, W; Hu, ZM; Zhao, YP; Zhang, XZ; Fan, YZ; Shi, PL; He, YT; Yu, GR; Li, YN				Yan, Wei; Hu, Zhongmin; Zhao, Yuping; Zhang, Xianzhou; Fan, Yuzhi; Shi, Peili; He, Yongtao; Yu, Guirui; Li, Yingnian			Modeling Net Ecosystem Carbon Exchange of Alpine Grasslands with a Satellite-Driven Model	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; USE EFFICIENCY MODEL; TEMPERATURE-DEPENDENCE; VEGETATION INDEXES; INTEGRATING MODIS; FLUX MEASUREMENTS; DIOXIDE EXCHANGE; UNITED-STATES; CO2 EXCHANGE; RESPIRATION	Estimate of net ecosystem carbon exchange (NEE) between the atmosphere and terrestrial ecosystems, the balance of gross primary productivity (GPP) and ecosystem respiration (Reco) has significant importance for studying the regional and global carbon cycles. Using models driven by satellite data and climatic data is a promising approach to estimate NEE at regional scales. For this purpose, we proposed a semi-empirical model to estimate NEE in this study. In our model, the component GPP was estimated with a light response curve of a rectangular hyperbola. The component Reco was estimated with an exponential function of soil temperature. To test the feasibility of applying our model at regional scales, the temporal variations in the model parameters derived from NEE observations in an alpine grassland ecosystem on Tibetan Plateau were investigated. The results indicated that all the inverted parameters exhibit apparent seasonality, which is in accordance with air temperature and canopy phenology. In addition, all the parameters have significant correlations with the remote sensed vegetation indexes or environment temperature. With parameters estimated with these correlations, the model illustrated fair accuracy both in the validation years and at another alpine grassland ecosystem on Tibetan Plateau. Our results also indicated that the model prediction was less accurate in drought years, implying that soil moisture is an important factor affecting the model performance. Incorporating soil water content into the model would be a critical step for the improvement of the model.	[Yan, Wei; Zhao, Yuping; Zhang, Xianzhou; Fan, Yuzhi; Shi, Peili; He, Yongtao] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Lhasa Plateau Ecosyst Res Stn, Beijing 100101, Peoples R China; [Yan, Wei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Yan, Wei] Beijing Meteorol Bur, Beijing 100089, Peoples R China; [Hu, Zhongmin; Yu, Guirui] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; [Li, Yingnian] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining 810001, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences	Zhang, XZ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Lhasa Plateau Ecosyst Res Stn, Beijing 100101, Peoples R China.	zhangxz@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; zhang, xian/GYA-0290-2022; Peili, SHi/AAT-6450-2021	于, 贵瑞/0000-0002-1859-8966; shi, pei li/0000-0002-1120-0003	National Natural Science Foundation of China [41301043, 41171044]; National Key Technology RD Program [2011BAC09B03]; CAS action-plan for West Development [KZCX2-XB3-08]; Foundation for young scholars of IGSNRR [2013RC203]; CAS [XDB03030401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); CAS action-plan for West Development; Foundation for young scholars of IGSNRR; CAS(Chinese Academy of Sciences)	This research was jointly funded by National Natural Science Foundation of China (Grant No. 41301043, 41171044), National Key Technology R&D Program (2011BAC09B03), CAS action-plan for West Development (No. KZCX2-XB3-08), Foundation for young scholars of IGSNRR (2013RC203), and the special fund for the Tibet of CAS (XDB03030401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Carter GA, 1998, REMOTE SENS ENVIRON, V63, P61, DOI 10.1016/S0034-4257(97)00110-7; Choudhury BJ, 2001, REMOTE SENS ENVIRON, V75, P1, DOI 10.1016/S0034-4257(00)00151-6; Dobrowski SZ, 2005, REMOTE SENS ENVIRON, V97, P403, DOI 10.1016/j.rse.2005.05.006; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fu YL, 2006, AGR FOREST METEOROL, V137, P234, DOI 10.1016/j.agrformet.2006.02.009; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Gilmanov TG, 2005, GLOBAL ECOL BIOGEOGR, V14, P271, DOI 10.1111/j.1466-822x.2005.00151.x; Gitelson AA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045003; Gockede M, 2008, BIOGEOSCIENCES, V5, P433; Goetz SJ, 1999, ECOL MODEL, V122, P239, DOI 10.1016/S0304-3800(99)00140-4; Goudriaan J., 1985, NATO ASI SERIES A, V86, P107; He MZ, 2013, AGR FOREST METEOROL, V173, P28, DOI 10.1016/j.agrformet.2013.01.003; Hirose T, 1997, ECOLOGY, V78, P2339; Hollinger DY, 1999, GLOB CHANGE BIOL, V5, P891, DOI 10.1046/j.1365-2486.1999.00281.x; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Ide R, 2010, AGR FOREST METEOROL, V150, P389, DOI 10.1016/j.agrformet.2009.12.009; Inoue Y, 2008, REMOTE SENS ENVIRON, V112, P156, DOI 10.1016/j.rse.2007.04.011; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Migliavacca M, 2014, GLOBAL CHANGE BIOL; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2006, AGR FOREST METEOROL, V141, P219, DOI 10.1016/j.agrformet.2006.10.010; Running S. W., 1999, MODIS DAILY PHOTOSYN; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Shi PL, 2006, SCI CHINA SER D, V49, P207, DOI 10.1007/s11430-006-8207-4; Smith ML, 2002, ECOL APPL, V12, P1286; Tang XG, 2012, AGR FOREST METEOROL, V156, P75, DOI 10.1016/j.agrformet.2012.01.003; Tang XG, 2011, ECOL ENG, V37, P1567, DOI 10.1016/j.ecoleng.2011.03.030; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Xiao JF, 2011, AGR FOREST METEOROL, V151, P60, DOI 10.1016/j.agrformet.2010.09.002; Xiao JF, 2010, REMOTE SENS ENVIRON, V114, P576, DOI 10.1016/j.rse.2009.10.013; Xiao JF, 2008, AGR FOREST METEOROL, V148, P1827, DOI 10.1016/j.agrformet.2008.06.015; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Xiao XM, 2003, REMOTE SENS ENVIRON, V84, P385, DOI 10.1016/S0034-4257(02)00129-3; Xu LL, 2007, ECOL MODEL, V208, P129, DOI 10.1016/j.ecolmodel.2007.05.013; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; [张东秋 ZHANG Dongqiu], 2006, [自然资源学报, Journal of Natural Resources], V21, P458; Zhang LM, 2006, AGR FOREST METEOROL, V137, P176, DOI 10.1016/j.agrformet.2006.02.006; Zhang LX, 2015, ECOL MODEL, V300, P30, DOI 10.1016/j.ecolmodel.2015.01.001; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhou Y, 2014, TELLUS B, P66	51	7	8	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122486	10.1371/journal.pone.0122486	http://dx.doi.org/10.1371/journal.pone.0122486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849325	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800134
J	van der Meij, L; Klauke, F; Moore, HL; Ludwig, YS; Almela, M; van Lange, PAM				van der Meij, Leander; Klauke, Fabian; Moore, Hannah L.; Ludwig, Yannick S.; Almela, Mercedes; van Lange, Paul A. M.			Football Fan Aggression: The Importance of Low Basal Cortisol and a Fair Referee	PLOS ONE			English	Article							SALIVARY CORTISOL; HOT SAUCE; VIOLENCE; PERSONALITY; BEHAVIOR; BOYS; TESTOSTERONE; BONFERRONI; IDENTITY; MODEL	Fan aggression in football (soccer) is a societal problem that affects many countries worldwide. However, to date, most studies use an epidemiological or survey approach to explain football fan aggression. This study used a controlled laboratory study to advance a model of predictors for fan aggression. To do so, football fans (n = 74) saw a match summary in which their favorite team lost against their most important rival. Next, we measured levels of aggression with the hot sauce paradigm, in which fans were given the opportunity to administer a sample of hot sauce that a rival football supporter had to consume. To investigate if media exposure had the ability to reduce aggression, before the match fans saw a video in which fans of the rival team commented in a neutral, negative, or positive manner on their favorite team. Results showed that the media exposure did not affect aggression. However, participants displayed high levels of aggression and anger after having watched the match. Also, aggression was higher in fans with lower basal cortisol levels, which suggests that part of the aggression displayed was proactive and related to anti-social behavior. Furthermore, aggression was higher when the referee was blamed and aggression was lower when the performance of the participants' favorite team was blamed for the match result. These results indicate that aggression increased when the match result was perceived as unfair. Interventions that aim to reduce football fan aggression should give special attention to the perceived fairness of the match result.	[van der Meij, Leander; Klauke, Fabian; Moore, Hannah L.; Ludwig, Yannick S.; van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands; [Almela, Mercedes] Univ Valencia, Dept Psychobiol, Lab Social Cognit Neurosci, Valencia, Spain	Vrije Universiteit Amsterdam; University of Valencia	van der Meij, L (corresponding author), Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands.	L.van.der.Meij@vu.nl	Almela, Mercedes/AAE-4481-2021; van der Meij, Leander/AAC-8945-2019	van der Meij, Leander/0000-0001-6394-3071; Almela, Mercedes/0000-0002-8930-0717				ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59; Bernhardt PC, 1998, PHYSIOL BEHAV, V65, P59, DOI 10.1016/S0031-9384(98)00147-4; Bettencourt BA, 2006, PSYCHOL BULL, V132, P751, DOI 10.1037/0033-2909.132.5.751; Braun R, 2008, INT SOCIOL, V23, P796, DOI 10.1177/0268580908095909; Bryant FB, 2001, J RES PERS, V35, P138, DOI 10.1006/jrpe.2000.2302; Card D, 2011, Q J ECON, V126, P103, DOI 10.1093/qje/qjr001; Chory-Assad RM., 2004, COMMUN EDUC, V53, P253, DOI [DOI 10.1080/0363452042000265189, 10.1080/0363452042000265189]; Chory-Assad RM., 2002, COMMUN Q, V50, P58, DOI [10.1080/01463370209385646, DOI 10.1080/01463370209385646]; DeWall CN, 2011, PSYCHOL VIOLENCE, V1, P245, DOI 10.1037/a0023842; Dickson A, 2013, DOMESTIC VIOLENCE AN; Dunning E., 2000, EUROPEAN J CRIMINAL, V8, P141, DOI [DOI 10.1023/A:1008773923878, https://doi.org/10.1023/A:1008773923878]; FoxSports, SAMENVATTING FEYENOO; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; HaaglandenVoetbalTV, CLUB IN BEELD DEEL 2; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Kirby S, 2014, J RES CRIME DELINQ, V51, P259, DOI 10.1177/0022427813494843; Lieberman JD, 1999, AGGRESSIVE BEHAV, V25, P331, DOI 10.1002/(SICI)1098-2337(1999)25:5<331::AID-AB2>3.0.CO;2-1; McBurnett K, 2000, ARCH GEN PSYCHIAT, V57, P38, DOI 10.1001/archpsyc.57.1.38; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oosterlaan J, 2005, PSYCHIAT RES, V134, P1, DOI 10.1016/j.psychres.2004.12.005; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pfattheicher S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085691; Poutvaara P, 2009, J PUBLIC ECON, V93, P403, DOI 10.1016/j.jpubeco.2008.10.004; Priks M, 2010, KYKLOS, V63, P450, DOI 10.1111/j.1467-6435.2010.00482.x; Ritter D, 2005, AGGRESSIVE BEHAV, V31, P407, DOI 10.1002/ab.20066; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Roversi A., 1991, International Review for the Sociology of Sport, V26, P311, DOI 10.1177/101269029102600406; RUSSELL GW, 1995, SOC BEHAV PERSONAL, V23, P199, DOI 10.2224/sbp.1995.23.2.199; Russell GW, 2004, AGGRESS VIOLENT BEH, V9, P353, DOI 10.1016/S1359-1789(03)00031-4; Semyonov M., 1989, Sociology of Sport Journal, V6, P50; Shoal GD, 2003, J AM ACAD CHILD PSY, V42, P1101, DOI 10.1097/01.CHI.0000070246.24125.6D; Skarlicki DP, 1997, J APPL PSYCHOL, V82, P434, DOI 10.1037/0021-9010.82.3.434; Spaaij R, 2008, J SPORT SOC ISSUES, V32, P369, DOI 10.1177/0193723508324082; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Tyler TR, 2005, LEADERSHIP QUART, V16, P529, DOI 10.1016/j.leaqua.2005.06.001; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; van den Bos K, 2002, ADV EXP SOC PSYCHOL, V34, P1, DOI 10.1016/S0065-2601(02)80003-X; van der Meij L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034814; Van Hiel A, 2007, J COMMUNITY APPL SOC, V17, P169, DOI 10.1002/casp.902; VANLIMBERGEN K, 1989, CURR PSYCHOL RES REV, V8, P4, DOI 10.1007/BF02686733; Wann DL, 1999, PERCEPT MOTOR SKILL, V88, P1296, DOI 10.2466/PMS.88.3.1296-1298; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; ZANI B, 1991, J COMMUNITY APPL SOC, V1, P5, DOI 10.1002/casp.2450010103	44	17	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0120103	10.1371/journal.pone.0120103	http://dx.doi.org/10.1371/journal.pone.0120103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VA	25844939	Green Published, gold			2022-12-27	WOS:000352475700003
J	Altekruse, SF; Petrick, JL; Rolin, AI; Cuccinelli, JE; Zou, ZH; Tatalovich, Z; McGlynn, KA				Altekruse, Sean F.; Petrick, Jessica L.; Rolin, Alicia I.; Cuccinelli, James E.; Zou, Zhaohui; Tatalovich, Zaria; McGlynn, Katherine A.			Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States	PLOS ONE			English	Article							LIVER-CANCER; RISK-FACTORS; C VIRUS; HEPATITIS-B; MORTALITY; CLASSIFICATION; EPIDEMIOLOGY; TRENDS	Background Intrahepatic (ICC) and extrahepatic cholangiocarcinomas (ECC) are tumors that arise from cholangiocytes in the bile duct, but ICCs are coded as primary liver cancers while ECCs are coded as biliary tract cancers. The etiology of these tumors is not well understood. It has been suggested that the etiology of ICC is more similar to that of another type of liver cancer, hepatocellular carcinoma (HCC), than to the etiology of ECC. If this is true, geographic incidence patterns and trends in ICC incidence should be more similar to that of HCC than ECC. Methods To examine this hypothesis, data from the North American Association of Central Cancer Registries Cancer in North America data file were analyzed. Incidence rates and joinpoint trends were calculated by demographic subgroup. County-level incidence rates were mapped. Results Overall incidence rates, racial distribution, male: female ratio, and peak ages were more similar between ICC and ECC than with HCC. During 2000-2009, average annual incidence rates of ECC increased. During 2005-2009, average annual ICC incidence rates also increased. High rates for all three cancer sites were found in the Pacific region, particularly Hawaii and Alaska. Rates of ICC and ECC were also high in the Northeast and the upper Midwest, while rates of HCC were high in the South. Conclusions Demographic patterns and geographical variation were more closely related between ICC and ECC than HCC, suggesting that the etiology of ICC and ECC may be similar. Increasing rates of both tumors suggest that further etiology studies are warranted.	[Altekruse, Sean F.; Rolin, Alicia I.; Tatalovich, Zaria] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Petrick, Jessica L.; McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA; [Cuccinelli, James E.; Zou, Zhaohui] Informat Management Serv Inc, Calverton, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.	Petrick, JL (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA.	jessica.petrick@nih.gov	Petrick, Jessica/P-1678-2017; Petrick, Jessica/AAA-9079-2020	Petrick, Jessica/0000-0001-6580-450X; Rolin, Alicia/0000-0001-8191-248X	National Cancer Institute's Surveillance, Epidemiology, and End Results Contracts; North American Association of Central Cancer Registries Cancer in North America project; Division of Cancer Control and Population Sciences; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Information Management Services, Inc.; NATIONAL CANCER INSTITUTE [ZIACP010158] Funding Source: NIH RePORTER	National Cancer Institute's Surveillance, Epidemiology, and End Results Contracts; North American Association of Central Cancer Registries Cancer in North America project; Division of Cancer Control and Population Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); Division of Cancer Epidemiology and Genetics, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Information Management Services, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute's Surveillance, Epidemiology, and End Results Contracts; North American Association of Central Cancer Registries Cancer in North America project; Division of Cancer Control and Population Sciences; and the Division of Cancer Epidemiology and Genetics, National Cancer Institute. Information Management Services, Inc. provided support in the form of salaries for authors [JEC and ZZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; [Anonymous], CENS 2000 SUMM FIL 1; [Anonymous], CENS 2000 SUMM FIL 3; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chapman RW, 1999, ANN ONCOL, V10, P308, DOI 10.1023/A:1008313809752; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fritz A, 2000, INT CLASSIFICATION D; Horner MJ, 2011, CANCER EPIDEM BIOMAR, V20, P591, DOI 10.1158/1055-9965.EPI-10-1183; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Kobayashi M, 2000, CANCER, V88, P2471, DOI 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T; Li M, 2012, J GASTROEN HEPATOL, V27, P1561, DOI 10.1111/j.1440-1746.2012.07207.x; McLean L, 2006, LIVER INT, V26, P1047, DOI 10.1111/j.1478-3231.2006.01350.x; National Center for Healthcare Statistics, PUBL US DAT FIL DOC; Pickle LW, 2007, CA-CANCER J CLIN, V57, P30, DOI 10.3322/canjclin.57.1.30; PICKLE LW, 2001, P BIOM SECT 2000 ANN, P45; Schottenfeld D., 2006, CANC EPIDEMIOLOGY PR, pxviii; Shaib YH, 2007, AM J GASTROENTEROL, V102, P1016, DOI 10.1111/j.1572-0241.2007.01104.x; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; Surveillance Epidemiology and End Results (SEER) Program, 2012, SEER STAT DAT N AM A; TOMIMATSU M, 1993, CANCER, V72, P683, DOI 10.1002/1097-0142(19930801)72:3<683::AID-CNCR2820720310>3.0.CO;2-C; U.S. Census Bureau, CENS HISP OR; U.S. Department of Agriculture, RUR URB CONT COD; *US DEP HHS, AR RES FIL 2006; Welzel TM, 2006, J NATL CANCER I, V98, P873, DOI 10.1093/jnci/djj234; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05.020	27	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120574	10.1371/journal.pone.0120574	http://dx.doi.org/10.1371/journal.pone.0120574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837669	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000025
J	Burelle, Y; Bemeur, C; Rivard, ME; Legault, JT; Boucher, G; Morin, C; Coderre, L; Des Rosiers, C				Burelle, Yan; Bemeur, Chantal; Rivard, Marie-Eve; Legault, Julie Thompson; Boucher, Gabrielle; Morin, Charles; Coderre, Lise; Des Rosiers, Christine		LSFC Consortium	Mitochondrial Vulnerability and Increased Susceptibility to Nutrient-Induced Cytotoxicity in Fibroblasts from Leigh Syndrome French Canadian Patients	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; PERMEABILITY TRANSITION PORE; PROPIONYL-L-CARNITINE; COMPLEX-I ACTIVITY; FREE FATTY-ACIDS; OXIDATIVE STRESS; CELL-DEATH; KETOGENIC DIET; DEFICIENCY; LRPPRC	Mutations in LRPPRC are responsible for the French Canadian variant of Leigh Syndrome (LSFC), a severe disorder characterized biochemically by a tissue-specific deficiency of cytochrome c oxidase (COX) and clinically by the occurrence of severe and deadly acidotic crises. Factors that precipitate these crises remain unclear. To better understand the physiopathology and identify potential treatments, we performed a comprehensive analysis of mitochondrial function in LSFC and control fibroblasts. Furthermore, we have used this cell-based model to screen for conditions that promote premature cell death in LSFC cells and test the protective effect of ten interventions targeting well-defined aspects of mitochondrial function. We show that, despite maintaining normal ATP levels, LSFC fibroblasts present several mitochondrial functional abnormalities under normal baseline conditions, which likely impair their capacity to respond to stress. This includes mitochondrial network fragmentation, impaired oxidative phosphorylation capacity, lower membrane potential, increased sensitivity to Ca2+-induced permeability transition, but no changes in reactive oxygen species production. We also show that LSFC fibroblasts display enhanced susceptibility to cell death when exposed to palmitate, an effect that is potentiated by high lactate, while high glucose or acidosis alone or in combination were neutral. Furthermore, we demonstrate that compounds that are known to promote flux through the electron transport chain independent of phosphorylation (methylene blue, dinitrophenol), or modulate fatty acid (L-carnitine) or Krebs cycle metabolism (propionate) are protective, while antioxidants (idebenone, N-acetyl cysteine, resveratrol) exacerbate palmitate plus lactate-induced cell death. Collectively, beyond highlighting multiple alterations in mitochondrial function and increased susceptibility to nutrient-induced cytotoxicity in LSFC fibroblasts, these results raise questions about the nature of the diets, particularly excess fat intake, as well as on the use of antioxidants in patients with LSFC and, possibly, other COX defects.	[Burelle, Yan; Bemeur, Chantal] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Rivard, Marie-Eve; Legault, Julie Thompson; Boucher, Gabrielle; Coderre, Lise; Des Rosiers, Christine] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Rivard, Marie-Eve; Legault, Julie Thompson; Coderre, Lise; Des Rosiers, Christine] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Morin, Charles] Complexe Hosp Sagamie, Dept Pediat, Chicoutimi, PQ, Canada; [Morin, Charles] Complexe Hosp Sagamie, Clin Res Unit, Chicoutimi, PQ, Canada; [Coderre, Lise] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Des Rosiers, C (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.	christine.des.rosiers@umontreal.ca	Burelle, Yan/AAF-8104-2021	Burelle, Yan/0000-0001-9379-146X; Bemeur, Chantal/0000-0003-2757-5958; Laprise, Catherine/0000-0001-5526-9945	Canadian Institutes of Health Research (CIHR) [102168]; Lactic Acidosis Association	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lactic Acidosis Association	This work was supported by the Canadian Institutes of Health Research (CIHR; Grant #102168 to the CIHR Emerging team in the Leigh Syndrome French Canadian Type (LSFC): Translating LSFC gene discovery into treatments for patients (awarded to CDR, YB, LC, CM)) and by the Lactic Acidosis Association.(http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Ascah A, 2011, AM J PHYSIOL-HEART C, V300, pH144, DOI 10.1152/ajpheart.00522.2010; Atamna H, 2012, BIOFACTORS, V38, P158, DOI 10.1002/biof.197; Aure K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Burelle Y, 2010, J MOL CELL CARDIOL, V48, P310, DOI 10.1016/j.yjmcc.2009.09.004; Cree MG, 2007, ANN SURG, V245, P214, DOI 10.1097/01.sla.0000250409.51289.ca; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350; DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598; Distelmaier F, 2009, J MOL MED, V87, P515, DOI 10.1007/s00109-009-0452-5; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012; Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x; Koene S, 2011, J INHERIT METAB DIS, V34, P293, DOI 10.1007/s10545-009-9005-x; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Kong JY, 2003, ARCH BIOCHEM BIOPHYS, V412, P196, DOI 10.1016/S0003-9861(03)00008-0; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Kumar S, 2009, LIFE SCI, V84, P328, DOI 10.1016/j.lfs.2008.12.016; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marcil M, 2006, J MOL CELL CARDIOL, V41, P998, DOI 10.1016/j.yjmcc.2006.08.117; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; MERANTE F, 1993, AM J HUM GENET, V53, P481; Minners J, 2000, CARDIOVASC RES, V47, P68, DOI 10.1016/S0008-6363(00)00069-9; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Moran M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001; MORIN C, 1993, AM J HUM GENET, V53, P488; Mutomba MC, 2000, FEBS LETT, V478, P19, DOI 10.1016/S0014-5793(00)01817-2; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0; Pecina P, 2003, BBA-MOL BASIS DIS, V1639, P53, DOI 10.1016/S0925-4439(03)00127-3; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Rabkin SW, 2008, PROSTAG LEUKOTR ESS, V78, P147, DOI 10.1016/j.plefa.2007.09.003; RUSSELL RR, 1995, AM J PHYSIOL-HEART C, V268, pH441, DOI 10.1152/ajpheart.1995.268.1.H441; Sasarman F, 2015, HUM MOL GENET, V24, P480, DOI 10.1093/hmg/ddu468; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schiff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028823; Skulachev VP, 2012, PRINCIPLES OF BIOENE; Teodoro JS, 2013, TOXICOL MECH METHOD, V23, P297, DOI 10.3109/15376516.2012.759305; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valsecchi F, 2013, MITOCHONDRION, V13, P436, DOI 10.1016/j.mito.2012.12.001; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Voloboueva LA, 2007, FASEB J, V21, P4077, DOI 10.1096/fj.07-8396com; Willems PHGM, 2009, INT J BIOCHEM CELL B, V41, P1773, DOI 10.1016/j.biocel.2009.01.012; Wojtczak L, 1999, J BIOENERG BIOMEMBR, V31, P447, DOI 10.1023/A:1005444322823; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	69	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120767	10.1371/journal.pone.0120767	http://dx.doi.org/10.1371/journal.pone.0120767			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835550	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000033
J	Grand, A; Davies, G; Holliman, R; Adams, A				Grand, Ann; Davies, Gareth; Holliman, Richard; Adams, Anne			Mapping Public Engagement with Research in a UK University	PLOS ONE			English	Article							SCIENCE COMMUNICATION; SCIENTISTS	Notwithstanding that 'public engagement' is conceptualised differently internationally and in different academic disciplines, higher education institutions largely accept the importance of public engagement with research. However, there is limited evidence on how researchers conceptualise engagement, their views on what constitutes engagement and the communities they would (or would not) like to engage with. This paper presents the results of a survey of researchers in the Open University that sought to gather data to fill these gaps. This research was part of an action research project designed to embed engagement in the routine practices of researchers at all levels. The findings indicate that researchers have a relatively narrow view of public engagement with research and the communities with which they interact. It also identified that very few strategically evaluate their public engagement activities. We conclude by discussing some of the interventions we have introduced with the aim of broadening and deepening future researcher engagement.	[Grand, Ann; Adams, Anne] Open Univ, Inst Educ Technol, Milton Keynes MK7 6AA, Bucks, England; [Davies, Gareth; Holliman, Richard] Open Univ, Fac Sci, Milton Keynes MK7 6AA, Bucks, England	Open University - UK; Open University - UK	Grand, A (corresponding author), Open Univ, Inst Educ Technol, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	ann.grand@open.ac.uk		Holliman, Richard/0000-0002-4587-0929; Davies, Gareth/0000-0001-6662-9299; Adams@open.ac.uk, Anne/0000-0001-8990-5014	RCUK;  [EP/J020087/1]; Engineering and Physical Sciences Research Council [EP/J020087/1, EP/K027786/1] Funding Source: researchfish	RCUK(UK Research & Innovation (UKRI)); ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research discussed in this paper arises from the Open University's Public Engagement with Research Catalyst, 'An open research university'. The project is jointly funded by RCUK and the Open University (Grant Number EP/J020087/1), through an initiative to embed culture change, and is one of eight similar projects based in universities around the UK. RCUK-http://www.rcuk.ac.uk/pe/catalysts/open University-http://www.open.ac.uk/research/public-engagement/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnett C, 2011, SEGMENTING PUBLICS; Bauer MW, 2011, PUBLIC UNDERST SCI, V20, P3, DOI 10.1177/0963662510394457; Bentley P, 2011, PUBLIC UNDERST SCI, V20, P48, DOI 10.1177/0963662510384461; Britner P.A., 2012, J HIGHER ED OUTREACH, V16, P61; Burchell K., 2009, PUBLIC CULTURE PROFE; Burns TW, 2003, PUBLIC UNDERST SCI, V12, P183, DOI 10.1177/09636625030122004; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Cook G, 2009, ECOLOGIST; Davies S, 2009, SIGHT SOUND, V19, P72; Davies S, 2009, PUBLIC UNDERST SCI, V18, P338, DOI 10.1177/0963662507079760; Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222; Davies SR, 2013, HIGH EDUC, V66, P725, DOI 10.1007/s10734-013-9631-y; Department for Business Innovation and Skills, ENG PUBL SCI ENG 201; DIUS, 2008, VIS SCI SOC; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; HEFCE, 2014, REF2014 RES; Holliman R, 2009, INVESTIGATING SCI CO, P274; Holliman R., 2013, CATALYST PUBLIC ENGA; Holliman R, 2014, RES IMP FEST LOUGHB; Holliman R., 2013, 1 YEAR REPORT OPEN R; Holliman R, 2005, SOCIOLOGIA RICERCA S, p[76, 254]; Holliman R., 2013, PUBL ENG RES CAT BRI; Holliman R, 2014, PRO VIC CHANC RES SC; Holliman R, 2009, INVESTIGATING SCI CO, P35; Horst M, 2011, SCI CULT-UK, V20, P283, DOI 10.1080/09505431.2010.524199; House of Lords, 2000, 3 HOUS LORDS SEL COM; IpsosMORI, 2011, PUBL ATT SCI 2011; Irwin A., 2009, INVESTIGATING SCI CO; Irwin A., 2008, HDB PUBLIC COMMUNICA, P199; Jensen E, INT J SCI B IN PRESS; Lewin K, 1946, J SOC ISSUES, V2, P34, DOI 10.1111/j.1540-4560.1946.tb02295.x; Marris C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000549; McCallie E., 2009, MANY EXPERTS MANY AU; Mellors-Bourne R, 2013, PRINCIPAL INVESTIGAT; Mellors-Bourne R, 2013, CAREERS RES ONLINE S; Mesure S., 2007, CRESCENDO PROJECT FI; Miller S, 2001, PUBLIC UNDERST SCI, V10, P115, DOI 10.1088/0963-6625/10/1/308; Moore M.H., 1996, CREATING PUBLIC VALU, V33, P33, DOI 10.5860/choice.33-4147,33-4147; NCCPE, 2010, WHAT IS PUBL ENG; New Economics Foundation, 1999, PART WORKS; Phillips LJ, 2011, PUBLIC UNDERST SCI, V20, P80, DOI 10.1177/0963662509340092; Poliakoff E, 2007, SCI COMMUN, V29, P242, DOI 10.1177/1075547007308009; PSP, 2006, SCI COMM SURV FACT A; RCUK, 2010, CONC ENG PUBL RES; Research Councils UK, 2014, PATHW IMP; Research Councils UK/Dept. for Industry Universities and Skills, 2008, PUBL ATT SCI 2008 SU; Rowe G, 2005, SCI TECHNOL HUM VAL, V30, P251, DOI 10.1177/0162243904271724; Royal Society, 1985, PUBL UND SCI BODM RE; Science for All, 2010, SCI ALL REP ACT PLAN; Staley K., 2009, EXPLORING IMPACT PUB; Trench B, 2008, COMMUNICATING SCIENCE IN SOCIAL CONTEXTS: NEW MODELS, NEW PRACTICES, P119, DOI 10.1007/978-1-4020-8598-7_7; Watermeyer R, 2012, TERT EDUC MANAG, V18, P115, DOI 10.1080/13583883.2011.641578; Wilkinson C, 2012, INT J SCI EDUC PART, V2, P43, DOI 10.1080/21548455.2011.628503; Wilsdon J., 2004, SEE THROUGH SCI WHY; Winston R., 2009, NEW SCI	55	40	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121874	10.1371/journal.pone.0121874	http://dx.doi.org/10.1371/journal.pone.0121874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837803	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000352139000065
J	Kim, HC; Jo, YJ; Kim, NH; Namgoong, S				Kim, Hak-Cheol; Jo, Yu-Jin; Kim, Nam-Hyung; Namgoong, Suk			Small Molecule Inhibitor of Formin Homology 2 Domains (SMIFH2) Reveals the Roles of the Formin Family of Proteins in Spindle Assembly and Asymmetric Division in Mouse Oocytes	PLOS ONE			English	Article							POLAR BODY EXTRUSION; MEIOTIC SPINDLE; ACTIN; CYTOKINESIS; MDIA1; GENE; RHO; ORGANIZATION; CYTOSKELETON; MAINTENANCE	Dynamic actin reorganization is the main driving force for spindle migration and asymmetric cell division in mammalian oocytes. It has been reported that various actin nucleators including Formin-2 are involved in the polarization of the spindle and in asymmetric cell division. In mammals, the formin family is comprised of 15 proteins. However, their individual roles in spindle migration and/or asymmetric division have not been elucidated yet. In this study, we employed a newly developed inhibitor for formin family proteins, small molecule inhibitor of formin homology 2 domains (SMIFH2), to assess the functions of the formin family in mouse oocyte maturation. Treatment with SMIFH2 during in vitro maturation of mouse oocytes inhibited maturation by decreasing cytoplasmic and cortical actin levels. In addition, treatment with SMIFH2, especially at higher concentrations (500 mu M), impaired the proper formation of meiotic spindles, indicating that formins play a role in meiotic spindle formation. Knockdown of the mDia2 formins caused a similar decrease in oocyte maturation and abnormal spindle morphology, mimicking the phenotype of SMIFH2-treated cells. Collectively, these results suggested that besides Formin-2, the other proteins of the formin, including mDia family play a role in asymmetric division and meiotic spindle formation in mammalian oocytes.	[Kim, Hak-Cheol; Jo, Yu-Jin; Kim, Nam-Hyung; Namgoong, Suk] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea	Chungbuk National University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea.	nhkim@chungbuk.ac.kr; suknamgoong@chungbuk.ac.kr			Next-Generation BioGreen 21 Program [PJ011206, PJ011126]; Rural Development Administration, Republic of Korea	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	Supported by grants from the Next-Generation BioGreen 21 Program (PJ011206 and PJ011126, Rural Development Administration, Republic of Korea. http://www.rda.go.kr/foreign/eng/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2011, DEVELOPMENT, V138, P2903, DOI 10.1242/dev.060269; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chaigne A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7027; Chaigne A, 2014, M S-MED SCI, V30, P18, DOI 10.1051/medsci/20143001005; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Dehapiot B, 2013, DEV BIOL, V377, P202, DOI 10.1016/j.ydbio.2013.01.029; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Jang WI, 2014, CELL CYCLE, V13, P2359, DOI 10.4161/cc.29333; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kwon S, 2011, MOL HUM REPROD, V17, P317, DOI 10.1093/molehr/gaq088; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li YH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109850; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rosero A, 2013, J EXP BOT, V64, P585, DOI 10.1093/jxb/ers351; Ryley DA, 2005, FERTIL STERIL, V83, P1363, DOI 10.1016/j.fertnstert.2004.10.051; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Sun SC, 2011, CELL CYCLE, V10, P1853, DOI 10.4161/cc.10.11.15796; Sun SC, 2011, MOL HUM REPROD, V17, P296, DOI 10.1093/molehr/gar006; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Ucar H, 2013, J CELL SCI, V126, P5153, DOI 10.1242/jcs.130476; Wang F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05596; Watanabe S, 2013, CELL REP, V5, P926, DOI 10.1016/j.celrep.2013.10.021; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yi KX, 2012, CYTOSKELETON, V69, P727, DOI 10.1002/cm.21048; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang Y, 2015, BBA-MOL CELL RES, V1853, P317, DOI 10.1016/j.bbamcr.2014.11.005	54	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123438	10.1371/journal.pone.0123438	http://dx.doi.org/10.1371/journal.pone.0123438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837661	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000144
J	Liu, JL; Chen, XY; Zeng, XN				Liu, Jia Li; Chen, Xiao Yan; Zeng, Xin Nian			Classical Olfactory Conditioning in the Oriental Fruit Fly, Bactrocera dorsalis	PLOS ONE			English	Article							HONEYBEES APIS-MELLIFERA; PROBOSCIS EXTENSION; MALE ANNIHILATION; METHYL EUGENOL; MEMORY; FLIES; TEPHRITIDAE; INTENSITY; INSECTS; DIPTERA	The oriental fruit fly, Bactrocera dorsalis, is a serious pest of fruits and vegetables. Methyl eugenol (ME), a male attractant, is used to against this fly by mass trapping. Control effect may be influenced by learning, which could modify the olfactory response of the fly to this attractant. To collect the behavioral evidence, studies on the capability of this fly for olfactory learning are necessary. We investigated olfactory learning in male flies with a classical olfactory conditioning procedure using restrained individuals under laboratory conditions. The acquisition of the proboscis extension reflex was used as the criterion for conditioning. A high conditioned response level was found in oriental fruit flies when an odor was presented in paired association with a sucrose reward but not when the odor and sucrose were presented unpaired. We also found that the conditioning performance was influenced by the odor concentration, intertrial interval, and starvation time. A slight sensitization elicited by imbibing sucrose was observed. These results indicate that oriental fruit flies have a high capacity to form an olfactory memory as a result of classical conditioning.	[Liu, Jia Li; Chen, Xiao Yan; Zeng, Xin Nian] South China Agr Univ, Coll Nat Resources & Environm, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zeng, XN (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China.	zengxn@scau.edu.cn			National Natural Science Foundation of China [31401800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31401800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Chabaud MA, 2006, J COMP PHYSIOL A, V192, P1335, DOI 10.1007/s00359-006-0160-3; Gerber B, 1996, ANIM BEHAV, V52, P1079, DOI 10.1006/anbe.1996.0255; Gerber B, 1998, NEUROBIOL LEARN MEM, V69, P71, DOI 10.1006/nlme.1997.3801; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hartlieb E, 1996, NATURWISSENSCHAFTEN, V83, P87, DOI 10.1007/s001140050253; ITO Y, 1974, STERILE INSECT TECHN, P45; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Laloi D, 1999, ENTOMOL EXP APPL, V90, P123, DOI 10.1023/A:1003598301272; Liu JL, 2013, APPL ENTOMOL ZOOL, V48, P387, DOI 10.1007/s13355-013-0199-x; MENZEL R, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P323; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R, 1990, COMPAR COGN, P237; Metcalf R. L., 1992, PLANT KAIROMONES INS, P109; METCALF RL, 1990, ANN ENTOMOL SOC AM, V83, P1017, DOI 10.1093/aesa/83.6.1017; Papaj Daniel R., 1993, P243; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; PAPAJ DR, 1990, J CHEM ECOL, V16, P3137, DOI 10.1007/BF00979616; PAPAJ DR, 1986, J CHEM ECOL, V12, P1125, DOI 10.1007/BF01639000; Pelz C, 1997, J EXP BIOL, V200, P837; PROKOPY R J, 1988, Journal of Insect Behavior, V1, P67, DOI 10.1007/BF01052504; PROKOPY R J, 1989, Proceedings of the Hawaiian Entomological Society, V29, P97; PROKOPY RJ, 1990, J INSECT BEHAV, V3, P663, DOI 10.1007/BF01052335; PROKOPY RJ, 1989, ENTOMOL EXP APPL, V53, P65, DOI 10.1007/BF00369233; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; SHELLY TE, 1994, FLA ENTOMOL, V77, P201, DOI 10.2307/3495505; Shelly T, 2010, APPL ENTOMOL ZOOL, V45, P349, DOI 10.1303/aez.2010.349; Simoes P, 2011, J EXP BIOL, V214, P2495, DOI 10.1242/jeb.055806; STEINER LF, 1965, J ECON ENTOMOL, V58, P961, DOI 10.1093/jee/58.5.961; Tan KH, 2002, J CHEM ECOL, V28, P1161, DOI 10.1023/A:1016277500007; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Vargas RI, 2010, J ECON ENTOMOL, V103, P409, DOI 10.1603/EC09299; VET LEM, 1990, J CHEM ECOL, V16, P3119, DOI 10.1007/BF00979615; Watanabe H, 2003, ZOOL SCI, V20, P1447, DOI 10.2108/zsj.20.1447; Wen-Hui Yu, 2013, THESIS SW U; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; Wright GA, 2002, J CHEM ECOL, V28, P721, DOI 10.1023/A:1015232608858	41	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122155	10.1371/journal.pone.0122155	http://dx.doi.org/10.1371/journal.pone.0122155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837420	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000081
J	Baumgartner, FA; Pavia, H; Toth, GB				Baumgartner, Finn A.; Pavia, Henrik; Toth, Gunilla B.			Acquired Phototrophy through Retention of Functional Chloroplasts Increases Growth Efficiency of the Sea Slug Elysia viridis	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PLAKOBRANCHUS-OCELLATUS; TIMIDA RISSO; PHOTOSYNTHESIS; FOOD; OPISTHOBRANCHIA; SACOGLOSSA; ACQUISITION; NUTRITION; HERBIVORE	Photosynthesis is a fundamental process sustaining heterotrophic organisms at all trophic levels. Some mixotrophs can retain functional chloroplasts from food (kleptoplasty), and it is hypothesized that carbon acquired through kleptoplasty may enhance trophic energy transfer through increased host growth efficiency. Sacoglossan sea slugs are the only known metazoans capable of kleptoplasty, but the relative fitness contributions of heterotrophy through grazing, and phototrophy via kleptoplasts, are not well understood. Fitness benefits (i.e. increased survival or growth) of kleptoplasty in sacoglossans are commonly studied in ecologically unrealistic conditions under extended periods of complete darkness and/or starvation. We compared the growth efficiency of the sacoglossan Elysia viridis with access to algal diets providing kleptoplasts of differing functionality under ecologically relevant light conditions. Individuals fed Codium fragile, which provide highly functional kleptoplasts, nearly doubled their growth efficiency under high compared to low light. In contrast, individuals fed Cladophora rupestris, which provided kleptoplasts of limited functionality, showed no difference in growth efficiency between light treatments. Slugs feeding on Codium, but not on Cladophora, showed higher relative electron transport rates (rETR) in high compared to low light. Furthermore, there were no differences in the consumption rates of the slugs between different light treatments, and only small differences in nutritional traits of algal diets, indicating that the increased growth efficiency of E. viridis feeding on Codium was due to retention of functional kleptoplasts. Our results show that functional kleptoplasts from Codium can provide sacoglossan sea slugs with fitness advantages through photosynthesis.	[Baumgartner, Finn A.; Pavia, Henrik; Toth, Gunilla B.] Univ Gothenburg, Dept Biol & Environm Sci Tjamo, Stromstad, Sweden	University of Gothenburg	Toth, GB (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci Tjamo, Stromstad, Sweden.	gunilla.toth@bioenv.gu.se	Toth, Gunilla B/E-8737-2013	Toth, Gunilla/0000-0002-1225-7773	Colliander foundation; Faculty of Natural Science at the University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE); Swedish National Science Foundation [621-2007-5874, 621-2011-5630]	Colliander foundation; Faculty of Natural Science at the University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE); Swedish National Science Foundation	This work was supported via grants from the Colliander foundation to F. A. B., the Faculty of Natural Science at the University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE) to H. P. and G. B. T., and the Swedish National Science Foundation grants 621-2007-5874 to G. B. T. and 621-2011-5630 to H. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto A, 2014, MAR BIOL, V161, P1095, DOI 10.1007/s00227-014-2402-1; ARNOLD KE, 1980, J EXP MAR BIOL ECOL, V43, P183, DOI 10.1016/0022-0981(80)90025-8; Barile PJ, 2004, J EXP MAR BIOL ECOL, V303, P65, DOI 10.1016/j.jembe.2003.11.004; Baumgartner FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102752; Baumgartner FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092472; Bhattacharya D, 2013, MOL BIOL EVOL, V30, P1843, DOI 10.1093/molbev/mst084; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casalduero FG, 2008, J EXP MAR BIOL ECOL, V357, P181, DOI 10.1016/j.jembe.2008.01.020; Christa Gregor, 2014, Communicative & Integrative Biology, V7, pe28029, DOI 10.4161/cib.28029; Christa G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2493; Christa G, 2013, PLANTA, V237, P559, DOI 10.1007/s00425-012-1788-6; CLARK KB, 1990, VELIGER, V33, P339; Cruz S, 2012, BIOL BULL-US, V223, P328, DOI 10.1086/BBLv223n3p328; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Curtis NE, 2010, INVERTEBR BIOL, V129, P297, DOI 10.1111/j.1744-7410.2010.00206.x; DAVIS EM, 1988, AM BIOTECHNOL LAB, V6, P28; Ellingson RA, 2006, EVOLUTION, V60, P2293; Evertsen J, 2009, MAR BIOL, V156, P847, DOI 10.1007/s00227-009-1128-y; GALLOP A, 1980, PROC R SOC SER B-BIO, V207, P335, DOI 10.1098/rspb.1980.0027; Gianguzza P, 2005, MAR BIOL, V148, P117, DOI 10.1007/s00227-005-0066-6; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Haendeler Katharina, 2007, Bonner Zoologische Beitraege, V55, P231; HANISAK MD, 1979, MAR BIOL, V50, P319, DOI 10.1007/BF00387009; Hansen PJ, 2011, J EUKARYOT MICROBIOL, V58, P203, DOI 10.1111/j.1550-7408.2011.00537.x; Hemmi A, 2002, ECOLOGY, V83, P1052, DOI 10.2307/3071913; HINDE R, 1972, NATURE-NEW BIOL, V239, P30, DOI 10.1038/newbio239030a0; HINDE R, 1975, BIOL J LINN SOC, V7, P161, DOI 10.1111/j.1095-8312.1975.tb00738.x; HINDE R, 1974, BIOL J LINN SOC, V6, P349, DOI 10.1111/j.1095-8312.1974.tb00729.x; Jesus B, 2010, J EXP MAR BIOL ECOL, V395, P98, DOI 10.1016/j.jembe.2010.08.021; Johnson MD, 2011, PHOTOSYNTH RES, V107, P117, DOI 10.1007/s11120-010-9546-8; JONES RI, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P87; Jormalainen V, 2001, OIKOS, V93, P77, DOI 10.1034/j.1600-0706.2001.930108.x; KLUMPP DW, 1994, MAR ECOL PROG SER, V115, P103, DOI 10.3354/meps115103; MARIN A, 1992, MAR BIOL, V112, P677, DOI 10.1007/BF00346186; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Pierce SK, 2012, INT REV CEL MOL BIO, V293, P123, DOI 10.1016/B978-0-12-394304-0.00009-9; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ralph PJ, 2002, MAR ECOL PROG SER, V226, P265, DOI 10.3354/meps226265; Ralph PJ, 1998, MAR BIOL, V132, P367, DOI 10.1007/s002270050403; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Raven JA, 2001, MAR BIOL, V138, P537, DOI 10.1007/s002270000488; Raven JA, 2009, J EXP BOT, V60, P3975, DOI 10.1093/jxb/erp282; Rumpho ME, 2011, J EXP BIOL, V214, P303, DOI 10.1242/jeb.046540; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Skovgaard A, 1998, AQUAT MICROB ECOL, V15, P293, DOI 10.3354/ame015293; Sotka EE, 2007, MAR BIOL, V151, P1831, DOI 10.1007/s00227-007-0612-5; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Teugels B, 2008, AQUAT BIOL, V4, P15, DOI 10.3354/ab00092; Trowbridge CD, 2000, J MAR BIOL ASSOC UK, V80, P1087, DOI 10.1017/S0025315400003155; Trowbridge CD, 2008, J MAR BIOL ASSOC UK, V88, P771, DOI 10.1017/S0025315408001690; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Ventura P, 2013, J EXP MAR BIOL ECOL, V441, P105, DOI 10.1016/j.jembe.2013.01.022; Vieira S, 2009, MAR BIOL, V156, P1007, DOI 10.1007/s00227-009-1144-y; Wagele H, 2011, MOL BIOL EVOL, V28, P699, DOI 10.1093/molbev/msq239; Williams SI, 1999, OCEANOGR MAR BIOL, V37, P87; Yamamoto S, 2013, J MAR BIOL ASSOC UK, V93, P209, DOI 10.1017/S0025315412000628	57	15	16	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120874	10.1371/journal.pone.0120874	http://dx.doi.org/10.1371/journal.pone.0120874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830355	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600047
J	Birkeland, E; Stokke, G; Tangvik, RJ; Torkildsen, EA; Boateng, J; Wollen, AL; Albrechtsen, S; Flaatten, H; Trovik, J				Birkeland, Elisabeth; Stokke, Guro; Tangvik, Randi J.; Torkildsen, Erik A.; Boateng, Jane; Wollen, Anne L.; Albrechtsen, Susanne; Flaatten, Hans; Trovik, Jone			Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and Nausea) Identifies Patients with Hyperemesis Gravidarum and Poor Nutritional Intake: A Prospective Cohort Validation Study	PLOS ONE			English	Article							OUTCOMES; MOTHER; WOMEN; DIET	Objective The English questionnaire Pregnancy-Unique Quantification of Emesis and nausea (PUQE) identifies women with severe Hyperemesis Gravidarum. Our aim was to investigate whether scores from the translated Norwegian version; SUKK (SvangerskapsUtlost Kvalme Kvantifisering) was associated with severity of hyperemesis and nutritional intake. Design A prospective cohort validation study. Setting Hospital cohort of Hyperemesis Gravidarum (HG) patients from western Norway and healthy pregnant women from Bergen, Norway. Sample 38 women hospitalized due to HG and 31 healthy pregnant controls attending routine antenatal check-up at health centers. Methods Data were collected May 2013-January 2014. The study participants answered the Norwegian PUQE-questionnaire (scores ranging from 3 to 15) and registered prospectively 24-hours nutritional intake by a food list form. Main outcome measures Differences of PUQE-scores, QOL-score and nutritional intake between hyperemesis patients and controls. Results Hyperemesis patients had shorter gestational age compared to controls (median 9.7 weeks; 95% CI 8.6-10.6 versus 11.9; 95% CI 10.1-12.9, p=0.004), and larger weight-change from pre-pregnant weight (loss of median 3 kg; 95% CI 3-4 versus gain of 2 kg; 95% CI 0.5-2, p<0.001) otherwise groups were similar regarding pre-pregnant BMI, age, gravidity, and inclusion weight. Compared to controls, hyperemesis patients had significant higher PUQE-score (median 13; 95% CI 11-14 vs. 7; 95% CI 4-8), lower QOL (median score 3; 95% CI 2-4 vs. 6; 95% CI 4.5-8) and lower nutritional intake (energy intake median 990 kcal/24 hours; 95% CI 709-1233 vs. 1652; 95% CI 1558-1880 all p<0.001). PUQE-score was inversely correlated to nutritional intake (-0.5, p<0.001). At discharge PUQE-score had fallen to median 6 (95% CI 5-8) and QOL score risen to 7 (95% CI 6-8) in the HG group, (both p<0.001 compared to admission values). Conclusion PUQE-scoring has been validated as a robust indicator of severe hyperemesis gravidarum and insufficient nutritional intake in a Norwegian setting.	[Birkeland, Elisabeth; Albrechtsen, Susanne] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Stokke, Guro; Albrechtsen, Susanne; Trovik, Jone] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Tangvik, Randi J.] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway; [Torkildsen, Erik A.] Stavanger Univ Hosp, Dept Obstet & Gynecol, Stavanger, Norway; [Boateng, Jane] Helse Foerde, Dept Obstet & Gynecol, Foerde, Norway; [Wollen, Anne L.] Volvat Med Ctr, Dept Bergen, Bergen, Norway; [Flaatten, Hans] Haukeland Hosp, Dept Anesthesia & Intens Care, N-5021 Bergen, Norway; [Flaatten, Hans] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Stavanger University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Trovik, J (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway.	jone.trovik@helse-bergen.no	Flaatten, Hans/AAG-7030-2020; Albrechtsen, Susanne/H-4680-2019	Flaatten, Hans/0000-0001-9186-3482; 				Albayrak M, 2013, J MATERN-FETAL NEO M, V26, P866, DOI 10.3109/14767058.2013.766699; Boskovic Rada, 2003, J Obstet Gynaecol Can, V25, P830; Chortatos A, 2013, BJOG-INT J OBSTET GY, V120, P1642, DOI 10.1111/1471-0528.12406; ClinicalTrials.gov, PREGN SPEC NAUS QUES; Dodds L, 2006, OBSTET GYNECOL, V107, P285, DOI 10.1097/01.AOG.0000195060.22832.cd; Ebrahimi N, 2009, J OBSTET GYNAECOL CA, V31, P803, DOI 10.1016/S1701-2163(16)34298-0; FAIRWEATHER DV, 1968, AM J OBSTET GYNECOL, V102, P135, DOI 10.1016/0002-9378(68)90445-6; Gibson R.S, 2005, PRINCIPLES NUTR ASSE; Guttormsen A. B., 2009, NASJONALE FAGLIGE RE; Helsedirektoratet, 2014, ANB KOSTH ERN FYS AK; Klauser CK, 2011, AM J PERINAT, V28, P715, DOI 10.1055/s-0031-1280594; Koren G, 2005, J Obstet Gynaecol, V25, P241; Koren G, 2002, AM J OBSTET GYNECOL, V186, pS228, DOI 10.1067/mob.2002.123054; Lacasse A, 2008, AM J OBSTET GYNECOL, V199, pE10, DOI 10.1016/j.ajog.2008.05.017; Latva-Pukkila U, 2010, J HUM NUTR DIET, V23, P69, DOI 10.1111/j.1365-277X.2009.01019.x; Lombardi David G, 2004, Manag Care, V13, P48; Maina A, 2014, BJOG-INT J OBSTET GY, V121, P1556, DOI 10.1111/1471-0528.12757; Maltepe C, 2013, J POPUL THER CLIN PH, V20, pE192; Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x; Power Z, 2010, BIRTH-ISS PERINAT C, V37, P237, DOI 10.1111/j.1523-536X.2010.00411.x; Power Z, 2010, INT J NURS STUD, V47, P67, DOI 10.1016/j.ijnurstu.2009.06.012; Stubbs RJ, 2014, BRIT J NUTR, V111, P2032, DOI 10.1017/S0007114514000154; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vandraas KF, 2013, BJOG-INT J OBSTET GY, V120, P1654, DOI 10.1111/1471-0528.12429; VANSTUIJVENBERG ME, 1995, AM J OBSTET GYNECOL, V172, P1585, DOI 10.1016/0002-9378(95)90501-4; Verberg MFG, 2005, HUM REPROD UPDATE, V11, P527, DOI 10.1093/humupd/dmi021; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wibowo N, 2012, INT J GYNECOL OBSTET, V116, P206, DOI 10.1016/j.ijgo.2011.09.030	28	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119962	10.1371/journal.pone.0119962	http://dx.doi.org/10.1371/journal.pone.0119962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830549	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600018
J	Blanco, I; Kuchenbaecker, K; Cuadras, D; Wang, XS; Barrowdale, D; Garibay, GR; Librado, P; Sanchez-Gracia, A; Rozas, J; Bonifaci, N; McGuffog, L; Pankratz, VS; Islam, A; Mateo, F; Berenguer, A; Petit, A; Catala, I; Brunet, J; Feliubadalo, L; Tornero, E; Benitez, J; Osorio, A; Cajal, TRY; Nevanlinna, H; Aittomaki, K; Arun, BK; Toland, AE; Karlan, BY; Walsh, C; Lester, J; Greene, MH; Mai, PL; Nussbaum, RL; Andrulis, IL; Domchek, SM; Nathanson, KL; Rebbeck, TR; Barkardottir, RB; Jakubowska, A; Lubinski, J; Durda, K; Jaworska-Bieniek, K; Claes, K; Van Maerken, T; Diez, O; Hansen, TV; Jonson, L; Gerdes, AM; Ejlertsen, B; de la Hoya, M; Caldees, T; Dunning, AM; Oliver, C; Fineberg, E; Cook, M; Peock, S; McCann, E; Murray, A; Jacobs, C; Pichert, G; Lalloo, F; Chu, C; Dorkins, H; Paterson, J; Ong, KR; Teixeira, MR; Teixeira; Hogervorst, FBL; van der Hout, AH; Seynaeve, C; van der Luijt, RB; Ligtenberg, MJL; Devilee, P; Wijnen, JT; Rookus, MA; Meijers-Heijboer, HEJ; Blok, MJ; van den Ouweland, AMW; Aalfs, CM; Rodriguez, GC; Phillips, KAA; Piedmonte, M; Nerenstone, SR; Bae-Jump, VL; O'Malley, DM; Ratner, ES; Schmutzler, RK; Wappenschmidt, B; Rhiem, K; Engel, C; Meindl, A; Ditsch, N; Arnold, N; Plendl, HJ; Niederacher, D; Sutter, C; Wang-Gohrke, S; Steinemann, D; Preisler-Adams, S; Kast, K; Varon-Mateeva, R; Gehrig, A; Bojesen, A; Pedersen, IS; Sunde, L; Jensen, UB; Thomassen, M; Kruse, TA; Foretova, L; Peterlongo, P; Bernard, L; Peissel, B; Scuvera, G; Manoukian, S; Radice, P; Ottini, L; Montagna, M; Agata, S; Maugard, C; Simard, J; Soucy, P; Berger, A; Fink-Retter, A; Singer, CF; Rappaport, C; Geschwantler-Kaulich, D; Tea, MK; Pfeiler, G; John, EM; Miron, A; Neuhausen, SL; Terry, MB; Chung, WK; Daly, MB; Goldgar, DE; Janavicius, R; Dorfling, CM; van Rensburg, EJ; Fostira, F; Konstantopoulou, I; Garber, J; Godwin, AK; Olah, E; Narod, SA; Rennert, G; Paluch, SS; Laitman, Y; Friedman, E; Liljegren, A; Rantala, J; Stenmark-Askmalm, M; Loman, N; Imyanitov, EN; Hamann, U; Spurdle, AB; Healey, S; Weitzel, JN; Herzog, J; Margileth, D; Gorrini, C; Esteller, M; Gomez, A; Sayols, S; Vidal, E; Heyn, H; Stoppa-Lyonnet,; Leone, M; Barjhoux, L; Fassy-Colcombet, M; de Pauw, A; Lasset, C; Ferrer, SF; Castera, L; Berthet, P; Cornelis, F; Bignon, YJ; Damiola, F; Mazoyer, S; Sinilnikova, OM; Maxwell, CA; Vijai, J; Robson, M; Kauff, N; Corines, MJ; Villano, D; Cunningham, J; Lee, A; Lindor, N; Lazaro, C; Easton, DF; Offit, K; Chenevix-Trench, G; Couch, FJ; Antoniou, AC; Pujana, MA				Blanco, Ignacio; Kuchenbaecker, Karoline; Cuadras, Daniel; Wang, Xianshu; Barrowdale, Daniel; Ruiz de Garibay, Gorka; Librado, Pablo; Sanchez-Gracia, Alejandro; Rozas, Julio; Bonifaci, Nuria; McGuffog, Lesley; Pankratz, Vernon S.; Islam, Abul; Mateo, Francesca; Berenguer, Antoni; Petit, Anna; Catala, Isabel; Brunet, Joan; Feliubadalo, Lidia; Tornero, Eva; Benitez, Javier; Osorio, Ana; Cajal, Teresa Ramon Y.; Nevanlinna, Heli; Aittomaki, Kristiina; Arun, Banu K.; Toland, Amanda E.; Karlan, Beth Y.; Walsh, Christine; Lester, Jenny; Greene, Mark H.; Mai, Phuong L.; Nussbaum, Robert L.; Andrulis, Irene L.; Domchek, Susan M.; Nathanson, Katherine L.; Rebbeck, Timothy R.; Barkardottir, Rosa B.; Jakubowska, Anna; Lubinski, Jan; Durda, Katarzyna; Jaworska-Bieniek, Katarzyna; Claes, Kathleen; Van Maerken, Tom; Diez, Orland; Hansen, Thomas V.; Jonson, Lars; Gerdes, Anne-Marie; Ejlertsen, Bent; de la Hoya, Miguel; Caldes, Trinidad; Dunning, Alison M.; Oliver, Clare; Fineberg, Elena; Cook, Margaret; Peock, Susan; McCann, Emma; Murray, Alex; Jacobs, Chris; Pichert, Gabriella; Lalloo, Fiona; Chu, Carol; Dorkins, Huw; Paterson, Joan; Ong, Kai-Ren; Teixeira, Manuel R.; Teixeira; Hogervorst, Frans B. L.; van der Hout, Annemarie H.; Seynaeve, Caroline; van der Luijt, Rob B.; Ligtenberg, Marjolijn J. L.; Devilee, Peter; Wijnen, Juul T.; Rookus, Matti A.; Meijers-Heijboer, Hanne E. J.; Blok, Marinus J.; van den Ouweland, Ans M. W.; Aalfs, Cora M.; Rodriguez, Gustavo C.; Phillips, Kelly-Anne A.; Piedmonte, Marion; Nerenstone, Stacy R.; Bae-Jump, Victoria L.; O'Malley, David M.; Ratner, Elena S.; Schmutzler, Rita K.; Wappenschmidt, Barbara; Rhiem, Kerstin; Engel, Christoph; Meindl, Alfons; Ditsch, Nina; Arnold, Norbert; Plendl, Hansjoerg J.; Niederacher, Dieter; Sutter, Christian; Wang-Gohrke, Shan; Steinemann, Doris; Preisler-Adams, Sabine; Kast, Karin; Varon-Mateeva, Raymonda; Gehrig, Andrea; Bojesen, Anders; Pedersen, Inge Sokilde; Sunde, Lone; Jensen, Uffe Birk; Thomassen, Mads; Kruse, Torben A.; Foretova, Lenka; Peterlongo, Paolo; Bernard, Loris; Peissel, Bernard; Scuvera, Giulietta; Manoukian, Siranoush; Radice, Paolo; Ottini, Laura; Montagna, Marco; Agata, Simona; Maugard, Christine; Simard, Jacques; Soucy, Penny; Berger, Andreas; Fink-Retter, Anneliese; Singer, Christian F.; Rappaport, Christine; Geschwantler-Kaulich, Daphne; Tea, Muy-Kheng; Pfeiler, Georg; John, Esther M.; Miron, Alex; Neuhausen, Susan L.; Terry, Mary Beth; Chung, Wendy K.; Daly, Mary B.; Goldgar, David E.; Janavicius, Ramunas; Dorfling, Cecilia M.; van Rensburg, Elisabeth J.; Fostira, Florentia; Konstantopoulou, Irene; Garber, Judy; Godwin, Andrew K.; Olah, Edith; Narod, Steven A.; Rennert, Gad; Paluch, Shani Shimon; Laitman, Yael; Friedman, Eitan; Liljegren, Annelie; Rantala, Johanna; Stenmark-Askmalm, Marie; Loman, Niklas; Imyanitov, Evgeny N.; Hamann, Ute; Spurdle, Amanda B.; Healey, Sue; Weitzel, Jeffrey N.; Herzog, Josef; Margileth, David; Gorrini, Chiara; Esteller, Manel; Gomez, Antonio; Sayols, Sergi; Vidal, Enrique; Heyn, Holger; Stoppa-Lyonnet, Dominique; Leone, Melanie; Barjhoux, Laure; Fassy-Colcombet, Marion; de Pauw, Antoine; Lasset, Christine; Ferrer, Sandra Fert; Castera, Laurent; Berthet, Pascaline; Cornelis, Francois; Bignon, Yves-Jean; Damiola, Francesca; Mazoyer, Sylvie; Sinilnikova, Olga M.; Maxwell, Christopher A.; Vijai, Joseph; Robson, Mark; Kauff, Noah; Corines, Marina J.; Villano, Danylko; Cunningham, Julie; Lee, Adam; Lindor, Noralane; Lazaro, Conxi; Easton, Douglas F.; Offit, Kenneth; Chenevix-Trench, Georgia; Couch, Fergus J.; Antoniou, Antonis C.; Angel Pujana, Miguel		BCFR; SWE-BRCA; KConFab Investigators; GEMO	Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; POLYMORPHISM; MODIFIERS	While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 x 10(-4) (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted p(interaction) values > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.	[Blanco, Ignacio; Feliubadalo, Lidia; Tornero, Eva; Lazaro, Conxi] Bellvitge Inst Biomed Res IDIBELL, Hereditary Canc Program, Catalan Inst Oncol ICO, Lhospitalet Del Llobrega, Catalonia, Spain; [Kuchenbaecker, Karoline; Barrowdale, Daniel; McGuffog, Lesley; Dunning, Alison M.; Oliver, Clare; Fineberg, Elena; Cook, Margaret; Peock, Susan; Easton, Douglas F.; Antoniou, Antonis C.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Epidemiol Study Familial Breast Canc,Ctr Canc Gen, Cambridge, England; [Cuadras, Daniel; Berenguer, Antoni] Bellvitge Inst Biomed Res IDIBELL, Stat Unit, Lhospitalet Del Llobrega, Catalonia, Spain; [Wang, Xianshu; Cunningham, Julie; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Ruiz de Garibay, Gorka; Bonifaci, Nuria; Mateo, Francesca; Angel Pujana, Miguel] Bellvitge Inst Biomed Res IDIBELL, Breast Canc & Syst Biol Unit, Catalan Inst Oncol ICO, Lhospitalet Del Llobrega, Catalonia, Spain; [Librado, Pablo; Sanchez-Gracia, Alejandro; Rozas, Julio] Univ Barcelona, Dept Genet & Biodivers Res Inst IRBio, Barcelona, Catalonia, Spain; [Pankratz, Vernon S.; Cunningham, Julie; Couch, Fergus J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Islam, Abul] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka 1000, Bangladesh; [Petit, Anna; Catala, Isabel] Bellvitge Inst Biomed Res IDIBELL, Univ Hosp Bellvitge, Dept Pathol, Lhospitalet Del Llobrega, Catalonia, Spain; [Brunet, Joan] Hosp Josep Trueta, Girona Biomed Res Inst IDIBGI, Hereditary Canc Program, Catalan Inst Oncol ICO, Girona, Catalonia, Spain; [Benitez, Javier; Osorio, Ana] Spanish Natl Canc Ctr CNIO, Human Genet Grp, Madrid, Spain; [Benitez, Javier; Osorio, Ana] Biomed Network Rare Dis, Madrid, Spain; [Cajal, Teresa Ramon Y.] Hosp Santa Creu & Sant Pau, Oncol Serv, Barcelona, Catalonia, Spain; [Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Arun, Banu K.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Toland, Amanda E.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med & Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA; [Karlan, Beth Y.; Walsh, Christine; Lester, Jenny] Cedars Sinai Med Ctr, Ctr Comprehens Canc, Womens Canc Program Samuel Oschin, Los Angeles, CA 90048 USA; [Greene, Mark H.; Mai, Phuong L.] Natl Canc Inst, Div Canc Epidemiol & Genet, Clin Genet Branch, Rockville, MD USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Dept Med & Genet, San Francisco, CA 94143 USA; [Andrulis, Irene L.] Univ Toronto, Samuel Lunenfeld Res Inst, Mt Sinai Hosp, Toronto, ON, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Domchek, Susan M.; Nathanson, Katherine L.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Domchek, Susan M.; Nathanson, Katherine L.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Univ Penn Perelman, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Univ Penn Perelman, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Barkardottir, Rosa B.] Univ Iceland, Dept Pathol, Landspitali Univ Hosp, Reykjavik, Iceland; [Barkardottir, Rosa B.] Univ Iceland, Fac Med, BMC, Reykjavik, Iceland; [Jakubowska, Anna; Lubinski, Jan; Durda, Katarzyna; Jaworska-Bieniek, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Claes, Kathleen; Van Maerken, Tom] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Diez, Orland] Vall Hebron Res Inst VHIR, Vall Hebron Inst Oncol, Oncogenet Grp, Barcelona, Catalonia, Spain; [Diez, Orland] Univ Autonoma Barcelona, E-08193 Barcelona, Catalonia, Spain; [Hansen, Thomas V.; Jonson, Lars] Copenhagen Univ Hosp, Ctr Genom Med, Rigshosp, Copenhagen, Denmark; [Gerdes, Anne-Marie] Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, Copenhagen, Denmark; [Ejlertsen, Bent] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark; [de la Hoya, Miguel; Caldes, Trinidad] San Carlos Res Inst IdISSC, Mol Oncol Lab, Hosp Clin San Carlos, Madrid, Spain; [McCann, Emma] Glan Clwyd Gen Hosp, All Wales Med Genet Serv, Rhyl, Wales; [Murray, Alex] Singleton Hosp, All Wales Med Genet Serv, Swansea SA2 8QA, W Glam, Wales; [Jacobs, Chris; Pichert, Gabriella] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Clin Genet, London, England; [Lalloo, Fiona] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, Manchester Acad Hlth Sci Ctr, Genet Med, Manchester, Lancs, England; [Chu, Carol] Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Dorkins, Huw] Kennedy Galton Ctr, North West Thames Reg Genet Serv, Harrow, Middx, England; [Paterson, Joan] Addenbrookes Hosp, Dept Clin Genet, East Anglian Reg Genet Serv, Cambridge, England; [Ong, Kai-Ren] Birmingham Womens Hosp Healthcare Natl Hlth Serv, West Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Teixeira, Manuel R.] Univ Porto, Dept Genet, Portuguese Oncol Inst, P-4100 Porto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, P-4100 Porto, Portugal; [Teixeira] Netherlands Canc Inst NKI, Hereditary Breast & Ovarian Canc Res Grp Netherla, Amsterdam, Netherlands; [Hogervorst, Frans B. L.] Netherlands Canc Inst NKI, Family Canc Clin, Amsterdam, Netherlands; [van der Hout, Annemarie H.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Seynaeve, Caroline] Erasmus Univ, Med Ctr, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ligtenberg, Marjolijn J. L.] Radboud Univ Nijmegen, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Ligtenberg, Marjolijn J. L.] Radboud Univ Nijmegen, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Ligtenberg, Marjolijn J. L.; Devilee, Peter; Wijnen, Juul T.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Wijnen, Juul T.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Rookus, Matti A.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Meijers-Heijboer, Hanne E. J.] Vrije Univ VJ Univ Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Blok, Marinus J.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [van den Ouweland, Ans M. W.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Aalfs, Cora M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Rodriguez, Gustavo C.] Univ Chicago, NorthShore Univ HealthSyst, Div Gynecol Oncol, Chicago, IL 60637 USA; [Phillips, Kelly-Anne A.] Peter MacCallum Canc Ctr, Div Canc Med, East Melbourne, Vic, Australia; [Piedmonte, Marion] Roswell Pk Canc Inst, Gynecol Oncol Grp, Stat & Data Ctr, Buffalo, NY 14263 USA; [Nerenstone, Stacy R.] Hartford Hosp, Helen & Harry Gray Canc Ctr, Cent Connecticut Canc Consortium, Hartford, CT USA; [Bae-Jump, Victoria L.] Univ N Carolina, Dept Obstet & Gynecol, Div Gynecol Oncol, Chapel Hill, NC USA; [O'Malley, David M.] Ohio State Univ, Columbus Canc Council, Div Gynecol Oncol, Hilliard, OH USA; [Ratner, Elena S.] Yale Univ, Sch Med, Div Gynecol Oncol, New Haven, CT USA; [Schmutzler, Rita K.; Wappenschmidt, Barbara; Rhiem, Kerstin] Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.; Wappenschmidt, Barbara; Rhiem, Kerstin] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Gynecol & Obstet, Klinikum Rechts Isar, Div Tumor Genet, D-80290 Munich, Germany; [Ditsch, Nina] Univ Munich, Dept Gynecol & Obstet, Munich, Germany; [Arnold, Norbert] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Gynecol & Obstet, Kiel, Germany; [Plendl, Hansjoerg J.] Univ Kiel, Univ Med Ctr Schleswig Holstein, Inst Human Genet, Kiel, Germany; [Niederacher, Dieter] Univ Dusseldorf, Univ Hosp Dseeldorf, Dept Gynecol & Obstet, Dusseldorf, Germany; [Sutter, Christian] Univ Heidelberg Hosp, Inst Human Genet, Dept Human Genet, Heidelberg, Germany; [Wang-Gohrke, Shan] Univ Hosp Ulm, Dept Gynecol & Obstet, Ulm, Germany; [Steinemann, Doris] Hannover Med Sch, Inst Cell & Mol Pathol, Hannover, Germany; [Preisler-Adams, Sabine] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Kast, Karin] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Gynecol & Obstet, D-01062 Dresden, Germany; [Varon-Mateeva, Raymonda] Charite, Inst Human Genet, Campus Virchov Klinikum, Berlin, Germany; [Gehrig, Andrea] Univ Wurzburg, Inst Human Genet, Dept Med Genet, Ctr Familial Breast & Ovarian Canc, D-97070 Wurzburg, Germany; [Bojesen, Anders] Vejle Hosp, Dept Clin Genet, Vejle, Denmark; [Pedersen, Inge Sokilde] Aalborg Univ Hosp, Dept Biochem, Sect Mol Diagnost, Aalborg, Denmark; [Sunde, Lone] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Peterlongo, Paolo] Fdn Italiana Ric Cancro, Fdn Ist Oncol Mol IFOM, Milan, Italy; [Bernard, Loris] Cogentech Canc Genet Test Lab, Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Peissel, Bernard; Scuvera, Giulietta; Manoukian, Siranoush] Fdn Ist Nazl Tumori INT, IRCCS, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Radice, Paolo] Fdn Ist Nazl Tumori INT, IRCCS, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Milan, Italy; [Ottini, Laura] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Montagna, Marco; Agata, Simona] IRCCS, Immunol & Mol Oncol Unit, Ist Oncol Veneto, Padua, Italy; [Maugard, Christine] Hop Univ Strasbourg, CHRU, Nouvel Hop Civil, Lab Diagnost Genet & Serv Onco Hematol, Strasbourg, France; [Simard, Jacques; Soucy, Penny] Ctr Hosp Univ Quebec, Res Ctr, Canc Genom Lab, Quebec City, PQ, Canada; [Simard, Jacques; Soucy, Penny] Univ Laval, Quebec City, PQ, Canada; [Berger, Andreas; Fink-Retter, Anneliese; Singer, Christian F.; Rappaport, Christine; Geschwantler-Kaulich, Daphne; Tea, Muy-Kheng; Pfeiler, Georg] Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria; [Berger, Andreas; Fink-Retter, Anneliese; Singer, Christian F.; Rappaport, Christine; Geschwantler-Kaulich, Daphne; Tea, Muy-Kheng; Pfeiler, Georg] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [BCFR] Canc Prevent Inst Calif, Breast Canc Family Registry, Fremont, CA USA; [John, Esther M.] Canc Prevent Inst Calif, Dept Epidemiol, Fremont, CA USA; [Miron, Alex] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Terry, Mary Beth] Columbia Univ, Dept Epidemiol, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat & Med, New York, NY USA; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Clin Genet, Philadelphia, PA 19111 USA; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Janavicius, Ramunas] Vilnius Univ, Dept Mol & Regenerat Med, Hematol Oncol & Transfus Med Ctr, Hosp Santariskiu Clin,State Res Ctr Inst Innovat, Vilnius, Lithuania; [Dorfling, Cecilia M.; van Rensburg, Elisabeth J.] Univ Pretoria, Dept Genet, Canc Genet Lab, Arcadia, South Africa; [Fostira, Florentia; Konstantopoulou, Irene] Natl Ctr Sci Res Demokritos, Inst Radioisotopes & Radiodiagnost Prod, Mol Diagnost Lab, Athens, Greece; [Garber, Judy] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genet & Prevent, Boston, MA USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Olah, Edith] Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Rennert, Gad] Clalit Natl Israeli Canc Control Ctr, Haifa, Israel; [Rennert, Gad] Carmel Hosp, Dept Commun Med & Epidemiol, Haifa, Israel; [Rennert, Gad] B Rappaport Fac Med, Haifa, Israel; [Paluch, Shani Shimon] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel; [Laitman, Yael; Friedman, Eitan] Chaim Sheba Med Ctr, Inst Human Genet, Susanne Levy Gertner Oncogenet Unit, Ramat Gan, Israel; [Friedman, Eitan] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [SWE-BRCA] Swedish BRCA1 & BRCA2 Study SWE BRCA, Stockholm, Sweden; [Liljegren, Annelie] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Rantala, Johanna] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Stenmark-Askmalm, Marie] Linkoping Univ, Dept Clin & Expt Med, Div Clin Genet, Linkoping, Sweden; [Loman, Niklas] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; [Imyanitov, Evgeny N.] NN Petrov Inst Oncol, St Petersburg, Russia; [Hamann, Ute] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [KConFab Investigators] Peter MacCallum Canc Ctr, Kathleen Cuningham Consortium Res Familial Breast, Melbourne, Vic, Australia; [Spurdle, Amanda B.; Healey, Sue; Chenevix-Trench, Georgia] Queensland Inst Med Res, Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Weitzel, Jeffrey N.; Herzog, Josef] City Hope Natl Med Ctr, Clin Canc Genet, Duarte, CA USA; [Margileth, David] Care City Hope Clin Canc Genet Commun Res Network, St Joseph Hosp Orange, Duarte, CA USA; [Gorrini, Chiara] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Esteller, Manel; Gomez, Antonio; Sayols, Sergi; Vidal, Enrique; Heyn, Holger] IDIBELL, Canc Epigenet & Biol Program PEBC, Lhospitalet Del Llobrega, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Lhospitalet Del Llobrega, Catalonia, Spain; [Esteller, Manel] Catalan Inst Res & Adv Studies ICREA, Barcelona, Catalonia, Spain; [GEMO] French Federat Comprehens Canc Ctr UNICANCER, Grp Genet & Canc GEMO, Natl Canc Genet Network, Paris, France; [Stoppa-Lyonnet, Dominique; Fassy-Colcombet, Marion; de Pauw, Antoine; Castera, Laurent] Inst Curie, Dept Tumor Biol, Paris, France; [Stoppa-Lyonnet, Dominique] Inst Curie, INSERM, U830, Paris, France; [Stoppa-Lyonnet, Dominique] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Leone, Melanie; Sinilnikova, Olga M.] Hosp Civils Lyon, Ctr Leon Berard, Unit Mixte Genet Constitut Canc Frequents, Lyon, France; [Barjhoux, Laure; Damiola, Francesca; Mazoyer, Sylvie; Sinilnikova, Olga M.] Univ Lyon 1, CNRS, INSERM, Ctr Rech Cancerol Lyon,U1052,UMR5286, F-69365 Lyon, France; [Lasset, Christine] Univ Lyon 1, CNRS, UMR5558, F-69365 Lyon, France; [Lasset, Christine] Ctr Leon Berard, Unit Prevent & Epidemiol Genet, F-69373 Lyon, France; [Ferrer, Sandra Fert] Hop Hotel Dieu, Ctr Hosp, Lab Genet Chromosom, Chambery, France; [Berthet, Pascaline] Ctr Francois Baclesse, F-14021 Caen, France; [Cornelis, Francois] Avicenne Hosp, AP HP, Genet Unit, Paris, France; [Cornelis, Francois] Sud Francilien Hosp, Evry, France; [Cornelis, Francois] Univ Hosp, Clermont Ferrand, France; [Bignon, Yves-Jean] Univ Clermont Ferrand 2, Ctr Jean Perrin, Dept Oncogenet, Clermont Ferrand, France; [Maxwell, Christopher A.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Vijai, Joseph; Robson, Mark; Kauff, Noah; Corines, Marina J.; Villano, Danylko; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Res Lab, New York, NY 10021 USA; [Lee, Adam] Mayo Clin, Dept Oncol, Rochester, MN USA; [Lindor, Noralane] Mayo Clin Scottsdale, Ctr Individualized Med, Scottsdale, AZ USA	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Cambridge; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Mayo Clinic; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Mayo Clinic; University of Dhaka; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital of Santa Creu i Sant Pau; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Landspitali National University Hospital; University of Iceland; University of Iceland; Pomeranian Medical University; Ghent University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Hospital Clinico San Carlos; Singleton Hospital; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Birmingham Women's Hospital; Portuguese Institute of Oncology; Universidade do Porto; Universidade do Porto; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Maastricht University; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; NorthShore University Health System; University of Chicago; Peter Maccallum Cancer Center; Roswell Park Cancer Institute; Hartford Hospital; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; Yale University; University of Cologne; University of Cologne; Leipzig University; Technical University of Munich; University of Munich; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Ulm University; Hannover Medical School; University of Munster; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University of Southern Denmark; Lillebaelt Hospital; Aalborg University; Aalborg University Hospital; Aarhus University; University of Southern Denmark; Odense University Hospital; Masaryk Memorial Cancer Institute; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Sapienza University Rome; IRCCS Istituto Oncologico Veneto (IOV); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Laval University; Laval University; Medical University of Vienna; Medical University of Vienna; Cancer Prevention Institute of California; Cancer Prevention Institute of California; Harvard University; Dana-Farber Cancer Institute; City of Hope; Beckman Research Institute of City of Hope; Columbia University; Columbia University; Fox Chase Cancer Center; Utah System of Higher Education; University of Utah; Vilnius University; University of Pretoria; National Centre of Scientific Research "Demokritos"; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Kansas; University of Kansas Medical Center; National Institute of Oncology Hungary; University of Toronto; University Toronto Affiliates; Womens College Hospital; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Lund University; Skane University Hospital; N.N. Petrov Research Institute of Oncology; Helmholtz Association; German Cancer Research Center (DKFZ); Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; City of Hope; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UNICANCER; Centre Leon Berard; UNICANCER; Centre Francois Baclesse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Centre Hospitalier Sud Francilien; CHU Clermont Ferrand; UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Child & Family Research Institute; University of British Columbia; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Antoniou, AC (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Epidemiol Study Familial Breast Canc,Ctr Canc Gen, Cambridge, England.	aca20@medschl.cam.ac.uk; mapujana@iconcologia.net	Pujana, Miquel Angel/N-3127-2014; Chenevix-Trench, Georgia/AAV-2014-2020; Devilee, Peter/GXV-8005-2022; Sanchez-Gracia, Alejandro/F-4686-2014; Rebbeck, Timothy/GLU-8348-2022; Vidal, Enrique/J-7118-2015; Radice, Paolo/O-3119-2013; Narod, Steven A/AAA-6112-2022; Jakubowska, Anna/O-8050-2014; bonifaci, nuria/B-8104-2019; van Rensburg, Elizabeth J./B-9104-2011; Teixeira, Manuel AC/AAZ-7251-2020; GARCIA, CONXI LAZARO/Q-2410-2016; Bojesen, Anders B/G-6308-2010; Vidal, Enrique/A-9455-2014; Jensen, Uffe Birk/ABA-8306-2021; Fostira, Florentia/Z-5730-2019; Andrulis, Irene L./E-7267-2013; Pedersen, Inge Søkilde/ABB-1019-2020; Feliu-Frasnedo, Evarist/AAN-1206-2021; Petit, Anna/GYU-5229-2022; Osorio, Ana/I-4324-2014; Hansen, Thomas/GWZ-2858-2022; Blanco, Ignacio/D-2565-2013; montagna, marco/E-2225-2012; Hansen, Thomas v. O./J-9361-2014; Spurdle, Amanda B/A-4978-2011; Claes, Kathleen/AFR-6830-2022; Ehrencrona, Hans/Q-4621-2019; Arnold, Norbert/E-3012-2010; Mazoyer, Sylvie/N-7559-2017; Vidal, Enrique/R-5593-2019; Jensen, Uffe Birk/E-6066-2017; Sunde, Lone/AAG-7303-2019; Saunders, Christobel M/H-5779-2014; , bignon/Y-3243-2019; Rozas, Julio/A-1733-2009; De Pauw, Antoine/ABC-6019-2020; Moruno, Antonio Gomez/H-7574-2015; Mateo, Francesca/K-7746-2015; manoukian, siranoush/E-7132-2017; Ligtenberg, Marjolijn/N-9666-2013; Blanco, Ignacio/AAN-5426-2021; Peissel, Bernard/E-8187-2017; Peterlongo, Paolo/Q-4717-2018; Esteller, Manel/L-5956-2014; Imyanitov, Evgeny/ABG-8619-2021; Feliubadalo, Lidia/G-4577-2016; Maxwell, Christopher A/B-3044-2011; de la Hoya, MIguel/Z-2911-2019; OMalley, David/E-3789-2011; Teixeira, Manuel António Rodrigues/E-4885-2011; Ehrencrona, Hans/M-5619-2014; DEVILEE, PETER/ABR-2140-2022; Joseph, Vijai/J-9158-2013; Brunet, Joan/C-5292-2018; benitez, javier/H-5232-2015; Konstantopoulou, Irene/B-5309-2009	Pujana, Miquel Angel/0000-0003-3222-4044; Chenevix-Trench, Georgia/0000-0002-1878-2587; Sanchez-Gracia, Alejandro/0000-0003-4543-4577; Rebbeck, Timothy/0000-0002-4799-1900; Vidal, Enrique/0000-0002-4217-1807; Radice, Paolo/0000-0001-6298-4111; Jakubowska, Anna/0000-0002-5650-0501; bonifaci, nuria/0000-0002-8193-6825; Teixeira, Manuel AC/0000-0002-1959-0624; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Vidal, Enrique/0000-0002-4217-1807; Jensen, Uffe Birk/0000-0002-6205-6355; Pedersen, Inge Søkilde/0000-0002-9902-8040; Feliu-Frasnedo, Evarist/0000-0001-5780-3136; Osorio, Ana/0000-0001-8124-3984; Blanco, Ignacio/0000-0002-7414-7481; montagna, marco/0000-0002-4929-2150; Hansen, Thomas v. O./0000-0003-4635-2653; Spurdle, Amanda B/0000-0003-1337-7897; Claes, Kathleen/0000-0003-0841-7372; Ehrencrona, Hans/0000-0002-5589-3622; Arnold, Norbert/0000-0003-4523-8808; Vidal, Enrique/0000-0002-4217-1807; Jensen, Uffe Birk/0000-0002-6205-6355; Sunde, Lone/0000-0002-8479-165X; Saunders, Christobel M/0000-0003-2281-9829; Rozas, Julio/0000-0002-6839-9148; De Pauw, Antoine/0000-0003-3898-073X; Moruno, Antonio Gomez/0000-0001-5308-981X; Mateo, Francesca/0000-0002-2342-7010; manoukian, siranoush/0000-0002-6034-7562; Ligtenberg, Marjolijn/0000-0003-1290-1474; Blanco, Ignacio/0000-0002-7414-7481; Peissel, Bernard/0000-0001-9233-3571; Peterlongo, Paolo/0000-0001-6951-6855; Esteller, Manel/0000-0003-4490-6093; Feliubadalo, Lidia/0000-0002-1736-0112; Maxwell, Christopher A/0000-0002-0713-7136; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Ehrencrona, Hans/0000-0002-5589-3622; diez, orland/0000-0001-7339-0570; van der Luijt, Rob/0000-0002-0018-1089; Barrowdale, Daniel/0000-0003-1661-3939; Simard, Jacques/0000-0001-6906-3390; Houdayer, Claude/0000-0002-5190-0389; Rennert, Gad/0000-0002-8512-068X; Bojesen, Anders/0000-0003-4289-8595; Joseph, Vijai/0000-0002-7933-151X; Durocher, Francine/0000-0001-8012-4641; Kauff, Noah/0000-0001-7242-6156; van Rensburg, Elizabeth/0000-0003-2077-230X; Gorrini, Chiara/0000-0002-5239-6671; Lubinski, Jan/0000-0003-2931-3003; Gerdes, Anne-Marie/0000-0002-0328-3320; Devilee, Peter/0000-0002-8023-2009; Brunet, Joan/0000-0003-1945-3512; OTTINI, LAURA/0000-0001-8030-0449; Terry, Mary Beth/0000-0002-4106-5033; Berenguer-LLergo, Antoni/0000-0002-3742-8161; OMalley, David/0000-0002-2828-0177; Librado, Pablo/0000-0001-5974-2189; benitez, javier/0000-0002-0923-7202; Damiola, Francesca/0000-0002-0238-1252; Thorne, Heather/0000-0003-3610-2511; Dunning, Alison Margaret/0000-0001-6651-7166; Konstantopoulou, Irene/0000-0002-0470-0309; Vaur, Dominique/0000-0003-2792-8506; Mazoyer, Sylvie/0000-0002-2135-0160; Sayols, Sergi/0000-0002-3877-4170; Robson, Mark/0000-0002-3109-1692; Maxwell, Christopher/0000-0002-0860-4031; Cuadras, Daniel/0000-0001-8780-1764; Dorkins, Huw/0000-0001-8421-9939; Ruiz de Garibay, Gorka/0000-0001-9936-8419; Heyn, Holger/0000-0002-3276-1889; Jacobs, Chris/0000-0002-9557-9080; Engel, Christoph/0000-0002-7247-282X; Foretova, Lenka/0000-0003-0494-2620; de la Hoya, Miguel/0000-0002-8113-1410; Islam, Abul/0000-0002-7274-0855; Phillips, Kelly-Anne/0000-0002-0475-1771; Castera, Laurent/0000-0002-0459-3400	National Cancer Institute [UM1 CA164920]; Lithuania (BFBOCC-LT): Research Council of Lithuania grant [LIG-07/2012]; Hereditary Cancer Association (Paveldimo vezio asociacija); LSC grant [10.0010.08]; ESF [2009/0220/1DP/1.1.1.2.0/09/APIA/VIAA/016]; Liepaja's municipal council; Cancer Association of South Africa (CANSA); Morris and Horowitz Familes Endowed Professorship; NEYE Foundation; Spanish Association against Cancer [AECC08, RTICC 06/0020/1060, FISPI08/1120]; Mutua Madrilena Foundation (FMMA); COH-CCGCRN: City of Hope Clinical Cancer Genetics Community Network from the National Cancer Institute and the Office of the Director, National Institutes of Health; Hereditary Cancer Research Registry from the National Cancer Institute and the Office of the Director, National Institutes of Health [RC4CA153828]; Fondazione IRCCS Istituto Nazionale Tumori; Cancer Research-United Kingdom grant [C12292/A11174, C1287/ A10118]; NHMRC Program Grant; DKFZ; European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA; European Social Fund; Cancer Research United Kingdom Grants [C1287/A10118, C1287/A11990]; National Institute of Health Research (NIHR) grant; NIHR grant; Royal Marsden NHS Foundation Trust; Cancer Research United Kingdom Grant [C5047/A8385]; University of Kansas Cancer Center [P30 CA168524]; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences Professorship; AKG [5U01CA113916, R01CA140323]; German Cancer Aid [109076]; Center for Molecular Medicine Cologne (CMMC); Ligue National Contre le Cancer; Association "Le cancer du sein, parlonsen!" Award; Canadian Institutes of Health Research; Fund for Scientific Research Flanders (FWO); National Cancer Institute grant [CA 27469]; GOG Statistical and Data Center [CA 37517]; GOG's Cancer Prevention and Control Committee [CA 101165]; Intramural Research Program, NCI; ISCIII (Spain) [RD12/00369/0006, 12/00539]; European Regional Development FEDER funds; Helsinki University Central Hospital Research Fund; Academy of Finland [132473]; Finnish Cancer Society; Sigrid Juselius Foundation; Dutch Cancer Society grant [NKI1998-1854, NKI2004-3088, NKI2007-3756]; Netherlands Organization of Scientific Research [NWO 91109024]; Pink Ribbon grant [110005]; BBMRI grant [NWO 184.021.007/CP46]; Hungarian Research Grant [KTIA-OTKA CK-80745]; Norwegian EEA Financial Mechanism [HU0115/NA/2008-3/OP-9]; Spanish Ministry of Health ISCIII FIS [PI10/01422, PI12/01528, PI13/00285]; RTICC [RD12/0036/0008]; Ramon Areces (XV) Foundation; Eugenio Rodriguez Pascual Foundation; Roses Contra el Cancer Foundation; Spanish Association Against Cancer (AECC); AGAUR Generalitat de Catalunya [2009-SGR290, 2009-SGR293]; Polish Foundation of Science; Icelandic Association "Walking for Breast Cancer Research"; Nordic Cancer Union; Landspitali University Hospital Research Fund; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program; Canadian Breast Cancer Research Alliance-grant [019511]; Ministry of Economic Development, Innovation and Export Trade-grant [PSR-SIIRI-701]; Ministero dell'Istruzione, dell'Universita e della Ricerca and Ministero della Salute; Liga Portuguesa Contra o Cancro; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Foundation of Western Australia; Cancer Councils of Tasmania; National Institutes of Health grant [CA128978]; NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; United States Department of Defence Ovarian Cancer Idea award [W81XWH-10-1-0341]; Breast Cancer Research Foundation; Jewish General Hospital Weekend; Quebec Ministry of Economic Development, Innovation and Export Trade; Cancer Councils of South Australia; European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; MH CZ-DRO (MMCI) [00209805]; Niehaus Family Genetics Research Fund; STARR Cancer Consortium Grant; NAROD [1R01 CA149429-01]; NCI Intramural Research Program, National Institutes of Health [NO2-CP-11019-50, N02-CP-65504]; Westat, Inc, Rockville, Maryland; Clalit Health Services in Israel; Israel Cancer Association; Breast Cancer Research Foundation (BCRF), New York; Russian Federation for Basic Research [11-04-00227, 12-04-00928, 12-04-01490]; Federal Agency for Science and Innovations, Russia [02.740.11.0780]; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program and grant from the National Cancer Institute [UM1 CA164920]; Breast Cancer Family Registry (BCFR); United States Government or the BCFR; Ohio State University Comprehensive Cancer Center; Isreal cancer association; Israeli Inherited breast cancer consortium; Swedish Cancer Society; Ralph and Marion Falk Medical Research Trust; Entertainment Industry Fund National Women's Cancer Research Alliance; National Institutes of Health (NIH) [R01-CA102776, R01-CA083855]; Rooney Family Foundation; Susan G. Komen Foundation for the cure, Basser Research Center; American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]; SAF2010-20493;  [PBZ_KBN_122/P05/2004]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; ICREA Funding Source: Custom; Cancer Research UK [11174, 16565] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06, PRAC-13-04] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U10CA180838, R01CA149429, R01CA102776, P30CA168524, U10CA027469, UM1CA164920, R01CA083855, U10CA101165, P50CA116201, R01CA128978, P50CA125183, U24CA196067, ZIACP010144, P30CA016672, R01CA142996, U01CA161032, U10CA180850, U01CA113916, U10CA037517, RC4CA153828, R01CA140323] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lithuania (BFBOCC-LT): Research Council of Lithuania grant(Research Council of Lithuania (LMTLT)); Hereditary Cancer Association (Paveldimo vezio asociacija); LSC grant; ESF(European Commission); Liepaja's municipal council; Cancer Association of South Africa (CANSA); Morris and Horowitz Familes Endowed Professorship; NEYE Foundation; Spanish Association against Cancer; Mutua Madrilena Foundation (FMMA); COH-CCGCRN: City of Hope Clinical Cancer Genetics Community Network from the National Cancer Institute and the Office of the Director, National Institutes of Health; Hereditary Cancer Research Registry from the National Cancer Institute and the Office of the Director, National Institutes of Health; Fondazione IRCCS Istituto Nazionale Tumori; Cancer Research-United Kingdom grant; NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); DKFZ(Helmholtz Association); European Union (European Social Fund-ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA; European Social Fund(European Social Fund (ESF)); Cancer Research United Kingdom Grants; National Institute of Health Research (NIHR) grant(National Institute for Health Research (NIHR)); NIHR grant; Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); Cancer Research United Kingdom Grant; University of Kansas Cancer Center; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences Professorship; AKG; German Cancer Aid(Deutsche Krebshilfe); Center for Molecular Medicine Cologne (CMMC); Ligue National Contre le Cancer(Ligue nationale contre le cancer); Association "Le cancer du sein, parlonsen!" Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fund for Scientific Research Flanders (FWO)(FWO); National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); GOG Statistical and Data Center; GOG's Cancer Prevention and Control Committee; Intramural Research Program, NCI; ISCIII (Spain)(Instituto de Salud Carlos III); European Regional Development FEDER funds(European Commission); Helsinki University Central Hospital Research Fund; Academy of Finland(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Dutch Cancer Society grant(KWF Kankerbestrijding); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Pink Ribbon grant; BBMRI grant; Hungarian Research Grant; Norwegian EEA Financial Mechanism; Spanish Ministry of Health ISCIII FIS(Spanish Government); RTICC(Instituto de Salud Carlos III); Ramon Areces (XV) Foundation; Eugenio Rodriguez Pascual Foundation; Roses Contra el Cancer Foundation; Spanish Association Against Cancer (AECC); AGAUR Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Polish Foundation of Science; Icelandic Association "Walking for Breast Cancer Research"; Nordic Cancer Union; Landspitali University Hospital Research Fund; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance-grant; Ministry of Economic Development, Innovation and Export Trade-grant; Ministero dell'Istruzione, dell'Universita e della Ricerca and Ministero della Salute; Liga Portuguesa Contra o Cancro; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Councils of Tasmania(Cancer Council Tasmania); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defence Ovarian Cancer Idea award; Breast Cancer Research Foundation; Jewish General Hospital Weekend; Quebec Ministry of Economic Development, Innovation and Export Trade; Cancer Councils of South Australia(Cancer Council South Australia); European Regional Development Fund(European Commission); State Budget of the Czech Republic (RECAMO); MH CZ-DRO (MMCI); Niehaus Family Genetics Research Fund; STARR Cancer Consortium Grant; NAROD; NCI Intramural Research Program, National Institutes of Health; Westat, Inc, Rockville, Maryland; Clalit Health Services in Israel; Israel Cancer Association; Breast Cancer Research Foundation (BCRF), New York; Russian Federation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Agency for Science and Innovations, Russia(Federal Agency for Science & Innovations (FASI)); Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program and grant from the National Cancer Institute(Canadian Institutes of Health Research (CIHR)); Breast Cancer Family Registry (BCFR); United States Government or the BCFR; Ohio State University Comprehensive Cancer Center; Isreal cancer association; Israeli Inherited breast cancer consortium; Swedish Cancer Society(Swedish Cancer Society); Ralph and Marion Falk Medical Research Trust; Entertainment Industry Fund National Women's Cancer Research Alliance; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rooney Family Foundation; Susan G. Komen Foundation for the cure, Basser Research Center(Susan G. Komen Breast Cancer Foundation); American Cancer Society Early Detection Professorship(American Cancer Society); SAF2010-20493; ; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); ICREA(ICREA); Cancer Research UK(Cancer Research UK); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	BCFR-all. This work was supported by grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the BCFR. BFBOCC: BFBOCC is supported by: Lithuania (BFBOCC-LT): Research Council of Lithuania grant LIG-07/2012 and Hereditary Cancer Association (Paveldimo vezio asociacija); Latvia (BFBOCC-LV) is partly supported by LSC grant 10.0010.08 and in part by a grant from the ESF Nr. 2009/0220/1DP/1.1.1.2.0/09/APIA/VIAA/016 and Liepaja's municipal council. BMBSA: BRCA-gene mutations and breast cancer in South African women (BMBSA) was supported by grants from the Cancer Association of South Africa (CANSA) to EJR. BRICOH: SLN was partially supported by the Morris and Horowitz Familes Endowed Professorship. CBCS: This work was supported by the NEYE Foundation. CNIO: This work was partially supported by Spanish Association against Cancer (AECC08), RTICC 06/0020/1060, FISPI08/1120, Mutua Madrilena Foundation (FMMA) and SAF2010-20493. COH-CCGCRN: City of Hope Clinical Cancer Genetics Community Network and the Hereditary Cancer Research Registry, supported in part by Award Number RC4CA153828 (PI: JW) from the National Cancer Institute and the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CONSIT TEAM: Funds from Italian citizens who allocated the 5x1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000') to SM. Italian Association for Cancer Research (AIRC) to LO. CORE: The CIMBA data management and data analysis were supported by Cancer Research-United Kingdom grants C12292/A11174 and C1287/A10118. SH is supported by an NHMRC Program Grant to GCT. ACA is a Cancer Research -United Kingdom Senior Cancer Research Fellow. GCT is an NHMRC Senior Principal Research Fellow. DKFZ: The DKFZ study was supported by the DKFZ. DEMOKRITOS: This research has been co-financed by the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA. Investing in knowledge society through the European Social Fund. EMBRACE: EMBRACE is supported by Cancer Research United Kingdom Grants C1287/A10118 and C1287/A11990. DGE and FL are supported by an National Institute of Health Research (NIHR) grant to the Biomedical Research Centre, Manchester. The Investigators at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are supported by an NIHR grant to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. RE and EB are supported by Cancer Research United Kingdom Grant C5047/A8385. FCCC: The authors acknowledge support from The University of Kansas Cancer Center (P30 CA168524) and the Kansas Bioscience Authority Eminent Scholar Program. AKG was funded by 5U01CA113916, R01CA140323, and by the Chancellors Distinguished Chair in Biomedical Sciences Professorship.; GC-HBOC: The German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC) is supported by the German Cancer Aid (grant no 109076, RKS) and by the Center for Molecular Medicine Cologne (CMMC). GEMO: The study was supported by the Ligue National Contre le Cancer; the Association "Le cancer du sein, parlonsen!" Award; and the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program. G-FAST: TVM is a postdoctoral researcher funded by the Fund for Scientific Research Flanders (FWO). GOG: This study was supported by National Cancer Institute grants to the Gynecologic Oncology Group (GOG) Administrative Office and Tissue Bank (CA 27469), the GOG Statistical and Data Center (CA 37517), and GOG's Cancer Prevention and Control Committee (CA 101165). MHG, PLM and Dr. Savage were supported by funding from the Intramural Research Program, NCI. HCSC: Was supported by a grant RD12/00369/0006 and 12/00539 from ISCIII (Spain), partially supported by European Regional Development FEDER funds. HEBCS: The HEBCS was financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland (132473), the Finnish Cancer Society and the Sigrid Juselius Foundation. HEBON: The HEBON study is supported by the Dutch Cancer Society grants NKI1998-1854, NKI2004-3088, NKI2007-3756, the Netherlands Organization of Scientific Research grant NWO 91109024, the Pink Ribbon grant 110005 and the BBMRI grant NWO 184.021.007/CP46. HUNBOCS: Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research Grant KTIA-OTKA CK-80745 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. ICO: The ICO-IDIBELL study was supported by grants from the Spanish Ministry of Health ISCIII FIS (PI10/01422, PI12/01528, and PI13/00285) and RTICC (RD12/0036/0008); the Ramon Areces (XV), Eugenio Rodriguez Pascual (2012), and Roses Contra el Cancer (2012) Foundations; the Spanish Association Against Cancer (AECC 2010); and the AGAUR Generalitat de Catalunya (2009-SGR290 and 2009-SGR293). IHCC: The IHCC was supported by Grant PBZ_KBN_122/P05/2004; Katarzyna Jaworska is a fellow of International PhD program, Postgraduate School of Molecular Medicine, Warsaw Medical University, supported by the Polish Foundation of Science. ILUH: The ILUH group was supported by the Icelandic Association "Walking for Breast Cancer Research", by the Nordic Cancer Union and by the Landspitali University Hospital Research Fund. INHERIT: This work was supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program, the Canadian Breast Cancer Research Alliance-grant #019511 and the Ministry of Economic Development, Innovation and Export Trade-grant #PSR-SIIRI-701. IOVHBOCS: The study was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca and Ministero della Salute. IPOBCS: This study was in part supported by Liga Portuguesa Contra o Cancro. KCONFAB: kConFab is supported by grants from the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. GCT and ABS are NHMRC Senior Research Fellows.; MAYO: MAYO is supported by National Institutes of Health grant CA128978, an NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a United States Department of Defence Ovarian Cancer Idea award (W81XWH-10-1-0341) and grants from the Breast Cancer Research Foundation. MCGILL: Jewish General Hospital Weekend to End Breast Cancer, Quebec Ministry of Economic Development, Innovation and Export Trade. MODSQUAD: The work was supported by the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101) and MH CZ-DRO (MMCI, 00209805). MSKCC: MSKCC is supported by Breast Cancer Research Foundation, the Niehaus Family Genetics Research Fund, and the STARR Cancer Consortium Grants. NAROD: 1R01 CA149429-01. NCI: The research of MHG and PLM was supported by the NCI Intramural Research Program, National Institutes of Health, and by support services contracts NO2-CP-11019-50 and N02-CP-65504 with Westat, Inc, Rockville, Maryland. This study was supported by National Cancer Institute grants to the Gynecologic Oncology Group (GOG) Administrative Office and Tissue Bank (CA 27469), the GOG Statistical and Data Center (CA 37517), and GOG's Cancer Prevention and Control Committee (CA 101165). NICCC: NICCC is supported by Clalit Health Services in Israel. Some of it's activities are supported by the Israel Cancer Association and the Breast Cancer Research Foundation (BCRF), New York. NNPIO: This work has been supported by the Russian Federation for Basic Research (grants 11-04-00227, 12-04-00928 and 12-04-01490) and the Federal Agency for Science and Innovations, Russia (contract 02.740.11.0780). OCGN: This work was supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program and grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the BCFR. OSUCCG: OSUCCG is supported by the Ohio State University Comprehensive Cancer Center. SMC: This project was partially funded through a grant by the Isreal cancer association and the funding for the Israeli Inherited breast cancer consortium. SWE-BRCA: SWE-BRCA collaborators are supported by the Swedish Cancer Society. UCHICAGO: UCHICAGO is supported by NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA125183), R01 CA142996, 1U01CA161032 and by the Ralph and Marion Falk Medical Research Trust, the Entertainment Industry Fund National Women's Cancer Research Alliance and the Breast Cancer research Foundation. OIO is an ACS Clinical Research Professor. UCSF: UCSF Cancer Risk Program and Helen Diller Family Comprehensive Cancer Center. UPENN: National Institutes of Health (NIH) (R01-CA102776 and R01-CA083855; Breast Cancer Research Foundation; Rooney Family Foundation; Susan G. Komen Foundation for the cure, Basser Research Center for BRCA. WCP: The Women's Cancer Program (WCP) at the Samuel Oschin Comprehensive Cancer Institute is funded by the American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Barnes DR, 2012, GENET EPIDEMIOL, V36, P274, DOI 10.1002/gepi.21620; Bonifaci N, 2014, CARCINOGENESIS, V35, P578, DOI 10.1093/carcin/bgt403; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Corona E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012236; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Couch FJ, 2007, CANCER EPIDEM BIOMAR, V16, P1416, DOI 10.1158/1055-9965.EPI-07-0129; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Douzery EJP, 2014, MOL BIOL EVOL, V31, P1923, DOI 10.1093/molbev/msu132; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Fletcher O, 2006, J NATL CANCER I, V98, P1014, DOI 10.1093/jnci/djj268; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hill SJ, 2014, GENE DEV, V28, P1957, DOI 10.1101/gad.241620.114; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kalmyrzaev B, 2008, CANCER EPIDEM BIOMAR, V17, P3618, DOI 10.1158/1055-9965.EPI-08-0216; Keane M, 2014, BIOINFORMATICS, V30, P3558, DOI 10.1093/bioinformatics/btu579; LONG JC, 1995, AM J HUM GENET, V56, P799; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Olson JE, 2011, BREAST CANCER RES TR, V125, P221, DOI 10.1007/s10549-010-0950-8; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rhie SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063925; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Shi H, 2011, BREAST CANCER RES TR, V130, P905, DOI 10.1007/s10549-011-1600-5; Sohr S, 2008, CELL CYCLE, V7, P3448, DOI 10.4161/cc.7.21.7014; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	43	29	29	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120020	10.1371/journal.pone.0120020	http://dx.doi.org/10.1371/journal.pone.0120020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830658	Green Published, gold			2022-12-27	WOS:000352135600019
J	Boeddeker, SJ; Baston-Buest, DM; Fehm, T; Kruessel, J; Hess, A				Boeddeker, Sarah Jean; Baston-Buest, Dunja Maria; Fehm, Tanja; Kruessel, Jan; Hess, Alexandra			Decidualization and Syndecan-1 Knock Down Sensitize Endometrial Stromal Cells to Apoptosis Induced by Embryonic Stimuli	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; HUMAN CHORIONIC VILLI; GROWTH-FACTOR-BETA; EPITHELIAL-CELLS; INTERFERON-GAMMA; EARLY-PREGNANCY; HELLP-SYNDROME; EXPRESSION; TROPHOBLAST; DEATH	Human embryo invasion and implantation into the inner wall of the maternal uterus, the endometrium, is the pivotal process for a successful pregnancy. Whereas disruption of the endometrial epithelial layer was already correlated with the programmed cell death, the role of apoptosis of the subjacent endometrial stromal cells during implantation is indistinct. The aim was to clarify whether apoptosis plays a role in the stromal invasion and to characterize if the apoptotic susceptibility of endometrial stromal cells to embryonic stimuli is influenced by decidualization and Syndecan-1. Therefore, the immortalized human endometrial stromal cell line St-T1 was used to first generate a new cell line with a stable Syndecan-1 knock down (KdS1), and second to further decidualize the cells with progesterone. As a replacement for the ethically inapplicable embryo all cells were treated with the embryonic factors and secretion products interleukin-1 beta, interferon-gamma, tumor necrosis factor-alpha, transforming growth factor-beta 1 and anti-Fas antibody to mimic the embryo contact. Detection of apoptosis was verified via Caspase ELISAs, PARP cleavage and Annexin V staining. Apoptosis-related proteins were investigated via antibody arrays and underlying signaling pathways were analyzed by Western blot. Non-decidualized endometrial stromal cells showed a resistance towards apoptosis which was rescinded by decidualization and Syndecan-1 knock down independent of decidualization. This was correlated with an altered expression of several pro-and anti-apoptotic proteins and connected to a higher activation of pro-survival Akt in non-differentiated St-T1 as an upstream mediator of apoptotis-related proteins. This study provides insight into the largely elusive process of implantation, proposing an important role for stromal cell apoptosis to successfully establish a pregnancy. The impact of Syndecan-1 in attenuating the apoptotic signal is particularly interesting in the light of an already described influence on pregnancy disorders and therefore might provide a useful clinical tool in the future to prevent pregnancy complications provoked by inadequate implantation.	[Boeddeker, Sarah Jean; Baston-Buest, Dunja Maria; Kruessel, Jan; Hess, Alexandra] Univ Duesseldorf, Dept Obstet Gynecol & Reprod Endocrinol & Inferti, Med Ctr, Dusseldorf, Germany; [Fehm, Tanja] Univ Duesseldorf, Dept Obstet & Gynecol, Med Ctr, Dusseldorf, Germany		Boeddeker, SJ (corresponding author), Univ Duesseldorf, Dept Obstet Gynecol & Reprod Endocrinol & Inferti, Med Ctr, Dusseldorf, Germany.	boeddeker@unikid.de		Fehm, Tanja/0000-0002-4926-0108	German Research Society (Deutsche Forschungsgemeinschaft [DFG] [HE 3544/2-2, HE 3544/2-3]	German Research Society (Deutsche Forschungsgemeinschaft [DFG](German Research Foundation (DFG))	This work was funded by the German Research Society (Deutsche Forschungsgemeinschaft [DFG]; http://www.dfg.de/en/index.jsp) to AH (HE 3544/2-2 and HE 3544/2-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Baston-Bust DM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-133; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bischofs S., 2012, ASIAN PAC J REPROD, V1, P277, DOI DOI 10.1016/S2305-0500(13)60092-5; Boeddeker SJ, 2014, MOL HUM REPROD, V20, P567, DOI 10.1093/molehr/gau009; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 1996, ENDOCRINOLOGY, V137, P2225, DOI 10.1210/en.137.6.2225; Cali U, 2013, CLIN EXP OBSTET GYN, V40, P45; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi DS, 2007, INT J CANCER, V121, P741, DOI 10.1002/ijc.22713; Chui A, 2012, AM J PATHOL, V180, P693, DOI 10.1016/j.ajpath.2011.10.023; Davies EJ, 2004, CLIN CANCER RES, V10, P5178, DOI 10.1158/1078-0432.CCR-03-0103; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dmowski WP, 2001, HUM REPROD, V16, P1802, DOI 10.1093/humrep/16.9.1802; DUNGY LJ, 1991, AM J OBSTET GYNECOL, V165, P853, DOI 10.1016/0002-9378(91)90428-T; Feroze-Zaidi F, 2007, ENDOCRINOLOGY, V148, P5020, DOI 10.1210/en.2007-0659; Fluhr H, 2007, J CELL SCI, V120, P4126, DOI 10.1242/jcs.009761; Fluhr H, 2013, REPROD BIOL, V13, P113, DOI 10.1016/j.repbio.2013.03.001; Fluhr H, 2011, MOL HUM REPROD, V17, P127, DOI 10.1093/molehr/gaq082; Galan A, 2000, BIOL REPROD, V63, P430, DOI 10.1093/biolreprod/63.2.430; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Germeyer A, 2007, FERTIL STERIL, V87, P657, DOI 10.1016/j.fertnstert.2006.07.1526; Gotte Martin, 2003, ScientificWorldJournal, V3, P1327; GU Y, 1994, ENDOCRINOLOGY, V135, P1272, DOI 10.1210/en.135.3.1272; Harada T, 2004, HUM REPROD UPDATE, V10, P29, DOI 10.1093/humupd/dmh007; Hayashida K, 2006, J BIOL CHEM, V281, P24365, DOI 10.1074/jbc.M509320200; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Heyer-Chauhan N, 2014, J PERINAT MED, V42, P329, DOI 10.1515/jpm-2013-0097; Joswig Anike, 2003, Reprod Biol Endocrinol, V1, P44; KAUMA S, 1990, AM J OBSTET GYNECOL, V163, P1430, DOI 10.1016/0002-9378(90)90601-3; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kokawa K, 1998, PLACENTA, V19, P21, DOI 10.1016/S0143-4004(98)90094-7; Kokawa K, 1998, MOL HUM REPROD, V4, P87, DOI 10.1093/molehr/4.1.87; Krussel JS, 1998, HUM REPROD, V13, P2206, DOI 10.1093/humrep/13.8.2206; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu YX, 2005, CONTRACEPTION, V71, P249, DOI 10.1016/j.contraception.2004.12.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Mutter GL, 2000, J CLIN ENDOCR METAB, V85, P2334, DOI 10.1210/jc.85.6.2334; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Numa F, 2002, INT J ONCOL, V20, P39; Oh JH, 2009, GYNECOL ONCOL, V114, P509, DOI 10.1016/j.ygyno.2009.05.027; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Phillips TA, 1999, J IMMUNOL, V162, P6053; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Popovici RM, 2006, ENDOCRINOLOGY, V147, P5662, DOI 10.1210/en.2006-0916; Prusac IK, 2011, ACTA OBSTET GYN SCAN, V90, P1157, DOI 10.1111/j.1600-0412.2011.01152.x; Roshangar L, 2013, IRAN J REPROD MED, V11, P399; Samalecos A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-76; Schmedt A, 2012, PRENATAL DIAG, V32, P131, DOI 10.1002/pd.2908; SHETH KV, 1991, FERTIL STERIL, V55, P952; Simon C, 2000, BEST PRACT RES CL OB, V14, P815, DOI 10.1053/beog.2000.0121; Straszewski-Chavez SL, 2004, MOL HUM REPROD, V10, P33, DOI 10.1093/molehr/gah001; Sugawara J, 1997, BIOL REPROD, V57, P936, DOI 10.1095/biolreprod57.4.936; Szabo S, 2013, VIRCHOWS ARCH, V463, P445, DOI 10.1007/s00428-013-1426-0; Tassell W, 2000, HISTOCHEM J, V32, P373, DOI 10.1023/A:1004069731540; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Wu YH, 2012, J IMMUNOL, V188, P2914, DOI 10.4049/jimmunol.1102065; Xuan YH, 2007, HISTOL HISTOPATHOL, V22, P227, DOI 10.14670/HH-22.227	65	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121103	10.1371/journal.pone.0121103	http://dx.doi.org/10.1371/journal.pone.0121103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830352	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600057
J	Croston, R; Hauber, ME				Croston, Rebecca; Hauber, Mark E.			Experimental Shifts in Intraclutch Egg Color Variation Do Not Affect Egg Rejection in a Host of a Non-Egg-Mimetic Avian Brood Parasite	PLOS ONE			English	Article							BROWN-HEADED COWBIRD; CUCULUS-CANORUS; REED WARBLERS; EUROPEAN PASSERINES; CLUTCH VARIATION; CUCKOO HOSTS; ARMS-RACE; APPEARANCE; RECOGNITION; EVOLUTION	Avian brood parasites lay their eggs in the nests of other birds, and impose the costs associated with rearing parasitic young onto these hosts. Many hosts of brood parasites defend against parasitism by removing foreign eggs from the nest. In systems where parasitic eggs mimic host eggs in coloration and patterning, extensive intraclutch variation in egg appearances may impair the host's ability to recognize and reject parasitic eggs, but experimental investigation of this effect has produced conflicting results. The cognitive mechanism by which hosts recognize parasitic eggs may vary across brood parasite hosts, and this may explain variation in experimental outcome across studies investigating egg rejection in hosts of egg-mimicking brood parasites. In contrast, for hosts of non-egg-mimetic parasites, intraclutch egg color variation is not predicted to co-vary with foreign egg rejection, irrespective of cognitive mechanism. Here we tested for effects of intraclutch egg color variation in a host of nonmimetic brood parasite by manipulating egg color in American robins (Turdus migratorius), hosts of brown-headed cowbirds (Molothrus ater). We recorded robins' behavioral responses to simulated cowbird parasitism in nests where color variation was artificially enhanced or reduced. We also quantified egg color variation within and between unmanipulated robin clutches as perceived by robins themselves using spectrophotometric measures and avian visual modeling. In unmanipulated nests, egg color varied more between than within robin clutches. As predicted, however, manipulation of color variation did not affect rejection rates. Overall, our results best support the scenario wherein egg rejection is the outcome of selective pressure by a nonmimetic brood parasite, because robins are efficient rejecters of foreign eggs, irrespective of the color variation within their own clutch.	[Croston, Rebecca; Hauber, Mark E.] CUNY, Grad Ctr, Ecol Evolutionary Biol & Behav Subprogram Biol, New York, NY USA; [Hauber, Mark E.] CUNY, Dept Psychol, Hunter Coll, New York, NY 10021 USA; [Hauber, Mark E.] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Croston, R (corresponding author), Univ Nevada, Ecol Evolut & Conservat Biol Program Biol, Reno, NV 89557 USA.	RebeccaLCroston@gmail.com		Croston, Rebecca/0000-0003-4696-0878	Human Frontiers Science Program	Human Frontiers Science Program(Human Frontier Science Program)	Funding for this project was provided by the Human Frontiers Science Program (to MEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy VE, 2014, AUK, V131, P467, DOI 10.1642/AUK-12-186-R1.1; Aidala Z, 2012, J COMP PHYSIOL A, V198, P495, DOI 10.1007/s00359-012-0724-3; Akre KL, 2014, TRENDS ECOL EVOL, V29, P291, DOI 10.1016/j.tree.2014.03.007; Antonov A, 2006, BEHAV ECOL SOCIOBIOL, V60, P11, DOI 10.1007/s00265-005-0132-6; Aviles JM, 2007, BEHAV ECOL SOCIOBIOL, V61, P475, DOI 10.1007/s00265-006-0275-0; Aviles JM, 2004, ANIM BEHAV, V67, P951, DOI 10.1016/j.anbehav.2003.08.022; Aviles JM, 2003, BIOL J LINN SOC, V79, P543, DOI 10.1046/j.1095-8312.2003.00208.x; Ban M, 2013, BEHAV ECOL, V24, P1014, DOI 10.1093/beheco/art004; Bennett ATD, 2007, AM NAT, V169, pS1, DOI 10.1086/510163; Bent A. C., 1958, US NATL MUSEUM B, V211; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRISKIE JV, 1992, EVOLUTION, V46, P334, DOI 10.1111/j.1558-5646.1992.tb02041.x; Cassey P, 2008, BIOL LETTERS, V4, P515, DOI 10.1098/rsbl.2008.0279; Cassey P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012054; Cassey P, 2009, IBIS, V151, P689, DOI 10.1111/j.1474-919X.2009.00953.x; CHEN DM, 1986, J COMP PHYSIOL A, V159, P473, DOI 10.1007/BF00604167; CHEN DM, 1984, SCIENCE, V225, P337, DOI 10.1126/science.6740315; Cherry MI, 2007, NATURWISSENSCHAFTEN, V94, P441, DOI 10.1007/s00114-007-0216-4; Croston R, 2013, BEHAV ECOL SOCIOBIOL, DOI [10.1007/s00265-013-1491-z, DOI 10.1007/S00265-013-1491-Z]; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; Davies NB, 1998, STUDIES COEVOLUTION; Feeney WE, 2012, ANIM BEHAV, V84, P3, DOI 10.1016/j.anbehav.2012.04.011; FRIEDMAN.H, 1971, AUK, V88, P239, DOI 10.2307/4083877; Friedmann H., 1929, COWBIRDS STUDY BIOL; Gomez D, 2010, AVICOL V 5 PROGRAM A; Grim T, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-14; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hauber ME, 2006, BIOL LETTERS, V2, P177, DOI 10.1098/rsbl.2005.0438; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Honza M, 2007, BIOL J LINN SOC, V92, P269, DOI 10.1111/j.1095-8312.2007.00848.x; Honza M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2665; Honza M, 2011, ETHOLOGY, V117, P539, DOI 10.1111/j.1439-0310.2011.01900.x; Igic B, 2012, P ROY SOC B-BIOL SCI, V279, P1068, DOI 10.1098/rspb.2011.1718; Igic B, 2010, J MORPHOL, V271, P697, DOI 10.1002/jmor.10827; Karcza Z, 2003, ETHOLOGY, V109, P15, DOI 10.1046/j.1439-0310.2003.00839.x; Klippenstine DR, 2010, WILSON J ORNITHOL, V122, P346, DOI 10.1676/08-143.1; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Landstrom MT, 2010, BEHAVIOUR, V147, P19, DOI 10.1163/000579509X12483520922043; Langmore NE, 2005, BEHAV ECOL, V16, P686, DOI 10.1093/beheco/ari041; Lorenzana JC, 2001, BEHAV ECOL, V12, P325, DOI 10.1093/beheco/12.3.325; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Lovaszi P, 2004, BEHAVIOUR, V141, P245, DOI 10.1163/156853904322890843; Lovell PG, 2013, CURR BIOL, V23, P260, DOI 10.1016/j.cub.2012.12.031; Lowther P, 1993, BROWN HEADED COWBIRD; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Lyon B, 2007, BEHAV ECOL SOCIOBIOL, V61, P455, DOI 10.1007/s00265-006-0273-2; MOKSNES A, 1991, AUK, V108, P348; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; Moreno J, 2011, ORNIS FENNICA, V88, P51; Moskat C, 2002, BEHAVIOUR, V139, P1313, DOI 10.1163/156853902321104181; Moskat C, 2008, BEHAV ECOL SOCIOBIOL, V62, P1885, DOI 10.1007/s00265-008-0618-0; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; Moskat C, 2014, ETHOLOGY, V120, P616, DOI 10.1111/eth.12234; Moskat C, 2010, J EXP BIOL, V213, P1976, DOI 10.1242/jeb.040394; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Peer BD, 2004, CONDOR, V106, P580, DOI 10.1650/7412; Peer BD, 2010, AUK, V127, P759, DOI 10.1525/auk.2010.10057; Prochazka P, 2003, J ORNITHOL, V144, P354, DOI 10.1046/j.1439-0361.2003.03009.x; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; ROTHSTEIN SI, 1974, AUK, V91, P796, DOI 10.2307/4084731; Rothstein SI, 2001, ANIM BEHAV, V61, P95, DOI 10.1006/anbe.2000.1570; Sallabanks R, 1999, AM ROBIN; Samas P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-34; Sealy SG, 1998, OX ORN SER, V9, P194; Soler JJ, 1996, BEHAV ECOL, V7, P89, DOI 10.1093/beheco/7.1.89; Soler Juan Jose, 2000, Etologia, V8, P9; Spottiswoode CN, 2012, AM NAT, V179, P633, DOI 10.1086/665031; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Stevens M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3475; Stokke BG, 2002, EVOLUTION, V56, P199; Stokke BG, 1999, P ROY SOC B-BIOL SCI, V266, P1483, DOI 10.1098/rspb.1999.0804; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Weidinger K, 2001, BEHAV ECOL SOCIOBIOL, V49, P456, DOI 10.1007/s002650100324	79	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121213	10.1371/journal.pone.0121213	http://dx.doi.org/10.1371/journal.pone.0121213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831051	gold, Green Published			2022-12-27	WOS:000352135600062
J	Diop, MM; Moiroux, N; Chandre, F; Martin-Herrou, H; Milesi, P; Boussari, O; Porciani, A; Duchon, S; Labbe, P; Pennetier, C				Diop, Malal M.; Moiroux, Nicolas; Chandre, Fabrice; Martin-Herrou, Hadrien; Milesi, Pascal; Boussari, Olayide; Porciani, Angelique; Duchon, Stephane; Labbe, Pierrick; Pennetier, Cedric			Behavioral Cost & Overdominance in Anopheles gambiae	PLOS ONE			English	Article							PYRETHROID INSECTICIDES; CULEX-QUINQUEFASCIATUS; RESISTANCE; MUTATION; KDR; DUPLICATION; ACTIVATION; HETEROSIS	In response to the widespread use of control strategies such as Insecticide Treated Nets (ITN), Anopheles mosquitoes have evolved various resistance mechanisms. Kdr is a mutation that provides physiological resistance to the pyrethroid insecticides family (PYR). In the present study, we investigated the effect of the Kdr mutation on the ability of female An. gambiae to locate and penetrate a 1cm-diameter hole in a piece of netting, either treated with insecticide or untreated, to reach a bait in a wind tunnel. Kdr homozygous, PYR-resistant mosquitoes were the least efficient at penetrating an untreated damaged net, with about 51% [39-63] success rate compared to 80% [70-90] and 78% [65-91] for homozygous susceptible and heterozygous respectively. This reduced efficiency, likely due to reduced host- seeking activity, as revealed by mosquito video-tracking, is evidence of a recessive behavioral cost of the mutation. Kdr heterozygous mosquitoes were the most efficient at penetrating nets treated with PYR insecticide, thus providing evidence for overdominance, the rarely-described case of heterozygote advantage conveyed by a single locus. The study also highlights the remarkable capacity of female mosquitoes, whether PYR-resistant or not, to locate holes in bed-nets.	[Diop, Malal M.; Boussari, Olayide; Porciani, Angelique; Pennetier, Cedric] IRD, UM1 UM2 CNRS 5290 IRD 224, MiVEGEC, Cotonou, Benin; [Diop, Malal M.; Boussari, Olayide; Porciani, Angelique; Pennetier, Cedric] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Moiroux, Nicolas; Chandre, Fabrice; Martin-Herrou, Hadrien; Duchon, Stephane] IRD, UM1 UM2 CNRS 5290 IRD 224, MiVEGEC, Montpellier, France; [Milesi, Pascal; Labbe, Pierrick] ISEM, CNRS 5554 UM2, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Pennetier, C (corresponding author), IRD, UM1 UM2 CNRS 5290 IRD 224, MiVEGEC, Cotonou, Benin.	cedric.pennetier@ird.fr	Pennetier, Cedric/K-2010-2016; Labbé, Pïerrick/AAL-5806-2020; Diop, Malal M/AAF-9151-2020; Moiroux, Nicolas/AFT-2925-2022; Milesi, Pascal/K-3234-2019; Chandre, Fabrice/Q-3429-2019	Labbé, Pïerrick/0000-0003-0806-1919; Moiroux, Nicolas/0000-0001-6755-6167; Chandre, Fabrice/0000-0002-1994-9705; Pennetier, Cedric/0000-0002-3362-6371; Porciani, Angelique/0000-0003-2816-1212; DUCHON, STEPHANE/0000-0002-0140-1020; Diop, Malal/0000-0002-9985-158X	Institut de Recherche pour le Developpement (IRD); IRD	Institut de Recherche pour le Developpement (IRD); IRD	This work has been funded by Institut de Recherche pour le Developpement (IRD). MMD is supported by an IRD PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alout H, 2014, J INFECT DIS, V210, P1464, DOI 10.1093/infdis/jiu276; Alout H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0389; Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Asthana S, 2005, TRENDS GENET, V21, P30, DOI 10.1016/j.tig.2004.11.001; Beeuwkes J., 2008, PROC, V19, P137; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Croisssant Y, 2012, ESTIMATION MULTINOMI; Djogbenou L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-70; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Fisher R. A., 1922, P ROY SOC EDINB B, V42, P321, DOI DOI 10.1007/BF02459576; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Giraudoux P., 2011, PGIRMESS DATA ANAL E; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Haldane JB., 1990, CAUSES EVOLUTION; Hedrick PW, 2012, TRENDS ECOL EVOL, V27, P698, DOI 10.1016/j.tree.2012.08.012; Hemingway J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0431; Hougard JM, 2003, B WORLD HEALTH ORGAN, V81, P324; Ignell R, ODOUR CODING NEURAL; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Labbe P, 2014, EVOLUTION, V68, P2092, DOI 10.1111/evo.12372; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lee D, 1999, MOL PHARMACOL, V55, P584; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lenormand T, 1998, GENETICS, V149, P1383; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; R Development Core Team, R LANG ENV STAT COMP; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Raymond-Delpech Valerie, 2005, Invertebrate Neuroscience, V5, P119; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Rousset F, ECOGRAPHY IN PRESS; SISON CP, 1995, J AM STAT ASSOC, V90, P366, DOI 10.2307/2291162; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; SPOFFORD JB, 1969, AM NAT, V103, P407, DOI 10.1086/282611; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Vontas J, 2014, TRENDS PARASITOL, V30, P191, DOI 10.1016/j.pt.2014.02.005; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2013, WHOHTMNTDWHOPES20133, P89; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604	49	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121755	10.1371/journal.pone.0121755	http://dx.doi.org/10.1371/journal.pone.0121755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831058	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600082
J	Horacek, M; Hansel-Hohl, K; Burg, K; Soja, G; Okello-Anyanga, W; Fluch, S				Horacek, Micha; Hansel-Hohl, Karin; Burg, Kornel; Soja, Gerhard; Okello-Anyanga, Walter; Fluch, Silvia			Control of Origin of Sesame Oil from Various Countries by Stable Isotope Analysis and DNA Based Markers-A Pilot Study	PLOS ONE			English	Article							GENETIC DIVERSITY; INDICUM L.; OLIVE OIL; MICROSATELLITE MARKERS; KOREAN BEEF; DISCRIMINATION; IDENTIFICATION; COLOR; PCR	The indication of origin of sesame seeds and sesame oil is one of the important factors influencing its price, as it is produced in many regions worldwide and certain provenances are especially sought after. We joined stable carbon and hydrogen isotope analysis with DNA based molecular marker analysis to study their combined potential for the discrimination of different origins of sesame seeds. For the stable carbon and hydrogen isotope data a positive correlation between both isotope parameters was observed, indicating a dominant combined influence of climate and water availability. This enabled discrimination between sesame samples from tropical and subtropical/moderate climatic provenances. Carbon isotope values also showed differences between oil from black and white sesame seeds from identical locations, indicating higher water use efficiency of plants producing black seeds. DNA based markers gave independent evidence for geographic variation as well as provided information on the genetic relatedness of the investigated samples. Depending on the differences in ambient environmental conditions and in the genotypic fingerprint, a combination of both analytical methods is a very powerful tool to assess the declared geographic origin. To our knowledge this is the first paper on food authenticity combining the stable isotope analysis of bio-elements with DNA based markers and their combined statistical analysis.	[Horacek, Micha; Hansel-Hohl, Karin; Burg, Kornel; Soja, Gerhard; Fluch, Silvia] AIT Austrian Inst Technol GmbH, Hlth & Environm Dept, A-3430 Tulln, Austria; [Okello-Anyanga, Walter] Makerere Univ, Sch Agr Sci, Dept Agr Prod, Kampala, Uganda; [Okello-Anyanga, Walter] Natl Semiarid Resources Res Inst NaSARRI, Serere, Soroti, Uganda	Austrian Institute of Technology (AIT); Makerere University	Horacek, M (corresponding author), HBLFA Francisco Josephinum, Res Ctr BLT Wieselburg, Rottenhauser Str 1, A-3250 Wieselburg, Austria.	micha.horacek@josephinum.at	Soja, Gerhard/A-9657-2008; Horacek, Micha/AAC-2700-2020; Horacek, Micha/ABC-4954-2021	Soja, Gerhard/0000-0001-7391-4899; Horacek, Micha/0000-0002-2471-1232; Fluch, Silvia/0000-0001-5713-7081	Independent Research Program of the AIT; ADA (Austrian Development Agency)	Independent Research Program of the AIT; ADA (Austrian Development Agency)	This work was partially funded by the Independent Research Program of the AIT and by a grant of ADA (Austrian Development Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatef E, 2008, AFR J BIOTECHNOL, V7, P4423; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Asfaha DG, 2011, J CEREAL SCI, V53, P170, DOI 10.1016/j.jcs.2010.11.004; Ballantyne AP, 2011, BIOGEOSCIENCES, V8, P3093, DOI 10.5194/bg-8-3093-2011; Bisht IS, 1998, GENET RESOUR CROP EV, V45, P325, DOI 10.1023/A:1008652420477; Bontempo L, 2009, RAPID COMMUN MASS SP, V23, P1043, DOI 10.1002/rcm.3968; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Camin F, 2007, ANAL BIOANAL CHEM, V389, P309, DOI 10.1007/s00216-007-1302-3; Camin F, 2010, J AGR FOOD CHEM, V58, P570, DOI 10.1021/jf902814s; Cho YI, 2011, GENES GENOM, V33, P187, DOI 10.1007/s13258-010-0130-6; Christoph N., 2004, MITT KLOSTERNEUBURG, V54, P155; Chung C, 2009, J AGR ECON, V60, P682, DOI 10.1111/j.1477-9552.2009.00218.x; Consolandi C, 2008, EUR FOOD RES TECHNOL, V227, P1429, DOI 10.1007/s00217-008-0863-5; Dixit A, 2005, MOL ECOL NOTES, V5, P736, DOI 10.1111/j.1471-8286.2005.01048.x; Ercan AG, 2004, GENET RESOUR CROP EV, V51, P599, DOI 10.1023/B:GRES.0000024651.45623.f2; Falusi OA, 2007, AFR J BIOTECHNOL, V6, P2780; Gailing O, 2007, J APPL BOT FOOD QUAL, V81, P165; Guo LX, 2010, J AM OIL CHEM SOC, V87, P839, DOI 10.1007/s11746-010-1564-3; Hai Z, 2006, EUR J LIPID SCI TECH, V108, P116, DOI 10.1002/ejlt.200501224; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Horacek M, 2010, ANAL CHIM ACTA, V682, P77, DOI 10.1016/j.aca.2010.09.046; Horacek M, 2010, FOOD CHEM, V121, P517, DOI 10.1016/j.foodchem.2009.12.018; Hormaza JI, 2002, THEOR APPL GENET, V104, P321, DOI 10.1007/s001220100684; Iacumin P, 2009, RAPID COMMUN MASS SP, V23, P448, DOI 10.1002/rcm.3896; Joebstl D, 2010, FOOD CHEM, V123, P1303, DOI 10.1016/j.foodchem.2010.06.009; Krull E, 2006, SOIL BIOL BIOCHEM, V38, P3211, DOI 10.1016/j.soilbio.2006.04.008; Laurentin H, 2014, PESQUI AGROPECU BRAS, V49, P290, DOI 10.1590/S0100-204X2014000400007; 배상균, 2009, 한국식품저장유통학회지, V16, P594; Longobardi F, 2011, FOOD CHEM, V124, P1708, DOI 10.1016/j.foodchem.2010.07.092; Nielsen LR, 2008, TRACING TIMBER FROM; Oksanen J., 2014, VEGAN COMMUNITY ECOL; Oplinger E.S., 1997, SESAME ALTERNATIVE F; Padmaja KL, 2005, THEOR APPL GENET, V111, P8, DOI 10.1007/s00122-005-1933-8; Pasqualone A, 2004, J AGR FOOD CHEM, V52, P1068, DOI 10.1021/jf0348424; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pham TD, 2009, GENET RESOUR CROP EV, V56, P679, DOI 10.1007/s10722-008-9393-z; R Core Team, 2020, R LANG ENV STAT COMP; Rummel S, 2010, FOOD CHEM, V118, P890, DOI 10.1016/j.foodchem.2008.05.115; Schellenberg A, 2010, FOOD CHEM, V121, P770, DOI 10.1016/j.foodchem.2009.12.082; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seo HY, 2010, J AM OIL CHEM SOC, V87, P621, DOI 10.1007/s11746-010-1545-6; 양용식, 2008, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V23, P212; 손희진, 2009, [Korean Journal of Food Science and Technology, 한국식품과학회지], V41, P609; Spangenberg JE, 2001, J AGR FOOD CHEM, V49, P1534, DOI 10.1021/jf001291y; Suits NS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002141; Tnah LH, 2009, FOREST ECOL MANAG, V258, P1918, DOI 10.1016/j.foreco.2009.07.029; Wills DM, 2005, THEOR APPL GENET, V110, P941, DOI 10.1007/s00122-004-1914-3	48	19	19	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123020	10.1371/journal.pone.0123020	http://dx.doi.org/10.1371/journal.pone.0123020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831054	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600132
J	Labate, C; De Santo, MP; Lombardo, G; Lombardo, M				Labate, Cristina; De Santo, Maria Penelope; Lombardo, Giuseppe; Lombardo, Marco			Understanding of the Viscoelastic Response of the Human Corneal Stroma Induced by Riboflavin/UV-A Cross-Linking at the Nano Level	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BIOMECHANICAL CHANGES; COLLAGEN; ULTRAVIOLET; TISSUE; GLUTARALDEHYDE; ANTERIOR	Purpose To investigate the viscoelastic changes of the human cornea induced by riboflavin/UV-A cross-linking using Atomic Force Microscopy (AFM) at the nano level. Methods Seven eye bank donor corneas were investigated, after gently removing the epithelium, using a commercial AFM in the force spectroscopy mode. Silicon cantilevers with tip radius of 10 nm and spring elastic constants between 26-and 86-N/m were used to probe the viscoelastic properties of the anterior stroma up to 3 mu m indentation depth. Five specimens were tested before and after riboflavin/UV-A cross-linking; the other two specimens were chemically cross-linked using glutaraldehyde 2.5% solution and used as controls. The Young's modulus (E) and the hysteresis (H) of the corneal stroma were quantified as a function of the application load and scan rate. Results The Young's modulus increased by a mean of 1.1-1.5 times after riboflavin/UV-A cross-linking (P<0.05). A higher increase of E, by a mean of 1.5-2.6 times, was found in chemically cross-linked specimens using glutaraldehyde 2.5% (P<0.05). The hysteresis decreased, by a mean of 0.9-1.5 times, in all specimens after riboflavin/UV-A cross-linking (P<0.05). A substantial decrease of H, ranging between 2.6 and 3.5 times with respect to baseline values, was observed in glutaraldehyde-treated corneas (P<0.05). Conclusions The present study provides the first evidence that riboflavin/UV-A cross-linking induces changes of the viscoelastic properties of the cornea at the scale of stromal molecular interactions.	[Labate, Cristina; De Santo, Maria Penelope] Univ Calabria, Dept Phys, I-87036 Arcavacata Di Rende, Italy; [Labate, Cristina; De Santo, Maria Penelope] CNR, Ist Proc Chim Fis, Unit Support Cosenza, I-87036 Arcavacata Di Rende, Italy; [Lombardo, Giuseppe] CNR, Ist Proc Chim Fis, I-98158 Messina, Italy; [Lombardo, Giuseppe] Vin Engn Italy Srl, I-00198 Rome, Italy; [Lombardo, Marco] Fdn GB Bietti IRCCS, I-00198 Rome, Italy	University of Calabria; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Lombardo, M (corresponding author), Fdn GB Bietti IRCCS, Via Livenza 3, I-00198 Rome, Italy.	mlombardo@visioeng.it	; Lombardo, Giuseppe/B-2656-2012	De Santo, Maria Penelope/0000-0001-6556-3611; Lombardo, Giuseppe/0000-0002-9416-967X; Lombardo, Marco/0000-0001-8842-7102	National Framework Program for Research and Innovation PON [01_00110]; Italian Ministry of Health and Fondazione Roma	National Framework Program for Research and Innovation PON; Italian Ministry of Health and Fondazione Roma(Fondazione Roma)	This work was supported by a grant of the National Framework Program for Research and Innovation PON (research program n. 01_00110), by the Italian Ministry of Health and Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GL is co-founder and CTO of Vision Engineering Italy srl; the Company did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beshtawi IM, 2014, INVEST OPHTH VIS SCI, V55, P1549, DOI 10.1167/iovs.13-13042; Beshtawi IM, 2013, J CATARACT REFR SURG, V39, P451, DOI 10.1016/j.jcrs.2013.01.026; Boyce BL, 2007, J BIOMECH, V40, P2367, DOI 10.1016/j.jbiomech.2006.12.001; Brummer G, 2011, INVEST OPHTH VIS SCI, V52, P6363, DOI 10.1167/iovs.11-7585; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Chan E, 2013, CLIN EXP OPTOM, V96, P155, DOI 10.1111/cxo.12020; DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371; Dias J, 2013, EXP EYE RES, V116, P58, DOI 10.1016/j.exer.2013.07.028; Elsheikh A, 2008, CURR EYE RES, V33, P205, DOI 10.1080/02713680701882519; FULLWOOD NJ, 1993, J MICROSC-OXFORD, V169, P53, DOI 10.1111/j.1365-2818.1993.tb03277.x; Hamaoui M, 2001, CORNEA, V20, P317, DOI 10.1097/00003226-200104000-00015; Hatami-Marbini H, 2013, EXP EYE RES, V116, P47, DOI 10.1016/j.exer.2013.07.016; Hayes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052860; Hovakimyan M, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/406850; Jayasuriya AC, 2003, J BIOMED MATER RES A, V66A, P260, DOI 10.1002/jbm.a.10536; Kling S, 2013, J REFRACT SURG, V29, P490, DOI 10.3928/1081597X-20130617-08; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092; Kontadakis GA, 2013, GRAEF ARCH CLIN EXP, V251, P543, DOI 10.1007/s00417-012-2082-9; Kymionis GD, 2014, CORNEA, V33, P1071, DOI 10.1097/ICO.0000000000000248; Lanchares E, 2011, GRAEF ARCH CLIN EXP, V249, P1223, DOI 10.1007/s00417-011-1674-0; Last JA, 2012, MICRON, V43, P1293, DOI 10.1016/j.micron.2012.02.014; Last JA, 2010, INVEST OPHTH VIS SCI, V51, P6083, DOI 10.1167/iovs.10-5470; Lombardo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112169; Lombardo M, 2015, J CATARACT REFR SURG, V41, P446, DOI 10.1016/j.jcrs.2014.12.013; Lombardo M, 2014, J CATARACT REFR SURG, V40, P1706, DOI 10.1016/j.jcrs.2014.04.024; Lombardo M, 2012, INVEST OPHTH VIS SCI, V53, P1050, DOI 10.1167/iovs.11-8720; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Meek KM, 2013, OPHTHAL PHYSL OPT, V33, P78, DOI 10.1111/opo.12032; Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Morishige N, 2007, INVEST OPHTH VIS SCI, V48, P1087, DOI 10.1167/iovs.06-1177; Palko JR, 2014, J CATARACT REFR SURG, V40, P1021, DOI 10.1016/j.jcrs.2013.09.022; Poggi MA, 2005, ANAL CHEM, V77, P1192, DOI 10.1021/ac048828h; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Scarcelli G, 2013, INVEST OPHTH VIS SCI, V54, P1418, DOI 10.1167/iovs.12-11387; Seifert J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088186; Sondergaard AP, 2013, INVEST OPHTH VIS SCI, V54, P1625, DOI 10.1167/iovs.12-10346; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2009, J CATARACT REFR SURG, V35, P540, DOI 10.1016/j.jcrs.2008.11.036; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813	43	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122868	10.1371/journal.pone.0122868	http://dx.doi.org/10.1371/journal.pone.0122868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830534	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600128
J	Maejima, R; Iijima, K; Kaihovaara, P; Hatta, W; Koike, T; Imatani, A; Shimosegawa, T; Salaspuro, M				Maejima, Ryuhei; Iijima, Katsunori; Kaihovaara, Pertti; Hatta, Waku; Koike, Tomoyuki; Imatani, Akira; Shimosegawa, Tooru; Salaspuro, Mikko			Effects of ALDH2 Genotype, PPI Treatment and L-Cysteine on Carcinogenic Acetaldehyde in Gastric Juice and Saliva after Intragastric Alcohol Administration	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CHRONIC ATROPHIC GASTRITIS; UPPER AERODIGESTIVE TRACT; ALDEHYDE DEHYDROGENASE 2; HELICOBACTER-PYLORI; ALDH2-DEFICIENT SUBJECTS; MICROBIAL-PRODUCTION; STOMACH-CANCER; RISK; ETHANOL	Acetaldehyde (ACH) associated with alcoholic beverages is Group 1 carcinogen to humans (IARC/WHO). Aldehyde dehydrogenase (ALDH2), a major ACH eliminating enzyme, is genetically deficient in 30-50% of Eastern Asians. In alcohol drinkers, ALDH2-deficiency is a well-known risk factor for upper aerodigestive tract cancers, i.e., head and neck cancer and esophageal cancer. However, there is only a limited evidence for stomach cancer. In this study we demonstrated for the first time that ALDH2 deficiency results in markedly increased exposure of the gastric mucosa to acetaldehyde after intragastric administration of alcohol. Our finding provides concrete evidence for a causal relationship between acetaldehyde and gastric carcinogenesis. A plausible explanation is the gastric first pass metabolism of ethanol. The gastric mucosa expresses alcohol dehydrogenase (ADH) enzymes catalyzing the oxidation of ethanol to acetaldehyde, especially at the high ethanol concentrations prevailing in the stomach after the consumption of alcoholic beverages. The gastric mucosa also possesses the acetaldehyde-eliminating ALDH2 enzyme. Due to decreased mucosal ALDH2 activity, the elimination of ethanol-derived acetaldehyde is decreased, which results in its accumulation in the gastric juice. We also demonstrate that ALDH2 deficiency, proton pump inhibitor (PPI) treatment, and L-cysteine cause independent changes in gastric juice and salivary acetaldehyde levels, indicating that intragastric acetaldehyde is locally regulated by gastric mucosal ADH and ALDH2 enzymes, and by oral microbes colonizing an achlorhydric stomach. Markedly elevated acetaldehyde levels were also found at low intragastric ethanol concentrations corresponding to the ethanol levels of many foodstuffs, beverages, and dairy products produced by fermentation. A capsule that slowly releases L-cysteine effectively eliminated acetaldehyde from the gastric juice of PPI-treated ALDH2-active and ALDH2-deficient subjects. These results provide entirely novel perspectives for the prevention of gastric cancer, especially in established risk groups.	[Maejima, Ryuhei; Iijima, Katsunori; Hatta, Waku; Koike, Tomoyuki; Imatani, Akira; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Kaihovaara, Pertti; Salaspuro, Mikko] Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland	Tohoku University; University of Helsinki	Iijima, K (corresponding author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan.	kiijima@med.tohoku.ac.jp	Salaspuro, Mikko/AAW-5575-2021	Salaspuro, Mikko/0000-0002-7562-5414	Astra Zeneca PLC; Biohit Oyj.; Eisai Co., Ltd.; Takeda Pharmaceutical Co., Ltd	Astra Zeneca PLC(AstraZeneca); Biohit Oyj.; Eisai Co., Ltd.(Eisai Co Ltd); Takeda Pharmaceutical Co., Ltd(Takeda Pharmaceutical Company Ltd)	KI has received unrestricted grants from Astra Zeneca PLC, Biohit Oyj., Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd, for his department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2013, WORLD J GASTROENTERO, V19, P2560, DOI 10.3748/wjg.v19.i16.2560; [Anonymous], 2012, IARC MONOGRAPHS EV E, V100E, P471; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Cao HX, 2010, ASIAN PAC J CANCER P, V11, P1073; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Dong YJ, 1996, ALCOHOL, V13, P257, DOI 10.1016/0741-8329(95)02052-7; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/ijc.11426; Hellstrom PM, 2014, GASTROENTEROLOGY S1, V146; Helminen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074418; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Hui, 2004, HDB FOOD BEVERAGE FE; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Iijima K, 2010, DIGEST DIS SCI, V55, P1349, DOI 10.1007/s10620-009-0853-x; Kurkivuori J, 2007, ORAL ONCOL, V43, P181, DOI 10.1016/j.oraloncology.2006.02.005; Lee CH, 2008, INT J CANCER, V122, P1347, DOI 10.1002/ijc.23264; Lee SL, 2006, ALCOHOL CLIN EXP RES, V30, P1132, DOI 10.1111/j.1530-0277.2006.00139.x; Li H, 2009, ANN HUM GENET, V73, P335, DOI 10.1111/j.1469-1809.2009.00517.x; Linderborg K, 2011, ALCOHOL CLIN EXP RES, V35, P516, DOI 10.1111/j.1530-0277.2010.01368.x; LINDROS KO, 1980, PHARMACOL BIOCHEM BE, V13, P119, DOI 10.1016/S0091-3057(80)80019-0; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Nagayoshi H, 2009, MUTAT RES-GEN TOX EN, V673, P74, DOI 10.1016/j.mrgentox.2008.11.009; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3175, DOI 10.3748/wjg.v11.i21.3175; Nieminen MT, 2013, CANCER EPIDEM BIOMAR, V22, P69, DOI 10.1158/1055-9965.EPI-12-0908; Oikawa T, 2010, SCAND J GASTROENTERO, V45, P1338, DOI 10.3109/00365521.2010.495419; Rabl Walter, 1994, Blutalkohol, V31, P76; ROINE RP, 1992, LIFE SCI, V51, P1333, DOI 10.1016/0024-3205(92)90632-Y; Salaspuro M., 2009, SCAND J GASTROENTERO, V5, P121; Salaspuro M, 2011, J DIGEST DIS, V12, P51, DOI 10.1111/j.1751-2980.2011.00480.x; Salaspuro V, 2004, INT J CANCER, V111, P480, DOI 10.1002/ijc.20293; Salaspuro V, 2002, INT J CANCER, V97, P361, DOI 10.1002/ijc.1620; Salaspuro VJ, 2006, CANCER EPIDEM BIOMAR, V15, P146, DOI 10.1158/1055-9965.EPI-05-0248; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; Shin CM, 2011, INT J EPIDEMIOL, V40, P1047, DOI 10.1093/ije/dyr067; SIPPONEN P, 1985, INT J CANCER, V35, P173; SPRINCE H, 1975, AGENTS ACTIONS, V5, P164, DOI 10.1007/BF02027359; Theruvathu JA, 2005, NUCLEIC ACIDS RES, V33, P3513, DOI 10.1093/nar/gki661; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Uno K, 2011, AM J GASTROENTEROL, V106, P1923, DOI 10.1038/ajg.2011.282; Vakevainen S, 2002, SCAND J GASTROENTERO, V37, P648, DOI 10.1080/00365520212500; Vakevainen S, 2001, ALCOHOL CLIN EXP RES, V25, P829, DOI 10.1111/j.1530-0277.2001.tb02286.x; Vakevainen S, 2000, ALCOHOL CLIN EXP RES, V24, P873, DOI 10.1111/j.1530-0277.2000.tb02068.x; Vakevainen S, 2000, ALIMENT PHARM THER, V14, P1511, DOI 10.1046/j.1365-2036.2000.00858.x; Wang H., 2014, AM J MAR SCI, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE.0088779; Wang XQ, 2012, J AM COLL NUTR, V31, P375, DOI 10.1080/07315724.2012.10720447; Wu AH, 2000, CANCER EPIDEM BIOMAR, V9, P1051; Xue FB, 2001, WORLD J GASTROENTERO, V7, P801, DOI 10.3748/wjg.v7.i6.801; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yin SJ, 1997, GASTROENTEROLOGY, V112, P766, DOI 10.1053/gast.1997.v112.pm9041238; Yokoyama A, 2008, ALCOHOL CLIN EXP RES, V32, P1607, DOI 10.1111/j.1530-0277.2008.00739.x; Yokoyama A, 2007, J GASTROEN HEPATOL, V22, P210, DOI 10.1111/j.1440-1746.2006.04377.x; Yokoyama Akira, 2010, Keio Journal of Medicine, V59, P115, DOI 10.2302/kjm.59.115	52	42	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120397	10.1371/journal.pone.0120397	http://dx.doi.org/10.1371/journal.pone.0120397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831092	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600032
J	Servian-Franco, F; Moreno-Dominguez, S; del Paso, GAR				Servian-Franco, Fatima; Moreno-Dominguez, Silvia; Reyes del Paso, Gustavo A.			Body Dissatisfaction and Mirror Exposure: Evidence for a Dissociation between Self-Report and Physiological Responses in Highly Body-Dissatisfied Women	PLOS ONE			English	Article							EATING-DISORDERS; BULIMIA-NERVOSA; IMAGE; ANXIETY; SHAPE; MAINTENANCE; PATHOLOGY; THOUGHTS; EMOTION; WEIGHT	Background Weight and shape concerns are widespread in the general population. Mirror exposure has been used to reduce body dissatisfaction but little is known about the mechanisms which underlie this therapeutic technique. The present study examined emotional, cognitive, and psychophysiological responses, in women with high and low levels of body dissatisfaction, exposed to their own bodies in a mirror. Method Forty-two university-attending women (21 high body-dissatisfied (HBD) and 21 low bodydissatisfied (LBD)), were confronted with their own body during four 5-min trials in which participants were instructed to focus their attention on different parts of their body under standardized conditions. Emotional and cognitive measures were taken after each exposure trial. Heart rate (HR) and skin conductance (SC) were recorded continuously. Results HBD women experienced more negative emotions and cognitions following body exposure compared to LBD women but, conversely, showed a reduced physiological reaction in terms of HR and SC. In both groups greater physiological responses were observed looking at the thighs, buttocks, and abdomen. Extent of negative emotions and cognitions were positively associated with HR and/or SC in LBD women but no associations were observed in HBD women. Conclusion The dissociation between self-report and psychophysiological measures in HBD women supports the existence of a passive-behavioral inhibited coping style in HBD women and suggests deficiencies in the generation of physiological correlates of emotion related to body dissatisfaction.	[Servian-Franco, Fatima; Moreno-Dominguez, Silvia; Reyes del Paso, Gustavo A.] Univ Jaen, Dept Psychol, Jaen, Spain	Universidad de Jaen	del Paso, GAR (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	greyes@ujaen.es	Moreno, Silvia/M-3857-2018; Reyes del Paso, Gustavo A./G-4179-2011	Reyes del Paso, Gustavo A./0000-0002-2188-8673				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bohon C, 2009, INT J EAT DISORDER, V42, P173, DOI 10.1002/eat.20600; Brenner SL, 2005, PSYCHOPHYSIOLOGY, V42, P108, DOI 10.1111/j.1469-8986.2005.00261.x; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Cash TF, 1990, BODY IMAGES DEV DEVI; COOPER MJ, 1992, BEHAV RES THER, V30, P501, DOI 10.1016/0005-7967(92)90034-E; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Delinsky SS, 2006, INT J EAT DISORDER, V39, P108, DOI 10.1002/eat.20207; FOWLES DC, 1980, PSYCHOPHYSIOLOGY, V17, P87, DOI 10.1111/j.1469-8986.1980.tb00117.x; Garcia-Leon A, 2003, INT J PSYCHOPHYSIOL, V47, P159, DOI 10.1016/S0167-8760(02)00124-1; Gerin W, 1996, J PSYCHOSOM RES, V40, P485, DOI 10.1016/0022-3999(95)00642-7; Hausenblas HA, 2002, INT J EAT DISORDER, V32, P179, DOI 10.1002/eat.10071; Hayaki J, 2002, INT J EAT DISORDER, V31, P57, DOI 10.1002/eat.1111; HEATHERTON TF, 1991, PSYCHOL BULL, V110, P86, DOI 10.1037/0033-2909.110.1.86; Heinberg LJ, 1995, J SOC CLIN PSYCHOL, V14, P325, DOI 10.1521/jscp.1995.14.4.325; Hildebrandt T, 2012, BEHAV RES THER, V50, P797, DOI 10.1016/j.brat.2012.09.004; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Jansen A, 2008, APPETITE, V51, P214, DOI 10.1016/j.appet.2008.01.011; Killen JD, 1996, J CONSULT CLIN PSYCH, V64, P936, DOI 10.1037/0022-006X.64.5.936; Koo-Loeb JH, 1998, PSYCHIAT RES, V80, P13, DOI 10.1016/S0165-1781(98)00057-2; LANG PJ, 1970, J ABNORM PSYCHOL, V76, P220, DOI 10.1037/h0029875; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LEON GR, 1993, J ABNORM PSYCHOL, V102, P438, DOI 10.1037/0021-843X.102.3.438; Light KC, 1993, PSYCHOPHYSIOLOGY, V20, P301; Lovallo W.R., 2005, STRESS HLTH BIOL PSY; LOVALLO WR, 1985, PSYCHOPHYSIOLOGY, V22, P283, DOI 10.1111/j.1469-8986.1985.tb01602.x; Luethcke CA, 2011, BODY IMAGE, V8, P251, DOI 10.1016/j.bodyim.2011.03.006; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; Moreno-Dominguez S, 2012, BODY IMAGE, V9, P285, DOI 10.1016/j.bodyim.2011.12.001; Ortega-Roldan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102595; PIRKE KM, 1992, BIOL PSYCHIAT, V32, P202, DOI 10.1016/0006-3223(92)90026-V; Raich R.M., 1996, CLIN SALUD, V7, P51; Ricciardelli LA, 1997, APPETITE, V29, P43, DOI 10.1006/appe.1997.0093; Sim L, 2006, J YOUTH ADOLESCENCE, V35, P219, DOI 10.1007/s10964-005-9003-8; Stice E, 2001, J ABNORM PSYCHOL, V110, P124, DOI 10.1037//0021-843X.110.1.124; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; STRIEGELMOORE RH, 1986, AM PSYCHOL, V41, P246, DOI 10.1037/0003-066X.41.3.246; Taylor KB., 2011, THESIS STATE U NEW J; Trentowska M, 2013, BEHAV RES THER, V51, P1, DOI 10.1016/j.brat.2012.03.012; Tuschen-Caffier B, 2003, BEHAV RES THER, V41, P573, DOI 10.1016/S0005-7967(02)00030-X; Tuschen-Caffier B, 2001, BEHAV RES THER, V39, P299, DOI 10.1016/S0005-7967(00)00004-8; Viken RJ, 2002, J ABNORM PSYCHOL, V111, P598, DOI 10.1037//0021-843X.111.4.598; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; Wertheim EH, 2001, J YOUTH ADOLESCENCE, V30, P69, DOI 10.1023/A:1005224921891; Williamson DA, 1999, BEHAV MODIF, V23, P556, DOI 10.1177/0145445599234003	47	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122737	10.1371/journal.pone.0122737	http://dx.doi.org/10.1371/journal.pone.0122737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830861	gold, Green Submitted, Green Published			2022-12-27	WOS:000352135600122
J	van Staaveren, N; Teixeira, DL; Hanlon, A; Boyle, LA				van Staaveren, Nienke; Teixeira, Dayane Lemos; Hanlon, Alison; Boyle, Laura Ann			The Effect of Mixing Entire Male Pigs Prior to Transport to Slaughter on Behaviour, Welfare and Carcass Lesions	PLOS ONE			English	Article							MEAT QUALITY; MOUNTING BEHAVIOR; ANIMAL-WELFARE; STRESS; CONDEMNATIONS; AGGRESSION; PREVALENCE; DAMAGE; BOARS; SOWS	Research is needed to validate lesions recorded at meat inspection as indicators of pig welfare on farm. The aims were to determine the influence of mixing pigs on carcass lesions and to establish whether such lesions correlate with pig behaviour and lesions scored on farm. Aggressive and mounting behaviour of pigs in three single sex pens was recorded on Day -5, -2, and -1 relative to slaughter (Day 0). On Day 0 pigs were randomly allocated to 3 treatments (n = 20/group) over 5 replicates: males mixed with females (MF), males mixed with males (MM), and males unmixed (MUM). Aggressive and mounting behaviours were recorded on Day 0 at holding on farm and lairage. Skin/tail lesions were scored according to severity at the farm (Day -1), lairage, and on the carcass (Day 0). Effect of treatment and time on behaviour and lesions were analysed by mixed models. Spearman rank correlations between behaviour and lesion scores and between scores recorded at different stages were determined. In general, MM performed more aggressive behaviour (50.4 +/- 10.72) than MUM (20.3 +/- 9.55, P < 0.05) and more mounting (30.9 +/- 9.99) than MF (11.4 +/- 3.76) and MUM (9.8 +/- 3.74, P < 0.05). Skin lesion scores increased between farm (Day-1) and lairage (P < 0.001), but this tended to be significant only for MF and MM (P = 0.08). There was no effect of treatment on carcass lesions and no associations were found with fighting/mounting. Mixing entire males prior to slaughter stimulated mounting and aggressive behaviour but did not influence carcass lesion scores. Carcass skin/tail lesions scores were correlated with scores recorded on farm (r(skin) = 0.21 and r(tail) = 0.18, P < 0.01) suggesting that information recorded at meat inspection could be used as indicators of pig welfare on farm.	[van Staaveren, Nienke; Teixeira, Dayane Lemos; Boyle, Laura Ann] TEAGASC, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland; [van Staaveren, Nienke; Hanlon, Alison] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland	Teagasc; University College Dublin	van Staaveren, N (corresponding author), TEAGASC, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland.	nienke.vanstaaveren@teagasc.ie	Teixeira, Dayane L/H-8640-2018; Van Staaveren, Nienke/AAN-7900-2020; Hanlon, Alison/AAB-9184-2020; Teixeira, Dayane/AAA-6807-2020	Van Staaveren, Nienke/0000-0003-3401-5553; Hanlon, Alison/0000-0002-3778-1790; Teixeira, Dayane/0000-0001-5063-7972; Boyle, Laura/0000-0001-7080-1776	Department of Agriculture, Food and the Marine (DAFM), Ireland	Department of Agriculture, Food and the Marine (DAFM), Ireland	This study was part of the PIGWELFIND project funded by the Department of Agriculture, Food and the Marine (DAFM), Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2351; Bjorklund L, 2005, EFFECTS REARING BOAR; Borberg C, 2009, LIVEST SCI, V125, P314, DOI 10.1016/j.livsci.2009.04.008; Boyle LA, 2007, ANIM WELFARE, V16, P259; Bradshaw RH, 1996, ANIM SCI, V62, P547, DOI 10.1017/S1357729800015095; Brunberg E, 2011, APPL ANIM BEHAV SCI, V133, P18, DOI 10.1016/j.applanim.2011.04.019; Chai J, 2010, LIVEST SCI, V127, P211, DOI 10.1016/j.livsci.2009.09.014; Clark CCA, 2013, APPL ANIM BEHAV SCI, V147, P81, DOI 10.1016/j.applanim.2013.04.014; D'Eath RB, 2010, ANIMAL, V4, P604, DOI 10.1017/S1751731109991406; European Commission, EUR DECL ALT SURG CA; European Food Safety Authority (EFSA), 2007, EFSA J, V611, P1, DOI DOI 10.2903/J.EFSA.2007.611; Fabrega E, 2013, APPL ANIM BEHAV SCI, V143, P31, DOI 10.1016/j.applanim.2012.11.006; Faucitano L, 2001, CAN J ANIM SCI, V81, P39, DOI 10.4141/A00-031; Gade PB, 2008, ANIMAL, V2, P1238, DOI 10.1017/S1751731108002565; Grandin T, 2010, MEAT SCI, V86, P56, DOI 10.1016/j.meatsci.2010.04.022; Harley S, 2014, ANIM WELFARE, V23, P275, DOI 10.7120/09627286.23.3.275; Harley S, 2012, VET REC, V171, P621, DOI 10.1136/vr.100986; Harley S, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-11; Keeling LJ, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-32; Kritas SK, 2007, VET REC, V160, P149, DOI 10.1136/vr.160.5.149; Perez MP, 2002, MEAT SCI, V61, P425, DOI 10.1016/S0309-1740(01)00216-9; Rydhmer L, 2006, ACTA AGR SCAND A-AN, V56, P109, DOI 10.1080/09064700601079527; Rydhmer L, 2013, ANIMAL, V7, P1532, DOI 10.1017/S1751731113000608; Schroder-Petersen DL, 2001, VET J, V162, P196, DOI 10.1053/tvjl.2001.0605; Stewart CL, 2008, APPL ANIM BEHAV SCI, V112, P235, DOI 10.1016/j.applanim.2007.09.006; Stukenborg A, 2011, APPL ANIM BEHAV SCI, V129, P28, DOI 10.1016/j.applanim.2010.10.004; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Teixeira DL, 2014, LIVEST SCI, V170, P142, DOI 10.1016/j.livsci.2014.09.026; Terlouw EMC, 2008, ANIMAL, V2, P1501, DOI 10.1017/S1751731108002723; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Vanheukelom V, 2012, APPL ANIM BEHAV SCI, V142, P154, DOI 10.1016/j.applanim.2012.10.004; Velarde A, 2005, 56 ANN M EUR ASS AN, P2; Velarde A, 2012, MEAT SCI, V92, P244, DOI 10.1016/j.meatsci.2012.04.009; Warriss PD, 1998, ANIM WELFARE, V7, P365; Warriss PD, 1998, MEAT SCI, V49, P137, DOI 10.1016/S0309-1740(97)00133-2	36	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122841	10.1371/journal.pone.0122841	http://dx.doi.org/10.1371/journal.pone.0122841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830336	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600126
J	Campa, VM; Capilla, A; Varela, MJ; de la Rocha, AMA; Fernandez-Troyano, JC; Barreiro, RB; Lopez-Gimenez, JF				Campa, Vctor M.; Capilla, Almudena; Varela, Mara J.; Acanda de la Rocha, Arlet M.; Fernandez-Troyano, Juan C.; Belen Barreiro, R.; Lopez-Gimenez, Juan F.			Endocytosis as a Biological Response in Receptor Pharmacology: Evaluation by Fluorescence Microscopy	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; MU-OPIOID RECEPTOR; SINGLE-PARTICLE TRACKING; FUNCTIONAL SELECTIVITY; INTERNALIZATION; TOLERANCE; DESENSITIZATION; QUANTIFICATION; TRAFFICKING; DEPENDENCE	The activation of G-protein coupled receptors by agonist compounds results in diverse biological responses in cells, such as the endocytosis process consisting in the translocation of receptors from the plasma membrane to the cytoplasm within internalizing vesicles or endosomes. In order to functionally evaluate endocytosis events resulted from pharmacological responses, we have developed an image analysis method - the Q-Endosomes algorithm-that specifically discriminates the fluorescent signal originated at endosomes from that one observed at the plasma membrane in images obtained from living cells by fluorescence microscopy. Mu opioid (MOP) receptor tagged at the carboxy-terminus with yellow fluorescent protein (YFP) and permanently expressed in HEK293 cells was used as experimental model to validate this methodology. Time-course experiments performed with several agonists resulted in different sigmoid curves depending on the drug used to initiate MOP receptor endocytosis. Thus, endocytosis resulting from the simultaneous activation of co-expressed MOP and serotonin 5-HT2C receptors by morphine plus serotonin was significantly different, in kinetics as well as in maximal response parameters, from the one caused by DAMGO, sufentanyl or methadone. Therefore, this analytical tool permits the pharmacological characterization of receptor endocytosis in living cells with functional and temporal resolution.	[Campa, Vctor M.; Acanda de la Rocha, Arlet M.; Fernandez-Troyano, Juan C.; Lopez-Gimenez, Juan F.] UC, CSIC, IBBTEC, Santander, Spain; [Capilla, Almudena] UAM, Dept Biol & Hlth Psychol, Madrid, Spain; [Varela, Mara J.] USC, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Belen Barreiro, R.] UC, CSIC, IFCA, Inst Phys Cantabria, Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Autonomous University of Madrid; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA)	Lopez-Gimenez, JF (corresponding author), UC, CSIC, IBBTEC, Santander, Spain.	jf.lopez.gimenez@csic.es	Capilla, Almudena/B-9387-2011; Lopez-Gimenez, Juan/K-5823-2014; Barreiro, Rita Belen/N-5442-2014; Campa, Victor M/K-5050-2014	Capilla, Almudena/0000-0002-4181-4284; Lopez-Gimenez, Juan/0000-0003-3021-6200; Barreiro, Rita Belen/0000-0002-6139-4272; Campa, Victor M/0000-0002-3842-1359	Spanish Government (MINECO) [SAF2010-15663]	Spanish Government (MINECO)	This work was supported by the SAF2010-15663 grant from the Spanish Government (MINECO) (http://www.idi.mineco.gob.es/portal/site/MICINN?lang choosen=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger AC, 2010, ANN NEUROL, V67, P559, DOI 10.1002/ana.22002; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Conway BR, 1999, J BIOMOL SCREEN, V4, P75, DOI 10.1177/108705719900400207; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Fukunaga S, 2006, LIFE SCI, V80, P17, DOI 10.1016/j.lfs.2006.08.022; Ghosh RN, 2000, BIOTECHNIQUES, V29, P170, DOI 10.2144/00291pf01; Haasen D, 2006, METHOD ENZYMOL, V414, P121, DOI 10.1016/S0076-6879(06)14008-2; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Lopez-Gimenez JF, 2008, MOL PHARMACOL, V74, P1278, DOI 10.1124/mol.108.048272; Lopez-Gimenez JF, 2010, CNS NEUROL DISORD-DR, V9, P616; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Ruthardt N, 2011, MOL THER, V19, P1199, DOI 10.1038/mt.2011.102; Schlag BD, 2004, J PHARMACOL EXP THER, V310, P865, DOI 10.1124/jpet.104.067306; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Whistler JL, 2012, DRUG ALCOHOL DEPEN, V121, P189, DOI 10.1016/j.drugalcdep.2011.10.031; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942	25	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122604	10.1371/journal.pone.0122604	http://dx.doi.org/10.1371/journal.pone.0122604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849355	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800146
J	Deng, ML; Ji, SK; Fei, WT; Raza, S; He, CF; Chen, YY; Chen, HC; Guo, AZ				Deng, Mingliang; Ji, Sukun; Fei, Wentao; Raza, Sohail; He, Chenfei; Chen, Yingyu; Chen, Huanchun; Guo, Aizhen			Prevalence Study and Genetic Typing of Bovine Viral Diarrhea Virus (BVDV) in Four Bovine Species in China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; RESPIRATORY-DISEASE; IDENTIFICATION; DIVERSITY; CATTLE; INFECTIONS; GENOTYPE-1; SUBTYPES; 1D	To determine the nationwide status of persistent BVDV infection in different bovine species in China and compare different test methods, a total of 1379 serum samples from clinical healthy dairy cattle, beef cattle, yaks (Bos grunniens), and water buffalo (Bubalus bubalis) were collected in eight provinces of China from 2010 to 2013. The samples were analyzed using commercial antibody (Ab) and antigen (Ag) detection kits, and RT-PCR based on the 5'-UTR and Npro gene sequencing. Results showed that the overall positive rates for BVDV Ab, Ag and RT-PCR detection were 58.09% (801/1379), 1.39% (14/1010), and 22.64% (146/645), respectively, while the individual positive rates varied among regions, species, and farms. The average Ab-positive rates for dairy cattle, beef cattle, yaks, and water buffalo were 89.49% (298/333), 63.27% (248/392), 45.38% (236/520), and 14.18% (19/134), respectively, while the Ag-positive rates were 0.00% (0/116), 0.77%(3/392), 0.82% (3/368), and 5.97% (8/134), respectively, and the nucleic acid-positive rates detected by RT-PCR were 32.06% (42/131), 13.00% (26/200), 28.89% (52/180), and 19.40% (26/134), respectively. In addition, the RT-PCR products were sequenced and 124 5'-UTR sequences were obtained. Phylogenetic analysis of the 5'-UTR sequences indicated that all of the 124 BVDV-positive samples were BVDV-1 and subtyped into either BVDV-1b (33.06%), BVDV-1m (49.19%), or a new cluster, designated as BVDV-1u (17.74%). Phylogenetic analysis based on Npro sequences confirmed this novel subtype. In conclusion, this study revealed the prevalence of BVDV-1 in bovine species in China and the dominant subtypes. The high proportion of bovines with detectable viral nucleic acids in the sera, even in the presence of high Ab levels, revealed a serious threat to bovine health.	[Deng, Mingliang; Ji, Sukun; Fei, Wentao; Raza, Sohail; He, Chenfei; Chen, Yingyu; Chen, Huanchun; Guo, Aizhen] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Deng, Mingliang; Ji, Sukun; Fei, Wentao; Raza, Sohail; He, Chenfei; Chen, Huanchun; Guo, Aizhen] Huazhong Agr Univ, Coll Vet Med, Wuhan 430070, Peoples R China; [He, Chenfei] Huazhong Agr Univ, Coll Anim Sci, Wuhan 430070, Peoples R China; [Guo, Aizhen] Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Guo, AZ (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	aizhen@mail.hzau.edu.cn	chen, ying/HHS-8254-2022; Raza, Sohail/AAU-7779-2020	Raza, Sohail/0000-0002-7943-9395	special fund for Agro-Scientific Research in the Public Interest [201003060]; Ning Xia Key S&T Special Project [2012ZDN0903]; Special Fund for China Agriculture Research System (Beef/Yak Cattle) [CARS-38]	special fund for Agro-Scientific Research in the Public Interest; Ning Xia Key S&T Special Project; Special Fund for China Agriculture Research System (Beef/Yak Cattle)	This work was funded by a special fund for Agro-Scientific Research in the Public Interest (#201003060), Ning Xia Key S&T Special Project (#2012ZDN0903) and Special Fund for China Agriculture Research System (Beef/Yak Cattle) (#CARS-38).	BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Becher P, 1997, J GEN VIROL, V78, P1357, DOI 10.1099/0022-1317-78-6-1357; BOLIN SR, 1985, AM J VET RES, V46, P2467; Brock KV, 2003, BIOLOGICALS, V31, P133, DOI 10.1016/S1045-1056(03)00029-0; BROWNLIE J, 1984, VET REC, V114, P535, DOI 10.1136/vr.114.22.535; CORIA MF, 1978, J AM VET MED ASSOC, V172, P449; Deng Y, 2012, VET MICROBIOL, V159, P490, DOI 10.1016/j.vetmic.2012.04.023; Flores EF, 2002, VIRUS RES, V87, P51, DOI 10.1016/S0168-1702(02)00080-1; Fulton RW, 2000, CAN J VET RES, V64, P151; Gao JF, 2013, TROP ANIM HEALTH PRO, V45, P791, DOI 10.1007/s11250-012-0290-2; Giammarioli M, 2014, VIRUS GENES, V28; Gong XW, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-30; Gong XW, 2013, VIRUS GENES, V46, P375, DOI 10.1007/s11262-012-0861-3; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; Jackova A, 2008, VET RES COMMUN, V32, P7, DOI 10.1007/s11259-007-9012-z; Kuta A, 2013, VET MICROBIOL, V166, P639, DOI 10.1016/j.vetmic.2013.07.002; LEE KM, 1957, AM J VET RES, V18, P952; Liu LH, 2009, VET MICROBIOL, V138, P62, DOI 10.1016/j.vetmic.2009.03.006; Luzzago C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/147145; Mahony TJ, 2005, VET MICROBIOL, V106, P1, DOI 10.1016/j.vetmic.2004.10.024; Mishra N, 2008, VET MICROBIOL, V130, P88, DOI 10.1016/j.vetmic.2008.01.005; Nagai M, 2008, VIRUS GENES, V36, P135, DOI 10.1007/s11262-007-0190-0; Oem JK, 2010, J VET DIAGN INVEST, V22, P518, DOI 10.1177/104063871002200404; Peletto S, 2012, RES VET SCI, V92, P147, DOI 10.1016/j.rvsc.2010.10.015; PELLERIN C, 1994, VIROLOGY, V203, P260, DOI 10.1006/viro.1994.1483; Qiu Changqing, 2000, CHINESE J PREVENTIVE, V22, P453; RICHER L, 1988, CAN VET J, V29, P713; Ridpath JF, 2000, VET MICROBIOL, V77, P145, DOI 10.1016/S0378-1135(00)00271-6; Strong R, 2013, VET MICROBIOL, V162, P315, DOI 10.1016/j.vetmic.2012.09.006; Sun K, 2012, THESIS SW U NATL CHI; Toplak I, 2004, VET MICROBIOL, V99, P175, DOI 10.1016/j.vetmic.2003.12.004; Vilcek S, 2001, ARCH VIROL, V146, P99, DOI 10.1007/s007050170194; Vilcek S, 2004, VET RES, V35, P609, DOI 10.1051/vetres:2004036; Wang Jintao, 2012, HEILONGJIANG ANIMAL, V24, P91; Xue F, 2010, VET MICROBIOL, V143, P379, DOI 10.1016/j.vetmic.2009.11.010; Yang De-Sheng, 2007, PROGR VET MED, V28, P4; Yesilbag K, 2014, VET MICROBIOL, V169, P42, DOI 10.1016/j.vetmic.2013.12.005; Zhong FG, 2011, VIRUS GENES, V42, P204, DOI 10.1007/s11262-010-0558-4; Zhu Liqian, 2011, CHINESE J ANIMAL INF, V19, P83	39	52	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121718	10.1371/journal.pone.0121718	http://dx.doi.org/10.1371/journal.pone.0121718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849315	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800074
J	Gao, K; Ma, HS; Cui, Y; Chen, XZ; Ma, J; Dai, JP				Gao, Kun; Ma, Housheng; Cui, Yong; Chen, Xuzhu; Ma, Jun; Dai, Jianping			Meningiomas of the Cerebellopontine Angle: Radiological Differences in Tumors with Internal Auditory Canal Involvement and Their Influence on Surgical Outcome	PLOS ONE			English	Article							INTRACANALICULAR MENINGIOMA; INTRACRANIAL MENINGIOMAS; CLASSIFICATION	This study explored the clinical, radiological, and pathological characteristics of cerebellopontine angle (CPA) meningiomas with internal auditory canal (IAC) involvement. The pre- and postoperative MR images of 193 consecutive patients with pathologically diagnosed meningioma centered around the IAC were analyzed, focusing on changes in the IAC, maximal axial tumor volume, peritumoral brain edema, and postoperative residual tumor. Patient age, sex, tumor volume, postoperative residual tumor, and pathological subtype were compared in patients with and without IAC involvement by the tumor and among the different types of IAC involvement. The results showed that the 71 patients (36.8%) with IAC involvement had a higher ratio of peritumoral edema (chi(2) = 5.922, P = 0.015), postoperative residual tumor (chi(2) = 22.183, P < 0.001), and a predominance of the meningothelial subtype (chi(2) = 5.89, P = 0.015). Peritumoral edema was a risk factor for IAC involvement (P = 0.016, OR = 2.186). Radiologically, IAC involvement could be distinguished as intruding (31%, 22/71), filled (29.6%, 21/71), and dilated (39.4%, 28/71). Patients with intruding IAC were significantly older (54.5 +/- 9.54 years, P = 0.021) and had the lowest postoperative residual tumor values (42%, chi(2) = 7.865, P = 0.005), while those with filled IAC were more likely to be female (95%,chi(2) = 9.404, P = 0.009). Our observations provide the basis for a morphological classification of IAC involvement by CPA meningiomas and further insight into the clinical features of these tumors.	[Gao, Kun] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Radiol, Beijing, Peoples R China; [Ma, Housheng] Yantai Yuhuangding Hosp, Dept Radiol, Yantai, Shandong, Peoples R China; [Cui, Yong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Chen, Xuzhu; Ma, Jun; Dai, Jianping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Ma, J (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China.	radiology888@aliyun.com			National Natural Science Foundation of China [81271541]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (81271541 to J. P. Dai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2009, J NEUROSURG, V111, P1053, DOI 10.3171/2007.11.17446; Seco AA, 2010, ACTA OTORRINOLAR ESP, V61, P387, DOI 10.1016/j.otorri.2009.09.001; Asaoka K, 2002, AM J NEURORADIOL, V23, P1493; Bacciu A, 2007, OTOL NEUROTOL, V28, P391, DOI 10.1097/MAO.0b013e31803261b4; Carney AS, 1999, SKULL BASE SURG, V9, P87, DOI 10.1055/s-2008-1058154; Desgeorges M, 1992, ACOUSTIC NEUROMA; Fathi AR, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0337-4; Hamilton BE, 2006, AM J NEURORADIOL, V27, P2204; He SH, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.10.FOCUS13360; Domingues PH, 2014, NEURO-ONCOLOGY, V16, P735, DOI 10.1093/neuonc/not325; Hou J, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13301; Ibebuike K, 2013, AFR HEALTH SCI, V13, P118, DOI 10.4314/ahs.v13i1.16; Ishikawa T, 2011, NEUROL MED-CHIR, V51, P233, DOI 10.2176/nmc.51.233; Kane AJ, 2011, J CLIN NEUROSCI, V18, P755, DOI 10.1016/j.jocn.2010.09.023; Kaur G, 2014, NEURO-ONCOLOGY, V16, P628, DOI 10.1093/neuonc/nou025; Kunii N, 2011, WORLD NEUROSURG, V75, P114, DOI 10.1016/j.wneu.2010.09.020; Nassehi D, 2013, DAN MED J, V60; Pollock BE, 2004, STEREOT FUNCT NEUROS, V82, P98, DOI 10.1159/000077659; Raper DMS, 2014, AM J NEURORADIOL, V35, P1798, DOI 10.3174/ajnr.A3919; Roser F, 2005, J NEUROSURG, V102, P17, DOI 10.3171/jns.2005.102.1.0017; Rousseau A, 2008, CURR OPIN NEUROL, V21, P720, DOI 10.1097/WCO.0b013e328312c3a7; Salehi F, 2013, ACTA NEUROCHIR, V155, P421, DOI 10.1007/s00701-012-1577-9; Tomogane Y, 2013, NEUROL MED-CHIR, V53, P482; von Eckardstein KL, 2010, NEUROSURGERY, V67, P1236, DOI 10.1227/NEU.0b013e3181efe412; Voss NF, 2000, SURG NEUROL, V53, P439, DOI 10.1016/S0090-3019(00)00195-6; Wang DJ, 2013, CHINESE MED J-PEKING, V126, P488, DOI 10.3760/cma.j.issn.0366-6999.20122874; Zielinski G, 2013, NEUROENDOCRINOL LETT, V34, P111	27	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122949	10.1371/journal.pone.0122949	http://dx.doi.org/10.1371/journal.pone.0122949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849220	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800181
J	de Olalla, PG; Molas, E; Barbera, MJ; Martin, S; Arellano, E; Gosch, M; Saladie, P; Carbonell, T; Knobel, H; Diez, E; Cayla, JA				Garcia de Olalla, Patricia; Molas, Ema; Jesus Barbera, Maria; Martin, Silvia; Arellano, Encarnacio; Gosch, Merce; Saladie, Pilar; Carbonell, Teresa; Knobel, Hernando; Diez, Elia; Cayla, Joan A.			Effectiveness of a Pilot Partner Notification Program for New HIV Cases in Barcelona, Spain	PLOS ONE			English	Article							REFERRAL SERVICES; UNDIAGNOSED HIV; INFECTION; MEN; SEX; ENGLAND; RISK	Background An estimated 30% of HIV cases in the European Union are not aware of their serological status. This study aimed to assess the effectiveness of a pilot HIV partner notification program. Methods HIV cases diagnosed between January 2012 and June 2013 at two healthcare settings in Barcelona were invited to participate in a prospective survey. We identified process and outcome measures to evaluate this partner notification program, including the number of partners identified per interviewed index case, the proportion of partners tested for HIV as a result of the partner notification, and the proportion of new HIV diagnoses among their sex or needle-sharing partners. Results Of the 125 index cases contacted, 108 (86.4%) agreed to provide information about partners. A total of 199 sexual partners were identified (1.8 partners per interviewed index case). HIV outcome was already known for 58 partners (70.7% were known to be HIV-positive), 141 partners were tested as result of partner notification, and 26 were newly diagnosed with HIV. The case-finding effectiveness of the program was 18.4%. Conclusion This pilot program provides evidence of the effectiveness of a partner notification program implemented in healthcare settings. This active partner notification program was feasible, acceptable to the user, and identified a high proportion of HIV-infected patients previously unaware of their status.	[Garcia de Olalla, Patricia; Molas, Ema; Cayla, Joan A.] Agencia Salut Publ Barcelona, Epidemiol Serv, Barcelona, Spain; [Molas, Ema; Carbonell, Teresa; Knobel, Hernando] Univ Hosp Mar, Internal Med Infect Dis, Barcelona, Spain; [Jesus Barbera, Maria; Arellano, Encarnacio; Gosch, Merce; Saladie, Pilar] Univ Hosp Vall dHebron, Sexually Transmitted Infect Unit, Barcelona, Spain; [Martin, Silvia; Diez, Elia] Agencia Salut Publ Barcelona, Prevent Intervent & Programs Serv, Barcelona, Spain; [Garcia de Olalla, Patricia; Diez, Elia; Cayla, Joan A.] Biomed Res Consortium Epidemiol & Publ Hlth Netwo, Barcelona, Spain	Public Health Agency of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Public Health Agency of Barcelona	de Olalla, PG (corresponding author), Agencia Salut Publ Barcelona, Epidemiol Serv, Barcelona, Spain.	polalla@aspb.cat	Knobel, Hernando/B-5223-2016; Knobel, Hernando/AAD-3582-2020; Carbonell, Teresa/L-9194-2014	Knobel, Hernando/0000-0003-3186-6416; Knobel, Hernando/0000-0003-3186-6416; Carbonell, Teresa/0000-0002-7131-3667; Carreras, Ramon/0000-0001-6740-5377; Diez, Elia/0000-0002-0353-3916; Molas Morena, Maria Ema/0000-0002-8858-501X; Cayla, Joan A./0000-0003-3891-111X	Ayudas para el fomento de la Investigacion Clinica Independiente from the Spanish Ministry of Health	Ayudas para el fomento de la Investigacion Clinica Independiente from the Spanish Ministry of Health	Funding for this pilot program was provided by a grant under the Ayudas para el fomento de la Investigacion Clinica Independiente from the Spanish Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, JAIDS-J ACQ IMM DEF, V46, P479, DOI 10.1097/QAI.0b013e3181594c61; Almeda J, 2004, Euro Surveill, V9, P35; Arthur G, 2005, SEX TRANSM DIS, V32, P734, DOI 10.1097/01.olq.0000175376.62297.73; Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679; Cayla JA, 2003, MED CLIN-BARCELONA, V121, P494, DOI 10.1157/13053140; Center for Disease Control, 1992, MMWR-MORBID MORTAL W; Europaisches Zentrum fur die Pravention und die Kontrolle von Krankheiten, 2010, HIV TEST INCR UPT EF; European Centre for Disease Prevention Control, 2013, PUBL HLTH BEN PARTN; Fernandez-Balbuena S, 2014, SEX TRANSM INFECT, V90, P112, DOI 10.1136/sextrans-2013-051234; Ferreira A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002843.pub2; de Olalla PG, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-22; Garrett NJ, 2012, HIV MED, V13, P444, DOI 10.1111/j.1468-1293.2012.00990.x; Golden MR, 2004, SEX TRANSM DIS, V31, P709, DOI 10.1097/01.olq.0000145847.65523.43; Goswami ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046029; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Klein H, 2012, PUBLIC HEALTH, V126, P471, DOI 10.1016/j.puhe.2012.01.023; Lunny C, 2011, HEALTH POLICY, V103, P111, DOI 10.1016/j.healthpol.2011.07.011; Mayer KH, 2012, JAIDS-J ACQ IMM DEF, V59, P194, DOI 10.1097/QAI.0b013e31823bbecf; Meulbroek M, 2013, HIV MED, V14, P25, DOI 10.1111/hiv.12054; NAT, 2012, HIV PARTN NOT MISS O; Passin WF, 2006, SEX TRANSM DIS, V33, P320, DOI 10.1097/01.olq.0000194597.16236.48; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Song Binwei, 2012, Open AIDS J, V6, P8, DOI 10.2174/1874613601206010008; Valles X, 2011, GAC SANIT, V25, P224, DOI 10.1016/j.gaceta.2010.12.003; van Aar F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-114	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121536	10.1371/journal.pone.0121536	http://dx.doi.org/10.1371/journal.pone.0121536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849451	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800063
J	Hidalgo-Tenorio, C; Rivero-Rodriguez, M; Gil-Anguita, C; Esquivias, J; Lopez-Castro, R; Ramirez-Taboada, J; de Hierro, ML; Lopez-Ruiz, MA; Martinez, RJ; Llano, JP				Hidalgo-Tenorio, Carmen; Rivero-Rodriguez, Mar; Gil-Anguita, Concepcin; Esquivias, Javier; Lopez-Castro, Rodrigo; Ramirez-Taboada, Jessica; Lopez de Hierro, Mercedes; Lopez-Ruiz, Miguel A.; Javier Martinez, R.; Llano, Juan P.			The Role of Polymerase Chain Reaction of High-Risk Human Papilloma Virus in the Screening of High-Grade Squamous Intraepithelial Lesions in the Anal Mucosa of Human Immunodeficiency Virus-Positive Males Having Sex with Males	PLOS ONE			English	Article							HIV-INFECTED MEN; NEOPLASTIC LESIONS; CANCER; CYTOLOGY; AIDS; PERFORMANCE; PREVALENCE; PREDICTORS; MANAGEMENT; SOCIETY	Objectives To evaluate the advantages of cytology and PCR of high-risk human papilloma virus (PCR HR-HPV) infection in biopsy-derived diagnosis of high-grade squamous intraepithelial lesions (HSIL = AIN2/AIN3) in HIV-positive men having sex with men (MSM). Methods This is a single-centered study conducted between May 2010 and May 2014 in patients (n = 201, mean age 37 years) recruited from our outpatient clinic. Samples of anal canal mucosa were taken into liquid medium for PCR HPV analysis and for cytology. Anoscopy was performed for histology evaluation. Results Anoscopy showed 33.8% were normal, 47.8% low-grade squamous intraepithelial lesions (LSIL), and 18.4% HSIL; 80.2% had HR-HPV. PCR of HR-HPV had greater sensitivity than did cytology (88.8% vs. 75.7%) in HSIL screening, with similar positive (PPV) and negative predictive value (NPV) of 20.3 vs. 22.9 and 89.7 vs. 88.1, respectively. Combining both tests increased the sensitivity and NPV of HSIL diagnosis to 100%. Correlation of cytology vs. histology was, generally, very low and PCR of HR-HPV vs. histology was non-existent (<0.2) or low (<0.4). Area under the receiver operating characteristics (AUROC) curve analysis of cytology and PCR HR-HPV for the diagnosis of HSIL was poor (<0.6). Multivariate regression analysis showed protective factors against HSIL were: viral suppression (OR: 0.312; 95% CI: 0.099-0.984), and/or syphilis infection (OR: 0.193; 95%CI: 0.045-0.827). HSIL risk was associated with HPV-68 genotype (OR: 20.1; 95%CI: 2.04-197.82). Conclusions When cytology and PCR HR-HPV findings are normal, the diagnosis of pre-malignant HSIL can be reliably ruled-out in HIV-positive patients. HPV suppression with treatment protects against the appearance of HSIL.	[Hidalgo-Tenorio, Carmen; Rivero-Rodriguez, Mar; Gil-Anguita, Concepcin; Ramirez-Taboada, Jessica; Lopez-Ruiz, Miguel A.; Javier Martinez, R.; Llano, Juan P.] Univ Hosp Virgen de las Nieves, Infect Dis Unit, Granada, Spain; [Esquivias, Javier; Lopez-Castro, Rodrigo] Univ Hosp Virgen de las Nieves, Pathol Serv, Granada, Spain; [Lopez de Hierro, Mercedes] Univ Hosp Virgen de las Nieves, Gastroenterol Serv, Granada, Spain	Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves	Hidalgo-Tenorio, C (corresponding author), Univ Hosp Virgen de las Nieves, Infect Dis Unit, Granada, Spain.	chidalgo72@gmail.com						Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Andres AM, 2005, STAT METHODS MED RES, V14, P473, DOI 10.1191/0962280205sm412oa; Berry JM, 2009, DIS COLON RECTUM, V52, P239, DOI 10.1007/DCR.0b013e31819793d9; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Botes LP, 2013, SEX HEALTH, V10, P9, DOI 10.1071/SH11135; CHAN SY, 1992, J VIROL, V66, P5714, DOI 10.1128/JVI.66.10.5714-5725.1992; Chin-Hong PV, 2008, ANN INTERN MED, V149, P300, DOI 10.7326/0003-4819-149-5-200809020-00004; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Darwich L, 2013, DIS COLON RECTUM, V56, P1043, DOI 10.1097/DCR.0b013e31829c654f; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Diamond C, 2005, SEX TRANSM DIS, V32, P314, DOI 10.1097/01.olq.0000162366.60245.02; Franceschi S, 2010, BRIT J CANCER, V103, P416, DOI 10.1038/sj.bjc.6605756; Fraunholz IB, 2014, DIS COLON RECTUM, V57, P423, DOI 10.1097/DCR.0000000000000057; Freeman DH, 1987, APPLIED CATEGORICAL; Garbuglia AR, 2012, J CLIN VIROL, V54, P141, DOI 10.1016/j.jcv.2012.02.013; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Goldstone SE, 2009, DIS COLON RECTUM, V52, P31, DOI 10.1007/DCR.0b013e31819736aa; Tenorio CH, 2013, MED CLIN-BARCELONA, V140, P193, DOI 10.1016/j.medcli.2012.05.044; Hidalgo-Tenorio C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092376; Kutlubay Z, 2013, CLIN DERMATOL, V31, P362, DOI 10.1016/j.clindermatol.2013.01.003; Lam JMC, 2011, AIDS, V25, P635, DOI 10.1097/QAD.0b013e3283434594; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Nathan M, 2010, AIDS, V24, P373, DOI 10.1097/QAD.0b013e328333ab8e; Padilla-Espana L, 2014, ENFERM INFECC MICROB, P4; Panel de expertos del Grupo de Estudio de Sida (GESIDA), 2014, GUIA DE PRACTICA CLI; Panther LA, 2004, CLIN INFECT DIS, V38, P1495; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Pinzone MR, 2012, EUR REV MED PHARMACO, V16, P1377; Salati SA, 2012, INT J HEALTH SCI-IJH, V6, P206, DOI 10.12816/0006000; Salit IE, 2010, AIDS, V24, P1307, DOI 10.1097/QAD.0b013e328339e592; Schim van der Loeff MF, 2014, CURR HIV AIDS REP; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Walts AE, 2005, DIAGN CYTOPATHOL, V33, P152, DOI 10.1002/dc.20212; Weis SE, 2013, ONCOTARGETS THER, V6, P651, DOI 10.2147/OTT.S38217	40	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123590	10.1371/journal.pone.0123590	http://dx.doi.org/10.1371/journal.pone.0123590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849412	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800243
J	Kim, JS; Lee, IK; Yun, BS				Kim, Jong Shik; Lee, In Kyoung; Yun, Bong Sik			A Novel Biosurfactant Produced by Aureobasidium pullulans L3-GPY from a Tiger Lily Wild Flower, Lilium lancifolium Thunb	PLOS ONE			English	Article							POLY(BETA-L-MALIC ACID); LIPID-COMPOSITION; POLYMALIC ACID; MALIC-ACID; MICROBIOLOGY; SURFACTANTS	Yeast biosurfactants are important biotechnological products in the food industry, and they have medical and cosmeceutical applications owing to their specific modes of action, low toxicity, and applicability. Thus, we have isolated and examined biosurfactant-producing yeast for various industrial and medical applications. A rapid and simple method was developed to screen biosurfactant-producing yeasts for high production of eco-friendly biosurfactants. Using this method, several potential niches of biosurfactant-producing yeasts, such as wild flowers, were investigated. We successfully selected a yeast strain, L3-GPY, with potent surfactant activity from a tiger lily, Lilium lancifolium Thunb. Here, we report the first identification of strain L3-GPY as the black yeast Aureobasidium pullulans. In addition, we isolated a new low-surface-tension chemical, designated glycerol-liamocin, from the culture supernatant of strain L3-GPY through consecutive chromatography steps, involving an ODS column, solvent partition, silica gel, Sephadex LH-20, and an ODS Sep-Pak cartridge column. The chemical structure of glycerol-liamocin, determined by mass spectrometry and nuclear magnetic resonance spectroscopy, indicates that it is a novel compound with the molecular formula C33H62O12. Furthermore, glycerol-liamocin exhibited potent biosurfactant activity (31 mN/m). These results suggest that glycerol-liamocin is a potential novel biosurfactantfor use in various industrial applications.	[Kim, Jong Shik] Gyeongbuk Inst Marine Bioind, Uljin 767813, Gyeongbuk, South Korea; [Lee, In Kyoung; Yun, Bong Sik] Chonbuk Natl Univ, Div Biotechnol, Iksan 570752, Chonbuk, South Korea; [Lee, In Kyoung; Yun, Bong Sik] Chonbuk Natl Univ, Adv Inst Environm & Biosci, Iksan 570752, Chonbuk, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, JS (corresponding author), Gyeongbuk Inst Marine Bioind, 22 Haeyanggwahak Gil, Uljin 767813, Gyeongbuk, South Korea.	jskim@gimb.or.kr; bsyun@jbnu.ac.kr		Kim, Jong-Shik/0000-0002-8181-1707	research program of Gyeongsangbuk-Do; National Research Foundation of Korea (NRF), via a grant from the Korean government (MSIP) [NRF-2014R1A2A1A11052888]	research program of Gyeongsangbuk-Do; National Research Foundation of Korea (NRF), via a grant from the Korean government (MSIP)	This work was supported by the research program of Gyeongsangbuk-Do and the National Research Foundation of Korea (NRF), via a grant from the Korean government (MSIP) (no. NRF-2014R1A2A1A11052888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PFF, 2010, ADV EXP MED BIOL, V672, P236; Campos-Takaki GM, 2010, ADV EXP MED BIOL, V672, P250; Cao WF, 2013, J CHEM TECHNOL BIOT, V88, P808, DOI 10.1002/jctb.3905; Certik M, 2005, INT BIODETER BIODEGR, V55, P195, DOI 10.1016/j.ibiod.2004.11.005; Cheng KC, 2011, APPL MICROBIOL BIOT, V92, P29, DOI 10.1007/s00253-011-3477-y; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; DESHPANDE MS, 1992, ENZYME MICROB TECH, V14, P514, DOI 10.1016/0141-0229(92)90122-5; Doshida J, 1996, J ANTIBIOT, V49, P1105, DOI 10.7164/antibiotics.49.1105; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; Gunde-Cimerman N, 2003, PHYS CHEM EARTH, V28, P1273, DOI 10.1016/j.pce.2003.08.056; Hewald S, 2005, APPL ENVIRON MICROB, V71, P3033, DOI 10.1128/AEM.71.6.3033-3040.2005; Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Leathers, 2011, RANGSIT J ARTS SCI, V1, P41; Leathers TD, 2013, BIOTECHNOL LETT, V35, P1701, DOI 10.1007/s10529-013-1268-5; Leathers TD, 2013, BIOTECHNOL LETT, V35, P83, DOI 10.1007/s10529-012-1045-x; Liu S, 1996, APPL MICROBIOL BIOT, V46, P273, DOI 10.1007/s002530050816; Ma ZC, 2012, PROCESS BIOCHEM, V47, P1807, DOI 10.1016/j.procbio.2012.06.024; Manitchotpisit P, 2012, J IND MICROBIOL BIOT, V39, P125, DOI 10.1007/s10295-011-1007-7; Manitchotpisit P, 2011, BIOTECHNOL LETT, V33, P1151, DOI 10.1007/s10529-011-0548-1; Mari M, 2012, POSTHARVEST BIOL TEC, V73, P56, DOI 10.1016/j.postharvbio.2012.05.014; Morita T, 2006, APPL MICROBIOL BIOT, V73, P305, DOI 10.1007/s00253-006-0466-7; Muramatsu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041399; Myers D, 2006, SURFACTANT SCIENCE AND TECHNOLOGY, 3RD EDITION, P1; NAGATA N, 1993, BIOSCI BIOTECH BIOCH, V57, P638, DOI 10.1271/bbb.57.638; Prasongsuk S, 2013, APPL MICROBIOL BIOT, V97, P7821, DOI 10.1007/s00253-013-5069-5; Price NPJ, 2013, CARBOHYD RES, V370, P24, DOI 10.1016/j.carres.2013.01.014; Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Singh A, 2007, BIOTECHNOL ADV, V25, P99, DOI 10.1016/j.biotechadv.2006.10.004; Singh RS, 2008, CARBOHYD POLYM, V73, P515, DOI 10.1016/j.carbpol.2008.01.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turk M, 2004, EXTREMOPHILES, V8, P53, DOI 10.1007/s00792-003-0360-5; Van Hamme JD, 2006, BIOTECHNOL ADV, V24, P604, DOI 10.1016/j.biotechadv.2006.08.001; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yurlova NA, 1997, ANTON LEEUW INT J G, V72, P141, DOI 10.1023/A:1000212003810; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02; Zan ZQ, 2013, J CHEM TECHNOL BIOT, V88, P1822, DOI 10.1002/jctb.4033; Zou X, 2013, BIOTECHNOL BIOENG, V110, P2105, DOI 10.1002/bit.24876	40	27	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122917	10.1371/journal.pone.0122917	http://dx.doi.org/10.1371/journal.pone.0122917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849549	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800173
J	Seneviratne, S; Lawrenson, R; Scott, N; Kim, B; Shirley, R; Campbell, I				Seneviratne, Sanjeewa; Lawrenson, Ross; Scott, Nina; Kim, Boa; Shirley, Rachel; Campbell, Ian			Breast Cancer Biology and Ethnic Disparities in Breast Cancer Mortality in New Zealand: A Cohort Study	PLOS ONE			English	Article							HORMONE-RECEPTOR STATUS; PROGNOSTIC-FACTORS; SURVIVAL; RACE; WOMEN; INEQUALITIES; DEPRIVATION; SUBTYPES; THERAPY; TRENDS	Introduction Indigenous Maori women have a 60% higher breast cancer mortality rate compared with European women in New Zealand. We investigated differences in cancer biological characteristics and their impact on breast cancer mortality disparity between Maori and NZ European women. Materials and Methods Data on 2849 women with primary invasive breast cancers diagnosed between 1999 and 2012 were extracted from the Waikato Breast Cancer Register. Differences in distribution of cancer biological characteristics between Maori and NZ European women were explored adjusting for age and socioeconomic deprivation in logistic regression models. Impacts of socioeconomic deprivation, stage and cancer biological characteristics on breast cancer mortality disparity between Maori and NZ European women were explored in Cox regression models. Results Compared with NZ European women (n=2304), Maori women (n=429) had significantly higher rates of advanced and higher grade cancers. Maori women also had non-significantly higher rates of ER/PR negative and HER-2 positive breast cancers. Higher odds of advanced stage and higher grade remained significant for Maori after adjusting for age and deprivation. Maori women had almost a 100% higher age and deprivation adjusted breast cancer mortality hazard compared with NZ European women (HR=1.98, 1.55-2.54). Advanced stage and lower proportion of screen detected cancer in Maori explained a greater portion of the excess breast cancer mortality (HR reduction from 1.98 to 1.38), while the additional contribution through biological differences were minimal (HR reduction from 1.38 to 1.35). Conclusions More advanced cancer stage at diagnosis has the greatest impact while differences in biological characteristics appear to be a minor contributor for inequities in breast cancer mortality between Maori and NZ European women. Strategies aimed at reducing breast cancer mortality in Maori should focus on earlier diagnosis, which will likely have a greater impact on reducing breast cancer mortality inequity between Maori and NZ European women.	[Seneviratne, Sanjeewa; Lawrenson, Ross; Campbell, Ian] Univ Auckland, Waikato Clin Sch, Hamilton, New Zealand; [Scott, Nina] Waikato Dist Hlth Board, Maori Hlth Serv, Hamilton, New Zealand; [Kim, Boa; Shirley, Rachel] Waikato Hosp, Waikato Breast Canc Trust, Hamilton, New Zealand	University of Auckland; Waikato Hospital	Seneviratne, S (corresponding author), Univ Auckland, Waikato Clin Sch, Hamilton, New Zealand.	Sanjeewa.Seneviratne@waikatodhb.health.nz	Seneviratne, Sanjeewa/V-5764-2019	Seneviratne, Sanjeewa/0000-0003-0310-1387	Waikato Breast Cancer Trust; Cancer Society of New Zealand; New Zealand Breast Cancer Foundation; Lion Foundation; WEL Energy Trust	Waikato Breast Cancer Trust; Cancer Society of New Zealand; New Zealand Breast Cancer Foundation; Lion Foundation; WEL Energy Trust	The authors acknowledge funding support received from the Waikato Breast Cancer Trust, Cancer Society of New Zealand, New Zealand Breast Cancer Foundation, Lion Foundation and the WEL Energy Trust towards the WBCR and for additional data collection included for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwani S., 2003, DECADES DISPARITY ET; Allred DC, 2008, ONCOLOGIST, V13, P1134, DOI 10.1634/theoncologist.2008-0184; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; American Joint Committee on Cancer, 2010, AM JOINT COMMITTEE C, V7th; [Anonymous], 2004, ETHN DAT PROT HLTH D; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cunningham R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-674; Dachs GU, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-543; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Haynes R, 2008, SOC SCI MED, V67, P928, DOI 10.1016/j.socscimed.2008.05.005; Jack RH, 2013, EUR J CANCER, V49, P696, DOI 10.1016/j.ejca.2012.09.012; Jeffreys M, 2005, AM J PUBLIC HEALTH, V95, P834, DOI 10.2105/AJPH.2004.053678; Li CI, 2002, CANCER EPIDEM BIOMAR, V11, P601; McKenzie F, 2008, CANCER CAUSE CONTROL, V19, P403, DOI 10.1007/s10552-007-9099-0; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; Pauletti G, 1996, ONCOGENE, V13, P63; Robson B, 2010, UNEQUAL IMPACT; Rosenberg J, 2005, BREAST CANCER RES TR, V89, P47, DOI 10.1007/s10549-004-1470-1; Salmond C., 2007, NZDEP2006 INDEX DEPR; Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7; Seneviratne S, 2015, BREAST, V24, P62, DOI 10.1016/j.breast.2014.11.011; Seneviratne S, 2015, ETHNIC HEALTH, V20, P178, DOI 10.1080/13557858.2014.895976; Seneviratne S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-839; Seneviratne S, 2014, CANCER EPIDEMIOL, V38, P638, DOI 10.1016/j.canep.2014.06.008; Taylor A, 2003, J PUBLIC HEALTH MED, V25, P228, DOI 10.1093/pubmed/fdg072; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Weston MK, 2008, BREAST CANCER RES TR, V111, P555, DOI 10.1007/s10549-007-9813-3	29	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123523	10.1371/journal.pone.0123523	http://dx.doi.org/10.1371/journal.pone.0123523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849101	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800240
J	Walker, AW; Smith, CM; Chua, BE; Krstew, EV; Zhang, C; Gundlach, AL; Lawrence, AJ				Walker, Andrew W.; Smith, Craig M.; Chua, Berenice E.; Krstew, Elena V.; Zhang, Cary; Gundlach, Andrew L.; Lawrence, Andrew J.			Relaxin-3 Receptor (RXFP3) Signalling Mediates Stress-Related Alcohol Preference in Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CHRONIC SWIM STRESS; NUCLEUS-INCERTUS; STRIA TERMINALIS; MESSENGER-RNA; BED NUCLEUS; MATERNAL SEPARATION; ETHANOL-CONSUMPTION; BRAIN; ANXIETY	Stressful life events are causally linked with alcohol use disorders (AUDs), providing support for a hypothesis that alcohol consumption is aimed at stress reduction. We have previously shown that expression of relaxin-3 mRNA in rat brain correlates with alcohol intake and that central antagonism of relaxin-3 receptors (RXFP3) prevents stress-induced reinstatement of alcohol-seeking. Therefore the objectives of these studies were to investigate the impact of Rxfp3 gene deletion in C57BL/6J mice on baseline and stress-related alcohol consumption. Male wild-type (WT) and Rxfp3 knockout (KO) (C57/B6J(RXFP3TM1/DGen)) littermate mice were tested for baseline saccharin and alcohol consumption and preference over water in a continuous access two-bottle free-choice paradigm. Another cohort of mice was subjected to repeated restraint followed by swim stress to examine stress-related alcohol preference. Hepatic alcohol and aldehyde dehydrogenase activity was assessed in mice following chronic alcohol intake and in naive controls. WT and Rxfp3 KO mice had similar baseline saccharin and alcohol preference, and hepatic alcohol processing. However, Rxfp3 KO mice displayed a stress-induced reduction in alcohol preference that was not observed in WT littermates. Notably, this phenotype, once established, persisted for at least six weeks after cessation of stress exposure. These findings suggest that in mice, relaxin-3/RXFP3 signalling is involved in maintaining high alcohol preference during and after stress, but does not appear to strongly regulate the primary reinforcing effects of alcohol.	[Walker, Andrew W.; Smith, Craig M.; Chua, Berenice E.; Zhang, Cary; Gundlach, Andrew L.] Florey Inst Neurosci & Mental Hlth, Neuropeptides Div, Melbourne, Vic, Australia; [Walker, Andrew W.; Smith, Craig M.; Krstew, Elena V.; Lawrence, Andrew J.] Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Melbourne, Vic, Australia; [Walker, Andrew W.; Smith, Craig M.; Zhang, Cary; Gundlach, Andrew L.; Lawrence, Andrew J.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Gundlach, Andrew L.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Lawrence, AJ (corresponding author), Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Melbourne, Vic, Australia.	andrew.lawrence@florey.edu.au	Gundlach, Andrew L/X-6421-2018	Gundlach, Andrew L/0000-0002-6066-9692	National Health and Medical Research Council (NHMRC) of Australia project grant [1021227]; NHMRC (Australia) [1005985, 1020737]; Pratt Foundation; Besen Foundation; Victorian Government's Operational Infrastructure Support Program; University of Melbourne International Postgraduate Research Scholarship (IPRS)	National Health and Medical Research Council (NHMRC) of Australia project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation; Besen Foundation; Victorian Government's Operational Infrastructure Support Program; University of Melbourne International Postgraduate Research Scholarship (IPRS)	This research was supported by a National Health and Medical Research Council (NHMRC) of Australia project grant (1021227 to ALG and AJL) and NHMRC (Australia) Research Fellowships (1005985 and 1020737) to ALG and AJL; a grant from the Pratt and Besen Foundations (ALG and AJL); and the Victorian Government's Operational Infrastructure Support Program. AWW was the recipient of a University of Melbourne International Postgraduate Research Scholarship (IPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013; Becker HC, 2011, PSYCHOPHARMACOLOGY, V218, P131, DOI 10.1007/s00213-011-2443-9; Bird MK, 2008, INT J NEUROPSYCHOPH, V11, P765, DOI 10.1017/S1461145708008572; Boyce-Rustay JM, 2008, BEHAV BRAIN RES, V186, P133, DOI 10.1016/j.bbr.2007.07.031; Boyce-Rustay JM, 2007, PHYSIOL BEHAV, V91, P77, DOI 10.1016/j.physbeh.2007.01.024; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Correia D, 2009, PROG NEURO-PSYCHOPH, V33, P880, DOI 10.1016/j.pnpbp.2009.04.015; Crestani CC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-30; Cruz FC, 2008, PSYCHOPHARMACOLOGY, V201, P459, DOI 10.1007/s00213-008-1307-4; Dahlhoff M, 2013, EXP CELL RES, V319, P529, DOI 10.1016/j.yexcr.2012.11.001; Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x; Donizetti A, 2008, DEV DYNAM, V237, P3864, DOI 10.1002/dvdy.21786; Funk CK, 2006, J NEUROSCI, V26, P11324, DOI 10.1523/JNEUROSCI.3096-06.2006; Hosken IT, 2015, BEHAV BRAIN RES, V278, P167, DOI 10.1016/j.bbr.2014.09.028; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Jupp B, 2011, BRIT J PHARMACOL, V162, P880, DOI 10.1111/j.1476-5381.2010.01088.x; Jupp B, 2011, BRAIN RES, V1391, P54, DOI 10.1016/j.brainres.2011.03.045; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lodge DJ, 2003, NEUROSCIENCE, V117, P243, DOI 10.1016/S0306-4522(02)00793-5; Lopez MF, 2011, ALCOHOL, V45, P355, DOI 10.1016/j.alcohol.2010.08.017; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; Ma S, 2013, J PHYSIOL-LONDON, V591, P3981, DOI 10.1113/jphysiol.2013.254300; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma SR, 2009, ANN NY ACAD SCI, V1160, P256, DOI 10.1111/j.1749-6632.2009.03954.x; McFarlane AC, 1998, ADDICT BEHAV, V23, P813, DOI 10.1016/S0306-4603(98)00098-7; Mercier S, 2003, BEHAV BRAIN RES, V139, P167, DOI 10.1016/S0166-4328(02)00265-6; Misawa H, 2001, J BIOL CHEM, V276, P9264, DOI 10.1074/jbc.M009334200; Molander A, 2012, NEUROPSYCHOPHARMACOL, V37, P1047, DOI 10.1038/npp.2011.297; Moorman DE, 2009, ALCOHOL, V43, P379, DOI 10.1016/j.alcohol.2009.07.002; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; Ostrander MM, 2009, STRESS, V12, P469, DOI 10.3109/10253890802641966; Ray LA, 2009, ALCOHOL CLIN EXP RES, V33, P2154, DOI 10.1111/j.1530-0277.2009.01053.x; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Richardson HN, 2008, PHARMACOL BIOCHEM BE, V88, P497, DOI 10.1016/j.pbb.2007.10.008; RITZ MC, 1989, ALCOHOL, V6, P227, DOI 10.1016/0741-8329(89)90023-2; Ryan PJ, 2014, DRUG ALCOHOL DEPEN, V140, P8, DOI 10.1016/j.drugalcdep.2014.04.017; Ryan Philip J, 2013, Proc Natl Acad Sci U S A, V110, P20789, DOI 10.1073/pnas.1317807110; Ryan PJ, 2013, BEHAV BRAIN RES, V244, P142, DOI 10.1016/j.bbr.2013.01.034; Ryan PJ, 2011, NEUROSCI BIOBEHAV R, V35, P1326, DOI 10.1016/j.neubiorev.2011.02.004; Sakharkar AJ, 2014, INT J NEUROPSYCHOPH, V17, P2057, DOI 10.1017/S1461145714001047; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Skelly MJ, 2014, BRAIN BEHAV, V4, P468, DOI 10.1002/brb3.230; Slopen N, 2011, SOC SCI MED, V73, P615, DOI 10.1016/j.socscimed.2011.06.022; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; Thomas SE, 2011, PSYCHOPHARMACOLOGY, V218, P19, DOI 10.1007/s00213-010-2163-6; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Verheul R, 1999, ALCOHOL ALCOHOLISM, V34, P197, DOI 10.1093/alcalc/34.2.197; Watanabe Y, 2011, J MOL NEUROSCI, V43, P169, DOI 10.1007/s12031-010-9468-0; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14	58	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122504	10.1371/journal.pone.0122504	http://dx.doi.org/10.1371/journal.pone.0122504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849482	Green Published, gold			2022-12-27	WOS:000352477800136
J	Xu, JJ; Jiang, HZ; Li, JQ; Cheng, KK; Dong, JY; Chen, Z				Xu, Jingjing; Jiang, Huaizhou; Li, Jinquan; Cheng, Kian-Kai; Dong, Jiyang; Chen, Zhong			H-1 NMR-Based Metabolomics Investigation of Copper-Laden Rat: A Model of Wilson's Disease	PLOS ONE			English	Article							DEHYDROGENASE COMPLEX; LIVER-FAILURE; METABONOMICS; TAURINE; INHIBITION; ACID; SPECTROSCOPY; SENSITIVITY; METABOLISM; DIAGNOSIS	Background and Purpose Wilson's disease (WD), also known as hepatoleticular degeneration (HLD), is a rare autosomal recessive genetic disorder of copper metabolism, which causes copper to accumulate in body tissues. In this study, rats fed with copper-laden diet are used to render the clinical manifestations of WD, and their copper toxicity-induced organ lesions are studied. To investigate metabolic behaviors of 'decoppering' process, penicillamine (PA) was used for treating copper-laden rats as this chelating agent could eliminate excess copper through the urine. To date, there has been limited metabolomics study on WD, while metabolic impacts of copper accumulation and PA administration have yet to be established. Materials and Methods A combination of (HNMR)-H-1 spectroscopy and multivariate statistical analysis was applied to examine the metabolic profiles of the urine and blood serum samples collected from the copper-laden rat model of WD with PA treatment. Results Copper accumulation in the copper-laden rats is associated with increased lactate, creatinine, valine and leucine, as well as decreased levels of glucose and taurine in the blood serum. There were also significant changes in p-hydroxyphenylacetate (p-HPA), creatinine, alpha-ketoglutarate (a-KG), dimethylamine, N-acetylglutamate (NAG), N-acetylglycoprotein (NAC) in the urine of these rats. Notably, the changes in p-HPA, glucose, lactate, taurine, valine, leucine, and NAG were found reversed following PA treatment. Nevertheless, there were no changes for dimethylamine, a-KG, and NAC as a result of the treatment. Compared with the controls, the concentrations of hippurate, formate, alanine, and lactate were changed when PA was applied and this is probably due to its side effect. A tool named SMPDB (Small Molecule Pathway Database) is introduced to identify the metabolic pathway influenced by the copper-laden diet. Conclusion The study has shown the potential application of NMR-based metabolomic analysis in providing further insights into the molecular mechanism underlying disorder due to WD.	[Xu, Jingjing; Li, Jinquan; Dong, Jiyang; Chen, Zhong] Xiamen Univ, Fujian Prov Key Lab Plasma & Magnet Resonance, Dept Elect Sci, Xiamen 361005, Peoples R China; [Jiang, Huaizhou] Anhui Univ Chinese Med, Hefei 230031, Peoples R China; [Cheng, Kian-Kai] Univ Teknol Malaysia, Dept Bioproc Engn, Johor Baharu 81310, Malaysia; [Cheng, Kian-Kai] Univ Teknol Malaysia, Innovat Ctr Agritechnol, Johor Baharu 81310, Malaysia	Xiamen University; Anhui University of Chinese Medicine; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Dong, JY (corresponding author), Xiamen Univ, Fujian Prov Key Lab Plasma & Magnet Resonance, Dept Elect Sci, Xiamen 361005, Peoples R China.	jydong@xmu.edu.cn	Chen, Zhong/G-4601-2010	chen, zhong/0000-0002-1473-2224	National Nature Science Fund (NNSF) of China [81371639, 81201143, 31372546]; Fundamental Research Fund for the Central Universities [2013121007]	National Nature Science Fund (NNSF) of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities	The authors are grateful for the technical assistance from Prof. Jianghua Feng and Mr. Yangyang Wei. This work was supported by the National Nature Science Fund (NNSF) of China under grants (No. 81371639, No. 81201143 and No. 31372546) and the Fundamental Research Fund for the Central Universities under grant (No. 2013121007).	Aberg KM, 2009, ANAL BIOANAL CHEM, V394, P151, DOI 10.1007/s00216-009-2628-9; Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bosgelmez II, 2008, BIOL TRACE ELEM RES, V125, P46, DOI 10.1007/s12011-008-8154-3; Brewer G J, 2001, Expert Opin Pharmacother, V2, P1473, DOI 10.1517/14656566.2.9.1473; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Brons C, 2004, EUR J CLIN NUTR, V58, P1239, DOI 10.1038/sj.ejcn.1601955; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Coffey AJ, 2013, BRAIN, V136, P1476, DOI 10.1093/brain/awt035; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; De Luca G, 2001, METABOLISM, V50, P60, DOI 10.1053/meta.2001.19432; De Meyer T, 2008, ANAL CHEM, V80, P3783, DOI 10.1021/ac7025964; Dong JY, 2011, CHEMOMETR INTELL LAB, V108, P123, DOI 10.1016/j.chemolab.2011.06.002; Filomeni G, 2009, CARCINOGENESIS, V30, P1115, DOI 10.1093/carcin/bgp105; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Gavaghan CL, 2002, FEBS LETT, V530, P191, DOI 10.1016/S0014-5793(02)03476-2; Gow PJ, 2000, GUT, V46, P415, DOI 10.1136/gut.46.3.415; Griffin JL, 2004, PHYSIOL GENOMICS, V16, P334, DOI 10.1152/physiolgenomics.00149.2003; Hickey JL, 2011, DALTON T, V40, P1338, DOI 10.1039/c0dt01176b; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Hoogenraad TU, 2006, BRAIN DEV-JPN, V28, P141, DOI 10.1016/j.braindev.2005.08.008; HORROBIN DF, 1978, CAN J NEUROL SCI, V5, P93, DOI 10.1017/S0317167100024835; Hursitoglu M, 2010, CENT EUR J MED, V5, P145, DOI 10.2478/s11536-010-0004-y; Jeitner TM, 2005, J NEUROCHEM, V92, P302, DOI 10.1111/j.1471-4159.2004.02868.x; Juan CJ, 2005, NEURORADIOLOGY, V47, P401, DOI 10.1007/s00234-004-1306-z; LEACH RM, 1990, POULTRY SCI, V69, P1905, DOI 10.3382/ps.0691905; Leung PSC, 2007, HEPATOLOGY, V46, P1436, DOI 10.1002/hep.21828; Li WJ, 2013, CHIN J INTEGR MED, V19, P233, DOI 10.1007/s11655-012-1089-8; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Nakaya Y, 2000, AM J CLIN NUTR, V71, P54; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; OOIWA T, 1995, BBA-GEN SUBJECTS, V1243, P216, DOI 10.1016/0304-4165(94)00061-2; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Scheiber IF, 2011, NEUROCHEM RES, V36, P894, DOI 10.1007/s11064-011-0419-0; Schmidt HHJ, 2009, J HEPATOL, V50, P449, DOI 10.1016/j.jhep.2008.11.008; Sheline CT, 2006, NEUROSCIENCE, V140, P235, DOI 10.1016/j.neuroscience.2006.02.019; Shimomura Y, 2000, METHOD ENZYMOL, V324, P229; Shimomura Y, 2004, BIOCHEM BIOPH RES CO, V313, P381, DOI 10.1016/j.bbrc.2003.07.022; Siaj R, 2012, WORLD J GASTROENTERO, V18, P5542, DOI 10.3748/wjg.v18.i39.5542; Trygg J, 2003, J CHEMOMETR, V17, P53, DOI 10.1002/cem.775; WALSHE JM, 1956, AM J MED, V21, P487, DOI 10.1016/0002-9343(56)90066-3; WALSHE JM, 1982, LANCET, V1, P643; Waters NJ, 2001, CHEM RES TOXICOL, V14, P1401, DOI 10.1021/tx010067f; Wei L, 2009, TOXICOL APPL PHARM, V234, P314, DOI 10.1016/j.taap.2008.11.010; Wilson SAK, 1912, BRIT MED J, V1912, P1645; Xi YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-324; Xu JJ, 2009, ANAL BIOANAL CHEM, V393, P1657, DOI 10.1007/s00216-009-2623-1; Yanagita T, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-38	51	11	12	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119654	10.1371/journal.pone.0119654	http://dx.doi.org/10.1371/journal.pone.0119654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849323	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800014
J	Ye, JQ; Fan, ZL; Shang, JJ; Tian, XY; Yang, JL; Chen, HJ; Shao, HX; Qin, AJ				Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Yang, Jialiang; Chen, Hongjun; Shao, Hongxia; Qin, Aijian			ALV-J GP37 Molecular Analysis Reveals Novel Virus-Adapted Sites and Three Tyrosine-Based Env Species	PLOS ONE			English	Article							AVIAN-LEUKOSIS VIRUS; SUBGROUP-J; PHYLOGENETIC ANALYSIS; GLYCOPROTEIN GP85; GENETIC DIVERSITY; PROTEIN; ITAM; TRANSFORMATION; CHICKENS; HPRS-103	Compared to other avian leukosis viruses (ALV), ALV-J primarily induces myeloid leukemia and hemangioma and causes significant economic loss for the poultry industry. The ALV-J Env protein is hypothesized to be related to its unique pathogenesis. However, the molecular determinants of Env for ALV-J pathogenesis are unclear. In this study, we compared and analyzed GP37 of ALV-J Env and the EAV-HP sequence, which has high homology to that of ALV-J Env. Phylogenetic analysis revealed five groups of ALV-J GP37 and two novel ALV-J Envs with endemic GP85 and EAV-HP-like GP37. Furthermore, at least 15 virus-adapted mutations were detected in GP37 compared to the EAV-HP sequence. Further analysis demonstrated that three tyrosine-based motifs (YxxM, ITIM (immune tyrosine-based inhibitory motif) and ITAM-like (immune tyrosine-based active motif like)) associated with immune disease and oncogenesis were found in the cytoplasmic tail of GP37. Based on the potential function and distribution of these motifs in GP37, ALV-J Env was grouped into three species, inhibitory Env, bifunctional Env and active Env. Accordingly, 36.91%, 61.74% and 1.34% of ALV-J Env sequences from GenBank are classified as inhibitory, bifunctional and active Env, respectively. Additionally, the Env of the ALV-J prototype strain, HPRS-103, and 17 of 18 EAV-HP sequences belong to the inhibitory Env. And models for signal transduction of the three ALV-J Env species were predicted. Our findings and models provide novel insights for identifying the roles and molecular mechanism of ALV-J Env in the unique pathogenesis of ALV-J.	[Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Shao, Hongxia; Qin, Aijian] Yangzhou Univ, Minist Educ, Key Lab Avian Prevent Med, Yangzhou 225009, Jiangsu, Peoples R China; [Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Shao, Hongxia; Qin, Aijian] Yangzhou Univ, Key Lab Jiangsu Prevent Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Shao, Hongxia; Qin, Aijian] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Yang, Jialiang] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Chen, Hongjun] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Yangzhou University; Yangzhou University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Ye, JQ (corresponding author), Yangzhou Univ, Minist Educ, Key Lab Avian Prevent Med, Yangzhou 225009, Jiangsu, Peoples R China.	jqye@yzu.edu.cn; aijian@yzu.edu.cn	ye, jianqiang/ABH-8988-2020		National Natural Science Foundation of China [31472171]; Key University Science Research Project of Jiangsu Province [14KJA230002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This project was partially funded by National Natural Science Foundation of China (31472171), Key University Science Research Project of Jiangsu Province (14KJA230002) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	BAI J, 1995, J VIROL, V69, P779, DOI 10.1128/JVI.69.2.779-784.1995; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; BROWN DW, 1988, J VIROL, V62, P4828, DOI 10.1128/JVI.62.12.4828-4831.1988; Chesters PM, 2002, J GEN VIROL, V83, P2553, DOI 10.1099/0022-1317-83-10-2553; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui ZZ, 2003, AVIAN DIS, V47, P1321, DOI 10.1637/6085; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Jiang LL, 2014, ARCH VIROL, V159, P1821, DOI 10.1007/s00705-014-2004-8; Katz E, 2005, J EXP MED, V201, P431, DOI 10.1084/jem.20041471; Lagunoff M, 2001, J VIROL, V75, P5891, DOI 10.1128/JVI.75.13.5891-5898.2001; Lanier LL, 2006, TRENDS CELL BIOL, V16, P388, DOI 10.1016/j.tcb.2006.06.004; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Pan W, 2012, VET MICROBIOL, V156, P205, DOI 10.1016/j.vetmic.2011.10.019; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; Qin AJ, 2001, AVIAN DIS, V45, P938, DOI 10.2307/1592872; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thu WL, 2003, J VET MED SCI, V65, P325, DOI 10.1292/jvms.65.325; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Wang ZF, 2006, SCI CHINA SER C, V49, P227, DOI 10.1007/s11427-006-0227-y; WILLEMS L, 1995, J VIROL, V69, P4137, DOI 10.1128/JVI.69.7.4137-4141.1995; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Wu XP, 2010, VET RES COMMUN, V34, P619, DOI 10.1007/s11259-010-9436-8; Yan Du ZC, 1999, CHINA POULTRY, V3, P1	28	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122887	10.1371/journal.pone.0122887	http://dx.doi.org/10.1371/journal.pone.0122887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849207	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800169
J	Brown, AE; Jones, DE; Walker, M; Newton, JL				Brown, Audrey E.; Jones, David E.; Walker, Mark; Newton, Julia L.			Abnormalities of AMPK Activation and Glucose Uptake in Cultured Skeletal Muscle Cells from Individuals with Chronic Fatigue Syndrome	PLOS ONE			English	Article							PROTEIN-KINASE; ENGINEERED MUSCLE; PERIPHERAL MUSCLE; IN-VIVO; EXERCISE; INTERLEUKIN-6; DIFFERENTIATION; MATURATION; IL-6; METABOLISM	Background Post exertional muscle fatigue is a key feature in Chronic Fatigue Syndrome (CFS). Abnormalities of skeletal muscle function have been identified in some but not all patients with CFS. To try to limit potential confounders that might contribute to this clinical heterogeneity, we developed a novel in vitro system that allows comparison of AMP kinase (AMPK) activation and metabolic responses to exercise in cultured skeletal muscle cells from CFS patients and control subjects. Methods Skeletal muscle cell cultures were established from 10 subjects with CFS and 7 age-matched controls, subjected to electrical pulse stimulation (EPS) for up to 24h and examined for changes associated with exercise. Results In the basal state, CFS cultures showed increased myogenin expression but decreased IL6 secretion during differentiation compared with control cultures. Control cultures subjected to 16h EPS showed a significant increase in both AMPK phosphorylation and glucose uptake compared with unstimulated cells. In contrast, CFS cultures showed no increase in AMPK phosphorylation or glucose uptake after 16h EPS. However, glucose uptake remained responsive to insulin in the CFS cells pointing to an exercise-related defect. IL6 secretion in response to EPS was significantly reduced in CFS compared with control cultures at all time points measured. Conclusion EPS is an effective model for eliciting muscle contraction and the metabolic changes associated with exercise in cultured skeletal muscle cells. We found four main differences in cultured skeletal muscle cells from subjects with CFS; increased myogenin expression in the basal state, impaired activation of AMPK, impaired stimulation of glucose uptake and diminished release of IL6. The retention of these differences in cultured muscle cells from CFS subjects points to a genetic/epigenetic mechanism, and provides a system to identify novel therapeutic targets.	[Brown, Audrey E.; Jones, David E.; Walker, Mark] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jones, David E.; Walker, Mark; Newton, Julia L.] NHS Fdn Trust, Newcastle Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Newton, Julia L.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Newton, JL (corresponding author), NHS Fdn Trust, Newcastle Hosp, Newcastle Upon Tyne, Tyne & Wear, England.	julia.newton@ncl.ac.uk		Brown, Audrey/0000-0002-0222-4214; Newton, Julia/0000-0002-1249-5253	ME Research UK; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University	ME Research UK; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University	This research was supported by ME Research UK and by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024; [Anonymous], 2007, CHRON FAT SYNDR MYAL, V7; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; Flynn JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013535; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Glund S, 2009, ENDOCRINOLOGY, V150, P600, DOI 10.1210/en.2008-1204; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Jones DEJ, 2010, J INTERN MED, V267, P394, DOI 10.1111/j.1365-2796.2009.02160.x; Jones DEJ, 2012, EUR J CLIN INVEST, V42, P186, DOI 10.1111/j.1365-2362.2011.02567.x; Juhas M, 2014, BIOMATERIALS, V35, P9438, DOI 10.1016/j.biomaterials.2014.07.035; Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Lambernd S, 2012, DIABETOLOGIA, V55, P1128, DOI 10.1007/s00125-012-2454-z; MacDonald C, 2003, J APPL PHYSIOL, V95, P2273, DOI 10.1152/japplphysiol.00242.2003; Martin NRW, 2013, BIOMATERIALS, V34, P5759, DOI 10.1016/j.biomaterials.2013.04.002; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nikolic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033203; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Player DJ, 2014, BIOTECHNOL LETT, V36, P1113, DOI 10.1007/s10529-014-1464-y; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Robinson M, 2010, SCAND J MED SCI SPOR, V20, P282, DOI 10.1111/j.1600-0838.2009.00895.x; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Sharples AP, 2012, AGING CELL, V11, P986, DOI 10.1111/j.1474-9726.2012.00869.x; Sorensen B, 2003, J ALLERGY CLIN IMMUN, V112, P397, DOI 10.1067/mai.2003.1615; VANDERVEN PFM, 1992, CELL TISSUE RES, V270, P189, DOI 10.1007/BF00381893; Wang CZ, 2010, J APPL PHYSIOL, V109, P840, DOI 10.1152/japplphysiol.00115.2010; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299	38	51	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122982	10.1371/journal.pone.0122982	http://dx.doi.org/10.1371/journal.pone.0122982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836975	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000119
J	Chu, C; Lagercrantz, H; Forssberg, H; Nagy, Z				Chu, Carlton; Lagercrantz, Hugo; Forssberg, Hans; Nagy, Zoltan			Investigating the Use of Support Vector Machine Classification on Structural Brain Images of Preterm-Born Teenagers as a Biological Marker	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BIRTH-WEIGHT; BEHAVIORAL OUTCOMES; ADOLESCENTS; TERM; AGE; CHILDREN; INFANTS; MATURATION; PATTERNS	Preterm birth has been shown to induce an altered developmental trajectory of brain structure and function. With the aid support vector machine (SVM) classification methods we aimed to investigate whether MRI data, collected in adolescence, could be used to predict whether an individual had been born preterm or at term. To this end we collected T1-weighted anatomical MRI data from 143 individuals (69 controls, mean age 14.6y). The inclusion criteria for those born preterm were birth weight <= 1500g and gestational age < 37w. A linear SVM was trained on the grey matter segment of MR images in two different ways. First, all the individuals were used for training and classification was performed by the leave-one-out method, yielding 93% correct classification (sensitivity = 0.905, specificity = 0.942). Separately, a random half of the available data were used for training twice and each time the other, unseen, half of the data was classified, resulting 86% and 91% accurate classifications. Both gestational age (R = -0.24, p < 0.04) and birth weight (R = -0.51, p < 0.001) correlated with the distance to decision boundary within the group of individuals born preterm. Statistically significant correlations were also found between IQ (R = -0.30, p < 0.001) and the distance to decision boundary. Those born small for gestational age did not form a separate subgroup in these analyses. The high rate of correct classification by the SVM motivates further investigation. The long-term goal is to automatically and non-invasively predict the outcome of preterm-born individuals on an individual basis using as early a scan as possible.	[Chu, Carlton] DeepMind Technol Ltd, London, England; [Lagercrantz, Hugo; Forssberg, Hans] Karolinska Inst, Lab Social & Neural Syst Res, Stockholm, Sweden; [Nagy, Zoltan] Univ Zurich, Lab Social & Neural Syst Res, Zurich, Switzerland; [Nagy, Zoltan] UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England	Karolinska Institutet; University of Zurich; University of London; University College London	Nagy, Z (corresponding author), Univ Zurich, Lab Social & Neural Syst Res, Zurich, Switzerland.	zoltan.nagy@uz.ch	Forssberg, Hans/A-2944-2009; Nagy, Zoltan/AAI-2485-2019	Nagy, Zoltan/0000-0001-6611-6362; Forssberg, Hans/0000-0003-2069-6618	Sallskapet Barnavard (Sweden); Swedish Research Council, the Bank of Sweden Tercentenary Foundation; Wellcome Trust [079866/Z/06/Z]	Sallskapet Barnavard (Sweden); Swedish Research Council, the Bank of Sweden Tercentenary Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding support was provided by Sallskapet Barnavard (Sweden), the Swedish Research Council, the Bank of Sweden Tercentenary Foundation and the Wellcome Trust (079866/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DeepMind Technologies Ltd., provided support in the form of salary for author Carlton Chu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ameye L, 2005, C P IEEE ENG MED BIO, P54622; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bohm B, 2002, DEV MED CHILD NEUROL, V44, P508; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Cristianini N, 2000, INTRO SUPPORT VECTOR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Erus G., 2014, CEREB CORTEX; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fenton TR, 2003, BMC PEDIATR, P313; Franke K, 2012, NEUROIMAGE, V63, P1305, DOI 10.1016/j.neuroimage.2012.08.001; Gaonkar B, 2013, NEUROIMAGE, V78, P270, DOI 10.1016/j.neuroimage.2013.03.066; Gressens P, 2002, J PEDIATR-US, V140, P646, DOI 10.1067/mpd.2002.123214; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Huppi PS, 1998, PEDIATR RES, V44, P584; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; KATZSALAMON M, 1997, ACTA PAEDIAT S419, V86, P1; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Murphy BP, 2001, PEDIATRICS, V107, P217, DOI 10.1542/peds.107.2.217; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Precup D, 2012, IEEE ENG MED BIO, P5630, DOI 10.1109/EMBC.2012.6347271; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Ullman H, 2014, J NEUROSCI, V34, P1592, DOI 10.1523/JNEUROSCI.0842-13.2014; Van Reempts P, 2007, PEDIATRICS, V120, pe815, DOI 10.1542/peds.2006-3122; Vapnik V.N., 1995, NATURE STAT LEARNING; Yung A, 2007, PEDIATR RES, V61, P732, DOI 10.1203/pdr.0b013e31805365db	41	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123108	10.1371/journal.pone.0123108	http://dx.doi.org/10.1371/journal.pone.0123108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837791	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000127
J	Forleo, C; Carmosino, M; Resta, N; Rampazzo, A; Valecce, R; Sorrentino, S; Iacoviello, M; Pisani, F; Procino, G; Gerbino, A; Scardapane, A; Simone, C; Calore, M; Torretta, S; Svelto, M; Favale, S				Forleo, Cinzia; Carmosino, Monica; Resta, Nicoletta; Rampazzo, Alessandra; Valecce, Rosanna; Sorrentino, Sandro; Iacoviello, Massimo; Pisani, Francesco; Procino, Giuseppe; Gerbino, Andrea; Scardapane, Arnaldo; Simone, Cristiano; Calore, Martina; Torretta, Silvia; Svelto, Maria; Favale, Stefano			Clinical and Functional Characterization of a Novel Mutation in Lamin A/C Gene in a Multigenerational Family with Arrhythmogenic Cardiac Laminopathy	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; SUDDEN-DEATH; ATRIOVENTRICULAR-BLOCK; LMNA GENE; APOPTOSIS; DISEASE; CARDIOMYOCYTES; ARRHYTHMIAS; PHENOTYPE	Mutations in the lamin A/C gene (LMNA) were associated with dilated cardiomyopathy (DCM) and, recently, were related to severe forms of arrhythmogenic right ventricular cardiomyopathy (ARVC). Both genetic and phenotypic overlap between DCM and ARVC was observed; molecular pathomechanisms leading to the cardiac phenotypes caused by LMNA mutations are not yet fully elucidated. This study involved a large Italian family, spanning 4 generations, with arrhythmogenic cardiomyopathy of different phenotypes, including ARVC, DCM, system conduction defects, ventricular arrhythmias, and sudden cardiac death. Mutation screening of LMNA and ARVC-related genes PKP2, DSP, DSG2, DSC2, JUP, and CTNNA3 was performed. We identified a novel heterozygous mutation (c.418_438dup) in LMNA gene exon 2, occurring in a highly conserved protein domain across several species. This newly identified variant was not found in 250 ethnically-matched control subjects. Genotype-phenotype correlation studies suggested a co-segregation of the LMNA mutation with the disease phenotype and an incomplete and age-related penetrance. Based on clinical, pedigree, and molecular genetic data, this mutation was considered likely disease-causing. To clarify its potential pathophysiologic impact, functional characterization of this LMNA mutant was performed in cultured cardiomyocytes expressing EGFP-tagged wild-type and mutated LMNA constructs, and indicated an increased nuclear envelope fragility, leading to stress-induced apoptosis as the main pathogenetic mechanism. This study further expands the role of the LMNA gene in the pathogenesis of cardiac laminopathies, suggesting that LMNA should be included in mutation screening of patients with suspected arrhythmogenic cardiomyopathy, particularly when they have ECG evidence for conduction defects. The combination of clinical, genetic, and functional data contribute insights into the pathogenesis of this form of life-threatening arrhythmogenic cardiac laminopathy.	[Forleo, Cinzia; Valecce, Rosanna; Sorrentino, Sandro; Iacoviello, Massimo; Favale, Stefano] Univ Bari, Dept Emergency & Organ Transplantat, Cardiol Unit, Bari, Italy; [Carmosino, Monica; Pisani, Francesco; Procino, Giuseppe; Gerbino, Andrea; Torretta, Silvia; Svelto, Maria] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Resta, Nicoletta; Simone, Cristiano] Univ Bari, Dept Biomed Sci & Human Oncol, Med Genet Sect, Bari, Italy; [Rampazzo, Alessandra; Calore, Martina] Univ Padua, Dept Biol, Padua, Italy; [Scardapane, Arnaldo] Univ Bari, Interdisciplinary Dept Med, Sect Radiol, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Padua; Universita degli Studi di Bari Aldo Moro	Forleo, C (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Cardiol Unit, Bari, Italy.	cinzia.forleo@uniba.it; monica.carmosino@uniba.it	PISANI, Francesco/AAC-1749-2019; Rampazzo, Alessandra/AAD-5936-2022; Resta, Nicoletta/I-8424-2018; Calore, Martina/B-3602-2018; Simone, Cristiano/K-3452-2018; Iacoviello, Massimo/AAW-4962-2021; Gerbino, Andrea/Y-6526-2018; Carmosino, Monica/O-2594-2014	PISANI, Francesco/0000-0001-8511-117X; Resta, Nicoletta/0000-0001-8640-5532; Calore, Martina/0000-0003-4751-1476; Simone, Cristiano/0000-0002-2628-7658; Iacoviello, Massimo/0000-0001-9613-5062; Gerbino, Andrea/0000-0002-2839-0130; Carmosino, Monica/0000-0001-7600-8816; Svelto, Maria/0000-0002-5584-9541; Torretta, Silvia/0000-0002-9060-7628; favale, stefano/0000-0002-9833-9576; Forleo, Cinzia/0000-0002-9452-4037; Procino, Giuseppe/0000-0002-0043-7523	Italian Ministry of University, Scientific and Technical Research [ORBA1085M0]; Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica [RBRN07BMCT_009]	Italian Ministry of University, Scientific and Technical Research; Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by the Italian Ministry of University, Scientific and Technical Research (grant number ORBA1085M0 to SF), and by Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica (grant number RBRN07BMCT_009 to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme F, 2013, HEART RHYTHM, V10, P1492, DOI [10.1016/j.hrthm.2013.06.020, 10.1016/j.hrthm.2013.06020]; Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Arbustini E, 2013, J AM COLL CARDIOL, V62, P2046, DOI 10.1016/j.jacc.2013.08.1644; Basso C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1233, DOI 10.1161/CIRCEP.111.962035; Basso C, 2012, NAT REV CARDIOL, V9, P223, DOI 10.1038/nrcardio.2011.173; Bauce B, 2010, HEART RHYTHM, V7, P22, DOI 10.1016/j.hrthm.2009.09.070; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; Carmosino M, 2014, BIOL CELL, V106, P346, DOI 10.1111/boc.201400033; Cattin ME, 2013, CURR OPIN CARDIOL, V28, P297, DOI 10.1097/HCO.0b013e32835f0c79; Cerrone M, 2012, CARDIOVASC RES, V95, P460, DOI 10.1093/cvr/cvs218; Charron P, 2010, EUR HEART J, V31, P2715, DOI 10.1093/eurheartj/ehq271; Davidson PM, 2014, TRENDS CELL BIOL, V24, P247, DOI 10.1016/j.tcb.2013.11.004; De Backer J, 2010, INT J CARDIOL, V138, P97, DOI 10.1016/j.ijcard.2008.06.008; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fernandez X, 2008, INT J CARDIOL, V126, P136, DOI 10.1016/j.ijcard.2007.01.072; Forissier JF, 2003, EUR J HEART FAIL, V5, P821, DOI 10.1016/S1388-9842(03)00149-1; Hasselberg NE, 2014, EUROPACE, V16, P563, DOI 10.1093/europace/eut291; Hermida-Prieto M, 2004, AM J CARDIOL, V94, P50, DOI 10.1016/j.amjcard.2004.03.029; Holmstrom M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-30; JAMES TN, 1994, CIRCULATION, V90, P556, DOI 10.1161/01.CIR.90.1.556; Jovanovic S, 2006, BIOCHEM BIOPH RES CO, V341, P57, DOI 10.1016/j.bbrc.2005.12.147; Mallat Z, 1996, NEW ENGL J MED, V335, P1190, DOI 10.1056/NEJM199610173351604; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Millat G, 2011, EUR J MED GENET, V54, pE570, DOI 10.1016/j.ejmg.2011.07.005; Millat G, 2009, CLIN BIOCHEM, V42, P892, DOI 10.1016/j.clinbiochem.2009.01.016; Nerheim Pamela, 2001, Cardiology Clinics, V19, P155, DOI 10.1016/S0733-8651(05)70201-0; Quarta G, 2012, EUR HEART J, V33, P1128, DOI 10.1093/eurheartj/ehr451; Sen-Chowdhry S, 2012, CIRCULATION, V125, P1563, DOI 10.1161/CIRCULATIONAHA.111.025528; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Tesson F, 2014, CARDIOL J, V21, P331, DOI 10.5603/CJ.a2014.0037; Tilgner K, 2009, J CELL SCI, V122, P401, DOI 10.1242/jcs.026179; Valente M, 1998, AM J PATHOL, V152, P479; Valtuille L, 2013, INT J CARDIOL, V168, P4325, DOI 10.1016/j.ijcard.2013.04.177; van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1; van der Zwaag PA, 2012, EUR J HEART FAIL, V14, P1199, DOI 10.1093/eurjhf/hfs119; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; van Tintelen JP, 2007, J AM COLL CARDIOL, V49, P2430, DOI 10.1016/j.jacc.2007.02.063; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Wright AR, 1998, PHARMACOL THERAPEUT, V80, P89, DOI 10.1016/S0163-7258(98)00025-4; Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079	45	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121723	10.1371/journal.pone.0121723	http://dx.doi.org/10.1371/journal.pone.0121723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837155	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000059
J	Han, YQ; Lei, WB; Wen, LZ; Hou, ML				Han, Yongqiang; Lei, Wenbin; Wen, Lizhang; Hou, Maolin			Silicon-Mediated Resistance in a Susceptible Rice Variety to the Rice Leaf Folder, Cnaphalocrocis medinalis Guenee (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							BORER ELDANA-SACCHARINA; ENHANCES RESISTANCE; WALKER LEPIDOPTERA; LEAFFOLDER; SUGARCANE; MECHANISMS; RESPONSES; ACCUMULATION; PHYTOALEXINS; PERFORMANCE	The rice leaf folder, Cnaphalocrocis medinalis (Guenee), is one of the most destructive rice pests in Asian countries. Rice varieties resistant to the rice leaf folder are generally characterized by high silicon content. In this study, silicon amendment, at 0.16 and 0.32 g Si/kg soil, enhanced resistance of a susceptible rice variety to the rice leaf folder. Silicon addition to rice plants at both the low and high rates significantly extended larval development and reduced larval survival rate and pupation rate in the rice leaf folder. When applied at the high rate, silicon amendment reduced third-instars' weight gain and pupal weight. Altogether, intrinsic rate of increase, finite rate of increase and net reproduction rate of the rice leaf folder population were all reduced at both the low and high silicon addition rates. Although the third instars consumed more in silicon-amended treatments, C:N ratio in rice leaves was significantly increased and food conversion efficiencies were reduced due to increased silicon concentration in rice leaves. Our results indicate that reduced food quality and food conversion efficiencies resulted from silicon addition account for the enhanced resistance in the susceptible rice variety to the rice leaf folder.	[Han, Yongqiang; Wen, Lizhang] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Han, Yongqiang; Lei, Wenbin; Hou, Maolin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wen, LZ (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.	weninsect123@yahoo.com.cn; mlhou@ippcaas.cn			National Natural Science Foundation of China [31371951]; Ministry of Science and Technology of China [2012BAD19B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was financially supported by National Natural Science Foundation of China (31371951) and a grant from Ministry of Science and Technology of China (2012BAD19B03) to MLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2001, CROP PROT, V20, P43, DOI 10.1016/S0261-2194(00)00051-X; Bezemer TM, 1998, OIKOS, V82, P212, DOI 10.2307/3546961; Brunings AM, 2009, ANN APPL BIOL, V155, P161, DOI 10.1111/j.1744-7348.2009.00347.x; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Chi H, 1997, COMPUTER PROGRAM FOR; Dai WM, 2005, CROP SCI, V45, P1345, DOI 10.2135/cropsci2004.0505; Dallagnol LJ, 2013, PLANT PATHOL, V62, P120, DOI 10.1111/j.1365-3059.2012.02606.x; DJAMIN A, 1967, J ECON ENTOMOL, V60, P347, DOI 10.1093/jee/60.2.347; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fauteux F, 2006, P NATL ACAD SCI USA, V103, P17554, DOI 10.1073/pnas.0606330103; Fawe A, 1998, PHYTOPATHOLOGY, V88, P396, DOI 10.1094/PHYTO.1998.88.5.396; [韩永强 Han Yongqiang], 2010, [生态学报, Acta Ecologica Sinica], V30, P5967; HANIFA AM, 1974, INDIAN J EXP BIOL, V12, P463; [郝丽霞 HAO LiXia], 2008, [生态学报, Acta Ecologica Sinica], V28, P5987; Heong KL, 1993, P INT WORKSH EC THRE, P8; Hou ML, 2010, J ECON ENTOMOL, V103, P1412, DOI 10.1603/EC09341; Islam Z, 1997, CROP PROT, V16, P215, DOI 10.1016/S0261-2194(96)00101-9; Keeping MG, 2002, AGR FOREST ENTOMOL, V4, P265, DOI 10.1046/j.1461-9563.2002.00150.x; Keeping MG, 2006, J APPL ENTOMOL, V130, P410, DOI 10.1111/j.1439-0418.2006.01081.x; KHAN ZR, 1989, ENTOMOL EXP APPL, V52, P7, DOI 10.1007/BF00163936; KHAN ZR, 1988, INSECT SCI APPL, V9, P129, DOI 10.1017/S1742758400005919; Kvedaras OL, 2007, B ENTOMOL RES, V97, P175, DOI 10.1017/S0007485307004853; Kvedaras OL, 2007, ENTOMOL EXP APPL, V125, P103, DOI 10.1111/j.1570-7458.2007.00604.x; Kvedaras OL, 2010, B ENTOMOL RES, V100, P367, DOI 10.1017/S0007485309990265; Laing M, 2005, P 3 SIL AGR C FED U, P41; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Li Xia, 2013, Acta Ecologica Sinica, V33, P4370; Liang YC, 2003, J PLANT PHYSIOL, V160, P1157, DOI 10.1078/0176-1617-01065; Ma J.F, 2001, SILICON AGR, V8, P17, DOI 10.1016/S0928-3420(01)80006-9; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2002, SOIL FERTILIZER AND; Ma TS, 1997, CHINESE J SOIL SCI, V28, P169; Massey FP, 2009, J ANIM ECOL, V78, P281, DOI 10.1111/j.1365-2656.2008.01472.x; Massey FP, 2006, J ANIM ECOL, V75, P595, DOI 10.1111/j.1365-2656.2006.01082.x; Mishra N. C., 1992, Indian Journal of Entomology, V54, P190; NAKANO K., 1961, Japanese Journal of Applied Entomology and Zoology, V5, P17, DOI 10.1303/jjaez.5.17; Padmavathi C, 2013, J APPL ENTOMOL, V137, P249, DOI 10.1111/j.1439-0418.2012.01741.x; Panzuto M, 2002, J CHEM ECOL, V28, P145, DOI 10.1023/A:1013571020783; PETERSON SS, 1988, J KANSAS ENTOMOL SOC, V61, P169; RAMACHANDRAN R, 1991, J CHEM ECOL, V17, P41, DOI 10.1007/BF00994421; Remus-Borel W, 2005, PHYSIOL MOL PLANT P, V66, P108, DOI 10.1016/j.pmpp.2005.05.006; Rodrigues FA, 2004, PHYTOPATHOLOGY, V94, P177, DOI 10.1094/PHYTO.2004.94.2.177; SALIM M, 1992, CROP SCI, V32, P212, DOI 10.2135/cropsci1992.0011183X003200010044x; Sangster A. G., 2001, SILICON AGR, V8, P85, DOI DOI 10.1016/S0928-3420(01)80009-4; Savant NK, 1997, ADV AGRON, V58, P151; Sidhu JK, 2013, B ENTOMOL RES, V103, P656, DOI 10.1017/S0007485313000369; Snyder GH., 2001, STUD PLANT SCI, P185, DOI [10.1016/S0928-3420(01)80015-X, DOI 10.1016/S0928-3420(01)80015-X]; SPSS Inc, 2004, SPSS 13 0 FOR WINDOW; Sudhakar GK, 1991, J ENTOMOL RES, V152, P79; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wang Feng-ying, 2009, Zhongguo Shuidao Kexue, V23, P537, DOI 10.3969/j.issn.1001-7216.2009.05.14; Wang Qi-Xiang, 2008, Acta Entomologica Sinica, V51, P1265; Wang XZ, 2002, PRINCIPLES AND METHO; Xu HongXing, 2006, Acta Phytophylacica Sinica, V33, P241; Xu J, 2010, J ECON ENTOMOL, V103, P1166, DOI 10.1603/EC09265; Ye M, 2013, P NATL ACAD SCI USA, V110, pE3631, DOI 10.1073/pnas.1305848110; Zhang Guo-Liang, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P600	58	68	84	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120557	10.1371/journal.pone.0120557	http://dx.doi.org/10.1371/journal.pone.0120557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837635	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000024
J	Lobo, JM; Dicker, AP; Buerki, C; Daviconi, E; Karnes, RJ; Jenkins, RB; Patel, N; Den, RB; Showalter, TN				Lobo, Jennifer Mason; Dicker, Adam P.; Buerki, Christine; Daviconi, Elai; Karnes, R. Jeffrey; Jenkins, Robert B.; Patel, Nirav; Den, Robert B.; Showalter, Timothy N.			Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis	PLOS ONE			English	Article							POSTPROSTATECTOMY RADIATION-THERAPY; RADICAL PROSTATECTOMY; ADJUVANT RADIOTHERAPY; COST-EFFECTIVENESS; POSTOPERATIVE RADIOTHERAPY; SALVAGE RADIOTHERAPY; BREAST-CANCER; RISK; TRIAL; MEN	Background Currently there is controversy surrounding the optimal way to treat patients with prostate cancer in the post-prostatectomy setting. Adjuvant therapies carry possible benefits of improved curative results, but there is uncertainty in which patients should receive adjuvant therapy. There are concerns about giving toxicity to a whole population for the benefit of only a subset. We hypothesized that making post-prostatectomy treatment decisions using genomics-based risk prediction estimates would improve cancer and quality of life outcomes. Methods We developed a state-transition model to simulate outcomes over a 10 year horizon for a cohort of post-prostatectomy patients. Outcomes included cancer progression rates at 5 and 10 years, overall survival, and quality-adjusted survival with reductions for treatment, side effects, and cancer stage. We compared outcomes using population-level versus individual-level risk of cancer progression, and for genomics-based care versus usual care treatment recommendations. Results Cancer progression outcomes, expected life-years (LYs), and expected quality-adjusted life-years (QALYs) were significantly different when individual genomics-based cancer progression risk estimates were used in place of population-level risk estimates. Use of the genomic classifier to guide treatment decisions provided small, but statistically significant, improvements in model outcomes. We observed an additional 0.03 LYs and 0.07 QALYs, a 12% relative increase in the 5-year recurrence-free survival probability, and a 4% relative reduction in the 5-year probability of metastatic disease or death. Conclusions The use of genomics-based risk prediction to guide treatment decisions may improve outcomes for prostate cancer patients. This study offers a framework for individualized decision analysis, and can be extended to incorporate a wide range of personal attributes to enable delivery of patient-centered tools for informed decision-making.	[Lobo, Jennifer Mason] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Dicker, Adam P.; Den, Robert B.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Dicker, Adam P.; Den, Robert B.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Buerki, Christine; Daviconi, Elai] GenomeDx Biosci, Vancouver, BC, Canada; [Karnes, R. Jeffrey] Mayo Clin, Dept Urol, Rochester, MN USA; [Jenkins, Robert B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Patel, Nirav; Showalter, Timothy N.] Univ Virginia, Sch Med, Dept Radiat Oncol, Charlottesville, VA 22908 USA	University of Virginia; Jefferson University; Jefferson University; GenomeDx Biosciences; Mayo Clinic; Mayo Clinic; University of Virginia	Lobo, JM (corresponding author), Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA.	jem4yb@virginia.edu	Lobo, Jennifer/AAK-6713-2021	Den, Robert/0000-0002-8653-1763; Dicker, Adam/0000-0003-0733-3337; Showalter, Timothy/0000-0003-1373-8496	GenomeDx Biosciences; Prostate Cancer Foundation Young Investigator Award; American Society for Radiation Oncology Comparative Effectiveness Research Award	GenomeDx Biosciences; Prostate Cancer Foundation Young Investigator Award; American Society for Radiation Oncology Comparative Effectiveness Research Award	This work was supported by a research grant from GenomeDx Biosciences (genomedx.com/), as well as by a 2011 Prostate Cancer Foundation Young Investigator Award (T.N.S.; www.pcf.org/) and an American Society for Radiation Oncology Comparative Effectiveness Research Award (T.N.S.; www.astro.org). GenomeDx Biosciences provided support in the form of salaries for authors CB and ED, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Badani K, 2013, ONCOTARGET, V4, P600, DOI 10.18632/oncotarget.918; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Basu A, 2007, MED DECIS MAKING, V27, P112, DOI 10.1177/0272989X06297393; Basu A, 2009, MED DECIS MAKING, V29, pNP9, DOI 10.1177/0272989X09351586; Blohmer J U, 2013, J Med Econ, V16, P30, DOI 10.3111/13696998.2012.722572; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Boorjian SA, 2012, J UROLOGY, V188, P1761, DOI 10.1016/j.juro.2012.07.037; Cowen ME, 1998, MED DECIS MAKING, V18, P376, DOI 10.1177/0272989X9801800404; Crawford ED, 2014, ONCOLOGY-NY, V28, P135; Den RB, 2014, INT J RADIAT ONCOL, V89, P1038, DOI 10.1016/j.ijrobp.2014.04.052; Efstathiou JA, 2012, LANCET, V380, P1974, DOI 10.1016/S0140-6736(12)61608-0; Elkin EB, 2004, MED DECIS MAKING, V24, P504, DOI 10.1177/0272989X04268954; Elliott SP, 2011, PROSTATE CANCER P D, V14, P270, DOI 10.1038/pcan.2011.27; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Ghia AJ, 2010, UROLOGY, V76, P1169, DOI 10.1016/j.urology.2010.04.047; Goddard KAB, 2012, GENET MED, V14, P633, DOI 10.1038/gim.2012.16; Grossfeld GD, 1998, J UROLOGY, V160, P1398, DOI 10.1016/S0022-5347(01)62548-5; Hall PS, 2012, JNCI-J NATL CANCER I, V104, P56, DOI 10.1093/jnci/djr484; Hayes JH, 2010, JAMA-J AM MED ASSOC, V304, P2373, DOI 10.1001/jama.2010.1720; Hoffman KE, 2011, J UROLOGY, V185, P116, DOI 10.1016/j.juro.2010.08.086; Hornberger J, 2012, VALUE HEALTH, V15, P1014, DOI 10.1016/j.jval.2012.07.012; Karnes RJ, 2013, J UROLOGY, V190, P2047, DOI 10.1016/j.juro.2013.06.017; Konety BR, 2008, J UROLOGY, V179, P1797, DOI 10.1016/j.juro.2008.01.044; Konski A, 2006, INT J RADIAT ONCOL, V66, P408, DOI 10.1016/j.ijrobp.2006.04.049; Krupski TL, 2007, J UROLOGY, V178, P1423, DOI 10.1016/j.juro.2007.05.135; Mishra MV, 2011, FUTURE ONCOL, V7, P1429, DOI [10.2217/FON.11.120, 10.2217/fon.11.120]; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Nielsen ME, 2010, J NATL COMPR CANC NE, V8, P228, DOI 10.6004/jnccn.2010.0015; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Showalter TN, 2011, INT J RAD ONCOL BIOL; Simonds NI, 2013, JNCI-J NATL CANCER I, V105, P929, DOI 10.1093/jnci/djt108; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stewart ST, 2005, MED CARE, V43, P347, DOI 10.1097/01.mlr.0000156862.33341.45; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Valicenti RK, 2013, INT J RADIAT ONCOL, V86, P822, DOI 10.1016/j.ijrobp.2013.05.029; Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563	42	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0116866	10.1371/journal.pone.0116866	http://dx.doi.org/10.1371/journal.pone.0116866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837660	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000003
J	Renna, C; Salaroli, R; Cocchi, C; Cenacchi, G				Renna, Cristiano; Salaroli, Roberta; Cocchi, Claudia; Cenacchi, Giovanna			XAV939-Mediated ARTD Activity Inhibition in Human MB Cell Lines	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ADP-RIBOSE POLYMERASE; NEUTRAL COMET ASSAY; BRAIN-TUMORS; THERAPEUTIC TARGET; MEDULLOBLASTOMA; RADIATION; TANKYRASE; RADIOSENSITIVITY; SURVIVORS	Diphtheria toxin-like ADP-ribosyltransferases 1 and 5 (ARTD-1, ARTD-5) are poly ADP-ribose enzymes (PARP) involved in non-homologous end-joining (NHEJ), which is the major pathway of double-strand break (DSB) repair. In addition, ARTD-5, or Tankyrase (TNKS), is a positive regulator of the WNT signaling implicated in the development and biological behavior of many neoplasms, such as Medulloblastoma (MB), in which radiotherapy is an essential part of the treatment. The use of radiosensitizing agents may improve the therapeutic index in MB patients by increasing the efficacy of radiotherapy, while reducing toxicity to the neuroaxis. ARTD-5 seems to be a good molecular target for improving the current treatment of MB. In this study, we used the small molecule XAV939, a potent ARTD-5 inhibitor with a slight affinity for ARTD-1, in different human MB cell lines. XAV939 inhibited the WNT pathway and DNA-PKcs in our MB cells, with many biological consequences. The co-administration of XAV939 and ionizing radiations (IR) inhibited MB cells proliferation and clonogenic capacity, decreased their efficacy in repairing DNA damage, and increased IR-induced cell mortality. In conclusion, our in vitro data show that XAV939 could be a very promising small molecule in MB treatment, and these results lay the basis for further in vivo studies with the aim of improving the current therapy available for MB patients.	[Renna, Cristiano; Salaroli, Roberta; Cocchi, Claudia; Cenacchi, Giovanna] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy	University of Bologna	Cenacchi, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	giovanna.cenacchi@unibo.it	Cocchi, Claudia/AAB-8902-2021	Cocchi, Claudia/0000-0002-7736-9039; CENACCHI, GIOVANNA/0000-0001-5824-3118	Bologna University RFO funds; Fondazione del Monte di Bologna e Ravenna, Italy	Bologna University RFO funds; Fondazione del Monte di Bologna e Ravenna, Italy	The work was supported by Bologna University RFO funds and Fondazione del Monte di Bologna e Ravenna (www.fondazionedelmonte.it), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasieva K, 2010, ELECTROPHORESIS, V31, P512, DOI 10.1002/elps.200900421; Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; [Anonymous], 2011, CURR PROB CANCER, V35, P7, DOI 10.1016/j.currproblcancer.2010.12.002; Banath JP, 1998, INT J RADIAT BIOL, V73, P649, DOI 10.1080/095530098141906; Baryawno N, 2010, CANCER RES, V70, P2138, DOI 10.1158/0008-5472.CAN-10-0016; Chanet F, 2010, TARGETING POLY ADP R; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Cimmino F, 2012, J NEURO-ONCOL, V106, P59, DOI 10.1007/s11060-011-0645-y; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Dregalla RC, 2010, AGING-US, V2, P691, DOI 10.18632/aging.100210; Eastham AM, 1999, BRIT J CANCER, V79, P1366, DOI 10.1038/sj.bjc.6690219; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gerber NU, 2008, ARCH DIS CHILD, V93, P582, DOI 10.1136/adc.2007.116202; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7; Guessous F, 2008, J CELL PHYSIOL, V217, P577, DOI 10.1002/jcp.21542; Holthouse DJ, 2009, NEUROPATHOLOGY, V29, P398, DOI 10.1111/j.1440-1789.2008.00989.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Krukenberg KA, 2014, CELL REP, V8, P1808, DOI 10.1016/j.celrep.2014.08.009; Kuimov AN, 2001, GENES IMMUN, V2, P52, DOI 10.1038/sj.gene.6363722; Luttjeboer M, 2010, INT J RADIAT BIOL, V86, P458, DOI 10.3109/09553000903568019; Merchant TE, 2010, SEMIN RADIAT ONCOL, V20, P58, DOI 10.1016/j.semradonc.2009.09.005; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; OBE G, 1992, MUTAGENESIS, V7, P3, DOI 10.1093/mutage/7.1.3; OLIVE PL, 1993, INT J RADIAT BIOL, V64, P349, DOI 10.1080/09553009314551531; OLIVE PL, 1995, RADIAT RES, V142, P144, DOI 10.2307/3579022; OLIVE PL, 1991, CANCER RES, V51, P4671; Olive PL, 2006, COMET ASSAY METHOD M, P675; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rydberg B, 2000, RADIAT RES, V153, P805, DOI 10.1667/0033-7587(2000)153[0805:RIHLST]2.0.CO;2; Salaroli R, 2008, J NEURO-ONCOL, V90, P243, DOI 10.1007/s11060-008-9659-5; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; van Vuurden DG, 2011, ONCOTARGET, V2, P984, DOI 10.18632/oncotarget.362; Vinchon M, 2011, CHILD NERV SYST, V27, P697, DOI 10.1007/s00381-010-1385-6; Wada S, 2003, J VET MED SCI, V65, P471, DOI 10.1292/jvms.65.471; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang Q, 2008, NEUROSCI LETT, V438, P168, DOI 10.1016/j.neulet.2008.04.012; Wojewodzka M, 2002, NUKLEONIKA, V47, P1; Wojewodzka M, 2002, MUTAT RES-GEN TOX EN, V518, P9, DOI 10.1016/S1383-5718(02)00070-0; Yamada M, 1989, No To Shinkei, V41, P695; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; ZAFFARONI N, 1994, INT J RADIAT BIOL, V66, P279, DOI 10.1080/09553009414551211	48	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0124149	10.1371/journal.pone.0124149	http://dx.doi.org/10.1371/journal.pone.0124149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835728	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000154
J	Ruggeberg, M; Burgert, I				Rueggeberg, Markus; Burgert, Ingo			Bio-Inspired Wooden Actuators for Large Scale Applications	PLOS ONE			English	Article							DYNAMIC SORPTION; PINE-CONES; BILAYER; HYGROEXPANSION; HUMIDITY	Implementing programmable actuation into materials and structures is a major topic in the field of smart materials. In particular the bilayer principle has been employed to develop actuators that respond to various kinds of stimuli. A multitude of small scale applications down to micrometer size have been developed, but up-scaling remains challenging due to either limitations in mechanical stiffness of the material or in the manufacturing processes. Here, we demonstrate the actuation of wooden bilayers in response to changes in relative humidity, making use of the high material stiffness and a good machinability to reach large scale actuation and application. Amplitude and response time of the actuation were measured and can be predicted and controlled by adapting the geometry and the constitution of the bilayers. Field tests in full weathering conditions revealed long-term stability of the actuation. The potential of the concept is shown by a first demonstrator. With the sensor and actuator intrinsically incorporated in the wooden bilayers, the daily change in relative humidity is exploited for an autonomous and solar powered movement of a tracker for solar modules.	[Rueggeberg, Markus; Burgert, Ingo] ETH, Swiss Fed Inst Technol Zurich, Inst Bldg Mat, Zurich, Switzerland; [Rueggeberg, Markus; Burgert, Ingo] Swiss Fed Las Mat Sci & Technol EMPA, Appl Wood Mat, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Ruggeberg, M (corresponding author), ETH, Swiss Fed Inst Technol Zurich, Inst Bldg Mat, Zurich, Switzerland.	mrueggeberg@ethz.ch			Empa/Marie-Curie COFUND Program; BTA flagship project of the Climate-KIC program; Wood Materials Science group at ETH Zurich; Empa by BAFU (Bundesamt fur Umwelt) and Lignum, Switzerland; Climate-KIC in the framework of the flagship project BTA (Building Technology Accelerator)	Empa/Marie-Curie COFUND Program; BTA flagship project of the Climate-KIC program; Wood Materials Science group at ETH Zurich; Empa by BAFU (Bundesamt fur Umwelt) and Lignum, Switzerland; Climate-KIC in the framework of the flagship project BTA (Building Technology Accelerator)	MR was funded by the Empa/Marie-Curie COFUND Program and within the framework of the BTA flagship project of the Climate-KIC program. IB receives supportive funding of the Wood Materials Science group at ETH Zurich and Empa by BAFU (Bundesamt fur Umwelt) and Lignum, Switzerland. The work also received funding from Climate-KIC in the framework of the flagship project BTA (Building Technology Accelerator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Bassik N, 2010, POLYMER, V51, P6093, DOI 10.1016/j.polymer.2010.10.035; Bi HC, 2013, NANOSCALE, V5, P9123, DOI 10.1039/c3nr01988h; CHOMCHARN A, 1983, WOOD SCI TECHNOL, V17, P259, DOI 10.1007/BF00349914; Cianchetti M, 2014, ACTUATORS, V3, P226, DOI 10.3390/act3030226; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; Erb RM, 2013, NATURE COMMUNICATION, P4; Hering S, 2012, WOOD SCI TECHNOL, V46, P927, DOI 10.1007/s00226-011-0449-4; Ma E, 2010, WOOD FIBER SCI, V42, P229; Menges A, 2012, ARCHIT DESIGN, V82, P52, DOI 10.1002/ad.1379; Ozyhar T, 2013, HOLZFORSCHUNG, V67, P395, DOI 10.1515/hf-2012-0089; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; Skaar C., 1988, WOOD WATER RELATION; Sreekumar M, 2007, IND ROBOT, V34, P285, DOI 10.1108/01439910710749609; Steiger R, 2009, WOOD SCI TECHNOL, V43, P259, DOI 10.1007/s00226-008-0221-6; Techawanitchai P, 2012, SOFT MATTER, V8, P2844, DOI 10.1039/c2sm07277g; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; Tzou HS, 2004, MECH ADV MATER STRUC, V11, P367, DOI 10.1080/15376490490451552; Viola EA, 2010, J PHYS CHEM C, V114, P20258, DOI 10.1021/jp106653c; Zhao Q, 2013, SOFT MATTER, V9, P1744, DOI 10.1039/c2sm27077c	21	232	255	11	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120718	10.1371/journal.pone.0120718	http://dx.doi.org/10.1371/journal.pone.0120718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835386	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000031
J	Ryan, JM; Hensey, O; McLoughlin, B; Lyons, A; Gormley, J				Ryan, Jennifer M.; Hensey, Owen; McLoughlin, Brenda; Lyons, Alan; Gormley, John			Associations of Sedentary Behaviour, Physical Activity, Blood Pressure and Anthropometric Measures with Cardiorespiratory Fitness in Children with Cerebral Palsy	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOMETABOLIC RISK; ACTIVITY INTENSITY; RT3 ACCELEROMETER; ACTIVITY LEVEL; FAT MASS; ADULTS; ADOLESCENTS; WALKING; CHILDHOOD	Background Children with cerebral palsy (CP) have poor cardiorespiratory fitness in comparison to their peers with typical development, which may be due to low levels of physical activity. Poor cardiorespiratory fitness may contribute to increased cardiometabolic risk. Purpose The aim of this study was to determine the association between sedentary behaviour, physical activity and cardiorespiratory fitness in children with CP. An objective was to determine the association between cardiorespiratory fitness, anthropometric measures and blood pressure in children with CP. Methods This study included 55 ambulatory children with CP [mean (SD) age 11.3 (0.2) yr, range 6-17 yr; Gross Motor Function Classification System (GMFCS) levels I and II]. Anthropometric measures (BMI, waist circumference and waist-height ratio) and blood pressure were taken. Cardiorespiratory fitness was measured using a 10 m shuttle run test. Children were classified as low, middle and high fitness according to level achieved on the test using reference curves. Physical activity was measured by accelerometry over 7 days. In addition to total activity, time in sedentary behaviour and light, moderate, vigorous, and sustained moderate-to-vigorous activity (>= 10 min bouts) were calculated. Results Multiple regression analyses revealed that vigorous activity (beta = 0.339, p < 0.01), sustained moderate-to-vigorous activity (beta = 0.250, p < 0.05) and total activity (beta = 0.238, p < 0.05) were associated with level achieved on the shuttle run test after adjustment for age, sex and GMFCS level. Children with high fitness spent more time in vigorous activity than children with middle fitness (p < 0.05). Shuttle run test level was negatively associated with BMI (r(2) = -0.451, p < 0.01), waist circumference (r(2) = -0.560, p < 0.001), waist-height ratio (r(2) = -0.560, p < 0.001) and systolic blood pressure (r(2) = -0.306, p < 0.05) after adjustment for age, sex and GMFCS level. Conclusions Participation in physical activity, particularly at a vigorous intensity, is associated with high cardiorespiratory fitness in children with CP. Low cardiorespiratory fitness is associated with increased cardiometabolic risk.	[Ryan, Jennifer M.; Gormley, John] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Ryan, Jennifer M.] Brunel Univ London, Inst Environm Hlth & Soc, London, England; [Hensey, Owen; McLoughlin, Brenda] Cent Remedial Clin, Dublin, Ireland; [Lyons, Alan] Enable Ireland, Dept Physiotherapy, Cork, Ireland	Trinity College Dublin; Brunel University	Ryan, JM (corresponding author), Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland.	Jennifer.Ryan@brunel.ac.uk		Gormley, John/0000-0003-4176-4122; Ryan, Jennifer/0000-0003-3768-2132				Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Capio CM, 2012, RES DEV DISABIL, V33, P1235, DOI 10.1016/j.ridd.2012.02.020; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dallmeijer AJ, 2011, DISABIL REHABIL, V33, P1351, DOI 10.3109/09638288.2010.531374; Dencker M, 2008, SCAND J MED SCI SPOR, V18, P728, DOI 10.1111/j.1600-0838.2007.00741.x; Denton SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061073; Fowler EG, 2007, PHYS THER, V87, P1495, DOI 10.2522/ptj.20060116; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Imms C, 2008, DEV MED CHILD NEUROL, V50, P363, DOI 10.1111/j.1469-8749.2008.02051.x; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Janssen I, 2007, DIABETES CARE, V30, P2143, DOI 10.2337/dc07-0734; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Klasson-Heggebo L, 2006, BRIT J SPORT MED, V40, P25, DOI 10.1136/bjsm.2004.016113; Kulinski JP, 2014, MAYO CLIN PROC, V89, P1063, DOI 10.1016/j.mayocp.2014.04.019; Kwon JH, 2011, YONSEI MED J, V52, P39, DOI 10.3349/ymj.2011.52.1.39; Maltais DB, 2005, MED SCI SPORT EXER, V37, P347, DOI 10.1249/01.MSS.0000155437.45937.82; Mc Manus V, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-50; Morrison JA, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-6; Myers R., 1990, CLASSICAL MODERN REG; Nieuwenhuijsen C, 2011, SCAND J MED SCI SPOR, V21, P535, DOI 10.1111/j.1600-0838.2009.01086.x; Opheim A, 2009, DEV MED CHILD NEUROL, V51, P381, DOI 10.1111/j.1469-8749.2008.03250.x; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Pan H, 2007, LMSGROWTH PROGRAM VE; Peterson MD, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-22; Peterson MD, 2012, ARCH PHYS MED REHAB, V93, P816, DOI 10.1016/j.apmr.2011.12.024; Ryan J, 2014, ADAPT PHYS ACT Q, V31, P310, DOI 10.1123/apaq.2013-0088; Ryan JM, 2014, PHYS THER, V94, P1144, DOI 10.2522/ptj.20130499; Ryan JM, 2014, ARCH PHYS MED REHAB, V95, P1540, DOI 10.1016/j.apmr.2014.03.029; Slaman J, 2013, ARCH PHYS MED REHAB, V94, P896, DOI 10.1016/j.apmr.2012.11.005; Stergiou GS, 2006, BLOOD PRESS MONIT, V11, P229, DOI 10.1097/01.mbp.0000209074.38331.16; Stevens SL, 2010, ARCH PHYS MED REHAB, V91, P1891, DOI 10.1016/j.apmr.2010.08.015; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Unnithan VB, 1998, SPORTS MED, V26, P239, DOI 10.2165/00007256-199826040-00003; Van den Berg-Emons RJ, 1998, INT J REHABIL RES, V21, P179, DOI 10.1097/00004356-199806000-00006; Vanhelst J, 2010, J SPORT SCI, V28, P381, DOI 10.1080/02640410903508821; Verschuren O, 2007, ARCH PEDIAT ADOL MED, V161, P1075, DOI 10.1001/archpedi.161.11.1075; Verschuren O, 2006, PHYS THER, V86, P1107, DOI 10.1093/ptj/86.8.1107; Verschuren O, 2012, J PEDIATR-US, V161, P488, DOI 10.1016/j.jpeds.2012.02.042; Verschuren O, 2010, RES DEV DISABIL, V31, P1352, DOI 10.1016/j.ridd.2010.07.005; Verschuren O, 2010, PHYS THER, V90, P1148, DOI 10.2522/ptj.20090318; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]	42	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123267	10.1371/journal.pone.0123267	http://dx.doi.org/10.1371/journal.pone.0123267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835955	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000135
J	Wojczewski, S; Willcox, M; Mubangizi, V; Hoffmann, K; Peersman, W; Niederkrotenthaler, T; Natukunda, S; Maling, S; Maier, M; Mant, D; Kutalek, R				Wojczewski, Silvia; Willcox, Merlin; Mubangizi, Vincent; Hoffmann, Kathryn; Peersman, Wim; Niederkrotenthaler, Thomas; Natukunda, Silvia; Maling, Samuel; Maier, Manfred; Mant, David; Kutalek, Ruth			Portrayal of the Human Resource Crisis and Accountability in Healthcare: A Qualitative Analysis of Ugandan Newspapers	PLOS ONE			English	Article							PRINT MEDIA; MIGRATION; AFRICA; POLICY	Background Uganda is one of the 57 countries with a critical shortage of health workers. The aim of this study was to determine how the human resources and health service crisis was covered in Ugandan newspapers and, in particular, how the newspapers attributed accountability for problems in the health services. Methods We collected all articles related to health workers and health services for the calendar year 2012 in the two largest national newspapers in Uganda (collection on daily basis) and in one local newspaper (collection on weekly basis). These articles were analysed qualitatively regarding the main themes covered and attribution of accountability. Results The two more urban national newspapers published 229 articles on human resources and health services in Uganda (on average over two articles per week), whereas the local more rural newspaper published only a single article on this issue in the 12 month period. The majority of articles described problems in the health service without discussing accountability. The question of accountability is raised in only 46% of articles (106 articles). The responsibility of the government was discussed in 50 articles (21%), and negligence, corruption and misbehaviour by individual health workers was reported in 56 articles (25%). In the articles about corruption (n=35), 60% (21 articles) mention corruption by health workers and 40% (14 articles) mention corruption by government officials. Six articles defended the situation of health workers in Uganda. Conclusions The coverage of accountability in the Ugandan newspapers surveyed is insufficient to generate informed debate on what political actions need to be taken to improve the crisis in health care and services. There exists not only an "inverse care law" but also an "inverse information law": those sections of society with the greatest health needs and problems in accessing quality health care receive the least information about health services.	[Wojczewski, Silvia; Hoffmann, Kathryn; Maier, Manfred; Kutalek, Ruth] Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice & Family Med, Vienna, Austria; [Willcox, Merlin; Mant, David] Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Mubangizi, Vincent; Natukunda, Silvia; Maling, Samuel] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Peersman, Wim] Univ Ghent, Dept Family Med & Primary Healthcare, Univ Hosp, B-9000 Ghent, Belgium; [Niederkrotenthaler, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Social Med, Vienna, Austria	Medical University of Vienna; University of Oxford; Mbarara University of Science & Technology; Ghent University; Ghent University Hospital; Medical University of Vienna	Kutalek, R (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice & Family Med, Vienna, Austria.	ruth.kutalek@meduniwien.ac.at	Willcox, Merlin/I-6255-2019; Peersman, Wim/K-3576-2019; Hoffmann, Kathryn/AAK-9099-2021	Willcox, Merlin/0000-0002-5227-3444; Peersman, Wim/0000-0002-4276-7408; Niederkrotenthaler, Thomas/0000-0001-9550-628X; Hoffmann, Kathryn/0000-0001-8760-4250; Wojczewski, Silvia/0000-0002-0065-7550	European Union's Seventh Framework Programme [265727]	European Union's Seventh Framework Programme	The research leading to these results was done in the framework of the HURAPRIM project which received funding from the European Union's Seventh Framework Programme (FP7 -AFRICA-2010) under grant agreement no 265727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ORUMURI NEWSPAPER IN; Ayebazibwe A, 2013, 2 000 DOCTORS LEAVE; BBC, 2013, UGANDAS DAILY MONITO; BBC Media Action, 2012, COUNTRY CASE STUDY U; Berridge V, 2005, MEDICINE THE MARKET; Blacklock C, 2014, SOC SCI MED, V100, P99, DOI 10.1016/j.socscimed.2013.10.032; Blacklock C, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-35; Bouchard M, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-5; Browne K, 2005, AN INTRODUCTION TO S; CDC. Centre for Disease Control and Prevention, 2012, CDCS VISION FOR PUBL; Chibita M, 2012, ASSESSING THE MEDIA; Clarke CE, 2011, PUBLIC UNDERST SCI, V20, P609, DOI 10.1177/0963662509359490; Clemens MA, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-1; Collins PA, 2006, SOC SCI MED, V63, P89, DOI 10.1016/j.socscimed.2005.12.012; Eaton L, 2005, BRIT MED J, V331, P718, DOI 10.1136/bmj.331.7519.718; Fennig Charles D, 2014, ETHNOLOGUE LANGUAGES, VSeventeenth; GHWA; Global Health Workforce Alliance, 2011, REVIEWING PROGRESS R; Gibbs GR, 2008, ANALYSING QUALITATIV; Gough B, 2007, SOC SCI MED, V64, P326, DOI 10.1016/j.socscimed.2006.09.011; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hayes M, 2007, SOC SCI MED, V64, P1842, DOI 10.1016/j.socscimed.2007.01.015; Hennink M, 2013, QUALITATIVE RESEARCH; Human Rights Watch, 2013, LETTING THE BIG FISH; Hunt J, 2010, J HEALTH ECON, V29, P699, DOI 10.1016/j.jhealeco.2010.06.004; Intermedia, 2010, NEWSPRINT IN UGANDA; Intrahealth, 2013, SURG NEW RECR UG HLT; Justesen MK, 2014, WORLD DEV, V58, P106, DOI 10.1016/j.worlddev.2014.01.002; Kaye DK., 2011, J MEDIA COMMUN STUD, V3, P112; Kelle U, 1999, VOM EINZELFALL ZUM T; Le Pelley M, 2012, THE FIRST HOMEGROWN; Levey NN, 2013, JAMA-J AM MED ASSOC, V310, P1941, DOI 10.1001/jama.2013.281852; Masselink LE, 2013, HEALTH POLICY PLANN, V28, P90, DOI 10.1093/heapol/czs028; McQuail D, 2008, MASS COMMUNICATION T; Moosa S, 2013, LANCET GLOB HEALTH, V1, pE332, DOI 10.1016/S2214-109X(13)70119-0; Mugisa A, 2012, UGANDA NEW VISION BU; Mulumba D, 2009, POLICY ANALYSIS REPO; Muzyka CN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-465; Niederkrotenthaler T, 2009, EUR J PUBLIC HEALTH, V19, P361, DOI 10.1093/eurpub/ckp034; Paredes-Solis S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S12; Poppe A, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24071; Riffe D., 2005, ANALYZING MEDIA MESS; Ruhweza Katahoire A, 2009, FROM PAPER TO MIKE 2; Seale C, 2003, SOCIOL HEALTH ILL, V25, P513, DOI 10.1111/1467-9566.t01-1-00356; Sekyewa R, 2013, UGANDA INTERNET UNDE; Uganda Khamalwa J., 2006, RESEARCH FINDINGS AN; WHO, 2006, WORK TOG HLTH; World Bank, 2012, INTERNET USERS PER 1	47	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121766	10.1371/journal.pone.0121766	http://dx.doi.org/10.1371/journal.pone.0121766			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837490	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000061
J	Detzel, CJ; Horgan, A; Henderson, AL; Petschow, BW; Warner, CD; Maas, KJ; Weaver, EM				Detzel, Christopher J.; Horgan, Alan; Henderson, Abigail L.; Petschow, Bryon W.; Warner, Christopher D.; Maas, Kenneth J.; Weaver, Eric M.			Bovine Immunoglobulin/Protein Isolate Binds Pro-Inflammatory Bacterial Compounds and Prevents Immune Activation in an Intestinal Co-Culture Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; BARRIER FUNCTION; PASSIVE-IMMUNITY; SECRETORY IGA; SERUM; TIGHT; LIPOPOLYSACCHARIDE; ANTIBODY; PROTEIN; PERMEABILITY	Intestinal barrier dysfunction is associated with chronic gastrointestinal tract inflammation and diseases such as IBD and IBS. Serum-derived bovine immunoglobulin/protein isolate (SBI) is a specially formulated protein preparation (>90%) for oral administration. The composition of SBI is greater than 60% immunoglobulin including contributions from IgG, IgA, and IgM. Immunoglobulin within the lumen of the gut has been recognized to have anti-inflammatory properties and is involved in maintaining gut homeostasis. The binding of common intestinal antigens (LPS and Lipid A) and the ligand Pam3CSK4, by IgG, IgA, and IgM in SBI was shown using a modified ELISA technique. Each of these antigens stimulated IL-8 and TNF-alpha cytokine production by THP-1 monocytes. Immune exclusion occurred as SBI (<= 50 mg/mL) bound free antigen in a dose dependent manner that inhibited cytokine production by THP-1 monocytes in response to 10 ng/mL LPS or 200 ng/mL Lipid A. Conversely, Pam3CSK4 stimulation of THP-1 monocytes was unaffected by SBI/antigen binding. A co-culture model of the intestinal epithelium consisted of a C2BBe1 monolayer separating an apical compartment from a basal compartment containing THP-1 monocytes. The C2BBe1 monolayer was permeabilized with dimethyl palmitoyl ammonio propanesulfonate (PPS) to simulate a damaged epithelial barrier. Results indicate that Pam3CSK4 was able to translocate across the PPS-damaged C2BBe1 monolayer. However, binding of Pam3CSK4 by immunoglobulins in SBI prevented Pam3CSK4 translocation across the damaged C2BBe1 barrier. These results demonstrated steric exclusion of antigen by SBI which prevented apical to basal translocation of antigen due to changes in the physical properties of Pam3CSK4, most likely as a result of immunoglobulin binding. This study demonstrates that immunoglobulins in SBI can reduce antigen-associated inflammation through immune and steric exclusion mechanisms and furthers the mechanistic understanding of how SBI might improve immune status and reduce inflammation in various intestinal disease states.	[Detzel, Christopher J.; Horgan, Alan; Henderson, Abigail L.; Warner, Christopher D.; Weaver, Eric M.] Entera Hlth Inc, Ankeny, IA 50021 USA; [Petschow, Bryon W.; Maas, Kenneth J.] Entera Hlth Inc, Cary, NC USA		Detzel, CJ (corresponding author), Entera Hlth Inc, Ankeny, IA 50021 USA.	Christopher.Detzel@enterahealth.com			Entera Health Inc	Entera Health Inc	This work was funded by Entera Health Inc. The funder provided support in the form of salaries for authors CJD, AH, ALH, BWP, CDW, KJM and EMW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aaltonen J, 2011, EUR J CLIN NUTR, V65, P10, DOI 10.1038/ejcn.2010.225; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Al-Sadi R, 2013, J IMMUNOL, V190, P6596, DOI 10.4049/jimmunol.1201876; Asmuth DM, 2013, AIDS, V27, P2207, DOI 10.1097/QAD.0b013e328362e54c; Balimane PV, 2005, DRUG DISCOV TODAY, V10, P335, DOI 10.1016/S1359-6446(04)03354-9; Begin F, 2008, EUR J CLIN NUTR, V62, P39, DOI 10.1038/sj.ejcn.1602682; Berdoz J, 2004, MOL IMMUNOL, V41, P1013, DOI 10.1016/j.molimm.2004.05.006; BESSER TE, 1988, J VIROL, V62, P2238, DOI 10.1128/JVI.62.7.2238-2242.1988; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; COPELAN EA, 1994, BONE MARROW TRANSPL, V13, P87; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dohler JR, 2002, CRIT CARE, V6, P536, DOI 10.1186/cc1819; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Fortuna VA, 2003, J CELL BIOCHEM, V90, P792, DOI 10.1002/jcb.10703; Gibbs RJ, 2004, J MED MICROBIOL, V53, P959, DOI 10.1099/jmm.0.45674-0; Gupta V, 2013, J CONTROL RELEASE, V172, P541, DOI 10.1016/j.jconrel.2013.05.002; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; HONMA K, 1994, INT ARCH ALLERGY IMM, V103, P28, DOI 10.1159/000236602; HURRELL RF, 1988, AM J CLIN NUTR, V47, P102, DOI 10.1093/ajcn/47.1.102; KANE AP, 1984, AM J CLIN NUTR, V39, P393, DOI 10.1093/ajcn/39.3.393; Kauffman AL, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00079; Kramski M, 2012, EUR J IMMUNOL, V42, P2771, DOI 10.1002/eji.201242469; Lembcke JL, 1997, J PEDIATR GASTR NUTR, V25, P381, DOI 10.1097/00005176-199710000-00003; Lochmann D, 2004, EUR J PHARM BIOPHARM, V58, P237, DOI 10.1016/j.ejpb.2004.03.031; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Martinez C, 2013, GUT, V62, P1160, DOI 10.1136/gutjnl-2012-302093; MCCLEAD RE, 1988, AM J MED, V85, P811, DOI 10.1016/S0002-9343(88)80026-3; McNeilly TN, 2010, VACCINE, V28, P1412, DOI 10.1016/j.vaccine.2009.10.148; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Navarro A, 2007, J MED MICROBIOL, V56, P1447, DOI 10.1099/jmm.0.47201-0; Nguyen DT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001049; Pacyna J, 2001, J PEDIATR GASTR NUTR, V32, P162, DOI 10.1097/00005176-200102000-00013; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Perez-Bosque A, 2006, J NUTR, V136, P2838, DOI 10.1093/jn/136.11.2838; Petherick A, 2010, NATURE, V468, pS5, DOI 10.1038/468S5a; Petschow BW, 2015, DIGEST DIS SCI, V60, P13, DOI 10.1007/s10620-014-3322-0; Petschow BW, 2014, CLIN EXP GASTROENTER, V7, P181, DOI 10.2147/CEG.S62823; PIERRE P, 1988, IMMUNOL LETT, V18, P51, DOI 10.1016/0165-2478(88)90069-7; Raiman J, 2003, INT J PHARM, V261, P129, DOI 10.1016/S0378-5173(03)00300-4; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; SENNHAUSER FH, 1989, IMMUNOLOGY, V66, P394; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Stockinger S, 2011, CELL MOL LIFE SCI, V68, P3699, DOI 10.1007/s00018-011-0831-2; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; TACKET CO, 1992, AM J TROP MED HYG, V47, P276, DOI 10.4269/ajtmh.1992.47.276; Tomita GM, 1995, J DAIRY SCI, V78, P2745, DOI 10.3168/jds.S0022-0302(95)76905-3; TOMITA M, 1994, BIOL PHARM BULL, V17, P753; Triantafilou M, 2012, VIRULENCE, V3, P136, DOI 10.4161/viru.19077; Tsunemitsu H, 2005, J GEN VIROL, V86, P2569, DOI 10.1099/vir.0.80938-0; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Watanabe F, 2004, BIOFACTORS, V21, P145, DOI 10.1002/biof.552210129; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Watson CJ, 2001, AM J PHYSIOL-CELL PH, V281, pC388, DOI 10.1152/ajpcell.2001.281.2.C388; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Weiner C, 1999, CLIN EXP IMMUNOL, V116, P193; Wilson D, 2013, CLIN MED INSIGHTS-GA, V6, P49, DOI 10.4137/CGast.S13200	62	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120278	10.1371/journal.pone.0120278	http://dx.doi.org/10.1371/journal.pone.0120278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830826	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600030
J	Grut, L; Sanudi, L; Braathen, SH; Jurgens, T; Eide, AH				Grut, Lisbet; Sanudi, Lifah; Braathen, Stine Hellum; Jurgens, Thomas; Eide, Arne H.			Access to Tuberculosis Services for Individuals with Disability in Rural Malawi, a Qualitative Study	PLOS ONE			English	Article								Tuberculosis occurs in all populations, but with higher prevalence in poor contexts. Vulnerable groups, including individuals with disability, run a particular risk due to poorer access to information and health services. Studying access to tuberculosis services for vulnerable groups in poor contexts may provide useful insight into the quality of such services in low-income contexts. This article aims to present a contextual understanding of access to tuberculosis services for people with disabilities in one district in southern Malawi. A qualitative method with semi-structured interviews and site observations was applied. In all, 89 participants were interviewed: 47 persons with disability, 11 parents/guardians of youths with disability, and the remaining 31 comprising eight health workers, four community rehabilitation assistants and volunteers, and 19 leaders in the community. Our main findings are that lack of information and knowledge, and considerable confusion related to tuberculosis, its cause and how to protect oneself, are major barrier to accessing services. Disease awareness and personal risk perception are key factors in this regard. Further findings concerns the pathways to tuberculosis related health services, in particular having a test and completing the treatment. The combination of lack of knowledge and barriers in accessing tests implies substantial availability and access problems. It is of importance to understand the combined impact of individual, social, contextual, and systems barriers to fully address the complexity of accessing tuberculosis services for vulnerable groups in poor populations. Lack of disability specific strategies in the local health services may be part of the reason why individuals with disability to not access such services.	[Grut, Lisbet; Braathen, Stine Hellum; Eide, Arne H.] SINTEF Technol & Soc, Oslo, Norway; [Sanudi, Lifah] Reach Trust, Lilongwe, Malawi; [Jurgens, Thomas] LHLs Int TB Fdn LHL Int, Oslo, Norway	SINTEF	Eide, AH (corresponding author), SINTEF Technol & Soc, Oslo, Norway.	arne.h.eide@sintef.no		Braathen, Stine Hellum/0000-0002-3968-1873	LHL International	LHL International	LHL International initiated and funded the study, contributed during planning, provided valuable TB and contextual expertise in the planning of research as well as during the write-up of the manuscript.	Centre Wm, 2013, MED CTR FACT SHEETS; Chimzizi R, 2007, B WORLD HEALTH ORGAN, V85, P325; Eide A.H., 2011, DISABILITY POVERTY G; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Holloway I, 2011, QUAL HEALTH RES, V21, P968, DOI 10.1177/1049732310395607; Holloway W., 2013, DOING QUALITATIVE RE; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Kleinman A., 1980, PATIENTS HEALERS CON; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; MacLachlan M, 2009, DISABILITY & INTERNATIONAL DEVELOPMENT: TOWARDS INCLUSIVE GLOBAL HEALTH, P1, DOI 10.1007/978-0-387-93840-0; MacLachlan M., 2011, OPEN MED, V5/1, P10; Mitra S, 2011, 1109 WORLD BANK; Mo H, 2008, GUIDELINES FOR INFEC; Morse J., 2002, READ ME 1 USERS GUID; Nhlema B, 2003, SYSTEMATIC ANAL TB P; Ross E, 2008, SOC WORK HEALTH CARE, V46, P15, DOI 10.1300/J010v4602_02; Silverman D., 2013, DOING QUALITATIVE RE; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; WHO, 2009, WHO MON INT MON TUB	19	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122748	10.1371/journal.pone.0122748	http://dx.doi.org/10.1371/journal.pone.0122748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830950	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600123
J	Yang, Y; Qiu, WQ; Hao, YL; Lv, ZY; Jiao, SJ; Teng, JF				Yang, Yan; Qiu, Wei Qing; Hao, Yan Lei; Lv, Zhan Yun; Jiao, Shu Ji; Teng, Jun Feng			The Efficacy of Traditional Chinese Medical Exercise for Parkinson's Disease: A Systematic Review and Meta-analysis	PLOS ONE			English	Review							TAI CHI EXERCISE; BEHAVIORAL RECOVERY; QIGONG; MOTOR; NEUROPLASTICITY; INDIVIDUALS; PERFORMANCE; QUALITY; BALANCE	Background and Objective Several studies assessed the efficacy of traditional Chinese medical exercise in the management of Parkinson's disease (PD), but its role remained controversial. Therefore, the purpose of this systematic review is to evaluate the evidence on the effect of traditional Chinese medical exercise for PD. Methods Seven English and Chinese electronic databases, up to October 2014, were searched to identify relevant studies. The PEDro scale was employed to assess the methodological quality of eligible studies. Meta-analysis was performed by RevMan 5.1 software. Results Fifteen trials were included in the review. Tai Chi and Qigong were used as assisting pharmacological treatments of PD in the previous studies. Tai Chi plus medication showed greater improvements in motor function (standardized mean difference, SMD, -0.57; 95% confidence intervals, CI, -1.11 to -0.04), Berg balance scale (BBS, SMD, -1.22; 95% CI -1.65 to -0.80), and time up and go test (SMD, -1.06; 95% CI -1.44 to -0.68). Compared with other therapy plus medication, Tai Chi plus medication also showed greater gains in motor function (SMD, -0.78; 95% CI -1.46 to -0.10), BBS (SMD, -0.99; 95% CI -1.44 to -0.54), and functional reach test (SMD, -0.77; 95% CI -1.51 to -0.03). However, Tai Chi plus medication did not showed better improvements in gait or quality of life. There was not sufficient evidence to support or refute the effect of Qigong plus medication for PD. Conclusions In the previous studies, Tai Chi and Qigong were used as assisting pharmacological treatments of PD. The current systematic review showed positive evidence of Tai Chi plus medication for PD of mild-to-moderate severity. So Tai Chi plus medication should be recommended for PD management, especially in improving motor function and balance. Qigong plus medication also showed potential gains in the management of PD. However, more high quality studies with long follow-up are warrant to confirm the current findings.	[Yang, Yan; Hao, Yan Lei; Lv, Zhan Yun] Jining Med Univ, Dept Neurol, Affiliated Hosp, Jining, Shandong, Peoples R China; [Qiu, Wei Qing] Laizhou Peoples Hosp Shangdong, Dept Neurol, Laizhou, Shandong, Peoples R China; [Qiu, Wei Qing] Binzhou Med Univ Hosp, Binzhou, Shandong, Peoples R China; [Jiao, Shu Ji; Teng, Jun Feng] First Peoples Hosp Hebi, Dept Neurol, Hebi, Henan, Peoples R China	Jining Medical University; Binzhou Medical University	Yang, Y (corresponding author), Jining Med Univ, Dept Neurol, Affiliated Hosp, Jining, Shandong, Peoples R China.	yanyangdr@126.com; qingweiqiudr@163.com	hao, yan/HGB-0465-2022; Northcote, Matthew/B-8209-2019; Northcote, Matthew/L-1135-2019		National Natural Science Fund Projects of China [81271398]	National Natural Science Fund Projects of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Fund Projects of China (81271398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2011, MOVEMENT DISORD, V26, P1605, DOI 10.1002/mds.23790; Amano S, 2013, PARKINSONISM RELAT D, V19, P955, DOI 10.1016/j.parkreldis.2013.06.007; An BC, 2008, J ALTERN COMPLEM MED, V14, P167, DOI 10.1089/acm.2007.0600; Burini D, 2006, Eura Medicophys, V42, P231; Canning CG, 2012, CLIN REHABIL, V26, P817, DOI 10.1177/0269215511432652; Cheng L., 2014, THESIS YUNNAN COLL T; Cheon SM, 2013, J CLIN NEUROL, V9, P237, DOI 10.3988/jcn.2013.9.4.237; Cheon SM, 2006, P 1 INT C TAI CHI HL, P68; Choi Hye-Jung, 2013, ISRN Neurol, V2013, P548240, DOI 10.1155/2013/548240; Ding M, 2014, J ALTERN COMPLEM MED, V20, P79, DOI 10.1089/acm.2013.0087; Fisher BE, 2004, J NEUROSCI RES, V77, P378, DOI 10.1002/jnr.20162; Frazzitta G, 2013, AM J PHYS MED REHAB, V92, P523, DOI 10.1097/PHM.0b013e31828cd254; Gao Q, 2014, CLIN REHABI IN PRESS; Gladfelter BA., 2011, THESIS VALPARAISO U; Gu AM, 2002, HENAN J PRACTICAL NE, V5, P3; Hackney ME, 2008, GAIT POSTURE, V28, P456, DOI 10.1016/j.gaitpost.2008.02.005; Hackney ME, 2009, PARKINSONISM RELAT D, V15, P644, DOI 10.1016/j.parkreldis.2009.03.003; Hackney ME, 2009, J REHABIL MED, V41, P475, DOI 10.2340/16501977-0362; Hass CJ, 2006, ANN M AM SOC BIOM; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; HEYES MP, 1988, LIFE SCI, V42, P1537, DOI 10.1016/0024-3205(88)90011-2; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; King LA, 2009, PHYS THER, V89, P384, DOI 10.2522/ptj.20080214; Lan C., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/502131; Lauche R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/635182; Lee MS, 2009, MOVEMENT DISORD, V24, P301, DOI 10.1002/mds.22275; Lee MS, 2008, PARKINSONISM RELAT D, V14, P589, DOI 10.1016/j.parkreldis.2008.02.003; Li F, 2001, Prev Sci, V2, P229, DOI 10.1023/A:1013614200329; Li FZ, 2007, J AGING PHYS ACTIV, V15, P139, DOI 10.1123/japa.15.2.139; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Li JX., 2011, THESIS NANJING U CHI; Li R, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/784059; Macedo LG, 2010, J CLIN EPIDEMIOL, V63, P920, DOI 10.1016/j.jclinepi.2009.10.005; MacLaggan L, 2000, THESIS DALHOUSIE U H; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Marjama-Lyons J, 2002, MOVEMENT DISORD, V17, pS70; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099377; Nocera Joe R, 2013, J Yoga Phys Ther, V3, DOI 10.4172/2157-7595.1000137; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Purchas MA, 2007, MOVEMENT DISORD, V22, pS80; Sung Hyeryun, 2006, [Korean Journal of Sport Studies, 한국체육학회지], V45, P583; Temlett JA, 2006, INTERN MED J, V36, P524, DOI 10.1111/j.1445-5994.2006.01123.x; Tian BW, 2012, THESIS BEIJING SPORT; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; Toh SFM, 2013, HONG KONG J OCCUP TH, V23, P69, DOI 10.1016/j.hkjot.2013.11.001; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Welsh M, 1997, MOV DISORD, V12, P137; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102942; Yu XH, 1998, CHINESE JOURNAL OF B, V7, P303; Zeng YC, 2014, COMPLEMENT THER MED, V22, P173, DOI 10.1016/j.ctim.2013.11.010; Zhang F, 2014, J PHYS THER SCI, V26, P881, DOI 10.1589/jpts.26.881; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1; [朱毅 Zhu Yi], 2011, [中国康复理论与实践, Chinese Journal of Rehabilitation Theory and Practice], V17, P355	55	26	26	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122469	10.1371/journal.pone.0122469	http://dx.doi.org/10.1371/journal.pone.0122469			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830664	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600110
J	Cornez, G; ter Haar, SM; Cornil, CA; Balthazart, J				Cornez, Gilles; ter Haar, Sita M.; Cornil, Charlotte A.; Balthazart, Jacques			Anatomically Discrete Sex Differences in Neuroplasticity in Zebra Finches as Reflected by Perineuronal Nets	PLOS ONE			English	Article							VOCAL CONTROL NUCLEI; SONG CONTROL PATHWAY; NEURAL MECHANISMS; FUNCTIONAL RECOVERY; PROJECTION NEURONS; ADULT MALE; BRAIN; FEMALE; PARVALBUMIN; AROMATASE	Large morphological sex differences in the vertebrate brain were initially identified in song control nuclei of oscines. Besides gross differences between volumes of nuclei in males and females, sex differences also concern the size and dendritic arborization of neurons and various neurochemical markers, such as the calcium-binding protein parvalbumin (PV). Perineuronal nets (PNN) of the extracellular matrix are aggregates of different compounds, mainly chondroitin sulfate proteoglycans, that surround subsets of neurons, often expressing PV. PNN develop in zebra finches song control nuclei around the end of the sensitive period for song learning and tutor deprivation, known to delay the end of the song learning sensitive period, decreases the numbers of PNN in HVC. We demonstrate here the existence in zebra finches of a major sex difference (males > females) affecting the number of PNN (especially those surrounding PV-positive cells) in HVC and to a smaller extent the robust nucleus of the arcopallium, RA, the two main nuclei controlling song production. These differences were not present in Area X and LMAN, the lateral magnocellular nucleus of the anterior nidopallium. A dense expression of material immunoreactive for chondroitin sulfate was also detected in several nuclei of the auditory and visual pathways. This material was often organized in perineuronal rings but quantification of these PNN did not reveal any sex difference with the exception that the percentage of PNN surrounding PV-ir cells in the dorsal lateral mesencephalic nucleus, MLd, was larger in females than in males, a sex difference in the opposite direction compared to what is seen in HVC and RA. These data confirm and extend previous studies demonstrating the sex difference affecting PNN in HVC-RA by showing that this sex difference is anatomically specific and does not concern visual or auditory pathways.	[Cornez, Gilles; ter Haar, Sita M.; Cornil, Charlotte A.; Balthazart, Jacques] Univ Liege, GIGA Neurosci, Res Grp Behav Neuroendocrinol, Liege, Belgium	University of Liege	Balthazart, J (corresponding author), Univ Liege, GIGA Neurosci, Res Grp Behav Neuroendocrinol, Liege, Belgium.	jbalthazart@ulg.ac.be	Cornil, Charlotte Anne/J-2462-2019	Cornil, Charlotte Anne/0000-0002-5536-7753	Belgian Science Policy [BELSPO: SSTC PAI P7/17]; Research Associate of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS)	Belgian Science Policy(Belgian Federal Science Policy Office); Research Associate of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS)	Funding for this work was provided by a grant from the Belgian Science Policy (BELSPO: SSTC PAI P7/17; url: https://www.belspo.be/belspo/index_en.stm) to JB and CAC. CAC is Research Associate of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS; url: http://www.fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; Ball GF, 2001, MICROSC RES TECHNIQ, V54, P327, DOI 10.1002/jemt.1146; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Benton S, 1998, BEHAV BRAIN RES, V96, P135, DOI 10.1016/S0166-4328(98)00011-4; Best BJ, 2012, ABST SOC NEUR, V30318; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; BRAUN K, 1991, NEUROSCIENCE, V40, P853, DOI 10.1016/0306-4522(91)90017-I; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; De Groof G, 2009, J NEUROSCI, V29, P13557, DOI 10.1523/JNEUROSCI.1788-09.2009; De Groof G, 2008, EUR J NEUROSCI, V28, P2475, DOI 10.1111/j.1460-9568.2008.06545.x; Del Negro C, 1998, BEHAV BRAIN RES, V96, P151, DOI 10.1016/S0166-4328(98)00009-6; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Evrard HC, 2004, J COMP NEUROL, V473, P194, DOI 10.1002/cne.20068; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; Gall MD, 2012, J COMP PHYSIOL A, V198, P61, DOI 10.1007/s00359-011-0687-9; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gati G, 2010, J CHEM NEUROANAT, V40, P243, DOI 10.1016/j.jchemneu.2010.07.002; GERLACH JL, 1983, DEV BRAIN RES, V11, P7, DOI 10.1016/0165-3806(83)90197-9; Handa R., 2014, CURR EYE RES, V40, P1; Hara E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029457; Hernandez AM, 2004, J NEUROBIOL, V59, P247, DOI 10.1002/neu.10312; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; Horvath TL, 1999, J NEUROENDOCRINOL, V11, P77; JURASKA JM, 1991, PSYCHONEUROENDOCRINO, V16, P105, DOI 10.1016/0306-4530(91)90073-3; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Karetko M, 2009, ACTA NEUROBIOL EXP, V69, P564; KIRN JR, 1993, J NEUROSCI, V13, P1654; Lucas JR, 2007, J COMP PHYSIOL A, V193, P201, DOI 10.1007/s00359-006-0180-z; MacDougall-Shackleton SA, 1998, NEUROREPORT, V9, P3047, DOI 10.1097/00001756-199809140-00024; MACLUSKY NJ, 1979, BRAIN RES, V178, P143, DOI 10.1016/0006-8993(79)90094-5; MacLusky NJ, 1989, ABST SOC NEUR, V3911; Madison F.N., 2014, GEN COMP ENDOCRINOL; Maguire SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063239; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Meyer CE, 2014, BASAL GANGLIA, V3, P229, DOI 10.1016/j.baga.2013.10.002; Miller-Sims VC, 2012, J NEUROPHYSIOL, V107, P1142, DOI 10.1152/jn.00614.2011; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; NIXDORF BE, 1989, J COMP NEUROL, V284, P337, DOI 10.1002/cne.902840302; Noirot IC, 2007, ASBT SOC NEUR, V672; Noirot IC, 2009, HEARING RES, V252, P49, DOI 10.1016/j.heares.2009.04.012; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Nowicka D, 2009, EUR J NEUROSCI, V30, P2053, DOI 10.1111/j.1460-9568.2009.06996.x; Peterson RS, 2005, P ROY SOC B-BIOL SCI, V272, P2089, DOI 10.1098/rspb.2005.3181; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Prbve E., 1974, J ORNITHOL, V115, P338; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Rohmann KN, 2005, HORM BEHAV, V48, P125; SHERIDAN PJ, 1979, BRAIN RES, V178, P201, DOI 10.1016/0006-8993(79)90101-X; Sun LN, 2010, NEUROSCI RES, V68, P22, DOI 10.1016/j.neures.2010.05.003; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Van Meir V, 2005, NEUROIMAGE, V25, P1242, DOI 10.1016/j.neuroimage.2004.12.058; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; Wild JM, 2001, BRAIN RES, V917, P235	68	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123199	10.1371/journal.pone.0123199	http://dx.doi.org/10.1371/journal.pone.0123199			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848776	Green Published, gold			2022-12-27	WOS:000352477800214
J	de Seny, D; Cobraiville, G; Charlier, E; Neuville, S; Lutteri, L; Le Goff, C; Malaise, D; Malaise, O; Chapelle, JP; Relic, B; Malaise, MG				de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Lutteri, Laurence; Le Goff, Caroline; Malaise, Denis; Malaise, Olivier; Chapelle, Jean-Paul; Relic, Biserka; Malaise, Michel G.			Apolipoprotein-A1 as a Damage-Associated Molecular Patterns Protein in Osteoarthritis: Ex Vivo and In Vitro Pro-Inflammatory Properties	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; A-I; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGET; SYNOVIAL-FLUID; CHOLESTEROL; SERUM; DISEASE; OBESITY; RISK	Osteoarthritis (OA) is associated with a local inflammatory process. Dyslipidemia is known to be an underlying cause for the development of OA. Therefore, lipid and inflammatory levels were quantified ex vivo in blood and synovial fluid of OA patients (n=29) and compared to those of rheumatoid arthritis (RA) patients (n=27) or healthy volunteers (HV) (n=35). The role of apolipoprotein A-I (ApoA1) was investigated in vitro on inflammatory parameters using human joint cells isolated from cartilage and synovial membrane obtained from OA patients after joint replacement. Cells were stimulated with ApoA1 in the presence or not of serum amyloid A (SAA) protein and/or lipoproteins (LDL and HDL) at physiological concentration observed in OA synovial fluid. In our ex vivo study, ApoA1, LDL-C and total cholesterol levels were strongly correlated to each other inside the OA joint cavity whereas same levels were not or weakly correlated to their corresponding serum levels. In OA synovial fluid, ApoA1 was not as strongly correlated to HDL as observed in OA serum or in RA synovial fluid, suggesting a dissociative level between ApoA1 and HDL in OA synovial fluid. In vitro, ApoA1 induced IL-6, MMP-1 and MMP-3 expression by primary chondrocytes and fibroblast-like synoviocytes through TLR4 receptor. HDL and LDL attenuated joint inflammatory response induced by ApoA1 and SAA in a ratio dependent manner. In conclusion, a dysregulated lipidic profile in the synovial fluid of OA patients was observed and was correlated with inflammatory parameters in the OA joint cavity. Pro-inflammatory properties of ApoA1 were confirmed in vitro.	[de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Malaise, Denis; Malaise, Olivier; Relic, Biserka; Malaise, Michel G.] Univ Liege, GIGA Res, Lab Rheumatol, B-4000 Liege, Belgium; [de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Malaise, Denis; Malaise, Olivier; Relic, Biserka; Malaise, Michel G.] CHU Hosp Liege, B-4000 Liege, Belgium; [Le Goff, Caroline; Malaise, Denis; Chapelle, Jean-Paul] CHU Hosp Liege, Clin Chem Lab, B-4000 Liege, Belgium	University of Liege	de Seny, D (corresponding author), Univ Liege, GIGA Res, Lab Rheumatol, B-4000 Liege, Belgium.	ddeseny@chu.ulg.ac.be	Le Goff, Caroline/AAE-8177-2021	Malaise, Denis/0000-0001-7454-819X	"Fond d'Investissement pour la Recherche Scientifique" (FIRS) of the authors' Institution (CHU Liege, Belgium)	"Fond d'Investissement pour la Recherche Scientifique" (FIRS) of the authors' Institution (CHU Liege, Belgium)	This study was supported by the "Fond d'Investissement pour la Recherche Scientifique" (FIRS) of the authors' Institution (CHU Liege, Belgium) for the entire group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman-Farinelli MA, 2008, MED J AUSTRALIA, V188, P317, DOI 10.5694/j.1326-5377.2008.tb01634.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beck WHJ, 2013, BBA-BIOMEMBRANES, V1828, P1503, DOI 10.1016/j.bbamem.2013.02.009; Busso N, 2001, AM J PATHOL, V159, P1445, DOI 10.1016/S0002-9440(10)62531-X; Chiang SL, 2014, SCAND J RHEUMATOL, V2014, P1, DOI [10. 3109/ 03009742. 2013. 805242 PMID: 25521915, DOI 10.3109/03009742.2013.805242]; Chiba T, 2011, ARTERIOSCL THROM VAS, V31, P1326, DOI 10.1161/ATVBAHA.111.226159; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Davies-Tuck ML, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2873; de Seny D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066769; Erb N, 2004, SCAND J RHEUMATOL, V33, P293, DOI 10.1080/03009740410006899; Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]; Gkretsi V, 2011, PROG LIPID RES, V50, P133, DOI 10.1016/j.plipres.2010.11.001; Katz JD, 2010, CURR OPIN RHEUMATOL, V22, P512, DOI 10.1097/BOR.0b013e32833bfb4b; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Moya MD, 2012, ATHEROSCLEROSIS, V222, P390, DOI 10.1016/j.atherosclerosis.2012.02.032; Ogasawara K, 2008, CLIN CHIM ACTA, V397, P42, DOI 10.1016/j.cca.2008.07.014; Oliviero F, 2012, CLIN CHIM ACTA, V413, P303, DOI 10.1016/j.cca.2011.10.019; Oliviero F, 2009, CLIN EXP RHEUMATOL, V27, P79; Onat A, 2010, INT J CARDIOL, V142, P72, DOI 10.1016/j.ijcard.2008.12.066; Onat A, 2013, EUR J CLIN INVEST, V43, P1129, DOI 10.1111/eci.12150; Onat A, 2013, ANADOLU KARDIYOL DER, V13, P306, DOI 10.5152/akd.2013.106; Onat A, 2009, METABOLISM, V58, P1393, DOI 10.1016/j.metabol.2009.05.004; Oram JF, 1996, J LIPID RES, V37, P2473; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Relic B, 2002, LAB INVEST, V82, P1661, DOI 10.1097/01.LAB.0000041714.05322.C0; Relic B, 2006, J BIOL CHEM, V281, P22597, DOI 10.1074/jbc.M512807200; Relic B, 2009, LAB INVEST, V89, P811, DOI 10.1038/labinvest.2009.41; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Santos-Gallego CG, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0512-5; Singh G, 2002, AM J MANAG CARE, V8, pS383; Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201; Sowers MR, 2010, CURR OPIN RHEUMATOL, V22, P533, DOI 10.1097/BOR.0b013e32833b4682; Tsezou A, 2010, J ORTHOP RES, V28, P1033, DOI 10.1002/jor.21084; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967	41	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122904	10.1371/journal.pone.0122904	http://dx.doi.org/10.1371/journal.pone.0122904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849372	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800171
J	Infurna, FJ; Rivers, CT; Reich, J; Zautra, AJ				Infurna, Frank J.; Rivers, Crystal T.; Reich, John; Zautra, Alex J.			Childhood Trauma and Personal Mastery: Their Influence on Emotional Reactivity to Everyday Events in a Community Sample of Middle-Aged Adults	PLOS ONE			English	Article							DAILY STRESSORS; PHYSICAL HEALTH; LIFE STRESS; PERCEIVED CONTROL; POSITIVE AFFECT; RISK; EXPERIENCES; RESILIENCE; ORIGINS; ABUSE	Childhood trauma is associated with premature declines in health in midlife and old age. Pathways that have been implicated, but less studied include social-emotional regulation, biological programming, and habitual patterns of thought and action. In this study we focused on childhood trauma's influence via alterations in social-emotional regulation to everyday life events, a pathway that has been linked to subsequent health effects. Data from a 30-day daily diary of community residents who participated in a study of resilience in Midlife (n = 191, M-age = 54, SD = 7.50, 54% women) was used to examine whether self-reports of childhood trauma were associated with daily well-being, as well as reported and emotional reactivity to daily negative and positive events. Childhood trauma reports were associated with reporting lower overall levels of and greater variability in daily well-being. Childhood trauma was linked to greater reports of daily negative events, but not to positive events. Focusing on emotional reactivity to daily events, residents who reported higher levels of childhood trauma showed stronger decreases in well-being when experiencing negative events and also stronger increases in well-being with positive events. For those reporting childhood trauma, higher levels of mastery were associated with stronger decreases in well-being with negative events and stronger increases in well-being with positive events, suggesting that mastery increases sensitivity to daily negative and positive events. Our results suggest that childhood trauma may lead to poorer health in midlife through disturbances in the patterns of everyday life events and responses to those events. Further, our findings indicate that mastery may have a different meaning for those who experienced childhood trauma. We discuss social-emotional regulation as one pathway linking childhood trauma to health, and psychosocial resources to consider when building resilience-promoting interventions for mitigating the detrimental health effects of childhood trauma.	[Infurna, Frank J.; Rivers, Crystal T.; Reich, John; Zautra, Alex J.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Infurna, FJ (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	Frank.Infurna@asu.edu			National Institute on Aging [R01 AG26006]; NATIONAL INSTITUTE ON AGING [R01AG026006] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institute on Aging R01 AG26006. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Almeida DM, 2010, HDB PSYCHOL AGING, P191; [Anonymous], 2006, SAS MIXED MODELS; BALTES PB, 1987, DEV PSYCHOL, V23, P611, DOI 10.1037/0012-1649.23.5.611; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bandura A, 1997, SELF EFFICACY THE EX; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Blackertz L, 1998, AMERICAN JOURNAL OF, V19, P307; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Bradbum N. M., 1969, THE STRUCTURE OF PSY; Carstensen LL, 2011, PSYCHOL AGING, V26, P21, DOI 10.1037/a0021285; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cassidy J., 2008, HANDBOOK OF ATTACHME; Charles ST, 2013, PSYCHOL SCI, V24, P733, DOI 10.1177/0956797612462222; Cloitre M, 2005, BEHAV THER, V36, P119, DOI 10.1016/S0005-7894(05)80060-7; Cook T. D., 1979, QUASIEXPERIMENTATION, P19; Davis MC, 2000, PSYCHOSOM MED, V62, P17, DOI 10.1097/00006842-200001000-00003; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Diehl M, 2010, DEV PSYCHOL, V46, P1132, DOI 10.1037/a0019937; Division of Behavioral and Social Research National Institute on Aging, 2013, NETWORK ON REVERSIBI; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferraro KF, 2009, GERONTOLOGIST, V49, P333, DOI 10.1093/geront/gnp034; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Goleman D., 2006, WORKING EMOTIONAL IN; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Hay EL, 2010, PSYCHOL AGING, V25, P118, DOI 10.1037/a0018747; Hostinar CE, 2013, CURR DIR PSYCHOL SCI, V22, P400, DOI 10.1177/0963721413488889; Infurna FJ, 2013, DEV PSYCHOL, V49, P1833, DOI 10.1037/a0031041; JAMES SA, 1983, J BEHAV MED, V6, P259, DOI 10.1007/BF01315113; Kahn RL, 1978, CLIN PSYCHOL AGING, P43; Kok BE, 2013, PSYCHOL SCI, V24, P1123, DOI 10.1177/0956797612470827; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lieberman MD, 2013, SOCIAL WHY ARE BRAIN; Little R. J. A., 1987, STATISTICAL ANALYSIS; Luecken LJ, 2004, CLIN PSYCHOL REV, V24, P171, DOI 10.1016/j.cpr.2004.01.003; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mallers MH, 2010, DEV PSYCHOL, V46, P1651, DOI 10.1037/a0021020; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Mroczek DK, JOURNALS OF GERONTOL; Neupert SD, 2007, J GERONTOL B-PSYCHOL, V62, pP216, DOI 10.1093/geronb/62.4.P216; O'Rand AM, 2005, J GERONTOL B-PSYCHOL, V60, P117, DOI 10.1093/geronb/60.Special_Issue_2.S117; Ong AD, 2013, ANN BEHAV MED, V46, P52, DOI 10.1007/s12160-013-9484-8; Pearlin LI, 2007, J HEALTH SOC BEHAV, V48, P164, DOI 10.1177/002214650704800205; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Piazza JR, 2013, ANN BEHAV MED, V45, P110, DOI 10.1007/s12160-012-9423-0; Piazza JR, 2010, J GERONTOL B-PSYCHOL, V65, P513, DOI 10.1093/geronb/gbq049; Pluess M, 2013, PSYCHOL BULL, V139, P901, DOI 10.1037/a0030196; Porter CA, 1999, J CHILD SEX ABUS, V8, P3, DOI DOI 10.1300/J070V08N01_02; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Raposa EB, PSYCHOLOGICAL SCIENC; REICH JW, 1984, J COMMUNITY PSYCHOL, V12, P312, DOI 10.1002/1520-6629(198410)12:4<312::AID-JCOP2290120404>3.0.CO;2-B; Reich JW, 1981, J PERS SOC PSYCHOL, V41, P1082; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Rivers C, THE ENCYCLO PEDIA OF; RODIN J, 1986, SCIENCE, V233, P1271, DOI 10.1126/science.3749877; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Schafer MH, 2012, GERONTOLOGIST, V52, P111, DOI 10.1093/geront/gnr071; Schafer MH, CHILD ABUSE NEGLECT; Shields A, 1998, J CLIN CHILD PSYCHOL, V27, P381, DOI 10.1207/s15374424jccp2704_2; Singer JD., 2003, APPL LONGITUDINAL AN; Skinner E. A., 1995, PERCEIVED CONTROL MO, V8; Steptoe A, 2012, PSYCHOSOM MED, V74, P501, DOI 10.1097/PSY.0b013e31824f82c8; Strand EB, 2007, COGNITIVE THER RES, V31, P503, DOI 10.1007/s10608-006-9028-7; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Thombs BD, 2006, ARCH INTERN MED, V166, P2020, DOI 10.1001/archinte.166.18.2020; Thorndike E.L., 1920, HARPERS MAGAZINE, V140, P227, DOI DOI 10.1234/12345678; van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Whitelock CF, 2013, CLIN PSYCHOL SCI, V1, P351, DOI 10.1177/2167702613480136; Zautra A., 2013, RESILIENCE HDB APPRO, P185; Zautra AJ, 2005, J PERS, V73, P1511, DOI 10.1111/j.0022-3506.2005.00357.x; Zautra AJ, NEW DEV EMOTIONAL AG; Zautra AJ, 2012, J PSYCHOTHER INTEGR, V22, P206, DOI 10.1037/a0029573	82	42	42	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121840	10.1371/journal.pone.0121840	http://dx.doi.org/10.1371/journal.pone.0121840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849572	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800078
J	Rabjerg, M; Olivan-Viguera, A; Hansen, LK; Jensen, L; Sevelsted-Moller, L; Walter, S; Jensen, BL; Marcussen, N; Kohler, R				Rabjerg, Maj; Olivan-Viguera, Aida; Hansen, Lars Koch; Jensen, Line; Sevelsted-Moller, Linda; Walter, Steen; Jensen, Boye L.; Marcussen, Niels; Koehler, Ralf			High Expression of KCa3.1 in Patients with Clear Cell Renal Carcinoma Predicts High Metastatic Risk and Poor Survival	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; POLYMERASE CHAIN-REACTION; VASCULAR SMOOTH-MUSCLE; INTERMEDIATE-CONDUCTANCE; RELATIVE QUANTIFICATION; T-LYMPHOCYTES; CANCER; PROLIFERATION; MODULATION	Background Ca2+-activated K+ channels have been implicated in cancer cell growth, metastasis, and tumor angiogenesis. Here we hypothesized that high mRNA and protein expression of the intermediate-conductance Ca2+-activated K+ channel, KCa3.1, is a molecular marker of clear cell Renal Cell Carcinoma (ccRCC) and metastatic potential and survival. Methodology/Principal Findings We analyzed channel expression by qRT-PCR, immunohistochemistry, and patch-clamp in ccRCC and benign oncocytoma specimens, in primary ccRCC and oncocytoma cell lines, as well as in two ccRCC cell lines (Caki-1 and Caki-2). CcRCC specimens contained 12-fold higher mRNA levels of KCa3.1 than oncocytoma specimens. The large-conductance channel, KCa1.1, was 3-fold more highly expressed in ccRCC than in oncocytoma. KCa3.1 mRNA expression in ccRCC was 2-fold higher than in the healthy cortex of the same kidney. Disease specific survival trended towards reduction in the subgroup of high-KCa3.1-expressing tumors (p < 0.08 vs. low-KCa3.1-expressing tumors). Progression-free survival (time to metastasis/recurrence) was reduced significantly in the subgroup of high-KCa3.1-expressing tumors (p < 0.02, vs. low-KCa3.1-expressing tumors). Immunohistochemistry revealed high protein expression of KCa3.1 in tumor vessels of ccRCC and oncocytoma and in a subset of ccRCC cells. Oncocytoma cells were devoid of KCa3.1 protein. In a primary ccRCC cell line and Caki-1/2-ccRCC cells, we found KCa3.1-protein as well as TRAM-34-sensitive KCa3.1-currents in a subset of cells. Furthermore, Caki-1/2-ccRCC cells displayed functional Paxilline-sensitive KCa1.1 currents. Neither KCa3.1 nor KCa1.1 were found in a primary oncocytoma cell line. Yet KCa-blockers, like TRAM-34 (KCa3.1) and Paxilline (KCa1.1), had no appreciable effects on Caki-1 proliferation in-vitro. Conclusions/Significance Our study demonstrated expression of KCa3.1 in ccRCC but not in benign oncocytoma. Moreover, high KCa3.1-mRNA expression levels were indicative of low disease specific survival of ccRCC patients, short progression-free survival, and a high metastatic potential. Therefore, KCa3.1 is of prognostic value in ccRCC.	[Rabjerg, Maj; Jensen, Line; Marcussen, Niels] Odense Univ Hosp, Dept Pathol, DK-5000 Odense C, Denmark; [Olivan-Viguera, Aida; Koehler, Ralf] Aragon Inst Hlth Sci I CS IIS, Zaragoza 50009, Spain; [Hansen, Lars Koch; Sevelsted-Moller, Linda; Jensen, Boye L.] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, DK-5000 Odense, Denmark; [Walter, Steen] Odense Univ Hosp, Dept Urol, DK-5000 Odense C, Denmark; [Koehler, Ralf] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza 50009, Spain	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Rabjerg, M (corresponding author), Odense Univ Hosp, Dept Pathol, DK-5000 Odense C, Denmark.	mrabjerg@health.sdu.dk	Oliván-Viguera, Aida/I-4260-2015; Oliván-Viguera, Aida/ABG-4048-2020	Oliván-Viguera, Aida/0000-0001-5348-924X; Oliván-Viguera, Aida/0000-0001-5348-924X; Rabjerg, Maj/0000-0002-6266-7906; Dalgaard, Line Barner/0000-0001-7676-5323; Kohler, Ralf/0000-0001-9563-2913	Region Syddanmark; University Hospital Odense; Foundation of Arvid Nielsson; Deutsche Forschungsgemeinschaft [KO1899/10-1]; Government of Aragon [GIPASC-B105]; Fondo de Investigacion Sanitaria [Red HERACLES RD12/0042/0014]; European Community [FP7-PEOPLE-CIG-321721]; Novo Nordisk Fonden [NNF13OC0006975] Funding Source: researchfish	Region Syddanmark(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); University Hospital Odense; Foundation of Arvid Nielsson; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Government of Aragon(Gobierno de Aragon); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); European Community(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	MR was supported by the "Region Syddanmark", by intramural funding of the University Hospital Odense and by the Foundation of Arvid Nielsson. RK and AO were supported by the Deutsche Forschungsgemeinschaft (KO1899/10-1 to RK), Government of Aragon (GIPASC-B105), and the Fondo de Investigacion Sanitaria (Red HERACLES RD12/0042/0014). Aida Olivan Viguera was also funded by the European Community (FP7-PEOPLE-CIG-321721). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; Arcangeli A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0101; Basrai D, 2002, NEUROREPORT, V13, P403, DOI 10.1097/00001756-200203250-00008; Bjerregaard H, 2011, DIAGN MOL PATHOL, V20, P212, DOI 10.1097/PDM.0b013e318212e0a9; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chantome A, 2013, CANCER RES, V73, P4852, DOI 10.1158/0008-5472.CAN-12-4572; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; D'Alessandro G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.279; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Flores CA, 2007, J PHYSIOL-LONDON, V583, P705, DOI 10.1113/jphysiol.2007.134387; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Girault A, 2012, CURR MED CHEM, V19, P697, DOI 10.2174/092986712798992039; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Grimm PR, 2007, CURR OPIN NEPHROL HY, V16, P430, DOI 10.1097/MNH.0b013e32826fbc7d; Haren N, 2010, HISTOL HISTOPATHOL, V25, P1247, DOI 10.14670/HH-25.1247; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hes O, 2007, ARCH PATHOL LAB MED, V131, P1782; Hua XQ, 2013, TRANSPLANTATION, V95, P285, DOI 10.1097/TP.0b013e318275a2f4; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; KIEFER H, 1980, P NATL ACAD SCI-BIOL, V77, P2200, DOI 10.1073/pnas.77.4.2200; Kohler R, 2000, CIRC RES, V87, P496; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, PFLUG ARCH EUR J PHY, V459, P969, DOI 10.1007/s00424-010-0819-z; Koshy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076740; Lallet-Daher H, 2009, ONCOGENE, V28, P1792, DOI 10.1038/onc.2009.25; Lambertsen KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047744; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; McFerrin MB, 2012, AM J PHYSIOL-CELL PH, V303, pC1070, DOI 10.1152/ajpcell.00040.2012; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; NILIUS B, 1992, J PHYSIOL-LONDON, V445, P537, DOI 10.1113/jphysiol.1992.sp018938; Oeggerli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041664; Olivan-Viguera A, 2014, ACTA PHYSIOL, V212, P32; Olivan-Viguera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058614; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Parihar AS, 2003, EUR J PHARMACOL, V471, P157, DOI 10.1016/S0014-2999(03)01825-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qian X, 2014, ARTERIOSCL THROM VAS, V34, P127, DOI 10.1161/ATVBAHA.113.302506; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Romine JL, 2007, J MED CHEM, V50, P528, DOI 10.1021/jm061006n; Ruggieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047825; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Skryma RN, 1997, PROSTATE, V33, P112, DOI 10.1002/(SICI)1097-0045(19971001)33:2<112::AID-PROS5>3.0.CO;2-M; Strobaek D, 1996, NEUROPHARMACOLOGY, V35, P903, DOI 10.1016/0028-3908(96)00096-2; Strobl JS, 1995, GEN PHARMACOL, V26, P1643, DOI 10.1016/0306-3623(95)00062-3; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Thompson-Vest N, 2006, J ANAT, V208, P219, DOI 10.1111/j.1469-7580.2006.00515.x; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Turner KL, 2014, GLIA, V62, P971, DOI 10.1002/glia.22655; Van Coppenolle F, 2004, BIOCHEM J, V377, P569, DOI 10.1042/BJ20030859; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Welling PA, 2013, SEMIN NEPHROL, V33, P215, DOI 10.1016/j.semnephrol.2013.04.002; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yang XW, 2013, J HUAZHONG U SCI-MED, V33, P86, DOI 10.1007/s11596-013-1076-0; Zhou XB, 2000, AM J PHYSIOL-CELL PH, V279, pC1751, DOI 10.1152/ajpcell.2000.279.6.C1751	73	41	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122992	10.1371/journal.pone.0122992	http://dx.doi.org/10.1371/journal.pone.0122992			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848765	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800190
J	Techa, S; Chung, JS				Techa, Sirinart; Chung, J. Sook			Ecdysteroids Regulate the Levels of Molt-Inhibiting Hormone (MIH) Expression in the Blue Crab, Callinectes sapidus	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; CRUSTACEAN HYPERGLYCEMIC HORMONE; Y-ORGANS INVITRO; CARCINUS-MAENAS; MANDUCA-SEXTA; FIDDLER-CRAB; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; UCA-PUGILATOR; PROCAMBARUS-CLARKII	Arthropod molt is coordinated through the interplay between ecdysteroids and neuropeptide hormones. In crustaceans, changes in the activity of Y-organs during the molt cycle have been regulated by molt-inhibiting hormone (MIH) and crustacean hyperglycemic hormone (CHH). Little has been known of the mode of direct effects of ecdysteroids on the levels of MIH and CHH in the eyestalk ganglia during the molt cycle. This study focused on a putative feedback of ecdysteroids on the expression levels of MIH transcripts using in vitro incubation study with ecdysteroids and in vivo RNAi in the blue crab, Callinectes sapidus. Our results show a specific expression of ecdysone receptor (EcR) in which EcR1 is the major isoform in eyestalk ganglia. The initial elevation of MIH expression at the early premolt stages is replicated by in vitro incubations of eyestalk ganglia with ecdysteroids that mimic the intrinsic conditions of D-0 stage: the concentration (75 ng/ml) and composition (ponasterone A and 20-hydroxyecdysone at a 3:1 (w:w) ratio). Additionally, multiple injections of EcR1-dsRNA reduce MIH expression by 67%, compared to the controls. Our data provide evidence on a putative feedback mechanism of hormonal regulation during molting cycle, specifically how the molt cycle is repeated during the life cycle of crustaceans. The elevated concentrations of ecdysteroids at early premolt stage may act positively on the levels of MIH expression in the eyestalk ganglia. Subsequently, the increased MIH titers in the hemolymph at postmolt would inhibit the synthesis and release of ecdysteroids by Y-organs, resulting in re-setting the subsequent molt cycle.	[Techa, Sirinart; Chung, J. Sook] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Columbus Ctr, Baltimore, MD 21202 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Chung, JS (corresponding author), Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Columbus Ctr, 701 E Pratt St, Baltimore, MD 21202 USA.	chung@umces.edu	Chung, J.Sook/D-3832-2012	Chung, J.Sook/0000-0002-9318-304X	United States-Israel Binational Agricultural Research and Development (BARD) fund [MB-8714-08]; Thai government scholarship (National Science and Technology Development Agency, NSTDA)	United States-Israel Binational Agricultural Research and Development (BARD) fund; Thai government scholarship (National Science and Technology Development Agency, NSTDA)	This work was supported by Research Grant MB-8714-08 from the United States-Israel Binational Agricultural Research and Development (BARD) fund. ST was supported by a Thai government scholarship (National Science and Technology Development Agency, NSTDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGER K, 1987, MAR BIOL, V94, P367, DOI 10.1007/BF00428242; Antoniewski C, 1996, MOL CELL BIOL, V16, P2977; Asazuma H, 2007, COMP BIOCHEM PHYS B, V148, P139, DOI 10.1016/j.cbpb.2007.05.002; BEYDON P, 1983, J INSECT PHYSIOL, V29, P529, DOI 10.1016/0022-1910(83)90084-7; BIDMON HJ, 1992, EXPERIENTIA, V48, P42, DOI 10.1007/BF01923604; Chan SM, 2003, GEN COMP ENDOCR, V134, P214, DOI 10.1016/S0016-6480(03)00263-6; Chan SM, 1998, GENE, V224, P23, DOI 10.1016/S0378-1119(98)00517-4; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chang ES, 2001, AM ZOOL, V41, P1090, DOI 10.1668/0003-1569(2001)041[1090:HITLOC]2.0.CO;2; Chung ACK, 1998, GEN COMP ENDOCR, V109, P375, DOI 10.1006/gcen.1997.7046; Chung ACK, 1998, MOL CELL ENDOCRINOL, V139, P209, DOI 10.1016/S0303-7207(98)00056-2; Chung JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046299; Chung JS, 2010, ARCH INSECT BIOCHEM, V73, P1, DOI 10.1002/arch.20327; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Chung J Sook, 2008, Saline Syst, V4, P18, DOI 10.1186/1746-1448-4-18; Chung JS, 2005, ENDOCRINOLOGY, V146, P5545, DOI 10.1210/en.2005-0859; Chung JS, 2003, EUR J BIOCHEM, V270, P3280, DOI 10.1046/j.1432-1033.2003.03720.x; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Dell S, 1999, ARCH INSECT BIOCHEM, V41, P148, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;148::AID-ARCH6&gt;3.0.CO;2-U; Diederen JHB, 2002, MICROSC RES TECHNIQ, V56, P227, DOI 10.1002/jemt.10026; DRACH P, 1967, VIE MILIEU A BIOL MA, V18, P595; Durica DS, 2006, INTEGR COMP BIOL, V46, P948, DOI 10.1093/icb/icl005; Durica DS, 2002, MOL CELL ENDOCRINOL, V189, P59, DOI 10.1016/S0303-7207(01)00740-7; Far RKK, 2003, NUCLEIC ACIDS RES, V31, P4417, DOI 10.1093/nar/gkg649; Ghbeish N, 2001, P NATL ACAD SCI USA, V98, P3867, DOI 10.1073/pnas.061437798; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gu PL, 1998, FEBS LETT, V441, P397, DOI 10.1016/S0014-5793(98)01573-7; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; HOPKINS PM, 1986, GEN COMP ENDOCR, V63, P362, DOI 10.1016/0016-6480(86)90135-8; HOPKINS PM, 1992, AM ZOOL, V32, P450; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; Kozlova T, 2000, TRENDS ENDOCRIN MET, V11, P276, DOI 10.1016/S1043-2760(00)00282-4; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lachaise A., 1993, J CRUSTACEAN BIOL, V13, P198; LACHAISE F, 1984, STEROIDS, V43, P243, DOI 10.1016/0039-128X(84)90043-6; LACHAISE F, 1989, J EXP ZOOL, V252, P283, DOI 10.1002/jez.1402520311; Lu WQ, 2000, GENE, V253, P197, DOI 10.1016/S0378-1119(00)00282-1; Luo KQ, 2004, BIOCHEM BIOPH RES CO, V318, P303, DOI 10.1016/j.bbrc.2004.04.027; Martin-Creuzburg D, 2007, GEN COMP ENDOCR, V151, P66, DOI 10.1016/j.ygcen.2006.11.015; MATTSON MP, 1986, BIOL BULL, V171, P264, DOI 10.2307/1541922; MATTSON MP, 1986, GEN COMP ENDOCR, V63, P414, DOI 10.1016/0016-6480(86)90141-3; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Nagaraju GPC, 2011, J ENDOCRINOL, V210, P379, DOI 10.1530/JOE-11-0154; Nakatsuji T, 2004, GEN COMP ENDOCR, V135, P358, DOI 10.1016/j.ygcen.2003.11.001; Nakatsuji T, 2006, MOL CELL ENDOCRINOL, V253, P76, DOI 10.1016/j.mce.2006.05.001; Nimitkul S, 2010, SICB M, V129; Oates AC, 2000, DEV BIOL, V224, P20, DOI 10.1006/dbio.2000.9761; REES HH, 1995, EUR J ENTOMOL, V92, P9; SAKURAI S, 1989, GEN COMP ENDOCR, V75, P204, DOI 10.1016/0016-6480(89)90072-5; Seinen E, 2011, BRIEF FUNCT GENOMICS, V10, P206, DOI 10.1093/bfgp/elr017; SNYDER MJ, 1991, GEN COMP ENDOCR, V81, P133, DOI 10.1016/0016-6480(91)90133-Q; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; SPAZIANI E, 1993, MOL CELL ENDOCRINOL, V95, P111, DOI 10.1016/0303-7207(93)90035-I; Styrishave B, 2008, J MAR BIOL ASSOC UK, V88, P575, DOI [10.1017/S0025315408000878, 10.1017/S0025315408000879]; Suganthi AS, 1999, ZOOL STUD, V38, P314; Takaki K, 2003, INSECT BIOCHEM MOLEC, V33, P1189, DOI 10.1016/j.ibmb.2003.06.006; TAMONE SL, 1993, GEN COMP ENDOCR, V89, P425, DOI 10.1006/gcen.1993.1050; Tarrant AM, 2011, GEN COMP ENDOCR, V173, P346, DOI 10.1016/j.ygcen.2011.06.010; Techa S, 2013, GENE, V527, P139, DOI 10.1016/j.gene.2013.05.035; Thomton JD, 2006, J CRUSTACEAN BIOL, V26, P176, DOI 10.1651/C-2625.1; TRAVIS DF, 1955, BIOL BULL, V109, P484, DOI 10.2307/1539178; Truman JW, 1996, SCIENCE, V271, P40, DOI 10.1126/science.271.5245.40; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Verhaegen Y, 2011, GEN COMP ENDOCR, V172, P158, DOI 10.1016/j.ygcen.2011.02.019; Wang WL, 2000, J EXP ZOOL, V286, P725, DOI 10.1002/(SICI)1097-010X(20000601)286:7<725::AID-JEZ7>3.0.CO;2-N; Wang YH, 2009, MOL CELL ENDOCRINOL, V309, P109, DOI 10.1016/j.mce.2009.05.016; WATSON RD, 1986, INSECT BIOCHEM, V16, P149, DOI 10.1016/0020-1790(86)90089-2; WEBSTER SG, 1986, GEN COMP ENDOCR, V61, P237, DOI 10.1016/0016-6480(86)90201-7; WEBSTER SG, 1986, J COMP PHYSIOL B, V156, P617, DOI 10.1007/BF00692738; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; WHISENTON LR, 1987, GEN COMP ENDOCR, V66, P62, DOI 10.1016/0016-6480(87)90350-9; WHISENTON LR, 1987, MOL CELL ENDOCRINOL, V54, P171, DOI 10.1016/0303-7207(87)90154-7; Zmora N, 2014, ENDOCRINOLOGY, V155, P230, DOI 10.1210/en.2013-1603; Zmora Nilli, 2009, Saline Syst, V5, P6, DOI 10.1186/1746-1448-5-6; Zmora Nilli, 2009, Saline Syst, V5, P7, DOI 10.1186/1746-1448-5-7	75	44	45	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0117278	10.1371/journal.pone.0117278	http://dx.doi.org/10.1371/journal.pone.0117278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849453	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800003
J	Yang, XJ; Wang, X; Wang, K; Su, LX; Li, HM; Li, R; Shen, QR				Yang, Xiujuan; Wang, Xuan; Wang, Kang; Su, Lanxi; Li, Hongmei; Li, Rong; Shen, Qirong			The Nematicidal Effect of Camellia Seed Cake on Root-Knot Nematode Meloidogyne javanica of Banana	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; SOLID-PHASE MICROEXTRACTION; PLANT-PARASITIC NEMATODES; TRITERPENOID SAPONINS; PANAX-NOTOGINSENG; IDENTIFICATION; STRATEGIES; INCOGNITA; EXTRACTS; SYSTEMS	Suppression of root-knot nematodes is crucially important for maintaining the worldwide development of the banana industry. Growing concerns about human and environmental safety have led to the withdrawal of commonly used nematicides and soil fumigants, thus motivating the development of alternative nematode management strategies. In this study, Meloidogyne javanica was isolated, and the nematicidal effect of Camellia seed cake on this pest was investigated. The results showed that in dish experiments, Camellia seed cake extracts under low concentration (2 g/L) showed a strong nematicidal effect. After treatment for 72 h, the eggs of M. javanica were gradually dissolved, and the intestine of the juveniles gradually became indistinct. Nematicidal compounds, including saponins identified by HPLC-ESI-MS and 8 types of volatile compounds identified by GC-MS, exhibited effective nematicidal activities, especially 4-methylphenol. The pot experiments demonstrated that the application of Camellia seed cake suppressed M. javanica, and promoted the banana plant growth. This study explored an effective nematicidal agent for application in soil and revealed its potential mechanism of nematode suppression.	[Yang, Xiujuan; Wang, Kang; Su, Lanxi; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China; [Yang, Xiujuan; Wang, Kang; Su, Lanxi; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Engn Ctr Solid Organ Waste Utilizat, Nanjing, Jiangsu, Peoples R China; [Wang, Xuan; Li, Hongmei] Nanjing Agr Univ, Dept Plant Pathol, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Li, R (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China.	lirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Yang, Xiujuan/HHC-5802-2022	Yang, Xiujuan/0000-0002-1923-0629	National Key Basic Research Program of China [2015CB150506]; National Natural Science Foundation of China [31372142]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project [B12009]; National Key Technology R&D Program of the Ministry of Science and Technology [2011BAD11B03]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project(Ministry of Education, China - 111 Project); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); Innovative Research Team Development Plan of the Ministry of Education of China	This work was supported by the National Key Basic Research Program of China (2015CB150506), the National Natural Science Foundation of China (31372142), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), 111 project (B12009), the National Key Technology R&D Program of the Ministry of Science and Technology (2011BAD11B03), and the Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MAM, 2007, PLANT PATHOL, V56, P190, DOI 10.1111/j.1365-3059.2006.01455.x; BYBD DW, 1983, J NEMATOL, V15, P142; Chen RS, 2012, PADDY WATER ENVIRON, V10, P291, DOI 10.1007/s10333-011-0280-4; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; D'Addabbo T, 2011, PHYTOCHEM REV, V10, P503, DOI 10.1007/s11101-010-9180-2; Dawar S, 2007, PAK J BOT, V39, P2209; Dinda B, 2010, CHEM BIODIVERS, V7, P2327, DOI 10.1002/cbdv.200800070; El-Rokiek Kowthar Gad, 2011, Journal of Plant Protection Research, V51, P121, DOI 10.2478/v10045-011-0021-0; Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P1463; Gowen S., 1990, P431; [贺国文 He Guowen], 2008, [理化检验. B, 化学分册, Physical Testing and Chemical Analysis], V44, P1169; Huang Yong, 2013, Journal of Southwest Forestry University, V33, P1; Hussain MA, 2011, PAK J BOT, V43, P197; Irshad U, 2011, SOIL BIOL BIOCHEM, V43, P2121, DOI 10.1016/j.soilbio.2011.06.015; Jabeen S., 1996, Proceedings of Parasitology, P11; JaizmeVega MC, 1997, PLANT SOIL, V196, P27, DOI 10.1023/A:1004236310644; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Lee CP, 2006, J AGR FOOD CHEM, V54, P779, DOI 10.1021/jf052325a; Li G, 2013, Patent No. [CN103439426A, 103439426]; Li H, 2008, NEMATOLOGY, V10, P335, DOI 10.1163/156854108783900294; Long J, 2010, N CHINA HORTICULTURE, V22, P148; Mansoor F, 2007, PAK J BOT, V39, P2113; MOJTAHEDI H, 1991, J NEMATOL, V23, P170; Njuguna D. G., 2013, International Journal of Research in Chemistry and Environment (IJRCE), V3, P253; Oka Y, 2000, PEST MANAG SCI, V56, P983, DOI 10.1002/1526-4998(200011)56:11<983::AID-PS233>3.0.CO;2-X; Oka Y, 2013, PEST MANAG SCI, V69, P1225, DOI 10.1002/ps.3487; Pradhan M. A. A., 2012, Bangladesh Journal of Agricultural Research, V37, P271, DOI 10.3329/bjar.v37i2.11230; Queneherve P, 2009, EUPHYTICA, V165, P123, DOI 10.1007/s10681-008-9773-7; Remen C, 2010, SOIL BIOL BIOCHEM, V42, P978, DOI 10.1016/j.soilbio.2010.02.017; Rumbos CI, 2011, AUST J CROP SCI, V5, P1388; Shen ZZ, 2013, EUR J SOIL BIOL, V57, P1, DOI 10.1016/j.ejsobi.2013.03.006; Siddiqui MA, 2003, SOIL BIOL BIOCHEM, V35, P1615, DOI 10.1016/j.soilbio.2003.08.006; SIKORA RA, 1973, PLANT DIS REP, V57, P615; Silva CL, 2011, BRIT J CANCER, V105, P1894, DOI 10.1038/bjc.2011.437; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Sun HX, 2005, VACCINE, V23, P5533, DOI 10.1016/j.vaccine.2005.07.036; Tian JK, 2006, CHEM PHARM BULL, V54, P567, DOI 10.1248/cpb.54.567; TOMASZEWSKI EK, 1994, J NEMATOL, V26, P436; Tranthim-Fryer DJ, 2001, J FORENSIC SCI, V46, P934; Vovlas N, 2005, PLANT PATHOL, V54, P657, DOI 10.1111/j.1365-3059.2005.01244.x; Wang BB, 2013, BIOL FERT SOILS, V49, P435, DOI 10.1007/s00374-012-0739-5; Wang KH, 2009, PLANT DIS, pPD; Wang LongPing, 2013, Journal of Anhui Agricultural University, V40, P642; Wardencki W, 2004, INT J FOOD SCI TECH, V39, P703, DOI 10.1111/j.1365-2621.2004.00839.x; Xiao TongJian, 2012, African Journal of Microbiology Research, V6, P2321; Yoshikawa M, 1997, CHEM PHARM BULL, V45, P1039, DOI 10.1248/cpb.45.1039	47	14	15	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119700	10.1371/journal.pone.0119700	http://dx.doi.org/10.1371/journal.pone.0119700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849382	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800015
J	Yin, L; Ling, XY; Zhang, YF; Shen, H; Min, J; Xi, W; Wang, J; Wang, ZN				Yin, Liang; Ling, Xinyu; Zhang, Yufeng; Shen, Hua; Min, Jie; Xi, Wang; Wang, Jing; Wang, Zhinong			CHADS(2) and CHA(2)DS(2)-VASc Scoring Systems for Predicting Atrial Fibrillation following Cardiac Valve Surgery	PLOS ONE			English	Article							MANAGEMENT; GUIDELINES; PREVENTION; MORTALITY; OUTCOMES; UPDATE; RISKS	Objective Clinical use of CHADS(2) and CHA(2)DS(2)-VASc scoring systems for predicting AF following cardiac surgery have been reported in previous studies and demonstrated well-validated predictive value. We sought to investigate whether the two scoring systems are effective for predicting new-onset of AF following cardiac valve surgery and to demonstrate its potential utility of clinical assessment. Methods Medical records of all patients underwent cardiac valve surgeries during the period of January 2003 and December 2013 without preoperative AF at the cardiac center of our university were reviewed. The main outcome end point of our study was the early new-onset of AF following cardiac valve surgery. Results There were overall 518 patients involved in this study, with 234 (45.17%) developed POAF following valve surgery. Patients with POAF had older age (P = 0.23) and higher BMI (P = 0.013) than those without POAF. History of heart failure (P = 0.025), hypertension (P = 0.021), previous stroke or TIA (P = 0.032), coronary artery disease (P = 0.001), carotid artery disease (P = 0.024) and preoperative medication of statins (P = 0.021) were significantly more recorded in POAF group. Patients with POAF also had higher LAD (P = 0.013) and E/e' ratio (P < 0.001). The CHADS(2) and CHA(2)DS(2)-VASc scores were significantly higher in patients with POAF (P = 0.002; P < 0.001), and under univariate and multivariate regression analysis the CHADS(2) and CHA(2)DS(2)-VASc scores were significant predictors of POAF (P = 0.001; P < 0.001). Based on stratification of CHADS(2) and CHA(2)DS(2)-VASc scores, the Kaplan-Meier analysis obtained a higher POAF rate on patients with higher stratification of CHADS(2) and CHA(2)DS(2)-VASc scores (P < 0.001; P < 0.001). Conclusion In conclusion, CHADS(2) and CHA(2)DS(2)-VASc scores were directly associated with the incidence of POAF following valve surgery and a higher score was strongly predictive of POAF.	[Yin, Liang; Ling, Xinyu; Zhang, Yufeng; Shen, Hua; Min, Jie; Xi, Wang; Wang, Jing; Wang, Zhinong] Second Mil Med Univ, Dept Cardiothorac Surg, Changzheng Hosp, Shanghai 200003, Peoples R China	Naval Medical University	Wang, ZN (corresponding author), Second Mil Med Univ, Dept Cardiothorac Surg, Changzheng Hosp, Shanghai 200003, Peoples R China.	wangzn007@163.com	Zhang, Yufeng/GZL-1973-2022		National Nature Science Foundation of China [81170232, 81300102]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (NO. 81170232 and 81300102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlsson A, 2014, SCANDINAVIAN CARDIOV; Anderson JL, 2013, CIRCULATION, V127, P1916, DOI 10.1161/CIR.0b013e318290826d; Andrikopoulos G, 2012, HELL J CARDIOL, V53, P407; Azemi T, 2012, J AM SOC ECHOCARDIOG, V25, P1327, DOI 10.1016/j.echo.2012.09.004; Benedetto U, 2013, J CARDIOVASC MED, V14, P104, DOI 10.2459/JCM.0b013e32834a13c1; Bhave PD, 2012, AM HEART J, V164, P918, DOI 10.1016/j.ahj.2012.09.004; Bramer S, 2011, ANN THORAC SURG, V92, P2091, DOI 10.1016/j.athoracsur.2011.06.079; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Carmo GAL, 2012, HEART RHYTHM, V9, pE12, DOI 10.1016/j.hrthm.2012.03.043; Chao TF, 2011, J AM COLL CARDIOL, V58, P2380, DOI 10.1016/j.jacc.2011.08.045; Chua SK, 2013, CIRCULATION J OFFICI, V78, P265; Chua SK, 2013, J THORAC CARDIOV SUR, V146, P919, DOI 10.1016/j.jtcvs.2013.03.040; Curtis AB, 2011, POSTGRAD MED, V123, P7, DOI 10.3810/pgm.2011.11.2491; Efird JT, 2014, EUR J CARDIO-THORAC, V45, pE20, DOI 10.1093/ejcts/ezt529; Erdil N, 2013, ANN THORACIC CARDIOV; Hashemzadeh K, 2013, J CARDIOVASC THORAC, V5, P101, DOI 10.5681/jcvtr.2013.022; Hogue CW, 2005, CHEST, V128, p9S, DOI 10.1378/chest.128.2_suppl.9S; Hung CY, 2013, AM J MED, V126, P133, DOI 10.1016/j.amjmed.2012.06.027; Kotowycz MA, 2011, CAN J CARDIOL, V27, P506, DOI 10.1016/j.cjca.2011.01.002; Lorenzo-Seva U, 2010, BEHAV RES METHODS, V42, P29, DOI 10.3758/BRM.42.1.29; Meiltz A, 2008, EUROPACE, V10, P674, DOI 10.1093/europace/eun086; Narducci ML, 2013, J CARDIOTHORACIC VAS; Omae T, 2012, J ANESTH, V26, P429, DOI 10.1007/s00540-012-1330-9; Yin L, 2010, HEART LUNG CIRC, V19, P579, DOI 10.1016/j.hlc.2010.06.664	25	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123858	10.1371/journal.pone.0123858	http://dx.doi.org/10.1371/journal.pone.0123858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849563	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800257
J	Zhang, ML; Wen, ZB; Fritsch, PW; Sanderson, SC				Zhang, Ming-Li; Wen, Zhi-Bin; Fritsch, Peter W.; Sanderson, Stewart C.			Spatiotemporal Evolution of Calophaca (Fabaceae) Reveals Multiple Dispersals in Central Asian Mountains	PLOS ONE			English	Article							TIBETAN PLATEAU; LATE MIOCENE; MOLECULAR PHYLOGENY; VICARIANCE ANALYSIS; GLACIAL REFUGIA; UPLIFT; DIVERSIFICATION; BIOGEOGRAPHY; RADIATION; PATTERNS	Background The Central Asian flora plays a significant role in Eurasia and the Northern Hemisphere. Calophaca, a member of this flora, includes eight currently recognized species, and is centered in Central Asia, with some taxa extending into adjacent areas. A phylogenetic analysis of the genus utilizing nuclear ribosomal ITS and plastid trnS-trnG and rbcL sequences was carried out in order to confirm its taxonomic status and reconstruct its evolutionary history. Methodology/Principal Finding We employed BEAST Bayesian inference for dating, and S-DIVA and BBM for ancestral area reconstruction, to study its spatiotemporal evolution. Our results show that Calophacais monophyletic and nested within Caragana. The divergence time of Calophaca is estimated at ca. 8.0 Ma, most likely driven by global cooling and aridification, influenced by rapid uplift of the Qinghai Tibet Plateau margins. Conclusions/Significance According to ancestral area reconstructions, the genus most likely originated in the Pamir Mountains, a global biodiversity hotspot and hypothesized Tertiary refugium of many Central Asian plant lineages. Dispersals from this location are inferred to the western Tianshan Mountains, then northward to the Tarbagatai Range, eastward to East Asia, and westward to the Caucasus, Russia, and Europe. The spatiotemporal evolution of Calophaca provides a case contributing to an understanding of the flora and biodiversity of the Central Asian mountains and adjacent regions.	[Zhang, Ming-Li; Wen, Zhi-Bin] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Fritsch, Peter W.] Calif Acad Sci, Dept Bot, San Francisco, CA 94118 USA; [Sanderson, Stewart C.] US Forest Serv, Shrub Sci Lab, Intermt Res Stn, USDA, Provo, UT USA	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; California Academy of Sciences; United States Department of Agriculture (USDA); United States Forest Service	Zhang, ML (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China.	zhangml@ibcas.ac.cn			China National Basic Research Special Program [2012FY111500]; Innovation Research Group Program of Chinese Academy of Sciences and State Administration of Foreign Experts Affairs of China [KZCX2-YW-T09]; State International Science and Technology Cooperation Program of China [2010DFA92720]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	China National Basic Research Special Program; Innovation Research Group Program of Chinese Academy of Sciences and State Administration of Foreign Experts Affairs of China; State International Science and Technology Cooperation Program of China; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by China National Basic Research Special Program (2012FY111500), Innovation Research Group Program of Chinese Academy of Sciences and State Administration of Foreign Experts Affairs of China (KZCX2-YW-T09), State International Science and Technology Cooperation Program of China (2010DFA92720), and Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAKHANJANZ O, 1995, ECOL STUD-ANAL SYNTH, V113, P63; Ali SS, 2012, ANN BOT-LONDON, V109, P95, DOI 10.1093/aob/mcr274; Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 1963, PLANTS CENTRAL ASIA, p[1, 1]; Borissova AG, 1945, FLORA USSR, V11, P327; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; [常朝阳 Chang Zhaoyang], 2004, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V24, P2312; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ducea MN, 2003, GEOLOGY, V31, P849, DOI 10.1130/G19707.1; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gorbunova NN, 1987, SYSTEMATICS CARAGANA; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kadereit JW, 2008, PLANT ECOL DIVERS, V1, P171, DOI 10.1080/17550870802328751; Kreuter E, 1955, CHROMOSOME ATLAS FLO, P163; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li S-F, 1998, ACTA BOT BOR OCCID S, V18, P58; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu XJ, 2012, QUAT GEOCHRONOL, V10, P37, DOI 10.1016/j.quageo.2012.01.016; Lock J.M., 2005, LEGUMES WORLD, P489; Ma Qian, 2012, Chinese Journal of Applied and Environmental Biology, V18, P391, DOI 10.3724/SP.J.1145.2012.00391; Magulaev A. Yu., 1980, Botanicheskii Zhurnal, V65, P836; Malyshev LI, 2008, CONTEMP PROBL ECOL+, V1, P440, DOI 10.1134/S1995425508040073; Mao KS, 2012, P NATL ACAD SCI USA, V109, P7793, DOI 10.1073/pnas.1114319109; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Miao YF, 2011, QUATERN INT, V236, P3, DOI 10.1016/j.quaint.2010.08.014; Molnar P, 2005, PALAEONTOL ELECTRON, V8; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Polhill R. M., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)]., P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyankov VI, 2000, OECOLOGIA, V123, P15, DOI 10.1007/s004420050985; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; QUADE J, 1995, PALAEOGEOGR PALAEOCL, V115, P91, DOI 10.1016/0031-0182(94)00108-K; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Sun JM, 2009, GEOLOGY, V37, P1051, DOI 10.1130/G30278A.1; Sun JM, 2009, TECTONOPHYSICS, V463, P60, DOI 10.1016/j.tecto.2008.09.008; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Takhtajan A, 1969, FLOWERING PLANTS ORI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang YJ, 2004, ACTA PHYTOTAXON SIN, V42, P481; Wang YJ, 2009, BIOL J LINN SOC, V97, P893, DOI 10.1111/j.1095-8312.2009.01225.x; Wojciechowski M.F., 2000, ADV LEGUME SYST, V9, P277; Wojciechowski MF, 2005, BRITTONIA, V57, P382, DOI 10.1663/0007-196X(2005)057[0382:AFAMPP]2.0.CO;2; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Wulff E, 1944, HIST PLANT GEOGRAPHY; Xu L-R, 1992, ACTA BOT BOREAL OCCI, V12, P149; Yakovlev G.P., 1996, LEGUMES NO EURASIA C; Yu Y., 2011, RASP RECONSTRUCT ANC; Zachos F.E., 2011, BIODIVERSITY HOTSPOT; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhang ML, 2009, MOL PHYLOGENET EVOL, V50, P547, DOI 10.1016/j.ympev.2008.12.001; Zhang Z-W, 1993, FLORA CHINA, V42, P67; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2; Zhu X-Y, 2010, FLORA CHINA, V10, P527	73	7	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123228	10.1371/journal.pone.0123228	http://dx.doi.org/10.1371/journal.pone.0123228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849146	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800216
J	Xu, L; Cao, F; Xu, F; He, BC; Dong, Z				Xu, Lu; Cao, Fang; Xu, Feng; He, Baicheng; Dong, Zhi			Bexarotene Reduces Blood-Brain Barrier Permeability in Cerebral Ischemia-Reperfusion Injured Rats	PLOS ONE			English	Article							APOLIPOPROTEIN-E; MATRIX METALLOPROTEINASES; IN-VITRO; MICE; MODELS; ISCHEMIA/REPERFUSION; INTEGRITY; INFUSION; DISEASE; STROKE	Background Matrix metalloproteinase-9 (MMP-9) over-expression disrupts the blood-brain barrier (BBB) in the ischemic brain. The retinoid X receptor agonist bexarotene suppresses MMP-9 expression in endothelial cells and displays neuroprotective effects. Therefore, we hypothesized that bexarotene may have a beneficial effect on I/R-induced BBB dysfunction. Methods A total of 180 rats were randomized into three groups (n = 60 each): (i) a sham-operation group, (ii) a cerebral ischemia-reperfusion (I/R) group, and (iii) an I/R+bexarotene group. Brain water content was measured by the dry wet weight method. BBB permeability was analyzed by Evans Blue staining and the magnetic resonance imaging contrast agent Omniscan. MMP-9 mRNA expression, protein expression, and activity were assessed by reverse transcription polymerase chain reaction, Western blotting, and gelatin zymography, respectively. Apolipoprotein E (apoE), claudin-5, and occludin expression were analyzed by Western blotting. Results After 24 h, 48 h, and 72 h post-I/R, several effects were observed with bexarotene administration: (i) brain water content and BBB permeability were significantly reduced; (ii) MMP-9 mRNA and protein expression as well as activity were significantly decreased; (iii) claudin-5 and occludin expression were significantly increased; and (iv) apoE expression was significantly increased. Conclusions Bexarotene decreases BBB permeability in rats with cerebral I/R injury. This effect may be due in part to bexarotene's upregulation of apoE expression, which has been previously shown to reduce BBB permeability through suppressing MMP-9-mediated degradation of the tight junction proteins claudin-5 and occludin. This work offers insight to aid future development of therapeutic agents for cerebral I/R injury in human patients.	[Xu, Lu; Cao, Fang; Xu, Feng; He, Baicheng; Dong, Zhi] Chongqing Med Univ, Coll Pharm, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China	Chongqing Medical University	Dong, Z (corresponding author), Chongqing Med Univ, Coll Pharm, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	dongzhi8623@163.com			 [2010ZX09401-306-1-1]		This study was financially supported by the national major special fund(2010ZX09401-306-1-1) 2010-2013, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Akamatsu Y, 2011, NEUROSCI LETT, V503, P110, DOI 10.1016/j.neulet.2011.08.018; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bomben V, 2014, NEUROBIOL AGING, V35, P2091, DOI 10.1016/j.neurobiolaging.2014.03.029; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Clark AW, 1997, NEUROSCI LETT, V238, P53, DOI 10.1016/S0304-3940(97)00859-8; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Fu JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-227; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Lerner V, 2013, J CLIN PSYCHIAT, V74, P1224, DOI 10.4088/JCP.12m08160; Liu Y, 2014, BRAIN RES, V1544, P45, DOI 10.1016/j.brainres.2013.11.031; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Shimbo D, 2014, BRAIN RES, V1554, P59, DOI 10.1016/j.brainres.2014.01.038; Ulrich JD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-13; Vonderheid Eric C, 2003, Dermatol Ther, V16, P276, DOI 10.1111/j.1396-0296.2003.01638.x; Wu YJ, 2014, NEUROSCI LETT, V558, P26, DOI 10.1016/j.neulet.2013.09.005; Xin HL, 2012, NEURAL REGEN RES, V7, P2405, DOI 10.3969/j.issn.1673-5374.2012.31.001; Yamashita T, 2011, ACTA MED OKAYAMA, V65, P219; Zheng MH, 2014, J MOL NEUROSCI, V54, P282, DOI 10.1007/s12031-014-0291-x; Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003	30	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122744	10.1371/journal.pone.0122744	http://dx.doi.org/10.1371/journal.pone.0122744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844636	gold, Green Published, Green Submitted			2022-12-27	WOS:000352475700013
J	Boittin, FX; Denis, J; Mayol, JF; Martigne, P; Raffin, F; Coulon, D; Grenier, N; Drouet, M; Herodin, F				Boittin, Francois-Xavier; Denis, Josiane; Mayol, Jean-Francois; Martigne, Patrick; Raffin, Florent; Coulon, David; Grenier, Nancy; Drouet, Michel; Herodin, Francis			The Extent of Irradiation-Induced Long-Term Visceral Organ Damage Depends on Cranial/Brain Exposure	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; PITUITARY-ADRENAL AXIS; NECROSIS-FACTOR-ALPHA; IONIZING-RADIATION; BRAIN IRRADIATION; DRUG PHARMACOKINETICS; DYSFUNCTION SYNDROME; RAT-BRAIN; ADULT-RAT; MICE	In case of high-dose radiation exposure, mechanisms controlling late visceral organ damage are still not completely understood and may involve the central nervous system. To investigate the influence of cranial/brain irradiation on late visceral organ damage in case of high-dose exposure, Wistar rats were irradiated at 12 Gy, with either the head and fore limbs or the two hind limbs protected behind a lead wall (head-and hind limbs-protected respectively), which allows long-term survival thanks to bone marrow protection. Although hind limbs- and head-protected irradiated rats exhibited similar hematopoietic and spleen reconstitution, a late body weight loss was observed in hind limbs-protected rats only. Histological analysis performed at this time revealed that late damages to liver, kidney and ileum were attenuated in rats with head exposed when compared to animals whose head was protected. Plasma measurements of inflammation biomarkers (haptoglobin and the chemokine CXCL1) suggest that the attenuated organ damage in hind limbs-protected rats may be in part related to reduced acute and chronic inflammation. Altogether our results demonstrate the influence of cranial/brain exposure in the onset of organ damage.	[Boittin, Francois-Xavier; Denis, Josiane; Mayol, Jean-Francois; Martigne, Patrick; Raffin, Florent; Coulon, David; Grenier, Nancy; Drouet, Michel; Herodin, Francis] Inst Rech Biomed Armees, Dept Radiobiol, Bretigny Sur Orge, France		Boittin, FX (corresponding author), Inst Rech Biomed Armees, Dept Radiobiol, Bretigny Sur Orge, France.	francois-xavier.boittin@irba.fr			DGA (Direction Generale de l'Armement) [PDH2-NRBC4-NR404]	DGA (Direction Generale de l'Armement)	This work was supported by a grant from DGA (Direction Generale de l'Armement): Grant PDH2-NRBC4-NR404.	Booth C, 2012, HEALTH PHYS, V103, P400, DOI 10.1097/HP.0b013e31826530e2; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45, DOI 10.1080/095530097143527; De la Cal C, 2012, OPEN DENT J, V6, P8, DOI 10.2174/1874210601206010008; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Fernandez R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00489; Franko AJ, 1997, RADIAT RES, V147, P245, DOI 10.2307/3579426; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; GERACI JP, 1995, RADIAT RES, V143, P58, DOI 10.2307/3578926; GIRINSKY TA, 1994, RADIAT RES, V139, P360, DOI 10.2307/3578835; Gourmelon P., 2005, BR J RADIOL S, V78, P62; Groza P, 1975, Physiologie, V12, P53; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; Johnston CJ, 2010, RADIAT RES, V173, P522, DOI 10.1667/RR1882.1; Lebaron-Jacobs L, 2004, RADIAT RES, V161, P712, DOI 10.1667/RR3180; Linard C, 2005, J NEUROIMMUNOL, V168, P83, DOI 10.1016/j.jneuroim.2005.07.007; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056607; Magana E, 2003, SOUTH MED J, V96, P521, DOI 10.1097/01.SMJ.0000054502.81803.A3; MAGIC Z, 1995, RADIAT RES, V143, P187, DOI 10.2307/3579156; Marquette C, 2003, INT J RADIAT BIOL, V79, P777, DOI 10.1080/09553000310001610998; Merino-Sanjuan M, 2011, NUTR HOSP, V26, P1296, DOI [10.1590/S0212-16112011000600016, 10.3305/nh.2011.26.6.5403]; MICHALOWSKI AS, 1994, ACTA ONCOL, V33, P139, DOI 10.3109/02841869409098397; MINKOVA M I, 1988, Acta Physiologica et Pharmacologica Bulgarica, V14, P63; Mizock BA, 2009, DM-DIS MON, V55, P476, DOI 10.1016/j.disamonth.2009.04.002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MOULDER JE, 1990, INT J RADIAT ONCOL, V19, P1389, DOI 10.1016/0360-3016(90)90349-O; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Rabbani ZN, 2007, INT J RADIAT ONCOL, V67, P573, DOI 10.1016/j.ijrobp.2006.09.053; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; RAO KR, 1988, BRIT J RADIOL, V61, P839, DOI 10.1259/0007-1285-61-729-839; Robinson ICAF, 2001, J ENDOCRINOL, V169, P519, DOI 10.1677/joe.0.1690519; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Slamberova Romana, 2014, Prague Med Rep, V115, P43; Spitz DR, 2014, ANTIOXID REDOX SIGN, V20, P1407, DOI 10.1089/ars.2013.5769; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tonomura Y, 2009, HUM EXP TOXICOL, V28, P293, DOI 10.1177/0960327109105404; VANDYKE D, 1964, BLOOD, V24, P356, DOI 10.1182/blood.V24.4.356.356; Velickovic N, 2012, CELL MOL NEUROBIOL, V32, P1175, DOI 10.1007/s10571-012-9843-1; Weidenfeld J, 2013, NEUROIMMUNOMODULAT, V20, P57, DOI 10.1159/000342522; Williams JP, 2011, INT J RADIAT BIOL, V87, P851, DOI 10.3109/09553002.2011.560996; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9; Zeilstra LJW, 2000, INT J RADIAT BIOL, V76, P419, DOI 10.1080/095530000138763	44	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122900	10.1371/journal.pone.0122900	http://dx.doi.org/10.1371/journal.pone.0122900			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836679	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000118
J	Guo, TC; Gamil, AAA; Koenig, M; Evensen, O				Guo, Tz Chun; Gamil, Amr Ahmed Abdelrahim; Koenig, Melanie; Evensen, Oystein			Sequence Analysis and Identification of New Isoform of EP4 Receptors in Different Atlantic Salmon Tissues (Salmo salar L.) and Its Role in PGE2 Induced Immunomodulation In Vitro	PLOS ONE			English	Article							AGONIST-INDUCED DESENSITIZATION; PROSTANOID RECEPTORS; MESSENGER-RNA; PROSTAGLANDIN E-2; PHARMACOLOGICAL CHARACTERIZATION; TERMINAL DOMAINS; SUBTYPE; INFLAMMATION; MACROPHAGES; PROTEIN	PGE2 plays an important role in a broad spectrum of physiological and pathological processes mediated through a membrane-bound G protein-coupled receptor (GPCR) called EP receptor. In mammals, four subtypes of EP receptor (EP 1-4) are identified and each of them functions through different signal transduction pathways. Orthologous EP receptors have also been identified in other non-mammalian species, such as chicken and zebrafish. EP4 is the only identified PGE2 receptor to date in Atlantic salmon but its tissue distribution and function have not been studied in any detail. In this study, we first sequenced EP4 receptor in different tissues and found that the presence of the 3nt deletion in the 5' untranslated region was accompanied by silent mutation at nt 668. While attempting to amplify the same sequence in TO cells (an Atlantic salmon macrophage-like cell line), we failed to obtain the full-length product. Further investigation revealed different isoform of EP4 receptor in TO cells and we subsequently documented its presence in different Atlantic salmon tissues. These two isoforms of EP4 receptor share high homology in their first half of sequence but differ in the second half part with several deletion segments though the final length of coding sequence is the same for two isoforms. We further studied the immunomodulation effect of PGE2 in TO cells and found that PGE2 inhibited the induction of CXCL-10, CCL-4, IL-8 and IL-1 beta genes expression in a time dependent manner and without cAMP upregulation.	[Guo, Tz Chun; Gamil, Amr Ahmed Abdelrahim; Evensen, Oystein] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Sea Lice Res Ctr, N-0033 Oslo, Norway; [Koenig, Melanie] Synapt Vesicle Dynam, European Neurosci Inst, D-37077 Gottingen, Germany	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Univ Life Sci, Fac Vet Med & Biosci, Sea Lice Res Ctr, POB 8146 Dep, N-0033 Oslo, Norway.	oystein.evensen@nmbu.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Gamil, Amr/0000-0001-9920-6487	Research Council of Norway, SFI-Sea Lice Research Centre [203513]	Research Council of Norway, SFI-Sea Lice Research Centre(Research Council of Norway)	The work was supported by Research Council of Norway, SFI-Sea Lice Research Centre, grant number 203513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Bastepe M, 1997, MOL PHARMACOL, V51, P343, DOI 10.1124/mol.51.2.343; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Fabre JE, 2001, J CLIN INVEST, V107, P603, DOI 10.1172/JCI10881; Frolov A, 2013, PROSTAG LEUKOTR ESS, V89, P351, DOI 10.1016/j.plefa.2013.08.003; Froystad MK, 1998, DEV COMP IMMUNOL, V22, P533, DOI 10.1016/S0145-305X(98)00032-9; Fujino H, 2006, MOL PHARMACOL, V69, P13, DOI 10.1124/mol.105.017749; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; GEROZISSIS K, 1991, PROSTAG OTH LIPID M, V41, P345, DOI 10.1016/0090-6980(91)90004-Y; Goodson ML, 2005, J BIOL CHEM, V280, P7493, DOI 10.1074/jbc.M411514200; Hansson MC, 2004, AQUAT TOXICOL, V68, P219, DOI 10.1016/j.aquatox.2004.02.006; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Horseman ND, 2002, TRENDS ENDOCRIN MET, V13, P47, DOI 10.1016/S1043-2760(01)00558-6; Hubbard NE, 2001, PROSTAG LEUKOTR ESS, V65, P287, DOI 10.1054/plef.2001.0327; Iwasaki R, 2013, BIOCHEM BIOPH RES CO, V438, P353, DOI 10.1016/j.bbrc.2013.07.075; KATOH H, 1995, BBA-GEN SUBJECTS, V1244, P41, DOI 10.1016/0304-4165(94)00182-W; KOTANI M, 1995, MOL PHARMACOL, V48, P869; Kwok AHY, 2012, GEN COMP ENDOCR, V179, P88, DOI 10.1016/j.ygcen.2012.07.019; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luschnig-Schratl P, 2011, CELL MOL LIFE SCI, V68, P3573, DOI 10.1007/s00018-011-0642-5; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NEGISHI M, 1993, J BIOL CHEM, V268, P9517; NOMURA T, 1976, BIOCHIM BIOPHYS ACTA, V431, P127; Plata G, 2014, NUCLEIC ACIDS RES, V42, P2405, DOI 10.1093/nar/gkt1200; RENZ H, 1988, J IMMUNOL, V141, P2388; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; SCHNEIDER WP, 1972, J AM CHEM SOC, V94, P2122, DOI 10.1021/ja00761a060; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tsuge K, 2013, BIOCHEM BIOPH RES CO, V436, P685, DOI 10.1016/j.bbrc.2013.06.017; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Warren IA, 2014, GENOME BIOL EVOL, V6, P1790, DOI 10.1093/gbe/evu131; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120483	10.1371/journal.pone.0120483	http://dx.doi.org/10.1371/journal.pone.0120483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837516	Green Published, Green Accepted, gold			2022-12-27	WOS:000352139000022
J	Barger, JL; Anderson, RM; Newton, MA; da Silva, C; Vann, JA; Pugh, TD; Someya, S; Prolla, TA; Weindruch, R				Barger, Jamie L.; Anderson, Rozalyn M.; Newton, Michael A.; da Silva, Cristina; Vann, James A.; Pugh, Thomas D.; Someya, Shinichi; Prolla, Tomas A.; Weindruch, Richard			A Conserved Transcriptional Signature of Delayed Aging and Reduced Disease Vulnerability Is Partially Mediated by SIRT3	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CALORIC RESTRICTION; GENE-EXPRESSION; INSULIN-RESISTANCE; DIETARY RESTRICTION; SKELETAL-MUSCLE; ADIPOSE-TISSUE; METABOLISM; GROWTH; MICE	Aging is the most significant risk factor for a range of diseases, including many cancers, neurodegeneration, cardiovascular disease, and diabetes. Caloric restriction (CR) without malnutrition delays aging in diverse species, and therefore offers unique insights into age-related disease vulnerability. Previous studies suggest that there are shared mechanisms of disease resistance associated with delayed aging, however quantitative support is lacking. We therefore sought to identify a common response to CR in diverse tissues and species and determine whether this signature would reflect health status independent of aging. We analyzed gene expression datasets from eight tissues of mice subjected to CR and identified a common transcriptional signature that includes functional categories of mitochondrial energy metabolism, inflammation and ribosomal structure. This signature is detected in flies, rats, and rhesus monkeys on CR, indicating aspects of CR that are evolutionarily conserved. Detection of the signature in mouse genetic models of slowed aging indicates that it is not unique to CR but rather a common aspect of extended longevity. Mice lacking the NAD-dependent deacetylase SIRT3 fail to induce mitochondrial and anti-inflammatory elements of the signature in response to CR, suggesting a potential mechanism involving SIRT3. The inverse of this transcriptional signature is detected with consumption of a high fat diet, obesity and metabolic disease, and is reversed in response to interventions that decrease disease risk. We propose that this evolutionarily conserved, tissue-independent, transcriptional signature of delayed aging and reduced disease vulnerability is a promising target for developing therapies for age-related diseases.	[Barger, Jamie L.; da Silva, Cristina; Prolla, Tomas A.; Weindruch, Richard] LifeGen Technol LLC, Madison, WI 53719 USA; [Anderson, Rozalyn M.; Pugh, Thomas D.; Weindruch, Richard] Univ Wisconsin, Dept Med, SMPH, Madison, WI USA; [Anderson, Rozalyn M.; Weindruch, Richard] William S Middleton Mem Vet Adm Med Ctr, Geriatr Res, Educ & Clin Ctr, Madison, WI USA; [Newton, Michael A.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Vann, James A.; Someya, Shinichi; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Vann, James A.; Someya, Shinichi; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Barger, JL (corresponding author), LifeGen Technol LLC, Madison, WI 53719 USA.	Jamie.L.Barger@gmail.com			National Institute on Aging [R01AG037000, P01AG011915, R01AG038679]; National Institute of General Medical Sciences [R21HG006568]; LifeGen Technologies, LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011915, R01AG037000, P30AG028740, R01AG038679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012552, R01DC014437] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); LifeGen Technologies, LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by National Institute on Aging R01AG037000 (RMA), National Institute on Aging P01AG011915 (RW), National Institute of General Medical Sciences R21HG006568 (MAN), and National Institute on Aging R01AG038679 (TAP). LifeGen Technologies, LLC, provided support in the form of salaries for authors JLB and CdS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012; Bartke Andrzej, 2012, Frontiers in Genetics, V3, P288, DOI 10.3389/fgene.2012.00288; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; de Wilde J, 2009, J NUTRIGENET NUTRIGE, V2, P280, DOI 10.1159/000308466; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Froy O, 2006, AM J PHYSIOL-ENDOC M, V291, pE1017, DOI 10.1152/ajpendo.00140.2006; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kumar R, 2014, AGING CELL, V13, P975, DOI 10.1111/acel.12260; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Oliva-Ramirez J, 2014, IMMUNOLOGY, V143, P490, DOI 10.1111/imm.12329; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Plank M, 2012, MOL BIOSYST, V8, P1339, DOI 10.1039/c2mb05255e; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Saini A, 2009, AGEING RES REV, V8, P251, DOI 10.1016/j.arr.2009.02.001; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skov V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002466; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Swindell WR, 2008, MECH AGEING DEV, V129, P138, DOI 10.1016/j.mad.2007.11.003; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Tome-Carneiro J, 2013, CARDIOVASC DRUG THER, V27, P37, DOI 10.1007/s10557-012-6427-8; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	58	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120738	10.1371/journal.pone.0120738	http://dx.doi.org/10.1371/journal.pone.0120738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830335	gold, Green Published			2022-12-27	WOS:000352135600037
J	Gasser, A; Brogi, S; Urayama, K; Nishi, T; Kurose, H; Tafi, A; Ribeiro, N; Desaubry, L; Nebigil, CG				Gasser, Adeline; Brogi, Simone; Urayama, Kyoji; Nishi, Toshishide; Kurose, Hitoshi; Tafi, Andrea; Ribeiro, Nigel; Desaubry, Laurent; Nebigil, Canan G.			Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CRYSTAL-STRUCTURE; PHARMACOLOGICAL CHARACTERIZATION; IDENTIFICATION; ANTAGONISTS; ANGIOGENESIS; LIGANDS; CELLS; BV8; SURVIVAL	Prokineticins are angiogenic hormones that activate two G protein-coupled receptors: PKR1 and PKR2. PKR1 has emerged as a critical mediator of cardiovascular homeostasis and cardioprotection. Identification of non-peptide PKR1 agonists that contribute to myocardial repair and collateral vessel growth hold promises for treatment of heart diseases. Through a combination of in silico studies, medicinal chemistry, and pharmacological profiling approaches, we designed, synthesized, and characterized the first PKR1 agonists, demonstrating their cardioprotective activity against myocardial infarction (MI) in mice. Based on high throughput docking protocol, 250,000 compounds were computationally screened for putative PKR1 agonistic activity, using a homology model, and 10 virtual hits were pharmacologically evaluated. One hit internalizes PKR1, increases calcium release and activates ERK and Akt kinases. Among the 30 derivatives of the hit compound, the most potent derivative, IS20, was confirmed for its selectivity and specificity through genetic gain- and loss-of-function of PKR1. Importantly, IS20 prevented cardiac lesion formation and improved cardiac function after MI in mice, promoting proliferation of cardiac progenitor cells and neovasculogenesis. The preclinical investigation of the first PKR1 agonists provides a novel approach to promote cardiac neovasculogenesis after MI.	[Gasser, Adeline; Urayama, Kyoji; Nishi, Toshishide; Nebigil, Canan G.] Univ Strasbourg, CNRS, Biotechnol & Cell Signaling Lab, UMR 7242, Illkirch Graffenstaden, France; [Brogi, Simone] Univ Siena, European Res Ctr Drug Discovery & Dev NatSynDrugs, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Chem, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Pharm, I-53100 Siena, Italy; [Nishi, Toshishide; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan; [Ribeiro, Nigel; Desaubry, Laurent] Univ Strasbourg, CNRS, Therapeut Innovat Lab, UMR7200, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Siena; University of Siena; University of Siena; University of Siena; Kyushu University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Desaubry, L (corresponding author), Univ Strasbourg, CNRS, Therapeut Innovat Lab, UMR7200, Illkirch Graffenstaden, France.	desaubry@unistra.fr; nebigil@unistra.fr	Brogi, Simone/AAP-4179-2020; Desaubry, Laurent G/R-5446-2017; Nebigil, Canan/AAK-7162-2021	Brogi, Simone/0000-0001-9375-6242; Desaubry, Laurent G/0000-0002-1192-2970; Nebigil, Canan/0000-0002-2035-5795; GASSER, Adeline/0000-0003-2678-327X	Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale en France (FRM); Region Alsace; Laboratory of Excellence, Medalis	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale en France (FRM)(Fondation pour la Recherche Medicale); Region Alsace(Region Grand-Est); Laboratory of Excellence, Medalis	This work was supported by Centre National de la Recherche Scientifique (CNRS), Fondation pour la Recherche Medicale en France (FRM), Region Alsace, and Laboratory of Excellence, Medalis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CPHMODELS 3 2 SERV; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Boulberdaa M, 2011, ARTERIOSCL THROM VAS, V31, P842, DOI 10.1161/ATVBAHA.110.222323; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Cappelli A, 2013, EUR J MED CHEM, V63, P85, DOI 10.1016/j.ejmech.2013.01.044; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carroll C, 2013, United States patent, Patent No. [WO2013179024A1, US20130324576, 2013179024]; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Congiu C, 2014, EUR J MED CHEM, V81, P334, DOI 10.1016/j.ejmech.2014.05.030; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Dai WM, 2011, J RECEPT SIG TRANSD, V31, P229, DOI 10.3109/10799893.2011.578141; DeVita RJ, 2007, CURR TOP MED CHEM, V7, P1433, DOI 10.2174/156802607782194789; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Gemma S, 2014, RSC ADV, V4, P4769, DOI 10.1039/c3ra45933k; Giovani S, 2014, BIOORG MED CHEM LETT, V24, P3582, DOI 10.1016/j.bmcl.2014.05.044; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guazzi M, 2014, PROG CARDIOVASC DIS, V56, P508, DOI 10.1016/j.pcad.2013.11.003; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jones G, 1995, J COMPUT AID MOL DES, V9, P532, DOI 10.1007/BF00124324; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kooistra AJ, 2013, METHOD ENZYMOL, V522, P279, DOI 10.1016/B978-0-12-407865-9.00015-7; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Li YY, 2010, CURR MED CHEM, V17, P1167, DOI 10.2174/092986710790827807; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Miserey-Lenkei S, 2002, J BIOL CHEM, V277, P5891, DOI 10.1074/jbc.M108398200; Nebigil CG, 2009, TRENDS CARDIOVAS MED, V19, P55, DOI 10.1016/j.tcm.2009.04.007; Nguyen TL, 2013, J DEV BIOL, V1, P20, DOI 10.3390/jdb1010020; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Szatkowski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081175; Urayama K, 2008, ARTERIOSCL THROM VAS, V28, P841, DOI 10.1161/ATVBAHA.108.162404; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Urayama K, 2009, CARDIOVASC RES, V81, P28, DOI 10.1093/cvr/cvn251; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Zhou QY, 2014, United States patent, Patent No. [WO2010077976A3, US8722896B2, 2010077976]	48	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121027	10.1371/journal.pone.0121027	http://dx.doi.org/10.1371/journal.pone.0121027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831128	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600053
J	Scaioli, G; Gualano, MR; Gili, R; Masucci, S; Bert, F; Siliquini, R				Scaioli, Giacomo; Gualano, Maria R.; Gili, Renata; Masucci, Simona; Bert, Fabrizio; Siliquini, Roberta			Antibiotic Use: A Cross-Sectional Survey Assessing the Knowledge, Attitudes and Practices amongst Students of a School of Medicine in Italy	PLOS ONE			English	Article							ANTIMICROBIAL STEWARDSHIP; GENERAL-PRACTITIONERS; PUBLIC KNOWLEDGE; CARE; PERCEPTIONS; RESISTANCE; QUESTIONNAIRE; MEDICATION; AWARENESS; BEHAVIOR	Background Since antibiotic resistance has become a worldwide public health concern and is in part related to physicians' lack of knowledge, it is essential to focus our attention on healthcare profession students. The present study aims at evaluating the knowledge and attitudes of the School of Medicine's students towards antibiotic usage and antibiotic resistance. Methods In December 2013, a cross sectional study was conducted amongst medical, dental, nursing and other health care profession students of the School of Medicine at the University of Torino. Students of all the academic years took part in this study. Questionnaires were submitted during regular lectures (only students who attended courses on one specific day were surveyed) and the data collected was analyzed using StataMP11 statistical software. Results Overall, 1,050 students were interviewed. The response rate was 100%. Around 20% of the sample stated that antibiotics are appropriate for viral infections and 15% of the students that they stop taking those drugs when symptoms decrease. Results of the multivariate analyses showed that females were more likely than males to take antibiotics only when prescribed (OR 1.43, 95% CI 1.04-1.98). Interestingly, students with a relative working in a health-related field, as well as those who took at least one course of antibiotics in the last year, had a lower probability of taking those drugs only under prescription (OR = 0.69 95% CI: 0.49-0.97 and OR = 0.38 95% CI: 0.27-0.53, respectively). Conclusion The present paper shows how healthcare profession students do not practice what they know. Since those students will be a behavioral model for citizens and patients, it is important to generate more awareness around this issue throughout their studies. It would be advisable to introduce a specific course and training on antibiotics in the core curriculum of the School of Medicine.	[Scaioli, Giacomo; Gualano, Maria R.; Gili, Renata; Masucci, Simona; Bert, Fabrizio; Siliquini, Roberta] Univ Turin, Dept Publ Hlth, Turin, Italy	University of Turin	Gili, R (corresponding author), Univ Turin, Dept Publ Hlth, Turin, Italy.	renata.gili@unito.it	Gualano, Maria Rosaria/AAJ-2525-2020	Scaioli, Giacomo/0000-0001-5189-1294; Bert, Fabrizio/0000-0002-4329-9028; Gualano, Maria Rosaria/0000-0001-7357-2892	Department of Public Health Sciences University of Torino	Department of Public Health Sciences University of Torino	Department of Public Health Sciences University of Torino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo LM, 2013, CLIN INFECT DIS, V57, P631, DOI 10.1093/cid/cit370; Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Centers for Disease Control and Prevention (CDC), 2013, ANT AR ALW ANSW; Chambers H.F., 2006, GOODMAN GILMANS PHAR, P1095; Corbett KK, 2005, PREV MED, V40, P162, DOI 10.1016/j.ypmed.2004.05.016; de Leeuw E. D., 2008, INT HDB SURVEY METHO; Dyar OJ, 2013, MED MALADIES INFECT, V43, P423, DOI 10.1016/j.medmal.2013.07.010; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P842, DOI 10.1093/jac/dkt440; El Ezz N F A, 2011, J Prev Med Hyg, V52, P196; European Center for Disease Prevention and Control (ECDC), 2013, ANT CONS INT DAT ESA; European Center for Disease Prevention and Control (ECDC), 2013, EUR ANT RES SURV NET; European commission, 2013, SPEC EUR 407 ANT RES; Faber MS, 2010, EURO SURVEILL B EUR, V15; Ficarra MG, 2011, EUR J PUBLIC HEALTH, V21, P29, DOI 10.1093/eurpub/ckq017; Gendel MH, 2012, J MED ETHICS, V38, P294, DOI 10.1136/medethics-2011-100167; Grigoryan L, 2007, J ANTIMICROB CHEMOTH, V59, P152, DOI 10.1093/jac/dkl457; Groves RM., 2011, SURV METHODOL; Gualano MR, 2015, PHARMACOEPIDEM DR S, V24, P2, DOI 10.1002/pds.3716; Gualano MR, 2011, EPIDEMIOL BIOSTAT PU, V8, P392; HOSMER DW, 1989, APPL LOGISTIC REGRES; Huang Y, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-163; Kardas P, 2007, INT J ANTIMICROB AG, V30, P530, DOI 10.1016/j.ijantimicag.2007.08.005; Khan AKA, 2013, J CLIN DIAGN RES, V7, P1613, DOI 10.7860/JCDR/2013/6290.3230; Kim SS, 2011, J KOREAN ACAD NURS, V41, P742, DOI 10.4040/jkan.2011.41.6.742; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; LAPUMA J, 1991, NEW ENGL J MED, V325, P1290, DOI 10.1056/NEJM199110313251806; Lim Ka Keat, 2012, South Med Rev, V5, P26; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; McNulty CAM, 2011, J ANTIMICROB CHEMOTH, V66, pV3, DOI 10.1093/jac/dkr119; Minen MT, 2010, MICROB DRUG RESIST, V16, P285, DOI 10.1089/mdr.2010.0009; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Ohl CA, 2014, INFECT DIS CLIN N AM, V28, P177, DOI 10.1016/j.idc.2014.02.001; Osservasalute, 2011, RAPP OSS 2011; Pulcini C, 2013, VIRULENCE, V4, P192, DOI 10.4161/viru.23706; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Suaifan GARY, 2012, AFR J PHARM PHARMACO, V6, P763, DOI 10.5897/AJPP12.080; Thriemer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055495; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; World Health Organization, 2014, ANT RES GLOB REP SUR; Wright EP, 2004, J ANTIMICROB CHEMOTH, V53, P550, DOI 10.1093/jac/dkh096	44	81	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122476	10.1371/journal.pone.0122476	http://dx.doi.org/10.1371/journal.pone.0122476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25831072	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600113
J	Bourque, CPA; Bayat, M				Bourque, Charles P. -A.; Bayat, Mahmoud			Landscape Variation in Tree Species Richness in Northern Iran Forests	PLOS ONE			English	Article							GROWTH; PATTERNS; ENVIRONMENTS; REGENERATION; MANAGEMENT; DIVERSITY	Mapping landscape variation in tree species richness (SR) is essential to the long term management and conservation of forest ecosystems. The current study examines the prospect of mapping field assessments of SR in a high-elevation, deciduous forest in northern Iran as a function of 16 biophysical variables representative of the area's unique physiography, including topography and coastal placement, biophysical environment, and forests. Basic to this study is the development of moderate-resolution biophysical surfaces and associated plot-estimates for 202 permanent sampling plots. The biophysical variables include: (i) three topographic variables generated directly from the area's digital terrain model; (ii) four ecophysiologically-relevant variables derived from process models or from first principles; and (iii) seven variables of Landsat-8-acquired surface reflectance and two, of surface radiance. With symbolic regression, it was shown that only four of the 16 variables were needed to explain 85% of observed plot-level variation in SR (i.e., wind velocity, surface reflectance of blue light, and topographic wetness indices representative of soil water content), yielding mean-absolute and root-mean-squared error of 0.50 and 0.78, respectively. Overall, localised calculations of wind velocity and surface reflectance of blue light explained about 63% of observed variation in SR, with wind velocity accounting for 51% of that variation. The remaining 22% was explained by linear combinations of soil-water-related topographic indices and associated thresholds. In general, SR and diversity tended to be greatest for plots dominated by Carpinus betulus (involving >= 33% of all trees in a plot), than by Fagus orientalis (median difference of one species). This study provides a significant step towards describing landscape variation in SR as a function of modelled and satellite-based information and symbolic regression. Methods in this study are sufficiently general to be applicable to the characterisation of SR in other forested regions of the world, providing plot-scale data are available for model generation.	[Bourque, Charles P. -A.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada; [Bayat, Mahmoud] Univ Tehran, Nat Resources Fac, Dept Forestry, Karaj, Iran	University of New Brunswick; University of Tehran	Bourque, CPA (corresponding author), Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada.	cbourque@unb.ca	Bayat, Mahmoud/AAA-9781-2019; Bayat, Mahmoud/S-1673-2016	Bayat, Mahmoud/0000-0002-2210-0710; Bayat, Mahmoud/0000-0003-4348-3228	University of Tehran, Karaj, Iran; Natural Sciences and Engineering Research Council of Canada	University of Tehran, Karaj, Iran; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors acknowledge the University of Tehran, Karaj, Iran, for the use of the Kheyrud Experimental Forest and for logistical and financial support to MB (http://www.ut.ac.ir); Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) for funding portion of this research by way of a Discovery Grant to CPAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf MI, 2015, MITIG ADAPT STRAT GL, V20, P159, DOI 10.1007/s11027-013-9484-9; Ashraf MI, 2012, HYDROL PROCESS, V26, P1119, DOI 10.1002/hyp.8195; Austin MP, 1996, AUST J ECOL, V21, P154, DOI 10.1111/j.1442-9993.1996.tb00596.x; Bang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011061; Bassow SL, 1998, ECOLOGY, V79, P2660, DOI 10.1890/0012-9658(1998)079[2660:HECACL]2.0.CO;2; Bayat M, 2013, EUR J FOREST RES, V132, P851, DOI 10.1007/s10342-013-0714-1; Beven K, 1997, HYDROL PROCESS, V11, P1069; Bourque CPA, 2012, J HYDROL, V454, P141, DOI 10.1016/j.jhydrol.2012.06.008; Bourque CPA, 1998, CAN J SOIL SCI, V78, P409, DOI 10.4141/S97-089; Bourque CPA, 2000, CAN J FOREST RES, V30, P1179, DOI 10.1139/cjfr-30-8-1179; Byun JG, 2013, J PLANT ECOL, V6, P380, DOI 10.1093/jpe/rtt001; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; CHAVEZ PS, 1988, REMOTE SENS ENVIRON, V24, P459, DOI 10.1016/0034-4257(88)90019-3; Detto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076296; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Geiger R., 1965, CLIMATE NEAR GROUND; Goudriaan J., 1977, CROP MICROMETEOROLOG; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Gruber S, 2009, DEV SOIL SCI, V33, P171, DOI 10.1016/S0166-2481(08)00007-X; Heikkinen RK, 1997, BIODIVERS CONSERV, V6, P1181, DOI 10.1023/A:1018356823171; Heshmati GA, 2007, INT J PLANT PROD, V1, P215; Heyder JC, 1986, WALDBAU WANDEL SILVI; JARVIS A, 2005, THESIS KINGS COLL LO; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kimmins J.P., 1997, FOREST ECOLOGY FDN S, V3rd; Kopecky M, 2010, APPL VEG SCI, V13, P450, DOI 10.1111/j.1654-109X.2010.01083.x; Lebourgeois F, 2005, TREES-STRUCT FUNCT, V19, P385, DOI 10.1007/s00468-004-0397-9; Ledo A, 2013, J VEG SCI, V24, P1086, DOI 10.1111/jvs.12023; Lopes AMG, 2003, ENVIRON MODELL SOFTW, V18, P81, DOI 10.1016/S1364-8152(02)00024-5; Marvie-Mohadjer MR, 2012, SILVICULTURE; McVicar TR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042255; MERRIAM JB, 1992, GEOPHYS J INT, V109, P488, DOI 10.1111/j.1365-246X.1992.tb00112.x; Moeslund JE, 2013, BIODIVERS CONSERV, V22, P2151, DOI 10.1007/s10531-013-0442-3; Murphy PNC, 2011, ECOL MODEL, V222, P2314, DOI 10.1016/j.ecolmodel.2011.01.003; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Namiranian M, 2009, INTERNAL REPORT; Nilsen ET, 1996, FIELD CROP RES, P192; Oliver C.D., 1996, FOREST STAND DYNAMIC; Papaik MJ, 2006, J ECOL, V94, P1011, DOI 10.1111/j.1365-2745.2006.01153.x; Patry C, 2013, FOREST CHRON, V89, P525, DOI 10.5558/tfc2013-093; Pausas JG, 2003, J VEG SCI, V14, P661, DOI 10.1111/j.1654-1103.2003.tb02198.x; Pausas JG, 2001, J VEG SCI, V12, P153, DOI 10.2307/3236601; Peckham SD, 2009, DEV SOIL SCI, V33, P411, DOI 10.1016/S0166-2481(08)00018-4; Rao LE, 2011, PLANT ECOL, V212, P1079, DOI 10.1007/s11258-010-9888-5; Redowan M, 2013, J INDIAN SOC REMOTE, V41, P567, DOI 10.1007/s12524-012-0254-z; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; RETUERTO R, 1992, OECOLOGIA, V92, P113, DOI 10.1007/BF00317271; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Sefidi K, 2011, FOREST ECOL MANAG, V262, P1094, DOI 10.1016/j.foreco.2011.06.008; Skov F, 2003, FOREST ECOL MANAG, V180, P583, DOI 10.1016/S0378-1127(02)00646-1; Sprugel DG, 1982, SCI, V211, P390; Tabari M., 2007, Caspian Journal of Environmental Sciences, V5, P35; Tabari M, 2005, FORESTRY, V78, P443, DOI 10.1093/forestry/cpi032; WADSWORTH R. M., 1959, ANN BOT, V23, P195; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x	56	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121172	10.1371/journal.pone.0121172	http://dx.doi.org/10.1371/journal.pone.0121172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849029	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800047
J	Chen, YY; Huang, XB; Xiao, Y; Jiang, Y; Shan, XW; Zhang, J; Cai, SX; Liu, JB				Chen, Yan-Yan; Huang, Xi-Bao; Xiao, Ying; Jiang, Yong; Shan, Xiao-wei; Zhang, Juan; Cai, Shun-Xiang; Liu, Jian-Bing			Spatial Analysis of Schistosomiasis in Hubei Province, China: A GIS-Based Analysis of Schistosomiasis from 2009 to 2013	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; GEOGRAPHIC INFORMATION-SYSTEM; JAPONICUM INFECTION; INTERVENTION TRIAL; ENDEMIC AREAS; RISK-FACTORS; LAKE REGION; TRANSMISSION; IMPACT; AUTOCORRELATION	Background Schistosomiasis remains a major public health problem in China. The major endemic areas are located in the lake and marshland regions of southern China, particularly in areas along the middle and low reach of the Yangtze River. Spatial analytical techniques are often used in epidemiology to identify spatial clusters in disease regions. This study assesses the spatial distribution of schistosomiasis and explores high-risk regions in Hubei Province, China to provide guidance on schistosomiasis control in marshland regions. Methods In this study, spatial autocorrelation methodologies, including global Moran's I and local Getis-Ord statistics, were utilized to describe and map spatial clusters and areas where human Schistosoma japonicum infection is prevalent at the county level in Hubei province. In addition, linear logistic regression model was used to determine the characteristics of spatial autocorrelation with time. Results The infection rates of S. japonicum decreased from 2009 to 2013. The global autocorrelation analysis results on the infection rate of S. japonicum for five years showed statistical significance (Moran's I > 0, P < 0.01), which suggested that spatial clusters were present in the distribution of S. japonicum infection from 2009 to 2013. Local autocorrelation analysis results showed that the number of highly aggregated areas ranged from eight to eleven within the five-year analysis period. The highly aggregated areas were mainly distributed in eight counties. Conclusions The spatial distribution of human S. japonicum infections did not exhibit a temporal change at the county level in Hubei Province. The risk factors that influence human S. japonicum transmission may not have changed after achieving the national criterion of infection control. The findings indicated that spatial-temporal surveillance of S. japonicumtransmission plays a significant role on schistosomiasis control. Timely and integrated prevention should be continued, especially in the Yangtze River Basin of Jianghan Plain area.	[Chen, Yan-Yan; Huang, Xi-Bao; Xiao, Ying; Jiang, Yong; Shan, Xiao-wei; Zhang, Juan; Cai, Shun-Xiang; Liu, Jian-Bing] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China		Cai, SX (corresponding author), Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China.	441711219@qq.com; hbcdcxf@126.com			Provinal Research of Schistosomiasis Prevention of Health Department of Hubei, China [XF2012-24, XF2012-26]	Provinal Research of Schistosomiasis Prevention of Health Department of Hubei, China	This study was funded by the Provinal Research of Schistosomiasis Prevention of Health Department of Hubei, China (XF2012-24, XF2012-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-186; Cai YC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-138; Torres RMC, 2013, CIENC SAUDE COLETIVA, V18, P1441, DOI 10.1590/S1413-81232013000500029; Chaput EK, 2002, EMERG INFECT DIS, V8, P943, DOI 10.3201/eid0809.020103; CHEN YL, 2014, PLOS NEGLECT TROP D, V8, P89779, DOI DOI 10.1371/JOURNAL.PONE.0089779; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Coulibaly D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-82; Estrada-Pena A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102905; Flahaut B, 2003, ACCIDENT ANAL PREV, V35, P991, DOI 10.1016/S0001-4575(02)00107-0; Gray DJ, 2007, AM J TROP MED HYG, V77, P866, DOI 10.4269/ajtmh.2007.77.866; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Guimaraes RJPS, 2008, ACTA TROP, V108, P234, DOI 10.1016/j.actatropica.2008.07.001; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Hu Y, 2014, PARASITOL INT, V63, P500, DOI 10.1016/j.parint.2014.01.009; Hui FM, 2009, AM J TROP MED HYG, V81, P503; Jackson MC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-55; Liu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031876; Mattsson BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055097; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Peng WX, 2010, PARASITOLOGY, V137, P1099, DOI 10.1017/S003118200999206X; Raso G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006947; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Seto EYW, 2008, ECOHEALTH, V5, P149, DOI 10.1007/s10393-008-0169-x; Shanghai WL, 2006, EPIDEMIC STATUS SCHI, P36; SHOUPAI M, 1982, AM J TROP MED HYG, V31, P92, DOI 10.4269/ajtmh.1982.31.92; Smith JL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002359; Szonyi B, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-31; Tsai PJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-464; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Viladomat J, 2014, BIOMETRICS, V70, P409, DOI 10.1111/biom.12139; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wang XH, 2006, INT J PARASITOL, V36, P895, DOI 10.1016/j.ijpara.2006.04.003; Wu JL, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-23; Yang GJ, 2005, ACTA TROP, V96, P117, DOI 10.1016/j.actatropica.2005.07.006; Yang GJ, 2005, INT J PARASITOL, V35, P155, DOI 10.1016/j.ijpara.2004.11.002; Yang H, 2010, CHIN J SCHISTO CONTR, V22, P521; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092700; Zhang ZJ, 2009, PARASITOLOGY, V136, P737, DOI 10.1017/S0031182009005885; Zhang ZJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001620; Zhou D, 1994, World Health Forum, V15, P387; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou XN, 2001, ACTA TROP, V79, P97, DOI 10.1016/S0001-706X(01)00107-3; Zhou YY, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-13; Zhou YB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-275; Zhu HQ, 2014, SE ASIAN J TROP MED, V45, P20; Zhu HM, 2008, ECOHEALTH, V5, P137, DOI 10.1007/s10393-008-0168-y; Zhu HuiGuo, 2008, Chinese Journal of Schistosomiasis Control, V20, P251; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	52	20	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118362	10.1371/journal.pone.0118362	http://dx.doi.org/10.1371/journal.pone.0118362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849567	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800005
J	Manalebh, A; Demissie, M; Mekonnen, D; Abera, B				Manalebh, Almaw; Demissie, Meaza; Mekonnen, Daniel; Abera, Bayeh			The Quality of Sputum Smear Microscopy in Public-Private Mix Directly Observed Treatment Laboratories in West Amhara Region, Ethiopia	PLOS ONE			English	Article							TUBERCULOSIS LABORATORIES; DIAGNOSIS; ASSURANCE; TB; RECHECKING; SYSTEM; GHANA; INDIA	Ethiopia adopted Public-Private Mix Directly Observed Treatment Short Course Chemotherapy (PPM-DOTS) strategy for tuberculosis (TB) control program. Quality of sputum smear microscopy has paramount importance for tuberculosis control program in resource-poor countries like Ethiopia. A cross-sectional study was conducted to assess the quality of sputum smear microscopy in 37 Public-Private Mix laboratories in West Amhara, Ethiopia. The three external quality assessment methods (onsite evaluation, panel testing and blind rechecking) were employed. Onsite assessment revealed that 67.6% of PPM-DOTS laboratories were below the standard physical space (5 X 6) m(2). The average monthly workload per laboratory technician was 19.5 (SD +/- 2.9) slides with 12.8% positivity rate. The quality of Acid Fast Bacilli (AFB) staining reagents was sub-standard. The overall agreement for blind rechecking of 1,123 AFB slides was 99.4% (Kappa = 0.97). Reading of 370 AFB panel slides showed 3.5% false reading (Kappa = 0.92). Moreover, the consistency of reading scanty bacilli slides was lower (93%) compared to 1+, 2+ and 3+ bacilli. Based on blind rechecking and panel testing results, PPM-DOTS site laboratories showed good agreement with the reference laboratory. Physical space and qualities of AFB reagents would be areas of intervention to sustain the quality of sputum smear microscopy. Therefore, regular external quality assessment and provision of basic laboratory supplies for TB diagnosis would be the way forward to improve the quality of sputum smear microscopy services in PPM-DOTS laboratories.	[Manalebh, Almaw] USAID Ethiopia, Private Hlth Sect Programme, Bahir Dar, Ethiopia; [Demissie, Meaza] Addis Continental Inst Publ Hlth, Gondar, Ethiopia; [Mekonnen, Daniel; Abera, Bayeh] Bahir Dar Univ, Dept Med Microbiol, Coll Med & Heath Sci, Bahir Dar, Ethiopia; [Mekonnen, Daniel; Abera, Bayeh] Bahir Dar Univ, Dept Parasitol, Coll Med & Heath Sci, Bahir Dar, Ethiopia; [Mekonnen, Daniel; Abera, Bayeh] Bahir Dar Univ, Dept Immunol, Coll Med & Heath Sci, Bahir Dar, Ethiopia	United States Agency for International Development (USAID); Addis Continental Institute of Public Health; Bahir Dar University; Bahir Dar University; Bahir Dar University	Abera, B (corresponding author), Bahir Dar Univ, Dept Med Microbiol, Coll Med & Heath Sci, Bahir Dar, Ethiopia.	bayeabera15@gmail.com	Abera, Bayeh/AAU-8754-2020		University of Gondar; Bahir Dar Regional Health Research Laboratory Center	University of Gondar; Bahir Dar Regional Health Research Laboratory Center	The authors would like to acknowledge the University of Gondar and Bahir Dar Regional Health Research Laboratory Center for supporting this study. We are also grateful for private laboratory personnel, heads and owners for their facilitation and cooperation in giving valid and relevant information for the study.	Addo KK, 2006, INT J TUBERC LUNG D, V10, P870; Addo KK, 2006, INT J TUBERC LUNG D, V10, P812; Ajaykumar T, 2006, NTI B, V42, P15; Aziz M, 2002, INT J TUBERC LUNG D, V6, P340; Basra D, 2006, East Afr Med J, V83, P306; Dave Paresh V, 2011, Indian J Tuberc, V58, P113; Federal Ministry of Health, 2012, TUB ANN B FMOH; Federal Ministry of Health (FMOH), 2013, GUID CLIN PROGR MAN, V5th; (FMOH) Federal Ministry of Health, 2006, PPM DOTS IMPL GUID; (FMOH) Federal Ministry of Health of Ethiopia, 2009, GUID QUAL ASS SMEAR; Hepple P, 2012, INT J TUBERC LUNG D, V16, P579, DOI 10.5588/ijtld.11.0617; Huong NT, 2006, INT J TUBERC LUNG D, V10, P277; Leon C. I., 1993, Boletin de la Oficina Sanitaria Panamericana, V115, P103; Malik S, 2011, SE ASIAN J TROP MED, V42, P342; Maloney SA, 2001, INT J TUBERC LUNG S1, V5, pS132; Martinez-Guarneros A, 2003, INT J TUBERC LUNG D, V7, P516; Mundy CJF, 2002, INT J TUBERC LUNG D, V6, P47; Paramasivan CN, 2003, INT J TUBERC LUNG D, V7, P522; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Private Sector Program, 2009, ETH INT TB HIV SERV; Shargie E. B., 2005, Ethiopian Journal of Health Development, V19, P104; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2003, QUAL ASS SPUT MICR D; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123749	10.1371/journal.pone.0123749	http://dx.doi.org/10.1371/journal.pone.0123749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849516	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800256
J	Sheng, M; Hosseinzadeh, A; Muralidharan, SV; Gaur, R; Selstam, E; Tuck, S				Sheng, Ming; Hosseinzadeh, Ava; Muralidharan, Somsundar Veppil; Gaur, Rahul; Selstam, Eva; Tuck, Simon			Aberrant Fat Metabolism in Caenorhabditis elegans Mutants with Defects in the Defecation Motor Program	PLOS ONE			English	Article							C-ELEGANS; RHYTHMIC BEHAVIOR; GENETICS; NEUROPEPTIDE; INSULIN; CONTRIBUTES; DISSECTION; INTESTINE; RECEPTOR; NEURONS	The molecular mechanisms by which dietary fatty acids are absorbed by the intestine, and the way in which the process is regulated are poorly understood. In a genetic screen for mutations affecting fat accumulation in the intestine of Caenorhabditis elegans, nematode worms, we have isolated mutations in the aex-5 gene, which encodes a Kex2/subtilisinfamily, Ca2+-sensitive proprotein convertase known to be required for maturation of certain neuropeptides, and for a discrete step in an ultradian rhythmic phenomenon called the defecation motor program. We demonstrate that aex-5 mutants have markedly lower steadystate levels of fat in the intestine, and that this defect is associated with a significant reduction in the rate at which labeled fatty acid derivatives are taken up from the intestinal lumen. Other mutations affecting the defecation motor program also affect steady-state levels of triglycerides, suggesting that the program is required per se for the proper accumulation of neutral lipids. Our results suggest that an important function of the defecation motor program in C. elegans is to promote the uptake of an important class of dietary nutrients. They also imply that modulation of the program might be one way in which worms adjust nutrient uptake in response to altered metabolic status.	[Sheng, Ming; Hosseinzadeh, Ava; Muralidharan, Somsundar Veppil; Gaur, Rahul; Tuck, Simon] Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden; [Selstam, Eva] Umea Univ, Dept Plant Physiol, SE-90187 Umea, Sweden	Umea University; Umea University	Tuck, S (corresponding author), Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden.	Simon.Tuck@umu.se		hosseinzadeh, ava/0000-0003-3069-0295	Vetenskapsradet [K2012-67X-20441-63]; Cancerfonden [12 0534]	Vetenskapsradet(Swedish Research Council); Cancerfonden(Swedish Cancer Society)	Work in ST's laboratory is supported by grants from Vetenskapsradet (K2012-67X-20441-63) and Cancerfonden (12 0534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman E, 2009, AM J PHYSIOL-CELL PH, V297, pC1071, DOI 10.1152/ajpcell.00284.2009; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi K, 2007, WORMBOOK; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery Leon, 1997, FEEDING DEFECATION; Beg AA, 2003, NAT NEUROSCI, V6, P1145, DOI 10.1038/nn1136; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Bender A, 2013, ACS CHEM BIOL, V8, P636, DOI 10.1021/cb300396j; Branicky R, 2006, TRENDS GENET, V22, P571, DOI 10.1016/j.tig.2006.08.006; BRENNER S, 1974, GENETICS, V77, P71; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Croll N, 1975, J ZOOL, V184, P507; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Iwasaki K, 1997, TRENDS GENET, V13, P111, DOI 10.1016/S0168-9525(97)01059-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kemp BJ, 2012, CURR BIOL, V22, P2213, DOI 10.1016/j.cub.2012.09.047; Kniazeva M, 2003, GENETICS, V163, P159; LIU DWC, 1994, J NEUROSCI, V14, P1953; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mahoney TR, 2008, P NATL ACAD SCI USA, V105, P16350, DOI 10.1073/pnas.0803617105; MCGHEE JD, 2007, WORMBOOK; Nassir N, 2009, MED CHEM, V9, P3; Nilsson L, 2011, TRAFFIC, V12, P1839, DOI 10.1111/j.1600-0854.2011.01271.x; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pfeiffer J, 2008, CURR BIOL, V18, P297, DOI 10.1016/j.cub.2008.01.054; Pino EC, 2013, JOVE; Rae R, 2012, INT J PARASITOL, V42, P747, DOI 10.1016/j.ijpara.2012.05.005; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; THOMAS JH, 1990, GENETICS, V124, P855; Wang H, 2013, CURR BIOL, V23, P746, DOI 10.1016/j.cub.2013.03.049; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2003, GENETICS, V163, P581; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	44	8	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124515	10.1371/journal.pone.0124515	http://dx.doi.org/10.1371/journal.pone.0124515			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849533	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800268
J	Sun, TJ; Lu, Y; Narusaka, M; Shi, C; Yang, YB; Wu, JX; Zeng, HY; Narusaka, Y; Yao, N				Sun, Tie-Jun; Lu, Yun; Narusaka, Mari; Shi, Chao; Yang, Yu-Bing; Wu, Jian-Xin; Zeng, Hong-Yun; Narusaka, Yoshihiro; Yao, Nan			A Novel Pyrimidin-Like Plant Activator Stimulates Plant Disease Resistance and Promotes Growth	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; APOPLASTIC OXIDATIVE BURST; MONOOXYGENASE FMO1; GENE-EXPRESSION; INNATE IMMUNITY; SALICYLIC-ACID; CELL-DEATH; ARABIDOPSIS; BENZOTHIADIAZOLE; SIGNAL	Plant activators are chemicals that induce plant defense responses to a broad spectrum of pathogens. Here, we identified a new potential plant activator, 5-(cyclopropylmethyl)-6-methyl-2-(2-pyridyl)pyrimidin-4-ol, named PPA (pyrimidin-type plant activator). Compared with benzothiadiazole S-methyl ester (BTH), a functional analog of salicylic acid (SA), PPA was fully soluble in water and increased fresh weight of rice (Oryza sativa) and Arabidopsis plants at low concentrations. In addition, PPA also promoted lateral root development. Microarray data and real-time PCR revealed that PPA-treated leaves not challenged with pathogen showed up-regulation of genes related to reactive oxygen species (ROS), defenses and SA. During bacterial infection, Arabidopsis plants pretreated with PPA showed dramatically decreased disease symptoms and an earlier and stronger ROS burst, compared with plants pretreated with BTH. Microscopy revealed that H2O2 accumulated in the cytosol, plasma membrane and cell wall around intracellular bacteria, and also on the bacterial cell wall, indicating that H2O2 was directly involved in killing bacteria. The increase in ROS-related gene expression also supported this observation. Our results indicate that PPA enhances plant defenses against pathogen invasion through the plant redox system, and as a water-soluble compound that can promote plant growth, has broad potential applications in agriculture.	[Sun, Tie-Jun; Lu, Yun; Shi, Chao; Yang, Yu-Bing; Wu, Jian-Xin; Zeng, Hong-Yun; Yao, Nan] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Narusaka, Mari; Narusaka, Yoshihiro] Res Inst Biol Sci Okayama, Okayama, Japan	Sun Yat Sen University	Narusaka, Y (corresponding author), Res Inst Biol Sci Okayama, Okayama, Japan.	yo_narusaka@bio-ribs.com; yaonan@mail.sysu.edu.cn			National Key Basic Science 973 Program [2012CB114006]; National Natural Science Foundation of China [31170247]; Fundamental Research Funds for the Central Universities [13lgjc27]; Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan; JSPS KAKENHI [24580071]	National Key Basic Science 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Key Basic Science 973 Program (2012CB114006), National Natural Science Foundation of China (31170247), Fundamental Research Funds for the Central Universities (13lgjc27), Industrial Technology Research Grant Program in 2009 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan and by JSPS KAKENHI Grant Number 24580071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Canet JV, 2010, PLANT BIOTECHNOL J, V8, P126, DOI 10.1111/j.1467-7652.2009.00468.x; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Chaturvedi R, 2012, PLANT J, V71, P161, DOI 10.1111/j.1365-313X.2012.04981.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; Godard JF, 1999, CROP PROT, V18, P397, DOI 10.1016/S0261-2194(99)00040-X; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Gozzo F, 2003, J AGR FOOD CHEM, V51, P4487, DOI 10.1021/jf030025s; Hamdoun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083219; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kunz W, 1997, PESTIC SCI, V50, P275, DOI 10.1002/(SICI)1096-9063(199708)50:4&lt;275::AID-PS593&gt;3.0.CO;2-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Skelly MJ, 2013, ANTIOXID REDOX SIGN, V19, P990, DOI 10.1089/ars.2013.5429; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Uehara F, 2013, BIOORG MED CHEM LETT, V23, P6928, DOI 10.1016/j.bmcl.2013.09.021; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	41	11	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123227	10.1371/journal.pone.0123227	http://dx.doi.org/10.1371/journal.pone.0123227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849038	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800215
J	Wang, B; Roth, JA; Nguyen, H; Felber, E; Furnback, W; Garrison, LP				Wang, Bruce; Roth, Joshua A.; Nguyen, Hiep; Felber, Eugene; Furnback, Wes; Garrison, Louis P.			The Short-Term Cost-Effectiveness of Once-Daily Liraglutide Versus Once-Weekly Exenatide for the Treatment of Type 2 Diabetes Mellitus in the United States	PLOS ONE			English	Article							IMPROVED GLYCEMIC CONTROL; HEALTH-CARE COSTS; OPEN-LABEL; RANDOMIZED-TRIAL; METFORMIN; SITAGLIPTIN; EFFICACY; SAFETY; OUTCOMES; PIOGLITAZONE	Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease with substantial morbidity, mortality, and economic impacts. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as once-daily (QD) liraglutide and once-weekly (QW) exenatide, are FDA-approved treatment for T2DM. Head-to-head trials and meta-analyses comparing these agents have reported clinically meaningful improvements but small differences in glycemic control between both agents. In this study, we calculate and compare the cost-effectiveness implications of these alternative effectiveness outcomes. Methods We developed a decision model to evaluate the short-term cost-effectiveness of exenatide QW 2 mg versus liraglutide QD 1.8 mg in T2DM patients, with effectiveness measured as reduction in glycated hemoglobin (HbA1c). In the base case, the model tracks change in HbA1c and direct medical expenditure over a 6-month time horizon. We calculated and compared the cost per 1% reduction in HbA1c of models populated with clinical data from a head-to-head randomized, controlled trial (DURATION-6) and a network meta-analysis. Expenditure inputs were derived from wholesale acquisition costs and published sources. Results In the base case, 6-month expenditure for the liraglutide and exenatide strategies were $3,509 and $2,618, respectively. Using clinical data from DURATION-6 and the network meta-analysis, the liraglutide strategy had an incremental cost per 1% reduction in HbA1c of $4,773 and $27,179, respectively. The most influential model parameters were drug costs, magnitude of HbA1c reduction in patients on treatment for >1 month, and liraglutide gastrointestinal adverse event rate. In probabilistic sensitivity analyses (PSA) using DURATION- 6 data, the exenatide strategy was optimal at willingness-to-pay levels below $4,800 per 1% reduction in HbA1c. In a PSA using meta-analysis data, the exenatide strategy was dominant. Conclusions Our modeled results demonstrate that the effectiveness and cost-effectiveness of liraglutide QD 1.8 mg relative to exenatide QW 2 mg depend largely on the chosen source of the clinical data.	[Wang, Bruce; Furnback, Wes] Elysia Grp LLC, New York, NY 10018 USA; [Roth, Joshua A.; Garrison, Louis P.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Roth, Joshua A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Nguyen, Hiep] AstraZeneca, Ft Washington, MD USA; [Felber, Eugene] Bristol Myers Squibb Co, New York, NY 10154 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; AstraZeneca; Bristol-Myers Squibb	Wang, B (corresponding author), Elysia Grp LLC, New York, NY 10018 USA.	bruce.wang@alscg.com		Roth, Joshua/0000-0001-6621-8342	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb Company. HN was an employee of Bristol-Myers Squibb Company during the study and was a contributor to the study design, decision to publish, and preparation of the manuscript.	Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Beckles GL, 2013, MMWR-MORBID MORTAL W, V62, P99; Bergenstal RM, 2013, DIABETES OBES METAB, V15, P264, DOI 10.1111/dom.12026; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; DeKoven M, 2014, ADV THER, V31, P202, DOI 10.1007/s12325-014-0098-8; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Gabriel SE, 2012, NEW ENGL J MED, V367, P787, DOI 10.1056/NEJMp1207437; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; Langer J, 2013, J MANAGE CARE PHARM, V19, P237, DOI 10.18553/jmcp.2013.19.3.237; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; McBrien KA, 2013, DIABETES CARE, V36, P1172, DOI 10.2337/dc12-0862; Menzin J, 2010, J MANAGE CARE PHARM, V16, P264, DOI 10.18553/jmcp.2010.16.4.264; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; O'Hagan A, 2005, PHARMACOECONOMICS, V23, P529, DOI 10.2165/00019053-200523060-00001; Pelletier Elise M, 2012, J Med Econ, V15, P1039, DOI 10.3111/13696998.2012.688903; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Saunders B, 2014, AM DIAB ASS ADA 74 S; Scott DA, 2013, DIABETES OBES METAB, V15, P213, DOI 10.1111/dom.12007; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182; Wild Howard, 2012, Am J Manag Care, V18, pS43; Zhuo XH, 2012, HEALTH AFFAIR, V31, P50, DOI 10.1377/hlthaff.2011.1115; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121915	10.1371/journal.pone.0121915	http://dx.doi.org/10.1371/journal.pone.0121915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849542	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800088
J	Estrabaud, E; Appourchaux, K; Bieche, I; Carrat, F; Lapalus, M; Lada, O; Martinot-Peignoux, M; Boyer, N; Marcellin, P; Vidaud, M; Asselah, T				Estrabaud, Emilie; Appourchaux, Kevin; Bieche, Ivan; Carrat, Fabrice; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Vidaud, Michel; Asselah, Tarik			IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; DISEASE PROGRESSION; ISG EXPRESSION; FIBROSIS; THERAPY; INFECTION; MICRORNA-122; POLYMORPHISM; MODULATION; GROWTH	Although, the treatment of chronic hepatitis C (CHC) greatly improved with the use of direct antiviral agents, pegylated-interferon (PEG-IFN) plus ribavirin remains an option for many patients, worldwide. The intra-hepatic level of expression of interferon stimulated genes (ISGs) and the rs12979860 CC genotype located within IFNL3 have been associated with sustained virological response (SVR), in patients with CHC. The aim of the study was to identify micro-RNAs associated with SVR and to build an accurate signature to predict SVR. Pre-treatment liver biopsies from 111 patients, treated with PEG-IFN plus ribavirin, were studied. Fifty-seven patients had SVR, 36 non-response (NR) and 18 relapse (RR). The expression of 851 human miRNAs and 30 selected mRNAs, including ISGs, was assessed by RT-qPCR. In the first group of patients (screen), 20 miRNAs out of the 851 studied were deregulated between NRs and SVRs. From the 4 miRNAs validated (mir-23a, mir-181a*, mir-217 and mir-99a), in the second group of patients (validation), 3 (mir-23a, mir-181a* and mir-99a) were down-regulated in NRs as compared to SVRs. The ISGs, studied, were accumulated in SVRs and IFNL3 rs12979860 CT/TT carriers compared respectively to NRs and CC carriers. Combining, clinical data together with the expression of selected genes and micro-RNAs, we identified a signature (IFI35, mir-99a and HCV genotype) to predict SVR (AUC:0.876) with a positive predictive value of 86.54% with high sensibility (80%) and specificity (80.4%). This signature may help to characterize patients with low chance to respond to PEG-IFN/ribavirin and to elucidate mechanisms of NR.	[Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] INSERM, Team Viral Hepatitis, Ctr Rech Inflammat, UMR1149, Paris, France; [Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] Univ Paris 07, Paris, France; [Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] PMAD Hop Beaujon, Serv Hepatol, Clichy, France; [Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] PRES Paris Sorbonne Cite, Lab Excellence Labex INFLAMEX, Paris, France; [Bieche, Ivan; Vidaud, Michel] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, INSERM UMR745, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Carrat, Fabrice] Univ Paris 06, Paris, France; [Carrat, Fabrice] INSERM, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Estrabaud, E (corresponding author), INSERM, Team Viral Hepatitis, Ctr Rech Inflammat, UMR1149, BP 416, Paris, France.	emilie.estrabaud@inserm.fr	Bièche, Ivan/O-7399-2017; Carrat, Fabrice/AAU-8480-2020; Vidaud, Michel/O-7346-2017	Bièche, Ivan/0000-0002-2430-5429; Carrat, Fabrice/0000-0002-8672-7918; 	french national agency for research on AIDS and viral hepatitis (ANRS)	french national agency for research on AIDS and viral hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	EE fellowship was supported by the french national agency for research on AIDS and viral hepatitis (ANRS). The study was supported by fundings from the french national agency for research on AIDS and viral hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Akamatsu S, 2014, J INFECT; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Asselah T, 2008, HEPATOLOGY, V48, P953, DOI 10.1002/hep.22411; Asselah T, 2014, J HEPATOL, V61, P193, DOI 10.1016/j.jhep.2014.03.006; Asselah T, 2014, LIVER INT, V34, P60, DOI 10.1111/liv.12424; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Das A, 2014, J VIROL, V88, P3103, DOI 10.1128/JVI.03202-13; de Yebenes VG, 2014, BLOOD, V124, P229, DOI 10.1182/blood-2013-12-543611; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Estrabaud E, 2012, J HEPATOL; Estrabaud E, 2014, J VIROL, V88, P6394, DOI 10.1128/JVI.00016-14; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gelley F, 2014, J GASTROEN HEPATOL, V29, P121, DOI 10.1111/jgh.12362; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Marcellin P, 2002, HEPATOLOGY, V36, pS47, DOI 10.1053/jhep.2002.36993; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; Nattermann J, 2007, HEPATOLOGY, V46, P1016, DOI 10.1002/hep.21778; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wang B, 2012, HEPATOLOGY; Yang ZP, 2014, ACTA DIABETOL, V51, P823, DOI 10.1007/s00592-014-0617-8; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121395	10.1371/journal.pone.0121395	http://dx.doi.org/10.1371/journal.pone.0121395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844942	Green Published, Green Submitted, gold			2022-12-27	WOS:000352475700007
J	Manning, VA; Ciuffetti, LM				Manning, Viola A.; Ciuffetti, Lynda M.			Necrotrophic Effector Epistasis in the Pyrenophora tritici-repentis-Wheat Interaction	PLOS ONE			English	Article							HOST-SELECTIVE TOXINS; TAN SPOT; CAUSAL AGENT; PTR TOXA; RACE STRUCTURE; VIRULENCE; GENE; CULTIVARS; CHLOROSIS; DISEASE	Pyrenophora tritici-repentis, the causal agent of tan spot disease of wheat, mediates disease by the production of host-selective toxins (HST). The known toxins are recognized in an 'inverse' gene-for-gene manner, where each is perceived by the product of a unique locus in the host and recognition leads to disease susceptibility. Given the importance of HSTs in disease development, we would predict that the loss of any of these major pathogenicity factors would result in reduced virulence and disease development. However, after either deletion of the gene encoding the HST ToxA or, reciprocally, heterologous expression of ToxA in a race that does not normally produce the toxin followed by inoculation of ToxA-sensitive and insensitive wheat cultivars, we demonstrate that ToxA symptom development can be epistatic to other HST-induced symptoms. ToxA epistasis on certain ToxA-sensitive wheat cultivars leads to genotype-specific increases in total leaf area affected by disease. These data indicate a complex interplay between host responses to HSTs in some genotypes and underscore the challenge of identifying additional HSTs whose activity may be masked by other toxins. Also, through mycelial staining, we acquire preliminary evidence that ToxA may provide additional benefits to fungal growth in planta in the absence of its cognate recognition partner in the host.	[Manning, Viola A.; Ciuffetti, Lynda M.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Ciuffetti, Lynda M.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Ciuffetti, LM (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	ciuffetL@science.oregonstate.edu			Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65108-20548]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2010-65108-20548 from the USDA National Institute of Food and Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhaddour R, 2013, CAN J PLANT PATHOL, V35, P256, DOI 10.1080/07060661.2013.782470; Aboukhaddour R, 2012, MOL PLANT PATHOL, V13, P318, DOI 10.1111/j.1364-3703.2011.00748.x; Adhikari T., 2009, FUNGAL LEAF SPOT DIS; Ali S, 2003, PLANT DIS, V87, P418, DOI 10.1094/PDIS.2003.87.4.418; Amaike S, 2008, PLANT PATHOL, V57, P623, DOI 10.1111/j.1365-3059.2007.01821.x; Andrie RA, 2007, PHYTOPATHOLOGY, V97, P694, DOI 10.1094/PHYTO-97-6-0694; [Anonymous], TAN SPOT WHEAT ARGEN; Ayliffe M, 2011, MOL PLANT MICROBE IN, V24, P1143, DOI 10.1094/MPMI-04-11-0100; Bailey KL, 1996, CAN J PLANT PATHOL, V18, P159, DOI 10.1080/07060669609500641; BALLANCE GM, 1989, PHYSIOL MOL PLANT P, V35, P203, DOI 10.1016/0885-5765(89)90051-9; Benslimane H, 2011, PHYTOPATHOL MEDITERR, V50, P203; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cho YR, 2006, MOL PLANT MICROBE IN, V19, P7, DOI 10.1094/MPMI-19-0007; Ciuffetti L.M., 2014, GENOMICS PLANT ASS F, P1, DOI [10.1007/978-3-662-44053-7_1, DOI 10.1007/978-3-662-44053-7_1]; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; De Wolf ED, 1998, CAN J PLANT PATHOL, V20, P349, DOI 10.1080/07060669809500404; Du Fall LA, 2013, NEW PHYTOL, V200, P185, DOI 10.1111/nph.12356; Dushnicky LG, 1998, CAN J PLANT PATHOL, V20, P19, DOI 10.1080/07060669809500441; Effertz RJ, 2002, PHYTOPATHOLOGY, V92, P527, DOI 10.1094/PHYTO.2002.92.5.527; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Faris J.D., 2013, THEOR APPL GENET, V29, P1; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Friesen TL, 2002, PHYTOPATHOLOGY, V92, P38, DOI 10.1094/PHYTO.2002.92.1.38; Fu HT, 2013, FUNGAL BIOL-UK, V117, P673, DOI 10.1016/j.funbio.2013.07.003; Heath MC, 2000, PROGRAMMED CELL DEAT, P77, DOI DOI 10.1007/978-94-010-0934-8_6; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Lamari L, 2005, CAN J PLANT PATHOL, V27, P383; Lamari L, 2003, PHYTOPATHOLOGY, V93, P391, DOI 10.1094/PHYTO.2003.93.4.391; LAMARI L, 1991, PLANT DIS, V75, P121, DOI 10.1094/PD-75-0121; LAMARI L, 1989, CAN J PLANT PATHOL, V11, P49, DOI 10.1080/07060668909501146; Lamari L, 1998, CAN J PLANT PATHOL, V20, P396, DOI 10.1080/07060669809500410; LAMARI L, 1989, CAN J PLANT PATHOL, V11, P284, DOI 10.1080/07060668909501114; Lamari L, 2010, CAN J PLANT PATHOL, V32, P4, DOI 10.1080/07060661003594117; LAREZ CR, 1986, PHYTOPATHOLOGY, V76, P931, DOI 10.1094/Phyto-76-931; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; LOUGHMAN R, 1986, PLANT PATHOL, V35, P443, DOI 10.1111/j.1365-3059.1986.tb02041.x; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Manning VA, 2010, NEW PHYTOL, V187, P1034, DOI 10.1111/j.1469-8137.2010.03363.x; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Meinhardt S, 2002, NEW RACE PYRENOPHORA, P117; Moffat CS, 2014, MOL PLANT PATHOL, V15, P918, DOI 10.1111/mpp.12154; Moreno MV, 2008, EUR J PLANT PATHOL, V122, P239, DOI 10.1007/s10658-008-9277-2; Morral R, 2014, SASKATOON SASKATCHWA, P1; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; OROLAZA NP, 1995, PHYTOPATHOLOGY, V85, P1282, DOI 10.1094/Phyto-85-1282; Pandelova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040240; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Rodriguez RW, 1996, PLANT DIS, V80, P478, DOI 10.1094/PD-80-0478; SCHUH W, 1990, PHYTOPATHOLOGY, V80, P804, DOI 10.1094/Phyto-80-804; Singh PK, 2007, CAN J PLANT PATHOL, V29, P166, DOI 10.1080/07060660709507453; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Strelkov SE, 2003, CAN J PLANT PATHOL, V25, P339; Strelkov SE, 2002, CAN J PLANT PATHOL, V24, P29, DOI 10.1080/07060660109506967; Tai Y. S., 2007, Biotechnology, V6, P288; TOMAS A, 1990, MOL PLANT MICROBE IN, V3, P221, DOI 10.1094/MPMI-3-221; TUORI RP, 1995, MOL PLANT MICROBE IN, V8, P41, DOI 10.1094/MPMI-8-0041; Vincent D, 2012, MOL PLANT PATHOL, V13, P467, DOI 10.1111/j.1364-3703.2011.00763.x; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210	63	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123548	10.1371/journal.pone.0123548	http://dx.doi.org/10.1371/journal.pone.0123548			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25845019	Green Published, Green Submitted, gold			2022-12-27	WOS:000352475700023
J	de Freitas, CT; Shepard, GH; Piedade, MTF				de Freitas, Carolina T.; Shepard, Glenn H., Jr.; Piedade, Maria T. F.			The Floating Forest: Traditional Knowledge and Use of Matupa Vegetation Islands by Riverine Peoples of the Central Amazon	PLOS ONE			English	Article							ECOLOGICAL KNOWLEDGE; INDIGENOUS KNOWLEDGE; CLASSIFICATION; CONSERVATION	Matupas are floating vegetation islands found in floodplain lakes of the central Brazilian Amazon. They form initially from the agglomeration of aquatic vegetation, and through time can accumulate a substrate of organic matter sufficient to grow forest patches of several hectares in area and up to 12 m in height. There is little published information on matupas despite their singular characteristics and importance to local fauna and people. In this study we document the traditional ecological knowledge of riverine populations who live near and interact with matupas. We expected that their knowledge, acquired through long term observations and use in different stages of the matupa life cycle, could help clarify various aspects about the ecology and natural history of these islands that field biologists may not have had the opportunity to observe. Research was carried out in five riverine communities of the Amana Sustainable Development Reserve (Brazil). Semistructured interviews were conducted with 45 inhabitants in order to register local understandings of how matupas are formed, biotic/abiotic factors related to their occurrence, the plants and animals that occur on them, their ecological relevance, and local uses. Local people elucidated several little-known aspects about matupa ecology, especially regarding the importance of seasonal dynamics of high/low water for matupas formation and the relevance of these islands for fish populations. Soil from matupas is especially fertile and is frequently gathered for use in vegetable gardens. In some cases, crops are planted directly onto matupas, representing an incipient agricultural experiment that was previously undocumented in the Amazon. Matupas are also considered a strategic habitat for fishing, mainly for arapaima (Arapaima gigas). The systematic study of traditional ecological knowledge proved to be an important tool for understanding this little-known Amazonian landscape.	[de Freitas, Carolina T.] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Shepard, Glenn H., Jr.] Museu Paraense Emilio Goeldi, Dept Anthropol, Belem, Para, Brazil; [Piedade, Maria T. F.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Pesquisas Dinam Ambiental, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia	de Freitas, CT (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	carol.tavares.freitas@gmail.com	Shepard, Glenn H./C-3667-2014; Piedade, Maria Teresa/C-5372-2013; Shepard, Glenn/AAS-4059-2021; Freitas, Carolina/D-3225-2019	Shepard, Glenn H./0000-0003-3195-8230; Piedade, Maria Teresa/0000-0002-7320-0498; Shepard, Glenn/0000-0003-3195-8230; Freitas, Carolina/0000-0002-2335-4229	Instituto de Desenvolvimento Sustentavel Mamiraua; National Geographic Society [9159-12]	Instituto de Desenvolvimento Sustentavel Mamiraua; National Geographic Society(National Geographic Society)	CTF received financial and logistical support from the Instituto de Desenvolvimento Sustentavel Mamiraua (http://www.mamiraua.org.br/) and also financial support from the National Geographic Society (Grant Number 9159-12; http://www.nationalgeographic.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraao MB, 2008, J BIOGEOGR, V35, P2237, DOI 10.1111/j.1365-2699.2008.01975.x; Agostinho AA, 2007, AQUAT ECOL, V41, P611, DOI 10.1007/s10452-007-9122-2; [Anonymous], 1998, ETHNOGRAPHERS TOOLKI; Balram S, 2004, BIODIVERS CONSERV, V13, P1195, DOI 10.1023/B:BIOC.0000018152.11643.9c; Banuri T., 1993, WHO WILL SAVE FOREST; Berkes F, 1999, SACRED ECOLOGY TRADI, P1; Berkes F., 1993, TRADITIONAL ECOLOGIC, P1; Bernard HR, 1994, RES METHODS ANTHR QU; Brook R, 2008, BIODIVERS CONSERV, V17, P3501, DOI 10.1007/s10531-008-9445-x; CASCUDO Luis da Camara, 2001, DICIONARIO FOLCLORE; Curtis JT, 1951, ECOLOGY, V31, P476; Fleck David W., 2000, Journal of Ethnobiology, V20, P1; GALVAO Eduardo, 1955, SANTOS VISAGENS ESTU; Halme KJ, 2007, BIODIVERS CONSERV, V16, P1785, DOI 10.1007/s10531-006-9071-4; Hoogmoed Marinus S., 1993, Monographiae Biologicae, V70, P199; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; IDSM, 2014, AM RES DES SUST; Ingold T, 2006, ETHNOS, V71, P9, DOI 10.1080/00141840600603111; Johnson Leslie M., 2010, LANDSCAPE ETHNOECOLO; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk W.J., 1983, P269; JUNK W.J., 1997, CENTRAL AMAZON FLOOD, P148, DOI DOI 10.1038/sdata.2017.122; Junk WJ, 1977, MACROFITAS AQUATICAS; Junk WJ, 2012, WETL ECOL MANAG, V20, P461, DOI 10.1007/s11273-012-9268-0; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Monteiro MY, 2006, CRENDICES SUPERSTICO; NODA H, 1978, Acta Amazonica, V8, P107; Parker E. P., 1989, Advances in Economic Botany, V7, P249; Pereira M.N., 1944, B MINISTERIO AGR, V33, P21; Petr T, 2000, 396 FAO; POSEY DA, 1984, HUM ORGAN, V43, P95, DOI 10.17730/humo.43.2.908kp82611x0w860; Sanchez-Botero Jorge Ivan, 2001, Acta Amazonica, V31, P437; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Shepard G.H., 2004, ADV EC BOT, V15, P133; Shepard GH Jr, 2001, DEBATE AGRARIO, V33, P19; Shepard Junior Glenn H., 2001, Journal of Ethnobiology, V21, P1; Sillitoe P, 1998, CURR ANTHROPOL, V39, P223, DOI 10.1086/204722; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; Toledo V., 1992, ETNOECOLOGICA, V1, P5; Ugarte JC., 2009, THESIS U NACL AGRARI; Villamarin F, 2011, BIOL CONSERV, V144, P913, DOI 10.1016/j.biocon.2010.12.012	41	7	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122542	10.1371/journal.pone.0122542	http://dx.doi.org/10.1371/journal.pone.0122542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837281	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000100
J	deVries, MS; del Rio, CM; Tunstall, TS; Dawson, TE				deVries, Maya S.; del Rio, Carlos Martinez; Tunstall, Tate S.; Dawson, Todd E.			Isotopic Incorporation Rates and Discrimination Factors in Mantis Shrimp Crustaceans	PLOS ONE			English	Article							CARBON INCORPORATION RATES; STABLE-ISOTOPES; TISSUE-CARBON; FOOD-WEB; NITROGEN; TURNOVER; DIET; RATIOS; STOMATOPODS; SULFUR	Stable isotope analysis has provided insights into the trophic ecology of a wide diversity of animals. Knowledge about isotopic incorporation rates and isotopic discrimination between the consumer and its diet for different tissue types is essential for interpreting stable isotope data, but these parameters remain understudied in many animal taxa and particularly in aquatic invertebrates. We performed a 292-day diet shift experiment on 92 individuals of the predatory mantis shrimp, Neogonodactylus bredini, to quantify carbon and nitrogen incorporation rates and isotope discrimination factors in muscle and hemolymph tissues. Average isotopic discrimination factors between mantis shrimp muscle and the new diet were 3.0 +/- 0.6% and 0.9 +/- 0.3% for carbon and nitrogen, respectively, which is contrary to what is seen in many other animals (e.g. C and N discrimination is generally 0-1% and 3-4%, respectively). Surprisingly, the average residence time of nitrogen in hemolymph (28.9 +/- 8.3 days) was over 8 times longer than that of carbon (3.4 +/- 1.4 days). In muscle, the average residence times of carbon and nitrogen were of the same magnitude (89.3 +/- 44.4 and 72.8 +/- 18.8 days, respectively). We compared the mantis shrimps' incorporation rates, along with rates from four other invertebrate taxa from the literature, to those predicted by an allometric equation relating carbon incorporation rate to body mass that was developed for teleost fishes and sharks. The rate of carbon incorporation into muscle was consistent with rates predicted by this equation. Our findings provide new insight into isotopic discrimination factors and incorporation rates in invertebrates with the former showing a different trend than what is commonly observed in other animals.	[deVries, Maya S.; Tunstall, Tate S.; Dawson, Todd E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [del Rio, Carlos Martinez] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of California System; University of California Berkeley; University of Wyoming	deVries, MS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mdevries@ucsd.edu			American Museum of Natural History Lerner-Gray Fund; Berkeley and National Sigma Xi Scientific Honors Society Grants-In-Aid-of-Research; Society of Integrative and Comparative Biology Grants-In-Aid-of-Research; Smithsonian Tropical Research Institute's Short-Term Fellowship Award; UC Berkeley Department of Integrative Biology Endowment; UC Museum of Paleontology Graduate Student Research Award; National Science Foundation [IOS-1014573]; Berkeley Research Impact Initative (BRII) - UC Berkeley Library	American Museum of Natural History Lerner-Gray Fund; Berkeley and National Sigma Xi Scientific Honors Society Grants-In-Aid-of-Research; Society of Integrative and Comparative Biology Grants-In-Aid-of-Research; Smithsonian Tropical Research Institute's Short-Term Fellowship Award; UC Berkeley Department of Integrative Biology Endowment; UC Museum of Paleontology Graduate Student Research Award; National Science Foundation(National Science Foundation (NSF)); Berkeley Research Impact Initative (BRII) - UC Berkeley Library	This research was funded by the American Museum of Natural History Lerner-Gray Fund (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships), the Berkeley and National Sigma Xi Scientific Honors Society Grants-In-Aid-of-Research (https://www.sigmaxi.org/programs/grants-in-aid), the Society of Integrative and Comparative Biology Grants-In-Aid-of-Research (http://www.sicb.org/grants/researchgrant.php3), the Smithsonian Tropical Research Institute's Short-Term Fellowship Award (http://www.stri.si.edu/english/education_fellowships/fellowships/index.php), the UC Berkeley Department of Integrative Biology Endowment, the UC Museum of Paleontology Graduate Student Research Award (all awards to MSdV). Funding was also provided by the National Science Foundation (IOS-1014573 to S. N. Patek). Publication made possible in part by support from the Berkeley Research Impact Initative (BRII) sponsored by the UC Berkeley Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Arneson LS, 2006, CAN J ZOOL, V84, P992, DOI 10.1139/Z06-081; Ballestrazzi R, 1998, AQUACULTURE, V161, P55, DOI 10.1016/S0044-8486(97)00256-1; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Blanchet-Aurigny A, 2012, J EXP MAR BIOL ECOL, V426, P68, DOI 10.1016/j.jembe.2012.05.013; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; BUNN SE, 1995, LIMNOL OCEANOGR, V40, P622, DOI 10.4319/lo.1995.40.3.0622; Caldwell R.L., 1989, Collana U.Z.I. Selected Symposia and Monographs, V3, P117; Caldwell RL, 1987, SHORT TERM ASSESMENT, P113; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Carleton SA, 2008, RAPID COMMUN MASS SP, V22, P3008, DOI 10.1002/rcm.3691; Carleton SA, 2010, FUNCT ECOL, V24, P805, DOI 10.1111/j.1365-2435.2010.01700.x; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carter CG, 2014, CENT EUR J BIOL, V9, P1, DOI 10.2478/s11535-013-0134-0; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Dattagupta S, 2004, LIMNOL OCEANOGR, V49, P1144, DOI 10.4319/lo.2004.49.4.1144; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DINGLE H, 1978, BIOL BULL, V155, P134, DOI 10.2307/1540871; DOMINGUEZ JH, 1988, J EXP MAR BIOL ECOL, V117, P47, DOI 10.1016/0022-0981(88)90070-6; Dubois S, 2007, J EXP MAR BIOL ECOL, V351, P121, DOI 10.1016/j.jembe.2007.06.020; Fantle MS, 1999, OECOLOGIA, V120, P416, DOI 10.1007/s004420050874; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Frazer T, 1997, J EXP MAR BIOL ECOL, P212; Fry B., 2006, STABLE ISOTOPE ECOLO; FULL RJ, 1989, ETHOLOGY, V81, P134; Gamboa-Delgado J, 2011, J SHELLFISH RES, V30, P969, DOI 10.2983/035.030.0340; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Kaufman MR, 2008, OECOLOGIA, V158, P11, DOI 10.1007/s00442-008-1122-y; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; KUNZE JC, 1981, PHILOS T ROY SOC B, V292, P255, DOI 10.1098/rstb.1981.0032; Kurle CM, 2013, CONDOR, V115, P492, DOI 10.1525/cond.2013.120107; Leal JCM, 2008, MAR BIOL, V153, P673, DOI 10.1007/s00227-007-0841-7; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; Mateo MA, 2008, OECOLOGIA, V157, P105, DOI 10.1007/s00442-008-1052-8; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Murray IW, 2012, PHYSIOL BIOCHEM ZOOL, V85, P96, DOI 10.1086/663867; Parker PL., 1989, STABLE ISOTOPES ECOL, P288; Patek SN, 2005, J EXP BIOL, V208, P3655, DOI 10.1242/jeb.01831; Patek SN, 2004, NATURE, V428, P819, DOI 10.1038/428819a; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; REAKA ML, 1976, BIOL BULL, V150, P468, DOI 10.2307/1540686; STEGER R, 1987, ECOLOGY, V68, P1520, DOI 10.2307/1939236; Suring E, 2009, J EXP MAR BIOL ECOL, V370, P56, DOI 10.1016/j.jembe.2008.11.014; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Warne RW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P608, DOI 10.1086/651585; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115; Zarai Z, 2011, J SCI FOOD AGR, V91, P1265, DOI 10.1002/jsfa.4309; [No title captured]	59	33	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122334	10.1371/journal.pone.0122334	http://dx.doi.org/10.1371/journal.pone.0122334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835953	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000095
J	Iffland, JR; Lockhofen, D; Gruppe, H; Gallhofer, B; Sammer, G; Hanewald, B				Iffland, Jona R.; Lockhofen, Denise; Gruppe, Harald; Gallhofer, Bernd; Sammer, Gebhard; Hanewald, Bernd			Validation of the German Version of the Social Functioning Scale (SFS) for Schizophrenia	PLOS ONE			English	Article							BIPOLAR DISORDER; OUTCOMES; DISABILITY; PEOPLE	Deficits in social functioning are a core symptom of schizophrenia and an important criterion for evaluating the success of treatment. However, there is little agreement regarding its measurement. A common, often cited instrument for assessing self-reported social functioning is the Social Functioning Scale (SFS). The study aimed to investigate the reliability and validity of the German translation. 101 patients suffering from schizophrenia (SZ) and 101 matched controls (C) (60 male / 41 female, 35.8 years in both groups) completed the German version. In addition, demographic, clinical, and functional data were collected. Internal consistency was investigated calculating Cronbach's alpha for SFS full scale (alpha:.81) and all subscales (alpha:.59-.88). Significant bivariate correlation coefficients were found between all subscales as well as between all subscales and full scale (p < .01). For the total sample, principal component analysis gave evidence to prefer a single-factor solution (eigenvalue >= 1) accounting for 48.5% of the variance. For the subsamples, a two-component solution (SZ; 57.0%) and a three-component solution (C; 65.6%) fitted best, respectively. For SZ and C, significant associations were found between SFS and external criteria. The main factor "group" emerged as being significant. C showed higher values on both subscales and full scale. The sensitivity of the SFS was examined using discriminant analysis. 86.5% of the participants could be categorized correctly to their actual group. The German translation of the SFS turned out to be a reliable and valid questionnaire comparable to the original English version. This is in line with Spanish and Norwegian translations of the SFS. Concluding, the German version of the SFS is well suited to become a useful and practicable instrument for the assessment of social functioning in both clinical practice and research. It accomplishes commonly used external assessment scales.	[Iffland, Jona R.; Lockhofen, Denise; Gruppe, Harald; Gallhofer, Bernd; Sammer, Gebhard; Hanewald, Bernd] Univ Giessen, Cognit NeuroSci, Ctr Psychiat, D-35390 Giessen, Germany; [Sammer, Gebhard] Univ Giessen, Bender Inst Neuroimaging, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Iffland, JR (corresponding author), Univ Giessen, Cognit NeuroSci, Ctr Psychiat, D-35390 Giessen, Germany.	Jona.R.Iffland@psychiat.med.uni-giessen.de			Research Grant of the University Medical Center Giessen and Marburg (UKGM)	Research Grant of the University Medical Center Giessen and Marburg (UKGM)	Supported by a Research Grant of the University Medical Center Giessen and Marburg (UKGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 1999, SCHIZOPHRENIA BULL, V25, P173, DOI 10.1093/oxfordjournals.schbul.a033363; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bellack AS, 2007, SCHIZOPHRENIA BULL, V33, P805, DOI 10.1093/schbul/sbl035; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; Bowie CR, 2007, J PSYCHIATR RES, V41, P1012, DOI 10.1016/j.jpsychires.2006.08.003; Brissos S, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-18; Burns T, 2007, ACTA PSYCHIAT SCAND, V116, P403, DOI 10.1111/j.1600-0447.2007.01108.x; Durand D, 2014, EUR NEUROPSYCHOPHARM; Duschek S, 2003, DIAGNOSTIK SOZIALER; Figueira ML, 2011, CURR OPIN PSYCHIATR, V24, P91, DOI 10.1097/YCO.0b013e3283438119; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Heinrichs RW, 2009, SCHIZOPHR RES, V109, P46, DOI 10.1016/j.schres.2009.01.001; Hellvin T, 2010, SCAND J PSYCHOL, V51, P525, DOI 10.1111/j.1467-9450.2010.00839.x; HOGARTY GE, 1979, ARCH GEN PSYCHIAT, V36, P1283; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Juckel G, 2008, CURR OPIN PSYCHIATR, V21, P630, DOI 10.1097/YCO.0b013e328314e144; Jung E, 1989, MANNHEIMER SKALA EIN; Karow A, 2012, EUR PSYCHIAT, V27, P401, DOI 10.1016/j.eurpsy.2011.01.012; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; LEIFKER FR, 2011, SCHIZOPHRENIA BULL, V37, P334, DOI [DOI 10.1093/schbul/sbp044, DOI 10.1093/SCHBUL/SBP044]; Medalia A, 2008, SCHIZOPHR RES, V105, P156, DOI 10.1016/j.schres.2008.07.007; Morejon AJV, 2000, PSYCHIAT RES, V93, P247, DOI 10.1016/S0165-1781(99)00123-7; Paul G. L., 1977, PSYCHOL TREATMENT CH; Priebe S, 2007, BRIT J PSYCHIAT, V191, pS15, DOI 10.1192/bjp.191.50.s15; ROSEN A, 1989, SCHIZOPHRENIA BULL, V15, P325, DOI 10.1093/schbul/15.2.325; Schennach R, 2012, CURR PSYCHIAT REP, V14, P229, DOI 10.1007/s11920-012-0261-3; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Torres A, 2005, ACTAS ESP PSIQUIATRI, V33, P216; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; UNESCO Institute for Statistics, 2012, COMP SOCIAL RES; Vaskinn A, 2011, NEUROPSYCHOLOGY, V25, P499, DOI 10.1037/a0022677; Velligan DI, 2009, PSYCHIAT RES, V169, P97, DOI 10.1016/j.psychres.2008.10.009; Ventura J, 2009, SCHIZOPHR RES, V113, P189, DOI 10.1016/j.schres.2009.03.035; Wittchen H.-U., 1997, SKID STRUKTURIERTES; World Health Organization, 1980, INT CLASS IMP DIS HA	36	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121807	10.1371/journal.pone.0121807	http://dx.doi.org/10.1371/journal.pone.0121807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837711	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000064
J	Jamba, A; Kondo, S; Urushihara, M; Nagai, T; Kim-Kaneyama, J; Miyazaki, A; Kagami, S				Jamba, Ariunbold; Kondo, Shuji; Urushihara, Maki; Nagai, Takashi; Kim-Kaneyama, Joo-ri; Miyazaki, Akira; Kagami, Shoji			Hydrogen Peroxide-Inducible Clone-5 Regulates Mesangial Cell Proliferation in Proliferative Glomerulonephritis in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PDGF RECEPTOR; EXPRESSION; HIC-5; GENE; GLOMERULOSCLEROSIS; ACTIVATION; PROTEIN; BETA-1-INTEGRINS	Hydrogen peroxide-inducible clone-5 (Hic-5) is a transforming growth factor (TGF)-beta 1-in-ducible focal adhesion protein. We previously demonstrated that Hic-5 was localized in mesangial cells and its expression was associated with glomerular cell proliferation and matrix expansion in human and rat glomerulonephritis (GN). In the present study, we first assessed the role of Hic-5 in mesangioproliferative GN by injecting Habu venom into heminephrectomized wild type (Hic-5+/+) and Hic-5-deficient (Hic-5-/-) mice. Hic-5+/+ GN mice exhibited glomerular cell proliferation on day 7. Surprisingly, glomerular cell number and Ki-67-positive cells in Hic-5-/- GN mice were significantly greater than those in Hic-5+/+ GN mice on day 7, although the number of glomerular apoptotic cells and the expression of growth factors (platelet-derived growth factor-BB and TGF-beta 1) and their receptors were similarly increased in both Hic-5+/+ and Hic-5-/- GN mice. In culture experiments, proliferation assays showed that platelet-derived growth factor-BB and TGF-beta 1 enhanced the proliferation of Hic-5-/- mesangial cells compared with Hic-5+/+ mesangial cells. In addition, mitogenic regulation by Hic-5 was associated with altered and coordinated expression of cell cycle-related proteins including cyclin D1 and p21. The present results suggest that Hic-5 might regulate mesangial cell proliferation in proliferative GN in mice. In conclusion, modulation of Hic-5 expression might have a potential to prevent mesangial cell proliferation in the acute mitogenic phase of glomerulonephritis.	[Jamba, Ariunbold; Kondo, Shuji; Urushihara, Maki; Nagai, Takashi; Kagami, Shoji] Univ Tokushima, Grad Sch, Dept Pediat, Inst Hlth Biosci, Tokushima, Japan; [Kim-Kaneyama, Joo-ri; Miyazaki, Akira] Showa Univ, Sch Med, Dept Biochem, Tokyo 142, Japan	Tokushima University; Showa University	Kondo, S (corresponding author), Univ Tokushima, Grad Sch, Dept Pediat, Inst Hlth Biosci, Tokushima, Japan.	shuchann@tokushima-u.ac.jp			Morinaga Foundation for Health and Nutrition;  [23591570];  [23591571];  [26461613]; Grants-in-Aid for Scientific Research [26461613] Funding Source: KAKEN	Morinaga Foundation for Health and Nutrition; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research, number 23591570 to Shoji Kagami, and number 23591571 and 26461613 to Shuji Kondo, (http://www.jsps.go.jp/english/index.html) and by the Morinaga Foundation for Health and Nutrition to Shuji Kondo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; ABBOUD HE, 1993, KIDNEY INT, V43, P252, DOI 10.1038/ki.1993.39; Amann K, 2012, NEPHROL DIAL TRANSPL, V27, P1755, DOI 10.1093/ndt/gfr603; [Anonymous], 2004, J CELL PHYSL; BARNES JL, 1993, AM J PATHOL, V143, P1366; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; Cove-Smith A, 2008, NEPHRON EXP NEPHROL, V108, pE74, DOI 10.1159/000127359; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; Hornigold N, 2010, KIDNEY INT, V77, P329, DOI 10.1038/ki.2009.417; IIDA H, 1991, P NATL ACAD SCI USA, V88, P6560, DOI 10.1073/pnas.88.15.6560; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Kagami S, 1999, J AM SOC NEPHROL, V10, P779; KAGAMI S, 1993, LAB INVEST, V69, P68; Kagami S, 2000, KIDNEY INT, V58, P1088, DOI 10.1046/j.1523-1755.2000.00266.x; Kagami Shoji, 2004, Journal of Medical Investigation, V51, P1, DOI 10.2152/jmi.51.1; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; Kinoshita Y, 2011, TRANSL RES, V158, P235, DOI 10.1016/j.trsl.2011.05.003; Kitamura M, 1997, NEPHROL DIAL TRANSPL, V12, P669, DOI 10.1093/ndt/12.4.669; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Kondo S, 2004, BBA-MOL CELL RES, V1693, P91, DOI 10.1016/j.bbamcr.2004.05.005; Kondo S, 2006, J AM SOC NEPHROL, V17, P783, DOI 10.1681/ASN.2005050519; Kuhara T, 1997, J AM SOC NEPHROL, V8, P1679; Matsuda M, 1997, AM J NEPHROL, V17, P25, DOI 10.1159/000169067; Matsuura S, 2011, J HISTOCHEM CYTOCHEM, V59, P864, DOI 10.1369/0022155411413929; Morita T, 1998, AM J KIDNEY DIS, V31, P559, DOI 10.1053/ajkd.1998.v31.pm9531171; Morita T, 2011, NEPHROL DIAL TRANSPL, V26, P4023, DOI 10.1093/ndt/gfr176; NIEMIR ZI, 1995, KIDNEY INT, V48, P1530, DOI 10.1038/ki.1995.443; Sakai N, 2005, PATHOL INT, V55, P19, DOI 10.1111/j.1440-1827.2005.01781.x; Schocklmann HO, 1999, KIDNEY INT, V56, P1199, DOI 10.1046/j.1523-1755.1999.00710.x; Schocklmann HO, 2000, KIDNEY INT, V58, P1108, DOI 10.1046/j.1523-1755.2000.00268.x; Schoecklmann HO, 1997, KIDNEY INT, V51, P1228, DOI 10.1038/ki.1997.168; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Shibanuma M, 1998, INT J BIOCHEM CELL B, V30, P39, DOI 10.1016/S1357-2725(97)00155-6; Suga K, 2012, NEPHRON EXP NEPHROL, V120, pE59, DOI 10.1159/000335780; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Urushihara M, 2010, AM J PHYSIOL-RENAL, V298, pF167, DOI 10.1152/ajprenal.00124.2009; Watanabe T, 2002, J PATHOL, V198, P397, DOI 10.1002/path.1213; Yamamoto T, 1998, J AM SOC NEPHROL, V9, P2253	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122773	10.1371/journal.pone.0122773	http://dx.doi.org/10.1371/journal.pone.0122773			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835392	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000111
J	Li, FJ; Duggal, RN; Oliva, OM; Karki, S; Surolia, R; Wang, Z; Watson, RD; Thannickal, VJ; Powell, M; Watts, S; Kulkarni, T; Batra, H; Bolisetty, S; Agarwal, A; Antony, VB				Li, Fu Jun; Duggal, Ryan N.; Oliva, Octavio M.; Karki, Suman; Surolia, Ranu; Wang, Zheng; Watson, R. Douglas; Thannickal, Victor J.; Powell, Mickie; Watts, Stephen; Kulkarni, Tejaswini; Batra, Hitesh; Bolisetty, Subhashini; Agarwal, Anupam; Antony, Veena B.			Heme Oxygenase-1 Protects Corexit 9500A-Induced Respiratory Epithelial Injury across Species	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ENDOTHELIAL-CELL APOPTOSIS; DIOCTYL SODIUM SULFOSUCCINATE; HORIZON OIL-SPILL; GULF-OF-MEXICO; OXIDATIVE STRESS; E-CADHERIN; NADPH OXIDASE; PARACELLULAR PERMEABILITY; HYDROGEN-PEROXIDE	The effects of Corexit 9500A (CE) on respiratory epithelial surfaces of terrestrial mammals and marine animals are largely unknown. This study investigated the role of CE-induced heme oxygenase-1 (HO-1), a cytoprotective enzyme with anti-apoptotic and antioxidant activity, in human bronchial airway epithelium and the gills of exposed aquatic animals. We evaluated CE-mediated alterations in human airway epithelial cells, mice lungs and gills from zebrafish and blue crabs. Our results demonstrated that CE induced an increase in gill epithelial edema and human epithelial monolayer permeability, suggesting an acute injury caused by CE exposure. CE induced the expression of HO-1 as well as C-reactive protein (CRP) and NADPH oxidase 4 (NOX4), which are associated with ROS production. Importantly, CE induced caspase-3 activation and subsequent apoptosis of epithelial cells. The expression of the intercellular junctional proteins, such as tight junction proteins occludin, zonula occludens (ZO-1), ZO-2 and adherens junctional proteins E-cadherin and Focal Adhesion Kinase (FAK), were remarkably inhibited by CE, suggesting that these proteins are involved in CE-induced increased permeability and subsequent apoptosis. The cytoskeletal protein F-actin was also disrupted by CE. Treatment with carbon monoxide releasing molecule-2 (CORM-2) significantly inhibited CE-induced ROS production, while the addition of HO-1 inhibitor, significantly increased CE-induced ROS production and apoptosis, suggesting a protective role of HO-1 or its reaction product, CO, in CE-induced apoptosis. Using HO-1 knockoutmice, we further demonstrated that HO-1 protected against CE-induced inflammation and cellular apoptosis and corrected CE-mediated inhibition of E-cadherin and FAK. These observations suggest that CE activates CRP and NOX4-mediated ROS production, alters permeability by inhibition of junctional proteins, and leads to caspase-3 dependent apoptosis of epithelial cells, while HO-1 and its reaction products protect against oxidative stress and apoptosis.	[Li, Fu Jun; Duggal, Ryan N.; Oliva, Octavio M.; Karki, Suman; Surolia, Ranu; Wang, Zheng; Thannickal, Victor J.; Kulkarni, Tejaswini; Batra, Hitesh; Antony, Veena B.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Watson, R. Douglas; Powell, Mickie; Watts, Stephen] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Bolisetty, Subhashini; Agarwal, Anupam] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Antony, VB (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	vantony@uab.edu	Bolisetty, Subhashini/F-6496-2011	Bolisetty, Subhashini/0000-0002-4650-3151; Surolia, Ranu/0000-0001-5389-3584	NIGMS [5R25GM086256]; BP/Gulf of Mexico Research Initiative (RDW); NIH/NHLBI [P01 HL114470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, T32DK007545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086256] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BP/Gulf of Mexico Research Initiative (RDW); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a NIGMS Grant 5R25GM086256, which funds the UAB PREP Scholars Program (OMO); BP/Gulf of Mexico Research Initiative (RDW); and NIH/NHLBI (P01 HL114470, VBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2011, J TOXICOL ENV HEAL A, V74, P1419, DOI 10.1080/15287394.2011.606797; Bolisetty S, 2013, AM J PHYSIOL-RENAL, V305, pF255, DOI 10.1152/ajprenal.00160.2013; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Buret AG, 2003, INT J PARASITOL, V33, P1363, DOI 10.1016/S0020-7519(03)00138-3; Castranova V, 2011, J TOXICOL ENV HEAL A, V74, P1367, DOI 10.1080/15287394.2011.606792; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Durante W, 2010, CURR DRUG TARGETS, V11, P1504, DOI 10.2174/1389450111009011504; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Gray JL, 2014, CHEMOSPHERE, V95, P124, DOI 10.1016/j.chemosphere.2013.08.049; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; Guo X, 2003, AM J PHYSIOL-CELL PH, V285, pC1174, DOI 10.1152/ajpcell.00015.2003; Hayashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P169, DOI 10.1016/j.bbrc.2011.11.078; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Jonsson ME, 2009, AQUAT TOXICOL, V91, P62, DOI 10.1016/j.aquatox.2008.10.010; Kaizaki A, 2006, BRAIN RES, V1108, P39, DOI 10.1016/j.brainres.2006.06.011; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Kim SJ, 2013, FREE RADICAL BIO MED, V65, P997, DOI 10.1016/j.freeradbiomed.2013.08.178; Kim Y, 2014, FEBS LETT, V588, P625, DOI 10.1016/j.febslet.2014.01.008; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; Krajnak K, 2011, J TOXICOL ENV HEAL A, V74, P1397, DOI 10.1080/15287394.2011.606795; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Li JZ, 2012, CAN J PHYSIOL PHARM, V90, P1569, DOI 10.1139/y2012-140; Liu B, 2006, CHEMOSPHERE, V62, P520, DOI 10.1016/j.chemosphere.2005.06.054; Liu GS, 2014, FREE RADICAL BIO MED, V70, P14, DOI 10.1016/j.freeradbiomed.2013.12.024; Lu Q, 2012, MICROVASC RES, V83, P56, DOI 10.1016/j.mvr.2011.05.003; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Menard N, 2012, PHARM RES-DORDR, V29, P1882, DOI 10.1007/s11095-012-0714-8; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; MOFFATT RE, 1975, CAN J COMP MED, V39, P434; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Nabata A, 2008, ATHEROSCLEROSIS, V196, P129, DOI 10.1016/j.atherosclerosis.2007.03.003; Nakatsuji T, 2006, MOL CELL ENDOCRINOL, V253, P96, DOI 10.1016/j.mce.2006.05.004; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13; Reiter TA, 2005, FREE RADICAL BIO MED, V39, P1075, DOI 10.1016/j.freeradbiomed.2005.05.023; Rico-Martinez R, 2013, ENVIRON POLLUT, V173, P5, DOI 10.1016/j.envpol.2012.09.024; Ryu J, 2007, CARDIOVASC RES, V75, P555, DOI 10.1016/j.cardiores.2007.04.027; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schmeiser K, 1999, CELL DEATH DIFFER, V6, P377, DOI 10.1038/sj.cdd.4400504; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA338, DOI 10.1289/ehp.118-a338; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shi YL, 2013, J TOXICOL ENV HEAL A, V76, P827, DOI 10.1080/15287394.2013.821396; Sriram K, 2011, J TOXICOL ENV HEAL A, V74, P1405, DOI 10.1080/15287394.2011.606796; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Wise James, 2011, Reviews on Environmental Health, V26, P281, DOI 10.1515/REVEH.2011.035; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zheng MY, 2014, LIFE SCI, V95, P108, DOI 10.1016/j.lfs.2013.12.010; Zolfaghari-Baghbaderani A, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/981365	65	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122275	10.1371/journal.pone.0122275	http://dx.doi.org/10.1371/journal.pone.0122275			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835394	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000091
J	Wang, Q; Wu, XH; Zhao, B; Qin, J; Peng, TC				Wang, Quan; Wu, Xianhua; Zhao, Bin; Qin, Jie; Peng, Tingchun			Combined Multivariate Statistical Techniques, Water Pollution Index (WPI) and Daniel Trend Test Methods to Evaluate Temporal and Spatial Variations and Trends of Water Quality at Shanchong River in the Northwest Basin of Lake Fuxian, China	PLOS ONE			English	Article							LAND-USE; EUTROPHICATION; APPORTIONMENT; NITROGEN; INDIA	Understanding spatial and temporal variations in river water quality and quantitatively evaluating the trend of changes are important in order to study and efficiently manage water resources. In this study, an analysis of Water Pollution Index (WPI), Daniel Trend Test, Cluster Analysis and Discriminant Analysis are applied as an integrated approach to quantitatively explore the spatial and temporal variations and the latent sources of water pollution in the Shanchong River basin, Northwest Basin of Lake Fuxian, China. We group all field surveys into 2 clusters (dry season and rainy season). Moreover, 14 sampling sites have been grouped into 3 clusters for the rainy season (highly polluted, moderately polluted and less polluted sites) and 2 clusters for the dry season (highly polluted and less polluted sites) based on their similarities and the level of pollution during the two seasons. The results show that the main trend of pollution was aggravated during the transition from the dry to the rainy season. The Water Pollution Index of Total Nitrogen is the highest of all pollution parameters, whereas the Chemical Oxygen Demand (Chromium) is the lowest. Our results also show that the main sources of pollution are farming activities alongside the Shanchong River, soil erosion and fish culture at Shanchong River reservoir area and domestic sewage from scattered rural residential area. Our results suggest that strategies to prevent water pollutionat the Shanchong River basin need to focus on non-point pollution control by employing appropriate fertilizer formulas in farming, and take the measures of soil and water conservation at Shanchong reservoir area, and purifying sewage from scattered villages.	[Wang, Quan; Wu, Xianhua; Zhao, Bin; Qin, Jie; Peng, Tingchun] Yuxi Normal Univ, Yuxi Res Ctr Ecoenvironm Sci Plateau Lakes, Yuxi, Yunnan Province, Peoples R China	Yuxi Normal University	Wu, XH (corresponding author), Yuxi Normal Univ, Yuxi Res Ctr Ecoenvironm Sci Plateau Lakes, Yuxi, Yunnan Province, Peoples R China.	xhw105@163.com	wang, quan/GXG-6960-2022	Wang, Quan/0000-0002-3559-4932	National Basic Research Program of China [2014CB460607]; Yunnan Applied Basic Research Projects [2013FD051]	National Basic Research Program of China(National Basic Research Program of China); Yunnan Applied Basic Research Projects	This work was supported by grants from National Basic Research Program of China (No. 2014CB460607), Yunnan Applied Basic Research Projects (No. 2013FD051). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGSTROM L, 1986, PLANT SOIL, V93, P333, DOI 10.1007/BF02374284; BROOKES PC, 1997, LOSSES PHOSPHORUS DR, P253; Bu HM, 2010, ECOTOX ENVIRON SAFE, V73, P907, DOI 10.1016/j.ecoenv.2009.11.007; Chang NB, 2005, STOCH ENV RES RISK A, V19, P97, DOI 10.1007/s00477-004-0217-1; Chen JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102714; Freddy N., 2008, HARMONIZED WORLD SOI; Gao Wei, 2013, Hupo Kexue, V25, P635; Huang F, 2010, WATER RES, V44, P1562, DOI 10.1016/j.watres.2009.11.003; Keatley BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015913; Kolovos A, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000743; Kowalkowski T, 2006, WATER RES, V40, P744, DOI 10.1016/j.watres.2005.11.042; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li X, 2011, J ANHUI AGR SCI, V39, p[18112, 18169]; [黎小正 Li Xiaozheng], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P121; Lin Wang, 2006, J YUXI TEACH COLL, V22, P64; Liu X, 2010, J ANHUI AGR SCI, V38, P16341; Ministry of Environmental Protection of the People's Republic of China, 2003, GB38382002 MIN ENV P; Ministry of Environmental Protection of the People's Republic of China, 2008, TECHN GUID SURF WAT; Parelho C, 2014, SCI TOTAL ENVIRON, V496, P241, DOI 10.1016/j.scitotenv.2014.07.053; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; SCHINDLE.DW, 1971, J PHYCOL, V7, P321, DOI 10.1111/j.1529-8817.1971.tb01527.x; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Shrestha S, 2007, ENVIRON MODELL SOFTW, V22, P464, DOI 10.1016/j.envsoft.2006.02.001; Singh EJK, 2013, ENVIRON SCI POLLUT R, V20, P2421, DOI 10.1007/s11356-012-1127-2; Singh KP, 2005, ANAL CHIM ACTA, V538, P355, DOI 10.1016/j.aca.2005.02.006; State Environment Protection Bureau of China, 2002, WAT WAST AN METH; Statistical Bureau of Yunnan Province, 2013, YUNN STAT YB 2013; Su SL, 2011, PHYS CHEM EARTH, V36, P379, DOI 10.1016/j.pce.2010.03.021; Tao T, 2014, NATURE, V511, P527, DOI 10.1038/511527a; The tobacco industry Office of Yuxi Municipal People's Government, 2008, YUX TOB SOIL MAN FER; Wan L, 2008, ENV PROT SCI, V34, P53; Wang Q, 2013, J YUXI NORM U, V29, P9; Wang Quan, 2012, Environmental Science & Technology (China), V35, P191; Wang XZ, 2012, QUATERN INT, V282, P137, DOI 10.1016/j.quaint.2012.05.015; Wang Y, 2013, J HYDRO-ENVIRON RES, V7, P30, DOI 10.1016/j.jher.2012.10.003; Wu Bin, 2010, J YUXI NORM U, V26, P39; Xu HS, 2012, PROCEDIA ENVIRON SCI, V13, P1641, DOI 10.1016/j.proenv.2012.01.157; Yuxi Federation of social science circles, 2013, YUXI FEDERATION SOCI; Zhang Y, 2009, ENVIRON MONIT ASSESS, V152, P105, DOI 10.1007/s10661-008-0300-z; Zhao L, 2012, J ENVIRON SCI-CHINA, V24, P1355, DOI 10.1016/S1001-0742(11)60967-4; Zhou NQ, 2011, J HYDROL, V396, P267, DOI 10.1016/j.jhydrol.2010.11.019	42	27	29	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0118590	10.1371/journal.pone.0118590	http://dx.doi.org/10.1371/journal.pone.0118590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837673	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000004
J	Xie, HS; Chung, JK; Mascelli, MA; McCauley, TG				Xie, Hongsheng; Chung, Jou-Ku; Mascelli, Mary Ann; McCauley, Thomas G.			Pharmacokinetics and Bioavailability of a Therapeutic Enzyme (Idursulfase) in Cynomolgus Monkeys after Intrathecal and Intravenous Administration	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; HUNTER-SYNDROME	Intravenous enzyme replacement therapy with iduronate-2-sulfatase is an approved treatment for Hunter syndrome, however, conventional intravenous delivery cannot treat the neurologic manifestations of the disease due to its limited central nervous system penetration. Intrathecal administration of iduronate-2-sulfatase for delivery to the central nervous system is currently under investigation. The objective of this study was to evaluate the pharmacokinetics of idursulfase in the central nervous system of cynomolgus monkeys (Macaca fasicularis) after intravenous and intrathecal administration. Twenty-seven monkeys, treatment-naive to enzyme replacement therapy, were placed into 4 groups according to body weight: Group 1 was administered 0.5 mg/kg idursulfase intravenously, Groups 2-4 were administered an intrathecal formulation (1-, 10-, and 30-mg doses). Blood samples and cerebrospinal fluid (sampled at the cisterna magna or lumbar level) were collected at the same time points for 72 hours post dosing. Following intravenous administration, a high maximum serum concentration and rapid distribution of iduronate-2-sulfatase out of the central compartment were observed (elimination half-life: 4.3 hours). Iduronate-2-sulfatase exposure in the cerebrospinal fluid was limited, suggesting intravenous administration provided minimal penetration of the blood-brain barrier. Following intrathecal administration, a high maximum observed concentration was immediately noted and elimination half-life ranged between 7.8-10 hours and 5.9-6.7 hours (cisterna magna and lumbar sampling, respectively). Cerebrospinal fluid pharmacokinetic profiles at different doses of iduronate-2-sulfatase were similar and the dose/exposure relationship was proportional. After intrathecal administration, movement of iduronate-2-sulfatase from cerebrospinal fluid to serum was observed (systemic bioavailability was 40-83%). The clear penetration of iduronate-2-sulfatase into the cerebrospinal fluid and the dose response suggest that intrathecal delivery of iduronate-2-sulfatase may be suitable for treating the central nervous system manifestations associated with Hunter syndrome.	[Xie, Hongsheng; Chung, Jou-Ku; Mascelli, Mary Ann; McCauley, Thomas G.] Shire, Lexington, MA 02421 USA	Shire Pharmaceuticals Limited	Chung, JK (corresponding author), Shire, Lexington, MA 02421 USA.	jchung@shire.com			Shire	Shire	This study was funded and conducted by Shire (http://www.shire.com/shireplc/en/home). Editorial assistance was provided by Robin Smith, PhD, of The Curry Rockefeller Group, LLC, Tarrytown, New York and this assistance was funded by Shire. The funders had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; Bernards C, 1999, SPINAL DRUG DELIVERY, P634; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; Felice BR, 2011, TOXICOL PATHOL, V39, P879, DOI 10.1177/0192623311409595; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; GREENE HL, 1969, ARCH NEUROL-CHICAGO, V20, P147, DOI 10.1001/archneur.1969.00480080047005; Hemsley KM, 2009, INT J CLIN PHARM TH, V47, pS118; Kapoor KG, 2008, BRAIN RES BULL, V77, P327, DOI 10.1016/j.brainresbull.2008.08.009; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Nagaraja Tavarekere N, 2005, Cerebrospinal Fluid Res, V2, P5, DOI 10.1186/1743-8454-2-5; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Yoshida K, 2009, MAGN RESON MED SCI, V8, P91, DOI 10.2463/mrms.8.91	16	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122453	10.1371/journal.pone.0122453	http://dx.doi.org/10.1371/journal.pone.0122453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836678	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000098
J	Li, M; Chen, MX; Zhang, Y; Fu, CX; Xing, B; Li, WY; Qian, JP; Li, S; Wang, H; Fan, XD; Yan, YJ; Wang, YA; Yang, XT				Li, Ming; Chen, Meixiang; Zhang, Yong; Fu, Chunxia; Xing, Bin; Li, Wenyong; Qian, Jianping; Li, Sha; Wang, Hui; Fan, Xiaodan; Yan, Yujing; Wang, Yan'an; Yang, Xinting			Apple Fruit Diameter and Length Estimation by Using the Thermal and Sunshine Hours Approach and Its Application to the Digital Orchard Management Information System	PLOS ONE			English	Article							CLIMATE-CHANGE; MODEL; GROWTH; PREDICTION; QUALITY; YIELD; TEMPERATURE; ACCURACY; EXAMPLE; WEIGHT	In apple cultivation, simulation models may be used to monitor fruit size during the growth and development process to predict production levels and to optimize fruit quality. Here, Fuji apples cultivated in spindle-type systems were used as the model crop. Apple size was measured during the growing period at an interval of about 20 days after full bloom, with three weather stations being used to collect orchard temperature and solar radiation data at different sites. Furthermore, a 2-year dataset (2011 and 2012) of apple fruit size measurements were integrated according to the weather station deployment sites, in addition to the top two most important environment factors, thermal and sunshine hours, into the model. The apple fruit diameter and length were simulated using physiological development time (PDT), an indicator that combines important environment factors, such as temperature and photoperiod, as the driving variable. Compared to the model of calendar-based development time (CDT), an indicator counting the days that elapse after full bloom, we confirmed that the PDT model improved the estimation accuracy to within 0.2 cm for fruit diameter and 0.1 cm for fruit length in independent years using a similar data collection method in 2013. The PDT model was implemented to realize a web-based management information system for a digital orchard, and the digital system had been applied in Shandong Province, China since 2013. This system may be used to compute the dynamic curve of apple fruit size based on data obtained from a nearby weather station. This system may provide an important decision support for farmers using the website and short message service to optimize crop production and, hence, economic benefit.	[Li, Ming; Chen, Meixiang; Zhang, Yong; Xing, Bin; Li, Wenyong; Qian, Jianping; Li, Sha; Wang, Hui; Yang, Xinting] Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Zhang, Yong; Fu, Chunxia; Fan, Xiaodan; Yan, Yujing; Wang, Yan'an] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Beijing Academy of Agriculture & Forestry; Shandong Agricultural University	Wang, YA (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	wyaapple@126.com; xintingyang@nercita.org.cn	Ming, Li/B-4439-2015		National Natural Science Foundation of China [31401683]; Climate Change Special Founding [CCSF201521]; China Meteorological Administration; Open Project of China National Engineering Research Center for Information Technology in Agriculture [KF2015W002]; FP7 International Research Staff Exchange Scheme Project [PIRSES-GA-2013-612659]; European Research Agency; International Cooperation Funding of Beijing Academy of Agricultural and Forestry Sciences [GJHZ2013-4]; National Public Benefit (Agricultural) Research Foundation of China, Ministry of Agriculture, China [200903044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Climate Change Special Founding; China Meteorological Administration; Open Project of China National Engineering Research Center for Information Technology in Agriculture; FP7 International Research Staff Exchange Scheme Project; European Research Agency; International Cooperation Funding of Beijing Academy of Agricultural and Forestry Sciences; National Public Benefit (Agricultural) Research Foundation of China, Ministry of Agriculture, China	Funding provided by National Natural Science Foundation of China (31401683), http://www.nsfc.gov.cn/, Climate Change Special Founding (CCSF201521), China Meteorological Administration, http://www.cma.gov.cn/en2014/, Open Project of China National Engineering Research Center for Information Technology in Agriculture (KF2015W002), www.nercita.org.cn, FP7 International Research Staff Exchange Scheme Project (PIRSES-GA-2013-612659), European Research Agency, http://ec.europa.eu/research/participants/portal/desktop/en/home.html, International Cooperation Funding of Beijing Academy of Agricultural and Forestry Sciences (GJHZ2013-4), http://www.baafs.net.cn/ and National Public Benefit (Agricultural) Research Foundation of China (Grant No. 200903044), Ministry of Agriculture, China, http://www.moa.gov.cn/. All of the authors received the above funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boote KJ, 2012, HORTSCIENCE, V47, P1038, DOI 10.21273/HORTSCI.47.8.1038; Cao W, 1997, J AGR SCI-CAMBRIDGE, V129, P163, DOI 10.1017/S0021859697004668; Caprio JM, 1999, CAN J PLANT SCI, V79, P129, DOI 10.4141/P98-028; Csoto M., 2010, J AGR INFORM, V1, P25, DOI DOI 10.17700/JAI.2010.1.2.17; Ding M, 2006, J TAISHAN U, V28, P70; Ghosh S. K., 2013, International Journal of Bio-resource and Stress Management, V4, P571; HAYNES D L, 1973, Environmental Entomology, V2, P889, DOI 10.1093/ee/2.5.889; [胡利平 HU Li-ping], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P237; Jones VP, 2010, PEST MANAG SCI, V66, P587, DOI 10.1002/ps.1913; Kaack K, 2010, EUR J HORTIC SCI, V75, P60; Kaloxylos A, 2012, COMPUT ELECTRON AGR, V89, P130, DOI 10.1016/j.compag.2012.09.002; Kumar R, 2014, ACTA HORTIC, V1029, P145; LAKSO AN, 1995, J HORTIC SCI, V70, P389, DOI 10.1080/14620316.1995.11515308; Legg DE, 2003, INT J PEST MANAGE, V49, P215, DOI 10.1080/0967087031000090659; Li HF, 2008, ACTA AGR JIANGXI, V20, P40; Li M, 2010, COMPUT ELECTRON AGR, V70, P69, DOI 10.1016/j.compag.2009.09.009; Luo WH, 2008, GROWTH MODEL GREENHO; Marini RP, 2001, J AM SOC HORTIC SCI, V126, P503, DOI 10.21273/JASHS.126.4.503; Mizushima A, 2011, ANN INT M PAP; Mohamed Y, 2014, WETL ECOL MANAG, V22, P191, DOI 10.1007/s11273-014-9337-7; Nordey T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092532; Rossi V, 2014, COMPUT ELECTRON AGR, V100, P88, DOI 10.1016/j.compag.2013.10.011; Shu H.R., 1999, APPLE SCI; Stajnko D, 2013, SCI HORTIC-AMSTERDAM, V160, P306, DOI 10.1016/j.scienta.2013.06.003; Sun HH, 2012, EUPHYTICA, V185, P185, DOI 10.1007/s10681-011-0515-x; Tang L, 2009, NJAS-WAGEN J LIFE SC, V57, P83, DOI 10.1016/j.njas.2009.12.003; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Wang YA, 2012, J FOOD AGRIC ENVIRON, V10, P997; [王衍安 Wang Yanan], 2005, [山东农业大学学报. 自然科学版, Journal of shandong agricultural university], V36, P475; Wang YL, 2011, APPLE GROWING SCI; Warrington IJ, 1999, J AM SOC HORTIC SCI, V124, P468, DOI 10.21273/JASHS.124.5.468; Wu H, 2011, ADV CLIMATE CHANGE R, V7, P228; Wu ShanShan, 2014, Journal of China Agricultural University, V19, P207; Xu Gang, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P157; Yan DC, 2006, PLANT PROD SCI, V9, P93, DOI 10.1626/pps.9.93; Yao QQ, 2012, SCI J EARTH SCI, V2, P77; Yuan ChangMei, 2005, Acta Horticulturae Sinica, V32, P262; Zadravec P, 2013, SCI HORTIC-AMSTERDAM, V160, P177, DOI 10.1016/j.scienta.2013.05.046; ZHANG J, 1992, ACTA HORTIC, V313, P107, DOI 10.17660/ActaHortic.1992.313.12; Zhang L, 2008, NJAS-WAGEN J LIFE SC, V56, P59, DOI 10.1016/S1573-5214(08)80017-6; Zhang Y, 2013, HORTTECHNOLOGY, V23, P490, DOI 10.21273/HORTTECH.23.4.490; Zhao CJ, 2011, COMPUT ELECTRON AGR, V76, P306, DOI 10.1016/j.compag.2011.02.009; Zhao WQ, 2012, ECOL MODEL, V243, P112, DOI 10.1016/j.ecolmodel.2012.06.015	43	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120124	10.1371/journal.pone.0120124	http://dx.doi.org/10.1371/journal.pone.0120124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831065	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600022
J	Ponceau, A; Albiges-Rizo, C; Colin-Aronovicz, Y; Destaing, O; Lecomte, MC				Ponceau, Aurelie; Albiges-Rizo, Corinne; Colin-Aronovicz, Yves; Destaing, Olivier; Lecomte, Marie Christine			alpha II-Spectrin Regulates Invadosome Stability and Extracellular Matrix Degradation	PLOS ONE			English	Article							CELL-CELL CONTACTS; TIGHT JUNCTION; PROTEIN 4.1R; ADHESION; PODOSOMES; MEMBRANE; CYTOSKELETON; INVADOPODIA; LOCALIZATION; PHOSPHORYLATION	Invadosomes are actin-rich adhesion structures involved in tissue invasion and extracellular matrix (ECM) remodelling. alpha II-Spectrin, an ubiquitous scaffolding component of the membrane skeleton and a partner of actin regulators (ABI1, VASP and WASL), accumulates highly and specifically in the invadosomes of multiple cell types, such as mouse embryonic fibroblasts (MEFs) expressing SrcY527F, the constitutively active form of Src or activated HMEC-1 endothelial cells. FRAP and live-imaging analysis revealed that alpha II-spectrin is a highly dynamic component of invadosomes as actin present in the structures core. Knock-down of alpha II-spectrin expression destabilizes invadosomes and reduces the ability of the remaining invadosomes to digest the ECM and to promote invasion. The ECM degradation defect observed in spectrin-depleted-cells is associated with highly dynamic and unstable invadosome rings. Moreover, FRAP measurement showed the specific involvement of alpha II-spectrin in the regulation of the mobile/immobile beta 3-integrin ratio in invadosomes. Our findings suggest that spectrin could regulate invadosome function and maturation by modulating integrin mobility in the membrane, allowing the normal processes of adhesion, invasion and matrix degradation. Altogether, these data highlight a new function for spectrins in the stability of invadosomes and the coupling between actin regulation and ECM degradation.	[Ponceau, Aurelie; Colin-Aronovicz, Yves; Lecomte, Marie Christine] Inst Natl Transfus Sanguine, INSERM, UMR S 665, F-75015 Paris, France; [Ponceau, Aurelie; Colin-Aronovicz, Yves; Lecomte, Marie Christine] Univ Paris 07, Paris, France; [Albiges-Rizo, Corinne; Destaing, Olivier] Univ Joseph Fourier, Inst Albert Bonniot, INSERM, CNRS,U823, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lecomte, MC (corresponding author), Inst Natl Transfus Sanguine, INSERM, UMR S 665, F-75015 Paris, France.	marie-christine.lecomte@inserm.fr	Albiges-Rizo, Corinne/M-2568-2013; colin, yves/O-1910-2017	colin, yves/0000-0001-5196-4254; ALBIGES-RIZO, Corinne/0000-0002-6333-4150; destaing, olivier/0000-0001-7622-3700	Institut National de la Transfusion Sanguine (INTS); Inserm [U665]; Ligue Nationale Contre le Cancer (Inserm) [U823]; Ligue Nationale Contre le Cancer (Equipe labellisee); "Fond d'intervention du Pole Chimie Sciences du Vivant" from J. Fourier-Grenoble university	Institut National de la Transfusion Sanguine (INTS)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer (Inserm); Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); "Fond d'intervention du Pole Chimie Sciences du Vivant" from J. Fourier-Grenoble university	This work was supported by the Institut National de la Transfusion Sanguine (INTS) and Inserm (U665) and in part by the Ligue Nationale Contre le Cancer (Inserm U823, Equipe labellisee 2010) and by the "Fond d'intervention du Pole Chimie Sciences du Vivant" from J. Fourier-Grenoble university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; An XL, 2008, BLOOD, V112, P5212, DOI 10.1182/blood-2008-03-146068; Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Beck KA, 1996, AM J PHYSIOL-CELL PH, V270, pC1263, DOI 10.1152/ajpcell.1996.270.5.C1263; Bennett V, 1990, CURR OPIN CELL BIOL, V2, P51, DOI 10.1016/S0955-0674(05)80030-4; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; Boateng LR, 2012, J CELL SCI, V125, P1329, DOI 10.1242/jcs.096529; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Chen LX, 2011, J CELL SCI, V124, P2478, DOI 10.1242/jcs.078170; Collec E, 2011, BIOCHEM J, V436, P699, DOI 10.1042/BJ20101717; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Destaing O, 2011, CURR OPIN CELL BIOL; Destaing O, 2014, CELL ADHES MIGR, V8, P256, DOI 10.4161/cam.28558; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N; Gallagher PG, 2004, SEMIN HEMATOL, V41, P142, DOI 10.1053/j.seminhematol.2004.01.003; Helfrich MH, 1996, BONE, V19, P317, DOI 10.1016/S8756-3282(96)00223-2; Kizhatil K, 2009, EXP EYE RES, V88, P55, DOI 10.1016/j.exer.2008.09.022; Kroviarski Y, 2004, BRIT J HAEMATOL, V126, P255, DOI 10.1111/j.1365-2141.2004.05010.x; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1984, EXP CELL RES, V154, P112, DOI 10.1016/0014-4827(84)90672-4; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Metral S, 2009, J BIOL CHEM, V284, P2409, DOI 10.1074/jbc.M801324200; MUELLER SC, 1991, J CELL SCI, V99, P213; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; OPAS M, 1985, CAN J BIOCHEM CELL B, V63, P553, DOI 10.1139/o85-074; OPAS M, 1985, DEV BIOL, V107, P269, DOI 10.1016/0012-1606(85)90310-0; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Sormunen RT, 1999, J PATHOL, V187, P416; Spinardi L, 2006, EUR J CELL BIOL, V85, P191, DOI 10.1016/j.ejcb.2005.08.005; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Ursitti JA, 2007, J MOL CELL CARDIOL, V42, P572, DOI 10.1016/j.yjmcc.2006.11.018; ZALLONE AZ, 1989, CONNECT TISSUE RES, V20, P143, DOI 10.3109/03008208909023882; Ziemnicka-Kotula D, 1998, J BIOL CHEM, V273, P13681, DOI 10.1074/jbc.273.22.13681	51	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120781	10.1371/journal.pone.0120781	http://dx.doi.org/10.1371/journal.pone.0120781			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830635	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600040
J	Qiu, J; Wang, KW; Wu, XL; Xiao, ZH; Lu, XL; Zhu, YM; Zuo, C; Yang, YJ; Wang, YJ				Qiu, Jun; Wang, Kewei; Wu, Xiaoli; Xiao, Zhenghui; Lu, Xiulan; Zhu, Yimin; Zuo, Chao; Yang, Yongjia; Wang, Youjie			Blood Lead Levels in Children Aged 0-6 Years Old in Hunan Province, China from 2009-2013	PLOS ONE			English	Article							YOUNG-CHILDREN; HEALTH; IMPAIRMENT; PREVENTION; BEHAVIORS; EXPOSURE; CADMIUM; CITIES	Objectives The aim of this study is to describe blood lead levels (BLLs) and the prevalence of elevated blood lead levels (EBLLs) in children aged 0-6 years old and to analyze the BLL trend in children from 2009 to 2013 in China. Methods A total of 124,376 children aged 0-6 years old were recruited for this study from January 1st 2009 to December 31st 2013. Their blood lead levels were analyzed using atomic absorption spectrometry. Results The median BLL was 64.3 mu g/L (IQR: 49.6-81.0), and the range was 4.3-799.0 mu g/L. Blood lead levels were significantly higher in boys (66.0 mu g/L) than in girls (61.9 mu g/L) (P<0.001). The overall prevalence of BLLs >= 100 mu g/L was 10.54% in children aged 0-6 years in Hunan Province. Between 2009 and 2013, the prevalence of EBLLs (>= 100 mu g/L) decreased from 18.31% to 4.26% in children aged 0-6 years and increased with age. The prevalence of EBLLs has dramatically decreased in two stages (2009-2010 and 2012-2013), with a slight fluctuation in 2010 and 2011. Conclusions Both BLLs and the prevalence of EBLLs in children aged 0-6 years old declined substantially from 2009 to 2013 in Hunan Province; however, both remain at unacceptably high levels compared to developed countries. Comprehensive strategies are required to further reduce blood lead levels in children.	[Qiu, Jun; Zuo, Chao; Wang, Youjie] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430030, Peoples R China; [Qiu, Jun; Wang, Kewei; Xiao, Zhenghui; Lu, Xiulan; Zhu, Yimin; Yang, Yongjia] Hunan Childrens Hosp, Dept Childrens Intens Res Ctr, Changsha 410007, Hunan, Peoples R China; [Wu, Xiaoli] Maternal & Child Hlth Hosp Hunan Prov, Dept Obstet & Gynecol, Changsha 41000, Hunan, Peoples R China	Huazhong University of Science & Technology	Wang, YJ (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430030, Peoples R China.	wangyoujie@mails.tjmu.edu.cn			Ministry of Science and Technology in China [2012GS430101, 2012BAI04B01]	Ministry of Science and Technology in China(Ministry of Science and Technology, China)	This study was supported by a grant from the Ministry of Science and Technology in China (Grant#: 2012GS430101 and Grant#: 2012BAI04B01). The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was given to the study.	Abadin H, 2007, TOXICOLOGICAL PROFIL; Akinyele IO, 2015, FOOD CHEM, V173, P702, DOI 10.1016/j.foodchem.2014.10.098; [Anonymous], 2009, NAT HLTH NUTR EX SUR; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Chandran L, 2010, PEDIATR REV, V31, P399, DOI 10.1542/pir.31-10-399; Chen HY, 2009, J POWER SOURCES, V191, P22, DOI 10.1016/j.jpowsour.2008.12.140; Chen LG, 2012, SCI TOTAL ENVIRON, V429, P191, DOI 10.1016/j.scitotenv.2012.04.015; Cleveland Lisa M, 2008, Am J Nurs, V108, P40, DOI 10.1097/01.NAJ.0000337736.76730.66; Etchevers A, 2014, INT J HYG ENVIR HEAL, V217, P528, DOI 10.1016/j.ijheh.2013.10.002; Freeman NCG, 2001, J EXPO ANAL ENV EPID, V11, P501, DOI 10.1038/sj.jea.7500193; GENNART JP, 1992, AM J EPIDEMIOL, V135, P1208, DOI 10.1093/oxfordjournals.aje.a116227; Glenn BS, 2006, EPIDEMIOLOGY, V17, P538, DOI 10.1097/01.ede.0000231284.19078.4b; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; Health Canada, 2013, 2 REP HUM BIOM ENV C; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Kennedy BS, 2014, AM J PREV MED, V46, P259, DOI 10.1016/j.amepre.2013.11.007; Keramati Mohammad Reza, 2013, Niger Med J, V54, P325, DOI 10.4103/0300-1652.122353; Kim R, 1996, JAMA-J AM MED ASSOC, V275, P1177, DOI 10.1001/jama.275.15.1177; Ko S, 2007, J EXPO SCI ENV EPID, V17, P47, DOI 10.1038/sj.jes.7500519; Li JM, 2005, CHINESE J EPIDEMIOLO, V22; [李军 Li Jun], 2009, [化工环保, Environmental Protection of Chemical Industry], V29, P376; Li T, 2014, WORLD J PEDIATR, V10, P29, DOI 10.1007/s12519-014-0452-6; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095284; Liu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065230; Liu JH, 2012, PAEDIATR PERINAT EP, V26, P61, DOI 10.1111/j.1365-3016.2011.01234.x; Maduabuchi JMU, 2006, SCI TOTAL ENVIRON, V366, P621, DOI 10.1016/j.scitotenv.2005.12.015; Malcoe LH, 2002, ENVIRON HEALTH PERSP, V110, P221, DOI 10.1289/ehp.02110s2221; Meng QY, 2014, ENVIRON SCI TECHNOL, V48, P1263, DOI 10.1021/es4039825; New York City [NYC] Department of Health and Mental Hygiene, 2009, ANN DATA REPORT; NTP, 2012, MON HLTH EFF LOW LEV; Piomelli S, 2002, PEDIATR CLIN N AM, V49, P1285, DOI 10.1016/S0031-3955(02)00097-4; Rahman A, 2012, ECOL FOOD NUTR, V51, P40, DOI 10.1080/03670244.2012.635571; Research in China, 2012, CHIN BI PORT CHIN LE; Rogan Walter J, 2003, J Pediatr, V143, P687; Schnur J, 2014, J AM ASSOC NURSE PRA, V26, P238, DOI 10.1002/2327-6924.12112; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; van der Kuijp TJ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-61; von Lindern I, 2003, SCI TOTAL ENVIRON, V303, P139, DOI 10.1016/S0048-9697(02)00352-2; Wang HJ, 2012, BIOL TRACE ELEM RES, V149, P143, DOI 10.1007/s12011-012-9413-x; Wang SQ, 2006, ENVIRON RES, V101, P412, DOI 10.1016/j.envres.2005.11.007; Wheeler W, 2013, MMWR-MORBID MORTAL W, V62, P245; Wong Suzy L, 2008, Health Rep, V19, P31; Xie XH, 2013, CHINESE MED J-PEKING, V126, P2291, DOI 10.3760/cma.j.issn.0366-6999.20122327	44	8	9	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122710	10.1371/journal.pone.0122710	http://dx.doi.org/10.1371/journal.pone.0122710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830596	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600120
J	Kumar, K; Muthamilarasan, M; Bonthala, VS; Roy, R; Prasad, M				Kumar, Karunesh; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Roy, Riti; Prasad, Manoj			Unraveling 14-3-3 Proteins in C-4 Panicoids with Emphasis on Model Plant Setaria italica Reveals Phosphorylation-Dependent Subcellular Localization of RS Splicing Factor	PLOS ONE			English	Article							FOXTAIL MILLET; ADAPTER PROTEINS; MESSENGER-RNA; ARABIDOPSIS; FAMILY; ISOFORMS; BINDING; IDENTIFICATION; EVOLUTION; SEQUENCE	14-3-3 proteins are a large multigenic family of regulatory proteins ubiquitously found in eukaryotes. In plants, 14-3-3 proteins are reported to play significant role in both development and response to stress stimuli. Therefore, considering their importance, genome-wide analyses have been performed in many plants including Arabidopsis, rice and soybean. But, till date, no comprehensive investigation has been conducted in any C-4 panicoid crops. In view of this, the present study was performed to identify 8, 5 and 26 potential 14-3-3 gene family members in foxtail millet (Si14-3-3), sorghum (Sb14-3-3) and maize (Zm14-3-3), respectively. In silico characterization revealed large variations in their gene structures; segmental and tandem duplications have played a major role in expansion of these genes in foxtail millet and maize. Gene ontology annotation showed the participation of 14-3-3 proteins in diverse biological processes and molecular functions, and in silico expression profiling indicated their higher expression in all the investigated tissues. Comparative mapping was performed to derive the orthologous relationships between 14-3-3 genes of foxtail millet and other Poaceae members, which showed a higher, as well as similar percentage of orthology among these crops. Expression profiling of Si14-3-3genes during different timepoints of abiotic stress and hormonal treatments showed a differential expression pattern of these genes, and sub-cellular localization studies revealed the site of action of Si14-3-3 proteins within the cells. Further downstream characterization indicated the interaction of Si14-3-3 with a nucleocytoplasmic shuttling phosphoprotein (SiRSZ21A) in a phosphorylationdependent manner, and this demonstrates that Si14-3-3 might regulate the splicing events by binding with phosphorylated SiRSZ21A. Taken together, the present study is a comprehensive analysis of 14-3-3 gene family members in foxtail millet, sorghum and maize, which provides interesting information on their gene structure, protein domains, phylogenetic and evolutionary relationships, and expression patterns during abiotic stresses and hormonal treatments, which could be useful in choosing candidate members for further functional characterization. In addition, demonstration of interaction between Si14-3-3 and SiRSZ21A provides novel clues on the involvement of 14-3-3 proteins in the splicing events.	[Kumar, Karunesh; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Roy, Riti; Prasad, Manoj] NIPGR, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), NIPGR, New Delhi, India.	manoj_prasad@nipgr.ac.in	Muthamilarasan, Mehanathan/H-9340-2017; Bonthala, Venkata Suresh/G-9852-2013; Prasad, Manoj/AAE-8540-2019	Muthamilarasan, Mehanathan/0000-0001-7589-6372; Bonthala, Venkata Suresh/0000-0001-6550-1648; Prasad, Manoj/0000-0003-0691-0163	National Institute of Plant Genome Research, New Delhi, India; Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi	National Institute of Plant Genome Research, New Delhi, India; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was financially supported by the core grant of National Institute of Plant Genome Research, New Delhi, India. KK and MM are the recipients of research fellowships from Council of Scientific and Industrial Research, New Delhi and University Grants Commission, New Delhi, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsterfjord M, 2004, PLANT CELL PHYSIOL, V45, P1202, DOI 10.1093/pcp/pch136; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bihn EA, 1997, PLANT J, V12, P1439, DOI 10.1046/j.1365-313x.1997.12061439.x; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Carlberg I, 2003, P NATL ACAD SCI USA, V100, P757, DOI 10.1073/pnas.0235452100; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Boer AH, 2013, PROTOPLASMA, V250, P425, DOI 10.1007/s00709-012-0437-z; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Diaz C, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-192; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jogl G, 2003, P NATL ACAD SCI USA, V100, P50, DOI 10.1073/pnas.0233793100; Konagaya Ken-ichi, 2004, Journal of General Plant Pathology, V70, P221, DOI 10.1007/s10327-003-0113-4; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Lopato S, 1999, PLANT MOL BIOL, V39, P761, DOI 10.1023/A:1006129615846; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Rausin G, 2010, PLANT PHYSIOL, V153, P273, DOI 10.1104/pp.110.154740; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 2000, PLANT PHYSIOL, V122, P235, DOI 10.1104/pp.122.1.235; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sottocornola B, 2008, PLANT BIOLOGY, V10, P231, DOI 10.1111/j.1438-8677.2007.00028.x; Sun GL, 2011, FUNCT INTEGR GENOMIC, V11, P627, DOI 10.1007/s10142-011-0242-3; Swartz JE, 2007, J BIOL CHEM, V282, P19844, DOI 10.1074/jbc.M701660200; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Yadav CB, 2015, PLANT MOL BIOL REP, V33, P43, DOI 10.1007/s11105-014-0736-y; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155	50	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123236	10.1371/journal.pone.0123236	http://dx.doi.org/10.1371/journal.pone.0123236			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849294	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800217
J	Lee, SJ; Kang, JH; Iqbal, W; Kwon, OS				Lee, Su Jin; Kang, Jeong Han; Iqbal, Waqas; Kwon, Oh-Shin			Proteomic Analysis of Mice Fed Methionine and Choline Deficient Diet Reveals Marker Proteins Associated with Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ACUTE ETHANOL INTOXICATION; INDUCED OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; MEDIATED APOPTOSIS; RAT MODEL; CURCUMIN; CELLS; GLUTATHIONE	The mechanisms underlying the progression of simple steatosis to steatohepatitis are yet to be elucidated. To identify the proteins involved in the development of liver tissue inflammation, we performed comparative proteomic analysis of non-alcoholic steatohepatitis (NASH). Mice fed a methionine and choline deficient diet (MCD) developed hepatic steatosis characterized by increased free fatty acid (FFA) and triglyceride levels as well as alpha-SMA. Two-dimensional proteomic analysis revealed that the change from the normal diet to the MCD diet affected the expressions of 50 proteins. The most-pronounced changes were observed in the expression of proteins involved in Met metabolism and oxidative stress, most of which were significantly downregulated in NASH model animals. Peroxiredoxin (Prx) is the most interesting among the modulated proteins identified in this study. In particular, cross-regulated Prx1 and Prx6 are likely to participate in cellular defense against the development of hepatitis. Thus, these Prx isoforms may be a useful new marker for early stage steatohepatitis. Moreover, curcumin treatment results in alleviation of the severity of hepatic inflammation in steatohepatitis. Notably, curcumin administration in MCD-fed mice dramatically reduced CYP2E1 as well as Prx1 expression, while upregulating Prx6 expression. These findings suggest that curcumin may have a protective role against MCD fed-induced oxidative stress.	[Lee, Su Jin; Iqbal, Waqas; Kwon, Oh-Shin] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu 702701, South Korea; [Kang, Jeong Han] Mayo Clin, Thorac Dis Res Unit, Dept Biochem & Mol Biol, Coll Med, Rochester, MN USA; [Kang, Jeong Han] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA	Kyungpook National University; Mayo Clinic; Mayo Clinic	Kwon, OS (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu 702701, South Korea.	oskwon@knu.ac.kr	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Ministry of Education, Science and Technology [2011-0014420]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Ministry of Education, Science and Technology (2011-0014420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; Banerjee A, 2008, PROTEOMICS, V8, P4327, DOI 10.1002/pmic.200700368; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chan WH, 2003, J CELL BIOCHEM, V90, P327, DOI 10.1002/jcb.10638; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dickinson DA, 2003, BIOL CHEM, V384, P527, DOI 10.1515/BC.2003.061; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Gao S, 2013, FOOD CHEM TOXICOL, V59, P739, DOI 10.1016/j.fct.2013.07.032; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Holley SL, 2007, CARCINOGENESIS, V28, P2268, DOI 10.1093/carcin/bgm135; Hsuuw YD, 2005, J CELL PHYSIOL, V205, P379, DOI 10.1002/jcp.20408; Jang EM, 2008, METABOLISM, V57, P1576, DOI 10.1016/j.metabol.2008.06.014; Kang JH, 2009, BBA-PROTEINS PROTEOM, V1794, P446, DOI 10.1016/j.bbapap.2008.11.015; Kang JH, 2009, PROTEOMICS, V9, P4445, DOI 10.1002/pmic.200800941; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; KORPELA H, 1985, AM J CLIN NUTR, V42, P147, DOI 10.1093/ajcn/42.1.147; Kuo ML, 1996, BBA-MOL BASIS DIS, V1317, P95, DOI 10.1016/S0925-4439(96)00032-4; Kurose I, 1997, HEPATOLOGY, V25, P368; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Luckey SW, 2001, ARCH BIOCHEM BIOPHYS, V389, P77, DOI 10.1006/abbi.2001.2307; MASINI A, 1994, BIOCHEM PHARMACOL, V47, P217, DOI 10.1016/0006-2952(94)90009-4; Miyazaki H, 2014, J CLIN BIOCHEM NUTR, V54, P190, DOI 10.3164/jcbn.13-74; Newton BW, 2009, J PROTEOME RES, V8, P1663, DOI 10.1021/pr800905w; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Okada K, 2001, J NUTR, V131, P2090, DOI 10.1093/jn/131.8.2090; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rivera-Espinoza Y, 2009, LIVER INT, V29, P1457, DOI 10.1111/j.1478-3231.2009.02086.x; Rodriguez-Suarez E, 2010, PROTEOM CLIN APPL, V4, P362, DOI 10.1002/prca.200900119; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Shao WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028784; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; WIELAND P, 1995, BIOCHEM BIOPH RES CO, V213, P815, DOI 10.1006/bbrc.1995.2202	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120577	10.1371/journal.pone.0120577	http://dx.doi.org/10.1371/journal.pone.0120577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849376	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800027
J	Liu, FQ; Li, ZX; Lv, XF; Ma, J				Liu, Fengqiong; Li, Zhongxia; Lv, Xiaofei; Ma, Jing			Dietary n-3 Polyunsaturated Fatty Acid Intakes Modify the Effect of Genetic Variation in Fatty Acid Desaturase 1 on Coronary Artery Disease	PLOS ONE			English	Article							HDL-CHOLESTEROL CONCENTRATIONS; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; DESATURASE ACTIVITY; AMERICAN-COLLEGE; FISH-OIL; INFLAMMATION; RISK; OMEGA-3-FATTY-ACIDS; ATHEROSCLEROSIS	Background Previous studies suggested that dietary fatty acids could affect blood lipids by interacting with genetic variations in fatty acid desaturase 1 (FADS1). However, little is known about their direct effects on coronary artery disease (CAD). The aim of this study was to evaluate whether dietary n-3 long-chain polyunsaturated fatty acids (LCPUFAs) -eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could modulate the effect of FADS1 rs174547 polymorphism on CAD. Methods FADS1 single-nucleotide polymorphisms rs174547 genotypes were measured in 440 CAD patients and 838 healthy controls. Dietary EPA and DHA intakes were assessed with a validated quantitative frequency food questionnaire. The association between FADS1 rs174547 and CAD was estimated using logistic regression under both dominant and additive genetic models. The interactions between rs174547 polymorphism and LCPUFAs were analyzed by using multiple logistic regression and the "genotype x n-3 LCPUFAs" interaction termwas included into the model. Results We found that the minor T allele of FADS1 rs174547 increased CAD risk (OR = 1.36, 95% CIs 1.03-1.80), and observed significant interaction between rs174547 and dietary EPA intakes on CAD (P-interaction = 0.028). The T-allele was only associated with higher CAD risk among individuals with lower dietary EPA intakes, but not in those with higher EPA intakes. Similarly, significant interaction was also observed between rs174547 and dietary DHA intakes on CAD (P-interaction = 0.020). Conclusions Dietary n-3 LCPUFA intakes could modulate the association between FADS1 rs174547 polymorphism and CAD. High dietary n-3 LCPUFA intakes could negate the unfavorable effect of genetic variation in FADS1 on CAD in middle-aged and elderly Chinese population.	[Liu, Fengqiong] Fujian Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Fuzhou, Fujian, Peoples R China; [Li, Zhongxia; Lv, Xiaofei; Ma, Jing] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Fujian Medical University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	majing@mail.sysu.edu.cn		Lv, Xiaofei/0000-0002-0995-798X	Key Project of National Science Foundation of China [81130052]	Key Project of National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by Key Project of National Science Foundation of China (81130052). URLs : http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hilal M, 2013, J LIPID RES, V54, P542, DOI 10.1194/jlr.P032276; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Chang CL, 2013, CURR OPIN LIPIDOL; De Caterina R, 2004, NEW ENGL J MED, V350, P4, DOI 10.1056/NEJMp038190; Dumont J, 2011, J NUTR, V141, P1247, DOI 10.3945/jn.111.140392; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hellstrand S, 2012, J LIPID RES, V53, P1183, DOI 10.1194/jlr.P023721; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lee JH, 2008, MAYO CLIN PROC, V83, P324, DOI 10.4065/83.3.324; Li X, 2013, SCI WORLD J, V2013, DOI DOI 10.1155/2013/416192; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Park MH, 2011, J MED GENET, V48, P10, DOI 10.1136/jmg.2010.081000; Qiu J, 2012, CIRC J; Yang YX, 2004, CHINA FOOD COMPOSITI; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhang G, 2012, J CLIN ENDOCR METAB, V97, pE973, DOI 10.1210/jc.2011-2997; Zhu JXX, 2013, SCI CHINA CHEM, V56, P1, DOI 10.1007/s11426-012-4811-7	27	16	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121255	10.1371/journal.pone.0121255	http://dx.doi.org/10.1371/journal.pone.0121255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849351	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800050
J	Schule, SA; Bolte, G				Schuele, Steffen Andreas; Bolte, Gabriele			Interactive and Independent Associations between the Socioeconomic and Objective Built Environment on the Neighbourhood Level and Individual Health: A Systematic Review of Multilevel Studies	PLOS ONE			English	Article							BODY-MASS INDEX; GEOGRAPHIC LIFE ENVIRONMENTS; BRIEF CONCEPTUAL TUTORIAL; ADVERSE BIRTH OUTCOMES; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; SOCIAL ENVIRONMENTS; WALKING BEHAVIOR; OBESITY; WALKABILITY	Background The research question how contextual factors of neighbourhood environments influence individual health has gained increasing attention in public health research. Both socioeconomic neighbourhood characteristics and factors of the built environment play an important role for health and health-related behaviours. However, their reciprocal relationships have not been systematically reviewed so far. This systematic review aims to identify studies applying a multilevel modelling approach which consider both neighbourhood socioeconomic position (SEP) and factors of the objective built environment simultaneously in order to disentangle their independent and interactive effects on individual health. Methods The three databases PubMed, PsycINFO, and Web of Science were systematically searched with terms for title and abstract screening. Grey literature was not included. Observational studies from USA, Canada, Australia, New Zealand, and Western European countries were considered which analysed simultaneously factors of neighbourhood SEP and the objective built environment with a multilevel modelling approach. Adjustment for individual SEP was a further inclusion criterion. Results Thirty-three studies were included in qualitative synthesis. Twenty-two studies showed an independent association between characteristics of neighbourhood SEP or the built environment and individual health outcomes or health-related behaviours. Twenty-one studies found cross-level or within-level interactions either between neighbourhood SEP and the built environment, or between neighbourhood SEP or the built environment and individual characteristics, such as sex, individual SEP or ethnicity. Due to the large variation of study design and heterogeneous reporting of results the identification of consistent findings was problematic and made quantitative analysis not possible. Conclusions There is a need for studies considering multiple neighbourhood dimensions and applying multilevel modelling in order to clarify their causal relationship towards individual health. Especially, more studies using comparable characteristics of neighbourhood SEP and the objective built environment and analysing interactive effects are necessary to disentangle health impacts and identify vulnerable neighbourhoods and population groups.	[Schuele, Steffen Andreas; Bolte, Gabriele] Univ Bremen, Inst Publ Hlth & Nursing Res, Dept Social Epidemiol, D-28359 Bremen, Germany	University of Bremen	Schule, SA (corresponding author), Univ Bremen, Inst Publ Hlth & Nursing Res, Dept Social Epidemiol, D-28359 Bremen, Germany.	steffen.schuele@uni-bremen.de		Bolte, Gabriele/0000-0002-0269-5059	foundation 'Fritz und Hildegard Berg-Stiftung' within the 'Stifterverband fur die Deutsche Wissenschaft e.V.', Essen, Germany	foundation 'Fritz und Hildegard Berg-Stiftung' within the 'Stifterverband fur die Deutsche Wissenschaft e.V.', Essen, Germany	S.A. Schule receives a doctoral scholarship within the framework of the Junior Research Group Salus, which is funded by the foundation 'Fritz und Hildegard Berg-Stiftung' within the 'Stifterverband fur die Deutsche Wissenschaft e.V.', Essen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1195; Ball K, 2008, PREV MED, V47, P294, DOI 10.1016/j.ypmed.2008.05.001; Bell B. A., 2010, SECTION SURVEY RES M, V1, P4057; Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037; Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x; Bolte G., 2011, ENCY ENV HLTH, P459, DOI [10.1016/B978-0-444-52272-6.00685-1, DOI 10.1016/B978-0-444-52272-6.00685-1]; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Chuang YC, 2005, J EPIDEMIOL COMMUN H, V59, P568, DOI 10.1136/jech.2004.029041; Corburn J, 2004, AM J PUBLIC HEALTH, V94, P541, DOI 10.2105/AJPH.94.4.541; Cummins S, 2005, J EPIDEMIOL COMMUN H, V59, P207, DOI 10.1136/jech.2003.016147; Daniel M, 2008, HEALTH PLACE, V14, P117, DOI 10.1016/j.healthplace.2007.05.003; De Meester Femke, 2012, BMC Public Health, V12, P7, DOI 10.1186/1471-2458-12-7; deFur PL, 2007, ENVIRON HEALTH PERSP, V115, P817, DOI 10.1289/ehp.9332; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Dragano N, 2009, OCCUP ENVIRON MED, V66, P628, DOI 10.1136/oem.2008.044032; Dragano N, 2009, EUR J EPIDEMIOL, V24, P25, DOI 10.1007/s10654-008-9292-9; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Freedman VA, 2008, SOC SCI MED, V66, P2253, DOI 10.1016/j.socscimed.2008.01.013; Freedman VA, 2011, AM J PUBLIC HEALTH, V101, P79, DOI 10.2105/AJPH.2009.178640; Galvez MP, 2010, CURR OPIN PEDIATR, V22, P202, DOI 10.1097/MOP.0b013e328336eb6f; Genereux M, 2008, J EPIDEMIOL COMMUN H, V62, P695, DOI 10.1136/jech.2007.066167; Grafova IB, 2008, AM J PUBLIC HEALTH, V98, P2065, DOI 10.2105/AJPH.2007.127712; Inagami S, 2009, J URBAN HEALTH, V86, P683, DOI 10.1007/s11524-009-9379-y; Kirtland KA, 2003, AM J PREV MED, V24, P323, DOI 10.1016/S0749-3797(03)00021-7; Krieger N, 2001, J EPIDEMIOL COMMUN H, V55, P693, DOI 10.1136/jech.55.10.693; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Levy JI, 2008, RISK ANAL, V28, P1507, DOI 10.1111/j.1539-6924.2008.01121.x; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Matthews SA, 2010, ANN BEHAV MED, V39, P170, DOI 10.1007/s12160-010-9175-7; Meijer M, 2012, SOC SCI MED, V74, P1204, DOI 10.1016/j.socscimed.2011.11.034; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Metcalfe A, 2011, PAEDIATR PERINAT EP, V25, P236, DOI 10.1111/j.1365-3016.2011.01192.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moineddin R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-34; Moore K, 2013, J EPIDEMIOL COMMUN H, V67, P846, DOI 10.1136/jech-2013-202682; Northridge ME, 2003, J URBAN HEALTH, V80, P556, DOI 10.1093/jurban/jtg064; Owen N, 2007, AM J PREV MED, V33, P387, DOI 10.1016/j.amepre.2007.07.025; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Pollack CE, 2005, INT J EPIDEMIOL, V34, P772, DOI 10.1093/ije/dyi026; Ponce NA, 2005, AM J EPIDEMIOL, V162, P140, DOI 10.1093/aje/kwi173; Prince SA, 2012, OBESITY, V20, P2093, DOI 10.1038/oby.2011.392; Prince SA, 2011, INT J ENV RES PUB HE, V8, P3953, DOI 10.3390/ijerph8103953; Reading R, 2008, SOC SCI MED, V67, P915, DOI 10.1016/j.socscimed.2008.05.018; Renalds A, 2010, FAM COMMUNITY HEALTH, V33, P68, DOI 10.1097/FCH.0b013e3181c4e2e5; Riva M, 2007, J EPIDEMIOL COMMUN H, V61, P853, DOI 10.1136/jech.2006.050740; Riva M, 2009, SOC SCI MED, V69, P1296, DOI 10.1016/j.socscimed.2009.07.019; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Ross NA, 2007, AM J PUBLIC HEALTH, V97, P500, DOI 10.2105/AJPH.2004.060954; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017; Schaefer-McDaniel N, 2010, SOC SCI MED, V70, P277, DOI 10.1016/j.socscimed.2009.10.018; Schreier HMC, 2013, PSYCHOL BULL, V139, P606, DOI 10.1037/a0029416; Schulz A, 2004, HEALTH EDUC BEHAV, V31, P455, DOI 10.1177/1090198104265598; Schulz AJ, 2005, ENVIRON HEALTH PERSP, V113, P1817, DOI 10.1289/ehp.7913; Scott MM, 2009, HEALTH PLACE, V15, P897, DOI 10.1016/j.healthplace.2009.02.010; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; Shaw M, 2007, HDB INEQUALITY SOCIO; Slater SJ, 2010, J ADOLESCENT HEALTH, V47, P496, DOI 10.1016/j.jadohealth.2010.03.017; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Sundquist K, 2011, SOC SCI MED, V72, P1266, DOI 10.1016/j.socscimed.2011.03.004; Tamburlini G., 2002, CHILDRENS SPECIAL VU; Van Dyck D, 2010, AM J PREV MED, V39, P25, DOI 10.1016/j.amepre.2010.03.004; Van Dyck D, 2010, PREV MED, V50, pS74, DOI 10.1016/j.ypmed.2009.07.027; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; Voigtlander S, 2012, GESUNDHEITSWESEN, V74, P702, DOI 10.1055/s-0031-1285863; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Wen M, 2012, HEALTH PLACE, V18, P1314, DOI 10.1016/j.healthplace.2012.09.002; Wen M, 2009, AM J HEALTH PROMOT, V23, P247, DOI 10.4278/ajhp.07052448; Williams BL, 2007, J EXPO SCI ENV EPID, V17, P445, DOI 10.1038/sj.jes.7500537; Yang TC, 2010, HEALTH PLACE, V16, P803, DOI 10.1016/j.healthplace.2010.04.005; Zeka A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-60	80	78	81	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123456	10.1371/journal.pone.0123456	http://dx.doi.org/10.1371/journal.pone.0123456			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849569	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800234
J	Shah, I; Adnan, R; Ngah, WSW; Mohamed, N				Shah, Irfan; Adnan, Rohana; Ngah, Wan Saime Wan; Mohamed, Norita			Iron Impregnated Activated Carbon as an Efficient Adsorbent for the Removal of Methylene Blue: Regeneration and Kinetics Studies	PLOS ONE			English	Article							AQUEOUS-SOLUTION; ADSORPTION CHARACTERISTICS; ENHANCED ADSORPTION; MALACHITE-GREEN; WASTE-WATER; DYE; THERMODYNAMICS; EQUILIBRIUM; DEGRADATION; OXIDATION	In this study, iron impregnated activated carbon (FeAC) was synthesized following an oxidation and iron impregnation of activated carbon (AC). Both the AC and FeAC were characterized by pHZPC and FTIR spectroscopy. The removal of Methylene Blue (MB) by AC and FeAC was examined under various experimental conditions. The FeAC showed up to 95% (higher than AC) MB removal in the pH range of 7-10. Although the reaction kinetics was pseudo-second order, the overall rate was controlled by a number of processes such as film diffusion, pore diffusion and intraparticle diffusion. The activation energy values for the MB uptake by AC and FeAC (21.79 and 14.82 kJ/mol, respectively) revealed a physisorption process. In the regeneration study, FeAC has shown consistently >= 90% MB removal even up to 10 repeated cycles. The reusable characteristic of the spent FeAC improved the practical use of activated carbon and can be a breakthrough for continuous flow system applications where it can work effectively without any significant reduction in its performance.	[Shah, Irfan; Adnan, Rohana; Ngah, Wan Saime Wan; Mohamed, Norita] Univ Sains Malaysia, Sch Chem Sci, George Town 11800, Malaysia	Universiti Sains Malaysia	Adnan, R (corresponding author), Univ Sains Malaysia, Sch Chem Sci, George Town 11800, Malaysia.	r_adnan@usm.my	Adnan, Rohana/E-5342-2012; Ngah, Wan Saime Wan/AAP-2305-2020; Ngah, Wan Saime Wan/A-3557-2009	Ngah, Wan Saime Wan/0000-0001-7675-2450; Adnan, Rohana/0000-0002-7628-7656	USM RUI Grant [1001/PKIMIA/815099]; The World Academy of Science (TWAS); Universiti Sains Malaysia (USM)	USM RUI Grant; The World Academy of Science (TWAS); Universiti Sains Malaysia (USM)(Universiti Sains Malaysia)	The authors gratefully acknowledge the USM RUI Grant No. 1001/PKIMIA/815099 for the current work. IS also acknowledges the support from The World Academy of Science (TWAS) and Universiti Sains Malaysia (USM) for awarding TWAS-USM Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONI C, 1979, J CHEM TECHNOL BIOT, V29, P404; [Anonymous], 2010, J CHEM PHARM RES; Auta M, 2014, CHEM ENG J, V237, P352, DOI 10.1016/j.cej.2013.09.066; Baig SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100704; Bakheet B, 2013, WATER RES, V47, P6234, DOI 10.1016/j.watres.2013.07.042; Benaissa H, 2010, J TAIBAH UNIV SCI, V4, P31, DOI 10.1016/S1658-3655(12)60024-7; Borah D, 2008, J COLLOID INTERF SCI, V319, P53, DOI 10.1016/j.jcis.2007.11.019; Chang MY, 2005, COLLOID SURFACE A, V269, P35, DOI 10.1016/j.colsurfa.2005.06.064; Chien H.-A., 2014, DESALIN WATER TREAT, P1; CHIEN SH, 1980, SOIL SCI SOC AM J, V44, P265, DOI 10.2136/sssaj1980.03615995004400020013x; Cottet L, 2014, APPL CLAY SCI, V95, P25, DOI 10.1016/j.clay.2014.03.023; Crini G, 2007, SEP PURIF TECHNOL, V53, P97, DOI 10.1016/j.seppur.2006.06.018; El Saliby I, 2013, WATER RES, V47, P4115, DOI 10.1016/j.watres.2012.12.045; Garcia-Vaquero N, 2014, DESALINATION, V347, P94, DOI 10.1016/j.desal.2014.05.036; Garg VK, 2004, DYES PIGMENTS, V62, P1, DOI 10.1016/j.dyepig.2003.10.016; Ghasemi J, 2007, J CHEM THERMODYN, V39, P967, DOI 10.1016/j.jct.2006.10.018; Gupta VK, 2011, WATER RES, V45, P4047, DOI 10.1016/j.watres.2011.05.016; He Y, 2008, J MEMBRANE SCI, V321, P183, DOI 10.1016/j.memsci.2008.04.056; Huang W, 2014, DESALINATION, V340, P67, DOI 10.1016/j.desal.2014.02.012; Jadhav AH, 2015, CHEM ENG J, V259, P348, DOI 10.1016/j.cej.2014.07.127; Kannan C, 2013, J HAZARD MATER, V244, P10, DOI 10.1016/j.jhazmat.2012.11.016; Kertesz S, 2014, DESALINATION, V343, P106, DOI 10.1016/j.desal.2013.11.013; Kim TH, 2004, J HAZARD MATER, V112, P95, DOI 10.1016/j.jhazmat.2004.04.008; Labanda J, 2011, CHEM ENG J, V166, P536, DOI 10.1016/j.cej.2010.11.013; Li XY, 2015, CHEM ENG J, V260, P28, DOI 10.1016/j.cej.2014.08.042; Lim L. B. L., 2013, DESALIN WATER TREAT, P1, DOI [10.1080/19443994.2013.852136, DOI 10.1080/19443994.2013.852136]; Liu JY, 2014, DESALINATION, V344, P446, DOI 10.1016/j.desal.2014.04.015; Liu Y, 2014, CHEM ENG J, V237, P403, DOI 10.1016/j.cej.2013.10.048; Liu Y, 2010, J ENVIRON SCI, V22, P486, DOI 10.1016/S1001-0742(09)60134-0; Lu XC, 2012, APPL SURF SCI, V258, P8247, DOI 10.1016/j.apsusc.2012.05.029; Sotelo JL, 2013, CHEM ENG J, V228, P102, DOI 10.1016/j.cej.2013.04.088; Nandi BK, 2009, J HAZARD MATER, V161, P387, DOI 10.1016/j.jhazmat.2008.03.110; Ofomaja AE, 2008, BIORESOURCE TECHNOL, V99, P5411, DOI 10.1016/j.biortech.2007.11.018; Onal Y, 2006, J HAZARD MATER, V137, P1719, DOI 10.1016/j.jhazmat.2006.05.036; Riera-Torres M, 2010, DESALINATION, V252, P53, DOI 10.1016/j.desal.2009.11.002; Romanos J, 2013, CARBON, V54, P208, DOI 10.1016/j.carbon.2012.11.031; Sen TK, 2011, WATER AIR SOIL POLL, V218, P499, DOI 10.1007/s11270-010-0663-y; Shah I, 2014, BIORESOURCE TECHNOL, V160, P52, DOI 10.1016/j.biortech.2014.02.047; Shan C, 2013, WATER RES, V47, P3411, DOI 10.1016/j.watres.2013.03.035; Tseng RL, 2003, CARBON, V41, P487, DOI 10.1016/S0008-6223(02)00367-6; Tseng RL, 2006, J COLLOID INTERF SCI, V303, P494, DOI 10.1016/j.jcis.2006.08.024; Tseng RL, 2006, J HAZARD MATER, V136, P671, DOI 10.1016/j.jhazmat.2005.12.048; Wang PF, 2014, APPL SURF SCI, V290, P116, DOI 10.1016/j.apsusc.2013.11.010; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Weng CH, 2006, COLLOID SURFACE A, V274, P154, DOI 10.1016/j.colsurfa.2005.08.044; Wu FC, 2006, J COLLOID INTERF SCI, V294, P21, DOI 10.1016/j.jcis.2005.06.084; Wu FC, 2009, CHEM ENG J, V150, P366, DOI 10.1016/j.cej.2009.01.014; Yan H, 2014, J HAZARD MATER, V268, P191, DOI 10.1016/j.jhazmat.2014.01.015; Yang GX, 2014, WATER RES, V48, P396, DOI 10.1016/j.watres.2013.09.050; Zelmanov G, 2014, DESALINATION, V333, P107, DOI 10.1016/j.desal.2013.11.027	50	82	85	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122603	10.1371/journal.pone.0122603	http://dx.doi.org/10.1371/journal.pone.0122603			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849291	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800145
J	Shen, B; Wong, CO; Lau, OC; Woo, T; Bai, SW; Huang, Y; Yao, XQ				Shen, Bing; Wong, Ching-On; Lau, On-Chai; Woo, Theodosia; Bai, Suwen; Huang, Yu; Yao, Xiaoqiang			Plasma Membrane Mechanical Stress Activates TRPC5 Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; CATION CHANNEL; ION CHANNELS; MECHANOSENSITIVE CHANNELS; LATERAL PRESSURE; TOUCH SENSATION; CALCIUM-CHANNEL; SMOOTH-MUSCLE; NEURONS; PROTEIN	Mechanical forces exerted on cells impose stress on the plasma membrane. Cells sense this stress and elicit a mechanoelectric transduction cascade that initiates compensatory mechanisms. Mechanosensitive ion channels in the plasma membrane are responsible for transducing the mechanical signals to electrical signals. However, the mechanisms underlying channel activation in response to mechanical stress remain incompletely understood. Transient Receptor Potential (TRP) channels serve essential functions in several sensory modalities. These channels can also participate in mechanotransduction by either being autonomously sensitive to mechanical perturbation or by coupling to other mechanosensory components of the cell. Here, we investigated the response of a TRP family member, TRPC5, to mechanical stress. Hypoosmolarity triggers Ca2+ influx and cationic conductance through TRPC5. Importantly, for the first time we were able to record the stretch-activated TRPC5 current at single-channel level. The activation threshold for TRPC5 was found to be 240 mOsm for hypoosmotic stress and between -20 and -40 mmHg for pressure applied to membrane patch. In addition, we found that disruption of actin filaments suppresses TRPC5 response to hypoosmotic stress and patch pipette pressure, but does not prevent the activation of TRPC5 by stretch-independent mechanisms, indicating that actin cytoskeleton is an essential transduction component that confers mechanosensitivity to TRPC5. In summary, our findings establish that TRPC5 can be activated at the single-channel level when mechanical stress on the cell reaches a certain threshold.	[Shen, Bing; Wong, Ching-On; Lau, On-Chai; Woo, Theodosia; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Shen, Bing; Bai, Suwen] Anhui Med Univ, Dept Physiol, Hefei, Peoples R China	Chinese University of Hong Kong; Anhui Medical University	Wong, CO (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77025 USA.	ching.o.wong@uth.tmc.edu; yao2068@cuhk.edu.hk	Yao, Xiaoqiang/I-5413-2016; Huang, Yu/K-2866-2017	Yao, Xiaoqiang/0000-0002-0687-8186; Huang, Yu/0000-0002-1277-6784; Wong, Ching On/0000-0002-8602-2125; Lau, Eva On-Chai/0000-0001-7998-0061; suwen, bai/0000-0001-9359-014X	Hong Kong RGC [CUHK478710, CUHK478011, T13-706/11, AoE/M-05/12, CUHK2/CRF/11G]; Natural Science Foundation of China [81371284]; third installment of Anhui Provincial Science and Technology Plan [1301043020]	Hong Kong RGC(Hong Kong Research Grants Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); third installment of Anhui Provincial Science and Technology Plan	This work was supported by CUHK478710, CUHK478011, T13-706/11, AoE/M-05/12 and CUHK2/CRF/11G from the Hong Kong RGC, Grant 81371284 from Natural Science Foundation of China, and Grant 1301043020 from the third installment of Anhui Provincial Science and Technology Plan 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; ANDRESEN MC, 1992, AM J PHYSIOL, V262, pH1415, DOI 10.1152/ajpheart.1992.262.5.H1415; Arnadottir J, 2011, J NEUROSCI, V31, P12695, DOI 10.1523/JNEUROSCI.4580-10.2011; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; AUERBACH A, 1991, BIOPHYS J, V60, P660, DOI 10.1016/S0006-3495(91)82095-1; Beech DJ, 2007, BIOCHEM SOC T, V35, P101, DOI 10.1042/BST0350101; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Dai JW, 1998, J NEUROSCI, V18, P6681; Dedman A, 2009, EUR BIOPHYS J BIOPHY, V38, P293, DOI 10.1007/s00249-008-0318-8; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Glazebrook PA, 2005, PFLUG ARCH EUR J PHY, V451, P125, DOI 10.1007/s00424-005-1468-5; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Jemal I, 2014, PFLUG ARCH EUR J PHY, V466, P1635, DOI 10.1007/s00424-013-1392-z; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mihara H, 2013, AM J PHYSIOL-GASTR L, V304, pG235, DOI 10.1152/ajpgi.00256.2012; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Ohya Y, 1998, HYPERTENSION, V31, P254, DOI 10.1161/01.HYP.31.1.254; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Raghunathan M, 2012, J PHYS CHEM B, V116, P3918, DOI 10.1021/jp211904j; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Son AR, 2009, J DENT RES, V88, P1014, DOI 10.1177/0022034509343413; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Trebak M., 2007, V179, P593; Ursell T, 2011, BIOPHYS J, V101, P1913, DOI 10.1016/j.bpj.2011.08.057; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Wong CO, 2010, BRIT J PHARMACOL, V159, P1486, DOI 10.1111/j.1476-5381.2010.00636.x; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Yip H, 2004, HISTOCHEM CELL BIOL, V122, P553, DOI 10.1007/s00418-004-0720-y; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	61	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122227	10.1371/journal.pone.0122227	http://dx.doi.org/10.1371/journal.pone.0122227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849346	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800109
J	Teixeira, AF; de Morais, ZM; Kirchgatter, K; Romero, EC; Vasconcellos, SA; Nascimento, ALTO				Teixeira, Aline F.; de Morais, Zenaide M.; Kirchgatter, Karin; Romero, Eliete C.; Vasconcellos, Silvio A.; Nascimento, Ana Lucia T. O.			Features of Two New Proteins with OmpA-Like Domains Identified in the Genome Sequences of Leptospira interrogans	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; IMMUNOGLOBULIN-LIKE PROTEINS; BINDING PROTEIN; PATHOGENIC LEPTOSPIRA; INTERACTING-PROTEIN; HUMAN PLASMINOGEN; SURFACE; LIPOPROTEIN; SEROVAR; FIBRONECTIN	Leptospirosis is an acute febrile disease caused by pathogenic spirochetes of the genus Leptospira. It is considered an important re-emerging infectious disease that affects humans worldwide. The knowledge about the mechanisms by which pathogenic leptospires invade and colonize the host remains limited since very few virulence factors contributing to the pathogenesis of the disease have been identified. Here, we report the identification and characterization of two new leptospiral proteins with OmpA-like domains. The recombinant proteins, which exhibit extracellular matrix-binding properties, are called Lsa46 -LIC13479 and Lsa77 -LIC10050 (Leptospiral surface adhesins of 46 and 77 kDa, respectively). Attachment of Lsa46 and Lsa77 to laminin was specific, dose dependent and saturable, with K-D values of 24.3 +/- 17.0 and 53.0 +/- 17.5 nM, respectively. Lsa46 and Lsa77 also bind plasma fibronectin, and both adhesins are plasminogen (PLG)-interacting proteins, capable of generating plasmin (PLA) and as such, increase the proteolytic ability of leptospires. The proteins corresponding to Lsa46 and Lsa77 are present in virulent L. interrogans L1-130 and in saprophyte L. biflexa Patoc 1 strains, as detected by immunofluorescence. The adhesins are recognized by human leptospirosis serum samples at the onset and convalescent phases of the disease, suggesting that they are expressed during infection. Taken together, our data could offer valuable information to the understanding of leptospiral pathogenesis.	[Teixeira, Aline F.; Nascimento, Ana Lucia T. O.] Inst Butantan, Ctr Biotechnol, Sao Paulo, SP, Brazil; [Teixeira, Aline F.; Nascimento, Ana Lucia T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Programa Posgrad Interunidades Biotecnol, Sao Paulo, SP, Brazil; [de Morais, Zenaide M.; Vasconcellos, Silvio A.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas, Sao Paulo, SP, Brazil; [Kirchgatter, Karin] Univ Sao Paulo, Superintendencia Controle Endemias Inst Med, Nucl Estudos Malaria, Sao Paulo, SP, Brazil; [Romero, Eliete C.] Adolfo Lutz Inst, Ctr Bacteriol, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz	Nascimento, ALTO (corresponding author), Inst Butantan, Ctr Biotechnol, Sao Paulo, SP, Brazil.	ana.nascimento@butantan.gov.br	Nascimento, Ana L. T. O./E-8488-2012; Romero, Eliete C/H-6976-2012; Kirchgatter, Karin/D-8376-2013	Nascimento, Ana L. T. O./0000-0003-4851-0870; Romero, Eliete C/0000-0002-8635-439X; Kirchgatter, Karin/0000-0002-2449-2316; Teixeira, Aline/0000-0002-1171-8312	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/23913-9]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [302758/2013-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant number 2012/23913-9 and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) grant number 302758/2013-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adindla S, 2004, COMP FUNCT GENOM, V5, P2, DOI 10.1002/cfg.358; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Atzingen MV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/564285; Atzingen MV, 2009, J INFECTION, V59, P264, DOI 10.1016/j.jinf.2009.07.010; Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carvalho E, 2009, FEBS LETT, V583, P1381, DOI 10.1016/j.febslet.2009.03.050; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Chou LF, 2012, GENE, V511, P364, DOI 10.1016/j.gene.2012.09.074; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003; Domingos RF, 2015, MICROBIOL-SGM, V161, P851, DOI 10.1099/mic.0.000041; Domingos RF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-50; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Fernandes LG., 2014, MICROBIOLOGY; Fernandes LGV, 2012, INFECT IMMUN, V80, P3679, DOI 10.1128/IAI.00474-12; Fink DL, 2002, INFECT IMMUN, V70, P4902, DOI 10.1128/IAI.70.9.4902-4907.2002; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLUGEL A, 1994, J BIOL CHEM, V269, P29732; Fraga TR, 2010, J BIOTECHNOL, V148, P156, DOI 10.1016/j.jbiotec.2010.04.007; Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Hsieh WJ, 2005, FEMS MICROBIOL LETT, V243, P339, DOI 10.1016/j.femsle.2004.12.021; Hull-Jackson C, 2006, J CLIN MICROBIOL, V44, P1853, DOI 10.1128/JCM.44.5.1853-1855.2006; Hussain M, 2001, MICROB PATHOGENESIS, V31, P261, DOI 10.1006/mpat.2001.0469; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Koizumi N, 2003, FEMS MICROBIOL LETT, V226, P215, DOI 10.1016/S0378-1097(03)00619-0; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Longhi MT, 2009, J MED MICROBIOL, V58, P1275, DOI 10.1099/jmm.0.011916-0; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Oliveira R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002396; Oliveira R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021962; Oliveira TR, 2010, MICROBES INFECT, V12, P207, DOI 10.1016/j.micinf.2009.12.004; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Pinne M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000815; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ricaldi JN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001853; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siqueira G.H., 2013, AM J TROP MED HYG; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Souza NM, 2012, MICROB PATHOGENESIS, V53, P125, DOI 10.1016/j.micpath.2012.06.001; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun MZ, 2006, BBA-PROTEINS PROTEOM, V1764, P1340, DOI 10.1016/j.bbapap.2006.06.003; TURNER LH, 1970, T ROY SOC TROP MED H, V64, P623, DOI 10.1016/0035-9203(70)90087-8; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2015, CRITICAL RE IN PRESS, DOI [10.3109/1040841X.2013.804031, DOI 10.3109/1040841X.2013.804031]; Vieira ML, 2013, MICROB PATHOG, V51, P360; Vieira ML, 2014, FEMS MICROBIOL LETT, V352, P129, DOI 10.1111/1574-6968.12349; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vieira ML, 2010, J INFECTION, V60, P52, DOI 10.1016/j.jinf.2009.10.047; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	79	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122762	10.1371/journal.pone.0122762	http://dx.doi.org/10.1371/journal.pone.0122762			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849456	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800159
J	Grunseit, AC; O'Hara, BJ; Chau, JY; Briggs, M; Bauman, AE				Grunseit, Anne C.; O'Hara, Blythe J.; Chau, Josephine Y.; Briggs, Megan; Bauman, Adrian E.			Getting the Message Across: Outcomes and Risk Profiles by Awareness Levels of the "Measure-Up" Obesity Prevention Campaign in Australia	PLOS ONE			English	Article							MASS-MEDIA CAMPAIGNS; PHYSICAL-ACTIVITY; VERB(TM) CAMPAIGN; HELP-SEEKING; POPULATION; PREVALENCE; BEHAVIORS; MORTALITY; IMPACT; ADULTS	Background Obesity campaign evaluations have used campaign awareness to assess impact, yet have not compared unprompted campaign recallers, with prompted recallers and those with no campaign recall. Using data from an Australian mass-media obesity prevention campaign linking waist circumference and chronic disease we examined whether those with different degrees of campaign recall are distinct groups demographically and for subsequent campaign effects. Methods A national cross-sectional telephone survey of randomly selected adults aged 18 to 65 years was conducted post-campaign (n = 2812) covering campaign recall, self-reported diet and physical activity (PA) and waist-measuring knowledge, behaviours and intentions to make lifestyle changes. Respondents were divided into three groups indicating campaign recall: Unprompted Recallers (n=1154); Prompted Recallers (n=1284); and No Recallers (n=374) and compared on demographic, knowledge, and behavioural risk factors for obesity/chronic disease. Results Unprompted Recallers were more likely to speak English at home (p<.001), be in the primary campaign target group (25-45 years with children) (p<0.001) than the other two groups and to be university educated and female than the Prompted Recall group only (p=0.001). Unprompted Recallers had better knowledge about recommended waist circumference (p<.001), fruit (p=0.004), vegetable (p<0.001) and PA guidelines (p<0.001) than both the other groups. The No Recall group was less likely than the other two to be overweight/obese (46% vs 55%, p=0.020 and 54%, p=0.037), comparable on meeting fruit consumption and PA guidelines but more likely to meet vegetable intake recommendations (than Unprompted Recallers only). Conclusions Unprompted recallers were more knowledgeable about campaign messages; behaviour change and intentions to change were stronger for the two recall groups compared with the No Recall group but not different between them. The current analysis revealed subtle differences in campaign exposure and/or attendance by different demographic subgroups that would not be apparent in a simple aware/unaware dichotomy.	[Grunseit, Anne C.; O'Hara, Blythe J.; Chau, Josephine Y.; Bauman, Adrian E.] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Camperdown, NSW, Australia; [Briggs, Megan] Dept Hlth, People Capabil & Commun Div, Hlth Mkt Unit, Canberra, ACT, Australia	University of Sydney	Grunseit, AC (corresponding author), Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Camperdown, NSW, Australia.	anne.grunseit@sydney.edu.au	Grunseit, Anne/AAF-2675-2020	Chau, Josephine/0000-0001-6261-2545; Grunseit, Anne/0000-0003-1250-3265				Australian Bureau of Statistics, 2009, 43640 AUSTR BUR STAT; Australian Bureau of Statistics, 2010, 32010 AUSTR BUR STAT; Australian Bureau of Statistics, 2012, 14364055001 AUSTR BU; Australian Bureau of Statistics, 2012, 62270 AUSTR BUR STAT; Australian Bureau of Statistics, 2009, 41020 AUSTR BUR STAT; Australian Bureau of Statistics, 2011, HOUS INC INC DISTR A; Australian Communications and Media Authority, 2010, CONV COMM REP 2 AUST; Australian Institute of Health and Welfare, 2006, CHRON DIS ASS RISK F; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Bauman A, 2008, AM J PREV MED, V34, pS249, DOI 10.1016/j.amepre.2008.03.015; Bauman A, 2006, EVAL PROGRAM PLANN, V29, P312, DOI 10.1016/j.evalprogplan.2005.12.004; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS196, DOI 10.1123/jpah.6.s2.s196; Brown WJ., 2005, CHOOSE HLTH BE ACTIV; Commonwealth Department of Health and Aged Care, 1998, AUSTR GUID HLTH EAT; Croker H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-404; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dixon J, 2000, Aust J Rural Health, V8, P254, DOI 10.1046/j.1440-1584.2000.00327.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; GfK Blue Moon Research and Planning, 2009, AUSTR BETT HLTH IN P, DOI [10.4066/AMJ.2011693, DOI 10.4066/AMJ.2011693]; GfK Blue Moon Research and Planning, 2010, MEAS PHAS 2 QUAL FOR; GfK Blue Moon Research and Planning, 2007, RES REPORT; Huhman M, 2008, AM J PREV MED, V34, pS241, DOI 10.1016/j.amepre.2008.03.006; James N, 2011, J SCI MED SPORT S1, V14, pe24, DOI [10.1016/j.jsams.2011.11.049, DOI 10.1016/J.JSAMS.2011.11.049]; King EL, 2013, HEALTH EDUC RES, V28, P1029, DOI 10.1093/her/cyt084; Leavy J, 2011, J SCI MED SPORT S11, V14; Leavy JE, 2011, HEALTH EDUC RES, V26, P1060, DOI 10.1093/her/cyr069; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Morley B, 2009, HEALTH EDUC RES, V24, P1069, DOI 10.1093/her/cyp034; National Health and Medical Research Council, 2001, CLIN PRACT GUID MAN; Noble G, 2005, PRISM, V3, P1; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; O'Hara BJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-762; Pennay DW, 2010, ACSPRI SOC SCI METH; Pollard C, 2009, AM J PUBLIC HEALTH, V99, P355, DOI 10.2105/AJPH.2007.131367; Smith JA, 2006, MED J AUSTRALIA, V184, P81, DOI 10.5694/j.1326-5377.2006.tb00124.x; StataCorp, 2013, STAT STAT SOFTW REL; The Social Research Centre, 2010, EV AUSTR BETT HLTH I; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Valente T, 2013, PUBLIC COMMUNICATION, P105; van der Feen de Lille J C, 1998, Nutr Health, V12, P107; van Wechem Sigrid N., 1998, Nutrition and Health (Bicester), V12, P119; Verheijden MW, 2012, FAM PRACT, V29, pi75, DOI 10.1093/fampra/cmr133; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wammes B, 2007, OBESITY, V15, P2780, DOI 10.1038/oby.2007.330; Wardle J, 2001, HEALTH EDUC RES, V16, P343, DOI 10.1093/her/16.3.343; Waters A-M, 2003, GROWING PROBLEM TREN; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2003, OB OV WHO GLOB STRAT; Xingjin W, 2003, EFFECT DESORPTION TI	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121387	10.1371/journal.pone.0121387	http://dx.doi.org/10.1371/journal.pone.0121387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VA	25844811	Green Published, gold, Green Submitted			2022-12-27	WOS:000352475700006
J	Schmitz, K; Koeppen, H; Binot, E; Fassunke, J; Kunstlinger, H; Ihle, MA; Heydt, C; Wardelmann, E; Buttner, R; Merkelbach-Bruse, S; Ruschoff, J; Schildhaus, HU				Schmitz, Katja; Koeppen, Hartmut; Binot, Elke; Fassunke, Jana; Kuenstlinger, Helen; Ihle, Michaela A.; Heydt, Carina; Wardelmann, Eva; Buettner, Reinhard; Merkelbach-Bruse, Sabine; Rueschoff, Josef; Schildhaus, Hans-Ulrich			MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas	PLOS ONE			English	Article							C-MET; SCATTER FACTOR; SIGNALING PATHWAY; FACTOR RECEPTOR; CELL; AMPLIFICATION; OVEREXPRESSION; ASSAY; RECOMMENDATIONS; RADIOTHERAPY	Soft tissue sarcomas are a heterogeneous group of tumors with many different subtypes. In 2014 an estimated 12,020 newly diagnosed cases and 4,740 soft tissue sarcoma related deaths can be expected in the United States. Many soft tissue sarcomas are associated with poor prognosis and therapeutic options are often limited. The evolution of precision medicine has not yet fully reached the clinical treatment of sarcomas since therapeutically tractable genetic changes have not been comprehensively studied so far. We analyzed a total of 484 adult-type malignant mesenchymal tumors by MET fluorescence in situ hybridization and MET and hepatocyte growth factor immunohistochemistry. Eleven different entities were included, among them the most common and clinically relevant subtypes and tumors with specific translocations or complex genetic changes. MET protein expression was observed in 2.6% of the cases, all of which were either undifferentiated pleomorphic sarcomas or angiosarcomas, showing positivity rates of 14% and 17%, respectively. 6% of the tumors showed hepatocyte growth factor overexpression, mainly seen in undifferentiated pleomorphic sarcomas and angiosarcomas, but also in clear cell sarcomas, malignant peripheral nerve sheath tumors, leiomyosarcomas and gastrointestinal stromal tumors. MET and hepatocyte growth factor overexpression were significantly correlated and may suggest an autocrine activation in these tumors. MET FISH amplification and copy number gain were present in 4% of the tumors (15/413). Two samples, both undifferentiated pleomorphic sarcomas, fulfilled the criteria for high level amplification of MET, one undifferentiated pleomorphic sarcoma reached an intermediate level copy number gain, and 12 samples of different subtypes were categorized as low level copy number gains for MET. Our findings indicate that angiosarcomas and undifferentiated pleomorphic sarcomas rather than other frequent adult-type sarcomas should be enrolled in screening programs for clinical trials with MET inhibitors. The screening methods should include both in situ hybridization and immunohistochemistry.	[Schmitz, Katja; Binot, Elke; Fassunke, Jana; Kuenstlinger, Helen; Ihle, Michaela A.; Heydt, Carina; Wardelmann, Eva; Buettner, Reinhard; Merkelbach-Bruse, Sabine; Schildhaus, Hans-Ulrich] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Schmitz, Katja; Schildhaus, Hans-Ulrich] Univ Hosp Gottingen, Inst Pathol, Gottingen, Germany; [Koeppen, Hartmut] Genentech Inc, San Francisco, CA 94080 USA; [Wardelmann, Eva] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Rueschoff, Josef] Targos Mol Pathol GmbH, Kassel, Germany	University of Cologne; University of Gottingen; Roche Holding; Genentech; University of Munster; Targos Molecular Pathology GmbH	Schildhaus, HU (corresponding author), Univ Hosp Cologne, Inst Pathol, Cologne, Germany.	hans-ulrich.schildhaus@med.uni-goettingen.de			German Cancer Aid (Deutsche Krebshilfe)	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	The German Cancer Aid (Deutsche Krebshilfe) supported the creation of the TMAs used here. The German Cancer Aid had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleman LJ, 2011, J CLIN ONCOL, V29, P4837, DOI 10.1200/JCO.2011.37.7929; Bramwell VHC, 2005, CANCER BIOL THER, V4, P1336, DOI 10.4161/cbt.4.12.2166; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Casali PG, 2009, ANN ONCOL, V20, P132, DOI 10.1093/annonc/mdp153; Davis IJ, 2010, CANCER RES, V70, P639, DOI 10.1158/0008-5472.CAN-09-1121; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Fletcher CDM BJ, 2013, PATHOLOGY GENETICS T; Gao CF, 2009, MOL CANCER THER, V8, P2803, DOI 10.1158/1535-7163.MCT-09-0125; Hou JX, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-64; Koeppen H, 2012, MODERN PATHOL, V25, p480A; Koeppen H, 2014, J CLIN ONCOL SUPPL, V32, p5s; Lee HJ, 2011, RADIAT ONCOL J, V29, P260, DOI 10.3857/roj.2011.29.4.260; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Lee J, 2012, RADIAT ONCOL J, V30, P62, DOI 10.3857/roj.2012.30.2.62; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Maier JAM, 1996, INT J CANCER, V65, P168, DOI 10.1002/(SICI)1097-0215(19960117)65:2<168::AID-IJC7>3.0.CO;2-X; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Mentzel T, 2012, MODERN PATHOL, V25, P75, DOI 10.1038/modpathol.2011.134; Miyamoto M, 2011, BRIT J CANCER, V105, P131, DOI 10.1038/bjc.2011.199; Movva S, 2014, J CLIN ONCOL SUPPL, V32, p5s; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Negri T, 2010, CLIN CANCER RES, V16, P3581, DOI 10.1158/1078-0432.CCR-09-2912; Neklason DW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-424; Rao UNM, 1997, HUM PATHOL, V28, P1066, DOI 10.1016/S0046-8177(97)90060-5; RONG S, 1993, CANCER RES, V53, P5355; ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P163; ROSEN EM, 1990, EXP CELL RES, V186, P22, DOI 10.1016/0014-4827(90)90205-O; Rosen EM, 1996, INT J CANCER, V67, P248, DOI 10.1002/(SICI)1097-0215(19960717)67:2<248::AID-IJC16>3.0.CO;2-7; ROSEN EM, 1994, INT J CANCER, V57, P706, DOI 10.1002/ijc.2910570517; Rosen LS, 2011, CLIN CANCER RES, V17, P7754, DOI 10.1158/1078-0432.CCR-11-1002; Schildhaus HU, 2015, CLIN CANCER RES, V21, P907, DOI 10.1158/1078-0432.CCR-14-0450; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Spigel DR, 2012, CLIN LUNG CANCER, V13, P500, DOI 10.1016/j.cllc.2012.05.009; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Torres KE, 2011, CLIN CANCER RES, V17, P3943, DOI 10.1158/1078-0432.CCR-11-0193; Tsuda M, 2007, CANCER RES, V67, P919, DOI 10.1158/0008-5472.CAN-06-2855; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Varella-Garcia M, 2009, J CLIN PATHOL, V62, P970, DOI 10.1136/jcp.2009.066548; Wallenius V, 2000, AM J PATHOL, V156, P821, DOI 10.1016/S0002-9440(10)64950-4; Weiss SW, 2001, ENZINGER AND WEISSS; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0120079	10.1371/journal.pone.0120079	http://dx.doi.org/10.1371/journal.pone.0120079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844809	Green Submitted, Green Published, gold			2022-12-27	WOS:000352475700002
J	Bernard, MC; Barban, V; Pradezynski, F; de Montfort, A; Ryall, R; Caillet, C; Londono-Hayes, P				Bernard, Marie-Clotilde; Barban, Veronique; Pradezynski, Fabrine; de Montfort, Aymeric; Ryall, Robert; Caillet, Catherine; Londono-Hayes, Patricia			Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs	PLOS ONE			English	Article							SIMPLEX-VIRUS 2; GENITAL HERPES; DELETION MUTANT; INFECTION; GLYCOPROTEIN; METAANALYSIS	HSV-2 vaccine is needed to prevent genital disease, latent infection, and virus transmission. A replication-deficient mutant virus (dl5-29) has demonstrated promising efficacy in animal models of genital herpes. However, the immunogenicity, protective efficacy, and non-replicative status of the highly purified clinical vaccine candidate (HSV529) derived from dl5-29 have not been evaluated. Humoral and cellular immune responses were measured in mice and guinea pigs immunized with HSV529. Protection against acute and recurrent genital herpes, mortality, latent infection, and viral shedding after vaginal HSV-2 infection was determined in mice or in naive and HSV-1 seropositive guinea pigs. HSV529 replication and pathogenicity were investigated in three sensitive models of virus replication: severe combined immunodeficient (SCID/Beige) mice inoculated by the intramuscular route, suckling mice inoculated by the intracranial route, and vaginally-inoculated guinea pigs. HSV529 immunization induced HSV-2-neutralizing antibody production in mice and guinea pigs. In mice, it induced production of specific HSV-2 antibodies and splenocytes secreting IFN. or IL-5. Immunization effectively prevented HSV-2 infection in all three animal models by reducing mortality, acute genital disease severity and frequency, and viral shedding. It also reduced ganglionic viral latency and recurrent disease in naive and HSV-1 seropositive guinea pigs. HSV529 replication/propagation was not detected in the muscles of SCID/Beige mice, in the brains of suckling mice, or in vaginal secretions of inoculated guinea pigs. These results confirm the non-replicative status, as well as its immunogenicity and efficacy in mice and guinea pigs, including HSV-1 seropositive guinea pigs. In mice, HSV529 produced Th1/Th2 characteristic immune response thought to be necessary for an effective vaccine. These results further support the clinical investigation of HSV529 in human subjects as a prophylactic vaccine.	[Bernard, Marie-Clotilde; Barban, Veronique; Pradezynski, Fabrine; de Montfort, Aymeric; Caillet, Catherine; Londono-Hayes, Patricia] Sanofi Pasteur, Res & Dev, Marcy Letoile, France; [Ryall, Robert] Sanofi Pasteur, Res & Dev, Swiftwater, PA USA	Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Bernard, MC (corresponding author), Sanofi Pasteur, Res & Dev, Marcy Letoile, France.	marie-clotilde.bernard@sanofipasteur.com						Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Hofstetter AM, 2014, CURR OPIN INFECT DIS, V27, P75, DOI 10.1097/QCO.0000000000000029; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mundle ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057224; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231	15	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121518	10.1371/journal.pone.0121518	http://dx.doi.org/10.1371/journal.pone.0121518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837802	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000047
J	Kato, S; Oshima, Y; Oka, H; Chikuda, H; Takeshita, Y; Miyoshi, K; Kawamura, N; Masuda, K; Kunogi, J; Okazaki, R; Azuma, S; Hara, N; Tanaka, S; Takeshita, K				Kato, So; Oshima, Yasushi; Oka, Hiroyuki; Chikuda, Hirotaka; Takeshita, Yujiro; Miyoshi, Kota; Kawamura, Naohiro; Masuda, Kazuhiro; Kunogi, Junichi; Okazaki, Rentaro; Azuma, Seiichi; Hara, Nobuhiro; Tanaka, Sakae; Takeshita, Katsushi			Comparison of the Japanese Orthopaedic Association (JOA) Score and Modified JOA (mJOA) Score for the Assessment of Cervical Myelopathy: A Multicenter Observational Study	PLOS ONE			English	Article							SPONDYLOTIC MYELOPATHY; RELIABILITY; DECOMPRESSION; AGREEMENT; VALIDITY; LIGAMENT	Objectives The Japanese Orthopaedic Association (JOA) score is widely used to assess the severity of clinical symptoms in patients with cervical compressive myelopathy, particularly in East Asian countries. In contrast, modified versions of the JOA score are currently accepted as the standard tool for assessment in Western countries. The objective of the present study is to compare these scales and clarify their differences and interchangeability and verify their validity by comparing them to other outcome measures. Materials and Methods Five institutions participated in this prospective multicenter observational study. The JOA and modified JOA (mJOA) proposed by Benzel were recorded preoperatively and at three months postoperatively in patients with cervical compressive myelopathy who underwent decompression surgery. Patient reported outcome (PRO) measures, including Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), the Short Form-12 (SF-12) and the Neck Disability Index (NDI), were also recorded. The preoperative JOA score and mJOA score were compared to each other and the PRO values. A Bland-Altman analysis was performed to investigate their limits of agreement. Results A total of ninety-two patients were included. The correlation coefficient (Spearman's rho) between the JOA and mJOA was 0.87. In contrast, the correlations between JOA/mJOA and the other PRO values were moderate (vertical bar rho vertical bar = 0.03 - 0.51). The correlation coefficient of the recovery rate between the JOA and mJOA was 0.75. The Bland-Altman analyses showed that limits of agreement were 3.6 to -1.2 for the total score, and 55.1% to -68.8% for the recovery rates. Conclusions In the present study, the JOA score and the mJOA score showed good correlation with each other in terms of their total scores and recovery rates. Previous studies using the JOA can be interpreted based on the mJOA; however it is not ideal to use them interchangeably. The validity of both scores was demonstrated by comparing these values to the PRO values.	[Kato, So; Oshima, Yasushi; Oka, Hiroyuki; Chikuda, Hirotaka; Tanaka, Sakae; Takeshita, Katsushi] Univ Tokyo, Dept Orthopaed Surg, Tokyo, Japan; [Takeshita, Yujiro; Miyoshi, Kota] Yokohama Rosai Hosp, Dept Orthopaed Surg, Yokohama, Kanagawa, Japan; [Kawamura, Naohiro; Masuda, Kazuhiro; Kunogi, Junichi] Japanese Red Cross Med Ctr, Dept Spine & Orthopaed Surg, Tokyo, Japan; [Okazaki, Rentaro; Azuma, Seiichi] Saitama Red Cross Hosp, Dept Orthopaed Surg, Saitama, Japan; [Hara, Nobuhiro] Musashino Red Cross Hosp, Dept Orthopaed Surg, Musashino, Tokyo, Japan	University of Tokyo; Yokohama Rosai Hospital; Japanese Red Cross Medical Center; University of Tokyo; Musashino RedCross Hospital	Kato, S (corresponding author), Univ Tokyo, Dept Orthopaed Surg, Tokyo, Japan.	skatou-tky@umin.org	Kawamura, Naohiro/J-8372-2019; Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Grants-in-Aid for Scientific Research [25293316] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		[Anonymous], 2001, J OUTCOME MEAS; ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Bartels RHMA, 2010, NEUROSURGERY, V66, P1013, DOI 10.1227/01.NEU.0000368391.79314.6F; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen FF, 2008, J PERS SOC PSYCHOL, V95, P1005, DOI 10.1037/a0013193; Chiles BW, 1999, NEUROSURGERY, V44, P762, DOI 10.1097/00006123-199904000-00041; COOPER PR, 1985, J NEUROSURG, V63, P492, DOI 10.3171/jns.1985.63.4.0492; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Fukui M, 2007, J ORTHOP SCI, V12, P227, DOI 10.1007/s00776-007-1118-1; Furlan JC, 2011, J NEUROSURG-SPINE, V14, P348, DOI 10.3171/2010.10.SPINE091029; Gasparovic H, 2014, J CRIT CARE, V29, P828, DOI 10.1016/j.jcrc.2014.04.012; HERDMANN J, 1994, ADV NEUROS, V22, P266; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Japanese Orthopedic Association, 1994, J JPN ORTHOP ASS, V68, P490; KELLER A, 1993, SCHWEIZ MED WSCHR, V123, P1682; King JT, 2004, SPINE, V29, P1271, DOI 10.1097/00007632-200406010-00018; Kopjar B, 2015, SPINE, V40, pE23, DOI 10.1097/BRS.0000000000000648; Kraemer HC, 2003, J AM ACAD CHILD PSY, V42, P1524, DOI 10.1097/00004583-200312000-00022; Leonardi M, 2008, SPINAL DISORDERS, P429; Madsen OR, 2013, J RHEUMATOL, V40, P379, DOI 10.3899/jrheum.120594; NURICK S, 1972, BRAIN, V95, P87; OTTENBACHER KJ, 1993, AM J PHYS MED REHAB, V72, P266, DOI 10.1097/00002060-199310000-00003; Randleman JB, 2014, J CATARACT REFRACT S; Revanappa KK, 2011, EUR SPINE J, V20, P1545, DOI 10.1007/s00586-011-1773-y; Rob YH, 2011, J HAND SURG-AM, V36A, P1497, DOI 10.1016/j.jhsa.2011.06.006; Siemons L, 2014, CLIN RHEUMATOL, V33, P783, DOI 10.1007/s10067-014-2538-x; Singh A, 2013, EUR SPINE J; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vitzthum HE, 2007, EUR SPINE J, V16, P2096, DOI 10.1007/s00586-007-0512-x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014	32	98	106	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123022	10.1371/journal.pone.0123022	http://dx.doi.org/10.1371/journal.pone.0123022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837285	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000120
J	McHugh, MJ; Broadhurst, MK; Sterling, DJ; Millar, RB				McHugh, Matthew J.; Broadhurst, Matt K.; Sterling, David J.; Millar, Russell B.			A 'Simple Anterior Fish Excluder' (SAFE) for Mitigating Penaeid-Trawl Bycatch	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; VISUAL-STIMULUS; BEHAVIOR; DESIGN; CATCH; GEAR	Various plastic strips and sheets (termed 'simple anterior fish excluders'-SAFEs) were positioned across the openings of penaeid trawls in attempts at reducing the unwanted bycatches of small teleosts. Initially, three SAFEs (a single wire without, and with small and large plastic panels) were compared against a control (no SAFE) on paired beam trawls. All SAFEs maintained targeted Metapenaeus macleayi catches, while the largest plastic SAFE significantly reduced total bycatch by 51% and the numbers of Pomatomus saltatrix, Mugil cephalus and Herklotsichthys castelnaui by up to 58%. A redesigned SAFE ('continuous plastic') was subsequently tested (against a control) on paired otter trawls, significantly reducing total bycatch by 28% and Pomatomus saltatrix and Herklotsichthys castelnaui by up to 42%. The continuous-plastic SAFE also significantly reduced Metapenaeus macleayi catches by similar to 7%, but this was explained by similar to 5% less wing-end spread, and could be simply negated through otter-board refinement. Further work is required to refine the tested SAFEs, and to quantify species-specific escape mechanisms. Nevertheless, the SAFE concept might represent an effective approach for improving penaeid-trawl selectivity.	[McHugh, Matthew J.; Broadhurst, Matt K.] Univ Queensland, Sch Biol Sci, Marine & Estuarine Ecol Unit, Brisbane, Qld, Australia; [Broadhurst, Matt K.] NSW Dept Primary Ind, Fisheries Conservat Technol Unit, Coffs Harbour, NSW, Australia; [Sterling, David J.] Sterling Trawl Gear Serv, Manly, Qld, Australia; [Millar, Russell B.] Univ Auckland, Dept Stat, Auckland 1, New Zealand	University of Queensland; NSW Department of Primary Industries; University of Auckland	McHugh, MJ (corresponding author), Univ Queensland, Sch Biol Sci, Marine & Estuarine Ecol Unit, Brisbane, Qld, Australia.	matthew.mchugh@uq.net.au	Broadhurst, Matt K/I-6783-2015; McHugh, Matthew/AAC-3288-2020	Broadhurst, Matt K/0000-0003-0184-7249; McHugh, Matthew/0000-0001-6210-0689				Alverson DL, 1996, REV FISH BIOL FISHER, V6, P443, DOI 10.1007/BF00164325; Bayse SM, 2014, FISH RES, V152, P55, DOI 10.1016/j.fishres.2013.03.018; Benjamini Y, 2001, ANN STAT, V29, P1165; Brewer D, 1998, FISH RES, V36, P195, DOI 10.1016/S0165-7836(98)00096-4; Broadhurst Matt K., 2007, V7, P1; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Broadhurst MK, 2014, FISH RES, V153, P24, DOI 10.1016/j.fishres.2013.12.018; Broadhurst MK, 2012, FISH RES, V131, P67, DOI 10.1016/j.fishres.2012.07.015; Broadhurst MK, 2000, REV FISH BIOL FISHER, V10, P27, DOI 10.1023/A:1008936820089; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Eayrs S, 2007, GUIDE BYCATCH REDUCT; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; GLASS CW, 1989, FISH RES, V7, P249, DOI 10.1016/0165-7836(89)90059-3; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hooper J, 2005, CCAMLR SCI, V12, P195; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Kim YH, 1998, FISH RES, V34, P151, DOI 10.1016/S0165-7836(97)00087-8; Kim YH, 1998, FISH RES, V34, P165, DOI 10.1016/S0165-7836(97)00089-1; Main J., 1981, SCOT FISH RES REP, V23, P1; McHugh MJ, 2014, FISHERIES MANAG ECOL, V21, P299, DOI 10.1111/fme.12079; Ryer CH, 2008, FISH RES, V90, P138, DOI 10.1016/j.fishres.2007.10.005; SEIDEL WR, 1978, MAR FISH REV, V40, P21; Sterling D, 2000, PHYS PERFORMANCE PRA; Walsh SJ, 2003, FISH RES, V63, P289, DOI 10.1016/S0165-7836(03)00130-9; Winger Paul D., 2010, P67	27	7	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123124	10.1371/journal.pone.0123124	http://dx.doi.org/10.1371/journal.pone.0123124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837892	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000128
J	Qi, JL; Zhang, DP; Fu, XJ; Li, CM; Meng, SN; Dai, M; Liu, H; Sun, JP				Qi, Jinlei; Zhang, Dapeng; Fu, Xiaojing; Li, Chengmei; Meng, Sining; Dai, Min; Liu, Hui; Sun, Jiangping			High Risks of HIV Transmission for Men Who Have Sex with Men - A Comparison of Risk Factors of HIV Infection among MSM Associated with Recruitment Channels in 15 Cities of China	PLOS ONE			English	Article							ONLINE; INTERNET; PREVALENCE; EPIDEMIC; BEHAVIOR	Objective While the HIV epidemic varies greatly by region and population group throughout China, the HIV incidence among men who have sex with men (MSM) continues to rise at an alarmingly fast pace. We seek to analyze the risk factors associated with HIV infection among MSM recruited from different channels in large urban centers across China, in an attempt to shed light on the design of future targeted intervention strategies. Methods A total of 33,684 MSM from 14 cities and one province were recruited from July to December 2011. Demographic (e.g. age, marital status, education) and behavioral (e.g. condom use, HIV testing history) data were collected using information collection cards. Blood samples were also collected to test for HIV and Syphilis. Results Participants were recruited from five different channels, and all demonstrated distinct characteristics. The overall rate of positive HIV screening was 6.27% and the rate of syphilis infection was 6.50%. Participants recruited from bathhouses had the highest HIV (11.80%) and syphilis infection rates (11.20%). Participants who were infected with syphilis had the highest HIV-positive screening rate (13.75%; 95% CI OR, 2.33-3.06). living in the southwest region of the country (11.64%; OR=2.76, 95% CI OR 2.19-3.47), Being >20 years of age (P<0.001), living in the southwest region of the country (OR=2.76, 95% CI 2.19-3.47), not having sex with female over the previous 3 months (OR=1.27, 95% CI 1.09-1.48), no condom use during the last anal intercourse (OR=1.54, 95% CI 1.39-1.70) and other factors were all associated with a higher probability of having an HIV-positive test result. Conclusion Depending on the way they are recruited, more targeted interventions are required to prevent the spread of HIV/AIDS among MSM with different characteristics and behaviors. Results from this study could provide evidence for researchers to conduct further studies and policy-makers to establish more effective and strategic interventions for MSM in China.	[Qi, Jinlei; Zhang, Dapeng; Fu, Xiaojing; Li, Chengmei; Meng, Sining; Liu, Hui; Sun, Jiangping] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Dai, Min] Bill & Melinda Gates Fdn China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Sun, JP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	jpsun@chinaaids.cn	DAI, M/GPS-8291-2022		China-Gates Foundation HIV Cooperation Program [Opp 49277]	China-Gates Foundation HIV Cooperation Program	This program was funded by the China-Gates Foundation HIV Cooperation Program (Opp 49277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bingham TA, 2008, SEX TRANSM DIS, V35, P631, DOI 10.1097/OLQ.0b013e31816b475a; Bolding G, 2004, AIDS CARE, V16, P993, DOI 10.1080/09540120412331292453; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P440; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Glick SN, 2012, J ACQ IMMUN DEF SYND, V60, P8; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han Mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P878; He Q, 2011, SEXUALLY TRANSMITTED, V88, P5; Hooper S, 2008, AIDS BEHAV, V12, P867, DOI 10.1007/s10461-008-9373-5; Horvath KJ, 2008, J URBAN HEALTH, V85, P744, DOI 10.1007/s11524-008-9299-2; Hospers HJ, 2005, AIDS, V19, P1097, DOI 10.1097/01.aids.0000174457.08992.62; Huebner DM, 2012, INT J STD AIDS, V23, P182, DOI 10.1258/ijsa.2009.009318; Huebner DM, 2006, JAIDS-J ACQ IMM DEF, V43, P239, DOI 10.1097/01.qai.0000242464.50947.16; Ko NY, 2011, AIDS BEHAV, V15, P292, DOI 10.1007/s10461-010-9748-2; Lewnard JA, 2014, SEXUALLY TRANSMITTED, V90, P7; LI H, 2011, PLOS GENET, V7, P23431, DOI DOI 10.1371/JOURNAL.PONE.0023431; Liau A, 2006, SEX TRANSM DIS, V33, P576, DOI 10.1097/01.olq.0000204710.35332.c5; Macdonald DS, 1996, SOC SCI MED, V42, P1325, DOI 10.1016/0277-9536(95)00223-5; Macdonald N, 2007, SEX TRANSM INFECT, V84, P8, DOI 10.1136/sti.2007.027946; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Van Beneden CA, 2002, J ACQ IMMUN DEF SYND, V30, P522, DOI 10.1097/00126334-200208150-00008; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Wohlfeiler D, 2005, SEX TRANSM DIS, V32, pS48, DOI 10.1097/01.olq.0000175394.81945.68; Woods WJ, 2007, JAIDS-J ACQ IMM DEF, V45, P231, DOI 10.1097/QAI.0b013e318055601e; Woods WJ, 2003, J HOMOSEXUAL, V44, P1, DOI 10.1300/J082v44n03_01; Wu Z, 2006, SCIENCE, V312, P2; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu JJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-3; Ybarra Michele L, 2007, Curr HIV/AIDS Rep, V4, P201, DOI 10.1007/s11904-007-0029-2; Zhang B, 2002, J CHINA AIDS STD PRE, V8, P3; Zhang D, 2011, INT J STD AIDS; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431	34	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121267	10.1371/journal.pone.0121267	http://dx.doi.org/10.1371/journal.pone.0121267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837667	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000044
J	Suprenand, PM; Drexler, M; Jones, DL; Ainsworth, CH				Suprenand, Paul Mark; Drexler, Michael; Jones, David L.; Ainsworth, Cameron H.			Strategic Assessment of Fisheries Independent Monitoring Programs in the Gulf of Mexico	PLOS ONE			English	Article							POPULATION-DYNAMICS; MODELS; MANAGEMENT; BAY; REPRODUCTION; INFORMATION; GROWTH; FISH; AGE	This study evaluates information produced from 14 fisheries independent monitoring programs (FIM) in the Gulf of Mexico. We consider the uniqueness of information from each program and its usefulness in estimating fisheries management indices. Biomass values of 35 functional groups are extracted from an operating model (Ecospace) with a method that replicates the patterns of historic FIM samplings. Observation error is added to these data in order to create a set of pseudo data that replicate the type and quality of information obtained from FIM programs. The pseudo data were put into a separate fishery assessment model (Pella-Tomlinson) to determine management indices of each functional group (maximum sustainable yield (MSY), biomass at MSY, and fishing mortality at MSY). These indices are compared against values in Ecospace, and against previously published single-species stock assessments. We also evaluate the full suite of information derived from FIM within an ecosystem context, considering whether functional roles are over- or under-sampled, and whether sampling effort is proportional to the value of fish stocks. Results reveal that model derived fishery indices closely matched published indices for the majority of the functional groups, economic and ecological evaluation suggests that several piscivorous functional groups are under-sampled include forage base species that are likely to indirectly support fisheries for piscivores, and sampling efforts are not proportional to the value of some fish stocks. Following ecological modelling we performed statistical analyses on historic FIM catch data to identify optimal species-specific sampling months and gear-types that can be used to refine future FIM sampling efforts.	[Suprenand, Paul Mark; Drexler, Michael; Jones, David L.; Ainsworth, Cameron H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Suprenand, Paul Mark] Mote Marine Lab, Sarasota, FL 34236 USA	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium	Suprenand, PM (corresponding author), Univ S Florida, Coll Marine Sci, 140 7th Ave S, St Petersburg, FL 33701 USA.	psuprenand@mote.org	jones, davey/AAN-5606-2020; Jones, Davey L/C-7411-2011	Jones, Davey L/0000-0002-1482-4209	Ocean Conservancy	Ocean Conservancy	This research was made possible by a grant from the Ocean Conservancy (www.oceanconservancy.org). The Ocean Conservancy reviewed the manuscript, but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the research proposal was submitted to the Ocean Conservancy prior to the research, and so they were aware of research methods and designs.	Ainsworth CH, 2008, ECOL MODEL, V214, P361, DOI 10.1016/j.ecolmodel.2008.02.039; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, SE AREA MONITORNING; [Anonymous], 2014, SEDAR27RD05; Arnold WS, 2002, ECOSYSTEM MODEL W FL, VII, P154; Berrick SW, 2009, IEEE T GEOSCI REMOTE, V47, P106, DOI 10.1109/TGRS.2008.2003183; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown H, 2013, NMFSSEFSC647; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; CARGO DG, 1958, J MAR RES, V16, P180; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Darden R.L., 2004, THESIS U SO MISSISSI; de Berg M., 2008, COMPUTATIONAL GEOMET, V3; Drexler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064458; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; ESRI, 2011, ARCGIS DESKT REL 10; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; FOX WW, 1970, T AM FISH SOC, V99, P80, DOI 10.1577/1548-8659(1970)99<80:AESMFO>2.0.CO;2; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Godinez-Dominguez E, 2003, MAR ECOL PROG SER, V253, P17, DOI 10.3354/meps253017; Gray A. M., 2013, SEDAR33AW21; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Jin D, 2003, ECOL ECON, V46, P367, DOI 10.1016/j.ecolecon.2003.06.001; Johnson GD, 1978, US FISH WILDL SER, P242; Jones D.L, 2017, FATHOM TOOLBOX MATLA; Karnauskas M, 2013, USE CONNECTIVITY MOD, P12; Lapolla AE, 2001, MAR ECOL PROG SER, V217, P93, DOI 10.3354/meps217093; Lassuy DR, 1983, US FISH WILDL SER; Latour RJ, 2003, FISHERIES, V28, P10, DOI 10.1577/1548-8446(2003)28[10:TEFM]2.0.CO;2; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Lindberg WJ, 1984, SPECIES PROFILES LIF, P1; Luczkovich JJ, 2002, ESTUARIES, V25, P1143, DOI 10.1007/BF02692212; MathWorks Inc, 2010, MATLAB DAT AN SOFTW; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McBride RS, 2001, FISH B-NOAA, V99, P443; McGarigal K, 2000, MULTIVARIATE STAT WI; Mcllwain T, 2008, LIST FISHERY RES SOC; More W, 1969, TEXAS PARKS WILDLIFE, V1, P1; Mullon C, 2005, FISH FISH, V6, P111, DOI 10.1111/j.1467-2979.2005.00181.x; Oesterling MJ, 1982, P BLUE CRAB C BILOXI, P37; Oesterling MJ, 1976, FLORIDA SEA GRANT PU; Patterson WF, 2001, FISH B-NOAA, V99, P617; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pearson J. C., 1928, B US BUR FISH, V44, P129; Pella J.J., 1969, B INTERAMERICAN TROP, V13, P419; Perret WS, 1980, GULF STATES MAR FISH, V6, P1; Perry H.M., 1975, Gulf Res Reps, V5, P39; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Reiter Michael A., 2013, Journal of Environmental Assessment Policy and Management, V15, P1350003, DOI 10.1142/S1464333213500038; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; Schaefer HC, 1994, MAR FISH REV, V56, P13; Schaefer M. B., 1954, INTERAM TROP TUNA CO, V1, P27, DOI DOI 10.1016/S0065-2881(09)56003-8; SEDAR, 2007, SE DAT ASS REV, P1; SEDAR, 2013, SEDAR 31 GULF MEX RE, P1103; Serebrennikova Y, 2008, DEEP-SEA RES PT II, V55, P393, DOI 10.1016/j.dsr2.2007.11.009; SHLOSSMAN PA, 1981, FISH B-NOAA, V79, P649; SIMMONS ERNEST G., 1962, PUBL INST MAR SCI, V8, P184; Sink TD, 2011, SO REGIONAL AQUACULT, V7208, P1; Steele P., 1991, P GULF CARIB FISH I, V40, P241; Steele P, 1984, GULF STATES MAR FISH, P241; Suprenand PM, 2014, STRATEGIC ASSESSMENT; Sutherland DE, 1980, NMFSSEFC12 NOAA DEP; Tabb D. C., 1961, Bulletin of Marine Science of the Gulf and Caribbean, V11, P552; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; Walters C, 2008, B MAR SCI, V83, P251; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; White JW, 2007, MAR ECOL PROG SER, V329, P301, DOI 10.3354/meps329301; WHITE ML, 1977, FISH B-NOAA, V75, P109; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Yoshie N, 2007, ECOL MODEL, V202, P26, DOI 10.1016/j.ecolmodel.2006.07.043	79	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120929	10.1371/journal.pone.0120929	http://dx.doi.org/10.1371/journal.pone.0120929			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835742	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000034
J	Xu, HY; Wang, ZY; Chen, JF; Wang, TY; Wang, LL; Tang, LL; Lin, XY; Zhang, CW; Chen, BC				Xu, Hui Ying; Wang, Zhang Yang; Chen, Jing Feng; Wang, Tian Yang; Wang, Ling Ling; Tang, Li Li; Lin, Xian-yang; Zhang, Chun-wu; Chen, Bi-cheng			Association between Ankylosing Spondylitis and the miR-146a and miR-499 Polymorphisms	PLOS ONE			English	Article							NF-KAPPA-B; PERIPHERAL-BLOOD; FUNCTIONAL POLYMORPHISM; TNF-ALPHA; MICRORNA; EXPRESSION; TOLL-LIKE-RECEPTOR-4; INFLAMMATION; BIOMARKERS; ARTHRITIS	miRNAs are small, non-coding RNAs that regulate the expression of multiple target genes at the post-transcriptional level. Single-nucleotide polymorphisms (SNPs) in miRNA sequences may alter miRNA expression and have been implicated in the pathogenesis of multiple forms of arthritis, including rheumatoid arthritis (RA) and osteoarthritis. The present study explored the association between ankylosing spondylitis (AS) and two single nucleotide polymorphisms (SNPs), miR-146a rs2910164G>C and miR-499 rs3746444T>C, in a Han Chinese population. A case-control study consisting of 102 subjects with AS and 105 healthy controls was designed. The two miRNA SNPs were identified by direct sequencing. Subsequently, their gene and genotype frequencies were compared with healthy controls. A significant difference was observed in the miR-146a rs2910164G>C SNP. The frequency of the G allele was markedly higher in the AS patients than in the healthy controls (P = 0.005, Pc = 0.01, OR = 1.787), and the frequency of the GG genotype was higher in AS patients than in controls (P = 0.014, Pc = 0.042, OR = 2.516). However, no significant association was found between the miR-499 rs3746444T>C variant and susceptibility to AS. This is the first study to address the association between the miR-146a rs2910164G>C and miR-499 rs3746444T>C polymorphisms and AS, and it suggests a potential pathogenic factor for AS. Further studies are needed to validate our findings in a larger series, as well as in other ethnic backgrounds.	[Xu, Hui Ying; Wang, Zhang Yang; Wang, Ling Ling; Tang, Li Li; Chen, Bi-cheng] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Surg, Wenzhou 325000, Peoples R China; [Chen, Jing Feng; Wang, Tian Yang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325000, Peoples R China; [Lin, Xian-yang; Zhang, Chun-wu] Wenzhou Med Univ, Affiliated Hosp 1, Injury Orthopaed Tradit Chinese Med, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhang, CW (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Injury Orthopaed Tradit Chinese Med, Wenzhou 325000, Peoples R China.	bisonch@163.com	Kumar, Sushmitha Vijaya/AAU-4235-2021; XU, HAO/B-3194-2011	XU, HAO/0000-0002-5776-0276	Technology Foundation of Zhejiang Province [2013C33173]; Zhejiang Provincial Undergraduate Scientific and Technological Innovation Project; Fresh Talent Program [2014R413014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Technology Foundation of Zhejiang Province; Zhejiang Provincial Undergraduate Scientific and Technological Innovation Project; Fresh Talent Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Technology Foundation of Zhejiang Province [grant number No. 2013C33173].(URLs: http://www.zjkjt.gov.cn/) and the Zhejiang Provincial Undergraduate Scientific and Technological Innovation Project and the Fresh Talent Program (grant number: 2014R413014) (URLs: http://www.zjkjt.gov.cn/html/node18/detail0104/2011/0104_22730.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, ASIAN PAC J CANCER P, V12, P3107; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Ciccacci C, 2014, ACTA DIABETOL, V51, P663, DOI 10.1007/s00592-014-0582-2; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; De Rycke L, 2005, ARTHRITIS RHEUM-US, V52, P2146, DOI 10.1002/art.21155; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Eggert M, 2007, RHEUMATOL INT, V27, P841, DOI 10.1007/s00296-007-0303-z; Green MJ, 2013, MOL PSYCHIATR, V18, P774, DOI 10.1038/mp.2012.84; Hasani SS, 2014, TUMOR BIOL, V35, P219, DOI 10.1007/s13277-013-1027-1; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Ji W, 2014, BIOMED REP, V2, P517, DOI 10.3892/br.2014.262; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550; Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Ma XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079584; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Qipshidze-Kelm N, 2014, REDOX BIOL, V2, P1, DOI 10.1016/j.redox.2013.10.009; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shao YM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/916202; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Szanto S, 2008, J RHEUMATOL, V35, P2372, DOI 10.3899/jrheum.070839; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Wang JH, 2013, OSTEOARTHR CARTILAGE, V21, P1987, DOI 10.1016/j.joca.2013.09.008; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Yamashita J, 2013, MELANOMA RES, V23, P13, DOI 10.1097/CMR.0b013e32835c5b30; Yang B, 2012, HUM IMMUNOL, V73, P101, DOI 10.1016/j.humimm.2011.10.005; Yang B, 2011, MOL BIOL REP, V38, P4913, DOI 10.1007/s11033-010-0633-x; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yang ZX, 2007, CLIN EXP IMMUNOL, V149, P48, DOI 10.1111/j.1365-2249.2007.03396.x; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao HF, 2014, AUTOIMMUNITY, V47, P173, DOI 10.3109/08916934.2014.883503; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	39	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122055	10.1371/journal.pone.0122055	http://dx.doi.org/10.1371/journal.pone.0122055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836258	gold, Green Published, Green Submitted			2022-12-27	WOS:000352139000076
J	Chen, HL; Wang, LX; Wang, SH; Liu, CJ; Blair, MW; Cheng, XZ				Chen, Honglin; Wang, Lixia; Wang, Suhua; Liu, Chunji; Blair, Matthew Wohlgemuth; Cheng, Xuzhen			Transcriptome Sequencing of Mung Bean (Vigna radiate L.) Genes and the Identification of EST-SSR Markers	PLOS ONE			English	Article							BRUCHID RESISTANCE GENE; MICROSATELLITE MARKERS; RNA-SEQ; TRANSFERABILITY; CHICKPEA; GENERATION; DIVERSITY; DISCOVERY; BARLEY; READS	Mung bean (Vigna radiate (L.) Wilczek) is an important traditional food legume crop, with high economic and nutritional value. It is widely grown in China and other Asian countries. Despite its importance, genomic information is currently unavailable for this crop plant species or some of its close relatives in the Vigna genus. In this study, more than 103 million high quality cDNA sequence reads were obtained from mung bean using Illumina paired-end sequencing technology. The processed reads were assembled into 48,693 unigenes with an average length of 874 bp. Of these unigenes, 25,820 (53.0%) and 23,235 (47.7%) showed significant similarity to proteins in the NCBI non-redundant protein and nucleotide sequence databases, respectively. Furthermore, 19,242 (39.5%) could be classified into gene ontology categories, 18,316 (37.6%) into Swiss-Prot categories and 10,918 (22.4%) into KOG database categories (E-value < 1.0E-5). A total of 6,585 (8.3%) were mapped onto 244 pathways using the Kyoto Encyclopedia of Genes and Genome (KEGG) pathway database. Among the unigenes, 10,053 sequences contained a unique simple sequence repeat (SSR), and 2,303 sequences contained more than one SSR together in the same expressed sequence tag (EST). A total of 13,134 EST-SSRs were identified as potential molecular markers, with mono-nucleotide A/T repeats being the most abundant motif class and G/C repeats being rare. In this SSR analysis, we found five main repeat motifs: AG/CT (30.8%), GAA/TTC (12.6%), AAAT/ATTT (6.8%), AAAAT/ATTTT (6.2%) and AAAAAT/ATTTTT (1.9%). A total of 200 SSR loci were randomly selected for validation by PCR amplification as EST-SSR markers. Of these, 66 marker primer pairs produced reproducible amplicons that were polymorphic among 31 mung bean accessions selected from diverse geographical locations. The large number of SSR-containing sequences found in this study will be valuable for the construction of a high-resolution genetic linkage maps, association or comparative mapping and genetic analyses of various Vigna species.	[Chen, Honglin; Wang, Lixia; Wang, Suhua; Cheng, Xuzhen] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Liu, Chunji] CSIRO, Plant Ind, Queensland Biosci Precinct, Brisbane, Qld, Australia; [Blair, Matthew Wohlgemuth] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Tennessee State University	Cheng, XZ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	chengxuzhen@caas.cn	Liu, Chunji/B-5243-2009	Chen, Honglin/0000-0002-5737-9336	Ministry of Agriculture of China [CARS-09]; National Natural Science Foundation of China [31401442]; Agricultural Science and Technology Innovation Program (ASTIP) of CAAS	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program (ASTIP) of CAAS	This work was supported by the Ministry of Agriculture of China (the earmarked fund for China Agriculture Research System [CARS-09]), National Natural Science Foundation of China (31401442) and the Agricultural Science and Technology Innovation Program (ASTIP) of CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blair M, 2008, THEOR APPL GENET, V118, P91, DOI 10.1007/s00122-008-0879-z; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-171; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-50; Blair MW, 2009, GENOME, V52, P772, DOI [10.1139/G09-053, 10.1139/g09-053]; Blair MW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-100; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chankaew S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104990; Chen HM, 2007, EUPHYTICA, V157, P113, DOI 10.1007/s10681-007-9400-z; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Englen MD, 2000, LETT APPL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2672.2000.00841.x; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gupta SK, 2014, EUPHYTICA, V195, P245, DOI 10.1007/s10681-013-0993-0; Gupta SK, 2012, INDIAN J GENET PL BR, V72, P468; Gupta SK, 2010, GENOME, V53, P508, DOI [10.1139/G10-028, 10.1139/g10-028]; Gwag JG, 2010, GENES GENOM, V32, P299, DOI 10.1007/s13258-010-0014-9; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang DN, 2014, MOL ECOL RESOUR, V14, P569, DOI 10.1111/1755-0998.12197; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Kaga A, 1998, MOL GEN GENET, V258, P378, DOI 10.1007/s004380050744; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Moe KT, 2012, PLANT BREEDING, V131, P110, DOI 10.1111/j.1439-0523.2011.01896.x; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Nair RM, 2013, J SCI FOOD AGR, V93, P1805, DOI 10.1002/jsfa.6110; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Somta P, 2009, CONSERV GENET, V10, P1939, DOI 10.1007/s10592-009-9860-x; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian AG, 2004, THEOR APPL GENET, V108, P903, DOI 10.1007/s00122-003-1499-2; Van K, 2013, THEOR APPL GENET, V126, P2017, DOI 10.1007/s00122-013-2114-9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xin DW, 2012, MOL BIOL REP, V39, P9047, DOI 10.1007/s11033-012-1776-8; YOUNG ND, 1992, THEOR APPL GENET, V84, P839, DOI 10.1007/BF00227394; Zhang XY, 2008, THEOR APPL GENET, V117, P629, DOI 10.1007/s00122-008-0807-2; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490	40	38	46	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120273	10.1371/journal.pone.0120273	http://dx.doi.org/10.1371/journal.pone.0120273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830701	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600029
J	Hindia, MN; Reza, AW; Noordin, KA; Chayon, MHR				Hindia, Mohammad Nour; Reza, Ahmed Wasif; Noordin, Kamarul Ariffin; Chayon, Muhammad Hasibur Rashid			A Novel LTE Scheduling Algorithm for Green Technology in Smart Grid	PLOS ONE			English	Article							NETWORKS; NEIGHBORHOOD; IMPACT	Smart grid (SG) application is being used nowadays to meet the demand of increasing power consumption. SG application is considered as a perfect solution for combining renewable energy resources and electrical grid by means of creating a bidirectional communication channel between the two systems. In this paper, three SG applications applicable to renewable energy system, namely, distribution automation (DA), distributed energy system-storage (DER) and electrical vehicle (EV), are investigated in order to study their suitability in Long Term Evolution (LTE) network. To compensate the weakness in the existing scheduling algorithms, a novel bandwidth estimation and allocation technique and a new scheduling algorithm are proposed. The technique allocates available network resources based on application's priority, whereas the algorithm makes scheduling decision based on dynamic weighting factors of multi-criteria to satisfy the demands (delay, past average throughput and instantaneous transmission rate) of quality of service. Finally, the simulation results demonstrate that the proposed mechanism achieves higher throughput, lower delay and lower packet loss rate for DA and DER as well as provide a degree of service for EV. In terms of fairness, the proposed algorithm shows 3%, 7% and 9% better performance compared to exponential rule (EXP-Rule), modified-largest weighted delay first (M-LWDF) and exponential/PF (EXP/PF), respectively.	[Hindia, Mohammad Nour; Reza, Ahmed Wasif; Noordin, Kamarul Ariffin; Chayon, Muhammad Hasibur Rashid] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Reza, AW (corresponding author), Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia.	wasif@um.edu.my	Noordin, Kamarul Ariffin/B-7751-2010; Chayon, Hasibur Rashid/P-3653-2014; HINDIA, MHD NOUR/AAE-3805-2020; Reza, Ahmed Wasif/ABE-5779-2020	Noordin, Kamarul Ariffin/0000-0003-4003-4793; Chayon, Hasibur Rashid/0000-0003-3741-6651; 	University of Malaya Research Grant (UMRG) scheme [RG286-14AFR]	University of Malaya Research Grant (UMRG) scheme	This research work is supported by the University of Malaya Research Grant (UMRG) scheme (RG286-14AFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gumaei YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109077; Ali S, 2013, EURASIP J WIREL COMM, V67, P1; Andria Gregorio, 2013, 2013 IEEE International Workshop on Measurements & Networking (M&N), P79, DOI 10.1109/IWMN.2013.6663781; Ang EM, 2014, INF SCI APPL ICISA 2, P1; Basukala R., 2009, IEEE 1 AS HIM C NOV, V1, P1, DOI DOI 10.1109/AHICI.2009.5340336; Berrio L., P 2012 IEEE 4 COL WO, P1, DOI [DOI 10.1109/CWCAS.2012.6404056, 10.1109/cwcas.2012.6404056]; Biswas SS, 2013, IEEE POW ENER SOC GE; Capozzi F, 2013, IEEE COMMUN SURV TUT, V15, P678, DOI 10.1109/SURV.2012.060912.00100; Casalegno S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107822; De Capua C, 2014, IEEE IMTC P, P878, DOI 10.1109/I2MTC.2014.6860868; Ericsson White paper, 2013, 284233208 UEN, V284, P23; Fang X, 2012, IEEE COMMUN SURV TUT, V14, P944, DOI 10.1109/SURV.2011.101911.00087; Gao S, 2013, IEEE T VEH TECHNOL, V63, P3019; Gungor VC, 2013, IEEE T IND INFORM, V9, P28, DOI 10.1109/TII.2012.2218253; Gungor VC, 2011, IEEE T IND INFORM, V7, P529, DOI 10.1109/TII.2011.2166794; Gungor VC, 2010, IEEE T IND ELECTRON, V57, P3557, DOI 10.1109/TIE.2009.2039455; Guttinger M., 2011, ENV EL ENG 10 INT C, V10, P1; Hindia MN, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/604752; Hosseini S. S., 2012, 2012 IEEE International Energy Conference (ENERGYCON 2012), P1101, DOI 10.1109/EnergyCon.2012.6347734; Iturralde M, 2013, WIRELESS PERS COMMUN, V72, P1415, DOI 10.1007/s11277-013-1086-z; Jain R, 1984, TR301 DEC; Kim KH, 2004, WRKS LOC METRO AREA, P217, DOI 10.1109/LANMAN.2004.1338435; Lee SB, 2009, IEEE INFOCOM SER, P2611, DOI 10.1109/INFCOM.2009.5062197; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Marsden J., 2011, GREEN TECHN C IEEE G, P1; Osterbo O., 2011, Proceedings of the 2011 23rd International Teletraffic Congress (ITC 2011), P63; Sauter T, 2011, IEEE T IND ELECTRON, V58, P1218, DOI 10.1109/TIE.2010.2070771; Su WC, 2012, IEEE T IND INFORM, V8, P1, DOI 10.1109/TII.2011.2172454; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang WY, 2011, COMPUT NETW, V55, P3604, DOI 10.1016/j.comnet.2011.07.010; Xia CY, 2013, CHAOS SOLITON FRACT, V51, P22, DOI 10.1016/j.chaos.2013.03.002; Yang Q, 2011, IEEE T IND INFORM, V7, P316, DOI 10.1109/TII.2011.2123903; Yilmaz M, 2013, IEEE T POWER ELECTR, V28, P5673, DOI 10.1109/TPEL.2012.2227500; Zavoda F., 2010, P CHIN INT C EL DIST, P1	34	15	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121901	10.1371/journal.pone.0121901	http://dx.doi.org/10.1371/journal.pone.0121901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830703	Green Published, gold			2022-12-27	WOS:000352135600089
J	Panunzi, S; D'Orsi, L; Iacoviello, D; De Gaetano, A				Panunzi, Simona; D'Orsi, Laura; Iacoviello, Daniela; De Gaetano, Andrea			A Stochastic Delay Differential Model of Cerebral Autoregulation	PLOS ONE			English	Article							CAROTID-ARTERY STENOSIS; BLOOD-PRESSURE; MATHEMATICAL-MODEL; ALZHEIMERS-DISEASE; STROKE; RISK; HEMODYNAMICS; FLUCTUATIONS; CIRCULATION; IMPAIRMENT	Mathematical models of the cardiovascular system and of cerebral autoregulation (CAR) have been employed for several years in order to describe the time course of pressures and flows changes subsequent to postural changes. The assessment of the degree of efficiency of cerebral auto regulation has indeed importance in the prognosis of such conditions as cerebro-vascular accidents or Alzheimer. In the quest for a simple but realistic mathematical description of cardiovascular control, which may be fitted onto non-invasive experimental observations after postural changes, the present work proposes a first version of an empirical Stochastic Delay Differential Equations (SDDEs) model. The model consists of a total of four SDDEs and two ancillary algebraic equations, incorporates four distinct delayed controls from the brain onto different components of the circulation, and is able to accurately capture the time course of mean arterial pressure and cerebral blood flow velocity signals, reproducing observed auto-correlated error around the expected drift.	[Panunzi, Simona; D'Orsi, Laura; De Gaetano, Andrea] CNR, Ist Analisi Sistemi & Informat Antonio Ruberti, Rome, Italy; [Iacoviello, Daniela] Dipartimento Ingn Informat Automat & Gestionale A, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	D'Orsi, L (corresponding author), CNR, Ist Analisi Sistemi & Informat Antonio Ruberti, Rome, Italy.	laura.dorsi@biomatematica.it	De Gaetano, Andrea/AAC-4805-2021; Panunzi, Simona/AAK-9337-2020	De Gaetano, Andrea/0000-0001-7712-056X; Panunzi, Simona/0000-0003-0956-8578; Iacoviello, Daniela/0000-0003-3506-1455				Aoi MC, 2009, OPTIMIZATION MATH MO; Aoi M, 2009, IEEE ENG MED BIO, P5470, DOI 10.1109/IEMBS.2009.5334057; Bekker A, 1996, J CLIN MONITOR, V12, P433, DOI 10.1007/BF02199704; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088232; Chiu C.C., 2005, J MED BIOL ENG, V25, P53; Derdeyn CP, 1999, NEUROLOGY, V53, P251, DOI 10.1212/WNL.53.2.251; Einstein A., 1934, PHILOS SCI, V2, P163, DOI DOI 10.1086/286316; Gommer ED, 2012, J ALZHEIMERS DIS, V30, P805, DOI 10.3233/JAD-2012-111628; Heesch CM, 1999, ADV PHYSIOL EDUC, V22, pS234, DOI 10.1152/advances.1999.277.6.S234; Kadas ZM, 1997, NEUROL RES, V19, P441, DOI 10.1080/01616412.1997.11740840; Kirkham SK, 2001, PHYSIOL MEAS, V22, P461, DOI 10.1088/0967-3334/22/3/305; Liau BY, 2008, MED BIOL ENG COMPUT, V46, P1, DOI 10.1007/s11517-007-0243-5; Liau BY, 2010, COMPUT CARDIOL CONF, V37, P605; Mader G, 2014, ANN BIOMED ENG; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Olufsen M, 2004, CARDIOVASC ENG, V4, P47, DOI 10.1023/B:CARE.0000025122.46013.1a; Olufsen MS, 2005, J APPL PHYSIOL, V99, P1523, DOI 10.1152/japplphysiol.00177.2005; PANERAI RB, 1993, PHYSIOL MEAS, V14, P411, DOI 10.1088/0967-3334/14/4/002; Panerai RB, 2003, PHYSIOL MEAS, V24, P367, DOI 10.1088/0967-3334/24/2/312; Panerai RB, 1998, MED BIOL ENG COMPUT, V36, P315, DOI 10.1007/BF02522477; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Paulson O. B., 1990, BRAIN METAB REV, V2, P161; Polidori MC, 2012, J ALZHEIMERS DIS, V32, P521, DOI 10.3233/JAD-2012-120871; Press W., 1994, NUMERICAL RECIPES C; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Roustan JP, 2009, ANESTH ANALG, V109, P1883, DOI 10.1213/ANE.0b013e3181b1286b; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Simpson DM, 2001, ANN BIOMED ENG, V29, P18, DOI 10.1114/1.1335537; Spronck B, 2012, AM J PHYSIOL-HEART C, V303, pH1143, DOI 10.1152/ajpheart.00303.2012; SVACINA S, 1990, COMPUT METH PROG BIO, V32, P259, DOI 10.1016/0169-2607(90)90108-L; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; Vokatch N, 2007, J NEUROL SCI, V254, P49, DOI 10.1016/j.jns.2006.12.017; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	33	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0118456	10.1371/journal.pone.0118456	http://dx.doi.org/10.1371/journal.pone.0118456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830915	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600002
J	Tseng, FY; Lin, WY; Li, CI; Li, TC; Lin, CC; Huang, KC				Tseng, Fen-Yu; Lin, Wen-Yuan; Li, Chia-Ing; Li, Tsai-Chung; Lin, Cheng-Chieh; Huang, Kuo-Chin			Subclinical Hypothyroidism Is Associated with Increased Risk for Cancer Mortality in Adult Taiwanese-A 10 Years Population-Based Cohort	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; RENAL-CELL CARCINOMA; ALL-CAUSE MORTALITY; BODY-MASS INDEX; THYROID-FUNCTION; BREAST-CANCER; CARDIOVASCULAR-DISEASE; SPONTANEOUS REMISSION; DIABETES-MELLITUS; HORMONE	Background The association between subclinical hypothyroidism (SCH) and cancer mortality is seldom discussed. Methods A total of 115,746 participants without thyroid disease history, aged 20 and above, were recruited from four nationwide health screening centers in Taiwan from 1998 to 1999. SCH was defined as a serum thyroid-stimulating hormone (TSH) level of 5.0-19.96 mIU/L with normal total thyroxine concentrations. Euthyroidism was defined as a serum TSH level of 0.47-4.9 mIU/L. Cox proportional hazards regression analyses were used to estimate the relative risks (RRs) of death from cancer for adults with SCH during a 10-year follow-up period. Results Among 115,746 adults, 1,841 had SCH (1.6%) and 113,905 (98.4%) had euthyroidism. There were 1,532 cancer deaths during the 1,034,082 person-years follow-up period. Adjusted for age, gender, body mass index, diabetes, hypertension, dyslipidemia, smoking, alcohol drinking, betel nut chewing, physical activity, income, and education level, the RRs (95% confidence interval) of cancer deaths among subjects with SCH versus euthyroid subjects were 1.51 (1.06 to 2.15). Cancer site analysis revealed a significant increased risk of bone, skin and breast cancer among SCH subjects (RR 2.79, (1.01, 7.70)). The risks of total cancer deaths were more prominent in the aged (RR 1.71, (1.02 to 2.87)), in females (RR 1.69 (1.08 to 2.65)), and in heavy smokers (RR 2.24, (1.19 to 4.21)). Conclusions Subjects with SCH had a significantly increased risk for cancer mortality among adult Taiwanese. This is the first report to demonstrate the association between SCH and cancer mortality.	[Tseng, Fen-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Family Med, Taipei, Taiwan; [Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Li, Chia-Ing; Li, Tsai-Chung] China Med Univ Hosp, Med Res, Taichung, Taiwan; [Lin, Wen-Yuan; Li, Chia-Ing; Lin, Cheng-Chieh] China Med Univ, Sch Med, Taichung, Taiwan; [Lin, Wen-Yuan; Lin, Cheng-Chieh; Huang, Kuo-Chin] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Tseng, Fen-Yu] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Li, Tsai-Chung; Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Inst Hlth Care Adm, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; Asia University Taiwan	Huang, KC (corresponding author), Natl Taiwan Univ Hosp, Family Med, Taipei, Taiwan.	bretthuang@ntu.edu.tw	Lin, Cheng-Chieh/P-2564-2015; Li, Tsai-Chung/P-2052-2015	Lin, Cheng-Chieh/0000-0002-9625-6216; Li, Tsai-Chung/0000-0002-3346-7462; Tseng, Fen-Yu/0000-0003-1571-5255	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; MJ Health Screening Center	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; MJ Health Screening Center	This study was financially supported by grants from Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MJ Health Screening Center provided support in the form of salaries for Dr. Pei-Kun Sung, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section.	Ashizawa K, 2010, CLIN ENDOCRINOL, V72, P689, DOI 10.1111/j.1365-2265.2009.03697.x; Asvold BO, 2007, EUR J ENDOCRINOL, V156, P707, DOI 10.1530/eje.1.02333e; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; BOREK C, 1983, P NATL ACAD SCI-BIOL, V80, P5749, DOI 10.1073/pnas.80.18.5749; BRINTON LA, 1984, J CHRON DIS, V37, P877, DOI 10.1016/0021-9681(84)90062-6; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Chuang CC, 1998, GERONTOLOGY, V44, P162, DOI 10.1159/000022002; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Cristofanilli M, 2005, CANCER-AM CANCER SOC, V103, P1122, DOI 10.1002/cncr.20881; Garduno-Garcia JD, 2010, EUR J ENDOCRINOL, V163, P273, DOI 10.1530/EJE-10-0312; Fatourechi V, 2009, MAYO CLIN PROC, V84, P65, DOI 10.1016/S0025-6196(11)60809-4; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; GOLDMAN MB, 1990, CANCER RES, V50, P2283; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; GUERNSEY DL, 1980, NATURE, V288, P591, DOI 10.1038/288591a0; Hellevik AI, 2009, CANCER EPIDEM BIOMAR, V18, P570, DOI 10.1158/1055-9965.EPI-08-0911; Hercbergs A, 1996, IN VIVO, V10, P245; HERCBERGS A, 1993, J NATL CANCER I, V85, P1342, DOI 10.1093/jnci/85.16.1342; Hercbergs A, 1999, ANTICANCER RES, V19, P4839; Hercbergs AH, 2010, CURR OPIN ENDOCRINOL, V17, P432, DOI 10.1097/MED.0b013e32833d9710; HOFFMAN DA, 1984, JAMA-J AM MED ASSOC, V251, P616, DOI 10.1001/jama.251.5.616; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Iacobellis G, 2005, CLIN ENDOCRINOL, V62, P487, DOI 10.1111/j.1365-2265.2005.02247.x; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Inoue M, 2012, J EPIDEMIOL COMMUN H, V66, P448, DOI 10.1136/jech.2010.121830; Iqbal A, 2006, J INTERN MED, V260, P53, DOI 10.1111/j.1365-2796.2006.01652.x; KAPDI CC, 1976, JAMA-J AM MED ASSOC, V236, P1124, DOI 10.1001/jama.236.10.1124; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Lee ET, 1997, ANNU REV PUBL HEALTH, V18, P105, DOI 10.1146/annurev.publhealth.18.1.105; Lin WY, 2008, AM J CLIN NUTR, V87, P1204, DOI 10.1093/ajcn/87.5.1204; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; LOESER AA, 1954, BMJ-BRIT MED J, V2, P1380, DOI 10.1136/bmj.2.4901.1380; Luboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512; Metso S, 2007, J CLIN ENDOCR METAB, V92, P2190, DOI 10.1210/jc.2006-2321; Ministry of Health and Welfare, STAT POP AN; Nagasaki T, 2006, J CLIN ENDOCR METAB, V91, P154, DOI 10.1210/jc.2005-1342; Nelson M, 2006, ARCH OTOLARYNGOL, V132, P1041, DOI 10.1001/archotol.132.10.1041; Noto H, 2011, ENDOCR PRACT, V17, P616, DOI 10.4158/EP10357.RA; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Perova Natalia V., 1995, Annals of Epidemiology, V5, P179, DOI 10.1016/1047-2797(94)00104-2; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Razvi S, 2010, J CLIN PATHOL, V63, P379, DOI 10.1136/jcp.2008.057414; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Riesenbeck LM, 2011, WORLD J UROL, V29, P807, DOI 10.1007/s00345-010-0627-2; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; ROSENBERG AG, 1990, UROLOGY, V35, P492, DOI 10.1016/0090-4295(90)80101-R; Rywik SL, 1999, AM J CARDIOL, V84, P540, DOI 10.1016/S0002-9149(99)00374-4; Schmidinger M, 2011, CANCER-AM CANCER SOC, V117, P534, DOI 10.1002/cncr.25422; Stocks T, 2012, HYPERTENSION, V59, P802, DOI 10.1161/HYPERTENSIONAHA.111.189258; Thvilum M, 2012, NAT REV ENDOCRINOL, V8, P417, DOI 10.1038/nrendo.2012.29; Trivedy CR, 2002, ADDICT BIOL, V7, P115, DOI 10.1080/13556210120091482; Tseng FY, 2012, J AM COLL CARDIOL, V60, P730, DOI 10.1016/j.jacc.2012.03.047; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467; Waring AC, 2012, J CLIN ENDOCR METAB, V97, P862, DOI 10.1210/jc.2011-2684	60	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122955	10.1371/journal.pone.0122955	http://dx.doi.org/10.1371/journal.pone.0122955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830770	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600130
J	Winnier, DA; Fourcaudot, M; Norton, L; Abdul-Ghani, MA; Hu, SL; Farook, VS; Coletta, DK; Kumar, S; Puppala, S; Chittoor, G; Dyer, TD; Arya, R; Carless, M; Lehman, DM; Curran, JE; Cromack, DT; Tripathy, D; Blangero, J; Duggirala, R; Goring, HHH; DeFronzo, RA; Jenkinson, CP				Winnier, Deidre A.; Fourcaudot, Marcel; Norton, Luke; Abdul-Ghani, Muhammad A.; Hu, Shirley L.; Farook, Vidya S.; Coletta, Dawn K.; Kumar, Satish; Puppala, Sobha; Chittoor, Geetha; Dyer, Thomas D.; Arya, Rector; Carless, Melanie; Lehman, Donna M.; Curran, Joanne E.; Cromack, Douglas T.; Tripathy, Devjit; Blangero, John; Duggirala, Ravindranath; Goering, Harald H. H.; DeFronzo, Ralph A.; Jenkinson, Christopher P.			Transcriptomic Identification of ADH1B as a Novel Candidate Gene for Obesity and Insulin Resistance in Human Adipose Tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES)	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; ETHANOL-PRODUCTION; GLUCOSE-TOLERANCE; LINKAGE ANALYSIS; FAMILY-HISTORY; WHOLE-BLOOD; TYPE-2; ALCOHOL; EXPRESSION	Type 2 diabetes (T2D) is a complex metabolic disease that is more prevalent in ethnic groups such as Mexican Americans, and is strongly associated with the risk factors obesity and insulin resistance. The goal of this study was to perform whole genome gene expression profiling in adipose tissue to detect common patterns of gene regulation associated with obesity and insulin resistance. We used phenotypic and genotypic data from 308 Mexican American participants from the Veterans Administration Genetic Epidemiology Study (VAGES). Basal fasting RNA was extracted from adipose tissue biopsies from a subset of 75 unrelated individuals, and gene expression data generated on the Illumina BeadArray platform. The number of gene probes with significant expression above baseline was approximately 31,000. We performed multiple regression analysis of all probes with 15 metabolic traits. Adipose tissue had 3,012 genes significantly associated with the traits of interest (false discovery rate, FDR <= 0.05). The significance of gene expression changes was used to select 52 genes with significant (FDR <= 10(-4)) gene expression changes across multiple traits. Gene sets/Pathways analysis identified one gene, alcohol dehydrogenase 1B (ADH1B) that was significantly enriched (P < 10(-60)) as a prime candidate for involvement in multiple relevant metabolic pathways. Illumina BeadChip derived ADH1B expression data was consistent with quantitative real time PCR data. We observed significant inverse correlations with waist circumference (2.8 x 10(-9)), BMI (5.4 x 10(-6)), and fasting plasma insulin (P < 0.001). These findings are consistent with a central role for ADH1B in obesity and insulin resistance and provide evidence for a novel genetic regulatory mechanism for human metabolic diseases related to these traits.	[Winnier, Deidre A.; Fourcaudot, Marcel; Norton, Luke; Abdul-Ghani, Muhammad A.; Tripathy, Devjit; DeFronzo, Ralph A.; Jenkinson, Christopher P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA; [Hu, Shirley L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA; [Farook, Vidya S.; Kumar, Satish; Puppala, Sobha; Chittoor, Geetha; Dyer, Thomas D.; Carless, Melanie; Curran, Joanne E.; Blangero, John; Duggirala, Ravindranath; Goering, Harald H. H.; Jenkinson, Christopher P.] Texas Biomed Res Inst, San Antonio, TX USA; [Cromack, Douglas T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Orthoped, San Antonio, TX 78229 USA; [Arya, Rector] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Endocrinol & Diabet, San Antonio, TX 78229 USA; [Lehman, Donna M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Clin Epidemiol, San Antonio, TX 78229 USA; [Cromack, Douglas T.; Tripathy, Devjit; DeFronzo, Ralph A.; Jenkinson, Christopher P.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Coletta, Dawn K.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Arizona State University; Arizona State University-Tempe	Jenkinson, CP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA.	jenkinsonc@uthscsa.edu	Coletta, Dawn/G-6382-2016; Norton, Luke/F-6685-2015; Blangero, John/ABA-7175-2021	Norton, Luke/0000-0002-0231-5722; Curran, Joanne/0000-0002-6898-155X; tripathy, devjit/0000-0003-2797-0659; Blangero, John/0000-0001-6250-5723; Carless, Melanie/0000-0001-8350-2302; Coletta, Dawn/0000-0001-5819-5152	Veterans Administration: Merit Review Award [11487646]; Genetic Epidemiologic Grant; National Institutes of Health [DK79195, DK067690, DK53889, HD41111, DK70746, MH59490]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070746, R01DK067690, R01DK053889, R01DK079195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	Veterans Administration: Merit Review Award(US Department of Veterans Affairs); Genetic Epidemiologic Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by grants from the Veterans Administration: Merit Review Award 11487646 (CPJ) and Genetic Epidemiologic Grant (RAD) and the National Institutes of Health: DK79195 (CPJ), DK067690 (CPJ), DK53889 (RD), HD41111 (RD), DK70746 (DML) and MH59490 (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL DP, 1990, PHARMACOL THERAPEUT, V45, P69, DOI 10.1016/0163-7258(90)90008-P; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Antoshechkin AG, 2001, ALCOHOL ALCOHOLISM, V36, P608, DOI 10.1093/alcalc/36.6.608; Atwood LD, 2001, GENET EPIDEMIOL, V20, P373, DOI 10.1002/gepi.7; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bays HE, 2011, J AM COLL CARDIOL, V57, P2461, DOI 10.1016/j.jacc.2011.02.038; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Carrigan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041175; Centers_for_Disease_Control_and_Prevention, 2011, DIAB SUCC OPP POP BA; Civitarese AE, 2004, DIABETOLOGIA, V47, P816, DOI 10.1007/s00125-004-1359-x; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; Cope K, 2000, GASTROENTEROLOGY, V119, P1340, DOI 10.1053/gast.2000.19267; Crabb DW, 2011, ALCOHOL CLIN EXP RES, V35, P1584, DOI 10.1111/j.1530-0277.2011.01504.x; DeFronzo RA, 1997, DIABETES REV, V5, P177; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Farook VS, 2013, HUM HERED, V76, P36, DOI 10.1159/000354849; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; HARLAN LC, 1987, AM J EPIDEMIOL, V126, P674, DOI 10.1093/oxfordjournals.aje.a114707; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; JONES AW, 1983, J ANAL TOXICOL, V7, P193, DOI 10.1093/jat/7.4.193; Kashyap SR, 2004, AM J PHYSIOL-ENDOC M, V287, pE537, DOI 10.1152/ajpendo.00541.2003; Keller P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-7; Klein BEK, 1996, DIABETES CARE, V19, P827, DOI 10.2337/diacare.19.8.827; KREBS HA, 1970, BIOCHEM J, V118, P635, DOI 10.1042/bj1180635; Lands WEM, 1998, ALCOHOL, V15, P147, DOI 10.1016/S0741-8329(97)00110-9; Levey DJ, 2004, INTEGR COMP BIOL, V44, P284, DOI 10.1093/icb/44.4.284; Liangpunsakul S, 2010, ANN EPIDEMIOL, V20, P670, DOI 10.1016/j.annepidem.2010.05.014; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Mitterberger MC, 2013, J GERONTOL A-BIOL, V68, P1356, DOI 10.1093/gerona/glt019; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Nair S, 2001, AM J GASTROENTEROL, V96, P1200, DOI 10.1111/j.1572-0241.2001.03702.x; PHILLIPS M, 1988, ALCOHOL, V5, P263, DOI 10.1016/0741-8329(88)90062-6; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Shmulewitz D, 2006, P NATL ACAD SCI USA, V103, P3502, DOI 10.1073/pnas.0510156103; Sibov TT, 2012, CYTOTECHNOLOGY, V64, P511, DOI 10.1007/s10616-012-9428-3; Simic M, 2012, FORENSIC SCI INT, V216, P97, DOI 10.1016/j.forsciint.2011.09.003; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Snyder EE, 2004, OBES RES, V12, P369, DOI 10.1038/oby.2004.47; STERN MP, 1983, DIABETOLOGIA, V24, P272, DOI 10.1007/BF00282712; Thorisson GA, 2009, NUCLEIC ACIDS RES, V37, pD797, DOI 10.1093/nar/gkn748; Tillonen J, 2000, ETHANOL ACETALDEHYDE; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Watanabe RM, 2010, CURR DIABETES REP, V10, P476, DOI 10.1007/s11892-010-0143-1; Watanabe-Suzuki K, 1999, J CHROMATOGR B, V727, P89, DOI 10.1016/S0378-4347(99)00063-8; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yi ZP, 2008, J PROTEOME RES, V7, P3230, DOI 10.1021/pr800064s; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	68	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119941	10.1371/journal.pone.0119941	http://dx.doi.org/10.1371/journal.pone.0119941			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830378	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600017
J	Xu, H; Arnold, MG; Kumar, SV				Xu, Hao; Arnold, Matthew Grant; Kumar, Sushmitha Vijay			Differential Effects of Munc18s on Multiple Degranulation-Relevant Trans-SNARE Complexes	PLOS ONE			English	Article							MEMBRANE-FUSION; MAST-CELLS; COMPOUND EXOCYTOSIS; N-PEPTIDE; SYNTAXIN; RELEASE; IDENTIFICATION; SNAP-23; DOCKING; NSF	Mast cell exocytosis, which includes compound degranulation and vesicle-associated piecemeal degranulation, requires multiple Q-and R-SNAREs. It is not clear how these SNAREs pair to form functional trans-SNARE complexes and how these trans-SNARE complexes are selectively regulated for fusion. Here we undertake a comprehensive examination of the capacity of two Q-SNARE subcomplexes (syntaxin3/SNAP-23 and syntaxin4/SNAP-23) to form fusogenic trans-SNARE complexes with each of the four granule-borne R-SNAREs (VAMP2, 3, 7, 8). We report the identification of at least six distinct trans-SNARE complexes under enhanced tethering conditions: i) VAMP2/syntaxin3/SNAP-23, ii) VAMP2/syntaxin4/SNAP-23, iii) VAMP3/syntaxin3/SNAP-23, iv) VAMP3/syntaxin4/SNAP23, v) VAMP8/syntaxin3/SNAP-23, and vi) VAMP8/syntaxin4/SNAP-23. We show for the first time that Munc18a operates synergistically with SNAP-23-based non-neuronal SNARE complexes (i to iv) in lipid mixing, in contrast to Munc18b and c, which exhibit no positive effect on any SNARE combination tested. Pre-incubation with Munc18a renders the SNARE-dependent fusion reactions insensitive to the otherwise inhibitory R-SNARE cytoplasmic domains, suggesting a protective role of Munc18a for its cognate SNAREs. Our findings substantiate the recently discovered but unexpected requirement for Munc18a in mast cell exocytosis, and implicate post-translational modifications in Munc18b/c activation.	[Xu, Hao; Arnold, Matthew Grant; Kumar, Sushmitha Vijay] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Xu, H (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	hao.xu@usm.edu	Kumar, Sushmitha Vijaya/AAU-4235-2021; XU, HAO/B-3194-2011	XU, HAO/0000-0002-5776-0276	University of Southern Mississippi Development Grant [DE01475]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	University of Southern Mississippi Development Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HX received The University of Southern Mississippi (http://www.usm.edu/) Development Grant DE01475 for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; Burgo A, 2013, J BIOL CHEM, V288, P11960, DOI 10.1074/jbc.M112.415075; CHAKRAVARTY N, 1990, EXP CELL RES, V186, P245, DOI 10.1016/0014-4827(90)90302-Q; Crivellato E, 2010, ANAT REC, V293, P1115, DOI 10.1002/ar.21146; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Frank SPC, 2011, MOL IMMUNOL, V49, P353, DOI 10.1016/j.molimm.2011.09.011; Furukawa N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04277; Genc O, 2014, ELIFE, V3, DOI 10.7554/eLife.01715; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kioumourtzoglou D, 2014, MOL CELL BIOL, V34, P1271, DOI 10.1128/MCB.01203-13; KOOPMANN WR, 1990, BIOCHEM J, V265, P365, DOI 10.1042/bj2650365; Lippert U, 2007, FEBS LETT, V581, P3479, DOI 10.1016/j.febslet.2007.06.057; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Lorentz A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00143; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Munson Mary, 2009, Biochem J, V418, pe1, DOI 10.1042/BJ20082389; Park Y, 2014, J BIOL CHEM, V289, P16326, DOI 10.1074/jbc.M114.556803; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Peng RW, 2010, BIOCHEM J, V431, P353, DOI 10.1042/BJ20100145; Pernas-Sueiras O, 2006, J CELL BIOCHEM, V99, P1651, DOI 10.1002/jcb.21009; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Pombo I, 2003, FEBS LETT, V550, P144, DOI 10.1016/S0014-5793(03)00864-0; Puri N, 2003, J IMMUNOL, V171, P5345, DOI 10.4049/jimmunol.171.10.5345; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Sakiyama H, 2009, INFLAMM RES, V58, P139, DOI 10.1007/s00011-008-7173-z; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tadokoro S, 2007, MOL IMMUNOL, V44, P3427, DOI 10.1016/j.molimm.2007.02.013; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; THEOHARIDES TC, 1985, BIOCHEM PHARMACOL, V34, P1389, DOI 10.1016/0006-2952(85)90675-6; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Tiwari N, 2009, Inflamm Res, V58 Suppl 1, P13, DOI 10.1007/s00011-009-0645-y; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woodman PG, 1997, BBA-MOL CELL RES, V1357, P155, DOI 10.1016/S0167-4889(97)00039-6; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Yang Y, 2013, BIOCHEM J, V450, P537, DOI 10.1042/BJ20121256; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200	63	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138683	10.1371/journal.pone.0138683	http://dx.doi.org/10.1371/journal.pone.0138683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	25836258	Green Submitted, Green Published, gold			2022-12-27	WOS:000361790200147
J	Dabrowski, W; Kotlinska-Hasiec, E; Jaroszynski, A; Zadora, P; Pilat, J; Rzecki, Z; Zaluska, W; Schneditz, D				Dabrowski, Wojciech; Kotlinska-Hasiec, Edyta; Jaroszynski, Andrzej; Zadora, Przemyslaw; Pilat, Jacek; Rzecki, Ziemowit; Zaluska, Wojciech; Schneditz, Daniel			Intra-Abdominal Pressure Correlates with Extracellular Water Content	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; ABDOMINAL COMPARTMENT SYNDROME; HEMODIALYSIS-PATIENTS; CLINICAL-PRACTICE; SEPTIC PATIENTS; VOLUME STATUS; FLUID VOLUME; HYPERTENSION; INJURY; BIOIMPEDANCE	Background Secondary increase in intra-abdominal pressure (IAP) may result from extra-abdominal pathology, such as massive fluid resuscitation, capillary leak or sepsis. All these conditions increase the extravascular water content. The aim of this study was to analyze the relationship between IAP and body water volume. Material and Methods Adult patients treated for sepsis or septic shock with acute kidney injury (AKI) and patients undergoing elective pharyngolaryngeal or orthopedic surgery were enrolled. IAP was measured in the urinary bladder. Total body water (TBW), extracellular water content (ECW) and volume excess (VE) were measured by whole body bioimpedance. Among critically ill patients, all parameters were analyzed over three consecutive days, and parameters were evaluated perioperatively in surgical patients. Results One hundred twenty patients were studied. Taken together, the correlations between IAP and VE, TBW, and ECW were measured at 408 time points. In all participants, IAP strongly correlated with ECW and VE. In critically ill patients, IAP correlated with ECW and VE. In surgical patients, IAP correlated with ECW and TBW. IAP strongly correlated with ECW and VE in the mixed population. IAP also correlated with VE in critically ill patients. ROC curve analysis showed that ECW and VE might be discriminative parameters of risk for increased IAP. Conclusion IAP strongly correlates with ECW.	[Dabrowski, Wojciech; Kotlinska-Hasiec, Edyta; Zadora, Przemyslaw; Rzecki, Ziemowit] Med Univ Lublin, Dept Anesthesiol & Intens Therapy, Lublin, Poland; [Jaroszynski, Andrzej] Med Univ Lublin, Dept Family Med, Lublin, Poland; [Pilat, Jacek] Med Univ Lublin, Dept Gen Surg Transplantol & Clin Nutr, Lublin, Poland; [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland; [Schneditz, Daniel] Med Univ Graz, Dept Physiol, Graz, Austria	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Graz	Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anesthesiol & Intens Therapy, Lublin, Poland.	w.dabrowski5@yahoo.com	Dabrowski, Wojciech/AAN-8425-2020; Schneditz, Daniel/E-6580-2010	Dabrowski, Wojciech/0000-0003-0449-2375; Schneditz, Daniel/0000-0002-0124-1012; Jaroszynski, Andrzej/0000-0001-8194-1723	Medical University of Lublin, Poland	Medical University of Lublin, Poland	This study was supported by Medical University of Lublin, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SR, 2014, BLOOD PURIFICAT, V37, P48, DOI 10.1159/000356830; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; BONE RC, 1991, CRIT CARE MED, V19, P973, DOI 10.1097/00003246-199107000-00024; Chiara O, 2011, MINERVA ANESTESIOL, V77, P457; Cordemans C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S1; Dabrowski W, 2014, CLIN NEPHROL, V82, P41, DOI 10.5414/CN108015; De Keulenaer BL, 2011, INTENS CARE MED, V37, P1620, DOI 10.1007/s00134-011-2298-x; FLECK A, 1985, LANCET, V1, P781; Heering P, 1997, INTENS CARE MED, V23, P288, DOI 10.1007/s001340050330; Holodinsky JK, 2013, CRIT CARE, V17, DOI 10.1186/cc13075; Ishibe S, 2004, SEMIN DIALYSIS, V17, P37, DOI 10.1111/j.1525-139X.2004.17112.x; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Malbrain MLNG, 2014, ANAESTH INTENSIVE TH, V46, P381, DOI 10.5603/AIT.2014.0061; Malbrain MLNG, 2013, BEST PRACT RES-CLIN, V27, P249, DOI 10.1016/j.bpa.2013.06.009; Medrano G, 2010, ASAIO J, V56, P215, DOI 10.1097/MAT.0b013e3181d89160; Moore-Olufemi SD, 2005, SHOCK, V23, P571, DOI 10.1097/01.shk.0000161388.61935.e6; ORGAN LW, 1994, J APPL PHYSIOL, V77, P98, DOI 10.1152/jappl.1994.77.1.98; Plank LD, 2000, ANN NY ACAD SCI, V904, P592, DOI 10.1111/j.1749-6632.2000.tb06521.x; Regli A, 2012, CRIT CARE, V16, DOI 10.1186/cc11840; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Santa-Teresa P, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S3; Savalle M, 2012, AM J PHYSIOL-ENDOC M, V303, pE389, DOI 10.1152/ajpendo.00502.2011; Scollay JM, 2009, WORLD J SURG, V33, P2372, DOI 10.1007/s00268-009-0191-3; Wauters J, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/763181; Yashiro M, 2007, THER APHER DIAL, V11, P131, DOI 10.1111/j.1744-9987.2007.00471.x; Zaluska WT, 1998, ASAIO J, V44, P823, DOI 10.1097/00002480-199811000-00011; Zhang P, 2010, CYTOKINE, V50, P186, DOI 10.1016/j.cyto.2010.02.005; Zhao G, 2013, WORLD J GASTROENTERO, V19, P2044, DOI 10.3748/wjg.v19.i13.2044	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122193	10.1371/journal.pone.0122193	http://dx.doi.org/10.1371/journal.pone.0122193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849102	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800107
J	Fisher, M; Wayal, S; Smith, H; Llewellyn, C; Alexander, S; Ison, C; Parry, JV; Singleton, G; Perry, N; Richardson, D				Fisher, Martin; Wayal, Sonali; Smith, Helen; Llewellyn, Carrie; Alexander, Sarah; Ison, Catherine; Parry, John V.; Singleton, Garth; Perry, Nicky; Richardson, Daniel		Brighton Home Sampling Kit Project	Home Sampling for Sexually Transmitted Infections and HIV in Men Who Have Sex with Men: A Prospective Observational Study	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; PREVENTION; ACCEPTABILITY; KITS	To determine uptake of home sampling kit (HSK) for STI/HIV compared to clinic-based testing, whether the availability of HSK would increase STI testing rates amongst HIV infected MSM, and those attending a community-based HIV testing clinic compared to historical control. Prospective observational study in three facilities providing STI/HIV testing services in Brighton, UK was conducted. Adult MSM attending/contacting a GUM clinic requesting an STI screen (group 1), HIV infected MSM attending routine outpatient clinic (group 2), and MSM attending a community-based rapid HIV testing service (group 3) were eligible. Participants were required to have no symptomatology consistent with STI and known to be immune to hepatitis A and B (group 1). Eligible men were offered a HSK to obtain self-collected specimens as an alternative to routine testing. HSK uptake compared to conventional clinic based STI/HIV testing in group 1, increase in STI testing rates due to availability of HSK compared to historical controls in group 2 and 3, and HSK return rates in all settings were calculated. Among the 128 eligible men in group 1, HSK acceptance was higher (62.5% (95% CI: 53.5-70.9)) compared to GUM clinic-based testing (37.5% (95% CI: 29.1-46.5)), (p = 0.0004). Two thirds of eligible MSM offered an HSK in all three groups accepted it, but HSK return rates varied (highest in group 1, 77.5%, lowest in group 3, 16%). HSK for HIV testing was acceptable to 81% of men in group 1. Compared to historical controls, availability of HSK increased the proportion of MSM testing for STIs in group 2 but not in group 3. HSK for STI/HIV offers an alternative to conventional clinic-based testing for MSM seeking STI screening. It significantly increases STI testing uptake in HIV infected MSM. HSK could be considered as an adjunct to clinic-based services to further improve STI/HIV testing in MSM.	[Fisher, Martin; Perry, Nicky; Richardson, Daniel] Brighton & Sussex Univ Hosp NHS Trust, Dept Genitourinary HIV Med, Brighton, E Sussex, England; [Wayal, Sonali; Smith, Helen; Llewellyn, Carrie] Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Falmer, E Sussex, England; [Alexander, Sarah; Ison, Catherine; Parry, John V.] Sexually Transmitted Bacteria Reference Lab, Publ Hlth England, London, England; [Alexander, Sarah; Ison, Catherine; Parry, John V.] Virus Reference Dept, London, England; [Singleton, Garth] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England	Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Brighton; University of Sussex; Public Health England; University of Sussex	Fisher, M (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Dept Genitourinary HIV Med, Brighton, E Sussex, England.	martin.fisher@bsuh.nhs.uk	Smith, Helen E/M-2449-2016	Smith, Helen E/0000-0003-1883-6124; Wayal, Sonali/0000-0002-5878-7665; Llewellyn, Carrie/0000-0002-9107-8473	Medical Research Council (MRC) Sexual Health and HIV Research Strategy Committee, UK [G03000706]; MRC [G0300706] Funding Source: UKRI; Medical Research Council [G0300706] Funding Source: researchfish	Medical Research Council (MRC) Sexual Health and HIV Research Strategy Committee, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC) Sexual Health and HIV Research Strategy Committee, UK programme grant (G03000706) awarded to Fisher et al., http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaizu A, 2013, HIV UK 2013 REP DAT; Alexander S, 2008, SEX TRANSM INFECT, V84, P488, DOI 10.1136/sti.2008.031443; Andersen B, 1998, FAM PRACT, V15, P223, DOI 10.1093/fampra/15.3.223; [Anonymous], 2001, BETT PREV BETT SERV; [Anonymous], 2021, HIV TESTING NEW HIV; [Anonymous], TIM TEST HIV EXP HEA; [Anonymous], 2013, NAT CHLAM SCR PROGR; Bowen AM, 2008, J BEHAV MED, V31, P463, DOI 10.1007/s10865-008-9171-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; CONNELL JA, 1993, J MED VIROL, V41, P159, DOI 10.1002/jmv.1890410212; Elliot E, 2012, SEX TRANSM INFECT, V88, pA8, DOI 10.1136/sextrans-2012-050601a.20; Fakoya A, 2008, HIV MED, V9, P681, DOI 10.1111/j.1468-1293.2008.00634.x; House of Lords Select Committee on HIV and AIDs in the United Kingdom, 2011, NO VACC NO CUR HIV A; Llewellyn C, 2009, J HEALTH SERV RES PO, V14, P35, DOI 10.1258/jhsrp.2008.007065; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; Munro HL, 2008, SEX TRANSM INFECT, V84, P265, DOI 10.1136/sti.2007.025536; Sadiq ST, 2005, SEX TRANSM INFECT, V81, P120, DOI 10.1136/sti.2004.010249; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201; Wayal S, 2009, SEX TRANSM INFECT, V85, P60, DOI 10.1136/sti.2008.032193; Wayal S, 2008, GAY MENS SEXUAL HLTH; Wayal S, 2011, CULT HEALTH SEX, V13, P343, DOI 10.1080/13691058.2010.535018; Wood M, 2015, INT J STD AIDS, V26, P428, DOI 10.1177/0956462414539668	23	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120810	10.1371/journal.pone.0120810	http://dx.doi.org/10.1371/journal.pone.0120810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848769	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000352477800034
J	Kobashi, H; Kamiya, K; Ali, MA; Igarashi, A; Elewa, MEM; Shimizu, K				Kobashi, Hidenaga; Kamiya, Kazutaka; Ali, Mohamed A.; Igarashi, Akihito; Elewa, Mohamed Ehab M.; Shimizu, Kimiya			Comparison of Astigmatic Correction after Femtosecond Lenticule Extraction and Small-Incision Lenticule Extraction for Myopic Astigmatism	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; REFRACTIVE SURGERY; LASER; OUTCOMES; EFFICACY; EYE	Purpose To compare postoperative astigmatic correction between femtosecond lenticule extraction (FLEx) and small-incision lenticule extraction (SMILE) in eyes with myopic astigmatism. Methods We examined 26 eyes of 26 patients undergoing FLEx and 26 eyes of 26 patients undergoing SMILE to correct myopic astigmatism (manifest astigmatism of 1 diopter (D) or more). Visual acuity, cylindrical refraction, the predictability of the astigmatic correction, and the astigmatic vector components using Alpin's method, were compared between the two groups 3 months postoperatively. Results We found no statistically significant difference in manifest cylindrical refraction (p=0.74) or in the percentage of eyes within +/- 0.50 D of their refraction (p=0.47) after the two surgical procedures. Moreover, no statistically significant difference was detected between the groups in astigmatic vector components, namely, surgically induced astigmatism (0.80), target induced astigmatism (p=0.87), astigmatic correction index (p=0.77), angle of error (p=0.24), difference vector (p=0.76), index of success (p=0.91), flattening effect (p=0.79), and flattening index (p=0.84). Conclusions Both FLEx and SMILE procedures are essentially equivalent in correcting myopic astigmatism using vector analysis, suggesting that the lifting or non-lifting of the flap does not significantly affect astigmatic outcomes after these surgical procedures.	[Kobashi, Hidenaga; Kamiya, Kazutaka; Ali, Mohamed A.; Igarashi, Akihito; Shimizu, Kimiya] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan; [Ali, Mohamed A.; Elewa, Mohamed Ehab M.] Menia Univ, Fac Med, Dept Ophthalmol, Al Minya, Egypt	Kitasato University; Egyptian Knowledge Bank (EKB); Minia University	Kobashi, H (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan.	himon@hotmail.co.jp	Ahmed, Mohamed Attia Ali/AAK-2121-2020	Ahmed, Mohamed Attia Ali/0000-0003-2445-9783				Ali MA, 2014, J REFRACT SURG, V30, P806, DOI 10.3928/1081597X-20141113-03; Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Blum M, 2010, KLIN MONATSBL AUGENH, V227, P961, DOI 10.1055/s-0029-1245894; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Durrie DS, 2005, J CATARACT REFR SURG, V31, P120, DOI 10.1016/j.jcrs.2004.09.046; Ivarsen A, 2014, J REFRACT SURG, V30, P240, DOI 10.3928/1081597X-20140320-02; Kamiya K, 2014, AM J OPHTHALMOL, V157, P128, DOI 10.1016/j.ajo.2013.08.011; Kamiya K, 2012, J CATARACT REFR SURG, V38, P1996, DOI 10.1016/j.jcrs.2012.06.052; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Krueger RR, 1998, J REFRACT SURG, V14, P467; Kunert KS, 2013, J CATARACT REFR SURG, V39, P759, DOI 10.1016/j.jcrs.2012.11.033; Prakash G, 2011, J CATARACT REFR SURG, V37, P574, DOI 10.1016/j.jcrs.2010.11.025; Ratkay-Traub I, 2003, J REFRACT SURG, V19, P94; Sekundo W, 2008, J CATARACT REFR SURG, V34, P1513, DOI 10.1016/j.jcrs.2008.05.033; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Tanna M, 2009, J REFRACT SURG, V25, pS668, DOI 10.3928/1081597X-20090611-08	18	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123408	10.1371/journal.pone.0123408	http://dx.doi.org/10.1371/journal.pone.0123408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849381	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800231
J	Melton, JT; Leliaert, F; Tronholm, A; Lopez-Bautista, JM				Melton, James T., III; Leliaert, Frederik; Tronholm, Ana; Lopez-Bautista, Juan M.			The Complete Chloroplast and Mitochondrial Genomes of the Green Macroalga Ulva sp UNA00071828 (Ulvophyceae, Chlorophyta)	PLOS ONE			English	Article							ALGA OLTMANNSIELLOPSIS-VIRIDIS; DNA-SEQUENCE; PHYLOGENETIC ANALYSES; EVOLUTIONARY TRENDS; DIVERSITY; REVEALS; VIRIDIPLANTAE; ARCHITECTURE; ALIGNMENT; INSIGHTS	Sequencing mitochondrial and chloroplast genomes has become an integral part in understanding the genomic machinery and the phylogenetic histories of green algae. Previously, only three chloroplast genomes (Oltmannsiellopsis viridis, Pseudendoclonium akinetum, and Bryopsis hypnoides) and two mitochondrial genomes (O. viridis and P. akinetum) from the class Ulvophyceae have been published. Here, we present the first chloroplast and mitochondrial genomes from the ecologically and economically important marine, green algal genus Ulva. The chloroplast genome of Ulva sp. was 99,983 bp in a circular-mapping molecule that lacked inverted repeats, and thus far, was the smallest ulvophycean plastid genome. This cpDNA was a highly compact, AT-rich genome that contained a total of 102 identified genes (71 protein-coding genes, 28 tRNA genes, and three ribosomal RNA genes). Additionally, five introns were annotated in four genes: atpA (1), petB (1), psbB (2), and rrl (1). The circular-mapping mitochondrial genome of Ulva sp. was 73,493 bp and follows the expanded pattern also seen in other ulvophyceans and trebouxiophyceans. The Ulva sp. mtDNA contained 29 protein-coding genes, 25 tRNA genes, and two rRNA genes for a total of 56 identifiable genes. Ten introns were annotated in this mtDNA: cox1 (4), atp1 (1), nad3 (1), nad5 (1), and rrs (3). Double-cut-and-join (DCJ) values showed that organellar genomes across Chlorophyta are highly rearranged, in contrast to the highly conserved organellar genomes of the red algae (Rhodophyta). A phylogenomic investigation of 51 plastid protein-coding genes showed that Ulvophyceae is not monophyletic, and also placed Oltmannsiellopsis (Oltmannsiellopsidales) and Tetraselmis (Chlorodendrophyceae) closely to Ulva (Ulvales) and Pseudendoclonium (Ulothrichales).	[Melton, James T., III; Leliaert, Frederik; Tronholm, Ana; Lopez-Bautista, Juan M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Leliaert, Frederik] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Tronholm, Ana] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA	University of Alabama System; University of Alabama Tuscaloosa; Ghent University; Smithsonian Institution; Smithsonian National Museum of Natural History	Melton, JT (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	melto006@crimson.ua.edu	Leliaert, Frederik/A-9162-2009	Leliaert, Frederik/0000-0002-4627-7318; Tronholm, Ana/0000-0002-0151-2804	National Science Foundation under the ATOL Program [DEB 1036495, 0937978]; College of Arts and Sciences (CARSCA Program); Office for Research (Research Stimulation Program); Department of Biological Sciences	National Science Foundation under the ATOL Program; College of Arts and Sciences (CARSCA Program); Office for Research (Research Stimulation Program); Department of Biological Sciences	This study was funded by The National Science Foundation under the ATOL Program, through grants DEB 1036495 and 0937978 to JMLB. Additional support was provided by the College of Arts and Sciences (CARSCA Program) and the Office for Research (Research Stimulation Program) at UA to JMLB, and the Department of Biological Sciences (research and travel awards) to JTM.	Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Braga MDV, 2011, J COMPUT BIOL, V18, P1167, DOI 10.1089/cmb.2011.0118; Brouard JS, 2010, GENOME BIOL EVOL, V2, P240, DOI 10.1093/gbe/evq014; Burger G, 2012, ADV PHOTOSYNTHESIS R, V35, P125, DOI DOI 10.1007/S11120-013-9921-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; DePriest MS, 2014, BIOL BULL-US, V227, P191, DOI 10.1086/BBLv227n2p191; DePriest MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068246; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fucikova K, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00063; Guidone M, 2013, J PHYCOL, V49, P979, DOI 10.1111/jpy.12108; Guiry MD, 2014, ALGAEBASE; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Heesch S, 2009, EUR J PHYCOL, V44, P143, DOI 10.1080/09670260802422477; Hilker R, 2012, BIOINFORMATICS, V28, P2509, DOI 10.1093/bioinformatics/bts440; Hofmann LC, 2010, EUR J PHYCOL, V45, P230, DOI 10.1080/09670261003746201; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkendale L, 2013, J PHYCOL, V49, P69, DOI 10.1111/jpy.12016; Knoop V, 2012, GENOMICS CHLOROPLAST, V35, P175, DOI DOI 10.1007/978-94-007-2920-9_; Kraft LGK, 2010, J PHYCOL, V46, P1257, DOI 10.1111/j.1529-8817.2010.00909.x; Lang B.F., 2012, ADV PHOTOSYNTHESIS R, P59, DOI DOI 10.1007/S11120-013-9921-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; Lehman RL, 1997, J PHYCOL, V33, P1055, DOI 10.1111/j.0022-3646.1997.01055.x; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Lemieux C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-857; Lemieux C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0211-2; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Liu Y, 2012, GENOMICS CHLOROPLAST, P159, DOI [10.1007/s11120-013-9921-3, DOI 10.1007/S11120-013-9921-3]; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014663; MANHART JR, 1989, MOL GEN GENET, V216, P417, DOI 10.1007/BF00334385; Marin B, 2012, PROTIST, V163, P778, DOI 10.1016/j.protis.2011.11.004; Norris JN, 2010, MARINE ALGAE NO GULF, P31; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; PADMANABHAN U, 1978, BIOCHIM BIOPHYS ACTA, V521, P67, DOI 10.1016/0005-2787(78)90249-6; Pombert J-F, 2010, PLOS ONE, DOI [10.1371/journal.pone.0008954, DOI 10.1371/J0URNAL.P0NE.0008954]; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Rambaut A., 2007, TRACER V1 4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Servin-Garciduenas LE, 2012, EUKARYOT CELL, V11, P1417, DOI 10.1128/EC.00244-12; Skaloud P, 2013, POLAR BIOL, V36, P1281, DOI 10.1007/s00300-013-1347-z; Smith DR, 2008, MOL BIOL EVOL, V25, P487, DOI 10.1093/molbev/msm245; Smith DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023624; Smith DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-132; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turmel M, 2007, BMC GENOMICS, V12, P1; WOLFF G, 1994, J MOL BIOL, V237, P75, DOI 10.1006/jmbi.1994.1210; XU JN, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PONE.0037438; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-565; Zuccarello GC, 2009, J PHYCOL, V45, P1206, DOI 10.1111/j.1529-8817.2009.00731.x	67	53	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121020	10.1371/journal.pone.0121020	http://dx.doi.org/10.1371/journal.pone.0121020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849557	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800041
J	Wang, ZJ; Gong, HL; Zhang, J				Wang, Zhengjun; Gong, Huili; Zhang, Jing			Receding Water Line and Interspecific Competition Determines Plant Community Composition and Diversity in Wetlands in Beijing	PLOS ONE			English	Article							LONG-TERM; SUCCESSION PROCESS; SPECIES RICHNESS; RAIN-FORESTS; BIODIVERSITY; LITTER; REGENERATION; RESTORATION; GRASSLAND; DYNAMICS	Climate and human-induced wetland degradation has accelerated in recent years, not only resulting in reduced ecosystem services but also greatly affecting the composition and diversity of wetland plant communities. To date, the knowledge of the differences in community parameters and their successional trends in degraded wetlands remains scarce. Here based on remote sensing images, geographic information system technology, and statistical methods, we produced a successional gradient map of the Yeyahu Wetland Nature Reserve in Beijing, which has experienced a steady decline in water level in recent decades. In addition, we analyzed community composition and diversity along with each identified gradient. The results showed that community diversity decreases while dominance increases with the progress of succession, with the highest diversity occurring during the early stage of succession. Moreover, the community demonstrates greater similarity among subareas during later successional stages, and the similarity coefficients calculated from the important value (IV) of each species are more accurate. Correlation analysis showed that the impact of soil factors on diversity was not significant at a subarea scale, although these nutrients showed an increasing trend with the community succession. Furthermore, the IVs of the dominant species had a particularly significant impact on diversity, showing a significantly negative correlation with diversity indices and a significantly positive correlation with dominance indices. Further analysis showed that the retreat of water level resulted from sustained drought and local human activities was a major extrinsic driving force resulting in observed differences in the community successional stages, which resulted in differences in community composition and diversity. On the other hand, interspecific competition was the main intrinsic mechanism, which significantly influenced the IVs of the dominant species and community diversity. The results of this study could aid in improving the understanding of community composition, diversity, and its successional trends in degraded wetlands.	[Wang, Zhengjun; Zhang, Jing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Gong, Huili] Capital Normal Univ, Coll Resources Environm & Tourism, Beijing, Peoples R China	Capital Normal University; Capital Normal University	Gong, HL (corresponding author), Capital Normal Univ, Coll Resources Environm & Tourism, Beijing, Peoples R China.	bjcnu@126.com		Gong, Huili/0000-0001-8691-0264	National Natural Science Foundation of China [01111210010046, 0111121010076]; International Science & Technology Cooperation Program of China [2010DFA92400]; Beijing Educational Committee [KM200810028014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Beijing Educational Committee	This research was financially supported by grants from the National Natural Science Foundation of China (01111210010046 and 0111121010076, HG received the funding, and the website of funder is: http://www.nsfc.gov.cn/), the International Science & Technology Cooperation Program of China (2010DFA92400, HG received the funding, and the website of funder is: http://www.most.gov.cn/) and the Beijing Educational Committee (KM200810028014, ZW received the funding, and the website of funder is: http://www.bjedu.gov.cn/publish/portal0/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez-Oreja JA, 2010, BIODIVERS CONSERV, V19, P1417, DOI 10.1007/s10531-009-9770-8; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2012, ACTA OECOL, V45, P8, DOI 10.1016/j.actao.2012.08.002; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Chazdon RL, 1998, MAN BIOSPH, V20, P285; [陈利云 Chen Liyun], 2014, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V28, P148; Chen Y.Y., 2003, WETLAND SCI, V1, P7, DOI DOI 10.13248/J.CNKI.WETLANDSCI.2003.01.003; CLIFFORD H T, 1975, P229; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; [崔丽娟 Cui Lijuan], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P1749; Czerepko J, 2008, FOREST ECOL MANAG, V255, P630, DOI 10.1016/j.foreco.2007.09.039; Ding Y, 2012, BIOL CONSERV, V145, P225, DOI 10.1016/j.biocon.2011.11.009; Dole-Olivier MJ, 2009, FRESHWATER BIOL, V54, P777, DOI 10.1111/j.1365-2427.2008.02133.x; FACELLI JM, 1993, OECOLOGIA, V95, P277, DOI 10.1007/BF00323500; Foster BL, 2000, PLANT ECOL, V146, P1, DOI 10.1023/A:1009895103017; Gao D, 2009, J CAPITAL NORMAL U N, V30, P34; Gimaret-Carpentier C, 1998, J VEG SCI, V9, P161, DOI 10.2307/3237115; Goldblum D, 1999, J TORREY BOT SOC, V126, P335, DOI 10.2307/2997317; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; Gong ZN, 2007, ECOLOGICAL EVOLUTION; Guan X, 2007, J CAPITAL NORMAL U N, V28, P44; Hartter J, 2009, LANDSCAPE ECOL, V24, P643, DOI 10.1007/s10980-009-9339-7; Hovstad KA, 2008, PLANT ECOL, V196, P251, DOI 10.1007/s11258-007-9349-y; Hu HX, 2004, FOREST HUMANKIND, V7, P22; [胡振鹏 Hu Zhenpeng], 2010, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V19, P597; Jing ZB, 2013, ECOL ENG, V57, P162, DOI 10.1016/j.ecoleng.2013.04.035; KENKEL NC, 1991, J VEG SCI, V2, P539, DOI 10.2307/3236036; Krebs CJ, 1999, ECOLOGICAL METHODOLO, P377; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Lande R, 2000, OIKOS, V89, P601, DOI 10.1034/j.1600-0706.2000.890320.x; LEPS J, 1988, FOLIA GEOBOT PHYTOTX, V23, P79, DOI 10.1007/BF02853297; [廖玉静 LIAO Yu-jing], 2009, [土壤通报, Journal of Soil Science], V40, P1199; Lu BM, 2010, J BEIJING FORESTRY U, V32, P36; Luan SS, 2010, J CAPITAL NORMAL U N, V31, P39; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Matuszkiewicz JM, 2013, FOREST ECOL MANAG, V310, P567, DOI 10.1016/j.foreco.2013.08.060; PAPANASTASIS VP, 1977, J RANGE MANAGE, V30, P446, DOI 10.2307/3897808; PIELOU E C, 1969, P286; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; [秦伟 QIN Wei], 2008, [干旱区研究, Arid Zone Research], V25, P507; SALE PF, 1974, OECOLOGIA, V17, P245, DOI 10.1007/BF00344924; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; [邵新庆 SHAO XinQing], 2008, [生态学报, Acta Ecologica Sinica], V28, P855; [沈蕊 Shen Rui], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P2821; Siles G, 2008, J APPL ECOL, V45, P1790, DOI 10.1111/j.1365-2664.2008.01574.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Tang CQ, 2013, FOREST ECOL MANAG, V294, P188, DOI 10.1016/j.foreco.2012.07.019; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; Wang B, 1987, PHYTOCOENOLOGY; [王慧亮 Wang Huiliang], 2010, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V19, P653; Wang Shi-xiong, 2013, Shengtaixue Zazhi, V32, P1135; [王颖 Wang Ying], 2005, [地理学报, Acta Geographica Sinica], V60, P656; Wang Zhouping, 2003, Yingyong Shengtai Xuebao, V14, P7; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; WILLIAMSLINERA G, 1990, J ECOL, V78, P356, DOI 10.2307/2261117; WOLDA H, 1983, OECOLOGIA, V58, P290, DOI 10.1007/BF00385226; Xiong ZB, 2010, GUIZHOU SCI, V28, P60; Ye D, 2006, SCI TECHNOLOGY ENG, V6, P2858; Ye D, 2006, SCI TECHNOLOGY ENG, V6, P2867; Zhang YB, 2011, FOREST ECOL MANAG, V262, P361, DOI 10.1016/j.foreco.2011.03.042; [张志鹏 Zhang Zhipeng], 2013, [灌溉排水学报, Journal of Irrigation and Drainage], V32, P46; [左小安 ZUO Xiao-an], 2009, [草业学报, Acta Prataculturae Sinica], V18, P9	65	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124156	10.1371/journal.pone.0124156	http://dx.doi.org/10.1371/journal.pone.0124156			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848799	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800262
J	Amissah, L; Mohren, GMJ; Kyereh, B; Poorter, L				Amissah, Lucy; Mohren, Godefridus M. J.; Kyereh, Boateng; Poorter, Lourens			The Effects of Drought and Shade on the Performance, Morphology and Physiology of Ghanaian Tree Species	PLOS ONE			English	Article							WATER RELATIONS; SEEDLING ESTABLISHMENT; DESICCATION-TOLERANCE; TRADE-OFFS; PHOTOSYNTHETIC ACCLIMATION; RELATIVE IMPORTANCE; BIOMASS ALLOCATION; ROOT MORPHOLOGY; LIGHT GRADIENT; CARBON BALANCE	In tropical forests light and water availability are the most important factors for seedling growth and survival but an increasing frequency of drought may affect tree regeneration. One central question is whether drought and shade have interactive effects on seedling growth and survival. Here, we present results of a greenhouse experiment, in which seedlings of 10 Ghanaian tree species were exposed to combinations of strong seasonal drought (continuous watering versus withholding water for nine weeks) and shade (5% irradiance versus 20% irradiance). We evaluated the effects of drought and shade on seedling survival and growth and plasticity of 11 underlying traits related to biomass allocation, morphology and physiology. Seedling survival under dry conditions was higher in shade than in high light, thus providing support for the "facilitation hypothesis" that shade enhances plant performance through improved microclimatic conditions, and rejecting the trade-off hypothesis that drought should have stronger impact in shade because of reduced root investment. Shaded plants had low biomass fraction in roots, in line with the trade-off hypothesis, but they compensated for this with a higher specific root length (i.e., root length per unit root mass), resulting in a similar root length per plant mass and, hence, similar water uptake capacity as high-light plants. The majority (60%) of traits studied responded independently to drought and shade, indicating that within species shade-and drought tolerances are not in trade-off, but largely uncoupled. When individual species responses were analysed, then for most of the traits only one to three species showed significant interactive effects between drought and shade. The uncoupled response of most species to drought and shade should provide ample opportunity for niche differentiation and species coexistence under a range of water and light conditions. Overall our greenhouse results suggest that, in the absence of root competition shaded tropical forest tree seedlings may be able to survive prolonged drought.	[Amissah, Lucy] KNUST, Council Sci & Ind Research, Forestry Res Inst Ghana, Kumasi, Ghana; [Amissah, Lucy; Mohren, Godefridus M. J.] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AP Wageningen, Netherlands; [Kyereh, Boateng; Poorter, Lourens] Kwame Nkrumah Univ Sci & Technol, Coll Agr & Nat Resources, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Wageningen University & Research; Kwame Nkrumah University Science & Technology	Amissah, L (corresponding author), KNUST, Council Sci & Ind Research, Forestry Res Inst Ghana, Kumasi, Ghana.	ewurakua.amissah@gmail.com	Poorter, Lourens/AAL-1709-2021; Mohren, Godefridus M.J./C-5608-2015	Mohren, Godefridus M.J./0000-0002-7004-4602; Poorter, Lourens/0000-0003-1391-4875	Netherlands Fellowship Programme (NFP) [CF7428/2011]; Wageningen University Sandwich Fellowship; Council for Scientific and Industrial Research-Forestry Research Institute of Ghana	Netherlands Fellowship Programme (NFP); Wageningen University Sandwich Fellowship; Council for Scientific and Industrial Research-Forestry Research Institute of Ghana	LA was supported by the Netherlands Fellowship Programme (NFP); grant number CF7428/2011 (http://www.nuffic.nl/en/scholarships/netherlands-fellowship-programmes-nfp), Wageningen University Sandwich Fellowship (http://www.wageningenur.nl/en/wageningen-university.htm) and the Council for Scientific and Industrial Research-Forestry Research Institute of Ghana (www.csir-forig.org.gh). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agyeman VK, 1999, J ECOL, V87, P815, DOI 10.1046/j.1365-2745.1999.00400.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Amissah L, 2014, J TROP ECOL, V30, P435, DOI 10.1017/S026646741400025X; Apetorgbor MM, 2007, PROTA, V1, P704; Aranda I, 2005, FOREST ECOL MANAG, V210, P117, DOI 10.1016/j.foreco.2005.02.012; Baltzer JL, 2008, FUNCT ECOL, V22, P221, DOI 10.1111/j.1365-2435.2007.01374.x; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Brodribb TJ, 2014, P NATL ACAD SCI USA, V111, P14489, DOI 10.1073/pnas.1407930111; BROUWER R., 1963, Jaarboek. Instituut voor biologisch en scheikundig Onderzoek van Landbouwgewassen 1963, P31; Burslem DFRP, 1996, MAN BIOSPHERE SERIES, V17; Cao KF, 2000, J TROP ECOL, V16, P101, DOI 10.1017/S0266467400001292; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Cheng HY, 2008, J INTEGR PLANT BIOL, V50, P1549, DOI 10.1111/j.1744-7909.2008.00723.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Condit R, 1998, CLIMATIC CHANGE, V39, P413, DOI 10.1023/A:1005395806800; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; De Smedt S, 2012, THESIS U ANTWERPEN B; Deines JM, 2011, AUST J BOT, V59, P620, DOI 10.1071/BT10321; DEKA RN, 1995, EUR J SOIL SCI, V46, P233, DOI 10.1111/j.1365-2389.1995.tb01831.x; Duclos V, 2013, BIOTROPICA, V45, P419, DOI 10.1111/btp.12039; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; FISHER BL, 1991, OECOLOGIA, V86, P292, DOI 10.1007/BF00317543; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Gommers CMM, 2013, TRENDS PLANT SCI, V18, P65, DOI 10.1016/j.tplants.2012.09.008; Gyakari, 2006, PHOTO GUIDE FOREST T; Hall J.B., 1981, DISTRIBUTION ECOLOGY, DOI 10.1007/978-94-009-8650-3; Hawthorne W. D., 1995, Tropical Forestry Papers; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Hoffmann WA, 2002, ANN BOT-LONDON, V90, P37, DOI 10.1093/aob/mcf140; Holmgren M, 2000, PLANT ECOL, V147, P49, DOI 10.1023/A:1009804726307; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Jiofack Tafokou R. B., 2008, PROTA; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Kyereh B, 1994, THESIS U ABERDEEN; Lemmens RHMJ, 2007, PROTA, P704; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Marod D, 2002, PLANT ECOL, V161, P41, DOI 10.1023/A:1020372401313; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; MORENO JM, 1992, OECOLOGIA, V90, P50, DOI 10.1007/BF00317808; Nepstad D., 2004, Global Change Biology, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; NEWMAN EI, 1966, J APPL ECOL, V3, P139, DOI 10.2307/2401670; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Owusu FW, 2008, PROTA, V1, P704; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Poorter L, 2000, J TROP ECOL, V16, P481, DOI 10.1017/S026646740000153X; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; Poorter Lourens, 2005, P35, DOI 10.1017/CBO9780511541971.003; Quero JL, 2008, FUNCT PLANT BIOL, V35, P725, DOI 10.1071/FP08149; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Sack L, 2004, OIKOS, V107, P110, DOI 10.1111/j.0030-1299.2004.13184.x; Sack L, 2003, PLANT ECOL, V168, P139, DOI 10.1023/A:1024423820136; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; Saldana A, 2005, Oecologia, V145, P252, DOI 10.1007/s00442-005-0116-2; Sanchez-Gomez D, 2006, NEW PHYTOL, V170, P795, DOI 10.1111/j.1469-8137.2006.01711.x; Sanchez-Gomez D, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008040; Schiotz M, 2006, FOREST ECOL MANAG, V225, P306, DOI 10.1016/j.foreco.2006.01.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; SIMS DA, 1994, PLANT CELL ENVIRON, V17, P881, DOI 10.1111/j.1365-3040.1994.tb00317.x; Slot M, 2007, BIOTROPICA, V39, P683, DOI 10.1111/j.1744-7429.2007.00328.x; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; Sterck F, 2014, ECOLOGY, V95, P2514, DOI 10.1890/13-2377.1; Sterck F, 2011, TREE PHYSIOL, V31, P1024, DOI 10.1093/treephys/tpr065; Tchinda A.T., 2008, PROTA 7 1 TIMBERS BO; THOMAS CM, 1989, OECOLOGIA, V80, P309, DOI 10.1007/BF00379032; Tyree MT, 2002, J EXP BOT, V53, P2239, DOI 10.1093/jxb/erf078; Tyree MT, 2003, PLANT PHYSIOL, V132, P1439, DOI 10.1104/pp.102.018937; TYREE MT, 1972, J EXP BOT, V23, P267, DOI 10.1093/jxb/23.1.267; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Valladares F, 2003, PROG BOT, V64, P439; Valladares F, 2002, PLANT CELL ENVIRON, V25, P749, DOI 10.1046/j.1365-3040.2002.00856.x; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Veenendaal EM, 1996, J ECOL, V84, P83, DOI 10.2307/2261702; Walters MB, 1999, NEW PHYTOL, V143, P143, DOI 10.1046/j.1469-8137.1999.00425.x; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; WRIGHT SJ, 1992, OECOLOGIA, V89, P457, DOI 10.1007/BF00317149	85	26	28	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121004	10.1371/journal.pone.0121004	http://dx.doi.org/10.1371/journal.pone.0121004			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836337	gold, Green Submitted, Green Published			2022-12-27	WOS:000352139000036
J	Matsuo, J; Kamio, Y; Takahashi, H; Ota, M; Teraishi, T; Hori, H; Nagashima, A; Takei, R; Higuchi, T; Motohashi, N; Kunugi, H				Matsuo, Junko; Kamio, Yoko; Takahashi, Hidetoshi; Ota, Miho; Teraishi, Toshiya; Hori, Hiroaki; Nagashima, Anna; Takei, Reiko; Higuchi, Teruhiko; Motohashi, Nobutaka; Kunugi, Hiroshi			Autistic-Like Traits in Adult Patients with Mood Disorders and Schizophrenia	PLOS ONE			English	Article							SOCIAL RESPONSIVENESS SCALE; SPECTRUM; CHILDREN; ANXIETY; POPULATIONS; PREVALENCE; PSYCHOSIS; MINI	Autism spectrum disorder often co-occurs with other psychiatric disorders. Although a high prevalence of autistic-like traits/symptoms has been identified in the pediatric psychiatric population of normal intelligence, there are no reports from adult psychiatric population. This study examined whether there is a greater prevalence of autistic-like traits/symptoms in patients with adult-onset psychiatric disorders such as major depressive disorder (MDD), bipolar disorder, or schizophrenia, and whether such an association is independent of symptom severity. The subjects were 290 adults of normal intelligence between 25 and 59 years of age (MDD, n=125; bipolar disorder, n=56; schizophrenia, n=44; healthy controls, n=65). Autistic-like traits/symptoms were measured using the Social Responsiveness Scale for Adults. Symptom severity was measured using the Positive and Negative Symptoms Scale, the Hamilton Depression Rating Scale, and/or the Young Mania Rating Scale. Almost half of the clinical subjects, except those with remitted MDD, exhibited autistic-like traits/symptoms at levels typical for sub-threshold or threshold autism spectrum disorder. Furthermore, the proportion of psychiatric patients that demonstrated high autistic-like traits/symptoms was significantly greater than that of healthy controls, and not different between that of remitted or unremitted subjects with bipolar disorder or schizophrenia. On the other hand, remitted subjects with MDD did not differ from healthy controls with regard to the prevalence or degree of high autistic-like traits/symptoms. A substantial proportion of adults with bipolar disorder and schizophrenia showed high autistic-like traits/symptoms independent of symptom severity, suggesting a shared pathophysiology among autism spectrum disorder and these psychiatric disorders. Conversely, autistic-like traits among subjects with MDD were associated with the depressive symptom severity. These findings suggest the importance of evaluating autistic-like traits/symptoms underlying adult-onset psychiatric disorders for the best-suited treatment. Further studies with a prospective design and larger samples are needed.	[Matsuo, Junko; Ota, Miho; Teraishi, Toshiya; Hori, Hiroaki; Nagashima, Anna; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1870031, Japan; [Kamio, Yoko; Takahashi, Hidetoshi; Takei, Reiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, Kodaira, Tokyo, Japan; [Hori, Hiroaki] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Kodaira, Tokyo, Japan; [Higuchi, Teruhiko] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Matsuo, Junko; Motohashi, Nobutaka; Kunugi, Hiroshi] Univ Yamanashi, Dept Neuropsychiat, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; University of Yamanashi	Kunugi, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1870031, Japan.	hkunugi@ncnp.go.jp	Kunugi, Hiroshi/ABC-5260-2021	Hori, Hiroaki/0000-0002-4548-7110; Kunugi, Hiroshi/0000-0002-7209-3790	Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry [21-9, 23-25, 24-11]; Health and Labor Sciences Research Grants [H20-KOKORO-004, H22-seisin-ippan-001]	Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry; Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Intramural Research Grant (21-9, 23-25, 24-11) for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry, and the Health and Labor Sciences Research Grants (H20-KOKORO-004, H22-seisin-ippan-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DSM 5 DIAGN STAT MAN, V5th; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; [Anonymous], 2000, DSM 4 TR DIAGN STAT; Bolte S, 2012, J AUTISM DEV DISORD, V42, P1998, DOI 10.1007/s10803-011-1424-5; Chung YS, 2014, SCHIZOPHRENIA BULL, V40, P602, DOI 10.1093/schbul/sbt048; Cochran DM, 2013, CHILD ADOL PSYCH CL, V22, P609, DOI 10.1016/j.chc.2013.04.005; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Constantino JN., 2012, SRS2 SOCIAL RESPONSI, V2nd ed; Constantino JN, 2005, SOCIAL REPONSIVENESS; de Lacy N, 2013, ANNU REV CLIN PSYCHO, V9, P555, DOI 10.1146/annurev-clinpsy-050212-185627; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Howlin P, 2013, J AM ACAD CHILD PSY, V52, P572, DOI 10.1016/j.jaac.2013.02.017; Howlin P, 2012, CAN J PSYCHIAT, V57, P275, DOI 10.1177/070674371205700502; Kaat AJ, 2013, J ABNORM CHILD PSYCH, V41, P959, DOI 10.1007/s10802-013-9739-7; Kamio Y, 2013, ACTA PSYCHIAT SCAND, V128, P45, DOI 10.1111/acps.12034; Kamio Y, 2013, ANN RES REPORT DEV G, P45; Kamio Y, 2009, J JAPANESE ASS PSYCH, V28, P14; Kamio Yoko, 2013, Seishin Shinkeigaku Zasshi, V115, P601; Kamio Y, 2013, AUTISM, V17, P15, DOI 10.1177/1362361312436848; Kanne SM, 2009, J AUTISM DEV DISORD, V39, P827, DOI 10.1007/s10803-008-0688-x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kunihira Y, 2006, J AUTISM DEV DISORD, V36, P553, DOI 10.1007/s10803-006-0094-1; Mazefsky CA, 2012, J CLIN CHILD ADOLESC, V41, P516, DOI 10.1080/15374416.2012.686102; Moricke E, 2010, EUR CHILD ADOLES PSY, V19, P659, DOI 10.1007/s00787-010-0103-y; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Pine DS, 2008, J AM ACAD CHILD PSY, V47, P652, DOI 10.1097/CHI.0b013e31816bffa5; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stewart ME, 2006, AUTISM, V10, P103, DOI 10.1177/1362361306062013; Takei R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0302-z; Tohen M, 2009, BIPOLAR DISORD, V11, P453, DOI 10.1111/j.1399-5618.2009.00726.x; Towbin KE, 2005, J CHILD ADOL PSYCHOP, V15, P452, DOI 10.1089/cap.2005.15.452; Vannucchi G, 2014, J AFFECT DISORDERS, V168, P151, DOI 10.1016/j.jad.2014.06.042; Wechsler D., 1997, WECHSLER ADULT INTEL; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	40	43	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122711	10.1371/journal.pone.0122711	http://dx.doi.org/10.1371/journal.pone.0122711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25838109	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000108
J	Menzel, C; Hayn-Leichsenring, GU; Langner, O; Wiese, H; Redies, C				Menzel, Claudia; Hayn-Leichsenring, Gregor U.; Langner, Oliver; Wiese, Holger; Redies, Christoph			Fourier Power Spectrum Characteristics of Face Photographs: Attractiveness Perception Depends on Low-Level Image Properties	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; SPATIAL-FREQUENCY; VISUAL-PERCEPTION; COLOR HOMOGENEITY; NATURAL IMAGES; AGE; BEAUTY; STATISTICS; HEALTH; EYE	We investigated whether low-level processed image properties that are shared by natural scenes and artworks - but not veridical face photographs - affect the perception of facial attractiveness and age. Specifically, we considered the slope of the radially averaged Fourier power spectrum in a log-log plot. This slope is a measure of the distribution of special frequency power in an image. Images of natural scenes and artworks possess - compared to face images - a relatively shallow slope (i.e., increased high spatial frequency power). Since aesthetic perception might be based on the efficient processing of images with natural scene statistics, we assumed that the perception of facial attractiveness might also be affected by these properties. We calculated Fourier slope and other beauty-associated measurements in face images and correlated them with ratings of attractiveness and age of the depicted persons (Study 1). We found that Fourier slope - in contrast to the other tested image properties - did not predict attractiveness ratings when we controlled for age. In Study 2A, we overlaid face images with random-phase patterns with different statistics. Patterns with a slope similar to those in natural scenes and artworks resulted in lower attractiveness and higher age ratings. In Studies 2B and 2C, we directly manipulated the Fourier slope of face images and found that images with shallower slopes were rated as more attractive. Additionally, attractiveness of unaltered faces was affected by the Fourier slope of a random-phase background (Study 3). Faces in front of backgrounds with statistics similar to natural scenes and faces were rated as more attractive. We conclude that facial attractiveness ratings are affected by specific image properties. An explanation might be the efficient coding hypothesis.	[Menzel, Claudia; Hayn-Leichsenring, Gregor U.; Langner, Oliver; Wiese, Holger; Redies, Christoph] Univ Jena, Person Percept Res Unit, Jena, Germany; [Menzel, Claudia; Hayn-Leichsenring, Gregor U.; Redies, Christoph] Univ Jena, Jena Univ Hosp, Inst Anat 1, Expt Aesthet Grp, Jena, Germany; [Langner, Oliver] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Wiese, Holger] Univ Durham, Dept Psychol, Durham DH1 3LE, England	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Lubeck; Durham University	Hayn-Leichsenring, GU (corresponding author), Univ Jena, Person Percept Res Unit, Jena, Germany.	gregorhaynleichsenring@googlemail.com	Wiese, Holger/M-5281-2014; Menzel, Claudia/AAE-8084-2020	Wiese, Holger/0000-0003-4928-0771; Menzel, Claudia/0000-0003-1156-5392	German Research Council [RE616/7-1]	German Research Council(German Research Foundation (DFG))	This work has been funded by the German Research Council, grant number RE616/7-1 (to CR and GUHL); www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2010, SPAN J PSYCHOL, V13, P525, DOI 10.1017/S1138741600002225; Albert AM, 2007, FORENSIC SCI INT, V172, P1, DOI 10.1016/j.forsciint.2007.03.015; Amirshahi SA, 2012, P SPIE HUMAN VISION, V8291; Arce-Lopera C, 2013, SKIN RES TECHNOL, V19, pE273, DOI 10.1111/j.1600-0846.2012.00638.x; Baudouin JY, 2004, ACTA PSYCHOL, V117, P313, DOI 10.1016/j.actpsy.2004.07.002; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Blickhan M, 2011, BIOL PSYCHOL, V88, P204, DOI 10.1016/j.biopsycho.2011.08.003; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Braun J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00808; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Chase C, 2009, OPTOMETRY VISION SCI, V86, P883, DOI 10.1097/OPX.0b013e3181ae1b7c; Cheung OS, 2008, J EXP PSYCHOL HUMAN, V34, P1327, DOI 10.1037/a0011752; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Dakin S., 2009, J VISION, V9; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; de Tommaso M, 2008, CONSCIOUS COGN, V17, P1152, DOI 10.1016/j.concog.2008.07.002; Dixson BJ, 2013, EVOL HUM BEHAV, V34, P236, DOI 10.1016/j.evolhumbehav.2013.02.003; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Ebner NC, 2008, BEHAV RES METHODS, V40, P130, DOI [10.3758/BRM.40.1.130, 10.3738/BRM.40.1.130]; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Fechner G.T., 1876, VORSCHULE STHETIK; Fernandez D, 2008, PERCEPTION, V37, P1098, DOI 10.1068/p5814; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2012, J EUR ACAD DERMATOL, V26, P1486, DOI 10.1111/j.1468-3083.2011.04316.x; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Foos PW, 2011, J GENET PSYCHOL, V172, P162, DOI 10.1080/00221325.2010.526154; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Goffaux V, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00143; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2008, SPATIAL VISION, V21, P149, DOI 10.1163/156856808782713771; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; HENSS R, 1991, J APPL SOC PSYCHOL, V21, P933, DOI 10.1111/j.1559-1816.1991.tb00451.x; Honekopp J, 2006, J EXP PSYCHOL HUMAN, V32, P199, DOI 10.1037/0096-1523.32.2.199; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Juricevic I, 2010, PERCEPTION, V39, P884, DOI 10.1068/p6656; Keil MS, 2008, P ROY SOC B-BIOL SCI, V275, P2095, DOI 10.1098/rspb.2008.0486; Koch M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012268; KORTHASE KM, 1982, PERCEPT MOTOR SKILL, V54, P1251, DOI 10.2466/pms.1982.54.3c.1251; Kwart DG, 2012, PERCEPTION, V41, P925, DOI 10.1068/p7136; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Little A, 2002, PSYCHOLOGIST, V15, P28; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; McKimmie B, 2002, A FACE ACAD FACIAL A; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nadal M., 2007, THESIS U ILLES BALEA; Neave N, 2008, PERS INDIV DIFFER, V45, P373, DOI 10.1016/j.paid.2008.05.007; O'Hare L, 2013, J VISION, V13, DOI 10.1167/13.5.7; O'Hare L, 2011, VISION RES, V51, P1767, DOI 10.1016/j.visres.2011.06.002; Pachai MV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00074; Parraga CA, CURRENT BIOL, V10, P35; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Porcheron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057985; Puccetti G, 2011, SKIN RES TECHNOL, V17, P129, DOI 10.1111/j.1600-0846.2010.00480.x; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Redies C, 2007, NETWORK-COMP NEURAL, V18, P235, DOI 10.1080/09548980701574496; Redies C, 2012, LECT NOTES COMPUT SC, V7583, P522, DOI 10.1007/978-3-642-33863-2_54; Redies C, 2008, SPATIAL VISION, V21, P97, DOI 10.1163/156856808782713780; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Rotshtein P, 2007, CEREB CORTEX, V17, P2713, DOI 10.1093/cercor/bhl180; Ruiz-Soler M, 2006, PSYCHOL RES-PSYCH FO, V70, P273, DOI 10.1007/s00426-005-0215-z; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Samson N, 2010, J COSMET DERMATOL-US, V9, P79, DOI 10.1111/j.1473-2165.2010.00489.x; Stephen ID, 2012, EVOL PSYCHOL-US, V10, P562; TADMOR Y, 1994, VISION RES, V34, P541, DOI 10.1016/0042-6989(94)90167-8; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Voelkle MC, 2012, PSYCHOL AGING, V27, P265, DOI 10.1037/a0025065; Wolff N, 2012, PSYCHOL AGING, V27, P1066, DOI 10.1037/a0029112	76	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122801	10.1371/journal.pone.0122801	http://dx.doi.org/10.1371/journal.pone.0122801			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835539	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000352139000113
J	Moghimi, S; Schudlo, L; Chau, T; Guerguerian, AM				Moghimi, Saba; Schudlo, Larissa; Chau, Tom; Guerguerian, Anne-Marie			Variability in Prefrontal Hemodynamic Response during Exposure to Repeated SelfSelected Music Excerpts, a Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							PATIENT; ANXIETY; CORTEX; RECOGNITION; CORRELATE; PLEASANT	Music-induced brain activity modulations in areas involved in emotion regulation may be useful in achieving therapeutic outcomes. Clinical applications of music may involve prolonged or repeated exposures to music. However, the variability of the observed brain activity patterns in repeated exposures to music is not well understood. We hypothesized that multiple exposures to the same music would elicit more consistent activity patterns than exposure to different music. In this study, the temporal and spatial variability of cerebral prefrontal hemodynamic response was investigated across multiple exposures to self-selected musical excerpts in 10 healthy adults. The hemodynamic changes were measured using prefrontal cortex near infrared spectroscopy and represented by instantaneous phase values. Based on spatial and temporal characteristics of these observed hemodynamic changes, we defined a consistency index to represent variability across these domains. The consistency index across repeated exposures to the same piece of music was compared to the consistency index corresponding to prefrontal activity from randomly matched non-identical musical excerpts. Consistency indexes were significantly different for identical versus non-identical musical excerpts when comparing a subset of repetitions. When all four exposures were compared, no significant difference was observed between the consistency indexes of randomly matched non-identical musical excerpts and the consistency index corresponding to repetitions of the same musical excerpts. This observation suggests the existence of only partial consistency between repeated exposures to the same musical excerpt, which may stem from the role of the prefrontal cortex in regulating other cognitive and emotional processes.	[Moghimi, Saba; Schudlo, Larissa; Chau, Tom; Guerguerian, Anne-Marie] Univ Toronto, Toronto, ON, Canada; [Moghimi, Saba; Guerguerian, Anne-Marie] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Schudlo, Larissa; Chau, Tom] Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Schudlo, Larissa; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Guerguerian, AM (corresponding author), Univ Toronto, Toronto, ON, Canada.	anne-marie.guerguerian@sickkids.ca	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316	Natural Sciences and Engineering Research Council of Canada [227451]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), Grant no. 227451, Title: Intelligent systems for pediatric rehabilitation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya J, 2001, INT J PSYCHOPHYSIOL, V42, P287, DOI 10.1016/S0167-8760(01)00153-2; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Brattico E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00308; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Chan MF, 2012, J CLIN NURS, V21, P776, DOI 10.1111/j.1365-2702.2011.03954.x; Chan MF, 2011, COMPLEMENT THER MED, V19, P332, DOI 10.1016/j.ctim.2011.08.003; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chlan LL, 2013, JAMA-J AM MED ASSOC, V309, P2335, DOI 10.1001/jama.2013.5670; Cope M., 1992, APPL NEAR INFRARED S, P214; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; Davis T, 2012, DIMENS CRIT CARE NUR, V31, P159, DOI 10.1097/DCC.0b013e31824dffc6; Garza-Villarreal EA, 2014, FRONT PSYCHOL, P5; Green AC, 2008, NEUROREPORT, V19, P711, DOI 10.1097/WNR.0b013e3282fd0dd8; Hoshi Y, 2011, J NEUROIMAGING, V21, pe94, DOI 10.1111/j.1552-6569.2009.00454.x; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Jiang J, 2013, ART PSYCHOTHER, V40, P201, DOI 10.1016/j.aip.2013.02.002; Katz MH, 2006, STUDY DESIGN STAT AN; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Korhonen MD, 2006, IEEE T SYST MAN CY B, V36, P588, DOI 10.1109/TSMCB.2005.862491; Minati L, 2009, NEUROREPORT, V20, P87, DOI 10.1097/WNR.0b013e32831af235; Moghimi S, 2012, NEUROSCI LETT, V525, P7, DOI 10.1016/j.neulet.2012.07.009; Morris JD, 1995, J ADVERTISING RES, V35, P63; Pereira CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027241; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Schudlo LC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046018; Schudlo LC., 2012, THESIS; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Trappe H-J, 2012, MUSIC MED, V4, P100, DOI DOI 10.1177/1943862112438106; Vachiramon V, 2013, DERMATOL SURG, V39, P298, DOI 10.1111/dsu.12047; Van Den Bosch I, 2013, FRONT HUM NEUROSCI, P7; VanDrongelen W, 2010, SIGNAL PROCESSING FOR NEUROSCIENTISTS, A COMPANION VOLUME: ADVANCED TOPICS, NONLINEAR TECHNIQUES AND MULTI-CHANNEL ANALYSIS, P1; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; Zhu H, 2010, IET IMAGE PROCESS, V4, P335, DOI 10.1049/iet-ipr.2009.0195	39	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122148	10.1371/journal.pone.0122148	http://dx.doi.org/10.1371/journal.pone.0122148			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837268	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000080
J	Stewart, GB; Higgins, JPT; Schunemann, H; Meader, N				Stewart, Gavin B.; Higgins, Julian P. T.; Schuenemann, Holger; Meader, Nick			The Use of Bayesian Networks to Assess the Quality of Evidence from Research Synthesis: 1.	PLOS ONE			English	Article								Background The grades of recommendation, assessment, development and evaluation (GRADE) approach is widely implemented in systematic reviews, health technology assessment and guideline development organisations throughout the world. A key advantage to this approach is that it aids transparency regarding judgments on the quality of evidence. However, the intricacies of making judgments about research methodology and evidence make the GRADE system complex and challenging to apply without training. Methods We have developed a semi-automated quality assessment tool (SAQAT) vertical bar based on GRADE. This is informed by responses by reviewers to checklist questions regarding characteristics that may lead to unreliability. These responses are then entered into the Bayesian network to ascertain the probabilities of risk of bias, inconsistency, indirectness, imprecision and publication bias conditional on review characteristics. The model then combines these probabilities to provide a probability for each of the GRADE overall quality categories. We tested the model using a range of plausible scenarios that guideline developers or review authors could encounter. Results Overall, the model reproduced GRADE judgements for a range of scenarios. Potential advantages over standard assessment are use of explicit and consistent weightings for different review characteristics, forcing consideration of important but sometimes neglected characteristics and principled downgrading where small but important probabilities of downgrading are accrued across domains. Conclusions Bayesian networks have considerable potential for use as tools to assess the validity of research evidence. The key strength of such networks lies in the provision of a statistically coherent method for combining probabilities across a complex framework based on both belief and evidence. In addition to providing tools for less experienced users to implement reliability assessment, the potential for sensitivity analyses and automation may be beneficial for application and the methodological development of reliability tools.	[Stewart, Gavin B.; Higgins, Julian P. T.; Meader, Nick] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Higgins, Julian P. T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Schuenemann, Holger] McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of York - UK; University of Bristol; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Stewart, GB (corresponding author), Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	gavin.stewart@newcastle.ac.uk	Higgins, Julian PT/H-4008-2011	Higgins, Julian PT/0000-0002-8323-2514; Meader, Nicholas/0000-0001-9332-6605; Schunemann, Holger/0000-0003-3211-8479	National Institute For Health Research, UK; MRC [MR/K025643/1] Funding Source: UKRI; Medical Research Council [MR/K025643/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114] Funding Source: researchfish	National Institute For Health Research, UK(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Gavin Stewart and Nick Meader were supported by Centre for Reviews and Dissemination core contract funding from the National Institute For Health Research, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003409.pub4; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Assareh H, 2011, THESIS U BRISBANE AU; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Brunetti M, 2013, J CLIN EPIDEMIOL, V66, P140, DOI 10.1016/j.jclinepi.2012.04.012; Dold M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006391.pub2; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P423, DOI [10.1016/j.jclinepi.2010.04.019, DOI 10.1016/J.JCLINEPI.2010.04.019]; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P173, DOI 10.1016/j.jclinepi.2012.08.001; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hartling L, 2012, PLOS ONE, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0034697; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-15; Jensen FV, 2007, BAYESIAN NETWORKS DE; Kavanagh BP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000094; Lindley D.V., 2006, UNDERSTANDING UNCERT; Llewellyn A, PLOS ONE UPCOMING; Meader N, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-82; Newton AC, 2007, J NAT CONSERV, V15, P144, DOI 10.1016/j.jnc.2007.03.001; Pourret O., 2008, BAYESIAN NETWORKS PR; Shea BJ, 2011, AMSTAR ASSESSING MET; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; SPIEGELHALTER DJ, 1993, STAT SCI, V8, P219, DOI 10.1214/ss/1177010888; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Wallace BC, 2012, GENET MED, V14, P663, DOI 10.1038/gim.2012.7	32	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0114497	10.1371/journal.pone.0114497	http://dx.doi.org/10.1371/journal.pone.0114497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837450	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000001
J	Tsao, HM; Sun, YC; Liou, DM				Tsao, Hsiao-Mei; Sun, Ying-Chou; Liou, Der-Ming			A Rational Approach to Estimating the Surgical Demand Elasticity Needed to Guide Manpower Reallocation during Contagious Outbreaks	PLOS ONE			English	Article							INFECTION-CONTROL; SARS OUTBREAK; EPIDEMIC; FEAR	Background Emerging infectious diseases continue to pose serious threats to global public health. So far, however, few published study has addressed the need for manpower reallocation needed in hospitals when such a serious contagious outbreak occurs. Aim To quantify the demand elasticity of the major surgery types in order to guide future manpower reallocation during contagious outbreaks. Materials and Methods Based on a nationwide research database in Taiwan, we extracted the monthly volumes of major surgery types for the period 1998-2003, which covered the SARS period, in order to carry out a time series analysis. The demand elasticity of each surgery type was then estimated by autoregressive integrated moving average (ARIMA) analysis. Results During the study period, the surgical volumes of most selected surgery types either increased or remained steady. We categorized these surgery types into low-, moderate- and high-elastic groups according to their demand elasticity. Appendectomy, 'open reduction of fracture with internal fixation' and 'free skin graft' were in the low demand elasticity group. Transurethral prostatectomy and extracorporeal shockwave lithotripsy (ESWL) were in the high demand elasticity group. The manpower of the departments carrying out the surgeries with low demand elasticity should be maintained during outbreaks. In contrast, departments in charge of surgeries mainly with high demand elasticity, like urology departments, may be in a position to have part of their staff reallocated. Conclusions Taking advantage of the demand variation during the SARS period in 2003, we adopted the concept of demand elasticity and used a time series approach to figure out an effective index of demand elasticity for various types of surgery that could be used as a rational reference to carry out manpower reallocation during contagious outbreak situations.	[Tsao, Hsiao-Mei; Sun, Ying-Chou; Liou, Der-Ming] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Sun, Ying-Chou] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Sun, Ying-Chou] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Liou, DM (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	dmliou@ym.edu.tw			Taipei Veterans General Hospital, Taiwan [V103B-039]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This work is supported by Taipei Veterans General Hospital, Taiwan, grant number (V103B-039). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LONG HLTH INS DAT LH; Chang HJ, 2004, AM J PUBLIC HEALTH, V94, P562, DOI 10.2105/AJPH.94.4.562; Chen YC, 2004, EMERG INFECT DIS, V10, P895, DOI 10.3201/eid1005.030777; Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016; Chow C B, 2004, Paediatr Respir Rev, V5, P289, DOI 10.1016/j.prrv.2004.07.006; Huang HH, 2006, J FORMOS MED ASSOC, V105, P31, DOI 10.1016/S0929-6646(09)60106-6; Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467; Murphy GT, 2013, HEALTH POLICY PLANN, V28, P739, DOI 10.1093/heapol/czs115; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Taylor BL, 2010, INTENS CARE MED, V36, pS45, DOI 10.1007/s00134-010-1764-1; Wang KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089405	11	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122625	10.1371/journal.pone.0122625	http://dx.doi.org/10.1371/journal.pone.0122625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837596	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000103
J	McAllister, CH; Good, AG				McAllister, Chandra H.; Good, Allen G.			Alanine Aminotransferase Variants Conferring Diverse NUE Phenotypes in Arabidopsis thaliana	PLOS ONE			English	Article							ROOT-SYSTEM ARCHITECTURE; NITROGEN USE EFFICIENCY; AMINO-ACID-TRANSPORT; MESOPHYLL PROTOPLASTS; TRANSGENE EXPRESSION; L-GLUTAMATE; HIGH LIGHT; NITRATE; NUTRIENT; GROWTH	Alanine aminotransferase (AlaAT, E.C. 2.6.1.2), is a pyridoxal-5'-phosphate-dependent (PLP) enzyme that catalyzes the reversible transfer of an amino group from alanine to 2-oxoglutarate to produce glutamate and pyruvate, or vice versa. It has been well documented in both greenhouse and field studies that tissue-specific over-expression of AlaAT from barley (Hordeum vulgare, HvAlaAT) results in a significant increase in plant NUE in both canola and rice. While the physical phenotypes associated with over-expression of HvAlaAT have been well characterized, the role this enzyme plays in vivo to create a more N efficient plant remains unknown. Furthermore, the importance of HvAlaAT, in contrast to other AlaAT enzyme homologues in creating this phenotype has not yet been explored. To address the role of AlaAT in NUE, AlaAT variants from diverse sources and different subcellular locations, were expressed in the wild-type Arabidopsis thaliana Col-0 background and alaat1;2 (alaat1-1;alaat2-1) knockout background in various N environments. The analysis and comparison of both the physical and physiological properties of AlaAT over-expressing transgenic plants demonstrated significant differences between plants expressing the different AlaAT enzymes under different external conditions. This analysis indicates that the over-expression of AlaAT variants other than HvAlaAT in crop plants could further increase the NUE phenotype(s) previously observed.	[McAllister, Chandra H.; Good, Allen G.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	McAllister, CH (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	chandram@ualberta.ca			Alberta Crop Industry Development Fund [ADICF2009C001R]; NSERC [NSERC RGPIN 89739]	Alberta Crop Industry Development Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by an NSERC Discovery Grant - NSERC RGPIN 89739 to the principal investigator, AGG (http://www.nserc-crsng.gc.ca), and a Research grant from the Alberta Crop Industry Development Fund; ADICF2009C001R to AGG (http://www.acidf.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Beatty PH, 2013, BOTANY, V91, P866, DOI 10.1139/cjb-2013-0171; Beatty PH, 2009, PLANT BIOTECHNOL J, V7, P562, DOI 10.1111/j.1467-7652.2009.00424.x; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Butaye KMJ, 2004, PLANT J, V39, P440, DOI 10.1111/j.1365-313X.2004.02144.x; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Crawford NM, 1998, TRENDS PLANT SCI, V3, P389, DOI 10.1016/S1360-1385(98)01311-9; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Bolle MFC, 2003, PLANT SCI, V165, P169, DOI 10.1016/S0168-9452(03)00156-0; DIETZ KJ, 1990, PLANT PHYSIOL, V92, P123, DOI 10.1104/pp.92.1.123; DREW MC, 1978, J EXP BOT, V29, P435, DOI 10.1093/jxb/29.2.435; DREW MC, 1973, J EXP BOT, V24, P1189, DOI 10.1093/jxb/24.6.1189; Duff SMG, 2012, ARCH BIOCHEM BIOPHYS, V528, P90, DOI 10.1016/j.abb.2012.06.006; FAO, 2011, CURR WORLD FERT TREN; *FAO, 2008, CURR WORLD FERT TREN; Filleur S, 2005, BIOCHEM SOC T, V33, P283, DOI 10.1042/BST0330283; Fischer WN, 1998, TRENDS PLANT SCI, V3, P188, DOI 10.1016/S1360-1385(98)01231-X; Freixes S, 2002, PLANT CELL ENVIRON, V25, P1357, DOI 10.1046/j.1365-3040.2002.00912.x; Garnett T, 2013, NEW PHYTOL, V198, P82, DOI 10.1111/nph.12166; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Good AG, 2007, US Patent, Patent No. [#20070162995, 20070162995]; Good AG, 2007, CAN J BOT, V85, P252, DOI 10.1139/B07-019; Gromova M, 2010, PHYSIOL PLANTARUM, V140, P111, DOI 10.1111/j.1399-3054.2010.01387.x; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Hatch M. D., 1987, BIOCHIM BIOPHYS ACTA, V895, P6048; HATCH MD, 1977, ARCH BIOCHEM BIOPHYS, V179, P361, DOI 10.1016/0003-9861(77)90123-0; Hawkesford MJ, 2011, MOL PHYSL BASIS NUTR, P9; Hills MJ, 2004, CURR OPIN PLANT BIOL, V7, P302, DOI 10.1016/j.pbi.2004.03.003; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Keurentjes JJB, 2011, TRENDS PLANT SCI, V16, P183, DOI 10.1016/j.tplants.2010.12.002; Krouk G, TRENDS PLANT SCI, V6, P178; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Lejay L, 1999, PLANT J, V18, P509, DOI 10.1046/j.1365-313X.1999.00480.x; Li X, 2011, ARABIDOPSIS GROWING; Liepman AH, 2003, PLANT PHYSIOL, V131, P215, DOI 10.1104/pp.011460; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacGregor DR, 2008, PLANT CELL, V20, P2643, DOI 10.1105/tpc.107.055475; Magori S, 2011, BBA-GENE REGUL MECH, V1809, P388, DOI 10.1016/j.bbagrm.2011.01.007; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Marin IC, 2011, PLANTA, V233, P539, DOI 10.1007/s00425-010-1316-5; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; McAllister CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055032; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Miller AJ, 2008, J EXP BOT, V59, P111, DOI 10.1093/jxb/erm208; Miyashita Y, 2008, THESIS U ALBERTA; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Murphy DV, 2000, BIOL FERT SOILS, V30, P374, DOI 10.1007/s003740050018; PICCINI D, 1987, PLANT SOIL, V101, P45, DOI 10.1007/BF02371029; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Ratcliffe OJ, 2001, PLANT PHYSIOL, V126, P122, DOI 10.1104/pp.126.1.122; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Roycewicz P, 2012, PHILOS T R SOC B, V367, P1489, DOI 10.1098/rstb.2011.0230; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Salerno GL, 2003, TRENDS PLANT SCI, V8, P63, DOI 10.1016/S1360-1385(02)00029-8; Schmitz J, 2014, J EXP BOT, V65, P1619, DOI 10.1093/jxb/eru027; Schmitz J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-8; Shrawat AK, 2008, PLANT BIOTECHNOL J, V6, P722, DOI 10.1111/j.1467-7652.2008.00351.x; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Smith S, 2012, PHILOS T R SOC B, V367, P1441, DOI 10.1098/rstb.2011.0234; Sylvester-Bradley R, 2009, J EXP BOT, V60, P1939, DOI 10.1093/jxb/erp116; Tegeder M, 2012, CURR OPIN PLANT BIOL, V15, P315, DOI 10.1016/j.pbi.2012.02.001; Tegeder M, 2010, MOL PLANT, V3, P997, DOI 10.1093/mp/ssq047; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Walch-Liu P, 2008, PLANT J, V54, P820, DOI 10.1111/j.1365-313X.2008.03443.x; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang HM, 2007, J EXP BOT, V58, P2329, DOI 10.1093/jxb/erm114; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540	79	21	22	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121830	10.1371/journal.pone.0121830	http://dx.doi.org/10.1371/journal.pone.0121830			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830496	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600087
J	Aoun, SM; Grande, G; Howting, D; Deas, K; Toye, C; Troeung, L; Stajduhar, K; Ewing, G				Aoun, Samar M.; Grande, Gunn; Howting, Denise; Deas, Kathleen; Toye, Chris; Troeung, Lakkhina; Stajduhar, Kelli; Ewing, Gail			The Impact of the Carer Support Needs Assessment Tool (CSNAT) in Community Palliative Care Using a Stepped Wedge Cluster Trial	PLOS ONE			English	Article							OF-LIFE CARE; FAMILY CAREGIVERS; HOME; END; CANCER; VALIDATION; INTERVENTIONS; MORTALITY; OUTCOMES; BASE	Family caregiving towards the end-of-life entails considerable emotional, social, financial and physical costs for caregivers. Evidence suggests that good support can improve caregiver psychological outcomes. The primary aimof this study was to investigate the impact of using the carer support needs assessment tool (CSNAT), as an intervention to identify and address support needs in end of life home care, on family caregiver outcomes. A stepped wedge design was used to trial the CSNAT intervention in three bases of Silver Chain Hospice Care in Western Australia, 2012-14. The intervention consisted of at least two visits from nurses (2-3 weeks apart) to identify, review and address caregivers' needs. The outcome measures for the intervention and control groups were caregiver strain and distress as measured by the Family Appraisal of Caregiving Questionnaire (FACQ-PC), caregiver mental and physical health as measured by SF-12v2, and caregiver workload as measured by extent of caregiver assistance with activities of daily living, at baseline and follow up. Total recruitment was 620. There was 45% attrition for each group between baseline and follow-up mainly due to patient deaths resulting in 322 caregivers completing the study (233 in the intervention group and 89 in the control group). At follow-up, the intervention group showed significant reduction in caregiver strain relative to controls, p=0.018, d=0.348 (95% CI 0.25 to 0.41). Priority support needs identified by caregivers included knowing what to expect in the future, having time for yourself in the day and dealing with your feelings and worries. Despite the challenges at the clinician, organisational and trial levels, the CSNAT intervention led to an improvement in caregiver strain. Effective implementation of an evidence-informed and caregiver-led tool represents a necessary step towards helping palliative care providers better assess and address caregiver needs, ensuring adequate family caregiver support and reduction in caregiver strain.	[Aoun, Samar M.; Howting, Denise; Deas, Kathleen; Toye, Chris] Curtin Univ, Sch Nursing & Midwifery, Perth, WA 6845, Australia; [Grande, Gunn] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Troeung, Lakkhina] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Troeung, Lakkhina] Univ Notre Dame Australia, Sch Med, Fremantle, WA, Australia; [Stajduhar, Kelli] Univ Victoria, Sch Nursing, Victoria, BC, Canada; [Stajduhar, Kelli] Univ Victoria, Ctr Aging, Victoria, BC, Canada; [Ewing, Gail] Univ Cambridge, Ctr Family Res, Cambridge, England	Curtin University; University of Manchester; University of Western Australia; University of Notre Dame Australia; University of Victoria; University of Victoria; University of Cambridge	Aoun, SM (corresponding author), Curtin Univ, Sch Nursing & Midwifery, Perth, WA 6845, Australia.	s.aoun@curtin.edu.au	Grande, Gunn/A-6163-2011; Howting, Denise Ann/GWU-5045-2022; Toye, Christine M/I-4288-2012; Stajduhar, Kelli/AAJ-5914-2021	Grande, Gunn/0000-0003-2200-1680; Howting, Denise Ann/0000-0001-8753-5849; Toye, Christine M/0000-0003-4932-0016; Stajduhar, Kelli/0000-0003-2381-4712; Aoun, Samar/0000-0002-4073-4805	Australian Research Council linkage grant and Silver Chain [LP110100622]	Australian Research Council linkage grant and Silver Chain(Australian Research Council)	This research was financially supported by an Australian Research Council linkage grant and Silver Chain (LP110100622).	Aoun S, 2015, PALLIAT MED; Aoun S., 2004, 0975229508 PALL CAR; Aoun SM, 2014, J PAIN SYMPTOM MANAG, V48, P1222, DOI 10.1016/j.jpainsymman.2014.01.007; Bedini LA, 2002, FAMILY CAREGIVERS LE, P25; Briggs H, 2000, WARNING CARING HLTH; Candy B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007617.pub2; Carers Association of Australia, 1997, CAR EN BE POOR SURV; Carers UK, 2003, MISS OPPRT IMP NEW R; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Cooper B, 2006, PSYCHO-ONCOLOGY, V15, P613, DOI 10.1002/pon.1001; Currow DC, 2012, J PAIN SYMPTOM MANAG, V44, P595, DOI 10.1016/j.jpainsymman.2011.10.028; Ewing G, 2013, J PAIN SYMPTOM MANAG, V46, P395, DOI 10.1016/j.jpainsymman.2012.09.008; Ewing G, 2013, PALLIATIVE MED, V27, P244, DOI 10.1177/0269216312440607; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Grande G, 2009, PALLIATIVE MED, V23, P339, DOI 10.1177/0269216309104875; Grande G, 2014, PALLIATIVE MED, V28, P609; Grande GE, 2009, PALLIATIVE MED, V23, P248, DOI 10.1177/0269216309102620; Harding R, 2003, PALLIATIVE MED, V17, P63, DOI 10.1191/0269216303pm667oa; Harrop E, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-22; Hawkins NG, 2007, AM J PREV MED, V33, P162, DOI 10.1016/j.amepre.2007.03.020; Henwood M, 1998, IGNORED INVISIBLE CA; Holden JE, 2008, AM J NEPHROL, V28, P792, DOI 10.1159/000131102; Hudson P., 2005, EUR J PALLAIT CARE, V12, P165; Hudson P, 2009, J PAIN SYMPTOM MANAG, V38, P299, DOI 10.1016/j.jpainsymman.2008.08.010; Hudson PL, 2011, J PALLIAT MED, V14, P397, DOI 10.1089/jpm.2010.0345; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Kristjanson LJ, 2004, CAN J PSYCHIAT, V49, P359, DOI 10.1177/070674370404900604; Lee LA, 2010, ENCY RES DESIGN; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; Nijboer C, 2001, CANCER, V91, P1029, DOI 10.1002/1097-0142(20010301)91:5<1029::AID-CNCR1094>3.3.CO;2-T; Northouse LL, 2010, CA-CANCER J CLIN, V60, P317, DOI 10.3322/caac.20081; Payne S, 2013, NURS STAND, V28, P57, DOI [10.7748/ns2013.09.28.3.57.s50, DOI 10.7748/NS2013.09.28.3.57.S50]; Peat J, 2002, HEALTH SCIENCE RESEA; Sanderson K, 2002, AUST NZ J PUBL HEAL, V26, P343, DOI 10.1111/j.1467-842X.2002.tb00182.x; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Tan H, 2010, EXPLORE-NY, V6, P159, DOI 10.1016/j.explore.2010.03.008; Wagenaar AC, 2000, J STUD ALCOHOL, V61, P85, DOI 10.15288/jsa.2000.61.85	38	59	60	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123012	10.1371/journal.pone.0123012	http://dx.doi.org/10.1371/journal.pone.0123012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849348	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800194
J	Che, SPY; DeLeonardis, C; Shuler, ML; Stokol, T				Che, Sara P. Y.; DeLeonardis, Christine; Shuler, Michael L.; Stokol, Tracy			Tissue Factor-Expressing Tumor Cells Can Bind to Immobilized Recombinant Tissue Factor Pathway Inhibitor under Static and Shear Conditions In Vitro	PLOS ONE			English	Article							CANCER-CELLS; COAGULATION; ADHESION; ENDOTHELIUM; INVASION; COMPLEX; DISSEMINATION; METASTASIS; MDA-MB-231; MIGRATION	Mammary tumors and malignant breast cancer cell lines over-express the coagulation factor, tissue factor (TF). High expression of TF is associated with a poor prognosis in breast cancer. Tissue factor pathway inhibitor (TFPI), the endogenous inhibitor of TF, is constitutively expressed on the endothelium. We hypothesized that TF-expressing tumor cells can bind to immobilized recombinant TFPI, leading to arrest of the tumor cells under shear in vitro. We evaluated the adhesion of breast cancer cells to immobilized TFPI under static and shear conditions (0.35 - 1.3 dyn/cm(2)). We found that high-TF-expressing breast cancer cells, MDA-MB-231 (with a TF density of 460,000/cell), but not low TF-expressing MCF-7 (with a TF density of 1,400/cell), adhered to recombinant TFPI, under static and shear conditions. Adhesion of MDA-MB-231 cells to TFPI required activated factor VII (FVIIa), but not FX, and was inhibited by a factor VIIa-blocking anti-TF antibody. Under shear, adhesion to TFPI was dependent on the TFPI-coating concentration, FVIIa concentration and shear stress, with no observed adhesion at shear stresses greater than 1.0 dyn/cm(2). This is the first study showing that TF-expressing tumor cells can be captured by immobilized TFPI, a ligand constitutively expressed on the endothelium, under low shear in vitro. Based on our results, we hypothesize that TFPI could be a novel ligand mediating the arrest of TF-expressing tumor cells in high TFPI-expressing vessels under conditions of low shear during metastasis.	[Che, Sara P. Y.; Shuler, Michael L.] Cornell Univ, Dept Biomed Engn, Coll Engn, Ithaca, NY USA; [DeLeonardis, Christine; Stokol, Tracy] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stokol, T (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	tracy.stokol@cornell.edu			Natural Sciences and Engineering Research Council of Canada; Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute [U54CA143876]; National Science Foundation [ECCS-0335765]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF))	S.C. is funded by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). The work described was supported by the Cornell Center on the Microenvironment & Metastasis through Award Number U54CA143876 from the National Cancer Institute (http://physics.cancer.gov/). This work was performed in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (Grant ECCS-0335765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERI A, 1992, BLOOD, V79, P3219; Andreasson-Ochsner M, 2011, LAB CHIP, V11, P2876, DOI 10.1039/c1lc20067d; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bahrami M, 2005, ICMM 2005, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON MICROCHANNELS AND MINICHANNELS, PT A, P269; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1047; BAJAJ MS, 1990, P NATL ACAD SCI USA, V87, P8869, DOI 10.1073/pnas.87.22.8869; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; Burdick MM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00103; CALLANDER NS, 1992, J BIOL CHEM, V267, P876; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chu AJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/367284; Cole M, 2013, ONCOLOGIST, V18, P14, DOI 10.1634/theoncologist.2012-0322; Fischer EG, 1999, J CLIN INVEST, V104, P1213, DOI 10.1172/JCI7750; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Glinskii OV, 2003, CLIN EXP METASTAS, V20, P451, DOI 10.1023/A:1025449031136; Green JV, 2009, LAB CHIP, V9, P677, DOI 10.1039/b813516a; Haier R, 2003, J GASTROINTEST SURG, V7, P507, DOI 10.1016/S1091-255X(03)00023-4; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Hook F, 2005, REV BTI MOL BIOL FEB, P8; Iversen N, 1998, BRIT J HAEMATOL, V102, P889, DOI 10.1046/j.1365-2141.1998.00875.x; Kakkar AK, 1999, BRIT J SURG, V86, P890, DOI 10.1046/j.1365-2168.1999.01153.x; Kato Hisao, 2008, P147, DOI 10.1007/978-4-431-78847-8_8; Kirby B., 2010, MICRO NANOSCALE FLUI; Koizume S, 2010, BREAST CANC CURRENT, P197; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; LAWRENCE MB, 1990, BLOOD, V75, P227; Liu Z, 2010, STUDIES BIOMACROMOLE; Ma ZW, 2011, INT J GYNECOL CANCER, V21, P616, DOI 10.1097/IGC.0b013e3182150e98; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Maity G, 2011, TUMOR BIOL, V32, P129, DOI 10.1007/s13277-010-0106-9; Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137; Milsom C, 2009, ARTERIOSCL THROM VAS, V29, P2005, DOI 10.1161/ATVBAHA.108.177444; MORRISSEY JH, 1988, THROMB RES, V52, P247, DOI 10.1016/0049-3848(88)90084-9; Myung JH, 2010, LANGMUIR, V26, P8589, DOI 10.1021/la904678p; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nista A, 1997, INT J CANCER, V72, P133, DOI 10.1002/(SICI)1097-0215(19970703)72:1<133::AID-IJC19>3.0.CO;2-K; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; OSTERUD B, 1995, THROMB HAEMOSTASIS, V73, P873; Otero LL, 2011, BIOMARKERS, V16, P58, DOI 10.3109/1354750X.2010.533282; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Rak J, 2009, BEST PRACT RES CL HA, V22, P71, DOI 10.1016/j.beha.2008.12.008; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Santana SM, 2012, BIOMED MICRODEVICES, V14, P401, DOI 10.1007/s10544-011-9616-5; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; St Hill CA, 2011, FRONT BIOSCI-LANDMRK, V16, P3233, DOI 10.2741/3909; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Thangawng AL, 2007, SMALL, V3, P132, DOI 10.1002/smll.200500418; Thierry B, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3480573; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yokota N, 2009, BRIT J CANCER, V101, P2023, DOI 10.1038/sj.bjc.6605406; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530; Zheng XJ, 2011, LAB CHIP, V11, P3431, DOI 10.1039/c1lc20455f	60	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123717	10.1371/journal.pone.0123717	http://dx.doi.org/10.1371/journal.pone.0123717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849335	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800254
J	Maillard, S; Damiola, F; Clero, E; Pertesi, M; Robinot, N; Rachedi, F; Boissin, JL; Sebbag, J; Shan, L; Bost-Bezeaud, F; Petitdidier, P; Doyon, F; Xhaard, C; Rubino, C; Blanche, H; Drozdovitch, V; Lesueur, F; de Vathaire, F				Maillard, Stephane; Damiola, Francesca; Clero, Enora; Pertesi, Maroulio; Robinot, Nivonirina; Rachedi, Frederique; Boissin, Jean-Louis; Sebbag, Joseph; Shan, Larrys; Bost-Bezeaud, Frederique; Petitdidier, Patrick; Doyon, Francoise; Xhaard, Constance; Rubino, Carole; Blanche, Helene; Drozdovitch, Vladimir; Lesueur, Fabienne; de Vathaire, Florent			Common Variants at 9q22.33, 14q13.3, and ATM Loci, and Risk of Differentiated Thyroid Cancer in the French Polynesian Population	PLOS ONE			English	Article							DNA-DAMAGE; POOLED ANALYSIS; RADIATION; FOXE1; SUSCEPTIBILITY; ASSOCIATION; CARCINOMA; GENE; POLYMORPHISMS; RADIOIODINE	Background French Polynesia has one of the highest incidence rates of thyroid cancer worldwide. Relationships with the atmospheric nuclear weapons tests and other environmental, biological, or behavioral factors have already been reported, but genetic susceptibility has yet to be investigated. We assessed the contribution of polymorphisms at the 9q22.33 and 14q13.3 loci identified by GWAS, and within the DNA repair gene ATM, to the risk of differentiated thyroid cancer (DTC) in 177 cases and 275 matched controls from the native population. Principal Findings For the GWAS SNP rs965513 near FOXE1, an association was found between genotypes G/A and A/A, and risk of DTC. A multiplicative effect of allele A was even noted. An excess risk was also observed in individuals carrying two long alleles of the poly-alanine tract expansion in FOXE1, while no association was observed with rs1867277 falling in the promoter region of the gene. In contrast, the GWAS SNP rs944289 (NKX2-1) did not show any significant association. Although the missense substitution D1853N (rs1801516) in ATM was rare in the population, carriers of the minor allele (A) also showed an excess risk. The relationships between these five polymorphisms and the risk of DTC were not contingent on the body surface area, body mass index, ethnicity or dietary iodine intake. However, an interaction was evidenced between the thyroid radiation dose and rs944289. Significance A clear link could not be established between the high incidence in French Polynesia and the studied polymorphisms, involved in susceptibility to DTC in other populations. Important variation in allele frequencies was observed in the Polynesian population as compared to the European populations. For FOXE1 rs965513, the direction of association and the effect size was similar to that observed in other populations, whereas for ATM rs1801516, the minor allele was associated to an increased risk in the Polynesian population and with a decreased risk in the European population.	[Maillard, Stephane; Clero, Enora; Doyon, Francoise; Xhaard, Constance; Rubino, Carole; de Vathaire, Florent] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, Radiat Epidemiol Grp, F-94800 Villejuif, France; [Maillard, Stephane; Clero, Enora; Doyon, Francoise; Xhaard, Constance; Rubino, Carole; de Vathaire, Florent] Univ Paris Sud, UMRS 1018, F-94807 Villejuif, France; [Maillard, Stephane; Clero, Enora; Doyon, Francoise; Xhaard, Constance; Rubino, Carole; de Vathaire, Florent] Inst Gustave Roussy, F-94800 Villejuif, France; [Damiola, Francesca; Pertesi, Maroulio; Robinot, Nivonirina; Lesueur, Fabienne] Int Agcy Res Canc, Genet Canc Susceptibil, F-69372 Lyon, France; [Damiola, Francesca] Ctr Leon Berard, INSERM, U1052, CRCL,CNRS,UMR5286, F-69373 Lyon, France; [Rachedi, Frederique; Bost-Bezeaud, Frederique] Terr Hosp Taaone, Papeete, France; [Boissin, Jean-Louis] 10 IPRAME, Papeete, France; [Sebbag, Joseph] Paofai Clin, Papeete, France; [Petitdidier, Patrick] Lab Boz, Papeete, France; [Blanche, Helene] Fdn Jean Dausset CEPH, F-75010 Paris, France; [Drozdovitch, Vladimir] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Lesueur, Fabienne] Mines ParisTech, Inst Curie, INSERM, U900, F-75248 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; World Health Organization; International Agency for Research on Cancer (IARC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Foundation Jean Dausset-CEPH; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	de Vathaire, F (corresponding author), INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, Radiat Epidemiol Grp, F-94800 Villejuif, France.	florent.devathaire@igr.fr	Lesueur, Fabienne/R-2178-2017; de Vathaire, Florent/L-2983-2016	Lesueur, Fabienne/0000-0001-7404-4549; Damiola, Francesca/0000-0002-0238-1252; , Enora Clero/0000-0001-6971-1554; de Vathaire, Florent/0000-0002-8374-9281; Ranoroarivony Robiniot, Nivonirina/0000-0002-2532-1455; Xhaard, Constance/0000-0002-1914-2696; Drozdovitch, Vladimir/0000-0002-7952-379X	Agence Nationale pour la Recherche (ANR); Ligue Nationale Contre le Cancer (LNCC); Direction Generale de la Sante; Agence Francaise de Securite Sanitaire de l'alimentation, de l'environnement et du travail (ANSES); CHILDTHYREEC program; Fondation de France; NATIONAL CANCER INSTITUTE [ZIACP010132] Funding Source: NIH RePORTER	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); Direction Generale de la Sante(General Electric); Agence Francaise de Securite Sanitaire de l'alimentation, de l'environnement et du travail (ANSES); CHILDTHYREEC program; Fondation de France(Fondation de France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Agence Nationale pour la Recherche (ANR), the Ligue Nationale Contre le Cancer (LNCC), the Direction Generale de la Sante, the Agence Francaise de Securite Sanitaire de l'alimentation, de l'environnement et du travail (ANSES), CHILDTHYREEC program, and the Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akulevich NM, 2009, ENDOCR-RELAT CANCER, V16, P491, DOI 10.1677/ERC-08-0336; Alsbeih G, 2007, INT J RADIAT ONCOL, V68, P229, DOI 10.1016/j.ijrobp.2006.12.050; Angele S, 2003, CANCER RES, V63, P8717; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; BEEBE G W, 1975, Journal of Radiation Research, V16, P97; Boice JD, 2006, JAMA-J AM MED ASSOC, V295, P1060, DOI 10.1001/jama.295.9.1060; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Breslow N E, 1980, IARC Sci Publ, P5; Brindel P, 2008, AM J EPIDEMIOL, V167, P219, DOI 10.1093/aje/kwm288; Brindel P, 2010, THYROID, V20, P393, DOI 10.1089/thy.2009.0350; Brindel P, 2009, CANCER CAUSE CONTROL, V20, P581, DOI 10.1007/s10552-008-9266-y; Bullock M, 2012, J CLIN ENDOCR METAB, V97, pE1814, DOI 10.1210/jc.2012-1456; Canman CE, 1998, ONCOGENE, V17, P3301, DOI 10.1038/sj.onc.1202577; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Carre A, 2007, HUM GENET, V122, P467, DOI 10.1007/s00439-007-0420-5; Clero E, 2012, NUTR CANCER, V64, P929, DOI 10.1080/01635581.2012.713538; Clero E, 2012, THYROID, V22, P422, DOI 10.1089/thy.2011.0173; Clero E, 2010, THYROID, V20, P1285, DOI 10.1089/thy.2009.0456; Damiola F, 2013, INT J CANC; de Vathaire F, 2010, BRIT J CANCER, V103, P1115, DOI 10.1038/sj.bjc.6605862; de Vathaire F, 2008, NAT CLIN PRACT ENDOC, V4, P180, DOI 10.1038/ncpendmet0761; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Drozdovitch V, 2008, HEALTH PHYS, V94, P418, DOI 10.1097/01.HP.0000299293.06218.88; Edvardsen H, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-25; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; Garsi JP, 2009, CLIN ENDOCRINOL, V71, P880, DOI 10.1111/j.1365-2265.2009.03561.x; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hayashi Y, 2010, CANCER-AM CANCER SOC, V116, P1646, DOI 10.1002/cncr.24872; International Agency for Research on Cancer (IARC), 2007, CANC INCIDENCE 5 CON, V9; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Matsuse M, 2011, J MED GENET, V48, P645, DOI 10.1136/jmedgenet-2011-100063; Nguyen-Dumont T, 2009, HUM MUTAT, V30, P884, DOI 10.1002/humu.20949; Parlato R, 2004, DEV BIOL, V276, P464, DOI 10.1016/j.ydbio.2004.08.048; Perna MG, 1997, THYROID, V7, P377, DOI 10.1089/thy.1997.7.377; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Schrauder M, 2008, J CANCER RES CLIN, V134, P873, DOI 10.1007/s00432-008-0355-9; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; WOOD JW, 1969, AM J EPIDEMIOL, V89, P4, DOI 10.1093/oxfordjournals.aje.a120914; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; Zhang P, 2006, PATHOL INT, V56, P240, DOI 10.1111/j.1440-1827.2006.01959.x	44	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123700	10.1371/journal.pone.0123700	http://dx.doi.org/10.1371/journal.pone.0123700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849217	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800253
J	Wang, YP; Wang, MC; Lin, HC; Lee, KS; Chou, P				Wang, Ying-Piao; Wang, Mao-Che; Lin, Hung-Ching; Lee, Kuo-Sheng; Chou, Pesus			Tonsillectomy and the Risk for Deep Neck Infection-A Nationwide Cohort Study	PLOS ONE			English	Article							IMMUNE FUNCTIONS; IMMUNOLOGICAL RESPONSE; INTRANASAL INFECTION; PROPENSITY SCORE; IMMUNOGLOBULIN-A; EARLY-STAGE; CHILDREN; TONSILS; SERUM; ADENOTONSILLECTOMY	Background Although the tonsils contribute to first line immunity against foreign pathogens in the upper aero-digestive tract, the association of tonsillectomy with the risk of deep neck infection remains unclear. The aim of this study was to assess the incidence rate and risk of deep neck infection among patients who had undergone a tonsillectomy. Methods This retrospective cohort study evaluated all patients who had undergone tonsillectomy between 2001 and 2009 as identified from the Taiwan National Health Insurance Research Database. For each post-tonsillectomy patient, 10 age-, sex-, and index date-matched controls without a history of tonsillectomy were randomly selected. Cox Proportional hazard model and propensity score model were performed to evaluate the association between tonsillectomy and deep neck infection after adjusting for demographic and clinical data. Results There were 34 (71.6 cases per 100,000 person-years) and 174 (36.6 cases per 100,000 person-years) patients that developed deep neck infection in the tonsillectomized and comparison cohorts, respectively. After adjusting for covariates, patients who had undergone a tonsillectomy had a 1.71-fold greater risk of deep neck infection by both Cox proportional hazard model (95% confidence interval, 1.13-2.59) and propensity score model (95% confidence interval, 1.10-2.66). This association was not altered regardless of the indication for tonsillectomy (i.e. chronic/recurrent tonsillitis or sleep apnea/hypertrophy of tonsil) (p = 0.9797).Conclusions Based on our review of a nationwide cohort study we identified that the risk of deep neck infection is significantly increased among patients who have undergone a tonsillectomy. Additional research is needed to explore the possible mechanisms behind these findings. Conclusions Based on our review of a nationwide cohort study we identified that the risk of deep neck infection is significantly increased among patients who have undergone a tonsillectomy. Additional research is needed to explore the possible mechanisms behind these findings.	[Wang, Ying-Piao; Lin, Hung-Ching; Lee, Kuo-Sheng] Mackay Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taipei 104, Taiwan; [Wang, Ying-Piao; Wang, Mao-Che; Chou, Pesus] Natl Yang Ming Univ, Med Res Ctr, Inst Publ Hlth & Community, Taipei 112, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching; Lee, Kuo-Sheng] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City 252, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching; Lee, Kuo-Sheng] Mackay Med Coll, Sch Med, New Taipei City 252, Taiwan; [Wang, Mao-Che] Taipei Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei 112, Taiwan; [Wang, Mao-Che] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chou, P (corresponding author), Natl Yang Ming Univ, Med Res Ctr, Inst Publ Hlth & Community, Taipei 112, Taiwan.	pschou@ym.edu.tw						Andreu-Ballester JC, 2003, AM J GASTROENTEROL, V98, P2806; Andreu-Ballester JC, 2007, CLIN IMMUNOL, V123, P289, DOI 10.1016/j.clim.2007.02.004; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bell S, 2012, MOL ORAL MICROBIOL, V27, P160, DOI 10.1111/j.2041-1014.2012.640.x; Bhattacharyya N, 2010, OTOLARYNG HEAD NECK, V143, P680, DOI 10.1016/j.otohns.2010.06.918; BOCK A, 1994, EUR ARCH OTO-RHINO-L, V251, P423; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Brandtzaeg P, 2003, INT J PEDIATR OTORHI, V67, pS69, DOI 10.1016/j.ijporl.2003.08.018; Brandtzaeg P, 2011, ADV OTO-RHINO-LARYNG, V72, P20, DOI 10.1159/000324588; Brasky TM, 2009, CANCER CAUSE CONTROL, V20, P369, DOI 10.1007/s10552-008-9251-5; CANTANI A, 1986, ANN ALLERGY, V57, P413; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036332; Chiu HF, 2011, AM J GASTROENTEROL, V106, P894, DOI 10.1038/ajg.2010.475; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Dai ZY, 2014, GENET MOL RES, V13, P3895, DOI 10.4238/2014.January.24.15; Duval M, 2008, INT J PEDIATR OTORHI, V72, P1765, DOI 10.1016/j.ijporl.2008.07.007; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Hoddeson EK, 2009, OTOLARYNG HEAD NECK, V140, P19, DOI 10.1016/j.otohns.2008.09.023; Janszky I, 2011, EUR HEART J, V32, P2290, DOI 10.1093/eurheartj/ehr137; Kaygusuz I, 2003, INT J PEDIATR OTORHI, V67, P1311, DOI 10.1016/j.ijporl.2003.07.017; Kaygusuz I, 2009, INT J PEDIATR OTORHI, V73, P445, DOI 10.1016/j.ijporl.2008.11.014; MORENO PM, 1992, CLIN OTOLARYNGOL, V17, P380, DOI 10.1111/j.1365-2273.1992.tb01678.x; Nasrin M, 2012, Bangladesh Med Res Counc Bull, V38, P59; National Center for Health Statistics, 1998, VIT HLTH STAT 13, V13; Nave H, 2001, ANAT EMBRYOL, V204, P367, DOI 10.1007/s004290100210; OGRA PL, 1971, NEW ENGL J MED, V284, P59, DOI 10.1056/NEJM197101142840201; Parker NP, 2011, INT J PEDIATR OTORHI, V75, P282, DOI 10.1016/j.ijporl.2010.11.019; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Rodriguez A, 2006, SCAND J IMMUNOL, V63, P177, DOI 10.1111/j.1365-3083.2006.01725.x; Rodriguez A, 2005, VACCINE, V23, P2565, DOI 10.1016/j.vaccine.2004.11.032; RUBIN DB, 1993, MED CARE, V31, pYS103, DOI 10.1097/00005650-199305001-00017; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SAINZ M, 1992, CLIN OTOLARYNGOL, V17, P376, DOI 10.1111/j.1365-2273.1992.tb01677.x; Sigurdardottir SL, 2012, CLIN IMMUNOL, V142, P139, DOI 10.1016/j.clim.2011.09.013; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Suzumoto M, 2006, ACTA OTO-LARYNGOL, V126, P1164, DOI 10.1080/00016480600681593; van den Akker EH, 2004, CLIN OTOLARYNGOL, V29, P161, DOI 10.1111/j.0307-7772.2004.00771.x; van den Akker EH, 2006, ANN ALLERG ASTHMA IM, V97, P251, DOI 10.1016/S1081-1206(10)60022-1; van Kempen MJP, 2000, INT ARCH ALLERGY IMM, V122, P8, DOI 10.1159/000024354; Vestergaard H, 2010, INT J CANCER, V127, P633, DOI 10.1002/ijc.24973; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Zielnik-Jurkiewicz B, 2002, INT J PEDIATR OTORHI, V64, P127, DOI 10.1016/S0165-5876(02)00042-3	45	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0117535	10.1371/journal.pone.0117535	http://dx.doi.org/10.1371/journal.pone.0117535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849535	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800004
J	Crucello, A; Sforca, DA; Horta, MAC; dos Santos, CA; Viana, AJC; Beloti, LL; de Toledo, MAS; Vincentz, M; Kuroshu, RM; de Souza, AP				Crucello, Aline; Sforca, Danilo Augusto; Crivelente Horta, Maria Augusta; dos Santos, Clelton Aparecido; Carvalho Viana, Americo Jose; Beloti, Lilian Luzia; Szymanski de Toledo, Marcelo Augusto; Vincentz, Michel; Kuroshu, Reginaldo Massanobu; de Souza, Anete Pereira			Analysis of Genomic Regions of Trichoderma harzianum IOC-3844 Related to Biomass Degradation	PLOS ONE			English	Article							REAL-TIME PCR; ENDOGLUCANASE III; SUGARCANE BAGASSE; GENE-EXPRESSION; O-GLYCOSYLATION; REESEI; CELLULASE; PROTEIN; SWOLLENIN; CEL12A	Trichoderma harzianum IOC-3844 secretes high levels of cellulolytic-active enzymes and is therefore a promising strain for use in biotechnological applications in second-generation bioethanol production. However, the T. harzianum biomass degradation mechanism has not been well explored at the genetic level. The present work investigates six genomic regions (similar to 150 kbp each) in this fungus that are enriched with genes related to biomass conversion. A BAC library consisting of 5,760 clones was constructed, with an average insert length of 90 kbp. The assembled BAC sequences revealed 232 predicted genes, 31.5% of which were related to catabolic pathways, including those involved in biomass degradation. An expression profile analysis based on RNA-Seq data demonstrated that putative regulatory elements, such as membrane transport proteins and transcription factors, are located in the same genomic regions as genes related to carbohydrate metabolism and exhibit similar expression profiles. Thus, we demonstrate a rapid and efficient tool that focuses on specific genomic regions by combining a BAC library with transcriptomic data. This is the first BAC-based structural genomic study of the cellulolytic fungus T. harzianum, and its findings provide new perspectives regarding the use of this species in biomass degradation processes.	[Crucello, Aline; Sforca, Danilo Augusto; Crivelente Horta, Maria Augusta; dos Santos, Clelton Aparecido; Carvalho Viana, Americo Jose; Beloti, Lilian Luzia; Szymanski de Toledo, Marcelo Augusto; Vincentz, Michel; de Souza, Anete Pereira] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil; [Vincentz, Michel; de Souza, Anete Pereira] Univ Estadual Campinas, Dept Biol Vegetal, Inst Biol, Sao Paulo, Brazil; [Kuroshu, Reginaldo Massanobu] Univ Fed Sao Paulo, Inst Ciencia & Tecnol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	de Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil.	anete@unicamp.br	Crucello, Aline/AHD-3584-2022; Horta, Maria/N-5051-2016; DE SOUZA, ANETE PEREIRA/B-8663-2012; Viana, Américo/AAB-6593-2019; Horta, Maria/Q-6194-2019; Sforça, Danilo A/I-1551-2014; Sforça, Danilo/AAQ-1129-2020; Santos, Clelton A/I-2202-2012	Horta, Maria/0000-0003-2159-5296; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Viana, Américo/0000-0001-9509-0093; Horta, Maria/0000-0003-2159-5296; Sforça, Danilo A/0000-0003-2304-8712; Sforça, Danilo/0000-0003-2304-8712; Santos, Clelton A/0000-0002-6725-8925	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Nivel Superior (CAPES, Proj Bio-Computacional); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP [proc. 2009/13185-3]; CNPQ	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Nivel Superior (CAPES, Proj Bio-Computacional); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Nivel Superior (CAPES, Proj Bio-Computacional) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). AJCV, CAS, DAS, LB, MACH and MAST were recipients of PhD fellowships from FAPESP, and AC was a recipient of graduate fellowships from CNPQ (PhD degree) and FAPESP (MSc. Degree, proc. 2009/13185-3). APS and MV were recipients of research fellowships from CNPq.	Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramanian N, 2008, AFR J BIOTECHNOL, V7; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Chaverri P, 2003, MOL PHYLOGENET EVOL, V27, P302, DOI 10.1016/S1055-7903(02)00400-1; Colussi F, 2011, J MICROBIOL BIOTECHN, V21, P808, DOI 10.4014/jmb.1010.10037; CONAB, 2013, AC SAFR BRAS CAN DE; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Horta MAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088689; Dantas GA, 2013, RENEW SUST ENERG REV, V21, P356, DOI 10.1016/j.rser.2012.11.080; de Castro AM, 2010, APPL BIOCHEM BIOTECH, V162, P1612, DOI 10.1007/s12010-010-8942-z; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Diener SE, 2004, FUNGAL GENET BIOL, V41, P1077, DOI 10.1016/j.fgb.2004.08.007; Eisentraut A., 2010, IEA ENERGY PAPERS; Generoso WC, 2012, GENET MOL RES, V11, P1544, DOI 10.4238/2012.May.21.11; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053; Hakkinen M, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-14; Hakulinen N, 2000, J STRUCT BIOL, V132, P180, DOI 10.1006/jsbi.2000.4318; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Karp SG, 2013, BRAZ ARCH BIOL TECHN, V56, P679, DOI 10.1590/S1516-89132013000400019; KUBICEK CP, 1981, EUR J APPL MICROBIOL, V13, P226, DOI 10.1007/BF00500103; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Liberato MV, 2012, ACTA CRYSTALLOGR F, V68, P306, DOI 10.1107/S1744309112000838; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Nakazawa H, 2008, APPL MICROBIOL BIOT, V81, P681, DOI 10.1007/s00253-008-1667-z; Ozbay N, 2004, ACTA HORTIC, P131, DOI 10.17660/ActaHortic.2004.635.16; Patil RS, 2000, ENZYME MICROB TECH, V26, P473, DOI 10.1016/S0141-0229(00)00134-4; Peterson D. G., 2000, Journal of Agricultural Genomics, V5, P1; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SADDLER JN, 1985, APPL MICROBIOL BIOT, V22, P139; Sadhasivam S, 2009, WORLD J MICROB BIOT, V25, P1733, DOI 10.1007/s11274-009-0069-4; Salamov A, 1998, FGENESH MULTIPLE GEN; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soccol CR, 2010, BIORESOURCE TECHNOL, V101, P4820, DOI 10.1016/j.biortech.2009.11.067; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; SUOMINEN PL, 1993, MOL GEN GENET, V241, P523, DOI 10.1007/BF00279894; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Wang LS, 2003, J MOL CATAL B-ENZYM, V24-5, P27, DOI 10.1016/S1381-1177(03)00070-5; Wang YG, 2011, APPL MICROBIOL BIOT, V91, P1353, DOI 10.1007/s00253-011-3421-1; WOOD TM, 1992, BIOCHEM SOC T, V20, P46, DOI 10.1042/bst0200046; Xia ZJ, 2014, ANAL BIOCHEM, V444, P38, DOI 10.1016/j.ab.2013.09.026	59	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122122	10.1371/journal.pone.0122122	http://dx.doi.org/10.1371/journal.pone.0122122			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836973	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000079
J	Diedenhofen, B; Musch, J				Diedenhofen, Birk; Musch, Jochen			cocor: A Comprehensive Solution for the Statistical Comparison of Correlations	PLOS ONE			English	Article							CORRELATION-COEFFICIENTS; DEPENDENT CORRELATIONS; CONFIDENCE-INTERVALS; PEARSON CORRELATIONS; TESTS; EQUALITY; PROGRAM	A valid comparison of the magnitude of two correlations requires researchers to directly contrast the correlations using an appropriate statistical test. In many popular statistics packages, however, tests for the significance of the difference between correlations are missing. To close this gap, we introduce cocor, a free software package for the R programming language. The cocor package covers a broad range of tests including the comparisons of independent and dependent correlations with either overlapping or nonoverlapping variables. The package also includes an implementation of Zou's confidence interval for all of these comparisons. The platform independent cocor package enhances the R statistical computing environment and is available for scripting. Two different graphical user interfaces -a plugin for RKWard and a web interface-make cocor a convenient and userfriendly tool.	[Diedenhofen, Birk; Musch, Jochen] Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Diedenhofen, B (corresponding author), Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany.	birk.diedenhofen@uni-duesseldorf.de		Diedenhofen, Birk/0000-0002-1495-4257				[Anonymous], 2014, R LANG ENV STAT COMP; Baguley T, 2012, SERIOUS STATS GUIDE; Bakeman, 2005, UNDERSTANDING STAT B; Bliese P., 2013, MULTILEVEL MULTILEVE; Cheung MWL, 2009, STRUCT EQU MODELING, V16, P267, DOI 10.1080/10705510902751291; Cheung MWL, 2004, ORGAN RES METHODS, V7, P206, DOI 10.1177/1094428104264024; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; DUNN OJ, 1969, J AM STAT ASSOC, V64, P366, DOI 10.2307/2283746; DUNN OJ, 1971, J AM STAT ASSOC, V66, P904, DOI 10.2307/2284252; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; FREUND JE, 1997, MODERN ELEMENTARY ST; Zou GY, 2007, PSYCHOL METHODS, V12, P399, DOI 10.1037/1082-989X.12.4.399; HENDRICKSON GF, 1970, AM EDUC RES J, V7, P189, DOI 10.2307/1162159; Hittner JB, 1998, APPL PSYCH MEAS, V22, P93, DOI 10.1177/01466216980221010; Hittner JB, 2003, J GEN PSYCHOL, V130, P149, DOI 10.1080/00221300309601282; Hotelling H, 1940, ANN MATH STAT, V11, P271, DOI 10.1214/aoms/1177731867; Larson R., 2011, ELEMENTARY STAT PICT; LEVY KJ, 1976, EDUC PSYCHOL MEAS, V36, P27, DOI 10.1177/001316447603600103; May K, 1997, J EXP EDUC, V65, P257, DOI 10.1080/00220973.1997.9943458; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; NEILL JJ, 1975, BIOMETRICS, V31, P531, DOI 10.2307/2529435; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; OLKIN I, 1995, PSYCHOL BULL, V118, P155, DOI 10.1037/0033-2909.118.1.155; Olkin I., 1967, IMPROVING EXPT DESIG, P102; PAUL SR, 1989, CAN J STAT, V17, P217, DOI 10.2307/3314850; Pearson K., 1898, PHILOS T ROYAL SOC A, V191, P229, DOI [10.1098/rsta.1898.0007, DOI 10.1098/RSTA.1898.0007]; Raghunathan TE, 1996, PSYCHOL METHODS, V1, P178, DOI 10.1037/1082-989X.1.2.178; Revelle W, 2012, PROCEDURES PSYCHOL P; Rodiger S, 2012, J STAT SOFTW, V49, P1; ROSNOW RL, 1989, AM PSYCHOL, V44, P1276, DOI 10.1037/0003-066X.44.10.1276; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; SI Inc, 2013, SAS STAT SOFTW VERS; Silver NC, 2008, MOL ECOL RESOUR, V8, P763, DOI 10.1111/j.1755-0998.2008.02107.x; Silver NC, 2006, APPL PSYCH MEAS, V30, P152, DOI 10.1177/0146621605277132; Silver NC, 2004, J EXP EDUC, V73, P53; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Weaver B, 2013, BEHAV RES METHODS, V45, P880, DOI 10.3758/s13428-012-0289-7; Wilcox RR, 2009, COMMUN STAT-SIMUL C, V38, P2220, DOI 10.1080/03610910903289151; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396; Wright D., 2009, 1 2 STEPS STAT, VSecond, P26	40	600	605	9	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121945	10.1371/journal.pone.0121945	http://dx.doi.org/10.1371/journal.pone.0121945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835001	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000069
J	Fedy, BC; Kirol, CP; Sutphin, AL; Maechtle, TL				Fedy, Bradley C.; Kirol, Christopher P.; Sutphin, Andrew L.; Maechtle, Thomas L.			The Influence of Mitigation on Sage-Grouse Habitat Selection within an Energy Development Field	PLOS ONE			English	Article							RESOURCE SELECTION; NESTING HABITAT; IMPACTS; WINTER; POPULATIONS; ABUNDANCE; ECOLOGY; OFFSETS; SCALE	Growing global energy demands ensure the continued growth of energy development. Energy development in wildlife areas can significantly impact wildlife populations. Efforts to mitigate development impacts to wildlife are on-going, but the effectiveness of such efforts is seldom monitored or assessed. Greater sage-grouse (Centrocercus urophasianus) are sensitive to energy development and likely serve as an effective umbrella species for other sagebrush-steppe obligate wildlife. We assessed the response of birds within an energy development area before and after the implementation of mitigation action. Additionally, we quantified changes in habitat distribution and abundance in pre-and post-mitigation landscapes. Sage-grouse avoidance of energy development at large spatial scales is well documented. We limited our research to directly within an energy development field in order to assess the influence of mitigation in close proximity to energy infrastructure. We used nestlocation data (n = 488) within an energy development field to develop habitat selection models using logistic regression on data from 4 years of research prior to mitigation and for 4 years following the implementation of extensive mitigation efforts (e.g., decreased activity, buried powerlines). The post-mitigation habitat selection models indicated less avoidance of wells (well density beta = 0.18 +/- 0.08) than the pre-mitigation models (well density beta = -0.09 +/- 0.11). However, birds still avoided areas of high well density and nests were not found in areas with greater than 4 wells per km(2) and the majority of nests (63%) were located in areas with <= 1 well per km(2). Several other model coefficients differed between the two time periods and indicated stronger selection for sagebrush (pre-mitigation beta = 0.30 +/- 0.09; postmitigation beta = 0.82 +/- 0.08) and less avoidance of rugged terrain (pre-mitigation beta = -0.35 +/- 0.12; post-mitigation beta = -0.05 +/- 0.09). Mitigation efforts implemented may be responsible for the measurable improvement in sage-grouse nesting habitats within the development area. However, we cannot reject alternative hypotheses concerning the influence of population density and intraspecific competition. Additionally, we were unable to assess the actual fitness consequences of mitigation or the source-sink dynamics of the habitats. We compared the pre-mitigation and post-mitigation models predicted as maps with habitats ranked from low to high relative probability of use (equal-area bins: 1 -5). We found more improvement in habitat rank between the two time periods around mitigated wells compared to non-mitigated wells. Informed mitigation within energy development fields could help improve habitats within the field. We recommend that any mitigation effort include well-informed plans to monitor the effectiveness of the implemented mitigation actions that assess both habitat use and relevant fitness parameters.	[Fedy, Bradley C.] Univ Waterloo, Dept Environm & Resource Studies, Waterloo, ON N2L 3G1, Canada; [Kirol, Christopher P.; Sutphin, Andrew L.; Maechtle, Thomas L.] Big Horn Environm Consultants, Sheridan, WY USA	University of Waterloo	Fedy, BC (corresponding author), Univ Waterloo, Dept Environm & Resource Studies, Waterloo, ON N2L 3G1, Canada.	bfedy@uwaterloo.ca	Fedy, Bradley C/A-6017-2015	Fedy, Bradley/0000-0003-3933-4043	Anadarko Petroleum Corporation	Anadarko Petroleum Corporation	The research presented here was supported in part by Anadarko Petroleum Corporation in addition to many non-commercial entities. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The nest location data presented in this manuscript were submitted annually to the Wyoming Game and Fish Department as required. All other data (e.g., GIS layers) are publicly available through the relevant sources.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2012, J WILDLIFE MANAGE, V76, P391, DOI 10.1002/jwmg.268; Beyer HL, 2011, GEOSPATIAL MODELLING; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2011, ENERGY DEV WILDLIFE, pix; Braun CE, 2002, TRANS N AM WILDL NAT, V67, P337; Buchanan CB, 2014, RANGELAND ECOL MANAG, V67, P369, DOI 10.2111/REM-D-13-00136.1; Carpenter J, 2010, J WILDLIFE MANAGE, V74, P1806, DOI 10.2193/2009-368; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 2011, STUD AVIAN BIOL, P69; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Dalke P. D., 1963, Journal of Wildlife Management, V27, P811; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026273; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; ENG ROBERT L., 1955, JOUR WILDLIFE MANAGEMENT, V19, P267, DOI 10.2307/3796862; Fedy BC, 2014, WILDLIFE MONOGR, V190, P1, DOI 10.1002/wmon.1014; Fedy BC, 2012, J WILDLIFE MANAGE, V76, P1062, DOI 10.1002/jwmg.337; Fedy BC, 2011, J WILDLIFE MANAGE, V75, P1022, DOI 10.1002/jwmg.155; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Hanser SE, 2011, STUD AVIAN BIOL, P475; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; Holloran MJ, J WILDL MAN IN PRESS; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kirol CP, WILDLIFE BI IN PRESS; Lyon AG, 2003, WILDLIFE SOC B, V31, P486; Manly B.F.J., 2002, RESOURCE SELECTION A; Patterson R.L., 1952, SAGE GROUSE WYOMING; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Rowland MM, 2006, BIOL CONSERV, V129, P323, DOI 10.1016/j.biocon.2005.10.048; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Schroeder MA, 1999, BIRDS N AM, V425; Smith KT, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00238; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; Theobald DM, 2007, LCAP V1 0 LANSCAPE C; U.S. Fish and Wildlife Service, 2010, FED REGISTER, V75, P13909; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker B.L., 2008, GREATER SAGE GROUSE; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Walker BL, 2011, STUD AVIAN BIOL, P127; Wisdom MJ, 2011, STUD AVIAN BIOL, P451	55	19	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121603	10.1371/journal.pone.0121603	http://dx.doi.org/10.1371/journal.pone.0121603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835296	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000050
J	Ma, XX; Wang, LC; Wu, H; Li, N; Ma, L; Zeng, CF; Zhou, Y; Yang, J				Ma, Xiaoxue; Wang, Lachun; Wu, Hao; Li, Na; Ma, Lei; Zeng, Chunfen; Zhou, Yi; Yang, Jun			Impact of Yangtze River Water Transfer on the Water Quality of the Lixia River Watershed, China	PLOS ONE			English	Article							MULTIVARIATE STATISTICAL TECHNIQUES; INDEX METHOD; LAKE TAIHU; POLLUTION; RESTORATION; RESERVOIR; PROVINCE; REGIME	To improve water quality and reduce the negative impacts of sudden inputs of water pollution in the Lixia River watershed, China, a series of experimental water transfers from the Yangtze River to the Lixia River were conducted from 2 December 2006 to 7 January 2007. Water samples were collected every six days at 55 monitoring sites during this period. Eight water parameters (water temperature, pH, dissolved oxygen (DO), chemical oxygen demand (COD), potassium permanganate index (CODMn), ammonia nitrogen (NH4+-N), electrical conductivity (EC), and water transparency (WT)) were analyzed to determine changes in nutrient concentrations during water transfers. The comprehensive pollution index (Pi) and single-factor (Si) evaluation methods were applied to evaluate spatio-temporal patterns of water quality during water transfers. Water quality parameters displayed different spatial and temporal distribution patterns within the watershed. Water quality was improved significantly by the water transfers, especially for sites closer to water intake points. The degree of improvement is positively related to rates of transfer inflow and drainage outflow. The effects differed for different water quality parameters at each site and at different water transfer times. There were notable decreases in NH4+-N, DO, COD, and CODMn across the entire watershed. However, positive effects on EC and pH were not observed. It is concluded that freshwater transfers from the Yangtze River can be used as an emergency measure to flush pollutants from the Lixia River watershed. Improved understanding of the effects of water transfers on water quality can help the development and implementation of effective strategies to improve water quality within this watershed.	[Ma, Xiaoxue; Wang, Lachun; Wu, Hao; Li, Na; Ma, Lei; Zeng, Chunfen] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi] Hydrol & Water Resources Invest Bur Jiang Su Prov, Nanjing, Jiangsu, Peoples R China; [Yang, Jun] Flood Control & Drought Relief Command Ctr Jiangs, Nanjing, Jiangsu, Peoples R China	Nanjing University	Wang, LC (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing 210008, Jiangsu, Peoples R China.	wang6312@263.net.cn; zengchunfen@nju.edu.cn	Wu, Hao/J-2570-2017	Wu, Hao/0000-0003-3323-464X	Science and Technology Foundation of Department of Water Resources of Jiangsu Province [2014050]; Natural Science Foundation of Jiangsu Province [BK20130567]; National Science and Technology Pillar Program [2013BAB05B01-3]	Science and Technology Foundation of Department of Water Resources of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science and Technology Pillar Program	This work was supported by the Science and Technology Foundation of Department of Water Resources of Jiangsu Province (No. 2014050), Natural Science Foundation of Jiangsu Province (No. BK20130567), National Science and Technology Pillar Program (No. 2013BAB05B01-3). The funders of National Science and Technology Pillar Program (No. 2013BAB05B01-3) and Natural Science Foundation of Jiangsu Province (No. BK20130567) had the role in data collection and analysis. The funders of National Science and Technology Pillar Program (No. 2013BAB05B01-3) had the role in study design.	[Anonymous], 2002, ENV QUALITY STANDARD; [Anonymous], 2006, REP STAT CHIN ENV; Chen D, 2013, APPL GEOGR, V45, P303, DOI 10.1016/j.apgeog.2013.09.025; Fornarelli R, 2011, WATER RES, V45, P5873, DOI 10.1016/j.watres.2011.08.048; Ganoulis J, 2008, ENG RISK ANAL WATER, P6; Gibbins CN, 2001, FISHERIES MANAG ECOL, V8, P463, DOI 10.1046/j.1365-2400.2001.00274.x; He T, 2012, PROCED EARTH PLAN SC, V5, P314, DOI 10.1016/j.proeps.2012.01.053; Hilt S, 2011, OIKOS, V120, P766, DOI 10.1111/j.1600-0706.2010.18553.x; Hu LM, 2010, ECOL ENG, V36, P471, DOI 10.1016/j.ecoleng.2009.11.016; Hu WP, 2008, ECOL ENG, V34, P30, DOI 10.1016/j.ecoleng.2008.05.018; Li YP, 2013, ECOL ENG, V60, P399, DOI 10.1016/j.ecoleng.2013.09.067; Li YP, 2011, ECOL ENG, V37, P325, DOI 10.1016/j.ecoleng.2010.11.024; Liu SG, 2011, MAR POLLUT BULL, V62, P2220, DOI 10.1016/j.marpolbul.2011.06.021; Ma XX, 2014, DESALIN WATER TREAT, P1; Su SL, 2011, WATER RES, V45, P1781, DOI 10.1016/j.watres.2010.11.030; Varol M, 2011, J HAZARD MATER, V195, P355, DOI 10.1016/j.jhazmat.2011.08.051; Voutsa D, 2001, WATER AIR SOIL POLL, V129, P13, DOI 10.1023/A:1010315608905; WELCH EB, 1980, WATER RES, V14, P1317, DOI 10.1016/0043-1354(80)90192-X; WELCH EB, 1981, J AM WATER RESOUR AS, V17, P558; Welch EB, 1992, ECOL ENG, V1, P173, DOI DOI 10.1016/0925-8574(92)90001-I; [谢兴勇 XIE Xing-yong], 2009, [环境科学研究, Research of Environmental Sciences], V22, P897; Yang LP, 2013, ENVIRON SCI POLLUT R, V20, P5341, DOI 10.1007/s11356-013-1536-x; Yao Qing-zheng, 2009, Huanjing Kexue, V30, P3534; Zhai SJ, 2010, ECOL ENG, V36, P406, DOI 10.1016/j.ecoleng.2009.11.007; Zhao Y, 2012, PROCEDIA ENVIRON SCI, V13, P1213, DOI 10.1016/j.proenv.2012.01.115	25	12	13	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119720	10.1371/journal.pone.0119720	http://dx.doi.org/10.1371/journal.pone.0119720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835525	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000013
J	Makumire, S; Revaprasadu, N; Shonhai, A				Makumire, Stanley; Revaprasadu, Neerish; Shonhai, Addmore			DnaK Protein Alleviates Toxicity Induced by Citrate-Coated Gold Nanoparticles in Escherichia coli	PLOS ONE			English	Article							OXIDE NANOPARTICLES; OVERPRODUCTION; AGGREGATION; CHAPERONES; SUPPRESS; GROWTH; IRON	A number of previously reported studies suggest that synthetic gold nanoparticles (AuNPs) are capable of stabilising proteins against heat stress in vitro. However, it remains to be understood if AuNPs confer stability to proteins against cellular stress in vivo. Heat shock proteins (Hsps) are conserved molecules whose main role is to facilitate folding of other proteins (chaperone function). Hsp70 (called DnaK in prokaryotes) is one of the most prominent molecular chaperones. Since gold nanoparticles exhibit chaperone-like function in vitro, we investigated the effect of citrate-coated gold nanoparticles on the growth of E. coli BB1553 cells that possess a deleted dnaK gene. We further investigated the effects of the AuNPs on the solubility of the E. coli BB1553 proteome. E. coli BB1553 cells exposed to AuNPs exhibited cellular defects such as filamentation and plasma membranes pulled off the cell wall. The toxic effects of the AuNPs were alleviated by transforming the E. coli BB1553 cells with a construct expressing DnaK. We also noted that cells in which DnaK was restored exhibited distinct zones to which the nanoparticles were restricted. Our study suggests a role for DnaK in alleviating nanoparticle induced stress in E. coli.	[Makumire, Stanley; Shonhai, Addmore] Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa; [Revaprasadu, Neerish] Univ Zululand, Dept Chem, ZA-3886 Kwa Dlangezwa, South Africa; [Makumire, Stanley; Shonhai, Addmore] Univ Zululand, Dept Biochem & Microbiol, ZA-3886 Kwa Dlangezwa, South Africa	University of Venda; University of Zululand; University of Zululand	Shonhai, A (corresponding author), Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa.	adshon@gmail.com	Shonhai, Addmore/AAS-4506-2021	Revaprasadu, Neerish/0000-0001-5730-1232; Makumire, Stanley/0000-0003-4355-1382	National Research Foundation (ZA)	National Research Foundation (ZA)	This work was supported by the National Research Foundation (ZA) grant number, UID, awarded to AS and the National Research Foundation (ZA) grant awarded to NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; Chatterjee S, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-34; Chatterjee T, 2010, FEBS J, V277, P4184, DOI 10.1111/j.1742-4658.2010.07807.x; Cui WJ, 2012, NANOMED-NANOTECHNOL, V8, P46, DOI 10.1016/j.nano.2011.05.005; De M, 2008, CHEM COMMUN, P3504, DOI 10.1039/b805242e; Doyen M, 2013, J COLLOID INTERF SCI, V399, P1, DOI 10.1016/j.jcis.2013.02.040; Dunpall R, 2012, IUBMB LIFE, V64, P995, DOI 10.1002/iub.1100; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Gagner JE, 2012, BIOMATERIALS, V33, P8503, DOI 10.1016/j.biomaterials.2012.07.009; Gagner JE, 2011, BIOMATERIALS, V32, P7241, DOI 10.1016/j.biomaterials.2011.05.091; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Klaper R, 2014, ANALYST, V139, P882, DOI 10.1039/c3an01644g; Klein J, 2007, P NATL ACAD SCI USA, V104, P2029, DOI 10.1073/pnas.0611610104; Liebscher M, 2007, J BIOL CHEM, V282, P4437, DOI 10.1074/jbc.M607667200; Luthuli SD, 2013, IUBMB LIFE, V65, P454, DOI 10.1002/iub.1146; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Makumire S, 2014, TOXICOL LETT, V227, P56, DOI 10.1016/j.toxlet.2014.02.027; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2000, BIOL CHEM, V381, P877, DOI 10.1515/BC.2000.109; Mogk A, 1999, J BACTERIOL, V181, P1320; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029; Prema P., 2013, INT J PHARM PHARM SC, V5, p310?314, DOI DOI 10.1016/J.EURP0LYMJ.2007.01.012; Rocha S, 2008, BIOPHYS CHEM, V137, P35, DOI 10.1016/j.bpc.2008.06.010; Selvaraj V, 2007, INT J PHARMACEUT, V337, P275, DOI 10.1016/j.ijpharm.2006.12.027; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A., 2014, HEAT SHOCK PROTEINS, P47, DOI [10.1007/978-94-007-7438-4_3, DOI 10.1007/978-94-007-7438-4_3]; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Sobczak-Kupiec A, 2011, DIG J NANOMATER BIOS, V6, P803; Suppini JP, 2004, J BACTERIOL, V186, P6248, DOI 10.1128/JB.186.18.6248-6253.2004; Thi Ha Lien Nghiem, 2010, Advances in Natural Sciences: Nanoscience & Nanotechnology, V1, DOI 10.1088/2043-6254/1/2/025009; Triulzi RC, 2008, COLLOID SURFACE B, V63, P200, DOI 10.1016/j.colsurfb.2007.12.006; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505; Zhang DM, 2009, NANO LETT, V9, P666, DOI 10.1021/nl803054h; Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19	39	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121243	10.1371/journal.pone.0121243	http://dx.doi.org/10.1371/journal.pone.0121243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837593	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000042
J	Andreou, AP; Efthymiou, M; Yu, Y; Watts, HR; Noormohamed, FH; Ma, DQ; Lane, DA; Crawley, JTB				Andreou, Anna P.; Efthymiou, Maria; Yu, Yao; Watts, Helena R.; Noormohamed, Faruq H.; Ma, Daqing; Lane, David A.; Crawley, James T. B.			Protective Effects of Non-Anticoagulant Activated Protein C Variant (D36A/L38D/A39V) in a Murine Model of Ischaemic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; HEPARIN-BINDING; BASIC RESIDUES; GLA DOMAIN; RECEPTOR 1; MICE; INHIBITOR; PATHWAY; BRAIN	Ischaemic stroke is caused by occlusive thrombi in the cerebral vasculature. Although tissue-plasminogen activator (tPA) can be administered as thrombolytic therapy, it has major limitations, which include disruption of the blood-brain barrier and an increased risk of bleeding. Treatments that prevent or limit such deleterious effects could be of major clinical importance. Activated protein C (APC) is a natural anticoagulant that regulates thrombin generation, but also confers endothelial cytoprotective effects and improved endothelial barrier function mediated through its cell signalling properties. In murine models of stroke, although APC can limit the deleterious effects of tPA due to its cell signalling function, its anticoagulant actions can further elevate the risk of bleeding. Thus, APC variants such as APC(5A), APC(Ca-ins) and APC(36-39) with reduced anticoagulant, but normal signalling function may have therapeutic benefit. Human and murine protein C (5A), (Ca-ins) and (36-39) variants were expressed and characterised. All protein C variants were secreted normally, but 5-20% of the protein C (Ca-ins) variants were secreted as disulphide-linked dimers. Thrombin generation assays suggested reductions in anticoagulant function of 50- to 57-fold for APC(36-39), 22- to 27-fold for APC(Ca-ins) and 14- to 17-fold for APC(5A). Interestingly, whereas human wt APC, APC(36-39) and APC(Ca-ins) were inhibited similarly by protein C inhibitor (t(1/2) - 33 to 39 mins), APC(5A) was inactivated 9-fold faster (t(1/2) - 4 mins). Using the murine middle cerebral artery occlusion ischaemia/repurfusion injury model, in combination with tPA, APC(36-39), which cannot be enhanced by its cofactor protein S, significantly improved neurological scores, reduced cerebral infarct area by similar to 50% and reduced oedema ratio. APC(36-39) also significantly reduced bleeding in the brain induced by administration of tPA, whereas wt APC did not. If our data can be extrapolated to clinical settings, then APC(36-39) could represent a feasible adjunctive therapy for ischaemic stroke.	[Andreou, Anna P.; Efthymiou, Maria; Yu, Yao; Lane, David A.; Crawley, James T. B.] Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, London, England; [Andreou, Anna P.; Watts, Helena R.; Noormohamed, Faruq H.; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Sect Anaesthet Pain Med & Intens Care, London, England	Imperial College London; Imperial College London	Andreou, AP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, London, England.	a.andreou@imperial.ac.uk	Ma, Daqing/GLT-2735-2022; Andreou, Anna P/J-6245-2012; Crawley, James/A-9290-2008	Ma, Daqing/0000-0003-1235-0537; Andreou, Anna P/0000-0002-7008-6626; Crawley, James/0000-0002-6723-7841; Ma, Daqing/0000-0002-0688-2097; Lane, David/0000-0003-4283-3695; Watts, Helena/0000-0002-8559-8376; Efthymiou, Maria/0000-0001-9704-2845	British Heart Foundation [PG/09/005/26627]; British Society for Thrombosis and Haemostasis; British Society for Haematology; LifeBlood: The Thrombosis Charity	British Heart Foundation(British Heart Foundation); British Society for Thrombosis and Haemostasis; British Society for Haematology; LifeBlood: The Thrombosis Charity	This work was supported by a British Heart Foundation (http://www.bhf.org.uk/) grant awarded to JTBC and DAL (PG/09/005/26627) and a PhD studentship jointly funded by the British Society for Thrombosis and Haemostasis (http://www.leeds.ac.uk/bsht/), the British Society for Haematology (http://www.b-s-h.org.uk/) and LifeBlood: The Thrombosis Charity (http://www.thrombosis-charity.org.uk/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnstrom J, 2012, BLOOD, V120, P5059, DOI 10.1182/blood-2012-05-432005; Ahnstrom J, 2011, BLOOD, V117, P6685, DOI 10.1182/blood-2010-11-317099; Ainle FN, 2011, J BIOL CHEM, V286, P1323, DOI 10.1074/jbc.M110.159475; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bouwens EAM, 2013, J THROMB HAEMOST, V11, P242, DOI 10.1111/jth.12247; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Fernandez JA, 2009, HAEMATOL-HEMATOL J, V94, P1721, DOI 10.3324/haematol.2009.009233; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; Glasscock LN, 2003, BBA-PROTEINS PROTEOM, V1649, P106, DOI 10.1016/S1570-9639(03)00164-X; Guo H, 2009, J NEUROCHEM, V109, P116, DOI 10.1111/j.1471-4159.2009.05921.x; Guo H, 2009, EUR J NEUROSCI, V29, P1119, DOI 10.1111/j.1460-9568.2009.06664.x; Harmon S, 2008, J BIOL CHEM, V283, P30531, DOI 10.1074/jbc.M802338200; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Lansberg MG, 2009, STROKE, V40, P2079, DOI 10.1161/STROKEAHA.108.540708; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; Lopez-Sagaseta J, 2009, PROTEIN EXPRES PURIF, V64, P194, DOI 10.1016/j.pep.2008.11.002; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; OKAJIMA K, 1990, THROMB HAEMOSTASIS, V63, P48; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Sen P, 2012, THROMB HAEMOSTASIS, V107, P951, DOI 10.1160/TH11-09-0672; Shen L, 2000, BIOCHEMISTRY-US, V39, P2853, DOI 10.1021/bi992357p; Suzuki Y, 2007, J THROMB HAEMOST, V5, P1732, DOI 10.1111/j.1538-7836.2007.02628.x; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655; Yang LK, 2002, BIOCHEMISTRY-US, V41, P6149, DOI 10.1021/bi015899r; ZHANG L, 1990, BIOCHEMISTRY-US, V29, P10828, DOI 10.1021/bi00500a016; ZHANG L, 1992, BLOOD, V80, P942	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122410	10.1371/journal.pone.0122410	http://dx.doi.org/10.1371/journal.pone.0122410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830552	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600109
J	Cai, YC; Jin, CJ; Wang, AZ; Guan, DX; Wu, JB; Yuan, FH; Xu, LL				Cai, Yancong; Jin, Changjie; Wang, Anzhi; Guan, Dexin; Wu, Jiabing; Yuan, Fenghui; Xu, Leilei			Spatio-Temporal Analysis of the Accuracy of Tropical Multisatellite Precipitation Analysis 3B42 Precipitation Data in Mid-High Latitudes of China	PLOS ONE			English	Article							RAIN-GAUGE DATA; SATELLITE RAINFALL; ANALYSIS TMPA; PRODUCTS; SURFACE; MODEL; UNCERTAINTY; INTENSITY; FREQUENCY; VERSION-6	Satellite-based precipitation data have contributed greatly to quantitatively forecasting precipitation, and provides a potential alternative source for precipitation data allowing researchers to better understand patterns of precipitation over ungauged basins. However, the absence of calibration satellite data creates considerable uncertainties for The Tropical Rainfall Measuring Mission (TRMM) Multisatellite Precipitation Analysis (TMPA) 3B42 product over high latitude areas beyond the TRMM satellites latitude band (38 degrees NS). This study attempts to statistically assess TMPA V7 data over the region beyond 40 degrees NS using data obtained from numerous weather stations in 1998-2012. Comparative analysis at three timescales (daily, monthly and annual scale) indicates that adoption of a monthly adjustment significantly improved correlation at a larger timescale increasing from 0.63 to 0.95; TMPA data always exhibits a slight overestimation that is most serious at a daily scale (the absolute bias is 103.54%). Moreover, the performance of TMPA data varies across all seasons. Generally, TMPA data performs best in summer, but worst in winter, which is likely to be associated with the effects of snow/ice-covered surfaces and shortcomings of precipitation retrieval algorithms. Temporal and spatial analysis of accuracy indices suggest that the performance of TMPA data has gradually improved and has benefited from upgrades; the data are more reliable in humid areas than in arid regions. Special attention should be paid to its application in arid areas and in winter with poor scores of accuracy indices. Also, it is clear that the calibration can significantly improve precipitation estimates, the overestimation by TMPA in TRMM-covered area is about a third as much as that in no-TRMM area for monthly and annual precipitation. The systematic evaluation of TMPA over mid-high latitudes provides a broader understanding of satellite-based precipitation estimates, and these data are important for the rational application of TMPA methods in climatic and hydrological research.	[Cai, Yancong; Jin, Changjie; Wang, Anzhi; Guan, Dexin; Wu, Jiabing; Yuan, Fenghui] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China; [Cai, Yancong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Xu, Leilei] Chinese Acad Trop Agr Sci, Inst Sci & Tech Informat, Danzhou, Hainan, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Tropical Agricultural Sciences	Wang, AZ (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China.	waz@iae.ac.cn	Yuan, Fenghui/W-3609-2019; Yuan, Fenghui/M-7424-2013; Guan, Dexin/I-4184-2018	Yuan, Fenghui/0000-0003-1004-873X; Yuan, Fenghui/0000-0003-1004-873X; Guan, Dexin/0000-0002-2183-3779	Major State Basic Research Development Program [2013CB429902]; Natural Science Foundation of China [31370614, 41371064]	Major State Basic Research Development Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by Major State Basic Research Development Program (2013CB429902, http://www.973.gov.cn/English/Index.aspx), Natural Science Foundation of China (31370614, http://www.nsfc.gov.cn/publish/portal0/default. htm), and Natural Science Foundation of China (41371064, http://www.nsfc.gov.cn/publish/portal0/default. htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Almazroui M, 2011, ATMOS RES, V99, P400, DOI 10.1016/j.atmosres.2010.11.006; Behrangi A, 2011, J HYDROL, V397, P225, DOI 10.1016/j.jhydrol.2010.11.043; Bitew MM, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009917; Chatfield C, 1996, J FORECASTING, V15, P495; Chen S, 2013, J GEOPHYS RES-ATMOS, V118, P13060, DOI 10.1002/2013JD019964; Chen S, 2013, WATER RESOUR RES, V49, P8174, DOI 10.1002/2012WR012795; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; Dai A, 2007, CLIM DYNAM, V29, P727, DOI 10.1007/s00382-007-0260-y; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; DeMoss JD, 2007, J ATMOS OCEAN TECH, V24, P1598, DOI 10.1175/JTECH2082.1; Gao YC, 2013, HYDROL EARTH SYST SC, V17, P837, DOI 10.5194/hess-17-837-2013; Gebremichael M, 2005, J APPL METEOROL, V44, P665, DOI 10.1175/JAM2233.1; GORDON HB, 1992, CLIM DYNAM, V8, P83, DOI 10.1007/BF00209165; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Habib E, 2009, ATMOS RES, V94, P373, DOI 10.1016/j.atmosres.2009.06.015; Hsu KL, 1997, J APPL METEOROL, V36, P1176, DOI 10.1175/1520-0450(1997)036<1176:PEFRSI>2.0.CO;2; Jamandre CA, 2013, ATMOS RES, V122, P599, DOI 10.1016/j.atmosres.2012.06.024; Joyce R, 1997, J ATMOS OCEAN TECH, V14, P997, DOI 10.1175/1520-0426(1997)014<0997:IEOTAS>2.0.CO;2; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kirstetter PE, 2013, J HYDROMETEOROL, V14, P661, DOI 10.1175/JHM-D-12-030.1; Liechti TC, 2012, HYDROL EARTH SYST SC, V16, P489, DOI 10.5194/hess-16-489-2012; Liu YQ, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005756; Lo Conti F, 2014, ATMOS RES, V138, P189, DOI 10.1016/j.atmosres.2013.11.011; Meehl GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023680; Meng J, 2014, J HYDROL, V509, P320, DOI 10.1016/j.jhydrol.2013.11.049; Moazami S, 2013, INT J REMOTE SENS, V34, P8156, DOI 10.1080/01431161.2013.833360; Oberkampf WL, 2002, RELIAB ENG SYST SAFE, V75, P333, DOI 10.1016/S0951-8320(01)00120-X; Ochoa-Sanchez A. E., 2014, HYDROL EARTH SYST SC, V11, P411, DOI [10.5194/hessd-11-411-2014, DOI 10.5194/HESSD-11-411-2014]; Ouma YO, 2012, INT J REMOTE SENS, V33, P7662, DOI 10.1080/01431161.2012.701347; Pan M, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008290; Peng SS, 2013, AGR FOREST METEOROL, V178, P46, DOI 10.1016/j.agrformet.2013.02.002; Prakash S, 2013, REMOTE SENS LETT, V4, P677, DOI 10.1080/2150704X.2013.783248; Prasetia R, 2013, THEOR APPL CLIMATOL, V112, P575, DOI 10.1007/s00704-012-0756-1; Ramarohetra J, 2013, AGR FOREST METEOROL, V180, P118, DOI 10.1016/j.agrformet.2013.05.010; Romilly TG, 2011, HYDROL EARTH SYST SC, V15, P1505, DOI 10.5194/hess-15-1505-2011; Scheel MLM, 2011, HYDROL EARTH SYST SC, V15, P2649, DOI 10.5194/hess-15-2649-2011; Serra YL, 2003, J APPL METEOROL, V42, P1045, DOI [10.1175/1520-0450(2003)042<1045:MTASCO>2.0.CO;2, 10.1175/1520-0450(2003)042&lt;1045:MTASCO&gt;2.0.CO;2]; Sorooshian S, 2000, B AM METEOROL SOC, V81, P2035, DOI 10.1175/1520-0477(2000)081<2035:EOPSSE>2.3.CO;2; Su FG, 2008, J HYDROMETEOROL, V9, P622, DOI 10.1175/2007JHM944.1; Tian Y, 2007, J HYDROMETEOROL, V8, P1165, DOI 10.1175/2007JHM859.1; Vila DA, 2009, J HYDROMETEOROL, V10, P533, DOI 10.1175/2008JHM1048.1; Wilks DS, 2011, STATISTICAL METHODS, V100; Xie PP, 1996, J CLIMATE, V9, P840, DOI 10.1175/1520-0442(1996)009<0840:AOGMPU>2.0.CO;2; Xue XW, 2013, J HYDROL, V499, P91, DOI 10.1016/j.jhydrol.2013.06.042; Yong B, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017069; Yong B, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008965	47	17	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120026	10.1371/journal.pone.0120026	http://dx.doi.org/10.1371/journal.pone.0120026			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830776	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600020
J	Puig-Ribera, A; Bort-Roig, J; Gonzalez-Saarez, AM; Martinez-Lemos, I; Gine-Garriga, M; Fortuno, J; Martori, JC; Munoz-Ortiz, L; Mila, R; McKenna, J; Gilson, ND				Puig-Ribera, Anna; Bort-Roig, Judit; Gonzalez-Suarez, Angel M.; Martinez-Lemos, Ivan; Gine-Garriga, Maria; Fortuno, Josep; Martori, Joan C.; Munoz-Ortiz, Laura; Mila, Raimon; McKenna, Jim; Gilson, Nicholas D.			Patterns of Impact Resulting from a 'Sit Less, Move More' Web-Based Program in Sedentary Office Employees	PLOS ONE			English	Article							REDUCING SITTING TIME; PHYSICAL-ACTIVITY; WORKPLACE; WORKSTATIONS; INTERVENTION; RELIABILITY; WALKING; WORK	Purpose Encouraging office workers to 'sit less and move more' encompasses two public health priorities. However, there is little evidence on the effectiveness of workplace interventions for reducing sitting, even less about the longer term effects of such interventions and still less on dual-focused interventions. This study assessed the short and mid-term impacts of a workplace web-based intervention (Walk@WorkSpain, W@WS; 2010-11) on self-reported sitting time, step counts and physical risk factors (waist circumference, BMI, blood pressure) for chronic disease. Methods Employees at six Spanish university campuses (n=264; 42 +/- 10 years; 171 female) were randomly assigned by worksite and campus to an Intervention (used W@WS; n=129; 87 female) or a Comparison group (maintained normal behavior; n=135; 84 female). This phased, 19-week program aimed to decrease occupational sitting time through increased incidental movement and short walks. A linear mixed model assessed changes in outcome measures between the baseline, ramping (8 weeks), maintenance (11 weeks) and follow-up (two months) phases for Intervention versus Comparison groups. Results A significant 2 (group) x 2 (program phases) interaction was found for self-reported occupational sitting (F[3]=7.97, p=0.046), daily step counts (F[3]=15.68, p=0.0013) and waist circumference (F[3]=11.67, p=0.0086). The Intervention group decreased minutes of daily occupational sitting while also increasing step counts from baseline (446 +/- 126; 8,862 +/- 2,475) through ramping (+425 +/- 120; 9,345 +/- 2,435), maintenance (+422 +/- 123; 9,638 +/- 3,131) and follow-up (+414 +/- 129; 9,786 +/- 3,205). In the Comparison group, compared to baseline (404 +/- 106), sitting time remained unchanged through ramping and maintenance, but decreased at follow-up (-388 +/- 120), while step counts diminished across all phases. The Intervention group significantly reduced waist circumference by 2.1cms from baseline to follow-up while the Comparison group reduced waist circumference by 1.3cms over the same period. Conclusions W@WSis a feasible and effective evidence-based intervention that can be successfully deployed with sedentary employees to elicit sustained changes on "sitting less and moving more".	[Puig-Ribera, Anna; Bort-Roig, Judit] Univ Vic Univ Cent Catalunya, Dept Ciencies Activitat Fis, Univ Vic, Barcelona 08500, Spain; [Gonzalez-Suarez, Angel M.] Univ Basque Country, Dept Educ Fis & Deport, Vitoria 01007, Spain; [Martinez-Lemos, Ivan] Univ Vigo, Fac CC EE & Deporte, Pontevedra 36005, Spain; [Gine-Garriga, Maria] Univ Ramon Llull, Phys Act & Sport Sci Dept, FPCEE Blanquerna, Barcelona 08022, Spain; [Gine-Garriga, Maria; Fortuno, Josep] Univ Ramon Llull, Phys Therapy Dept, FCS Blanquerna, Barcelona 08025, Spain; [Martori, Joan C.] Univ Vic Univ Cent Catalunya, Dept Econ & Business, Barcelona 08500, Spain; [Munoz-Ortiz, Laura] Inst Univ Invest Atencio Primaria Jordi Gol, Unitat Suport Recerca Metropolitana Nord, Barcelona 08303, Spain; [Mila, Raimon] Univ Vic Univ Cent Catalunya, Dept Salut & Accio Social, Barcelona, Spain; [McKenna, Jim] Leeds Beckett Univ, Sch Sport, Leeds LS6 3QS, W Yorkshire, England; [Gilson, Nicholas D.] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld 4072, Australia	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Basque Country; Universidade de Vigo; Universitat Ramon Llull; Universitat Ramon Llull; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Leeds Beckett University; University of Queensland	Puig-Ribera, A (corresponding author), Univ Vic Univ Cent Catalunya, Dept Ciencies Activitat Fis, Univ Vic, C Sagrada Familia 7, Barcelona 08500, Spain.	annam.puig@uvic.cat	Giné-Garriga, Maria/AAF-9828-2019; Giné-Garriga, Maria/F-4089-2016; Martínez-Lemos, R. Iván/F-3543-2016; Martori, Joan-Carles/K-8641-2014; Martínez-Lemos, R. Iván/K-8563-2019	Giné-Garriga, Maria/0000-0003-4449-3524; Giné-Garriga, Maria/0000-0003-4449-3524; Martínez-Lemos, R. Iván/0000-0002-0111-2413; Martori, Joan-Carles/0000-0002-8400-5487; Martínez-Lemos, R. Iván/0000-0002-0111-2413; GONZALEZ-SUAREZ, ANGEL MANUEL/0000-0003-1470-2241; Bort Roig, Judit/0000-0003-4622-4897	Spanish Ministry of Science and Innovation (MICCIN) [DEP 2009-1147]	Spanish Ministry of Science and Innovation (MICCIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The study was funded by the Spanish Ministry of Science and Innovation (MICCIN)(project reference DEP 2009-1147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; American College of Sports Medicine, 2009, ACSM GUID EX TEST PR; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chau JY, 2010, PREV MED, V51, P352, DOI 10.1016/j.ypmed.2010.08.012; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Clemes SA, 2014, J OCCUP ENVIRON MED, V56, P298, DOI 10.1097/JOM.0000000000000101; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Freak-Poli R, 2011, PREV MED, V53, P162, DOI 10.1016/j.ypmed.2011.06.005; Gilson N, 2008, J PHYS ACT HEALTH, V5, pS176, DOI 10.1123/jpah.5.s1.s176; Gilson ND, 2013, PREV MED, V56, P283, DOI 10.1016/j.ypmed.2013.01.022; Gilson ND, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-43; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Haynes L, 2012, LEARN ADAPT DEV PUBL; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Lobb R, 2013, ANNU REV PUBL HEALTH, V34, P235, DOI 10.1146/annurev-publhealth-031912-114444; Neuhaus M, 2014, AM J PREV MED, V46, P30, DOI 10.1016/j.amepre.2013.09.009; Organizacion Mundial de la Salud & Forum Economico Mundial, 2008, PREV ENF TRANSM LUG, DOI [10.3265/Nefrologia.pre2014.Apr.12481, DOI 10.3265/NEFROLOGIA.PRE2014]; Parry S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078957; Pedersen SJ, 2013, WORK, V9, P14, DOI [10.1182/asheducation-2013.1.9, DOI 10.1182/ASHEDUCATION-2013.1.9]; Plotnikoff R, 2012, ARCH ENVIRON OCCUP H, V67, P125, DOI 10.1080/19338244.2012.697407; Puig-Ribera A, 2011, MED SCI SPORTS EXERC, V43, ps372; Puig-Ribera Anna, 2008, Promot Educ, V15, P11, DOI 10.1177/1025382308097693; Saidj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070213; Stamatakis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073753; Swift DL, 2012, AM J PREV MED, V43, P629, DOI 10.1016/j.amepre.2012.08.024; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Torbeyns T, 2014, SPORTS MED, V44, P1261, DOI 10.1007/s40279-014-0202-x; Tudor-Locke C, 2014, INT J OBESITY, V38, P755, DOI 10.1038/ijo.2013.223; Tudor-Locke C, 2013, APPL PHYSIOL NUTR ME, V38, P100, DOI 10.1139/apnm-2012-0235; Tudor-Locke C, 2011, J OCCUP ENVIRON MED, V53, P1382, DOI 10.1097/JOM.0b013e31823c1402; Tudor-Locke C, 2011, PREV MED, V53, P178, DOI 10.1016/j.ypmed.2011.06.004; Van Dyck D, 2015, INT J OBESITY, V39, P199, DOI 10.1038/ijo.2014.115; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wijndaele K, 2014, MED SCI SPORT EXER, V46, P1248, DOI 10.1249/MSS.0000000000000214	36	46	46	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122474	10.1371/journal.pone.0122474	http://dx.doi.org/10.1371/journal.pone.0122474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830782	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000352135600111
J	Saito, K; Fukumoto, E; Yamada, A; Yuasa, K; Yoshizaki, K; Iwamoto, T; Saito, M; Nakamura, T; Fukumoto, S				Saito, Kan; Fukumoto, Emiko; Yamada, Aya; Yuasa, Kenji; Yoshizaki, Keigo; Iwamoto, Tsutomu; Saito, Masahiro; Nakamura, Takashi; Fukumoto, Satoshi			Interaction between Fibronectin and beta 1 Integrin Is Essential for Tooth Development	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; DENTAL-PULP CELLS; IMMUNOFLUORESCENT LOCALIZATION; RECEPTOR ACTIVATOR; MATRIX PROTEINS; GENE-EXPRESSION; BINDING DOMAIN; MESSENGER-RNA; INTEGRIN; DIFFERENTIATION	The dental epithelium and extracellular matrix interact to ensure that cell growth and differentiation lead to the formation of teeth of appropriate size and quality. To determine the role of fibronectin in differentiation of the dental epithelium and tooth formation, we analyzed its expression in developing incisors. Fibronectin mRNA was expressed during the presecretory stage in developing dental epithelium, decreased in the secretory and early maturation stages, and then reappeared during the late maturation stage. The binding of dental epithelial cells derived from postnatal day-1 molars to a fibronectin-coated dish was inhibited by the RGD but not RAD peptide, and by a beta 1 integrin-neutralizing antibody, suggesting that fibronectin-beta 1 integrin interactions contribute to dental epithelial-cell binding. Because fibronectin and beta 1 integrin are highly expressed in the dental mesenchyme, it is difficult to determine precisely how their interactions influence dental epithelial differentiation in vivo. Therefore, we analyzed beta 1 integrin conditional knockout mice (Int beta 1(lox-/lox-)/K14-Cre) and found that they exhibited partial enamel hypoplasia, and delayed eruption of molars and differentiation of ameloblasts, but not of odontoblasts. Furthermore, a cyst-like structure was observed during late ameloblast maturation. Dental epithelial cells from knockout mice did not bind to fibronectin, and induction of ameloblastin expression in these cells by neurotrophic factor-4 was inhibited by treatment with RGD peptide or a fibronectin siRNA, suggesting that the epithelial interaction between fibronectin and beta 1 integrin is important for ameloblast differentiation and enamel formation.	[Saito, Kan; Fukumoto, Emiko; Yamada, Aya; Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 980, Japan; [Saito, Masahiro] Tohoku Univ, Grad Sch Dent, Dept Restorat Dent, Operat Dent, Sendai, Miyagi 980, Japan; [Yuasa, Kenji] St Marys Hosp, Pediat Dent, Kurume, Fukuoka, Japan; [Yoshizaki, Keigo] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Orthodont, Fukuoka 812, Japan; [Iwamoto, Tsutomu] Univ Tokushima, Grad Sch, Dept Pediat Dent, Tokushima 770, Japan	Tohoku University; Tohoku University; Kyushu University; Tokushima University	Saito, K (corresponding author), Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 980, Japan.	kanta@dent.tohoku.ac.jp	Saito, Kan/AFS-5564-2022; Saito, Kan/AAG-3507-2020; Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021; Nakamura, Takashi/P-7796-2016; Nakamura, Takashi/A-8931-2012	Saito, Kan/0000-0002-2151-6204; Saito, Kan/0000-0002-2151-6204; Iwamoto, Tsutomu/0000-0001-8472-605X; Nakamura, Takashi/0000-0001-9904-1037; Nakamura, Takashi/0000-0001-9904-1037; Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891	Ministry of Education, Science, Culture of Japan [20679006]; NEXT program [LS010, 24792294, 21792054]	Ministry of Education, Science, Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid from the Ministry of Education, Science (20679006), Culture of Japan, and the NEXT program (LS010), Grant-in-Aid for Young Scientists (24792294), Grant-in-Aid for Scientific Research (21792054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; BERNFIELD M, 1982, DEV BIOL, V90, P291, DOI 10.1016/0012-1606(82)90378-5; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Castaneda B, 2011, J CELL PHYSIOL, V226, P74, DOI 10.1002/jcp.22305; Chen B, 2009, J DENT RES, V88, P539, DOI 10.1177/0022034509338008; EKBLOM P, 1986, ANNU REV CELL BIOL, V2, P27, DOI 10.1146/annurev.cb.02.110186.000331; Faraldo MM, 2001, EMBO REP, V2, P431, DOI 10.1093/embo-reports/kve086; Fukumoto E, 2003, J DENT RES, V82, P17, DOI 10.1177/154405910308200105; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Khan SZ, 2013, AUST ENDOD J, V39, P137, DOI 10.1111/j.1747-4477.2012.00351.x; Kreiborg S, 1999, J CRAN GENET DEV BIO, V19, P75; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LESOT H, 1992, DIFFERENTIATION, V49, P109, DOI 10.1111/j.1432-0436.1992.tb00775.x; LESOT H, 1981, DEV BIOL, V82, P371, DOI 10.1016/0012-1606(81)90460-7; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Miyazaki Y, 1998, ARCH ORAL BIOL, V43, P367, DOI 10.1016/S0003-9969(98)00014-4; Mizuno M, 2008, INT ENDOD J, V41, P933, DOI 10.1111/j.1365-2591.2008.01420.x; Mizuno M, 2003, J CELL BIOCHEM, V88, P1112, DOI 10.1002/jcb.10466; Modolo F, 2004, ORAL DIS, V10, P277, DOI 10.1111/j.1601-0825.2004.01028.x; Mohazab L, 2013, J CELL SCI, V126, P732, DOI 10.1242/jcs.112599; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; Narani N, 2007, EUR J ORAL SCI, V115, P288, DOI 10.1111/j.1600-0722.2007.00467.x; Nishiguchi M, 2007, ARCH ORAL BIOL, V52, P237, DOI 10.1016/j.archoralbio.2006.09.016; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pulkkinen L, 1998, AM J HUM GENET, V63, P1376, DOI 10.1086/302116; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakai T, 1996, ARCH ORAL BIOL, V41, P885, DOI 10.1016/S0003-9969(96)00014-3; Salmivirta K, 1996, DEV DYNAM, V205, P104, DOI 10.1002/(SICI)1097-0177(199602)205:2<104::AID-AJA2>3.0.CO;2-M; SAWADA T, 1995, ARCH ORAL BIOL, V40, P1029, DOI 10.1016/0003-9969(95)00073-X; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069343; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; THESLEFF I, 1989, International Journal of Developmental Biology, V33, P91; THESLEFF I, 1979, DEV BIOL, V70, P116, DOI 10.1016/0012-1606(79)90011-3; Wang P, 2000, Chin J Dent Res, V3, P55; Wang SK, 2013, HUM MOL GENET; Wang Y, 2013, DEV BIOL, V382, P27, DOI 10.1016/j.ydbio.2013.08.003; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WIKTORJEDRZEJCZAK W, 1994, ENDOCRINOLOGY, V134, P1932, DOI 10.1210/en.134.4.1932; WU CY, 1995, J CELL SCI, V108, P821; YAMADA S, 1994, INT J DEV BIOL, V38, P553; Yang Y, 1998, EUR J IMMUNOL, V28, P995, DOI 10.1002/(SICI)1521-4141(199803)28:03<995::AID-IMMU995>3.0.CO;2-D; YOSHIBA N, 1994, ARCH ORAL BIOL, V39, P395, DOI 10.1016/0003-9969(94)90169-4; Yoshida T, 2012, J DENT RES, V91, P1154, DOI 10.1177/0022034512462722; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200	51	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121667	10.1371/journal.pone.0121667	http://dx.doi.org/10.1371/journal.pone.0121667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830530	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600078
J	Mieila, M; Popescu, C; Tudorache, AM; Toplicianu, V				Mieila, Mihai; Popescu, Constanta; Tudorache, Ana-Maria; Toplicianu, Valerica			Modelling Discrete Choice Variables in Assessment of Teaching Staff Work Satisfaction	PLOS ONE			English	Article							JOB-SATISFACTION; MOTIVATION; TEACHERS; PROFESSION; INTENTIONS; COMMITMENT	Levels of self-reported job satisfaction and motivation were measured by survey in a sample of 286 teachers. Using the discrete choice framework, the paper tries to assess the relevance of the considered indicators (demographic, social, motivational) in overall teaching work satisfaction. The findings provide evidence that job satisfaction is correlated significantly with level of university degree held by the teacher, type of secondary school where the teacher is enrolled, revenues, and salary-tasks adequacy. This is important for the Romanian economy, since the education system is expected to provide future human resources with enhanced skills and abilities.	[Mieila, Mihai; Popescu, Constanta; Tudorache, Ana-Maria; Toplicianu, Valerica] Valahia Univ, Fac Econ Sci, Targoviste 130105, Romania	Valahia University of Targoviste	Mieila, M (corresponding author), Valahia Univ, Fac Econ Sci, 35 Lt Stancu Ion, Targoviste 130105, Romania.	m_mieila@yahoo.com						Andrei T., 2008, ECONOMETRIE; Anthony G, 2008, ASIA-PAC J TEACH EDU, V36, P359, DOI 10.1080/13598660802395865; Baltagi B.H., 2008, ECONOMETRIC ANAL PAN; Barnabe C, 1988, CANADIAN J ED REV CA, V13, P391; Batchler M, 1981, J EDUC ADMIN, V19, P44; Bishay A., 1996, J UNDERGRADUATE SCI, V3, P147; Bruinsma M, 2010, EUR J TEACH EDUC, V33, P185, DOI 10.1080/02619760903512927; Brunetti G. J., 2001, TEACHER ED Q, V28, P49; Cameron AC, 2005, MICROECONOMETRICS ME, DOI [10.1002/hec.1560, DOI 10.1002/HEC.1560]; Canrinus ET, 2012, EUR J PSYCHOL EDUC, V27, P115, DOI 10.1007/s10212-011-0069-2; Celikoz N, 2010, EDUCATION, V131, P113; Cicea C., 2004, EC SERIA MANAGEMENT, V1, P102; Day C., 2006, VARIATION TEACHERS W; de Jesus SN, 2005, APPL PSYCHOL-INT REV, V54, P119; Evans L., 2001, EDUC MANAGE ADM, V29, P291; Gilpin G, 2012, J PUBLIC ECON, V96, P417, DOI 10.1016/j.jpubeco.2011.10.003; Gokce F, 2010, SCH LEADERSH MANAG, V30, P487, DOI 10.1080/13632434.2010.525228; GOLDFELD SM, 1966, ECONOMETRICA, V34, P541, DOI 10.2307/1909768; Greene, 2011, ECONOMETRIE; Greene W.H., 2010, MODELING ORDERED CHO, DOI [10.1017/CBO9780511845062, DOI 10.1017/CBO9780511845062]; Griffin D. K., 2010, J INVITATIONAL THEOR, V16, P56; Gruneberg E, 1979, UNDERSTANDING JOB SA; Guzel H, 2011, KURAM UYGUL EGIT BIL, V11, P1046; Herzberg F., 1957, JOB ATTITUDES REV RE; Klassen RM, 2011, TEACH TEACH EDUC, V27, P579, DOI 10.1016/j.tate.2010.10.012; Kocabas I., 2009, EDUCATION, V129, P724; Kyriacou C, 2000, J EDUC TEACHING, V26, P117, DOI DOI 10.1080/02607470050127036; Kyriacou C., 1999, TEACHER DEV, V3, P373, DOI DOI 10.1080/13664539900200087; Marsh JA, 2011, PHI DELTA KAPPAN, V93, P52, DOI 10.1177/003172171109300413; Marston S., 2010, EDUCATION, V131, P437; Muller K, 2009, EDUC MANAG ADM LEAD, V37, P574, DOI 10.1177/1741143209339651; Sergiovanni T, 1993, J EDUC ADMIN, V5, P66; Sinclair C, 2008, ASIA-PAC J TEACH EDU, V36, P79, DOI 10.1080/13598660801971658; Skaalvik EM, 2011, TEACH TEACH EDUC, V27, P1029, DOI 10.1016/j.tate.2011.04.001; Telfer R, 1993, J EDUC ADMIN, V24, P35; Thomson MM, 2012, TEACH TEACH EDUC, V28, P324, DOI 10.1016/j.tate.2011.10.007; Verbeek M., 2008, GUIDE MODERN ECONOME, V3rd ed.; WRIGHT JD, 1978, SOC FORCES, V56, P1140, DOI 10.2307/2577515	38	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0115735	10.1371/journal.pone.0115735	http://dx.doi.org/10.1371/journal.pone.0115735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849295	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800001
J	Park, YH; Shin, JA; Han, JH; Park, YM; Yim, HW				Park, Young-Hoon; Shin, Jeong Ah; Han, Jae-Hyung; Park, Yong-Moon; Yim, Hyeon Woo			The Association between Chronic Kidney Disease and Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; POPULATION; EYE; TRENDS; ADULTS	Purpose To explore the relationship between chronic kidney disease and diabetic retinopathy in a representative population of Korean diabetic adults. Methods We analyzed data from the Korea National Health and Nutrition Examination Surveys (2008-2010). A total of 15,409 individuals (weighted frequency, 32,168,636) aged 19 and over who completed ophthalmologic and renal functional examinations were evaluated. Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate of < 60 ml/min/1.73 m(2) or proteinuria greater than 1+. Seven standard photographs from the Early Treatment for Diabetic Retinopathy Study were obtained from each eye after pharmacological pupil dilatation. Diabetic retinopathy (DR) was defined as the presence of 1 or more retinal microaneurysms or retinal blot hemorrhages with or without more severe lesions. Vision-threatening diabetic retinopathy (VTDR) was defined as the presence of a clinically significant macular edema (CSME) or proliferative diabetic retinopathy. Results CKD was significantly associated with DR and VTDR (odds ratio (OR), 95% confidence interval (CI); 2.49(1.43-4.35) and 3.74(1.56-8.95), respectively) in the diabetic population. After controlling for confounders, however, CKD was significantly associated only with DR [adjusted OR (aOR), 95% CI; 2.34(1.04-5.28)]. In the subgroup analysis for CKD, only proteinuria was significantly associated with DR and VTDR (aOR, 95% CI; 4.56(1.51-13.77) and 5.61(1.06-29.87), respectively) in this population. Conclusions Our results show that CKD appears to be associated with DR and VTDR in a Korean diabetic population. In particular, proteinuria, not decreased eGFR, is more significantly associated with DR or VTDR.	[Park, Young-Hoon; Shin, Jeong Ah; Han, Jae-Hyung] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Park, Yong-Moon; Yim, Hyeon Woo] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Yim, HW (corresponding author), Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea.	y1693@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879				Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Barri Yousri M, 2006, Curr Cardiol Rep, V8, P411, DOI 10.1007/s11886-006-0098-7; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; CRUICKSHANKS KJ, 1993, OPHTHALMOLOGY, V100, P862; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Girach A, 2006, J DIABETES COMPLICAT, V20, P228, DOI 10.1016/j.jdiacomp.2006.03.001; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Kang HT, 2013, NEPHROL DIAL TRANSPL, V28, P927, DOI 10.1093/ndt/gfs535; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Lee SW, 2011, NEPHROL DIAL TRANSPL, V26, P3975, DOI 10.1093/ndt/gfr154; Liew G, 2012, KIDNEY BLOOD PRESS R, V35, P589, DOI 10.1159/000339173; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mottl AK, 2012, DIABETES RES CLIN PR, V98, P487, DOI 10.1016/j.diabres.2012.09.041; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Ohta M, 2010, DIABETIC MED, V27, P1017, DOI 10.1111/j.1464-5491.2010.03049.x; Park YM, 2014, DIABETES RES CLIN PR, V104, P435, DOI 10.1016/j.diabres.2014.04.003; Penno G, 2012, DIABETES CARE, V35, P2317, DOI 10.2337/dc12-0628; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Rodriguez-Poncelas A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-46; Shankar A, 2008, NEPHROL DIAL TRANSPL, V23, P1910, DOI 10.1093/ndt/gfm878; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sivaprasad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032182; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong CW, 2014, KIDNEY INT, V85, P1290, DOI 10.1038/ki.2013.491; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009	33	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0125338	10.1371/journal.pone.0125338	http://dx.doi.org/10.1371/journal.pone.0125338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849364	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800278
J	Rodriguez-Diaz, R; Manni, F; Blanco-Villegas, MJ				Rodriguez-Diaz, Roberto; Manni, Franz; Jose Blanco-Villegas, Mara			Footprints of Middle Ages Kingdoms Are Still Visible in the Contemporary Surname Structure of Spain	PLOS ONE			English	Article							POPULATION STRUCTURES; DISTANCE; ISONYMY; EUROPE	To assess whether the present-day geographical variability of Spanish surnames mirrors historical phenomena occurred at the times of their introduction (13th-16th century), and to infer the possible effect of foreign immigration (about 11% of present-day) on the observed patterns of diversity, we have analyzed the frequency distribution of 33,753 unique surnames (tokens) occurring 51,419,788 times, according to the list of Spanish residents of the year 2008. Isonymy measures and surname distances have been computed for, and between, the 47 mainland Spanish provinces and compared to a numerical classification of corresponding language varieties spoken in Spain. The comparison of the two bootstrap consensus trees, representing surname and linguistic variability, suggests a similar picture; major clusters are located in the east (Aragon, Cataluna, Valencia), and in the north of the country (Asturias, Galicia, Leon). Remaining regions appear to be considerably homogeneous. We interpret this pattern as the long-lasting effect of the surname and linguistic normalization actively led by the Christian kingdoms of the north (Reigns of Castilla y Leon and Aragon) during and after the southwards reconquest (Reconquista) of the territories ruled by the Arabs from the 8th century to the late 15th century, that is when surnames became transmitted in a fixed way and when Castilian linguistic varieties became increasingly prestigious and spread out. The geography of contemporary surname and linguistic variability in Spain corresponds to the political geography at the end of the Middle-Ages. The synchronicity between surname adoption and the political and cultural effects of the Reconquista have permanently forged a Spanish identity that subsequent migrations, internal or external, did not deface.	[Rodriguez-Diaz, Roberto; Jose Blanco-Villegas, Mara] Univ Salamanca, Fac Biol, Dept Biol Anim, Area Antropol Fis, E-37008 Salamanca, Spain; [Rodriguez-Diaz, Roberto; Manni, Franz] Univ Paris Diderot, Dept Hommes Nat Soc Ecoanthropol & Ethnobiol, UMR CNRS 7206, Sorbonne Paris Cite,Musee Homme,Natl Museum Nat H, Paris, France	University of Salamanca; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Manni, F (corresponding author), Univ Paris Diderot, Dept Hommes Nat Soc Ecoanthropol & Ethnobiol, UMR CNRS 7206, Sorbonne Paris Cite,Musee Homme,Natl Museum Nat H, Paris, France.	franz.manni@mnhn.fr						Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; [Anonymous], 1962, ALPI ATL LING PEN IB, VI; [Anonymous], 2014, ETHNOLOGUE LANGUAGES; Aznar A, 1998, EMPIRIA, V1, P121; Baldinger Kurt, 1963, FORMACION DOMINIOS L; Beech G, 2002, PERSONAL NAMES STUDI; Boattini A, 2012, HUM BIOL, V84, P235, DOI 10.3378/027.084.0302; Cheshire J, 2014, J ANTHROPOL SCI, V92, P99, DOI 10.4436/JASS.92004; Cheshire J, 2011, HUM BIOL, V83, P573, DOI 10.3378/027.083.0501; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; Darlu P, 2012, HUM BIOL, V84, P169, DOI 10.3378/027.084.0205; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goebl H., 1993, CONTRIBUTIONS QUANTI, P277; Goebl H, 1984, DIALEKTOMETRISCHE ST, VI, P75, DOI [10.1111/j.1439-0388.1997.tb00532.x, DOI 10.1111/J.1439-0388.1997.TB00532.X]; GOEBL Hans, 2013, ACT 26 C INT LING FI, VVI, P143; HEDRICK PW, 1971, EVOLUTION, V25, P276, DOI [10.2307/2406918, 10.1111/j.1558-5646.1971.tb01880.x]; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; Kleiweg P, 2004, LECT NOTES ARTIF INT, V2980, P392; Kreienbrink A, 2008, RESIDENT FOREIGN POP; Kremer D, 1992, LEXIKON ROMANISTISCH, V6, P457; Kremer D, 2003, DICT AM FAMILY NAMES; Kremer D, 2001, STUDI RICORDO FERNAN, V7, P337; Kremer D, 1996, INT HDB ALLGEMEINEN, V2, P1263; LASKER GW, 1977, HUM BIOL, V49, P489; Manly BFJ, 1997, RANDOMIZATION BOOTST, P399; Manni F, 2005, AM J PHYS ANTHROPOL, V126, P214, DOI 10.1002/ajpa.10429; MANTEL N, 1967, CANCER RES, V27, P209; Mateos P, 2014, NAMES ETHNICITY POPU; Mateos Pablo, 2008, NAMES, V56, P165, DOI DOI 10.1179/175622708X332860; Nei M, 1973, GENETIC STRUCTURE PO; Nerbonne J, 2008, STUD CLASS DATA ANAL, P647, DOI 10.1007/978-3-540-78246-9_76; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; RELETHFORD JH, 1988, HUM BIOL, V60, P475; Rodriguez-Larralde A, 2003, AM J PHYS ANTHROPOL, V121, P280, DOI 10.1002/ajpa.10209; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scapoli C, 2007, THEOR POPUL BIOL, V71, P37, DOI 10.1016/j.tpb.2006.06.010; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Valls E, 2012, VERBA, V39, P35	38	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121472	10.1371/journal.pone.0121472	http://dx.doi.org/10.1371/journal.pone.0121472			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CF3VU	25849152	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800060
J	Su, LX; Li, H; Xie, AM; Liu, D; Rao, WQ; Lan, LP; Li, X; Li, F; Xiao, K; Wang, HJ; Yan, P; Li, X; Xie, LX				Su, Longxiang; Li, Hua; Xie, Aimei; Liu, Dan; Rao, Weiqiao; Lan, Liping; Li, Xuan; Li, Fang; Xiao, Kun; Wang, Huijuan; Yan, Peng; Li, Xin; Xie, Lixin			Dynamic Changes in Amino Acid Concentration Profiles in Patients with Sepsis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; N-ACETYLCYSTEINE; ORGAN FAILURE; TAURINE; GLUTATHIONE; METABOLISM; CYSTEINE; TRAUMA; INJURY	Objectives The goal of this work was to explore the dynamic concentration profiles of 42 amino acids and the significance of these profiles in relation to sepsis, with the aim of providing guidance for clinical therapies. Methods Thirty-five critically ill patients with sepsis were included. These patients were further divided into sepsis (12 cases) and severe sepsis (23 cases) groups or survivor (20 cases) and non-survivor (15 cases) groups. Serum samples from the patients were collected on days 1, 3, 5, 7, 10, and 14 following intensive care unit (ICU) admission, and the serum concentrations of 42 amino acids were measured. Results The metabolic spectrum of the amino acids changed dramatically in patients with sepsis. As the disease progressed further or with poor prognosis, the levels of the different amino acids gradually increased, decreased, or fluctuated over time. The concentrations of sulfurcontaining amino acids (SAAs), especially taurine, decreased significantly as the severity of sepsis worsened or with poor prognosis of the patient. The serum concentrations of SAAs, especially taurine, exhibited weak negative correlations with the Sequential Organ Failure Assessment (SOFA) (r=-0.319) and Acute Physiology and Chronic Health Evaluation (APACHE) II (r=-0.325) scores. The areas under the receiver operating characteristic curves of cystine, taurine, and SAA levels and the SOFA and APACHE II scores, which denoted disease prognosis, were 0.623, 0.674, 0.678, 0.86, and 0.857, respectively. Conclusions Critically ill patients with disorders of amino acid metabolism, especially of SAAs such as cystine and taurine, may provide an indicator of the need for the nutritional support of sepsis in the clinic.	[Su, Longxiang; Liu, Dan; Xiao, Kun; Wang, Huijuan; Yan, Peng; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing 100853, Peoples R China; [Su, Longxiang] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Crit Care Med, Beijing 100021, Peoples R China; [Su, Longxiang] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Li, Hua; Xie, Aimei; Rao, Weiqiao; Lan, Liping; Li, Xuan; Li, Fang] BGI Shenzhen, BGI Hlth, Clin Metabol Platform, Shenzhen, Peoples R China; [Liu, Dan] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Li, Xin] Chinese Peoples Liberat Army Gen Hosp, Clin Div Internal Med, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Genomics Institute (BGI); Nankai University; Chinese People's Liberation Army General Hospital	Li, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Clin Div Internal Med, Beijing 100853, Peoples R China.	xielx@263.net; lixin301@sina.com	Xie, li/HGE-6052-2022; Su, Longxiang/I-6788-2019	Su, Longxiang/0000-0002-0942-2870	National Natural Science Foundation of China [813701013]; General Program "Twelfth Five-Year"Key Project of Chinese PLA [CWSJ130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program "Twelfth Five-Year"Key Project of Chinese PLA	The study was supported by the general program of the National Natural Science Foundation of China ( 813701013) and the General Program "Twelfth Five-Year"Key Project of Chinese PLA (No. CWSJ130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JW, 1980, ANN SURG, V192, P505, DOI 10.1097/00000658-198010000-00009; Andrades M, 2011, J SURG RES, V167, pE307, DOI 10.1016/j.jss.2009.08.005; Beale RJ, 2008, CRIT CARE MED, V36, P131, DOI 10.1097/01.CCM.0000297954.45251.A9; Biolo G, 1997, NUTRITION, V13, pS52, DOI 10.1016/S0899-9007(97)00206-2; Btaiche IF, 2008, PHARMACOTHERAPY, V28, P600, DOI 10.1592/phco.28.5.600; Campbell IT, 1999, EUR J CLIN NUTR, V53, pS143, DOI 10.1038/sj.ejcn.1600755; Campos R, 2012, AM J PHYSIOL-LUNG C, V302, P1640, DOI 10.1152/ajplung.00097.2011; CERRA FB, 1980, ANN SURG, V192, P570, DOI 10.1097/00000658-198010000-00015; Chiarla C, 2000, J NUTR, V130, P2222, DOI 10.1093/jn/130.9.2222; De Bandt JP, 2006, J NUTR, V136, p308S, DOI 10.1093/jn/136.1.308S; de Mello RO, 2011, INFLAMMATION, V34, P539, DOI 10.1007/s10753-010-9261-9; de Poll MCGV, 2006, J NUTR, V136, p1694S, DOI 10.1093/jn/136.6.1694S; Decker EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P766; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Druml W, 2001, AM J CLIN NUTR, V73, P908; Ekremoglu M, 2007, AMINO ACIDS, V32, P413, DOI 10.1007/s00726-006-0382-2; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; Gul M, 2011, ULUS TRAVMA ACIL CER, V17, P293, DOI 10.5505/tjtes.2011.66743; KINNEY JM, 1995, CRIT CARE CLIN, V11, P569, DOI 10.1016/S0749-0704(18)30053-8; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Lloyd DAJ, 2007, P NUTR SOC, V66, P530, DOI 10.1017/S002966510700585X; Malmezat T, 1998, J NUTR, V128, P97, DOI 10.1093/jn/128.1.97; Mao Xiangbing, 2011, Front Biosci (Elite Ed), V3, P1192; Michie HR, 1996, WORLD J SURG, V20, P460, DOI 10.1007/s002689900072; Leyba CO, 2011, NUTR HOSP, V26, P67, DOI 10.1590/S0212-16112011000800015; Ortolani O, 2000, AM J RESP CRIT CARE, V161, P1907, DOI 10.1164/ajrccm.161.6.9903043; Ortolani Oreste, 2002, Recenti Progressi in Medicina, V93, P125; Piton G, 2011, INTENS CARE MED, V37, P911, DOI 10.1007/s00134-011-2172-x; Santangelo F, 2002, AMINO ACIDS, V23, P359, DOI 10.1007/s00726-002-0206-y; Suliman ME, 2002, NEPHROL DIAL TRANSPL, V17, P528, DOI 10.1093/ndt/17.3.528; Takala J, 1997, BAILLIERE CLIN ENDOC, V11, P617, DOI 10.1016/S0950-351X(97)80894-4; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P439, DOI 10.1016/S0753-3322(02)00284-6; VENTE JP, 1989, ANN SURG, V209, P57, DOI 10.1097/00000658-198901000-00009	34	71	77	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121933	10.1371/journal.pone.0121933	http://dx.doi.org/10.1371/journal.pone.0121933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849571	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800089
J	Xu, J; Li, DS; Xie, L; Tang, S; Guo, W				Xu, Jie; Li, Dasen; Xie, Lu; Tang, Shun; Guo, Wei			Mesenchymal Chondrosarcoma of Bone and Soft Tissue: A Systematic Review of 107 Patients in the Past 20 Years	PLOS ONE			English	Article							CONDITIONAL SURVIVAL; EXTRASKELETAL; ORBIT; CELL; MIMICKING; DIAGNOSIS; THERAPY; SPINE; YOUNG	Background Mesenchymal chondrosarcoma(MCS) is a rare high-grade variant of chondrosarcoma. Consensus has not been reached on its optimal management. Resection with wide margins is usually recommended, but the effect of margins has been demonstrated by little positive evidence. Moreover, the effectiveness of adjuvant chemo- and/or radiotherapy remains controversial. Objectives To describe the clinical characteristics and outcomes of MCS of bone and soft tissue, to assess the efficacies of surgery, chemotherapy and radiation, and finally to deliver a more appropriate therapy. Materials and Methods We reviewed EMBASE-, MEDLINE-, Cochrane-, Ovid- and PubMed-based to find out all cases of MCS of bone and soft tissue described between April 1994 and April 2014. Description of treatment and regular follow-up was required for each study. Language was restricted to English and Chinese. Issues of age, gender, location, metastasis, and treatment were all evaluated for each case. Kaplan-Meier Method and Cox Proportional Hazard Regression Model were used in the survival analysis. Results From the 630 identified publications, 18 meeting the inclusion criteria were selected, involving a total of 107 patients. Based on these data, the 5-, 10- and 20-year overall survival are 55.0%, 43.5% and 15.7% respectively. The 5-, 10-, 20-year event-free survival rates are 45.0%, 27.2% and 8.1%, respectively. Treatment without surgery is associated with poorer overall survival and event-free survival. Negative surgical margins could significantly bring down the local-recurrence rate and are associated with a higher event-free survival rate. Chemotherapy regime based on anthracyclines does not benefit the overall survival. The addition of radiation therapy is not significantly associated with the overall or event-free survival. However, we recommend radiation as the salvage therapy for patients with positive margin so as to achieve better local control. Conclusions This review shows that surgery is essential in the management of MCS of bone and soft tissue. Appropriate adjuvant therapy may reduce local recurrence, but cannot benefit the overall survival.	[Xu, Jie; Li, Dasen; Xie, Lu; Tang, Shun; Guo, Wei] Peking Univ, Peoples Hosp, Musculoskeletal Tumour Ctr, Beijing 100871, Peoples R China	Peking University	Guo, W (corresponding author), Peking Univ, Peoples Hosp, Musculoskeletal Tumour Ctr, Beijing 100871, Peoples R China.	bonetumor_guowei@163.com	Li, D/N-4549-2019	amukotuwa, shalini/0000-0002-1678-3930				Abbas M, 2004, APMIS, V112, P384, DOI 10.1111/j.1600-0463.2004.apm1120609.x; Amukotuwa SA, 2006, SKELETAL RADIOL, V35, P311, DOI 10.1007/s00256-005-0044-6; Anderson JT, 2007, J HAND SURG-AM, V32A, P389, DOI 10.1016/j.jhsa.2007.01.003; Angotti-Neto H, 2006, OPHTHAL PLAST RECONS, V22, P378, DOI 10.1097/01.iop.0000229691.87499.99; Aoki T, 1996, SURG TODAY, V26, P1020, DOI 10.1007/BF00309966; Belhachmi A, 2008, J NEURORADIOLOGY, V35, P189, DOI 10.1016/j.neurad.2007.11.005; Bencheikh R, 2007, REV STOMATOL CHIR, V108, P156, DOI 10.1016/j.stomax.2006.10.002; Bingaman KD, 2000, NEUROSURGERY, V46, P207, DOI 10.1093/neurosurgery/46.1.207; Bloch OG, 2009, J CLIN NEUROSCI, V16, P1547, DOI 10.1016/j.jocn.2009.05.003; Bresadola V, 2011, TUMORI J, V97, P316, DOI [10.1700/950.10413, 10.1700/912.10028]; Cai Lei, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P501; Cesari M, 2007, TUMORI J, V93, P423; Cheim Adonai P Jr, 2011, J Oral Sci, V53, P245; Chen S. H., 2005, Acta Paediatrica Taiwanica, V46, P308; D'Andrea G, 2008, NEUROSURG REV, V31, P225, DOI 10.1007/s10143-007-0106-4; DABSKA M, 1983, VIRCHOWS ARCH A, V399, P89; Nguyen DV, 2013, MALAYS J MED SCI, V20, P71; Dantonello TM, 2008, CANCER, V112, P2424, DOI 10.1002/cncr.23457; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dickman P, STANDARD ERRORS OF O; Glien A, 2012, HNO, V60, P1086, DOI 10.1007/s00106-012-2643-6; Gomez-Brouchet A, 2001, J UROLOGY, V166, P2305, DOI 10.1016/S0022-5347(05)65561-9; Hamada H, 2005, OTOLARYNG HEAD NECK, V133, P639, DOI 10.1016/j.otohns.2004.09.057; Hanakita S, 2012, NEUROL MED-CHIR, V52, P747, DOI 10.2176/nmc.52.747; HARWOOD AR, 1981, CLIN ORTHOP RELAT R, P144; Hashimoto N, 2005, SKELETAL RADIOL, V34, P785, DOI 10.1007/s00256-005-0025-9; Herrera A, 2012, CASE REP MED, V2012, DOI 10.1155/2012/292147; Heyer C M, 2007, Pneumologie, V61, P94, DOI 10.1055/s-2006-944299; Hoang MP, 2000, INT J SURG PATHOL, V8, P291, DOI 10.1177/106689690000800408; Hsing Chien Ter, 2007, Cancer Res Treat, V39, P131, DOI 10.4143/crt.2007.39.3.131; Hu HJ, 2014, ONCOL LETT, V7, P1970, DOI 10.3892/ol.2014.2012; Huang HY, 2002, ANN THORAC SURG, V73, P1960, DOI 10.1016/S0003-4975(01)03462-2; Huang Kuo-Feng, 2003, Chang Gung Med J, V26, P370; HUVOS AG, 1983, CANCER, V51, P1230, DOI 10.1002/1097-0142(19830401)51:7<1230::AID-CNCR2820510710>3.0.CO;2-Q; Inenaga C, 2003, ACTA NEUROCHIR, V145, P593, DOI 10.1007/s00701-003-0059-5; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; Jain Manjula, 2011, Indian J Med Sci, V65, P552; Jambhekar Nirmala A, 2004, Indian J Pathol Microbiol, V47, P491; Jeh Eun Ae, 2013, Obstet Gynecol Sci, V56, P345, DOI 10.5468/ogs.2013.56.5.345; Johnson DBS, 1997, SKELETAL RADIOL, V26, P501, DOI 10.1007/s002560050274; Kan ZS, 2012, BRIT J NEUROSURG, V26, P912, DOI 10.3109/02688697.2012.697219; Kaneko T, 2006, INT J UROL, V13, P285, DOI 10.1111/j.1442-2042.2006.01293.x; Kashyap S, 2001, Orbit, V20, P63, DOI 10.1076/orbi.20.1.63.2646; Kaur A, 2008, ORBIT, V27, P63, DOI 10.1080/01676830601169007; Kawaguchi S, 2014, CLIN ORTHOP RELAT R, V472, P856, DOI 10.1007/s11999-013-3064-x; Khouja N, 1999, SURG NEUROL, V52, P50, DOI 10.1016/S0090-3019(99)00033-6; Knott PD, 2003, LARYNGOSCOPE, V113, P783, DOI 10.1097/00005537-200305000-00004; Kupeli S, 2010, PEDIATR HEMAT ONCOL, V27, P564, DOI 10.3109/08880018.2010.503333; LICHTENSTEIN L, 1959, CANCER-AM CANCER SOC, V12, P1142, DOI 10.1002/1097-0142(195911/12)12:6<1142::AID-CNCR2820120610>3.0.CO;2-D; Liu MM, 2010, CLIN IMAG, V34, P379, DOI 10.1016/j.clinimag.2009.12.002; LOUVET C, 1985, J CLIN ONCOL, V3, P858, DOI 10.1200/JCO.1985.3.6.858; Matsuda Y, 2006, SPINE, V31, pE231, DOI 10.1097/01.brs.0000210297.02677.66; Miller BJ, 2013, CLIN ORTHOP RELAT R, V471, P3398, DOI 10.1007/s11999-013-3147-8; Misra V, 2008, ACTA CYTOL, V52, P366, DOI 10.1159/000325525; NAKASHIMA Y, 1986, CANCER-AM CANCER SOC, V57, P2444, DOI 10.1002/1097-0142(19860615)57:12<2444::AID-CNCR2820571233>3.0.CO;2-K; Nesi G, 2000, Ital Heart J, V1, P435; Nussbeck W, 2004, PATHOLOGY, V36, P230, DOI 10.1080/00313020410001716669; Odashiro Alexandre Nakao, 2009, International Ophthalmology, V29, P173, DOI 10.1007/s10792-007-9184-0; Pellitteri PK, 2007, ORAL ONCOL, V43, P970, DOI 10.1016/j.oraloncology.2007.04.007; Ram H, 2011, J MAXILLOFAC ORAL SU, V10, P340, DOI 10.1007/s12663-010-0095-7; Razak ARA, 2010, EUR J CANCER CARE, V19, P551, DOI 10.1111/j.1365-2354.2008.01028.x; SALVADOR AH, 1971, CANCER, V28, P605, DOI 10.1002/1097-0142(197109)28:3<605::AID-CNCR2820280312>3.0.CO;2-R; Salvati M, 2005, J EXP CLIN CANC RES, V24, P317; Sans M, 1996, MED PEDIATR ONCOL, V26, P139; Sardi I, 2011, PEDIATR BLOOD CANCER, V56, P685, DOI 10.1002/pbc.22906; Seo CY, 2012, KOREAN J PATHOL, V46, P483, DOI 10.4132/KoreanJPathol.2012.46.5.483; Shakked RJ, 2012, ARCH PATHOL LAB MED, V136, P61, DOI 10.5858/arpa.2010-0362-OA; Solov'ev Iu N, 1983, Vopr Onkol, V29, P21; Sushma NR, 2011, AUSTRALAS MED J, V4, P448, DOI 10.4066/AMJ.2011.866; Tsukamoto S, 2014, CASE REP ONCOL MED, V2014, DOI 10.1155/2014/249757; van Oosterwijk JG, 2013, AM J PATHOL, V182, P1347, DOI 10.1016/j.ajpath.2012.12.036; Vencio EF, 1998, CANCER, V82, P2350, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2350::AID-CNCR8>3.0.CO;2-W; White DW, 2003, CLIN IMAG, V27, P187, DOI 10.1016/S0899-7071(02)00538-7; Xu H, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-125; Yassa M, 2005, J NEURO-ONCOL, V74, P329, DOI 10.1007/s11060-005-0374-1; Yu XQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-460; Zhang Jiang-yu, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P127; Zhao FD, 2007, FOOT ANKLE INT, V28, P1095, DOI 10.3113/FAI.2007.1095; Zibis AH, 2010, CLIN ORTHOP RELAT R, V468, P2288, DOI 10.1007/s11999-010-1297-5	79	94	97	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122216	10.1371/journal.pone.0122216	http://dx.doi.org/10.1371/journal.pone.0122216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849226	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800108
J	Zhao, CQ; Fan, XF; Hou, XC; Zhu, Y; Yue, YS; Zhang, S; Wu, JY				Zhao, Chunqiao; Fan, Xifeng; Hou, Xincun; Zhu, Yi; Yue, Yuesen; Zhang, Shuang; Wu, Juying			Tassel Removal Positively Affects Biomass Production Coupled with Significantly Increasing Stem Digestibility in Switchgrass	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; ENZYMATIC DIGESTIBILITY; CHEMICAL-COMPOSITION; TRADE-OFFS; CELL-WALLS; FORAGE; QUALITY; YIELD; FEATURES; BIOFUEL	In this study, tassels of Cave-in-Rock (upland) and Alamo (lowland) were removed at or near tassel emergence to explore its effects on biomass production and quality. Tassel-removed (TR) Cave-in-Rock and Alamo both exhibited a significant (P<0.05) increase in plant heights (not including tassel length), tiller number, and aboveground biomass dry weight (10% and 12%, 30% and 13%, 13% and 18%, respectively by variety) compared to a control (CK) treatment. Notably, total sugar yields of TR Cave-in-Rock and Alamo stems increased significantly (P<0.05 or 0.01) by 19% and 19%, 21% and 14%, 52% and 18%, respectively by variety, compared to those of control switchgrass under 3 treatments by direct enzymatic hydrolysis (DEH), enzymatic hydrolysis after 1% NaOH pretreatment (EHAL) and enzymatic hydrolysis after 1% H2SO4 pretreatment (EHAC). These differences were mainly due to significantly (P<0.05 or 0.01) higher cellulose content, lower cellulose crystallinity indexes (CrI) caused by higher arabinose (Ara) substitution in xylans, and lower S/G ratio in lignin. However, the increases of nitrogen (N) and sulphur (S) concentration negatively affects the combustion quality of switchgrass aboveground biomass. This work provides information for increasing biomass production and quality in switchgrass and also facilitates the inhibition of gene dispersal of switchgrass in China.	[Zhao, Chunqiao; Fan, Xifeng; Hou, Xincun; Zhu, Yi; Yue, Yuesen; Zhang, Shuang; Wu, Juying] Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China; [Zhao, Chunqiao] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China	Beijing Academy of Agriculture & Forestry; China Agricultural University	Fan, XF (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China.	fanxifengcau@163.com			Beijing Nova Program [Z131105000413020]; youth scientific research funds of Beijing Academy of Agriculture and Forestry [QNJJ201219, QNJJ201316]	Beijing Nova Program(Beijing Municipal Science & Technology Commission); youth scientific research funds of Beijing Academy of Agriculture and Forestry	This work was supported in part by grants from Beijing Nova Program (Z131105000413020), youth scientific research funds of Beijing Academy of Agriculture and Forestry (QNJJ201219), and youth scientific research funds of Beijing Academy of Agriculture and Forestry (QNJJ201316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Baxter HL, 2014, PLANT BIOTECHNOL J, V12, P914, DOI 10.1111/pbi.12195; Bell G., 1986, Oxford Surveys in Evolutionary Biology, V3, P83; Bilgin A, 2009, POL J ECOL, V57, P261; Boe A, 2003, CROP SCI, V43, P63, DOI 10.2135/cropsci2003.0063; Boe A, 2007, CROP SCI, V47, P636, DOI 10.2135/cropsci2006.04.0260; BREJDA JJ, 1994, J RANGE MANAGE, V47, P22, DOI 10.2307/4002835; Chen L, 2002, J AGR FOOD CHEM, V50, P5558, DOI 10.1021/jf020516x; Cruz A, 2001, ACTA OECOL, V22, P121, DOI 10.1016/S1146-609X(01)01107-9; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Dische Z., 1962, METHODS CARBOHYDRATE, V1, P477; Dixon RA, 2013, NATURE, V493, P36, DOI 10.1038/493036a; Fry S. C., 1988, The growing plant cell wall: chemical and metabolic analysis.; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Holou RAY, 2013, BIOFUELS-UK, V4, P169, DOI [10.4155/bfs.12.79, 10.4155/BFS.12.79]; Hsu TC, 2010, BIORESOURCE TECHNOL, V101, P4907, DOI 10.1016/j.biortech.2009.10.009; Iiyama K, 2001, ASIAN AUSTRAL J ANIM, V14, P862, DOI 10.5713/ajas.2001.862; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Jorgensen U, 1997, BIOMASS BIOENERG, V12, P155, DOI 10.1016/S0961-9534(97)00002-0; Kering MK, 2013, CROP SCI, V53, P1809, DOI 10.2135/cropsci2012.10.0568; Kumar V, 1999, INT J PHARM, V177, P173, DOI 10.1016/S0378-5173(98)00340-8; Lemus R, 2002, BIOMASS BIOENERG, V23, P433, DOI 10.1016/S0961-9534(02)00073-9; Lewandowski I, 1997, EUR J AGRON, V6, P163, DOI 10.1016/S1161-0301(96)02044-8; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li M, 2014, BIORESOURCE TECHNOL, V169, P447, DOI 10.1016/j.biortech.2014.07.017; Li ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105115; LUNDVALL JP, 1994, CROP SCI, V34, P1672, DOI 10.2135/cropsci1994.0011183X003400060046x; Madakadze IC, 1999, AGRON J, V91, P696, DOI 10.2134/agronj1999.914696x; Mclaughlin S., 1999, PERSPECTIVES NEW CRO, P282, DOI DOI 10.1081/E-EPCS; Miles TR, 1996, BIOMASS BIOENERG, V10, P125, DOI 10.1016/0961-9534(95)00067-4; Mitchell R, 2014, COMPEND BIOENERG PLA, P1; Mittal A, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-41; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; PAKONEN T, 1991, ACTA OECOL, V12, P249; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Rajendran C, 2000, J AGRON CROP SCI, V185, P23, DOI 10.1046/j.1439-037X.2000.00386.x; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Rinehart L, 2006, SWITCHGRASS BIOENERG; Roff Derek A., 1992; Sanderson MA, 1999, AGRON J, V91, P5, DOI 10.2134/agronj1999.00021962009100010002x; Sanderson MA, 1996, BIORESOURCE TECHNOL, V56, P83, DOI 10.1016/0960-8524(95)00176-X; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Sluiter A, 2007, DETERMINATION STRUCT; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Tang Y, 2010, J INTEGR PLANT BIOL, V52, P112, DOI 10.1111/j.1744-7909.2010.00903.x; WESTLEY LC, 1993, ECOLOGY, V74, P2136, DOI 10.2307/1940858; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Yi Zheng, 2009, International Journal of Agricultural and Biological Engineering, V2, P51, DOI 10.3965/j.issn.1934-6344.2009.03.051-068; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029	56	13	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120845	10.1371/journal.pone.0120845	http://dx.doi.org/10.1371/journal.pone.0120845			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849123	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800036
J	Hellrung, L; Hollmann, M; Zscheyge, O; Schlumm, T; Kalberlah, C; Roggenhofer, E; Okon-Singer, H; Villringer, A; Horstmann, A				Hellrung, Lydia; Hollmann, Maurice; Zscheyge, Oliver; Schlumm, Torsten; Kalberlah, Christian; Roggenhofer, Elisabeth; Okon-Singer, Hadas; Villringer, Arno; Horstmann, Annette			Flexible Adaptive Paradigms for fMRI Using a Novel Software Package 'Brain Analysis in Real-Time' (BART)	PLOS ONE			English	Article							EMOTION; FLUCTUATIONS; AMYGDALA	In this work we present a new open source software package offering a unified framework for the real-time adaptation of fMRI stimulation procedures. The software provides a straightforward setup and highly flexible approach to adapt fMRI paradigms while the experiment is running. The general framework comprises the inclusion of parameters from subject's compliance, such as directing gaze to visually presented stimuli and physiological fluctuations, like blood pressure or pulse. Additionally, this approach yields possibilities to investigate complex scientific questions, for example the influence of EEG rhythms or fMRI signals results themselves. To prove the concept of this approach, we used our software in a usability example for an fMRI experiment where the presentation of emotional pictures was dependent on the subject's gaze position. This can have a significant impact on the results. So far, if this is taken into account during fMRI data analysis, it is commonly done by the post-hoc removal of erroneous trials. Here, we propose an a priori adaptation of the paradigm during the experiment's runtime. Our fMRI findings clearly show the benefits of an adapted paradigm in terms of statistical power and higher effect sizes in emotion-related brain regions. This can be of special interest for all experiments with low statistical power due to a limited number of subjects, a limited amount of time, costs or available data to analyze, as is the case with real-time fMRI.	[Hellrung, Lydia; Hollmann, Maurice; Zscheyge, Oliver; Kalberlah, Christian; Roggenhofer, Elisabeth; Villringer, Arno; Horstmann, Annette] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Hellrung, Lydia; Kalberlah, Christian; Horstmann, Annette] Univ Leipzig, Med Ctr, D-04109 Leipzig, Germany; [Schlumm, Torsten] Max Planck Inst Human Cognit & Brain Sci, NMR Unit, Leipzig, Germany; [Roggenhofer, Elisabeth; Villringer, Arno; Horstmann, Annette] Univ Leipzig, Med Ctr, IFB Adipos Dis, D-04109 Leipzig, Germany; [Roggenhofer, Elisabeth; Villringer, Arno] Univ Hosp, Clin Cognit Neurol, Leipzig, Germany; [Okon-Singer, Hadas] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel; [Villringer, Arno] Humboldt Univ & Charite, Berlin Sch Mind & Brain, Mind & Brain Inst, Berlin, Germany	Max Planck Society; Leipzig University; Max Planck Society; Leipzig University; Leipzig University; University of Haifa; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hellrung, L (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	hellrung@cbs.mpg.de	Horstmann, Annette/C-9083-2011; Hellrung, Lydia/AAC-3062-2019	Horstmann, Annette/0000-0001-6184-8484; Hellrung, Lydia/0000-0003-0317-4770; Villringer, Arno/0000-0003-2604-2404	IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01E01001]; German Research Foundation (DFG), within the framework of the CRC 1052 'Obesity Mechanisms'; BMBF (Bernstein Focus, State Dependencies of Learning) [01GQ0975, 18GL4DW4]	IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG), within the framework of the CRC 1052 'Obesity Mechanisms'(German Research Foundation (DFG)); BMBF (Bernstein Focus, State Dependencies of Learning)(Federal Ministry of Education & Research (BMBF))	The work of AH and AV is supported by the IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01E01001 (http://www.bmbf.de). The work of AH, AV, CK and LH is funded by the German Research Foundation (DFG) (http://www.dfg.de), within the framework of the CRC 1052 'Obesity Mechanisms'. The work of MH is supported the BMBF (Bernstein Focus, State Dependencies of Learning 01GQ0975; Project 18GL4DW4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend I, 2008, BRAIN, V131, P2140, DOI 10.1093/brain/awn135; Becker R, 2011, J NEUROSCI, V31, P11016, DOI 10.1523/JNEUROSCI.0210-11.2011; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brosch T, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13786; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Hinds O, 2011, NEUROIMAGE, V54, P361, DOI 10.1016/j.neuroimage.2010.07.060; Hollmann M, 2008, J NEUROSCI METH, V175, P154, DOI 10.1016/j.jneumeth.2008.08.013; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Lang PJ, 2008, INT AFFECTIVE PICTUR; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Padmala S, 2010, COGN AFFECT BEHAV NE, V10, P279, DOI 10.3758/CABN.10.2.279; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Rotshtein P, 2011, NEUROPSYCHOLOGIA, V49, P1544, DOI 10.1016/j.neuropsychologia.2010.12.002; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Smyser C, 2001, MAGN RESON MED, V45, P289, DOI 10.1002/1522-2594(200102)45:2<289::AID-MRM1038>3.0.CO;2-U; Voyvodic James T, 2011, Front Neuroinform, V5, P27, DOI 10.3389/fninf.2011.00027; Voyvodic JT, 1999, NEUROIMAGE, V10, P91, DOI 10.1006/nimg.1999.0457; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; Wilms M, 2010, SOC COGN AFFECT NEUR, V5, P98, DOI 10.1093/scan/nsq024; Yoo JJ, 2012, NEUROIMAGE, V59, P846, DOI 10.1016/j.neuroimage.2011.07.063; Zscheyge O, 2010, DEV PLATFORM INDEPEN	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0118890	10.1371/journal.pone.0118890	http://dx.doi.org/10.1371/journal.pone.0118890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837719	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000006
J	Sen, R; Raychoudhury, R; Cai, YP; Sun, YJ; Lietze, VU; Peterson, BF; Scharf, ME; Boucias, DG				Sen, Ruchira; Raychoudhury, Rhitoban; Cai, Yunpeng; Sun, Yijun; Lietze, Verena-Ulrike; Peterson, Brittany F.; Scharf, Michael E.; Boucias, Drion G.			Molecular Signatures of Nicotinoid-Pathogen Synergy in the Termite Gut	PLOS ONE			English	Article							RETICULITERMES-FLAVIPES ISOPTERA; INSECT IMMUNITY; LIGNOCELLULOSE; RHINOTERMITIDAE; BACTERIAL; ANTIFUNGAL; EXPRESSION; COMMUNITY; RESPONSES; SELECTION	Previous studies in lower termites revealed unexpected synergies between nicotinoid insecticides and fungal entomopathogens. The present study investigated molecular mechanisms of nicotinoid-pathogen synergy in the lower termite Reticulitermes flavipes, using the nicotinoid, imidacloprid, in combination with fungal and bacterial entomopathogens. Particular focus was placed on metatranscriptome composition and microbial dynamics in the symbiont- rich termite gut, which houses diverse mixes of protists and bacteria. cDNA microarrays containing a mix of host and protist symbiont oligonucleotides were used to simultaneously assess termite and protist gene expression. Five treatments were compared that included single challenges with sublethal doses of fungi (Metharizium anisopliae), bacteria (Serratia marcescens) or imidacloprid, and dual challenges with fungi + imidacloprid or bacteria + imidacloprid. Our findings point towards protist dysbiosis and compromised social behavior, rather than suppression of stereotypical immune defense mechanisms, as the dominant factors underlying nicotinoid-pathogen synergy in termites. Also, greater impacts observed for the fungal pathogen than for the bacterial pathogen suggest that the rich bacterial symbiont community in the R. flavipes gut (>5000 species-level phylotypes) exists in an ecological balance that effectively excludes exogenous bacterial pathogens. These findings significantly advance our understanding of antimicrobial defenses in this important eusocial insect group, as well as provide novel insights into how nicotinoids can exert deleterious effects on social insect colonies.	[Sen, Ruchira; Raychoudhury, Rhitoban; Peterson, Brittany F.; Scharf, Michael E.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Cai, Yunpeng; Sun, Yijun] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Lietze, Verena-Ulrike; Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Scharf, ME (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	mscharf@purdue.edu	Cai, Yunpeng/O-8823-2018; Sen, Ruchira/AAJ-4776-2021	Sen, Ruchira/0000-0001-7794-4315; Raychoudhury, Rhitoban/0000-0001-6835-1008	USDA-NIFA-AFRI [2009-05245, 2010-65106-30727]; O.W. Rollins/Orkin Endowment at Purdue University	USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); O.W. Rollins/Orkin Endowment at Purdue University	This study was funding by USDA-NIFA-AFRI (http://www.nifa.usda.gov/) grants 2009-05245 and 2010-65106-30727 to MES and DGB and by the O.W. Rollins/Orkin Endowment (http://www.orkin.net/community/social-responsibility/rollins-philanthropic-foundations) at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boucias D. G., 1996, Pflanzenschutz-Nachrichten Bayer (English ed.), V49, P103; Boucias DG, 2013, MOL ECOL, V22, P1836, DOI 10.1111/mec.12230; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Chouvenc T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1885; Connick WJ, 2001, ENVIRON ENTOMOL, V30, P449, DOI 10.1603/0046-225X-30.2.449; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Elliott KL, 2009, PEPTIDES, V30, P855, DOI 10.1016/j.peptides.2009.01.009; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gibson G., 2002, PRIMER GENOME SCI; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; Husseneder C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105582; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang D, 2002, DEV COMP IMMUNOL, V26, P495, DOI 10.1016/S0145-305X(02)00009-5; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Matsuura K, 2009, CURR BIOL, V19, P30, DOI 10.1016/j.cub.2008.11.030; Mikonranta L, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-23; Nuss AB, 2010, PEPTIDES, V31, P419, DOI 10.1016/j.peptides.2009.09.001; Osbrink WLA, 2001, ENVIRON ENTOMOL, V30, P443, DOI 10.1603/0046-225X-30.2.443; Parman V, 2010, J ECON ENTOMOL, V103, P791, DOI 10.1603/EC09386; Pavia CS, 2000, J MED MICROBIOL, V49, P675, DOI 10.1099/0022-1317-49-7-675; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramakrishnan R, 1999, J ECON ENTOMOL, V92, P1125, DOI 10.1093/jee/92.5.1125; Raychoudhury R, 2013, INSECT MOL BIOL, V22, P155, DOI 10.1111/imb.12011; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P544, DOI 10.1007/s001140050672; Rosengaus RB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00607; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; Rubin BER, 2014, MICROBIOLOGYOPEN, V3, P910, DOI 10.1002/mbo3.216; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Schwinghammer MA, 2011, GENE, V474, P12, DOI 10.1016/j.gene.2010.11.012; Sen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-491; Sethi A, 2013, ARCH INSECT BIOCHEM, V84, P175, DOI 10.1002/arch.21135; Sethi A, 2013, INSECT BIOCHEM MOLEC, V43, P91, DOI 10.1016/j.ibmb.2012.10.001; Stathopoulos S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003897; Stokstad E, 2013, SCIENCE, V340, P674, DOI [10.1126/science.340.6133.674, 10.1126/science.340.6133.675]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Szalanski AL, 2003, J ECON ENTOMOL, V96, P1514, DOI 10.1603/0022-0493-96.5.1514; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Tarver MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-28; Tomalski M, 2010, ANN ENTOMOL SOC AM, V103, P84, DOI 10.1603/008.103.0111; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Wheeler MM, 2007, INSECT BIOCHEM MOLEC, V37, P1366, DOI 10.1016/j.ibmb.2007.09.010; Yanagawa A, 2008, J INVERTEBR PATHOL, V97, P165, DOI 10.1016/j.jip.2007.09.005	53	11	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123391	10.1371/journal.pone.0123391	http://dx.doi.org/10.1371/journal.pone.0123391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837376	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000141
J	Shoji, JY; Charlton, ND; Yi, MH; Young, CA; Craven, KD				Shoji, Jun-Ya; Charlton, Nikki D.; Yi, Mihwa; Young, Carolyn A.; Craven, Kelly D.			Vegetative Hyphal Fusion and Subsequent Nuclear Behavior in Epichloe Grass Endophytes	PLOS ONE			English	Article							CONIDIAL ANASTOMOSIS TUBES; HORIZONTAL GENE-TRANSFER; TALL FESCUE; INTERSPECIFIC HYBRIDIZATION; FUNGAL ENDOPHYTES; ASPERGILLUS-NIDULANS; PROTOPLAST FUSION; COMPATIBILITY; DYNAMICS; GROWTH	Epichloe species (including the former genus Neotyphodium) are fungal symbionts of many agronomically important forage grasses, and provide their grass hosts with protection from a wide range of biotic and abiotic stresses. Epichloe species include many interspecific hybrids with allodiploid-like genomes, which may provide the potential for combined traits or recombination to generate new traits. Though circumstantial evidence suggests that such interspecific hybrids might have arisen from nuclear fusion events following vegetative hyphal fusion between different Epichloe strains, this hypothesis has not been addressed empirically. Here, we investigated vegetative hyphal fusion and subsequent nuclear behavior in Epichloe species. A majority of Epichloe strains, especially those having a sexual stage, underwent self vegetative hyphal fusion. Vegetative fusion also occurred between two hyphae from different Epichloe strains. Though Epichloe spp. are uninucleate fungi, hyphal fusion resulted in two nuclei stably sharing the same cytoplasm, which might ultimately lead to nuclear fusion. In addition, protoplast fusion experiments gave rise to uninucleate putative hybrids, which apparently had two markers, one from each parent within the same nucleus. These results are consistent with the notion that interspecific hybrids arise from vegetative hyphal fusion. However, we also discuss additional factors, such as post-hybridization selection, that may be important to explain the recognized prevalence of hybrids in Epichloe species.	[Shoji, Jun-Ya; Craven, Kelly D.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; [Charlton, Nikki D.; Yi, Mihwa; Young, Carolyn A.] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA	Noble Research Institute; Noble Research Institute	Craven, KD (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	kdcraven@noble.org	Young, Carolyn Anne/Q-2963-2019	Young, Carolyn Anne/0000-0003-0406-8398; Craven, Kelly/0000-0002-1597-9413; Charlton, Nikki/0000-0001-9580-5466	Samuel Roberts Noble Foundation; NSF [DBI 0400580]	Samuel Roberts Noble Foundation; NSF(National Science Foundation (NSF))	This study was financially supported by The Samuel Roberts Noble Foundation (internal grant) and the NSF (equipment grant DBI 0400580).	Aanen DK, 2008, BIOESSAYS, V30, P1193, DOI 10.1002/bies.20840; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; BACON CW, 1986, AGRON J, V78, P106, DOI 10.2134/agronj1986.00021962007800010023x; Becker Y, 2015, MOL PLANT MICROBE IN, V28, P69, DOI 10.1094/MPMI-06-14-0183-R; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Boddy L, 1999, MYCOLOGIA, V91, P13, DOI 10.2307/3761190; BRAUER KL, 1987, APPL ENVIRON MICROB, V53, P70, DOI 10.1128/AEM.53.1.70-73.1987; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; Charlton ND, 2014, FEMS MICROBIOL ECOL, V90, P276, DOI 10.1111/1574-6941.12393; Charlton ND, 2012, EUKARYOT CELL, V11, P1463, DOI 10.1128/EC.00191-12; Charlton ND, 2012, MYCOLOGIA, V104, P1187, DOI 10.3852/11-403; Christensen MJ, 2000, MYCOL RES, V104, P974, DOI 10.1017/S0953756299002300; Christensen MJ, 2002, MYCOL RES, V106, P93, DOI 10.1017/S095375620100510X; Chung KR, 1997, MYCOLOGIA, V89, P558, DOI 10.2307/3760992; Chung KR, 1997, MYCOL RES, V101, P295, DOI 10.1017/S0953756296002602; CLAY K, 1985, OECOLOGIA, V66, P1, DOI 10.1007/BF00378545; Clewes E, 2008, NEW PHYTOL, V177, P583, DOI 10.1111/j.1469-8137.2007.02327.x; Clutterbuck AJ, 1996, J GENET, V75, P281, DOI 10.1007/BF02966308; Cox MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004180; Craven KD, 2001, ANN MO BOT GARD, V88, P14, DOI 10.2307/2666129; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; DALES RBG, 1983, J GEN MICROBIOL, V129, P3643; de Barros Lopes Miguel, 2002, FEMS Yeast Res, V1, P323, DOI 10.1016/S1567-1356(01)00051-4; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Fischer-Harman V, 2012, FUNGAL GENET BIOL, V49, P896, DOI 10.1016/j.fgb.2012.08.004; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Gentile A, 2005, MOL PHYLOGENET EVOL, V35, P196, DOI 10.1016/j.ympev.2005.01.008; Gibson AK, 2012, EVOLUTION, V66, P1917, DOI 10.1111/j.1558-5646.2011.01563.x; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hyde GJ, 1999, CELL MOTIL CYTOSKEL, V42, P114; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Kayano Y, 2013, FUNGAL GENET BIOL, V56, P87, DOI 10.1016/j.fgb.2013.05.001; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KEVEI F, 1977, J GEN MICROBIOL, V102, P255, DOI 10.1099/00221287-102-2-255; KEVEI F, 1984, J GEN MICROBIOL, V130, P2229; Kucsera J, 1998, CAN J MICROBIOL, V44, P959; Kuldau GA, 1999, MYCOLOGIA, V91, P776, DOI 10.2307/3761531; LEUCHTMANN A, 1994, MYCOLOGIA, V86, P802, DOI 10.2307/3760595; Leuchtmann A, 1998, MYCOL RES, V102, P1169, DOI 10.1017/S0953756298006236; Leuchtmann A, 2014, MYCOLOGIA, V106, P202, DOI 10.3852/106.2.202; Lichius A., 2010, FUNGAL GENET, V57, P8, DOI [10.4148/1941-4765.1070, DOI 10.4148/1941-4765.1070]; Lichius A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042565; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mabashi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1882, DOI 10.1271/bbb.60052; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Oliver R, 2012, NEW PHYTOL, V196, P1015, DOI 10.1111/j.1469-8137.2012.04330.x; Olson A, 2002, MICROBES INFECT, V4, P1353, DOI 10.1016/S1286-4579(02)00005-9; Palma-Guerrero J, 2009, FUNGAL GENET BIOL, V46, P585, DOI 10.1016/j.fgb.2009.02.010; Querol A, 2009, FEMS MICROBIOL LETT, V293, P1, DOI 10.1111/j.1574-6968.2008.01480.x; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Rech C, 2007, CURR GENET, V52, P259, DOI 10.1007/s00294-007-0158-6; RICE GC, 1989, CYTOMETRY, V10, P103, DOI 10.1002/cyto.990100119; Richards Thomas A., 2011, Fungal Biology Reviews, V25, P98, DOI 10.1016/j.fbr.2011.04.003; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2003, FUNGAL GENET BIOL, V40, P138, DOI 10.1016/S1087-1845(03)00088-4; Roper M, 2013, P NATL ACAD SCI USA, V110, P12875, DOI 10.1073/pnas.1220842110; Saari S, 2012, NEW PHYTOL, V195, P231, DOI 10.1111/j.1469-8137.2012.04140.x; Schardl CL, 2013, TOXINS, V5, P1064, DOI 10.3390/toxins5061064; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schardl CL, 2010, ANN MO BOT GARD, V97, P646, DOI 10.3417/2009144; Schardl CL, 1999, MYCOLOGIA, V91, P95, DOI 10.2307/3761196; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schardl CL, 1997, MOL BIOL EVOL, V14, P133, DOI 10.1093/oxfordjournals.molbev.a025746; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schmid J, 2000, BOOK SOIL P, P295; Scott B., 2012, TOPICS CURRENT GENET, P243, DOI DOI 10.1007/978-3-642-22916-9_12; Selosse MA, 2007, NEW PHYTOL, V173, P452, DOI 10.1111/j.1469-8137.2007.01978.x; Shoji JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015650; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Simonin A, 2012, EUKARYOT CELL, V11, P1345, DOI 10.1128/EC.00213-12; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tadych M, 2007, MYCOL RES, V111, P466, DOI 10.1016/j.mycres.2007.02.002; Tadych M, 2012, FUNGAL DIVERS, V54, P117, DOI 10.1007/s13225-012-0170-0; Takach JE, 2014, CROP SCI, V54, P667, DOI 10.2135/cropsci2013.06.0423; Takach JE, 2012, APPL ENVIRON MICROB, V78, P5501, DOI 10.1128/AEM.01084-12; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tan YY, 2001, APPL ENVIRON MICROB, V67, P5377, DOI 10.1128/AEM.67.12.5377-5383.2001; Tanaka A, 2013, MOL MICROBIOL, V90, P551, DOI 10.1111/mmi.12385; TSAI HF, 1994, P NATL ACAD SCI USA, V91, P2542, DOI 10.1073/pnas.91.7.2542; TSAI HF, 1992, CURR GENET, V22, P399, DOI 10.1007/BF00352441; WEST CP, 1993, AGRON J, V85, P264, DOI 10.2134/agronj1993.00021962008500020019x; Westermann B, 2002, FUNGAL GENET BIOL, V36, P91, DOI 10.1016/S1087-1845(02)00019-1; WHITE JF, 1993, MYCOLOGIA, V85, P444, DOI 10.2307/3760705; Wille PA, 1999, PLANT J, V18, P349, DOI 10.1046/j.1365-313X.1999.00462.x; Young C, 1998, CURR GENET, V33, P368, DOI 10.1007/s002940050349	93	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121875	10.1371/journal.pone.0121875	http://dx.doi.org/10.1371/journal.pone.0121875			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837972	Green Submitted, Green Published, gold			2022-12-27	WOS:000352139000066
J	Thonon, F; Boulkedid, R; Delory, T; Rousseau, S; Saghatchian, M; van Harten, W; O'Neill, C; Alberti, C				Thonon, Frederique; Boulkedid, Rym; Delory, Tristan; Rousseau, Sophie; Saghatchian, Mahasti; van Harten, Wim; O'Neill, Claire; Alberti, Corinne			Measuring the Outcome of Biomedical Research: A Systematic Literature Review	PLOS ONE			English	Review							H-INDEX; RESEARCH PERFORMANCE; BIBLIOMETRIC INDICATORS; RESEARCH COLLABORATION; SCIENTIFIC-RESEARCH; RESEARCH IMPACT; HIRSCH-INDEX; CHEMISTRY; MEDICINE; QUALITY	Background There is an increasing need to evaluate the production and impact of medical research produced by institutions. Many indicators exist, yet we do not have enough information about their relevance. The objective of this systematic review was (1) to identify all the indicators that could be used to measure the output and outcome of medical research carried out in institutions and (2) enlist their methodology, use, positive and negative points. Methodology We have searched 3 databases (Pubmed, Scopus, Web of Science) using the following keywords: [Research outcome* OR research output* OR bibliometric* OR scientometric* OR scientific production] AND [indicator* OR index* OR evaluation OR metrics]. We included articles presenting, discussing or evaluating indicators measuring the scientific production of an institution. The search was conducted by two independent authors using a standardised data extraction form. For each indicator we extracted its definition, calculation, its rationale and its positive and negative points. In order to reduce bias, data extraction and analysis was performed by two independent authors. Findings We included 76 articles. A total of 57 indicators were identified. We have classified those indicators into 6 categories: 9 indicators of research activity, 24 indicators of scientific production and impact, 5 indicators of collaboration, 7 indicators of industrial production, 4 indicators of dissemination, 8 indicators of health service impact. The most widely discussed and described is the h-index with 31 articles discussing it. Discussion The majority of indicators found are bibliometric indicators of scientific production and impact. Several indicators have been developed to improve the h-index. This indicator has also inspired the creation of two indicators to measure industrial production and collaboration. Several articles propose indicators measuring research impact without detailing a methodology for calculating them. Many bibliometric indicators identified have been created but have not been used or further discussed.	[Thonon, Frederique; Saghatchian, Mahasti] Gustave Roussy, European & Int Affairs Unit, Villejuif, France; [Thonon, Frederique; Boulkedid, Rym; O'Neill, Claire; Alberti, Corinne] Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France; [Thonon, Frederique; Alberti, Corinne] Univ Paris Diderot, Sorbonne Paris Cite, UMR S 1123, Paris, France; [Thonon, Frederique; Boulkedid, Rym; Alberti, Corinne] ECEVE, CIC EC 1426, Paris, France; [Boulkedid, Rym; Alberti, Corinne] INSERM, U 1123, Paris, France; [Delory, Tristan] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol & Rech Clin, F-75877 Paris, France; [Rousseau, Sophie] Gustave Roussy, Direct Rech Clin, Villejuif, France; [Rousseau, Sophie] Lucien Neuwirth Canc Inst, Dept Publ Hlth, Ctr Hygee, CIC EC 3 Inserm,IFR 143, St Etienne, France; [van Harten, Wim] Netherlands Canc Inst, Amsterdam, Netherlands	UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut de Cancerologie de la Loire; Institut National de la Sante et de la Recherche Medicale (Inserm); Netherlands Cancer Institute	Thonon, F (corresponding author), Gustave Roussy, European & Int Affairs Unit, Villejuif, France.	frederique.thonon@gustaveroussy.fr	DELORY, Tristan/H-8110-2019; Van Harten, Wim H/AAE-8671-2020; van+Harten, Wim/AAE-8517-2020	DELORY, Tristan/0000-0002-0165-8934; van+Harten, Wim/0000-0001-9580-0489; Thonon, Frederique/0000-0002-5384-1001	European Commission under the 7th Framework Programme (FP7) [260791]	European Commission under the 7th Framework Programme (FP7)	This study was funded by the European Commission under the 7th Framework Programme (FP7) under grant agreement no 260791 for the project entitled 'EurocanPlatform'. The URL of the funders is http://ec.europa.eu/index_en.htm and, URL of the FP7 is http://ec.europa.eu/research/fp7/index_en.cfm and the URL of the EurocanPltaform project is http://eurocanplatform.eu. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manual.	Abramo G, 2011, SCIENTOMETRICS, V86, P629, DOI 10.1007/s11192-010-0284-7; Academy of Health Sciences, 2006, MED RES ASS BEN SOC; Adams J, 2009, ARCH IMMUNOL THER EX, V57, P19, DOI 10.1007/s00005-009-0003-3; Alonso S, 2010, SCIENTOMETRICS, V82, P391, DOI 10.1007/s11192-009-0047-5; Battersby J., 2006, OXFORD HDB PUBLIC HL, P334; Baudoin L, 2004, M S-MED SCI, V20, P909, DOI 10.1051/medsci/20042010909; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1381, DOI 10.1002/asi.20609; Canadian Institutes of Health Research, 2005, DEV CIHR FRAM MEAS I; Costas R, 2008, SCIENTOMETRICS, V77, P267, DOI 10.1007/s11192-007-1997-0; Dorta-Gonzalez P, 2011, SCIENTOMETRICS, V88, P729, DOI 10.1007/s11192-011-0453-3; Durieux V, 2010, RADIOLOGY, V255, P342, DOI 10.1148/radiol.09090626; Egghe L, 2010, ANNU REV INFORM SCI, V44, P65, DOI 10.1002/aris.2010.1440440109; Derrick GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018521; Franceschini F, 2011, SCIENTOMETRICS, V86, P339, DOI 10.1007/s11192-010-0261-1; Franceschini F, 2010, SCIENTOMETRICS, V85, P203, DOI 10.1007/s11192-010-0165-0; Franco G, 2013, ARCH ENVIRON OCCUP H, V68, P123, DOI 10.1080/19338244.2011.639819; Frenken K, 2005, J ENG TECHNOL MANAGE, V22, P9, DOI 10.1016/j.jengtecman.2004.11.002; Froghi S, 2012, BJU INT, V109, P321, DOI 10.1111/j.1464-410X.2011.10856.x; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Joshi Medha A, 2014, J Contemp Dent Pract, V15, P258; Kato M, 2013, SCIENTOMETRICS, V97, P535, DOI 10.1007/s11192-013-1011-y; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kelly E, 2006, HLTH CARE INDICATORS; Kim Y, 2014, SCIENTOMETRICS, V99, P97, DOI 10.1007/s11192-013-1095-4; Koskinen J, 2008, NORD J PSYCHIAT, V62, P136, DOI 10.1080/08039480801961667; Lascurain-Sanchez ML, 2008, SCIENTOMETRICS, V77, P131, DOI 10.1007/s11192-007-1922-6; Lavis John, 2003, J Health Serv Res Policy, V8, P165, DOI 10.1258/135581903322029520; Lawrence P.A., 2008, ETHICS SCI ENV POLIT, V8, P9, DOI [10.3354/esep00079, DOI 10.3354/ESEP00079]; Lewison G, 2008, BRIT J CANCER, V99, P569, DOI 10.1038/sj.bjc.6604531; Lewison G, 2012, PSYCHOL MED, V42, P435, DOI 10.1017/S0033291711001012; Lewison G, 2003, ASLIB PROC, V55, P32, DOI 10.1108/00012530310462698; Lewison G, 2002, SCIENTOMETRICS, V54, P179, DOI 10.1023/A:1016005710371; Lundberg J, 2006, SCIENTOMETRICS, V69, P575, DOI 10.1007/s11192-006-0170-5; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mostert SP, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-30; Ovseiko PV, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-478; Panel on Return on Investment in Health Research, 2009, MAK IMP PREF FRAM IN; Patel VM, 2011, J ROY SOC MED, V104, P251, DOI 10.1258/jrsm.2011.110005; Pozen R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002085; Romanovsky AA, 2012, CELL CYCLE, V11, P4118, DOI 10.4161/cc.22179; Schubert A, 2012, SCIENTOMETRICS, V91, P303, DOI 10.1007/s11192-011-0559-7; Sharma B, 2013, SURGERY, V153, P493, DOI 10.1016/j.surg.2012.09.006; Smith R, 2001, BRIT MED J, V323, P528, DOI 10.1136/bmj.323.7312.528; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Todeschini R, 2011, SCIENTOMETRICS, V87, P621, DOI 10.1007/s11192-011-0346-5; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Vanecek J, 2010, SCIENTOMETRICS, V83, P103, DOI 10.1007/s11192-009-0028-8; Wallin JA, 2005, BASIC CLIN PHARMACOL, V97, P261, DOI 10.1111/j.1742-7843.2005.pto_139.x; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2419, DOI 10.1002/asi.22708; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P406, DOI 10.1002/asi.21678; Weiss AP, 2007, AM J PSYCHIAT, V164, P206, DOI 10.1176/appi.ajp.164.2.206; Wells Robert, 2007, Aust New Zealand Health Policy, V4, P14, DOI 10.1186/1743-8462-4-14; Wooding S, 2005, RHEUMATOLOGY, V44, P1145, DOI 10.1093/rheumatology/keh708; Wu Q, 2010, J AM SOC INF SCI TEC, V61, P609, DOI 10.1002/asi.21276; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429	56	30	32	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122239	10.1371/journal.pone.0122239	http://dx.doi.org/10.1371/journal.pone.0122239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837969	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000088
J	Watabe, M; Kato, TA; Teo, AR; Horikawa, H; Tateno, M; Hayakawa, K; Shimokawa, N; Kanba, S				Watabe, Motoki; Kato, Takahiro A.; Teo, Alan R.; Horikawa, Hideki; Tateno, Masaru; Hayakawa, Kohei; Shimokawa, Norihiro; Kanba, Shigenobu			Relationship between Trusting Behaviors and Psychometrics Associated with Social Network and Depression among Young Generation: A Pilot Study	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; JAPANESE VERSION; DECISION-MAKING; UNITED-STATES; VALIDITY; PHQ-9; WITHDRAWAL; HIKIKOMORI; COOPERATION; MINOCYCLINE	Maladaptive social interaction and its related psychopathology have been highlighted in psychiatry especially among younger generations. In Japan, novel expressive forms of psychiatric phenomena such as "modern-type depression" and "hikikomori" (a syndrome of severe social withdrawal lasting for at least six months) have been reported especially among young people. Economic games such as the trust game have been utilized to evaluate real-world interpersonal relationships as a novel candidate for psychiatric evaluations. To investigate the relationship between trusting behaviors and various psychometric scales, we conducted a trust game experiment with eighty-one Japanese university students as a pilot study. Participants made a risky financial decision about whether to trust each of 40 photographed partners. Participants then answered a set of questionnaires with seven scales including the Lubben Social Network Scale (LSNS)-6 and the Patient Health Questionnaire (PHQ)-9. Consistent with previous research, male participants trusted partners more than female participants. Regression analysis revealed that LSNS-family (perceived support from family) for male participants, and item 8 of PHQ-9 (subjective agitation and/or retardation) for female participants were associated with participants' trusting behaviors. Consistent with claims by social scientists, our data suggest that, for males, support from family was negatively associated with cooperative behavior toward non-family members. Females with higher subjective agitation (and/or retardation) gave less money toward males and high attractive females, but not toward low attractive females in interpersonal relationships. We believe that our data indicate the possible impact of economic games in psychiatric research and clinical practice, and validation in clinical samples including modern-type depression and hikikomori should be investigated.	[Watabe, Motoki] Monash Univ, Sch Business, Bandar Sunway 46150, Selangor Darul, Malaysia; [Watabe, Motoki] Waseda Univ, Org Japan US Studies, Shinjuku Ku, Tokyo 1620041, Japan; [Kato, Takahiro A.; Horikawa, Hideki; Hayakawa, Kohei; Shimokawa, Norihiro; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Higashi Ku, Fukuoka 8128582, Japan; [Kato, Takahiro A.] Kyushu Univ, Innovat Ctr Med Redox Nav, Brain Res Unit, Higashi Ku, Fukuoka 8128582, Japan; [Teo, Alan R.] VA Portland Hlth Care Syst, Portland, OR 97239 USA; [Teo, Alan R.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97239 USA; [Tateno, Masaru] Sapporo Med Univ, Dept Neuropsychiat, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Monash University; Monash University Sunway; Waseda University; Kyushu University; Kyushu University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Sapporo Medical University	Watabe, M (corresponding author), Monash Univ, Sch Business, Bandar Sunway 46150, Selangor Darul, Malaysia.	motokiw@gmail.com; takahiro@npsych.med.kyushu-u.ac.jp	Kato, Takahiro/R-7665-2019; Watabe, Motoki/H-2094-2018	Kato, Takahiro/0000-0001-5169-2930; Teo, Alan/0000-0002-2393-088X	Japanese Ministry of Health, Labor, and Welfare (H24-Seishin-Jitsuyouka (Seishin)-Ippan-001); Japanese Ministry of Education, Culture, Sports, Science, and Technology KAKENHI [24650227, 25117011, 25380856, 26713039]; Pfizer Health Research Foundation; SENSHIN Medical Research Foundation for material development; Grants-in-Aid for Scientific Research [26713039] Funding Source: KAKEN	Japanese Ministry of Health, Labor, and Welfare (H24-Seishin-Jitsuyouka (Seishin)-Ippan-001); Japanese Ministry of Education, Culture, Sports, Science, and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pfizer Health Research Foundation; SENSHIN Medical Research Foundation for material development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japanese Ministry of Health, Labor, and Welfare (H24-Seishin-Jitsuyouka (Seishin)-Ippan-001) for material development and data collection; the Japanese Ministry of Education, Culture, Sports, Science, and Technology KAKENHI (Grant-in-Aid 24650227, 25117011, 25380856 & 26713039) for data collection; Pfizer Health Research Foundation; and SENSHIN Medical Research Foundation for material development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon RD, 2009, WORLD PSYCHIATRY, V8, P131; Bayraktar F, 2012, CYBERPSYCH BEH SOC N, V15, P263, DOI 10.1089/cyber.2011.0337; Beard KW, 2005, CYBERPSYCHOL BEHAV, V8, P7, DOI 10.1089/cpb.2005.8.7; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Buss D., 2011, EVOLUTIONARY PSYCHOL, DOI DOI 10.1146/annurev.anthro.012809.104925; Chiu PH, 2008, NEURON, V57, P463, DOI 10.1016/j.neuron.2007.12.020; Clark CB, 2013, J AFFECT DISORDERS, V150, P1184, DOI 10.1016/j.jad.2013.05.011; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Croson R, 1999, AM ECON REV, V89, P386, DOI 10.1257/aer.89.2.386; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; Doi T., 1973, ANATOMY DEPENDENCE; Forkmann T, 2013, J AFFECT DISORDERS, V148, P323, DOI 10.1016/j.jad.2012.12.019; Fukuyama F, 1996, TRUST HUMAN NATURE R; Furlong A, 2008, SOCIOL REV, V56, P309, DOI 10.1111/j.1467-954X.2008.00790.x; Gheorghiu MA, 2009, SOC PSYCHOL QUART, V72, P365, DOI 10.1177/019027250907200408; Hidano N, 2000, STAI MANUAL NEW EDIT; Jagannath V, 2011, ASIAN J PSYCHIATR, V4, P288, DOI 10.1016/j.ajp.2011.10.006; Kato Takahiro A, 2013, Front Psychiatry, V4, P139, DOI 10.3389/fpsyt.2013.00139; Kato TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040461; Kato TA, 2012, SOC PSYCH PSYCH EPID, V47, P1061, DOI 10.1007/s00127-011-0411-7; Kato TA, 2011, J AFFECT DISORDERS, V135, P66, DOI 10.1016/j.jad.2011.06.030; Kato TA, 2011, LANCET, V378, P1070, DOI 10.1016/S0140-6736(11)61475-X; Kendel F, 2010, J AFFECT DISORDERS, V122, P241, DOI 10.1016/j.jad.2009.07.004; Kijima N, 2000, PSYCHOL REP, V86, P1050, DOI 10.2466/PR0.86.3.1050-1058; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Kiyonari T, 1996, JAPANESE J EXPT SOCI, V36, P56; Klapow J, 2002, PSYCHOSOM MED, V64, P635, DOI 10.1097/01.PSY.0000021942.35402.C3; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kudoh T., 1983, JAPANESE J EXPT SOCI, V22, P99, DOI [10.2130/jjesp.22.99, DOI 10.2130/JJESP.22.99]; Kung S, 2013, J AFFECT DISORDERS, V145, P341, DOI 10.1016/j.jad.2012.08.017; Kurimoto Ayumi, 2011, Nihon Ronen Igakkai Zasshi, V48, P149; Lavania S, 2012, J ADDICT MED, V6, P247, DOI 10.1097/ADM.0b013e31826508c0; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; Nakagama H, 2008, KAZOKU SHINRIGAKU KE, V22, P28; Nakano M, 2014, RINSHO SHINRIGAKU JA, V14, P235; Nandi Madhumita, 2012, Indian J Med Sci, V66, P1; Osada H, 2005, JPN J ADDICT FAM, V22, P269; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tarumi S., 2005, JAPANESE B SOCIAL PS, V13, P129; Tarumi S., 2005, JPN J CLIN PSYCHIAT, V34, P687; Teo AR, 2010, INT J SOC PSYCHIATR, V56, P178, DOI 10.1177/0020764008100629; Teo AR, 2014, INT J SOC PSYCHIAT; Tsujii H, 2010, NIHON SEISHINKA KANG, V52, P72; Umeda M, 2012, PSYCHIAT CLIN NEUROS, V66, P121, DOI 10.1111/j.1440-1819.2011.02292.x; Wang Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-18; Watabe M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01685; Watabe Motoki, 2012, Psychopharmacology (Berl), V220, P551, DOI 10.1007/s00213-011-2509-8; Yamagishi T, 2011, SCI MIND, P1, DOI 10.1007/978-4-431-53936-0; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Zhang HJ, 2012, BRAIN BEHAV, V2, P415, DOI 10.1002/brb3.62; Zhong QY, 2014, J AFFECT DISORDERS, V158, P148, DOI 10.1016/j.jad.2014.02.012	55	11	11	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120183	10.1371/journal.pone.0120183	http://dx.doi.org/10.1371/journal.pone.0120183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25836972	Green Published, gold, Green Submitted			2022-12-27	WOS:000352139000019
J	Zhang, Y; Grosse-Honebrink, A; Minton, NP				Zhang, Ying; Grosse-Honebrink, Alexander; Minton, Nigel P.			A Universal Mariner Transposon System for Forward Genetic Studies in the Genus Clostridium	PLOS ONE			English	Article							BACILLUS-SUBTILIS; IN-VIVO; DIPICOLINIC ACID; ACETOBUTYLICUM; MUTAGENESIS; PERFRINGENS; DIFFICILE; SPORES; METABOLISM; EXPRESSION	DNA transposons represent an essential tool in the armoury of the molecular microbiologist. We previously developed a catP-based mini transposon system for Clostridium difficile in which the expression of the transposase gene was dependent on a sigma factor unique to C. difficile, TcdR. Here we have shown that the host range of the transposon is easily extended through the rapid chromosomal insertion of the tcdRgene at the pyrElocus of the intended clostridial target using Allele-Coupled Exchange (ACE). To increase the effectiveness of the system, a novel replicon conditional for plasmid maintenance was developed, which no longer supports the effective retention of the transposon delivery vehicle in the presence of the inducer isopropyl beta-D-1-thiogalactopyranoside (IPTG). As a consequence, those thiamphenicol resistant colonies that arise in clostridial recipients, following plating on agar medium supplemented with IPTG, are almost exclusively due to insertion of the mini transposon into the genome. The system has been exemplified in both Clostridium acetobutylicum and Clostridium sporogenes, where transposon insertion has been shown to be entirely random. Moreover, appropriate screening of both libraries resulted in the isolation of auxotrophic mutants as well as cells deficient in spore formation/germination. This strategy is capable of being implemented in any Clostridium species.	[Zhang, Ying; Grosse-Honebrink, Alexander; Minton, Nigel P.] Univ Nottingham, Sch Life Sci, BBSRC EPSRC Synthet Biol Res Ctr SBRC, Clostridia Res Grp, Nottingham NG7 2RD, England	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Nottingham	Zhang, Y (corresponding author), Univ Nottingham, Sch Life Sci, BBSRC EPSRC Synthet Biol Res Ctr SBRC, Clostridia Res Grp, Nottingham NG7 2RD, England.	ying.zhang@nottingham.ac.uk; nigel.minton@nottingham.ac.uk	zhang, ying/E-2718-2017	Minton, Nigel/0000-0002-9277-1261; Grosse-Honebrink, Alexander/0000-0003-3893-7483; Zhang, Ying/0000-0003-3074-9998	Biotechnology and Biological Sciences Research Council (BBSRC), UK; European Union [BB/I004475/1, BB/G016224/1, PEOPLE-ITN-2008-237942]; Biotechnology and Biological Sciences Research Council [BB/G016224/1, BB/I004475/1] Funding Source: researchfish; BBSRC [BB/G016224/1, BB/I004475/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), UK and the European Union, through grant codes BB/I004475/1, BB/G016224/1 and PEOPLE-ITN-2008-237942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Al-Hinai MA, 2012, APPL ENVIRON MICROB, V78, P8112, DOI 10.1128/AEM.02214-12; Amador-Noguez D, 2010, J BACTERIOL, V192, P4452, DOI 10.1128/JB.00490-10; BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; Brazier JS, 2008, BRIT J BIOMED SCI, V65, P39, DOI 10.1080/09674845.2008.11732796; Cao M, 2007, APPL ENVIRON MICROB, V73, P2758, DOI 10.1128/AEM.02844-06; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chen Y, 2004, VIROLOGY, V329, P226, DOI 10.1016/j.virol.2004.08.018; Crown SB, 2011, BIOTECHNOL J, V6, P300, DOI 10.1002/biot.201000282; Durre P., 2005, HDB CLOSTRIDIA; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Feustel L, 2004, APPL ENVIRON MICROB, V70, P798, DOI 10.1128/AEM.70.2.798-803.2004; Fox ME, 1996, GENE THER, V3, P173; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Hartman AH, 2011, APPL ENVIRON MICROB, V77, P471, DOI 10.1128/AEM.01536-10; HARTMANIS MGN, 1984, APPL ENVIRON MICROB, V47, P1277, DOI 10.1128/AEM.47.6.1277-1283.1984; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2014, ONCOTARGET, V5, P1761, DOI 10.18632/oncotarget.1761; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Heap JT, 2010, METHODS MOL BIOL, V646, P165, DOI 10.1007/978-1-60327-365-7_11; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hillmann F, 2009, J BACTERIOL, V191, P6082, DOI 10.1128/JB.00351-09; Kodama T, 2000, J BIOCHEM, V128, P655, DOI 10.1093/oxfordjournals.jbchem.a022798; Le Breton Y, 2006, APPL ENVIRON MICROB, V72, P327, DOI 10.1128/AEM.72.1.327-333.2006; Leang C, 2013, APPL ENVIRON MICROB, V79, P1102, DOI 10.1128/AEM.02891-12; Lehmann Y, 1996, J BACTERIOL, V178, P7152, DOI 10.1128/jb.178.24.7152-7158.1996; Liu HL, 2013, J BACTERIOL, V195, P629, DOI 10.1128/JB.01288-12; LOVITT RW, 1987, J APPL BACTERIOL, V62, P71, DOI 10.1111/j.1365-2672.1987.tb02382.x; Maier TM, 2006, APPL ENVIRON MICROB, V72, P1878, DOI 10.1128/AEM.72.3.1878-1885.2006; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; MINTON N, 1981, J GEN MICROBIOL, V127, P325; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nariya H, 2011, APPL ENVIRON MICROB, V77, P1375, DOI 10.1128/AEM.01572-10; Ng YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056051; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; OBRIEN RW, 1971, J GEN MICROBIOL, V68, P307, DOI 10.1099/00221287-68-3-307; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Riebe O, 2009, MICROBIOL-SGM, V155, P16, DOI 10.1099/mic.0.022756-0; Shaw W V, 1975, Methods Enzymol, V43, P737; Tovar-Rojo F, 2002, J BACTERIOL, V184, P584, DOI 10.1128/JB.184.2.584-587.2002; Vepachedu VR, 2007, J BACTERIOL, V189, P1565, DOI 10.1128/JB.01613-06; Wilson AC, 2007, J MICROBIOL METH, V71, P332, DOI 10.1016/j.mimet.2007.09.006	46	24	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122411	10.1371/journal.pone.0122411	http://dx.doi.org/10.1371/journal.pone.0122411			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836262	Green Submitted, gold, Green Published			2022-12-27	WOS:000352139000096
J	Garcia-Carmona, JA; Baroja-Mazo, A; Milanes, MV; Laorden, ML				Garcia-Carmona, Juan-Antonio; Baroja-Mazo, Alberto; Milanes, Maria-Victoria; Luisa Laorden, Maria			Sex Differences between CRF1 Receptor Deficient Mice following Naloxone-Precipitated Morphine Withdrawal in a Conditioned Place Aversion Paradigm: Implication of HPA Axis	PLOS ONE			English	Article							PHYSICAL-DEPENDENCE; OPIATE WITHDRAWAL; EXPRESSION; EXTINCTION; PREFERENCE; TOLERANCE; DOPAMINE; NUCLEUS; SYSTEM; INVOLVEMENT	Background Extinction period of positive affective memory of drug taking and negative affective memory of drug withdrawal, as well as the different response of men and women might be important for the clinical treatment of drug addiction. We investigate the role of corticotropin releasing factor receptor type one (CRF1R) and the different response of male and female mice in the expression and extinction of the aversive memory. Methodology/Principal Finding We used genetically engineered male and female mice lacking functional CRF1R. The animals were rendered dependent on morphine by intraperitoneally injection of increasing doses of morphine (10-60 mg/kg). Negative state associated with naloxone (1 mg/kg s.c.)-precipitated morphine withdrawal was examined by using conditioned place aversion (CPA) paradigm. No sex differences for CPA expression were found in wild-type (n = 29) or CRF1R knockout (KO) mice (n = 29). However, CRF1R KO mice presented less aversion score than wild-type mice, suggesting that CRF1R KO mice were less responsive than wild-type to continuous associations between drug administration and environmental stimuli. In addition, CPA extinction was delayed in wild-type and CRF1R KO male mice compared with females of both genotypes. The genetic disruption of the CRF1R pathway decreased the period of extinction in males and females suggesting that CRF/CRF1R is implicated in the duration of aversive memory. Our results also showed that the increase in adrenocorticotropic hormone (ACTH) levels observed in wild-type (n = 11) mice after CPA expression, were attenuated in CRF1R KO mice (n = 10). In addition, ACTH returned to the baseline levels in males and females once CPA extinction was finished. Conclusion/Significance These results suggest that, at least, CPA expression is partially due to an increase in plasma ACTH levels, through activation of CRF1R, which can return when CPA extinction is finished.	[Garcia-Carmona, Juan-Antonio; Milanes, Maria-Victoria; Luisa Laorden, Maria] Univ Murcia, Sch Med, Dept Pharmacol, Murcia, Spain; [Baroja-Mazo, Alberto] FFIS Univ Hosp VA, Grp Inflammat, Murcia, Spain	University of Murcia	Laorden, ML (corresponding author), Univ Murcia, Sch Med, Dept Pharmacol, Murcia, Spain.	laorden@um.es	Baroja-Mazo, Alberto/E-6270-2016; Milanés, M Victoria/K-6591-2017; Milanés, M. Victoria/AGB-4075-2022; García-Carmona, Juan-Antonio/AAA-8173-2021	Baroja-Mazo, Alberto/0000-0001-5212-5006; Milanés, M Victoria/0000-0002-0984-2218; Milanés, M. Victoria/0000-0002-0984-2218; Garcia-Carmona, Juan Antonio/0000-0003-3938-7698	Ministerio de Ciencia e Innovacion (SAF/FEDER) Spain [2010-17907, 2013-49076-P]; Red de trastornos adictivos (RETICS) [RD12/0028//0003]; Instituto de Salud Carlos III, Spain; Fundacion Seneca [15405/PI/10]; Region de Murcia, Spain; Fundacion Seneca; Agencia de Ciencia y Tecnologia de la Region de Murcia [15519/FPI/10]	Ministerio de Ciencia e Innovacion (SAF/FEDER) Spain; Red de trastornos adictivos (RETICS); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Fundacion Seneca(Fundacion Seneca); Region de Murcia, Spain; Fundacion Seneca(Fundacion Seneca); Agencia de Ciencia y Tecnologia de la Region de Murcia	This research was supported by grants from the Ministerio de Ciencia e Innovacion (Grants SAF/FEDER 2010-17907; 2013-49076-P), Spain, Red de trastornos adictivos (RETICS RD12/0028//0003), Instituto de Salud Carlos III, Spain. Fundacion Seneca (15405/PI/10, Region de Murcia, Spain. JAGC was supported by a predoctoral fellowship from Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia (ref. 15519/FPI/10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker JJ, 2011, CURR TOP BEHAV NEURO, V8, P73, DOI 10.1007/7854_2010_93; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; BLUM K, 1976, AM J DRUG ALCOHOL AB, V3, P363, DOI 10.3109/00952997609077204; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Brandao M L, 1993, Rev Neurosci, V4, P397; Bruijnzeel AW, 2009, BIOL PSYCHIAT, V66, P110, DOI 10.1016/j.biopsych.2009.01.010; Budzynska B, 2012, BEHAV BRAIN RES, V228, P144, DOI 10.1016/j.bbr.2011.12.003; Carroll ME, 2010, HORM BEHAV, V58, P44, DOI 10.1016/j.yhbeh.2009.10.001; Carroll ME, 2004, TRENDS PHARMACOL SCI, V25, P273, DOI 10.1016/j.tips.2004.03.011; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Cicero TJ, 2002, PHARMACOL BIOCHEM BE, V72, P691, DOI 10.1016/S0091-3057(02)00740-2; Contarino A, 2005, P NATL ACAD SCI USA, V102, P18649, DOI 10.1073/pnas.0506999102; Craft RM, 1999, PSYCHOPHARMACOLOGY, V143, P1, DOI 10.1007/s002130050911; Deshmukh A, 2003, J STUD ALCOHOL, V64, P375, DOI 10.15288/jsa.2003.64.375; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; Devaud LL, 2001, ALCOHOL CLIN EXP RES, V25, P1689, DOI 10.1111/j.1530-0277.2001.tb02176.x; Diaz SL, 2001, BEHAV PHARMACOL, V12, P75, DOI 10.1097/00008877-200102000-00009; ELKADI AOS, 1994, GEN PHARMACOL-VASC S, V25, P1505, DOI 10.1016/0306-3623(94)90181-3; Feltenstein MW, 2007, NEUROBIOL LEARN MEM, V88, P435, DOI 10.1016/j.nlm.2007.05.006; Garcia-Carmona JA, 2012, PSYCHOPHARMACOLOGY, V220, P379, DOI 10.1007/s00213-011-2478-y; Goeldner C, 2011, BIOL PSYCHIAT, V69, P236, DOI 10.1016/j.biopsych.2010.08.021; Gomez-Milanes I, 2012, NEUROCHEM INT, V61, P433, DOI 10.1016/j.neuint.2012.06.011; Harris GC, 2007, BEHAV BRAIN RES, V176, P251, DOI 10.1016/j.bbr.2006.10.012; Hilderbrand ER, 2014, NEUROREPORT, V25, P105, DOI 10.1097/WNR.0000000000000053; Hsu E, 2008, NEUROBIOL LEARN MEM, V89, P504, DOI 10.1016/j.nlm.2007.08.006; Iredale PA, 2000, J NEUROCHEM, V74, P199, DOI 10.1046/j.1471-4159.2000.0740199.x; Kest B, 2001, PHARMACOL BIOCHEM BE, V70, P149, DOI 10.1016/S0091-3057(01)00600-1; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Korosi A, 2006, BRAIN RES, V1072, P46, DOI 10.1016/j.brainres.2005.12.034; Liang DY, 2007, BEHAV BRAIN RES, V181, P118, DOI 10.1016/j.bbr.2007.03.037; Liang DY, 2006, PAIN, V121, P232, DOI 10.1016/j.pain.2005.12.026; Martinez-Laorden E, 2014, BRIT J PHARMACOL, V171, P688, DOI 10.1111/bph.12511; MIYAMOTO Y, 1993, LIFE SCI, V52, P1039, DOI 10.1016/0024-3205(93)90196-A; Myers KM, 2010, BIOL PSYCHIAT, V67, P85, DOI 10.1016/j.biopsych.2009.08.015; Navarro-Zaragoza J, 2010, MOL PHARMACOL, V77, P864, DOI 10.1124/mol.109.062463; Papaleo F, 2007, NEURON, V53, P577, DOI 10.1016/j.neuron.2007.01.022; Papaleo F, 2006, BEHAV BRAIN RES, V170, P110, DOI 10.1016/j.bbr.2006.02.009; Perry JL, 2006, EXP CLIN PSYCHOPHARM, V14, P68, DOI 10.1037/1064-1297.14.1.68; Radke AK, 2013, PSYCHOPHARMACOLOGY, V227, P117, DOI 10.1007/s00213-012-2945-0; Radke AK, 2012, NEUROPSYCHOPHARMACOL, V37, P2405, DOI 10.1038/npp.2012.97; Sharf R, 2010, BRAIN RES, V1314, P130, DOI 10.1016/j.brainres.2009.08.028; Solecki W, 2009, PSYCHOPHARMACOLOGY, V207, P245, DOI 10.1007/s00213-009-1672-7; SUZUKI T, 1988, PHARMACOL BIOCHEM BE, V30, P483, DOI 10.1016/0091-3057(88)90484-4; SUZUKI T, 1985, JPN J PHARMACOL, V39, P453, DOI 10.1254/jjp.39.453; Torregrossa MM, 2010, J NEUROSCI, V30, P10526, DOI 10.1523/JNEUROSCI.2523-10.2010; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ueno K, 2011, DRUG DISCOV THER, V5, P71, DOI 10.5582/ddt.2011.v5.2.71; Valverde O, 1996, PSYCHOPHARMACOLOGY, V123, P119, DOI 10.1007/BF02246168; WAY EL, 1969, J PHARMACOL EXP THER, V167, P1; Wu P, 2014, PSYCHOPHARMACOLOGY, V231, P4659, DOI 10.1007/s00213-014-3615-1; Ziolkowska B, 2012, PHARMACOL REP, V64, P1091	55	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121125	10.1371/journal.pone.0121125	http://dx.doi.org/10.1371/journal.pone.0121125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830629	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600059
J	Liu, JL; Sun, K; Zheng, CL; Chen, XT; Zhang, WJ; Wang, ZZ; Shar, PA; Xiao, W; Wang, YH				Liu, Jianling; Sun, Ke; Zheng, Chunli; Chen, Xuetong; Zhang, Wenjuan; Wang, Zhengzhong; Shar, Piar Ali; Xiao, Wei; Wang, Yonghua			Pathway as a Pharmacological Target for Herbal Medicines: An Investigation from Reduning Injection	PLOS ONE			English	Article							NF-KAPPA-B; NETWORK PHARMACOLOGY; SYSTEMS PHARMACOLOGY; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; DRUG DISCOVERY; INFLAMMATION; COMBINATION; ALPHA	As a rich natural resource for drug discovery, Traditional Chinese Medicine (TCM) plays an important role in complementary and alternative medical systems. TCM shows a daunting complexity of compounds featuring multi-components and multi-targets to cure diseases, which thus always makes it extremely difficult to systematically explain the molecular mechanisms adequately using routine methods. In the present work, to reveal the systematic mechanism of herbal formulae, we developed a pathway-based strategy by combining the pathways integrating, target selection, reverse drug targeting and network analysis together, and then exemplified it by Reduning injection (RDN), a clinically widely used herbal medicine injection, in combating inflammation. The anti-inflammatory effects exerted by the major ingredients of RDN at signaling pathways level were systematically investigated. More importantly, our predicted results were also experimentally validated. Our strategy provides a deep understanding of the pharmacological functions of herbal formulae from molecular to systematic level, which may lead to more successful applications of systems pharmacology for drug discovery and development.	[Liu, Jianling; Sun, Ke] NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Sun, Ke; Zheng, Chunli; Chen, Xuetong; Zhang, Wenjuan; Shar, Piar Ali; Wang, Yonghua] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Sun, Ke; Zheng, Chunli; Chen, Xuetong; Zhang, Wenjuan; Shar, Piar Ali; Wang, Yonghua] Northwest A&F Univ, Ctr Bioinformat, Yangling 712100, Shaanxi, Peoples R China; [Wang, Zhengzhong; Xiao, Wei] State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang 222001, Jiangsu, Peoples R China	Northwest University Xi'an; Northwest A&F University - China; Northwest A&F University - China	Xiao, W (corresponding author), State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang 222001, Jiangsu, Peoples R China.	kanionlunwen@163.com; yh_wang@nwsuaf.edu.cn		Jiang, Meng/0000-0002-2488-1389	Fund of Northwest A F University; National Natural Science Foundation of China [31170796, 81373892]; Jiangsu Kanion Pharmaceutical Co. Ltd.	Fund of Northwest A F University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Kanion Pharmaceutical Co. Ltd.	The research is supported by the Fund of Northwest A & F University (http://www.nwsuaf.edu.cn/) and is financially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant No. 31170796 and 81373892). Jiangsu Kanion Pharmaceutical Co. Ltd. provided support in the form of salaries for authors ZW and WX and provided experimental devices and laboratory for this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; [Anonymous], 2013, STUDIES PHARMACODYNA; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Castoreno AB, 2010, NAT CHEM BIOL, V6, P457, DOI 10.1038/nchembio.363; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Christman JW, 1998, INTENS CARE MED, V24, P1131, DOI 10.1007/s001340050735; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang C, 2014, BRIEF BIOINFORM, V15, P710, DOI 10.1093/bib/bbt035; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim TH, 2012, MOL MED, V18, P455, DOI 10.2119/molmed.2011.00308; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Li BH, 2012, INT J MOL SCI, V13, P13501, DOI 10.3390/ijms131013501; Li P, 2015, BIOINFORMATICS; Li P, 2014, J ETHNOPHARMACOL, V151, P93, DOI 10.1016/j.jep.2013.07.001; Liang XJ, 2014, MOL BIOSYST, V10, P1014, DOI 10.1039/c3mb70507b; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Tung YT, 2008, BIORESOURCE TECHNOL, V99, P3908, DOI 10.1016/j.biortech.2007.07.050; Wang X, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/519031; Xu HM, 2009, PHARM WORLD SCI, V31, P458, DOI 10.1007/s11096-009-9297-9; Yao XJ, 2012, INT IMMUNOPHARMACOL, V14, P454, DOI 10.1016/j.intimp.2012.07.024; Yao Y, 2013, J ETHNOPHARMACOL, V150, P619, DOI 10.1016/j.jep.2013.09.018; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608	36	26	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123109	10.1371/journal.pone.0123109	http://dx.doi.org/10.1371/journal.pone.0123109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830385	Green Submitted, gold, Green Published			2022-12-27	WOS:000352135600139
J	Monnerat, R; Martins, E; Macedo, C; Queiroz, P; Praca, L; Soares, CM; Moreira, H; Grisi, I; Silva, J; Soberon, M; Bravo, A				Monnerat, Rose; Martins, Erica; Macedo, Cristina; Queiroz, Paulo; Praca, Lilian; Soares, Carlos Marcelo; Moreira, Helio; Grisi, Isabella; Silva, Joseane; Soberon, Mario; Bravo, Alejandra			Evidence of Field-Evolved Resistance of Spodoptera frugiperda to Bt Corn Expressing Cry1F in Brazil That Is Still Sensitive to Modified Bt Toxins	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; INSECT RESISTANCE; LEPIDOPTERA-NOCTUIDAE; MAIZE; POPULATIONS; PROTEINS; MUTANTS; CROPS; CELLS; SMITH	Brazil ranked second only to the United States in hectares planted to genetically modified crops in 2013. Recently corn producers in the Cerrado region reported that the control of Spodoptera frugiperda with Bt corn expressing Cry1Fa has decreased, forcing them to use chemicals to reduce the damage caused by this insect pest. A colony of S. frugiperda was established from individuals collected in 2013 from Cry1Fa corn plants (SfBt) in Brazil and shown to have at least more than ten-fold higher resistance levels compared with a susceptible colony (Sflab). Laboratory assays on corn leaves showed that in contrast to SfLab population, the SfBt larvae were able to survive by feeding on Cry1Fa corn leaves. The SfBt population was maintained without selection for eight generations and shown to maintain high levels of resistance to Cry1Fa toxin. SfBt showed higher cross-resistance to Cry1Aa than to Cry1Ab or Cry1Ac toxins. As previously reported, Cry1A toxins competed the binding of Cry1Fa to brush border membrane vesicles (BBMV) from SfLab insects, explaining cross-resistance to Cry1A toxins. In contrast Cry2A toxins did not compete Cry1Fa binding to SfLab-BBMV and no cross-resistance to Cry2A was observed, although Cry2A toxins show low toxicity to S. frugiperda. Bioassays with Cry1AbMod and Cry1AcMod show that they are highly active against both the SfLab and the SfBt populations. The bioassay data reported here show that insects collected from Cry1Fa corn in the Cerrado region were resistant to Cry1Fa suggesting that resistance contributed to field failures of Cry1Fa corn to control S. frugiperda.	[Monnerat, Rose; Macedo, Cristina; Praca, Lilian; Moreira, Helio; Grisi, Isabella; Silva, Joseane] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Martins, Erica; Queiroz, Paulo; Soares, Carlos Marcelo] Inst Mato Grossense Algodao, Cuiaba, MG, Brazil; [Macedo, Cristina] Univ Brasilia, Dept Microbiol, Brasilia, DF, Brazil; [Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidad Nacional Autonoma de Mexico	Monnerat, R (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	rose.monnerat@embrapa.br	de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475; Queiroz, Paulo/0000-0002-4672-8123; QUEIROZ, ERICA SOARES MARTINS/0000-0002-1612-7837	internal organization (Embrapa Recursos Geneticos e Biotecnologia); internal organization (Instituto Mato-Grossense do Algodao); internal organization (Universidad Nacional Autonoma de Mexico); internal organization (UniCEUB)	internal organization (Embrapa Recursos Geneticos e Biotecnologia); internal organization (Instituto Mato-Grossense do Algodao); internal organization (Universidad Nacional Autonoma de Mexico); internal organization (UniCEUB)	This work was supported by the internal organizations (Embrapa Recursos Geneticos e Biotecnologia; Instituto Mato-Grossense do Algodao; Universidad Nacional Autonoma de Mexico and UniCEUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda E, 1996, J INVERTEBR PATHOL, V68, P203, DOI 10.1006/jipa.1996.0087; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; de Macedo CL, 2012, PESQUI AGROPECU BRAS, V47, P1759, DOI 10.1590/S0100-204X2012001200012; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Finney D, 1971, PROBIT ANAL, P50; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Girard F, 2008, APPL ENVIRON MICROB, V74, P2565, DOI 10.1128/AEM.00094-08; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Grigolli JFJ, 2013, ALTA INFESTACAO LARG; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Jakka SRK, 2014, J INVERTEBR PATHOL, V122, P52, DOI 10.1016/j.jip.2014.08.009; James C., 2013, GLOBAL STATUS COMMER, P46; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Jurat-Fuentes JL, 2011, APPL ENVIRON MICROB, V67, P323; Leite N, 2011, SERIE DOCUMENTOS, V133; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; Monnerat RG, 2001, CATALOGO BANCO GERMO; Monnerat R, 2006, APPL ENVIRON MICROB, V72, P7029, DOI 10.1128/AEM.01454-06; Monnerat RG, 2007, BIOL CONTROL, V41, P291, DOI 10.1016/j.biocontrol.2006.11.008; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Praca LB, 2004, PESQUI AGROPECU BRAS, V39, P11, DOI 10.1590/S0100-204X2004000100002; R Development Core Team, 2014, R LANG ENV STAT COMP; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; Schmidt F, 2001, 9 EMBR; Slamti L, 2014, TOXINS, V6, P2239, DOI 10.3390/toxins6082239; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, APPL ENVIRON MICROB, V60, P4627, DOI 10.1128/AEM.60.12.4627-4629.1994; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; THOMAS WE, 1983, J CELL SCI, V60, P181; Vachon V, 2002, BIOCHEMISTRY-US, V41, P6178, DOI 10.1021/bi011572e; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WOLFERSBERGER MG, 1990, EXPERIENTIA, V46, P475, DOI 10.1007/BF01954236; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	43	68	75	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119544	10.1371/journal.pone.0119544	http://dx.doi.org/10.1371/journal.pone.0119544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830928	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600012
J	Nie, HX; Yang, QY; Zhang, G; Wang, AL; He, Q; Liu, M; Li, P; Yang, J; Huang, Y; Ding, XH; Yu, HY; Hu, SP				Nie, Hanxiang; Yang, Qiaoyu; Zhang, Guqin; Wang, Ailing; He, Qing; Liu, Min; Li, Ping; Yang, Jiong; Huang, Yi; Ding, Xuhong; Yu, Hongying; Hu, Suping			Invariant NKT Cells Act as an Adjuvant to Enhance Th2 Inflammatory Response in an OVA-Induced Mouse Model of Asthma	PLOS ONE			English	Article							KILLER T-CELLS; AIRWAY INFLAMMATION; DENDRITIC CELLS; IN-VIVO; ACTIVATION; CD4(+); HYPERREACTIVITY; INFECTION; IMMUNITY; INNATE	Background Invariant natural killer T cells (iNKT cells) are a unique subset of T lymphocytes and are considered to play an important role in the development of allergic bronchial asthma. Recently, iNKT cells were shown to play an immunoregulatory role in CD4(+) and CD8(+) T cell-mediated adaptive immune response. Allergen-specific Th2 inflammatory responses are an important part of the adaptive immune response in asthma. However, the regulatory functions of the Th2 inflammatory response in asthma have not been studied in detail. Method In this study, we have investigated the regulatory functions of iNKT cells on the Th2 inflammatory response in an ovalbumin (OVA)-induced murine model of asthma. Results Our results demonstrate that alpha-Galactosylceramide (alpha-GalCer) administration activated iNKT cells but could not induce the Th2 inflammatory response in wild-type (WT) mice. In the OVA-induced asthma model, alpha-GalCer administration and adoptive transfer of iNKT cells significantly augmented the Th2 inflammatory responses, including elevated inflammatory cell infiltration in the lung and bronchoalveolar lavage fluid (BALF); increased levels of IL-4, IL-5, and IL-13 in the BALF and splenocyte culture supernatant; and increased serum levels of OVA-specific IgE and IgG1. In addition, the Th2 inflammatory response was reduced, but not completely abrogated in CD1d(-/)-mice immunized and challenged with OVA, compared with WT mice. Conclusion These results suggest that iNKT cells may serve as an adjuvant to enhance Th2 inflammatory response in an OVA-induced murine model of asthma.	[Nie, Hanxiang; Yang, Qiaoyu; He, Qing; Liu, Min; Huang, Yi; Ding, Xuhong; Yu, Hongying; Hu, Suping] Wuhan Univ, Renmin Hosp, Dept Resp Med, Wuhan 430072, Peoples R China; [Zhang, Guqin; Li, Ping; Yang, Jiong] Wuhan Univ, Zhongnan Hosp, Dept Resp Med, Wuhan 430072, Peoples R China; [Wang, Ailing] Wuhan Univ, HOPE Sch Nursing, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Nie, HX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Resp Med, Wuhan 430072, Peoples R China.	nhxbj@sohu.com			National Natural Science Foundation of China [81270076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 81270076). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Balato A, 2009, J INVEST DERMATOL, V129, P1628, DOI 10.1038/jid.2009.30; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Eberl G, 2000, J IMMUNOL, V165, P4305, DOI 10.4049/jimmunol.165.8.4305; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hong C, 2006, J IMMUNOL, V177, P6747, DOI 10.4049/jimmunol.177.10.6747; Hong C, 2009, CANCER RES, V69, P4301, DOI 10.1158/0008-5472.CAN-08-1721; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Matangkasombut P, 2009, MUCOSAL IMMUNOL, V2, P383, DOI 10.1038/mi.2009.96; Matangkasombut P, 2009, J ALLERGY CLIN IMMUN, V123, P1181, DOI 10.1016/j.jaci.2009.02.013; Novak J, 2011, CYTOKINE, V53, P263, DOI 10.1016/j.cyto.2010.11.001; Oki Shinji, 2007, Allergol Int, V56, P7, DOI 10.2332/allergolint.R-06-137; Reynolds C, 2009, J ALLERGY CLIN IMMUN, V124, P860, DOI 10.1016/j.jaci.2009.07.022; Shin Y, 2010, J IMMUNOL, V184, P5589, DOI 10.4049/jimmunol.0903121; Thomas SY, 2010, J ALLERGY CLIN IMMUN, V125, P980, DOI 10.1016/j.jaci.2010.01.032; Wiethe C, 2008, J IMMUNOL, V180, P4371, DOI 10.4049/jimmunol.180.7.4371; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Zhang GQ, 2011, AM J PHYSIOL-LUNG C, V301, pL975, DOI 10.1152/ajplung.00114.2011	26	38	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119901	10.1371/journal.pone.0119901	http://dx.doi.org/10.1371/journal.pone.0119901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830340	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600016
J	Pena, C; Espeland, M				Pena, Carlos; Espeland, Marianne			Diversity Dynamics in Nymphalidae Butterflies: Effect of Phylogenetic Uncertainty on Diversification Rate Shift Estimates	PLOS ONE			English	Article							HIGHER-LEVEL PHYLOGENY; LEPIDOPTERA NYMPHALIDAE; SATYRINAE; PATTERNS; PLANTS; CLASSIFICATION; HELICONIINAE; EUPTYCHIINA; SYSTEMATICS; RADIATIONS	The species rich butterfly family Nymphalidae has been used to study evolutionary interactions between plants and insects. Theories of insect-hostplant dynamics predict accelerated diversification due to key innovations. In evolutionary biology, analysis of maximum credibility trees in the software MEDUSA (modelling evolutionary diversity using stepwise AIC) is a popular method for estimation of shifts in diversification rates. We investigated whether phylogenetic uncertainty can produce different results by extending the method across a random sample of trees from the posterior distribution of a Bayesian run. Using the MultiMEDUSA approach, we found that phylogenetic uncertainty greatly affects diversification rate estimates. Different trees produced diversification rates ranging from high values to almost zero for the same clade, and both significant rate increase and decrease in some clades. Only four out of 18 significant shifts found on the maximum clade credibility tree were consistent across most of the sampled trees. Among these, we found accelerated diversification for Ithomiini butterflies. We used the binary speciation and extinction model (BiSSE) and found that a hostplant shift to Solanaceae is correlated with increased net diversification rates in Ithomiini, congruent with the diffuse cospeciation hypothesis. Our results show that taking phylogenetic uncertainty into account when estimating net diversification rate shifts is of great importance, as very different results can be obtained when using the maximum clade credibility tree and other trees from the posterior distribution.	[Pena, Carlos] Univ Turku, Dept Biol, Genet Lab, SF-20500 Turku, Finland; [Espeland, Marianne] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Espeland, Marianne] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Turku; Harvard University; Harvard University	Pena, C (corresponding author), Univ Turku, Dept Biol, Genet Lab, SF-20500 Turku, Finland.	mycalesis@gmail.com		Espeland, Marianne/0000-0002-6800-4783	Kone Foundation grant, Finland; Research Council of Norway [204308]	Kone Foundation grant, Finland; Research Council of Norway(Research Council of Norway)	The study was supported by a Kone Foundation grant (awarded to Niklas Wahlberg), Finland (C. Pena) and the Research Council of Norway (grant no. 204308 to M. Espeland).	ACKERY PR, 1988, BIOL J LINN SOC, V33, P95, DOI 10.1111/j.1095-8312.1988.tb00446.x; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; [Anonymous], 2008, CATALOGUE HOSTPLANTS; [Anonymous], 2007, TREE LIFE WEB PROJEC; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Brakefield PM, 2009, COLD SPRING HARB PRO, V2009; Brower AVZ, 2010, SYST BIODIVERS, V8, P75, DOI 10.1080/14772001003626814; Brower AVZ, 2006, SYST ENTOMOL, V31, P288, DOI 10.1111/j.1365-3113.2006.00321.x; BROWN KS, 1987, ANN MO BOT GARD, V74, P359, DOI 10.2307/2399406; Core Team R, 2013, R LANG ENV STAT COMP; Davis MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-38; de-Silva DL, 2010, MOL PHYLOGENET EVOL, V55, P1032, DOI 10.1016/j.ympev.2010.01.010; Dyer L. A., 2002, CATERPILLARS PARASIT; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Elias M, 2009, MOL ECOL, V18, P1716, DOI 10.1111/j.1365-294X.2009.04149.x; Ferrer-Paris JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063570; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Freitas AVL, 2004, SYST BIOL, V53, P363, DOI 10.1080/10635150490445670; GBN, 2014, GLOB BUTT NAM PROJ; Hardy NB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2960; Harmon LJ, 2011, TURBOMEDUSA MEDUSA M; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Janzen D.H., 2009, DYNAMIC DATABASE INV; Joron M, 2006, HEREDITY, V97, P157, DOI 10.1038/sj.hdy.6800873; Kodandaramaiah U, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-172; Kodandaramaiah U, 2010, MOL PHYLOGENET EVOL, V54, P386, DOI 10.1016/j.ympev.2009.08.012; Lamas G., 2004, ATLAS NEOTROPICAL A, V5A; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; Litman JR, 2011, P ROY SOC B-BIOL SCI, V278, P3593, DOI 10.1098/rspb.2011.0365; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Matos-Maravi PF, 2013, MOL PHYLOGENET EVOL, V66, P54, DOI 10.1016/j.ympev.2012.09.005; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Nylin S, 2014, EVOLUTION, V68, P105, DOI 10.1111/evo.12227; Nyman T, 2012, ECOL LETT, V15, P889, DOI 10.1111/j.1461-0248.2012.01782.x; Ortiz-Acevedo E, 2013, SYST ENTOMOL, V38, P440, DOI 10.1111/syen.12008; Pena C, 2008, BIOL LETTERS, V4, P274, DOI 10.1098/rsbl.2008.0062; Pena C, 2006, MOL PHYLOGENET EVOL, V40, P29, DOI 10.1016/j.ympev.2006.02.007; Pena C, 2011, ZOOL J LINN SOC-LOND, V161, P64, DOI 10.1111/j.1096-3642.2009.00627.x; Pena C, 2010, ZOOL SCR, V39, P243, DOI 10.1111/j.1463-6409.2010.00421.x; Penz CM, 1999, ZOOL J LINN SOC-LOND, V127, P277, DOI 10.1111/j.1096-3642.1999.tb00680.x; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Ryberg M, 2012, P ROY SOC B-BIOL SCI, V279, P2003, DOI 10.1098/rspb.2011.2428; SCOTT JA, 1986, BUTTERFLIES N AM; Silva-Brandao KL, 2008, MOL PHYLOGENET EVOL, V46, P515, DOI 10.1016/j.ympev.2007.11.024; Wahlberg N, 2011, SYST ENTOMOL, V36, P362, DOI 10.1111/j.1365-3113.2010.00566.x; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Willmott KR, 2006, CLADISTICS, V22, P297, DOI 10.1111/j.1096-0031.2006.00108.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	53	9	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120928	10.1371/journal.pone.0120928	http://dx.doi.org/10.1371/journal.pone.0120928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830910	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600051
J	Peyret, H; Gehin, A; Thuenemann, EC; Blond, D; El Turabi, A; Beales, L; Clarke, D; Gilbert, RJC; Fry, EE; Stuart, DI; Holmes, K; Stonehouse, NJ; Whelan, M; Rosenberg, W; Lomonossoff, GP; Rowlands, DJ				Peyret, Hadrien; Gehin, Annick; Thuenemann, Eva C.; Blond, Donatienne; El Turabi, Aadil; Beales, Lucy; Clarke, Dean; Gilbert, Robert J. C.; Fry, Elizabeth E.; Stuart, David I.; Holmes, Kris; Stonehouse, Nicola J.; Whelan, Mike; Rosenberg, William; Lomonossoff, George P.; Rowlands, David J.			Tandem Fusion of Hepatitis B Core Antigen Allows Assembly of Virus-Like Particles in Bacteria and Plants with Enhanced Capacity to Accommodate Foreign Proteins	PLOS ONE			English	Article							MALARIA VACCINE; IMMUNOGENICITY; EPITOPES; SURFACE; DISPLAY; PRODUCE; CARRIER; EXPRESSION; MOLSCRIPT; VECTORS	The core protein of the hepatitis B virus, HBcAg, assembles into highly immunogenic virus-like particles (HBc VLPs) when expressed in a variety of heterologous systems. Specifically, the major insertion region (MIR) on the HBcAg protein allows the insertion of foreign sequences, which are then exposed on the tips of surface spike structures on the outside of the assembled particle. Here, we present a novel strategy which aids the display of whole proteins on the surface of HBc particles. This strategy, named tandem core, is based on the production of the HBcAg dimer as a single polypeptide chain by tandem fusion of two HBcAg open reading frames. This allows the insertion of large heterologous sequences in only one of the two MIRs in each spike, without compromising VLP formation. We present the use of tandem core technology in both plant and bacterial expression systems. The results show that tandem core particles can be produced with unmodified MIRs, or with one MIR in each tandem dimer modified to contain the entire sequence of GFP or of a camelid nanobody. Both inserted proteins are correctly folded and the nanobody fused to the surface of the tandem core particle (which we name tandibody) retains the ability to bind to its cognate antigen. This technology paves the way for the display of natively folded proteins on the surface of HBc particles either through direct fusion or through non-covalent attachment via a nanobody.	[Peyret, Hadrien; Thuenemann, Eva C.; Lomonossoff, George P.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Gehin, Annick; Blond, Donatienne; El Turabi, Aadil; Beales, Lucy; Clarke, Dean; Holmes, Kris; Stonehouse, Nicola J.; Rowlands, David J.] Univ Leeds, Fac Biol, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Gehin, Annick; Blond, Donatienne; El Turabi, Aadil; Beales, Lucy; Clarke, Dean; Holmes, Kris; Stonehouse, Nicola J.; Rowlands, David J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [El Turabi, Aadil; Beales, Lucy; Whelan, Mike; Rosenberg, William] iQur Ltd, London, England; [Gilbert, Robert J. C.; Fry, Elizabeth E.; Stuart, David I.] Univ Oxford, UK Div Struct Biol, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Leeds; University of Leeds; University of Oxford	Rowlands, DJ (corresponding author), Univ Leeds, Fac Biol, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	D.j.rowlands@leeds.ac.uk	El-Turabi, Aadil/AAH-4786-2020; Peyret, Hadrien/A-3836-2019; Rosenberg, William/ABA-1071-2021	El-Turabi, Aadil/0000-0003-1092-8155; Peyret, Hadrien/0000-0002-7808-5089; Rosenberg, William/0000-0002-2732-2304; Gilbert, Robert/0000-0001-9336-5604; Fry, Elizabeth/0000-0001-9754-5303; Stuart, David/0000-0002-3426-4210; Stonehouse, Nicola/0000-0003-1146-5519	Biotechnology and Biological Science Research Council (BBSRC) http://www.bbsrc.ac.uk/) doctoral training grant; University of Leeds; BBSRC; MRC [G1000099]; Marie Curie Early Stage Training Fellowship [MEST-CT-2005-019727]; Trustees of the John Innes Foundation; BBSRC Institute Strategic Programme Grant "Understanding and Exploiting Plant and Microbial Secondary Metabolism" [BB/J004596/1]; John Innes Foundation; BBSRC project grant [24/SBD07645]; Wellcome Trust JIF award [060208/Z/00/Z]; Wellcome Trust equipment grant [093305/Z/10/Z]; iQur Ltd.; BBSRC [BBS/E/J/000CA374] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA374, 982578, BBS/E/J/00000166] Funding Source: researchfish; Medical Research Council [G1000099] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10124] Funding Source: researchfish	Biotechnology and Biological Science Research Council (BBSRC) http://www.bbsrc.ac.uk/) doctoral training grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Leeds; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Early Stage Training Fellowship(European Commission); Trustees of the John Innes Foundation; BBSRC Institute Strategic Programme Grant "Understanding and Exploiting Plant and Microbial Secondary Metabolism"(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC project grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust JIF award; Wellcome Trust equipment grant(Wellcome Trust); iQur Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	H.P. and K.H. were supported by Biotechnology and Biological Science Research Council (BBSRC, http://www.bbsrc.ac.uk/) doctoral training grants to the John Innes Centre (JIC) and University of Leeds, respectively. In addition, K.H. received CASE funding (http://www.bbsrc.ac.uk/ funding/studentships/case.aspx) from BBSRC. D.I.S. is an MRC (http://www.mrc.ac.uk/) Research Professor, grant number G1000099. E.C.T. was funded from a Marie Curie Early Stage Training Fellowship (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/index_en.htm) MEST-CT-2005-019727 and the Trustees of the John Innes Foundation. The research at JIC was also supported by BBSRC Institute Strategic Programme Grant "Understanding and Exploiting Plant and Microbial Secondary Metabolism" (BB/J004596/1) and the John Innes Foundation. A.G. and D.B. were supported by BBSRC project grant (24/SBD07645). The OPIC electron microscopy facility was funded by a Wellcome Trust JIF award (060208/Z/00/Z) and is supported by a Wellcome Trust equipment grant (093305/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. iQur Ltd. provided support in the form of salaries for authors A. E.T., L.B., M.W., and W.R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Blokhina EA, 2013, VIROLOGY, V435, P293, DOI 10.1016/j.virol.2012.09.014; Borisova G, 1996, INTERVIROLOGY, V39, P16, DOI 10.1159/000150470; BORISOVA GP, 1989, FEBS LETT, V259, P121, DOI 10.1016/0014-5793(89)81509-1; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BROWN AL, 1991, VACCINE, V9, P595, DOI 10.1016/0264-410X(91)90248-5; Chambers M, 1996, J VIROL, V70, P4045, DOI 10.1128/JVI.70.6.4045-4052.1996; CHENG RH, 1995, CELL, V80, P621; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; CLARKE BE, 1990, J GEN VIROL, V71, P1109, DOI 10.1099/0022-1317-71-5-1109; Conway JF, 1998, J MOL BIOL, V279, P1111, DOI 10.1006/jmbi.1998.1845; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRANCIS MJ, 1990, P NATL ACAD SCI USA, V87, P2545, DOI 10.1073/pnas.87.7.2545; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; Gehin A, 2004, HEPATITIS B CORE ANT; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mechtcheriakova IA, 2006, J VIROL METHODS, V131, P10, DOI 10.1016/j.jviromet.2005.06.020; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Meshcheryakova Yu. A., 2008, Voprosy Virusologii, V53, P15; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Murray K, 1999, BIOL CHEM, V380, P277, DOI 10.1515/BC.1999.038; Muyldermans S, 2001, J Biotechnol, V74, P277; Oliveira GA, 2005, INFECT IMMUN, V73, P3587, DOI 10.1128/IAI.73.6.3587-3597.2005; Peyret H, 2013, PLANT MOL BIOL, V83, P51, DOI 10.1007/s11103-013-0036-1; Pumpens P, 1999, FEBS LETT, V442, P1, DOI 10.1016/S0014-5793(98)01599-3; Pumpens P, 1995, INTERVIROLOGY, V38, P63, DOI 10.1159/000150415; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHODEL F, 1992, J VIROL, V66, P106; STAHL SJ, 1989, P NATL ACAD SCI USA, V86, P6283, DOI 10.1073/pnas.86.16.6283; Thuenemann EC, 2013, PLANT BIOTECHNOL J, V11, P839, DOI 10.1111/pbi.12076; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Vogel M, 2005, FEBS LETT, V579, P5211, DOI 10.1016/j.febslet.2005.08.044; Walker A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00005; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5	54	76	84	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120751	10.1371/journal.pone.0120751	http://dx.doi.org/10.1371/journal.pone.0120751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830365	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600038
J	Sinha, S; Sinharoy, P; Bratz, IN; Damron, DS				Sinha, Sayantani; Sinharoy, Pritam; Bratz, Ian N.; Damron, Derek S.			Propofol Causes Vasodilation In Vivo via TRPA1 Ion Channels: Role of Nitric Oxide and BKCa Channels	PLOS ONE			English	Article							MUSTARD OIL RESPONSES; VANILLOID RECEPTOR; SENSORY NEURONS; CAPSAICIN; DESENSITIZATION; MECHANISMS; TRPV1; ACTIVATION; DILATION; ARTERIES	Background Transient receptor potential (TRP) ion channels of the A1 (TRPA1) and V1 (TRPV1) subtypes are key regulators of vasomotor tone. Propofol is an intravenous anesthetic known to cause vasorelaxation. Our objectives were to examine the extent to which TRPA1 and/or TRPV1 ion channels mediate propofol-induced depressor responses in vivo and to delineate the signaling pathway(s) involved. Methods Mice were subjected to surgery under 1.5-2.5% sevoflurane gas with supplemental oxygen. After a stable baseline in mean arterial pressure (MAP) was achieved propofol (2.5, 5.0, 10.0 mg/kg/min) was administered to assess the hemodynamic actions of the intravenous anesthetic. The effect of nitric oxide synthase (NOS) inhibition with L-NAME and/or calcium- gated K+ channel (BKCa) inhibition with Penetrim A (Pen A), alone and in combination, on propofol-induced decreases in mean arterial pressure were assessed in control C57Bl/6J, TRPA1(-/-), TRPV1(-/)-and double-knockout mice (TRPAV(-/-)). Results Propofol decreased MAP in control mice and this effect was markedly attenuated in TRPA1(-/-) and TRPAV(-/-) mice but unaffected in TRPV1(-/-) mice. Moreover, pretreatment with L-NAME or Pen A attenuated the decrease in MAP in control and TRPV1(-/-) mice, and combined inhibition abolished the depressor response. In contrast, the markedly attenuated propofol- induced depressor response observed in TRPA1(-/-) and TRPAV(-/-)mice was unaffected by pre-treatment with Pen A or L-NAME when used either alone or in combination. Conclusion These data demonstrate for the first time that propofol-induced depressor responses in vivo are predominantly mediated by TRPA1 ion channels with no involvement of TRPV1 ion channels and includes activation of both NOS and BKCa channels.	[Sinha, Sayantani; Sinharoy, Pritam; Damron, Derek S.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Bratz, Ian N.] Northeast Ohio Med Coll, Dept Integrat Med Sci, Rootstown, OH USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Northeast Ohio Medical University (NEOMED)	Damron, DS (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	ddamron@kent.edu	Roy, Pritam Sinha/P-7955-2019; Sinha, Sayantani/S-9063-2019	Roy, Pritam Sinha/0000-0002-6322-260X; 	NIH [HL 65701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH HL 65701 (DSD) (http://www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2008, J NEUROSCI, V28, P1064, DOI 10.1523/JNEUROSCI.1565-06.2008; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Bratz IN, 2008, AM J PHYSIOL-HEART C, V294, pH2489, DOI 10.1152/ajpheart.01191.2007; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Doursout MF, 2002, BRIT J ANAESTH, V89, P492, DOI 10.1093/bja/aef205; Earley S, 2010, CLIN SCI, V119, P19, DOI 10.1042/CS20090641; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Eilers H, 2010, ANESTHESIOLOGY, V112, P1452, DOI 10.1097/ALN.0b013e3181d94e00; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Fischer MJM, 2014, PFLUG ARCH EUR J PHY, V466, P2229, DOI 10.1007/s00424-014-1497-z; Fischer MJM, 2010, J BIOL CHEM, V285, P34781, DOI 10.1074/jbc.M110.143958; GOODCHILD CS, 1989, BRIT J ANAESTH, V63, P87, DOI 10.1093/bja/63.1.87; Gragasin FS, 2009, AM J PHYSIOL-HEART C, V297, pH466, DOI 10.1152/ajpheart.01317.2008; Guarini G, 2012, AM J PHYSIOL-HEART C, V303, pH216, DOI 10.1152/ajpheart.00011.2012; Gupta S, 2007, N-S ARCH PHARMACOL, V375, P29, DOI 10.1007/s00210-007-0137-y; INTRONA RPS, 1993, GEN PHARMACOL, V24, P497, DOI 10.1016/0306-3623(93)90337-W; Kassam SI, 2011, ANESTH ANALG, V112, P1339, DOI 10.1213/ANE.0b013e318215e094; Kehl F, 2002, ANESTH ANALG, V94, P1421, DOI 10.1097/00000539-200206000-00008; Klockgether-Radke AP, 2000, EUR J ANAESTH, V17, P485, DOI 10.1046/j.1365-2346.2000.00713.x; Klockgether-Radke AP, 2004, EUR J ANAESTH, V21, P226, DOI 10.1017/S0265021504003126; Lam CF, 2010, CRIT CARE RESUSC, V12, P186; Leffler A, 2011, MOL PAIN, V7, P1, DOI [10.1186/1744-8069-7-1, DOI 10.1186/1744-8069-7-1]; Liu Y, 2009, VASC PHARMACOL, V51, P182, DOI 10.1016/j.vph.2009.06.003; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; Nagakawa T, 2003, ANESTH ANALG, V97, P1639, DOI 10.1213/01.ANE.0000087043.61777.1F; Nishimoto R, 2014, EUR J PHYS; Ouattara A, 2001, ANESTHESIOLOGY, V95, P699, DOI 10.1097/00000542-200109000-00024; Ouattara A, 2004, ANESTH ANALG, V98, P595, DOI 10.1213/01.ANE.0000100681.15355.AC; PARK KW, 1995, ANESTH ANALG, V81, P1191, DOI 10.1097/00000539-199512000-00013; PARK WK, 1992, ANESTHESIOLOGY, V77, P956, DOI 10.1097/00000542-199211000-00019; Pozsgai G, 2010, CARDIOVASC RES, V87, P760, DOI 10.1093/cvr/cvq118; Royse CF, 2008, ANESTHESIOLOGY, V108, P87, DOI 10.1097/01.anes.0000296077.32685.26; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Story GM, 2006, CURR NEUROPHARMACOL, V4, P183, DOI 10.2174/157015906778019482; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tsutsumi S, 2001, NEUROSCI LETT, V312, P45, DOI 10.1016/S0304-3940(01)02185-1; Wang YP, 2006, HYPERTENSION, V47, P609, DOI 10.1161/01.HYP.0000197390.10412.c4; Wickley PJ, 2010, ANESTHESIOLOGY, V113, P833, DOI 10.1097/ALN.0b013e3181eaa9a0; Wu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078203; Yang DC, 2010, CELL METAB, V12, P130, DOI 10.1016/j.cmet.2010.05.015; Zhang HY, 2011, ANESTHESIOLOGY, V114, P1169, DOI 10.1097/ALN.0b013e31820dee67	45	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122189	10.1371/journal.pone.0122189	http://dx.doi.org/10.1371/journal.pone.0122189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830814	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600102
J	Whitehouse-Tedd, KM; Lefebvre, SL; Janssens, GPJ				Whitehouse-Tedd, Katherine M.; Lefebvre, Sandra L.; Janssens, Geert P. J.			Dietary Factors Associated with Faecal Consistency and Other Indicators of Gastrointestinal Health in the Captive Cheetah (Acinonyx jubatus)	PLOS ONE			English	Article							STRICT CARNIVORES; BLOOD VALUES; DISEASES; DOGS; FERMENTATION; NUTRIENT; MARKERS; FELIDS; SPP.; BEEF	Gastrointestinal diseases pose significant risks to captive cheetah survival and welfare. Multiple factors are thought to be associated with these diseases, but to date a comprehensive epidemiological survey of disease risk factors has not been conducted. A survey of diet and health parameters was completed for 184 captive cheetahs in 86 international facilities. Comparisons were made among dietary factors with respect to disease status and observed faecal consistency, incidence of vomiting and diarrhoea in the past 4 weeks. Extremely dry faeces were most common in cheetahs fed carcasses, but was still of low incidence (15%). Contrastingly, cheetahs fed commercially prepared diets had the highest prevalence of liquid faeces "always" or "often" (9%). Cheetahs fed raw meat diets had the highest prevalence of soft faeces with no shape (22%), as well as of firm and dry faeces (40%). No broad category of diet exerted any influence on the health parameters investigated. However, feeding of ribs at least once per week reduced the odds of diarrhoea (P = 0.020) and feeding of long bones (limbs) at least once per week was associated with a lower odds of vomiting (P = 0.008). Cheetahs fed muscle meat at least once per week had reduced odds of suffering from chronic gastritis (P = 0.005) or non-specific gastrointestinal disease (P < 0.001). The only factor identified as increasing the odds of chronic gastritis was feeding of horse "often" or "always" (P = 0.023). The findings of the current study build on existing empirical research to support a recommendation towards a greater inclusion of skeletal components. Current husbandry guidelines advocating the use of supplemented raw meat diets are likewise supported, but the use of horse meat, as well as commercially prepared diets for captive cheetahs, warrants caution until further research is conducted.	[Whitehouse-Tedd, Katherine M.] Cheetah Outreach, Somerset West, Western Cape, South Africa; [Whitehouse-Tedd, Katherine M.] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, England; [Lefebvre, Sandra L.] Banfield Pet Hosp, Banfield Appl Res & Knowledge Team, Portland, OR USA; [Janssens, Geert P. J.] Univ Ghent, Dept Nutr Genet & Ethol, Merelbeke, Belgium	Nottingham Trent University; Ghent University	Whitehouse-Tedd, KM (corresponding author), Breeding Ctr Endangered Arabian Wildlife, Sharjah, U Arab Emirates.	katherine.whitehousetedd@ntu.ac.uk	Whitehouse-Tedd, Katherine Mary/I-4156-2019; Janssens, Geert/C-2264-2008	Whitehouse-Tedd, Katherine Mary/0000-0003-0061-489X; Lefebvre, Sandra/0000-0002-7964-7442	Angel Fund of Cincinnati Zoo and Botanical Gardens; Cheetah Outreach	Angel Fund of Cincinnati Zoo and Botanical Gardens; Cheetah Outreach	Funding for the project was provided by The Angel Fund of Cincinnati Zoo and Botanical Gardens (http://cincinnatizoo.org/conservation/angelfund/) and Cheetah Outreach (www.cheetah.co.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZA SSP, 2005, CHEET DIS MAN WORKSH; Badiani A., 1997, Journal of Food Composition and Analysis, V10, P254, DOI 10.1006/jfca.1997.0540; Bechert U, 2002, J ZOO WILDLIFE MED, V33, P16, DOI 10.1638/1042-7260(2002)033[0016:DCABVO]2.0.CO;2; Bell KM, 2010, J ANIM PHYSIOL AN N, V94, pE329, DOI 10.1111/j.1439-0396.2010.01017.x; Clauss M, 2009, ZOO BIOL, V28, P279, DOI 10.1002/zoo.20225; Depauw S, 2013, J ANIM PHYSIOL AN N, V97, P146, DOI 10.1111/j.1439-0396.2011.01252.x; Depauw S, 2012, J ANIM SCI, V90, P2540, DOI 10.2527/jas.2011-4377; Depauw S, 2014, J ZOO AQUAR RES, V2, P33; Depauw S, 2012, ZOO BIOL, V31, P629, DOI 10.1002/zoo.20427; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Hedberg GE, 2007, ZOO BIOL, V26, P517, DOI 10.1002/zoo.20158; Heilmann RM, 2012, J VET INTERN MED, V26, P767; Hussein HS, 1999, J NUTR, V129, p1454S, DOI 10.1093/jn/129.7.1454S; International Species Information System, ZOO AN HOLD; IUCN, 2012, IUCN RED LIST THREAT; Kotsch V, 2002, WIEN TIERARZTL MONAT, V89, P341; Lane EP, 2012, ZOO BIOL, V31, P669, DOI 10.1002/zoo.20431; Marker L., 2010, 2010 INT CHEETAH ACI; Marker LL, 2003, S AFR J WILDL RES, V33, P43; McDonald P, 2011, EVALUATION OF FOODS, P237; Meyer H, 1991, P PUR INT NUTR S ORL, P13; Morris JG, 1994, J NUTR, V124, P2520, DOI [DOI 10.1093/JN/124.SUPPL_, 10.1093/jn/124.suppl_12.2520S, DOI 10.1093/JN/124.SUPPL_12.2520S]; Moxham G., 2001, WALTHAM FOCUS, V11, P24; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; MUNSON L, 1993, ZOO BIOL, V12, P105, DOI 10.1002/zoo.1430120110; NARAMA I, 1990, JPN J VET SCI, V52, P581; National Research Council, 2006, NUTR REQ DOGS CATS, P319; Nery J, 2012, J ANIM SCI, V90, P2570, DOI 10.2527/jas.2011-4112; Nery J, 2010, J ANIM SCI, V88, P159, DOI 10.2527/jas.2008-1666; Otoni CC, 2012, J VET INTERN MED, V26, P768; Pearson R., 2005, Proceedings of the 7th Annual Symposium on Zoo Research, Twycross Zoo, Warwickshire, UK, 7-8th July 2005, P194; Rochus K, 2013, ARCH ANIM NUTR, V67, P416, DOI 10.1080/1745039X.2013.830519; Terio KA, 2005, J CLIN MICROBIOL, V43, P229, DOI 10.1128/JCM.43.1.229-234.2005; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Une Y, 2001, VET PATHOL, V38, P585; Vester BM, 2008, ZOO BIOL, V27, P126, DOI 10.1002/zoo.20172; Vester BM, 2010, ZOO BIOL, V29, P432, DOI 10.1002/zoo.20275; Webb EC, 2005, SMALL RUMINANT RES, V60, P153, DOI 10.1016/j.smallrumres.2005.06.009; Wielebnowski NC, 1999, ZOO BIOL, V18, P335, DOI 10.1002/(SICI)1098-2361(1999)18:4<335::AID-ZOO8>3.0.CO;2-X; Zoran D, 2003, CLIN TECH SMALL AN P, V18, P211, DOI 10.1016/S1096-2867(03)00074-4	42	15	15	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120903	10.1371/journal.pone.0120903	http://dx.doi.org/10.1371/journal.pone.0120903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830636	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600049
J	Cheng, XJ; Zheng, ZX; Bu, ZD; Wu, XJ; Zhang, LH; Xing, XF; Wang, XH; Hu, Y; Du, H; Li, L; Li, S; Zhou, RL; Wen, XZ; Ji, JF				Cheng, Xiaojing; Zheng, Zhixue; Bu, Zhaode; Wu, Xiaojiang; Zhang, Lianhai; Xing, Xiaofang; Wang, Xiaohong; Hu, Ying; Du, Hong; Li, Lin; Li, Shen; Zhou, Rouli; Wen, Xian-Zi; Ji, Jia-Fu			LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients	PLOS ONE			English	Article							TETRATRANSMEMBRANE PROTEIN; OVEREXPRESSION; CARCINOMA; EXPRESSION; MARKER; ADENOCARCINOMA; PROGRESSION; RESISTANCE; TOLERANCE; SURVIVAL	Background Lysosome-associated transmembrane protein 4 beta-35 (LAPTM4B-35), a member of the mammalian 4-tetratransmembrane spanning protein superfamily, has been reported to be overexpressed in several cancers. However the expression of LAPTM4B-35 and its role in the progression of gastric cancer (GC) remains unknown. The aim of this study was to investigate LAPTM4B-35 expression in GC, its potential relevance to clinicopathologic parameters and role of LAPTM4B-35 during gastric carcinogenesis. Methods In the present study, paraffin-embedded specimens with GC (n = 240, including 180 paired specimens) and 24 paired fresh frozen tissues were analyzed. qRT-PCR and immunohistochemistry (IHC) were used to analyze the expression of LAPTM4B-35 in GC. The effects of LAPTM4B-35 on GC cell proliferation, migration and invasion were determined by overexpression and knockdown assays. Results IHC showed that LAPTM4B-35 was expressed in 68.3% (123/180) of GC tissues, while in 16.1% (29/180) of their paired adjacent noncancerous gastric tissues (P = 0.000). LAPTM4B-35 mRNA levels in GC tissues were also significantly elevated when compared with their paired adjacent noncancerous tissues (P = 0.017). Overexpression of LAPTM4B-35 was significantly associated with degree of differentiation, depth of invasion, lymphovascular invasion and lymph node metastasis (P<0.05). Kaplan-Meier survival curves revealed that patients with LAPTM4B-35 expression had a significant decrease in overall survival (OS) in stages I-III GC patients (P = 0.006). Multivariate analysis showed high expression of LAPTM4B-35 was an independent prognostic factor for OS in stage I-III GC patients (P = 0.025). Conclusion These findings indicate that LAPTM4B-35 overexpression may be related to GC progression and poor prognosis, and thus may serve as a new prediction marker of prognosis in GC patients.	[Cheng, Xiaojing; Xing, Xiaofang; Du, Hong; Li, Lin; Li, Shen; Wen, Xian-Zi] Peking Univ, Canc Hosp & Inst, Gastrointestinal Carcinoma Translat Res Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zheng, Zhixue; Bu, Zhaode; Wu, Xiaojiang; Zhang, Lianhai; Ji, Jia-Fu] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Wang, Xiaohong; Hu, Ying] Peking Univ, Canc Hosp & Inst, Biol Tissue Bank, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zhou, Rouli] Peking Univ, Dept Cell Biol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Wen, XZ (corresponding author), Peking Univ, Canc Hosp & Inst, Gastrointestinal Carcinoma Translat Res Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	wenxianzi@hotmail.com; jiafuj@hotmail.com	Hu, Ying/GQZ-8100-2022	JI, JIAFU/0000-0001-6878-5543; Zheng, Zhixue/0000-0002-4314-9847	National Natural Science Foundation of China [30471677, 81141024]; National Key Technology R&D Program (Beijing Municipal Science and Technology Project) [Z121100007512010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program (Beijing Municipal Science and Technology Project)	This work was supported by National Natural Science Foundation of China (No. 30471677 and 81141024) and National Key Technology R&D Program (Beijing Municipal Science and Technology Project Z121100007512010). The funders contributed to the study design, performance, reagents, materials, data analysis and decision to publish.	Brenner H, 2009, EUR J CANCER, V45, P1028, DOI 10.1016/j.ejca.2008.11.005; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen WQ, 2014, CHIN J CANCER, V33, P402, DOI 10.5732/cjc.014.10084; Dassen AE, 2010, EUR J CANCER, V46, P1101, DOI 10.1016/j.ejca.2010.02.013; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang Y, 2012, AM J SURG, V204, P677, DOI 10.1016/j.amjsurg.2012.02.003; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2012, AUTOPHAGY, V8, P273, DOI 10.4161/auto.8.2.18941; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu Xinrong, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P340; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Marrelli D, 2011, BRIT J SURG, V98, P1273, DOI 10.1002/bjs.7528; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Milkereit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027478; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Nobili S, 2011, WORLD J GASTROENTERO, V17, P290, DOI 10.3748/wjg.v17.i3.290; Osterheld MC, 2004, CELL ONCOL, V26, P21; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Xiao M, 2013, J CANCER RES CLIN, V139, P661, DOI 10.1007/s00432-012-1368-y; Yang H, 2011, SURG TODAY, V41, P810, DOI 10.1007/s00595-010-4338-5; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yin MZ, 2012, INT J GYNECOL CANCER, V22, P54, DOI 10.1097/IGC.0b013e318234f9ac; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2011, SURGERY, V150, P25, DOI 10.1016/j.surg.2010.12.010; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	36	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121559	10.1371/journal.pone.0121559	http://dx.doi.org/10.1371/journal.pone.0121559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849595	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800065
J	Guan, M; Ma, LJ; Li, L; Yan, B; Zhao, L; Tong, L; Dou, SW; Xia, LJ; Wang, MY; Shi, DP				Guan, Min; Ma, Lijia; Li, Li; Yan, Bin; Zhao, Lu; Tong, Li; Dou, Shewei; Xia, Linjie; Wang, Meiyun; Shi, Dapeng			Self-Regulation of Brain Activity in Patients with Postherpetic Neuralgia: A Double-Blind Randomized Study Using Real-Time fMRI Neurofeedback	PLOS ONE			English	Article							ANTERIOR CINGULATE; VISUAL FEEDBACK; CORTEX ACTIVITY; INSULAR CORTEX; CHRONIC PAIN; MODULATION; ACTIVATION; BIOFEEDBACK; GYRUS	Background A pilot study has shown that real-time fMRI (rtfMRI) neurofeedback could be an alternative approach for chronic pain treatment. Considering the relative small sample of patients recruited and not strictly controlled condition, it is desirable to perform a replication as well as a double-blinded randomized study with a different control condition in chronic pain patients. Here we conducted a rtfMRI neurofeedback study in a subgroup of pain patients - patients with postherpetic neuralgia (PHN) and used a different sham neurofeedback control. We explored the feasibility of self-regulation of the rostral anterior cingulate cortex (rACC) activation in patients with PHN through rtfMRI neurofeedback and regulation of pain perception. Methods Sixteen patients (46-71 years) with PHN were randomly allocated to a experimental group (n = 8) or a control group (n = 8). 2 patients in the control group were excluded for large head motion. The experimental group was given true feedback information from their rACC whereas the control group was given sham feedback information from their posterior cingulate cortex (PCC). All subjects were instructed to perform an imagery task to increase and decrease activation within the target region using rtfMRI neurofeedback. Results Online analysis showed 6/8 patients in the experimental group were able to increase and decrease the blood oxygen level dependent (BOLD) fMRI signal magnitude during intermittent feedback training. However, this modulation effect was not observed in the control group. Offline analysis showed that the percentage of BOLD signal change of the target region between the last and first training in the experimental group was significantly different from the control group's and was also significantly different than 0. The changes of pain perception reflected by numerical rating scale (NRS) in the experimental group were significantly different from the control group. However, there existed no significant correlations between BOLD signal change and NRS change. Conclusion Patients with PHN could learn to voluntarily control over activation in rACC through rtfMRI neurofeedback and alter their pain perception level. The present study may provide new evidence that rtfMRI neurofeedback training may be a supplemental approach for chronic clinical pain management.	[Guan, Min; Ma, Lijia; Dou, Shewei; Wang, Meiyun; Shi, Dapeng] Zhengzhou Univ, Peoples Hosp, Dept Radiol, Zhengzhou 450052, Henan, Peoples R China; [Li, Li] Zhengzhou Univ, Peoples Hosp 2, Dept Dermatol, Zhengzhou 450052, Henan, Peoples R China; [Yan, Bin; Tong, Li] China Natl Digital Switching Syst Engn & Technol, Zhengzhou, Henan, Peoples R China; [Zhao, Lu] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Quebec City, PQ, Canada; [Xia, Linjie] Zhengzhou Univ, Peoples Hosp, Dept Pain Management, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; PLA Information Engineering University; McGill University; Zhengzhou University	Wang, MY (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Radiol, Zhengzhou 450052, Henan, Peoples R China.	meiyun9999@gmail.com; cjr.shidapeng@vip.163.com	li, li/AAT-2097-2020; Li, Li/AEM-3636-2022; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; li, li/GPX-3938-2022		National High Technology Research and Development Program of China [2012AA011603]; National Natural Science Foundation of China [81271534]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by 1. The National High Technology Research and Development Program of China (no. 2012AA011603). (http://www.863.gov.cn/). BY, LT, MYW, DPS received the funding. 2. The National Natural Science Foundation of China (no. 81271534). (http://www.nsfc.gov.cn/). MG, LJM, DPS received the funding. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; Caro XJ, 2011, APPL PSYCHOPHYS BIOF, V36, P193, DOI 10.1007/s10484-011-9159-9; Cauda F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041929; Chapin H, 2012, NEUROSCI LETT, V520, P174, DOI 10.1016/j.neulet.2012.02.076; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Decharms RC, 2012, 1ST SWISS RTFMRI NEU; Denkinger MD, 2014, AGE AGEING, V43, P510, DOI 10.1093/ageing/afu013; Emmert K, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00350; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Geha PY, 2007, PAIN, V128, P88, DOI 10.1016/j.pain.2006.09.014; Glick RM, 2010, PRIMARY CARE, V37, P91, DOI 10.1016/j.pop.2009.09.005; Goebel R, 2012, NEUROIMAGE, V62, P748, DOI 10.1016/j.neuroimage.2012.01.083; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Johnson RW, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-37; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Melzack R, 1999, PAIN, pS121, DOI 10.1016/S0304-3959(99)00145-1; Mercier C, 2009, NEUROREHAB NEURAL RE, V23, P587, DOI 10.1177/1545968308328717; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Oaklander AL, 2001, PAIN, V92, P139, DOI 10.1016/S0304-3959(00)00481-4; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Rance M, 2014, HUM BRAIN MAPP, V35, P5784, DOI 10.1002/hbm.22585; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Sato K, 2010, PAIN MED, V11, P622, DOI 10.1111/j.1526-4637.2010.00819.x; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schmidt-Wilcke T, 2010, HEADACHE, V50, P1278, DOI 10.1111/j.1526-4610.2010.01637.x; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; TURNER JA, 1982, PAIN, V12, P1, DOI 10.1016/0304-3959(82)90167-1; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Young KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088785	44	34	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123675	10.1371/journal.pone.0123675	http://dx.doi.org/10.1371/journal.pone.0123675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848773	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800250
J	Jin, SY; Merchant, ML; Ritzenthaler, JD; McLeish, KR; Lederer, ED; Torres-Gonzalez, E; Fraig, M; Barati, MT; Lentsch, AB; Roman, J; Klein, JB; Rane, MJ				Jin, Shunying; Merchant, Michael L.; Ritzenthaler, Jeffrey D.; McLeish, Kenneth R.; Lederer, Eleanor D.; Torres-Gonzalez, Edilson; Fraig, Mostafa; Barati, Michelle T.; Lentsch, Alex B.; Roman, Jesse; Klein, Jon B.; Rane, Madhavi J.			Baclofen, a GABA(B)R Agonist, Ameliorates Immune-Complex Mediated Acute Lung Injury by Modulating Pro-Inflammatory Mediators	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; NF-KAPPA-B; CELL-SURFACE EXPRESSION; MOUSE MODEL; RECEPTOR; ACTIVATION; PROTEIN; INHIBITION; RESPONSES; LIPOPOLYSACCHARIDE	Immune-complexes play an important role in the inflammatory diseases of the lung. Neutrophil activation mediates immune-complex (IC) deposition-induced acute lung injury (ALI). Components of gamma amino butyric acid (GABA) signaling, including GABA B receptor 2 (GABA(B)R2), GAD65/67 and the GABA transporter, are present in the lungs and in the neutrophils. However, the role of pulmonary GABA(B)R activation in the context of neutrophilmediated ALI has not been determined. Thus, the objective of the current study was to determine whether administration of a GABA(B)R agonist, baclofen would ameliorate or exacerbate ALI. We hypothesized that baclofen would regulate IC-induced ALI by preserving pulmonary GABA(B)R expression. Rats were subjected to sham injury or IC-induced ALI and two hours later rats were treated intratracheally with saline or 1 mg/kg baclofen for 2 additional hours and sacrificed. ALI was assessed by vascular leakage, histology, TUNEL, and lung caspase-3 cleavage. ALI increased total protein, tumor necrosis factor a (TNF-alpha and interleukin-1 receptor associated protein (IL-1R AcP), in the bronchoalveolar lavage fluid (BALF). Moreover, ALI decreased lung GABA(B)R2 expression, increased phospho-p38 MAPK, promoted I kappa B degradation and increased neutrophil influx in the lung. Administration of baclofen, after initiation of ALI, restored GABA(B)R expression, which was inhibited in the presence of a GABA(B)R antagonist, CGP52432. Baclofen administration activated pulmonary phospho-ERK and inhibited p38 MAPK phosphorylation and I kappa B degradation. Additionally, baclofen significantly inhibited pro-inflammatory TNF-alpha and IL-1 beta AcP release and promoted BAL neutrophil apoptosis. Protective effects of baclofen treatment on ALI were possibly mediated by inhibition of TNF-alpha-and IL-1 beta-mediated inflammatory signaling. Interestingly, GABA(B)R2 expression was regulated in the type II pneumocytes in lung tissue sections from lung injured patients, further suggesting a physiological role for GABA(B)R2 in the repair process of lung damage. GABA(B)R2 agonists may play a potential therapeutic role in ALI.	[Jin, Shunying; Merchant, Michael L.; Ritzenthaler, Jeffrey D.; McLeish, Kenneth R.; Lederer, Eleanor D.; Torres-Gonzalez, Edilson; Barati, Michelle T.; Roman, Jesse; Klein, Jon B.; Rane, Madhavi J.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [McLeish, Kenneth R.; Klein, Jon B.; Rane, Madhavi J.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [McLeish, Kenneth R.; Lederer, Eleanor D.; Roman, Jesse; Klein, Jon B.] Robley Rex VA Med Ctr, Louisville, KY USA; [Lederer, Eleanor D.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Fraig, Mostafa] Univ Louisville, Dept Pathol, Louisville, KY 40292 USA; [Lentsch, Alex B.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University System of Ohio; University of Cincinnati	Rane, MJ (corresponding author), Univ Louisville, Dept Med, Louisville, KY 40292 USA.	mjrane01@louisville.edu	Klein, Jon/B-9833-2013; McLeish, Kenneth R./B-9819-2013; Merchant, Michael/F-7109-2013; Fraig, Mostafa M/I-1670-2016; Merchant, Michael/N-7444-2013	McLeish, Kenneth R./0000-0002-7816-3286; Fraig, Mostafa M/0000-0003-1119-3672; Merchant, Michael/0000-0003-4128-4057	NIH NIAID [R01-AI075212]; VA merit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075212] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001838] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); VA merit(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH NIAID R01-AI075212 to MJR (http://www.niaid.nih.gov/researchfunding/contract/Pages/default.aspx), and VA merit to KRM, JR, and JBK (http://www.research.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benke D, 2013, BIOCHEM PHARMACOL, V86, P1525, DOI 10.1016/j.bcp.2013.09.016; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bless NM, 1998, AM J PATHOL, V153, P1113, DOI 10.1016/S0002-9440(10)65655-6; CHAPMAN RW, 1993, TRENDS PHARMACOL SCI, V14, P26, DOI 10.1016/0165-6147(93)90110-6; Chen QH, 2013, MOL MED REP, V8, P565, DOI 10.3892/mmr.2013.1537; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Chi GF, 2013, INFLAMMATION, V36, P501, DOI 10.1007/s10753-012-9571-1; Chintagari NR, 2012, CRIT CARE, V16, DOI 10.1186/cc11298; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014171; Cullinan EB, 1998, J IMMUNOL, V161, P5614; Denora N, 2007, PHARM RES-DORDR, V24, P1309, DOI 10.1007/s11095-007-9255-y; DICPINIGAITIS PV, 1994, CHEST, V106, P758, DOI 10.1378/chest.106.3.758; Dowdy DW, 2006, INTENS CARE MED, V32, P1115, DOI 10.1007/s00134-006-0217-3; Duthey B, 2010, EXP DERMATOL, V19, P661, DOI 10.1111/j.1600-0625.2010.01076.x; Fan WM, 2013, DIGEST DIS SCI, V58, P1909, DOI 10.1007/s10620-013-2623-z; Fortis S, 2012, INTENS CARE MED, V38, P1548, DOI 10.1007/s00134-012-2610-4; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Gaiarsa JL, 2011, PHARMACOL THERAPEUT, V132, P170, DOI 10.1016/j.pharmthera.2011.06.004; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao MY, 2013, INT IMMUNOPHARMACOL, V15, P240, DOI 10.1016/j.intimp.2012.11.019; Guo RF, 2002, FREE RADICAL BIO MED, V33, P303, DOI 10.1016/S0891-5849(02)00823-7; Howland RH, 2012, J PSYCHOSOC NURS MEN, V50, P11, DOI 10.3928/02793695-20120906-92; Im BH, 2012, NEUROSCI LETT, V513, P89, DOI 10.1016/j.neulet.2012.02.014; JOHNSON KJ, 1974, J CLIN INVEST, V54, P349, DOI 10.1172/JCI107770; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Laffray S, 2012, EMBO J, V31, P3239, DOI 10.1038/emboj.2012.161; Lentsch AB, 1999, CLIN CHEM LAB MED, V37, P205, DOI 10.1515/CCLM.1999.038; Lentsch AB, 1998, AM J PATHOL, V152, P1327; Lentsch AB, 1999, J IMMUNOL, V162, P1071; Lentsch AB, 2001, RESP PHYSIOL, V128, P17, DOI 10.1016/S0034-5687(01)00260-2; Lentsch Alex B., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P59; Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009; Lu WY, 2009, CLIN EXP ALLERGY, V39, P956, DOI 10.1111/j.1365-2222.2009.03265.x; Lu Y, 2001, BRAIN RES, V889, P118, DOI 10.1016/S0006-8993(00)03124-3; Luerman GC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001552; Lujan R, 2012, CURR DRUG TARGETS, V13, P129, DOI 10.2174/138945012798868425; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Merlo D, 2007, NEUROBIOL DIS, V25, P631, DOI 10.1016/j.nbd.2006.11.005; Mizukami K, 2002, PROG NEURO-PSYCHOPH, V26, P393, DOI 10.1016/S0278-5846(01)00247-0; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL1206, DOI 10.1152/ajplung.00287.2007; Mulligan MS, 1996, P ASSOC AM PHYSICIAN, V108, P198; Osawa Y, 2006, AM J PHYSIOL-LUNG C, V291, pL923, DOI 10.1152/ajplung.00185.2006; Rane MJ, 2005, J IMMUNOL, V174, P7242, DOI 10.4049/jimmunol.174.11.7242; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Sasaki S, 2007, BIOL PHARM BULL, V30, P687, DOI 10.1248/bpb.30.687; Sauter K, 2005, J BIOL CHEM, V280, P33566, DOI 10.1074/jbc.M503482200; Straessle A, 2003, EUR J NEUROSCI, V18, P2213, DOI 10.1046/j.1460-9568.2003.02964.x; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Uriarte SM, 2008, J IMMUNOL, V180, P5575, DOI 10.4049/jimmunol.180.8.5575; Uriarte SM, 2013, SHOCK, V39, P286, DOI 10.1097/SHK.0b013e318282c9a1; Vanhoose AM, 2002, J BIOL CHEM, V277, P9049, DOI 10.1074/jbc.M108309200; Wang XL, 2011, NEUROSCI LETT, V490, P112, DOI 10.1016/j.neulet.2010.12.038; Ward AB, 2002, DISABIL REHABIL, V24, P443, DOI 10.1080/09638280110108878; Ward PA, 1997, J LAB CLIN MED, V129, P400, DOI 10.1016/S0022-2143(97)90072-X; Ward PA, 2002, MOL CELL BIOCHEM, V234, P225, DOI 10.1023/A:1015944709177; WARD PA, 1979, AM J PATHOL, V97, P85; William R, 1998, J IMMUNOL, V161, P957; WOOD JD, 1965, CAN J PHYSIOL PHARM, V43, P405, DOI 10.1139/y65-040; Wu JZ, 2011, NEUROIMMUNOMODULAT, V18, P150, DOI 10.1159/000323141; Xiang YY, 2013, ANESTHESIOLOGY, V118, P1065, DOI 10.1097/ALN.0b013e31828e180e; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	65	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121637	10.1371/journal.pone.0121637	http://dx.doi.org/10.1371/journal.pone.0121637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848767	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800070
J	Rossi, S; Cassotti, M; Moutier, S; Delcroix, N; Houde, O				Rossi, Sandrine; Cassotti, Mathieu; Moutier, Sylvain; Delcroix, Nicolas; Houde, Olivier			Helping Reasoners Succeed in the Wason Selection Task: When Executive Learning Discourages Heuristic Response but Does Not Necessarily Encourage Logic	PLOS ONE			English	Article							OVERCOMING PERCEPTUAL FEATURES; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; INSPECTION TIMES; INHIBITION; RETRIEVAL; PREMISES; EMOTION; AREA	Reasoners make systematic logical errors by giving heuristic responses that reflect deviations from the logical norm. Influential studies have suggested first that our reasoning is often biased because we minimize cognitive effort to surpass a cognitive conflict between heuristic response from system 1 and analytic response from system 2 thinking. Additionally, cognitive control processes might be necessary to inhibit system 1 responses to activate a system 2 response. Previous studies have shown a significant effect of executive learning (EL) on adults who have transferred knowledge acquired on the Wason selection task (WST) to another isomorphic task, the rule falsification task (RFT). The original paradigm consisted of teaching participants to inhibit a classical matching heuristic that sufficed the first problem and led to significant EL transfer on the second problem. Interestingly, the reasoning tasks differed in inhibiting-heuristic metacognitive cost. Success on the WST requires half-suppression of the matching elements. In contrast, the RFT necessitates a global rejection of the matching elements for a correct answer. Therefore, metacognitive learning difficulty most likely differs depending on whether one uses the first or second task during the learning phase. We aimed to investigate this difficulty and various matching-bias inhibition effects in a new (reversed) paradigm. In this case, the transfer effect from the RFT to the WST could be more difficult because the reasoner learns to reject all matching elements in the first task. We observed that the EL leads to a significant reduction in matching selections on the WST without increasing logical performances. Interestingly, the acquired metacognitive knowledge was too "strictly" transferred and discouraged matching rather than encouraging logic. This finding underlines the complexity of learning transfer and adds new evidence to the pedagogy of reasoning.	[Rossi, Sandrine; Cassotti, Mathieu; Houde, Olivier] CNRS, Lab Psychol Child Dev & Educ, Sorbonne, Unit 8240, Paris, France; [Moutier, Sylvain] Lab Psychopathol & Proc Sante, EA 4057, Paris, France; [Delcroix, Nicolas] CNRS, GIP, CYCERON, UMS 3408, Caen, France; [Rossi, Sandrine; Cassotti, Mathieu; Delcroix, Nicolas; Houde, Olivier] Univ Caen Low Normandy, Caen, France; [Rossi, Sandrine; Cassotti, Mathieu; Delcroix, Nicolas; Houde, Olivier] Univ Caen, Normandy Alliance Higher Educ & Res, F-14032 Caen, France; [Rossi, Sandrine; Cassotti, Mathieu; Moutier, Sylvain; Houde, Olivier] Paris Descartes Univ, Paris, France; [Rossi, Sandrine; Cassotti, Mathieu; Moutier, Sylvain; Houde, Olivier] Paris Descartes Univ, Sorbonne Paris Cite, Alliance Higher Educ & Res, Paris, France; [Cassotti, Mathieu; Houde, Olivier] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Caen Normandie; Universite de Caen Normandie; Universite de Caen Normandie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Rossi, S (corresponding author), CNRS, Lab Psychol Child Dev & Educ, Sorbonne, Unit 8240, Paris, France.	sandrine.rossi@unicaen.fr	Rossi, Sandrine/B-8667-2008	Rossi, Sandrine/0000-0001-9285-2152; Cassotti, Mathieu/0000-0003-4837-4442; Garbui, Maria Cristina/0000-0003-2100-9461				Ansari D, 2012, NEUROETHICS-NETH, V5, P105, DOI 10.1007/s12152-011-9119-3; Ball LJ, 2003, Q J EXP PSYCHOL-A, V56, P1053, DOI 10.1080/02724980244000729; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Borst G, 2014, NEW APPROACHES REASO; Cassotti M, 2010, BRAIN COGNITION, V72, P378, DOI 10.1016/j.bandc.2009.11.004; CHENG PW, 1986, COGNITIVE PSYCHOL, V18, P293, DOI 10.1016/0010-0285(86)90002-2; CHENG PW, 1985, COGNITIVE PSYCHOL, V17, P391, DOI 10.1016/0010-0285(85)90014-3; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; De Neys W, 2005, THINK REASONING, V11, P349, DOI 10.1080/13546780442000222; De Neys W, 2008, J EXP CHILD PSYCHOL, V100, P252, DOI 10.1016/j.jecp.2008.03.003; De Neys W, 2008, COGNITION, V106, P1248, DOI 10.1016/j.cognition.2007.06.002; De Neys W, 2013, TRENDS COGN SCI, V17, P172, DOI 10.1016/j.tics.2013.02.001; De Neys W, 2013, PSYCHON B REV, V20, P269, DOI 10.3758/s13423-013-0384-5; De Neys W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015954; De Neys W, 2009, COGNITION, V113, P45, DOI 10.1016/j.cognition.2009.07.009; De Neys W, 2009, DEVELOPMENTAL SCI, V12, P123, DOI 10.1111/j.1467-7687.2008.00746.x; De Neys Wim, 2014, NEW APPROACHES REASO; Dempster F.N., 1995, INTERFERENCE INHIBIT; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Evans J, 2011, ANNU REV PSYCHOL, V59, P255; EVANS JSBT, 1972, BRIT J PSYCHOL, V63, P213, DOI 10.1111/j.2044-8295.1972.tb02102.x; Evans JSBT, 1996, DE RATIONALITY REASO; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Franssens S, 2009, THINK REASONING, V15, P105, DOI 10.1080/13546780802711185; Goldstone RL, 2012, EDUC PSYCHOL-US, V47, P149, DOI 10.1080/00461520.2012.695710; Goswami U, 2011, NEUROIMAGE, V57, P651, DOI 10.1016/j.neuroimage.2010.08.072; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Handley SJ, 2004, THINK REASONING, V10, P175, DOI 10.1080/13546780442000051; Houde O, 2000, COGNITIVE DEV, V15, P63, DOI 10.1016/S0885-2014(00)00015-0; Houde O, 2000, J COGNITIVE NEUROSCI, V12, P721, DOI 10.1162/089892900562525; Houde O, 1996, CAH PSYCHOL COGN, V15, P409; Houde O, 2001, NEUROIMAGE, V14, P1486, DOI 10.1006/nimg.2001.0930; Houde O, 2008, TRENDS COGN SCI, V12, P173, DOI 10.1016/j.tics.2008.02.007; Houde O, 2007, THINK REASONING, V13, P81, DOI 10.1080/13546780500450599; Kahneman D., 2011, THINKING FAST SLOW; Lanoe C., 2012, NEUROEDUCATION, V1, P29, DOI DOI 10.1186/1687-9856-2012-29; Lohmann D.F., 2011, INTELLIGENCE REASONI, P419; Manktelow K, 2011, SCIENCE OF REASON: A FESTSCHRIFT FOR JONATHAN ST B.T. EVANS, P1; MANKTELOW KI, 1991, COGNITION, V39, P85, DOI 10.1016/0010-0277(91)90039-7; Markovits H, 2004, MEM COGNITION, V32, P592, DOI 10.3758/BF03195850; Meltzer L., 2007, EXECUTIVE FUNCTION E; Meltzer L., 2010, PROMOTING EXECUTIVE; Moutier S, 2000, CAH PSYCHOL COGN, V19, P429; Moutier S., 2002, THINK REASONING, V8, P205, DOI [10.1080/13546780244000033, DOI 10.1080/13546780244000033]; Nokes TJ, 2009, THINK REASONING, V15, P1, DOI 10.1080/13546780802490186; OAKSFORD M, 1994, PSYCHOL REV, V101, P608, DOI 10.1037/0033-295X.101.4.608; Osman M, 2001, PSYCHOL RES-PSYCH FO, V65, P128, DOI 10.1007/s004260000023; Osman M, 2007, MEM COGNITION, V35, P342, DOI 10.3758/BF03193455; Perner J., 1998, LANGUAGE THOUGHT INT, P270; Prado J, 2008, NEUROPSYCHOLOGIA, V46, P2629, DOI 10.1016/j.neuropsychologia.2008.04.017; Prado J, 2007, J COGNITIVE NEUROSCI, V19, P642, DOI 10.1162/jocn.2007.19.4.642; Roberts MJ, 2001, Q J EXP PSYCHOL-A, V54, P1031, DOI 10.1080/02724980143000082; Rossi S., 2012, NEUROEDUCATION, V1, P55; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Simoneau M, 2003, DEV PSYCHOL, V39, P964, DOI 10.1037/0012-1649.39.6.964; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stenning K, 2004, COGNITIVE SCI, V28, P481, DOI 10.1016/j.cogsci.2004.02.002; Stenning K., 2001, Journal of Logic, Language and Information, V10, P273, DOI 10.1023/A:1011211207884; Venables WN., 2002, MODERN APPL STAT S 4; WASON PC, 1960, Q J EXP PSYCHOL, V12, P129, DOI 10.1080/17470216008416717; Wason PC, 1996, NEW HORIZONS PSYCHOL, P135	61	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123024	10.1371/journal.pone.0123024	http://dx.doi.org/10.1371/journal.pone.0123024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849555	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800197
J	Schuster, A; Paul, M; Bettencourt, N; Hussain, ST; Morton, G; Kutty, S; Bigalke, B; Chiribiri, A; Perera, D; Nagel, E; Beerbaum, P				Schuster, Andreas; Paul, Matthias; Bettencourt, Nuno; Hussain, Shazia T.; Morton, Geraint; Kutty, Shelby; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp			Myocardial Feature Tracking Reduces Observer-Dependence in Low-Dose Dobutamine Stress Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							WALL-MOTION; STRAIN; REPRODUCIBILITY; QUANTIFICATION; PREDICTION; VIABILITY; HEART	Objectives To determine whether quantitative wall motion assessment by CMR myocardial feature tracking (CMR-FT) would reduce the impact of observer experience as compared to visual analysis in patients with ischemic cardiomyopathy (ICM). Methods 15 consecutive patients with ICM referred for assessment of hibernating myocardium were studied at 3 Tesla using SSFP cine images at rest and during low dose dobutamine stress (5 and 10 mu g/kg/min of dobutamine). Conventional visual, qualitative analysis was performed independently and blinded by an experienced and an inexperienced reader, followed by post-processing of the same images by CMR-FT to quantify subendocardial and subepicardial circumferential (Ecc(endo) and Ecc(epi)) and radial (Err) strain. Receiver operator characteristics (ROC) were assessed for each strain parameter and operator to detect the presence of inotropic reserve as visually defined by the experienced observer. Results 141 segments with wall motion abnormalities at rest were eligible for the analysis. Visual scoring of wall motion at rest and during dobutamine was significantly different between the experienced and the inexperienced observer (p<0.001). All strain values (Ecc(endo), Ecc(epi) and Err) derived during dobutamine stress (5 and 10 mu g/kg/min) showed similar diagnostic accuracy for the detection of contractile reserve for both operators with no differences in ROC (p>0.05). Eccendo was the most accurate (AUC of 0.76, 10 mu g/kg/min of dobutamine) parameter. Diagnostic accuracy was worse for resting strain with differences between operators for Eccendo and Eccepi (p<0.05) but not Err (p>0.05). Conclusion Whilst visual analysis remains highly dependent on operator experience, quantitative CMR-FT analysis of myocardial wall mechanics during DS-CMR provides diagnostic accuracy for the detection of inotropic reserve regardless of operator experience and hence may improve diagnostic robustness of low-dose DS-CMR in clinical practice.	[Schuster, Andreas] Univ Gottingen, Dept Cardiol & Pulmonol, D-37073 Gottingen, Germany; [Schuster, Andreas] DZHK, German Ctr Cardiovasc Res, Gottingen, Germany; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Kings Coll London, British Heart Fdn, Ctr Excellence, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Ctr, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Wellcome Trust Res Labs, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Engn & Phys Sci Res Council, Med Engn Ctr, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] St Thomas Hosp, Rayne Inst, London SE1 7EH, England; [Bettencourt, Nuno] Ctr Hosp Gaia Espinho, Dept Cardiol, Porto, Portugal; [Kutty, Shelby] Creighton Univ, Univ Nebraska, Childrens Hosp & Med Ctr, Joint Div Pediat Cardiol, Omaha, NE 68178 USA; [Bigalke, Boris] Charite, Campus Benjamin Franklin, Dept Cardiol, Berlin, Germany; [Perera, Divaka] Kings Coll London, BHF Ctr Excellence, NIHR Biomed Res Ctr, London, England; [Perera, Divaka] Guys & St Thomas NHS Fdn Trust, Dept Cardiol, London, England; [Beerbaum, Philipp] Hannover Med Sch, Dept Paediat Cardiol, Hannover, Germany	University of Gottingen; German Centre for Cardiovascular Research; University of London; King's College London; University College London; Guy's & St Thomas' NHS Foundation Trust; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Creighton University; University of Nebraska System; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Hannover Medical School	Schuster, A (corresponding author), Univ Gottingen, Dept Cardiol & Pulmonol, D-37073 Gottingen, Germany.	andreas_schuster@gmx.net	Chiribiri, Amedeo/T-2771-2019; Nagel, Eike/C-6903-2008; Bettencourt, Nuno/AAX-1905-2020	Nagel, Eike/0000-0002-6044-950X; Bettencourt, Nuno/0000-0002-9582-7881; Chiribiri, Amedeo/0000-0003-3394-4289; Perera, Divaka/0000-0001-6362-1291	Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany; British Heart Foundation (BHF) [RE/08/003, FS/10/029/28253]; Biomedical Research Centre [BRC-CTF 196]; American College of Cardiology Foundation; Edna Ittner Pediatric Foundation; Children's Hospital and Medical Center Foundation; BHF [RE/08/003]; Wellcome Trust; Engineering and Physical Sciences Research Council (EPSRC) [WT 088641/Z/09/Z]; National Institute for Health Research (NIHR) via the comprehensive BRC award; St Thomas' NHS Foundation Trust; King's College London; British Heart Foundation [FS/10/029/28253] Funding Source: researchfish	Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany; British Heart Foundation (BHF)(British Heart Foundation); Biomedical Research Centre; American College of Cardiology Foundation(General Electric); Edna Ittner Pediatric Foundation; Children's Hospital and Medical Center Foundation; BHF(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research (NIHR) via the comprehensive BRC award(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London(General Electric); British Heart Foundation(British Heart Foundation)	AS receives grant support from the Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany, the British Heart Foundation (BHF) (RE/08/003 and FS/10/029/28253) and the Biomedical Research Centre (BRC-CTF 196). SK receives grant support from the American College of Cardiology Foundation, the Edna Ittner Pediatric Foundation, and the Children's Hospital and Medical Center Foundation. EN receives grant support from BHF (RE/08/003), the Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC, WT 088641/Z/09/Z) and the National Institute for Health Research (NIHR) via the comprehensive BRC award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Cardiology Foundation Task Force on Expert Consensus Documents, 2010, J Am Coll Cardiol, V55, P2614, DOI [10.1161/CIR.0b013e3181d44a8f, 10.1016/j.jacc.2009.11.011]; Bertini M, 2012, CIRC-CARDIOVASC IMAG, V5, P383, DOI 10.1161/CIRCIMAGING.111.970434; Bettencourt Nuno, 2009, Curr Heart Fail Rep, V6, P142; Bree D, 2006, CIRCULATION, V114, pI33, DOI 10.1161/CIRCULATIONAHA.105.000885; Buss SJ, 2015, EUR HEART J-CARD IMG, V16, P307, DOI 10.1093/ehjci/jeu181; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Glaveckaite S, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-35; Hor KN, 2011, JOVE-J VIS EXP, DOI 10.3791/2356; Hor KN, 2010, JACC-CARDIOVASC IMAG, V3, P144, DOI 10.1016/j.jcmg.2009.11.006; Ibrahim ESH, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-36; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kirschbaum SW, 2012, INT J CARDIOL, V159, P192, DOI 10.1016/j.ijcard.2011.02.048; Kowallick JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109164; Kowallick JT, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0060-6; Kowallick JT, 2014, J CARDIOL THER, V1, P58, DOI DOI 10.6051/J; Maret E, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-53; Morton G, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-43; Morton G, 2010, EUR HEART J, V31, P2209, DOI 10.1093/eurheartj/ehq256; Nagel E, 2012, JACC-CARDIOVASC IMAG, V5, P509, DOI 10.1016/j.jcmg.2012.03.005; Nagel E, 2010, JACC-CARDIOVASC IMAG, V3, P731, DOI 10.1016/j.jcmg.2010.05.002; Padiyath A, 2013, ECHOCARDIOGR-J CARD, V30, P203, DOI 10.1111/echo.12016; Paetsch I, 2005, AM J PHYSIOL-HEART C, V288, pH2708, DOI 10.1152/ajpheart.01017.2003; Paetsch I, 2006, EUR HEART J, V27, P1459, DOI 10.1093/eurheartj/ehi883; Schuster A, 2013, EUR J RADIOL, V82, P296, DOI 10.1016/j.ejrad.2012.11.012; Schuster A, 2012, J AM COLL CARDIOL, V59, P359, DOI 10.1016/j.jacc.2011.08.076; Schuster A, 2013, INT J CARDIOL, V166, P413, DOI 10.1016/j.ijcard.2011.10.137; Schuster A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-58; Schuster A, 2011, CURR CARDIOVASC IMAG, V4, P85, DOI 10.1007/s12410-011-9072-x; Shehata ML, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-55; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Thiele H, 2002, J CARDIOV MAGN RESON, V4, P327, DOI 10.1081/JCMR-120013298; Thiele H, 2009, INT J CARDIOL, V135, P287, DOI 10.1016/j.ijcard.2008.03.055; Wellnhofer E, 2004, CIRCULATION, V109, P2172, DOI 10.1161/01.CIR.0000128862.34201.74	33	23	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122858	10.1371/journal.pone.0122858	http://dx.doi.org/10.1371/journal.pone.0122858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848764	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800166
J	Tarr, SJ; Osborne, AR				Tarr, Sarah J.; Osborne, Andrew R.			Experimental Determination of the Membrane Topology of the Plasmodium Protease Plasmepsin V	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; INFECTED ERYTHROCYTE; MALARIA VIRULENCE; MAURERS CLEFTS; FALCIPARUM; PROTEINS; EXPORT; TRAFFICKING; SURFACE; TRANSFORMATION	The malaria parasite exports hundreds of proteins into its host cell. The majority of exported proteins contain a Host-Targeting motif (also known as a Plasmodium export element) that directs them for export. Prior to export, the Host-Targeting motif is cleaved by the endoplasmic reticulum-resident protease Plasmepsin V and the newly generated N-terminus is N-alpha-acetylated by an unidentified enzyme. The cleaved, N-a-acetylated protein is trafficked to the parasitophorous vacuole, where it is translocated across the vacuole membrane. It is clear that cleavage and N-alpha-acetylation of the Host-Targeting motif occur at the endoplasmic reticulum, and it has been proposed that Host-Targeting motif cleavage and N-alpha-acetylation occur either on the luminal or cytosolic side of the endoplasmic reticulum membrane. Here, we use self-associating 'split' fragments of GFP to determine the topology of Plasmepsin V in the endoplasmic reticulum membrane; we show that the catalytic protease domain of Plasmepsin V faces the endoplasmic reticulum lumen. These data support a model in which the Host-Targeting motif is cleaved and N-alpha-acetylated in the endoplasmic reticulum lumen. Furthermore, these findings suggest that cytosolic N-alpha-acetyltransferases are unlikely to be candidates for the N-alpha-acetyltransferase of Host-Targeting motif-containing exported proteins.	[Tarr, Sarah J.; Osborne, Andrew R.] Birkbeck & Univ Coll London, Inst Struct & Mol Biol, Div Biosci, London, England	University of London; Birkbeck University London	Osborne, AR (corresponding author), Birkbeck & Univ Coll London, Inst Struct & Mol Biol, Div Biosci, London, England.	a.osborne@ucl.ac.uk		Tarr, Sarah/0000-0003-0746-7319	Wellcome Trust [09095/Z/10/Z]; Institute of Structural and Molecular Biology	Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Structural and Molecular Biology	This work was supported by a Wellcome Trust Grant to AO (Grant Number: 09095/Z/10/Z, www.wellcome.ac.uk), and by an Institute of Structural and Molecular Biology Start-up grant to AO (http://www.ismb.lon.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; ELMENDORF HG, 1992, MOL BIOCHEM PARASIT, V52, P215, DOI 10.1016/0166-6851(92)90054-N; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Kulzer S, 2013, MOL BIOCHEM PARASIT, V187, P87, DOI 10.1016/j.molbiopara.2012.11.004; Kulzer S, 2009, PARASITOL RES, V104, P1535, DOI 10.1007/s00436-009-1397-x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Osborne AR, 2010, MOL BIOCHEM PARASIT, V171, P25, DOI 10.1016/j.molbiopara.2010.01.003; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Romisch K, 2012, F1000 RESEARCH, V1, DOI [10.3410/f1000research.1-12.v1, DOI 10.3410/F1000RESEARCH.1-12.V1]; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Tarr SJ, 2013, MOL MICROBIOL, V87, P835, DOI 10.1111/mmi.12133; Toddo S, 2012, PROTEIN SCI, V21, P1571, DOI 10.1002/pro.2131; WHO, 2011, WORLD MALARIA REPORT 2011, P1	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121786	10.1371/journal.pone.0121786	http://dx.doi.org/10.1371/journal.pone.0121786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849462	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800076
J	Wang, ML; Khera, P; Pandey, MK; Wang, H; Qiao, LX; Feng, SP; Tonnis, B; Barkley, NA; Pinnow, D; Holbrook, CC; Culbreath, AK; Varshney, RK; Guo, BZ				Wang, Ming Li; Khera, Pawan; Pandey, Manish K.; Wang, Hui; Qiao, Lixian; Feng, Suping; Tonnis, Brandon; Barkley, Noelle A.; Pinnow, David; Holbrook, Corley C.; Culbreath, Albert K.; Varshney, Rajeev K.; Guo, Baozhu			Genetic Mapping of QTLs Controlling Fatty Acids Provided Insights into the Genetic Control of Fatty Acid Synthesis Pathway in Peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							LINOLENIC ACID; OLEIC-ACID; TRAIT; OIL; PHOTOSYNTHESIS; IDENTIFICATION; REGISTRATION; GENOMICS; CORE	Peanut, a high-oil crop with about 50% oil content, is either crushed for oil or used as edible products. Fatty acid composition determines the oil quality which has high relevance to consumer health, flavor, and shelf life of commercial products. In addition to the major fatty acids, oleic acid (C18:1) and linoleic acid (C18:2) accounting for about 80% of peanut oil, the six other fatty acids namely palmitic acid (C16:0), stearic acid (C18:0), arachidic acid (C20:0), gadoleic acid (C20:1), behenic acid (C22:0), and lignoceric acid (C24:0) are accounted for the rest 20%. To determine the genetic basis and to improve further understanding on effect of FAD2 genes on these fatty acids, two recombinant inbred line (RIL) populations namely S-population (high oleic line 'SunOleic 97R' x low oleic line 'NC94022') and T-population (normal oleic line 'Tifrunner' x low oleic line 'GT-C20') were developed. Genetic maps with 206 and 378 marker loci for the S-and the T-population, respectively were used for quantitative trait locus (QTL) analysis. As a result, a total of 164 main-effect (M-QTLs) and 27 epistatic (E-QTLs) QTLs associated with the minor fatty acids were identified with 0.16% to 40.56% phenotypic variation explained (PVE). Thirty four major QTLs (>10% of PVE) mapped on five linkage groups and 28 clusters containingmore than three QTLs were also identified. These results suggest that the major QTLs with large additive effects would play an important role in controlling composition of these minor fatty acids in addition to the oleic and linoleic acids in peanut oil. The interrelationship among these fatty acids should be considered while breeding for improved peanut genotypes with good oil quality and desired fatty acid composition.	[Wang, Ming Li; Tonnis, Brandon; Barkley, Noelle A.; Pinnow, David] USDA ARS, Plant Genet Resources Conservat Unit, Griffin, GA USA; [Khera, Pawan; Pandey, Manish K.; Wang, Hui; Qiao, Lixian; Feng, Suping; Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Khera, Pawan; Pandey, Manish K.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India; [Khera, Pawan; Pandey, Manish K.; Wang, Hui; Qiao, Lixian; Feng, Suping; Culbreath, Albert K.; Guo, Baozhu] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Wang, Hui] Fujian Agr & Forestry Univ, Fuzhou, Fujian, Peoples R China; [Qiao, Lixian] Qingdao Agr Univ, Coll Life Sci, Qingdao, Shandong, Peoples R China; [Feng, Suping] Qiongzhou Univ, Coll Biosci & Biotechnol, Sanya, Hainan, Peoples R China; [Holbrook, Corley C.] USDA ARS, Crop Genet & Breeding Res Unit, Tifton, GA 31793 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University System of Georgia; University of Georgia; Fujian Agriculture & Forestry University; Qingdao Agricultural University; Hainan Tropical Ocean University; United States Department of Agriculture (USDA)	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India.	r.k.varshney@cgiar.org; baozhu.guo@ars.usda.gov	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; Pandey, Manish/0000-0002-4101-6530; Anglin, Noelle L./0000-0002-3454-1142	USDA Agricultural Research Service; Georgia Agricultural Commodity Commission for Peanuts; Peanut Foundation; National Peanut Board; ARS [ARS-0425281] Funding Source: Federal RePORTER	USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Georgia Agricultural Commodity Commission for Peanuts; Peanut Foundation; National Peanut Board; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was partially supported by funds provided by the USDA Agricultural Research Service, the Georgia Agricultural Commodity Commission for Peanuts, Peanut Foundation and National Peanut Board. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GC, 2007, PLANT PHYSIOL, V144, P1827, DOI 10.1104/pp.107.096172; Barkley NA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-62; Bobinski R, 2013, EUR J CLIN NUTR, V67, P966, DOI 10.1038/ejcn.2013.96; Cloutier S, 2011, MOL BREEDING, V28, P437, DOI 10.1007/s11032-010-9494-1; Crupkin M, 2008, COMPR REV FOOD SCI F, V7, P271, DOI 10.1111/j.1541-4337.2008.00045.x; Dean L. L., 2009, Peanut Science, V36, P104, DOI 10.3146/PS07-103.1; Fretts AM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000889; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gorbet DW, 2000, CROP SCI, V40, P1190, DOI 10.2135/cropsci2000.0032rcv; Guo Baozhu, 2013, Peanut Science, V40, P95, DOI 10.3146/PS13-03.1; Ha BK, 2014, THEOR APPL GENET, V127, P1501, DOI 10.1007/s00122-014-2314-y; Holbrook CC, 2007, J PLANT REGIST, V1, P124, DOI 10.3198/jpr2006.09.0575crc; HUGLY S, 1989, PLANT PHYSIOL, V90, P1134, DOI 10.1104/pp.90.3.1134; Johnson S, 2008, FATTY ACIDS PROFILE; Kavera B., 2008, THESIS U AGR SCI; Kratz M, 2002, EUR J CLIN NUTR, V56, P72, DOI 10.1038/sj.ejcn.1601288; Lopez Y, 2000, THEOR APPL GENET, V101, P1131, DOI 10.1007/s001220051589; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Montoya C, 2013, TREE GENET GENOMES, V9, P1207, DOI 10.1007/s11295-013-0629-5; MOORE KM, 1989, J HERED, V80, P252, DOI 10.1093/oxfordjournals.jhered.a110845; NORDEN A J, 1987, Peanut Science, V14, P7, DOI 10.3146/i0095-3679-14-1-3; Pandey MK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0133-4; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; RIZZO WB, 1986, NEUROLOGY, V36, P357, DOI 10.1212/WNL.36.3.357; Sanyal A, 2012, THEOR APPL GENET, V124, P723, DOI 10.1007/s00122-011-1742-1; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Sultana R, 2012, J AM OIL CHEM SOC, V89, P1611, DOI 10.1007/s11746-012-2073-3; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Wang H, 2013, PLANT GENOME, V6, P3; Wang ML, 2010, PLANT GENET RESOUR-C, V8, P71, DOI [10.1017/S1479262108048247, 10.1017/S1479262109990177]; Wang ML, 2013, J AGR FOOD CHEM, V61, P2875, DOI 10.1021/jf305208e; Wang S., 2011, WINDOWS QTL CARTOGRA; Wilson JN, 2013, J CROP IMPROV, V27, P430, DOI 10.1080/15427528.2013.790330; Yang J, 2005, QTL NETWORK 2 0; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1	39	43	53	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119454	10.1371/journal.pone.0119454	http://dx.doi.org/10.1371/journal.pone.0119454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849082	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352477800012
J	Zeng, YL; Lan, JH; Ran, B; Wang, Q; Gao, J				Zeng, Yiliang; Lan, Jinhui; Ran, Bin; Wang, Qi; Gao, Jing			Restoration of Motion-Blurred Image Based on Border Deformation Detection: A Traffic Sign Restoration Model	PLOS ONE			English	Article							SEGMENTATION	Due to the rapid development of motor vehicle Driver Assistance Systems (DAS), the safety problems associated with automatic driving have become a hot issue in Intelligent Transportation. The traffic sign is one of the most important tools used to reinforce traffic rules. However, traffic sign image degradation based on computer vision is unavoidable during the vehicle movement process. In order to quickly and accurately recognize traffic signs in motion-blurred images in DAS, a new image restoration algorithm based on border deformation detection in the spatial domain is proposed in this paper. The border of a traffic sign is extracted using color information, and then the width of the border is measured in all directions. According to the width measured and the corresponding direction, both the motion direction and scale of the image can be confirmed, and this information can be used to restore the motion-blurred image. Finally, a gray mean grads (GMG) ratio is presented to evaluate the image restoration quality. Compared to the traditional restoration approach which is based on the blind deconvolution method and Lucy-Richardson method, our method can greatly restore motion blurred images and improve the correct recognition rate. Our experiments show that the proposed method is able to restore traffic sign information accurately and efficiently.	[Zeng, Yiliang; Lan, Jinhui; Wang, Qi; Gao, Jing] Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Dept Instrument Sci & Technol, Beijing 100083, Peoples R China; [Ran, Bin] Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China	University of Science & Technology Beijing; Southeast University - China	Zeng, YL (corresponding author), Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Dept Instrument Sci & Technol, Beijing 100083, Peoples R China.	ustbzengyiliang@163.com; ustblanjinhui@gmail.com			National Natural Science Foundation of China [61174181]; Advanced Research Fund [9140A05030214QT02070]; National Basic Research Program of China (973 Program) [2012CB725405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advanced Research Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 61174181), the Advanced Research Fund (Grant No. 9140A05030214QT02070), and the National Basic Research Program of China (973 Program, Project No. 2012CB725405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JM, 2011, IEEE T INTELL TRANSP, V12, P184, DOI 10.1109/TITS.2010.2076349; Barnes N, 2008, IEEE T INTELL TRANSP, V9, P322, DOI 10.1109/TITS.2008.922935; de la Escalera A, 2004, IEEE T INTELL TRANSP, V5, P57, DOI 10.1109/TITS.2004.828173; Deshpande AM, 2014, OPTIK, V125, P3612, DOI 10.1016/j.ijleo.2014.01.126; Fang CY, 2003, PROC CVPR IEEE, P750; Fleyeh H, 2011, IET INTELL TRANSP SY, V5, P190, DOI 10.1049/iet-its.2010.0159; Franke U, 1998, IEEE INTELL SYST APP, V13, P40, DOI 10.1109/5254.736001; Gao Yue, 2010, P INT C MULT, P123; Gomez-Moreno H, 2010, IEEE T INTELL TRANSP, V11, P917, DOI 10.1109/TITS.2010.2054084; Gonzalez A, 2011, IEEE T INTELL TRANSP, V12, P485, DOI 10.1109/TITS.2010.2098029; Ji H, 2008, PROC CVPR IEEE, P1515; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Jiang XY, MOTION DEBLURRING; Khan JF, 2011, IEEE T INTELL TRANSP, V12, P83, DOI 10.1109/TITS.2010.2073466; Ko J, 2009, 11TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY, VOLS I-III, PROCEEDINGS,, P1605; Kotera Jan, 2013, Computer Analysis of Images and Patterns. 15th International Conference, CAIP 2013. Proceedings: LNCS 8048, P59, DOI 10.1007/978-3-642-40246-3_8; Lin HT, 2011, IEEE T PATTERN ANAL, V33, P2329, DOI 10.1109/TPAMI.2011.93; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Maldonado-Bascon S, 2007, IEEE T INTELL TRANSP, V8, P264, DOI 10.1109/TITS.2007.895311; Paclik P, 2006, IEEE T INTELL TRANSP, V7, P309, DOI 10.1109/TITS.2006.880627; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Singh MK., 2008, EURASIP J ADV SIG PR, V2008, P1; Stallkamp J, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1453, DOI 10.1109/IJCNN.2011.6033395; Sun HW, 2009, IEEE IND ELEC, P1973, DOI 10.1109/IECON.2009.5415110; Wang W, 2011, 2011 8 INT C FUZZ SY, V4, P2158; Yang HL, 2014, SIGNAL PROCESS, V103, P399, DOI 10.1016/j.sigpro.2014.01.023; Zhang FQ, 2010, 2010 INT C INT COMP, P193	27	11	11	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120885	10.1371/journal.pone.0120885	http://dx.doi.org/10.1371/journal.pone.0120885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849350	Green Published, gold			2022-12-27	WOS:000352477800038
J	Yeh, ML; Peng, CY; Dai, CY; Lai, HC; Huang, CF; Hsieh, MY; Huang, JF; Chen, SC; Lin, ZY; Yu, ML; Chuang, WL				Yeh, Ming-Lun; Peng, Cheng-Yuan; Dai, Chia-Yen; Lai, Hsueh-Chou; Huang, Chung-Feng; Hsieh, Ming-Yen; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Yu, Ming-Lung; Chuang, Wan-Long			Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients	PLOS ONE			English	Article							E-ANTIGEN SEROCONVERSION; HBEAG-NEGATIVE PATIENTS; PEGINTERFERON ALPHA-2A; SERUM HBSAG; HEPATOCELLULAR-CARCINOMA; SUSTAINED RESPONSE; STRONG PREDICTOR; VIRUS INFECTION; LAMIVUDINE; ENTECAVIR	Background Studies are limited on pegylated interferon (Peg-IFN) therapy for chronic hepatitis B (CHB) patients who failed or relapsed on previous antiviral therapy. Objectives We aimed to investigate the effect of Peg-IFN therapy in treatment-experienced CHB patients. Study Design A total of 57 treatment-experienced CHB patients at two medical centers were enrolled. All of the patients were treated with Peg-IFN alpha-2a at 180 mu g weekly for 24 or 48 weeks. The hepatitis B serological markers and viral loads were tested every 3 months until 1 year after stopping Peg-IFN therapy. The endpoints were HBV DNA <2000IU/mL, hepatitis B e antigen (HBeAg) seroconversion, and a hepatitis B surface antigen (HBsAg) loss at 12 months post-treatment. Results In HBeAg-positive patients, 25.0%, 29.2%, and 12.5% of the patients achieved HBeAg seroconversion, HBV DNA < 2000 IU/mL and a combined response, respectively, at 12 months post-treatment. Prior IFN therapy, a high baseline ALT level, a low creatinine level, undetectable HBV DNA at 12 weeks and a decline in HBV DNA >2 log(10) IU/mL at 12 weeks of therapy were factors associated with treatment response. In HBeAg-negative patients, 9.1%, 15.2%, and 6.1% of the patients achieved undetectable HBV DNA, HBV DNA <2000 IU/mL, and an HBsAg loss, respectively, at 12 months post-treatment. No factor was significantly associated with the treatment response in the HBeAg-negative patients. The median HBsAg level declined from 3.4 to 2.6 log(10) IU/mL in all the patients, and the 5-year cumulative rate of the HBsAg loss was 9.8% in the HBeAg-negative patients. Overall, none of the patients prematurely discontinued the Peg-IFN therapy. Conclusions Peg-IFN re-treatment is effective for a proportion of HBeAg-positive treatment-experienced patients; it has limited efficacy for HBeAg-negative treatment-experienced patients. PegIFN might facilitate HBsAg loss in HBeAg-negative treatment-experienced patients.	[Yeh, Ming-Lun; Dai, Chia-Yen; Huang, Chung-Feng; Hsieh, Ming-Yen; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan; [Peng, Cheng-Yuan; Lai, Hsueh-Chou] China Med Univ Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan; [Yeh, Ming-Lun; Dai, Chia-Yen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Chung-Feng; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Chung-Feng; Yu, Ming-Lung] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University	Yu, ML (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan.	fish6069@gmail.com; waloch@kmu.edu.tw	Yu, Ming-Lung/AAZ-4306-2020; Huang, Jee-Fu/AAX-4622-2020; Chuang, Wan-Long/ABF-7427-2021	Yu, Ming-Lung/0000-0001-8145-1900; Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X				Brunetto MR, 2013, J HEPATOL, V59, P1153, DOI 10.1016/j.jhep.2013.07.017; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Chan HLY, 2010, ALIMENT PHARM THER, V32, P1323, DOI 10.1111/j.1365-2036.2010.04474.x; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Jeng WJ, 2013, HEPATOLOGY, V58, P1888, DOI 10.1002/hep.26549; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liaw YF, 2011, HEPATOLOGY, V54, P1591, DOI 10.1002/hep.24555; Lin SM, 2007, J HEPATOL, V46, P45, DOI 10.1016/j.jhep.2006.08.021; Liu F, 2011, J GASTROEN HEPATOL, V26, P456, DOI 10.1111/j.1440-1746.2010.06492.x; Ma H, 2010, J GASTROEN HEPATOL, V25, P1498, DOI 10.1111/j.1440-1746.2010.06282.x; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2013, HEPATOL INT, V7, P88, DOI 10.1007/s12072-012-9343-x; Mizokami M, 1999, FEBS LETT, V450, P66, DOI 10.1016/S0014-5793(99)00471-8; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Peng CY, 2012, ALIMENT PHARM THER, V35, P458, DOI 10.1111/j.1365-2036.2011.04973.x; Piratvisuth T, 2013, HEPATOL INT, V7, P429, DOI 10.1007/s12072-011-9280-0; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Rijckborst V, 2012, J HEPATOL, V56, P1006, DOI 10.1016/j.jhep.2011.12.007; Singal AK, 2013, ALIMENT PHARM THER, V38, P98, DOI 10.1111/apt.12344; Sonneveld MJ, 2010, HEPATOLOGY, V52, P1251, DOI 10.1002/hep.23844; Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301	24	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122259	10.1371/journal.pone.0122259	http://dx.doi.org/10.1371/journal.pone.0122259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835020	gold, Green Submitted, Green Published			2022-12-27	WOS:000352139000089
J	Dorn, TW; Wang, JM; Hicks, JL; Delp, SL				Dorn, Tim W.; Wang, Jack M.; Hicks, Jennifer L.; Delp, Scott L.			Predictive Simulation Generates Human Adaptations during Loaded and Inclined Walking	PLOS ONE			English	Article							MUSCLE CONTRIBUTIONS; DYNAMIC SIMULATIONS; BIPEDAL LOCOMOTION; TRANSVERSE PLANE; SLOPED SURFACES; GAIT; OPTIMIZATION; PATTERNS; STRATEGY; SUPPORT	Predictive simulation is a powerful approach for analyzing human locomotion. Unlike techniques that track experimental data, predictive simulations synthesize gaits by minimizing a high-level objective such as metabolic energy expenditure while satisfying task requirements like achieving a target velocity. The fidelity of predictive gait simulations has only been systematically evaluated for locomotion data on flat ground. In this study, we construct a predictive simulation framework based on energy minimization and use it to generate normal walking, along with walking with a range of carried loads and up a range of inclines. The simulation is muscle-driven and includes controllers based on muscle force and stretch reflexes and contact state of the legs. We demonstrate how human-like locomotor strategies emerge from adapting the model to a range of environmental changes. Our simulation dynamics not only show good agreement with experimental data for normal walking on flat ground (92% of joint angle trajectories and 78% of joint torque trajectories lie within 1 standard deviation of experimental data), but also reproduce many of the salient changes in joint angles, joint moments, muscle coordination, and metabolic energy expenditure observed in experimental studies of loaded and inclined walking.	[Dorn, Tim W.; Hicks, Jennifer L.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Wang, Jack M.] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; University of Hong Kong; Stanford University	Wang, JM (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	jmwang@cs.hku.hk		Hicks, Jennifer/0000-0002-2516-9334; Delp, Scott/0000-0002-9643-7551	National Institutes of Health [R24 HD065690]; National Center for Simulation in Rehabilitation Research [U54 GM072970]; Simbios; National Center for Physics-Based Simulation of Biological Structures, Computation; Defense Advanced Research Projects Agency (DARPA) Warrior Web Program; University of Hong Kong Seed Funding Programme for Basic Research [201403159005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Simulation in Rehabilitation Research; Simbios; National Center for Physics-Based Simulation of Biological Structures, Computation; Defense Advanced Research Projects Agency (DARPA) Warrior Web Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); University of Hong Kong Seed Funding Programme for Basic Research(University of Hong Kong); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health through R24 HD065690, which funds the National Center for Simulation in Rehabilitation Research and through U54 GM072970, which funds Simbios, the National Center for Physics-Based Simulation of Biological Structures, Computation (SLD, JLH, TWD). This work was additionally supported by the Defense Advanced Research Projects Agency (DARPA) Warrior Web Program (SLD, JLH, JMW), and the University of Hong Kong Seed Funding Programme for Basic Research (201403159005; JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2012, J BIOMECH, V45, P1293, DOI 10.1016/j.jbiomech.2012.01.029; Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; BECKETT R, 1968, Journal of Biomechanics, V1, P147, DOI 10.1016/0021-9290(68)90017-1; Brown C, 2011, AM J SPORT MED, V39, P1769, DOI 10.1177/0363546511408872; CHOW C K, 1971, Mathematical Biosciences, V10, P239, DOI 10.1016/0025-5564(71)90062-9; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; DeMers MS, 2014, J ORTHOP RES, V32, P769, DOI 10.1002/jor.22601; Dorn TW, 2012, J EXP BIOL, V215, P1944, DOI 10.1242/jeb.064527; Dzeladini F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00371; Fey NP, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007824; Fregly BJ, 2007, IEEE T BIO-MED ENG, V54, P1687, DOI 10.1109/TBME.2007.891934; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; GHOSH TK, 1976, J OPTIMIZ THEORY APP, V19, P327, DOI 10.1007/BF00934100; Hamner SR, 2013, J BIOMECH, V46, P780, DOI 10.1016/j.jbiomech.2012.11.024; Hansen N, 2003, EVOL COMPUT, V11, P1, DOI 10.1162/106365603321828970; Hatze H, 1983, J SPORT SCI, V1, P3, DOI 10.1080/02640418308729656; HUNT KH, 1975, J APPL MECH-T ASME, V42, P440, DOI 10.1115/1.3423596; Kaplan ML, 2001, J BIOMECH, V34, P1077, DOI 10.1016/S0021-9290(01)00057-4; Kim HJ, 2009, J ORTHOP RES, V27, P1326, DOI 10.1002/jor.20876; Kotosaka S., 1995, J ROBOTICS SOC JAPAN, V73, P113; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Lay AN, 2007, J BIOMECH, V40, P1276, DOI 10.1016/j.jbiomech.2006.05.023; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Miller RH, 2011, P BIOL SCI; Miller RH, 2014, J BIOMECH, V47, P1373, DOI 10.1016/j.jbiomech.2014.01.049; Miller RH, 2012, J BIOMECH, V45, P1092, DOI 10.1016/j.jbiomech.2011.04.040; Mordatch I, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2508363.2508365; Neptune RR, 2009, J BIOMECH, V42, P1282, DOI 10.1016/j.jbiomech.2009.03.009; NUBAR Y, 1961, B MATH BIOPHYS, V23, P377, DOI 10.1007/BF02476493; Ogihara N, 2001, BIOL CYBERN, V84, P1, DOI 10.1007/PL00007977; POZZO T, 1990, EXP BRAIN RES, V82, P97; Rethlefsen SA, 2013, J PEDIATR ORTHOPED, V33, P422, DOI 10.1097/BPO.0b013e3182784e16; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Sherman M, IUTAM S HUM BOD DYN; Silder A, 2013, J BIOMECH, V46, P2522, DOI 10.1016/j.jbiomech.2013.06.020; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; TAGA G, 1991, BIOL CYBERN, V65, P147, DOI 10.1007/BF00198086; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; van Werkhoven H, 2013, J BIOMECH, V46, P1092, DOI 10.1016/j.jbiomech.2013.01.016; Wang JM, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185521; YAMAGUCHI GT, 1990, IEEE T BIO-MED ENG, V37, P886, DOI 10.1109/10.58599; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1	49	57	57	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121407	10.1371/journal.pone.0121407	http://dx.doi.org/10.1371/journal.pone.0121407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830913	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600071
J	Kawashima, M; Uchino, M; Yokoi, N; Uchino, Y; Dogru, M; Komuro, A; Sonomura, Y; Kato, H; Kinoshita, S; Mimura, M; Tsubota, K				Kawashima, Motoko; Uchino, Miki; Yokoi, Norihiko; Uchino, Yuichi; Dogru, Murat; Komuro, Aoi; Sonomura, Yukiko; Kato, Hiroaki; Kinoshita, Shigeru; Mimura, Masaru; Tsubota, Kazuo			Associations between Subjective Happiness and Dry Eye Disease: A New Perspective from the Osaka Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISPLAY TERMINAL USERS; RISK-FACTORS; SJOGRENS-SYNDROME; DIAGNOSTIC-TESTS; OCULAR SURFACE; PREVALENCE; SYMPTOMS; POPULATION; IMPACT	Importance Dry eye disease has become an important health problem. A lack of concordance between self-reported symptoms and the outcome of dry eye examinations has raised questions about dry eye disease. Objective To explore the association between subjective happiness and objective and subjective symptoms of dry eye disease. Design The study adopted a cross-sectional design. Setting All the employees of a company in Osaka, Japan. Participants 672 Japanese office workers using Visual Display Terminals (age range: 26-64 years). Methods The dry eye measurement tools included the Schirmer test, conjunctivocorneal staining, the tear film break-up time, as well as the administration of a dry eye symptoms questionnaire. Happiness was measured by the Subjective Happiness Scale. Main Outcome Measures Dry eye examination parameters, dry eye symptoms questionnaires, and the Subjective Happiness Scale score. Results Of the 672 workers, 561 (83.5%) completed the questionnaires and examinations. The mean Subjective Happiness Scale score was 4.91 (SD = 1.01). This score was inversely correlated with the dry eye symptom score (r = -0.188, p < 0.001), but was not associated with objective findings which include conjunctivocorneal staining, low Schirmer test score, or low tear film break-up time. The level of subjective happiness was the lowest in the group without objective results, but reported subjective symptoms of dry eyes (p < 0.05). Conclusions and Relevance There is evidence of the relationship between subjective happiness and self-reported symptoms of dry eyes. Findings of this study revealed a new perspective on dry eye disease, including the potential for innovative treatments of a specific population with dry eye disease.	[Kawashima, Motoko; Uchino, Miki; Uchino, Yuichi; Dogru, Murat; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yokoi, Norihiko; Komuro, Aoi; Sonomura, Yukiko; Kato, Hiroaki; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Keio University; Kyoto Prefectural University of Medicine; Keio University	Kawashima, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	motoko-k@a3.keio.jp	Uchino, Miki/T-9102-2019		Ministry of Education, Science, Sports and Culture [2279192]; Santen Pharmaceutical Co., Ltd.; Santen Pharmaceutical Co., Ltd, Osaka	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Santen Pharmaceutical Co., Ltd.; Santen Pharmaceutical Co., Ltd, Osaka	This study was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture, and Grant-in-Aid for Young Scientists (B), 2279192, 2010. Part of this study was sponsored by Santen Pharmaceutical Co., Ltd. Provision of facilities, transport of equipment were supported by Santen Pharmaceutical Co., Ltd, Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abetz L, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-111; Adatia FA, 2004, CAN J OPHTHALMOL, V39, P767, DOI 10.1016/S0008-4182(04)80071-1; DEGARGINO JP, 2004, CHILDRENS HLTH ENV G; Fairchild CJ, 2008, OPTOMETRY VISION SCI, V85, P699, DOI 10.1097/OPX.0b013e3181824e0d; Friedman NJ, 2010, CURR OPIN OPHTHALMOL, V21, P310, DOI 10.1097/ICU.0b013e32833a8c15; Kim KW, 2011, INVEST OPHTH VIS SCI, V52, P7954, DOI 10.1167/iovs.11-8050; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Li MY, 2011, CURR EYE RES, V36, P1, DOI 10.3109/02713683.2010.519850; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Mattei D, 2004, PSYCHOL REP, V94, P288; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; Mertzanis P, 2005, INVEST OPHTH VIS SCI, V46, P46, DOI 10.1167/iovs.03-0915; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mizuno Y, 2010, JPN J OPHTHALMOL, V54, P259, DOI 10.1007/s10384-010-0812-2; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Pflugfelder SC, 1998, CORNEA, V17, P38, DOI 10.1097/00003226-199801000-00007; Pouyeh B, 2012, AM J OPHTHALMOL, V153, P1061, DOI 10.1016/j.ajo.2011.11.030; Rajagopalan K, 2005, VALUE HEALTH, V8, P168, DOI 10.1111/j.1524-4733.2005.03074.x; Savini G, 2008, CLIN OPHTHALMOL, V2, P31; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shimai Satoshi, 2004, Nihon Koshu Eisei Zasshi, V51, P845; Shimazaki S., 2006, J EYE, V24, P181; Smith JA, 2007, OCUL SURF, V5, P93; Takeyachi Y, 2003, SPINE, V28, P1461, DOI 10.1097/00007632-200307010-00018; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Tse MM, 2012, J ADV NURS, V68, P312, DOI 10.1111/j.1365-2648.2011.05738.x; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Uchino M, 2011, OPHTHALMOLOGY, V118, P2361, DOI 10.1016/j.ophtha.2011.05.029; Uchino Y, 2012, JPN J OPHTHALMOL, V56, P8, DOI 10.1007/s10384-011-0099-y; Vriezekolk JE, 2005, J RHEUMATOL, V32, P2351; Wen W, 2012, CORNEA, V31, P686, DOI 10.1097/ICO.0b013e3182261590	38	54	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123299	10.1371/journal.pone.0123299	http://dx.doi.org/10.1371/journal.pone.0123299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830665	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600141
J	McMurray, F; Demetriades, M; Aik, WS; Merkestein, M; Kramer, H; Andrew, DS; Scudamore, CL; Hough, TA; Wells, S; Ashcroft, FM; McDonough, MA; Schofield, CJ; Cox, RD				McMurray, Fiona; Demetriades, Marina; Aik, WeiShen; Merkestein, Myrte; Kramer, Holger; Andrew, Daniel S.; Scudamore, Cheryl L.; Hough, Tertius A.; Wells, Sara; Ashcroft, Frances M.; McDonough, Michael A.; Schofield, Christopher J.; Cox, Roger D.			Pharmacological Inhibition of FTO	PLOS ONE			English	Article							HIF-ALPHA; FAT MASS; GENE; EXPRESSION; RNA; HYDROXYLATION; HYPOXIA; TRANSLATION; ADAPTATION; SUBSTRATE	In 2007, a genome wide association study identified a SNP in intron one of the gene encoding human FTO that was associated with increased body mass index. Homozygous risk allele carriers are on average three kg heavier than those homozygous for the protective allele. FTO is a DNA/RNA demethylase, however, how this function affects body weight, if at all, is unknown. Here we aimed to pharmacologically inhibit FTO to examine the effect of its demethylase function in vitro and in vivo as a first step in evaluating the therapeutic potential of FTO. We showed that IOX3, a known inhibitor of the HIF prolyl hydroxylases, decreased protein expression of FTO (in C2C12 cells) and reduced maximal respiration rate in vitro. However, FTO protein levels were not significantly altered by treatment of mice with IOX3 at 60 mg/kg every two days. This treatment did not affect body weight, or RER, but did significantly reduce bone mineral density and content and alter adipose tissue distribution. Future compounds designed to selectively inhibit FTO's demethylase activity could be therapeutically useful for the treatment of obesity.	[McMurray, Fiona; Andrew, Daniel S.; Scudamore, Cheryl L.; Hough, Tertius A.; Wells, Sara; Cox, Roger D.] MRC Harwell, Oxford OX11 0RD, England; [Demetriades, Marina; Aik, WeiShen; McDonough, Michael A.; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Merkestein, Myrte; Kramer, Holger; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Henry Wellcome Ctr Gene Funct, Oxford OX1 3PT, England	University of Oxford; University of Oxford	McMurray, F (corresponding author), MRC Harwell, Harwell Oxford Campus, Oxford OX11 0RD, England.	Fmcmurra@uottawa.ca	McDonough, Michael A/G-2744-2013; Kramer, Holger/AAL-4433-2020; McDonough, Michael/N-8913-2019	McDonough, Michael A/0000-0003-4664-6942; Kramer, Holger/0000-0002-6400-0945; McDonough, Michael/0000-0003-4664-6942; Schofield, Christopher/0000-0002-0290-6565; Cox, Roger/0000-0001-7170-5014; Scudamore, Cheryl/0000-0002-7101-1714; Aik, Wei Shen/0000-0003-4414-173X	Medical Research Council; Wellcome Trust [093136]; MRC; MRC [MC_UP_1502/1, MC_U142661184, G0901338] Funding Source: UKRI; Medical Research Council [MC_U142661184, MC_UP_1502/1, G0901338] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research was funded by the Medical Research Council and Wellcome Trust (093136). FM was in receipt of an MRC doctoral training studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Arend MP, 2004, Patent No. [2004/108681, 2004108681]; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Berulava T, 2013, EUR J HUM GENET, V21, P317, DOI 10.1038/ejhg.2012.168; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Chen RL, 2014, J NEUROCHEM, V131, P177, DOI 10.1111/jnc.12804; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Katz MJ, 2014, P NATL ACAD SCI USA, V111, P4025, DOI 10.1073/pnas.1314485111; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Leger AJ, 2010, J BONE MINER METAB, V28, P510, DOI 10.1007/s00774-010-0171-6; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Merkestein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097162; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761; Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853; Singleton RS, 2014, P NATL ACAD SCI USA, V111, P4031, DOI 10.1073/pnas.1314482111; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Sridharan V, 2007, AM J PHYSIOL-CELL PH, V292, pC719, DOI 10.1152/ajpcell.00100.2006; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tan SC, 2011, HEART, V97, P13, DOI 10.1136/heartjnl-2011-300920b.37; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006	43	25	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121829	10.1371/journal.pone.0121829	http://dx.doi.org/10.1371/journal.pone.0121829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830347	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600086
J	Pinheiro, MM; Ahmed, MA; Millar, SB; Sanderson, T; Otto, TD; Lu, WC; Krishna, S; Rayner, JC; Cox-Singh, J				Pinheiro, Miguel M.; Ahmed, Md Atique; Millar, Scott B.; Sanderson, Theo; Otto, Thomas D.; Lu, Woon Chan; Krishna, Sanjeev; Rayner, Julian C.; Cox-Singh, Janet			Plasmodium knowlesi Genome Sequences from Clinical Isolates Reveal Extensive Genomic Dimorphism	PLOS ONE			English	Article							DNA-BINDING; MALARIA; VISUALIZATION; INFECTIONS; TOOL; IDENTIFICATION; FALCIPARUM; PROTEINS; TRAVELER; FEATURES	Plasmodium knowlesi is a newly described zoonosis that causes malaria in the human population that can be severe and fatal. The study of P. knowlesi parasites from human clinical isolates is relatively new and, in order to obtain maximum information from patient sample collections, we explored the possibility of generating P. knowlesi genome sequences from archived clinical isolates. Our patient sample collection consisted of frozen whole blood samples that contained excessive human DNA contamination and, in that form, were not suitable for parasite genome sequencing. We developed a method to reduce the amount of human DNA in the thawed blood samples in preparation for high throughput parasite genome sequencing using Illumina HiSeq and MiSeq sequencing platforms. Seven of fifteen samples processed had sufficiently pure P. knowlesi DNA for whole genome sequencing. The reads were mapped to the P. knowlesi H strain reference genome and an average mapping of 90% was obtained. Genes with low coverage were removed leaving 4623 genes for subsequent analyses. Previously we identified a DNA sequence dimorphism on a small fragment of the P. knowlesi normocyte binding protein xa gene on chromosome 14. We used the genome data to assemble full-length Pknbpxa sequences and discovered that the dimorphism extended along the gene. An in-house algorithm was developed to detect SNP sites co-associating with the dimorphism. More than half of the P. knowlesi genome was dimorphic, involving genes on all chromosomes and suggesting that two distinct types of P. knowlesi infect the human population in Sarawak, Malaysian Borneo. We use P. knowlesi clinical samples to demonstrate that Plasmodium DNA from archived patient samples can produce high quality genome data. We show that analyses, of even small numbers of difficult clinical malaria isolates, can generate comprehensive genomic information that will improve our understanding of malaria parasite diversity and pathobiology.	[Pinheiro, Miguel M.; Millar, Scott B.; Cox-Singh, Janet] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Ahmed, Md Atique] Univ Malaysia Sarawak, Malaria Res Ctr, Kuching, Sarawak, Malaysia; [Sanderson, Theo; Otto, Thomas D.; Rayner, Julian C.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England; [Lu, Woon Chan] Sarikei Hosp, Sarikei 96100, Sarawak, Malaysia; [Krishna, Sanjeev] St Georges Univ London, Div Clin Sci, London, England	University of St Andrews; University of Malaysia Sarawak; Wellcome Trust Sanger Institute; St Georges University London	Cox-Singh, J (corresponding author), Univ St Andrews, Sch Med, Med & Biol Sci Bldg, St Andrews, Fife, Scotland.	jcs26@st-andrews.ac.uk	Pinheiro, Miguel/K-6572-2017; Ahmed, Atique/L-7820-2015; Janet Cox, Janet Cox/GLU-3838-2022; Singh, Balbir/A-3610-2009; Otto, Thomas/ABE-7632-2020; Millar, Scott/GPX-7987-2022	Pinheiro, Miguel/0000-0002-6601-7513; Janet Cox, Janet Cox/0000-0003-4878-5188; Otto, Thomas/0000-0002-1246-7404; Ahmed, Md Atique/0000-0002-3407-7220; Sanderson, Theo/0000-0003-4177-2851; Millar, Scott/0000-0003-1718-1947; Krishna, Sanjeev/0000-0003-0066-0634; Rayner, Julian/0000-0002-9835-1014	Bioinformatics Unit at St Andrews University - Wellcome Trust ISSF [097831/Z/11/Z]; Medial Research Council [G0801971]; University of St Andrews; Wellcome Trust [098051]; European Union 7th framework (EVIMalaR); Medical Research Council [MR/J500355/1]; MRC [G0801971] Funding Source: UKRI; Medical Research Council [G0801971] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091595] Funding Source: NIH RePORTER	Bioinformatics Unit at St Andrews University - Wellcome Trust ISSF; Medial Research Council; University of St Andrews; Wellcome Trust(Wellcome Trust); European Union 7th framework (EVIMalaR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MMP and Bioinformatics support was provided by the Bioinformatics Unit at St Andrews University funded by a Wellcome Trust ISSF grant 097831/Z/11/Z. This research was funded by Medial Research Council (www.mrc.ac.uk, grant G0801971) (to JCS and SK) and the University of St Andrews. TS, TDO and JCR were supported by the Wellcome Trust (www.wellcome.ac.uk, grant number 098051). TDO was supported by the European Union 7th framework (EVIMalaR) (www.evimalar.org). TS was supported by the Medical Research Council (www.mrc.ac.uk, grant number MR/J500355/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003086; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Bronner U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-15; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Cox-Singh J, 2012, CURR OPIN INFECT DIS, V25, P530, DOI 10.1097/QCO.0b013e3283558780; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Divis PCS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-344; Ecker A, 2012, TREATMENT PREVENTION, P249; Fatih FA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-425; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Koenderink JB, 2010, TRENDS PARASITOL, V26, P440, DOI 10.1016/j.pt.2010.05.002; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau YL, 2011, EMERG INFECT DIS, V17, P1314, DOI 10.3201/eid1707.101295; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindner SE, 2010, J MOL BIOL, V395, P558, DOI 10.1016/j.jmb.2009.11.004; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Meyer EVS, 2009, MOL BIOCHEM PARASIT, V165, P111, DOI 10.1016/j.molbiopara.2009.01.012; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1988, MOL BIOCHEM PARASIT, V31, P217, DOI 10.1016/0166-6851(88)90151-X; Oyola SO, 2013, J CLIN MICROBIOL, V51, P745, DOI 10.1128/JCM.02507-12; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Roy SW, 2008, HEREDITY, V100, P103, DOI 10.1038/sj.hdy.6800887; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Tanizaki R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-128; Tripathi R, 2005, PARASITOLOGY, V130, P475, DOI 10.1017/S0031182004006481; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; Yeo TC, 2014, COMB CHEM HIGH T SCR, V17, P192, DOI 10.2174/1386207317666140109114553; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	49	46	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121303	10.1371/journal.pone.0121303	http://dx.doi.org/10.1371/journal.pone.0121303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830531	Green Accepted, Green Published, gold			2022-12-27	WOS:000352135600068
J	Ding, CJ; Lu, J; Song, ZQ				Ding, Changjiang; Lu, Jun; Song, Zhiqing			Electrohydrodynamic Drying of Carrot Slices	PLOS ONE			English	Article							EHD; AIR; KINETICS; APPLE; RICE	Carrots have one of the highest levels of carotene, and they are rich in vitamins, fiber and minerals. However, since fresh carrots wilt rapidly after harvest under inappropriate storage conditions, drying has been used to improve their shelf life and retain nutritional quality. Therefore, to further investigate the potential of this method, carrot slices were dried in an EHD system in order to study the effect of different voltages on drying rate. As measures of quality, carotene content and rehydration ratio were, respectively, compared against the conventional oven drying regime. Carotene, the main component of the dried carrot, and rehydration characteristics of the dried product can both indicate quality by physical and chemical changes during the drying process. Mathematical modeling and simulation of drying curves were also performed, using root mean square error, reduced mean square of the deviation and modeling efficiency as the primary criteria to select the equation that best accounts for the variation in the drying curves of the dried samples. Theoretically, the Page model was best suited for describing the drying rate curve of carrot slices at 10kV to 30kV. Experimentally, the drying rate of carrots was notably greater in the EHD system when compared to control, and quality, as determined by carotene content and rehydration ratio, was also improved when compared to oven drying. Therefore, this work presents a facile and effective strategy for experimentally and theoretically determining the drying properties of carrots, and, as a result, it provides deeper insight into the industrial potential of the EHD drying technique.	[Ding, Changjiang; Lu, Jun; Song, Zhiqing] Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China	Inner Mongolia University of Technology	Ding, CJ (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China.	ding9713@163.com	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	National Natural Science Foundations of China [51467015]; Natural Science Foundation of Inner Mongolia Autonomous Region of china [2013MS0106]; Science Foundation of Inner Mongolia of Technology [ZD201311]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia Autonomous Region of china; Science Foundation of Inner Mongolia of Technology	This work was Supported by National Natural Science Foundations of China(No. 51467015), Natural Science Foundation of Inner Mongolia Autonomous Region of china (No. 2013MS0106) and Science Foundation of Inner Mongolia of Technology (No. ZD201311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemrajabi AA, 2012, DRY TECHNOL, V30, P88, DOI 10.1080/07373937.2011.608913; Bai YX, 2012, J AQUAT FOOD PROD T, V21, P238, DOI 10.1080/10498850.2011.590271; Bai YX, 2011, J FOOD PROCESS PRES, V35, P891, DOI 10.1111/j.1745-4549.2011.00542.x; Bai YX, 2013, LWT-FOOD SCI TECHNOL, V54, P570, DOI 10.1016/j.lwt.2013.06.026; Bai YX, 2011, INT J APPL ELECTROM, V36, P217, DOI 10.3233/JAE-2011-1361; Balcer BE, 2004, DRY TECHNOL, V22, P821, DOI 10.1081/DRT-120034265; Basiry M, 2010, J ELECTROSTAT, V68, P360, DOI 10.1016/j.elstat.2010.05.002; Cao W, 2004, BIOSYST ENG, V87, P445, DOI 10.1016/j.biosystemseng.2003.12.007; Celma AR, 2008, CHEM ENG PROCESS, V47, P1810, DOI 10.1016/j.cep.2007.10.003; Demir V, 2007, BIOSYST ENG, V98, P47, DOI 10.1016/j.biosystemseng.2007.06.011; Dinani ST, 2014, ENERG CONVERS MANAGE, V86, P70, DOI 10.1016/j.enconman.2014.05.010; Dinani ST, 2014, DRY TECHNOL, V32, P597, DOI 10.1080/07373937.2013.851086; Ding CJ, 2014, INT J APPL ELECTROM, V46, P455, DOI 10.3233/JAE-141781; Esehaghbeygi A, 2012, DRY TECHNOL, V30, P1644, DOI 10.1080/07373937.2012.701262; Esehaghbeygi A, 2011, J FOOD ENG, V104, P628, DOI 10.1016/j.jfoodeng.2011.01.032; Hashinaga F, 1999, DRY TECHNOL, V17, P479, DOI 10.1080/07373939908917547; Lai FC, 2002, DRY TECHNOL, V20, P1393, DOI 10.1081/DRT-120005858; Li FD, 2006, J FOOD ENG, V77, P275, DOI 10.1016/j.jfoodeng.2005.06.028; Li FD, 2005, DRY TECHNOL, V23, P565, DOI 10.1081/DRT-200054133; Li ZF, 2010, LWT-FOOD SCI TECHNOL, V43, P291, DOI 10.1016/j.lwt.2009.08.002; Meisami-asl E., 2009, Pakistan Journal of Nutrition, V8, P804; Menges HO, 2006, J FOOD ENG, V77, P119, DOI 10.1016/j.jfoodeng.2005.06.049; Pardeshi IL, 2010, FOOD BIOPROCESS TECH, V3, P415, DOI 10.1007/s11947-008-0100-z; Romano G, 2009, DRY TECHNOL, V27, P574, DOI 10.1080/00304940802716233; Senadeera W, 2003, J FOOD ENG, V58, P277, DOI 10.1016/S0260-8774(02)00386-2; Singh A, 2012, DRY TECHNOL, V30, P1812, DOI 10.1080/07373937.2012.708912; Srikiatden J, 2008, J FOOD ENG, V84, P516, DOI 10.1016/j.jfoodeng.2007.06.009; Wu BG, 2014, J FOOD PROCESS ENG, V37, P111, DOI 10.1111/jfpe.12066; Zhang J, 2000, J INNER MONGOLIA AGR, V21, P121; Zhang Y, 2014, J ELECTROSTAT, V72, P76, DOI 10.1016/j.elstat.2013.11.010	30	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124077	10.1371/journal.pone.0124077	http://dx.doi.org/10.1371/journal.pone.0124077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25835017	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800131
J	de Oliveira, ML; Santos, LMP; da Silva, EN				de Oliveira, Michele Lessa; Pacheco Santos, Leonor Maria; da Silva, Everton Nunes			Direct Healthcare Cost of Obesity in Brazil: An Application of the Cost-of-Illness Method from the Perspective of the Public Health System in 2011	PLOS ONE			English	Article							BODY-MASS INDEX; ECONOMIC BURDEN; OVERWEIGHT; CANCER; MORTALITY; CONSEQUENCES; METAANALYSIS; WEIGHT; IMPACT; RISK	Background Obesity is a global public health problem and a risk factor for several diseases that financially impact healthcare systems. Objective To estimate the direct costs attributable to obesity (body mass index {BMI} >= 30 kg/m(2)) and morbid obesity (BMI >= 40 kg/m(2)) in adults aged >= 20 incurred by the Brazilian public health system in 2011. Settings Public hospitals and outpatient care. Methods A cost-of-illness method was adopted using a top-down approach based on prevalence. The proportion of the cost of each obesity-associated comorbidity was calculated and obesity prevalence was used to calculate attributable risk. Direct healthcare cost data (inpatient care, bariatric surgery, outpatient care, medications and diagnostic procedures) were extracted from the Ministry of Health information systems, available on the web. Results Direct costs attributable to obesity totaled US$ 269.6 million (1.86% of all expenditures on medium-and high-complexity health care). The cost of morbid obesity accounted for 23.8% (US$ 64.2 million) of all obesity-related costs despite being 18 times less prevalent than obesity. Bariatric surgery costs in Brazil totaled US$ 17.4 million in 2011. The cost of morbid obesity in women was five times higher than it was in men. Conclusion The cost of morbid obesity was found to be proportionally higher than the cost of obesity. If the current epidemic were not reversed, the prevalence of obesity in Brazil will increase gradually in the coming years, as well as its costs, having serious implications for the financial sustainability of the Brazilian public health system.	[de Oliveira, Michele Lessa; Pacheco Santos, Leonor Maria; da Silva, Everton Nunes] Univ Brasilia, Brasilia, DF, Brazil	Universidade de Brasilia	da Silva, EN (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	evertonsilva@unb.br	Porto, Jorge/T-4694-2019; Oliveira, Claudio/D-7713-2012; Porto, Jorge/K-1441-2014; da Silva Batista, Jacqueline/AAD-4349-2020; Zuanon, Jansen A. S./E-5791-2013	Oliveira, Claudio/0000-0002-7010-8880; Porto, Jorge/0000-0003-1393-6492; da Silva Batista, Jacqueline/0000-0002-6649-6200; Zuanon, Jansen A. S./0000-0001-8354-2750; santos, leonor maria pacheco/0000-0002-6739-6260; Silva, Everton/0000-0001-8747-4185				Access Economics, 2006, EC COSTS OB REP ACC; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; [Anonymous], 2000, WHO TECH REP SER, P894; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bachman KH, 2007, DIS MANAGE, V10, P129, DOI 10.1089/dis.2007.103643; Bahia L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-440; Barrett A, 2008, ISPOR 13 ANN INT M; Branca F, 2007, CHALLENGE OBESITY WH, P11; Brasil, PROD AMB PROC MENT H; Brasil. Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20, P130; Brasil. Ministerio da Saude, 2008, AR EC SAUD DES AV EC, P104, DOI [10.1016/j.rpsm.2014.10.004, DOI 10.1016/J.RPSM.2014.10.004]; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cordeiro Ricardo, 2005, Rev. bras. epidemiol., V8, P111; Cremieux PY, 2008, AM J MANAG CARE, V14, P589; Dai Z, 2007, WORLD J GASTROENTERO, V13, P4199, DOI 10.3748/wjg.v13.i31.4199; Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3; Ezzati M, 2004, COMP QUANTIFICATION, V1, P497; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hensrud DD, 2006, MAYO CLIN PROC, V81, pS5; International Association for the Study of Obesity International Obesity Taskforce, EST REL RISKS BMI CA; Lehnert T, 2013, BEST PRACT RES CL EN, V27, P105, DOI 10.1016/j.beem.2013.01.002; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Oliveira IV, 2007, THESIS U BRASILIA BR; Santos LMP, 2010, OBES SURG, V20, P943, DOI 10.1007/s11695-008-9570-3; Pereira J, 1999, CUSTOS OBESIDADE POR; Pereira MG, 2001, EPIDEMIOLOGIA TEORIA, P412; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sarno F, 2007, REV SAUDE PUBL, V41, P788, DOI 10.1590/S0034-89102007000500013; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sichieri R, 2007, CAD SAUDE PUBLICA, V23, P1721, DOI 10.1590/S0102-311X2007000700025; Sussenbach SP, 2012, OBES SURG, V22, P266, DOI 10.1007/s11695-011-0558-z; Sussenbach SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099976; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Wagner M.B., 1998, J PEDIAT, V74, P247; Wang GJ, 2002, AM J PREV MED, V23, P1, DOI 10.1016/S0749-3797(02)00448-8; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization (WHO), 2012, WORLD HLTH STAT 2012; Yang P, 2009, EUR J CANCER, V45, P2867, DOI 10.1016/j.ejca.2009.04.019	51	117	121	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121160	10.1371/journal.pone.0121160	http://dx.doi.org/10.1371/journal.pone.0121160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25658694	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600061
J	Zhao, SY; Ding, C; He, JZ				Zhao, Siyan; Ding, Chang; He, Jianzhong			Detoxification of 1,1,2-Trichloroethane to Ethene by Desulfitobacterium and Identification of Its Functional Reductase Gene	PLOS ONE			English	Article							DEHALOCOCCOIDES-ETHENOGENES; SP NOV.; DEHALOGENASE; GROWTH; 1,1,2,2-TETRACHLOROETHANE; DECHLORINATION; SPP.	1,1,2-trichloroethane (1,1,2-TCA) has become a common groundwater pollutant due to historically extensive utilization, improper disposal, as well as from incomplete dechlorination of 1,1,2,2-tetrachloroethane. Currently, limited information is available on microbial detoxification of 1,1,2-TCA. Desulfitobacterium sp. strain PR, which was isolated from an anaerobic bioreactor maintained to dechlorinate chloroethenes/ethanes, exhibited the capacity to dechlorinate 1,1,1-trichloroethane and chloroform. In this study, the dechlorinating ability of strain PR was further explored. Strain PR showed the capability to dechlorinate 1,1,2-TCA (similar to 1.12 mM) predominantly to 1,2-dichloroethane (1,2-DCA) and chloroethane, and to trace amounts of vinyl chloride and ethene within 20 days. Strain PR coupled growth with dechlorination of 1,1,2-TCA to 1,2-DCA, while no cell growth was observed with dechlorination of 1,2-DCA to chloroethane. Later, through transcriptomic and enzymatic analysis, the reductive dehalogenase CtrA, which was previously reported to be responsible for 1,1,1-trichloroethane and chloroform dechlorination, was identified as the 1,1,2-TCA reductive dehalogenase. Since trichloroethene (TCE) is usually co-contaminated with 1,1,2-TCA, a co-culture containing Dehalococcoides mccartyi strain 11a capable of detoxifying TCE and 1,2-DCA and strain PR was established. Interestingly, this co-culture dechlorinated 1,1,2-TCA and TCE to the non-toxic end-product ethene within 48 days without chloroethane production. This novel pathway avoids production of the carcinogenic intermediate dechlorination product vinyl chloride, providing a more environmentally friendly strategy to treat 1,1,2-TCA.	[Zhao, Siyan; Ding, Chang; He, Jianzhong] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore	National University of Singapore	He, JZ (corresponding author), Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore.	jianzhong.he@nus.edu.sg	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council [102 101 0025]; National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme [NRF-CRP5-2009-05]	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council(Agency for Science Technology & Research (A*STAR)); National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme(National Research Foundation, Singapore)	This study was supported by Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council under project no.: 102 101 0025 and the National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme with a project no.: NRF-CRP5-2009-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2007, APPL ENVIRON MICROB, V73, P7717, DOI 10.1128/AEM.01649-07; ATSDR, 2006, TOX PROF VIN CHLOR; ATSDR, 2010, TOX PROF 1 1 2 TRICH; Aulenta F, 2006, BIODEGRADATION, V17, P193, DOI 10.1007/s10532-005-4218-7; Bowman KS, 2013, INT J SYST EVOL MICR, V63, P1492, DOI 10.1099/ijs.0.045054-0; CASTRO CE, 1994, ENVIRON TOXICOL CHEM, V13, P429, DOI [10.1897/1552-8618(1994)13[429:BRDBMT]2.0.CO;2, 10.1002/etc.5620130310]; Chen C, 1996, ENVIRON SCI TECHNOL, V30, P542, DOI 10.1021/es9502987; Chow WL, 2010, ISME J, V4, P1020, DOI 10.1038/ismej.2010.27; Coons DE, 2000, CHEMICAL OXIDATION AND REACTIVE BARRIERS, P161; De Wildeman S, 2003, APPL ENVIRON MICROB, V69, P5643, DOI 10.1128/AEM.69.9.5643-5647.2003; Ding C, 2014, ENVIRON MICROBIOL, V15, P1462; FATHEPURE BZ, 1994, ENVIRON SCI TECHNOL, V28, P746, DOI 10.1021/es00053a031; Grostern A, 2006, APPL ENVIRON MICROB, V72, P428, DOI 10.1128/AEM.72.1.428-436.2006; He JZ, 2007, APPL ENVIRON MICROB, V73, P2847, DOI 10.1128/AEM.02574-06; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LK, 2010, APPL ENVIRON MICROB, V76, P794, DOI 10.1128/AEM.01872-09; Lee PKH, 2013, ENVIRON MICROBIOL, V15, P2293, DOI 10.1111/1462-2920.12099; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Maness AD, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-54; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Plagentz V, 2006, ENVIRON GEOL, V49, P684, DOI 10.1007/s00254-005-0106-z; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; Schiffmann CL, 2014, J PROTEOMICS, V98, P59, DOI 10.1016/j.jprot.2013.12.009	24	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119507	10.1371/journal.pone.0119507	http://dx.doi.org/10.1371/journal.pone.0119507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835017	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000009
J	Benzaquem, DC; Oliveira, C; Batista, JD; Zuanon, J; Porto, JIR				Benzaquem, Denise Correa; Oliveira, Claudio; Batista, Jaqueline da Silva; Zuanon, Jansen; Rebelo Porto, Jorge Ivan			DNA Barcoding in Pencilfishes (Lebiasinidae: Nannostomus) Reveals Cryptic Diversity across the Brazilian Amazon	PLOS ONE			English	Article							FRESH-WATER FISHES; INDO-WEST PACIFIC; CHARACIFORMES CHARACIDAE; TAXONOMY; NOV	Nannostomus is comprised of 20 species. Popularly known as pencilfishes the vast majority of these species lives in the flooded forests of the Amazon basin and are popular in the ornamental trade. Among the lebiasinids, it is the only genus to have undergone more than one taxonomic revision. Even so, it still possesses poorly defined species. Here, we report the results of an application of DNA barcoding to the identification of pencilfishes and highlight the deeply divergent clades within four nominal species. We surveyed the sequence variation in the mtDNA cytochrome c oxidase subunit I gene among 110 individuals representing 14 nominal species that were collected from several rivers along the Amazon basin. The mean Kimura-2-parameter distances within species and genus were 2% and 19,0%, respectively. The deep lineage divergences detected in N. digrammus, N. trifasciatus, N. unifasciatus and N. eques suggest the existence of hidden diversity in Nannostomus species. For N. digrammus and N. trifasciatus, in particular, the estimated divergences in some lineages were so high that doubt about their conspecific status is raised.	[Benzaquem, Denise Correa; Rebelo Porto, Jorge Ivan] Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim, BR-69067375 Manaus, Amazonas, Brazil; [Oliveira, Claudio] UNESP, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil; [Batista, Jaqueline da Silva] Inst Nacl de Pesquisas da Amazonia, Lab Temat Biol Mol, Lab Fisiol Comportamental & Evolucao, BR-69067375 Manaus, Amazonas, Brazil; [Zuanon, Jansen] Inst Nacl de Pesquisas da Amazonia, Lab Sistemat & Ecol Peixes, BR-69067375 Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Estadual Paulista; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Porto, JIR (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim, Av Andre Araujo 2-936, BR-69067375 Manaus, Amazonas, Brazil.	jirporto@inpa.gov.br	Porto, Jorge/T-4694-2019; Oliveira, Claudio/D-7713-2012; Porto, Jorge/K-1441-2014; da Silva Batista, Jacqueline/AAD-4349-2020; Zuanon, Jansen A. S./E-5791-2013	Oliveira, Claudio/0000-0002-7010-8880; Porto, Jorge/0000-0003-1393-6492; da Silva Batista, Jacqueline/0000-0002-6649-6200; Zuanon, Jansen A. S./0000-0001-8354-2750; santos, leonor maria pacheco/0000-0002-6739-6260; Silva, Everton/0000-0001-8747-4185	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL) [564953/2010-5]; FAPEAM/CNPq/PRONEX [003/2009]; CNPq/FAPEAM (INCT CENBAM); CNPq/FAPEAM (SISBIOTA Rede BIOPHAM) [563348/2010-0]; Fundacao de Amparo a Pesquisa do Estado do Amazonas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEAM/CNPq/PRONEX; CNPq/FAPEAM (INCT CENBAM); CNPq/FAPEAM (SISBIOTA Rede BIOPHAM); Fundacao de Amparo a Pesquisa do Estado do Amazonas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL #564953/2010-5); FAPEAM/CNPq/PRONEX (Call 003/2009), CNPq/FAPEAM (INCT CENBAM), CNPq/FAPEAM (SISBIOTA Rede BIOPHAM #563348/2010-0). Fundacao de Amparo a Pesquisa do Estado do Amazonas and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided PhD fellowship to DCB. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provided fellowship to CO and JZ. DNA sequencing core facility was provided by Instituto Nacional de Pesquisas da Amazonia (INPA) and Universidade Estadual de Sao Paulo (UNESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Allen Gerald R., 2013, Journal of the Ocean Science Foundation, V6, P33; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Benine RC, 2009, NEOTROP ICHTHYOL, V7, P161, DOI 10.1590/S1679-62252009000200005; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Borsa P, 2013, CR BIOL, V336, P82, DOI 10.1016/j.crvi.2013.01.004; Carvalho LN, 2007, TROPICAL BIOL CONSER, P1, DOI [10.1007/s12033-007-0062-9, DOI 10.1007/S12033-007-0062-9]; Clare EL, 2011, PLOS ONE; de Carvalho DC, 2011, MITOCHONDR DNA, V22, P80, DOI 10.3109/19401736.2011.588214; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Froese R., 2021, FISHBASE WORLD WIDE; Galimberti A, 2012, MOL ECOL RESOUR, V12, P403, DOI 10.1111/j.1755-0998.2011.03110.x; Gery J, 1877, CHARACOIDS WORLD, P672; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson NF, 2011, INVERTEBR SYST, V25, P471, DOI 10.1071/IS11052; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lundberg John G., 1998, P13; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paepke Hans-Joachim, 2001, Verhandlungen der Gesellschaft fuer Ichthyologie (GfI) e V, V2, P143; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Roxo FF, 2012, ZOOTAXA, P1; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrook J., 2001, MOL CLONING LAB MANU; Silva GSC, 2013, J FISH BIOL, V82, P1613, DOI 10.1111/jfb.12094; Sistrom MJ, 2009, J ZOOL, V278, P287, DOI 10.1111/j.1469-7998.2009.00576.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terencio ML, 2012, J FISH BIOL, V81, P110, DOI 10.1111/j.1095-8649.2012.03320.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Victor BC, 2010, ZOOL STUD, V49, P865; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weitzman H, 1982, BIOL DIVERSIFICATION; WEITZMAN S H, 1978, Smithsonian Contributions to Zoology, P1; Weitzman SH, 1975, SMITHSONIAN CONTRIBU, V186, P1; Weitzman SH, 2003, CHECK LIST FRESHWATE; WEITZMAN STANLEY H., 1966, PROC U S NAT MUS, V119, P1; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zarske A, 2013, VERTEBR ZOOL, V63, P125; Zarske A, 2011, VERTEBR ZOOL, V61, P283; Zarske Axel, 2009, Vertebrate Zoology, V59, P11; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	65	117	121	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0112217	10.1371/journal.pone.0112217	http://dx.doi.org/10.1371/journal.pone.0112217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658694	Green Published, gold, Green Submitted			2022-12-27	WOS:000349444900002
